Identifier	label	type	Category	Group	NumTargets
DB13088	AZD-0424	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Protein Kinase Inhibitors	investigational	0
DB13089	Enoxolone	Drug	Triterpenes, Anti-Inflammatory Agents, Dermatologicals, Pentacyclic Triterpenes, Preparations for Treatment of Wounds and Ulcers, Terpenes, Cicatrizants	investigational	0
DB13082	Nefiracetam	Drug	Neuroprotective Agents, Central Nervous System Depressants, Protective Agents, Pyrrolidines, Central Nervous System Agents, Compounds used in a research, industrial, or household setting, Psychotropic Drugs, Nootropic Agents	investigational	0
DB13083	Talarozole	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Sulfur Compounds, Chemically-Induced Disorders, Cytochrome P-450 Enzyme Inhibitors, Thiazoles	investigational	1
DB13080	Roluperidone	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB13086	SCYX-7158	Drug	Benzoates, Acids, Carbocyclic, Amides, Benzene Derivatives	investigational	0
DB13087	Miridesap	Drug	0	investigational	0
DB13084	Pyritinol	Drug	Pyridines, Nervous System, Psychostimulants, Agents Used for Adhd and Nootropics, Psychoanaleptics	investigational	0
DB13085	Riamet	Drug	0	approved, investigational	0
DB13099	Valnoctamide	Drug	Psycholeptics, Nervous System, Central Nervous System Depressants, Hypnotics and Sedatives	investigational	0
DB13090	Zidebactam	Drug	Cycloparaffins, Aza Compounds	investigational	0
DB13093	TAK-593	Drug	Aza Compounds, Receptors, Vascular Endothelial Growth Factor, antagonists & inhibitors, Receptors, Platelet-Derived Growth Factor, antagonists & inhibitors	investigational	0
DB13094	Pruvanserin	Drug	0	investigational	0
DB13091	Tiropramide	Drug	Amino Acids, Aromatic, Autonomic Agents, Amino Acids, Cyclic, Synthetic Antispasmodics, Amides With Tertiary Amines, Alimentary Tract and Metabolism, Amino Acids, Peptides, and Proteins, Parasympatholytics, Drugs for Functional Gastrointestinal Disorders, Amino Acids, Peripheral Nervous System Agents	investigational	0
DB13092	Meclocycline	Drug	Anti-Bacterial Agents, Tetracyclines, Antiinfectives for Treatment of Acne, Dermatologicals, Naphthacenes, Anti-Acne Preparations, Anti-Acne Preparations for Topical Use, Anti-Infective Agents	investigational	1
DB13097	1alpha-Hydroxyvitamin D5	Drug	Cholestanes, Secosteroids, Sterols, Vitamin D and Analogues, Vitamins (Fat Soluble), Lipids, Membrane Lipids, Cholestenes, Fused-Ring Compounds, Vitamins, Steroids	investigational	0
DB13098	CT-2584	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Purines, Phospholipase D, antagonists & inhibitors, Purinones	investigational	0
DB13095	JTK-853	Drug	0	investigational	0
DB13096	Gacyclidine	Drug	Neuroprotective Agents, Neurotransmitter Agents, Cycloparaffins, Protective Agents, Central Nervous System Agents, Excitatory Amino Acid Agents, Compounds used in a research, industrial, or household setting, Excitatory Amino Acid Antagonists, Cyclohexanes	investigational	0
DB03700	D-Threonine	Drug	0	experimental	1
DB03701	Vanoxerine	Drug	Neurotransmitter Agents, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Neurotransmitter Uptake Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Membrane Transport Modulators, Dopamine Agents, Dopamine Uptake Inhibitors	investigational	1
DB03706	1-Hydroxy-2-S-glutathionyl-3-para-nitrophenoxy-propane	Drug	0	experimental	1
DB03707	S-Ethyl-N-Phenyl-Isothiourea	Drug	0	experimental	2
DB03708	Adenosine 5'-phosphosulfate	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides, Adenine Nucleotides	investigational, experimental	2
DB03709	Bicine	Drug	Amino Acids, Peptides, and Proteins, Amino Acids	experimental	3
DB03702	N-{4-[(Carboxymethyl)carbamoyl]benzoyl}-L-valyl-N-[(3S)-1,1,1-trifluoro-4-methyl-2-oxo-3-pentanyl]-L-prolinamide	Drug	0	experimental	1
DB03703	Cyclohexanol	Drug	Cycloparaffins, Hexanols, Lipids, Fatty Alcohols, Alcohols, Cyclohexanes	experimental	1
DB03704	12-Hydroxydodecanoic Acid	Drug	Fatty Acids, Lipids	experimental	1
DB03705	6-Methylamino-5-Nitroisocytosine	Drug	0	experimental	1
DB03710	[(1S)-4-(1-Aminobutylideneamino)-1-carboxybutyl]azanium	Drug	0	experimental	1
DB03711	6-Hydroxy-6-Methyl-Heptan-3-One	Drug	0	experimental	1
DB03712	RU85053	Drug	0	experimental	1
DB03717	3-Hydroxy-4-(3,4,5-trihydroxy-tetrahydro-pyran-2-yloxy)-piperidin-2-one	Drug	0	experimental	1
DB03718	6-aza uridine 5'-monophosphate	Drug	Carbohydrates, Pyrimidines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Uracil Nucleotides, Nucleotides, Pyrimidine Nucleotides	experimental	0
DB03719	N-Ethyl-5'-Carboxamido Adenosine	Drug	0	experimental	1
DB03714	4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid	Drug	0	experimental	1
DB03716	5'-Fluoro-5'-Deoxyadenosine	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purines, Ribonucleosides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Deoxyribonucleosides, Purine Nucleosides	experimental	1
DB14410	Human adenovirus b serotype 7	Drug	0	approved	0
DB14411	Influenza A virus A/Victoria/361/2011 IVR-165 (H3N2) hemagglutinin antigen (propiolactone inactivated)	Drug	0	approved	0
DB14414	Influenza A virus A/California/7/2009 X-179A (H1N1) hemagglutinin antigen (UV, formaldehyde inactivated)	Drug	0	approved	0
DB14415	Influenza A virus A/Switzerland/9715293/2013 NIB-88 (H3N2) hemagglutinin antigen (UV, formaldehyde inactivated)	Drug	0	approved	0
DB14412	Influenza B virus B/Hubei-Wujiagang/158/2009 BX-39 hemagglutinin antigen (propiolactone inactivated)	Drug	0	approved	0
DB14413	Influenza A virus A/Hong Kong/4801/2014 X-263B (H3N2) hemagglutinin antigen (formaldehyde inactivated)	Drug	0	approved	0
DB14418	Influenza B virus B/Brisbane/60/2008 recombinant hemagglutinin antigen	Drug	0	approved	0
DB14419	Influenza A virus A/Christchurch/16/2010 NIB-74XP (H1N1) hemagglutinin antigen (formaldehyde inactivated)	Drug	0	approved	0
DB14416	Influenza B virus B/Phuket/3073/2013 hemagglutinin antigen (UV, formaldehyde inactivated)	Drug	0	approved	0
DB14417	Influenza A virus A/Hong Kong/4801/2014 (H3N2) recombinant hemagglutinin antigen	Drug	0	approved	0
DB01101	Capecitabine	Drug	Ribonucleosides, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (strong), Fluorouracil and prodrugs, Pyrimidine Analogues, Cardiotoxic antineoplastic agents, Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index, Nucleic Acid Synthesis Inhibitors, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Cytochrome P-450 CYP2C9 Inhibitors, Glycosides, Carbohydrates, Pyrimidine Nucleosides, Noxae, Antineoplastic and Immunomodulating Agents, Pyrimidinones, Antineoplastic Agents, Antimetabolites, Myelosuppressive Agents, Fluoropyrimidines, Cytochrome P-450 CYP2C9 Substrates, Deoxycytidine, Nucleoside Metabolic Inhibitor, Nucleosides, Toxic Actions, Deoxyribonucleosides	approved, investigational	3
DB03764	4-Hydroperoxy-2-Methoxy-Phenol	Drug	0	experimental	0
DB02432	RU90395	Drug	0	experimental	1
DB03765	2'-cytidylic acid	Drug	0	experimental	1
DB01100	Pimozide	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Highest Risk QTc-Prolonging Agents, Psycholeptics, QTc Prolonging Agents, Tranquilizing Agents, Benzimidazoles, Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Antipsychotic Agents (First Generation Typical), Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index, Anti-Dyskinesia Agents, Antipsychotic Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Diphenylbutylpiperidine Derivatives, Dopamine Antagonists, Agents that reduce seizure threshold, Dopamine Agents, Neurotoxic agents, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index, Psychotropic Drugs, Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Miscellaneous Antipsychotics, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors, Dopamine D2 Receptor Antagonists	approved	4
DB02431	Cytidine-5'-Triphosphate	Drug	0	experimental	8
DB02430	Trehalose-6-Phosphate	Drug	Carbohydrates, Enzyme Inhibitors, Polysaccharides, Disaccharides, Hexokinase, antagonists & inhibitors, Glucans, Oligosaccharides, Polymers, Biopolymers, Compounds used in a research, industrial, or household setting, Macromolecular Substances	experimental	1
DB03766	Propanoic acid	Drug	Ophthalmologicals, Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Lipids, Sensory Organs, Anti-Infective Agents	approved, vet_approved	3
DB03767	Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide	Drug	0	experimental	1
DB01105	Sibutramine	Drug	Appetite Depressants, Cytochrome P-450 Substrates, Serotonin Agents, Antidepressive Agents, Norepinephrine, Serotonin, and Dopamine Reuptake Inhibitor Anorectic, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Serotonin Modulators, Stimulants, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Alimentary Tract and Metabolism, Norepinephrine Uptake Inhibitors, Appetite Suppression, Dopamine Uptake Inhibitors, Selective Serotonin Reuptake Inhibitors, Centrally Acting Antiobesity Products, Cycloparaffins, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Agents producing tachycardia, Psychotropic Drugs, Cytochrome P-450 CYP3A Substrates, Anti-Obesity Agents, Central Nervous System Depressants, Serotonin and Noradrenaline Reuptake Inhibitors, Antiobesity Preparations, Excl. Diet Products, Central Nervous System Agents	approved, illicit, investigational, withdrawn	3
DB02436	{4-[(2S)-2-({[(1S)-1-Carboxy-2-phenylethyl]carbamoyl}amino)-3-oxo-3-(pentylamino)propyl]phenoxy}malonic acid	Drug	0	experimental	1
DB03760	Dihydrolipoic Acid	Drug	Antioxidants, Coenzymes, Sulfur Compounds, Fatty Acids, Thiophenes, Protective Agents, Enzymes and Coenzymes, Lipids, Compounds used in a research, industrial, or household setting	experimental	4
DB03761	5-fluoro-2'-deoxyuridine-5'-monophosphate	Drug	0	experimental	4
DB01104	Sertraline	Drug	Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Hypoglycemia-Associated Agents, Cytochrome P-450 CYP2C19 Inhibitors, Antidepressive Agents, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Serotonin Modulators, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Cytochrome P-450 CYP2C9 Inhibitors, Drugs causing inadvertant photosensitivity, Monoamine Oxidase A Substrates, Agents that reduce seizure threshold, Selective Serotonin Reuptake Inhibitors, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 CYP2C19 Inhibitors (moderate), Psychotropic Drugs, Membrane Transport Modulators, Naphthalenes, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Central Nervous System Depressants, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Neurotransmitter Uptake Inhibitors, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), P-glycoprotein inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (weak), Psychoanaleptics	approved	5
DB02435	Aminomethylcyclohexane	Drug	0	experimental	2
DB01103	Quinacrine	Drug	Anticestodal Agents, Enzyme Inhibitors, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Acridines, Antimalarials, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Substrates, OCT2 Inhibitors, Antiplatyhelmintic Agents, Aminoacridines, P-glycoprotein inhibitors, Antinematodal Agents, Antiparasitic Agents	investigational	4
DB02434	4-(2-Thienyl)Butyric Acid	Drug	Acids, Acyclic, Sulfur Compounds, Fatty Acids, Fatty Acids, Volatile, Lipids	experimental	1
DB03763	5-methyl-2'-deoxypseudouridine	Drug	0	experimental	1
DB02433	{[(2,2-Dihydroxy-Ethyl)-(2,3,4,5-Tetrahydroxy-6-Phosphonooxy-Hexyl)-Amino]-Methyl}-Phosphonic Acid	Drug	0	experimental	2
DB01102	Arbutamine	Drug	Amines, Protective Agents, Agents producing tachycardia, Catechols, Adrenergic and Dopaminergic Agents, Cardiovascular Agents, Adrenergic beta-2 Receptor Agonists, Cardiotonic Agents, Adrenergic beta-Agonists, Neurotransmitter Agents, Adrenergic Agonists, Cardiac Stimulants Excl. Cardiac Glycosides, Adrenergic beta-1 Receptor Agonists, Agents that produce hypertension, Phenols, Cardiac Therapy, Compounds used in a research, industrial, or household setting, Adrenergic Agents, Adrenergic beta-3 Receptor Agonists, Benzene Derivatives	approved	3
DB01109	Heparin	Drug	Anticoagulants, Carbohydrates, Miscellaneous Therapeutic Agents, Blood and Blood Forming Organs, Glycosaminoglycans, Fibrin Modulating Agents, Heparin Group, Agents causing hyperkalemia, Hematologic Agents, Cardiovascular Agents, Heparins or Heparinoids for Topical Use, Thyroxine-binding globulin substrates, Ophthalmologicals, Vasoprotectives, Polysaccharides, Narrow Therapeutic Index Drugs, Antivaricose Therapy, Heparin and similars, Sensory Organs	approved, investigational	12
DB01108	Trilostane	Drug	Enzyme Inhibitors, Cytochrome P-450 Substrates, Immunosuppressive Agents, Adrenal Cortex Hormones, Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Abortifacient Agents, Steroidal, Anticorticosteroids, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Gonadal Hormones, Androstanols, Corticosteroids for Systemic Use, Corticosteroids, Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Reproductive Control Agents, Antineoplastic Agents, 3-Hydroxysteroid Dehydrogenases, antagonists & inhibitors, Oxidative Phosphorylation Coupling Factors, Gonadal Steroid Hormones, Androstanes, Narrow Therapeutic Index Drugs, Abortifacient Agents, Cytochrome P-450 CYP3A Substrates, Testosterone Congeners, Antiadrenal Preparations, Steroids	approved, investigational, withdrawn, vet_approved	4
DB02438	3-O-Methylfructose in Linear Form	Drug	0	experimental	1
DB01107	Methyprylon	Drug	Psycholeptics, Nervous System, Piperidinedione Derivatives, Central Nervous System Depressants, Piperidines, Hypnotics and Sedatives	approved, illicit, withdrawn	2
DB02437	(5r)-5-Amino-6-Hydroxyhexylcarbamic Acid	Drug	0	experimental	3
DB01106	Levocabastine	Drug	QTc Prolonging Agents, Anti-Allergic Agents, Decongestants and Antiallergics, Ophthalmologicals, Neurotransmitter Agents, Histamine H1 Antagonists, Histamine H1 Antagonists, Non-Sedating, Nasal Preparations, Histamine Antagonists, Central Nervous System Depressants, Antiallergic Agents, Excl. Corticosteroids, Potential QTc-Prolonging Agents, Sensory Organs, Histamine Agents	approved, investigational	2
DB03768	N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3	Drug	0	experimental	1
DB03769	D-Eritadenine	Drug	Heterocyclic Compounds, Fused-Ring, Purines, Enzyme Inhibitors	experimental	1
DB14421	Influenza B virus B/Utah/9/2014 hemagglutinin antigen (MDCK cell derived, propiolactone inactivated)	Drug	0	approved	0
DB14422	Influenza A virus A/Michigan/45/2015 X-275 (H1N1) hemagglutinin antigen (formaldehyde inactivated)	Drug	0	approved	0
DB14420	Influenza A virus A/South Australia/55/2014 (H3N2) hemagglutinin antigen (MDCK cell derived, propiolactone inactivated)	Drug	0	approved	0
DB14425	Influenza A virus A/Slovenia/2903/2015 (H1N1) live (attenuated) antigen	Drug	0	approved	0
DB14426	Influenza A virus A/New caledonia/71/2014 (H3N2) live (attenuated) antigen	Drug	0	approved	0
DB14423	Influenza A virus A/Michigan/45/2015 (H1N1) recombinant hemagglutinin antigen	Drug	0	approved	0
DB14424	Influenza A virus A/Hong Kong/4801/2014 X-263B (H3N2) hemagglutinin antigen (propiolactone inactivated)	Drug	0	approved	0
DB14429	Neisseria meningitidis group w-135 capsular oligosaccharide diphtheria crm197 protein conjugate antigen	Drug	Actively Acquired Immunity, Inactivated Meningococcal Vaccine	approved	0
DB14427	Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen	Drug	Actively Acquired Immunity, Inactivated Meningococcal Vaccine	approved	0
DB03770	N-hydroxyguanidine	Drug	Antineoplastic Agents, Amidines, Antiviral Agents, Anti-Infective Agents	experimental	0
DB14428	Neisseria meningitidis group c capsular oligosaccharide diphtheria crm197 protein conjugate antigen	Drug	Actively Acquired Immunity, Inactivated Meningococcal Vaccine	approved	0
DB03775	Dethiobiotin	Drug	Immunologic Factors, Coenzymes, Imidazoles, Immunosuppressive Agents, Enzymes and Coenzymes, Mitosis Modulators, Mitogens	experimental	3
DB01112	Cefuroxime	Drug	Nephrotoxic agents, Second-Generation Cephalosporins, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, Ophthalmologicals, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Sensory Organs, Antibacterials for Systemic Use	approved	1
DB02443	Methicillin Acyl-Serine	Drug	0	experimental	1
DB02442	Dioxyselenocysteine	Drug	Selenium Compounds	experimental	1
DB03776	Lactaldehyde	Drug	0	experimental	0
DB01111	Colistimethate	Drug	Nephrotoxic agents, Peptides, Antimicrobial Cationic Peptides, Amino Acids, Peptides, and Proteins, Lipids, Agents that produce neuromuscular block (indirect), Membrane Proteins, Peptides, Cyclic, Proteins, Polymyxin-class Antibacterial, Pore Forming Cytotoxic Proteins, Lipopeptides, Polymyxins	approved, vet_approved	1
DB02441	2-Butyl-5,6-Dihydro-1h-Imidazo[4,5-D]Pyridazine-4,7-Dione	Drug	0	experimental	1
DB01110	Miconazole	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (strong), Cytochrome P-450 CYP3A4 Inhibitors (moderate), Genito Urinary System and Sex Hormones, Otologicals, Antifungals for Dermatological Use, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2A6 Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (moderate), Cytochrome P-450 CYP2B6 Inhibitors, Anti-Infective Agents, Cytochrome P-450 CYP2A6 Inhibitors (strong), Cytochrome P-450 CYP2E1 Inhibitors (strong), Antiinfectives and Antiseptics for Local Oral Treatment, Intestinal Antiinfectives, Antifungals for Topical Use, Cytochrome P-450 CYP2C9 Inhibitors, Antifungal Agents, Vaginal Creams, Foams, and Jellies, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Hormone Antagonists, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Steroid Synthesis Inhibitors, Chemically-Induced Disorders, Cytochrome P-450 CYP2E1 Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP2C8 Inhibitors, Gynecological Antiinfectives and Antiseptics, Dermatologicals, Cytochrome P-450 CYP2C19 Inhibitors (strong), Azole Antifungals, Cytochrome P-450 CYP3A Inhibitors, Imidazoles, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Antifungal Agents (Vaginal), Imidazole and Triazole Derivatives, Imidazole Derivatives, Sensory Organs, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), P-glycoprotein inhibitors, 14-alpha Demethylase Inhibitors, Stomatological Preparations	approved, investigational, vet_approved	8
DB03777	Bisindolylmaleimide I	Drug	Acids, Acyclic, Heterocyclic Compounds, Fused-Ring, Maleates, Enzyme Inhibitors, Anti-Inflammatory Agents, Dicarboxylic Acids, Imides, Protein Kinase C, antagonists & inhibitors	experimental	3
DB03771	Allyl-{4-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-but-2-Enyl}-Methyl-Amine	Drug	0	experimental	1
DB01116	Trimethaphan	Drug	Autonomic Agents, Ganglion Blockers, Cardiovascular Agents, Nicotinic Antagonists, Antiadrenergic Agents, Ganglion-Blocking, Peripheral Nervous System Agents, Anticholinergic Agents, Neurotransmitter Agents, Cholinergic Agents, Imidazoles, Sulfonium Derivatives, Cholinesterase substrates, Adjuvants, Anesthesia, Antihypertensive Agents, Central Nervous System Agents, Vasodilating Agents	approved, investigational	1
DB02447	3,8,9,10-tetrahydroxy-7-hydroxymethyl-6-oxa-1,3-diaza-spiro[4.5]decane-2,4-dione	Drug	0	experimental	1
DB03772	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,5-Diol	Drug	0	experimental	1
DB02446	Glutamine hydroxamate	Drug	Amines, Hydroxy Acids, Amino Acids, Dicarboxylic, Hydroxylamines, Amino Acids, Peptides, and Proteins, Amino Acids, Acidic, Aspartate Aminotransferases, antagonists & inhibitors, Amino Acids	experimental	1
DB01115	Nifedipine	Drug	Calcium Channel Blockers (Dihydropyridine), Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Adrenal Cortex Hormones, Agents causing hyperkalemia, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP2B6 Inducers (strength unknown), BSEP/ABCB11 Substrates, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Tocolytic Agents, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Calcium-Regulating Hormones and Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Antiarrhythmic agents, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Selective Calcium Channel Blockers With Mainly Vascular Effects, Antihypertensive Agents Indicated for Hypertension, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Inducers, Reproductive Control Agents, Membrane Transport Modulators, Calcium Channel Blockers, Beta blocking agents and calcium channel blockers, Cytochrome P-450 CYP2A6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2D6 Inhibitors, Dihydropyridine Derivatives, QTc Prolonging Agents, BSEP/ABCB11 Inhibitors, Calcium Channel Blockers and Diuretics, Hypotensive Agents, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2B6 Inducers, Antihypertensive Agents, Bradycardia-Causing Agents, Pyridines, Cytochrome P-450 CYP2E1 Inhibitors, P-glycoprotein substrates, Moderate Risk QTc-Prolonging Agents, P-glycoprotein inducers, Dihydropyridines, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2C9 Inducers, P-glycoprotein inhibitors, Vasodilating Agents	approved	8
DB01114	Chlorpheniramine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Cytochrome P-450 Substrates, Serotonin Agents, Substituted Alkylamines, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, OCT1 inhibitors, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Serotonin Modulators, Histamine H1 Antagonists, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Propylamine Derivatives, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Antihistamines for Systemic Use, Antipruritics, Pyridines, Anti-Allergic Agents, Cytochrome P-450 CYP3A5 Substrates, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Dermatologicals, Moderate Risk QTc-Prolonging Agents, Neurotransmitter Agents, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, OCT2 Inhibitors, Cytochrome P-450 CYP2D6 Substrates, Histamine Agents	approved	4
DB03773	alpha-D-quinovopyranose	Drug	Carbohydrates, Deoxy Sugars	experimental	5
DB02445	2-Deoxy-2-Amino Glucitol-6-Phosphate	Drug	0	experimental	3
DB03774	Glutamyl Group	Drug	0	experimental	0
DB01113	Papaverine	Drug	Phosphodiesterase Inhibitors, QTc Prolonging Agents, Enzyme Inhibitors, Miscellaneous Vasodilatating Agents, Benzylisoquinolines, Isoquinolines, Genito Urinary System and Sex Hormones, Urologicals, Papaverine and Derivatives, Cardiovascular Agents, Hypotensive Agents, Moderate Risk QTc-Prolonging Agents, Urological Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Opiate Alkaloids, Drugs Used in Erectile Dysfunction, Alimentary Tract and Metabolism, Drugs for Functional Gastrointestinal Disorders, Vasodilating Agents	approved, investigational	2
DB01119	Diazoxide	Drug	Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Amides, Cardiovascular Agents, Hypotensive Agents, Direct Vasodilators, Heterocyclic Compounds, Fused-Ring, Drugs for Treatment of Hypoglycemia, Sulfur Compounds, Benzothiadiazines, Sulfonamides, Arteriolar Smooth Muscle, Agents Acting On, Diuretics, Antihypertensive Agents, Vasodilating Agents, Hyperglycemia-Associated Agents, Sulfones, Thiazide Derivatives	approved	5
DB02449	3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid	Drug	0	experimental	1
DB01118	Amiodarone	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Agents causing hyperkalemia, BSEP/ABCB11 Substrates, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors (moderate), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index, Potassium Channel Blockers, Cytochrome P-450 CYP2C8 Substrates, Antiarrhythmic agents, Antiarrhythmics, Class III, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index, Membrane Transport Modulators, Cytochrome P-450 CYP2A6 Inhibitors (moderate), Cytochrome P-450 CYP2C19 Substrates, Calcium Channel Blockers, Narrow Therapeutic Index Drugs, Photosensitizing Agents, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP2C19 Inhibitors (weak), Cytochrome P-450 CYP2D6 Substrates, Sodium Channel Blockers, Cytochrome P-450 CYP2D6 Inhibitors (weak), Cytochrome P-450 CYP2D6 Inhibitors, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, BSEP/ABCB11 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2A6 Inhibitors, Hypotensive Agents, Benzofurans, Cytochrome P-450 CYP1A2 Inhibitors, BSEP/ABCB11 Substrates with Narrow Therapeutic Index, Cytochrome P-450 CYP2C9 Inhibitors, Drugs causing inadvertant photosensitivity, Bradycardia-Causing Agents, P-glycoprotein inducers, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, alpha-Galactosidase, antagonists & inhibitors, OCT2 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors, Vasodilating Agents, Cardiac Therapy	approved, investigational	8
DB01117	Atovaquone	Drug	Miscellaneous Antiprotozoals, Enzyme Inhibitors, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Antibiotics for Pneumocystis Pneumonia, Antimalarials, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Naphthalenes, Quinones, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors, Naphthoquinones, P-glycoprotein inhibitors, Antiparasitic Agents	approved	3
DB02448	N-Tridecanoic Acid	Drug	0	experimental	3
DB03779	Glucosaminyl-(Alpha-6)-D-Myo-Inositol	Drug	0	experimental	1
DB13101	4SC-202	Drug	Benzoates, Acids, Carbocyclic, Amides, Benzene Derivatives	investigational	0
DB14432	Influenza A virus A/Singapore/gp1908/2015 IVR-180 (H1N1) hemagglutinin antigen (formaldehyde inactivated)	Drug	0	approved	0
DB13102	AZD-8418	Drug	0	investigational	0
DB14433	Influenza A virus A/Singapore/gp1908/2015 IVR-180 (H1N1) hemagglutinin antigen (MDCK cell derived, propiolactone inactivated)	Drug	0	approved	0
DB14430	Neisseria meningitidis group y capsular oligosaccharide diphtheria crm197 protein conjugate antigen	Drug	Actively Acquired Immunity, Inactivated Meningococcal Vaccine	approved	0
DB13100	Biguanide	Drug	0	approved, investigational	0
DB14431	Influenza A virus A/Singapore/gp1908/2015 IVR-180 (H1N1) hemagglutinin antigen (propiolactone inactivated)	Drug	0	approved	0
DB14436	Influenza A virus A/Hong Kong/4801/2014 (H3N2) hemagglutinin antigen (MDCK cell derived, propiolactone inactivated)	Drug	0	approved	0
DB13105	Resolvin E1	Drug	Biological Factors, Autacoids, Inflammation Mediators, Fatty Acids, Oils, Eicosanoids, Lipids, Dietary Fats, Unsaturated, Fatty Acids, Unsaturated, Physiological Phenomena, Dietary Fats, Food and Beverages, Fish Oils, Fats, Fatty Acids, Omega-3, Diet, Food, and Nutrition, Food	investigational	0
DB14437	Influenza A virus A/Singapore/gp1908/2015 IVR-180 (H1N1) hemagglutinin antigen (UV, formaldehyde inactivated)	Drug	0	approved	0
DB13106	Glycovir	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Lipids	investigational	0
DB14434	Influenza A virus A/Singapore/gp2050/2015 (H3N2) hemagglutinin antigen (MDCK cell derived, propiolactone inactivated)	Drug	0	approved	0
DB13103	GPX-150	Drug	Carbohydrates, Anthracyclines, Naphthacenes, Glycosides	investigational	0
DB14435	Influenza B virus B/Hong Kong/259/2010 hemagglutinin antigen (MDCK cell derived, propiolactone inactivated)	Drug	0	approved	0
DB13104	X-396	Drug	Enzyme Inhibitors, Protein Kinase Inhibitors, Antineoplastic Agents	investigational	0
DB13109	PKI-179	Drug	Oxazines	investigational	0
DB14438	Influenza A virus A/Hong Kong/4801/2014 X-263B (H3N2) hemagglutinin antigen (UV, formaldehyde inactivated)	Drug	0	approved	0
DB13107	QGC-001	Drug	Gases, Sulfides, Anions, Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfur Acids, Hydrogen Sulfide, Electrolytes, Ions, Glutamyl Aminopeptidase, antagonists & inhibitors	investigational	0
DB03780	2-Aminoquinazolin-4(3h)-One	Drug	0	experimental	1
DB14439	Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (UV, formaldehyde inactivated)	Drug	0	approved	0
DB03781	2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid	Drug	0	experimental	1
DB13108	Mephedrone	Drug	Street Drugs, Amines, Ethylamines, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Sympathomimetics, Agents that produce hypertension, Amphetamines, Agents producing tachycardia, Designer Drugs, Phenethylamines	investigational	0
DB02450	2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid	Drug	0	experimental	2
DB01123	Proflavine	Drug	Heterocyclic Compounds, Fused-Ring, Acridines, Aminoacridines, Anti-Infective Agents, Anti-Infective Agents, Local	approved	4
DB02454	5-(6-Amino-9h-Purin-9-Yl)-4-Hydroxytetrahydrofuran-3-Yl Dihydrogen Phosphate	Drug	0	experimental	0
DB01122	Ambenonium	Drug	Autonomic Agents, Enzyme Inhibitors, Amines, Ammonium Compounds, Cholinesterase Inhibitors, Nervous System, Quaternary Ammonium Compounds, Parasympathomimetics, Onium Compounds, Peripheral Nervous System Agents, Neurotransmitter Agents, Benzylammonium Compounds, Cholinergic Agents, Nitrogen Compounds	approved	1
DB03787	(5-Hydroxy-6-methyl-4-{[(E)-(3-oxo-1,2-oxazolidin-4-ylidene)amino]methyl}-3-pyridinyl)methyl dihydrogen phosphate	Drug	0	experimental	1
DB02453	Antimonous acid	Drug	0	experimental	1
DB01121	Phenacemide	Drug	Acids, Acyclic, Anticonvulsants, Fatty Acids, Nervous System, Central Nervous System Depressants, Fatty Acids, Volatile, Amides, Lipids, Acetamides, Acetates, Benzene Derivatives	approved	1
DB03788	GC-24	Drug	0	experimental	1
DB02452	Thymidine 5'-triphosphate	Drug	Carbohydrates, Pyrimidines, Deoxyribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides, Pyrimidine Nucleotides	experimental	10
DB03789	2,3-Dimethylimidazolium Ion	Drug	0	experimental	0
DB02451	B-nonylglucoside	Drug	0	experimental	14
DB01120	Gliclazide	Drug	Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Sulfur Compounds, Cytochrome P-450 Substrates, Alimentary Tract and Metabolism, Hypoglycemia-Associated Agents, Sulfonylureas, Drugs Used in Diabetes, Blood Glucose Lowering Agents, Sulfones	approved	2
DB01127	Econazole	Drug	Enzyme Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Genito Urinary System and Sex Hormones, Antifungals for Dermatological Use, Anti-Infective Agents, Cytochrome P-450 CYP3A4 Inhibitors (strong), Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Antifungals for Topical Use, Antifungal Agents, Hormone Antagonists, Steroid Synthesis Inhibitors, Chemically-Induced Disorders, Cytochrome P-450 CYP2E1 Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Gynecological Antiinfectives and Antiseptics, Dermatologicals, Azole Antifungals, Cytochrome P-450 CYP3A Inhibitors, Imidazoles, Cytochrome P-450 CYP3A4 Inhibitors, Antifungal Agents (Vaginal), Imidazole and Triazole Derivatives, Imidazole Derivatives, P-glycoprotein inhibitors, 14-alpha Demethylase Inhibitors	approved	2
DB03782	N-(1-adamantyl)-N'-(4-guanidinobenzyl)urea	Drug	0	experimental	1
DB02458	S-(2,4-dinitrophenyl)glutathione	Drug	Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins, Haptens	experimental	2
DB02457	Undecyl-Phosphinic Acid Butyl Ester	Drug	0	experimental	1
DB01126	Dutasteride	Drug	Enzyme Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Steroid Synthesis Inhibitors, Adrenergic alpha-Antagonists, Hormones, Hormone Substitutes, and Hormone Antagonists, Genito Urinary System and Sex Hormones, Urologicals, 5-alpha Reductase Inhibitors, Fused-Ring Compounds, Azasteroids, Cytochrome P-450 CYP3A Substrates, Adrenergic Antagonists, Agents that produce hypertension, Hormone Antagonists, Drugs Used in Benign Prostatic Hypertrophy, Steroids	approved, investigational	2
DB03783	Phenacetin	Drug	Analgesics, Non-Narcotic, Cytochrome P-450 CYP2E1 Substrates, Amines, Cytochrome P-450 Substrates, Sensory System Agents, Nervous System, Aniline Compounds, Amides, Cytochrome P-450 CYP3A4 Substrates, OAT1/SLC22A6 inhibitors, Peripheral Nervous System Agents, Anilides, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Analgesics, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2A6 Substrates, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Acetanilides	withdrawn	1
DB01125	Anisindione	Drug	Indans, Indenes	approved	1
DB02456	Aracytidine 5'-monophosphate	Drug	0	experimental	1
DB03784	Elaidamide	Drug	0	experimental	1
DB01124	Tolbutamide	Drug	Cytochrome P-450 CYP2C18 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Hypoglycemia-Associated Agents, Blood Glucose Lowering Agents, Drugs that are Mainly Renally Excreted, OAT1/SLC22A6 inhibitors, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Sulfur Compounds, Alimentary Tract and Metabolism, Sulfonylureas, Drugs Used in Diabetes, Diagnostic Agents, Cytochrome P-450 CYP2C8 Substrates, Tests for Diabetes, Sulfones, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)	approved, investigational	2
DB02455	Fluoresceinylthioureido	Drug	0	experimental	0
DB03785	Mevinolinic acid	Drug	Naphthalenes	experimental	1
DB01129	Rabeprazole	Drug	Acids, Acyclic, Benzimidazoles, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Anti-Ulcer Agents, Cytochrome P-450 CYP3A4 Substrates, Acetates, Drugs that are Mainly Renally Excreted, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Antiinflammatory and Antirheumatic Products, Non-Steroids, Alimentary Tract and Metabolism, Acid Reducers, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Drugs for Acid Related Disorders, Proton Pump Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP2C19 Substrates, Gastric Acid Lowering Agents, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inducers, 2-Pyridinylmethylsulfinylbenzimidazoles, Cytochrome P-450 CYP2D6 Inhibitors (weak), Cytochrome P-450 CYP2D6 Inhibitors, Enzyme Inhibitors, Proton-pump Inhibitors, Fatty Acids, Cytochrome P-450 CYP2C19 Inhibitors, Lipids, Butylpyrazolidines, Pyrazolones, Cytochrome P-450 Enzyme Inducers, Sulfur Compounds, Fatty Acids, Volatile, Musculo-Skeletal System, Cytochrome P-450 CYP2C9 Inhibitors, Gastrointestinal Agents, Pyridines, Hydroxy Acids, Pyrazoles, BCRP/ABCG2 Inhibitors, Sulfoxides, Antiinflammatory Preparations, Non-Steroids for Topical Use, Topical Products for Joint and Muscular Pain, Heterocyclic Compounds, Fused-Ring, Antiinflammatory and Antirheumatic Products, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors	approved, investigational	1
DB02459	4-guanidinobenzoic acid	Drug	Acids, Carbocyclic, Amidines, Benzene Derivatives	experimental	1
DB01128	Bicalutamide	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Endocrine Therapy, Androgen Receptor Antagonists, Amines, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Aniline Compounds, Amides, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Hormone Antagonists and Related Agents, Cytochrome P-450 CYP3A4 Substrates, Hormones and Related Agents, Sulfur Compounds, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Hormone Antagonists, Benzene Derivatives, Sulfones, Hormones, Hormone Substitutes, and Hormone Antagonists, Antineoplastic and Immunomodulating Agents, Androgen Receptor Inhibitor, Antineoplastic Agents, Cytochrome P-450 CYP3A Inhibitors, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Antiandrogens, P-glycoprotein inhibitors, Antiandrogens, non-steroidal, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved	1
DB13112	Dolcanatide	Drug	Enzyme Activators, Guanylyl Cyclase C Agonists, Amino Acids, Peptides, and Proteins, Gastrointestinal Agents	investigational	0
DB14443	Vibrio cholerae CVD 103-HgR strain live antigen	Drug	Live vaccines, Vaccines, Live Attenuated Cholera Vaccine	approved, investigational	0
DB14444	Influenza A virus A/California/7/2009 (H1N1)-like antigen (propiolactone inactivated)	Drug	0	approved	0
DB13113	JNJ-38877605	Drug	0	investigational	0
DB14441	Influenza B virus B/Brisbane/46/2015 hemagglutinin antigen (propiolactone inactivated)	Drug	0	approved	0
DB13110	Antimony	Drug	Metalloids, Metals, Metals, Heavy, Elements	investigational	0
DB13111	Chromanol	Drug	Antioxidants, Heterocyclic Compounds, Fused-Ring, Protective Agents, Benzopyrans, Compounds used in a research, industrial, or household setting, Pyrans	investigational	0
DB14442	Influenza B virus B/Phuket/3073/2013 BVR-1B hemagglutinin antigen (propiolactone inactivated)	Drug	0	approved	0
DB14447	Influenza A virus A/Uruguay/716/2007(H3N2) live (attenuated) antigen	Drug	0	approved	0
DB13116	Norflurane	Drug	Complex Mixtures, Investigative Techniques, Aerosol Propellants, Colloids, Aerosols, Hydrocarbons, Halogenated, Pharmaceutical Preparations, Central Nervous System Agents, Anesthetics	approved, experimental	0
DB13117	Pentafluoropropane	Drug	Hydrocarbons, Halogenated	approved, investigational	0
DB14445	Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated)	Drug	Actively Acquired Immunity, Influenza Vaccines, Vaccines, Inactivated Influenza A Virus Vaccine	approved	0
DB13114	Amitriptylinoxide	Drug	Narrow Therapeutic Index Drugs, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Antidepressive Agents, Tricyclic, Agents that produce hypertension, Antidepressive Agents, Benzocycloheptenes, Dibenzocycloheptenes, Agents that reduce seizure threshold, Neurotoxic agents	approved, investigational	0
DB13115	Saroglitazar	Drug	Acids, Carbocyclic	investigational	0
DB14446	Influenza A virus A/South Dakota/6/2007 (H1N1) live (attenuated) antigen	Drug	0	approved	0
DB03790	L-methionine sulfone	Drug	Amino Acids, Neutral, Sulfur Compounds, Amino Acids, Essential, Amino Acids, Sulfur, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	1
DB13118	Paquinimod	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB14449	Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen	Drug	Live Attenuated Influenza A Virus Vaccine, Actively Acquired Immunity, Influenza Vaccines, Vaccines	approved	0
DB03791	GW-3965	Drug	Amines, Benzyl Compounds, Acids, Carbocyclic, Ligands, Benzene Derivatives	experimental	1
DB13119	GSK-364735	Drug	Heterocyclic Compounds, Fused-Ring	investigational	1
DB03792	5-Aminouracil	Drug	Pyrimidines, Pyrimidinones	experimental	1
DB02461	S-Methyl Phosphocysteine	Drug	0	experimental	1
DB01130	Prednicarbate	Drug	Corticosteroids, Dermatological Preparations, Pregnadienetriols, Corticosteroids, Cytochrome P-450 Substrates, Immunosuppressive Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Dermatologicals, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Corticosteroids, Potent (Group III), Cytochrome P-450 CYP3A Substrates, Pregnanes, Corticosteroid Hormone Receptor Agonists, Steroids	approved, investigational	1
DB02460	Hydrogenobyrinic acid	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Pigments, Biological, Porphyrins	experimental	1
DB01134	Desoxycorticosterone pivalate	Drug	Hydroxycorticosteroids, Cytochrome P-450 Substrates, Pregnenediones, Cytochrome P-450 CYP3A Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Adrenal Cortex Hormones, Pregnanes, Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Pregnenes, Steroids	experimental, vet_approved	1
DB03797	3-Aminomethyl-Pyridinium-Adenine-Dinucleotide	Drug	0	experimental	0
DB02465	Methoxy arachidonyl fluorophosphonate	Drug	Fatty Acids, Essential, Biological Factors, Phospholipases A, antagonists & inhibitors, Autacoids, Enzyme Inhibitors, Fatty Acids, Unsaturated, Inflammation Mediators, Fatty Acids, Eicosanoids, Organophosphorus Compounds, Lipids	experimental	1
DB01133	Tiludronic acid	Drug	Organophosphonates, Phospholipases A, antagonists & inhibitors, Musculo-Skeletal System, Drugs for Treatment of Bone Diseases, Bone Density Conservation Agents, Organophosphorus Compounds, Drugs Affecting Bone Structure and Mineralization, Bisphosphonates, Drugs that are Mainly Renally Excreted	approved, investigational, vet_approved	6
DB02464	Benzylamine	Drug	Amines, Benzyl Compounds, Benzene Derivatives	experimental	2
DB03798	2'-Deoxycytidine-5'-Monophosphate	Drug	0	experimental	2
DB03799	Trifluoromethionine	Drug	Amino Acids, Neutral, Sulfur Compounds, Amino Acids, Essential, Amino Acids, Sulfur, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	2
DB01132	Pioglitazone	Drug	OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Hypoglycemia-Associated Agents, OATP1B3 inhibitors, Peroxisome Proliferator Receptor gamma Agonist, Peroxisome Proliferator-activated Receptor Activity, Blood Glucose Lowering Agents, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 Enzyme Inducers, Sulfur Compounds, Cytochrome P-450 CYP3A Substrates, Alimentary Tract and Metabolism, Thiazoles, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Drugs Used in Diabetes, Cytochrome P-450 CYP2C8 Substrates, Thiazolidinediones	approved, investigational	2
DB02463	2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine	Drug	0	experimental	1
DB01131	Proguanil	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Noxae, Folic Acid Antagonists, Antimalarials, Amidines, Guanidines, Antimetabolites, Anti-Infective Agents, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Biguanides, Cytochrome P-450 CYP3A Substrates, Toxic Actions, Antiparasitic Agents, Cytochrome P-450 CYP2D6 Inhibitors (weak)	approved	2
DB02462	Thiocoumarin	Drug	0	experimental	1
DB02469	4,6-dideoxy-4-amino-beta-D-glucopyranoside	Drug	0	experimental	1
DB01138	Sulfinpyrazone	Drug	Renal Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Pyrazoles, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Preparations Increasing Uric Acid Excretion, Cytochrome P-450 CYP2B6 Inducers (strength unknown), BSEP/ABCB11 Substrates, Cytochrome P-450 CYP2C9 Inhibitors (moderate), Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Pyrazolones, Antigout Preparations, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A Substrates, Musculo-Skeletal System, Uricosuric Agents, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2B6 Inducers, Antiplatelet agents, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)	approved	4
DB03793	Benzoic acid	Drug	Food Additives, Nitrogen Binding Agent, Benzoates, Various Alimentary Tract and Metabolism Products, Acids, Carbocyclic, Tests for Gastric Secretion, Ammonium Ion Binding Activity, Anti-Infective Agents, Physiological Phenomena, Urea Cycle Disorder Agents, Alimentary Tract and Metabolism, Food and Beverages, Food Ingredients, Antifungal Agents, Diagnostic Agents, Food Preservatives, OAT3/SLC22A8 Inhibitors, Compounds used in a research, industrial, or household setting, Benzene Derivatives, Diet, Food, and Nutrition, Food	approved, investigational	9
DB03794	Trifluoroalanine	Drug	0	experimental	0
DB01137	Levofloxacin	Drug	Fluoroquinolones, Quinolines, QTc Prolonging Agents, Enzyme Inhibitors, Renal Agents, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, MATE 1 Substrates, OCT1 inhibitors, MATE inhibitors, MATE 1 Inhibitors, OAT1/SLC22A6 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Quinolones, Cytochrome P-450 CYP1A2 Inhibitors, Anti-Bacterial Agents, Alimentary Tract and Metabolism, Cytochrome P-450 CYP2C9 Inhibitors, Topoisomerase II Inhibitors, Drugs causing inadvertant photosensitivity, MATE substrates, Quinolone Antimicrobial, Anti-Infective Agents, Urinary, P-glycoprotein substrates, Antiinfectives for Systemic Use, Moderate Risk QTc-Prolonging Agents, Ophthalmologicals, Heterocyclic Compounds, Fused-Ring, Photosensitizing Agents, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), OCT2 Inhibitors, MATE 2 Inhibitors, Sensory Organs, P-glycoprotein inhibitors, Antibacterials for Systemic Use	approved, investigational	2
DB02468	12-Phenylheme	Drug	0	experimental	1
DB01136	Carvedilol	Drug	Amines, Cytochrome P-450 Substrates, Adrenergic beta2-Antagonists, Agents causing hyperkalemia, Adrenergic beta-Antagonists, Cardiovascular Agents, Hypotensive Agents, Cytochrome P-450 CYP3A4 Substrates, Adrenergic beta-1 Receptor Antagonists, Alcohols, Antioxidants, UGT2B7 substrates, Adrenergic Antagonists, Calcium-Regulating Hormones and Agents, Adrenergic alpha-1 Receptor Antagonists, Antihypertensive Agents, Indoles, Compounds used in a research, industrial, or household setting, Adrenergic Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Antihypertensive Agents Indicated for Hypertension, Cytochrome P-450 CYP2E1 Substrates, Propanols, Adrenergic alpha-Antagonists, Protective Agents, Amino Alcohols, Membrane Transport Modulators, Calcium Channel Blockers, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Carbazoles, Cytochrome P-450 CYP3A Substrates, Alpha and Beta Blocking Agents, UGT1A1 Substrates, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors, Vasodilating Agents, Propanolamines	approved, investigational	19
DB02467	L-methionine (S)-S-oxide	Drug	0	experimental	6
DB03795	2-Dehydropantoate	Drug	0	experimental	1
DB03796	Palmitic Acid	Drug	Enzyme Inhibitors, Fatty Acids, Palmitic Acids, Lipids	approved	11
DB01135	Doxacurium	Drug	Neuromuscular Agents, Neuromuscular-Blocking Agents (Nondepolarizing), Muscarinic Antagonists, Muscle Relaxants, Nicotinic Antagonists, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Anticholinergic Agents, Heterocyclic Compounds, Fused-Ring, Muscle Relaxants, Peripherally Acting Agents, Central Nervous System Depressants, Musculo-Skeletal System, Neuromuscular Blocking Agents, Cholinesterase substrates	approved	2
DB02466	BMS-181156	Drug	0	experimental	1
DB01139	Cefapirin	Drug	Nephrotoxic agents, Cephacetrile, Amides, Lactams, Thiazines, beta-Lactams, First-Generation Cephalosporins, Antiinfectives for Systemic Use, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Antibacterials for Systemic Use	approved, vet_approved	1
DB14440	Influenza A virus A/Singapore/GP1908/2015 IVR-180A (H1N1) hemagglutinin antigen (propiolactone inactivated)	Drug	0	approved	0
DB03720	alpha,beta-Dehydroaminobutyric acid	Drug	0	experimental	0
DB03721	N-acetyl-alpha-neuraminic acid	Drug	0	experimental	18
DB03722	3,4-Dihydro-5-Methyl-Isoquinolinone	Drug	0	experimental	1
DB03723	2'-Deoxy-Thymidine-Beta-L-Rhamnose	Drug	0	experimental	2
DB03728	p-Chlorobenzoic acid	Drug	Benzoates, Acids, Carbocyclic, Benzene Derivatives	experimental	1
DB03729	2-Amino-1H-benzimidazol-5-ol	Drug	0	experimental	1
DB03724	(1s,2s)-1-Amino-1-(1,3-Thiazol-2-Yl)Propan-2-Ol	Drug	0	experimental	0
DB03725	5'-Guanylylmethylenebisphosphonate	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Guanine Nucleotides, Antiviral Agents, Nucleotides, Anti-Infective Agents	experimental	1
DB03726	Purine Riboside-5'-Monophosphate	Drug	0	experimental	1
DB03727	Coproporphyrin I	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Pigments, Biological, Porphyrins	experimental	1
DB03731	S-2-(Boronoethyl)-L-Cysteine	Drug	0	experimental	2
DB03732	Etheno-Nadp	Drug	0	experimental	1
DB03733	Ethylene Dichloride	Drug	Hydrocarbons, Chlorinated, Hydrocarbons, Acyclic, Alkanes, Hydrocarbons, Halogenated, Ethane	experimental	1
DB03734	Xylarohydroxamate	Drug	Acids, Acyclic, Carbohydrates, Amines, Hydroxy Acids, Hydroxylamines	experimental	1
DB02403	2-Fluoroaniline	Drug	Amines	experimental	1
DB02402	5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine	Drug	0	experimental	2
DB02401	4-Hydroxy-1,2,5-oxadiazole-3-carboxylic acid	Drug	Oxazoles	experimental	2
DB03730	3,9-Dimethyladenine	Drug	0	experimental	1
DB02400	ES-936	Drug	0	experimental	1
DB03739	3-Hydroxyimino Quinic Acid	Drug	0	experimental	1
DB02407	6-O-Cyclohexylmethyl Guanine	Drug	0	experimental	2
DB02406	N-Valeric Acid	Drug	0	experimental	1
DB02405	12-Bromododecanoic Acid	Drug	Fatty Acids, Lipids	experimental	1
DB02404	1-Deoxy-1-Thio-Heptaethylene Glycol	Drug	0	experimental	1
DB03735	9-(2-Deoxy-Beta-D-Ribofuranosyl)-6-Methylpurine	Drug	0	experimental	1
DB03736	2-Cyclopropylmethylenepropanal	Drug	0	experimental	1
DB02409	(1r,4s)-2-Azabornane	Drug	0	experimental	0
DB03737	4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One	Drug	0	experimental	1
DB03738	Pantothenoylaminoethenethiol	Drug	0	experimental	1
DB02408	(3s)-3-Amino-1-(Cyclopropylamino)Heptane-2,2-Diol	Drug	0	experimental	2
DB02410	2-Acetyl-3-[(4-Amino-2-Methyl-5-Pyrimidinyl)Methyl]-4-Methyl-5-(4,6,6-Trihydroxy-3,5-Dioxa-4,6-Diphosphahex-1-Yl)Thiazolium Inner Salt P,P'-Dioxide	Drug	0	experimental	1
DB03742	Compound 4-D	Drug	0	experimental	1
DB03744	Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate	Drug	0	experimental	1
DB03745	Arabinose-5-phosphate	Drug	0	experimental	2
DB02414	Cyclo(his-pro)	Drug	Antioxidants, Neurotransmitter Agents, Peptides, Protective Agents, Neurotransmitter Uptake Inhibitors, Amino Acids, Peptides, and Proteins, Compounds used in a research, industrial, or household setting, Membrane Transport Modulators	experimental	1
DB02413	Hydroxyethylcysteine	Drug	0	experimental	1
DB03740	N-acetyl-alpha-D-glucosamine	Drug	0	experimental	9
DB02412	Tetrahydropyran	Drug	0	experimental	0
DB03741	2-Methylbutanoic Acid	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Lipids	experimental	1
DB02411	2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2	Drug	0	experimental	1
DB02418	(R,R)-2,3-Butanediol	Drug	0	experimental	1
DB02417	2,4,6-Tribromophenol	Drug	Benzene Derivatives	experimental	0
DB02416	2-Ribofuranosyl-3-Iodo-2,3-Dihydro-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine	Drug	0	experimental	0
DB02415	N-Octyl-2-Hydroxyethyl Sulfoxide	Drug	0	experimental	3
DB03746	3-Amino-4,5-Dihydroxy-Cyclohex-1-Enecarboxylate	Drug	0	experimental	1
DB03747	N-Acetyl-glucosamine thiazoline	Drug	Amino Sugars, Carbohydrates, Sulfur Compounds, Hexosamines	experimental	2
DB03748	Methyl-[4-(4-Piperidine-1-Ylmethyl-Phenyl)-Cyclohexyl]-Carbaminic Acid-(4-Chlorophenyl)-Ester	Drug	0	experimental	1
DB02419	Ethyl Oxo(Piperidin-1-Yl)Acetate	Drug	0	experimental	1
DB03749	4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole	Drug	0	experimental	1
DB14400	Influenza B virus B/Massachusetts/2/2012 hemagglutinin antigen (MDCK cell derived, propiolactone inactivated)	Drug	0	approved	0
DB14403	Influenza B virus B/Phuket/3073/2013 hemagglutinin antigen (propiolactone inactivated)	Drug	0	approved	0
DB14404	Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (formaldehyde inactivated)	Drug	0	approved	0
DB14401	Influenza B virus B/Massachusetts/2/2012 BX-51B hemagglutinin antigen (propiolactone inactivated)	Drug	0	approved	0
DB14402	Influenza A virus A/Switzerland/9715293/2013 NIB-88 (H3N2) hemagglutinin antigen (propiolactone inactivated)	Drug	0	approved	0
DB14407	Influenza B virus B/Phuket/3073/2013 hemagglutinin antigen (formaldehyde inactivated)	Drug	0	approved	0
DB14408	Influenza A virus A/South Australia/55/2014 IVR-175 (H3N2) hemagglutinin antigen (propiolactone inactivated)	Drug	0	approved	0
DB14405	Influenza A virus A/Switzerland/9715293/2013 NIB-88 (H3N2) hemagglutinin antigen (formaldehyde inactivated)	Drug	0	approved	0
DB14406	Influenza B virus B/Brisbane/9/2014 hemagglutinin antigen (formaldehyde inactivated)	Drug	0	approved	0
DB14409	Human adenovirus e serotype 4 strain cl-68578 antigen	Drug	Live vaccines, Live Human Adenovirus Type 4 Vaccine, Actively Acquired Immunity, Adenovirus Vaccines, Vaccines	approved	0
DB03753	Flurbiprofen Methyl Ester	Drug	0	experimental	1
DB02421	Uridine-5'-diphosphate-mannose	Drug	0	experimental	1
DB03754	Tromethamine	Drug	Excipients, Blood and Blood Forming Organs, Laboratory Chemicals, Blood Substitutes and Perfusion Solutions, Propylene Glycols, i.v. Solutions, Pharmaceutic Aids, Alcohols, Drug Delivery Systems, Solutions Affecting the Electrolyte Balance, I.V. Solution Additives, Glycols, Pharmaceutical Preparations, Buffers, Compounds used in a research, industrial, or household setting, Pharmaceutical Vehicles	approved	1
DB02420	[[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid,	Drug	0	experimental	1
DB03755	Adenosine-5'-[Beta, Gamma-Methylene]Tetraphosphate	Drug	0	experimental	1
DB03756	Doconexent	Drug	Cytochrome P-450 Substrates, Fatty Acids, Cytochrome P-450 Enzyme Inhibitors, Oils, Lipids, Dietary Fats, Unsaturated, Cytochrome P-450 CYP2C9 Substrates, Fatty Acids, Unsaturated, Physiological Phenomena, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors, Dietary Fats, Food and Beverages, Fish Oils, Fats, Fatty Acids, Omega-3, Diet, Food, and Nutrition, Food	approved, investigational	6
DB02425	Hexadecyl Octanoate	Drug	0	experimental	1
DB02424	Geldanamycin	Drug	Quinones, Enzyme Inhibitors, Tyrosine Kinase Inhibitors, HSP90 Heat-Shock Proteins, Cysteine Proteinase Inhibitors, Protease Inhibitors, Antineoplastic Agents, Amides, Lactams, Antibiotics, Antineoplastic, Anti-Infective Agents	investigational, experimental	3
DB03750	Isovaleric Acid	Drug	Acids, Acyclic, Valerates, Fatty Acids, Fatty Acids, Volatile, Lipids	experimental	3
DB02423	Thiopyrophosphate	Drug	Anions, Acids, Noncarboxylic, Acids, Phosphoric Acids, Electrolytes, Ions, Phosphorus Compounds, Polyphosphates, Phosphate salts, Phosphorus Acids	experimental	0
DB03751	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	Drug	0	experimental	5
DB03752	P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid	Drug	Sulfur Compounds	experimental	1
DB02422	Methyl-2-S-(Alpha-D-Mannopyranosyl)-2-Thio-Alpha-D-Mannopyranoside	Drug	0	experimental	1
DB02429	4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide	Drug	0	experimental	1
DB02428	Quinaldic Acid	Drug	Heterocyclic Compounds, Fused-Ring	experimental	1
DB02427	2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline	Drug	0	experimental	2
DB02426	Carboxyatractyloside	Drug	Carbohydrates, Diterpenes, Glycosides, Terpenes	experimental	1
DB03757	N-{[(2-Methyl-2-propanyl)oxy]carbonyl}-L-alanyl-L-alaninamide	Drug	0	experimental	1
DB03758	Radicicol	Drug	Enzyme Inhibitors, Polyketides, Antiprotozoals, Tyrosine Kinase Inhibitors, Antifungal Agents, Anti-Infective Agents, Antiparasitic Agents, Lactones	experimental	5
DB03759	FG-9041	Drug	Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Excitatory Amino Acid Agents, Excitatory Amino Acid Antagonists	experimental	1
DB14498	Potassium acetate	Drug	Acids, Acyclic, Potassium Salt, Blood and Blood Forming Organs, Fatty Acids, Agents causing hyperkalemia, Lipids, Blood Substitutes and Perfusion Solutions, Acetates, Electrolyte Solutions, Potassium Compounds, Drugs that are Mainly Renally Excreted, I.V. Solution Additives, Replacement Preparations, Fatty Acids, Volatile	approved, investigational	1
DB13167	Alclofenac	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Acetic Acid Derivatives and Related Substances, Sensory System Agents, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Musculo-Skeletal System, Agents that produce hypertension, Central Nervous System Agents	approved, withdrawn	1
DB14499	Potassium sulfate	Drug	Potassium Salt, Anions, Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfur Acids, Osmotic Laxatives, Electrolytes, Ions, Laxatives, Drugs that are Mainly Renally Excreted, Sulfuric Acids	approved, investigational	1
DB13168	Omega-6 fatty acids	Drug	Fatty Acids, Unsaturated, Fatty Acids, Lipids	nutraceutical	0
DB13165	Ripasudil	Drug	rho-Associated Kinases, antagonists & inhibitors, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amides, Sulfones	experimental	2
DB14496	Sodium molybdate	Drug	Metals, Metals, Heavy, Elements, Transition Elements	approved, experimental	0
DB14497	Calcium magnesium potassium carbonate chloride hydroxide	Drug	0	experimental	0
DB13166	Zofenopril	Drug	Acids, Acyclic, Enzyme Inhibitors, Agents causing hyperkalemia, Protease Inhibitors, Amino Acids, Peptides, and Proteins, Cardiovascular Agents, Amino Acids, Amino Acids, Cyclic, Imines, Angiotensin-Converting Enzyme Inhibitors, Agents Acting on the Renin-Angiotensin System, Agents causing angioedema, ACE Inhibitors and Diuretics, Antihypertensive Agents, Imino Acids	approved	1
DB13169	Nandrolone	Drug	Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, Estrenes, Anabolic Agents, Hormones, Fused-Ring Compounds, Gonadal Steroid Hormones, Ophthalmologicals, Androgens, Alimentary Tract and Metabolism, Anabolic Steroids, Testosterone Congeners, Anabolic Agents for Systemic Use, Estren Derivatives, Thyroxine-binding globulin inhibitors, Sensory Organs, Nandrolone and esters, Gonadal Hormones, Steroids	investigational, experimental	0
DB01181	Ifosfamide	Drug	Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Nitrogen Mustard Analogues, Hydrocarbons, Halogenated, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Anions, Cytochrome P-450 CYP2C8 Substrates, Phosphoramide Mustards, Cytochrome P-450 CYP2C18 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A4 Inducers, Alkylating Activity, Organophosphorus Compounds, Ions, Nitrogen Mustard Compounds, Phosphorus Compounds, Alkylating Drugs, Cytochrome P-450 CYP2C19 Substrates, Acids, Noncarboxylic, Cytochrome P-450 CYP2A6 Substrates, Toxic Actions, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Oxazines, Cytochrome P-450 CYP2C8 Inducers, Cardiotoxic antineoplastic agents, Cytochrome P-450 Enzyme Inducers, Phosphoramides, Antineoplastic Agents, Alkylating, Noxae, Antineoplastic Agents, Mustard Compounds, Phosphorus Acids, Myelosuppressive Agents, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Inhibitors, Acids, Cytochrome P-450 CYP3A Substrates, Phosphoric Acids, Cytochrome P-450 CYP3A4 Inhibitors, Electrolytes, Methemoglobinemia Associated Agents	approved	2
DB01180	Rescinnamine	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Angiotensin-Converting Enzyme Inhibitors, Agents causing hyperkalemia, Agents that produce hypertension, Agents Acting on the Renin-Angiotensin System, Agents causing angioedema, Antiadrenergic Agents, Centrally Acting, Antihypertensive Agents, Indoles, Secologanin Tryptamine Alkaloids, Indole Alkaloids	approved	1
DB01185	Fluoxymesterone	Drug	Sex Hormones and Modulators of the Genital System, Hormones, Hormone Substitutes, and Hormone Antagonists, Genito Urinary System and Sex Hormones, Anabolic Agents, Androstenes, Hormones, Androstenediols, Fused-Ring Compounds, Androgens, Androstanes, Androstenols, 3-Oxoandrosten (4) Derivatives, Steroids, Fluorinated, Steroids	approved, illicit	4
DB01184	Domperidone	Drug	Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Benzimidazoles, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Prokinetic Agents, Cytochrome P-450 CYP3A4 Substrates, Peripheral Nervous System Agents, Propulsives, Alimentary Tract and Metabolism, Piperidines, Drugs for Functional Gastrointestinal Disorders, Cytochrome P-450 CYP2C8 Substrates, Dopamine Antagonists, Dopamine Agents, Gastrointestinal Agents, Autonomic Agents, Cytochrome P-450 CYP3A5 Substrates, P-glycoprotein substrates, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Antiemetics, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Dopamine D2 Receptor Antagonists	approved, investigational, vet_approved	2
DB01183	Naloxone	Drug	Sensory System Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Peripheral Opioid Receptor Antagonists, Drugs that are Mainly Renally Excreted, Morphinans, Peripheral Nervous System Agents, Cytochrome P-450 CYP3A4 Inhibitors (strong), Alkaloids, Analgesics, Alimentary Tract and Metabolism, Antidotes, Narcotics, P-glycoprotein substrates, Drugs for Constipation, Natural Opium Alkaloids, Opiate Antagonists, Opioid Antagonists, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, Cytochrome P-450 CYP3A Inhibitors, UGT1A1 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Central Nervous System Agents	approved, vet_approved	7
DB01182	Propafenone	Drug	Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Voltage-Gated Sodium Channel Blockers, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Agents causing hyperkalemia, Adrenergic beta-Antagonists, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inhibitors, Adrenergic Antagonists, Antiarrhythmics, Class I, Bradycardia-Causing Agents, Antiarrhythmic agents, Ketones, Moderate Risk QTc-Prolonging Agents, Membrane Transport Modulators, Cytochrome P-450 CYP3A Substrates, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Propiophenones, Cytochrome P-450 CYP2D6 Substrates, Sodium Channel Blockers, Cytochrome P-450 CYP2D6 Inhibitors (strong), P-glycoprotein inhibitors, Cardiac Therapy, Antiarrhythmics, Class Ic	approved	4
DB01189	Desflurane	Drug	Anesthetics, Inhalation, QTc Prolonging Agents, Nervous System, Ethyl Ethers, Methyl Ethers, Hydrocarbons, Halogenated, Hypotensive Agents, Anesthetics, Hydrocarbons, Fluorinated, Anesthetics, General, Central Nervous System Depressants, Agents that produce hypertension, Potential QTc-Prolonging Agents, Central Nervous System Agents, Ethers	approved	7
DB01188	Ciclopirox	Drug	Pyridines, Cycloparaffins, Gynecological Antiinfectives and Antiseptics, Decreased RNA Replication, Dermatologicals, Genito Urinary System and Sex Hormones, Antifungals for Dermatological Use, Pyridones, Anti-Infective Agents, Cyclohexanes, Decreased Protein Synthesis, Hydroxypyridones, Antifungals for Topical Use, Decreased DNA Replication, Antifungal Agents, Vaginal Creams, Foams, and Jellies, Protein Synthesis Inhibitors	approved, investigational	1
DB01187	Iophendylate	Drug	Contrast Media, Diagnostic Uses of Chemicals, Non-Watersoluble X-Ray Contrast Media, Iodobenzenes, Hydrocarbons, Halogenated, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting, Benzene Derivatives, Hydrocarbons, Iodinated	approved	0
DB01186	Pergolide	Drug	Ergot-derivative Dopamine Receptor Agonists, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Adrenergic alpha-1 Receptor Agonists, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Antidepressive Agents, Ergolines, Ergot-derived Dopamine Receptor Agonist, Dopamine Agonists, Ergot Alkaloids and Derivatives, Alkaloids, Adrenergic alpha-2 Receptor Agonists, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Dopamine Agents, Adrenergic alpha-Agonists, Serotonin Receptor Agonists, Agents producing tachycardia, Anti-Parkinson Drugs, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Inhibitors, Central Nervous System Depressants, Adrenergic Agonists, Agents that produce hypertension, Cytochrome P-450 CYP3A4 Inhibitors, Serotonin 5-HT2 Receptor Agonists	approved, investigational, withdrawn, vet_approved	15
DB14490	Ferrous ascorbate	Drug	Iron Bivalent, Oral Preparations, Antianemic Preparations, Blood and Blood Forming Organs, Iron Preparations, Polyvalent cation containing laxatives, antacids, oral supplements, Urinary Acidifying Agents, Compounds used in a research, industrial, or household setting	approved	13
DB13160	Alphaprodine	Drug	Sensory System Agents, Analgesics, Narcotics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Piperidines, Opioids, Central Nervous System Agents, Peripheral Nervous System Agents	illicit	0
DB14491	Ferrous fumarate	Drug	Iron Bivalent, Oral Preparations, Blood and Blood Forming Organs, Iron Compounds, Minerals, Organometallic Compounds, Trace Elements, Micronutrients, Antianemic Preparations, Physiological Phenomena, Food and Beverages, Iron Preparations, Growth Substances, Diet, Food, and Nutrition, Food	approved	13
DB13163	Terpin hydrate	Drug	Cycloparaffins, Cyclohexanols, Expectorants, Hexanols, Lipids, Monoterpenes, Terpenes, Respiratory System Agents, Fatty Alcohols, Alcohols, Cyclohexanes	approved, experimental	0
DB14494	Zinc carbonate	Drug	Alkalies, Zinc Compounds, Ions, Carbonic Acid, Carbon Compounds, Inorganic, Anions, Acids, Noncarboxylic, Metal cations, Acids, Metal divalent cations, Electrolytes, Copper Absorption Inhibitor, Polyvalent cation containing laxatives, antacids, oral supplements	experimental	0
DB14495	Manganese citrate	Drug	Paramagnetic Contrast Agent	experimental	0
DB13164	Olmutinib	Drug	Protein Kinase Inhibitors, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents	investigational	1
DB14492	Potassium triiodide	Drug	Potassium Salt, Noxae, Coloring Agents, Hematologic Agents, Ions, Coagulants, Irritants, Anions, Disinfectants, Iodine Compounds, Electrolytes, Toxic Actions, Hemostatics, Compounds used in a research, industrial, or household setting	experimental	0
DB13161	Nusinersen	Drug	Carbohydrates, Increased Protein Synthesis, Nucleic Acids, Nucleotides, and Nucleosides, Oligonucleotides, Antisense, Musculo-Skeletal System, Glycosides, Other Miscellaneous Therapeutic Agents, Nucleotides, Polynucleotides, Survival Motor Neuron-2-directed RNA Interaction	approved, investigational	1
DB14493	Zinc glycinate	Drug	Antigens, Neoplasm, Metal cations, Zinc Compounds, Metal divalent cations, Amino Acids, Peptides, and Proteins, Copper Absorption Inhibitor, Biomarkers, Tumor, Amino Acids	experimental	0
DB13178	Inositol	Drug	Carbohydrates, Drugs that are Mainly Renally Excreted, Vitamins, Alcohols, Micronutrients, Other Nutritional Agents, Physiological Phenomena, Alimentary Tract and Metabolism, Food and Beverages, Sugar Alcohols, Vitamin B Complex, Growth Substances, Diet, Food, and Nutrition, Food	approved, investigational, withdrawn	0
DB13179	Troleandomycin	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Macrolides, Cytochrome P-450 CYP3A5 Inhibitors, Macrolides, Lincosamides and Streptogramins, Cytochrome P-450 CYP3A5 Inhibitors (strong), Cytochrome P-450 CYP3A4 Substrates, Antiinfectives for Systemic Use, Anti-Infective Agents, Lactones, Cytochrome P-450 CYP3A4 Inhibitors (strong), Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A7 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A7 Inhibitors (strong), P-glycoprotein inhibitors, Antibacterials for Systemic Use, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)	approved	3
DB13177	4-methylumbelliferyl beta-D-glucoside	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Coumarins, Glycosides, Benzopyrans, Umbelliferones, Pyrans	experimental	0
DB01192	Oxymorphone	Drug	Cytochrome P-450 Substrates, Sensory System Agents, Narcotics, Adjuvants, Cytochrome P-450 CYP3A4 Substrates, Morphinans, Opiate Agonists, Peripheral Nervous System Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, High-risk opioids, Opiate Alkaloids, Analgesics, Cytochrome P-450 CYP3A Substrates, Morphine Derivatives, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Opioid Agonist, Opioids, Adjuvants, Anesthesia, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates	approved, investigational, vet_approved	2
DB01191	Dexfenfluramine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Centrally Acting Antiobesity Products, Amines, Cytochrome P-450 Substrates, Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2E1 Inhibitors (weak), Phenethylamines, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Neurotransmitter Agents, Ethylamines, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Alimentary Tract and Metabolism, Cytochrome P-450 CYP1A2 Substrates, Antiobesity Preparations, Excl. Diet Products, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2D6 Inhibitors (weak)	approved, illicit, investigational, withdrawn	2
DB01190	Clindamycin	Drug	Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Genito Urinary System and Sex Hormones, Macrolides, Lincosamides and Streptogramins, Agents that produce neuromuscular block (indirect), Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Anti-Bacterial Agents, Antiinfectives for Treatment of Acne, Glycosides, Lincomycins, Pyrrolidines, Protein Synthesis Inhibitors, Neurotoxic agents, Cytochrome P-450 CYP3A5 Substrates, Antibiotics for Pneumocystis Pneumonia, Gynecological Antiinfectives and Antiseptics, P-glycoprotein substrates, Dermatologicals, Decreased Sebaceous Gland Activity, Anti-Acne Preparations, Antiinfectives for Systemic Use, Cytochrome P-450 CYP3A Inhibitors, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Lincosamides, Anti-Acne Preparations for Topical Use, Antibacterials for Systemic Use, Lincosamide Antibacterial	approved, vet_approved	1
DB01196	Estramustine	Drug	Cytochrome P-450 Substrates, Immunosuppressive Agents, Hydrocarbons, Halogenated, Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Estradiol Congeners, Antineoplastic Agents, Alkylating, Gonadal Hormones, Antineoplastic Agents, Hormonal, Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, Noxae, Antineoplastic and Immunomodulating Agents, Estrenes, Alkylating Activity, Antineoplastic Agents, Mustard Compounds, Nitrogen Mustard Compounds, Gonadal Steroid Hormones, Alkylating Drugs, Cytochrome P-450 CYP3A Substrates, Toxic Actions, P-glycoprotein inhibitors, Steroids	approved, investigational	4
DB01195	Flecainide	Drug	Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Voltage-Gated Sodium Channel Blockers, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, MATE 1 Substrates, MATE inhibitors, Cardiovascular Agents, MATE 1 Inhibitors, Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C9 Inhibitors, Piperidines, Antiarrhythmics, Class I, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), MATE substrates, Antiarrhythmic agents, P-glycoprotein substrates, Moderate Risk QTc-Prolonging Agents, Membrane Transport Modulators, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2D6 Substrates, Sodium Channel Blockers, Cardiac Therapy, Antiarrhythmics, Class Ic	approved, withdrawn	4
DB01194	Brinzolamide	Drug	Enzyme Inhibitors, Cytochrome P-450 Substrates, Antiglaucoma Preparations and Miotics, Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Amides, Cytochrome P-450 CYP3A4 Substrates, Ophthalmics, Ophthalmologicals, Carbonic Anhydrase Inhibitors, Sulfur Compounds, Cytochrome P-450 CYP3A Substrates, Sulfonamides, Diuretics, Sensory Organs, Sulfones	approved	5
DB01193	Acebutolol	Drug	Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Agents causing hyperkalemia, Adrenergic beta-Antagonists, Cardiovascular Agents, Hypotensive Agents, Adrenergic beta-1 Receptor Antagonists, Alcohols, Peripheral Nervous System Agents, Adrenergic Antagonists, Antihypertensive Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Adrenergic Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Autonomic Agents, Beta Blocking Agents, Selective, and Thiazides, Antihypertensive Agents Indicated for Hypertension, Propanols, P-glycoprotein substrates, Phenoxypropanolamines, Amino Alcohols, Beta Blocking Agents and Thiazides, Moderate Risk QTc-Prolonging Agents, Neurotransmitter Agents, Sympathomimetics, Beta Blocking Agents, Selective, Beta-Blockers (Beta1 Selective), Cytochrome P-450 CYP2D6 Substrates, Propanolamines	approved, investigational	2
DB01199	Tubocurarine	Drug	Curare Alkaloids, Neuromuscular Agents, OCT1 substrates, Amines, Ammonium Compounds, Benzylisoquinolines, Isoquinolines, Ganglion Blockers, Onium Compounds, Muscle Relaxants, Peripheral Nervous System Agents, Anticholinergic Agents, Alkaloids, Cholinergic Agents, Musculo-Skeletal System, Tetrahydroisoquinolines, Nitrogen Compounds, Neurotoxic agents, Cholinesterase Inhibitors, Quaternary Ammonium Compounds, Neuromuscular-Blocking Agents (Nondepolarizing), Nicotinic Antagonists, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Muscle Relaxants, Peripherally Acting Agents, Central Nervous System Depressants, Neuromuscular Blocking Agents, Cholinesterase substrates	approved	4
DB01198	Zopiclone	Drug	Psycholeptics, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 Substrates, Nervous System, Cytochrome P-450 CYP3A4 Substrates, Miscellaneous Anxiolytics Sedatives and Hypnotics, Sleep Initiation and Maintenance Disorders, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Central Nervous System Depressants, Aza Compounds, Hypnotics (Nonbenzodiazepine), Hypnotics and Sedatives, Central Nervous System Agents, Methemoglobinemia Associated Agents, Cytochrome P-450 CYP2C8 Substrates, Drugs causing inadvertant photosensitivity, Benzodiazepine hypnotics and sedatives, Zopiclone and prodrugs	approved	5
DB01197	Captopril	Drug	Acids, Acyclic, Antihypertensive Agents Indicated for Hypertension, Enzyme Inhibitors, Agents causing hyperkalemia, Protease Inhibitors, Amino Acids, Peptides, and Proteins, Cardiovascular Agents, Hypotensive Agents, OAT1/SLC22A6 Substrates, Amino Acids, OAT1/SLC22A6 inhibitors, OAT3/SLC22A8 Substrates, Amino Acids, Cyclic, Imines, Photosensitizing Agents, Agents Causing Muscle Toxicity, Angiotensin-Converting Enzyme Inhibitors, Agents Acting on the Renin-Angiotensin System, Agents causing angioedema, ACE Inhibitors and Diuretics, Antihypertensive Agents, Drugs causing inadvertant photosensitivity, Imino Acids, P-glycoprotein inhibitors	approved	5
DB13170	Plecanatide	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Drugs for Constipation, Amino Acids, Peptides, and Proteins, Hormones, Guanylate Cyclase Activators, Guanylate Cyclase-C Agonist, Peptide Hormones, Enzyme Activators, Alimentary Tract and Metabolism, Guanylyl Cyclase C Agonists, Receptors, Guanylate Cyclase-Coupled, agonists, Laxatives, Gastrointestinal Agents	approved, investigational	1
DB13171	Glyceryl 1-oleate	Drug	Lipids	experimental	0
DB13174	Rhein	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Anthracenes, Enzyme Inhibitors, Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2E1 Inhibitors (weak), NADH, NADPH Oxidoreductases, antagonists & inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inhibitors, Mixed Function Oxygenases, Quinones, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Cytochrome P-450 CYP2C9 Inhibitors (weak)	experimental	4
DB13175	Rheinanthrone	Drug	0	experimental	0
DB13172	Tunicamycin	Drug	Carbohydrates, Anti-Bacterial Agents, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Glycosides, Nucleosides, Anti-Infective Agents	experimental	0
DB13173	Cerliponase alfa	Drug	Proteins, Enzymes, Exopeptidases, Alimentary Tract and Metabolism, Hydrolytic Lysosomal N-terminal Tripeptidyl Peptidase, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Hydrolases, Peptide Hydrolases	approved, investigational	1
DB13189	Calcitonin porcine	Drug	Calcitonin Preparations, Bone Density Conservation Agents, Calcium Homeostasis, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins	experimental	0
DB13181	Methylbenactyzium	Drug	Amines, Ammonium Compounds, Onium Compounds, Nitrogen Compounds	experimental	0
DB13182	Daidzein	Drug	Enzyme Inhibitors, Phytoestrogens, Topoisomerase Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Estrogens, Non-Steroidal, Antineoplastic Agents, Benzopyrans, Growth Inhibitors, Hormones, Heterocyclic Compounds, Fused-Ring, Flavonoids, Topoisomerase II Inhibitors, Chromones, Pyrans	experimental	0
DB13180	Gluconic Acid	Drug	Acids, Acyclic, Carbohydrates, Hydroxy Acids, Osmotic Laxatives, Laxatives, Sugar Acids, Chelating Agents	approved, investigational	0
DB13185	Oxabolone cipionate	Drug	Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, Estrenes, Hormones, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Gonadal Steroid Hormones, Alimentary Tract and Metabolism, Anabolic Steroids, Anabolic Agents for Systemic Use, Estren Derivatives, Estradiol Congeners, Gonadal Hormones, Steroids	experimental	0
DB13183	Technetium Tc-99m etifenin	Drug	Hepatic and Reticulo Endothelial System, Diagnostic Radiopharmaceuticals, Technetium (99Mtc) Compounds	experimental	0
DB13198	Pepsin	Drug	Aspartic Acid Proteases, Enzymes, Alimentary Tract and Metabolism, Aspartic Acid Endopeptidases, Enzymes and Coenzymes, Digestives, Incl. Enzymes, Hydrolases, Pepsin A, antagonists & inhibitors, Enzyme Preparations, Peptide Hydrolases, Endopeptidases, Gastrointestinal Agents	approved, investigational, experimental	0
DB13199	Brinase	Drug	Anticoagulants, Enzymes, Cell-mediated Immunity, Blood and Blood Forming Organs, Fibrin Modulating Agents, Enzymes and Coenzymes, Hematologic Agents, Non-Standardized Fungal Allergenic Extract, Cardiovascular Agents, Fibrinolytic Agents, Hydrolases, Peptide Hydrolases, Endopeptidases, Increased IgG Production, Increased Histamine Release	experimental	0
DB13192	Antihemophilic factor human	Drug	Proteins, Biological Factors, Blood and Blood Forming Organs, Increased Coagulation Activity, Blood Proteins, Blood Coagulation Factors, Amino Acids, Peptides, and Proteins, Hemostatics, Human Antihemophilic Factor, Hemophilia A	approved	2
DB13193	Vitex agnus-castus fruit extract	Drug	Genito Urinary System and Sex Hormones	experimental	0
DB13191	Phosphocreatine	Drug	Cardiotonic Agents, Protective Agents, Amidines, Amino Acids, Peptides, and Proteins, Cardiovascular Agents, Guanidines, Phosphoamino Acids, Cardiac Therapy, Compounds used in a research, industrial, or household setting, Amino Acids, Drugs that are Mainly Renally Excreted	nutraceutical	6
DB13196	Valerian	Drug	Psycholeptics, Nervous System, Central Nervous System Depressants, Herbs and Natural Products, Hypnotics and Sedatives, Miscellaneous Anxiolytics Sedatives and Hypnotics	approved, investigational, experimental	0
DB13197	Kallidinogenase	Drug	Biological Factors, Enzymes, Reproductive Control Agents, Blood Coagulation Factors, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Hematologic Agents, Coagulants, Kallikreins, antagonists & inhibitors, Fertility Agents, Kallikreins, Proteins, Fertility Agents, Male, Blood Proteins, Peripheral Vasodilators, Serine Proteases, Hydrolases, Peptide Hydrolases, Serine Endopeptidases, Endopeptidases	experimental	0
DB13194	Hedera helix leaf extract	Drug	Cough and Cold Preparations, Expectorants	experimental	0
DB13195	Horse chestnut	Drug	Vasoprotectives, Capillary Stabilizing Agents	experimental	0
DB13123	OTX-008	Drug	0	investigational	0
DB14454	Influenza B virus B/Massachusetts/2/2012 BX-51B antigen (formaldehyde inactivated)	Drug	0	approved	0
DB13124	Troxerutin	Drug	Radiation-Protective Agents, Anticoagulants, Flavonols, Heterocyclic Compounds, Fused-Ring, Vasoprotectives, Flavonoids, Capillary Stabilizing Agents, Hematologic Agents, Benzopyrans, Chromones, Pyrans	investigational	0
DB14455	Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (formaldehyde inactivated)	Drug	0	approved	0
DB14452	Influenza A virus A/Texas/50/2012 X-223A (H3N2) antigen (formaldehyde inactivated)	Drug	0	approved	0
DB13121	Hydroxypropyl tetrahydropyrantriol	Drug	0	investigational	0
DB14453	Influenza B virus B/Massachusetts/2/2012 antigen (formaldehyde inactivated)	Drug	0	approved	0
DB13122	Trabodenoson	Drug	Adenosine A1 Receptor Agonists, Carbohydrates, Ribonucleosides, Ions, Purine Nucleosides, Heterocyclic Compounds, Fused-Ring, Purines, Anions, Acids, Noncarboxylic, Nucleic Acids, Nucleotides, and Nucleosides, Acids, Glycosides, Nucleosides, Electrolytes, Nitric Acid, Nitrogen Compounds	investigational	0
DB13127	Olokizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB14458	Influenza A virus A/Michigan/45/2015 X-275 (H1N1) antigen (formaldehyde inactivated)	Drug	0	approved	0
DB13128	Sizofiran	Drug	Carbohydrates, Immunologic Factors, Antineoplastic Agents, Phytogenic, Polysaccharides, Adjuvants, Immunologic, Glucans, Antineoplastic Agents, Polymers, beta-Glucans, Biopolymers, Compounds used in a research, industrial, or household setting, Macromolecular Substances	investigational	0
DB14459	Influenza A virus A/Hong Kong/4801/2014 X-263B (H3N2) antigen (propiolactone inactivated)	Drug	0	approved	0
DB14456	Influenza B virus B/Brisbane/9/2014 antigen (formaldehyde inactivated)	Drug	0	approved	0
DB13125	Lusutrombopag	Drug	Sulfur Compounds, BCRP/ABCG2 Substrates, Blood and Blood Forming Organs, P-glycoprotein substrates, Acids, Carbocyclic, Hemostatics	approved, investigational	1
DB14457	Influenza A virus A/Hong Kong/4801/2014 X-263B (H3N2) antigen (formaldehyde inactivated)	Drug	0	approved	0
DB13126	BMS-986115	Drug	Heterocyclic Compounds, Fused-Ring, Benzazepines	investigational	0
DB13129	Trimegestone	Drug	Sex Hormones and Modulators of the Genital System, Norsteroids, Progestogens and Estrogens, Sequential Preparations, Genito Urinary System and Sex Hormones, Norpregnadienes, Norpregnanes, Fused-Ring Compounds, Steroids	investigational	0
DB01141	Micafungin	Drug	Peptides, Cyclic, Peptides, Antimycotics for Systemic Use, Echinocandins, Amino Acids, Peptides, and Proteins, Lipids, Antifungal Agents, COMT Substrates, Antiinfectives for Systemic Use, Echinocandin Antifungal, Lipopeptides, Anti-Infective Agents	approved, investigational	1
DB02472	7,8-dihydroinosine	Drug	0	experimental	1
DB01140	Cefadroxil	Drug	Nephrotoxic agents, Amides, Lactams, Thiazines, beta-Lactams, First-Generation Cephalosporins, Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, OAT1/SLC22A6 inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, OAT3/SLC22A8 Inhibitors, Antibacterials for Systemic Use	approved, withdrawn, vet_approved	4
DB02471	Nojirimycine Tetrazole	Drug	0	experimental	3
DB02470	D-Glycero-D-Mannopyranose-7-Phosphate	Drug	0	experimental	1
DB01145	Sulfoxone	Drug	Sulfur Compounds, Antimycobacterials, Antiinfectives for Systemic Use, Drugs for Treatment of Lepra, Sulfones	approved	1
DB01144	Diclofenamide	Drug	Enzyme Inhibitors, Antiglaucoma Preparations and Miotics, Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Amides, Hypotensive Agents, Ophthalmics, Ophthalmologicals, Carbonic Anhydrase Inhibitors, Sulfur Compounds, Sulfonamides, Diuretics, Sensory Organs, Sulfones	approved, investigational	5
DB02475	Deoxyamidinoproclavaminic acid	Drug	0	experimental	1
DB01143	Amifostine	Drug	Radiation-Protective Agents, Organothiophosphorus Compounds, Sulfur Compounds, Protective Agents, Detoxifying Agents for Antineoplastic Treatment, Organophosphorus Compounds, Organothiophosphates, Hypotensive Agents, Cytoprotective Agent, Free Radical Scavenging Activity, Compounds used in a research, industrial, or household setting, Organophosphates	approved, investigational	1
DB02474	BMSC-0013	Drug	0	experimental	1
DB01142	Doxepin	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Sleep Aids, Pharmaceutical, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Anticholinergic Agents, Serotonin 5-HT2 Receptor Antagonists, Tricyclics and Other Norepinephrine-reuptake Inhibitors, Antipruritics and Local Anesthetics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Acid Reducers, Hypnotics and Sedatives, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Dopamine Antagonists, Agents that reduce seizure threshold, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Agents producing tachycardia, Histamine H2 Antagonists, Cytochrome P-450 CYP2C19 Substrates, Neurotransmitter Agents, Tertiary amine tricyclic antidepressants, Central Nervous System Depressants, Antidepressive Agents, Tricyclic, Cytochrome P-450 CYP2D6 Substrates, Ethers, Cyclic, Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Serotonin Agents, Nervous System, Muscarinic Antagonists, Antidepressive Agents, Serotonin Modulators, Histamine H1 Antagonists, Antipruritics, Incl. Antihistamines, Anesthetics, Etc., Adrenergic Antagonists, Potential QTc-Prolonging Agents, Adrenergic alpha-1 Receptor Antagonists, Neurotoxic agents, Dibenzoxepins, Adrenergic alpha-Antagonists, P-glycoprotein substrates, Dermatologicals, Psychotropic Drugs, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Non-Selective Monoamine Reuptake Inhibitors, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Serotonin Receptor Antagonists, Central Nervous System Agents, Histamine Agents, Serotonin 5-HT1 Receptor Antagonists, Psychoanaleptics	approved, investigational	19
DB02473	6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine	Drug	0	experimental	1
DB01149	Nefazodone	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Hypoglycemia-Associated Agents, OATP1B3 inhibitors, BSEP/ABCB11 Substrates, Antidepressive Agents, Antidepressive Agents, Triazolopyridine, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP3A4 Inhibitors (strong), Serotonin 5-HT2 Receptor Antagonists, Serotonin Modulators, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Adrenergic Antagonists, Adrenergic alpha-1 Receptor Antagonists, Selective Serotonin Reuptake Inhibitors, Adrenergic alpha-Antagonists, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Antidepressive Agents, Second-Generation, Psychotropic Drugs, Membrane Transport Modulators, P-glycoprotein inducers, Neurotransmitter Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Neurotransmitter Uptake Inhibitors, Serotonin and Noradrenaline Reuptake Inhibitors, Agents that produce hypertension, Cytochrome P-450 CYP3A4 Inhibitors, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors, Serotonin 5-HT1 Receptor Antagonists, Cytochrome P-450 CYP2D6 Inhibitors (weak), Psychoanaleptics	approved, withdrawn	10
DB01148	Flavoxate	Drug	Autonomic Agents, Flavones, Drugs for Urinary Frequency and Incontinence, Genito Urinary System and Sex Hormones, Urologicals, Agents producing tachycardia, Parasympatholytics, Benzopyrans, Muscarinic Antagonists, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Anticholinergic Agents, Urological Agents, Heterocyclic Compounds, Fused-Ring, Flavonoids, Chromones, Pyrans	approved	2
DB02479	(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide	Drug	0	experimental	1
DB01147	Cloxacillin	Drug	Penicillinase-resistant Penicillins, Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Anti-Infective Agents, OAT1/SLC22A6 inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Beta-Lactamase Resistant Penicillins, Antibacterials for Systemic Use	approved, investigational, vet_approved	6
DB01146	Diphenylpyraline	Drug	Histamine H1 Antagonists, Histamine Antagonists, Aminoalkyl Ethers, Antihistamines for Systemic Use	approved, investigational	2
DB02477	N-({4-[4-(2-Methyl-1H-imidazol-1-yl)butyl]phenyl}acetyl)-L-seryl-N-(2-cyclohexylethyl)-L-lysinamide	Drug	0	experimental	1
DB14450	Influenza A virus A/Victoria/361/2011 IVR-165 (H3N2) antigen (formaldehyde inactivated)	Drug	0	approved	0
DB13120	Deferitazole	Drug	Sulfur Compounds, Iron Chelating Agents, Ethers	investigational	0
DB14451	Influenza B virus B/Texas/6/2011 antigen (formaldehyde inactivated)	Drug	0	approved	0
DB14465	Influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen (MDCK cell derived, propiolactone inactivated)	Drug	0	approved	0
DB13134	Fluorine F-18	Drug	Radioisotopes, Isotopes	investigational	0
DB13135	AGN-201904	Drug	Heterocyclic Compounds, Fused-Ring, Pyridines, Benzimidazoles, Sulfur Compounds, 2-Pyridinylmethylsulfinylbenzimidazoles, Sulfoxides	investigational	0
DB14466	Influenza A virus A/Singapore/GP1908/2015 IVR-180 (H1N1) antigen (UV, formaldehyde inactivated)	Drug	0	approved	0
DB13132	Artemisinin	Drug	Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Cytochrome P-450 Substrates, Reactive Oxygen Species, Free Radicals, Antimalarials, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Ions, Oxides, Anti-Infective Agents, Artemisia, Anions, Cytochrome P-450 Enzyme Inducers, Sesquiterpenes, Artemisinin and Derivatives, Plain, Cytochrome P-450 CYP2B6 Inducers, Electrolytes, Peroxides, Cytochrome P-450 CYP2B6 Substrates, Terpenes, Oxygen Compounds	investigational	0
DB14463	Influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen (MDCK cell derived, propiolactone inactivated)	Drug	0	approved	0
DB13133	Von Willebrand Factor Human	Drug	Proteins, Biological Factors, Blood and Blood Forming Organs, Increased Coagulation Activity, Blood Proteins, Blood Coagulation Factors, Increased Platelet Aggregation, Amino Acids, Peptides, and Proteins, von Willebrand Factor, antagonists & inhibitors, Hemostatics, von Willebrand Factor	approved, investigational	2
DB14464	Influenza B virus B/Hong Kong/259/2010 antigen (MDCK cell derived, propiolactone inactivated)	Drug	0	approved	0
DB14469	Influenza B virus B/Brisbane/46/2015 antigen (propiolactone inactivated)	Drug	0	approved	0
DB13138	Neladenoson bialanate	Drug	Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins	investigational	0
DB13139	Levosalbutamol	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Amines, Cytochrome P-450 Enzyme Inhibitors, Agents producing tachycardia, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), OATP1B3 substrates, Adrenergic beta-2 Receptor Agonists, Amino Alcohols, Ethanolamines, Phenethylamines, Drugs that are Mainly Renally Excreted, Alcohols, Adrenergic beta-Agonists, Agents to Treat Airway Disease, Cytochrome P-450 CYP3A Inhibitors, Ethylamines, Adrenergic Agonists, Agents that produce hypertension, Cytochrome P-450 CYP3A4 Inhibitors, OATP1B1/SLCO1B1 Substrates, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)	approved, investigational	1
DB14467	Influenza A virus A/Hong Kong/4801/2014 X-263B (H3N2) antigen (UV, formaldehyde inactivated)	Drug	0	approved	0
DB13136	Fluindione	Drug	Anticoagulants, Blood and Blood Forming Organs, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Hematologic Agents, Indans, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index, Vitamin K Antagonists, Cytochrome P-450 CYP2C9 Substrates, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Indenes	approved, investigational	0
DB13137	PM-060184	Drug	Lactones, Pyrans	investigational	0
DB14468	Influenza A virus A/Singapore/GP1908/2015 IVR-180A (H1N1) antigen (propiolactone inactivated)	Drug	0	approved	0
DB01152	Candicidin	Drug	Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Gynecological Antiinfectives and Antiseptics, Macrolides, Genito Urinary System and Sex Hormones, Cytochrome P-450 CYP3A4 Inhibitors, Antifungal Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Anti-Infective Agents, Lactones	approved, withdrawn	1
DB02483	Etheno-NAD	Drug	0	experimental	2
DB02482	Phosphonothreonine	Drug	0	experimental	10
DB01151	Desipramine	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, OCT1 inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Anticholinergic Agents, Serotonin 5-HT2 Receptor Antagonists, Tricyclics and Other Norepinephrine-reuptake Inhibitors, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Adrenergic Agents, Agents that reduce seizure threshold, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Cytochrome P-450 CYP2E1 Inhibitors (weak), Agents producing tachycardia, Membrane Transport Modulators, Neurotransmitter Agents, Central Nervous System Depressants, Antidepressive Agents, Tricyclic, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2D6 Inhibitors (weak), Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Enzyme Inhibitors, Adrenergic Uptake Inhibitors, Serotonin Agents, Nervous System, Muscarinic Antagonists, Antidepressive Agents, Cytochrome P-450 CYP2B6 Inhibitors, Serotonin Modulators, Histamine H1 Antagonists, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Potential QTc-Prolonging Agents, Neurotoxic agents, Cytochrome P-450 CYP2E1 Inhibitors, Dibenzazepines, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Non-Selective Monoamine Reuptake Inhibitors, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, OCT2 Inhibitors, Neurotransmitter Uptake Inhibitors, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), P-glycoprotein inhibitors, Psychoanaleptics	approved, investigational	17
DB02481	N-Benzylformamide	Drug	Acids, Acyclic, Amides, Formates	experimental	1
DB01150	Cefprozil	Drug	Nephrotoxic agents, Second-Generation Cephalosporins, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Antibacterials for Systemic Use	approved	3
DB02480	(S)-4-bromo-3-hydroxy-3-methylbutyl diphosphate	Drug	0	experimental	1
DB01156	Bupropion	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Antidepressive Agents, Drugs that are Mainly Renally Excreted, Increased Norepinephrine Activity, Norepinephrine Uptake Inhibitors, Increased Dopamine Activity, Drugs causing inadvertant photosensitivity, Agents that reduce seizure threshold, Dopamine Agents, Dopamine Uptake Inhibitors, Centrally Acting Antiobesity Products, Cytochrome P-450 CYP2E1 Substrates, Ketones, Psychotropic Drugs, Cytochrome P-450 CYP2C9 Substrates, Aminoketone, Photosensitizing Agents, Central Nervous System Depressants, OCT2 Inhibitors, Miscellaneous Antidepressants, Neurotransmitter Uptake Inhibitors, Antiobesity Preparations, Excl. Diet Products, Smoking Cessation Agents, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Inhibitors (strong), Psychoanaleptics	approved	4
DB02486	2-Hydroxyethyl Disulfide	Drug	Gases, Sulfides, Anions, Sulfur Compounds, Acids, Noncarboxylic, Acids, Hydrogen Sulfide, Electrolytes, Ions, Alcohols	experimental	2
DB01155	Gemifloxacin	Drug	Fluoroquinolones, Quinolines, QTc Prolonging Agents, Quinolone Antimicrobial, Enzyme Inhibitors, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Naphthyridines, Antiinfectives for Systemic Use, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Moderate Risk QTc-Prolonging Agents, Anti-Infective Agents, Quinolones, Cytochrome P-450 CYP1A2 Inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Topoisomerase II Inhibitors, Antibacterials for Systemic Use	approved, investigational	2
DB02485	Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid	Drug	0	experimental	1
DB01154	Thiamylal	Drug	Psycholeptics, Cytochrome P-450 Substrates, Nervous System, GABA Modulators, Cytochrome P-450 CYP3A Inducers, Anesthetics, Intravenous, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Anesthetics, General, Cytochrome P-450 Enzyme Inducers, Pyrimidines, Hypnotics and Sedatives, Barbiturates, Cytochrome P-450 CYP2E1 Substrates, GABA Agents, Cytochrome P-450 CYP3A4 Inducers, Pyrimidinones, Anesthetics, Cytochrome P-450 CYP2C9 Substrates, Neurotransmitter Agents, Anticonvulsants, Thiobarbiturates, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Central Nervous System Agents	approved, vet_approved	3
DB02484	Cytidine 5'-diphosphoglycerol	Drug	0	experimental	1
DB01153	Sertaconazole	Drug	Sulfur Compounds, Azole Antifungals, Gynecological Antiinfectives and Antiseptics, Antifungals for Topical Use, Dermatologicals, Genito Urinary System and Sex Hormones, Antifungals for Dermatological Use, Antifungal Agents, Imidazole and Triazole Derivatives, Imidazole Derivatives, Anti-Infective Agents	approved, investigational	1
DB01159	Halothane	Drug	Anesthetics, Inhalation, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 Substrates, Nervous System, Hydrocarbons, Halogenated, Hypotensive Agents, Anesthetics, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Substrates, Anesthetics, General, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Agents that produce hypertension, Cytochrome P-450 CYP2A6 Substrates, NMDA Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates	approved, vet_approved	17
DB01158	Bretylium	Drug	Antiarrhythmics, Class III, QTc Prolonging Agents, Amines, Ammonium Compounds, Quaternary Ammonium Compounds, Onium Compounds, Cardiovascular Agents, Hypotensive Agents, Neurotransmitter Agents, Benzylammonium Compounds, Adrenergic Antagonists, Potential QTc-Prolonging Agents, Antihypertensive Agents, Cardiac Therapy, Adrenergic Agents, Bradycardia-Causing Agents, Nitrogen Compounds, Antiarrhythmic agents, Bretylium Compounds	approved	1
DB02489	9-Methylguanine	Drug	Heterocyclic Compounds, Fused-Ring, Purines, Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 Substrates, Xanthine derivatives, Purinones	experimental	1
DB01157	Trimetrexate	Drug	Acids, Acyclic, Carbohydrates, Enzyme Inhibitors, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Hydroxy Acids, Noxae, Folic Acid Antagonists, Antineoplastic Agents, Quinazolines, Antimetabolites, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Heterocyclic Compounds, Fused-Ring, Narrow Therapeutic Index Drugs, Hepatotoxic Agents, Sugar Acids, Toxic Actions, Uronic Acids, Acids, Aldehydic, Pharmaceutical Preparations	approved, investigational	1
DB02488	1-(2-Ethanone)-2-Hydroxy-2-(1-Amino-2-Methyl-2-Ethanol)-4-(2-Dimethyl)Ethane-Imidazoline-5-One;Chromophore (Thr-Leu-Gly)	Drug	0	experimental	0
DB14461	Influenza A virus A/Singapore/gp1908/2015 IVR-180 (H1N1) antigen (formaldehyde inactivated)	Drug	0	approved	0
DB14462	Influenza A virus A/Singapore/GP1908/2015 IVR-180 (H1N1) antigen (MDCK cell derived, propiolactone inactivated)	Drug	0	approved	0
DB13131	Serrapeptase	Drug	Analgesics, Non-Narcotic, Enzymes, Sensory System Agents, Analgesics, Anti-Inflammatory Agents, Antirheumatic Agents, Enzymes and Coenzymes, Hydrolases, Central Nervous System Agents, Serratia, Peripheral Nervous System Agents	investigational	0
DB14460	Influenza A virus A/Singapore/gp1908/2015 IVR-180 (H1N1) antigen (propiolactone inactivated)	Drug	0	approved	0
DB13145	Nedaplatin	Drug	Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Organometallic Compounds, Antineoplastic Agents, Platinum Compounds, Drugs that are Mainly Renally Excreted	approved, investigational	2
DB14476	DL-alpha-Tocopherol	Drug	Vitamin E, Vitamins (Fat Soluble), Vitamins	approved, investigational, experimental	0
DB14477	DL-alpha tocopheryl acetate	Drug	0	approved, experimental	0
DB13146	Fluciclovine (18F)	Drug	Cycloparaffins, Tumour Detection, Diagnostic Radiopharmaceuticals, Radioactive Diagnostic Agent, Positron Emitting Activity	approved	8
DB14474	Sorbitan	Drug	0	experimental	0
DB13143	Methallenestril	Drug	Sex Hormones and Modulators of the Genital System, Estrogens, Genito Urinary System and Sex Hormones, Synthetic Estrogens, Plain	experimental	0
DB13144	Lenograstim	Drug	Biological Factors, Carbohydrates, Immunologic Factors, Cytokines, Glycoconjugates, Peptides, Adjuvants, Immunologic, Antineoplastic and Immunomodulating Agents, Granulocyte Colony-Stimulating Factors, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Hematologic Agents, Glycoproteins, Hematopoietic Cell Growth Factors, Proteins, Colony-Stimulating Factors	approved, investigational	1
DB14475	L-Lactic acid	Drug	0	experimental	0
DB13149	Protein S human	Drug	Proteins, Anticoagulants, Biological Factors, Carbohydrates, Glycoconjugates, Blood Proteins, Amino Acids, Peptides, and Proteins, Hematologic Agents, Glycoproteins, Blood Coagulation Factor Inhibitors	approved	3
DB13147	Pancrelipase lipase	Drug	Enzymes, Lipase, antagonists & inhibitors, Carboxylic Ester Hydrolases, Enzymes and Coenzymes, Hydrolases, Esterases, Lipase, Gastrointestinal Agents	approved	1
DB14478	Povidone K30	Drug	0	approved, experimental	0
DB14479	Acetylcysteine zinc	Drug	Metal cations, Zinc Compounds, Metal divalent cations, Copper Absorption Inhibitor, Compounds used in a research, industrial, or household setting	experimental	0
DB13148	Coagulation factor X human	Drug	Proteins, Biological Factors, Factor X, Blood and Blood Forming Organs, Increased Coagulation Activity, Blood Proteins, Blood Coagulation Factors, Amino Acids, Peptides, and Proteins, Hemostatics, Factor X, agonists, Factor X, antagonists & inhibitors	approved, investigational	0
DB02490	(Diaminomethyl-Methyl-Amino)-Acetic Acid	Drug	0	experimental	1
DB01163	Amdinocillin	Drug	Renal Agents, Anti-Infective Agents, Urinary, Penicillins With Extended Spectrum, Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Antibacterials for Systemic Use	investigational, withdrawn	6
DB02494	(S)-3-phenyllactic acid	Drug	0	experimental	15
DB01162	Terazosin	Drug	Antihypertensive Agents Indicated for Hypertension, Adrenergic alpha-Antagonists, Genito Urinary System and Sex Hormones, Peripheral alpha-1 blockers, Urologicals, Hypotensive Agents, Quinazolines, Urological Agents, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Adrenergic Antagonists, Adrenergic alpha-1 Receptor Antagonists, Antihypertensive Agents, Drugs Used in Benign Prostatic Hypertrophy, P-glycoprotein inhibitors, Adrenergic Agents	approved	7
DB02493	Hydantocidin-5'-phosphate	Drug	0	experimental	1
DB01161	Chloroprocaine	Drug	Aminobenzoates, para-Aminobenzoates, Benzoates, Sensory System Agents, Nervous System, Local Anesthesia, Acids, Carbocyclic, Ester Local Anesthetic, Anesthetics, Nicotinic Antagonists, Peripheral Nervous System Agents, Anticholinergic Agents, Esters of Aminobenzoic Acid, NMDA Receptor Antagonists, Cholinesterase substrates, Central Nervous System Agents, Benzene Derivatives, Anesthetics, Local	approved	2
DB02492	Ghavamiol	Drug	Carbohydrates, Amines, Ammonium Compounds, Glycoside Hydrolases, antagonists & inhibitors, Onium Compounds, Imino Sugars, Alcohols, Monosaccharides, Pentoses, Imines, Sugar Alcohols, Pyrrolidines, Nitrogen Compounds	experimental	1
DB02491	4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine	Drug	0	experimental	1
DB01160	Dinoprost tromethamine	Drug	Biological Factors, Autacoids, Inflammation Mediators, Fatty Acids, Angiography, Reproductive Control Agents, Eicosanoids, Lipids, Abortifacient Agents, Nonsteroidal, Uterotonic agents, Fatty Acids, Unsaturated, Prostaglandins, Abortifacient Agents, Prostaglandins F	approved, vet_approved	2
DB01167	Itraconazole	Drug	QTc Prolonging Agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Antimycotics for Systemic Use, Agents causing hyperkalemia, Cytochrome P-450 CYP3A5 Inhibitors (strong), Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Cytochrome P-450 CYP3A4 Inhibitors (strong), Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Triazoles, Breast Cancer Resistance Protein Inhibitors, Cytochrome P-450 CYP3A7 Inhibitors (strong), Potential QTc-Prolonging Agents, Antifungal Agents, Hormone Antagonists, Drugs causing inadvertant photosensitivity, Triazole Derivatives, Piperazines, Steroid Synthesis Inhibitors, Chemically-Induced Disorders, Cytochrome P-450 CYP2E1 Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP3A5 Inhibitors, Antiinfectives for Systemic Use, Azole Antifungals, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Cytochrome P-450 CYP3A7 Inhibitors, Cytochrome P-450 CYP2B6 Inhibitors (strong), Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors, 14-alpha Demethylase Inhibitors	approved, investigational	2
DB02498	Carba-nicotinamide-adenine-dinucleotide	Drug	0	experimental	1
DB02497	L-Alpha-Glycerophosphorylserine	Drug	0	experimental	1
DB01166	Cilostazol	Drug	Quinolines, Neuroprotective Agents, QTc Prolonging Agents, Enzyme Inhibitors, Blood and Blood Forming Organs, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cardiovascular Agents, Tetrazoles, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Potential QTc-Prolonging Agents, Compounds used in a research, industrial, or household setting, Antiplatelet agents, Autonomic Agents, Phosphodiesterase Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Anti-Asthmatic Agents, Fibrin Modulating Agents, Protective Agents, Phosphodiesterase 3 Inhibitors, Agents producing tachycardia, Hematologic Agents, Bronchodilator Agents, Respiratory System Agents, Cytochrome P-450 CYP2C19 Substrates, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Substrates, Platelet Aggregation Inhibitors Excl. Heparin, Cytochrome P-450 CYP1A2 Substrates, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Vasodilating Agents	approved, investigational	1
DB02496	1-Deoxy-D-xylulose 5-phosphate	Drug	Carbohydrates, Sugar Phosphates	experimental	2
DB01165	Ofloxacin	Drug	Fluoroquinolones, Quinolines, QTc Prolonging Agents, Enzyme Inhibitors, Renal Agents, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Otologicals, BSEP/ABCB11 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Anti-Infective Agents, Quinolones, Cytochrome P-450 CYP1A2 Inhibitors, Anti-Bacterial Agents, Topoisomerase II Inhibitors, Quinolone Antimicrobial, Anti-Infective Agents, Urinary, Chemically-Induced Disorders, Antiinfectives for Systemic Use, Moderate Risk QTc-Prolonging Agents, OAT1/SLC22A6 inhibitors, Ophthalmologicals, Heterocyclic Compounds, Fused-Ring, Agents Causing Muscle Toxicity, Sensory Organs, Antibacterials for Systemic Use	approved	3
DB01164	Calcium chloride	Drug	Blood and Blood Forming Organs, Phosphate Binder, Calcium Compounds, Genito Urinary System and Sex Hormones, Blood Coagulation Factors, Urologicals, Ions, Mineral Supplements, Blood Substitutes and Perfusion Solutions, Hemodialysis Solution, Electrolyte Solutions, Supplements, Calcium Salts, Anions, Acids, Noncarboxylic, I.V. Solution Additives, Acids, Replacement Preparations, Acidifiers, Alimentary Tract and Metabolism, Chlorides, Electrolytes, Chlorine Compounds	approved	1
DB02495	9-(4-hydroxybutyl)-N2-phenylguanine	Drug	0	experimental	1
DB01169	Arsenic trioxide	Drug	Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Arsenicals, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Cardiotoxic antineoplastic agents, Ions, Oxides, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Hypotensive Agents, Drugs that are Mainly Renally Excreted, Myelosuppressive Agents, Organometallic Compounds, Anions, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Electrolytes, Hyperglycemia-Associated Agents, Oxygen Compounds	approved, investigational	10
DB01168	Procarbazine	Drug	Benzoates, Immunosuppressive Agents, Serotonin Agents, Acids, Carbocyclic, Antineoplastic and Immunomodulating Agents, Benzamides and benzamide derivatives, Alkylating Activity, Antineoplastic Agents, Monoamine Oxidase Inhibitors, Amides, Antidepressive Agents, Myelosuppressive Agents, Alkylating Drugs, Serotonin Modulators, Narrow Therapeutic Index Drugs, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Agents Causing Muscle Toxicity, Central Nervous System Depressants, Methylhydrazines, Benzene Derivatives	approved, investigational	2
DB02499	Dinor-N(Omega)-Hydroxy-L-Arginine	Drug	0	experimental	1
DB13141	Ambroxol acefyllinate	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Purines, Cycloparaffins, Amines, Aniline Compounds, Cyclohexylamines, Purinones, Cyclohexanes	investigational, experimental	0
DB14472	Insulin-like growth factor II	Drug	Proteins, Biological Factors, Somatomedins, Peptides, Blood Proteins, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins	experimental	0
DB13142	Calcium glubionate anhydrous	Drug	Calcium Salts, Carbohydrates, Polysaccharides, Alimentary Tract and Metabolism, Infant Food, Mineral Supplements, Oligosaccharides	approved	0
DB14473	Beroctocog alfa	Drug	Proteins, Biological Factors, Blood Proteins, Blood Coagulation Factors, Factor VIII, Amino Acids, Peptides, and Proteins, Hematologic Agents, Coagulants, Human Antihemophilic Factor	approved, investigational	0
DB14470	Influenza B virus B/Phuket/3073/2013 BVR-1B antigen (propiolactone inactivated)	Drug	0	approved	0
DB14471	2-Ethylhexyl 4-phenylbenzophenone-2'-carboxylate	Drug	0	experimental	0
DB13140	Bezlotoxumab	Drug	Proteins, Serum Globulins, Specific Immunoglobulins, Immunoglobulins, Immune Sera and Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antiinfectives for Systemic Use, Immunoproteins	approved, investigational	1
DB14487	Zinc acetate	Drug	Acids, Acyclic, Fatty Acids, Zinc Compounds, Various Alimentary Tract and Metabolism Products, Lipids, Acetates, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Vasoprotectives, Metal cations, Alimentary Tract and Metabolism, Fatty Acids, Volatile, Metal divalent cations, Copper Absorption Inhibitor	approved, investigational	124
DB13156	Inosine pranobex	Drug	Carbohydrates, Immunologic Factors, Ribonucleosides, Amines, Adjuvants, Immunologic, Aniline Compounds, Amides, Antiviral Agents, Purine Nucleosides, Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Anilides, Heterocyclic Compounds, Fused-Ring, Purines, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Acetanilides	approved	0
DB13157	Sodium lauryl sulfoacetate	Drug	Alimentary Tract and Metabolism, Drugs for Constipation, Enemas	approved, experimental	0
DB14488	Ferrous gluconate	Drug	Hematinics, Organometallic Compounds, Iron Bivalent, Oral Preparations, Antianemic Preparations, Blood and Blood Forming Organs, Antianemia Drugs, Iron Compounds, Hematologic Agents, Iron Preparations, Polyvalent cation containing laxatives, antacids, oral supplements, Minerals, Anemia, Iron-Deficiency	approved	13
DB14485	Zinc ascorbate	Drug	Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Vasoprotectives, Metal cations, Zinc Compounds, Metal divalent cations, Vitamin C and analogues, Polyvalent cation containing laxatives, antacids, oral supplements, Urinary Acidifying Agents, Vitamins	approved, nutraceutical	0
DB13154	Parachlorophenol	Drug	Hydrocarbons, Chlorinated, Phenols, Hydrocarbons, Halogenated, OATP1B3 substrates, Chlorobenzenes, Anti-Infective Agents, Anti-Infective Agents, Local, Benzene Derivatives, Drugs that are Mainly Renally Excreted	approved	1
DB14486	Niacinamide ascorbate	Drug	Vitamin C and analogues, Urinary Acidifying Agents, Vitamins	approved, nutraceutical	0
DB13155	Esculin	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Coumarins, Glycosides, Benzopyrans, Glucosides, Pyrans	approved	1
DB14489	Ferrous succinate	Drug	Hematinics, Organometallic Compounds, Iron Bivalent, Oral Preparations, Antianemic Preparations, Blood and Blood Forming Organs, Iron Compounds, Hematologic Agents, Iron Preparations	approved	13
DB13158	Clobetasone	Drug	Corticosteroids, Dermatological Preparations, Pregnadienetriols, Corticosteroids, Cytochrome P-450 Substrates, Immunosuppressive Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Dermatologicals, Hormones, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Ophthalmologicals, Corticosteroids, Moderately Potent (Group II), Cytochrome P-450 CYP3A Substrates, Pregnanes, Sensory Organs, Steroids, Fluorinated, Ointments, Steroids	approved	1
DB01170	Guanethidine	Drug	Autonomic Agents, Guanidine Derivatives and Diuretics, Sympatholytics, Antiglaucoma Preparations and Miotics, Antiadrenergic Agents, Peripherally Acting, Amidines, Cardiovascular Agents, Guanidines, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Ophthalmologicals, Neurotransmitter Agents, Guanidine Derivatives, Adrenergic Antagonists, Gastrointestinal Acidifying Agents, Catecholamine-depleting Sympatholytic, Antihypertensive Agents, Sensory Organs, Adrenergic Agents	approved	1
DB01174	Phenobarbital	Drug	Psycholeptics, Cytochrome P-450 Substrates, GABA Modulators, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Cytochrome P-450 CYP2C19 Inducers (strength unknown), UGT1A1 Inducers, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Cytochrome P-450 CYP2B6 Inducers (strong), Anticholinergic Agents, Cytochrome P-450 CYP3A4 Inducers (strong), Cytochrome P-450 CYP2C19 Inducers, BSEP/ABCB11 inducers, Hypnotics and Sedatives, P-glycoprotein substrates with narrow therapeutic index, Cytochrome P-450 CYP2E1 Inducers (strength unknown), Cytochrome P-450 CYP2C18 Substrates, Chemically-Induced Disorders, Cytochrome P-450 CYP3A Inducers (strong), Cytochrome P-450 CYP3A4 Inducers, Pyrimidinones, Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C19 Substrates, Neurotransmitter Agents, Narrow Therapeutic Index Drugs, Central Nervous System Depressants, Cytochrome P-450 CYP2C18 Inducers (strength unknown), Cytochrome P-450 CYP1A2 Inducers, Phenobarbital and similars, Cytochrome P-450 CYP3A5 Inducers (strong), Cytochrome P-450 CYP2C8 Inducers (strength unknown), Cytochrome P-450 CYP2C8 Inducers, Nervous System, Barbiturates and Derivatives, Enzyme Inducing Antiepileptic Drugs, UGT2B7 inducers, Cytochrome P-450 Enzyme Inducers, Pyrimidines, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2E1 Inducers (weak), Barbiturates, Excitatory Amino Acid Agents, Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 CYP2E1 Inducers, Cytochrome P-450 CYP2A6 Inducers, Cytochrome P-450 CYP2C8 Inducers (strong), GABA Agents, P-glycoprotein substrates, Nicotinic Antagonists, Cytochrome P-450 CYP3A7 Inducers, P-glycoprotein inducers, Cytochrome P-450 CYP2C9 Substrates, Anticonvulsants, Cytochrome P-450 2C18 Inducers, Central Nervous System Agents, Cytochrome P-450 CYP2C9 Inducers, Methemoglobinemia Associated Agents, Excitatory Amino Acid Antagonists, Cytochrome P-450 CYP3A7 Inducers (strength unknown)	approved, investigational	7
DB01173	Orphenadrine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Ethers, Chemically Close to Antihistamines, QTc Prolonging Agents, Enzyme Inhibitors, Amines, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Centrally-mediated Muscle Relaxation, Muscarinic Antagonists, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Muscle Relaxants, Peripheral Nervous System Agents, Anticholinergic Agents, Cytochrome P-450 CYP1A2 Inhibitors, Anti-Dyskinesia Agents, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Histamine H1 Antagonists, Cholinergic Agents, Musculo-Skeletal System, Muscle Relaxants, Centrally Acting Agents, Potential QTc-Prolonging Agents, Benzene Derivatives, Autonomic Agents, Benzhydryl Compounds, Chemically-Induced Disorders, Cytochrome P-450 CYP2E1 Inhibitors, Agents producing tachycardia, Parasympatholytics, Anti-Parkinson Drugs, Neurotransmitter Agents, Cytochrome P-450 CYP3A Inhibitors, Histamine Antagonists, Miscellaneous Skeletal Muscle Relaxants, Cytochrome P-450 CYP3A Substrates, Ethylamines, Central Nervous System Depressants, Cytochrome P-450 CYP2B6 Inhibitors (strong), Cytochrome P-450 CYP3A4 Inhibitors, NMDA Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Inhibitors (strong), Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved	7
DB01172	Kanamycin	Drug	Nephrotoxic agents, Carbohydrates, Enzyme Inhibitors, Agents that produce neuromuscular block (indirect), Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Ophthalmologicals, Anti-Bacterial Agents, Narrow Therapeutic Index Drugs, Intestinal Antiinfectives, Alimentary Tract and Metabolism, Aminoglycoside Antibacterials, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Glycosides, Sensory Organs, Antibacterials for Systemic Use, Protein Synthesis Inhibitors	approved, investigational, vet_approved	2
DB01171	Moclobemide	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, Enzyme Inhibitors, Cytochrome P-450 Substrates, Monoamine Oxidase A Inhibitors, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Acids, Carbocyclic, Amides, Cytochrome P-450 CYP2C19 Inhibitors, Antidepressive Agents, Chlorobenzoates, Serotonin Modulators, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Benzene Derivatives, Agents that reduce seizure threshold, Benzoates, Benzamides and benzamide derivatives, Monoamine Oxidase Inhibitors, Psychotropic Drugs, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Central Nervous System Depressants, Agents that produce hypertension, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Psychoanaleptics	approved, investigational	3
DB01178	Chlormezanone	Drug	Neuromuscular Agents, Tranquilizing Agents, Oxazol, Thiazine, and Triazine Derivatives, Thiazines, Muscle Relaxants, Psychotropic Drugs, Peripheral Nervous System Agents, Sulfur Compounds, Central Nervous System Depressants, Musculo-Skeletal System, Muscle Relaxants, Centrally Acting Agents, Anti-Anxiety Agents, Central Nervous System Agents	approved, investigational, withdrawn	1
DB01177	Idarubicin	Drug	Anthracycline Topoisomerase Inhibitor, Carbohydrates, Anthracyclines, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytotoxic Antibiotics and Related Substances, Immunosuppressive Agents, Topoisomerase Inhibitors, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Cardiotoxic antineoplastic agents, Antibiotics, Antineoplastic, Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index, Myelosuppressive Agents, Cytochrome P-450 CYP2C9 Substrates, Topoisomerase II Inhibitors, Naphthacenes, Glycosides, Cytochrome P-450 CYP2D6 Substrates, Anthracyclines and Related Substances	approved	2
DB01176	Cyclizine	Drug	Autonomic Agents, QTc Prolonging Agents, Piperazines, Cytochrome P-450 Enzyme Inhibitors, Peripheral Nervous System Agents, Neurotransmitter Agents, Histamine H1 Antagonists, Piperazine Derivatives, Histamine Antagonists, Central Nervous System Depressants, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors, Antiemetics, Potential QTc-Prolonging Agents, Central Nervous System Agents, Histamine Agents, Antihistamines for Systemic Use, Gastrointestinal Agents	approved	2
DB01175	Escitalopram	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Hypoglycemia-Associated Agents, Muscarinic Antagonists, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Benzofurans, Anticholinergic Agents, Serotonin Modulators, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Nitriles, Drugs causing inadvertant photosensitivity, Selective Serotonin Reuptake Inhibitors, P-glycoprotein substrates, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Antidepressive Agents, Second-Generation, Psychotropic Drugs, Membrane Transport Modulators, Cytochrome P-450 CYP2C19 Substrates, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Central Nervous System Depressants, Neurotransmitter Uptake Inhibitors, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2D6 Inhibitors (weak), Propylamines, Psychoanaleptics	approved	11
DB01179	Podofilox	Drug	Antineoplastic Agents, Phytogenic, Tubulin Modulators, Benzyl Compounds, Dermatologicals, Lignans, Mitosis Modulators, Decreased Mitosis, Antiviral Agents, Tetrahydronaphthalenes, Misc. Skin and Mucous Membrane Agents, Naphthalenes, Antimitotic Agents, Keratolytic Agents, Benzene Derivatives	approved	3
DB14480	Acetylcysteine amide	Drug	Amino Acids, Neutral, Cysteine, Sulfur Compounds, Amino Acids, Sulfur, Amino Acids, Peptides, and Proteins, Amino Acids, Sulfhydryl Compounds	experimental	0
DB14483	Calcium ascorbate	Drug	Acids, Acyclic, Carbohydrates, Hydroxy Acids, Protective Agents, Vitamins, Antioxidants, Micronutrients, Physiological Phenomena, Food and Beverages, Vitamin C and analogues, Sugar Acids, Urinary Acidifying Agents, Growth Substances, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food	approved, nutraceutical	0
DB13152	Coagulation Factor IX Human	Drug	Increased Coagulation Activity, Blood Coagulation Factors, Hemostatics	approved	7
DB13153	Levomenol	Drug	Complex Mixtures, Oils, Plant Preparations, Biological Products, OATP1B1/SLCO1B1 Substrates, Lipids, OATP1B3 substrates, Pharmaceutical Preparations, Terpenes	approved, experimental	0
DB14484	Magnesium ascorbate	Drug	Urinary Acidifying Agents, Compounds used in a research, industrial, or household setting	approved, nutraceutical	0
DB13150	Coagulation factor VII human	Drug	Proteins, Biological Factors, Increased Coagulation Activity, Blood Proteins, Blood Coagulation Factors, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Enzyme Precursors	approved, investigational	3
DB14481	Calcium phosphate dihydrate	Drug	Anions, Acids, Noncarboxylic, Acids, Phosphoric Acids, Calcium Compounds, Electrolytes, Ions, Phosphorus Compounds, Phosphate salts, Phosphorus Acids	approved	33
DB14482	Sodium ascorbate	Drug	Osmotic Laxatives, Vitamin C and analogues, Laxatives, Urinary Acidifying Agents, Compounds used in a research, industrial, or household setting, Vitamins	approved, nutraceutical	0
DB13151	Anti-inhibitor coagulant complex	Drug	Proteins, Biological Factors, Blood and Blood Forming Organs, Blood Proteins, Blood Coagulation Factors, Amino Acids, Peptides, and Proteins, Hematologic Agents, Coagulants, Hemostatics, Reversed Anticoagulation Activity	approved, investigational	8
DB03800	Deoxyuridine monophosphate	Drug	Carbohydrates, Pyrimidines, Ribonucleotides, Deoxyribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Uracil Nucleotides, Nucleotides, Pyrimidine Nucleotides	experimental	8
DB03807	1-(2-Chlorophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester	Drug	0	experimental	1
DB03808	Hexamidine	Drug	Ophthalmologicals, Nasal Preparations, Throat Preparations, Antiseptics and Disinfectants, Dermatologicals, Amidines, Biguanides and Amidines, Sensory Organs, Ophthalmological and Otological Preparations, Anti-Infective Agents, Anti-Infective Agents, Local	experimental	2
DB03801	Lysine Nz-Carboxylic Acid	Drug	0	experimental	19
DB03802	1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol	Drug	0	experimental	1
DB03803	N,N-[2,5-O-dibenzyl-glucaryl]-DI-[valinyl-aminomethanyl-pyridine]	Drug	0	experimental	1
DB03804	5-Bromothienyldeoxyuridine	Drug	0	experimental	1
DB03809	9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine	Drug	0	experimental	1
DB03810	3-Methylglutamic acid	Drug	Amino Acids, Dicarboxylic, Excitatory Amino Acids, Amino Acids, Peptides, and Proteins, Amino Acids, Acidic, Glutamates, Amino Acids	experimental	0
DB03811	Histidinol	Drug	Amines, Imidazoles, Propanols, Amino Alcohols, Alcohols, Propanolamines	experimental	2
DB03816	Difluoromethionine	Drug	0	experimental	1
DB03817	L-2,4-diaminobutyric acid	Drug	Acids, Acyclic, Fatty Acids, Butyrates, Fatty Acids, Volatile, Amino Acids, Peptides, and Proteins, Lipids, Amino Acids	experimental	1
DB03818	N-[Tosyl-D-Prolinyl]Amino-Ethanethiol	Drug	0	experimental	1
DB03819	Salicylhydroxamic Acid	Drug	Antiprotozoals, Trypanocidal Agents, Amides, Antifungal Agents, Anti-Infective Agents, Antiparasitic Agents	experimental	0
DB03812	3-{2,6,8-trioxo-9-[(2S,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate	Drug	0	experimental	1
DB03813	2-Decenoyl N-Acetyl Cysteamine	Drug	0	experimental	2
DB03814	2-(N-morpholino)ethanesulfonic acid	Drug	Oxazines, Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfur Acids, Hydrocarbons, Acyclic, Sulfonic Acids, Alkanes, Buffers	experimental	39
DB03815	Fucitol	Drug	Carbohydrates, Alcohols	experimental	1
DB03820	(2S,5R,6R)-6-({(6S)-6-[(Ammonioacetyl)amino]-6-carboxylatohexanoyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate	Drug	0	experimental	1
DB03821	2-Amino-3-Hydroxy-3-Phosphonooxy-Propionic Acid	Drug	0	experimental	1
DB03822	Ethyl dihydrogen phosphate	Drug	Anions, Acids, Noncarboxylic, Acids, Phosphoric Acids, Organophosphorus Compounds, Electrolytes, Ions, Phosphorus Compounds, Phosphorus Acids	experimental	2
DB03827	(3s)-3,4-Di-N-Hexanoyloxybutyl-1-Phosphocholine	Drug	0	experimental	1
DB03828	RU78299	Drug	0	experimental	1
DB03829	Pseudouridine-5'-Monophosphate	Drug	0	experimental	0
DB03823	Epigallocatechin	Drug	Heterocyclic Compounds, Fused-Ring, Flavonoids, Chromans, Benzopyrans, Chromones, Pyrans	investigational, experimental	0
DB03824	7-Iodo-1,2,3,4-Tetrahydro-Isoquinoline	Drug	0	experimental	1
DB03825	Rhodamine 6G	Drug	Luminescent Agents, Xanthenes, Heterocyclic Compounds, Fused-Ring, P-glycoprotein substrates, Coloring Agents, Laboratory Chemicals, Antineoplastic Agents, Indicators and Reagents, Compounds used in a research, industrial, or household setting, Fluorescent Dyes	experimental	2
DB03826	5,6-Diaminouracil	Drug	Pyrimidines, Pyrimidinones	experimental	0
DB03830	Phosphorylated Dihydropteroate	Drug	0	experimental	1
DB03831	[(Z)-octadec-9-enyl] (2R)-2,3-bis(oxidanyl)propanoate	Drug	0	experimental	0
DB03832	3-Carboxy-N,N,N-Trimethyl-2-(Octanoyloxy)Propan-1-Aminium	Drug	0	experimental	1
DB03833	2-Prolyl-5-Tert-Butyl-[1,3,4]Oxadiazole	Drug	0	experimental	1
DB02502	8-hydroxy-2'-deoxyguanosine	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Immunologic Factors, Purines, Ribonucleosides, Nucleic Acids, Nucleotides, and Nucleosides, Adjuvants, Immunologic, Glycosides, Nucleosides, Deoxyribonucleosides, Purine Nucleosides	experimental	0
DB02501	N(2)-succinyl-L-arginine	Drug	0	experimental	1
DB02500	6-(Dihydroxy-Isobutyl)-Thymine	Drug	0	experimental	1
DB02506	2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid	Drug	0	experimental	5
DB03839	D-Tyrosine	Drug	0	experimental	0
DB02505	N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl)	Drug	0	experimental	1
DB02504	[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid	Drug	0	experimental	1
DB02503	4-(Carboxyvin-2-Yl)Phenylboronic Acid	Drug	0	experimental	1
DB03834	(3S)-3-(dioxidosulfanyl)-N-[(1Z)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine	Drug	0	experimental	1
DB03835	N-[(5S,7R,8S,9S,10R)-8,9,10-Trihydroxy-7-(hydroxymethyl)-2,4-dioxo-6-oxa-1,3-diazaspiro[4.5]dec-3-yl]acetamide	Drug	0	experimental	1
DB02509	Farnesol	Drug	Sesquiterpenes, Lipids, Terpenes, Fatty Alcohols, Alcohols	experimental	2
DB03836	1,3,5-trichlorobenzene	Drug	Hydrocarbons, Chlorinated, Hydrocarbons, Halogenated, Benzene Derivatives	experimental	1
DB02508	Isopentyl Pyrophosphate	Drug	0	experimental	4
DB03837	Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide	Drug	0	experimental	1
DB14531	Carbonate ion	Drug	0	experimental	0
DB13200	Lipegfilgrastim	Drug	Biological Factors, Carbohydrates, Cytokines, Glycoconjugates, Peptides, Adjuvants, Immunologic, Antineoplastic and Immunomodulating Agents, Granulocyte Colony-Stimulating Factors, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Glycoproteins, Alcohols, Hematopoietic Cell Growth Factors, Macromolecular Substances, Proteins, Ethylene Glycols, Pegylated agents, Glycols, Polymers, Compounds used in a research, industrial, or household setting, Colony-Stimulating Factors	approved, investigational	1
DB14532	Zinc cation	Drug	Metal cations, Zinc Compounds, Metal divalent cations, Copper Absorption Inhibitor, Polyvalent cation containing laxatives, antacids, oral supplements, Decreased Copper Ion Absorption	experimental	0
DB13201	Trenonacog alfa	Drug	Proteins, Biological Factors, Blood Proteins, Blood Coagulation Factors, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Enzyme Precursors	investigational	0
DB14530	Chromous sulfate	Drug	Drugs that are Mainly Renally Excreted	approved	1
DB13204	Dimethyl carbate	Drug	Insecticides and Repellents, Antiparasitic Products, Insecticides and Repellents, Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents	experimental	0
DB14535	Indium cation In-111	Drug	0	experimental	0
DB14536	Strontium cation Sr-89	Drug	Radioactive Therapeutic Agent, Radiopharmaceutical Activity	experimental	0
DB13205	Teclozan	Drug	Dichloroacetamide Derivatives, Amines, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Benzyl Compounds, Benzene Derivatives	experimental	0
DB14533	Zinc chloride	Drug	Mouthwashes, Blood and Blood Forming Organs, Zinc Compounds, Ions, Blood Substitutes and Perfusion Solutions, Electrolyte Solutions, Household Products, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, EENT Drugs, Miscellaneous, Vasoprotectives, Anions, Acids, Noncarboxylic, Basic Ointments and Protectants, I.V. Solution Additives, Metal cations, Acids, Metal divalent cations, Dental Agents, Skin Ulcer, drug therapy, Cosmetics, Electrolytes, Copper Absorption Inhibitor, Compounds used in a research, industrial, or household setting, Chlorine Compounds	approved, investigational	97
DB13202	Piprozolin	Drug	Sulfur Compounds, Alimentary Tract and Metabolism, Thiazoles, Bile Therapy, Bile and Liver Therapy	experimental	0
DB14534	Gold cation (1+)	Drug	0	experimental	0
DB13203	Bamifylline	Drug	Autonomic Agents, Cytochrome P-450 Substrates, Sensory System Agents, Anti-Asthmatic Agents, Cardiovascular Agents, Bronchodilator Agents, Respiratory System Agents, Peripheral Nervous System Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Purines, Analgesics, Cytochrome P-450 CYP1A2 Substrates, Drugs for Obstructive Airway Diseases, Xanthine derivatives, Central Nervous System Agents, Vasodilating Agents, Purinones	experimental	0
DB14539	Hydrocortisone acetate	Drug	Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 Substrates, Immunosuppressive Agents, Pregnenediones, Cytochrome P-450 CYP3A7 Substrates, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, 11-Hydroxycorticosteroids, 17-Hydroxycorticosteroids, Corticosteroids, Cytochrome P-450 CYP3A5 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP3A4 Inducers, Hydrocortisone and derivatives, Hydroxycorticosteroids, Cytochrome P-450 CYP3A Substrates, Aerosols, Pregnanes, Administration, Topical, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Pregnenes, Steroids	approved, vet_approved	4
DB13208	Prednylidene	Drug	Corticosteroids for Systemic Use, Pregnadienetriols, Corticosteroids, Cytochrome P-450 Substrates, Immunosuppressive Agents, Corticosteroids for Systemic Use, Plain, Glucocorticoids, Pregnadienes, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A Substrates, Pregnanes, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Hyperglycemia-Associated Agents, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Cytochrome P-450 CYP3A5 Inducers, Steroids	experimental	0
DB13209	Bismuth subnitrate	Drug	Metals, Elements, Radioactive, Radioisotopes, Metals, Heavy, Elements, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Gastric Acid Lowering Agents, Alimentary Tract and Metabolism, Drugs for Acid Related Disorders, Isotopes, Antacids, Bismuth containing drugs, Gastrointestinal Agents, Neurotoxic agents	approved	0
DB14537	Chromate ion Cr-51	Drug	Radioactive Diagnostic Agent, Radiopharmaceutical Activity	experimental	0
DB13206	Bamethan	Drug	2-Amino-1-Phenylethanol Derivatives, Amines, Ethylamines, Peripheral Vasodilators, Cardiovascular Agents, Amino Alcohols, Vasodilating Agents, Alcohols	experimental	0
DB03880	Batimastat	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Enzyme Inhibitors, Sulfur Compounds, Amino Acids, Essential, Protease Inhibitors, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Amino Acids, Metalloendopeptidases, antagonists & inhibitors	experimental	5
DB13207	Arginine glutamate	Drug	Liver Therapy, Oligopeptides, Peptides, Alimentary Tract and Metabolism, Liver Therapy, Lipotropics, Amino Acids, Peptides, and Proteins, Bile and Liver Therapy	investigational	0
DB14538	Hydrocortisone aceponate	Drug	Corticosteroids, Dermatological Preparations, Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 Substrates, Immunosuppressive Agents, Pregnenediones, Cytochrome P-450 CYP3A7 Substrates, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Corticosteroids, Potent (Group III), 11-Hydroxycorticosteroids, 17-Hydroxycorticosteroids, Corticosteroids, Cytochrome P-450 CYP3A5 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP3A4 Inducers, Dermatologicals, Hydrocortisone and derivatives, Hydroxycorticosteroids, Cytochrome P-450 CYP3A Substrates, Pregnanes, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Pregnenes, Steroids	experimental, vet_approved	4
DB01222	Budesonide	Drug	Corticosteroids, Dermatological Preparations, Cytochrome P-450 Substrates, Immunosuppressive Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP2C19 Inducers (strength unknown), Cytochrome P-450 CYP2B6 Inducers (strength unknown), BSEP/ABCB11 Substrates, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Drugs that are Mainly Renally Excreted, OAT3/SLC22A8 Substrates, Peripheral Nervous System Agents, Intestinal Antiinflammatory Agents, Nasal Preparations, Corticosteroids, Potent (Group III), Alimentary Tract and Metabolism, Cytochrome P-450 CYP2C19 Inducers, Corticosteroids Acting Locally, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Corticosteroid Hormone Receptor Agonists, Corticosteroids for Systemic Use, Corticosteroids, Anti-Asthmatic Agents, Cytochrome P-450 CYP3A4 Inducers, Respiratory System Agents, Pregnanes, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Pregnenes, Cytochrome P-450 CYP2C8 Inducers, Pregnenediones, Anti-Inflammatory Agents, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Adrenals, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP3A5 Inducers, Autonomic Agents, Cytochrome P-450 CYP3A5 Inducers (moderate), Cytochrome P-450 CYP2A6 Inducers, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein substrates, Dermatologicals, Bronchodilator Agents, Agents to Treat Airway Disease, Cytochrome P-450 CYP3A Substrates, Drugs for Obstructive Airway Diseases, Cytochrome P-450 CYP2C9 Inducers, Steroids	approved	2
DB03885	L-gamma-glutamyl-S-(naphthalen-1-ylmethyl)-L-cysteinylglycine	Drug	0	experimental	0
DB02553	Glutathionylspermidine disulfide	Drug	0	experimental	1
DB03886	Biopterin	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Coenzymes, Pterins, Enzymes and Coenzymes, Pteridines, Pigments, Biological	experimental	3
DB02552	Geranyl Diphosphate	Drug	Anions, Acids, Noncarboxylic, Acids, Phosphoric Acids, Electrolytes, Ions, Phosphorus Compounds, Terpenes, Polyphosphates, Phosphate salts, Phosphorus Acids	experimental	8
DB01221	Ketamine	Drug	Cytochrome P-450 Substrates, Excitatory Amino Acid Agonists, Sensory System Agents, Nervous System, Cytochrome P-450 CYP3A Inducers, Amino Acids, Peptides, and Proteins, Anesthetics, Intravenous, Amino Acids, Acidic, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Miscellaneous General Anesthetics, Cyclohexanes, Peripheral Nervous System Agents, Anesthetics, General, Cytochrome P-450 Enzyme Inducers, Amino Acids, Dicarboxylic, Analgesics, Excitatory Amino Acids, N-Methylaspartate, antagonists & inhibitors, Cytochrome P-450 CYP2C8 Substrates, Excitatory Amino Acid Agents, Cycloparaffins, Cholinesterase Inhibitors, Cytochrome P-450 CYP3A4 Inducers, N-Methylaspartate, agonists, Agents producing tachycardia, Anesthetics, Amino Acids, Cytochrome P-450 CYP2C9 Substrates, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, NMDA Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates, Anesthetics, Dissociative, Vasodilating Agents, Excitatory Amino Acid Antagonists	approved, vet_approved	14
DB01220	Rifaximin	Drug	Antibiotics for Topical Use, Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Inducers, Amides, Lactams, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C19 Inducers (strong), Rifamycins, Anti-Infective Agents, Lactams, Macrocyclic, Cytochrome P-450 CYP3A4 Inducers (strong), Anti-Bacterial Agents, Cytochrome P-450 Enzyme Inducers, Intestinal Antiinfectives, Alimentary Tract and Metabolism, Cytochrome P-450 CYP2C19 Inducers, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Rifamycin Antibacterial, Gastrointestinal Agents, Cytochrome P-450 CYP3A Inducers (strong), Cytochrome P-450 CYP3A4 Inducers, Dermatologicals, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C8 Inducers (strength unknown)	approved, investigational	2
DB03887	Alpha-Adenosine Monophosphate	Drug	0	experimental	1
DB02551	6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine	Drug	0	experimental	1
DB03888	N-Allyl-6-{[3-(4-bromophenyl)-1-methyl-1H-indazol-6-yl]oxy}-N-methyl-1-hexanamine	Drug	0	experimental	1
DB02550	8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine	Drug	0	experimental	1
DB01226	Mivacurium	Drug	Neuromuscular Agents, Isoquinolines, Neuromuscular-Blocking Agents (Nondepolarizing), Agents producing tachycardia, Muscarinic Antagonists, Muscle Relaxants, Nicotinic Antagonists, Peripheral Nervous System Agents, Anticholinergic Agents, Heterocyclic Compounds, Fused-Ring, Cholinergic Agents, Muscle Relaxants, Peripherally Acting Agents, Central Nervous System Depressants, Musculo-Skeletal System, Neuromuscular Blocking Agents	approved	4
DB02557	Phosphoramidon	Drug	Carbohydrates, Enzyme Inhibitors, Glycoconjugates, Peptides, Protease Inhibitors, Amino Acids, Peptides, and Proteins, Anti-Infective Agents, Metalloendopeptidases, antagonists & inhibitors	experimental	2
DB03881	(2S,3R,4S,5S)-3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidinium	Drug	0	experimental	2
DB02556	D-Phenylalanine	Drug	0	experimental	2
DB01225	Enoxaparin	Drug	Anticoagulants, Carbohydrates, Polysaccharides, Blood and Blood Forming Organs, Glycosaminoglycans, Fibrin Modulating Agents, Heparin (Low Molecular Weight), Heparin Group, Agents causing hyperkalemia, Heparin and similars, Hematologic Agents, Cardiovascular Agents	approved	2
DB03882	5-Alpha-Androstane-3-Beta,17beta-Diol	Drug	0	experimental	1
DB02555	SP4160	Drug	0	experimental	1
DB01224	Quetiapine	Drug	Psycholeptics, QTc Prolonging Agents, Tranquilizing Agents, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 CYP3A7 Substrates, Nervous System, Diazepines, Oxazepines, Thiazepines and Oxepines, Hypotensive Agents, Muscarinic Antagonists, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Azepines, Drugs that are Mainly Renally Excreted, Anticholinergic Agents, Serotonin 5-HT2 Receptor Antagonists, Antipsychotic Agents, Histamine H1 Antagonists, Antipsychotic Agents (Second Generation Atypical), Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Adrenergic Antagonists, Adrenergic alpha-1 Receptor Antagonists, Dopamine Antagonists, Cytochrome P-450 CYP3A5 Substrates, Adrenergic alpha-Antagonists, P-glycoprotein substrates, Agents producing tachycardia, Moderate Risk QTc-Prolonging Agents, Psychotropic Drugs, Cytochrome P-450 CYP2C19 Substrates, Dibenzothiazepines, Heterocyclic Compounds, Fused-Ring, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Thiepins, Agents that produce hypertension, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Dopamine D2 Receptor Antagonists, Hyperglycemia-Associated Agents, Thiazepines, Serotonin 5-HT1 Receptor Antagonists	approved	24
DB03883	Carboxyethyllumazine	Drug	0	experimental	0
DB01223	Aminophylline	Drug	Purinergic P1 Receptor Antagonists, Enzyme Inhibitors, Amines, Cytochrome P-450 Substrates, Cardiovascular Agents, Purinergic Agents, Cytochrome P-450 CYP3A4 Substrates, Polyamines, Ethylenediamines, Peripheral Nervous System Agents, Alkaloids, Diamines, Purines, Xanthines and Adrenergics, Purinergic Antagonists, Xanthine derivatives, Compounds used in a research, industrial, or household setting, Purinones, Agents that reduce seizure threshold, Autonomic Agents, Phosphodiesterase Inhibitors, Cytochrome P-450 CYP2E1 Substrates, Anti-Asthmatic Agents, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Protective Agents, Bronchodilator Agents, Respiratory Smooth Muscle Relaxants, Respiratory System Agents, Cardiotonic Agents, Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Drugs for Obstructive Airway Diseases, Pharmaceutical Preparations	approved	4
DB03884	Phenylpyruvic acid	Drug	Pyruvates, Acids, Carbocyclic, Keto Acids	experimental	6
DB02554	UDP-6-sulfoquinovose	Drug	0	experimental	0
DB01229	Paclitaxel	Drug	Microtubule Inhibitors, Taxane Derivatives, Antineoplastic Agents, Phytogenic, BSEP/ABCB11 Inhibitors, Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 CYP3A7 Substrates, Tubulin Modulators, Cytochrome P-450 CYP3A Inducers, Mitosis Modulators, BSEP/ABCB11 Substrates, Cardiotoxic antineoplastic agents, Hypotensive Agents, OATP1B3 substrates, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, BSEP/ABCB11 Substrates with Narrow Therapeutic Index, Cytochrome P-450 Enzyme Inducers, Taxoids, Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C8 Substrates, P-glycoprotein substrates with narrow therapeutic index, Neurotoxic agents, Cycloparaffins, Cytochrome P-450 CYP3A5 Substrates, Cyclodecanes, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A4 Inducers, Antineoplastic Agents, Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index, Microtubule Inhibition, Myelosuppressive Agents, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Antimitotic Agents, Diterpenes, P-glycoprotein inhibitors, Terpenes	approved, vet_approved	6
DB01228	Encainide	Drug	QTc Prolonging Agents, Voltage-Gated Sodium Channel Blockers, Amines, Cytochrome P-450 Substrates, Aniline Compounds, Amides, Cardiovascular Agents, Membrane Transport Modulators, Anilides, Antiarrhythmics, Class I, Potential QTc-Prolonging Agents, Cytochrome P-450 CYP2D6 Substrates, Sodium Channel Blockers, Cardiac Therapy, Antiarrhythmic agents, Antiarrhythmics, Class Ic	approved, investigational, withdrawn	1
DB02559	6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine	Drug	0	experimental	2
DB01227	Levacetylmethadol	Drug	QTc Prolonging Agents, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Sensory System Agents, Cytochrome P-450 CYP3A7 Substrates, Ketones, Narcotics, Nervous System, Drugs Used in Addictive Disorders, Cytochrome P-450 CYP3A4 Substrates, Moderate Risk QTc-Prolonging Agents, Nicotinic Antagonists, Peripheral Nervous System Agents, Anticholinergic Agents, Analgesics, Cytochrome P-450 CYP3A Substrates, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Drugs Used in Opioid Dependence, Opioids, Central Nervous System Agents	approved, investigational	3
DB02558	N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine	Drug	0	experimental	1
DB03889	S-(N-hydroxy-N-bromophenylcarbamoyl)glutathione	Drug	Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins	experimental	1
DB14542	Hydrocortisone phosphate	Drug	Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Pregnenediones, Cytochrome P-450 CYP3A7 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Adrenal Cortex Hormones, Hydrocortisone and derivatives, Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Hydroxycorticosteroids, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A Substrates, Pregnanes, 11-Hydroxycorticosteroids, 17-Hydroxycorticosteroids, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Pregnenes, Steroids	approved, vet_approved	4
DB13211	Guanoxan	Drug	Guanidine Derivatives, Antiadrenergic Agents, Peripherally Acting, Amidines, Antihypertensive Agents	approved	0
DB14543	Hydrocortisone probutate	Drug	Corticosteroids, Dermatological Preparations, Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 Substrates, Immunosuppressive Agents, Pregnenediones, Cytochrome P-450 CYP3A7 Substrates, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Corticosteroids, Moderately Potent (Group II), Cytochrome P-450 Enzyme Inducers, 11-Hydroxycorticosteroids, 17-Hydroxycorticosteroids, Corticosteroids, Cytochrome P-450 CYP3A5 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP3A4 Inducers, Dermatologicals, Hydrocortisone and derivatives, Hydroxycorticosteroids, Cytochrome P-450 CYP3A Substrates, Pregnanes, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Pregnenes, Steroids	approved, vet_approved	4
DB13212	Phenolsulfonphthalein	Drug	Phenolphthaleins, Coloring Agents, Laboratory Chemicals, Tests for Renal Function and Ureteral Injuries, Phenols, Indicators and Reagents, Diagnostic Agents, Compounds used in a research, industrial, or household setting, Benzene Derivatives	experimental	0
DB14540	Hydrocortisone butyrate	Drug	Corticosteroids, Dermatological Preparations, Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 Substrates, Immunosuppressive Agents, Pregnenediones, Cytochrome P-450 CYP3A7 Substrates, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Corticosteroids, Moderately Potent (Group II), Cytochrome P-450 Enzyme Inducers, 11-Hydroxycorticosteroids, 17-Hydroxycorticosteroids, Corticosteroids, Cytochrome P-450 CYP3A5 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP3A4 Inducers, Dermatologicals, Hydrocortisone and derivatives, Hydroxycorticosteroids, Cytochrome P-450 CYP3A Substrates, Pregnanes, Administration, Topical, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Pregnenes, Steroids	approved, vet_approved	4
DB14541	Hydrocortisone cypionate	Drug	Corticosteroids, Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Pregnenediones, Cytochrome P-450 CYP3A7 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Adrenal Cortex Hormones, Hydrocortisone and derivatives, Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Hydroxycorticosteroids, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A Substrates, Pregnanes, 11-Hydroxycorticosteroids, 17-Hydroxycorticosteroids, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Pregnenes, Steroids	approved, investigational, vet_approved	4
DB13210	Sodium chlorite	Drug	Anions, Acids, Noncarboxylic, Acids, Dermatologicals, Electrolytes, Ions, Preparations for Treatment of Wounds and Ulcers, Chlorine Compounds, Cicatrizants	experimental	0
DB13215	Sulfobromophthalein	Drug	Phenolphthaleins, Tests for Liver Functional Capacity, Coloring Agents, Laboratory Chemicals, Phenols, Indicators and Reagents, Diagnostic Agents, Compounds used in a research, industrial, or household setting, Benzene Derivatives	experimental	0
DB14546	Sulfate ion	Drug	Osmotic Laxatives, Laxatives, Increased Large Intestinal Motility, Osmotic Activity, Inhibition Large Intestine Fluid/Electrolyte Absorption	investigational, experimental	0
DB14547	Chloride ion	Drug	Adrenergic Agonists	experimental	0
DB13216	Oxolamine	Drug	Antitussive Agents, Cough and Cold Preparations, Oxazoles, Central Nervous System Agents, Respiratory System Agents	approved	0
DB14544	Hydrocortisone valerate	Drug	Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 Substrates, Immunosuppressive Agents, Pregnenediones, Cytochrome P-450 CYP3A7 Substrates, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, 11-Hydroxycorticosteroids, 17-Hydroxycorticosteroids, Corticosteroids, Cytochrome P-450 CYP3A5 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP3A4 Inducers, Hydrocortisone and derivatives, Hydroxycorticosteroids, Cytochrome P-450 CYP3A Substrates, Pregnanes, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Pregnenes, Steroids	approved, vet_approved	4
DB13213	Butaperazine	Drug	Heterocyclic Compounds, Fused-Ring, Psycholeptics, Antipsychotic Agents, Sulfur Compounds, Nervous System, Central Nervous System Depressants, Phenothiazines, Phenothiazines With Piperazine Structure, Neurotoxic agents	approved	0
DB13214	Sulfadicramide	Drug	Ophthalmologicals, Sulfonamides, Sensory Organs, Anti-Infective Agents	experimental	0
DB14545	Hydrocortisone succinate	Drug	Corticosteroids, Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 Substrates, Immunosuppressive Agents, Pregnenediones, Hormones, Hormone Substitutes, and Hormone Antagonists, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Hydrocortisone and derivatives, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Hydroxycorticosteroids, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A Substrates, Pregnanes, 11-Hydroxycorticosteroids, 17-Hydroxycorticosteroids, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Pregnenes, Steroids	approved	0
DB13219	Medifoxamine	Drug	Amines, Nervous System, Central Nervous System Depressants, Antidepressive Agents, Psychoanaleptics	approved	0
DB03890	N-[2-(1-Formyl-2-Methyl-Propyl)-1-(4-Piperidin-1-Yl-but-2-Enoyl)-Pyrrolidin-3-Yl]-Methanesulfonamide	Drug	0	experimental	1
DB13217	Fentiazac	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Acids, Acyclic, Acetic Acid Derivatives and Related Substances, Fatty Acids, Sensory System Agents, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Lipids, Antiinflammatory Preparations, Non-Steroids for Topical Use, Topical Products for Joint and Muscular Pain, Peripheral Nervous System Agents, Sulfur Compounds, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Fatty Acids, Volatile, Musculo-Skeletal System, Agents that produce hypertension, Central Nervous System Agents	experimental	0
DB14548	Zinc sulfate, unspecified form	Drug	Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Vasoprotectives, Metal cations, Zinc Compounds, Metal divalent cations, Copper Absorption Inhibitor	approved, experimental	97
DB13218	Mandelic acid	Drug	Blood and Blood Forming Organs, Hydroxy Acids, Acids, Carbocyclic, Blood Substitutes and Perfusion Solutions, Irrigating Solutions, Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use	approved	0
DB03891	Dibenzyl (carbonylbis{2,1-hydrazinediyl[(2S)-4-methyl-1-oxo-1,2-pentanediyl]})biscarbamate	Drug	0	experimental	1
DB14549	Gallium cation Ga-67	Drug	0	experimental	0
DB02560	[(1S)-1-acetamido-2-(4-chlorophenyl)ethyl]-[(2S)-2-amino-3-hydroxy-3-oxo-propoxy]-dihydroxy-boron	Drug	0	experimental	1
DB01233	Metoclopramide	Drug	Aminobenzoates, Cytochrome P-450 CYP2D6 Inhibitors, para-Aminobenzoates, QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Acids, Carbocyclic, Amides, Prokinetic Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Chlorobenzoates, Peripheral Nervous System Agents, Propulsives, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Alimentary Tract and Metabolism, Potential QTc-Prolonging Agents, Drugs for Functional Gastrointestinal Disorders, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Dopamine Antagonists, Dopamine Agents, Gastrointestinal Agents, Autonomic Agents, Benzoates, Cholinesterase Inhibitors, P-glycoprotein substrates, Benzamides and benzamide derivatives, Hydroxybenzoates, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Central Nervous System Depressants, Cytochrome P-450 CYP1A2 Substrates, Antiemetics, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Methemoglobinemia Associated Agents, Dopamine D2 Receptor Antagonists	approved, investigational	4
DB03896	Triphosphoric acid	Drug	Anions, Acids, Noncarboxylic, Acids, Phosphoric Acids, Electrolytes, Ions, Phosphorus Compounds, Phosphorus Acids	experimental	1
DB01232	Saquinavir	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Quinolines, QTc Prolonging Agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Isoquinolines, Protease Inhibitors, OCT1 inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (strong), BSEP/ABCB11 Substrates, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Cytochrome P-450 CYP3A7 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors (strong), Antivirals for Systemic Use, Direct Acting Antivirals, Cytochrome P-450 CYP3A7 Inhibitors (strong), Cytochrome P-450 CYP2C8 Inhibitors (moderate), Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Cytochrome P-450 CYP3A7 Inhibitors (weak), Cytochrome P-450 CYP3A5 Substrates, Chemically-Induced Disorders, Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, Cytochrome P-450 CYP3A5 Inhibitors, BCRP/ABCG2 Inhibitors, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Antiinfectives for Systemic Use, HIV Protease Inhibitors, Moderate Risk QTc-Prolonging Agents, P-glycoprotein inducers, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Cytochrome P-450 CYP3A7 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors, Hyperglycemia-Associated Agents, Cytochrome P-450 CYP2D6 Inhibitors (weak)	approved, investigational	1
DB03897	Phloretic acid	Drug	Acids, Carbocyclic	experimental	3
DB02563	Hexanoyl-CoA	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Coenzymes, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Thioesters of coenzyme A, Enzymes and Coenzymes, Glycosides, Nucleotides, Adenine Nucleotides	experimental	1
DB01231	Diphenidol	Drug	Anticholinergic Agents, Autonomic Agents, Emesis Suppression, Antiemetics, Agents producing tachycardia, Muscarinic Antagonists, Central Nervous System Agents, Gastrointestinal Agents, Peripheral Nervous System Agents	approved, investigational, withdrawn	3
DB03898	3-Chloro-4-Hydroxyphenylglycine	Drug	0	experimental	0
DB02562	Quinonoid 7,8-Tetrahydrobiopterin	Drug	0	experimental	1
DB02561	Beta-D-Fructopyranose	Drug	0	experimental	1
DB03899	9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine	Drug	0	experimental	1
DB01230	Pemoline	Drug	Centrally Acting Sympathomimetics, Central Nervous System Stimulants, Nervous System, Oxazoles, Psychostimulants, Agents Used for Adhd and Nootropics, Central Nervous System Agents, Psychoanaleptics	approved, illicit, investigational, withdrawn	0
DB03892	5-N-Allyl-arginine	Drug	0	experimental	1
DB01237	Bromodiphenhydramine	Drug	Histamine H1 Antagonists, Amines, Histamine Antagonists, Benzhydryl Compounds, Ethylamines, Aminoalkyl Ethers, Antihistamines for Systemic Use, Benzene Derivatives	approved	1
DB02568	Peldesine	Drug	Heterocyclic Compounds, Fused-Ring, Purines, Cytochrome P-450 Substrates, N-Glycosyl Hydrolases, antagonists & inhibitors, Cytochrome P-450 CYP1A2 Substrates, Xanthine derivatives, Purinones	investigational	1
DB02567	PD173955	Drug	Pyridines, Tyrosine Kinase Inhibitors	experimental	1
DB01236	Sevoflurane	Drug	Anesthetics, Inhalation, QTc Prolonging Agents, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 Substrates, Nervous System, Methyl Ethers, Hematologic Agents, Hydrocarbons, Halogenated, Hypotensive Agents, Anesthetics, Cytochrome P-450 CYP3A4 Substrates, Hydrocarbons, Fluorinated, Anesthetics, General, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Agents that produce hypertension, Cytochrome P-450 CYP2A6 Substrates, Potential QTc-Prolonging Agents, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates, Ethers, Antiplatelet agents	approved, vet_approved	7
DB03893	Thionicotinamide-Adenine-Dinucleotide	Drug	0	experimental	1
DB03894	N-Propargyl-1(S)-Aminoindan	Drug	0	experimental	1
DB01235	Levodopa	Drug	Amines, Nervous System, Amino Acids, Peptides, and Proteins, Hypotensive Agents, Anti-Dyskinesia Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Anti-Parkinson Agents (Dopamine Agonist), Biogenic Amines, Benzene Derivatives, Dopa and Dopa Derivatives, Dopamine Agents, Amino Acids, Aromatic, Dihydroxyphenylalanine, Phenylalanine, Amino Acids, Essential, Catecholamines, Catechols, Levodopa, antagonists & inhibitors, Amino Acids, Biogenic Monoamines, Anti-Parkinson Drugs, Amino Acids, Cyclic, Neurotransmitter Agents, Central Nervous System Depressants, Phenols, Central Nervous System Agents	approved	5
DB02566	8-Hydroxy-4-(1-Hydroxyethyl)Quinoline-2-Carboxylic Acid	Drug	0	experimental	2
DB02565	4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide	Drug	Anilides, Enzyme Inhibitors, Amines, Hydroxy Acids, Aniline Compounds, Hydroxylamines, Antineoplastic Agents, Amides, Histone Deacetylase Inhibitors, Hydroxamic Acids	experimental	1
DB03895	Malachite Green	Drug	Fungicides, Industrial, Amines, Agrochemicals, Aniline Compounds, Coloring Agents, Pesticides, Toxic Actions, Compounds used in a research, industrial, or household setting, Anti-Infective Agents, Anti-Infective Agents, Local	experimental	1
DB01234	Dexamethasone	Drug	Corticosteroids, Dermatological Preparations, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Otologicals, Cytochrome P-450 CYP2C19 Inducers (strength unknown), Cytochrome P-450 CYP2B6 Inducers (strength unknown), Experimental Unapproved Treatments for COVID-19, Hormones, Cytochrome P-450 CYP3A4 Substrates, Corticosteroids for Local Oral Treatment, Cytochrome P-450 CYP3A4 Inducers (moderate), OAT3/SLC22A8 Substrates, Peripheral Nervous System Agents, Cytochrome P-450 CYP3A4 Inducers (strong), Nasal Preparations, Alimentary Tract and Metabolism, Cytochrome P-450 CYP2C19 Inducers, BSEP/ABCB11 inducers, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Corticosteroid Hormone Receptor Agonists, Cytochrome P-450 CYP2E1 Inducers (strength unknown), Corticosteroids for Systemic Use, Pregnadienetriols, Corticosteroids, Cytochrome P-450 CYP3A5 Substrates, Corticosteroids for Systemic Use, Plain, Cytochrome P-450 CYP3A Inducers (strong), Pregnadienes, Cytochrome P-450 CYP3A4 Inducers, Inducers of Drug Clearance, Ophthalmologicals, Antiemetics, Pregnanes, Steroids, Fluorinated, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Cytochrome P-450 CYP2C8 Inducers, Anti-Inflammatory Agents, Ophthalmological and Otological Preparations, Fused-Ring Compounds, Vasoprotectives, Corticosteroids, Moderately Potent (Group II), Cytochrome P-450 Enzyme Inducers, Adrenals, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP3A5 Inducers, Gastrointestinal Agents, Autonomic Agents, Cytochrome P-450 CYP3A5 Inducers (moderate), Antineoplastic Agents, Hormonal, Cytochrome P-450 CYP2E1 Inducers, Cytochrome P-450 CYP2A6 Inducers, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein substrates, Dermatologicals, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, Anti-Acne Preparations, Cytochrome P-450 CYP3A7 Inducers, P-glycoprotein inducers, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Cytochrome P-450 CYP3A4 Inhibitors, Central Nervous System Agents, Sensory Organs, P-glycoprotein inhibitors, Hyperglycemia-Associated Agents, Anti-Acne Preparations for Topical Use, Stomatological Preparations, Cytochrome P-450 CYP3A4 Inhibitors (weak), Cytochrome P-450 CYP3A7 Inducers (strength unknown), Steroids	approved, investigational, vet_approved	5
DB01239	Chlorprothixene	Drug	Psycholeptics, QTc Prolonging Agents, Tranquilizing Agents, Serotonin Agents, Nervous System, Antipsychotic Agents (First Generation Typical), Muscarinic Antagonists, Antidepressive Agents, Thioxanthenes, Anticholinergic Agents, Serotonin 5-HT2 Receptor Antagonists, Antipsychotic Agents, Histamine H1 Antagonists, Sulfur Compounds, Potential QTc-Prolonging Agents, Thioxanthene Derivatives, Dopamine Antagonists, Dopamine Agents, Neurotoxic agents, Agents producing tachycardia, Psychotropic Drugs, Xanthenes, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Histamine Antagonists, Central Nervous System Depressants, Serotonin Receptor Antagonists, Central Nervous System Agents, P-glycoprotein inhibitors, Dopamine D2 Receptor Antagonists	approved, investigational, withdrawn, experimental	11
DB02569	2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate	Drug	0	experimental	1
DB01238	Aripiprazole	Drug	Quinolines, Serotonin 5-HT1 Receptor Agonists, Psycholeptics, QTc Prolonging Agents, Tranquilizing Agents, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 CYP3A7 Substrates, Nervous System, Muscarinic Antagonists, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Dopamine Agonists, Quinolones, Anticholinergic Agents, Serotonin 5-HT2 Receptor Antagonists, Antipsychotic Agents, Histamine H1 Antagonists, Antipsychotic Agents (Second Generation Atypical), Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Adrenergic Antagonists, Potential QTc-Prolonging Agents, Adrenergic alpha-1 Receptor Antagonists, Dopamine Antagonists, Dopamine Agents, Neurotoxic agents, Cytochrome P-450 CYP3A5 Substrates, Piperazines, Adrenergic alpha-Antagonists, Serotonin Receptor Agonists, Agents producing tachycardia, QTc shortening agents, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Aripiprazole and prodrugs, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Agents that produce hypertension, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Dopamine D2 Receptor Antagonists, Hyperglycemia-Associated Agents, Serotonin 5-HT1 Receptor Antagonists	approved, investigational	38
DB13222	Tilbroquinol	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Hydroxyquinolines, Hydroxyquinoline Derivatives	approved	0
DB14553	Borate ion	Drug	Anions, Acids, Noncarboxylic, Acids, Electrolytes, Ions, Boric Acids, Boron Compounds	experimental	0
DB13223	Fluocortin	Drug	Corticosteroids, Dermatological Preparations, Corticosteroids, Moderately Potent (Group II), Corticosteroids, Immunosuppressive Agents, Adrenal Cortex Hormones, Dermatologicals	experimental	0
DB14554	Dotatate	Drug	Radioactive Diagnostic Agent	approved, experimental	0
DB14551	Phosphorus P-32	Drug	Phosphorus Isotopes, Radioisotopes, Phosphorus, Elements, Isotopes	experimental	0
DB13220	Ferrous aspartate	Drug	Iron Bivalent, Oral Preparations, Antianemic Preparations, Blood and Blood Forming Organs, Iron Preparations	experimental	0
DB14552	Cupric cation	Drug	0	experimental	0
DB13221	Apronalide	Drug	Psycholeptics, Nervous System, Central Nervous System Depressants, Hypnotics and Sedatives	approved	0
DB13226	Acetylleucine	Drug	Antivertigo Preparations, Nervous System, Amino Acids, Essential, Amino Acids, Branched-Chain, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	0
DB14557	Ethylhexylglycerin	Drug	Carbohydrates, Sugar Alcohols, Ethers, Triose Sugar Alcohols, Alcohols	experimental	0
DB14558	Influenza A virus A/Singapore/INFIMH-16-0019/2016 NIB-104 (H3N2) antigen (formaldehyde inactivated)	Drug	0	approved	0
DB13227	Tribenoside	Drug	Analgesics, Non-Narcotic, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Carbohydrates, Vasoprotectives, Sensory System Agents, Analgesics, Anti-Inflammatory Agents, Capillary Stabilizing Agents, Antirheumatic Agents, Central Nervous System Agents, Peripheral Nervous System Agents	experimental	0
DB14555	Ursadiol	Drug	0	experimental	0
DB13224	Piperidione	Drug	Cough and Cold Preparations	experimental	0
DB13225	Dibenzepin	Drug	Nervous System, Antidepressive Agents, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Non-Selective Monoamine Reuptake Inhibitors, Narrow Therapeutic Index Drugs, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Antidepressive Agents, Tricyclic, Agents that produce hypertension, Central Nervous System Agents, Agents that reduce seizure threshold, Neurotoxic agents, Psychoanaleptics	approved	0
DB14556	Peracetic acid	Drug	Acids, Acyclic, Fatty Acids, Disinfectants, Noxae, Oxidants, Fatty Acids, Volatile, Lipids, Toxic Actions, Acetates, Compounds used in a research, industrial, or household setting, Anti-Infective Agents	experimental	0
DB13228	Flosequinan	Drug	Quinolone Vasodilators, Heterocyclic Compounds, Fused-Ring, Vasodilators Used in Cardiac Diseases, Cardiovascular Agents, Vasodilating Agents, Cardiac Therapy	approved	0
DB14559	Influenza B virus B/Maryland/15/2016 BX-69A antigen (formaldehyde inactivated)	Drug	0	approved	0
DB13229	Enibomal	Drug	Anesthetics, General, Pyrimidines, Nervous System, Pyrimidinones, Anesthetics	experimental	0
DB01240	Epoprostenol	Drug	Anticoagulants, Biological Factors, Autacoids, Inflammation Mediators, Blood and Blood Forming Organs, Fatty Acids, Prostacycline Vasodilator, Eicosanoids, Hematologic Agents, Lipids, Cardiovascular Agents, Hypotensive Agents, Drugs that are Mainly Renally Excreted, Prostacyclin Analogues, Vasodilation, Fatty Acids, Unsaturated, Prostaglandins, Platelet Aggregation Inhibitors Excl. Heparin, Prostaglandins I, Antihypertensive Agents, Vasodilating Agents, Antiplatelet agents	approved	3
DB02571	Allysine	Drug	Acids, Acyclic, Amino Acids, Dicarboxylic, Amino Acids, Peptides, and Proteins, Dicarboxylic Acids, Adipates, Amino Acids	experimental	1
DB02570	PD150606	Drug	Acids, Acyclic	experimental	1
DB01244	Bepridil	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Agents causing hyperkalemia, Phenylalkylamine Derivatives, Non-Selective Calcium Channel Blockers, Cardiovascular Agents, Hypotensive Agents, Cytochrome P-450 CYP3A4 Substrates, Membrane Transport Modulators, Calcium Channel Blockers, Cytochrome P-450 CYP3A Substrates, Calcium-Regulating Hormones and Agents, Pyrrolidines, Antihypertensive Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors, Vasodilating Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	approved, withdrawn	10
DB02574	BV2	Drug	0	experimental	1
DB01243	Chloroxine	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Antifungal Agents, Hydroxyquinolines, Anti-Infective Agents	approved	0
DB02573	2'-deoxycytidine-2'-deoxyadenosine-3',5'-monophosphate	Drug	0	experimental	1
DB01242	Clomipramine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP2C19 Inhibitors, Hypotensive Agents, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Serotonin 5-HT2 Receptor Antagonists, Tricyclics and Other Norepinephrine-reuptake Inhibitors, Serotonin Modulators, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Agents that reduce seizure threshold, Neurotoxic agents, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Dibenzazepines, Moderate Risk QTc-Prolonging Agents, Psychotropic Drugs, Cytochrome P-450 CYP2C19 Inhibitors (strong), Membrane Transport Modulators, Cytochrome P-450 CYP2C19 Substrates, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Non-Selective Monoamine Reuptake Inhibitors, Cytochrome P-450 CYP3A Substrates, Tertiary amine tricyclic antidepressants, Central Nervous System Depressants, Antidepressive Agents, Tricyclic, Neurotransmitter Uptake Inhibitors, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors, Psychoanaleptics	approved, investigational, vet_approved	6
DB01241	Gemfibrozil	Drug	Acids, Acyclic, Peroxisome Proliferator Receptor alpha Agonist, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, UGT1A3 substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Drugs that are Mainly Renally Excreted, Phenyl Ethers, UGT1A3 Inhibitors, UGT2B7 substrates, Butyrates, Pentanoic Acids, Fibric Acids, Ethers, Benzene Derivatives, OATP1B1/SLCO1B1 Inhibitors, Chemically-Induced Disorders, Cytochrome P-450 CYP2C8 Inhibitors, Isobutyrates, Cytochrome P-450 CYP2C8 Inhibitors (strong), Valerates, Photosensitizing Agents, Toxic Actions, OAT3/SLC22A8 Inhibitors, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inducers, Fatty Acids, Cytochrome P-450 CYP2C9 Inhibitors (strong), OATP1B3 inhibitors, Cytochrome P-450 CYP2C19 Inhibitors, Hypolipidemic Agents Indicated for Hyperlipidemia, Lipids, Cytochrome P-450 CYP1A2 Inhibitors, Fribic Acid Derivatives, Lipid Modifying Agents, Lipid Modifying Agents, Plain, Cytochrome P-450 Enzyme Inducers, Fatty Acids, Volatile, Cytochrome P-450 CYP2C9 Inhibitors, Drugs causing inadvertant photosensitivity, Hypolipidemic Agents, Peroxisome Proliferator-activated Receptor alpha Agonists, Noxae, UGT1A1 Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors (strong), Lipid Regulating Agents, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, UGT1A1 Substrates, Phenols, UGT1A9 Substrates	approved	5
DB02572	1,3-bis-([3-[3-[3-(4-{3-[3-nitro-5-(galactopyranosyloxy)-benzoylamino]-propyl}-piperazin-1-yl)-propylamino-3,4-dioxo-cyclobutenyl]-amino-propoxy-ethoxy-ethoxy]-propyl-]amino-carbonyloxy)-2-amino-propane	Drug	0	experimental	1
DB02579	Acrylic Acid	Drug	Acids, Acyclic, Equipment and Supplies, Surgical Equipment, Tissue Adhesives, Compounds used in a research, industrial, or household setting, Surgical Fixation Devices	experimental	1
DB01248	Docetaxel	Drug	Microtubule Inhibitors, Taxane Derivatives, Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Tubulin Modulators, Mitosis Modulators, Cardiotoxic antineoplastic agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), OATP1B3 substrates, Cytochrome P-450 CYP3A4 Substrates, Taxoids, Hepatotoxic Agents, P-glycoprotein substrates with narrow therapeutic index, Cycloparaffins, Cytochrome P-450 CYP3A5 Substrates, Cyclodecanes, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index, Microtubule Inhibition, Myelosuppressive Agents, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Antimitotic Agents, Cytochrome P-450 CYP3A4 Inhibitors, Diterpenes, Terpenes	approved, investigational	6
DB01247	Isocarboxazid	Drug	Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, Enzyme Inhibitors, Serotonin Agents, Nervous System, Monoamine Oxidase Inhibitors, Hypotensive Agents, Antidepressive Agents, Psychotropic Drugs, Monoamine Oxidase Inhibitors, Non-Selective, Serotonin Modulators, Photosensitizing Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Agents that produce hypertension, Isoxazoles, Central Nervous System Agents, Drugs causing inadvertant photosensitivity, Agents that reduce seizure threshold, Psychoanaleptics	approved	2
DB02578	N-[(6S)-6-Carboxy-6-(glycylamino)hexanoyl]-D-alanyl-D-alanine	Drug	Peptides, Amino Acids, Peptides, and Proteins	experimental	1
DB01246	Alimemazine	Drug	QTc Prolonging Agents, Phenothiazines, Cytochrome P-450 CYP3A Inducers, Dermatologicals, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Antipsychotic Agents, Cytochrome P-450 Enzyme Inducers, Histamine H1 Antagonists, Sulfur Compounds, Histamine Antagonists, Central Nervous System Depressants, Potential QTc-Prolonging Agents, Histamine Agents, Phenothiazine Derivatives, Antihistamines for Systemic Use, Antipruritics, Neurotoxic agents	approved, vet_approved	1
DB02577	Mesoheme	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Pigments, Biological, Porphyrins	experimental	0
DB01245	Decamethonium	Drug	Neuromuscular Agents, Amines, Ammonium Compounds, Cholinesterase Inhibitors, Quaternary Ammonium Compounds, Onium Compounds, Peripheral Nervous System Agents, Central Nervous System Depressants, Bis-Trimethylammonium Compounds, Neuromuscular Blocking Agents, Neuromuscular Depolarizing Agents, Nitrogen Compounds, Neurotoxic agents	approved	4
DB02576	F-Loop of Vitamin B12	Drug	0	experimental	1
DB01249	Iodixanol	Drug	Benzoates, Acids, Carbocyclic, Roentgenography, Drugs that are Mainly Renally Excreted, Iodobenzoates, Iodinated Contrast Agents, Contrast Media, Diagnostic Uses of Chemicals, Radiographic Contrast Agent, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting, X-Ray Contrast Activity, Benzene Derivatives, Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media	approved	0
DB14550	Gallium chloride Ga-67	Drug	0	approved	0
DB14564	Kale	Drug	0	experimental	0
DB13233	Alaproclate	Drug	Selective Serotonin Reuptake Inhibitors, Serotonin Agents, Nervous System, Hypoglycemia-Associated Agents, Amino Acids, Peptides, and Proteins, Antidepressive Agents, Psychotropic Drugs, Amino Acids, Membrane Transport Modulators, Neurotransmitter Agents, Serotonin Modulators, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Neurotransmitter Uptake Inhibitors, Central Nervous System Agents, Psychoanaleptics	experimental	0
DB14565	Sophora flavescens root	Drug	Complex Mixtures, Plant Preparations, Plant Extracts, Biological Products, Pharmaceutical Preparations	experimental	0
DB13234	Propanidid	Drug	Anesthetics, General, Amines, Ethylamines, Nervous System, Central Nervous System Depressants, Acids, Carbocyclic, Diethylamines, Phenylacetates, Anesthetics, Intravenous, Central Nervous System Agents, Anesthetics	experimental	0
DB13231	Calcium lactate	Drug	Calcium Salts, Hydroxy Acids, Alimentary Tract and Metabolism, Mineral Supplements	approved, investigational, vet_approved	0
DB14562	Andexanet alfa	Drug	Biological Factors, Enzymes, Antidotes, Blood Coagulation Factors, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Coagulants, Proteins, Factor X, Blood Proteins, Serine Proteases, Hydrolases, Peptide Hydrolases, Serine Endopeptidases, Endopeptidases	approved, investigational	1
DB14563	Magnolia kobus bark	Drug	0	experimental	0
DB13232	Suxibuzone	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Sensory System Agents, Anti-Inflammatory Agents, Pyrazoles, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Antiinflammatory Preparations, Non-Steroids for Topical Use, Topical Products for Joint and Muscular Pain, Pyrazolones, Peripheral Nervous System Agents, Analgesics, Musculo-Skeletal System, Agents that produce hypertension, Central Nervous System Agents	experimental	0
DB14568	Ivosidenib	Drug	QTc Prolonging Agents, Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Antineoplastic Agents, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Amino Acids, Peptides, and Proteins, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Moderate Risk QTc-Prolonging Agents, Amino Acids, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2C9 Inducers, OAT3/SLC22A8 Inhibitors, P-glycoprotein inhibitors, P-glycoprotein substrates with narrow therapeutic index, Cytochrome P-450 CYP2C8 Inducers (strength unknown)	approved, investigational	1
DB13237	Clofoctol	Drug	Phenols, Antiinfectives for Systemic Use, Antibacterials for Systemic Use, Benzene Derivatives	experimental	0
DB13238	Tuaminoheptane	Drug	Nasal Preparations, Sympathomimetics, Plain	experimental	0
DB14569	Tedizolid	Drug	Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, Oxazolidinone Antibacterial, Anti-Bacterial Agents, Oxazoles, Breast Cancer Resistance Protein Inhibitors, Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use	approved, investigational	1
DB13235	Perboric acid	Drug	Anions, Acids, Noncarboxylic, Acids, Antiinfectives and Antiseptics for Local Oral Treatment, Alimentary Tract and Metabolism, Electrolytes, Ions, Boric Acids, Boron Compounds, Stomatological Preparations, Tooth Bleaching	approved	0
DB14566	Lavender oil	Drug	Lavandula, Complex Mixtures, Oils, Plant Preparations, Biological Products, Lipids	approved, experimental	0
DB14567	Brown iron oxide	Drug	0	approved, experimental	0
DB13236	Stibophen	Drug	Arylsulfonates, Sulfur Compounds, Acids, Noncarboxylic, Antiparasitic Products, Insecticides and Repellents, Acids, Sulfur Acids, Antitrematodals, Sulfonic Acids, Arylsulfonic Acids, Anthelmintics, Antiparasitic Agents, Benzene Derivatives	experimental	0
DB13239	Neltenexine	Drug	Cycloparaffins, Amines, Cough and Cold Preparations, Expectorants, Aniline Compounds, Cyclohexylamines, Cyclohexanes	experimental	0
DB01251	Gliquidone	Drug	Cytochrome P-450 CYP2C9 Substrates, Sulfur Compounds, Cytochrome P-450 Substrates, Alimentary Tract and Metabolism, Sulfonylureas, Drugs Used in Diabetes, Blood Glucose Lowering Agents, Sulfones	approved, investigational	2
DB02582	(6Z)-6-{[(1Z)-1-{[(1R)-1-Carboxy-2-methyl-2-propen-1-yl]imino}-1-hydroxy-3-sulfanyl-2-propanyl]imino}-6-hydroxynorleucine	Drug	0	experimental	0
DB01250	Olsalazine	Drug	Aminosalicylate, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Benzoates, Hydroxy Acids, Sensory System Agents, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Hydroxybenzoates, Non COX-2 selective NSAIDS, Peripheral Nervous System Agents, Intestinal Antiinflammatory Agents, Analgesics, Alimentary Tract and Metabolism, Agents that produce hypertension, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Phenols, Central Nervous System Agents, Salicylates, Benzene Derivatives, Gastrointestinal Agents	approved	2
DB02581	N(2)-carbamimidoyl-N-{2-[4-(3-{4-[(5-carboxyfuran-2-yl)methoxy]-2,3-dichlorophenyl}-1-methyl-1H-pyrazol-5-yl)piperidin-1-yl]-2-oxoethyl}-D-leucinamide	Drug	0	experimental	1
DB02580	Pentaglyme	Drug	0	experimental	11
DB01255	Lisdexamfetamine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Central Nervous System Stimulants, Amines, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Phenethylamines, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Dopamine Agents, Dopamine Uptake Inhibitors, Psychostimulants, Agents Used for Adhd and Nootropics, Agents producing tachycardia, Central Nervous System Stimulation, Membrane Transport Modulators, Centrally Acting Sympathomimetics, Neurotransmitter Agents, Ethylamines, Sympathomimetics, Neurotransmitter Uptake Inhibitors, Agents that produce hypertension, Amphetamines, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2D6 Inhibitors (weak), Psychoanaleptics	approved, investigational	1
DB02586	4,7-Dimethyl-[1,10]Phenanthroline	Drug	0	experimental	1
DB01254	Dasatinib	Drug	QTc Prolonging Agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Pyrimidines, Sulfur Compounds, Thiazoles, Potential QTc-Prolonging Agents, Drugs causing inadvertant photosensitivity, P-glycoprotein substrates with narrow therapeutic index, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index, Myelosuppressive Agents, Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index, Protein Kinase Inhibitors, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (weak), Kinase Inhibitor	approved, investigational	23
DB02585	4-(Hydroxymethyl)Benzamidine	Drug	0	experimental	1
DB01253	Ergometrine	Drug	Adrenergic alpha-Agonists, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Genito Urinary System and Sex Hormones, Reproductive Control Agents, Adrenergic alpha-1 Receptor Agonists, Agents producing tachycardia, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Ergolines, Uterotonic agents, Ergot Alkaloids and Derivatives, Alkaloids, Heterocyclic Compounds, Fused-Ring, Serotonin Modulators, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Adrenergic Agonists, Agents that produce hypertension, P-glycoprotein inhibitors	approved	1
DB01252	Mitiglinide	Drug	Heterocyclic Compounds, Fused-Ring, UGT2B7 substrates, Alimentary Tract and Metabolism, UGT1A3 substrates, Drugs Used in Diabetes, Blood Glucose Lowering Agents	investigational	2
DB02583	N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine	Drug	0	experimental	1
DB01259	Lapatinib	Drug	QTc Prolonging Agents, Enzyme Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Quinazolines, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C19 Substrates, Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Hepatotoxic Agents, Potential QTc-Prolonging Agents, Cytochrome P-450 CYP2C8 Substrates, P-glycoprotein inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors (weak), Kinase Inhibitor	approved, investigational	2
DB02589	Se-Ethyl-Isoselenourea	Drug	Selenium Compounds	experimental	1
DB02588	(2R)-2-[(1R)-1-{[(2S)-2-Carboxy-2-(4-hydroxyphenyl)acetyl]amino}-1-methoxy-2-oxoethyl]-5-methylene-5,6-dihydro-2H-1,3-oxazine-4-carboxylic acid	Drug	0	experimental	1
DB01257	Eculizumab	Drug	Immunoglobulins, Immunosuppressive Agents, Antineoplastic and Immunomodulating Agents, Antibodies, Complement Inactivating Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Selective Immunosuppressants, Immunoproteins, Proteins, Serum Globulins, Globulins, Blood Proteins	approved, investigational	1
DB01256	Retapamulin	Drug	Anti-Bacterial Agents, Antibiotics for Topical Use, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Dermatologicals, Pleuromutilin Antibacterial, Cytochrome P-450 CYP3A4 Substrates, Terpenes, Anti-Infective Agents	approved	1
DB02587	Colforsin	Drug	Autonomic Agents, Immunologic Factors, Adjuvants, Immunologic, Anti-Asthmatic Agents, Protective Agents, Cardiovascular Agents, Bronchodilator Agents, Respiratory System Agents, Peripheral Nervous System Agents, Cardiotonic Agents, Diterpenes, P-glycoprotein inhibitors, Terpenes, Vasodilating Agents, Compounds used in a research, industrial, or household setting	investigational, experimental	4
DB14560	Influenza A virus A/Singapore/INFIMH-16-0019/2016 IVR-186 (H3N2) antigen (UV, formaldehyde inactivated)	Drug	0	approved	0
DB13230	Gestonorone	Drug	Endocrine Therapy, Sex Hormones and Modulators of the Genital System, Hormones and Related Agents, Pregnen (4) Derivatives, Adrenal Cortex Hormones, Antineoplastic and Immunomodulating Agents, Genito Urinary System and Sex Hormones, Progestins	experimental	0
DB14561	Influenza B virus B/Maryland/15/2016 BX-69A antigen (UV, formaldehyde inactivated)	Drug	0	approved	0
DB03841	Niraxostat	Drug	0	experimental	1
DB03842	2-Chloro-6-Methyl-Aniline	Drug	0	experimental	1
DB03843	Formaldehyde	Drug	Cell-mediated Immunity, Disinfectants, Fixatives, Standardized Chemical Allergen, Aldehydes, Compounds used in a research, industrial, or household setting, Anti-Infective Agents, Anti-Infective Agents, Local, Increased Histamine Release, Macromolecular Substances	approved, vet_approved	2
DB03844	N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide	Drug	0	experimental	1
DB02513	Thymol	Drug	Antifungal Agents, Monoterpenes, Terpenes, Anti-Infective Agents, Anti-Infective Agents, Local, Benzene Derivatives	approved	0
DB02512	1,6-Fructose Diphosphate (Linear Form)	Drug	0	experimental	2
DB02511	2-Hydroxy-5-({1-[(2-Naphthyloxy)Methyl]-3-Oxoprop-1-Enyl}Amino)Tyrosine	Drug	0	experimental	1
DB03840	Tetra(Imidazole)Diaquacopper (Ii)	Drug	0	experimental	1
DB02510	5'-O-(L-Prolylsulfamoyl)adenosine	Drug	0	experimental	1
DB03849	Cilomilast	Drug	Phosphodiesterase Inhibitors, Cycloparaffins, Enzyme Inhibitors, Acids, Carbocyclic, Phosphodiesterase 4 Inhibitors, Cyclohexanes	investigational	2
DB02517	D-Glutamic Acid	Drug	0	experimental	1
DB02516	(R)-carnitinyl-CoA betaine	Drug	0	experimental	1
DB02515	sn-glycerol 3-phosphate	Drug	0	experimental	4
DB02514	(2Z)-3-{[Oxido(oxo)phosphoranyl]oxy}-2-phenylacrylate	Drug	0	experimental	1
DB03845	P1-(5'-Adenosyl)P5-(5'-(3'azido-3'-Deoxythymidyl))Pentaphosphate	Drug	0	experimental	1
DB03846	2'-deoxy-5-(hydroxymethyl)uridine 5'-(dihydrogen phosphate)	Drug	0	experimental	1
DB03847	gamma-carboxy-L-glutamic acid	Drug	0	experimental	3
DB02519	Indirubin-5-sulphonate	Drug	0	experimental	2
DB02518	N-Acetylalanine	Drug	Amino Acids, Peptides, and Proteins, Amino Acids	experimental	1
DB03848	Benzenesulfinic acid	Drug	Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfur Acids	experimental	1
DB14502	Sodium phosphate, dibasic	Drug	Anions, Acids, Noncarboxylic, Acids, Phosphoric Acids, Osmotic Laxatives, Electrolytes, Ions, Laxatives, Urinary Acidifying Agents, Phosphorus Compounds, Phosphorus Acids	approved	0
DB14503	Sodium phosphate, monobasic, unspecified form	Drug	Osmotic Laxatives, Laxatives	approved	0
DB14500	Potassium	Drug	Metals, Light, Potassium Salt, High-Ceiling Diuretics, Replacement Preparations, Agents causing hyperkalemia, Metals, Diuretics, Low-Ceiling Diuretics, Excl. Thiazides, Minerals, Elements, Metals, Alkali	approved, experimental	1
DB14501	Ferrous glycine sulfate	Drug	Iron Bivalent, Oral Preparations, Antianemic Preparations, Blood and Blood Forming Organs, Iron Preparations	approved	13
DB14506	Lithium hydroxide	Drug	Lithium Compounds, Drugs that are Mainly Renally Excreted	approved, withdrawn	0
DB14507	Lithium citrate	Drug	Nephrotoxic agents, Acids, Acyclic, QTc Prolonging Agents, Serotonin Agents, Antimanic Agents, Mood Stabilizer, Antidepressive Agents, Psychotropic Drugs, Drugs that are Mainly Renally Excreted, Lithium Compounds, Serotonin Modulators, Tricarboxylic Acids, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Neurotoxic agents	approved	4
DB14504	Sodium phosphate, dibasic, unspecified form	Drug	Osmotic Laxatives, Laxatives	approved, experimental	0
DB14505	Sodium borate	Drug	Ophthalmologicals, Anions, Acids, Noncarboxylic, Acids, Electrolytes, Ions, Sensory Organs, Boric Acids, Anti-Infective Agents, Boron Compounds	approved, experimental	0
DB14508	Lithium succinate	Drug	Acids, Acyclic, Lithium Compounds, Dermatologicals, Dicarboxylic Acids, Ointments	experimental	4
DB14509	Lithium carbonate	Drug	Nephrotoxic agents, Psycholeptics, QTc Prolonging Agents, Tranquilizing Agents, Enzyme Inhibitors, Serotonin Agents, Nervous System, Antimanic Agents, Mood Stabilizer, Carbonic Acid, Antidepressive Agents, Carbon Compounds, Inorganic, Drugs that are Mainly Renally Excreted, Serotonin Modulators, Anions, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Carbonates, Neurotoxic agents, Alkalies, Ions, Psychotropic Drugs, Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Lithium Compounds, Acids, Noncarboxylic, Narrow Therapeutic Index Drugs, Acids, Central Nervous System Depressants, Electrolytes, Central Nervous System Agents	approved	4
DB03852	Eucalyptol	Drug	Antitussive Agents, Cyclohexanols, Flavoring Agents, Lipids, Anti-Infective Agents, Alcohols, Cyclohexanes, Physiological Phenomena, Agrochemicals, Cough and Cold Preparations, Food and Beverages, Food Ingredients, Cosmetics, Monoterpenes, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Fatty Alcohols, Food, Food Additives, Solvents, Cycloparaffins, Mouthwashes, Protective Agents, Pesticides, Respiratory System Agents, Household Products, Pharmaceutic Aids, Insect Repellents, Expectorants, Hexanols, Toxic Actions, Pharmaceutical Preparations, Central Nervous System Agents, Terpenes	nutraceutical, experimental	0
DB02520	Ditiocarb	Drug	Acids, Acyclic, Immunologic Factors, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Adjuvants, Immunologic, Cytochrome P-450 CYP3A5 Inhibitors, Thiocarbamates, Anti-Infective Agents, Cytochrome P-450 CYP3A4 Inhibitors (strong), Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Sulfur Compounds, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A7 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Sequestering Agents, Carbamates, Compounds used in a research, industrial, or household setting, Chelating Agents	experimental	0
DB03853	Reactive Red 6 hapten	Drug	0	experimental	0
DB03854	Cadaverine	Drug	Carbohydrates, Amines, Sugar Phosphates, Lipids, Phospholipids, Phosphatidic Acids, Polyamines, Glycerophospholipids, Alcohols, Biogenic Polyamines, Diamines, Glycerophosphates, Sugar Alcohols, Biogenic Amines, Membrane Lipids, Triose Sugar Alcohols	experimental	1
DB03855	L-Threonohydroxamate 4-Phosphate	Drug	0	experimental	1
DB02524	2',3'-O-{4-[Hydroxy(oxido)-λ5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)	Drug	0	experimental	1
DB02523	2-aminooxyethyl-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl]-methyl-sulfonium	Drug	0	experimental	0
DB03850	Jaspisamide A	Drug	0	experimental	1
DB02522	Phosphonopyruvate	Drug	0	experimental	1
DB02521	Flaviolin	Drug	Quinones, Naphthalenes	experimental	2
DB03851	Carbazole Butanoic Acid	Drug	0	experimental	0
DB02528	Tetrazolyl Histidine	Drug	0	experimental	1
DB02527	Cyclic adenosine monophosphate	Drug	Carbohydrates, Cyclic AMP, OAT1/SLC22A6 Substrates, Nucleotides, Nucleotides, Cyclic, OAT3/SLC22A8 Substrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Adenine Nucleotides	experimental	6
DB02526	CRA_10655	Drug	0	experimental	2
DB02525	D-galactohydroximo-1,5-lactam	Drug	0	experimental	0
DB03856	L-Eflornithine	Drug	0	investigational, experimental	1
DB03857	1,4-dithio-beta-D-glucopyranose	Drug	0	experimental	1
DB03858	S-Acetonylcysteine	Drug	0	experimental	0
DB03859	1-thio-beta-D-glucopyranose	Drug	Carbohydrates, Hexoses, Monosaccharides	experimental	1
DB02529	(2R,4S,5R,6R)-5-Acetamido-4-amino-6-(diethylcarbamoyl)oxane-2-carboxylic acid	Drug	0	experimental	1
DB14510	Ferrous cation	Drug	0	experimental	0
DB14513	Magnesium	Drug	Metals, Light, Metal cations, Metal divalent cations, Osmotic Laxatives, Metals, Metals, Alkaline Earth, Calculi Dissolution Agent, Laxatives, Minerals, Elements, Magnesium Compounds	approved, investigational, experimental	0
DB14514	Magnesium levulinate	Drug	Enzyme Inhibitors, Metal cations, Alimentary Tract and Metabolism, Metal divalent cations, Keto Acids, Mineral Supplements, Magnesium Compounds	nutraceutical	1
DB14511	Acetate	Drug	0	experimental	0
DB14512	Mometasone furoate	Drug	Adrenergics, Inhalants, Corticosteroids, Dermatological Preparations, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Glucocorticoids, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Nasal Preparations, Corticosteroids, Potent (Group III), Adrenals, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Cytochrome P-450 CYP3A5 Inducers, Anti-Allergic Agents, Corticosteroids, Pregnadienes, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Inducers, Dermatologicals, Cytochrome P-450 CYP2C8 Inhibitors (strong), Cytochrome P-450 CYP3A Substrates, Drugs for Obstructive Airway Diseases, Thyroxine-binding globulin inhibitors, Hyperglycemia-Associated Agents, Steroids	approved, investigational, vet_approved	2
DB14517	Aluminium phosphate	Drug	Immunologic Factors, Adjuvants, Immunologic, Ions, Phosphorus Compounds, Phosphorus Acids, Aluminum and magnesium containing antacids, Anions, Gastric Acid Lowering Agents, Acids, Noncarboxylic, Metal cations, Acids, Phosphoric Acids, Alimentary Tract and Metabolism, Metal divalent cations, Aluminium Compounds, Electrolytes, Drugs for Acid Related Disorders, Antacids, Gastrointestinal Agents	approved, investigational	4
DB14518	Aluminum acetate	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Lipids	approved, investigational	4
DB14515	Magnesium lactate	Drug	Metal cations, Alimentary Tract and Metabolism, Metal divalent cations, Mineral Supplements, Magnesium Compounds	nutraceutical	1
DB14516	Sodium cation	Drug	Osmotic Laxatives, Laxatives, Increased Large Intestinal Motility, Osmotic Activity, Inhibition Large Intestine Fluid/Electrolyte Absorption	experimental	0
DB14519	Aluminum cation	Drug	Polyvalent cation containing laxatives, antacids, oral supplements	experimental	0
DB02531	Isobutyric acid	Drug	Acids, Acyclic, Fatty Acids, Butyrates, Fatty Acids, Volatile, Lipids	experimental	1
DB03863	2-O-Methyl-beta-L-fucopyranose	Drug	0	experimental	2
DB01200	Bromocriptine	Drug	Ergot-derivative Dopamine Receptor Agonists, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Genito Urinary System and Sex Hormones, Adrenergic alpha-1 Receptor Agonists, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Hypotensive Agents, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Ergolines, Dopamine Agonists, Ergot Alkaloids and Derivatives, Ergotamines, Alkaloids, Anti-Dyskinesia Agents, Serotonin Modulators, Adrenergic alpha-2 Receptor Agonists, Adrenergic Antagonists, Anti-Parkinson Agents (Dopamine Agonist), Adrenergic alpha-1 Receptor Antagonists, Hormone Antagonists, Prolactine Inhibitors, Dopamine Agents, Adrenergic alpha-Agonists, Adrenergic alpha-Antagonists, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein substrates, Serotonin Receptor Agonists, Agents producing tachycardia, Blood Glucose Lowering Agents, Anti-Parkinson Drugs, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Adrenergic Agonists, Agents that produce hypertension, Cytochrome P-450 CYP3A4 Inhibitors, Central Nervous System Agents, Serotonin 5-HT2 Receptor Agonists, P-glycoprotein inhibitors	approved, investigational	18
DB03864	Monothioglycerol	Drug	Carbohydrates, Sugar Alcohols, Triose Sugar Alcohols, Alcohols	experimental	1
DB02530	gamma-Aminobutyric acid	Drug	Acids, Acyclic, Neurotransmitter Agents, Fatty Acids, Butyrates, GABA Agents, Fatty Acids, Volatile, Amino Acids, Peptides, and Proteins, Lipids, Aminobutyrates, Amino Acids	approved, investigational	3
DB03865	6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine	Drug	0	experimental	4
DB03866	Prostaglandin G2	Drug	Biological Factors, Autacoids, Inflammation Mediators, Fatty Acids, Prostaglandin Endoperoxides, Reactive Oxygen Species, Free Radicals, Eicosanoids, Ions, Lipids, Oxides, Anions, Fatty Acids, Unsaturated, Prostaglandins, Electrolytes, Peroxides, Oxygen Compounds	experimental	1
DB02535	Aminodi(Ethyloxy)Ethylaminocarbonylbenzenesulfonamide	Drug	0	experimental	1
DB01204	Mitoxantrone	Drug	Anthracenes, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytotoxic Antibiotics and Related Substances, Immunosuppressive Agents, Sensory System Agents, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Cardiotoxic antineoplastic agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Peripheral Nervous System Agents, Quinones, Cytochrome P-450 Enzyme Inducers, Analgesics, Topoisomerase II Inhibitors, P-glycoprotein substrates with narrow therapeutic index, Cytochrome P-450 CYP2E1 Inducers (strength unknown), Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 CYP2E1 Inducers, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index, Antineoplastic Agents, Myelosuppressive Agents, P-glycoprotein inducers, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Anthraquinones, Cytochrome P-450 CYP3A4 Inhibitors, Central Nervous System Agents, P-glycoprotein inhibitors, Anthracyclines and Related Substances	approved, investigational	2
DB03860	ICI-164384	Drug	Estranes, Alkenes, Hormones, Hormone Substitutes, and Hormone Antagonists, Estrenes, Hydrocarbons, Acyclic, Amides, Hormones, Fused-Ring Compounds, Gonadal Steroid Hormones, Estrogen Antagonists, Estradiol Congeners, Hormone Antagonists, Alkynes, Gonadal Hormones, Steroids	experimental	1
DB01203	Nadolol	Drug	Amines, Cytochrome P-450 Substrates, Sympatholytics, Agents causing hyperkalemia, MATE 1 Substrates, Beta Blocking Agents, Non-Selective, and Thiazides, Adrenergic beta-Antagonists, Cardiovascular Agents, Hypotensive Agents, Drugs that are Mainly Renally Excreted, Alcohols, Peripheral Nervous System Agents, Adrenergic Antagonists, Antihypertensive Agents, Drugs causing inadvertant photosensitivity, MATE substrates, Adrenergic Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Autonomic Agents, Antihypertensive Agents Indicated for Hypertension, Propanols, P-glycoprotein substrates, Phenoxypropanolamines, Amino Alcohols, Beta Blocking Agents and Thiazides, Beta Blocking Agents, Non-Selective, Neurotransmitter Agents, Photosensitizing Agents, MATE 2 Substrates, Cytochrome P-450 CYP2D6 Substrates, Propanolamines	approved	2
DB02534	2-Allylphenol	Drug	Benzene Derivatives	experimental	1
DB01202	Levetiracetam	Drug	Anticonvulsants, Decreased Central Nervous System Disorganized Electrical Activity, Miscellaneous Anticonvulsants, Pyrrolidinones, Nervous System, Central Nervous System Depressants, P-glycoprotein substrates, Pyrrolidines, Amides, Acetamides, Central Nervous System Agents	approved	2
DB03861	(2R,3R,4S,5R)-2-acetamido-3,4-dihydroxy-5-hydroxymethyl-piperidine	Drug	0	experimental	2
DB02532	2,4,6-Triaminoquinazoline	Drug	0	experimental	2
DB01201	Rifapentine	Drug	Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Amides, Lactams, Antimycobacterials, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C19 Inducers (strong), Rifamycins, Anti-Infective Agents, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Lactams, Macrocyclic, Anti-Bacterial Agents, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C19 Inducers, Antibiotics, Antitubercular, Cytochrome P-450 CYP2B6 Inducers, Rifamycin Antimycobacterial, Antituberculosis Agents, Cytochrome P-450 CYP3A Inducers (strong), Cytochrome P-450 CYP3A4 Inducers, Antiinfectives for Systemic Use, Leprostatic Agents, Heterocyclic Compounds, Fused-Ring, Drugs for Treatment of Tuberculosis, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inducers, Cytochrome P-450 CYP2C8 Inducers (strength unknown)	approved, investigational	1
DB03862	Tetrahydrooxazine	Drug	0	experimental	2
DB01208	Sparfloxacin	Drug	Fluoroquinolones, Quinolines, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Enzyme Inhibitors, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, P-glycoprotein substrates, Antiinfectives for Systemic Use, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Anti-Infective Agents, Quinolones, Cytochrome P-450 CYP1A2 Inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Topoisomerase II Inhibitors, Antibacterials for Systemic Use, Antituberculosis Agents	approved, investigational, withdrawn	3
DB02538	N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide	Drug	0	experimental	1
DB01207	Ridogrel	Drug	Acids, Acyclic, Valerates, Enzyme Inhibitors, Fatty Acids, Fatty Acids, Volatile, Hematologic Agents, Lipids, Thromboxane-A Synthase, antagonists & inhibitors, Antiplatelet agents, Gastrointestinal Agents	experimental	2
DB01206	Lomustine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Nitroso Compounds, Noxae, Nitrosoureas, Antineoplastic and Immunomodulating Agents, Alkylating Activity, Antineoplastic Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Nitrosourea Compounds, Myelosuppressive Agents, Alkylating Drugs, Cytochrome P-450 CYP3A Inhibitors, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A4 Inhibitors, Toxic Actions, Antineoplastic Agents, Alkylating, Cytochrome P-450 CYP2D6 Inhibitors (weak)	approved, investigational	2
DB02537	2-Hydroxy-5-({1-[(4-Methylphenoxy)Methyl]-3-Oxoprop-1-Enyl}Amino)-L-Tyrosine	Drug	0	experimental	1
DB02536	D-glyceraldehyde	Drug	0	experimental	0
DB01205	Flumazenil	Drug	Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Antidotes, Benzodiazepine Antagonist, Benzazepines, GABA Agents, GABA Modulators, Protective Agents, Benzodiazepinones, Miscellaneous Central Nervous System Agents, Compounds used in a research, industrial, or household setting, Drugs that are Mainly Renally Excreted	approved	4
DB03867	3-nitro-L-tyrosine	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	1
DB03868	3-Dehydroquinic Acid	Drug	Cycloparaffins, Hydroxy Acids, Acids, Carbocyclic, Cyclohexanecarboxylic Acids, Cyclohexanes	experimental	1
DB03869	5'-O-(L-Serylsulfamoyl)adenosine	Drug	0	experimental	1
DB01209	Dezocine	Drug	Opioid Antagonists, Sensory System Agents, Analgesics, Narcotics, Nervous System, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Opioids, Central Nervous System Agents, Naphthalenes, Peripheral Nervous System Agents	approved, investigational	2
DB14520	Tetraferric tricitrate decahydrate	Drug	Organometallic Compounds, Phosphate Binder, Iron Compounds, Drugs for Treatment of Hyperkalemia and Hyperphosphatemia, Anemia, Iron-Deficiency	approved	2
DB14521	Silver cation	Drug	Anti-Bacterial Agents	experimental	0
DB14524	Gallium cation	Drug	0	experimental	0
DB14525	Chromic cation	Drug	0	experimental	0
DB14522	Hydroxide ion	Drug	Alkalies, Anions, Electrolytes, Ions	experimental	0
DB14523	Phosphate ion	Drug	Anions, Acids, Noncarboxylic, Acids, Phosphoric Acids, Electrolytes, Ions, Phosphorus Compounds, Phosphate salts, Phosphorus Acids	experimental	0
DB14528	Chromium gluconate	Drug	Drugs that are Mainly Renally Excreted	approved	1
DB14529	Chromium nicotinate	Drug	Nicotinic Acids, Drugs that are Mainly Renally Excreted	approved, experimental	1
DB14526	Chromic citrate	Drug	Drugs that are Mainly Renally Excreted	experimental	1
DB14527	Chromic nitrate	Drug	Anions, Acids, Noncarboxylic, Acids, Electrolytes, Ions, Nitric Acid, Drugs that are Mainly Renally Excreted, Nitrogen Compounds	approved	1
DB02542	(4s)-5-Fluoro-L-Leucine	Drug	0	experimental	1
DB03874	(4e,8e,12z,16z)-N,N,4,8,13,17,21-Heptamethyldocosa-4,8,12,16,20-Pentaen-1-Amine	Drug	0	experimental	1
DB01211	Clarithromycin	Drug	QTc Prolonging Agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Macrolides, Lincosamides and Streptogramins, OATP1B3 inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (strong), BSEP/ABCB11 Substrates, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Lactones, Cytochrome P-450 CYP3A4 Inhibitors (strong), Anti-Bacterial Agents, Cytochrome P-450 Enzyme Inducers, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Alimentary Tract and Metabolism, Drugs for Acid Related Disorders, Macrolide Antimicrobial, Protein Synthesis Inhibitors, Other Macrolides, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Chemically-Induced Disorders, Macrolides, P-glycoprotein substrates, Cytochrome P-450 CYP3A5 Inhibitors, Erythromycin and similars, Antiinfectives for Systemic Use, Moderate Risk QTc-Prolonging Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors, Antibacterials for Systemic Use	approved	4
DB02541	4-Hydroxybutan-1-Aminium	Drug	0	experimental	1
DB01210	Levobunolol	Drug	Amines, Cytochrome P-450 Substrates, Sympatholytics, Agents causing hyperkalemia, Adrenergic beta-Antagonists, Hypotensive Agents, Tetrahydronaphthalenes, Alcohols, Peripheral Nervous System Agents, Beta-adrenergic Agents, Bunolol, Adrenergic Antagonists, Adrenergic Agents, Bradycardia-Causing Agents, Autonomic Agents, Propanols, Antiglaucoma Preparations and Miotics, Phenoxypropanolamines, Amino Alcohols, Naphthalenes, Ophthalmologicals, Neurotransmitter Agents, Cytochrome P-450 CYP2D6 Substrates, Sensory Organs, Propanolamines	approved	2
DB02540	10-formyl-5,8,10-trideazafolic acid	Drug	0	experimental	1
DB03876	Thieno[2,3-B]Pyridine-2-Carboxamidine	Drug	0	experimental	2
DB03877	AL-4623	Drug	0	experimental	1
DB03870	Ara-Alpha(1,3)-Xyl	Drug	0	experimental	1
DB02546	Vorinostat	Drug	QTc Prolonging Agents, Enzyme Inhibitors, Amines, Hydroxy Acids, Immunosuppressive Agents, Aniline Compounds, Antineoplastic and Immunomodulating Agents, Hydroxylamines, Antineoplastic Agents, Amides, Hydroxamic Acids, Myelosuppressive Agents, Anilides, Narrow Therapeutic Index Drugs, Potential QTc-Prolonging Agents, Histone Deacetylase Inhibitors, Hyperglycemia-Associated Agents	approved, investigational	6
DB01215	Estazolam	Drug	Psycholeptics, Tranquilizing Agents, Cytochrome P-450 Substrates, GABA Agents, Nervous System, GABA Modulators, Benzodiazepines and benzodiazepine derivatives, Cytochrome P-450 CYP3A4 Substrates, Psychotropic Drugs, Drugs that are Mainly Renally Excreted, Triazolobenzodiazepines, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Anticonvulsants, Benzazepines, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Central Nervous System Depressants, Anti-Anxiety Agents, Hypnotics and Sedatives, Central Nervous System Agents, Drugs causing inadvertant photosensitivity, Benzodiazepine hypnotics and sedatives	approved, illicit	2
DB03871	lambda-bis(2,2'-bipyridine)imidazole ruthenium (II)	Drug	0	experimental	1
DB02545	Fexaramine	Drug	0	experimental	1
DB01214	Metipranolol	Drug	Amines, Cytochrome P-450 Substrates, Sympatholytics, Agents causing hyperkalemia, Beta Blocking Agents, Non-Selective, and Thiazides, Adrenergic beta-Antagonists, Cardiovascular Agents, Hypotensive Agents, Alcohols, Peripheral Nervous System Agents, Adrenergic Antagonists, Antihypertensive Agents, Adrenergic Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Autonomic Agents, Propanols, Antiglaucoma Preparations and Miotics, Phenoxypropanolamines, Amino Alcohols, Beta Blocking Agents and Thiazides, Ophthalmologicals, Neurotransmitter Agents, Cytochrome P-450 CYP2D6 Substrates, Sensory Organs, Propanolamines	approved	2
DB03872	2,3-Dideoxyfucose	Drug	0	experimental	0
DB01213	Fomepizole	Drug	Cytochrome P-450 CYP2E1 Substrates, Enzyme Inhibitors, Antidotes, Cytochrome P-450 CYP2E1 Inducers, Cytochrome P-450 Substrates, Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Protective Agents, Pyrazoles, Cytochrome P-450 CYP2A6 Inhibitors, Cytochrome P-450 CYP2A6 Inhibitors (strength unknown), Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Cytochrome P-450 Enzyme Inducers, Compounds used in a research, industrial, or household setting, Cytochrome P-450 CYP2E1 Inducers (strength unknown)	approved, vet_approved	4
DB02544	N-(6-{[3-(4-Bromophenyl)-1,2-Benzisothiazol-6-Yl]Oxy}Hexyl)-N-Methylprop-2-En-1-Amine	Drug	0	experimental	1
DB01212	Ceftriaxone	Drug	Nephrotoxic agents, Third-Generation Cephalosporins, Cephacetrile, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, OAT1/SLC22A6 inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, OAT3/SLC22A8 Inhibitors, P-glycoprotein inhibitors, Antibacterials for Systemic Use	approved	5
DB02543	Pyrrole-2-Carboxylate	Drug	Acids, Acyclic, Amino Acids, Cyclic, Imines, Amino Acids, Peptides, and Proteins, Imino Acids, Amino Acids	experimental	1
DB01219	Dantrolene	Drug	Neuromuscular Agents, Cytochrome P-450 Substrates, Decreased Striated Muscle Contraction, Agents causing hyperkalemia, Direct-acting Skeletal Muscle Relaxants, Dantrolene and Derivatives, Agents that produce neuromuscular block (indirect), Hydantoins, Imidazolidines, Muscle Relaxants, Peripheral Nervous System Agents, Thyroxine-binding globulin substrates, Imidazoles, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Musculo-Skeletal System, Decreased Striated Muscle Tone, Muscle Relaxants, Centrally Acting Agents, Hepatotoxic Agents, Central Nervous System Agents	approved, investigational	1
DB02549	3'-O-Acetylthymidine-5'-diphosphate	Drug	0	experimental	1
DB01218	Halofantrine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Antimalarials, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP2D6 Inhibitors (strong), Antiparasitic Agents, Agents that reduce seizure threshold	approved	3
DB02548	D-glucitol 6-phosphate	Drug	Carbohydrates, Sugar Phosphates	experimental	1
DB01217	Anastrozole	Drug	Endocrine Therapy, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, UGT1A3 substrates, Cardiotoxic antineoplastic agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Hormone Antagonists and Related Agents, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inhibitors, Estrogen Antagonists, UGT2B7 substrates, Triazoles, Cytochrome P-450 CYP2C9 Inhibitors, Nitriles, Hormone Antagonists, Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Antineoplastic Agents, Hormonal, Cytochrome P-450 CYP3A5 Substrates, Steroid Synthesis Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Aromatase Inhibitors, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, UGT1A4 substrates	approved, investigational	1
DB02547	Guanosine-5'-Diphosphate-Rhamnose	Drug	0	experimental	1
DB01216	Finasteride	Drug	Enzyme Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Steroid Synthesis Inhibitors, Adrenergic alpha-Antagonists, Cytochrome P-450 CYP3A7 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Dermatologicals, Genito Urinary System and Sex Hormones, Urologicals, 5-alpha Reductase Inhibitors, Androstenes, Misc. Skin and Mucous Membrane Agents, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Urological Agents, Androstanes, Azasteroids, Cytochrome P-450 CYP3A Substrates, Adrenergic Antagonists, Agents that produce hypertension, Hormone Antagonists, Drugs Used in Benign Prostatic Hypertrophy, Steroids	approved	3
DB03878	N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide	Drug	0	experimental	2
DB03879	alpha-L-methyl-fucose	Drug	0	experimental	2
DB13288	Tromantadine	Drug	Antivirals for Systemic Use, Direct Acting Antivirals, Cycloparaffins, Dermatologicals, Antiviral Agents, Antiinfectives for Systemic Use, Anti-Infective Agents, Cyclic Amines	approved	0
DB13289	Rimazolium	Drug	Pyrimidines, Analgesics, Nervous System	experimental	0
DB13286	Bumadizone	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Acids, Acyclic, Acetic Acid Derivatives and Related Substances, Sensory System Agents, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Dicarboxylic Acids, Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Musculo-Skeletal System, Agents that produce hypertension, Central Nervous System Agents	approved	0
DB13287	Miocamycin	Drug	Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Cytochrome P-450 CYP3A4 Inhibitors, Macrolides, Lincosamides and Streptogramins, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use, Lactones	approved	0
DB13280	Aluminium acetoacetate	Drug	Aluminum and magnesium containing antacids, Gastric Acid Lowering Agents, Metal cations, Alimentary Tract and Metabolism, Metal divalent cations, Aluminium Compounds, Drugs for Acid Related Disorders, Antacids	experimental	0
DB13281	Bromelains	Drug	Cysteine Endopeptidases, Enzymes, Cysteine Proteases, Musculo-Skeletal System, Dermatologicals, Enzymes and Coenzymes, Hydrolases, Peptide Hydrolases, Preparations for Treatment of Wounds and Ulcers, Endopeptidases, Gastrointestinal Agents	investigational	0
DB13284	Meticrane	Drug	Gynecological Antiinfectives and Antiseptics, Sulfonamides, Genito Urinary System and Sex Hormones, Diuretics, Low-Ceiling Diuretics, Excl. Thiazides	approved	0
DB13285	Etilamfetamine	Drug	Centrally Acting Antiobesity Products, Alimentary Tract and Metabolism, Antiobesity Preparations, Excl. Diet Products	experimental	0
DB13282	Benzododecinium	Drug	Amines, Ammonium Compounds, Medicated Dressings, Quaternary Ammonium Compounds, Dermatologicals, Onium Compounds, Anti-Infective Agents, Anti-Infective Agents, Local, Benzylammonium Compounds, Medicated Dressings With Antiinfectives, Disinfectants, Compounds used in a research, industrial, or household setting, Nitrogen Compounds	approved	0
DB13283	Sulfaisodimidine	Drug	Short-Acting Sulfonamides, SULFONAMIDES AND TRIMETHOPRIM, Sulfur Compounds, Amines, Sulfonamides, Aniline Compounds, Amides, Sulfanilamides, Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use, Sulfones	experimental	0
DB13299	Sulglicotide	Drug	Proteins, Carbohydrates, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Glycoconjugates, Peptides, Alimentary Tract and Metabolism, Amino Acids, Peptides, and Proteins, Glycoproteins, Anti-Ulcer Agents, Drugs for Acid Related Disorders, Glycopeptides, Gastrointestinal Agents	experimental	0
DB13297	Idrocilamide	Drug	Amines, Musculo-Skeletal System, Amino Alcohols, Topical Products for Joint and Muscular Pain, Alcohols	experimental	0
DB13298	Alsactide	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pituitary Hormones, Tests for Renal Function and Ureteral Injuries, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Hormones, Proteins, Peptide Hormones, Hypothalamic Hormones, Protein Precursors, Melanocortins, Diagnostic Agents, Pituitary Hormones, Anterior, Pro-Opiomelanocortin	experimental	0
DB13291	Cloridarol	Drug	Heterocyclic Compounds, Fused-Ring, Vasodilators Used in Cardiac Diseases, Cardiac Therapy	experimental	0
DB13292	Pimethixene	Drug	Xanthenes, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Antihistamines for Systemic Use	approved	0
DB13290	Olaflur	Drug	Cariostatic Agents, Amines, Protective Agents, Hydrofluoric Acid, Fluorine Compounds, Ions, Polyamines, Caries Prophylactic Agents, Anions, Acids, Noncarboxylic, Acids, Alimentary Tract and Metabolism, Electrolytes, Compounds used in a research, industrial, or household setting, Stomatological Preparations	experimental	0
DB13295	Atracurium	Drug	Neuromuscular Agents, Benzylisoquinolines, Isoquinolines, Neuromuscular-Blocking Agents (Nondepolarizing), Muscle Relaxants, Nicotinic Antagonists, Peripheral Nervous System Agents, Anticholinergic Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cholinergic Agents, Neuromuscular Nondepolarizing Blockade, Muscle Relaxants, Peripherally Acting Agents, Central Nervous System Depressants, Musculo-Skeletal System, Neuromuscular Blocking Agents	approved, investigational, experimental	0
DB13296	Propamidine	Drug	Ophthalmologicals, Antiprotozoals, Antiseptics and Disinfectants, Dermatologicals, Amidines, Biguanides and Amidines, Sensory Organs, Anti-Infective Agents, Antiparasitic Agents	investigational, experimental	0
DB13293	Ipecac	Drug	Autonomic Agents, Antidotes, Cytochrome P-450 Substrates, Plant Extracts, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Emetics, Complex Mixtures, Cough and Cold Preparations, Cytochrome P-450 CYP3A Substrates, Expectorants, Plant Preparations, Agents Causing Muscle Toxicity, Biological Products, Pharmaceutical Preparations, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Gastrointestinal Agents	approved, withdrawn	0
DB13294	Azidamfenicol	Drug	Ophthalmologicals, Anti-Bacterial Agents, Nitrobenzenes, Nitro Compounds, Glycols, Sensory Organs, Propylene Glycols, Anti-Infective Agents, Benzene Derivatives, Alcohols	experimental	0
DB13244	Aminomethylbenzoic acid	Drug	Antifibrinolytic Agents, Blood and Blood Forming Organs, Hemostatics, Amino Acids	experimental	0
DB14575	Eslicarbazepine	Drug	Voltage-Gated Sodium Channel Blockers, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP2C19 Inhibitors, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Membrane Transport Modulators, Carboxamide Derivatives, Heterocyclic Compounds, Fused-Ring, Anticonvulsants, Cytochrome P-450 Enzyme Inducers, Eslicarbazepine and prodrugs, Central Nervous System Depressants, UGT1A1 Substrates, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Sodium Channel Blockers	approved	1
DB13245	Thiram	Drug	Fungicides, Industrial, Acids, Acyclic, Cell-mediated Immunity, Antiparasitic Products, Insecticides and Repellents, Noxae, Ectoparasiticides, Incl. Scabicides, Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents, Pesticides, Dimethyldithiocarbamate, Standardized Chemical Allergen, Sulfur Containing Products, Thiocarbamates, Sulfur Compounds, Agrochemicals, Mutagens, Carbamates, Toxic Actions, Compounds used in a research, industrial, or household setting, Increased Histamine Release	approved, experimental	0
DB14576	Thallous cation Tl-201	Drug	Radioactive Diagnostic Agent, Radiopharmaceutical Activity	experimental	0
DB14573	Phosphate ion P-32	Drug	Radioactive Therapeutic Agent, Radiopharmaceutical Activity	experimental	0
DB13242	Bucladesine	Drug	Carbohydrates, Phosphodiesterase Inhibitors, Cyclic AMP, Nucleotides, Nucleotides, Cyclic, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Cardiac Stimulants Excl. Cardiac Glycosides, Glycosides, Adenine Nucleotides, Cardiac Therapy	experimental	0
DB14574	Cobalt	Drug	Cell-mediated Immunity, Metals, Standardized Chemical Allergen, Metals, Heavy, Elements, Transition Elements, Cobalt, Trace Elements, Micronutrients, Physiological Phenomena, Food and Beverages, Growth Substances, Diet, Food, and Nutrition, Food, Increased Histamine Release	approved, experimental	0
DB13243	Tiazofurine	Drug	Carbohydrates, Ribonucleosides, Nucleic Acids, Nucleotides, and Nucleosides, Noxae, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Glycosides, Nucleosides, Toxic Actions, Antimetabolites	experimental	0
DB13248	Phthalylsulfathiazole	Drug	Amines, Gynecological Antiinfectives and Antiseptics, Aniline Compounds, Genito Urinary System and Sex Hormones, Amides, Sulfanilamides, Sulfur Compounds, Intestinal Antiinfectives, Alimentary Tract and Metabolism, Sulfonamides, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Thiazoles, Sulfones	approved	0
DB14579	Lanthanum III cation	Drug	Phosphate Chelating Activity, Metal cations, Phosphate Binder	experimental	0
DB13249	Magnesium silicate	Drug	Ions, Oxides, Agents that produce neuromuscular block (indirect), Minerals, Silicates, Silicon Compounds, Aluminum and magnesium containing antacids, Anions, Gastric Acid Lowering Agents, Acids, Noncarboxylic, Metal cations, Acids, Alimentary Tract and Metabolism, Metal divalent cations, Electrolytes, Drugs for Acid Related Disorders, Antacids, Oxygen Compounds, Magnesium Compounds	approved	0
DB14577	Calcium cation	Drug	Calcium Salts, Increased Coagulation Factor Activity, Blood Coagulation Factors, Polyvalent cation containing laxatives, antacids, oral supplements	experimental	0
DB13246	Quinupramine	Drug	Heterocyclic Compounds, Fused-Ring, Non-Selective Monoamine Reuptake Inhibitors, Narrow Therapeutic Index Drugs, Nervous System, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Antidepressive Agents, Tricyclic, Agents that produce hypertension, Antidepressive Agents, Agents that reduce seizure threshold, Neurotoxic agents, Psychoanaleptics	approved	0
DB14578	Gadolinium cation (3+)	Drug	Magnetic Resonance Contrast Activity, Gadolinium-based Contrast Agent	experimental	0
DB13247	Pramiracetam	Drug	Nervous System, Psychostimulants, Agents Used for Adhd and Nootropics, Psychoanaleptics	approved	0
DB02593	7,8-Dihydroxy-1-Methoxy-3-Methyl-10-Oxo-4,10-Dihydro-1h,3h-Pyrano[4,3-B]Chromene-9-Carboxylic Acid	Drug	0	experimental	1
DB01262	Decitabine	Drug	Carbohydrates, Ribonucleosides, Enzyme Inhibitors, Immunosuppressive Agents, Pyrimidine Nucleosides, Noxae, Antineoplastic and Immunomodulating Agents, Pyrimidine Analogues, Antineoplastic Agents, Antimetabolites, Myelosuppressive Agents, Nucleic Acid Synthesis Inhibitors, Pyrimidines, Narrow Therapeutic Index Drugs, Nucleic Acids, Nucleotides, and Nucleosides, Nucleoside Metabolic Inhibitor, Aza Compounds, Glycosides, Nucleosides, Toxic Actions	approved, investigational	2
DB02592	Carbaphosphonate	Drug	0	experimental	1
DB01261	Sitagliptin	Drug	Enzyme Inhibitors, Cytochrome P-450 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein substrates, Protease Inhibitors, Hypoglycemia-Associated Agents, Blood Glucose Lowering Agents, Hormones, Cytochrome P-450 CYP3A4 Substrates, DPP-IV Inhibitors, Drugs that are Mainly Renally Excreted, OAT3/SLC22A8 Substrates, Incretins, Cytochrome P-450 CYP3A Substrates, Alimentary Tract and Metabolism, Triazoles, Drugs Used in Diabetes, Agents causing angioedema, Cytochrome P-450 CYP2C8 Substrates	approved, investigational	1
DB01260	Desonide	Drug	Pregnadienetriols, Corticosteroids, Cytochrome P-450 Substrates, Immunosuppressive Agents, Pregnadienes, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Dermatologicals, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Ophthalmologicals, Corticosteroids, Moderately Potent (Group II), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A Substrates, Pregnanes, Sensory Organs, Corticosteroid Hormone Receptor Agonists, Steroids	approved, investigational	1
DB02591	5,6-Dimethylbenzimidazole	Drug	Heterocyclic Compounds, Fused-Ring	experimental	1
DB02590	Abequose	Drug	Carbohydrates, Monosaccharides	experimental	1
DB01266	Sinecatechins	Drug	Dermatologicals, Antiviral Agents	approved, investigational, nutraceutical	0
DB02597	[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala	Drug	0	experimental	3
DB01265	Telbivudine	Drug	Carbohydrates, Enzyme Inhibitors, Pyrimidine Nucleosides, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Antiviral Agents, Antiinfectives for Systemic Use, Anti-Infective Agents, Antivirals for Systemic Use, Direct Acting Antivirals, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors, Nucleic Acid Synthesis Inhibitors, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Deoxyribonucleosides, Nucleoside Reverse Transcriptase Inhibitors, Nucleosides and Nucleotides	approved, investigational	2
DB02596	alpha,beta-Methyleneadenosine 5'-triphosphate	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Antineoplastic Agents, Glycosides, Nucleotides, Adenine Nucleotides	experimental	8
DB02595	(2R,3S,5S)-2-(Hydroxymethyl)-5-[(2-sulfoethyl)carbamoyl]-3-pyrrolidiniumyl 2-acetamido-2-deoxy-4-O-sulfo-beta-D-glucopyranoside	Drug	0	experimental	2
DB01264	Darunavir	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Genito Urinary System and Sex Hormones, Protease Inhibitors, Amides, Experimental Unapproved Treatments for COVID-19, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Cytochrome P-450 CYP3A4 Inhibitors (strong), Antivirals for Systemic Use, Direct Acting Antivirals, Sulfur Compounds, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Sulfones, OATP1B1/SLCO1B1 Inhibitors, Gynecological Antiinfectives and Antiseptics, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Antiinfectives for Systemic Use, HIV Protease Inhibitors, P-glycoprotein inducers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Sulfonamides, Cytochrome P-450 CYP3A4 Inhibitors, Carbamates, Furans, P-glycoprotein inhibitors, Hyperglycemia-Associated Agents	approved	1
DB02594	2'-Deoxycytidine	Drug	0	investigational, experimental	3
DB01263	Posaconazole	Drug	QTc Prolonging Agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Antimycotics for Systemic Use, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Cytochrome P-450 CYP3A4 Inhibitors (strong), Potential QTc-Prolonging Agents, Antifungal Agents, Hormone Antagonists, Triazole Derivatives, Antiprotozoals, Steroid Synthesis Inhibitors, Chemically-Induced Disorders, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein substrates, Antiinfectives for Systemic Use, Azole Antifungals, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Trypanocidal Agents, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors, 14-alpha Demethylase Inhibitors, Antiparasitic Agents	approved, investigational, vet_approved	1
DB01269	Panitumumab	Drug	Immunoglobulins, Antineoplastic and Immunomodulating Agents, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, HER1 Antagonists, Immunoproteins, Proteins, Serum Globulins, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, Globulins, Blood Proteins, Epidermal Growth Factor Receptor Antagonist	approved, investigational	1
DB02599	2,6-Diamino-8-Propylsulfanylmethyl-3h-Quinazoline-4-One	Drug	0	experimental	1
DB01268	Sunitinib	Drug	QTc Prolonging Agents, Enzyme Inhibitors, Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, Hypoglycemia-Associated Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Growth Inhibitors, Angiogenesis Modulating Agents, Cytochrome P-450 CYP3A4 Substrates, Hepatotoxic Agents, Potential QTc-Prolonging Agents, Indoles, Growth Substances, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index, Blood Glucose Lowering Agents, Angiogenesis Inhibitors, Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors, Cytochrome P-450 CYP3A Inhibitors, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors, Kinase Inhibitor	approved, investigational	8
DB01267	Paliperidone	Drug	Highest Risk QTc-Prolonging Agents, Psycholeptics, QTc Prolonging Agents, Tranquilizing Agents, Cytochrome P-450 Substrates, Serotonin Agents, Nervous System, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Serotonin 5-HT2 Receptor Antagonists, Antipsychotic Agents, Pyrimidines, Antipsychotic Agents (Second Generation Atypical), Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Adrenergic Antagonists, Isoxazoles, Adrenergic alpha-1 Receptor Antagonists, Dopamine Antagonists, Dopamine Agents, Neurotoxic agents, Cytochrome P-450 CYP3A5 Substrates, Adrenergic alpha-Antagonists, P-glycoprotein substrates, Psychotropic Drugs, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Agents that produce hypertension, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors, Dopamine D2 Receptor Antagonists, Hyperglycemia-Associated Agents	approved	15
DB02598	N-Alpha-Acetyl-3,5-Diiodotyrosylglycine	Drug	0	experimental	1
DB14571	Radium Ra-223 cation	Drug	alpha-Particle Emitting Activity, Radioactive alpha-Particle Emitting Therapeutic Agent	experimental	0
DB13240	Cymarin	Drug	Carbohydrates, Cardanolides, Cardiac Glycosides, Protective Agents, Cardiovascular Agents, Fused-Ring Compounds, Strophanthins, Cardiotonic Agents, Glycosides, Strophanthus Glycosides, Cardenolides, Cardiac Therapy, Compounds used in a research, industrial, or household setting, Antiarrhythmic agents, Steroids	experimental	0
DB14572	Bismuth cation	Drug	0	experimental	0
DB13241	Begelomab	Drug	Immunosuppressive Agents, Antineoplastic and Immunomodulating Agents, Selective Immunosuppressants	investigational, experimental	0
DB14570	Hydroxyprogesterone	Drug	Sex Hormones and Modulators of the Genital System, Pregnen (4) Derivatives, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, Progestins, Cytochrome P-450 CYP3A4 Substrates	experimental	0
DB13255	Propatyl nitrate	Drug	Antianginal Agents, Vasodilators Used in Cardiac Diseases, Glycols, Vasodilating Agents, Cardiac Therapy, Organic Nitrates, Alcohols	investigational, experimental	0
DB14586	Citrus bioflavonoids	Drug	Heterocyclic Compounds, Fused-Ring, Flavonoids, Benzopyrans, Chromones, Pyrans	approved, experimental	0
DB13256	Clothiapine	Drug	Psycholeptics, Tranquilizing Agents, Nervous System, Diazepines, Oxazepines, Thiazepines and Oxepines, Psychotropic Drugs, Azepines, Heterocyclic Compounds, Fused-Ring, Antipsychotic Agents, Sulfur Compounds, Central Nervous System Depressants, Thiepins, Central Nervous System Agents, Thiazepines, Neurotoxic agents	approved	0
DB14587	Influenza A virus A/Singapore/INFIMH-16-0019/2016 IVR-186 (H3N2) antigen (formaldehyde inactivated)	Drug	0	approved	0
DB14584	Segesterone	Drug	0	experimental	0
DB13253	Proxibarbal	Drug	Psycholeptics, Pyrimidines, Nervous System, Central Nervous System Depressants, Barbiturates, Plain, Pyrimidinones, Hypnotics and Sedatives, Central Nervous System Agents	approved	0
DB14585	Plantago ovata seed	Drug	Complex Mixtures, Plant Preparations, Alimentary Tract and Metabolism, Plant Extracts, Drugs for Constipation, Biological Products, Laxatives, Pharmaceutical Preparations, Bulk-Forming Laxatives, Gastrointestinal Agents	approved, investigational, experimental	0
DB13254	Prifinium	Drug	Anticholinergic Agents, Synthetic Anticholinergics, Quaternary Ammonium Compounds, Alimentary Tract and Metabolism, Agents producing tachycardia, Drugs for Functional Gastrointestinal Disorders, Muscarinic Antagonists	experimental	0
DB13259	Ethyl chloride	Drug	Hydrocarbons, Chlorinated, Sensory System Agents, Nervous System, Central Nervous System Depressants, Hydrocarbons, Halogenated, Central Nervous System Agents, Anesthetics, Anesthetics, Local, Peripheral Nervous System Agents	approved, investigational, experimental	0
DB14588	Bambusa arundinacea stem	Drug	0	experimental	0
DB13257	Ferrous sulfate anhydrous	Drug	Hematinics, Organometallic Compounds, Iron Compounds, Iron Preparations, Pharmaceutical Preparations, Polyvalent cation containing laxatives, antacids, oral supplements, Minerals, Delayed-Action Preparations, Anemia, Iron-Deficiency	approved	2
DB14589	Caprylyl glycol	Drug	Lipids, Fatty Alcohols, Alcohols	experimental	0
DB13258	Etofamide	Drug	Acids, Acyclic, Dichloroacetamide Derivatives, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Fatty Acids, Fatty Acids, Volatile, Amides, Lipids, Acetates, Anti-Infective Agents, Antiparasitic Agents, Amebicides	approved	0
DB01273	Varenicline	Drug	Partial Cholinergic Nicotinic Agonists, Cholinergic Agonists, Nervous System, OCT2 Substrates, Miscellaneous Autonomic Drugs, Quinoxalines, Drugs Used in Addictive Disorders, Drugs that are Mainly Renally Excreted, Drugs Used in Nicotine Dependence, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cholinergic Agents, Partial Cholinergic Nicotinic Agonist, Benzazepines, Nicotinic Agonists, OCT2 Inhibitors, Smoking Cessation Agents	approved, investigational	5
DB01272	Alglucosidase alfa	Drug	Glucosidases, Enzymes, Glycoside Hydrolases, Alimentary Tract and Metabolism, Enzymes and Coenzymes, alpha-Glucosidases, Hydrolases, Glycogen Storage Disease Type II, Hydrolytic Lysosomal Glycogen-specific Enzyme	approved	2
DB01271	Idursulfase	Drug	Enzymes, Alimentary Tract and Metabolism, Enzymes and Coenzymes, Sulfatases, Hydrolases, Esterases, Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme	approved	3
DB01270	Ranibizumab	Drug	Immunoglobulins, Vascular Endothelial Growth Factor Inhibitor, Antibodies, Amino Acids, Peptides, and Proteins, Growth Inhibitors, Angiogenesis Modulating Agents, Antibodies, Monoclonal, Antineovascularisation Agents, Ocular Vascular Disorder Agents, Angiogenesis Inhibitors, Vascular Endothelial Growth Factor Inhibitors, Immunoproteins, Ophthalmics, Ophthalmologicals, Proteins, Serum Globulins, Antibodies, Monoclonal, Humanized, EENT Drugs, Miscellaneous, Globulins, Blood Proteins, Sensory Organs, Growth Substances	approved	1
DB01277	Mecasermin	Drug	Biological Factors, Somatropin and Somatropin Agonists, Somatomedins, Peptides, Intercellular Signaling Peptides and Proteins, Hypoglycemia-Associated Agents, Pituitary and Hypothalamic Hormones and Analogues, Amino Acids, Peptides, and Proteins, Blood Glucose Lowering Agents, Proteins, Anterior Pituitary Lobe Hormones and Analogues, Blood Proteins, Growth Substances, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins	approved, investigational	4
DB01276	Exenatide	Drug	Biological Factors, Glucagon-Like Peptide 1, Glucagon-like Peptide-1 (GLP-1) Agonists, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Hypoglycemia-Associated Agents, Glucagon-like peptide-1 (GLP-1) analogues, Amino Acids, Peptides, and Proteins, Blood Glucose Lowering Agents, GLP-1 Agonists, Hormones, Incretins, Toxins, Biological, Alimentary Tract and Metabolism, Anti-Obesity Agents, Incretin Mimetics, Venoms, Drugs Used in Diabetes, Fluids and Secretions, Bodily Secretions	approved, investigational	1
DB01275	Hydralazine	Drug	Antihypertensive Agents Indicated for Hypertension, Phthalazines, Cytochrome P-450 Enzyme Inhibitors, Hydrazinophthalazine Derivatives, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Hypotensive Agents, Direct Vasodilators, Drugs that are Mainly Renally Excreted, Hydrazinophthalazine Derivatives and Diuretics, Arteriolar Vasodilator, Pyridazines, Cytochrome P-450 CYP3A Inhibitors, Arteriolar Smooth Muscle, Agents Acting On, Cytochrome P-450 CYP3A4 Inhibitors, Arteriolar Vasodilation, Antihypertensive Agents, Vasodilating Agents	approved	3
DB01274	Arformoterol	Drug	QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Adrenergic beta-2 Receptor Agonists, Drugs that are Mainly Renally Excreted, Alcohols, Peripheral Nervous System Agents, Potential QTc-Prolonging Agents, Adrenergic Agents, Autonomic Agents, Anti-Asthmatic Agents, Agents producing tachycardia, Bronchodilator Agents, Amino Alcohols, Ethanolamines, Respiratory System Agents, Cytochrome P-450 CYP2C19 Substrates, Adrenergic beta-Agonists, Cytochrome P-450 CYP2C9 Substrates, Neurotransmitter Agents, Agents to Treat Airway Disease, Adrenergic Agonists, Agents that produce hypertension, Cytochrome P-450 CYP2A6 Substrates, Cytochrome P-450 CYP2D6 Substrates	approved, investigational	1
DB01279	Galsulfase	Drug	Enzymes, Arylsulfatases, Enzymes and Coenzymes, Sulfatases, Amino Acids, Peptides, and Proteins, Esterases, Lyases, Chondroitinsulfatases, Chondroitinases and Chondroitin Lyases, Proteins, Alimentary Tract and Metabolism, Carbon-Oxygen Lyases, Hydrolases, Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme, Polysaccharide-Lyases	approved, investigational	2
DB01278	Pramlintide	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pancreatic Hormones, Multiprotein Complexes, Hypoglycemia-Associated Agents, Amino Acids, Peptides, and Proteins, Blood Glucose Lowering Agents, Hormones, Amylin Agonists, Amyloidogenic Proteins, Macromolecular Substances, Proteins, Amylin Analog, Peptide Hormones, Alimentary Tract and Metabolism, Drugs Used in Diabetes, Amyloid	approved, investigational	4
DB14582	Patisiran	Drug	Molecular Probes, RNA, Antisense, Antisense Elements (Genetics), Nervous System, RNA, RNA, Untranslated, Laboratory Chemicals, Other Miscellaneous Therapeutic Agents, Nucleic Acid Probes, Nucleic Acids, Diagnostic Uses of Chemicals, Nucleic Acids, Nucleotides, and Nucleosides, RNA, Small Untranslated, Compounds used in a research, industrial, or household setting	approved, investigational	1
DB13251	Octopamine	Drug	Adrenergic alpha-Agonists, Amines, Agents producing tachycardia, Adrenergic and Dopaminergic Agents, Cardiovascular Agents, Amino Alcohols, Ethanolamines, Phenethylamines, Biogenic Monoamines, Alcohols, Neurotransmitter Agents, Ethylamines, Vasoconstrictor Agents, Adrenergic Agonists, Cardiac Stimulants Excl. Cardiac Glycosides, Agents that produce hypertension, Biogenic Amines, Cardiac Therapy, Adrenergic Agents	experimental	0
DB13252	Tropatepine	Drug	Anticholinergic Agents, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Nervous System, Thiepins, Agents producing tachycardia, Muscarinic Antagonists, Tertiary Amines, Anti-Parkinson Drugs	experimental	0
DB14583	Segesterone acetate	Drug	Cytochrome P-450 Substrates, Norsteroids, Adrenal Cortex Hormones, Reproductive Control Agents, Drug Implants, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 CYP3A Substrates, Norpregnenes, Hormonal Contraceptives for Systemic Use, Norpregnanes, Contraceptive Agents, Female, Intravaginal Contraceptives, Steroids	approved, investigational, experimental	3
DB14580	Lecanemab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB14581	CPI-1205	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors	investigational	1
DB13250	Methylmethionine chloride	Drug	Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Alimentary Tract and Metabolism, Drugs for Acid Related Disorders	experimental	0
DB13266	Cefatrizine	Drug	Nephrotoxic agents, Amides, Lactams, Thiazines, beta-Lactams, First-Generation Cephalosporins, Antiinfectives for Systemic Use, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Antibacterials for Systemic Use	experimental	0
DB14597	Lanadelumab	Drug	Immunoglobulins, Blood and Blood Forming Organs, Antibodies, Complement Inactivating Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins, Proteins, Serum Globulins, Antibodies, Monoclonal, Humanized, Globulins, Blood Proteins, Drugs Used in Hereditary Angioedema	approved, investigational	1
DB14598	Edetate calcium disodium anhydrous	Drug	Anticoagulants, Cytochrome P-450 Enzyme Inhibitors, Metal Chelating Activity, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Calcium Chelating Agents, Calcium Chelating Activity, Cytochrome P-450 CYP3A Inhibitors, Iron Chelating Agents, Chelating Activity, Lead Chelator, Cytochrome P-450 CYP3A4 Inhibitors, Iron Chelating Activity, Metal Chelator, Compounds used in a research, industrial, or household setting, Lead Chelating Activity, Chelating Agents	approved	3
DB13267	Ritiometan	Drug	Nasal Preparations	approved	0
DB13264	Penimepicycline	Drug	Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Tetracyclines, Naphthacenes, Amides, Lactams, Agents that produce neuromuscular block (indirect), beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use	experimental	0
DB14595	Influenza B virus B/Maryland/15/2016 recombinant hemagglutinin antigen	Drug	0	approved	0
DB14596	Loteprednol etabonate	Drug	Androstanes, Anti-Allergic Agents, Corticosteroids, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 CYP3A Substrates, Adrenal Cortex Hormones, Androstadienes, Androstenes, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Steroids	approved	1
DB13265	Hexobendine	Drug	Benzoates, Hydroxy Acids, Acids, Carbocyclic, Hydroxybenzoates, Cardiovascular Agents, Phenyl Ethers, Phenols, Vasodilators Used in Cardiac Diseases, Ethers, Vasodilating Agents, Cardiac Therapy, Hydroxybenzoate Ethers, Benzene Derivatives	approved	0
DB13268	Acetarsol	Drug	Organometallic Compounds, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Agents Against Leishmaniasis and Trypanosomiasis, Intestinal Antiinfectives, Alimentary Tract and Metabolism, Arsenicals, Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Anti-Infective Agents, Drugs that are Mainly Renally Excreted	approved, withdrawn	0
DB14599	Edetate copper disodium	Drug	0	experimental	0
DB13269	Dichlorobenzyl alcohol	Drug	Throat Preparations, Benzyl Compounds, Anti-Infective Agents, Local, Benzene Derivatives, Drugs that are Mainly Renally Excreted, Alcohols	approved	1
DB01280	Nelarabine	Drug	Carbohydrates, Immunosuppressive Agents, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Antimetabolites, Myelosuppressive Agents, Nucleic Acid Synthesis Inhibitors, Narrow Therapeutic Index Drugs, Nucleic Acids, Nucleotides, and Nucleosides, Purine Analogues, Nucleoside Metabolic Inhibitor, Glycosides, Nucleosides	approved, investigational	2
DB01284	Tetracosactide	Drug	Adrenocortical Insufficiency, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pituitary Hormones, Pituitary and Hypothalamic Hormones and Analogues, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Hormones, Proteins, Anterior Pituitary Lobe Hormones and Analogues, Peptide Hormones, Adrenals, Pituitary, Protein Precursors, Adrenocorticotropic Hormone, Melanocortins, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Pituitary Hormones, Anterior, Pro-Opiomelanocortin	approved	1
DB01283	Lumiracoxib	Drug	Nephrotoxic agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Sensory System Agents, Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Selective Cyclooxygenase 2 Inhibitors (NSAIDs), Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Non-Steroids, COX-2 Inhibitors, Analgesics, Musculo-Skeletal System, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Antirheumatic Agents, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Antiinflammatory and Antirheumatic Products, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Phenylacetates, UGT1A9 Substrates, Central Nervous System Agents	approved, investigational	2
DB01282	Carbetocin	Drug	Oxytocin and Analogues, Hormones, Hormone Substitutes, and Hormone Antagonists, Investigative Techniques, Peptides, Pituitary Hormones, Reproductive Control Agents, Pituitary and Hypothalamic Hormones and Analogues, Amino Acids, Peptides, and Proteins, Hypotensive Agents, Hormones, Uterotonic agents, Drug Delivery Systems, Peptide Hormones, Pituitary Hormones, Posterior, Pharmaceutical Preparations, Posterior Pituitary Lobe Hormones, Delayed-Action Preparations, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins	approved, investigational	1
DB01281	Abatacept	Drug	Immunologic Factors, Decreased Cytokine Activity, Biologics for Rheumatoid Arthritis Treatment, Immunosuppressive Agents, Noxae, Antineoplastic and Immunomodulating Agents, CD86-directed Antibody Interactions, Antibodies, Antirheumatic Agents, Amino Acids, Peptides, and Proteins, Agents reducing cytokine levels, CD80-directed Antibody Interactions, Disease-modifying Antirheumatic Agents, Selective Immunosuppressants, Immunoproteins, Proteins, Serum Globulins, Globulins, Immunoconjugates, Blood Proteins, Selective T Cell Costimulation Modulator, Toxic Actions	approved	2
DB01288	Fenoterol	Drug	Adrenergics, Inhalants, Amines, Genito Urinary System and Sex Hormones, Adrenergic beta-2 Receptor Agonists, Tocolytic Agents, Alcohols, Peripheral Nervous System Agents, Anticholinergic Agents, Selective Beta 2-adrenergic Agonists, Metaproterenol, Adrenergic Agents, Benzene Derivatives, Autonomic Agents, Adrenergics for Systemic Use, Anti-Asthmatic Agents, Reproductive Control Agents, Sympathomimetics, Labour Repressants, Agents producing tachycardia, Catechols, Bronchodilator Agents, Amino Alcohols, Ethanolamines, Respiratory System Agents, Adrenergic beta-Agonists, Neurotransmitter Agents, Agents to Treat Airway Disease, Sympathomimetics, Adrenergic Agonists, Agents that produce hypertension, Phenols, Drugs for Obstructive Airway Diseases	approved, investigational	3
DB01285	Corticotropin	Drug	Cytochrome P-450 Substrates, Immunosuppressive Agents, Peptides, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Pituitary and Hypothalamic Hormones and Analogues, Amino Acids, Peptides, and Proteins, Neuropeptides, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Proteins, Anterior Pituitary Lobe Hormones and Analogues, Cytochrome P-450 Enzyme Inducers, Peptide Hormones, Protein Precursors, Adrenocorticotropic Hormone, Melanocortins, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Pituitary Hormones, Anterior, Corticosteroids for Systemic Use, Corticosteroids, Hormones, Hormone Substitutes, and Hormone Antagonists, Pituitary Hormones, Cytochrome P-450 CYP3A4 Inducers, Nerve Tissue Proteins, Cytochrome P-450 CYP3A Substrates, Hyperglycemia-Associated Agents, Pro-Opiomelanocortin	approved, investigational, vet_approved	2
DB01289	Glisoxepide	Drug	Cytochrome P-450 CYP2C9 Substrates, Sulfur Compounds, Cytochrome P-450 Substrates, Alimentary Tract and Metabolism, Sulfonylureas, Drugs Used in Diabetes, Blood Glucose Lowering Agents, Sulfones	investigational	1
DB14590	Anemarrhena asphodeloides root	Drug	0	experimental	0
DB14593	Influenza B virus B/Maryland/15/2016 antigen (propiolactone inactivated)	Drug	0	approved	0
DB13262	Aceclidine	Drug	Autonomic Agents, Ophthalmologicals, Antiglaucoma Preparations and Miotics, Parasympathomimetics, Miotics, Sensory Organs, Peripheral Nervous System Agents	approved	0
DB13263	Quassia	Drug	Antiparasitic Products, Insecticides and Repellents, Ectoparasiticides, Incl. Scabicides, Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents	experimental	0
DB14594	Influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) recombinant hemagglutinin antigen	Drug	0	approved	0
DB13260	Lysozyme	Drug	Enzymes, Glycoside Hydrolases, Muramidase, Dermatologicals, Enzymes and Coenzymes, Hydrolases, Antiinfectives for Systemic Use, Anti-Infective Agents, Muramidase, antagonists & inhibitors	investigational, experimental	0
DB14591	Influenza B virus B/Maryland/15/2016 antigen (formaldehyde inactivated)	Drug	0	approved	0
DB14592	Influenza A virus A/Singapore/INFIMH-16-0019/2016 IVR-186 (H3N2) antigen (propiolactone inactivated)	Drug	0	approved	0
DB13261	Sitafloxacin	Drug	Fluoroquinolones, Quinolines, QTc Prolonging Agents, Enzyme Inhibitors, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Antiinfectives for Systemic Use, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Moderate Risk QTc-Prolonging Agents, Anti-Infective Agents, Quinolones, Cytochrome P-450 CYP1A2 Inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Topoisomerase II Inhibitors, Antibacterials for Systemic Use	investigational, experimental	0
DB13277	Benziodarone	Drug	Heterocyclic Compounds, Fused-Ring, Antigout Preparations, Renal Agents, Uricosuric Agents, Antirheumatic Agents, Vasodilators Used in Cardiac Diseases, Cardiac Therapy	approved, withdrawn	0
DB13278	Bucetin	Drug	Anilides, Amines, Analgesics, Nervous System, Aniline Compounds, Ethyl Ethers, Phenols, Ethers, Aminophenols, Benzene Derivatives, Phenyl Ethers	approved, withdrawn	0
DB13275	Clorindione	Drug	Anticoagulants, Blood and Blood Forming Organs, Cytochrome P-450 Substrates, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Indenes, Cytochrome P-450 CYP3A4 Substrates, Vitamin K Antagonists	experimental	0
DB13276	Idanpramine	Drug	Alimentary Tract and Metabolism, Drugs for Functional Gastrointestinal Disorders	experimental	0
DB13279	Carbocromen	Drug	Heterocyclic Compounds, Fused-Ring, Coumarins, Vasodilators Used in Cardiac Diseases, Benzopyrans, Cardiovascular Agents, Vasodilating Agents, Cardiac Therapy, Pyrans	approved, withdrawn	0
DB01291	Pirbuterol	Drug	Autonomic Agents, Adrenergics, Inhalants, Amines, Adrenergics for Systemic Use, Anti-Asthmatic Agents, Protective Agents, Agents producing tachycardia, Cardiovascular Agents, Bronchodilator Agents, Adrenergic beta-2 Receptor Agonists, Amino Alcohols, Respiratory System Agents, Alcohols, Peripheral Nervous System Agents, Cardiotonic Agents, Adrenergic beta-Agonists, Neurotransmitter Agents, Selective Beta 2-adrenergic Agonists, Agents to Treat Airway Disease, Adrenergic Agonists, Agents that produce hypertension, Drugs for Obstructive Airway Diseases, Compounds used in a research, industrial, or household setting, Adrenergic Agents	approved	2
DB01295	Bevantolol	Drug	Beta Blocking Agents, Selective, and Thiazides, Amines, Cytochrome P-450 Substrates, Propanols, Adrenergic alpha-Antagonists, Agents causing hyperkalemia, Adrenergic beta-Antagonists, Amino Alcohols, Beta Blocking Agents and Thiazides, Adrenergic beta-1 Receptor Antagonists, Alcohols, Neurotransmitter Agents, Adrenergic Antagonists, Beta Blocking Agents, Selective, Adrenergic alpha-1 Receptor Antagonists, Antihypertensive Agents, Cytochrome P-450 CYP2D6 Substrates, Adrenergic Agents, Bradycardia-Causing Agents	experimental	3
DB01294	Bismuth subsalicylate	Drug	Benzoates, Hydroxy Acids, Antidiarrheals, Acids, Carbocyclic, Metals, Elements, Radioactive, Hydroxybenzoates, Radioisotopes, Metals, Heavy, Helicobacter Infections, Elements, Antacids and Adsorbents, Phenols, Salicylates, Isotopes, Benzene Derivatives, Bismuth containing drugs, Gastrointestinal Agents, Neurotoxic agents	approved, vet_approved	0
DB01299	Sulfadoxine	Drug	Long-Acting Sulfonamides, Renal Agents, Amines, Anti-Infective Agents, Urinary, Antiprotozoals, Gynecological Antiinfectives and Antiseptics, Aniline Compounds, Genito Urinary System and Sex Hormones, Antimalarials, Amides, Sulfanilamides, Anti-Infective Agents, Sulfur Compounds, Sulfonamides, Antiparasitic Agents, Sulfones	approved, investigational	2
DB01298	Sulfacytine	Drug	Sulfur Compounds, Amines, Gynecological Antiinfectives and Antiseptics, Sulfonamides, Aniline Compounds, Genito Urinary System and Sex Hormones, Amides, Sulfones	approved	1
DB01297	Practolol	Drug	Amines, Cytochrome P-450 Substrates, Propanols, Agents causing hyperkalemia, Aniline Compounds, Phenoxypropanolamines, Adrenergic beta-Antagonists, Amides, Cardiovascular Agents, Amino Alcohols, Adrenergic beta-1 Receptor Antagonists, Alcohols, Anilides, Neurotransmitter Agents, Adrenergic Antagonists, Beta Blocking Agents, Selective, Antihypertensive Agents, Cytochrome P-450 CYP2D6 Substrates, Acetanilides, Adrenergic Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Propanolamines	approved	1
DB01296	Glucosamine	Drug	Amino Sugars, Carbohydrates, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Musculo-Skeletal System, Hexosamines	approved, investigational	5
DB13270	Dibekacin	Drug	Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Nephrotoxic agents, Carbohydrates, Anti-Bacterial Agents, Narrow Therapeutic Index Drugs, Aminoglycoside Antibacterials, Glycosides, Agents that produce neuromuscular block (indirect), Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use, Drugs that are Mainly Renally Excreted	approved	0
DB13273	Sultopride	Drug	Psycholeptics, QTc Prolonging Agents, Tranquilizing Agents, Benzoates, Nervous System, Acids, Carbocyclic, Benzamides and benzamide derivatives, Amides, Antidepressive Agents, Second-Generation, Antidepressive Agents, Moderate Risk QTc-Prolonging Agents, Psychotropic Drugs, Neurotransmitter Agents, Antipsychotic Agents, Central Nervous System Depressants, Central Nervous System Agents, Dopamine Antagonists, Benzene Derivatives, Dopamine Agents, Neurotoxic agents	approved	0
DB13274	Micronomicin	Drug	Nephrotoxic agents, Carbohydrates, Agents that produce neuromuscular block (indirect), Irritants, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Ophthalmologicals, Benzalkonium Compounds, Anti-Bacterial Agents, Narrow Therapeutic Index Drugs, Aminoglycoside Antibacterials, Glycosides, Ophthalmic Solutions, Sensory Organs	approved	0
DB13271	Wood creosote	Drug	Cough and Cold Preparations, Expectorants, Cresols, Phenols, Benzene Derivatives	investigational, experimental	0
DB13272	Meladrazine	Drug	Drugs for Urinary Frequency and Incontinence, Genito Urinary System and Sex Hormones, Urologicals	experimental	0
DB03919	Ethyl-Carbamic Acid Methyl Ester	Drug	0	experimental	1
DB03920	N-Methyl-Alpha-Beta-Dehydroalanine	Drug	0	experimental	0
DB03921	4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline	Drug	0	experimental	1
DB03926	5alpha-androstane-3beta,17alpha-diol	Drug	0	experimental	0
DB03927	Glycyl-L-alpha-amino-epsilon-pimelyl-D-alanine	Drug	0	experimental	1
DB03928	Carboxymethylthio-3-(3-Chlorophenyl)-1,2,4-Oxadiazol	Drug	0	experimental	1
DB03929	D-Serine	Drug	0	approved, experimental	4
DB03923	Feruloyl Coenzyme A	Drug	0	experimental	1
DB03924	5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone	Drug	0	experimental	1
DB03925	Freselestat	Drug	Pyrimidines, Oxazoles, Leukocyte Elastase, antagonists & inhibitors	investigational, experimental	2
DB03930	4-Methyl-Pyrroline-5-Carboxylic Acid	Drug	0	experimental	0
DB03931	Diguanosine-5'-Triphosphate	Drug	0	experimental	1
DB03932	LFA703	Drug	0	experimental	1
DB02601	4-Hydroxyphenylglycine	Drug	Enzyme Inhibitors, Amino Acids, Peptides, and Proteins, Carnitine O-Palmitoyltransferase, antagonists & inhibitors, Amino Acids	experimental	0
DB02600	Oseltamivir acid	Drug	Acids, Acyclic, Cycloparaffins, Enzyme Inhibitors, Fatty Acids, Cyclohexenes, Amides, Lipids, Antiviral Agents, Acetates, Anti-Infective Agents, Cyclohexanes, Fatty Acids, Volatile, Acetamides	experimental	1
DB03937	D-erythrose 4-phosphate	Drug	0	experimental	3
DB03938	Deacetoxycephalosporin C	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amides, Lactams, Thiazines, beta-Lactams, Agents that reduce seizure threshold	experimental	1
DB02604	2-Deoxy-Glucose-6-Phosphate	Drug	0	experimental	1
DB03939	(4S)-4-hydroxy-3,4-dihydro-2(1H)-pyrimidinone	Drug	0	experimental	1
DB02603	1-Amino-6-Cyclohex-3-Enylmethyloxypurine	Drug	0	experimental	1
DB02602	AL7182	Drug	0	experimental	1
DB03933	C-1027 Aromatized chromophore	Drug	0	experimental	1
DB02609	4-Hydroxy-L-Threonine-5-Monophosphate	Drug	0	experimental	1
DB03934	Protoporphyrin Ix Containing Zn	Drug	0	experimental	1
DB02608	N-[(1R,2R)-1,3-Dihydroxy-1-(4-nitrophenyl)-2-propanyl]acetamide	Drug	0	experimental	1
DB03935	1,4-Dideoxy-O2-Sulfo-Glucuronic Acid	Drug	0	experimental	2
DB02607	Adenosine Phosphonoacetic Acid	Drug	Acids, Acyclic, Carbohydrates, Fatty Acids, Organophosphorus Compounds, Lipids, Nucleotides, Acetates, Organophosphonates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Fatty Acids, Volatile, Glycosides, Adenine Nucleotides	experimental	1
DB02606	2-Butanol	Drug	Lipids, Fatty Alcohols, Alcohols	investigational, experimental	1
DB03936	1-Deoxy-Ribofuranose-5'-Phosphate	Drug	0	experimental	1
DB03940	Oxamic Acid	Drug	Amino Acids, Peptides, and Proteins, Acids, Aldehydic, Glyoxylates, Amino Acids	experimental	6
DB03941	p-Heptylphenol	Drug	0	experimental	0
DB03942	Carboxylic PRPP	Drug	0	experimental	3
DB03943	D-Asparagine	Drug	0	experimental	0
DB02611	Balanol Analog 1	Drug	0	experimental	1
DB02610	N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide	Drug	0	experimental	1
DB03948	6-Chloropurine Riboside, 5'-Monophosphate	Drug	0	experimental	2
DB02616	FR117016	Drug	0	experimental	1
DB03949	N-[(2S)-3-Phenyl-2-sulfanylpropanoyl]-L-phenylalanyl-L-tyrosine	Drug	0	experimental	1
DB02615	Compound 19	Drug	0	experimental	2
DB02614	1(R)-1-Acetamido-2-(3-Carboxyphenyl)Ethyl Boronic Acid	Drug	0	experimental	2
DB02613	Capric dimethyl amine oxide	Drug	0	experimental	4
DB03944	5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One	Drug	0	experimental	1
DB02619	12-Bromo-1-dodecanol	Drug	0	experimental	0
DB03945	N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium	Drug	Amines, Ammonium Compounds, Quaternary Ammonium Compounds, Trimethyl Ammonium Compounds, Onium Compounds, Phosphorylcholine, Amino Alcohols, Ethanolamines, Nitrogen Compounds, Alcohols	experimental	3
DB03946	3,4-Dihydroxybenzoic Acid	Drug	Drugs, Chinese Herbal, Benzoates, Hydroxy Acids, Protective Agents, Acids, Carbocyclic, Antineoplastic Agents, Phenols, Anticarcinogenic Agents, Compounds used in a research, industrial, or household setting, Benzene Derivatives	experimental	0
DB02618	Ethyl Dimethyl Ammonio Propane Sulfonate	Drug	0	experimental	0
DB02617	1-(N-Imidazolyl)-2-Hydroxy-2-(2,3-Dichlorophenyl)Octane	Drug	0	experimental	1
DB03947	D-Xylulose	Drug	0	experimental	1
DB14601	Barley malt syrup	Drug	0	approved	0
DB14602	Influenza A virus A/Victoria/361/2011 IVR-165 (H3N2) antigen (UV, formaldehyde inactivated)	Drug	0	approved	0
DB14600	Edetate disodium anhydrous	Drug	Anticoagulants, Calcium Chelating Activity, Cytochrome P-450 CYP3A Inhibitors, Iron Chelating Agents, Chelating Activity, Cytochrome P-450 Enzyme Inhibitors, Lead Chelator, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Calcium Chelating Agents, Metal Chelator, Chelating Agents	approved, vet_approved	3
DB14605	Influenza B virus B/Massachusetts/2/2012 BX-51B antigen (UV, formaldehyde inactivated)	Drug	0	approved	0
DB14606	Influenza A virus A/Texas/50/2012 (H3N2) live (attenuated) antigen	Drug	0	approved	0
DB14603	Influenza B virus B/Hubei-Wujiagang/158/2009 BX-39 antigen (UV, formaldehyde inactivated)	Drug	0	approved	0
DB14604	Influenza A virus A/Texas/50/2012 X-223A (H3N2) antigen (UV, formaldehyde inactivated)	Drug	0	approved	0
DB14609	Influenza B virus B/Wisconsin/1/2010) antigen (MDCK cell derived, propiolactone inactivated)	Drug	0	approved	0
DB14607	Influenza B virus B/Massachusetts/2/2012 live (attenuated) antigen	Drug	0	approved	0
DB14608	Influenza A virus A/Victoria/361/2011 IVR-165 (H3N2) antigen (MDCK cell derived, propiolactone inactivated)	Drug	0	approved	0
DB03951	N-acetyl-D-glucosamine-6-phosphate	Drug	0	experimental	2
DB03952	9-(6-deoxy-beta-D-allofuranosyl)-6-methylpurine	Drug	0	experimental	1
DB03953	Thiocitrulline	Drug	Enzyme Inhibitors, Sulfur Compounds, Nitric Oxide Synthase, antagonists & inhibitors, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	1
DB02623	Aminophosphonic acid-guanylate ester	Drug	0	experimental	1
DB02622	2-(Oxalyl-Amino)-Benzoic Acid	Drug	0	experimental	1
DB02621	Latrunculin A	Drug	Sulfur Compounds, Porifera, Thiazoles, Marine Toxins	experimental	3
DB02620	3-(4-{2-[2-(2-bromo-acetylamino)-ethyldisulfanyl]-ethylcarbamoyl}-cyclohexylcarbamoyl)-pyrazine-2-carboxylic acid	Drug	0	experimental	1
DB03950	(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide	Drug	0	experimental	1
DB03959	N,O6-Disulfo-Glucosamine	Drug	0	experimental	6
DB02627	4,4'-Biphenyldiboronic Acid	Drug	0	experimental	1
DB02626	Phenylferricrocin-iron	Drug	0	experimental	1
DB02625	(2r)-2-{[Formyl(Hydroxy)Amino]Methyl}Hexanoic Acid	Drug	0	experimental	1
DB02624	Homoserine Lactone	Drug	Quorum Sensing, Furans, Luminescent Proteins, Lactones	experimental	1
DB03955	1-deoxymannojirimycin	Drug	0	experimental	1
DB03956	Inositol 2,4,5-trisphosphate	Drug	Carbohydrates, Sugar Phosphates, Sugar Alcohols, Alcohols	experimental	1
DB03957	SP2456	Drug	0	experimental	1
DB02629	N,N-[2,5-O-di-2-fluoro-benzyl-glucaryl]-di-[1-amino-indan-2-ol]	Drug	0	experimental	1
DB02628	1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide	Drug	0	experimental	1
DB03958	7-methyl-guanosine-5'-triphosphate-5'-guanosine	Drug	0	experimental	2
DB03904	Urea	Drug	Diuretics, Osmotic, Blood and Blood Forming Organs, Carbamide products, Solutions Producing Osmotic Diuresis, Dermatologicals, Blood Substitutes and Perfusion Solutions, Keratolytic Agents, Emollients and Protectives, i.v. Solutions	approved, investigational	5
DB03905	Succinamide-CoA	Drug	0	experimental	1
DB03906	2-Phenylheme	Drug	0	experimental	1
DB03907	N-[(E)-3-[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]prop-2-enyl]-2,3-dihydroxy-5-nitrobenzamide	Drug	0	experimental	1
DB03900	tert-butanol	Drug	Lipids, Butanols, Fatty Alcohols, Alcohols	experimental	5
DB03901	5-Oxoprolinal	Drug	Acids, Acyclic, Amino Acids, Cyclic, Imines, Amino Acids, Peptides, and Proteins, Pyroglutamyl-Peptidase I, antagonists & inhibitors, Imino Acids, Amino Acids	experimental	1
DB03902	Oxalic Acid	Drug	Acids, Acyclic, Laboratory Chemicals, Dicarboxylic Acids, Indicators and Reagents, Oxalates, Compounds used in a research, industrial, or household setting, Reducing Agents, OAT3/SLC22A8 Substrates	experimental	1
DB03903	Tmr	Drug	0	experimental	1
DB03908	N,N-[2,5-O-[Dibenzyl]-glucaryl]-DI-[isoleucyl-amido-methane]	Drug	0	experimental	1
DB03909	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	Drug	0	experimental	14
DB03910	S,S'-(1,3-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea	Drug	0	experimental	1
DB03915	2-Amino-3-Ketobutyric Acid	Drug	0	experimental	1
DB03916	4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine	Drug	0	experimental	2
DB03917	N-Ethylretinamide	Drug	Biological Factors, Cycloparaffins, Alkenes, Hydrocarbons, Acyclic, Cyclohexenes, Retinoids, Vitamins, Cyclohexanes, Pigments, Biological, Vitamin A, Carotenoids, Vitamins (Fat Soluble), Polyenes, Terpenes	experimental	0
DB03918	6S-5,6,7,8-Tetrahydrobiopterin	Drug	0	experimental	1
DB03911	L-Xylopyranose	Drug	0	experimental	1
DB03912	D-pantetheine 4'-phosphate	Drug	Sulfur Compounds, Sulfhydryl Compounds	experimental	3
DB03913	Coenzyme F420	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Coenzymes, Enzymes and Coenzymes, Pteridines, Flavins, Pigments, Biological	experimental	0
DB03914	[2-(1-amino-2-hydroxy-propyl)-4-(1H-indol-3-ylmethylene)-5-oxo-4,5-dihydro-imidazol-1-yl]-acetaldehyde	Drug	0	experimental	0
DB13321	Methiodal	Drug	Alkanesulfonic Acids, Sulfur Compounds, Acids, Noncarboxylic, Alkanesulfonates, Contrast Media, Acids, Sulfur Acids, Hydrocarbons, Acyclic, Sulfonic Acids, Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media, Alkanes, X-Ray Contrast Media, Iodinated	experimental	0
DB14652	Clocortolone acetate	Drug	Pregnadienediols, Corticosteroids, Glucocorticoids, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Pregnanes, Steroids, Fluorinated, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inducers, Steroids	experimental	0
DB13322	Hydrotalcite	Drug	Alkalies, Hydroxides, Ions, Aluminum and magnesium containing antacids, Anions, Gastric Acid Lowering Agents, Metal cations, Alimentary Tract and Metabolism, Metal divalent cations, Aluminium Compounds, Electrolytes, Drugs for Acid Related Disorders, Antacids, Gastrointestinal Agents, Magnesium Compounds	approved, investigational, experimental	0
DB14653	Clocortolone caproate	Drug	0	experimental	0
DB14650	Menadiol diphosphate	Drug	Quinones, Phytol, Naphthoquinones, Diterpenes, Terpenes, Naphthalenes	approved, nutraceutical	0
DB13320	Sulfaperin	Drug	Long-Acting Sulfonamides, SULFONAMIDES AND TRIMETHOPRIM, Sulfonamides, Antiinfectives for Systemic Use, Antibacterials for Systemic Use	experimental	0
DB14651	Perphenazine enanthate	Drug	Heterocyclic Compounds, Fused-Ring, Antipsychotic Agents, Sulfur Compounds, Central Nervous System Depressants, Phenothiazines, Neurotoxic agents	experimental	0
DB13325	Nifurzide	Drug	Intestinal Antiinfectives, Alimentary Tract and Metabolism, Nitro Compounds, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Furans	experimental	0
DB14656	Chlorphenesin carbamate	Drug	Glycols, Propylene Glycols, Alcohols	approved, withdrawn, vet_approved	0
DB14657	Paramethasone acetate	Drug	Pregnadienetriols, Pregnadienes, Pregnanes, Steroids, Fluorinated, Fused-Ring Compounds, Steroids	approved	0
DB13326	Euflavine	Drug	Acridine Derivatives, Heterocyclic Compounds, Fused-Ring, Acridines, Antiseptics and Disinfectants, Dermatologicals	experimental	0
DB13323	Trichloroethylene	Drug	Anesthetics, Inhalation, Hydrocarbons, Chlorinated, Solvents, Anesthetics, General, Nervous System, Central Nervous System Depressants, Agents that produce hypertension, Hydrocarbons, Halogenated, Central Nervous System Agents, Anesthetics, Compounds used in a research, industrial, or household setting	approved	0
DB14654	Bisoxatin acetate	Drug	0	experimental	0
DB14655	Drostanolone propionate	Drug	Androstanes, Testosterone and derivatives, Fused-Ring Compounds, Steroids	approved, illicit	0
DB13324	Tetrazepam	Drug	Neuromuscular Agents, Heterocyclic Compounds, Fused-Ring, Benzazepines, Central Nervous System Depressants, Musculo-Skeletal System, Muscle Relaxants, Centrally Acting Agents, Central Nervous System Agents, Muscle Relaxants, Peripheral Nervous System Agents	experimental	0
DB13329	Guaiazulen	Drug	Ophthalmologicals, Cycloparaffins, Cycloheptanes, Sensory Organs, Terpenes	experimental	0
DB13327	Picotamide	Drug	Blood and Blood Forming Organs, Platelet Aggregation Inhibitors Excl. Heparin, Acids, Carbocyclic, Hematologic Agents, Antiplatelet agents	experimental	0
DB14658	Chloramphenicol palmitate	Drug	Nitrobenzenes, Nitro Compounds, Glycols, Propylene Glycols, Benzene Derivatives, Alcohols	approved, vet_approved	0
DB13328	Butanilicaine	Drug	Anilides, Amines, Nervous System, Aniline Compounds, Amides, Anesthetics, Anesthetics, Local	experimental	0
DB14659	Melengestrol acetate	Drug	Corticosteroids, Glucocorticoids, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Pregnanes, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inducers, Steroids	experimental	0
DB02670	4-Deoxy-Alpha-D-Glucose	Drug	0	experimental	2
DB02674	4-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Butyricacid	Drug	0	experimental	1
DB00011	Interferon alfa-n1	Drug	Biological Factors, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Cytokines, Peptides, Adjuvants, Immunologic, Interferons, Antineoplastic and Immunomodulating Agents, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Antiviral Agents, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Interferon Type I, Myelosuppressive Agents, Cytochrome P-450 CYP1A2 Inhibitors, Proteins	approved, investigational	2
DB00012	Darbepoetin alfa	Drug	Hematinics, Biological Factors, Carbohydrates, Blood and Blood Forming Organs, Cytokines, Glycoconjugates, Peptides, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Hematologic Agents, Glycoproteins, Erythropoiesis-Stimulating Agents, Hematopoietic Cell Growth Factors, Proteins, Increased Erythroid Cell Production, Antianemic Preparations, Colony-Stimulating Factors	approved, investigational	1
DB01342	Forasartan	Drug	Angiotensin II Type 1 Receptor Blockers, Angiotensin Receptor Antagonists, Agents causing hyperkalemia, Agents Acting on the Renin-Angiotensin System, Agents causing angioedema	experimental	1
DB02673	(4aS,6R,8aS)-11-[8-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)octyl]-6-hydroxy-3-methoxy-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11-ium	Drug	0	experimental	1
DB01341	Dihydroquinidine barbiturate	Drug	0	experimental	1
DB01340	Cilazapril	Drug	Antihypertensive Agents Indicated for Hypertension, Enzyme Inhibitors, Agents causing hyperkalemia, Protease Inhibitors, Cardiovascular Agents, Hypotensive Agents, Pyridazines, Angiotensin-Converting Enzyme Inhibitors, Agents Acting on the Renin-Angiotensin System, Agents causing angioedema, ACE Inhibitors and Diuretics, Antihypertensive Agents, P-glycoprotein inhibitors	approved	1
DB02671	1-Methylimidazole	Drug	0	experimental	2
DB00010	Sermorelin	Drug	Somatropin and Somatropin Agonists, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pituitary and Hypothalamic Hormones and Analogues, Amino Acids, Peptides, and Proteins, Neuropeptides, Tests for Pituitary Function, Nerve Tissue Proteins, Hormones, Pituitary Hormone-Releasing Hormones, Growth Hormone-Releasing Hormone, Proteins, Anterior Pituitary Lobe Hormones and Analogues, Peptide Hormones, Hypothalamic Hormones, Diagnostic Agents, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins	approved, withdrawn	1
DB01347	Saprisartan	Drug	Angiotensin II Type 1 Receptor Blockers, Heterocyclic Compounds, Fused-Ring, Angiotensin Receptor Antagonists, Agents causing hyperkalemia, Agents Acting on the Renin-Angiotensin System, Agents causing angioedema, Cardiovascular Agents, Antihypertensive Agents	experimental	1
DB02678	beta-D-Galactosamine	Drug	0	experimental	1
DB00015	Reteplase	Drug	Anticoagulants, Biological Factors, Enzymes, Blood and Blood Forming Organs, Plasminogen Activators, Fibrin Modulating Agents, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Hematologic Agents, Cardiovascular Agents, Fibrinolytic Agents, Proteins, Blood Proteins, Serine Proteases, Hydrolases, Agents causing angioedema, Peptide Hydrolases, Serine Endopeptidases, Endopeptidases	approved, investigational	3
DB02677	D-naphthyl-1-acetamido boronic acid alanine	Drug	0	experimental	1
DB00016	Erythropoietin	Drug	Hematinics, Biological Factors, Carbohydrates, Blood and Blood Forming Organs, Erythropoietin, genetics, Cytokines, Glycoconjugates, Peptides, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Hematologic Agents, Glycoproteins, Erythropoiesis-Stimulating Agents, Hematopoietic Cell Growth Factors, Proteins, Increased Erythroid Cell Production, Antianemic Preparations, Colony-Stimulating Factors	approved	1
DB01346	Quinidine barbiturate	Drug	0	approved	5
DB00013	Urokinase	Drug	Anticoagulants, Biological Factors, Enzymes, Blood and Blood Forming Organs, Plasminogen Activators, Increased Thrombolysis, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Fibrinolytic Agents, Proteins, Blood Proteins, Serine Proteases, Hydrolases, Agents causing angioedema, Peptide Hydrolases, Serine Endopeptidases, Endopeptidases, Urokinase-Type Plasminogen Activator, antagonists & inhibitors	approved, investigational, withdrawn	8
DB01345	Potassium cation	Drug	Potassium Salt, Replacement Preparations, Agents causing hyperkalemia, Diuretics, Minerals, Increased Large Intestinal Motility, Osmotic Activity, Drugs that are Mainly Renally Excreted, Inhibition Large Intestine Fluid/Electrolyte Absorption	approved, investigational	1
DB02676	2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol	Drug	0	experimental	1
DB00014	Goserelin	Drug	Endocrine Therapy, QTc Prolonging Agents, Gonadotropins and Antigonadotropins, Oligopeptides, Peptides, Adrenal Cortex Hormones, Gonadotropin Releasing Hormone Receptor Agonists, Amino Acids, Peptides, and Proteins, Neuropeptides, Hormones, Pituitary Hormone-Releasing Hormones, Drugs that are Mainly Renally Excreted, Proteins, Hormones and Related Agents, Peptide Hormones, Gonadotropin-releasing hormone agonist, Antineoplastic Agents, Hormonal, Miscellaneous Therapeutic Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Nerve Tissue Proteins, Moderate Risk QTc-Prolonging Agents, Gonadotropin Releasing Hormone Receptor Agonist, Hypothalamic Hormones, Hyperglycemia-Associated Agents	approved	2
DB01344	Tolevamer	Drug	Polystyrene Sulfonates, Ion Exchange Resins, Sulfur Acids, Laboratory Chemicals, Benzylidene Compounds, Potassium-removing Agents, Macromolecular Substances, Sulfur Compounds, Acids, Noncarboxylic, Acids, Styrenes, Sequestering Agents, Styrene, Drugs for Treatment of Hyperkalemia and Hyperphosphatemia, Potassium Ion Exchange Activity, Potassium Binder, Cation Exchange Resins, Plastics, Polymers, Compounds used in a research, industrial, or household setting, Benzene Derivatives, Chelating Agents	approved, investigational	1
DB02675	(4-Hydroxymaltosephenyl)Glycine	Drug	0	experimental	0
DB00019	Pegfilgrastim	Drug	Hematinics, Biological Factors, Carbohydrates, Increased Myeloid Cell Production, Cytokines, Glycoconjugates, Peptides, Adjuvants, Immunologic, Antineoplastic and Immunomodulating Agents, Granulocyte Colony-Stimulating Factors, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Glycoproteins, Alcohols, Hematopoietic Cell Growth Factors, Macromolecular Substances, Proteins, Leukocyte Growth Factor, Ethylene Glycols, Pegylated agents, Glycols, Polymers, Compounds used in a research, industrial, or household setting, Colony-Stimulating Factors	approved	1
DB00017	Salmon calcitonin	Drug	Calcitonin Preparations, Thyroid Products, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Amino Acids, Peptides, and Proteins, Bone Density, drug effects, Calcium Homeostasis, Neuropeptides, Nerve Tissue Proteins, Hormones, Drugs that are Mainly Renally Excreted, Proteins, Peptide Hormones, Bone Density Conservation Agents, Calcium-Regulating Hormones and Agents, Parathyroid and Antiparathyroid Agents, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Parathyroid Hormones and Analogues	approved, investigational	1
DB01349	Tasosartan	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Angiotensin Receptor Antagonists, Agents causing hyperkalemia, Agents Acting on the Renin-Angiotensin System, Angiotensin II receptor blockers (ARBs), plain, Cytochrome P-450 CYP3A4 Substrates	experimental	2
DB01348	Spirapril	Drug	Enzyme Inhibitors, Oligopeptides, Peptides, Angiotensin-Converting Enzyme Inhibitors, Agents causing hyperkalemia, Protease Inhibitors, Agents Acting on the Renin-Angiotensin System, Dipeptides, Amino Acids, Peptides, and Proteins, Agents causing angioedema, Cardiovascular Agents, Antihypertensive Agents	approved	1
DB02679	Cyanamide	Drug	Anions, Acids, Noncarboxylic, Acids, Imines, Hydrogen Cyanide, Electrolytes, Ions, Cyanides, Carbodiimides, Nitrogen Compounds	experimental	2
DB00018	Interferon alfa-n3	Drug	Biological Factors, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Cytokines, Peptides, Interferon-alpha, Interferons, Intercellular Signaling Peptides and Proteins, Interferon alpha, Alfa Interferons, Amino Acids, Peptides, and Proteins, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Interferon Type I, Myelosuppressive Agents, Cytochrome P-450 CYP1A2 Inhibitors, Proteins	approved, investigational	2
DB14663	Ribavirin monophosphate	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides	experimental	0
DB12000	Apabetalone	Drug	Heterocyclic Compounds, Fused-Ring, Quinazolines	investigational	0
DB13332	Dibutylsuccinate	Drug	Insecticides and Repellents, Antiparasitic Products, Insecticides and Repellents, Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents	experimental	0
DB14664	Difluocortolone pivalate	Drug	0	experimental	0
DB13333	Efloxate	Drug	Heterocyclic Compounds, Fused-Ring, Vasodilators Used in Cardiac Diseases, Benzopyrans, Cardiac Therapy, Chromones, Pyrans	experimental	0
DB12002	AZD-4818	Drug	0	investigational	0
DB13330	Amezinium metilsulfate	Drug	Cardiac Stimulants Excl. Cardiac Glycosides, Adrenergic and Dopaminergic Agents, Cardiac Therapy	experimental	0
DB14661	Loperamide oxide	Drug	Alimentary Tract and Metabolism, Antidiarrheals, Piperidines, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Antipropulsives, Gastrointestinal Agents	experimental	0
DB14662	Flunisolide acetate	Drug	0	experimental	0
DB12001	Abemaciclib	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Amines, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, MATE 1 Substrates, MATE inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), MATE 1 Inhibitors, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), MATE substrates, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Pyridines, Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), OCT2 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, MATE 2 Inhibitors, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), P-glycoprotein inhibitors, Kinase Inhibitor, MATE 1 Substrates with a Narrow Therapeutic Index	approved, investigational	2
DB13331	Pyrithyldione	Drug	Psycholeptics, Pyridines, Nervous System, Piperidinedione Derivatives, Central Nervous System Depressants, Hypnotics and Sedatives	experimental	0
DB13336	Dimethylphthalate	Drug	Insecticides and Repellents, Plasticizers, Antiparasitic Products, Insecticides and Repellents, Insect Repellents, Agrochemicals, Fixatives, Protective Agents, Acids, Carbocyclic, Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents, Pesticides, Toxic Actions, Compounds used in a research, industrial, or household setting	experimental	0
DB12004	Briciclib	Drug	0	investigational	0
DB14667	Phenyl hydrogen sulfate	Drug	Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfur Acids, Sulfuric Acids	experimental	0
DB14668	Dienestrol diacetate	Drug	Phenols, Benzene Derivatives	experimental	0
DB12003	Thymosin beta-4	Drug	Proteins, Peptide Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Microfilament Proteins, Amino Acids, Peptides, and Proteins, Thymus Hormones, Hormones	investigational	0
DB13337	Pheneticillin	Drug	Anti-Bacterial Agents, Penicillins, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Beta-Lactamase Sensitive Penicillins, Antibacterials for Systemic Use	approved	0
DB14665	Bornyl acetate	Drug	Monoterpenes, Terpenes, Norbornanes	experimental	0
DB13334	Mannosulfan	Drug	Alkanesulfonic Acids, Alkylating Drugs, Sulfur Compounds, Acids, Noncarboxylic, Alkanesulfonates, Acids, Sulfur Acids, Antineoplastic and Immunomodulating Agents, Hydrocarbons, Acyclic, Sulfonic Acids, Antineoplastic Agents, Alkanes	experimental	0
DB12006	BMS-906024	Drug	Heterocyclic Compounds, Fused-Ring, Benzazepines	investigational	0
DB13335	Pinazepam	Drug	Heterocyclic Compounds, Fused-Ring, Psycholeptics, Tranquilizing Agents, Benzazepines, Nervous System, Central Nervous System Depressants, Benzodiazepines and benzodiazepine derivatives, Anti-Anxiety Agents, Central Nervous System Agents, Psychotropic Drugs	experimental	2
DB12005	Nirogacestat	Drug	Amino Acids, Essential, Amino Acids, Branched-Chain, Amino Acids, Peptides, and Proteins, Amino Acids, Amyloid Precursor Protein Secretases, antagonists & inhibitors, Naphthalenes	investigational	0
DB14666	Oleoyl chloride	Drug	0	experimental	0
DB12008	Prexasertib	Drug	0	investigational	0
DB12007	Isoflavone	Drug	Drugs that are Mainly Renally Excreted	experimental	2
DB13338	Flurithromycin	Drug	Enzyme Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Macrolides, Lincosamides and Streptogramins, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Antiinfectives for Systemic Use, Lactones, Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Leukocyte Elastase, antagonists & inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Antibacterials for Systemic Use	experimental	0
DB14669	Betamethasone phosphate	Drug	Pregnadienetriols, Corticosteroids, Cytochrome P-450 Substrates, Glucocorticoids, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, P-glycoprotein substrates, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, OAT3/SLC22A8 Substrates, P-glycoprotein inducers, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A Substrates, Pregnanes, Steroids, Fluorinated, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inducers, Steroids	approved, vet_approved	2
DB12009	GW-406381	Drug	0	investigational	0
DB13339	Etoglucid	Drug	Alkylating Drugs, Epoxy Compounds, Noxae, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Toxic Actions, Ethers, Antineoplastic Agents, Alkylating, Ethers, Cyclic	experimental	0
DB02681	2,8-bis[oxido(oxo)vanadio]-1,1,1,3,5,5,7,7,9,9,9-undecaoxopentavanadoxane-2,8-diium	Drug	0	experimental	2
DB02680	1,3-Dinitrobenzene	Drug	Nitrobenzenes, Nitro Compounds, Benzene Derivatives	experimental	1
DB00022	Peginterferon alfa-2b	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Peptides, Interferons, Interferon alpha, Amino Acids, Peptides, and Proteins, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Anti-Infective Agents, Alcohols, Drug Carriers, Cytochrome P-450 CYP1A2 Inhibitors, Proteins, Cytochrome P-450 Enzyme Inducers, Ethylene Glycols, Cytochrome P-450 CYP2C9 Inducers (weak), Polymers, Compounds used in a research, industrial, or household setting, Biological Factors, Cytokines, Adjuvants, Immunologic, Interferon-alpha, Antineoplastic and Immunomodulating Agents, Intercellular Signaling Peptides and Proteins, Alfa Interferons, Antiviral Agents, Interferon Type I, Macromolecular Substances, Myelosuppressive Agents, Pegylated agents, Glycols, Cytochrome P-450 CYP2C9 Inducers, Hepatitis C, Cytochrome P-450 CYP2D6 Inhibitors (weak)	approved	2
DB02685	3-Methylphenylalanine	Drug	0	experimental	1
DB01354	Heptabarbital	Drug	Anticholinergic Agents, Psycholeptics, Pyrimidines, Nervous System, Central Nervous System Depressants, Barbiturates, Plain, Pyrimidinones, Hypnotics and Sedatives, Nicotinic Antagonists	experimental	10
DB00023	Asparaginase Escherichia coli	Drug	Amidohydrolases, Enzymes, Narrow Therapeutic Index Drugs, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Asparagine-specific Enzyme, Enzymes and Coenzymes, Hydrolases, Thyroxine-binding globulin inhibitors, Asparaginase	approved, investigational	1
DB01353	Butobarbital	Drug	Anticholinergic Agents, Psycholeptics, Pyrimidines, Nervous System, Central Nervous System Depressants, Barbiturates, Plain, Pyrimidinones, Hypnotics and Sedatives, Central Nervous System Agents, Nicotinic Antagonists	approved, illicit	10
DB02684	5'-O-(L-Cysteinylsulfamoyl)adenosine	Drug	0	experimental	1
DB02683	Inhibitor Bea428	Drug	0	experimental	1
DB01352	Aprobarbital	Drug	Psycholeptics, Nervous System, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Pyrimidinones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Nicotinic Antagonists, Anticholinergic Agents, Cytochrome P-450 Enzyme Inducers, Pyrimidines, Central Nervous System Depressants, Barbiturates, Plain, Hypnotics and Sedatives	illicit, experimental	10
DB00020	Sargramostim	Drug	Biological Factors, Carbohydrates, Immunologic Factors, Increased Myeloid Cell Production, Cytokines, Glycoconjugates, Peptides, Adjuvants, Immunologic, Antineoplastic and Immunomodulating Agents, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Glycoproteins, Hematopoietic Cell Growth Factors, Proteins, Leukocyte Growth Factor, Colony-Stimulating Factors	approved, investigational	5
DB01351	Amobarbital	Drug	Psycholeptics, GABA Agents, Nervous System, GABA Modulators, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Pyrimidinones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Nicotinic Antagonists, Anticholinergic Agents, Neurotransmitter Agents, Anticonvulsants, Cytochrome P-450 Enzyme Inducers, Pyrimidines, Central Nervous System Depressants, Barbiturates, Plain, Hypnotics and Sedatives, Central Nervous System Agents, Barbiturates	approved, illicit	10
DB00026	Anakinra	Drug	Interleukin-1 Receptor Antagonist, Biological Factors, Biologics for Rheumatoid Arthritis Treatment, Immunosuppressive Agents, Cytokines, Peptides, Antineoplastic and Immunomodulating Agents, Intercellular Signaling Peptides and Proteins, Antirheumatic Agents, Amino Acids, Peptides, and Proteins, Agents reducing cytokine levels, Disease-modifying Antirheumatic Agents, Interleukin Inhibitors, Proteins	approved	1
DB02689	S-{2-[Amino(Dihydroxy)-Lambda~4~-Sulfanyl]Ethyl}-D-Cysteine	Drug	0	experimental	1
DB00027	Gramicidin D	Drug	Membrane Proteins, Peptides, Cyclic, Proteins, Anti-Bacterial Agents, Throat Preparations, Peptides, P-glycoprotein substrates, Amino Acids, Peptides, and Proteins, Pore Forming Cytotoxic Proteins, P-glycoprotein inhibitors, Anti-Infective Agents, Anti-Infective Agents, Local	approved	0
DB01357	Mestranol	Drug	Norpregnatrienes, Estrogen Contraceptives, Cytochrome P-450 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Norsteroids, Adrenal Cortex Hormones, Estrogens, Estrogenic Steroids, Alkylated, Hormones, Cytochrome P-450 CYP3A4 Substrates, Ethinyl Estradiol, Fused-Ring Compounds, Gonadal Steroid Hormones, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, Thyroxine-binding globulin inducers, Estradiol Congeners, Cytochrome P-450 CYP2C8 Substrates, Hormonal Contraceptives for Systemic Use, Hyperglycemia-Associated Agents, Norpregnanes, Contraceptive Agents, Female, Gonadal Hormones, Steroids	approved	1
DB02688	2,3-Didehydroalanine	Drug	0	experimental	1
DB01356	Lithium cation	Drug	Nephrotoxic agents, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Serotonin Agents, Antimanic Agents, Mood Stabilizer, Antidepressive Agents, Psychotropic Drugs, Drugs that are Mainly Renally Excreted, Lithium Compounds, Serotonin Modulators, Antipsychotic Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Neurotoxic agents	experimental	4
DB00024	Thyrotropin alfa	Drug	Anterior Pituitary Lobe Hormones and Analogues, Peptide Hormones, Thyroid Products, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pituitary Hormones, Pituitary and Hypothalamic Hormones and Analogues, Amino Acids, Peptides, and Proteins, Hormones, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Agents used to treat hypothyroidism, Pituitary Hormones, Anterior	approved, vet_approved	1
DB00025	Antihemophilic factor, human recombinant	Drug	Biological Factors, Carbohydrates, Blood and Blood Forming Organs, Disaccharides, Blood Coagulation Factors, Amino Acids, Peptides, and Proteins, Oligosaccharides, Human Antihemophilic Factor, Hemophilia A, Proteins, Polysaccharides, Increased Coagulation Activity, Blood Proteins, Hemostatics	approved, investigational	11
DB01355	Hexobarbital	Drug	Psycholeptics, Cytochrome P-450 Substrates, GABA Agents, Nervous System, GABA Modulators, Cytochrome P-450 CYP3A Inducers, Pyrimidinones, Adjuvants, Anesthetics, Nicotinic Antagonists, Anticholinergic Agents, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Neurotransmitter Agents, Anesthetics, General, Anticonvulsants, Cytochrome P-450 Enzyme Inducers, Pyrimidines, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Barbiturates, Plain, Hypnotics and Sedatives, Central Nervous System Agents, Barbiturates	experimental	10
DB02686	Undecyl-Beta-D-Maltopyranoside	Drug	0	experimental	1
DB00028	Human immunoglobulin G	Drug	Immunologic Factors, Immunoglobulins, Immunoglobulin G, Immunoglobulin Isotypes, Antibodies, Amino Acids, Peptides, and Proteins, Human Immunoglobulin G, Immunoproteins, Proteins, Serum Globulins, Globulins, Blood Proteins, Passively Acquired Immunity, Antigen Neutralization, Serum, Immunoglobulins, Intravenous	approved, investigational	11
DB00029	Anistreplase	Drug	Anticoagulants, Biological Factors, Enzymes, Blood and Blood Forming Organs, Plasminogen Activators, Fibrin Modulating Agents, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Hematologic Agents, Cardiovascular Agents, Fibrinolytic Agents, Proteins, Blood Proteins, Serine Proteases, Hydrolases, Agents causing angioedema, Peptide Hydrolases, Serine Endopeptidases, Endopeptidases	approved	3
DB01359	Penbutolol	Drug	Amines, Cytochrome P-450 Substrates, Propanols, Serotonin Agents, Agents causing hyperkalemia, Phenoxypropanolamines, Adrenergic beta-Antagonists, Cardiovascular Agents, Hypotensive Agents, Antidepressive Agents, Amino Alcohols, Beta Blocking Agents, Non-Selective, Drugs that are Mainly Renally Excreted, Alcohols, Neurotransmitter Agents, Central Nervous System Depressants, Adrenergic Antagonists, Serotonin Receptor Antagonists, Antihypertensive Agents, Cytochrome P-450 CYP2D6 Substrates, Adrenergic Agents, Bradycardia-Causing Agents, Serotonin 5-HT1 Receptor Antagonists, Propanolamines	approved, investigational	4
DB14660	Trenbolone acetate	Drug	Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, Estrenes, Anabolic Agents, Hormones, Fused-Ring Compounds, Steroids	vet_approved	0
DB14674	Estramustine phosphate	Drug	0	approved, investigational	0
DB12011	Fevipiprant	Drug	Heterocyclic Compounds, Fused-Ring, Indoles	investigational	0
DB13343	Tioxolone	Drug	Dermatologicals, Preparations Containing Sulfur, Anti-Acne Preparations, Anti-Acne Preparations for Topical Use	experimental	0
DB14675	Temsavir	Drug	HIV Fusion Inhibitors	investigational	0
DB13344	Mercuric amidochloride	Drug	Antiseptics and Disinfectants, Dermatologicals, Mercurial Products, Ions, Gases, Anions, Acids, Noncarboxylic, Acids, Chlorides, Electrolytes, Mercury Compounds, Chlorine Compounds, Nitrogen Compounds	experimental	0
DB12010	Fostamatinib	Drug	Blood and Blood Forming Organs, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, Phosphodiesterase 5 Inhibitors, BCRP/ABCG2 Inhibitors, UGT1A1 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, UGT1A9 Substrates, Hemostatics, Vasodilating Agents	approved, investigational	300
DB14672	Oxazepam acetate	Drug	Heterocyclic Compounds, Fused-Ring, Benzazepines, Central Nervous System Depressants, Benzodiazepines and benzodiazepine derivatives, Benzodiazepinones	experimental	2
DB12013	Axelopran	Drug	Opioid Antagonists, Alkaloids, Benzoates, Acids, Carbocyclic, Aza Compounds, Amides, Azabicyclo Compounds, Benzene Derivatives	investigational	0
DB13341	Fenozolone	Drug	Autonomic Agents, Centrally Acting Sympathomimetics, Nervous System, Oxazoles, Sympathomimetics, Agents that produce hypertension, Psychostimulants, Agents Used for Adhd and Nootropics, Agents producing tachycardia, Peripheral Nervous System Agents, Psychoanaleptics	experimental	0
DB14673	Flurandrenolide acetate	Drug	0	experimental	0
DB12012	PF-04457845	Drug	0	investigational	0
DB13342	Cinepazet	Drug	Vasodilators Used in Cardiac Diseases, Cardiac Therapy	experimental	0
DB12015	Alpelisib	Drug	Phosphatidylinositol 3-Kinases, antagonists & inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP2C19 Inhibitors, Breast Neoplasms, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Cytochrome P-450 Enzyme Inducers, Sulfur Compounds, Cytochrome P-450 CYP2B6 Inducers (moderate), Breast Cancer Resistance Protein Inhibitors, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inducers (moderate), Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A4 Inducers, Antineoplastic Agents, Cytochrome P-450 CYP3A4 Inducers (weak), BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2C9 Inducers, P-glycoprotein inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved, investigational	1
DB13347	Diphenadione	Drug	Anticoagulants, Blood and Blood Forming Organs, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Indans, Indenes, Cytochrome P-450 CYP3A4 Substrates, Vitamin K Antagonists	experimental	0
DB14678	Norethindrone enanthate	Drug	Cytochrome P-450 Substrates, Norsteroids, Adrenal Cortex Hormones, Reproductive Control Agents, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Contraceptives, Oral, Progesterone Congeners, Cytochrome P-450 CYP3A Substrates, Contraceptives, Oral, Synthetic, Progestins, Norpregnenes, Hormonal Contraceptives for Systemic Use, Norpregnanes, Contraceptive Agents, Female, Steroids	experimental	0
DB12014	Ozoralizumab	Drug	0	investigational	0
DB13348	Tiadenol	Drug	Lipid Modifying Agents, Lipid Modifying Agents, Plain, Lipid Regulating Agents, Hypolipidemic Agents, Noxae, Lipids, Toxic Actions, Alcohols	experimental	0
DB14679	Quingestanol acetate	Drug	Norsteroids, Adrenal Cortex Hormones, Progestins, Norpregnanes, Fused-Ring Compounds, Steroids	experimental	0
DB12017	Ozagrel	Drug	Acids, Acyclic, Acrylates, Neurotransmitter Agents, Enzyme Inhibitors, Fibrin Modulating Agents, Hematologic Agents, Thromboxane-A Synthase, antagonists & inhibitors, Cardiovascular Agents, Histamine Agents	investigational	0
DB13345	Dihydroergocristine	Drug	Cytochrome P-450 Substrates, BSEP/ABCB11 Substrates, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Ergot Alkaloids and Derivatives, Ergotamines, Alkaloids, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Adrenergic Antagonists, Agents that produce hypertension, Peripheral Vasodilators, Vasodilating Agents, Adrenergic Agents	approved, experimental	4
DB14676	Fagrocorat	Drug	0	experimental	0
DB14677	Gestonorone caproate	Drug	Pregnenediones, Norsteroids, Pregnanes, Norpregnenes, Norpregnanes, Fused-Ring Compounds, Pregnenes, Steroids	approved	0
DB12016	Ponesimod	Drug	Receptors, Lysosphingolipid, antagonists & inhibitors, Sulfur Compounds	investigational	0
DB13346	Bufexamac	Drug	Nephrotoxic agents, Acids, Acyclic, Amines, Fatty Acids, Sensory System Agents, Anti-Inflammatory Agents, Agents causing hyperkalemia, Hydroxylamines, Non COX-2 selective NSAIDS, Amides, Lipids, Acetates, Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Fatty Acids, Volatile, Musculo-Skeletal System, Acetamides, Benzene Derivatives, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Acetic Acid Derivatives and Related Substances, Hydroxy Acids, Antineoplastic Agents, Antirheumatic Agents, Antiinflammatory Preparations, Non-Steroids for Topical Use, Topical Products for Joint and Muscular Pain, Benzeneacetamides, Hydroxamic Acids, Antiinflammatory and Antirheumatic Products, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Histone Deacetylase Inhibitors, Central Nervous System Agents	approved, withdrawn	4
DB12019	Tesetaxel	Drug	Cycloparaffins, Cyclodecanes, Diterpenes, Terpenes	investigational	0
DB12018	Ulocuplumab	Drug	0	investigational	0
DB13349	Talastine	Drug	Pyridazines, Substituted Alkylamines, Antihistamines for Systemic Use	experimental	0
DB00030	Insulin human	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pancreatic Hormones, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Hypoglycemia-Associated Agents, Amino Acids, Peptides, and Proteins, Insulins and Analogues for Injection, Fast-Acting, Blood Glucose Lowering Agents, Hormones, Insulin, Cytochrome P-450 Enzyme Inducers, Peptide Hormones, Insulin, Short-Acting, Alimentary Tract and Metabolism, Cytochrome P-450 CYP1A2 Inducers, Drugs Used in Diabetes	approved, investigational	4
DB02691	Glycocholic acid	Drug	Surface-Active Agents, Peptides, Amino Acids, Peptides, and Proteins, N-substituted Glycines, Peptoids, Detergents, Bile Acids and Salts, Cholic Acids, Amino Acids, Fused-Ring Compounds, Household Products, Cholagogues and Choleretics, Cholanes, Compounds used in a research, industrial, or household setting, Gastrointestinal Agents, Steroids	investigational, experimental	1
DB02690	NU1025	Drug	Heterocyclic Compounds, Fused-Ring	experimental	1
DB00033	Interferon gamma-1b	Drug	Biological Factors, Immunosuppressive Agents, Macrophage-Activating Factors, Cytochrome P-450 Enzyme Inhibitors, Cytokines, Peptides, Interferons, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Lymphokines, Myelosuppressive Agents, Cytochrome P-450 CYP1A2 Inhibitors, Proteins, Interferon gamma	approved, investigational	2
DB01365	Mephentermine	Drug	Autonomic Agents, Adrenergic alpha-Agonists, Amines, Adrenergic alpha-1 Receptor Agonists, Agents producing tachycardia, Adrenergic and Dopaminergic Agents, Cardiovascular Agents, Phenethylamines, Peripheral Nervous System Agents, Neurotransmitter Agents, Ethylamines, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Sympathomimetics, Vasoconstrictor Agents, Adrenergic Agonists, Cardiac Stimulants Excl. Cardiac Glycosides, Agents that produce hypertension, Amphetamines, Cardiac Therapy, Adrenergic Agents	approved	2
DB02696	6-Aminohexyl-uridine-C1,5'-diphosphate	Drug	0	experimental	1
DB01364	Ephedrine	Drug	Central Nervous System Stimulants, Amines, Cardiovascular Agents, Antidepressive Agents, Phenethylamines, Alcohols, Peripheral Nervous System Agents, Sympathomimetic (Adrenergic) Agents, Increased Norepinephrine Activity, Nasal Preparations, Alimentary Tract and Metabolism, Alpha-and Beta-adrenergic Agonists, Adrenergic Agents, Autonomic Agents, Sympathomimetics Excl. Antiglaucoma Preparations, Adrenergic alpha-Agonists, Centrally Acting Antiobesity Products, Propanols, Mydriatics and Cycloplegics, Adrenergics for Systemic Use, Epinephrine and similars, Agents producing tachycardia, Herbs and Natural Products, Adrenergic and Dopaminergic Agents, Norepinephrine Releasing Agent, Amino Alcohols, Ophthalmologicals, Adrenergic beta-Agonists, Neurotransmitter Agents, Ethylamines, Sympathomimetics, Central Nervous System Depressants, Vasoconstrictor Agents, Adrenergic Agonists, Cardiac Stimulants Excl. Cardiac Glycosides, Sympathomimetics, Plain, Agents that produce hypertension, Antiobesity Preparations, Excl. Diet Products, Cholinesterase substrates, Drugs for Obstructive Airway Diseases, Central Nervous System Agents, Sensory Organs, Cardiac Therapy, Propanolamines	approved	4
DB02695	O1-Pentyl-Mannose	Drug	0	experimental	1
DB00034	Interferon alfa-2a, Recombinant	Drug	Cytochrome P-450 CYP1A2 Inhibitors, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Adjuvants, Immunologic, Interferons, Antineoplastic and Immunomodulating Agents, Interferon alpha, Alfa Interferons, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Myelosuppressive Agents	approved, investigational	2
DB02694	Pantoyl Adenylate	Drug	0	experimental	1
DB00031	Tenecteplase	Drug	Anticoagulants, Biological Factors, Enzymes, Blood and Blood Forming Organs, Plasminogen Activators, Fibrin Modulating Agents, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Hematologic Agents, Cardiovascular Agents, Fibrinolytic Agents, Proteins, Tissue Plasminogen Activator, Blood Proteins, Serine Proteases, Hydrolases, Agents causing angioedema, Peptide Hydrolases, Serine Endopeptidases, Endopeptidases	approved	11
DB01363	Ephedra sinica root	Drug	Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, Adrenergic beta-Agonists, Adrenergic alpha-2 Receptor Agonists, Adrenergic alpha-Agonists, Adrenergic Agonists, Agents that produce hypertension, Alpha-and Beta-adrenergic Agonists, Agents producing tachycardia, Herbs and Natural Products, Adrenergic beta-2 Receptor Agonists, Hyperglycemia-Associated Agents, Sympathomimetic (Adrenergic) Agents	nutraceutical	13
DB00032	Menotropins	Drug	Sex Hormones and Modulators of the Genital System, Gonadotropins and Antigonadotropins, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pituitary Hormones, Genito Urinary System and Sex Hormones, Reproductive Control Agents, Fertility Agents, Female, Amino Acids, Peptides, and Proteins, Gonadotropins, Hormones, Fertility Agents, Gonadotropins, Pituitary, Peptide Hormones, Complex Mixtures, Biological Products, Pituitary Hormones, Anterior	approved	2
DB01362	Iohexol	Drug	Benzoates, Acids, Carbocyclic, Roentgenography, Iodobenzoates, Iodinated Contrast Agents, Contrast Media, Diagnostic Uses of Chemicals, Radiographic Contrast Agent, Triiodobenzoic Acids, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting, X-Ray Contrast Activity, Benzene Derivatives, Agents that reduce seizure threshold, Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media	approved	0
DB02693	(4S,5S)-1,2-dithiane-4,5-diol	Drug	0	experimental	1
DB01369	Quinupristin	Drug	Peptides, Cyclic, Anti-Bacterial Agents, Streptogramin Antibacterial, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Peptides, Cytochrome P-450 CYP3A4 Inhibitors, Streptogramins, Amino Acids, Peptides, and Proteins, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Anti-Infective Agents, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved	3
DB00038	Oprelvekin	Drug	Proteins, Biological Factors, Megakaryocyte Growth Factor, Cytokines, Interleukins, Peptides, Adjuvants, Immunologic, Antineoplastic and Immunomodulating Agents, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins	approved, investigational	1
DB02699	4-Oxoretinol	Drug	Biological Factors, Cycloparaffins, Carotenoids, Alkenes, Hydrocarbons, Acyclic, Polyenes, Cyclohexenes, Retinoids, Terpenes, Cyclohexanes, Pigments, Biological	experimental	0
DB01367	Rasagiline	Drug	Neuroprotective Agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Serotonin Agents, Nervous System, Protective Agents, Monoamine Oxidase Inhibitors, Hypotensive Agents, Antidepressive Agents, Drugs that are Mainly Renally Excreted, Anti-Parkinson Drugs, Serotonin Modulators, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Indenes, Monoamine Oxidase B Inhibitors, Central Nervous System Agents, Compounds used in a research, industrial, or household setting, Agents that reduce seizure threshold, Dopamine Agents	approved	2
DB00035	Desmopressin	Drug	Factor VIII Activator, Oligopeptides, Peptides, Pituitary and Hypothalamic Hormones and Analogues, Amino Acids, Peptides, and Proteins, Neuropeptides, Cardiovascular Agents, Hormones, Drugs that are Mainly Renally Excreted, Increased Coagulation Factor VIII Concentration, Proteins, Peptide Hormones, Vasopressin Analog, Posterior Pituitary Lobe Hormones, Hemostatics, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Antidiuretic Agents, Vasopressins, Vasopressin and Analogues, Hormones, Hormone Substitutes, and Hormone Antagonists, Arginine Vasopressin, Pituitary Hormones, Hematologic Agents, Coagulants, Nerve Tissue Proteins, Pituitary, Agents that produce hypertension, Increased Coagulation Factor VIII Activity, Natriuretic Agents, Pituitary Hormones, Posterior	approved	3
DB02698	N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid	Drug	0	experimental	0
DB01366	Procaterol	Drug	Autonomic Agents, Quinolines, Adrenergics, Inhalants, Amines, Adrenergics for Systemic Use, Anti-Asthmatic Agents, Agents producing tachycardia, Bronchodilator Agents, Adrenergic beta-2 Receptor Agonists, Amino Alcohols, Ethanolamines, Hydroxyquinolines, Respiratory System Agents, Alcohols, Peripheral Nervous System Agents, Adrenergic beta-Agonists, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Selective Beta 2-adrenergic Agonists, Sympathomimetics, Adrenergic Agonists, Agents that produce hypertension, Drugs for Obstructive Airway Diseases, Adrenergic Agents	approved, investigational	1
DB00036	Coagulation factor VIIa Recombinant Human	Drug	Biological Factors, Enzymes, Blood and Blood Forming Organs, Blood Coagulation Factors, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Increased Coagulation Factor IX Activity, Factor VII, Proteins, Blood Proteins, Serine Proteases, Hydrolases, Peptide Hydrolases, Enzyme Precursors, Hemostatics, Serine Endopeptidases, Endopeptidases, Increased Coagulation Factor X Activity	approved	5
DB02697	Hydroxyaminovaline	Drug	0	experimental	2
DB00039	Palifermin	Drug	Increased Epithelial Proliferation, Proteins, Biological Factors, Peptides, Intercellular Signaling Peptides and Proteins, Detoxifying Agents for Antineoplastic Treatment, Amino Acids, Peptides, and Proteins, Fibroblast Growth Factors, Mucocutaneous Epithelial Cell Growth Factor	approved	6
DB14670	Lauroyl chloride	Drug	0	experimental	0
DB14671	Temazepam acetate	Drug	0	experimental	0
DB13340	Suloctidil	Drug	Amines, Propanols, Ethylamines, Peripheral Vasodilators, Cardiovascular Agents, Amino Alcohols, Vasodilating Agents, Phenethylamines, Alcohols, Propanolamines	experimental	0
DB13354	Phenprobamate	Drug	Acids, Acyclic, Central Nervous System Depressants, Musculo-Skeletal System, Muscle Relaxants, Centrally Acting Agents, Carbamic Acid Esters, Muscle Relaxants	experimental	0
DB14685	Adenovirus type 7 vaccine live	Drug	Live vaccines, Actively Acquired Immunity, Live Human Adenovirus Type 7 Vaccine, Adenovirus Vaccines, Vaccines	approved	0
DB12022	Evatanepag	Drug	0	investigational	0
DB13355	Visnadine	Drug	Heterocyclic Compounds, Fused-Ring, Peripheral Vasodilators, Benzopyrans, Pyrans	investigational, experimental	0
DB14686	Chamaecyparis obtusa leaf	Drug	0	experimental	0
DB12021	Dinaciclib	Drug	Pyridines, Cyclin-Dependent Kinases, antagonists & inhibitors	investigational	0
DB14683	Prezatide copper	Drug	0	experimental	0
DB13352	Deanol	Drug	Amines, Nervous System, Psychostimulants, Agents Used for Adhd and Nootropics, Antidepressive Agents, Amino Alcohols, Ethanolamines, Psychotropic Drugs, Alcohols, Anti-Dyskinesia Agents, Central Nervous System Depressants, Methylamines, Central Nervous System Agents, Psychoanaleptics	experimental	0
DB12024	PF-04418948	Drug	Receptors, Prostaglandin E, EP2 Subtype, Azetines	investigational	0
DB12023	Benralizumab	Drug	Immunoglobulins, Interleukin-5 Receptor alpha-directed Cytolytic Antibody, Anti-Asthmatic Agents, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Respiratory System Agents, Immunoproteins, Proteins, Serum Globulins, Globulins, Interleukin 5 Receptor alpha-directed Antibody Interactions, Blood Proteins, Intreleukin Antagonists, Drugs for Obstructive Airway Diseases	approved, investigational	2
DB14684	Calcium polycarbophil	Drug	Phosphate Binder, Antidiarrheals, Drugs for Constipation, Drug Carriers, Macromolecular Substances, Calcium Salts, Alimentary Tract and Metabolism, Laxatives, Bulk-Forming Laxatives, Plastics, Polymers, Compounds used in a research, industrial, or household setting, Dental Materials, Gastrointestinal Agents, Resins, Synthetic	approved	0
DB13353	Viminol	Drug	Amines, Analgesics, Nervous System, Amino Alcohols, Alcohols	experimental	0
DB14689	Rosemary oil	Drug	Oils, Lipids	approved, experimental	0
DB13358	Cibenzoline	Drug	QTc Prolonging Agents, Hypoglycemia-Associated Agents, Antiarrhythmics, Class I, Potential QTc-Prolonging Agents, Cardiovascular Agents, Antiarrhythmics, Class Ia, Cardiac Therapy, Antiarrhythmic agents	experimental	0
DB12026	Voxilaprevir	Drug	Antivirals for treatment of HCV infections, Cytochrome P-450 Substrates, OATP1B3 inhibitors, Amides, OATP1B3 substrates, Cytochrome P-450 CYP3A4 Substrates, HCV NS3/4A Protease Inhibitors, Antivirals for Systemic Use, Direct Acting Antivirals, Organic Anion Transporting Polypeptide 1B3 Inhibitors, Sulfur Compounds, Breast Cancer Resistance Protein Inhibitors, Cytochrome P-450 CYP2C8 Substrates, Sulfones, OATP1B1/SLCO1B1 Inhibitors, P-glycoprotein substrates, BCRP/ABCG2 Inhibitors, Antiviral Agents, Organic Anion Transporting Polypeptide 1B1 Inhibitors, Antiinfectives for Systemic Use, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, OATP1B1/SLCO1B1 Substrates, NS3/4A Protease Inhibitors, P-glycoprotein inhibitors	approved, investigational	1
DB13359	Magnesium aspartate	Drug	Metal cations, Alimentary Tract and Metabolism, Metal divalent cations, Mineral Supplements, Agents that produce neuromuscular block (indirect), Magnesium Compounds	experimental	0
DB12025	Triptolide	Drug	Antispermatogenic Agents, Immunologic Factors, Contraceptive Agents, Male, Immunosuppressive Agents, Noxae, Adrenal Cortex Hormones, Reproductive Control Agents, Tripterygium, Antineoplastic Agents, Alkylating Drugs, Toxic Actions, Ethers, Terpenes, Hormonal Contraceptives for Systemic Use, Antineoplastic Agents, Alkylating, Ethers, Cyclic	investigational	0
DB12028	Broxuridine	Drug	Carbohydrates, Ribonucleosides, Pyrimidine Nucleosides, Noxae, Deoxyuridine, Antineoplastic Agents, Antimetabolites, Radiation-Sensitizing Agents, Anti-Infective Agents, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Toxic Actions, Deoxyribonucleosides	investigational	0
DB13356	Mesulfen	Drug	Antiparasitic Products, Insecticides and Repellents, Ectoparasiticides, Incl. Scabicides, Dermatologicals, Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents, Preparations Containing Sulfur, Ions, Sulfur Containing Products, Anti-Acne Preparations, Gases, Sulfides, Anions, Sulfur Compounds, Acids, Noncarboxylic, Acids, Hydrogen Sulfide, Electrolytes, Anti-Acne Preparations for Topical Use	experimental	0
DB14687	Centella asiatica leaf	Drug	0	experimental	0
DB12027	Serdemetan	Drug	Heterocyclic Compounds, Fused-Ring, Amines, Biogenic Amines, Indoles, Radiation-Sensitizing Agents, Biogenic Monoamines	investigational	0
DB13357	Styramate	Drug	Central Nervous System Depressants, Musculo-Skeletal System, Muscle Relaxants, Centrally Acting Agents, Carbamic Acid Esters, Muscle Relaxants	experimental	0
DB14688	Sambucus nigra flower	Drug	0	experimental	0
DB12029	Chlorogenic Acid	Drug	Cycloparaffins, Acids, Carbocyclic, Cyclohexanecarboxylic Acids, Cinnamates, Cyclohexanes	investigational	0
DB00040	Glucagon	Drug	Gastrointestinal Motility Inhibitor, Decreased Glycolysis, Glycogenolytic Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Gastrointestinal Hormones, Pancreatic Hormones, Decreased GI Motility, Glucagon, antagonists & inhibitors, Amino Acids, Peptides, and Proteins, Hormones, Increased Glycogenolysis, Proteins, Peptide Hormones, Increased Gluconeogenesis, Glycogenolytic Hormones, Protein Precursors, Decreased GI Smooth Muscle Tone, Antihypoglycemic Agent, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Gastrointestinal Agents, Proglucagon	approved	3
DB00041	Aldesleukin	Drug	Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Peptides, Amino Acids, Peptides, and Proteins, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Hypotensive Agents, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Lymphokines, Lymphocyte Growth Factor, Proteins, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Interleukins, Biological Factors, Cytochrome P-450 CYP2E1 Inhibitors, Cytokines, Adjuvants, Immunologic, Antineoplastic and Immunomodulating Agents, Intercellular Signaling Peptides and Proteins, Antineoplastic Agents, Anti-HIV Agents, Myelosuppressive Agents, Cytochrome P-450 CYP3A Inhibitors, Increased Lymphocyte Cell Production, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Increased Lymphocyte Activation	approved	3
DB01370	Aluminium	Drug	Aluminum and magnesium containing antacids, Metals, Light, Gastric Acid Lowering Agents, Metal cations, Metal divalent cations, Metals, Aluminium Compounds, Elements, Antacids	approved, investigational	4
DB00044	Lutropin alfa	Drug	Sex Hormones and Modulators of the Genital System, Gonadotropins and Antigonadotropins, Genito Urinary System and Sex Hormones, Gonadotropins	approved	1
DB01375	Aluminium monostearate	Drug	Fatty Acids, Lipids	experimental	4
DB00045	Lyme disease vaccine (recombinant OspA)	Drug	0	approved, withdrawn	1
DB00042	Botulinum Toxin Type B	Drug	Metalloproteases, Ganglion Blockers, Enzymes and Coenzymes, Other Miscellaneous Therapeutic Agents, Amino Acids, Peptides, and Proteins, Metalloendopeptidases, Agents that produce neuromuscular block (indirect), Muscle Relaxants, Botulinum Toxins, Proteins, Toxins, Biological, Anti-Dyskinesia Agents, Acetylcholine Release Inhibitors, Cholinergic Agents, Complex Mixtures, Bacterial Toxins, Musculo-Skeletal System, Fluids and Secretions, Bodily Secretions, Biological Factors, Enzymes, Neurotoxins, Amphibian Venoms, Membrane Transport Modulators, Bacterial Proteins, Neurotransmitter Agents, Muscle Relaxants, Peripherally Acting Agents, Central Nervous System Depressants, Venoms, Hydrolases, Peptide Hydrolases, Central Nervous System Agents, Endopeptidases	approved, investigational	3
DB00043	Omalizumab	Drug	Immunoglobulins, Anti-Allergic Agents, IgE-directed Antibody Interactions, Decreased IgE Activity, Anti-Asthmatic Agents, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Respiratory System Agents, Immunoproteins, Proteins, Serum Globulins, Antibodies, Monoclonal, Humanized, Agents to Treat Airway Disease, Globulins, Anti-IgE, Blood Proteins, Respiratory Agents, Miscellaneous	approved, investigational	2
DB01373	Calcium	Drug	Biological Factors, Phosphate Binder, Calcium, agonists, Metals, Blood Coagulation Factors, Amino Acids, Peptides, and Proteins, Minerals, Drugs Affecting Bone Structure and Mineralization, Elements, Antacids and Adsorbents, Calcium Salts, Proteins, Phosphate Chelating Activity, Replacement Preparations, Alimentary Tract and Metabolism, Blood Proteins, Musculo-Skeletal System, Drugs for Treatment of Bone Diseases, Calcium-Regulating Hormones and Agents, Metals, Alkaline Earth	nutraceutical	20
DB00048	Collagenase clostridium histolyticum	Drug	Metalloproteases, Enzymes, Dermatologicals, Enzymes and Coenzymes, Metalloendopeptidases, Misc. Skin and Mucous Membrane Agents, Collagen-specific Enzyme, Collagenases, Musculo-Skeletal System, Hydrolases, Peptide Hydrolases, Preparations for Treatment of Wounds and Ulcers, Endopeptidases	approved, investigational	4
DB00049	Rasburicase	Drug	Enzymes, Antigout Preparations, Musculo-Skeletal System, Detoxifying Agents for Antineoplastic Treatment, Enzymes and Coenzymes, Urate Oxidase, antagonists & inhibitors, Oxidoreductases, Recombinant Proteins, Urate Oxidase, Uric Acid-specific Enzyme	approved, investigational	1
DB00046	Insulin lispro	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pancreatic Hormones, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Hypoglycemia-Associated Agents, Amino Acids, Peptides, and Proteins, Insulins and Analogues for Injection, Fast-Acting, Blood Glucose Lowering Agents, Hormones, Insulin, Cytochrome P-450 Enzyme Inducers, Peptide Hormones, Insulin, Short-Acting, Alimentary Tract and Metabolism, Cytochrome P-450 CYP1A2 Inducers, Drugs Used in Diabetes, Insulin Analog	approved	2
DB01378	Magnesium cation	Drug	Inhibition Small Intestine Fluid/Electrolyte Absorption, Osmotic Laxatives, Magnesium Ion Exchange Activity, Calculi Dissolution Agent, Laxatives, Stimulation Large Intestine Fluid/Electrolyte Secretion, Polyvalent cation containing laxatives, antacids, oral supplements, Agents that produce neuromuscular block (indirect), Minerals, Increased Large Intestinal Motility, Osmotic Activity, Inhibition Large Intestine Fluid/Electrolyte Absorption	approved, nutraceutical	1
DB01377	Magnesium oxide	Drug	Drugs for Constipation, Calculi Dissolution Agent, Ions, Oxides, Laxatives, magnesium containing, Mineral Supplements, Agents that produce neuromuscular block (indirect), Minerals, Aluminum and magnesium containing antacids, Anions, Gastric Acid Lowering Agents, Metal cations, Alimentary Tract and Metabolism, Metal divalent cations, Osmotic Laxatives, Electrolytes, Laxatives, Drugs for Acid Related Disorders, Antacids, Oxygen Compounds, Gastrointestinal Agents, Magnesium Compounds, Magnesium Salts	approved	0
DB00047	Insulin glargine	Drug	Hypolipidemic Agents, Insulin, Long-Acting, Hormones, Hormone Substitutes, and Hormone Antagonists, Noxae, Peptides, Pancreatic Hormones, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Hypoglycemia-Associated Agents, Amino Acids, Peptides, and Proteins, Blood Glucose Lowering Agents, Hormones, Antimetabolites, Insulin, Lipid Regulating Agents, Cytochrome P-450 Enzyme Inducers, Peptide Hormones, Complex Mixtures, Alimentary Tract and Metabolism, Biological Products, Cytochrome P-450 CYP1A2 Inducers, Drugs Used in Diabetes, Toxic Actions, Insulin Analog	approved	2
DB14681	Cortisone	Drug	Corticosteroids for Systemic Use, Corticosteroids, Corticosteroids for Systemic Use, Plain, Glucocorticoids, Hormones, Hormone Substitutes, and Hormone Antagonists, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Fused-Ring Compounds, Hydroxycorticosteroids, Ophthalmologicals, Cytochrome P-450 Enzyme Inducers, Pregnanes, Sensory Organs, 17-Hydroxycorticosteroids, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Corticosteroid Hormone Receptor Agonists, Cytochrome P-450 CYP3A5 Inducers, Pregnenes, Steroids	experimental	0
DB13350	Azanidazole	Drug	Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Imidazoles, Gynecological Antiinfectives and Antiseptics, Nitroimidazole Derivatives, Genito Urinary System and Sex Hormones, Nitro Compounds, Imidazole Derivatives	experimental	0
DB13351	Piperidolate	Drug	Anticholinergic Agents, Alimentary Tract and Metabolism, Acids, Carbocyclic, Phenylacetates, Agents producing tachycardia, Drugs for Functional Gastrointestinal Disorders, Muscarinic Antagonists, Synthetic Anticholinergics, Esters With Tertiary Amino Group	experimental	0
DB14682	Dextrorphan	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Neuroprotective Agents, Neurotransmitter Agents, Phenanthrenes, Opiate Alkaloids, Protective Agents, Central Nervous System Agents, Excitatory Amino Acid Agents, Compounds used in a research, industrial, or household setting, Excitatory Amino Acid Antagonists, Morphinans	experimental	0
DB12020	Tecovirimat	Drug	Heterocyclic Compounds, Fused-Ring, Benzoates, UGT1A1 Substrates, Acids, Carbocyclic, Amides, UGT1A4 substrates, Antiviral Agents, Benzene Derivatives	approved, investigational	1
DB14680	Combretastatin A4	Drug	Antineoplastic Agents, Phytogenic, Antineoplastic Agents, Benzylidene Compounds, Benzene Derivatives	experimental	0
DB14612	Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (UV, formaldehyde inactivated)	Drug	0	approved	0
DB14613	Serum, horse	Drug	0	approved	0
DB14610	Influenza B virus B/Hubei-Wujiagang/158/2009 BX-39 antigen (formaldehyde inactivated)	Drug	0	approved	0
DB14611	Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (UV, formaldehyde inactivated)	Drug	0	approved	0
DB14616	Influenza A virus A/Brisbane/59/2007 (H1N1) antigen (formaldehyde inactivated)	Drug	0	approved	0
DB14617	Influenza A virus A/Uruguay/716/2007(H3N2) hemagglutinin antigen (formaldehyde inactivated)	Drug	0	approved, investigational	0
DB14614	Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (UV, formaldehyde inactivated)	Drug	0	approved	0
DB14615	Influenza A virus A/Uruguay/716/2007(H3N2) antigen (formaldehyde inactivated)	Drug	0	approved	0
DB14618	Influenza A virus A/Brisbane/59/2007 (H1N1) hemagglutinin antigen (formaldehyde inactivated)	Drug	0	approved, investigational	0
DB14619	Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated)	Drug	Actively Acquired Immunity, Influenza Vaccines, Vaccines, Inactivated Influenza A Virus Vaccine	approved	0
DB03962	Nicotinamide 8-bromo-adenine dinucleotide phosphate	Drug	0	experimental	1
DB02630	L-xylitol 5-phosphate	Drug	Carbohydrates, Sugar Phosphates	experimental	1
DB03963	S-(Dimethylarsenic)Cysteine	Drug	0	experimental	8
DB03964	4-Hydroxy-Aconitate Ion	Drug	0	experimental	1
DB01303	Oxtriphylline	Drug	Autonomic Agents, Amines, Ammonium Compounds, Cytochrome P-450 Substrates, Anti-Asthmatic Agents, Quaternary Ammonium Compounds, Trimethyl Ammonium Compounds, Onium Compounds, Bronchodilator Agents, Respiratory Smooth Muscle Relaxants, Amino Alcohols, Ethanolamines, Respiratory System Agents, Alcohols, Peripheral Nervous System Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Purines, Xanthines and Adrenergics, Cytochrome P-450 CYP1A2 Substrates, Drugs for Obstructive Airway Diseases, Xanthine derivatives, Nitrogen Compounds, Purinones	approved	5
DB02633	Cibacron Blue	Drug	0	experimental	2
DB01301	Rolitetracycline	Drug	Anti-Bacterial Agents, Tetracyclines, Naphthacenes, Agents that produce neuromuscular block (indirect), Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use	approved	2
DB03960	Cp-Coeleneterazine	Drug	0	experimental	0
DB02632	4-nitrophenyl-beta-D-galactoside	Drug	Affinity Labels, Galactosides, Carbohydrates, Photoaffinity Labels, Laboratory Chemicals, Glycosides, Indicators and Reagents, Compounds used in a research, industrial, or household setting	experimental	2
DB03961	2c-Methyl-D-Erythritol 2,4-Cyclodiphosphate	Drug	0	experimental	1
DB01307	Insulin detemir	Drug	Insulin, Long-Acting, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pancreatic Hormones, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Hypoglycemia-Associated Agents, Amino Acids, Peptides, and Proteins, Blood Glucose Lowering Agents, Hormones, Insulin, Cytochrome P-450 Enzyme Inducers, Peptide Hormones, Alimentary Tract and Metabolism, Cytochrome P-450 CYP1A2 Inducers, Drugs Used in Diabetes, Insulin Analog	approved	2
DB02638	Terlipressin	Drug	QTc Prolonging Agents, Vasopressin and Analogues, Hormones, Hormone Substitutes, and Hormone Antagonists, Oligopeptides, Peptides, Pituitary Hormones, Pituitary and Hypothalamic Hormones and Analogues, Amino Acids, Peptides, and Proteins, Neuropeptides, Cardiovascular Agents, Nerve Tissue Proteins, Hormones, Moderate Risk QTc-Prolonging Agents, Proteins, Peptide Hormones, Vasoconstrictor Agents, Pituitary Hormones, Posterior, Posterior Pituitary Lobe Hormones, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Vasopressins	approved, investigational	3
DB02637	Oxaloacetate Ion	Drug	0	experimental	5
DB01306	Insulin aspart	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pancreatic Hormones, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Hypoglycemia-Associated Agents, Amino Acids, Peptides, and Proteins, Insulins and Analogues for Injection, Fast-Acting, Blood Glucose Lowering Agents, Hormones, Insulin, Cytochrome P-450 Enzyme Inducers, Peptide Hormones, Insulin, Short-Acting, Alimentary Tract and Metabolism, Cytochrome P-450 CYP1A2 Inducers, Drugs Used in Diabetes, Insulin Analog	approved	2
DB02636	9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid	Drug	0	experimental	1
DB02635	N-[O-Phosphono-Pyridoxyl]-Isoleucine	Drug	0	experimental	1
DB03966	Clorobiocin	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Coumarins, Glycosides, Aminocoumarins, Benzopyrans, Pyrans	experimental	1
DB03967	Dodecyl sulfate	Drug	Alkanesulfonic Acids, Surface-Active Agents, Sulfur Acids, Hydrocarbons, Acyclic, Alkanes, Lipids, Alcohols, Sulfur Compounds, Acids, Noncarboxylic, Alkanesulfonates, Acids, Sulfonic Acids, Dodecanol, Compounds used in a research, industrial, or household setting, Fatty Alcohols	experimental	2
DB03968	1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine	Drug	0	experimental	1
DB01309	Insulin glulisine	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pancreatic Hormones, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Hypoglycemia-Associated Agents, Amino Acids, Peptides, and Proteins, Insulins and Analogues for Injection, Fast-Acting, Blood Glucose Lowering Agents, Hormones, Insulin, Proteins, Cytochrome P-450 Enzyme Inducers, Peptide Hormones, Insulin, Short-Acting, Alimentary Tract and Metabolism, Cytochrome P-450 CYP1A2 Inducers, Drugs Used in Diabetes, Insulin Analog	approved	2
DB02639	7-(alpha-D-Glucopyranosyloxy)-4-methyl-2H-1-benzopyran-2-one	Drug	0	experimental	0
DB14620	Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated)	Drug	Actively Acquired Immunity, Vaccines, Inactivated, Influenza Vaccines, Vaccines, Inactivated Influenza A Virus Vaccine	approved	0
DB14623	Acetyl chloride	Drug	Acids, Acyclic, Anions, Acids, Noncarboxylic, Fatty Acids, Acids, Fatty Acids, Volatile, Electrolytes, Ions, Lipids, Chlorine Compounds	experimental	0
DB14624	Nandrolone hydrogen sulfate	Drug	0	investigational, experimental	0
DB14622	Sodium phosphate tribasic dodecahydrate	Drug	Anions, Acids, Noncarboxylic, Acids, Phosphoric Acids, Electrolytes, Ions, Phosphorus Compounds, Phosphorus Acids	experimental	0
DB14627	Oxyphenisatin acetate	Drug	Heterocyclic Compounds, Fused-Ring, Laxatives, Indoles, Gastrointestinal Agents	approved, investigational, withdrawn	0
DB14628	Pseudosaccharin chloride	Drug	0	experimental	0
DB14625	Meprednisone acetate	Drug	0	experimental	0
DB14626	Pregnenolone acetate	Drug	0	investigational	0
DB14629	Trifluoroethyl acetate	Drug	0	experimental	0
DB03973	3-[2,6,8-Trioxo-9-[(2R,3R,4R)-2,3,4,5-tetrahydroxypentyl]-3H-purin-7-yl]propyl dihydrogen phosphate	Drug	0	experimental	1
DB02641	Heptanamide	Drug	0	experimental	1
DB02640	Fumagillin	Drug	Cycloparaffins, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Fatty Acids, Antineoplastic Agents, Lipids, Growth Inhibitors, Angiogenesis Modulating Agents, Angiogenesis Inhibitors, Anti-Infective Agents, Growth Substances, Terpenes, Antiparasitic Agents	experimental	1
DB03974	L-homoarginine	Drug	Arginine, Amino Acids, Basic, Amino Acids, Essential, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	1
DB03975	Mercuribenzoic Acid	Drug	0	experimental	2
DB03976	Phosphorylisopropane	Drug	0	experimental	4
DB02645	3,4-Epoxybutyl-Alpha-D-Glucopyranoside	Drug	0	experimental	1
DB03970	(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid	Drug	0	experimental	3
DB02644	N-omega-propyl-L-arginine	Drug	0	experimental	2
DB02643	N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate	Drug	Surface-Active Agents, Amines, Ammonium Compounds, Onium Compounds, Detergents, Compounds used in a research, industrial, or household setting, Household Products, Nitrogen Compounds	experimental	3
DB03971	Acarbose Derived Hexasaccharide	Drug	0	experimental	2
DB03972	2-Amino-4h-1,3-Benzoxathiin-4-Ol	Drug	0	experimental	0
DB02642	[[N-(Benzyloxycarbonyl)Amino]Methyl]Phosphate	Drug	0	experimental	3
DB02649	3-Amino-3-Oxopropanoic Acid	Drug	0	experimental	1
DB02648	(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium	Drug	0	experimental	2
DB02647	N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide	Drug	0	experimental	1
DB02646	Nitrosoethane	Drug	0	experimental	1
DB03977	Trimethyllysine	Drug	Amino Acids, Basic, Amino Acids, Essential, Amino Acids, Diamino, Mitosis Modulators, Amino Acids, Peptides, and Proteins, Mitogens, Amino Acids	experimental	2
DB03978	Tyrosinal	Drug	0	experimental	4
DB03979	1-[Glycerolylphosphonyl]-2-[8-(2-Hexyl-Cyclopropyl)-Octanal-1-Yl]-3-[Hexadecanal-1-Yl]-Glycerol	Drug	0	experimental	1
DB01319	Fosamprenavir	Drug	Acids, Acyclic, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Protease Inhibitors, Amides, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Antivirals for Systemic Use, Direct Acting Antivirals, Sulfur Compounds, Sulfones, Organophosphorus Compounds, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Antiinfectives for Systemic Use, HIV Protease Inhibitors, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Amprenavir and Prodrugs, Hyperglycemia-Associated Agents	approved	1
DB14630	Tyramine O-sulfate	Drug	Amines, Biogenic Amines, Biogenic Monoamines	experimental	0
DB14631	Prednisolone phosphate	Drug	Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 Substrates, Glucocorticoids, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP2C19 Inducers (strength unknown), Cytochrome P-450 CYP2B6 Inducers (strength unknown), Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Fused-Ring Compounds, OAT3/SLC22A8 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C19 Inducers, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inducers, Pregnadienetriols, Corticosteroids, Cytochrome P-450 CYP2A6 Inducers, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inducers, P-glycoprotein inducers, Cytochrome P-450 CYP3A Substrates, Pregnanes, Cytochrome P-450 CYP2C9 Inducers, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Steroids	approved, vet_approved	2
DB13300	Epicillin	Drug	Penicillins With Extended Spectrum, Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Penicillin G, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Antibacterials for Systemic Use	experimental	0
DB13303	Febarbamate	Drug	Pyrimidines, Central Nervous System Depressants, Musculo-Skeletal System, Muscle Relaxants, Centrally Acting Agents, Carbamic Acid Esters, Pyrimidinones, Muscle Relaxants	experimental	0
DB14634	Fluprednidene acetate	Drug	Corticosteroids, Glucocorticoids, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Pregnanes, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inducers, Steroids	experimental	0
DB14635	Curcumin sulfate	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)	experimental	5
DB13304	Triaziquone	Drug	Alkylating Drugs, Aziridines, Noxae, Ethylene Imines, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Toxic Actions, Azirines, Antineoplastic Agents, Alkylating	experimental	0
DB14632	Prednisolone tebutate	Drug	Pregnadienetriols, Pregnadienes, Pregnanes, Fused-Ring Compounds, Steroids	approved, vet_approved	0
DB13302	Hachimycin	Drug	Antimycotics for Systemic Use, Gynecological Antiinfectives and Antiseptics, Antifungals for Topical Use, Dermatologicals, Genito Urinary System and Sex Hormones, Antifungals for Dermatological Use, Antiinfectives for Systemic Use, Anti-Infective Agents, Antiparasitic Agents	experimental	0
DB14633	Prednisolone hemisuccinate	Drug	Pregnadienetriols, Corticosteroids, Glucocorticoids, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Pregnanes, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inducers, Steroids	experimental	0
DB14638	Diloxanide furoate	Drug	Antiprotozoals, Anti-Infective Agents, Antiparasitic Agents, Amebicides	approved	0
DB13307	Proscillaridin	Drug	Carbohydrates, Cardanolides, Cardiac Glycosides, Enzyme Inhibitors, Protective Agents, Scilla Glycosides, Cardiovascular Agents, Fused-Ring Compounds, Cardiotonic Agents, Bufanolides, Glycosides, Cardiac Therapy, Compounds used in a research, industrial, or household setting, Steroids	experimental	0
DB14639	Boldenone undecylenate	Drug	Androstanes, Hormones, Hormone Substitutes, and Hormone Antagonists, Androstenols, Androstenes, Hormones, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Steroids	illicit, vet_approved	1
DB13308	Oxametacin	Drug	Acetic Acid Derivatives and Related Substances, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Musculo-Skeletal System	experimental	0
DB13305	Tolpropamine	Drug	Amines, Antipruritics, Incl. Antihistamines, Anesthetics, Etc., Antihistamines for Topical Use, Dermatologicals, Benzene Derivatives	experimental	0
DB14636	Triciribine phosphate	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides, Naphthalenes	investigational	0
DB14637	Fluprednisolone acetate	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates	experimental	0
DB13306	Chlorquinaldol	Drug	Quinolines, Cell-mediated Immunity, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Chloroquinolinols, Gynecological Antiinfectives and Antiseptics, Antiseptics and Disinfectants, Dermatologicals, Genito Urinary System and Sex Hormones, Standardized Chemical Allergen, Hydroxyquinolines, Anti-Infective Agents, Anti-Infective Agents, Local, Hydroxyquinoline Derivatives, Heterocyclic Compounds, Fused-Ring, Quinoline Derivatives, Throat Preparations, Increased Histamine Release	approved	0
DB13309	Benproperine	Drug	Cough and Cold Preparations, Benzene Derivatives	experimental	0
DB02652	L-[(N-Hydroxyamino)Carbonyl]Phenylalanine	Drug	0	experimental	1
DB01321	Josamycin	Drug	Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Macrolides, Lincosamides and Streptogramins, Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use, Lactones	investigational	1
DB03984	Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide	Drug	0	experimental	1
DB01320	Fosphenytoin	Drug	Decreased Central Nervous System Disorganized Electrical Activity, Cytochrome P-450 Substrates, Nervous System, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Enzyme Inducing Antiepileptic Drugs, Anti-epileptic Agent, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Cytochrome P-450 CYP2B6 Inducers (strong), Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index, Thyroxine-binding globulin substrates, Cytochrome P-450 CYP3A4 Inducers (strong), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index, Phenytoin and Prodrugs, Cytochrome P-450 CYP2C8 Substrates, Prodrugs, Cytochrome P-450 CYP3A Inducers (strong), Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index, Hydantoins, Imidazolidines, Membrane Transport Modulators, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Anticonvulsants, UGT1A9 Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Imidazoles, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Cytochrome P-450 CYP1A2 Inducers, UGT1A6 Inhibitors, Central Nervous System Agents, Cytochrome P-450 CYP2C9 Inducers, Sodium Channel Blockers	approved, investigational	1
DB03985	R-azabisabolene	Drug	0	experimental	0
DB02651	{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)	Drug	0	experimental	1
DB03986	6-methyl-formycin A	Drug	0	experimental	1
DB02650	Trichloroacetaldehyde	Drug	Ethylene Glycols, Glycols, Alcohols	experimental	0
DB03987	2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine	Drug	0	experimental	2
DB03980	4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole	Drug	0	experimental	1
DB02656	LY-294002	Drug	Phosphatidylinositol 3-Kinases, antagonists & inhibitors, Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Oxazines, Benzopyrans, Pyrans	experimental	2
DB01325	Quinethazone	Drug	Sodium Chloride Symporter Inhibitors, Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Amides, Cardiovascular Agents, Low-Ceiling Diuretics, Excl. Thiazides, Membrane Transport Modulators, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Sulfonamides, Diuretics, Natriuretic Agents, Sulfones	approved	5
DB02655	D-Aspartic Acid	Drug	Amino Acids, Dicarboxylic, Excitatory Amino Acids, Amino Acids, Peptides, and Proteins, Amino Acids, Acidic, Amino Acids	experimental	2
DB03981	1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid	Drug	0	experimental	3
DB01324	Polythiazide	Drug	Antihypertensive Agents Indicated for Hypertension, Increased Diuresis, Sodium Chloride Symporter Inhibitors, Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Amides, Cardiovascular Agents, Membrane Transport Modulators, OAT3/SLC22A8 Substrates, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Photosensitizing Agents, Benzothiadiazines, Sulfonamides, Diuretics, Natriuretic Agents, Antihypertensive Agents, Drugs causing inadvertant photosensitivity, Thiazides, Hyperglycemia-Associated Agents, Sulfones	approved	1
DB03982	Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid	Drug	0	experimental	1
DB01323	St. John's Wort	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Inducers (strong), Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP2C19 Inducers (strength unknown), Herbs and Natural Products, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C19 Substrates, P-glycoprotein inducers, Cytochrome P-450 CYP3A4 Inducers (strong), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Cytochrome P-450 CYP2C19 Inducers, Hyperglycemia-Associated Agents, Cytochrome P-450 CYP2D6 Inhibitors (weak), Psychoanaleptics	approved, investigational, nutraceutical	0
DB02654	6-hydroxy-FAD	Drug	Biological Factors, Carbohydrates, Coenzymes, Enzymes and Coenzymes, Nucleotides, Pteridines, Vitamins, Pigments, Biological, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Vitamin B Complex, Adenine Nucleotides, Flavins	experimental	0
DB01322	Kava	Drug	0	approved, investigational, nutraceutical	0
DB03983	{[2-Amino-4-oxo-6,7-di(sulfanyl-κS)-3,5,5a,8,9a,10-hexahydro-4H-pyrano[3,2-g]pteridin-8-yl]methyl dihydrogenato(2-) phosphate}(dioxo)sulfanylmolybdenum	Drug	0	experimental	1
DB01329	Cefoperazone	Drug	Nephrotoxic agents, Third-Generation Cephalosporins, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, OAT1/SLC22A6 inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, OAT3/SLC22A8 Inhibitors, Antibacterials for Systemic Use	approved, investigational	9
DB01328	Cefonicid	Drug	Nephrotoxic agents, Second-Generation Cephalosporins, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Antibacterials for Systemic Use	approved, investigational	5
DB02659	Cholic Acid	Drug	OATP1B1/SLCO1B1 Inhibitors, BSEP/ABCB11 Inhibitors, Bile Acid Preparations, BSEP/ABCB11 Substrates, Bile Therapy, OATP1B3 substrates, Bile Acids and Salts, Cholic Acids, Fused-Ring Compounds, OAT3/SLC22A8 Substrates, P-glycoprotein inducers, Alimentary Tract and Metabolism, Bile acids and derivatives, BSEP/ABCB11 inducers, OATP1B1/SLCO1B1 Substrates, OAT3/SLC22A8 Inhibitors, OATP1B1/SLCO1B1 Inducers, Cholanes, Bile and Liver Therapy, Steroids	approved	23
DB01327	Cefazolin	Drug	Nephrotoxic agents, Amides, Lactams, OAT1/SLC22A6 Substrates, Thiazines, beta-Lactams, First-Generation Cephalosporins, Antiinfectives for Systemic Use, Anti-Infective Agents, OAT1/SLC22A6 inhibitors, OAT3/SLC22A8 Substrates, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, OAT3/SLC22A8 Inhibitors, Antibacterials for Systemic Use	approved	8
DB02658	2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Allopyranoside	Drug	0	experimental	1
DB01326	Cefamandole	Drug	Nephrotoxic agents, Second-Generation Cephalosporins, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, OAT1/SLC22A6 inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, OAT3/SLC22A8 Inhibitors, Antibacterials for Systemic Use	approved, experimental	1
DB02657	Glucosamine 6-Phosphate	Drug	Amino Sugars, Carbohydrates, Hexosephosphates, Sugar Phosphates, Hexosamines, Glucosephosphates	experimental	2
DB03988	2,6-Diamino-Hexanoic Acid Amide	Drug	0	experimental	1
DB03989	D-Allopyranose	Drug	0	experimental	1
DB14641	Estriol tripropionate	Drug	0	experimental	3
DB13310	Ormeloxifene	Drug	Heterocyclic Compounds, Fused-Ring, Sex Hormones and Modulators of the Genital System, Contraceptives, Oral, Selective Estrogen Receptor Modulators, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, Hormonal Contraceptives for Systemic Use, Contraceptive Agents, Female, Pyrans	experimental	0
DB14642	Lypressin	Drug	Vasopressin and Analogues, Hormones, Hormone Substitutes, and Hormone Antagonists, Oligopeptides, Peptides, Pituitary Hormones, Pituitary and Hypothalamic Hormones and Analogues, Amino Acids, Peptides, and Proteins, Hematologic Agents, Neuropeptides, Cardiovascular Agents, Coagulants, Nerve Tissue Proteins, Hormones, Proteins, Peptide Hormones, Vasoconstrictor Agents, Natriuretic Agents, Pituitary Hormones, Posterior, Posterior Pituitary Lobe Hormones, Hemostatics, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Antidiuretic Agents, Vasopressins	approved	3
DB13311	Trepibutone	Drug	Alimentary Tract and Metabolism, Drugs for Functional Gastrointestinal Disorders	experimental	0
DB14640	Isoflupredone acetate	Drug	Pregnadienetriols, Pregnadienes, Pregnanes, Steroids, Fluorinated, Fused-Ring Compounds, Steroids	vet_approved	0
DB14645	Nitrogen trichloride	Drug	Anions, Acids, Noncarboxylic, Acids, Electrolytes, Ions, Chlorine Compounds	experimental	0
DB13314	Alminoprofen	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Acids, Acyclic, Fatty Acids, Sensory System Agents, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Lipids, Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Fatty Acids, Volatile, Musculo-Skeletal System, Propionates, Agents that produce hypertension, Central Nervous System Agents	experimental	0
DB13315	Sobrerol	Drug	Cough and Cold Preparations, Expectorants, Respiratory System Agents	experimental	0
DB14646	Prednisone acetate	Drug	Pregnadienediols, Antineoplastic Agents, Hormonal, Corticosteroids, Glucocorticoids, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Antineoplastic Agents, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Pregnanes, Thyroxine-binding globulin inhibitors, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inducers, Steroids	approved, investigational, experimental	0
DB13312	Delapril	Drug	ACE Inhibitors and Calcium Channel Blockers, Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors, Agents causing hyperkalemia, Protease Inhibitors, Agents Acting on the Renin-Angiotensin System, Agents causing angioedema, Cardiovascular Agents, Indenes, ACE Inhibitors and Diuretics, Antihypertensive Agents	investigational	0
DB14643	Methylprednisolone aceponate	Drug	Corticosteroids, Dermatological Preparations, Pregnadienetriols, Corticosteroids, Corticosteroids, Potent (Group III), Pregnadienes, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Dermatologicals, Pregnanes, Fused-Ring Compounds, Steroids	approved, vet_approved	0
DB13313	Melevodopa	Drug	Amino Acids, Aromatic, Dihydroxyphenylalanine, Amines, Nervous System, Phenylalanine, Amino Acids, Essential, Amino Acids, Peptides, and Proteins, Catecholamines, Catechols, Amino Acids, Anti-Parkinson Drugs, Amino Acids, Cyclic, Anti-Dyskinesia Agents, Phenols, Central Nervous System Agents, Benzene Derivatives, Dopa and Dopa Derivatives, Dopamine Agents	experimental	0
DB14644	Methylprednisolone hemisuccinate	Drug	Neuroprotective Agents, Antineoplastic Agents, Hormonal, Pregnadienetriols, Corticosteroids, Glucocorticoids, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Anti-Inflammatory Agents, Protective Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Antineoplastic Agents, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Pregnanes, Central Nervous System Agents, Compounds used in a research, industrial, or household setting, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inducers, Steroids	approved	0
DB14649	Dexamethasone acetate	Drug	Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Anti-Inflammatory Agents, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP2C19 Inducers (strength unknown), Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 CYP3A4 Inducers (moderate), OAT3/SLC22A8 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C19 Inducers, BSEP/ABCB11 inducers, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2E1 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (moderate), Pregnadienetriols, Cytochrome P-450 CYP2E1 Inducers, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP2A6 Inducers, Pregnadienes, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inducers, BCRP/ABCG2 Inhibitors, Cytochrome P-450 CYP3A7 Inducers, P-glycoprotein inducers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Pregnanes, Steroids, Fluorinated, P-glycoprotein inhibitors, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors (weak), Cytochrome P-450 CYP3A7 Inducers (strength unknown), Steroids	approved, investigational, vet_approved	5
DB13318	Demecolcine	Drug	Alkaloids, Antineoplastic Agents, Phytogenic, Colchicine Derivatives, Tubulin Modulators, Antineoplastic and Immunomodulating Agents, Antimitotic Agents, Antineoplastic Agents, Mitosis Modulators	experimental	0
DB13319	Propenidazole	Drug	Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Gynecological Antiinfectives and Antiseptics, Nitroimidazole Derivatives, Genito Urinary System and Sex Hormones, Imidazole Derivatives	experimental	0
DB13316	Ibopamine	Drug	Amines, Cardiovascular Agents, Alcohols, Dopamine Agonists, Peripheral Nervous System Agents, Biogenic Amines, Diuretics, Dopamine D1 Receptor Agonists, Compounds used in a research, industrial, or household setting, Benzene Derivatives, Dopamine Agents, Autonomic Agents, Sympathomimetics Excl. Antiglaucoma Preparations, Mydriatics and Cycloplegics, Protective Agents, Epinephrine and similars, Catecholamines, Catechols, Adrenergic and Dopaminergic Agents, Amino Alcohols, Ethanolamines, Biogenic Monoamines, Cardiotonic Agents, Ophthalmologicals, Neurotransmitter Agents, Mydriatics, Cardiac Stimulants Excl. Cardiac Glycosides, Agents that produce hypertension, Natriuretic Agents, Phenols, Sensory Organs, Vasodilating Agents, Cardiac Therapy	experimental	0
DB14647	Sulfur chloride	Drug	0	experimental	0
DB03990	4'-nitrophenyl-3i-thiolaminaritrioside	Drug	0	experimental	0
DB13317	Flunoxaprofen	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Antiinflammatory Products for Vaginal Administration, Sensory System Agents, Anti-Inflammatory Agents, Agents causing hyperkalemia, Genito Urinary System and Sex Hormones, Antirheumatic Agents, Non COX-2 selective NSAIDS, Peripheral Nervous System Agents, Heterocyclic Compounds, Fused-Ring, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Musculo-Skeletal System, Propionates, Agents that produce hypertension, Central Nervous System Agents	experimental	0
DB14648	Acetyl simvastatin	Drug	0	experimental	0
DB02663	2-Amino-4-(Hydroxymethyl-Phosphinyl)Butanoic Acid	Drug	0	experimental	1
DB01332	Ceftizoxime	Drug	Nephrotoxic agents, Third-Generation Cephalosporins, Cephacetrile, Amides, Lactams, OAT1/SLC22A6 Substrates, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, OAT1/SLC22A6 inhibitors, OAT3/SLC22A8 Substrates, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, OAT3/SLC22A8 Inhibitors, Antibacterials for Systemic Use	approved, withdrawn	4
DB03995	Betadex	Drug	Food Additives, Carbohydrates, Dietary Carbohydrates, Starch, Cyclodextrins, Biopolymers, Macromolecular Substances, Polysaccharides, Physiological Phenomena, Food and Beverages, Glucans, Sequestering Agents, Food Ingredients, Dextrins, Polymers, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food	experimental	3
DB03996	3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol	Drug	0	experimental	1
DB01331	Cefoxitin	Drug	Nephrotoxic agents, Second-Generation Cephalosporins, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Cephamycins, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Antibacterials for Systemic Use	approved	12
DB02662	Novo Nordisk a/S Compound	Drug	0	experimental	1
DB00001	Lepirudin	Drug	Anticoagulants, Enzyme Inhibitors, Blood and Blood Forming Organs, Peptides, Fibrin Modulating Agents, Protease Inhibitors, Serpins, Amino Acids, Peptides, and Proteins, Hematologic Agents, Cardiovascular Agents, Proteins, Antithrombins, Thrombin Inhibitors, Antithrombin Proteins, Serine Protease Inhibitors	approved	1
DB01330	Cefotetan	Drug	Nephrotoxic agents, Second-Generation Cephalosporins, Amides, Lactams, Tetrazoles, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Cephamycins, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Antibacterials for Systemic Use	approved	1
DB03997	L-histidinol phosphate	Drug	0	experimental	2
DB02661	Adenosine-5'-diphosphate-2',3'-vanadate	Drug	Vanadates	experimental	1
DB03998	[2-(Methyleneamine)-4-(4-Hydroxy-Benzylidine)-5-Oxo-4,5-Dihydro-Imidazol-1-Yl]-Acetaldehyde	Drug	0	experimental	0
DB02660	Filaminast	Drug	Amines, Hydroxylamines	experimental	1
DB02667	Factor IIIm	Drug	0	experimental	1
DB03991	2-deoxy-2,3-dehydro-N-acetylneuraminic acid	Drug	Amino Sugars, Neuraminidase, antagonists & inhibitors, Acids, Acyclic, Carbohydrates, Enzyme Inhibitors, Hydroxy Acids, Neuraminic Acids, Sugar Acids, Sialic Acids	experimental	5
DB01336	Metocurine	Drug	Curare Alkaloids, Neuromuscular Agents, Drugs, Chinese Herbal, Amines, Ammonium Compounds, Benzylisoquinolines, Isoquinolines, Quaternary Ammonium Compounds, Neuromuscular-Blocking Agents (Nondepolarizing), Agents producing tachycardia, Onium Compounds, Muscarinic Antagonists, Muscle Relaxants, Nicotinic Antagonists, Peripheral Nervous System Agents, Anticholinergic Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Muscle Relaxants, Peripherally Acting Agents, Central Nervous System Depressants, Musculo-Skeletal System, Neuromuscular Blocking Agents, Tetrahydroisoquinolines, Nitrogen Compounds	approved	2
DB00004	Denileukin diftitox	Drug	Biological Factors, Enzymes, Cytokines, Peptides, Antineoplastic and Immunomodulating Agents, Intercellular Signaling Peptides and Proteins, Transferases, Glycosyltransferases, Antineoplastic Agents, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Recombinant Proteins, CD25-directed Cytotoxin, Lymphokines, Proteins, Toxins, Biological, Narrow Therapeutic Index Drugs, Interleukins, Bacterial Toxins, ADP Ribose Transferases, Pentosyltransferases	approved, investigational	3
DB03992	3-(Benzoylamino)-L-Alanine	Drug	0	experimental	0
DB00005	Etanercept	Drug	Immunologic Factors, Peptide Fragments, Receptors, Cytokine, Immunosuppressive Agents, Peptides, Anti-Inflammatory Agents, Antibodies, Amino Acids, Peptides, and Proteins, Receptors, Cell Surface, Disease-modifying Antirheumatic Agents, Immunoglobulin Fragments, Immunoproteins, Proteins, Complex Mixtures, Tumor Necrosis Factor Receptor Blocking Activity, Biological Products, Biologics for Rheumatoid Arthritis Treatment, Tumor Necrosis Factor Alpha (TNF-α) Inhibitors, Dermatologicals, Immunoglobulin Fc Fragments, Immunoglobulin Isotypes, Antirheumatic Agents, Agents reducing cytokine levels, Membrane Proteins, Serum Globulins, Receptors, Tumor Necrosis Factor, Immunoglobulin Constant Regions, Receptors, Immunologic, Tumor Necrosis Factor Blocker	approved, investigational	9
DB02666	(C8-R)-hydantocidin 5'-phosphate	Drug	0	experimental	1
DB02665	(1R,2S)-2-Phenylcyclopropanaminium	Drug	0	experimental	1
DB03993	Isocaproic acid	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Lipids	experimental	1
DB00002	Cetuximab	Drug	Immunoglobulins, Antineoplastic and Immunomodulating Agents, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, HER1 Antagonists, Immunoproteins, Proteins, Serum Globulins, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, Narrow Therapeutic Index Drugs, Globulins, Blood Proteins, Epidermal Growth Factor Receptor Antagonist	approved	8
DB01333	Cefradine	Drug	Nephrotoxic agents, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, MATE 1 Substrates, Amides, Lactams, Thiazines, beta-Lactams, Cytochrome P-450 CYP3A4 Inducers (strength unknown), First-Generation Cephalosporins, Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, OAT1/SLC22A6 inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Cytochrome P-450 Enzyme Inducers, Sulfur Compounds, Cephalosporins, MATE substrates, Antibacterials for Systemic Use	approved	1
DB00003	Dornase alfa	Drug	Enzymes, Recombinant Human Deoxyribonuclease 1, Decreased Respiratory Secretion Viscosity, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Esterases, Deoxyribonucleases, Proteins, Endodeoxyribonucleases, Cough and Cold Preparations, Expectorants, Endonucleases, Hydrolases	approved	1
DB02664	1-Butane Boronic Acid	Drug	0	experimental	1
DB03994	Ethanolamine	Drug	Amines, Sclerosing Activity, Sclerosing Solutions, Amino Alcohols, Ethanolamines, Vascular Sclerosing Activity, Alcohols	experimental	2
DB00008	Peginterferon alfa-2a	Drug	Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Peptides, Interferons, Interferon alpha, Amino Acids, Peptides, and Proteins, Cardiotoxic antineoplastic agents, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Anti-Infective Agents, Alcohols, Drug Carriers, Cytochrome P-450 CYP1A2 Inhibitors, Proteins, Ethylene Glycols, Hepatotoxic Agents, Polymers, Compounds used in a research, industrial, or household setting, Biological Factors, Cytokines, Adjuvants, Immunologic, Antineoplastic and Immunomodulating Agents, Intercellular Signaling Peptides and Proteins, Antineoplastic Agents, Alfa Interferons, Antiviral Agents, Interferon Type I, Macromolecular Substances, Myelosuppressive Agents, Narrow Therapeutic Index Drugs, Pegylated agents, Glycols	approved, investigational	2
DB01339	Vecuronium	Drug	Neuromuscular Agents, Androstanols, P-glycoprotein substrates, Neuromuscular-Blocking Agents (Nondepolarizing), Muscle Relaxants, Nicotinic Antagonists, Fused-Ring Compounds, Peripheral Nervous System Agents, Anticholinergic Agents, Neurotransmitter Agents, Androstanes, Cholinergic Agents, Neuromuscular Nondepolarizing Blockade, Muscle Relaxants, Peripherally Acting Agents, Central Nervous System Depressants, Musculo-Skeletal System, Neuromuscular Blocking Agents, Steroids	approved, investigational	1
DB00009	Alteplase	Drug	Anticoagulants, Biological Factors, Enzymes, Blood and Blood Forming Organs, Plasminogen Activators, Fibrin Modulating Agents, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Hematologic Agents, Cardiovascular Agents, Fibrinolytic Agents, Ophthalmologicals, Proteins, Tissue Plasminogen Activator, Blood Proteins, Serine Proteases, Tissue Plasminogen Activator, antagonists & inhibitors, Hydrolases, Agents causing angioedema, Peptide Hydrolases, Sensory Organs, Serine Endopeptidases, Endopeptidases	approved	4
DB00006	Bivalirudin	Drug	Anticoagulants, Enzyme Inhibitors, Blood and Blood Forming Organs, Peptides, Protease Inhibitors, Serpins, Amino Acids, Peptides, and Proteins, Hematologic Agents, Proteins, Antithrombins, Thrombin Inhibitors, Antithrombin Proteins, Serine Protease Inhibitors	approved, investigational	1
DB01338	Pipecuronium	Drug	Neuromuscular Agents, Cholinesterase Inhibitors, Piperazines, Neuromuscular-Blocking Agents (Nondepolarizing), Agents producing tachycardia, Muscarinic Antagonists, Muscle Relaxants, Nicotinic Antagonists, Peripheral Nervous System Agents, Anticholinergic Agents, Neurotransmitter Agents, Cholinergic Agents, Muscle Relaxants, Peripherally Acting Agents, Central Nervous System Depressants, Musculo-Skeletal System, Neuromuscular Blocking Agents	approved	3
DB02669	RB106	Drug	0	experimental	2
DB00007	Leuprolide	Drug	Endocrine Therapy, QTc Prolonging Agents, Oligopeptides, Peptides, Adrenal Cortex Hormones, Gonadotropin Releasing Hormone Receptor Agonists, Amino Acids, Peptides, and Proteins, Neuropeptides, Hormones, Pituitary Hormone-Releasing Hormones, Drugs that are Mainly Renally Excreted, Proteins, Hormones and Related Agents, Peptide Hormones, Gonadotropin-releasing hormone agonist, Drugs causing inadvertant photosensitivity, Antineoplastic Agents, Hormonal, Antineoplastic and Immunomodulating Agents, Reproductive Control Agents, Fertility Agents, Female, Antineoplastic Agents, Gonadotropins, Nerve Tissue Proteins, Moderate Risk QTc-Prolonging Agents, Fertility Agents, Gonadotropin Releasing Hormone Receptor Agonist, Photosensitizing Agents, Agents Causing Muscle Toxicity, Hypothalamic Hormones, Hyperglycemia-Associated Agents	approved, investigational	1
DB01337	Pancuronium	Drug	Neuromuscular Agents, OCT1 substrates, Androstanols, Cholinesterase Inhibitors, Neuromuscular-Blocking Agents (Nondepolarizing), OCT1 inhibitors, Agents producing tachycardia, Muscarinic Antagonists, Muscle Relaxants, Nicotinic Antagonists, Fused-Ring Compounds, Peripheral Nervous System Agents, Anticholinergic Agents, Neurotransmitter Agents, Androstanes, Cholinergic Agents, Neuromuscular Nondepolarizing Blockade, Muscle Relaxants, Peripherally Acting Agents, Central Nervous System Depressants, Musculo-Skeletal System, Neuromuscular Blocking Agents, Steroids	approved	3
DB02668	JE-2147	Drug	Sulfur Compounds, Oligopeptides, Peptides, Acids, Carbocyclic, Amino Acids, Peptides, and Proteins, Antiviral Agents, HIV Protease Inhibitors	experimental	1
DB03999	Butylphosphonate	Drug	0	experimental	1
DB12077	Urelumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	1
DB12076	Surotomycin	Drug	Peptides, Amino Acids, Peptides, and Proteins, Lipids	investigational	0
DB12079	Gefarnate	Drug	Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Fatty Acids, Unsaturated, Fatty Acids, Alimentary Tract and Metabolism, Lipids, Anti-Ulcer Agents, Drugs for Acid Related Disorders, Terpenes, Gastrointestinal Agents	investigational	0
DB12078	Enobosarm	Drug	Amines, Aniline Compounds, Amides	investigational	0
DB00091	Cyclosporine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Nephrotoxic agents, Immunologic Factors, BSEP/ABCB11 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Peptides, Anti-Inflammatory Agents, Calcineurin Inhibitor Immunosuppressant, Cyclosporins, Agents causing hyperkalemia, Cytochrome P-450 CYP3A4 Inhibitors (moderate), OATP1B3 inhibitors, Amino Acids, Peptides, and Proteins, BSEP/ABCB11 Substrates, Cytochrome P-450 CYP2C19 Inhibitors, OAT1/SLC22A6 Substrates, Agents that produce neuromuscular block (indirect), Cytochrome P-450 CYP3A4 Substrates, Calcineurin Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (moderate), P-glycoprotein substrates with narrow therapeutic index, Agents that reduce seizure threshold, Neurotoxic agents, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Dermatologicals, Antirheumatic Agents, BCRP/ABCG2 Inhibitors, Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index, OAT1/SLC22A6 inhibitors, Ophthalmologicals, Peptides, Cyclic, Cytochrome P-450 CYP3A Inhibitors, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Agents that produce hypertension, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, OATP1B1/SLCO1B1 Substrates, P-glycoprotein inhibitors	approved, investigational, vet_approved	4
DB00092	Alefacept	Drug	Carbohydrates, Immunologic Factors, Immunosuppressive Agents, Glycoconjugates, Antineoplastic and Immunomodulating Agents, Dermatologicals, Immunoglobulin Isotypes, Antibodies, Amino Acids, Peptides, and Proteins, CD2-directed LFA-3/Fc Fusion Protein, Glycoproteins, Recombinant Proteins, Selective Immunosuppressants, Recombinant Fusion Proteins, Immunoproteins, Membrane Proteins, Proteins, Serum Globulins, Globulins, Blood Proteins, CD2-directed Antibody Interactions, CD58 Antigens, Membrane Glycoproteins	approved, investigational, withdrawn	3
DB00090	Laronidase	Drug	Enzymes, Alimentary Tract and Metabolism, Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme	approved	1
DB00095	Efalizumab	Drug	CD11a-directed Antibody Interactions, Immunoglobulins, Immunosuppressive Agents, CD11 Antigens, Antineoplastic and Immunomodulating Agents, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Cell Migration Inhibition, Selective Immunosuppressants, Immunoproteins, Proteins, Serum Globulins, CD11a-directed Humanized IgG1 Antibody, Globulins, Blood Proteins	approved, investigational	2
DB00093	Felypressin	Drug	Vasopressin and Analogues, Hormones, Hormone Substitutes, and Hormone Antagonists, Oligopeptides, Peptides, Pituitary Hormones, Amino Acids, Peptides, and Proteins, Neuropeptides, Cardiovascular Agents, Nerve Tissue Proteins, Hormones, Proteins, Peptide Hormones, Vasoconstrictor Agents, Pituitary Hormones, Posterior, Vasopressins	experimental	1
DB00094	Urofollitropin	Drug	Sex Hormones and Modulators of the Genital System, Gonadotropins and Antigonadotropins, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pituitary Hormones, Genito Urinary System and Sex Hormones, Amino Acids, Peptides, and Proteins, Gonadotropins, Hormones, Gonadotropins, Pituitary, Peptide Hormones, Complex Mixtures, Biological Products, Pituitary Hormones, Anterior	approved, vet_approved	1
DB00099	Filgrastim	Drug	Biological Factors, Increased Myeloid Cell Production, Glycoconjugates, Peptides, Antineoplastic and Immunomodulating Agents, Granulocyte Colony-Stimulating Factors, Amino Acids, Peptides, and Proteins, Hematologic Agents, Glycoproteins, Hematopoietic Cell Growth Factors, Proteins, Leukocyte Growth Factor, Colony-Stimulating Factors	approved	2
DB00097	Choriogonadotropin alfa	Drug	Sex Hormones and Modulators of the Genital System, Gonadotropins and Antigonadotropins, Genito Urinary System and Sex Hormones, Gonadotropins	approved	2
DB00098	Antithymocyte immunoglobulin (rabbit)	Drug	Immunologic Factors, Immunosuppressive Agents, Immune Sera, Immunoglobulin G, Antibodies, Amino Acids, Peptides, and Proteins, Hemic and Immune Systems, Selective Immunosuppressants, Blood, Immunoproteins, Proteins, Complex Mixtures, Biological Products, Serum, Fluids and Secretions, Antibody-Surface Protein Interactions, Immunoglobulins, Miscellaneous Therapeutic Agents, Antineoplastic and Immunomodulating Agents, Increased T Lymphocyte Destruction, Serum Globulins, Globulins, Blood Proteins, Lymphocyte Function Alteration, Body Fluids	approved	9
DB12071	Vabicaserin	Drug	Heterocyclic Compounds, Fused-Ring, Serotonin Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Serotonin Receptor Agonists, Antidepressive Agents, Serotonin 5-HT2 Receptor Agonists, Serotonin 5-HT2C Receptor Agonists	investigational	0
DB12070	Letermovir	Drug	Acids, Acyclic, BSEP/ABCB11 Inhibitors, Cytochrome P-450 Substrates, Fatty Acids, Cytochrome P-450 Enzyme Inhibitors, UGT1A3 substrates, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Lipids, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), OATP1B3 substrates, Cytochrome P-450 CYP2C19 Inducers (moderate), Cytochrome P-450 CYP2C9 Inducers (strength unknown), Cytochrome P-450 CYP3A7 Inhibitors (strength unknown), Antivirals for Systemic Use, Direct Acting Antivirals, Cytochrome P-450 Enzyme Inducers, Organic Anion Transporting Polypeptide 1B3 Inhibitors, Cytochrome P-450 CYP2C19 Inducers, Fatty Acids, Volatile, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), DNA Terminase Complex Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Cytomegalovirus DNA Terminase Complex Inhibitor, Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, Cytochrome P-450 CYP3A5 Inhibitors, BCRP/ABCG2 Inhibitors, Antiviral Agents, Organic Anion Transporting Polypeptide 1B1 Inhibitors, Antiinfectives for Systemic Use, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A7 Inhibitors, UGT1A1 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, OATP1B1/SLCO1B1 Substrates, Cytochrome P-450 CYP2C9 Inducers, Cytochrome P-450 CYP2D6 Substrates, OAT3/SLC22A8 Inhibitors, P-glycoprotein inhibitors	approved, investigational	3
DB12073	Albaconazole	Drug	Heterocyclic Compounds, Fused-Ring, Azole Antifungals, Stereoisomerism, Triazoles, Antifungal Agents, Anti-Infective Agents	investigational	0
DB12072	Orantinib	Drug	Acids, Acyclic, Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Protein Kinase Inhibitors, Fatty Acids, Fatty Acids, Volatile, Lipids	investigational	0
DB12075	Nagrestipen	Drug	Proteins, Biological Factors, Inflammation Mediators, Cytokines, Peptides, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Chemotactic Factors, Chemokines	investigational	0
DB12074	Censavudine	Drug	Carbohydrates, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Glycosides, Nucleosides, Deoxyribonucleosides, Reverse Transcriptase Inhibitors, Anti-HIV Agents	investigational	0
DB12088	TT-232	Drug	Proteins, Peptide Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pancreatic Hormones, Hypothalamic Hormones, Pituitary Hormone Release Inhibiting Hormones, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Hormones	investigational	0
DB12087	Vanillyl alcohol	Drug	Benzyl Compounds, Benzene Derivatives, Alcohols	investigational	0
DB12089	Lorvotuzumab mertansine	Drug	Antineoplastic Agents, Phytogenic, Cytochrome P-450 Enzyme Inhibitors, Antibodies, Amides, Amino Acids, Peptides, and Proteins, Lactams, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Immunoproteins, Lactones, Lactams, Macrocyclic, Proteins, Antineoplastic Agents, Immunological, Anti-Bacterial Agents, Immunoglobulins, Noxae, Macrolides, Antineoplastic Agents, Serum Globulins, Immunotoxins, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Globulins, Immunoconjugates, Blood Proteins, Cytochrome P-450 CYP3A4 Inhibitors, Toxic Actions	investigational	0
DB12080	Ritobegron	Drug	Acids, Acyclic, Amines, Fatty Acids, Agents producing tachycardia, Lipids, Phenethylamines, Adrenergic beta-Agonists, Neurotransmitter Agents, Ethylamines, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Sympathomimetics, Fatty Acids, Volatile, Adrenergic Agonists, Agents that produce hypertension, Amphetamines, Adrenergic Agents, Adrenergic beta-3 Receptor Agonists	investigational	0
DB12082	Vesnarinone	Drug	Cardiotonic Agents, Heterocyclic Compounds, Fused-Ring, Immunologic Factors, Phosphodiesterase Inhibitors, Enzyme Inhibitors, Adjuvants, Immunologic, Protective Agents, Antineoplastic Agents, Cardiovascular Agents, Compounds used in a research, industrial, or household setting, Anti-Infective Agents	investigational	0
DB12081	Anecortave	Drug	Pregnenediones, Hormones, Hormone Substitutes, and Hormone Antagonists, Adrenal Cortex Hormones, Antineoplastic Agents, Growth Inhibitors, Angiogenesis Modulating Agents, Antineovascularisation Agents, Hormones, Ocular Vascular Disorder Agents, Angiogenesis Inhibitors, Fused-Ring Compounds, Hydroxycorticosteroids, Ophthalmologicals, Pregnanes, 11-Hydroxycorticosteroids, Sensory Organs, Growth Substances, 17-Hydroxycorticosteroids, Pregnenes, Steroids	investigational	0
DB12084	ADP-597	Drug	0	investigational	0
DB12083	Mafosfamide	Drug	Immunologic Factors, Adjuvants, Immunologic, Antineoplastic Agents, Organophosphorus Compounds, Hydrocarbons, Halogenated, Ions, Mustard Compounds, Nitrogen Mustard Compounds, Phosphorus Compounds, Phosphorus Acids, Anions, Acids, Noncarboxylic, Acids, Phosphoric Acids, Phosphoramides, Electrolytes, Phosphoramide Mustards	investigational	0
DB12086	Oxitropium	Drug	Anticholinergic Agents, Autonomic Agents, Alkaloids, Synthetic Anticholinergics, Quaternary Ammonium Compounds, Tropanes, Aza Compounds, Agents producing tachycardia, Parasympatholytics, Azabicyclo Compounds, Drugs for Obstructive Airway Diseases, Muscarinic Antagonists, Peripheral Nervous System Agents	investigational	0
DB12085	LCL-161	Drug	Proto-Oncogene Proteins c-bcl-2, antagonists & inhibitors, Sulfur Compounds, Antineoplastic Agents	investigational	0
DB12099	UK-396,082	Drug	Amino Acids, Peptides, and Proteins	investigational	0
DB12098	L-Baclofen	Drug	0	investigational	0
DB12091	Gadolinium	Drug	Lanthanoid Series Elements, Contrast Media, Diagnostic Uses of Chemicals, Anti-Inflammatory Agents, Metals, Elements, Compounds used in a research, industrial, or household setting, Metals, Rare Earth	approved, investigational	0
DB12090	Patritumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB12093	Tetrahydropalmatine	Drug	QTc Prolonging Agents, Tranquilizing Agents, Benzylisoquinolines, Cytochrome P-450 Substrates, Sensory System Agents, Isoquinolines, Agents causing hyperkalemia, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Peripheral Nervous System Agents, Alkaloids, Antipsychotic Agents, Analgesics, Calcium-Regulating Hormones and Agents, Potential QTc-Prolonging Agents, Antihypertensive Agents, Dopamine Antagonists, Adrenergic Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Dopamine Agents, Neurotoxic agents, Analgesics, Non-Narcotic, Psychotropic Drugs, Membrane Transport Modulators, Calcium Channel Blockers, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Central Nervous System Agents, Vasodilating Agents, Dopamine D2 Receptor Antagonists	investigational	2
DB12092	Naftopidil	Drug	Cytochrome P-450 Substrates, Adrenergic alpha-Antagonists, Agents causing hyperkalemia, Hematologic Agents, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Membrane Transport Modulators, Calcium Channel Blockers, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Adrenergic Antagonists, Agents that produce hypertension, Calcium-Regulating Hormones and Agents, Antihypertensive Agents, Vasodilating Agents, Adrenergic Agents, Antiplatelet agents, Bradycardia-Causing Agents, Antiarrhythmic agents	investigational	0
DB12095	Telotristat ethyl	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Antidiarrheals, Amino Acids, Essential, Tryptophan Hydroxylase Inhibitor, Amino Acids, Peptides, and Proteins, Amino Acids	approved, investigational	2
DB12094	Semapimod	Drug	Analgesics, Non-Narcotic, Hydrazines, Immunologic Factors, Sensory System Agents, Analgesics, Anti-Inflammatory Agents, Antirheumatic Agents, Central Nervous System Agents, Peripheral Nervous System Agents	investigational	0
DB12097	Mannitol busulfan	Drug	Agents causing hyperkalemia	approved, investigational	0
DB12096	PF-05175157	Drug	0	investigational	0
DB14696	Influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) live (attenuated) antigen	Drug	0	approved	0
DB13365	Calcium lactate gluconate	Drug	Calcium Salts, Alimentary Tract and Metabolism, Mineral Supplements	experimental	0
DB14697	Influenza B virus B/Colorado/06/2017 live (attenuated) antigen	Drug	0	approved	0
DB13366	Hydrochloric acid	Drug	Acids, Noncarboxylic, Blood and Blood Forming Organs, I.V. Solution Additives, Acids, Alimentary Tract and Metabolism, Digestives, Incl. Enzymes, Acid Preparations, Blood Substitutes and Perfusion Solutions, Electrolyte Solutions, Chlorine Compounds	experimental	0
DB12032	Atagabalin	Drug	Acids, Acyclic, Cycloparaffins, Fatty Acids, Fatty Acids, Volatile, Lipids	investigational	0
DB12035	Sarecycline	Drug	Anti-Acne Preparations for Systemic Use, Anti-Bacterial Agents, Tetracyclines, Dermatologicals, Naphthacenes, P-glycoprotein inhibitors, Anti-Acne Preparations, Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use	approved, investigational	0
DB13363	Oxaceprol	Drug	Acids, Acyclic, Amino Acids, Cyclic, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Imines, Musculo-Skeletal System, Dermatologicals, Antirheumatic Agents, Amino Acids, Peptides, and Proteins, Imino Acids, Amino Acids	experimental	0
DB14694	Beef liver	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB14695	Ferric oxyhydroxide	Drug	Organometallic Compounds, Phosphate Chelating Activity, Phosphate Binder, Iron Compounds	experimental	0
DB12034	Gantenerumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB13364	Feprazone	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Sensory System Agents, Anti-Inflammatory Agents, Pyrazoles, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Antiinflammatory Preparations, Non-Steroids for Topical Use, Topical Products for Joint and Muscular Pain, Pyrazolones, Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Musculo-Skeletal System, Agents that produce hypertension, Central Nervous System Agents	experimental	0
DB13369	Benzilone	Drug	Anticholinergic Agents, Synthetic Anticholinergics, Quaternary Ammonium Compounds, Alimentary Tract and Metabolism, Agents producing tachycardia, Drugs for Functional Gastrointestinal Disorders, Muscarinic Antagonists	experimental	0
DB12037	Vedroprevir	Drug	Heterocyclic Compounds, Fused-Ring, Antiviral Agents	investigational	0
DB12036	Naquotinib	Drug	Enzyme Inhibitors, Protein Kinase Inhibitors, Antineoplastic Agents	investigational	0
DB14698	Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (UV,formaldehyde inactivated)	Drug	0	approved	0
DB13367	Cloricromen	Drug	Heterocyclic Compounds, Fused-Ring, Blood and Blood Forming Organs, Platelet Aggregation Inhibitors Excl. Heparin, Coumarins, Hematologic Agents, Benzopyrans, Antiplatelet agents, Pyrans	experimental	0
DB12039	Epicatechin	Drug	Heterocyclic Compounds, Fused-Ring, Catechin, Flavonoids, Chromans, Benzopyrans, Chromones, Pyrans	investigational	0
DB13368	Motretinide	Drug	Biological Factors, Cycloparaffins, Alkenes, Dermatologicals, Hydrocarbons, Acyclic, Retinoids for Topical Use in Acne, Cyclohexenes, Retinoids, Anti-Acne Preparations, Vitamins, Cyclohexanes, Pigments, Biological, Vitamin A, Carotenoids, Vitamins (Fat Soluble), Polyenes, Terpenes, Anti-Acne Preparations for Topical Use	experimental	0
DB12038	Ulinastatin	Drug	Proteins, Carbohydrates, Enzyme Inhibitors, Glycoconjugates, Protease Inhibitors, Amino Acids, Peptides, and Proteins, Serine Protease Inhibitors, Trypsin Inhibitors	investigational	0
DB14699	Influenza A virus A/Uruguay/716/2007(H3N2) hemagglutinin antigen (UV,formaldehyde inactivated)	Drug	0	approved	0
DB00051	Adalimumab	Drug	Immunoglobulins, Biologics for Rheumatoid Arthritis Treatment, Immunosuppressive Agents, Tumor Necrosis Factor Alpha (TNF-α) Inhibitors, Anti-Inflammatory Agents, Antineoplastic and Immunomodulating Agents, Antibodies, Antirheumatic Agents, Amino Acids, Peptides, and Proteins, Agents reducing cytokine levels, Antibodies, Monoclonal, Disease-modifying Antirheumatic Agents, Immunoproteins, Proteins, Serum Globulins, Antibodies, Monoclonal, Humanized, Complex Mixtures, Globulins, Blood Proteins, Miscellaneous GI Drugs, Tumor Necrosis Factor Receptor Blocking Activity, Biological Products, Immunomodulatory Agents, Tumor Necrosis Factor Blocker	approved	1
DB00052	Somatotropin	Drug	Somatropin and Somatropin Agonists, Growth Hormone, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pituitary Hormones, Human Growth Hormone, antagonists & inhibitors, Pituitary and Hypothalamic Hormones and Analogues, Amino Acids, Peptides, and Proteins, Hormones, Anterior Pituitary Lobe Hormones and Analogues, Peptide Hormones, Agents Causing Muscle Toxicity, Growth Hormone, antagonists & inhibitors, Pituitary, Recombinant Human Growth Hormone, Somatotropin Agonists, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Pituitary Hormones, Anterior	approved, investigational	2
DB01382	Glymidine	Drug	Sulfur Compounds, Alimentary Tract and Metabolism, Gynecological Antiinfectives and Antiseptics, Sulfonamides, Genito Urinary System and Sex Hormones, Amides, Drugs Used in Diabetes, Blood Glucose Lowering Agents, Sulfones	approved, investigational	2
DB01381	Ginkgo biloba	Drug	Cholinesterase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Ginkgolides, Complex Mixtures, Cytochrome P-450 CYP3A Inhibitors, Plant Preparations, Anti-Dementia Drugs, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Biological Products, Pharmaceutical Preparations, Blood Circulation, Psychoanaleptics	approved, investigational, nutraceutical	6
DB01380	Cortisone acetate	Drug	Cytochrome P-450 Substrates, Immunosuppressive Agents, Glucocorticoids, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Adrenals, 17-Hydroxycorticosteroids, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inducers, Corticosteroids for Systemic Use, Corticosteroids, Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP3A4 Inducers, Hydroxycorticosteroids, Cytochrome P-450 CYP3A Substrates, Pregnanes, Hyperglycemia-Associated Agents, Pregnenes, Steroids	approved, investigational	1
DB00050	Cetrorelix	Drug	Gonadotropin-releasing Hormone Antagonists, Hormones, Hormone Substitutes, and Hormone Antagonists, Oligopeptides, Peptides, Gonadotropin Releasing Hormone Receptor Antagonists, Reproductive Control Agents, Fertility Agents, Female, Pituitary and Hypothalamic Hormones and Analogues, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Hormones, Decreased GnRH Secretion, Pituitary Hormone-Releasing Hormones, Fertility Agents, Proteins, Peptide Hormones, Hypothalamic Hormones, Anti-Gonadotropin-Releasing Hormones, Hormone Antagonists, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins	approved, investigational	2
DB00055	Drotrecogin alfa	Drug	Anticoagulants, Biological Factors, Carbohydrates, Enzymes, Blood and Blood Forming Organs, Glycoconjugates, Recombinant Activated Protein C, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Glycoproteins, Fibrinolytic Agents, Anti-Infective Agents, Proteins, Blood Proteins, Enzyme Precursors, Blood Coagulation Factor Inhibitors	approved, investigational, withdrawn	10
DB00056	Gemtuzumab ozogamicin	Drug	Carbohydrates, Immunoglobulins, Immunosuppressive Agents, CD33-directed Cytotoxin, Noxae, Antineoplastic and Immunomodulating Agents, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins, Myelosuppressive Agents, Proteins, Serum Globulins, Antineoplastic Agents, Immunological, Immunotoxins, Narrow Therapeutic Index Drugs, Globulins, Immunoconjugates, Blood Proteins, Glycosides, Hepatotoxic Agents, Toxic Actions, CD33-directed Antibody Interactions	approved, investigational	4
DB00053	Imiglucerase	Drug	Glucosidases, Enzyme Replacement Therapy, Enzymes, Glycoside Hydrolases, Alimentary Tract and Metabolism, Enzymes and Coenzymes, Hydrolases, Gaucher Disease, Recombinant Proteins, Hydrolytic Lysosomal Glucocerebroside-specific Enzyme	approved	1
DB00054	Abciximab	Drug	Anticoagulants, Immunoglobulins, Miscellaneous Therapeutic Agents, Peptide Fragments, Blood and Blood Forming Organs, Peptides, Antibodies, Amino Acids, Peptides, and Proteins, Hematologic Agents, Antibodies, Monoclonal, Fibrinolytic Agents, Immunoglobulin Fragments, Immunoproteins, Proteins, Serum Globulins, Antibodies, Monoclonal, Humanized, Globulins, Platelet Aggregation Inhibitors Excl. Heparin, Blood Proteins, Immunoglobulin Fab Fragments, Antiplatelet agents	approved	5
DB01384	Paramethasone	Drug	Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Glucocorticoids, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Cytochrome P-450 CYP3A5 Inducers, Corticosteroids for Systemic Use, Pregnadienetriols, Corticosteroids, Corticosteroids for Systemic Use, Plain, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Pregnanes, Steroids, Fluorinated, Hyperglycemia-Associated Agents, Steroids	experimental	1
DB00059	Pegaspargase	Drug	Amidohydrolases, Enzymes, Immunosuppressive Agents, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Enzymes and Coenzymes, Enzymes, Immobilized, Alcohols, Macromolecular Substances, Ethylene Glycols, Asparagine-specific Enzyme, Pegylated agents, Hydrolases, Glycols, Thyroxine-binding globulin inhibitors, Polymers, Compounds used in a research, industrial, or household setting, Delayed-Action Preparations, Asparaginase	approved, investigational	1
DB00057	Indium In-111 satumomab pendetide	Drug	Acids, Acyclic, Immunoglobulins, Amines, Fatty Acids, Peptides, Antibodies, Amino Acids, Peptides, and Proteins, Lipids, Polyamines, Acetates, Indium (111In) Compounds, Immunoproteins, Proteins, Serum Globulins, Globulins, Blood Proteins, Fatty Acids, Volatile, Tumour Detection, Diagnostic Radiopharmaceuticals, Indium Radioisotopes	withdrawn, experimental	1
DB01388	Mibefradil	Drug	Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Benzimidazoles, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Agents causing hyperkalemia, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Tetrahydronaphthalenes, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP3A7 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inhibitors, Calcium-Regulating Hormones and Agents, Antihypertensive Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Bradycardia-Causing Agents, Antiarrhythmic agents, Selective Calcium Channel Blockers With Mainly Vascular Effects, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Chemically-Induced Disorders, P-glycoprotein substrates, Cytochrome P-450 CYP3A5 Inhibitors, Moderate Risk QTc-Prolonging Agents, Membrane Transport Modulators, Naphthalenes, Calcium Channel Blockers, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A7 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors, Vasodilating Agents	investigational, withdrawn	11
DB00058	Alpha-1-proteinase inhibitor	Drug	Carbohydrates, Enzymes, Enzyme Inhibitors, Blood and Blood Forming Organs, Glycoconjugates, Peptides, Acute-Phase Proteins, Protease Inhibitors, Serpins, Amino Acids, Peptides, and Proteins, Glycoproteins, Human alpha-1 Proteinase Inhibitor, Antifibrinolytic Agents, Proteins, Serum Globulins, Alpha-Globulins, Globulins, Blood Proteins, Hemostatics, Proteinase Inhibitors, Serine Protease Inhibitors, Trypsin Inhibitors	approved	1
DB14692	Turmeric oil	Drug	0	approved, experimental	0
DB13361	Trimethyldiphenylpropylamine	Drug	Alimentary Tract and Metabolism, Drugs for Functional Gastrointestinal Disorders	experimental	0
DB14693	Atractylodes lancea root	Drug	0	approved, experimental	0
DB13362	Pheneturide	Drug	Anticonvulsants, Nervous System, Central Nervous System Depressants, Central Nervous System Agents	experimental	0
DB12031	Ammonio methacrylate copolymer type A	Drug	0	investigational	0
DB14690	Ginger oil	Drug	0	approved, experimental	0
DB14691	Willow bark	Drug	Herbs and Natural Products	approved, experimental	0
DB12030	Fluorescein lisicol	Drug	Spiro Compounds, Xanthenes, Heterocyclic Compounds, Fused-Ring	investigational	0
DB13360	Tolciclate	Drug	Acids, Acyclic, Sulfur Compounds, Antifungals for Topical Use, Dermatologicals, Antifungals for Dermatological Use, Carbamates, Antifungal Agents, Anti-Infective Agents	experimental	0
DB12044	MK-0893	Drug	Receptors, Glucagon, antagonists & inhibitors, Alanine, Amino Acids, Peptides, and Proteins, Amino Acids	investigational	0
DB13376	Succinimide	Drug	Pyrrolidinones, Genito Urinary System and Sex Hormones, Urologicals, Pyrrolidines, Imides	experimental	0
DB13377	Vinbarbital	Drug	Psycholeptics, Nervous System, Central Nervous System Depressants, Barbiturates, Plain, Hypnotics and Sedatives	experimental	0
DB12043	Sepetaprost	Drug	Ethers, Ethers, Cyclic	investigational	0
DB12046	Atopaxar	Drug	Receptors, Thrombin, antagonists & inhibitors	investigational	0
DB13374	Vincamine	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Vinca Alkaloids, Antineoplastic Agents, Peripheral Vasodilators, Cardiovascular Agents, Antihypertensive Agents, Indoles, Vasodilating Agents, Secologanin Tryptamine Alkaloids, Indole Alkaloids	experimental	0
DB12045	Mericitabine	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Glycosides, Nucleosides, Deoxyribonucleosides	investigational	0
DB13375	Edrecolomab	Drug	Immunologic Factors, Immunoglobulins, Adjuvants, Immunologic, Antineoplastic and Immunomodulating Agents, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins, Proteins, Serum Globulins, Globulins, Blood Proteins	investigational, experimental	0
DB12048	Savolitinib	Drug	Tyrosine Kinase Inhibitors	investigational	0
DB12047	Ganetespib	Drug	HSP90 Heat-Shock Proteins, antagonists & inhibitors	investigational	0
DB13378	Norfenefrine	Drug	Adrenergic alpha-Agonists, Amines, Agents producing tachycardia, Adrenergic and Dopaminergic Agents, Amino Alcohols, Ethanolamines, Phenethylamines, Biogenic Monoamines, Alcohols, Neurotransmitter Agents, Ethylamines, Adrenergic Agonists, Cardiac Stimulants Excl. Cardiac Glycosides, Agents that produce hypertension, Biogenic Amines, Cardiac Therapy, Adrenergic Agents	experimental	0
DB12049	Dasolampanel etibutil	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB13379	Chiniofon	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals	experimental	0
DB01390	Sodium bicarbonate	Drug	Alkalies, Blood and Blood Forming Organs, Bicarbonates, Ions, Carbonic Acid, Blood Substitutes and Perfusion Solutions, Carbon Compounds, Inorganic, Hemodialysis Solution, Irrigating Solutions, Electrolyte Solutions, Salt Solutions, Antacids and Adsorbents, Sodium Compounds, Anions, Gastric Acid Lowering Agents, Urinary Alkalinisers, Acids, Noncarboxylic, I.V. Solution Additives, Acids, Radiographic Contrast Agent, Electrolytes, Carbonates, Antacids	approved	1
DB01394	Colchicine	Drug	Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Tubulin Modulators, Cytochrome P-450 CYP3A Inducers, Mitosis Modulators, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Alkaloids, Cytochrome P-450 Enzyme Inducers, Musculo-Skeletal System, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Cytochrome P-450 CYP2E1 Inducers (strength unknown), Cytochrome P-450 CYP2E1 Inducers, Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inducers, P-glycoprotein inducers, Antigout Preparations, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Antimitotic Agents, Cytochrome P-450 CYP3A4 Inhibitors, Preparations With No Effect on Uric Acid Metabolism, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)	approved	1
DB00062	Albumin human	Drug	Proteins, Serum Albumin, Albumins, Increased Intravascular Volume, Blood Proteins, Cardiac Function, Amino Acids, Peptides, and Proteins, Human Serum Albumin, Blood Derivatives, Osmotic Activity, Diluents, Increased Oncotic Pressure	approved	1
DB01393	Bezafibrate	Drug	Acids, Acyclic, Cytochrome P-450 Substrates, Fatty Acids, Cytochrome P-450 Enzyme Inhibitors, Acids, Carbocyclic, Amides, Hypolipidemic Agents Indicated for Hyperlipidemia, Lipids, Cytochrome P-450 CYP3A4 Substrates, Chlorobenzoates, Phenyl Ethers, Fribic Acid Derivatives, Lipid Modifying Agents, Lipid Modifying Agents, Plain, Butyrates, Cytochrome P-450 CYP2C8 Inhibitors (weak), Fatty Acids, Volatile, Fibric Acids, Ethers, Benzene Derivatives, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), OATP1B1/SLCO1B1 Inhibitors, Hypolipidemic Agents, Benzoates, Noxae, Cytochrome P-450 CYP2C8 Inhibitors, Benzamides and benzamide derivatives, Isobutyrates, Lipid Regulating Agents, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Phenols, Toxic Actions	approved, investigational	7
DB00063	Eptifibatide	Drug	Peptides, Cyclic, Blood and Blood Forming Organs, Peptides, Platelet Aggregation Inhibitors Excl. Heparin, Decreased Platelet Aggregation, Amino Acids, Peptides, and Proteins, Hematologic Agents, Antiplatelet agents	approved, investigational	1
DB00060	Interferon beta-1a	Drug	Biological Factors, Immunologic Factors, Interferon-beta, Cytochrome P-450 Enzyme Inhibitors, Cytokines, Peptides, Adjuvants, Immunologic, Interferons, Recombinant Human Interferon beta, Antineoplastic and Immunomodulating Agents, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Antiviral Agents, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Anti-Infective Agents, Interferon Type I, Cytochrome P-450 CYP1A2 Inhibitors, Proteins, Immunomodulatory Agents	approved, investigational	2
DB01392	Yohimbine	Drug	Cytochrome P-450 Substrates, Serotonin Agents, Genito Urinary System and Sex Hormones, Urologicals, Other Miscellaneous Therapeutic Agents, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Indole Alkaloids, Peripheral Nervous System Agents, Serotonin 5-HT2 Receptor Antagonists, Alkaloids, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Adrenergic Antagonists, Indoles, Dopamine Antagonists, Adrenergic Agents, Autonomic Agents, Adrenergic alpha-Antagonists, Secologanin Tryptamine Alkaloids, Urological Agents, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Mydriatics, Cytochrome P-450 CYP3A Substrates, Drugs Used in Erectile Dysfunction, Central Nervous System Depressants, Agents that produce hypertension, Serotonin Receptor Antagonists, Cytochrome P-450 CYP2D6 Substrates, Adrenergic alpha-2 Receptor Antagonists, P-glycoprotein inhibitors, Dopamine D2 Receptor Antagonists, Serotonin 5-HT1 Receptor Antagonists	approved, investigational, vet_approved	12
DB00061	Pegademase	Drug	Enzymes, Adjuvants, Immunologic, Antineoplastic and Immunomodulating Agents, Enzymes and Coenzymes, Pegylated agents, Bovine Intestinal Adenosine Deaminase, Hydrolases, Severe Combined Immunodeficiency, Nucleoside Deaminases, Aminohydrolases, Drug Carriers	approved	2
DB00066	Follitropin	Drug	Sex Hormones and Modulators of the Genital System, Gonadotropins and Antigonadotropins, Thyroid Products, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pituitary Hormones, Genito Urinary System and Sex Hormones, Amino Acids, Peptides, and Proteins, Gonadotropins, Follicle Stimulating Hormone, Hormones, Chorionic Gonadotropin, Pregnancy Proteins, Proteins, Gonadotropins, Pituitary, Peptide Hormones, Placental Hormones, Pituitary Hormones, Anterior	approved	1
DB00067	Vasopressin	Drug	Oligopeptides, Peptides, Arginine Vasopressin, antagonists & inhibitors, Amino Acids, Peptides, and Proteins, Neuropeptides, Cardiovascular Agents, Hormones, Proteins, Peptide Hormones, Vasopressins, antagonists & inhibitors, Hemostatics, Antidiuretic Agents, Vasopressins, Arginine Vasopressin, analogs & derivatives, Vasopressin and Analogues, Arginine Vasopressin, agonists, Hormones, Hormone Substitutes, and Hormone Antagonists, Arginine Vasopressin, Pituitary Hormones, Hematologic Agents, Coagulants, Nerve Tissue Proteins, Vasoconstrictor Agents, Pituitary, Natriuretic Agents, Pituitary Hormones, Posterior	approved	3
DB01397	Magnesium salicylate	Drug	Nephrotoxic agents, Enzyme Inhibitors, Sensory System Agents, Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Non COX-2 selective NSAIDS, Peripheral Nervous System Agents, Metal cations, Analgesics, Benzene Derivatives, Magnesium Salts, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Benzoates, Hydroxy Acids, Antirheumatic Agents, Hydroxybenzoates, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Metal divalent cations, Agents that produce hypertension, Phenols, Central Nervous System Agents, Magnesium Compounds	experimental	2
DB01396	Digitoxin	Drug	Carbohydrates, Cardanolides, Cardiac Glycosides, QTc Prolonging Agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Protective Agents, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cardiotonic Agents, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Digitalis Glycosides, Glycosides, Cardenolides, Potential QTc-Prolonging Agents, P-glycoprotein substrates with narrow therapeutic index, Cardiac Therapy, Compounds used in a research, industrial, or household setting, Antiarrhythmic agents, Steroids	approved, investigational	1
DB01395	Drospirenone	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Adrenal Cortex Hormones, Agents causing hyperkalemia, Genito Urinary System and Sex Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Androstanes, Contraceptives, Oral, Progesterone Congeners, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Progestins, Diuretics, Natriuretic Agents, Combination Contraceptives (with Estrogen and derivatives), Hormone Antagonists, Hormonal Contraceptives for Systemic Use, Hyperglycemia-Associated Agents, Mineralocorticoid Receptor Antagonists, Contraceptive Agents, Female, Progestin Contraceptives, Steroids	approved	4
DB00065	Infliximab	Drug	Immunoglobulins, Biologics for Rheumatoid Arthritis Treatment, Immunosuppressive Agents, Tumor Necrosis Factor Alpha (TNF-α) Inhibitors, Antineoplastic and Immunomodulating Agents, Dermatologicals, Antibodies, Antirheumatic Agents, Amino Acids, Peptides, and Proteins, Agents reducing cytokine levels, Antibodies, Monoclonal, Disease-modifying Antirheumatic Agents, Immunoproteins, Proteins, Serum Globulins, Complex Mixtures, Globulins, Agents Causing Muscle Toxicity, Blood Proteins, Tumor Necrosis Factor Receptor Blocking Activity, Biological Products, Tumor Necrosis Factor Blocker, Gastrointestinal Agents	approved	1
DB00068	Interferon beta-1b	Drug	Biological Factors, Immunologic Factors, Immunosuppressive Agents, Interferon-beta, Cytochrome P-450 Enzyme Inhibitors, Cytokines, Peptides, Adjuvants, Immunologic, Interferons, Recombinant Human Interferon beta, Antineoplastic and Immunomodulating Agents, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Interferon Type I, Myelosuppressive Agents, Cytochrome P-450 CYP1A2 Inhibitors, Proteins, Immunomodulatory Agents	approved	2
DB01399	Salsalate	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Benzoates, Hydroxy Acids, Sensory System Agents, Nervous System, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Antirheumatic Agents, Hydroxybenzoates, Non COX-2 selective NSAIDS, Peripheral Nervous System Agents, Analgesics, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Agents that produce hypertension, Phenols, Central Nervous System Agents, Salicylic Acid and Derivatives, Benzene Derivatives	approved	2
DB00069	Interferon alfacon-1	Drug	Biological Factors, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Cytokines, Peptides, Adjuvants, Immunologic, Interferons, Antineoplastic and Immunomodulating Agents, Intercellular Signaling Peptides and Proteins, Interferon alpha, Alfa Interferons, Amino Acids, Peptides, and Proteins, Antiviral Agents, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Anti-Infective Agents, Interferon Type I, Myelosuppressive Agents, Cytochrome P-450 CYP1A2 Inhibitors, Proteins	approved, investigational	2
DB13372	Calcium alginate	Drug	Blood and Blood Forming Organs, Local Hemostatics, Hemostatics, Compounds used in a research, industrial, or household setting	approved, experimental	0
DB12040	2-octyl cyanoacrylate	Drug	Acids, Acyclic, Acrylates, Equipment and Supplies, Nitriles, Surgical Equipment, Polymers, Tissue Adhesives, Compounds used in a research, industrial, or household setting, Surgical Fixation Devices, Macromolecular Substances	investigational	0
DB13373	Acriflavinium chloride	Drug	Throat Preparations, Anti-Infective Agents, Local	experimental	0
DB13370	Bromisoval	Drug	Psycholeptics, Nervous System, Central Nervous System Depressants, Hypnotics and Sedatives, Central Nervous System Agents	experimental	0
DB12042	Ibodutant	Drug	Sulfur Compounds, Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins, Receptors, Neurokinin-2, antagonists & inhibitors	investigational	0
DB12041	Mapracorat	Drug	Heterocyclic Compounds, Fused-Ring, Lipids, Receptors, Glucocorticoid, agonists, Fatty Alcohols, Alcohols	investigational	0
DB13371	Difenpiramide	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Acids, Acyclic, Acetic Acid Derivatives and Related Substances, Fatty Acids, Sensory System Agents, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Amides, Lipids, Acetates, Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Fatty Acids, Volatile, Musculo-Skeletal System, Agents that produce hypertension, Central Nervous System Agents	experimental	0
DB12055	MK-0767	Drug	Sulfur Compounds	investigational	0
DB13387	Hematin	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Blood and Blood Forming Organs, Heme, Metalloporphyrins, Pigments, Biological, Porphyrins	experimental	0
DB12054	BQ-123	Drug	Peptides, Amino Acids, Peptides, and Proteins, Cardiovascular Agents, Antihypertensive Agents, Endothelin Receptor Antagonists	investigational	0
DB13388	Phenylmercuric nitrate	Drug	Medicated Dressings With Antiinfectives, Medicated Dressings, Dermatologicals	experimental	0
DB13385	Dihydroergocryptine	Drug	Ergot-derivative Dopamine Receptor Agonists, Cytochrome P-450 Substrates, Nervous System, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Anti-Parkinson Drugs, Dopamine Agonists, Ergot Alkaloids and Derivatives, Ergotamines, Alkaloids, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Agents that produce hypertension, Vasodilating Agents, Dopamine Agents	experimental	0
DB12057	ORM-12741	Drug	Heterocyclic Compounds, Fused-Ring, Quinolizines, Adrenergic alpha-Antagonists, Adrenergic Antagonists, Adrenergic alpha-2 Receptor Antagonists	investigational	0
DB13386	Epimestrol	Drug	Sex Hormones and Modulators of the Genital System, Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, Estrenes, Estrogens, Genito Urinary System and Sex Hormones, Hormones, Ovulation Stimulants, Synthetic, Fused-Ring Compounds, Steroids	experimental	0
DB12056	Trebananib	Drug	Proteins, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Growth Inhibitors, Angiogenesis Modulating Agents, Recombinant Proteins, Growth Substances, Angiogenesis Inhibitors	investigational	0
DB12059	JNJ-40411813	Drug	Pyridines	investigational	0
DB12058	Recoflavone	Drug	Heterocyclic Compounds, Fused-Ring, Benzopyrans, Chromones, Pyrans	investigational	0
DB13389	Iopydol	Drug	Contrast Media, Non-Watersoluble X-Ray Contrast Media, X-Ray Contrast Media, Iodinated	experimental	0
DB00070	Hyaluronidase (ovine)	Drug	Enzymes, Glycoside Hydrolases	approved, investigational	2
DB00073	Rituximab	Drug	Immunologic Factors, Immunoglobulins, Antibodies, Monoclonal, Murine-Derived, Biologics for Rheumatoid Arthritis Treatment, Immunosuppressive Agents, Antibodies, Antineoplastic Agents, Antirheumatic Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins, Myelosuppressive Agents, Proteins, Serum Globulins, Antineoplastic Agents, Immunological, CD20-directed Cytolytic Antibody, Narrow Therapeutic Index Drugs, Globulins, Blood Proteins, CD20-directed Antibody Interactions	approved	1
DB00074	Basiliximab	Drug	Immunologic Factors, Interleukin-2 Receptor Blocking Antibody, Immunoglobulins, Immunosuppressive Agents, Interleukin 2 Receptor-directed Antibody Interactions, Antineoplastic and Immunomodulating Agents, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Interleukin Inhibitors, Immunoproteins, Proteins, Serum Globulins, Antibodies, Monoclonal, Humanized, Globulins, Blood Proteins, Interleukin-2 Receptor Antagonist	approved, investigational	2
DB00071	Insulin pork	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pancreatic Hormones, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Amino Acids, Peptides, and Proteins, Insulins and Analogues for Injection, Fast-Acting, Blood Glucose Lowering Agents, Hormones, Insulin, Proteins, Cytochrome P-450 Enzyme Inducers, Peptide Hormones, Insulin, Short-Acting, Alimentary Tract and Metabolism, Protein Precursors, Cytochrome P-450 CYP1A2 Inducers, Drugs Used in Diabetes	approved	14
DB00072	Trastuzumab	Drug	Immunoglobulins, Immunosuppressive Agents, Antineoplastic and Immunomodulating Agents, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Cardiotoxic antineoplastic agents, Antibodies, Monoclonal, HER2/Neu/cerbB2 Antagonists, Immunoproteins, Proteins, Serum Globulins, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, Narrow Therapeutic Index Drugs, Globulins, Blood Proteins, HER2 Receptor Antagonist	approved, investigational	1
DB00078	Ibritumomab tiuxetan	Drug	Immunoglobulins, Antigens, CD20, Immunosuppressive Agents, Therapeutic Radiopharmaceuticals, Antibodies, Amino Acids, Peptides, and Proteins, Radiopharmaceutical Activity, Lymphoma, B-Cell, Immunoproteins, Myelosuppressive Agents, Proteins, Serum Globulins, Globulins, Blood Proteins, CD20-directed Antibody Interactions, CD20-directed Radiotherapeutic Antibody, Yttrium Radioisotopes, Various Therapeutic Radiopharmaceuticals	approved, investigational	1
DB00075	Muromonab	Drug	Immunologic Factors, Immunoglobulins, Antibodies, Monoclonal, Murine-Derived, Immunosuppressive Agents, Antineoplastic and Immunomodulating Agents, Immunoglobulin G, Immunoglobulin Isotypes, CD3-directed Antibody Interactions, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Selective Immunosuppressants, Immunoproteins, Proteins, Serum Globulins, CD3 Receptor Antagonists, Globulins, Blood Proteins, Decreased Immunologic Activity, CD3 Blocker Immunosuppressant	approved, investigational	5
DB00076	Digoxin Immune Fab (Ovine)	Drug	Serum Globulins, Immunoglobulins, Antidotes, Immunoglobulin G, Digoxin Binding Activity, Serum	approved	1
DB13380	Difemerine	Drug	Anticholinergic Agents, Hydroxy Acids, Alimentary Tract and Metabolism, Acids, Carbocyclic, Diphenylacetic Acids, Phenylacetates, Agents producing tachycardia, Drugs for Functional Gastrointestinal Disorders, Muscarinic Antagonists, Synthetic Anticholinergics, Esters With Tertiary Amino Group	experimental	0
DB12051	Setrobuvir	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Sulfonamides, Amides, Sulfones	investigational	0
DB13383	Diiodohydroxypropane	Drug	Antiseptics and Disinfectants, Dermatologicals, Iodine Products, Alcohols	experimental	0
DB13384	Melitracen	Drug	Non-Selective Monoamine Reuptake Inhibitors, Cytochrome P-450 Substrates, Nervous System, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Antidepressive Agents, Tricyclic, Agents that produce hypertension, Antidepressive Agents, Cytochrome P-450 CYP2B6 Substrates, Agents that reduce seizure threshold, Neurotoxic agents, Psychoanaleptics	investigational, experimental	0
DB12050	LY-3039478	Drug	0	investigational	0
DB13381	Sodium feredetate	Drug	Acids, Acyclic, Iron Trivalent, Oral Preparations, Amines, Blood and Blood Forming Organs, Fatty Acids, Iron Compounds, Polyamines, Acetates, Ethylenediamines, Organometallic Compounds, Parenteral Iron Replacement, Diamines, Antianemic Preparations, Iron Chelating Agents, Fatty Acids, Volatile, Sequestering Agents, Iron Preparations, Compounds used in a research, industrial, or household setting	approved	0
DB12053	Visilizumab	Drug	Proteins, Serum Globulins, Immunologic Factors, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB12052	Icariin	Drug	Heterocyclic Compounds, Fused-Ring, Drugs, Chinese Herbal, Benzopyrans, Chromones, Pyrans	investigational	0
DB13382	Chlorproethazine	Drug	Neuromuscular Agents, Psycholeptics, Nervous System, Phenothiazines, Phenothiazines With Aliphatic Side-Chain, Muscle Relaxants, Peripheral Nervous System Agents, Heterocyclic Compounds, Fused-Ring, Antipsychotic Agents, Sulfur Compounds, Central Nervous System Depressants, Muscle Relaxants, Centrally Acting Agents, Central Nervous System Agents, Neurotoxic agents	experimental	0
DB13398	Oxyfedrine	Drug	Amines, Propanols, Ketones, Protective Agents, Agents producing tachycardia, Cardiovascular Agents, Amino Alcohols, Phenethylamines, Alcohols, Cardiotonic Agents, Adrenergic beta-Agonists, Neurotransmitter Agents, Ethylamines, Adrenergic Agonists, Agents that produce hypertension, Propiophenones, Vasodilators Used in Cardiac Diseases, Vasodilating Agents, Cardiac Therapy, Compounds used in a research, industrial, or household setting, Adrenergic Agents, Propanolamines	experimental	0
DB12066	Orteronel	Drug	0	investigational	0
DB12065	Radalbuvir	Drug	Sulfur Compounds	investigational	0
DB13399	Terguride	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Genito Urinary System and Sex Hormones, Agents that produce hypertension, Prolactine Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Ergolines, Dopamine Agents, Ergot Alkaloids and Derivatives	experimental	0
DB12068	T-900607	Drug	Sulfur Compounds, Amides, Sulfones	investigational	0
DB13396	Neocitrullamon	Drug	Anticonvulsants, Nervous System, Central Nervous System Depressants, Hydantoins, Thyroxine-binding globulin substrates	experimental	0
DB12067	BMS-394136	Drug	0	investigational	0
DB13397	Prenoxdiazine	Drug	Cough and Cold Preparations	experimental	0
DB12069	Sovaprevir	Drug	0	investigational	0
DB00080	Daptomycin	Drug	Peptides, Cyclic Lipopeptides, Lipopeptide Antibacterial, Amino Acids, Peptides, and Proteins, Lipids, Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Peptides, Cyclic, Anti-Bacterial Agents, Agents Causing Muscle Toxicity, Lipopeptides, Antibacterials for Systemic Use	approved, investigational	1
DB00081	Tositumomab	Drug	Immunoglobulins, Antigens, CD20, Immunosuppressive Agents, Iodine Radioisotopes, Therapeutic Radiopharmaceuticals, Iodine (131I) Compounds, Radioimmunotherapy, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Radiopharmaceutical Activity, Drugs that are Mainly Renally Excreted, Immunoproteins, Myelosuppressive Agents, Proteins, Serum Globulins, Globulins, Blood Proteins, CD20-directed Antibody Interactions, CD20-directed Radiotherapeutic Antibody	approved, investigational	2
DB00085	Pancrelipase	Drug	Enzymes, Carboxylic Ester Hydrolases, Pancreatic Extracts, Enzymes and Coenzymes, Esterases, Lipase, Complex Mixtures, Alimentary Tract and Metabolism, Digestives, Incl. Enzymes, Hydrolases, Enzyme Preparations, Tissue Extracts, Gastrointestinal Agents	approved, investigational	3
DB00082	Pegvisomant	Drug	Cytochrome P-450 Enzyme Inhibitors, Peptides, Cytochrome P-450 CYP3A Inducers, Hypoglycemia-Associated Agents, Pituitary and Hypothalamic Hormones and Analogues, Acromegaly, Amino Acids, Peptides, and Proteins, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Anterior Pituitary Lobe Hormones and Analogues, Cytochrome P-450 Enzyme Inducers, Peptide Hormones, Growth Hormone Receptor Antagonists, Receptors, Somatotropin, antagonists & inhibitors, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Pituitary Hormones, Anterior, Cholinesterase Inhibitors, Cytochrome P-450 CYP2C18 Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Pituitary Hormones, Cytochrome P-450 CYP3A4 Inducers, Growth Hormone Receptor Antagonist, Somatotropin Antagonists, Cytochrome P-450 CYP2C18 Inhibitors (strength unknown), Pegylated agents	approved	1
DB00083	Botulinum toxin type A	Drug	Metalloproteases, Neuromuscular Agents, Ganglion Blockers, Enzymes and Coenzymes, Other Miscellaneous Therapeutic Agents, Amino Acids, Peptides, and Proteins, Metalloendopeptidases, Agents that produce neuromuscular block (indirect), Muscle Relaxants, Peripheral Nervous System Agents, Botulinum Toxins, Proteins, Toxins, Biological, Acetylcholine Release Inhibitors, Cholinergic Agents, Bacterial Toxins, Botulinum Toxins, Type A, Musculo-Skeletal System, Biological Factors, Enzymes, Neurotoxins, Noxae, Botulinum Toxins, Type A, antagonists & inhibitors, Membrane Transport Modulators, Bacterial Proteins, Neurotransmitter Agents, Muscle Relaxants, Peripherally Acting Agents, Central Nervous System Depressants, Hydrolases, Toxic Actions, Peptide Hydrolases, Endopeptidases	approved, investigational	2
DB00088	Alglucerase	Drug	Glucosidases, Enzyme Replacement Therapy, Enzymes, Glycoside Hydrolases, Alimentary Tract and Metabolism, Enzymes and Coenzymes, Hydrolases, Gaucher Disease, Recombinant Proteins, Hydrolytic Lysosomal Glucocerebroside-specific Enzyme	approved, investigational	1
DB00089	Capromab pendetide	Drug	Immunoglobulins, Laboratory Chemicals, Antibodies, Amino Acids, Peptides, and Proteins, Indium (111In) Compounds, Immunoproteins, Proteins, Serum Globulins, Prostatic Neoplasms, Globulins, Blood Proteins, Tumour Detection, Diagnostic Radiopharmaceuticals, Indicators and Reagents, Compounds used in a research, industrial, or household setting, Indium Radioisotopes	approved	1
DB00086	Streptokinase	Drug	Anticoagulants, Biological Factors, Enzymes, Blood and Blood Forming Organs, Plasminogen Activators, Fibrin Modulating Agents, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Hematologic Agents, Cardiovascular Agents, Hypotensive Agents, Fibrinolytic Agents, Streptokinase, antagonists & inhibitors, Proteins, Blood Proteins, Serine Proteases, Hydrolases, Agents causing angioedema, Peptide Hydrolases, Serine Endopeptidases, Endopeptidases	approved, investigational	2
DB00087	Alemtuzumab	Drug	Immunoglobulins, Immunosuppressive Agents, Antineoplastic and Immunomodulating Agents, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, CD52-directed Cytolytic Antibody, Antibodies, Monoclonal, Selective Immunosuppressants, Immunoproteins, Myelosuppressive Agents, Proteins, Serum Globulins, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, Narrow Therapeutic Index Drugs, Globulins, Blood Proteins, CD52-directed Antibody Interactions	approved, investigational	7
DB13391	Levoverbenone	Drug	Cough and Cold Preparations, Expectorants	experimental	0
DB12060	RRx-001	Drug	Azetines, Carbon Radioisotopes	investigational	0
DB12062	Volasertib	Drug	Heterocyclic Compounds, Fused-Ring, Antineoplastic Agents	investigational	0
DB13394	Adrenalone	Drug	Amines, Blood and Blood Forming Organs, Catecholamines, Catechols, Hematologic Agents, Cardiovascular Agents, Coagulants, Amino Alcohols, Ethanolamines, Biogenic Monoamines, Alcohols, Alimentary Tract and Metabolism, Vasoconstrictor Agents, Biogenic Amines, Local Hemostatics, Phenols, Hemostatics, Benzene Derivatives, Stomatological Preparations	experimental	0
DB13395	Eprozinol	Drug	Drugs for Obstructive Airway Diseases	experimental	0
DB12061	Pardoprunox	Drug	Heterocyclic Compounds, Fused-Ring	investigational	4
DB13392	Merbromin	Drug	Organometallic Compounds, Antiseptics and Disinfectants, Dermatologicals, Mercurial Products, Organomercury Compounds	experimental	0
DB12064	BMS-777607	Drug	Pyridines, Amines	investigational	0
DB13393	Emetine	Drug	Autonomic Agents, Enzyme Inhibitors, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Isoquinolines, Anti-Infective Agents, Peripheral Nervous System Agents, Alkaloids, Emetics, Heterocyclic Compounds, Fused-Ring, Agents Causing Muscle Toxicity, Central Nervous System Agents, Antinematodal Agents, Antiparasitic Agents, Protein Synthesis Inhibitors, Amebicides, Gastrointestinal Agents	experimental	0
DB12063	CERC-301	Drug	Receptors, N-Methyl-D-Aspartate, antagonists & inhibitors	investigational	0
DB02709	Resveratrol	Drug	Antineoplastic Agents, Phytogenic, Enzyme Inhibitors, Cytochrome P-450 Substrates, Sensory System Agents, Cytochrome P-450 Enzyme Inhibitors, Flavones, Anti-Inflammatory Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Peripheral Nervous System Agents, Antioxidants, Cytochrome P-450 CYP1A2 Inhibitors, Stilbenes, Analgesics, Polyphenols, Anticarcinogenic Agents, Compounds used in a research, industrial, or household setting, Antiplatelet agents, Benzene Derivatives, Analgesics, Non-Narcotic, Protective Agents, Antirheumatic Agents, Hematologic Agents, Antimutagenic Agents, Benzopyrans, Benzylidene Compounds, Angiogenesis Inhibitors, Heterocyclic Compounds, Fused-Ring, Flavonoids, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Phenols, Central Nervous System Agents, Vasodilating Agents, Chromones, Pyrans	investigational	26
DB02711	4-{2,6,8-Trioxo-9-[(2S,3R,4R)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate	Drug	0	experimental	1
DB02710	2,3,-Dihydroxybenzoylserine	Drug	0	experimental	1
DB02715	Compound 18	Drug	Iodobenzoates, Benzoates, Acids, Carbocyclic, Benzene Derivatives	experimental	1
DB02714	3'-Uridinemonophosphate	Drug	Carbohydrates, Pyrimidines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Uracil Nucleotides, Nucleotides, Pyrimidine Nucleotides	experimental	1
DB02713	Acetylamino-Acetic Acid	Drug	0	experimental	1
DB02712	Sorbinil	Drug	Imidazoles, Aldehyde Reductase, antagonists & inhibitors	investigational, experimental	1
DB02719	C-(1-hydrogyl-beta-D-glucopyranosyl) formamide	Drug	0	experimental	1
DB02717	Cellotetraose	Drug	Carbohydrates, Polysaccharides, Glucans, Polymers, Biopolymers, Compounds used in a research, industrial, or household setting, Macromolecular Substances, Monosaccharides	experimental	1
DB02716	7-methyl-guanosine-5'-triphosphate	Drug	0	experimental	1
DB14700	Damoctocog alfa pegol	Drug	Blood Coagulation Factors, Pegylated agents	approved, investigational	1
DB14701	Ethyl 8-hydroxy-alpha-(2-propynylamino)-5-quinolinepropanoate	Drug	0	experimental	0
DB14704	Ribitol	Drug	Carbohydrates, Sugar Alcohols, Alcohols	experimental	0
DB14705	Ceramide AP	Drug	Carbohydrates, Glycosphingolipids, Glycoconjugates, Glycolipids, Amides, Lipids, Membrane Lipids, Sphingolipids, Neutral Glycosphingolipids	experimental	0
DB14702	Sodium metavanadate	Drug	Vanadates	approved, experimental	0
DB14703	Dexamethasone metasulfobenzoate	Drug	Pregnadienetriols, Pregnadienes, Pregnanes, Steroids, Fluorinated, Fused-Ring Compounds, Steroids	approved, experimental	0
DB14708	Tosylchloramide	Drug	Amines, Noxae, Antiseptics and Disinfectants, Dermatologicals, Laboratory Chemicals, Anti-Infective Agents, Anti-Infective Agents, Local, Sulfur Compounds, Disinfectants, Oxidants, Sulfonamides, Indicators and Reagents, Toxic Actions, Compounds used in a research, industrial, or household setting, Benzene Derivatives, Chlorine Compounds, Sulfones	experimental	0
DB14709	Bean	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB14706	Ceramide NG	Drug	Carbohydrates, Glycosphingolipids, Glycoconjugates, Glycolipids, Amides, Lipids, Membrane Lipids, Sphingolipids, Neutral Glycosphingolipids	experimental	0
DB14707	Cemiplimab	Drug	Proteins, Serum Globulins, Antineoplastic Agents, Immunological, Immunoglobulins, Narrow Therapeutic Index Drugs, Globulins, Blood Proteins, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Immunoproteins	approved, investigational	1
DB02722	4-O-methyl-beta-D-glucuronic acid	Drug	0	experimental	1
DB02721	4-Iodopyrazole	Drug	0	experimental	4
DB02720	alpha-D-glucopyranosyl-2-carboxylic acid amide	Drug	0	experimental	1
DB02726	2-Phosphoglycolic Acid	Drug	0	experimental	13
DB02725	2-Amino-4-(4-Amino-Cyclohexa-2,5-Dienyl)-Butyric Acid	Drug	0	experimental	1
DB02724	Delta-2-Albomycin A1	Drug	0	experimental	2
DB02723	4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide	Drug	0	experimental	1
DB02729	SD146	Drug	0	experimental	1
DB02728	7-Hydroxy-2-Oxo-Chromene-3-Carboxylic Acid Ethyl Ester	Drug	0	experimental	1
DB02727	2-butyl-1-hydroxyguanidine	Drug	Amidines	experimental	1
DB14711	Vaccinia virus strain new york city board of health live antigen	Drug	Actively Acquired Immunity, Vaccines, Live Vaccinia Virus Vaccine	approved	0
DB14712	Elapegademase	Drug	Proteins, Enzyme Replacement Therapy, Pegylated agents, Recombinant Proteins	approved	1
DB14710	Camponotus pennsylvanicus	Drug	Cell-mediated Immunity, Non-Standardized Insect Venom Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB14715	Cinazepam	Drug	Heterocyclic Compounds, Fused-Ring, Benzazepines, Central Nervous System Depressants, Benzodiazepines and benzodiazepine derivatives	experimental	2
DB14716	Clonazolam	Drug	0	experimental	0
DB14713	Inotersen	Drug	Molecular Probes, Nephrotoxic agents, Antisense Elements (Genetics), Carbohydrates, QTc Prolonging Agents, Decreased RNA Integrity, Oligonucleotides, Antisense, Transthyretin-directed RNA Interaction, Laboratory Chemicals, Oligonucleotides, Miscellaneous Central Nervous System Agents, Nucleic Acid Probes, Nucleotides, Nucleic Acids, Polynucleotides, Diagnostic Uses of Chemicals, DNA, Antisense, Nucleic Acids, Nucleotides, and Nucleosides, DNA, Glycosides, Potential QTc-Prolonging Agents, Increased Protein Breakdown, Oligodeoxyribonucleotides, Antisense, Compounds used in a research, industrial, or household setting	approved, investigational	1
DB14714	Tenivastatin	Drug	0	experimental	0
DB14719	Bentazepam	Drug	Psycholeptics, Nervous System, Central Nervous System Depressants, Benzodiazepines and benzodiazepine derivatives, Anti-Anxiety Agents, Hypnotics and Sedatives, Central Nervous System Agents	experimental	2
DB14717	Nitrazolam	Drug	0	experimental	0
DB14718	Pyrazolam	Drug	Street Drugs, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Benzazepines, GABA Agents, Central Nervous System Depressants, GABA Modulators, Hypnotics and Sedatives, Central Nervous System Agents	experimental	0
DB02733	Purvalanol	Drug	0	experimental	6
DB01401	Choline magnesium trisalicylate	Drug	Nephrotoxic agents, Amines, Ammonium Compounds, Sensory System Agents, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Non COX-2 selective NSAIDS, Trimethyl Ammonium Compounds, Onium Compounds, Alcohols, Peripheral Nervous System Agents, Analgesics, Benzene Derivatives, Nitrogen Compounds, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Benzoates, Hydroxy Acids, Quaternary Ammonium Compounds, Antirheumatic Agents, Hydroxybenzoates, Amino Alcohols, Ethanolamines, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Agents that produce hypertension, Phenols, Central Nervous System Agents	approved	2
DB02732	[(2R,3S,4R,5R)-5-(4-acetonyl-3-carbamoyl-pyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] phosphate	Drug	0	experimental	0
DB02731	Ethylmercurithiosalicylic acid	Drug	0	experimental	2
DB01400	Neostigmine	Drug	Autonomic Agents, Enzyme Inhibitors, Amines, Ammonium Compounds, Cholinesterase Inhibitors, Nervous System, Antiglaucoma Preparations and Miotics, Quaternary Ammonium Compounds, Parasympathomimetics, Onium Compounds, Parasympathomemetic (Cholinergic) Agents, Peripheral Nervous System Agents, Ophthalmologicals, Neurotransmitter Agents, Cholinergic Agents, Phenylammonium Compounds, Sensory Organs, Nitrogen Compounds	approved, vet_approved	1
DB02730	4-Methylthio-Alpha-D-Mannose	Drug	0	experimental	1
DB01406	Danazol	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Enzyme Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Genito Urinary System and Sex Hormones, Fused-Ring Compounds, Cytochrome P-450 CYP3A4 Inhibitors (strong), Androgens, Estrogen Antagonists, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Pregnanes, Antigonadotropins and Similar Agents, Thyroxine-binding globulin inhibitors, Hormone Antagonists, Hyperglycemia-Associated Agents, Steroids	approved	6
DB01405	Temafloxacin	Drug	Fluoroquinolones, Quinolines, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Antiinfectives for Systemic Use, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Anti-Infective Agents, Quinolones, Cytochrome P-450 CYP1A2 Inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Topoisomerase II Inhibitors, Cytochrome P-450 CYP1A2 Substrates, Antibacterials for Systemic Use	withdrawn	2
DB02736	Acetamide	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Amides, Lipids, Acetates	experimental	1
DB02735	2-Amino-3-Oxo-4-Sulfo-Butyric Acid	Drug	0	experimental	1
DB01404	Ginseng	Drug	Herbs and Natural Products	approved, investigational, nutraceutical	3
DB02734	4-Deoxy-D-Mannuronic Acid	Drug	0	experimental	2
DB01403	Methotrimeprazine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Psycholeptics, QTc Prolonging Agents, Tranquilizing Agents, Cytochrome P-450 Substrates, Sensory System Agents, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Antipsychotic Agents (First Generation Typical), Muscarinic Antagonists, Antidepressive Agents, Peripheral Nervous System Agents, Anticholinergic Agents, Serotonin 5-HT2 Receptor Antagonists, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Antipsychotic Agents, Histamine H1 Antagonists, Sulfur Compounds, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Adrenergic Antagonists, Potential QTc-Prolonging Agents, Adrenergic alpha-1 Receptor Antagonists, Drugs causing inadvertant photosensitivity, Dopamine Antagonists, Dopamine Agents, Neurotoxic agents, Analgesics, Non-Narcotic, Adrenergic alpha-Antagonists, Cytochrome P-450 CYP2E1 Inhibitors, Phenothiazines, Agents producing tachycardia, Phenothiazines With Aliphatic Side-Chain, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Histamine Antagonists, Photosensitizing Agents, Central Nervous System Depressants, Agents that produce hypertension, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2D6 Inhibitors (strong), Dopamine D2 Receptor Antagonists, Hyperglycemia-Associated Agents	approved, investigational	19
DB01409	Tiotropium	Drug	Adrenergics, Inhalants, Antimuscarinics Antispasmodics, Cytochrome P-450 Substrates, Muscarinic Antagonists, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Anticholinergic Agents, Alkaloids, Cholinergic Agents, Aza Compounds, Azabicyclo Compounds, Scopolamine Derivatives, Autonomic Agents, Anti-Asthmatic Agents, Agents producing tachycardia, Parasympatholytics, Bronchodilator Agents, Respiratory System Agents, Neurotransmitter Agents, Tropanes, Agents to Treat Airway Disease, Cytochrome P-450 CYP3A Substrates, Drugs for Obstructive Airway Diseases, Cytochrome P-450 CYP2D6 Substrates	approved	5
DB01408	Bambuterol	Drug	Autonomic Agents, Amines, Cholinesterase Inhibitors, Prodrugs, Adrenergics for Systemic Use, Anti-Asthmatic Agents, Agents producing tachycardia, Bronchodilator Agents, Adrenergic beta-2 Receptor Agonists, Amino Alcohols, Ethanolamines, Respiratory System Agents, Alcohols, Peripheral Nervous System Agents, Adrenergic beta-Agonists, Selective Beta 2-adrenergic Agonists, Agents to Treat Airway Disease, Adrenergic Agonists, Agents that produce hypertension, Cholinesterase substrates, Drugs for Obstructive Airway Diseases, Delayed-Action Preparations	investigational	1
DB02738	Adenosine-5'-Pentaphosphate	Drug	0	experimental	1
DB01407	Clenbuterol	Drug	Autonomic Agents, Adrenergics, Inhalants, Amines, Adrenergics for Systemic Use, Anti-Asthmatic Agents, Agents producing tachycardia, Bronchodilator Agents, Adrenergic beta-2 Receptor Agonists, Amino Alcohols, Ethanolamines, Respiratory System Agents, Alcohols, Peripheral Nervous System Agents, Adrenergic beta-Agonists, Neurotransmitter Agents, Selective Beta 2-adrenergic Agonists, Agents to Treat Airway Disease, Sympathomimetics, Adrenergic Agonists, Agents that produce hypertension, Drugs for Obstructive Airway Diseases, Adrenergic Agents	approved, investigational, vet_approved	5
DB14722	ADU-S100	Drug	0	investigational	0
DB14723	Larotrectinib	Drug	BCRP/ABCG2 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Tyrosine Kinase Inhibitors, P-glycoprotein substrates, Antineoplastic Agents, Cytochrome P-450 CYP3A4 Substrates	approved, investigational	3
DB14720	Brovanexine	Drug	Benzoates, Acids, Carbocyclic, Amides, Benzene Derivatives	experimental	0
DB14721	MK-1454	Drug	0	investigational	0
DB14726	Dabigatran	Drug	Anticoagulants, Heterocyclic Compounds, Fused-Ring, Pyridines, Benzimidazoles, Enzyme Inhibitors, Antithrombins, Protease Inhibitors, Hematologic Agents, Serine Protease Inhibitors	investigational	0
DB14727	Riboflavin tetrabutyrate	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Coenzymes, Enzymes and Coenzymes, Pteridines, Flavins, Pigments, Biological	experimental	0
DB14724	Emapalumab	Drug	Interferon-gamma, Immunoglobulins, Immunosuppressive Agents, Antineoplastic and Immunomodulating Agents, Antibodies, Amino Acids, Peptides, and Proteins, Agents reducing cytokine levels, Antibodies, Monoclonal, Selective Immunosuppressants, Immunoproteins, Proteins, Serum Globulins, Globulins	approved, investigational	1
DB14725	Cefamandole nafate	Drug	Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Amides, Lactams, Thiazines, beta-Lactams, Anti-Infective Agents	approved	0
DB14728	Mebenil	Drug	Amines, Aniline Compounds, Amides	experimental	0
DB14729	Rebeccamycin	Drug	Heterocyclic Compounds, Fused-Ring, Indoles	experimental	0
DB02740	3-Indolebutyric Acid	Drug	Heterocyclic Compounds, Fused-Ring	experimental	5
DB02744	RPR131247	Drug	0	experimental	1
DB01413	Cefepime	Drug	Fourth-Generation Cephalosporins, Nephrotoxic agents, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Antibacterials for Systemic Use	approved, investigational	4
DB01412	Theobromine	Drug	Autonomic Agents, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 Substrates, Anti-Asthmatic Agents, Cardiovascular Agents, Low-Ceiling Diuretics, Excl. Thiazides, Bronchodilator Agents, Respiratory System Agents, Peripheral Nervous System Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Purines, Cytochrome P-450 CYP1A2 Substrates, Diuretics, Drugs for Obstructive Airway Diseases, Xanthine derivatives, Vasodilating Agents, Purinones	investigational	3
DB02743	beta-D-galactopyranosyl-(1->4)-beta-D-galactopyranose	Drug	Carbohydrates, Polysaccharides, Oligosaccharides	experimental	1
DB01411	Pranlukast	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Anti-Asthmatic Agents, Leukotriene Antagonists, Benzopyrans, Cytochrome P-450 CYP3A4 Substrates, Respiratory System Agents, Heterocyclic Compounds, Fused-Ring, Agents to Treat Airway Disease, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors, Drugs for Obstructive Airway Diseases, Hormone Antagonists, Pyrans	investigational	6
DB02742	Kifunensine	Drug	Enzyme Inhibitors	experimental	3
DB02741	CD564	Drug	0	experimental	1
DB01410	Ciclesonide	Drug	Anti-Allergic Agents, Corticosteroids, Cytochrome P-450 Substrates, Immunosuppressive Agents, Glucocorticoids, Hormones, Hormone Substitutes, and Hormone Antagonists, Adrenal Cortex Hormones, Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Nasal Preparations, Agents to Treat Airway Disease, Cytochrome P-450 CYP3A Substrates, Adrenals, Pregnanes, Drugs for Obstructive Airway Diseases, Thyroxine-binding globulin inhibitors, Cytochrome P-450 CYP2D6 Substrates, Hyperglycemia-Associated Agents, Pregnenes, Steroids	approved, investigational	1
DB02747	Diamino-N-[(4S)-5-anilino-4-{[(2S)-2-{[(1R)-1-carboxyethyl]amino}-4-phenylbutanoyl]amino}-5-oxopentyl]methaniminium	Drug	0	experimental	0
DB01416	Cefpodoxime	Drug	Nephrotoxic agents, Prodrugs, Third-Generation Cephalosporins, Cephacetrile, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Antibacterials for Systemic Use	approved, vet_approved	1
DB01415	Ceftibuten	Drug	Nephrotoxic agents, Third-Generation Cephalosporins, Amides, Lactams, OAT1/SLC22A6 Substrates, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, OAT3/SLC22A8 Substrates, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, OAT3/SLC22A8 Inhibitors, Antibacterials for Systemic Use	approved, investigational	4
DB02746	Phthalic Acid	Drug	Acids, Carbocyclic	experimental	10
DB01414	Cefacetrile	Drug	Nephrotoxic agents, Amides, Lactams, OAT1/SLC22A6 Substrates, Thiazines, beta-Lactams, First-Generation Cephalosporins, Antiinfectives for Systemic Use, Anti-Infective Agents, OAT1/SLC22A6 inhibitors, OAT3/SLC22A8 Substrates, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, OAT3/SLC22A8 Inhibitors, Antibacterials for Systemic Use	experimental, vet_approved	2
DB02745	Uridine	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Pyrimidine Analog, Analogs/Derivatives, Glycosides, Nucleosides	investigational, experimental	2
DB01419	Antrafenine	Drug	Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Anti-Inflammatory Agents, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Agents causing hyperkalemia, Agents that produce hypertension, Non COX-2 selective NSAIDS	approved	2
DB01418	Acenocoumarol	Drug	Anticoagulants, Blood and Blood Forming Organs, Cytochrome P-450 Substrates, 4-Hydroxycoumarins, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Coumarins, Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index, Hematologic Agents, Benzopyrans, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index, Vitamin K Antagonists, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Pyrans	approved, investigational	1
DB02749	Pyromellitic Acid	Drug	Acids, Carbocyclic, Benzene Derivatives	experimental	1
DB02700	3-Deoxy-D-Glucosamine	Drug	0	experimental	1
DB02704	(2R,3R,4R,5R)-3,4-Dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2,5-bis(2-phenylethyl)hexanediamide	Drug	0	experimental	1
DB02703	Fusidic acid	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cholestanes, BSEP/ABCB11 Inhibitors, Enzyme Inhibitors, Antibiotics for Topical Use, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Medicated Dressings, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Other Miscellaneous Antibacterial Agents, Lipids, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Fused-Ring Compounds, Anti-Bacterial Agents, Medicated Dressings With Antiinfectives, Sterols, Cholestadienols, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Membrane Lipids, Protein Synthesis Inhibitors, OATP1B1/SLCO1B1 Inhibitors, Dermatologicals, Steroid Antibacterials, BCRP/ABCG2 Inhibitors, Antiinfectives for Systemic Use, Ophthalmologicals, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, UGT1A1 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Cholestadienes, Cholestenes, Cytochrome P-450 CYP2D6 Substrates, Sensory Organs, Antibacterials for Systemic Use, Steroids	approved, investigational	3
DB02702	XV638	Drug	0	experimental	1
DB02701	Nicotinamide	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Pyridines, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Nicotinic Acids, Vitamins, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Micronutrients, Cytochrome P-450 CYP3A Inhibitors, Physiological Phenomena, Alimentary Tract and Metabolism, Food and Beverages, Cytochrome P-450 CYP3A4 Inhibitors, Vitamin B Complex, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Growth Substances, Diet, Food, and Nutrition, Food	approved, investigational	5
DB02707	Pentyl Trihydrogen Diphosphate	Drug	0	experimental	0
DB02706	Mercaptocarboxylate Inhibitor	Drug	0	experimental	1
DB02705	6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine	Drug	0	experimental	1
DB13442	Citiolone	Drug	Liver Therapy, Sulfur Compounds, Expectorants, Alimentary Tract and Metabolism, Liver Therapy, Lipotropics, Bile and Liver Therapy	experimental	0
DB12110	m-Chlorophenylpiperazine	Drug	Neurotransmitter Agents, Serotonin Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Serotonin Receptor Agonists, Antidepressive Agents, Serotonin 5-HT2 Receptor Agonists	investigational	1
DB14773	Lifirafenib	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB13443	Esatenolol	Drug	Cytochrome P-450 Substrates, Agents causing hyperkalemia, Adrenergic Antagonists, Beta Blocking Agents, Selective, Adrenergic beta-Antagonists, Antihypertensive Agents, Cytochrome P-450 CYP2D6 Substrates, Bradycardia-Causing Agents	experimental	0
DB14774	Balipodect	Drug	0	investigational	0
DB14771	Polyacrylamide (crosslinked; 2 mole percent bisacrylamide)	Drug	Complex Mixtures, Investigative Techniques, Colloids, Biocompatible Materials, Pharmaceutical Preparations, Plastics, Polymers, Compounds used in a research, industrial, or household setting, Dental Materials, Macromolecular Substances, Resins, Synthetic	investigational	0
DB12112	Zuretinol acetate	Drug	Biological Factors, Immunologic Factors, Cycloparaffins, Alkenes, Adjuvants, Immunologic, Protective Agents, Hydrocarbons, Acyclic, Cyclohexenes, Retinoids, Cyclohexanes, Pigments, Biological, Carotenoids, Polyenes, Anticarcinogenic Agents, Terpenes, Compounds used in a research, industrial, or household setting	investigational	0
DB13441	Niceritrol	Drug	Lipid Modifying Agents, Lipid Modifying Agents, Plain, Lipid Regulating Agents, Pyridines, Hypolipidemic Agents, Noxae, Nicotinic Acid and Derivatives, Toxic Actions, Nicotinic Acids	experimental	0
DB12111	MK-212	Drug	Neurotransmitter Agents, Serotonin Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Serotonin Receptor Agonists, Antidepressive Agents	investigational	0
DB14772	DCFBC F-18	Drug	0	investigational	0
DB13446	Guar gum	Drug	Carbohydrates, Plant Exudates, Blood Glucose Lowering Agents, Biopolymers, Macromolecular Substances, Polysaccharides, Complex Mixtures, Alimentary Tract and Metabolism, Biological Products, Dietary Fiber, Drugs Used in Diabetes, Polymers, Compounds used in a research, industrial, or household setting	experimental	0
DB14777	Murepavadin	Drug	Anti-Bacterial Agents, Peptides, Amino Acids, Peptides, and Proteins, Anti-Infective Agents	investigational	0
DB12114	Poziotinib	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB13447	Prethcamide	Drug	Acids, Acyclic, Fatty Acids, Butyrates, Fatty Acids, Volatile, Amino Acids, Peptides, and Proteins, Lipids, Respiratory System Agents, Amino Acids	experimental	0
DB14778	Setrusumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB12113	CE-224535	Drug	Purinergic P2X Receptor Agonists, Pyrimidines, Benzoates, Acids, Carbocyclic, Pyrimidinones, Amides, Benzene Derivatives	investigational	0
DB14775	Cavosonstat	Drug	Benzene Derivatives	investigational	0
DB12116	Epigallocatechin gallate	Drug	Radiation-Protective Agents, Neuroprotective Agents, Protective Agents, Antineoplastic Agents, Antimutagenic Agents, Benzopyrans, Antioxidants, Heterocyclic Compounds, Fused-Ring, Flavonoids, Chromans, Anticarcinogenic Agents, Central Nervous System Agents, Compounds used in a research, industrial, or household setting, Urokinase-Type Plasminogen Activator, antagonists & inhibitors, Chromones, Pyrans	investigational	3
DB13444	Ioxitalamic acid	Drug	Carbohydrates, Benzoates, Acids, Carbocyclic, Alcohols, Amino Sugars, Iodobenzoates, Contrast Media, Diagnostic Uses of Chemicals, Sugar Alcohols, Hexosamines, Triiodobenzoic Acids, Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting, Benzene Derivatives	approved	0
DB12115	AZD-9164	Drug	Receptor, Muscarinic M3, antagonists & inhibitors	investigational	0
DB14776	Camrelizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB13445	Nepinalone	Drug	Cough and Cold Preparations	experimental	0
DB12118	Sotatercept	Drug	Proteins, Serum Globulins, Immunoglobulins, Immunoglobulin G, Amino Acids, Peptides, and Proteins, Recombinant Proteins	investigational	1
DB12117	Mitometh	Drug	Hydrocarbons, Chlorinated, Hydrocarbons, Halogenated	investigational	0
DB13448	Mazaticol	Drug	Acids, Acyclic, Fatty Acids, Hydroxy Acids, Nervous System, Agents producing tachycardia, Lipids, Muscarinic Antagonists, Acetates, Tertiary Amines, Anti-Parkinson Drugs, Anticholinergic Agents, Sulfur Compounds, Fatty Acids, Volatile, Synthetic Anticholinergics, Esters With Tertiary Amino Group	experimental	0
DB14779	LGD-6972	Drug	Alkanesulfonic Acids, Sulfur Compounds, Acids, Noncarboxylic, Benzoates, Acids, Sulfur Acids, Acids, Carbocyclic, Hydrocarbons, Acyclic, Sulfonic Acids, Alkanes, Amides, Benzene Derivatives	investigational	0
DB12119	Gevokizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	1
DB13449	Proxyphylline	Drug	Autonomic Agents, Cytochrome P-450 Substrates, Anti-Asthmatic Agents, Bronchodilator Agents, Respiratory System Agents, Peripheral Nervous System Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Purines, Xanthines and Adrenergics, Cytochrome P-450 CYP1A2 Substrates, Drugs for Obstructive Airway Diseases, Xanthine derivatives, Purinones	experimental	0
DB01460	Diethyltryptamine	Drug	Amines, Benzoates, Protective Agents, Acids, Carbocyclic, Pesticides, Amides, Biogenic Monoamines, Heterocyclic Compounds, Fused-Ring, Insect Repellents, Agrochemicals, Biogenic Amines, Toxic Actions, Indoles, Compounds used in a research, industrial, or household setting, Benzene Derivatives	illicit, experimental	0
DB02790	Phenyl-uridine-5'-diphosphate	Drug	0	experimental	1
DB01464	Furethidine	Drug	0	illicit, experimental	0
DB02795	P-Anisic Acid	Drug	Benzoates, Hydroxy Acids, Acids, Carbocyclic, Hydroxybenzoates, Phenols, Ethers, Benzene Derivatives, Phenyl Ethers	experimental	2
DB00132	alpha-Linolenic acid	Drug	Fatty Acids, Oils, Lipids, Dietary Fats, Unsaturated, Linolenic Acids, Supplements, Fatty Acids, Essential, Fatty Acids, Unsaturated, Physiological Phenomena, Dietary Fats, Food and Beverages, Fish Oils, Fats, Dietary Supplements, Fatty Acids, Omega-3, Diet, Food, and Nutrition, Food	approved, investigational, nutraceutical	11
DB01463	Fencamfamin	Drug	Centrally Acting Sympathomimetics, Tranquilizing Agents, Central Nervous System Stimulants, Nervous System, Central Nervous System Depressants, Psychostimulants, Agents Used for Adhd and Nootropics, Monoterpenes, Central Nervous System Agents, Terpenes, Psychotropic Drugs, Psychoanaleptics	illicit, withdrawn, experimental	1
DB02794	(2S)-2-({4-[(2S)-1-(2-Amino-4-oxo-1,4-dihydro-6-quinazolinyl)-3-{[2-({(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]tetrahydro-2-furanyl}amino)-2-oxoethyl]amino}-2-hydroxy-2-propanyl]benzoyl}ami no)pentanedioic acid	Drug	0	experimental	1
DB00133	Serine	Drug	Amino Acids, Neutral, Amino Acids, Peptides, and Proteins, Dietary Supplements, Amino Acids, Supplements	investigational, nutraceutical	7
DB01462	Etonitazene	Drug	Heterocyclic Compounds, Fused-Ring	illicit, experimental	0
DB00130	L-Glutamine	Drug	Amino Acids, Neutral, Alimentary Tract and Metabolism, Amino Acids and Derivatives, Amino Acids, Basic, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, Dietary Supplements, Amino Acids, Supplements, Glutamine	approved, investigational, nutraceutical	3
DB02793	Isochorismic Acid	Drug	Cycloparaffins, Acids, Carbocyclic, Cyclohexenes, Cyclohexanecarboxylic Acids, Isomerism, Cyclohexanes	experimental	1
DB02792	Deglucobalhimycin	Drug	0	experimental	0
DB00131	Adenosine phosphate	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides, Adenine Nucleotides, Dietary Supplements, Supplements	approved, investigational, nutraceutical	14
DB01461	Dimenoxadol	Drug	Hydroxy Acids, Acids, Carbocyclic, Diphenylacetic Acids, Phenylacetates	illicit, experimental	0
DB02799	N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide	Drug	0	experimental	1
DB00136	Calcitriol	Drug	Cholestanes, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Inducers, Lipids, Misc. Skin and Mucous Membrane Agents, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Antipsoriatics, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Physiological Phenomena, Sterols, Vitamin D and Analogues, Alimentary Tract and Metabolism, Food and Beverages, Bone Density Conservation Agents, Calcium-Regulating Hormones and Agents, Membrane Lipids, Growth Substances, Diet, Food, and Nutrition, Food, Secosteroids, Antipsoriatics for Topical Use, Cytochrome P-450 CYP3A4 Inducers, Membrane Transport Modulators, Vitamins, Micronutrients, Cytochrome P-450 CYP3A Substrates, Vitamins (Fat Soluble), Cholestenes, Steroids	approved, nutraceutical	2
DB01468	Ethylmethylthiambutene	Drug	0	illicit, experimental	0
DB02798	Alpha-Methylene Adenosine Monophosphate	Drug	0	experimental	1
DB01467	2,5-Dimethoxy-4-ethylamphetamine	Drug	Amines, Ethylamines, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Sympathomimetics, Agents that produce hypertension, Amphetamines, Agents producing tachycardia, Phenethylamines	illicit, experimental	0
DB00137	Lutein	Drug	Xanthophylls, Biological Factors, Cycloparaffins, Alkenes, Hydrocarbons, Acyclic, Cyclohexenes, Supplements, Cyclohexanes, Pigments, Biological, Carotenoids, Polyenes, Terpenes, Dietary Supplements	approved, investigational, nutraceutical	0
DB01466	Ethylmorphine	Drug	Antitussive Agents, Cytochrome P-450 Substrates, Sensory System Agents, Cytochrome P-450 CYP3A4 Substrates, Morphinans, Peripheral Nervous System Agents, Alkaloids, Analgesics, Cough and Cold Preparations, Morphine Derivatives, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Opioids, Narcotics, Respiratory System Agents, Ophthalmologicals, Heterocyclic Compounds, Fused-Ring, Opium Alkaloids and Derivatives, Phenanthrenes, Opiate Alkaloids, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Sensory Organs	illicit, experimental	1
DB00134	Methionine	Drug	Amino Acids, Neutral, Sulfur Compounds, Antidotes, Amino Acids, Essential, Amino Acids, Sulfur, Amino Acids, Peptides, and Proteins, Dietary Supplements, Amino Acids, Supplements	approved, nutraceutical	5
DB02797	3-Nitrophenylboronic Acid	Drug	Acids, Noncarboxylic, Acids, Boron Compounds	experimental	1
DB01465	2,5-Dimethoxyamphetamine	Drug	Amines, Ethylamines, Phenethylamines	illicit, experimental	0
DB00135	Tyrosine	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Amino Acids, Peptides, and Proteins, Dietary Supplements, Amino Acids, Supplements	approved, investigational, nutraceutical	4
DB02796	9-deazainosine	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purines, Ribonucleosides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Purine Nucleosides	experimental	1
DB00138	Cystine	Drug	Amino Acids, Neutral, Cysteine, Amino Acids, Diamino, Disulfides, Amino Acids, Sulfur, Amino Acids, Peptides, and Proteins, Ions, Amino Acids, Supplements, Gases, Sulfides, Anions, Sulfur Compounds, Acids, Noncarboxylic, Acids, Amino Acids, Dicarboxylic, Hydrogen Sulfide, Electrolytes, Dietary Supplements, Sulfhydryl Compounds	approved, nutraceutical	2
DB01469	Acetorphine	Drug	0	illicit, experimental	0
DB00139	Succinic acid	Drug	Acids, Acyclic, Succinates, Dicarboxylic Acids, Dietary Supplements, Supplements, OAT3/SLC22A8 Substrates	approved, nutraceutical	2
DB14770	Lanraplenib	Drug	0	investigational	0
DB12121	Entospletinib	Drug	Heterocyclic Compounds, Fused-Ring, Pyrazoles	investigational	0
DB14784	Gancotamab	Drug	Anthracyclines, Peptide Fragments, Peptides, Antibodies, Molecular Sequence Data, Amino Acids, Peptides, and Proteins, Information Science, Information Services, Immunoglobulin Fragments, Immunoproteins, Proteins, Naphthacenes, Glycosides, Biochemical Phenomena, Immunoglobulin Variable Region, Molecular Structure, Immunoglobulin Fab Fragments, Amino Acid Sequence, Carbohydrates, Immunoglobulins, Noxae, Antibodies, Monoclonal, Serum Globulins, Globulins, Blood Proteins, Toxic Actions	investigational	0
DB13453	Xenon	Drug	Anesthetics, Inhalation, Gases, Anesthetics, General, Nervous System, Agents that produce hypertension, Xenon, Central Nervous System Agents, Anesthetics, Elements, Noble Gases	experimental	0
DB13454	Nicomorphine	Drug	Pyridines, Sensory System Agents, Narcotics, Nervous System, Natural Opium Alkaloids, Morphinans, Peripheral Nervous System Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Opioids, Central Nervous System Agents	experimental	0
DB14785	Fenebrutinib	Drug	Pyridines	investigational	0
DB12120	Avoralstat	Drug	0	investigational	0
DB13451	Tioclomarol	Drug	Anticoagulants, Heterocyclic Compounds, Fused-Ring, Blood and Blood Forming Organs, Benzopyrans, Pyrans, Vitamin K Antagonists	experimental	0
DB12123	Cinepazide	Drug	Peripheral Vasodilators, Cardiovascular Agents, Vasodilating Agents	investigational	0
DB14782	Tofersen	Drug	0	investigational	0
DB12122	Figopitant	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Amides, Lipids, Acetamides, Acetates, Benzene Derivatives	investigational	0
DB14783	Diroximel fumarate	Drug	Fumarates, Hepatotoxic Agents	approved, investigational	1
DB13452	Cadralazine	Drug	Hydrazinophthalazine Derivatives, Arteriolar Smooth Muscle, Agents Acting On, Cardiovascular Agents, Antihypertensive Agents, Vasodilating Agents	experimental	0
DB12125	Dianicline	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB13457	Oxaflozane	Drug	Oxazines, Nervous System, Central Nervous System Depressants, Antidepressive Agents, Psychoanaleptics	experimental	0
DB14788	Prasinezumab	Drug	0	investigational	0
DB12124	Namitecan	Drug	Alkaloids, Antineoplastic Agents, Phytogenic, Antineoplastic Agents	investigational	0
DB14789	Dectrekumab	Drug	0	investigational	0
DB13458	Thebacon	Drug	Opium Alkaloids and Derivatives, Cough and Cold Preparations	experimental	0
DB12127	Sultamicillin	Drug	Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Penicillin G, Anti-Infective Agents, Antibacterials for Systemic Use	approved, investigational	0
DB13455	Phenibut	Drug	Acids, Acyclic, Tranquilizing Agents, Central Nervous System Stimulants, Fatty Acids, GABA Agents, Nervous System, GABA Agonists, Psychostimulants, Agents Used for Adhd and Nootropics, Amino Acids, Peptides, and Proteins, Lipids, Aminobutyrates, Psychotropic Drugs, Amino Acids, Neurotransmitter Agents, Anticonvulsants, Butyrates, Central Nervous System Depressants, Fatty Acids, Volatile, Convulsants, Hypnotics and Sedatives, Central Nervous System Agents, Psychoanaleptics	experimental	0
DB14786	Nerofe	Drug	Amino Acids, Peptides, and Proteins	investigational	0
DB14787	BMS-830216	Drug	0	investigational	0
DB13456	Midecamycin	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Macrolides, Lincosamides and Streptogramins, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Antiinfectives for Systemic Use, Anti-Infective Agents, Lactones, Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Antibacterials for Systemic Use	experimental	0
DB12126	Bradykinin	Drug	Biological Factors, Autacoids, Inflammation Mediators, Bradykinin, agonists, Oligopeptides, Peptides, Intercellular Signaling Peptides and Proteins, Bradykinin, antagonists & inhibitors, Kinins, Amino Acids, Peptides, and Proteins, Neuropeptides, Cardiovascular Agents, Nerve Tissue Proteins, Proteins, Vasodilating Agents	investigational	0
DB12129	Tideglusib	Drug	Glycogen Synthase Kinase 3, antagonists & inhibitors, Sulfur Compounds, Thiazoles	investigational, withdrawn	1
DB12128	Ulimorelin	Drug	0	investigational	1
DB13459	Pecilocin	Drug	Antifungals for Topical Use, Dermatologicals, Antifungals for Dermatological Use, Pyrrolidines, Antifungal Agents	experimental	0
DB01471	Bolasterone	Drug	Androstanes, Hormones, Hormone Substitutes, and Hormone Antagonists, Androstenols, Anabolic Agents, Androstenes, Testosterone Congeners, Hormones, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Steroids	illicit, experimental	0
DB00140	Riboflavin	Drug	Biological Factors, Coenzymes, Dermatologicals, Enzymes and Coenzymes, Pteridines, Radiation-Sensitizing Agents, Vitamins, OAT1/SLC22A6 inhibitors, Pigments, Biological, Ophthalmologicals, Heterocyclic Compounds, Fused-Ring, Micronutrients, Physiological Phenomena, Photosensitizing Agents, Alimentary Tract and Metabolism, Food and Beverages, Vitamin B Complex, Sensory Organs, Growth Substances, Diet, Food, and Nutrition, Flavins, Food	approved, investigational, nutraceutical, vet_approved	3
DB01470	alpha-methylthiofentanyl	Drug	0	illicit	0
DB00143	Glutathione	Drug	Antidotes, Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins, Dietary Supplements, Supplements, Glutathione, antagonists & inhibitors	approved, investigational, nutraceutical	41
DB01475	Dioxaphetyl butyrate	Drug	0	illicit, experimental	0
DB00144	Phosphatidyl serine	Drug	Carbohydrates, Phosphatidylserines, Sugar Phosphates, Lipids, Phospholipids, Phosphatidic Acids, Glycerophospholipids, Supplements, Alcohols, Glycerophosphates, Sugar Alcohols, Membrane Lipids, Triose Sugar Alcohols, Dietary Supplements	approved, investigational, nutraceutical	10
DB01474	17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene	Drug	0	illicit, experimental	0
DB01473	Betaprodine	Drug	0	illicit, experimental	0
DB00141	N-Acetylglucosamine	Drug	Dietary Supplements, Supplements	approved, investigational, nutraceutical	6
DB00142	Glutamic acid	Drug	Amino Acids, Peptides, and Proteins, Amino Acids, Acidic, Amino Acids, Supplements, Amino Acids, Dicarboxylic, Alimentary Tract and Metabolism, Excitatory Amino Acids, Gastrointestinal Acidifying Agents, Digestives, Incl. Enzymes, Acid Preparations, Glutamates, Dietary Supplements, Gastrointestinal Agents	approved, nutraceutical	62
DB01472	4-Methoxyamphetamine	Drug	Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, Adrenergic alpha-Agonists, Amines, Cytochrome P-450 Substrates, Adrenergic alpha-1 Receptor Agonists, Agents producing tachycardia, Hallucinogens, Phenethylamines, Psychotropic Drugs, Ethylamines, Central Nervous System Depressants, Adrenergic Agonists, Agents that produce hypertension, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates	illicit, experimental	7
DB00147	Pyridoxal	Drug	Micronutrients, Pyridines, Physiological Phenomena, Food and Beverages, Vitamin B Complex, Growth Substances, Dietary Supplements, Diet, Food, and Nutrition, Picolines, Supplements, Vitamins, Food	nutraceutical, experimental	1
DB01479	BA-2664	Drug	0	illicit, experimental	0
DB00148	Creatine	Drug	Amidines, Amino Acids, Peptides, and Proteins, Guanidines, Dietary Supplements, Amino Acids, Supplements	approved, investigational, nutraceutical	6
DB01478	Desmethylprodine	Drug	Piperidines, Isonipecotic Acids	illicit, experimental	0
DB01477	Codeine methylbromide	Drug	0	illicit, experimental	0
DB00145	Glycine	Drug	Glycine Agents, Neurotransmitter Agents, Blood and Blood Forming Organs, Amino Acids, Peptides, and Proteins, Blood Substitutes and Perfusion Solutions, Irrigating Solutions, Dietary Supplements, Amino Acids, Supplements	approved, nutraceutical, vet_approved	25
DB00146	Calcifediol	Drug	Cholestanes, Secosteroids, Lipids, Fused-Ring Compounds, Vitamins, Micronutrients, Physiological Phenomena, Sterols, Vitamin D and Analogues, Alimentary Tract and Metabolism, Vitamins (Fat Soluble), Food and Beverages, Bone Density Conservation Agents, Membrane Lipids, Cholestenes, Growth Substances, Diet, Food, and Nutrition, Food, Steroids	approved, nutraceutical	1
DB01476	Haloxazolam	Drug	Heterocyclic Compounds, Fused-Ring, Benzazepines	illicit, experimental	0
DB00149	Leucine	Drug	Amino Acids, Essential, Amino Acids, Branched-Chain, Amino Acids, Peptides, and Proteins, Dietary Supplements, Amino Acids, Supplements	investigational, nutraceutical	6
DB14780	Pegzilarginase	Drug	0	investigational	0
DB14781	Vofatamab	Drug	0	investigational	0
DB12132	Vanutide cridificar	Drug	Proteins, Amino Acids, Peptides, and Proteins, Recombinant Proteins	investigational	0
DB14795	AZD-3759	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB13464	Ornipressin	Drug	Vasopressin and Analogues, Hormones, Hormone Substitutes, and Hormone Antagonists, Oligopeptides, Peptides, Pituitary Hormones, Pituitary and Hypothalamic Hormones and Analogues, Amino Acids, Peptides, and Proteins, Hematologic Agents, Neuropeptides, Cardiovascular Agents, Coagulants, Nerve Tissue Proteins, Hormones, Proteins, Peptide Hormones, Vasoconstrictor Agents, Pituitary Hormones, Posterior, Posterior Pituitary Lobe Hormones, Hemostatics, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Vasopressins	experimental	0
DB12131	Vinpocetine	Drug	Neuroprotective Agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Nervous System, Agents causing hyperkalemia, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Indole Alkaloids, Alkaloids, Indoles, Compounds used in a research, industrial, or household setting, Bradycardia-Causing Agents, Antiarrhythmic agents, Phosphodiesterase Inhibitors, Protective Agents, Psychostimulants, Agents Used for Adhd and Nootropics, Secologanin Tryptamine Alkaloids, Calcium Channel Blockers, Heterocyclic Compounds, Fused-Ring, Anticonvulsants, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Central Nervous System Agents, Vasodilating Agents, Nootropic Agents, Psychoanaleptics	investigational	0
DB13465	Ciclobendazole	Drug	Heterocyclic Compounds, Fused-Ring, Antiparasitic Products, Insecticides and Repellents, Anthelmintics, Antinematodal Agents, Antiparasitic Agents, Benzimidazole Derivatives	experimental	0
DB14796	Talacotuzumab	Drug	0	investigational	0
DB13462	Bephenium	Drug	Antiparasitic Products, Insecticides and Repellents, Anthelmintics, Antinematodal Agents, Antiparasitic Agents	experimental	0
DB12134	Gepotidacin	Drug	Heterocyclic Compounds, Fused-Ring, Naphthalenes	investigational	0
DB14793	RO-5045337	Drug	0	investigational	0
DB13463	Oxetorone	Drug	Heterocyclic Compounds, Fused-Ring, Analgesics, Nervous System, Antimigraine Preparations	experimental	0
DB14794	Glepaglutide	Drug	0	investigational	0
DB12133	BLXA4	Drug	0	investigational	0
DB12136	Solnatide	Drug	Peptides, Amino Acids, Peptides, and Proteins	investigational	0
DB14799	PF-06821497	Drug	0	investigational	0
DB13468	Etybenzatropine	Drug	Anticholinergic Agents, Alkaloids, Ethers of Tropine or Tropine Derivatives, Nervous System, Aza Compounds, Agents producing tachycardia, Azabicyclo Compounds, Muscarinic Antagonists, Anti-Parkinson Drugs	experimental	0
DB13469	Phanquinone	Drug	Heterocyclic Compounds, Fused-Ring, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals	experimental	0
DB12135	Elubrixin	Drug	Receptors, Interleukin-8B, antagonists & inhibitors, Sulfur Compounds, Amides, Benzene Derivatives, Sulfones	investigational	0
DB13466	Deptropine	Drug	Alkaloids, Neurotransmitter Agents, Histamine H1 Antagonists, Histamine Antagonists, Aza Compounds, Azabicyclo Compounds, Histamine Agents, Antihistamines for Systemic Use	experimental	0
DB14797	SEphB4-HSA	Drug	0	investigational	0
DB12138	PF-03715455	Drug	Aza Compounds, p38 Mitogen-Activated Protein Kinases, antagonists & inhibitors	investigational	0
DB14798	Afasevikumab	Drug	0	investigational	0
DB13467	Lanatoside C	Drug	Carbohydrates, Cardanolides, Cardiac Glycosides, Digitalis Glycosides, Glycosides, Cardenolides, Cardiac Therapy, Fused-Ring Compounds, Steroids	experimental	0
DB12137	GSK-256066	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Phosphodiesterase Inhibitors, Enzyme Inhibitors, Sulfur Compounds, Phosphodiesterase 4 Inhibitors	investigational	0
DB12139	Alisporivir	Drug	Peptides, Cyclic, Peptides, Amino Acids, Peptides, and Proteins, Cyclosporin Derivatives	investigational	0
DB00150	Tryptophan	Drug	Amino Acids, Aromatic, Nervous System, Amino Acids, Essential, Tryptophan, Amino Acids, Peptides, and Proteins, Antidepressive Agents, Second-Generation, Antidepressive Agents, Psychotropic Drugs, Amino Acids, Supplements, Amino Acids, Cyclic, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Miscellaneous Antidepressants, Central Nervous System Agents, Dietary Supplements, Psychoanaleptics	approved, nutraceutical, withdrawn	3
DB01482	Fenethylline	Drug	Central Nervous System Stimulants, Amines, Cytochrome P-450 Substrates, Nervous System, Psychostimulants, Agents Used for Adhd and Nootropics, Phenethylamines, Centrally Acting Sympathomimetics, Alkaloids, Heterocyclic Compounds, Fused-Ring, Purines, Ethylamines, Cytochrome P-450 CYP1A2 Substrates, Xanthine derivatives, Central Nervous System Agents, Purinones, Psychoanaleptics	experimental	0
DB01481	1-Testosterone	Drug	Androstanes, Testosterone and derivatives, Hormones, Hormone Substitutes, and Hormone Antagonists, Androstenols, Androstenes, Testosterone Congeners, Hormones, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Steroids	illicit, investigational, experimental	1
DB00151	Cysteine	Drug	Amino Acids, Neutral, Cysteine, Sulfur Compounds, Caloric Agents, Amino Acids, Sulfur, Amino Acids, Peptides, and Proteins, Nutritional Support, Dietary Supplements, Amino Acids, Supplements, Sulfhydryl Compounds	approved, nutraceutical	13
DB01480	Cyprenorphine	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids	illicit, experimental	0
DB01486	Cathine	Drug	Centrally Acting Antiobesity Products, Amines, Appetite Depressants, Propanols, Alimentary Tract and Metabolism, Anti-Obesity Agents, Antiobesity Preparations, Excl. Diet Products, Amino Alcohols, Alcohols, Propanolamines	illicit, experimental	0
DB00154	Dihomo-gamma-linolenic acid	Drug	Biological Factors, Autacoids, Fatty Acids, Unsaturated, Inflammation Mediators, Fatty Acids, Eicosanoids, Lipids, Dietary Supplements, Supplements	investigational, nutraceutical	2
DB01485	4-Hydroxytestosterone	Drug	Androstanes, Testosterone and derivatives, Hormones, Hormone Substitutes, and Hormone Antagonists, Androstenols, Androstenes, Testosterone Congeners, Hormones, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Steroids	illicit, experimental	0
DB00155	Citrulline	Drug	Proteins, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, OAT1/SLC22A6 Substrates, Dietary Supplements, Amino Acids, Supplements, OAT3/SLC22A8 Substrates	approved, investigational, nutraceutical	13
DB01484	4-Bromo-2,5-dimethoxyamphetamine	Drug	Amines, Serotonin Agents, Serotonin Receptor Agonists, Agents producing tachycardia, Antidepressive Agents, Hallucinogens, Phenethylamines, Psychotropic Drugs, Neurotransmitter Agents, Ethylamines, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Sympathomimetics, Central Nervous System Depressants, Agents that produce hypertension, Amphetamines, Central Nervous System Agents	illicit, experimental	0
DB00152	Thiamine	Drug	OCT1 substrates, Vitamins, Micronutrients, Pyrimidines, Sulfur Compounds, Physiological Phenomena, Alimentary Tract and Metabolism, OCT2 Inhibitors, Food and Beverages, Thiazoles, Vitamin B Complex, Growth Substances, Diet, Food, and Nutrition, Food	approved, investigational, nutraceutical, vet_approved	1
DB01483	Barbital	Drug	Psycholeptics, Cytochrome P-450 Substrates, GABA Agents, Nervous System, GABA Modulators, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP2C19 Inducers (strength unknown), Pyrimidinones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Nicotinic Antagonists, Anticholinergic Agents, Cytochrome P-450 CYP2C19 Substrates, Neurotransmitter Agents, Anticonvulsants, Cytochrome P-450 Enzyme Inducers, Pyrimidines, Central Nervous System Depressants, Cytochrome P-450 CYP2C19 Inducers, Barbiturates, Plain, Hypnotics and Sedatives, Central Nervous System Agents, Barbiturates	illicit	10
DB00153	Ergocalciferol	Drug	Secosteroids, Lipids, Fused-Ring Compounds, Vitamins, Micronutrients, Physiological Phenomena, Vitamin D and Analogues, Alimentary Tract and Metabolism, Vitamins (Fat Soluble), Food and Beverages, Bone Density Conservation Agents, Calcium-Regulating Hormones and Agents, Growth Substances, Diet, Food, and Nutrition, Food	approved, nutraceutical	2
DB00158	Folic acid	Drug	Hematinics, Biological Factors, Autacoids, Hematologic Agents, Pteridines, Drugs that are Mainly Renally Excreted, Supplements, Vitamins, OAT1/SLC22A6 inhibitors, Heterocyclic Compounds, Fused-Ring, Micronutrients, Antianemic Preparations, BCRP/ABCG2 Substrates, Pterins, Folic Acid and Derivatives, Food and Beverages, Vitamin B Complex, Growth Substances, Dietary Supplements, Diet, Food, and Nutrition, Food, VITAMIN B12 AND FOLIC ACID	approved, nutraceutical, vet_approved	3
DB01489	Camazepam	Drug	Heterocyclic Compounds, Fused-Ring, Psycholeptics, Benzazepines, Nervous System, Central Nervous System Depressants, Benzodiazepines and benzodiazepine derivatives, Benzodiazepinones, Anti-Anxiety Agents	illicit, experimental	2
DB00159	Icosapent	Drug	Nephrotoxic agents, Fatty Acids, Anti-Inflammatory Agents, Agents causing hyperkalemia, Eicosanoids, Non COX-2 selective NSAIDS, Lipids, Dietary Fats, Unsaturated, Physiological Phenomena, Dietary Fats, Food and Beverages, Diet, Food, and Nutrition, Food, Anti-Inflammatory Agents, Non-Steroidal, Biological Factors, Autacoids, Hypolipidemic Agents, Inflammation Mediators, Oils, Supplements, Fatty Acids, Unsaturated, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Agents that produce hypertension, Fish Oils, Fats, Dietary Supplements, Fatty Acids, Omega-3	approved, nutraceutical	10
DB00156	Threonine	Drug	Amino Acids, Neutral, Amino Acids, Essential, Amino Acids, Peptides, and Proteins, Threonine, antagonists & inhibitors, Dietary Supplements, Amino Acids, Supplements	approved, nutraceutical	2
DB01488	Dimethyltryptamine	Drug	Amines, Serotonin Agents, Serotonin Receptor Agonists, Antidepressive Agents, Hallucinogens, Psychotropic Drugs, Biogenic Monoamines, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Biogenic Amines, Central Nervous System Agents, Indoles, Tryptamines	illicit, experimental	3
DB00157	NADH	Drug	Carbohydrates, Coenzymes, Enzymes and Coenzymes, Nucleotides, Supplements, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Adenine Nucleotides, Dietary Supplements	approved, nutraceutical	144
DB01487	Embutramide	Drug	Aminobenzoates, para-Aminobenzoates, Amines, Ammonium Compounds, Benzoates, Acids, Carbocyclic, Onium Compounds, Pharmaceutical Preparations, Benzene Derivatives, Nitrogen Compounds	illicit, experimental	0
DB13460	Ronifibrate	Drug	Lipid Modifying Agents, Lipid Modifying Agents, Plain, Lipid Regulating Agents, Agents Causing Muscle Toxicity, Fibric Acids	experimental	0
DB14791	GDC-0425	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB14792	AZD-5991	Drug	Antineoplastic Agents	investigational	0
DB13461	Cefcapene	Drug	Nephrotoxic agents, Anti-Bacterial Agents, Cephalosporins, Third-Generation Cephalosporins, Antiinfectives for Systemic Use, Antibacterials for Systemic Use	experimental	0
DB12130	Lorlatinib	Drug	Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, UGT1A3 substrates, Antineoplastic Agents, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Amides, Lactams, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 Enzyme Inducers, Protein Kinase Inhibitors, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2C8 Substrates, Kinase Inhibitor	approved, investigational	1
DB14790	BPN-14770	Drug	0	investigational	0
DB12143	Rezatomidine	Drug	0	investigational	0
DB13475	Furazidin	Drug	Renal Agents, Anti-Infective Agents, Urinary, Nitro Compounds, Nitrofuran Derivatives, Nitrofurans, Furans, Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use	experimental	0
DB12142	Duligotuzumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Immunoglobulin Isotypes, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB13476	Diisopromine	Drug	Alimentary Tract and Metabolism, Drugs for Functional Gastrointestinal Disorders	experimental	0
DB13473	Antimony pentasulfide	Drug	Metalloids, Metals, Ions, Metals, Heavy, Elements, Gases, Anions, Sulfur Compounds, Acids, Noncarboxylic, Acids, Cough and Cold Preparations, Expectorants, Air Pollutants, Hydrogen Sulfide, Electrolytes	experimental	0
DB12145	AZD-0328	Drug	Receptors, Nicotinic	investigational	0
DB12144	BMS-275183	Drug	0	investigational	0
DB13474	Tipepidine	Drug	Cough and Cold Preparations	experimental	0
DB12147	Erdafitinib	Drug	Cytochrome P-450 Substrates, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic Agents, Receptors, Fibroblast Growth Factor, antagonists & inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Substrates, OCT2 Inhibitors, P-glycoprotein inhibitors, P-glycoprotein substrates with narrow therapeutic index, Tumor Suppressor Proteins	approved, investigational	10
DB13479	Histapyrrodine	Drug	Antihistamines for Systemic Use, Substituted Ethylene Diamines	experimental	0
DB12146	Rigosertib	Drug	Enzyme Inhibitors, Protein Kinase Inhibitors, Sulfur Compounds, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Amino Acids	investigational	0
DB13477	Sodium apolate	Drug	Alkenes, Sulfur Acids, Hydrocarbons, Acyclic, Vinyl Compounds, Macromolecular Substances, Vasoprotectives, Sulfur Compounds, Acids, Noncarboxylic, Acids, Polyenes, Antivaricose Therapy, Plastics, Polymers, Compounds used in a research, industrial, or household setting, Phosphogluconate Dehydrogenase, antagonists & inhibitors	experimental	0
DB12149	S-3304	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Sulfur Compounds, Protease Inhibitors, Matrix Metalloproteinase Inhibitors	investigational	0
DB13478	Meptazinol	Drug	Opioid Antagonists, Sensory System Agents, Analgesics, Narcotics, Nervous System, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Opioids, Central Nervous System Agents, Azepines, Peripheral Nervous System Agents	experimental	0
DB12148	Menatetrenone	Drug	Quinones, Vitamins (Fat Soluble), Phytol, Naphthoquinones, Diterpenes, Hematologic Agents, Coagulants, Hemostatics, Terpenes, Vitamins, Naphthalenes, Vitamin K	investigational	0
DB01493	Ethylestrenol	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, Alimentary Tract and Metabolism, Norsteroids, Anabolic Steroids, Anabolic Agents, Anabolic Agents for Systemic Use, Estren Derivatives, Hormones, Norpregnenes, Norpregnanes, Fused-Ring Compounds, Steroids	withdrawn	0
DB00161	Valine	Drug	Valine, Amino Acids, Essential, Amino Acids, Branched-Chain, Amino Acids, Peptides, and Proteins, Dietary Supplements, Amino Acids	approved, nutraceutical	3
DB00162	Vitamin A	Drug	Immunologic Factors, Alkenes, Retinoids for Topical Use in Acne, Cyclohexenes, Retinoids, Cyclohexanes, Antioxidants, Vitamin A, Nasal Preparations, Carotenoids, Physiological Phenomena, Alimentary Tract and Metabolism, Food and Beverages, Polyenes, Tests for Fat Absorption, Anticarcinogenic Agents, Growth Substances, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food, Biological Factors, Cycloparaffins, Adjuvants, Immunologic, Protective Agents, Dermatologicals, Anti-Acne Preparations, Vitamins, Pigments, Biological, Ophthalmologicals, Micronutrients, Vitamins (Fat Soluble), Diagnostic Agents, Sensory Organs, Terpenes, Anti-Acne Preparations for Topical Use	approved, nutraceutical, vet_approved	15
DB01491	Dipipanone	Drug	Ketones	illicit, experimental	0
DB01490	Aminorex	Drug	Oxazoles	illicit, experimental	0
DB00160	Alanine	Drug	Alanine, Amino Acids, Peptides, and Proteins, Dietary Supplements, Amino Acids, Supplements	nutraceutical	13
DB00165	Pyridoxine	Drug	Pyridines, Antimycobacterials, Antiinfectives for Systemic Use, Drugs that are Mainly Renally Excreted, Picolines, Vitamins, Micronutrients, Drugs for Treatment of Tuberculosis, Alimentary Tract and Metabolism, Food and Beverages, Analogs/Derivatives, Vitamin B Complex, Diet, Food, and Nutrition, Food	approved, investigational, nutraceutical, vet_approved	1
DB01497	Etorphine	Drug	Sensory System Agents, Narcotics, Morphinans, Peripheral Nervous System Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Opioids, Central Nervous System Agents	illicit, vet_approved	6
DB01496	Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione	Drug	Anticholinergic Agents, Nicotinic Antagonists	illicit, experimental	10
DB00166	Lipoic acid	Drug	Coenzymes, Fatty Acids, Various Alimentary Tract and Metabolism Products, Protective Agents, Hypoglycemia-Associated Agents, Enzymes and Coenzymes, Lipids, Supplements, Vitamins, Antioxidants, Micronutrients, Sulfur Compounds, Physiological Phenomena, Thiophenes, Alimentary Tract and Metabolism, Food and Beverages, Vitamin B Complex, Growth Substances, Compounds used in a research, industrial, or household setting, Dietary Supplements, Diet, Food, and Nutrition, Food	approved, investigational, nutraceutical	3
DB00163	Vitamin E	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Antioxidants, Cytochrome P-450 Enzyme Inducers, Basic Ointments and Protectants, Physiological Phenomena, Vitamin E, Food and Beverages, Growth Substances, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food, Protective Agents, Cytochrome P-450 CYP3A4 Inducers, Benzopyrans, Vitamin E, analogs & derivatives, Supplements, Vitamins, Heterocyclic Compounds, Fused-Ring, Micronutrients, Cytochrome P-450 CYP3A Substrates, Vitamins (Fat Soluble), Dietary Supplements, Pyrans	approved, nutraceutical, vet_approved	10
DB01495	Dichloralphenazone	Drug	Psycholeptics, Nervous System, Central Nervous System Depressants, Ethylene Glycols, Pyrazoles, Glycols, Hypnotics and Sedatives, Pyrazolones, Alcohols	approved, illicit	0
DB01494	Chloral betaine	Drug	0	illicit, withdrawn	0
DB00169	Cholecalciferol	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cholestanes, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Lipids, Cytochrome P-450 CYP3A4 Substrates, Cholecalciferol, antagonists & inhibitors, Fused-Ring Compounds, Physiological Phenomena, Sterols, Vitamin D and Analogues, Alimentary Tract and Metabolism, Musculo-Skeletal System, Food and Beverages, Bone Density Conservation Agents, Calcium-Regulating Hormones and Agents, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Membrane Lipids, Growth Substances, Diet, Food, and Nutrition, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Food, Secosteroids, Cytochrome P-450 CYP2C8 Inhibitors, Drugs Affecting Bone Structure and Mineralization, Vitamins, Micronutrients, Cytochrome P-450 CYP3A Substrates, Vitamins (Fat Soluble), Drugs for Treatment of Bone Diseases, Cholestenes, Steroids	approved, nutraceutical	1
DB00167	Isoleucine	Drug	Amino Acids, Essential, Amino Acids, Branched-Chain, Amino Acids, Peptides, and Proteins, Dietary Supplements, Amino Acids, Supplements	investigational, nutraceutical	5
DB01499	Alphameprodine	Drug	0	illicit, experimental	0
DB01498	Alphamethadol	Drug	0	illicit, experimental	0
DB00168	Aspartame	Drug	Food Additives, Oligopeptides, Peptides, Flavoring Agents, Amino Acids, Peptides, and Proteins, Pharmaceutic Aids, Supplements, OAT1/SLC22A6 inhibitors, Physiological Phenomena, Food and Beverages, Dipeptides, Food Ingredients, Pharmaceutical Preparations, OAT3/SLC22A8 Inhibitors, Compounds used in a research, industrial, or household setting, Dietary Supplements, Diet, Food, and Nutrition, Food, Sweetening Agents	investigational, nutraceutical	3
DB13471	Nalfurafine	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, Receptors, Opioid, kappa, agonists	investigational, experimental	0
DB13472	Cyclofenil	Drug	Sex Hormones and Modulators of the Genital System, Selective Estrogen Receptor Modulators, Cresols, Genito Urinary System and Sex Hormones, Reproductive Control Agents, Fertility Agents, Female, Phenols, Ovulation Stimulants, Synthetic, Benzene Derivatives, Fertility Agents	experimental	0
DB12141	Gilteritinib	Drug	QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Tyrosine Kinase Inhibitors, P-glycoprotein substrates, OCT1 inhibitors, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, MATE inhibitors, MATE 1 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Moderate Risk QTc-Prolonging Agents, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates	approved, investigational	4
DB13470	Cefodizime	Drug	Nephrotoxic agents, Third-Generation Cephalosporins, Cephacetrile, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Antibacterials for Systemic Use	experimental	0
DB12140	Dilmapimod	Drug	Pyridines, p38 Mitogen-Activated Protein Kinases, antagonists & inhibitors	investigational	3
DB14730	Calaspargase pegol	Drug	Amidohydrolases, Enzymes, Ethylene Glycols, Asparagine-specific Enzyme, Enzymes and Coenzymes, Hydrolases, Glycols, Polymers, Compounds used in a research, industrial, or household setting, Alcohols, Macromolecular Substances	approved	1
DB14733	Ceftobiprole medocaril	Drug	Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use	investigational, experimental	0
DB13402	Acetylglycinamide chloral hydrate	Drug	Psycholeptics, Nervous System, Central Nervous System Depressants, Hypnotics and Sedatives	experimental	0
DB14734	Cannabigerol	Drug	Terpenes	experimental	0
DB13403	Oxypertine	Drug	Psycholeptics, Antipsychotic Agents, Nervous System, Central Nervous System Depressants, Indole Derivatives, Neurotoxic agents	experimental	0
DB14731	Tagraxofusp	Drug	Proteins, Narrow Therapeutic Index Drugs, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Recombinant Proteins, Recombinant Fusion Proteins	approved, investigational	2
DB13400	Linsidomine	Drug	Enzyme Inhibitors, Oxadiazoles, Oxazines, Sydnones, Hematologic Agents, Cardiovascular Agents, Morpholines, Sodium-Potassium-Exchanging ATPase, antagonists & inhibitors, Nitric Oxide Donors, Oxazoles, Vasodilators Used in Cardiac Diseases, Antihypertensive Agents, Vasodilating Agents, Cardiac Therapy, Antiplatelet agents	experimental	0
DB13401	Metildigoxin	Drug	Carbohydrates, Cardanolides, Cardiac Glycosides, Enzyme Inhibitors, Protective Agents, Digoxin and derivatives, Cardiovascular Agents, Fused-Ring Compounds, Cardiotonic Agents, Digitalis Glycosides, Glycosides, Cardenolides, Cardiac Therapy, Compounds used in a research, industrial, or household setting, Antiarrhythmic agents, Steroids	experimental	0
DB14732	Queuine	Drug	Heterocyclic Compounds, Fused-Ring, Purines, Purinones	nutraceutical, experimental	0
DB13406	Carbutamide	Drug	Cytochrome P-450 CYP2C9 Substrates, Sulfur Compounds, Cytochrome P-450 Substrates, Alimentary Tract and Metabolism, Sulfonylureas, Drugs Used in Diabetes, Blood Glucose Lowering Agents, Sulfones	experimental	0
DB14737	Cannabinol	Drug	Cannabinoids and similars, Terpenes	investigational, experimental	0
DB13407	Nifenazone	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Pyridines, Sensory System Agents, Nervous System, Anti-Inflammatory Agents, Pyrazoles, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Antiinflammatory Preparations, Non-Steroids for Topical Use, Nicotinic Acids, Topical Products for Joint and Muscular Pain, Pyrazolones, Peripheral Nervous System Agents, Analgesics, Musculo-Skeletal System, Agents that produce hypertension, Central Nervous System Agents	experimental	0
DB14738	Turoctocog alfa pegol	Drug	Proteins, Biological Factors, Blood Proteins, Blood Coagulation Factors, Factor VIII, Amino Acids, Peptides, and Proteins, Hemostatics, Recombinant Proteins	approved	3
DB14735	Cannabichromene	Drug	Terpenes	experimental	0
DB13404	Edetate sodium	Drug	Ophthalmologicals, Sensory Organs	experimental	0
DB14736	Cannabivarin	Drug	Terpenes	experimental	0
DB13405	Mefruside	Drug	Sulfur Compounds, Sulfonamides, Diuretics, Natriuretic Agents, Amides, Cardiovascular Agents, Low-Ceiling Diuretics, Excl. Thiazides, Sulfones	experimental	0
DB13408	Methylpropylpropanediol dinitrate	Drug	Antianginal Agents, Vasodilators Used in Cardiac Diseases, Vasodilating Agents, Cardiac Therapy, Organic Nitrates	experimental	0
DB14739	Phenolsulfonic acid	Drug	0	experimental	0
DB13409	Rokitamycin	Drug	Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Cytochrome P-450 CYP3A4 Inhibitors, Macrolides, Lincosamides and Streptogramins, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Antiinfectives for Systemic Use, Antibacterials for Systemic Use, Lactones	experimental	0
DB01420	Testosterone propionate	Drug	Cytochrome P-450 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein substrates, Androstenes, Hormones, UGT1A1 Inducers, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Gonadal Steroid Hormones, Androgens, Androstanes, Testosterone and derivatives, COMT Inhibitors, Cytochrome P-450 CYP3A Substrates, Androstenols, Testosterone Congeners, Thyroxine-binding globulin inhibitors, Gonadal Hormones, Steroids	approved, investigational, withdrawn, vet_approved	1
DB02751	Glycocyamine	Drug	Affinity Labels, Laboratory Chemicals, Amino Acids, Peptides, and Proteins, Indicators and Reagents, Compounds used in a research, industrial, or household setting, Amino Acids	experimental	1
DB02750	S-(Methylmercury)-L-Cysteine	Drug	0	experimental	1
DB02755	1-3 Sugar Ring of Pentamannosyl 6-Phosphate	Drug	0	experimental	1
DB01424	Aminophenazone	Drug	Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Cytochrome P-450 CYP2C18 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Anti-Inflammatory Agents, Pyrazoles, Agents causing hyperkalemia, Non COX-2 selective NSAIDS, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Pyrazolones, OAT1/SLC22A6 inhibitors, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Analgesics, Cytochrome P-450 CYP3A Substrates, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2C8 Substrates	approved, withdrawn	0
DB02754	9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine	Drug	0	experimental	2
DB01423	Stepronin	Drug	Immunologic Factors, Immunosuppressive Agents, Cough and Cold Preparations, Expectorants, Amino Acids, Peptides, and Proteins, Respiratory System Agents, Amino Acids, Anti-Infective Agents	experimental	0
DB02753	Selenoinosine	Drug	Selenium Compounds	experimental	1
DB01422	Nitroxoline	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Renal Agents, Anti-Infective Agents, Urinary, Nitro Compounds, Antifungal Agents, Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use	experimental	3
DB01421	Paromomycin	Drug	Nephrotoxic agents, Carbohydrates, Antiprotozoals, Agents that produce neuromuscular block (indirect), Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Anti-Bacterial Agents, Narrow Therapeutic Index Drugs, Intestinal Antiinfectives, Alimentary Tract and Metabolism, Aminoglycoside Antibacterials, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Glycosides, Antiparasitic Agents, Amebicides	approved, investigational	2
DB02752	Tosyl-D-Proline	Drug	0	experimental	1
DB01428	Oxybenzone	Drug	Radiation-Protective Agents, Ketones, Protective Agents, Dermatologicals, Cosmetics, Sunscreen Agents, Compounds used in a research, industrial, or household setting, Benzene Derivatives, Drugs that are Mainly Renally Excreted, Household Products	approved, investigational	4
DB02759	4-methyl-umbelliferyl-N-acetyl-chitobiose	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Polysaccharides, Coumarins, Benzopyrans, Umbelliferones, Muramidase, antagonists & inhibitors, Pyrans	experimental	1
DB01427	Amrinone	Drug	Aminopyridines, Phosphodiesterase Inhibitors, Pyridines, Enzyme Inhibitors, Amines, Protective Agents, Phosphodiesterase 3 Inhibitors, Cardiovascular Agents, Drugs that are Mainly Renally Excreted, Membrane Transport Modulators, Cardiotonic Agents, Cardiac Stimulants Excl. Cardiac Glycosides, Calcium-Regulating Hormones and Agents, Vasodilating Agents, Cardiac Therapy, Compounds used in a research, industrial, or household setting	approved	5
DB02758	Indolepropionic acid	Drug	Acids, Acyclic, Heterocyclic Compounds, Fused-Ring, Fatty Acids, Fatty Acids, Volatile, Lipids	experimental	3
DB02757	Pyrazole	Drug	Enzyme Inhibitors, Alcohol Dehydrogenase, antagonists & inhibitors	experimental	3
DB01426	Ajmaline	Drug	QTc Prolonging Agents, Voltage-Gated Sodium Channel Blockers, Ajmaline and derivatives, Cardiovascular Agents, Secologanin Tryptamine Alkaloids, Membrane Transport Modulators, Indole Alkaloids, Alkaloids, Heterocyclic Compounds, Fused-Ring, Antiarrhythmics, Class I, Potential QTc-Prolonging Agents, Indoles, Sodium Channel Blockers, Antiarrhythmics, Class Ia, Cardiac Therapy, Antiarrhythmic agents, Antiarrhythmics, Class Ic	approved, experimental	1
DB02756	Pyroquilon	Drug	Heterocyclic Compounds, Fused-Ring, Antifungal Agents	experimental	0
DB01425	Alizapride	Drug	Autonomic Agents, Propulsives, Alimentary Tract and Metabolism, Antiemetics, Drugs for Functional Gastrointestinal Disorders, Central Nervous System Agents, Dopamine Antagonists, Dopamine D2 Receptor Antagonists, Gastrointestinal Agents, Peripheral Nervous System Agents	investigational	1
DB01429	Aprindine	Drug	Voltage-Gated Sodium Channel Blockers, Cytochrome P-450 Substrates, Antiarrhythmics, Class I, Indans, Cardiovascular Agents, Indenes, Cytochrome P-450 CYP2D6 Substrates, Sodium Channel Blockers, Antiarrhythmics, Class Ib, Cardiac Therapy, Membrane Transport Modulators, Antiarrhythmic agents	experimental	2
DB14740	Hyaluronidase	Drug	Enzymes, Blood and Blood Forming Organs, Glycoside Hydrolases, Enzymes and Coenzymes, Carbon-Oxygen Lyases, Hydrolases, Lyases, Polysaccharide-Lyases, Hyaluronoglucosaminidase, antagonists & inhibitors	approved	2
DB13410	Guanoxabenz	Drug	Guanidine Derivatives, Antiadrenergic Agents, Peripherally Acting, Amidines, Guanidines, Antihypertensive Agents	experimental	0
DB14741	Luteinizing hormone	Drug	Gonadotropins, Pituitary, Peptide Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pituitary Hormones, Amino Acids, Peptides, and Proteins, Gonadotropins, Hormones, Pituitary Hormones, Anterior	approved	0
DB14744	Spirulina platensis	Drug	0	experimental	0
DB13413	Phenglutarimide	Drug	Anticholinergic Agents, Neurotransmitter Agents, Cholinergic Agents, Nervous System, Piperidines, Agents producing tachycardia, Muscarinic Antagonists, Piperidones, Tertiary Amines, Anti-Parkinson Drugs	experimental	0
DB14745	Olea europaea leaf	Drug	0	experimental	0
DB13414	Fenyramidol	Drug	Central Nervous System Depressants, Musculo-Skeletal System, Muscle Relaxants, Centrally Acting Agents, Muscle Relaxants	experimental	0
DB13411	Lofepramine	Drug	Cytochrome P-450 Substrates, Nervous System, Dibenzazepines, Antidepressive Agents, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Non-Selective Monoamine Reuptake Inhibitors, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Antidepressive Agents, Tricyclic, Agents that produce hypertension, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates, Agents that reduce seizure threshold, Neurotoxic agents, Psychoanaleptics	experimental	0
DB14743	Avenanthramides	Drug	0	experimental	0
DB13412	Pirisudanol	Drug	Nervous System, Psychostimulants, Agents Used for Adhd and Nootropics, Psychoanaleptics	experimental	0
DB14748	Polygala tenuifolia root	Drug	0	experimental	0
DB13417	Morinamide	Drug	Drugs for Treatment of Tuberculosis, Antimycobacterials, Antiinfectives for Systemic Use	experimental	0
DB13418	Moxestrol	Drug	Norpregnatrienes, Sex Hormones and Modulators of the Genital System, Hormones, Hormone Substitutes, and Hormone Antagonists, Norsteroids, Estrogens, Genito Urinary System and Sex Hormones, Synthetic Estrogens, Plain, Estrogenic Steroids, Alkylated, Hormones, Fused-Ring Compounds, Gonadal Steroid Hormones, Estrogen Antagonists, Estradiol Congeners, Hormone Antagonists, Norpregnanes, Gonadal Hormones, Steroids	experimental	0
DB14749	Polygala senega root	Drug	Cough and Cold Preparations, Expectorants	experimental	0
DB13415	Pentetrazol	Drug	Neurotransmitter Agents, Central Nervous System Stimulants, GABA Agents, Convulsants, Central Nervous System Agents, Respiratory System Agents, Azepines, GABA Antagonists	experimental	0
DB14746	Lauryl glucoside	Drug	0	experimental	0
DB14747	Ephedra sinica stem	Drug	0	experimental	0
DB13416	Sulbutiamine	Drug	Pyrimidines, Sulfur Compounds, Alimentary Tract and Metabolism, Thiazoles, Vitamin B Complex, Vitamins	experimental	0
DB13419	Troxipide	Drug	Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Alimentary Tract and Metabolism, Drugs for Acid Related Disorders	experimental	0
DB01431	Allylestrenol	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, Adrenal Cortex Hormones, Estrenes, Genito Urinary System and Sex Hormones, Hormones, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Progestins, Estren Derivatives, Steroids	experimental	2
DB02762	RU79072	Drug	0	experimental	1
DB02761	S-Mercaptocysteine	Drug	0	experimental	9
DB01430	Almitrine	Drug	Triazines, Neuroprotective Agents, Piperazines, Protective Agents, Respiratory System Agents, Secologanin Tryptamine Alkaloids, Indole Alkaloids, Alkaloids, Heterocyclic Compounds, Fused-Ring, Pharmaceutical Preparations, Central Nervous System Agents, Indoles, Compounds used in a research, industrial, or household setting	approved	1
DB00100	Coagulation Factor IX (Recombinant)	Drug	Increased Coagulation Activity, Blood Coagulation Factors, Hemostatics	approved, investigational	7
DB02760	1,6-Di-O-Phosphono-D-Allitol	Drug	0	experimental	0
DB02766	N-[(2R)-4-diazonio-3-oxoniumylidene-1-phenylbutan-2-yl]-1-phenylmethoxymethanimidate	Drug	0	experimental	1
DB00103	Agalsidase beta	Drug	Proteins, Enzymes, Glycoside Hydrolases, Alimentary Tract and Metabolism, Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme, Protein Isoforms, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Hydrolases, Galactosidases	approved, investigational	1
DB01435	Antipyrine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Nephrotoxic agents, Cytochrome P-450 Substrates, Sensory System Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Anti-Inflammatory Agents, Agents causing hyperkalemia, Otologicals, Non COX-2 selective NSAIDS, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Pyrazolones, Peripheral Nervous System Agents, Analgesics, Cytochrome P-450 CYP2C8 Substrates, Analgesics and Anesthetics, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 CYP2C18 Substrates, Pyrazoles, OAT1/SLC22A6 inhibitors, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2A6 Substrates, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Methemoglobinemia Associated Agents, Sensory Organs	approved, investigational	2
DB02765	R-9-(2-hydroxypropyl)adenine	Drug	0	experimental	1
DB01434	19-norandrostenedione	Drug	Androstanes, Hormones, Hormone Substitutes, and Hormone Antagonists, 17-Ketosteroids, Adrenal Cortex Hormones, Androstenes, Testosterone Congeners, Hormones, Ketosteroids, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Steroids	illicit, experimental	0
DB00104	Octreotide	Drug	QTc Prolonging Agents, Antineoplastic Agents, Hormonal, Miscellaneous Therapeutic Agents, Cytochrome P-450 Enzyme Inhibitors, Peptides, Hypoglycemia-Associated Agents, Pituitary and Hypothalamic Hormones and Analogues, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Peptides, Cyclic, Cytochrome P-450 CYP3A Inhibitors, Somatostatin Receptor Agonists, Cytochrome P-450 CYP3A4 Inhibitors, Hypothalamic Hormones, Potential QTc-Prolonging Agents, Somatostatin and Analogues, Hyperglycemia-Associated Agents, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Bradycardia-Causing Agents, Cytochrome P-450 CYP3A4 Inhibitors (weak), Gastrointestinal Agents	approved, investigational	1
DB01433	Methadyl acetate	Drug	Sensory System Agents, Analgesics, Ketones, Narcotics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Opioids, Central Nervous System Agents, Peripheral Nervous System Agents	illicit, experimental	1
DB00102	Becaplermin	Drug	Human Platelet-derived Growth Factor, Angiogenesis Inducing Agents, Peptides, Calcium Compounds, Oncogene Proteins, Amino Acids, Peptides, and Proteins, Angiogenesis Modulating Agents, Proteins, Anions, Alimentary Tract and Metabolism, Neoplasm Proteins, Proto-Oncogene Proteins, Preparations for Treatment of Wounds and Ulcers, Growth Substances, DNA-Binding Proteins, Biological Factors, Proto-Oncogene Proteins c-sis, Dermatologicals, Intercellular Signaling Peptides and Proteins, Hematologic Agents, Ions, Phosphorus Compounds, Phosphorus Acids, Acids, Noncarboxylic, Acids, Phosphoric Acids, Blood Proteins, Electrolytes, Platelet-Derived Growth Factor, Stomatological Preparations, Cicatrizants	approved, investigational	3
DB02763	5-Mercapto-2-Nitro-Benzoic Acid	Drug	0	experimental	2
DB01432	Cholestyramine	Drug	Anticholesteremic Agents, Hypolipidemic Agents, Ion Exchange Resins, Noxae, Laboratory Chemicals, Hypolipidemic Agents Indicated for Hyperlipidemia, Benzylidene Compounds, Bile-acid Binding Activity, Macromolecular Substances, Lipid Modifying Agents, Lipid Modifying Agents, Plain, Lipid Regulating Agents, Styrenes, Polystyrenes, Styrene, Toxic Actions, Anion Exchange Resins, Plastics, Polymers, Bile Acid Sequestrants, Compounds used in a research, industrial, or household setting, Benzene Derivatives	approved, investigational	1
DB01439	3-Methylthiofentanyl	Drug	0	illicit, experimental	3
DB00107	Oxytocin	Drug	QTc Prolonging Agents, Oxytocin and Analogues, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pituitary Hormones, Genito Urinary System and Sex Hormones, Reproductive Control Agents, Pituitary and Hypothalamic Hormones and Analogues, Amino Acids, Peptides, and Proteins, Hormones, Uterotonic agents, Oxytocin, analogs & derivatives, Oxytocin, antagonists & inhibitors, Peptide Hormones, Increased Uterine Smooth Muscle Contraction or Tone, Pituitary Hormones, Posterior, Potential QTc-Prolonging Agents, Posterior Pituitary Lobe Hormones, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins	approved, vet_approved	2
DB01438	Phenazopyridine	Drug	Nephrotoxic agents, Aminopyridines, Pyridines, Amines, Antipruritics and Local Anesthetics, Genito Urinary System and Sex Hormones, Urologicals, Methemoglobinemia Associated Agents, Drugs that are Mainly Renally Excreted	approved	2
DB00108	Natalizumab	Drug	Immunologic Factors, Immunoglobulins, Immunosuppressive Agents, Antineoplastic and Immunomodulating Agents, Antibodies, Integrin Receptor Antagonist, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Selective Immunosuppressants, Immunoproteins, Proteins, Serum Globulins, Antibodies, Monoclonal, Humanized, Globulins, Blood Proteins, Immunomodulatory Agents	approved, investigational	4
DB02768	Tert-Butyloxycarbonyl Group	Drug	0	experimental	1
DB00105	Interferon alfa-2b	Drug	Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Adjuvants, Immunologic, Interferons, Antineoplastic and Immunomodulating Agents, Interferon alpha, Antineoplastic Agents, Alfa Interferons, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Myelosuppressive Agents, Cytochrome P-450 CYP1A2 Inhibitors, Narrow Therapeutic Index Drugs, Photosensitizing Agents, Hepatotoxic Agents, Drugs causing inadvertant photosensitivity	approved	2
DB01437	Glutethimide	Drug	Psycholeptics, Nervous System, Piperidinedione Derivatives, Central Nervous System Depressants, Piperidines, Hypnotics and Sedatives, Central Nervous System Agents, Piperidones	approved, illicit	2
DB00106	Abarelix	Drug	Endocrine Therapy, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Antineoplastic and Immunomodulating Agents, Amino Acids, Peptides, and Proteins, Hormone Antagonists and Related Agents, Hormone Antagonists	approved, investigational, withdrawn	1
DB01436	Alfacalcidol	Drug	Cholestanes, Secosteroids, Lipids, Drugs Affecting Bone Structure and Mineralization, Fused-Ring Compounds, Vitamins, Sterols, Vitamin D and Analogues, Alimentary Tract and Metabolism, Musculo-Skeletal System, Vitamins (Fat Soluble), Drugs for Treatment of Bone Diseases, Bone Density Conservation Agents, Membrane Lipids, Cholestenes, Steroids	approved, nutraceutical	3
DB02767	(R)-3-hydroxytetradecanoic acid	Drug	0	experimental	4
DB00109	Enfuvirtide	Drug	Peptide Fragments, Cytochrome P-450 Substrates, Peptides, Human Immunodeficiency Virus 1 Fusion Inhibitor, Viral Envelope Proteins, Viral Fusion Protein Inhibitors, Amino Acids, Peptides, and Proteins, Gene Products, env, Viral Proteins, Anti-Infective Agents, Viral Structural Proteins, Proteins, Antivirals for Systemic Use, Direct Acting Antivirals, Antigens, Viral, HIV Antigens, Antigens, Biological Factors, Cytochrome P-450 CYP2E1 Substrates, Fusion Protein Inhibitors, HIV Fusion Inhibitors, HIV Envelope Protein gp41, Human Immunodeficiency Virus Proteins, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Retroviridae Proteins, Membrane Fusion Proteins, Antiinfectives for Systemic Use, env Gene Products, Human Immunodeficiency Virus, Cytochrome P-450 CYP2C19 Substrates, Membrane Proteins, Polyproteins, Viral Fusion Proteins	approved, investigational	1
DB13420	Thiazinam	Drug	Heterocyclic Compounds, Fused-Ring, Antipsychotic Agents, Sulfur Compounds, Amines, Central Nervous System Depressants, Phenothiazines, Phenothiazine Derivatives, Antihistamines for Systemic Use, Neurotoxic agents, Propylamines	experimental	0
DB14751	Mecasermin rinfabate	Drug	Anterior Pituitary Lobe Hormones and Analogues, Somatropin and Somatropin Agonists, Pituitary and Hypothalamic Hormones and Analogues, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins	approved	3
DB13421	Edoxudine	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Dermatologicals, Glycosides, Nucleosides, Antiviral Agents, Deoxyribonucleosides, Anti-Infective Agents	approved, investigational, withdrawn	1
DB14752	Racephedrine	Drug	Adrenergic Agonists, Alpha-and Beta-adrenergic Agonists, Herbs and Natural Products, Sympathomimetic (Adrenergic) Agents	approved, experimental	0
DB14750	Cidoxepin	Drug	0	experimental	0
DB14755	beta-Isosparteine	Drug	0	experimental	0
DB13424	Clofenotane	Drug	Hydrocarbons, Chlorinated, Antiparasitic Products, Insecticides and Repellents, Ectoparasiticides, Incl. Scabicides, Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents, Hydrocarbons, Halogenated, Chlorine Containing Products	experimental	0
DB14756	meso-Tartaric acid	Drug	0	experimental	0
DB13425	Flutrimazole	Drug	Azole Antifungals, Imidazoles, Gynecological Antiinfectives and Antiseptics, Antifungals for Topical Use, Dermatologicals, Genito Urinary System and Sex Hormones, Antifungals for Dermatological Use, Antifungal Agents, Imidazole and Triazole Derivatives, Imidazole Derivatives, Anti-Infective Agents	experimental	0
DB13422	Nicofuranose	Drug	Lipid Modifying Agents, Lipid Modifying Agents, Plain, Pyridines, Nicotinic Acid and Derivatives, Cardiovascular Agents, Nicotinic Acids, Vasodilating Agents	experimental	0
DB14753	Hydroxystilbamidine	Drug	Stilbenes, Amidines, Benzylidene Compounds, Benzene Derivatives	approved	1
DB14754	Solriamfetol	Drug	Amino Acids, Aromatic, Acids, Acyclic, Adrenergic Uptake Inhibitors, OCT2 Substrates, Amino Acids, Essential, MATE 1 Substrates, Agents producing tachycardia, Amino Acids, Peptides, and Proteins, Antidepressive Agents, Amino Acids, Drugs that are Mainly Renally Excreted, Amino Acids, Cyclic, Central Nervous System Depressants, Agents that produce hypertension, Central Nervous System Agents, MATE substrates, Adrenergic Agents, Norepinephrine Reuptake Inhibitor, Dopamine Agents, Dopamine Uptake Inhibitors	approved	2
DB13423	Ferric hydroxide	Drug	Organometallic Compounds, Iron Trivalent, Oral Preparations, Antianemic Preparations, Blood and Blood Forming Organs, Iron Compounds, Iron Preparations	experimental	0
DB13428	Iobenzamic acid	Drug	Iodobenzoates, Benzoates, Contrast Media, Diagnostic Uses of Chemicals, Acids, Carbocyclic, Amides, Watersoluble, Hepatotropic X-Ray Contrast Media, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting, Benzene Derivatives	experimental	0
DB14759	Red pepper	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB13429	Tolonidine	Drug	Imidazolines, Imidazoles, Imidazoline Receptor Agonists, Antiadrenergic Agents, Centrally Acting, Antihypertensive Agents	experimental	0
DB14757	Agrostis gigantea top	Drug	0	approved	0
DB13427	Gold Au-198	Drug	Gold, Gold Isotopes, Anti-Inflammatory Agents, Therapeutic Radiopharmaceuticals, Metals, Radioisotopes, Metals, Heavy, Elements, Transition Elements, Isotopes	experimental	0
DB14758	Catfish	Drug	0	approved	0
DB01442	MMDA	Drug	Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, Amines, Serotonin Agents, Serotonin Receptor Agonists, Agents producing tachycardia, Antidepressive Agents, Phenethylamines, Ethylamines, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Sympathomimetics, Central Nervous System Depressants, Agents that produce hypertension, Amphetamines, Serotonin 5-HT2 Receptor Agonists	illicit, experimental	8
DB00110	Palivizumab	Drug	Fusion Protein Inhibitors, Immunoglobulins, Immune Sera and Immunoglobulins, Antibodies, Amino Acids, Peptides, and Proteins, Antiviral Agents, Antibodies, Monoclonal, Antiinfectives for Systemic Use, Anti-Infective Agents, Immunoproteins, Proteins, Serum Globulins, Antibodies, Monoclonal, Humanized, Specific Immunoglobulins, Globulins, Blood Proteins, Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody	approved, investigational	9
DB02773	(3-Chloro-4-Propoxy-Phenyl)-Acetic Acid	Drug	0	experimental	1
DB00111	Daclizumab	Drug	Immunologic Factors, Interleukin-2 Receptor Blocking Antibody, Immunoglobulins, Immunosuppressive Agents, Interleukin 2 Receptor-directed Antibody Interactions, Antineoplastic and Immunomodulating Agents, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Interleukin Inhibitors, Immunoproteins, Proteins, Serum Globulins, Antibodies, Monoclonal, Humanized, Globulins, Blood Proteins, Interleukin-2 Receptor Antagonist, Immunomodulatory Agents	investigational, withdrawn	12
DB02772	Sucrose	Drug	Food Additives, Carbohydrates, Disaccharides, Flavoring Agents, Oligosaccharides, Pharmaceutic Aids, Polysaccharides, Physiological Phenomena, Food and Beverages, Food Ingredients, Pharmaceutical Preparations, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food, Sweetening Agents	approved, investigational, experimental	14
DB01441	5-Methoxy-N,N-diisopropyltryptamine	Drug	Biological Factors, Autacoids, Inflammation Mediators, Amines, Biogenic Monoamines, Morphinans, Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, Morphine Derivatives, Biogenic Amines, Indoles, Tryptamines	illicit, experimental	0
DB01440	gamma-Hydroxybutyric acid	Drug	Acids, Acyclic, Anesthetics, General, Fatty Acids, Hydroxy Acids, Butyrates, Central Nervous System Depressants, Fatty Acids, Volatile, Central Nervous System Depression, Anesthetics, Intravenous, Lipids, Anesthetics, Decreased Central Nervous System Organized Electrical Activity	approved, illicit, investigational	2
DB02770	7-alpha-D-Ribofuranosyl-2-aminopurine-5'-phosphate	Drug	0	experimental	1
DB02777	Diundecyl Phosphatidyl Choline	Drug	0	experimental	0
DB01446	Indopan	Drug	Heterocyclic Compounds, Fused-Ring, Amines, Stimulants, Biogenic Amines, Indoles, Biogenic Monoamines	illicit, experimental	0
DB00114	Pyridoxal phosphate	Drug	Pyridines, Coenzymes, Enzymes and Coenzymes, Picolines, Supplements, Vitamins, Micronutrients, Physiological Phenomena, Alimentary Tract and Metabolism, Food and Beverages, Vitamin B Complex, Growth Substances, Dietary Supplements, Diet, Food, and Nutrition, Food	approved, investigational, nutraceutical	61
DB01445	Bufotenine	Drug	Biological Factors, Autacoids, Inflammation Mediators, Amines, N,N-Dimethyltryptamine, Amphibian Venoms, Hallucinogens, Psychotropic Drugs, Biogenic Monoamines, Toxins, Biological, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Complex Mixtures, Central Nervous System Depressants, Venoms, Biogenic Amines, Central Nervous System Agents, Indoles, Tryptamines, Monoamine Oxidase A Substrates, Fluids and Secretions, Bodily Secretions	illicit, experimental	0
DB02776	1-Hexadecanosulfonic Acid	Drug	0	experimental	2
DB00115	Cyanocobalamin	Drug	Blood and Blood Forming Organs, Vitamin B 12, biosynthesis, Drugs that are Mainly Renally Excreted, Vitamins, Heterocyclic Compounds, Fused-Ring, Micronutrients, Antianemic Preparations, Food and Beverages, Iron Preparations, Vitamin B Complex, Corrinoids, Growth Substances, Diet, Food, and Nutrition, Food, VITAMIN B12 AND FOLIC ACID	approved, nutraceutical	6
DB01444	Dimethylthiambutene	Drug	0	illicit, experimental	2
DB00112	Bevacizumab	Drug	Immunoglobulins, Vascular Endothelial Growth Factor-directed Antibody Interactions, Immunosuppressive Agents, Vascular Endothelial Growth Factor Inhibitor, Antineoplastic and Immunomodulating Agents, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Cardiotoxic antineoplastic agents, Experimental Unapproved Treatments for COVID-19, Growth Inhibitors, Angiogenesis Modulating Agents, Antibodies, Monoclonal, Angiogenesis Inhibitors, Vascular Endothelial Growth Factor Inhibitors, Immunoproteins, Proteins, Serum Globulins, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, Globulins, Blood Proteins	approved, investigational	9
DB00113	Technetium Tc-99m arcitumomab	Drug	Organometallic Compounds, Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Tumour Detection, Antibodies, Diagnostic Radiopharmaceuticals, Amino Acids, Peptides, and Proteins, Immunoproteins, Technetium (99Mtc) Compounds	experimental	1
DB02774	1,3-Propanediol	Drug	Glycols, Alcohols	experimental	2
DB01443	19-Nor-5-androstenedione	Drug	0	illicit, experimental	0
DB00118	Ademetionine	Drug	Amino Acids, Neutral, Carbohydrates, Ribonucleosides, Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Amino Acids, Essential, Cytochrome P-450 CYP2E1 Inhibitors (weak), Amino Acids, Sulfur, Amino Acids, Peptides, and Proteins, Purine Nucleosides, Amino Acids, Supplements, Heterocyclic Compounds, Fused-Ring, Purines, Sulfur Compounds, Nucleic Acids, Nucleotides, and Nucleosides, Alimentary Tract and Metabolism, Amino Acids and Derivatives, Glycosides, Nucleosides, Dietary Supplements	approved, investigational, nutraceutical	8
DB00119	Pyruvic acid	Drug	Pyruvates, Keto Acids, Dietary Supplements, Supplements	approved, investigational, nutraceutical	14
DB01448	19-Nor-4-androstenedione	Drug	0	illicit, experimental	0
DB00116	Tetrahydrofolic acid	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Coenzymes, Pterins, Folic Acid and Derivatives, Enzymes and Coenzymes, Vitamin B Complex, Dietary Supplements, Pteridines, Supplements, Vitamins, Pigments, Biological	nutraceutical	12
DB02779	Dodecyltrimethylammonium	Drug	Surface-Active Agents, Amines, Ammonium Compounds, Onium Compounds, Detergents, Compounds used in a research, industrial, or household setting, Household Products, Nitrogen Compounds	experimental	1
DB02778	2,5-Anhydroglucitol-1,6-Biphosphate	Drug	0	experimental	1
DB01447	4-Methylaminorex	Drug	Street Drugs, Central Nervous System Stimulants, Central Nervous System Agents	illicit, experimental	0
DB00117	Histidine	Drug	Amino Acids, Cyclic, Amino Acids, Essential, Amino Acids, Peptides, and Proteins, Dietary Supplements, Amino Acids, Supplements	investigational, nutraceutical	4
DB14762	Risankizumab	Drug	Immunoglobulins, Immunosuppressive Agents, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Misc. Skin and Mucous Membrane Agents, Selective Immunosuppressants, Immunoproteins, Proteins, Serum Globulins, Antibodies, Monoclonal, Humanized, Globulins, Blood Proteins	approved, investigational	1
DB13431	Proglumide	Drug	Amino Acids, Neutral, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Alimentary Tract and Metabolism, Amino Acids, Basic, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, Anti-Ulcer Agents, Drugs for Acid Related Disorders, Amino Acids, Gastrointestinal Agents, Glutamine	experimental	0
DB13432	Lonazolac	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Acetic Acid Derivatives and Related Substances, Sensory System Agents, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Prostaglandin Antagonists, Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Musculo-Skeletal System, Agents that produce hypertension, Central Nervous System Agents	experimental	0
DB14763	Cycloguanil	Drug	Enzyme Inhibitors, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Biguanides, Folic Acid Antagonists, Antimalarials, Amidines, Guanidines, Anti-Infective Agents, Antiparasitic Agents	approved	0
DB14760	Narlaprevir	Drug	Sulfur Compounds, Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins	experimental	0
DB12101	CC-220	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB13430	Mebutizide	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Sulfonamides, Diuretics, Low-Ceiling Diuretics and Potassium-Sparing Agents, Amides, Thiazides, Hyperglycemia-Associated Agents, Sulfones	experimental	0
DB14761	Remdesivir	Drug	Carbohydrates, OATP1B1/SLCO1B1 Inhibitors, BSEP/ABCB11 Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, P-glycoprotein substrates, OATP1B3 inhibitors, Amino Acids, Peptides, and Proteins, Experimental Unapproved Treatments for COVID-19, Antiviral Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Nucleotides, Cytochrome P-450 CYP3A4 Substrates, Amino Acids, Cytochrome P-450 CYP3A Inhibitors, Nucleic Acids, Nucleotides, and Nucleosides, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Glycosides, OATP1B1/SLCO1B1 Substrates, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2C8 Substrates	investigational	2
DB12100	Abediterol	Drug	Quinolines, Adrenergic beta-Agonists, Heterocyclic Compounds, Fused-Ring, Adrenergic Agonists, Agents that produce hypertension, Agents producing tachycardia, Adrenergic beta-2 Receptor Agonists	investigational	0
DB13435	Endralazine	Drug	Hydrazinophthalazine Derivatives, Arteriolar Smooth Muscle, Agents Acting On, Cardiovascular Agents, Antihypertensive Agents, Vasodilating Agents	experimental	0
DB14766	Etrasimod	Drug	0	investigational	0
DB13436	Droxypropine	Drug	Cough and Cold Preparations	experimental	0
DB12102	Fulranumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB14767	Peginterferon lambda-1a	Drug	Proteins, Biological Factors, Cytokines, Peptides, Ethylene Glycols, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Glycols, Polymers, Compounds used in a research, industrial, or household setting, Alcohols, Macromolecular Substances	investigational	0
DB14764	Dengue tetravalent vaccine, live	Drug	0	approved	0
DB13433	Simfibrate	Drug	Acids, Acyclic, Fatty Acids, Lipids, Isobutyrates, Phenyl Ethers, Lipid Modifying Agents, Lipid Modifying Agents, Plain, Lipid Regulating Agents, Butyrates, Agents Causing Muscle Toxicity, Fatty Acids, Volatile, Phenols, Clofibric Acid, Fibric Acids, Ethers, Benzene Derivatives	experimental	0
DB12105	Imagabalin	Drug	Central Nervous System Depressants, Amino Acids, Peptides, and Proteins, Anti-Anxiety Agents	investigational	0
DB14765	Rivoceranib	Drug	Enzyme Inhibitors, Protein Kinase Inhibitors, Antineoplastic Agents	investigational	0
DB12104	Tarextumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB13434	Fenticonazole	Drug	Azole Antifungals, Gynecological Antiinfectives and Antiseptics, Antifungals for Topical Use, Dermatologicals, Genito Urinary System and Sex Hormones, Antifungals for Dermatological Use, Antifungal Agents, Imidazole and Triazole Derivatives, Imidazole Derivatives, Anti-Infective Agents	experimental	0
DB12107	Vaborbactam	Drug	Enzyme Inhibitors, Acids, Noncarboxylic, Acids, beta-Lactamase Inhibitors, Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use, Boron Compounds, Drugs that are Mainly Renally Excreted	approved, investigational	9
DB13439	Fenpiprane	Drug	Alimentary Tract and Metabolism, Drugs for Functional Gastrointestinal Disorders, Benzene Derivatives	experimental	0
DB12106	PF-06305591	Drug	0	investigational	0
DB13437	Medazepam	Drug	Neuromuscular Agents, Psycholeptics, Tranquilizing Agents, GABA Agents, Nervous System, GABA Modulators, Benzodiazepines and benzodiazepine derivatives, Muscle Relaxants, Psychotropic Drugs, Peripheral Nervous System Agents, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Anticonvulsants, Benzazepines, Central Nervous System Depressants, Muscle Relaxants, Centrally Acting Agents, Anti-Anxiety Agents, Hypnotics and Sedatives, Central Nervous System Agents, Benzodiazepine hypnotics and sedatives	experimental	2
DB14768	PF-06459988	Drug	0	investigational	0
DB12109	CPI-613	Drug	Acids, Acyclic, Gases, Anions, Sulfur Compounds, Acids, Noncarboxylic, Fatty Acids, Acids, Hydrogen Sulfide, Electrolytes, Ions, Lipids	investigational	0
DB12108	Taselisib	Drug	Phosphatidylinositol 3-Kinases, antagonists & inhibitors, Antineoplastic Agents, Azepines	investigational	0
DB14769	Pamiparib	Drug	0	investigational	0
DB13438	Prolintane	Drug	Central Nervous System Stimulants, Nervous System, Psychostimulants, Agents Used for Adhd and Nootropics, Central Nervous System Agents, Psychoanaleptics	experimental	0
DB02780	Beta-3-Cysteine	Drug	0	experimental	1
DB00121	Biotin	Drug	Coenzymes, Enzymes and Coenzymes, Supplements, Vitamins, Micronutrients, Imidazoles, Physiological Phenomena, Alimentary Tract and Metabolism, Food and Beverages, Vitamin B Complex, Growth Substances, Dietary Supplements, Diet, Food, and Nutrition, Food	approved, investigational, nutraceutical	8
DB01453	Beta-hydroxyfentanyl	Drug	0	illicit, experimental	0
DB02784	N-(Bromoacetyl)-beta-alanyl-N-(2-{4-[(carboxycarbonyl)amino]phenyl}ethyl)-L-serinamide	Drug	0	experimental	1
DB02783	4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate	Drug	0	experimental	2
DB01452	Diamorphine	Drug	Sensory System Agents, Narcotics, Nervous System, Drugs Used in Addictive Disorders, Morphinans, Peripheral Nervous System Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, Analgesics, Morphine Derivatives, Thyroxine-binding globulin inducers, Central Nervous System Depressants, Heroin, agonists, Drugs Used in Opioid Dependence, Opioids, Central Nervous System Agents	approved, illicit, investigational	4
DB00122	Choline	Drug	OCT1 substrates, Amines, Ammonium Compounds, Nervous System, OCT2 Substrates, OCT1 inhibitors, Trimethyl Ammonium Compounds, Onium Compounds, Alcohols, Analgesics, Nitrogen Compounds, Gastrointestinal Agents, Hypolipidemic Agents, Noxae, Quaternary Ammonium Compounds, Amino Alcohols, Ethanolamines, Antimetabolites, Supplements, Vitamins, Lipid Regulating Agents, Other Nutritional Agents, OCT2 Inhibitors, Toxic Actions, Vitamin B Complex, Lipotropic Agents, Central Nervous System Agents, Salicylic Acid and Derivatives, Dietary Supplements, Nootropic Agents	approved, nutraceutical	8
DB01451	1-Androstenedione	Drug	0	illicit, experimental	0
DB01450	Dihydroetorphine	Drug	Sensory System Agents, Narcotics, Morphinans, Peripheral Nervous System Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Opioids, Central Nervous System Agents	illicit, experimental	0
DB02781	4-{(Z)-[2-[3-(Methylsulfanyl)Propanoyl]-5-Oxo-1-(2-Oxoethyl)-1,5-Dihydro-4h-Imidazol-4-Ylidene]Methyl}Benzenolate	Drug	0	experimental	0
DB00120	Phenylalanine	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Immunosuppressive Agents, Amino Acids, Essential, Amino Acids, Peptides, and Proteins, Dietary Supplements, Amino Acids, Supplements, Myelosuppressive Agents	approved, investigational, nutraceutical	7
DB02788	(S)-acetoin	Drug	0	experimental	0
DB00125	Arginine	Drug	Blood and Blood Forming Organs, I.V. Solution Additives, Arginine, Amino Acids, Basic, Amino Acids, Essential, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, Blood Substitutes and Perfusion Solutions, Pituitary Function, Dietary Supplements, Amino Acids, Supplements	investigational, nutraceutical	9
DB00126	Ascorbic acid	Drug	Acids, Acyclic, Carbohydrates, Hydroxy Acids, Gynecological Antiinfectives and Antiseptics, Protective Agents, Genito Urinary System and Sex Hormones, Organic Acids, Vitamins, Antioxidants, Ophthalmologicals, Micronutrients, Physiological Phenomena, Alimentary Tract and Metabolism, Food and Beverages, Gastrointestinal Acidifying Agents, Vitamin C and analogues, Sugar Acids, Urinary Acidifying Agents, Sensory Organs, Growth Substances, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food	approved, nutraceutical	24
DB02787	N-Acetylmannosaminitol	Drug	0	experimental	1
DB01456	5-androstenedione	Drug	Cytochrome P-450 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, 17-Ketosteroids, Adrenal Cortex Hormones, Androstenes, Hormones, Ketosteroids, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Gonadal Steroid Hormones, Androstanes, Cytochrome P-450 CYP3A Substrates, Testosterone Congeners, Gonadal Hormones, Steroids	illicit, experimental	0
DB00123	L-Lysine	Drug	Blood and Blood Forming Organs, I.V. Solution Additives, Lysine, Amino Acids, Basic, Amino Acids, Essential, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, Blood Substitutes and Perfusion Solutions, Dietary Supplements, Amino Acids, Supplements	approved, nutraceutical	5
DB02786	2-Anhydro-3-Fluoro-Quinic Acid	Drug	0	experimental	1
DB01455	19-Nor-5-androstenediol	Drug	0	illicit, experimental	0
DB01454	Midomafetamine	Drug	Adrenergic Uptake Inhibitors, Amines, Cytochrome P-450 Substrates, Serotonin Agents, Serotonin Receptor Agonists, Agents producing tachycardia, Antidepressive Agents, Hallucinogens, Phenethylamines, Psychotropic Drugs, Membrane Transport Modulators, Neurotransmitter Agents, Ethylamines, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Sympathomimetics, Central Nervous System Depressants, Neurotransmitter Uptake Inhibitors, Agents that produce hypertension, Amphetamines, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Serotonin 5-HT2 Receptor Agonists, Adrenergic Agents	illicit, investigational, experimental	7
DB02785	(2S)-1-[(2S,4R)-4-Benzyl-2-hydroxy-5-{[(1S,2R,5S)-2-hydroxy-5-methylcyclopentyl]amino}-5-oxopentyl]-4-{[6-chloro-5-(4-methyl-1-piperazinyl)-2-pyrazinyl]carbonyl}-N-(2-methyl-2-propanyl)-2-piperazineca rboxamide	Drug	0	experimental	1
DB00129	Ornithine	Drug	Liver Therapy, Oligopeptides, Peptides, Alimentary Tract and Metabolism, Amino Acids, Basic, Amino Acids, Diamino, Liver Therapy, Lipotropics, Amino Acids, Peptides, and Proteins, Dietary Supplements, Amino Acids, Supplements, Bile and Liver Therapy	approved, nutraceutical	10
DB00127	Spermine	Drug	OCT1 substrates, Diamines, Amines, Biogenic Amines, Polyamines, Dietary Supplements, Supplements, Biogenic Polyamines	nutraceutical, experimental	7
DB01459	Bezitramide	Drug	Heterocyclic Compounds, Fused-Ring, Sensory System Agents, Analgesics, Nervous System, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Diphenylpropylamine Derivatives, Opioids, Central Nervous System Agents, Peripheral Nervous System Agents	illicit, withdrawn, experimental	0
DB02789	Pregnenolone	Drug	Cytochrome P-450 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Adrenal Cortex Hormones, Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Gonadal Steroid Hormones, Hydroxycorticosteroids, Progesterone Congeners, Cytochrome P-450 CYP3A Substrates, Pregnanes, Gonadal Hormones, Pregnenes, Steroids	approved, experimental	2
DB00128	Aspartic acid	Drug	Amino Acids, Dicarboxylic, Excitatory Amino Acids, Amino Acids, Peptides, and Proteins, Amino Acids, Acidic, Dietary Supplements, Amino Acids, Supplements	approved, nutraceutical	19
DB01458	2,5-Dimethoxy-4-(n)-propylthiophenethylamine	Drug	0	illicit, experimental	0
DB12198	Fosdagrocorat	Drug	Organophosphorus Compounds	investigational	0
DB12197	Auriclosene	Drug	Alkanesulfonic Acids, Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfur Acids, Hydrocarbons, Acyclic, Sulfonic Acids, Alkanes	investigational	0
DB12199	TRV-120027	Drug	Peptides, Amino Acids, Peptides, and Proteins	investigational	0
DB12190	Faropenem	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amides, Lactams, Antiinfectives for Systemic Use, Antibacterials for Systemic Use	investigational	0
DB12192	Emeramide	Drug	Sulfur Compounds, Sequestering Agents, Compounds used in a research, industrial, or household setting, Chelating Agents	investigational	0
DB12191	Obatoclax	Drug	Enzyme Inhibitors	investigational	1
DB12194	Atamestane	Drug	Enzyme Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, 17-Ketosteroids, Adrenal Cortex Hormones, Androstenes, Hormones, Ketosteroids, Fused-Ring Compounds, Gonadal Steroid Hormones, Androstanes, Testosterone Congeners, Gonadal Hormones, Steroids	investigational	0
DB12193	Ajulemic acid	Drug	Neurotransmitter Agents, Cannabinoid Receptor Agonists, Hormones, Hormone Substitutes, and Hormone Antagonists, Cannabinoids and similars, Agents producing tachycardia, Hormones, Terpenes	investigational	0
DB12196	CP-866087	Drug	Aza Compounds	investigational	0
DB12195	VP-14637	Drug	Benzene Derivatives	investigational	0
DB13486	Magnesium peroxide	Drug	Reactive Oxygen Species, Free Radicals, Drugs for Constipation, Ions, Oxides, Aluminum and magnesium containing antacids, Anions, Gastric Acid Lowering Agents, Metal cations, Alimentary Tract and Metabolism, Metal divalent cations, Osmotic Laxatives, Electrolytes, Laxatives, Drugs for Acid Related Disorders, Antacids, Oxygen Compounds, Magnesium Compounds	experimental	0
DB12154	Itacitinib	Drug	Pyridines, Azetines	investigational	0
DB13487	Iodine (131I) norcholesterol	Drug	Cholestanes, Sterols, Iodine (131I) Compounds, Diagnostic Radiopharmaceuticals, Lipids, Membrane Lipids, Cholestenes, Fused-Ring Compounds, Steroids	experimental	0
DB12153	Citicoline	Drug	Carbohydrates, Amines, Ammonium Compounds, Cytosine Nucleotides, Nervous System, Quaternary Ammonium Compounds, Psychostimulants, Agents Used for Adhd and Nootropics, Trimethyl Ammonium Compounds, Onium Compounds, Cytidine Diphosphate, Nucleotides, Amino Alcohols, Ethanolamines, Alcohols, Pyrimidines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Central Nervous System Agents, Pyrimidine Nucleotides, Nitrogen Compounds, Nootropic Agents, Psychoanaleptics	approved, experimental	1
DB12156	Cordycepin	Drug	Carbohydrates, Ribonucleosides, Noxae, Antineoplastic Agents, Purine Nucleosides, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Purines, Nucleic Acids, Nucleotides, and Nucleosides, Mutagens, Glycosides, Nucleosides, Toxic Actions, Antifungal Agents, Deoxyribonucleosides	investigational	0
DB13484	Quinbolone	Drug	Androstanes, Alimentary Tract and Metabolism, Anabolic Steroids, Androstenes, Anabolic Agents for Systemic Use, Fused-Ring Compounds, Androstan Derivatives, Steroids	experimental	0
DB13485	Sulfametomidine	Drug	Long-Acting Sulfonamides, SULFONAMIDES AND TRIMETHOPRIM, Sulfonamides, Antiinfectives for Systemic Use, Antibacterials for Systemic Use	experimental	0
DB12155	Napabucasin	Drug	Heterocyclic Compounds, Fused-Ring, Quinones, Naphthalenes	investigational	0
DB12158	Filorexant	Drug	0	investigational	0
DB12157	Fasinumab	Drug	Analgesics, Non-Narcotic, Immunoglobulins, Sensory System Agents, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins, Peripheral Nervous System Agents, Proteins, Serum Globulins, Analgesics, Globulins, Blood Proteins, Central Nervous System Agents	investigational	0
DB13488	Bencyclane	Drug	QTc Prolonging Agents, Cycloparaffins, Cytochrome P-450 Substrates, Agents causing hyperkalemia, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Membrane Transport Modulators, Calcium Channel Blockers, Cytochrome P-450 CYP3A Substrates, Cycloheptanes, Calcium-Regulating Hormones and Agents, Peripheral Vasodilators, Potential QTc-Prolonging Agents, Vasodilating Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	experimental	0
DB13489	Bamipine	Drug	Neurotransmitter Agents, Antipruritics, Incl. Antihistamines, Anesthetics, Etc., Histamine Antagonists, Antihistamines for Topical Use, Dermatologicals, Histamine Agents, Antihistamines for Systemic Use	experimental	0
DB12159	Dupilumab	Drug	Agents for Dermatitis, Excluding Corticosteroids, Immunoglobulins, Anti-Asthmatic Agents, Dermatologicals, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Misc. Skin and Mucous Membrane Agents, Interleukin 4 Receptor alpha Antagonists, Immunoproteins, Proteins, Serum Globulins, Interleukin-4 Receptor alpha Subunit, antagonists & inhibitors, Interleukin-4 Receptor alpha Antagonist, Globulins, Blood Proteins	approved, investigational	1
DB00172	Proline	Drug	Acids, Acyclic, Amino Acids, Cyclic, Imines, Amino Acids, Peptides, and Proteins, Imino Acids, Dietary Supplements, Amino Acids, Supplements	nutraceutical	22
DB00173	Adenine	Drug	Heterocyclic Compounds, Fused-Ring, Purines, UGT1A1 Inhibitors, Dietary Supplements, Supplements	approved, nutraceutical	12
DB00170	Menadione	Drug	Blood and Blood Forming Organs, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Cytochrome P-450 CYP2A6 Inhibitors, Cytochrome P-450 CYP2A6 Inhibitors (strength unknown), Antifibrinolytic Agents, Quinones, Cytochrome P-450 Enzyme Inducers, Physiological Phenomena, Food and Beverages, Hemostatics, Growth Substances, Diet, Food, and Nutrition, Food, Vitamin K, Fibrin Modulating Agents, Phytol, Hematologic Agents, Coagulants, Supplements, Vitamins, Naphthalenes, Micronutrients, Vitamins (Fat Soluble), Naphthoquinones, Cytochrome P-450 CYP1A2 Inducers, Diterpenes, Terpenes, Dietary Supplements	approved, nutraceutical	10
DB00171	ATP	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Adenosine Triphosphate, Nucleotides, Adenine Nucleotides, Dietary Supplements, Supplements	investigational, nutraceutical	42
DB00176	Fluvoxamine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Oximes, Tranquilizing Agents, Enzyme Inhibitors, Amines, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Hydroxylamines, Hypoglycemia-Associated Agents, BSEP/ABCB11 Substrates, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Antidepressive Agents, Cytochrome P-450 CYP2C9 Inhibitors (moderate), Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP3A7 Inhibitors (moderate), Serotonin Modulators, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Selective Serotonin Reuptake Inhibitors, Chemically-Induced Disorders, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (strong), Antidepressive Agents, Second-Generation, Psychotropic Drugs, Cytochrome P-450 CYP2C19 Inhibitors (strong), Membrane Transport Modulators, Neurotransmitter Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Cytochrome P-450 CYP3A7 Inhibitors, Neurotransmitter Uptake Inhibitors, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Anti-Anxiety Agents, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), P-glycoprotein inhibitors, Psychoanaleptics	approved, investigational	2
DB00177	Valsartan	Drug	Antihypertensive Agents Indicated for Hypertension, OATP1B1/SLCO1B1 Inhibitors, Angiotensin II receptor blockers (ARBs) and diuretics, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Angiotensin Receptor Antagonists, Agents causing hyperkalemia, Angiotensin II receptor blockers (ARBs) and calcium channel blockers, Cardiovascular Agents, Hypotensive Agents, OATP1B3 substrates, Angiotensin II receptor blockers (ARBs), plain, Angiotensin II Type 1 Receptor Blockers, Cytochrome P-450 CYP2C9 Substrates, Angiotensin II Antagonists and Calcium Channel Blockers, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors, Agents Acting on the Renin-Angiotensin System, Angiotensin II Antagonists and Diuretics, OATP1B1/SLCO1B1 Substrates, Angiotensin II Type 2 Receptor Blockers, Agents causing angioedema, Angiotensin 2 Receptor Blocker, Antihypertensive Agents	approved, investigational	1
DB00174	Asparagine	Drug	Amino Acids, Neutral, Amino Acids, Basic, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, Dietary Supplements, Amino Acids, Supplements	approved, investigational, nutraceutical	6
DB00175	Pravastatin	Drug	Anticholesteremic Agents, Enzyme Inhibitors, Hypolipidemic Agents, Noxae, P-glycoprotein substrates, BCRP/ABCG2 Inhibitors, BSEP/ABCB11 Substrates, Hypolipidemic Agents Indicated for Hyperlipidemia, OATP1B3 substrates, OAT1/SLC22A6 inhibitors, OAT3/SLC22A8 Substrates, Lipid Modifying Agents, Lipid Modifying Agents, Plain, Lipid Regulating Agents, BCRP/ABCG2 Substrates, Photosensitizing Agents, Agents Causing Muscle Toxicity, OATP1B1/SLCO1B1 Substrates, Toxic Actions, OAT3/SLC22A8 Inhibitors, Drugs causing inadvertant photosensitivity, Hydroxymethylglutaryl-CoA Reductase Inhibitors	approved	2
DB00178	Ramipril	Drug	Antihypertensive Agents Indicated for Hypertension, Enzyme Inhibitors, Cholinesterase Inhibitors, Agents causing hyperkalemia, Protease Inhibitors, Cardiovascular Agents, Hypotensive Agents, ACE Inhibitors and Calcium Channel Blockers, Heterocyclic Compounds, Fused-Ring, Lipid Modifying Agents, Photosensitizing Agents, Angiotensin-Converting Enzyme Inhibitors, Agents Acting on the Renin-Angiotensin System, Agents causing angioedema, ACE Inhibitors and Diuretics, Antihypertensive Agents, Drugs causing inadvertant photosensitivity	approved	2
DB00179	Masoprocol	Drug	Analgesics, Non-Narcotic, Enzyme Inhibitors, Sensory System Agents, Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Benzyl Compounds, Protective Agents, Antineoplastic and Immunomodulating Agents, Lignans, Antineoplastic Agents, Catechols, Peripheral Nervous System Agents, Antioxidants, Analgesics, Phenols, Central Nervous System Agents, Compounds used in a research, industrial, or household setting, Lipoxygenase Inhibitors, Benzene Derivatives	approved, investigational	2
DB13482	Dimefline	Drug	Heterocyclic Compounds, Fused-Ring, Benzopyrans, Respiratory System Agents, Chromones, Pyrans	experimental	0
DB12150	Pelubiprofen	Drug	Acids, Carbocyclic	investigational	0
DB13483	Etamsylate	Drug	Arylsulfonates, Blood and Blood Forming Organs, Sulfur Acids, Arylsulfonic Acids, Hematologic Agents, Coagulants, Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfonic Acids, Hemostatics, Benzene Derivatives, Benzenesulfonates	experimental	0
DB12152	Simtuzumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB13480	Lentinan	Drug	Carbohydrates, Immunologic Factors, Polysaccharides, Adjuvants, Immunologic, Antineoplastic and Immunomodulating Agents, Glucans, Antineoplastic Agents, Polymers, beta-Glucans, Biopolymers, Compounds used in a research, industrial, or household setting, Macromolecular Substances	investigational, experimental	0
DB13481	Tenidap	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Enzyme Inhibitors, Sensory System Agents, Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Indole Alkaloids, Peripheral Nervous System Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Musculo-Skeletal System, Agents that produce hypertension, Central Nervous System Agents, Indoles	experimental	0
DB12151	Brincidofovir	Drug	Nephrotoxic agents, Pyrimidines, Pyrimidinones, Organophosphorus Compounds, Drugs that are Mainly Renally Excreted	investigational	0
DB13497	Valethamate	Drug	Amines, Ammonium Compounds, Alimentary Tract and Metabolism, Onium Compounds, Drugs for Functional Gastrointestinal Disorders, Nitrogen Compounds	experimental	0
DB12165	Presatovir	Drug	Sulfur Compounds, Amides, Sulfones	investigational	0
DB12167	LY-3023414	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring	investigational	0
DB13495	Paraoxon	Drug	Enzyme Inhibitors, Cholinesterase Inhibitors, Antiglaucoma Preparations and Miotics, Parasympathomimetics, Pesticides, Organophosphorus Compounds, Insecticides, Organophosphates, Ophthalmologicals, Neurotransmitter Agents, Cholinergic Agents, Agrochemicals, Toxic Actions, Sensory Organs, Compounds used in a research, industrial, or household setting	experimental	0
DB13496	Iprindole	Drug	Cycloparaffins, Nervous System, Antidepressive Agents, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Non-Selective Monoamine Reuptake Inhibitors, Narrow Therapeutic Index Drugs, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Antidepressive Agents, Tricyclic, Agents that produce hypertension, Cyclooctanes, Central Nervous System Agents, Indoles, Agents that reduce seizure threshold, Neurotoxic agents, Psychoanaleptics	experimental	0
DB12169	Tralokinumab	Drug	Proteins, Serum Globulins, Asthma, drug therapy, Immunoglobulins, Globulins, Blood Proteins, Interleukin-13, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB12168	MK-0557	Drug	Cycloparaffins	investigational	0
DB13499	Cefsulodin	Drug	Nephrotoxic agents, Third-Generation Cephalosporins, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Antibacterials for Systemic Use	experimental	0
DB00180	Flunisolide	Drug	Corticosteroids for Systemic Use, Corticosteroids, Cytochrome P-450 Substrates, Immunosuppressive Agents, Pregnadienes, Anti-Asthmatic Agents, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Respiratory System Agents, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Nasal Preparations, Agents to Treat Airway Disease, Cytochrome P-450 CYP3A Substrates, Adrenals, Pregnanes, Drugs for Obstructive Airway Diseases, Steroids, Fluorinated, Corticosteroid Hormone Receptor Agonists, Steroids	approved, investigational	1
DB00183	Pentagastrin	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, Oligopeptides, Peptides, Gastrointestinal Hormones, Pentagastrin, antagonists & inhibitors, Tests for Gastric Secretion, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Hormones, Proteins, Gastrins, Peptide Hormones, Diagnostic Agents	approved	1
DB00184	Nicotine	Drug	Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, Solanaceous Alkaloids, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Ganglion Blockers, Cytochrome P-450 CYP1A2 Inducers (strength unknown), OCT1 inhibitors, Cytochrome P-450 CYP2A6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2A6 Inhibitors (strength unknown), Peripheral Nervous System Agents, Alkaloids, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Cytochrome P-450 Enzyme Inducers, Cholinergic Agents, Nicotinic Agonists, Nicotine, metabolism, Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP2E1 Inducers (strength unknown), Autonomic Agents, Nicotine, antagonists & inhibitors, Pyridines, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 CYP2E1 Inducers, Cholinergic Agonists, Cytochrome P-450 CYP2E1 Inhibitors, Miscellaneous Autonomic Drugs, Agents producing tachycardia, Ganglionic Stimulants, Drugs Used in Addictive Disorders, Cytochrome P-450 CYP2C19 Substrates, Drugs Used in Nicotine Dependence, Cytochrome P-450 CYP2C9 Substrates, Neurotransmitter Agents, Cholinergic Nicotinic Agonist, Cytochrome P-450 CYP3A Substrates, OCT2 Inhibitors, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2A6 Substrates, Cytochrome P-450 CYP1A2 Inducers, Smoking Cessation Agents, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates	approved	13
DB00181	Baclofen	Drug	gamma-Aminobutyric Acid-ergic Agonist, GABA Agents, Gaba-derivative Skeletal Muscle Relaxants, GABA Agonists, Amino Acids, Peptides, and Proteins, Aminobutyrates, Muscle Relaxants, Amino Acids, Drugs that are Mainly Renally Excreted, Neurotransmitter Agents, Butyrates, Muscle Relaxants, Peripherally Acting Agents, Agents Causing Muscle Toxicity, Central Nervous System Depressants, Musculo-Skeletal System, Muscle Relaxants, Centrally Acting Agents, GABA-B Receptor Agonists, Central Nervous System Agents	approved	2
DB00182	Amphetamine	Drug	Central Nervous System Stimulants, Adrenergic Uptake Inhibitors, Amines, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP2A6 Inhibitors, Antidepressive Agents, Phenethylamines, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Biogenic Amines, Adrenergic Agents, Benzene Derivatives, Agents that reduce seizure threshold, Dopamine Agents, Dopamine Uptake Inhibitors, Autonomic Agents, Psychostimulants, Agents Used for Adhd and Nootropics, Monoamine Oxidase Inhibitors, Agents producing tachycardia, Catechols, Biogenic Monoamines, Central Nervous System Stimulation, Membrane Transport Modulators, Centrally Acting Sympathomimetics, Neurotransmitter Agents, Photosensitizing Agents, Sympathomimetics, Central Nervous System Depressants, Neurotransmitter Uptake Inhibitors, Agents that produce hypertension, Amphetamines, Phenols, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2A6 Inhibitors (weak), Psychoanaleptics	approved, illicit, investigational	12
DB00187	Esmolol	Drug	Antihypertensive Agents Indicated for Hypertension, QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Propanols, Agents causing hyperkalemia, Adrenergic beta-Antagonists, Hypotensive Agents, Amino Alcohols, Adrenergic beta-1 Receptor Antagonists, Alcohols, Neurotransmitter Agents, Adrenergic Antagonists, Beta Blocking Agents, Selective, Beta-Blockers (Beta1 Selective), Potential QTc-Prolonging Agents, Antihypertensive Agents, Cytochrome P-450 CYP2D6 Substrates, Adrenergic Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	approved	1
DB00188	Bortezomib	Drug	QTc Prolonging Agents, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, OATP1B3 inhibitors, Cardiotoxic antineoplastic agents, Cytochrome P-450 CYP2C19 Inhibitors, Hypotensive Agents, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inhibitors, Boronic Acids, Cytochrome P-450 CYP2C9 Inhibitors, Hepatotoxic Agents, Potential QTc-Prolonging Agents, P-glycoprotein substrates with narrow therapeutic index, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Myelosuppressive Agents, Cytochrome P-450 CYP2C19 Substrates, Pyrazines, Cytochrome P-450 CYP2C9 Substrates, Acids, Noncarboxylic, Narrow Therapeutic Index Drugs, Acids, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2C19 Inhibitors (weak), Cytochrome P-450 CYP2D6 Substrates, Proteasome Inhibitors, Boron Compounds, Cytochrome P-450 CYP1A2 Inhibitors (moderate)	approved, investigational	2
DB00185	Cevimeline	Drug	Autonomic Agents, Cytochrome P-450 Substrates, Cholinergic Agonists, Nervous System, Cholinergic Receptor Agonist, Parasympathomimetics, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Muscarinic Agonists, Neurotransmitter Agents, Sulfur Compounds, Cholinergic Agents, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2D6 Substrates	approved	2
DB00186	Lorazepam	Drug	Psycholeptics, Tranquilizing Agents, Cytochrome P-450 Substrates, Nervous System, GABA Modulators, Benzodiazepines and benzodiazepine derivatives, Cytochrome P-450 CYP3A4 Substrates, Muscle Relaxants, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Benzazepines, Muscle Relaxants, Centrally Acting Agents, Hypnotics and Sedatives, Benzodiazepine hypnotics and sedatives, Gastrointestinal Agents, Autonomic Agents, GABA Agents, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Anticonvulsants, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Antiemetics, Benzodiazepinones, Anti-Anxiety Agents, Central Nervous System Agents	approved	2
DB00189	Ethchlorvynol	Drug	Psycholeptics, Chlorohydrins, Nervous System, Central Nervous System Depressants, Hypnotics and Sedatives, Central Nervous System Agents, Alcohols	approved, illicit, withdrawn	1
DB13490	Hidrosmin	Drug	Heterocyclic Compounds, Fused-Ring, Vasoprotectives, Flavonoids, Flavones, Capillary Stabilizing Agents, Benzopyrans, Chromones, Pyrans	experimental	0
DB13493	Cyclobutyrol	Drug	Acids, Acyclic, Fatty Acids, Alimentary Tract and Metabolism, Fatty Acids, Volatile, Lipids, Bile Therapy, Bile and Liver Therapy	experimental	0
DB12161	Deutetrabenazine	Drug	Heterocyclic Compounds, Fused-Ring, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Quinolizines, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted	approved, investigational	1
DB12160	Bucillamine	Drug	Analgesics, Non-Narcotic, Amino Acids, Neutral, Sensory System Agents, Anti-Inflammatory Agents, Protective Agents, Amino Acids, Sulfur, Antirheumatic Agents, Amino Acids, Peptides, and Proteins, Amino Acids, Peripheral Nervous System Agents, Antioxidants, Sulfur Compounds, Antiinflammatory and Antirheumatic Products, Analgesics, Musculo-Skeletal System, Penicillamine and Similar Agents, Central Nervous System Agents, Specific Antirheumatic Agents, Compounds used in a research, industrial, or household setting, Sulfhydryl Compounds	investigational	0
DB13494	Dimetofrine	Drug	Amines, Cardiac Stimulants Excl. Cardiac Glycosides, Adrenergic and Dopaminergic Agents, Amino Alcohols, Cardiac Therapy, Alcohols	experimental	0
DB13491	Fluperolone	Drug	Corticosteroids, Dermatological Preparations, Corticosteroids, Moderately Potent (Group II), Corticosteroids, Immunosuppressive Agents, Adrenal Cortex Hormones, Dermatologicals	experimental	0
DB12163	Sarpogrelate	Drug	Acids, Acyclic, Neurotransmitter Agents, Serotonin Agents, Central Nervous System Depressants, Fibrin Modulating Agents, Dicarboxylic Acids, Hematologic Agents, Cardiovascular Agents, Serotonin Receptor Antagonists, Antidepressive Agents, Antiplatelet agents	investigational	2
DB12162	HX-1171	Drug	Phenols, Benzene Derivatives	investigational	0
DB13492	Policresulen	Drug	Gynecological Antiinfectives and Antiseptics, Antiseptics and Disinfectants, Dermatologicals, Genito Urinary System and Sex Hormones, Phenols, Pharmaceutical Preparations, Benzene Derivatives, Phenol and Derivatives	investigational, experimental	0
DB12176	Tricaprylin	Drug	Glycerides, Acids, Acyclic, Alzheimer Disease, drug therapy, Excipients, Fatty Acids, Lipids, Pharmaceutical Preparations, Compounds used in a research, industrial, or household setting, Pharmaceutic Aids, Drug Delivery Systems, Pharmaceutical Vehicles	investigational	0
DB12178	Telinavir	Drug	0	investigational	0
DB12177	Eplivanserin	Drug	Neurotransmitter Agents, Serotonin Agents, Central Nervous System Depressants, Fibrin Modulating Agents, Hematologic Agents, Hydrocarbons, Halogenated, Cardiovascular Agents, Serotonin Receptor Antagonists, Antidepressive Agents, Hydrocarbons, Fluorinated, Benzene Derivatives	investigational	2
DB12179	Secoisolariciresinol	Drug	Phytoestrogens, Hormones, Hormone Substitutes, and Hormone Antagonists, Benzyl Compounds, Estrogens, Non-Steroidal, Glycols, Hormones, Benzene Derivatives, Alcohols	investigational	0
DB00190	Carbidopa	Drug	Hydrazines, Enzyme Inhibitors, Amines, Aromatic L-amino Acid Decarboxylase Inhibitors, Catecholamines, Catechols, Biogenic Monoamines, Drugs that are Mainly Renally Excreted, Anti-Parkinson Drugs, Aromatic Amino Acid Decarboxylase Inhibitors, Anti-Dyskinesia Agents, Biogenic Amines, Phenols, Central Nervous System Agents, Benzene Derivatives	approved	1
DB00191	Phentermine	Drug	Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, Amines, Appetite Depressants, Cytochrome P-450 Substrates, Increased Sympathetic Activity, Cytochrome P-450 CYP3A4 Substrates, Phenethylamines, Peripheral Nervous System Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Alimentary Tract and Metabolism, Appetite Suppression, Adrenergic Agents, Autonomic Agents, Centrally Acting Antiobesity Products, Sympathomimetic Amine Anorectic, Agents producing tachycardia, Neurotransmitter Agents, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Sympathomimetics, Anti-Obesity Agents, Agents that produce hypertension, Amphetamines, Antiobesity Preparations, Excl. Diet Products, Central Nervous System Agents	approved, illicit	6
DB00194	Vidarabine	Drug	Carbohydrates, Ribonucleosides, Arabinonucleosides, Noxae, Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors, Antiviral Agents, Purine Nucleosides, Antiinfectives for Systemic Use, Antimetabolites, Anti-Infective Agents, Ophthalmologicals, Antivirals for Systemic Use, Direct Acting Antivirals, Heterocyclic Compounds, Fused-Ring, Purines, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Toxic Actions, Sensory Organs	approved, investigational	3
DB00195	Betaxolol	Drug	QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Sympatholytics, Agents causing hyperkalemia, Adrenergic beta-Antagonists, Cardiovascular Agents, Hypotensive Agents, Adrenergic beta-1 Receptor Antagonists, Alcohols, Peripheral Nervous System Agents, Beta-adrenergic Agents, Adrenergic Antagonists, Antihypertensive Agents, Adrenergic Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Autonomic Agents, Antihypertensive Agents Indicated for Hypertension, Propanols, Antiglaucoma Preparations and Miotics, Phenoxypropanolamines, Amino Alcohols, Moderate Risk QTc-Prolonging Agents, Ophthalmologicals, Neurotransmitter Agents, Beta Blocking Agents, Selective, Beta-Blockers (Beta1 Selective), Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2D6 Substrates, Sensory Organs, Propanolamines	approved, investigational	2
DB00192	Indecainide	Drug	0	approved	1
DB00193	Tramadol	Drug	Amines, Cytochrome P-450 Substrates, Sensory System Agents, Serotonin Agents, Cyclohexanols, Nervous System, Muscarinic Antagonists, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Alcohols, Cyclohexanes, Opiate Agonists, Peripheral Nervous System Agents, Anticholinergic Agents, Serotonin 5-HT2 Receptor Antagonists, Serotonin Modulators, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Opioids, Agents that reduce seizure threshold, Cycloparaffins, Dimethylamines, Narcotics, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Agents producing tachycardia, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Opioid Agonist, UGT1A1 Substrates, NMDA Receptor Antagonists, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates	approved, investigational	15
DB00198	Oseltamivir	Drug	Antivirals for Systemic Use, Direct Acting Antivirals, Amides, Antiviral Agents, Acetamides, Neuraminidase Inhibitors, Acetates, Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, OAT3/SLC22A8 Substrates	approved	3
DB00199	Erythromycin	Drug	QTc Prolonging Agents, BSEP/ABCB11 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Macrolides, Lincosamides and Streptogramins, OATP1B3 inhibitors, BSEP/ABCB11 Substrates, OATP1B3 substrates, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Cytochrome P-450 CYP3A7 Inhibitors (strength unknown), Lactones, Anti-Bacterial Agents, Antiinfectives for Treatment of Acne, Erythromycins, Macrolide Antimicrobial, Protein Synthesis Inhibitors, Gastrointestinal Agents, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Cytochrome P-450 CYP3A5 Substrates, Macrolides, P-glycoprotein substrates, Cytochrome P-450 CYP3A5 Inhibitors, Dermatologicals, Erythromycin and similars, Anti-Acne Preparations, Antiinfectives for Systemic Use, Moderate Risk QTc-Prolonging Agents, Ophthalmologicals, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A7 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, OATP1B1/SLCO1B1 Substrates, P-glycoprotein inhibitors, Anti-Acne Preparations for Topical Use, Antibacterials for Systemic Use	approved, investigational, vet_approved	3
DB00196	Fluconazole	Drug	QTc Prolonging Agents, Enzyme Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Antimycotics for Systemic Use, Cytochrome P-450 CYP2C9 Inhibitors (strong), Agents causing hyperkalemia, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Antifungals for Dermatological Use, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (weak), Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Triazoles, Antifungals for Topical Use, Cytochrome P-450 CYP2C9 Inhibitors, Potential QTc-Prolonging Agents, Antifungal Agents, Hormone Antagonists, Triazole Derivatives, Steroid Synthesis Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP3A5 Inhibitors, Dermatologicals, Antiinfectives for Systemic Use, Azole Antifungals, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Imidazole and Triazole Derivatives, P-glycoprotein inhibitors, 14-alpha Demethylase Inhibitors	approved, investigational	1
DB00197	Troglitazone	Drug	BSEP/ABCB11 Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, UGT1A3 substrates, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (moderate), Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A7 Inhibitors (strength unknown), Cytochrome P-450 Enzyme Inducers, Sulfur Compounds, UGT2B7 substrates, Alimentary Tract and Metabolism, Chromans, Cytochrome P-450 CYP2C9 Inhibitors, Thiazoles, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Drugs Used in Diabetes, Cytochrome P-450 CYP2C8 Substrates, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A5 Inhibitors, Benzopyrans, Blood Glucose Lowering Agents, UGT1A6 substrate, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A7 Inhibitors, UGT1A1 Substrates, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), UGT1A9 Substrates, UGT1A4 substrates, UGT1A6 Inhibitors, Thiazolidinediones, Pyrans	approved, investigational, withdrawn	9
DB12170	Veledimex	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB12172	Nimorazole	Drug	Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Imidazoles, Nitroimidazole Derivatives, Nitro Compounds, Antitrichomonal Agents, Nitroimidazoles, Anti-Infective Agents, Antiparasitic Agents	investigational	0
DB12171	ATU-027	Drug	0	investigational	0
DB12174	CUDC-101	Drug	Heterocyclic Compounds, Fused-Ring, QTc Prolonging Agents, Amines, Hydroxy Acids, Hydroxylamines, Antineoplastic Agents, Histone Deacetylase Inhibitors, Moderate Risk QTc-Prolonging Agents	investigational	0
DB12173	Diphencyprone	Drug	Cycloparaffins	investigational	0
DB12187	Abacavir hydroxyacetate	Drug	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor	investigational	0
DB12186	SRT-2104	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Activators	investigational	0
DB12189	Etrolizumab	Drug	Proteins, Serum Globulins, Immunologic Factors, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Integrin Receptor Antagonist, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Gastrointestinal Agents, Immunoproteins	investigational	0
DB12188	Zicronapine	Drug	0	investigational	0
DB12181	Dalcetrapib	Drug	Lipid Regulating Agents, Anticholesteremic Agents, Hypolipidemic Agents, Sulfur Compounds, Noxae, Toxic Actions	investigational	0
DB12180	Apitolisib	Drug	Phosphatidylinositol 3-Kinase, antagonists & inhibitors	investigational	0
DB12183	Sapitinib	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB12182	Binetrakin	Drug	Proteins, Biological Factors, Immunologic Factors, Cytokines, Interleukins, Peptides, Adjuvants, Immunologic, Intercellular Signaling Peptides and Proteins, Antineoplastic Agents, Antirheumatic Agents, Amino Acids, Peptides, and Proteins, Interleukin-4, antagonists & inhibitors	investigational	0
DB12185	Exatecan	Drug	Alkaloids, Enzyme Inhibitors, Topoisomerase Inhibitors, Topoisomerase I Inhibitors, Antineoplastic Agents	investigational	0
DB12184	Gepirone	Drug	Neurotransmitter Agents, Tranquilizing Agents, Serotonin Agents, Nervous System, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Serotonin Receptor Agonists, Anti-Anxiety Agents, Antidepressive Agents, Central Nervous System Agents, Psychotropic Drugs, Psychoanaleptics	investigational	0
DB14810	AZD-1656	Drug	Glucokinase, Azetines	investigational	0
DB14811	Isatuximab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Multiple Myeloma, drug therapy, Antibodies, Monoclonal, CD38-directed Cytolytic Antibody, Immunoproteins	approved, investigational	1
DB14814	Lanabecestat	Drug	0	investigational	0
DB14815	Ginsenoside B2	Drug	Carbohydrates, Panax, Saponins, Triterpenes, Glycosides, Terpenes	investigational	0
DB14812	Procalcitonin	Drug	Proteins, Peptide Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Protein Precursors, Amino Acids, Peptides, and Proteins, Hormones	investigational	0
DB14813	PF-232798	Drug	Aza Compounds, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Anti-Infective Agents, CCR5 Receptor Antagonists	investigational	0
DB14818	Osocimab	Drug	0	investigational	0
DB14819	Cobitolimod	Drug	0	investigational	0
DB14816	Biropepimut-S	Drug	0	investigational	0
DB14817	Pegapamodutide	Drug	0	investigational	0
DB14809	Anetumab ravtansine	Drug	Immunoglobulins, Noxae, Antibodies, Amides, Amino Acids, Peptides, and Proteins, Lactams, Immunoproteins, Lactones, Lactams, Macrocyclic, Proteins, Serum Globulins, Polyketides, Globulins, Blood Proteins, Toxic Actions	investigational	0
DB01501	Difenoxin	Drug	Alimentary Tract and Metabolism, Antidiarrheals, Central Nervous System Depressants, Piperidines, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Antipropulsives, Isonipecotic Acids	approved, illicit	0
DB02832	Siroheme	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Metalloporphyrins, Pigments, Biological, Porphyrins	experimental	1
DB01500	Oxabolone	Drug	0	illicit, experimental	0
DB02831	Dihydrogenphosphate	Drug	0	experimental	2
DB02830	FR236913	Drug	0	experimental	1
DB01505	Etoxeridine	Drug	0	illicit, experimental	0
DB02836	Guanosine 5'-diphosphate 2':3'-cyclic monophosphate	Drug	0	experimental	2
DB02835	Alpha-D-Glucose 1,6-Bisphosphate	Drug	0	experimental	2
DB01503	1-Androstenediol	Drug	0	illicit, experimental	0
DB02834	IDD552	Drug	Sulfur Compounds, Hydrocarbons, Halogenated, Hydrocarbons, Fluorinated, Benzene Derivatives	experimental	1
DB02833	[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine	Drug	0	experimental	2
DB01502	Diampromide	Drug	0	illicit, experimental	0
DB01509	Tenamfetamine	Drug	Adrenergic Uptake Inhibitors, Amines, Serotonin Agents, Agents producing tachycardia, Antidepressive Agents, Hallucinogens, Phenethylamines, Psychotropic Drugs, Membrane Transport Modulators, Neurotransmitter Agents, Serotonin Modulators, Ethylamines, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Sympathomimetics, Central Nervous System Depressants, Neurotransmitter Uptake Inhibitors, Agents that produce hypertension, Amphetamines, Central Nervous System Agents, Adrenergic Agents	illicit, experimental	0
DB02839	2,4-Dihydroxybenzoic Acid	Drug	Benzoates, Hydroxy Acids, Acids, Carbocyclic, Phenols, Benzene Derivatives	experimental	2
DB02838	3,4-Dihydro-2h-Pyrrolium-5-Carboxylate	Drug	0	experimental	1
DB01506	1-Phenylcyclohexylamine	Drug	Cycloparaffins, Amines, Cyclohexanes	illicit, experimental	0
DB02837	4-(Hydrogen sulfate)-beta-D-galactopyranose	Drug	0	experimental	1
DB14821	Macozinone	Drug	Sulfur Compounds	investigational	0
DB14822	SB-649868	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Carbon Radioisotopes	investigational	0
DB14820	Profoxydim	Drug	0	investigational	0
DB14825	Danvatirsen	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides, Polynucleotides	investigational	0
DB14826	Topramezone	Drug	0	investigational	0
DB14823	Balovaptan	Drug	0	investigational	0
DB14824	Icrucumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB14829	Uproleselan	Drug	0	investigational	0
DB14827	Modotuximab	Drug	0	investigational	0
DB14828	ABX-464	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB01512	Hydromorphinol	Drug	0	illicit, experimental	0
DB02843	alpha-D-glucose-1-phosphate	Drug	Carbohydrates, Hexosephosphates, Sugar Phosphates	experimental	5
DB01511	Delorazepam	Drug	Heterocyclic Compounds, Fused-Ring, Anticonvulsants, Benzazepines, Central Nervous System Depressants, Benzodiazepines and benzodiazepine derivatives, Benzodiazepinones, Central Nervous System Agents	illicit, experimental	2
DB02842	9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide	Drug	0	experimental	1
DB01510	Dehydrochloromethyltestosterone	Drug	Testosterone and derivatives	illicit, experimental	0
DB02841	[(2-Ethoxy-1-Naphthoyl)Amino]Methylboronic Acid	Drug	0	experimental	3
DB02840	4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid	Drug	0	experimental	1
DB01516	3,4,5-Trimethoxyamphetamine	Drug	0	illicit, experimental	0
DB02847	(2s,3r)-1-Amino-2-Methylbutane-2,3-Diol	Drug	0	experimental	0
DB01515	Benzoylecgonine	Drug	Alkaloids, Tropanes, Aza Compounds, Azabicyclo Compounds	illicit, experimental	0
DB02846	L-thioproline	Drug	0	experimental	1
DB01514	Furazabol	Drug	Androstanes, Fused-Ring Compounds, Steroids	illicit	0
DB02845	Methylphosphinic Acid	Drug	Acids, Noncarboxylic, Cholinesterase Inhibitors, Acids, Organophosphorus Compounds, Phosphorus Compounds, Phosphorus Acids	experimental	3
DB02844	S-Adenosyl-1,8-Diamino-3-Thiooctane	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purines, Ribonucleosides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Purine Nucleosides	experimental	1
DB01513	17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane	Drug	0	illicit, experimental	0
DB01518	Benzethidine	Drug	0	illicit, experimental	0
DB02849	N-Pyridoxyl-1-Amino-Cyclopropanecarboxylic Acid-5-Monophosphate	Drug	0	experimental	1
DB02848	{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol	Drug	0	experimental	1
DB14832	Polydioxanone	Drug	Polyesters, Biocompatible Materials, Polymers, Compounds used in a research, industrial, or household setting, Macromolecular Substances	investigational	0
DB13501	Bendazac	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Sensory System Agents, Anti-Inflammatory Agents, Pyrazoles, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Antiinflammatory Preparations, Non-Steroids for Topical Use, Topical Products for Joint and Muscular Pain, Peripheral Nervous System Agents, Ophthalmologicals, Heterocyclic Compounds, Fused-Ring, Analgesics, Musculo-Skeletal System, Agents that produce hypertension, Central Nervous System Agents, Sensory Organs	approved, withdrawn	3
DB14833	Recombinant human lecithin:cholesterol acyltransferase	Drug	0	investigational	0
DB13502	Budipine	Drug	Anti-Dyskinesia Agents, Nervous System, Central Nervous System Agents, Anti-Parkinson Drugs, Dopamine Agents	experimental	0
DB14830	Fluoromisonidazole F-18	Drug	0	investigational	0
DB14831	BMS-986012	Drug	0	investigational	0
DB13500	Otilonium	Drug	QTc Prolonging Agents, Amines, Ammonium Compounds, Cytochrome P-450 Substrates, Agents causing hyperkalemia, Onium Compounds, Cardiovascular Agents, Muscarinic Antagonists, Cytochrome P-450 CYP3A4 Substrates, Peripheral Nervous System Agents, Anticholinergic Agents, Synthetic Anticholinergics, Quaternary Ammonium Compounds, Cholinergic Agents, Alimentary Tract and Metabolism, Calcium-Regulating Hormones and Agents, Drugs for Functional Gastrointestinal Disorders, Bradycardia-Causing Agents, Nitrogen Compounds, Antiarrhythmic agents, Gastrointestinal Agents, Autonomic Agents, Agents producing tachycardia, Parasympatholytics, Moderate Risk QTc-Prolonging Agents, Membrane Transport Modulators, Calcium Channel Blockers, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Vasodilating Agents	investigational, experimental	0
DB13505	Emepronium	Drug	Autonomic Agents, Psycholeptics, Amines, Ammonium Compounds, Nervous System, Quaternary Ammonium Compounds, Drugs for Urinary Frequency and Incontinence, Genito Urinary System and Sex Hormones, Urologicals, Agents producing tachycardia, Onium Compounds, Parasympatholytics, Muscarinic Antagonists, Peripheral Nervous System Agents, Anticholinergic Agents, Urological Agents, Neurotransmitter Agents, Cholinergic Agents, Alimentary Tract and Metabolism, Central Nervous System Depressants, Drugs for Functional Gastrointestinal Disorders, Hypnotics and Sedatives, Nitrogen Compounds	experimental	0
DB14836	Polydextrose	Drug	Food Additives, Carbohydrates, Polysaccharides, Physiological Phenomena, Food and Beverages, Food Ingredients, Polymers, Biopolymers, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food, Macromolecular Substances	investigational	0
DB13506	Carfecillin	Drug	Renal Agents, Anti-Infective Agents, Urinary, Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Amides, Lactams, beta-Lactams, Penicillin G, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins	experimental	0
DB14834	Olendalizumab	Drug	0	investigational	0
DB13503	Tyrothricin	Drug	Ophthalmologicals, Peptides, Cyclic, Anti-Bacterial Agents, Antibiotics for Topical Use, Cholinesterase Inhibitors, Throat Preparations, Peptides, Dermatologicals, Amino Acids, Peptides, and Proteins, Sensory Organs, Anti-Infective Agents, Anti-Infective Agents, Local	approved	3
DB14835	SUVN-G3031	Drug	0	investigational	0
DB13504	Cefetamet	Drug	Nephrotoxic agents, Third-Generation Cephalosporins, Cephacetrile, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Antibacterials for Systemic Use	experimental	0
DB13509	Aloxiprin	Drug	Benzoates, Blood and Blood Forming Organs, Hydroxy Acids, Analgesics, Nervous System, Platelet Aggregation Inhibitors Excl. Heparin, Acids, Carbocyclic, Hydroxybenzoates, Phenols, Salicylates, Salicylic Acid and Derivatives, Benzene Derivatives	experimental	0
DB14838	Telisotuzumab	Drug	0	investigational	0
DB13507	Poldine	Drug	Anticholinergic Agents, Synthetic Anticholinergics, Quaternary Ammonium Compounds, Hydroxy Acids, Alimentary Tract and Metabolism, Acids, Carbocyclic, Diphenylacetic Acids, Phenylacetates, Agents producing tachycardia, Drugs for Functional Gastrointestinal Disorders, Muscarinic Antagonists	experimental	0
DB14839	TOP-1288	Drug	0	investigational	0
DB13508	Cloranolol	Drug	Amines, Cytochrome P-450 Substrates, Propanols, Agents causing hyperkalemia, Adrenergic beta-Antagonists, Cardiovascular Agents, Amino Alcohols, Beta Blocking Agents, Non-Selective, Alcohols, Neurotransmitter Agents, Adrenergic Antagonists, Antihypertensive Agents, Cytochrome P-450 CYP2D6 Substrates, Adrenergic Agents, Bradycardia-Causing Agents	experimental	0
DB02850	DAS869	Drug	0	experimental	1
DB02854	Aetiocholanolone	Drug	0	experimental	4
DB01523	Clonitazene	Drug	0	illicit, experimental	0
DB01522	Betacetylmethadol	Drug	0	illicit, experimental	0
DB02853	D-Proline	Drug	0	experimental	0
DB01521	Clostebol	Drug	Androstanes, Hormones, Hormone Substitutes, and Hormone Antagonists, Androstenols, Androstenes, Testosterone Congeners, Hormones, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Steroids	illicit, experimental	0
DB02852	Domoic Acid	Drug	Neuromuscular Agents, Neurotoxins, Central Nervous System Depressants, Pyrrolidines, Marine Toxins, Peripheral Nervous System Agents	experimental	1
DB01520	Tenocyclidine	Drug	Street Drugs, Neuroprotective Agents, Protective Agents, Piperidines, NMDA Receptor Antagonists, Central Nervous System Agents, Compounds used in a research, industrial, or household setting	illicit, investigational, experimental	7
DB02851	Thiocamphor	Drug	Bornanes, Ketones, Monoterpenes, Terpenes, Norbornanes	experimental	1
DB02858	3-(4-Benzenesulfonyl-Thiophene-2-Sulfonylamino)-Phenylboronic Acid	Drug	0	experimental	1
DB01527	Clortermine	Drug	0	experimental	0
DB01526	4-Androstenediol	Drug	0	illicit, experimental	0
DB02857	Guanosine	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purines, Ribonucleosides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Purine Nucleosides	investigational, experimental	3
DB01525	Ecgonine	Drug	Alkaloids, Tropanes, Sensory System Agents, Analgesics, Narcotics, Aza Compounds, Azabicyclo Compounds, Central Nervous System Agents, Peripheral Nervous System Agents	illicit, experimental	0
DB02856	Ethyl N-methylcarbamate	Drug	Acids, Acyclic, Carbamates	experimental	1
DB01524	Androstenediol	Drug	Androstanes, Hormones, Hormone Substitutes, and Hormone Antagonists, Androstenols, Anabolic Agents, Androstenes, Testosterone Congeners, Hormones, Androstenediols, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Steroids	illicit, experimental	0
DB02855	N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline	Drug	Neuroprotective Agents, Enzyme Inhibitors, Cathepsin B, antagonists & inhibitors, Oligopeptides, Peptides, Protective Agents, Cysteine Proteinase Inhibitors, Protease Inhibitors, Amino Acids, Peptides, and Proteins, Central Nervous System Agents, Compounds used in a research, industrial, or household setting	experimental	1
DB01529	Dextromoramide	Drug	Oxazines, Sensory System Agents, Analgesics, Narcotics, Nervous System, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Diphenylpropylamine Derivatives, Opioids, Central Nervous System Agents, Morpholines, Peripheral Nervous System Agents	illicit, experimental	0
DB02859	Soraphen A	Drug	Polyketides, Lactones	experimental	1
DB01528	4-Methyl-2,5-dimethoxyamphetamine	Drug	0	illicit, experimental	0
DB14840	Ripretinib	Drug	Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, BCRP/ABCG2 Inhibitors, MATE inhibitors, MATE 1 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Protein Kinase Inhibitors, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)	approved	6
DB14843	Codrituzumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB13512	Clefamide	Drug	Acids, Acyclic, Dichloroacetamide Derivatives, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Fatty Acids, Fatty Acids, Volatile, Nitro Compounds, Phenols, Amides, Lipids, Acetates, Benzene Derivatives	experimental	0
DB13513	Tribromometacresol	Drug	Antifungals for Topical Use, Dermatologicals, Antifungals for Dermatological Use	experimental	0
DB14844	ONC-201	Drug	Heterocyclic Compounds, Fused-Ring, Antineoplastic Agents	investigational	0
DB13510	Buflomedil	Drug	Adrenergic alpha-Antagonists, Adrenergic Antagonists, Agents that produce hypertension, Peripheral Vasodilators, Cardiovascular Agents, Vasodilating Agents, Antiplatelet agents	experimental	0
DB14841	Centanafadine	Drug	0	investigational	0
DB13511	Clebopride	Drug	Autonomic Agents, Benzoates, Acids, Carbocyclic, Amides, Peripheral Nervous System Agents, Propulsives, Alimentary Tract and Metabolism, Antiemetics, Drugs for Functional Gastrointestinal Disorders, Central Nervous System Agents, Dopamine Antagonists, Benzene Derivatives, Gastrointestinal Agents	experimental	0
DB13516	Clodantoin	Drug	Imidazoles, Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Imidazolidines	experimental	0
DB14847	Azintuxizumab vedotin	Drug	0	investigational	0
DB14848	Tibulizumab	Drug	0	investigational	0
DB13517	Angiotensinamide	Drug	Biological Factors, Autacoids, Inflammation Mediators, Hormones, Hormone Substitutes, and Hormone Antagonists, Oligopeptides, Peptides, Angiotensins, Amino Acids, Peptides, and Proteins, Neuropeptides, Cardiovascular Agents, Nerve Tissue Proteins, Hormones, Proteins, Peptide Hormones, Vasoconstrictor Agents, Cardiac Stimulants Excl. Cardiac Glycosides, Cardiac Therapy	experimental	0
DB13514	Pranoprofen	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Acids, Acyclic, Fatty Acids, Sensory System Agents, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Lipids, Peripheral Nervous System Agents, Ophthalmologicals, Heterocyclic Compounds, Fused-Ring, Antigout Preparations, Analgesics, Fatty Acids, Volatile, Agents that produce hypertension, Central Nervous System Agents, Sensory Organs, Pyrans	investigational, experimental	0
DB14845	Filgotinib	Drug	Janus Kinase 1, antagonists & inhibitors	investigational	0
DB14846	Bimiralisib	Drug	0	investigational	0
DB13515	Levomethadone	Drug	Nervous System, Drugs Used in Opioid Dependence, Drugs Used in Addictive Disorders	experimental	0
DB14849	Nebicapone	Drug	Ketones	investigational	0
DB13518	Alginic acid	Drug	Acids, Acyclic, Carbohydrates, Hydroxy Acids, Alginates, Hexuronic Acids, Glucuronates, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Polysaccharides, Alimentary Tract and Metabolism, Sugar Acids, Uronic Acids, Acids, Aldehydic, Drugs for Acid Related Disorders, Compounds used in a research, industrial, or household setting	approved, investigational	0
DB13519	Cerium oxalate	Drug	Antiemetics and Antinauseants, Alimentary Tract and Metabolism	experimental	0
DB01530	5alpha-androstane-3alpha,17beta-diol	Drug	0	illicit, experimental	0
DB02861	4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide	Drug	0	experimental	1
DB02860	Calyculin A	Drug	Carcinogens, Enzyme Inhibitors, Noxae, Vasoconstrictor Agents, Toxic Actions, Cardiovascular Agents, Phosphoprotein Phosphatases, antagonists & inhibitors	experimental	1
DB02865	Glucosamine 4-Phosphate	Drug	Amino Sugars, Carbohydrates, Hexosephosphates, Sugar Phosphates, Hexosamines	experimental	1
DB01534	Chlorhexadol	Drug	Psycholeptics, Nervous System, Central Nervous System Depressants, Hypnotics and Sedatives, Aldehydes	illicit, experimental	0
DB00202	Succinylcholine	Drug	Neuromuscular Agents, Acids, Acyclic, Amines, Ammonium Compounds, Agents causing hyperkalemia, Trimethyl Ammonium Compounds, Onium Compounds, Muscle Relaxants, Alcohols, Choline Derivatives, Peripheral Nervous System Agents, Musculo-Skeletal System, Neuromuscular Depolarizing Blockade, Nitrogen Compounds, Neurotoxic agents, Quaternary Ammonium Compounds, Dicarboxylic Acids, Amino Alcohols, Ethanolamines, Muscle Relaxants, Peripherally Acting Agents, Succinates, Central Nervous System Depressants, Neuromuscular Blocking Agents, Neuromuscular Depolarizing Agents, Cholinesterase substrates	approved	5
DB01533	Diethylthiambutene	Drug	Sulfur Compounds	illicit, experimental	0
DB00203	Sildenafil	Drug	Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Phosphodiesterase 5 Inhibitors, Urologicals, Amides, Cytochrome P-450 CYP2C19 Inhibitors, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Purines, Sulfur Compounds, Cytochrome P-450 CYP2C9 Inhibitors, Sulfones, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 CYP3A5 Substrates, Piperazines, Cytochrome P-450 CYP2E1 Inhibitors, P-glycoprotein substrates, Cytochrome P-450 CYP2C19 Substrates, Urological Agents, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Substrates, Drugs Used in Erectile Dysfunction, Agents Causing Muscle Toxicity, Sulfonamides, Cytochrome P-450 CYP2C19 Inhibitors (weak), Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors, Vasodilating Agents, Cytochrome P-450 CYP2C9 Inhibitors (weak)	approved, investigational	3
DB02864	Biliverdin Ix Gamma Chromophore	Drug	0	experimental	0
DB01532	α-Methylacetylfentanyl	Drug	0	illicit	0
DB00200	Hydroxocobalamin	Drug	Hematinics, Antidotes, Blood and Blood Forming Organs, Hematologic Agents, Drugs that are Mainly Renally Excreted, Vitamins, Heterocyclic Compounds, Fused-Ring, Micronutrients, Antianemic Preparations, Physiological Phenomena, Food and Beverages, Vitamin B Complex, Corrinoids, Growth Substances, Nutritional Support, Diet, Food, and Nutrition, Food, VITAMIN B12 AND FOLIC ACID	approved	7
DB01531	Desomorphine	Drug	Sensory System Agents, Narcotics, Morphinans, Peripheral Nervous System Agents, Street Drugs, Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, Analgesics, Morphine Derivatives, Central Nervous System Depressants, Opioids, Central Nervous System Agents	illicit, experimental	0
DB02862	Gluco-Phenylimidazole	Drug	0	experimental	0
DB00201	Caffeine	Drug	Central Nervous System Stimulants, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Respiratory and CNS Stimulants, Purinergic Agents, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inhibitors, Alkaloids, Caffeine and Caffeine Containing Products, Purines, Tricarboxylic Acids, Purinergic Antagonists, Xanthine derivatives, Cytochrome P-450 CYP2C8 Substrates, Purinones, Phosphodiesterase Inhibitors, Cytochrome P-450 CYP2E1 Substrates, Psychostimulants, Agents Used for Adhd and Nootropics, Anorexigenic Agents & Respiratory and CNS Stimulants, BCRP/ABCG2 Inhibitors, Tests for Gastric Secretion, Central Nervous System Stimulation, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Drugs for Obstructive Airway Diseases, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Diagnostic Agents, Cytochrome P-450 CYP1A2 Inhibitors (moderate), Psychoanaleptics	approved	14
DB00206	Reserpine	Drug	Tranquilizing Agents, BSEP/ABCB11 Inhibitors, Adrenergic Uptake Inhibitors, Decreased Sympathetic Activity, OCT2 Substrates, Cytochrome P-450 CYP3A Inducers, OCT1 inhibitors, Cardiovascular Agents, Hypotensive Agents, Antiadrenergic Agents, Centrally Acting, Antidepressive Agents, Drugs that are Mainly Renally Excreted, Indole Alkaloids, Alkaloids, Antipsychotic Agents, Cytochrome P-450 Enzyme Inducers, Gastrointestinal Acidifying Agents, Antihypertensive Agents, Indoles, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Adrenergic Agents, Cytochrome P-450 CYP3A5 Inducers, Neurotoxic agents, Antihypertensive Agents Indicated for Hypertension, OATP1B1/SLCO1B1 Inhibitors, P-glycoprotein substrates, Psychotropic Drugs, Secologanin Tryptamine Alkaloids, Membrane Transport Modulators, P-glycoprotein inducers, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Central Nervous System Depressants, Neurotransmitter Uptake Inhibitors, Catecholamine-depleting Sympatholytic, Central Nervous System Agents, P-glycoprotein inhibitors	approved, investigational	3
DB01538	Acetyldihydrocodeine	Drug	Opium Alkaloids and Derivatives, Cough and Cold Preparations	illicit, experimental	0
DB02869	3-amino-5-phenylpentane	Drug	0	experimental	2
DB02868	Deacetoxyvinzolidine	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Vinca Alkaloids, Antineoplastic Agents, Indoles, Secologanin Tryptamine Alkaloids, Indole Alkaloids	experimental	1
DB01537	4-Bromo-2,5-dimethoxyphenethylamine	Drug	Neurotransmitter Agents, Adrenergic alpha-Agonists, Amines, Ethylamines, Adrenergic Agonists, Adrenergic alpha-1 Receptor Agonists, Phenethylamines, Adrenergic Agents	illicit, experimental	2
DB00207	Azithromycin	Drug	QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Lincosamides and Streptogramins, Experimental Unapproved Treatments for COVID-19, Cytochrome P-450 CYP2A6 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2A6 Inhibitors (strength unknown), Anti-Infective Agents, Lactones, Anti-Bacterial Agents, Drugs causing inadvertant photosensitivity, Macrolide Antimicrobial, Macrolides, P-glycoprotein substrates, Antiinfectives for Systemic Use, Moderate Risk QTc-Prolonging Agents, Ophthalmologicals, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors, Antibacterials for Systemic Use	approved	2
DB01536	Androstenedione	Drug	Cytochrome P-450 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, 17-Ketosteroids, Adrenal Cortex Hormones, Androstenes, Hormones, Ketosteroids, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Gonadal Steroid Hormones, Androstanes, Cytochrome P-450 CYP3A Substrates, Testosterone Congeners, Gonadal Hormones, Steroids	illicit, experimental	4
DB02867	D-Mannose 1-Phosphate	Drug	0	experimental	1
DB00204	Dofetilide	Drug	Antiarrhythmics, Class III, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, OCT2 Substrates, Amides, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Membrane Transport Modulators, Sulfur Compounds, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Ethylamines, OCT2 substrates with narrow therapeutic index, Potassium Channel Blockers, Cardiac Therapy, Sulfones, Antiarrhythmic agents	approved, investigational	3
DB01535	Carfentanil	Drug	High-risk opioids, Phenylpiperidine opioids, Sensory System Agents, Analgesics, Narcotics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Piperidines, Opioids, Central Nervous System Agents, Carbon Radioisotopes, Peripheral Nervous System Agents	illicit, investigational, vet_approved	3
DB00205	Pyrimethamine	Drug	Enzyme Inhibitors, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Cytochrome P-450 Enzyme Inhibitors, Antibiotics for Pneumocystis Pneumonia, Cytochrome P-450 CYP2C8 Inhibitors, Folic Acid Antagonists, Antimalarials, MATE inhibitors, Diaminopyrimidines, MATE 1 Inhibitors, Anti-Infective Agents, Pyrimidines, Cytochrome P-450 CYP2C8 Inhibitors (weak), MATE 2 Inhibitors, Antiparasitic Agents	approved, investigational, vet_approved	3
DB02866	Dansylamide	Drug	Luminescent Agents, Sulfur Compounds, Coloring Agents, Laboratory Chemicals, Indicators and Reagents, Compounds used in a research, industrial, or household setting, Fluorescent Dyes, Sulfones, Naphthalenes	experimental	1
DB00208	Ticlopidine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Enzyme Inhibitors, Blood and Blood Forming Organs, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors, Cardiovascular Agents, Purinergic Agents, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP1A2 Inhibitors, Sulfur Compounds, Cytochrome P-450 CYP2B6 Inhibitors (moderate), Thiophenes, Cytochrome P-450 CYP2C8 Inhibitors (weak), Cytochrome P-450 CYP2C9 Inhibitors, Purinergic Antagonists, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Antiplatelet agents, Pyridines, Chemically-Induced Disorders, Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Fibrin Modulating Agents, Cytochrome P-450 CYP2E1 Inhibitors (weak), Purinergic P2 Receptor Antagonists, Thienopyridines, Hematologic Agents, Cytochrome P-450 CYP2C19 Inhibitors (moderate), Cytochrome P-450 CYP2C19 Inhibitors (strong), Cytochrome P-450 CYP2C19 Substrates, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Platelet Aggregation Inhibitors Excl. Heparin, Decreased Platelet Aggregation, Cytochrome P-450 CYP2B6 Inhibitors (strong), Purinergic P2Y Receptor Antagonists, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2C9 Inhibitors (weak)	approved	1
DB01539	1-Piperidinocyclohexanecarbonitrile	Drug	Piperidines	illicit, experimental	0
DB00209	Trospium	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Acids, Carbocyclic, Drugs for Urinary Frequency and Incontinence, Genito Urinary System and Sex Hormones, Urologicals, Muscarinic Antagonists, Peripheral Nervous System Agents, Anticholinergic Agents, Alkaloids, Cholinergic Agents, Alimentary Tract and Metabolism, Aza Compounds, Azabicyclo Compounds, Drugs for Functional Gastrointestinal Disorders, Autonomic Agents, Hydroxy Acids, Agents producing tachycardia, Parasympatholytics, Urological Agents, Neurotransmitter Agents, Tropanes, Diphenylacetic Acids, Phenylacetates, Cytochrome P-450 CYP2D6 Inhibitors (weak)	approved	2
DB02803	3-Phenyl-1,2-Propandiol	Drug	0	experimental	1
DB02802	3-(alpha-D-Galactopyranosyloxy)-5-nitrobenzamide	Drug	0	experimental	1
DB02801	2,3-Anhydro-quinic acid	Drug	0	experimental	2
DB02800	5-hydroxymethyl-5,6-dihydrofolic acid	Drug	0	experimental	2
DB02807	3-deoxy-D-lyxo-hexonic acid	Drug	0	experimental	0
DB02806	2-Methoxyethanol	Drug	Immunologic Factors, Solvents, Immunosuppressive Agents, Noxae, Teratogens, Toxic Actions, Glycols, Alcohols	experimental	0
DB02805	Arabinouridine 3'-phosphate	Drug	0	experimental	1
DB02804	A-98881	Drug	0	experimental	1
DB02809	Brodimoprim-4,6-Dicarboxylate	Drug	0	experimental	1
DB02808	Trifluorofurnesyl Diphosphate	Drug	0	experimental	0
DB02810	N-(2-Acetamido)Iminodiacetic Acid	Drug	Acids, Acyclic, Amino Acids, Cyclic, Imines, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	1
DB02814	3'-Deazo-Thiamin Diphosphate	Drug	0	experimental	0
DB02813	2-Acetamido-2-Deoxy-D-Glucono-1,5-Lactone	Drug	0	experimental	2
DB02812	RWJ-56423	Drug	0	experimental	1
DB02811	Diethyl phosphonate	Drug	0	experimental	2
DB02818	Iodo-Willardiine	Drug	0	experimental	1
DB02817	5-Exo-Hydroxycamphor	Drug	0	experimental	1
DB02816	7-(1-Methyl-1,2,3-Triazol-4-Yl)-6-Formyl-2,7-Dihydro-[1,4]Thiazepine-3-Carboxylic Acid, Brl42715, C6-(N1-Methyl-1,2,3-Triazolylmethylene)Penem	Drug	0	experimental	1
DB02819	Mono-[3,4-Dihydroxy-5-(5-Methyl-Benzoimidazol-1-Yl)-Tetrahydor-Furan-2-Ylmethyl] Ester	Drug	0	experimental	1
DB14800	GP-100 antigen	Drug	0	investigational	0
DB14803	AMY-101	Drug	0	investigational	0
DB14804	Iodine I-125	Drug	0	investigational	0
DB14801	Lanifibranor	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Thiazoles, Amides, Sulfones	investigational	0
DB14802	ONO-2952	Drug	Heterocyclic Compounds, Fused-Ring, Cycloparaffins	investigational	0
DB14807	Demplatin pegraglumer	Drug	Organometallic Compounds, Amino Acids, Dicarboxylic, Peptides, Amino Acids, Peptides, and Proteins, Amino Acids, Acidic, Glutamates, Amino Acids	investigational	0
DB14808	Lumicitabine	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Glycosides, Nucleosides, Deoxyribonucleosides	investigational	0
DB14805	DCFPyL F-18	Drug	0	investigational	0
DB14806	Avexitide	Drug	Glucagon-Like Peptide 1, Peptides, Venoms, Amino Acids, Peptides, and Proteins	investigational	0
DB02821	Canaline	Drug	Acids, Acyclic, Fatty Acids, Butyrates, Fatty Acids, Volatile, Amino Acids, Peptides, and Proteins, Lipids, Amino Acids	experimental	1
DB02820	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	Drug	0	experimental	1
DB02825	Methylphosphinate	Drug	0	experimental	1
DB02824	N-Pyridoxyl-Glycine-5-Monophosphate	Drug	0	experimental	4
DB02823	Phosphonoacetic Acid	Drug	Organophosphonates, Acids, Acyclic, Enzyme Inhibitors, Nucleic Acid Synthesis Inhibitors, Fatty Acids, Fatty Acids, Volatile, Organophosphorus Compounds, Lipids, Reverse Transcriptase Inhibitors, Acetates, Anti-Infective Agents	experimental	1
DB02822	Para-Bromobenzyl Alcohol	Drug	Benzyl Compounds, Benzene Derivatives, Alcohols	experimental	1
DB02829	4-(Acetylamino)-3-[(Aminoacetyl)Amino]Benzoic Acid	Drug	0	experimental	1
DB02828	5-Fluorolevulinic Acid	Drug	Keto Acids	experimental	1
DB02827	7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid	Drug	0	experimental	1
DB14894	Galicaftor	Drug	0	investigational	0
DB12231	Temefos	Drug	Organothiophosphorus Compounds, QTc Prolonging Agents, Sulfur Compounds, Agrochemicals, Pesticides, Organophosphorus Compounds, Insecticides, Organothiophosphates, Potential QTc-Prolonging Agents, Toxic Actions, Compounds used in a research, industrial, or household setting, Organophosphates	investigational	0
DB13563	Norgestrienone	Drug	Norpregnatrienes, Sex Hormones and Modulators of the Genital System, Norsteroids, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, Reproductive Control Agents, Fused-Ring Compounds, Contraceptives, Oral, Contraceptives, Oral, Synthetic, Progestins, Combination Contraceptives (with Estrogen and derivatives), Hormonal Contraceptives for Systemic Use, Norpregnanes, Contraceptive Agents, Female, Progestin Contraceptives, Steroids	experimental	0
DB12230	Bunazosin	Drug	Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Adrenergic alpha-Antagonists, Adrenergic Antagonists, Peripheral alpha-1 blockers, Adrenergic alpha-1 Receptor Antagonists, Adrenergic Agents	investigational	0
DB14895	Vibegron	Drug	Pyrimidines	investigational	0
DB13564	Zipeprol	Drug	Antitussive Agents, Cough and Cold Preparations, Central Nervous System Agents, Respiratory System Agents	experimental	0
DB12233	Iguratimod	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amides, Benzopyrans, Sulfones, Pyrans	investigational	0
DB13561	Clobenzorex	Drug	Central Nervous System Stimulants, Centrally Acting Antiobesity Products, Amines, Ethylamines, Alimentary Tract and Metabolism, Antiobesity Preparations, Excl. Diet Products, Phenethylamines	experimental	0
DB14892	Spartalizumab	Drug	0	investigational	0
DB12232	KRN-7000	Drug	Carbohydrates, Immunologic Factors, Cerebrosides, Glycoconjugates, Adjuvants, Immunologic, Antineoplastic Agents, Amides, Lipids, Sphingolipids, Neutral Glycosphingolipids, Glycosphingolipids, Glycolipids, Ceramides, Membrane Lipids	investigational	0
DB13567	Desaspidin	Drug	Antiparasitic Products, Insecticides and Repellents, Ketones, Anthelmintics, Antiparasitic Agents, Anticestodals	experimental	0
DB14898	Retagliptin	Drug	0	investigational	0
DB12235	Estetrol	Drug	Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, Estrenes, Estradiol Congeners, Hormones, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Steroids	investigational	0
DB12234	BMS-214662	Drug	Heterocyclic Compounds, Fused-Ring, Benzazepines	investigational	0
DB13568	Diodone	Drug	Pyridines, Contrast Media, Diagnostic Uses of Chemicals, Iodopyridones, Pyridones, Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting	experimental	0
DB14899	Tavapadon	Drug	0	investigational	0
DB13565	Benzoxonium	Drug	Benzylammonium Compounds, Amines, Ammonium Compounds, Antiinfectives and Antiseptics for Local Oral Treatment, Alimentary Tract and Metabolism, Quaternary Ammonium Compounds, Antiseptics and Disinfectants, Dermatologicals, Onium Compounds, Nitrogen Compounds, Stomatological Preparations	experimental	0
DB12237	GW-274150	Drug	Gases, Anions, Sulfur Compounds, Acids, Noncarboxylic, Nitric Oxide Synthase, antagonists & inhibitors, Acids, Hydrogen Sulfide, Electrolytes, Ions	investigational	0
DB14896	Selitrectinib	Drug	Enzyme Inhibitors	investigational	0
DB14897	Parsatuzumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB12236	Bexagliflozin	Drug	0	investigational	0
DB13566	Sequifenadine	Drug	Antihistamines for Systemic Use	experimental	0
DB12239	Balicatib	Drug	Benzoates, Acids, Carbocyclic, Amides, Benzene Derivatives	investigational	0
DB12238	MK-0777	Drug	0	investigational	0
DB13569	Ferrous chloride	Drug	Organometallic Compounds, Iron Bivalent, Oral Preparations, Antianemic Preparations, Blood and Blood Forming Organs, Iron Compounds, Iron Preparations	experimental	0
DB01581	Sulfamerazine	Drug	Long-Acting Sulfonamides, Amines, Gynecological Antiinfectives and Antiseptics, Aniline Compounds, Dermatologicals, Genito Urinary System and Sex Hormones, Amides, Sulfanilamides, Antiinfectives for Systemic Use, Anti-Infective Agents, SULFONAMIDES AND TRIMETHOPRIM, Anti-Bacterial Agents, Sulfur Compounds, Sulfonamide Antibacterial, Sulfonamides, Antibacterials for Systemic Use, Sulfones	approved, vet_approved	1
DB00250	Dapsone	Drug	Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Folic Acid Antagonists, Antimalarials, Antimycobacterials, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Anti-Bacterial Agents, Cytochrome P-450 Enzyme Inducers, Sulfur Compounds, Cytochrome P-450 CYP2C8 Substrates, Drugs causing inadvertant photosensitivity, Sulfones, Cytochrome P-450 CYP2E1 Substrates, Antiprotozoals, Cytochrome P-450 CYP2C18 Substrates, Cytochrome P-450 CYP3A5 Substrates, Antibiotics for Pneumocystis Pneumonia, Dermatologicals, Anti-Acne Preparations, Antiinfectives for Systemic Use, Drugs for Treatment of Lepra, Leprostatic Agents, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Cytochrome P-450 CYP2C9 Inducers, Methemoglobinemia Associated Agents, Anti-Acne Preparations for Topical Use, Antiparasitic Agents, Miscellaneous Antimycobacterials, Miscellaneous Local Anti-infectives	approved, investigational	2
DB01580	Oxprenolol	Drug	Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Tranquilizing Agents, Amines, Cytochrome P-450 Substrates, Sympatholytics, Cytochrome P-450 Enzyme Inhibitors, Agents causing hyperkalemia, Beta Blocking Agents, Non-Selective, and Thiazides, Adrenergic beta-Antagonists, Cardiovascular Agents, Hypotensive Agents, Alcohols, Peripheral Nervous System Agents, Adrenergic Antagonists, Antihypertensive Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Adrenergic Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Autonomic Agents, Propanols, Phenoxypropanolamines, Amino Alcohols, Beta Blocking Agents and Thiazides, Beta Blocking Agents, Non-Selective, Moderate Risk QTc-Prolonging Agents, Neurotransmitter Agents, Central Nervous System Depressants, OCT2 Inhibitors, Anti-Anxiety Agents, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Vasodilating Agents, Propanolamines	approved	3
DB00253	Medrysone	Drug	Cytochrome P-450 Substrates, Immunosuppressive Agents, Glucocorticoids, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, OAT3/SLC22A8 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Corticosteroid Hormone Receptor Agonists, Cytochrome P-450 CYP3A5 Inducers, Corticosteroids, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inducers, Ophthalmologicals, Cytochrome P-450 CYP3A Substrates, Pregnanes, Thyroxine-binding globulin inhibitors, Sensory Organs, Hyperglycemia-Associated Agents, Pregnenes, Steroids	approved	1
DB00254	Doxycycline	Drug	Antiprotozoals, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Agents that produce neuromuscular block (indirect), Cytochrome P-450 CYP3A4 Substrates, Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, OAT1/SLC22A6 inhibitors, Anti-Bacterial Agents, Cytochrome P-450 CYP3A Inhibitors, Antiinfectives and Antiseptics for Local Oral Treatment, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Alimentary Tract and Metabolism, Tetracyclines, Cytochrome P-450 CYP3A4 Inhibitors, Naphthacenes, Drugs causing inadvertant photosensitivity, Antibacterials for Systemic Use, Antiparasitic Agents, Stomatological Preparations	approved, investigational, vet_approved	1
DB01584	Thyroglobulin	Drug	Proteins, Carbohydrates, Globulins, Glycoconjugates, Iodoproteins, Amino Acids, Peptides, and Proteins, Glycoproteins	approved, withdrawn	0
DB01583	Liotrix	Drug	Amino Acids, Aromatic, Thyroid Products, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP2C8 Inhibitors, Amino Acids, Peptides, and Proteins, OATP1B3 substrates, Hormones, Cytochrome P-450 CYP3A4 Substrates, Amino Acids, Agents used to treat hypothyroidism, Thyroxine-binding globulin substrates, P-glycoprotein inducers, Amino Acids, Cyclic, l-Triiodothyronine, Cytochrome P-450 CYP3A Substrates, OATP1B1/SLCO1B1 Substrates, Pharmaceutical Preparations, OAT3/SLC22A8 Inhibitors, Thyronines, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)	approved	2
DB00251	Terconazole	Drug	Triazole Derivatives, Azole Antifungals, Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Antifungal Agents, Antifungal Agents (Vaginal), Anti-Infective Agents	approved	1
DB00252	Phenytoin	Drug	Voltage-Gated Sodium Channel Blockers, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Cytochrome P-450 CYP2B6 Inducers (strength unknown), UGT1A1 Inducers, Cytochrome P-450 CYP2C19 Inducers (moderate), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Cytochrome P-450 CYP2B6 Inducers (strong), Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A4 Inducers (strong), Cytochrome P-450 CYP2C19 Inducers, Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index, COMT Substrates, Cytochrome P-450 CYP2C8 Substrates, P-glycoprotein substrates with narrow therapeutic index, Cytochrome P-450 CYP2C18 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A Inducers (strong), Cytochrome P-450 CYP3A4 Inducers, Inducers of Drug Clearance, Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index, Hydantoins, Membrane Transport Modulators, Cytochrome P-450 CYP2C19 Substrates, Narrow Therapeutic Index Drugs, Central Nervous System Depressants, Cytochrome P-450 CYP2A6 Substrates, Cytochrome P-450 CYP1A2 Inducers, UGT1A4 substrates, UGT1A6 Inhibitors, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Sodium Channel Blockers, Decreased Central Nervous System Disorganized Electrical Activity, Cytochrome P-450 CYP2C8 Inducers, Nervous System, Enzyme Inducing Antiepileptic Drugs, Anti-epileptic Agent, Cytochrome P-450 CYP3A7 Inducers (weak), Thyroxine-binding globulin substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2B6 Inducers, Phenytoin and Prodrugs, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 CYP2C18 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C8 Inducers (strong), P-glycoprotein substrates, UGT1A6 substrate, Imidazolidines, Cytochrome P-450 CYP3A7 Inducers, Cytochrome P-450 CYP2C9 Substrates, Anticonvulsants, UGT1A9 Inhibitors, Imidazoles, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), UGT1A1 Substrates, UGT1A9 Substrates, Central Nervous System Agents, Cytochrome P-450 CYP2C9 Inducers, Methemoglobinemia Associated Agents	approved, vet_approved	10
DB01582	Sulfamethazine	Drug	Amines, Gynecological Antiinfectives and Antiseptics, Aniline Compounds, Genito Urinary System and Sex Hormones, Amides, Sulfanilamides, Antiinfectives for Systemic Use, Anti-Infective Agents, Short-Acting Sulfonamides, SULFONAMIDES AND TRIMETHOPRIM, Sulfur Compounds, Sulfonamides, Antibacterials for Systemic Use, Sulfones	approved, investigational, vet_approved	1
DB00257	Clotrimazole	Drug	OATP1B3 inducers, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Antifungals for Dermatological Use, Cytochrome P-450 CYP2B6 Inducers (strength unknown), BSEP/ABCB11 Substrates, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors (moderate), Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Local, Antiinfectives and Antiseptics for Local Oral Treatment, Cytochrome P-450 CYP2C8 Inhibitors (moderate), OATP1B1/SLCO1B1 Inhibitors, Steroid Synthesis Inhibitors, Cytochrome P-450 CYP3A Inducers (strong), Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP2C8 Inhibitors (strong), OATP1B1/SLCO1B1 Substrates, Imidazole and Triazole Derivatives, Cytochrome P-450 CYP2D6 Inhibitors, BSEP/ABCB11 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (strong), Cytochrome P-450 CYP2A6 Inhibitors, Cytochrome P-450 CYP2B6 Inhibitors, Anti-Infective Agents, Cytochrome P-450 CYP3A7 Inducers (weak), Cytochrome P-450 CYP2A6 Inhibitors (strong), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A7 Inducers (strong), Antifungals for Topical Use, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Antifungal Agents, Hormone Antagonists, Cytochrome P-450 CYP2E1 Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Gynecological Antiinfectives and Antiseptics, P-glycoprotein substrates, Dermatologicals, Cytochrome P-450 CYP3A7 Inducers, P-glycoprotein inducers, Azole Antifungals, Cytochrome P-450 CYP3A Inhibitors, Imidazoles, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2B6 Inhibitors (strong), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2E1 Inhibitors (moderate), Antifungal Agents (Vaginal), Imidazole Derivatives, P-glycoprotein inhibitors, Stomatological Preparations	approved, vet_approved	5
DB01589	Quazepam	Drug	Psycholeptics, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Benzodiazepines and benzodiazepine derivatives, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Benzazepines, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Hypnotics and Sedatives, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), Benzodiazepine hypnotics and sedatives	approved, illicit	2
DB01588	Prazepam	Drug	Psycholeptics, Tranquilizing Agents, Cytochrome P-450 Substrates, GABA Agents, Nervous System, GABA Modulators, Benzodiazepines and benzodiazepine derivatives, Cytochrome P-450 CYP3A4 Substrates, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Benzazepines, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Benzodiazepinones, Anti-Anxiety Agents, Central Nervous System Agents	approved, illicit	2
DB00258	Calcium acetate	Drug	Arylsulfonates, Acids, Acyclic, Fatty Acids, Phosphate Binder, Sulfur Acids, Arylsulfonic Acids, Blood Coagulation Factors, Lipids, Minerals, Calcium Salts, Sulfur Compounds, Acids, Noncarboxylic, Acids, Alimentary Tract and Metabolism, Fatty Acids, Volatile, Sulfonic Acids, Phosphate-removing Agents, Sequestering Agents, Drugs for Treatment of Hyperkalemia and Hyperphosphatemia, Compounds used in a research, industrial, or household setting, Benzene Derivatives, Chelating Agents	approved, investigational	1
DB01587	Ketazolam	Drug	Psycholeptics, Tranquilizing Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, P-glycoprotein substrates, Benzodiazepines and benzodiazepine derivatives, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Psychotropic Drugs, Drugs that are Mainly Renally Excreted, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Benzazepines, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Cytochrome P-450 CYP3A4 Inhibitors, Anti-Anxiety Agents, Central Nervous System Agents	approved	2
DB00255	Diethylstilbestrol	Drug	Endocrine Therapy, Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Estrogens, Non-Steroidal, Adrenal Cortex Hormones, Estrogens, Genito Urinary System and Sex Hormones, Synthetic Estrogens, Plain, BSEP/ABCB11 Substrates, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Hormones, Cytochrome P-450 CYP3A4 Substrates, Carcinogens, Hormones and Related Agents, Cytochrome P-450 CYP2E1 Inhibitors (strong), Stilbenes, Cytochrome P-450 CYP2C9 Inhibitors, COMT Substrates, Cytochrome P-450 CYP2C8 Substrates, Hormonal Contraceptives for Systemic Use, Benzene Derivatives, Contraceptive Agents, Female, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Estrogen Contraceptives, OATP1B1/SLCO1B1 Inhibitors, Antineoplastic Agents, Hormonal, Contraceptive Agents, Male, Contraceptives, Postcoital, Cytochrome P-450 CYP2E1 Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Noxae, Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, BCRP/ABCG2 Inhibitors, Benzylidene Compounds, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Thyroxine-binding globulin inducers, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Toxic Actions	approved, investigational	9
DB01586	Ursodeoxycholic acid	Drug	BSEP/ABCB11 Inhibitors, Cytochrome P-450 CYP2E1 Inducers, Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Bile Acid Preparations, BSEP/ABCB11 Substrates, Bile Therapy, Bile Acids and Salts, Cholic Acids, Fused-Ring Compounds, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Cytochrome P-450 Enzyme Inducers, Alimentary Tract and Metabolism, Bile acids and derivatives, BSEP/ABCB11 inducers, Cholagogues and Choleretics, Cholanes, Bile and Liver Therapy, Cholelitholytic Agents, Cytochrome P-450 CYP2E1 Inducers (strength unknown), Gastrointestinal Agents, Steroids	approved, investigational	2
DB00256	Lymecycline	Drug	Anti-Bacterial Agents, Tetracyclines, Naphthacenes, Agents that produce neuromuscular block (indirect), Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use	approved, investigational	1
DB00259	Sulfanilamide	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Amines, Cytochrome P-450 Enzyme Inhibitors, Aniline Compounds, Genito Urinary System and Sex Hormones, Amides, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Sulfanilamides, Anti-Infective Agents, Short-Acting Sulfonamides, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), SULFONAMIDES AND TRIMETHOPRIM, Anti-Bacterial Agents, Sulfur Compounds, Sulfonamide Antibacterial, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Sulfones, Cytochrome P-450 CYP2E1 Inhibitors, Gynecological Antiinfectives and Antiseptics, Dermatologicals, Antiinfectives for Systemic Use, Cytochrome P-450 CYP3A Inhibitors, Sulfonamides, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Methemoglobinemia Associated Agents, Antibacterials for Systemic Use	approved	1
DB14890	Obicetrapib	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB13560	Dextranomer	Drug	Carbohydrates, Polysaccharides, Vesico-Ureteral Reflux, Dermatologicals, Glucans, Sorption Detoxification, Preparations for Treatment of Wounds and Ulcers, Polymers, Biopolymers, Compounds used in a research, industrial, or household setting, Cicatrizants, Macromolecular Substances	experimental	0
DB14891	Vobarilizumab	Drug	Amino Acid Sequence, Immunoglobulins, Peptide Fragments, Peptides, Molecular Sequence Data, Amino Acids, Peptides, and Proteins, Information Science, Information Services, Immunoglobulin Fragments, Immunoproteins, Proteins, Serum Globulins, Globulins, Blood Proteins, Biochemical Phenomena, Immunoglobulin Variable Region, Molecular Structure, Immunoglobulin Fab Fragments	investigational	0
DB12242	AZD-7762	Drug	Sulfur Compounds	investigational	0
DB13574	Heptaminol	Drug	Amines, Vasodilators Used in Cardiac Diseases, Amino Alcohols, Cardiac Therapy, Alcohols	experimental	0
DB13575	Bietaserpine	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Cardiovascular Agents, Antiadrenergic Agents, Centrally Acting, Antihypertensive Agents, Indoles, Secologanin Tryptamine Alkaloids, Indole Alkaloids	experimental	0
DB12241	TAK-733	Drug	Pyridines, Pyrimidines	investigational	0
DB13572	Emylcamate	Drug	Acids, Acyclic, Psycholeptics, Nervous System, Central Nervous System Depressants, Carbamates, Anti-Anxiety Agents	experimental	0
DB12244	CP-601927	Drug	0	investigational	0
DB13573	Acefylline	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Purines, Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 Substrates, Drugs for Obstructive Airway Diseases, Xanthine derivatives, Purinones	experimental	0
DB12243	Edaravone	Drug	Antioxidants, Neuroprotective Agents, Nervous System, Protective Agents, Pyrazoles, Free Radical Scavengers, Miscellaneous Central Nervous System Agents, OAT1/SLC22A6 Substrates, Central Nervous System Agents, Compounds used in a research, industrial, or household setting, Pyrazolones, OAT3/SLC22A8 Substrates	approved, investigational	0
DB12246	Inclacumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB13578	Metabutethamine	Drug	Nervous System, Esters of Aminobenzoic Acid, Anesthetics, Anesthetics, Local	experimental	0
DB12245	Triclabendazole	Drug	Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Benzimidazoles, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Anthelmintics, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2A6 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP2A6 Inhibitors (strength unknown), Anti-Infective Agents, Cytochrome P-450 CYP1A2 Inhibitors, Antitrematodals, Cytochrome P-450 CYP2C9 Inhibitors, Potential QTc-Prolonging Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Antiparasitic Products, Insecticides and Repellents, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Antiplatyhelmintic Agents, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), Antiparasitic Agents	approved, investigational	1
DB13579	Mepixanox	Drug	Xanthenes, Heterocyclic Compounds, Fused-Ring, Respiratory System Agents	experimental	0
DB13576	Aluminium nicotinate	Drug	Lipid Modifying Agents, Lipid Modifying Agents, Plain, Nicotinic Acid and Derivatives	experimental	0
DB12248	Tulobuterol	Drug	Autonomic Agents, Adrenergics, Inhalants, Amines, Adrenergics for Systemic Use, Anti-Asthmatic Agents, Agents producing tachycardia, Bronchodilator Agents, Amino Alcohols, Ethanolamines, Respiratory System Agents, Alcohols, Peripheral Nervous System Agents, Adrenergic beta-Agonists, Neurotransmitter Agents, Selective Beta 2-adrenergic Agonists, Agents to Treat Airway Disease, Adrenergic Agonists, Agents that produce hypertension, Drugs for Obstructive Airway Diseases, Adrenergic Agents	investigational	1
DB13577	Allobarbital	Drug	Psycholeptics, Pyrimidines, Nervous System, Central Nervous System Depressants, Barbiturates, Plain, Pyrimidinones, Hypnotics and Sedatives	experimental	0
DB12247	AZD-4547	Drug	0	investigational	0
DB12249	Stem bromelain	Drug	Cysteine Endopeptidases, Enzymes, Cysteine Proteases, Enzymes and Coenzymes, Hydrolases, Peptide Hydrolases, Endopeptidases	approved, investigational	0
DB00260	Cycloserine	Drug	Amino Acids, Neutral, Renal Agents, Anti-Infective Agents, Urinary, Noxae, Amino Acids, Peptides, and Proteins, Antimycobacterials, Antiinfectives for Systemic Use, Antimetabolites, Amino Acids, Anti-Infective Agents, Anti-Bacterial Agents, Drugs for Treatment of Tuberculosis, Oxazoles, Oxazolidinones, Antibiotics, Antitubercular, Isoxazoles, Toxic Actions, Antituberculosis Agents, Neurotoxic agents	approved	2
DB01592	Iron	Drug	Blood and Blood Forming Organs, Antianemia Drugs, Iron Compounds, Metals, Metals, Heavy, Minerals, Elements, Transition Elements, Supplements, Organometallic Compounds, Trace Elements, Micronutrients, Antianemic Preparations, Physiological Phenomena, Alimentary Tract and Metabolism, Food and Beverages, Iron Preparations, Growth Substances, Diet, Food, and Nutrition, Food	approved	13
DB01591	Solifenacin	Drug	QTc Prolonging Agents, Cytochrome P-450 Substrates, Isoquinolines, Drugs for Urinary Frequency and Incontinence, Genito Urinary System and Sex Hormones, Urologicals, Agents producing tachycardia, Muscarinic Antagonists, Cytochrome P-450 CYP3A4 Substrates, Anticholinergic Agents, Urological Agents, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cholinergic Agents, Cytochrome P-450 CYP3A Substrates, Agents that produce hypertension, Potential QTc-Prolonging Agents, Cytochrome P-450 CYP2D6 Substrates, Drugs Used in Benign Prostatic Hypertrophy, Tetrahydroisoquinolines, Quinuclidines	approved	5
DB00261	Anagrelide	Drug	Cytochrome P-450 CYP1A2 Inhibitors (weak), Highest Risk QTc-Prolonging Agents, Phosphodiesterase Inhibitors, QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Antineoplastic and Immunomodulating Agents, Phosphodiesterase 3 Inhibitors, Antineoplastic Agents, Agents producing tachycardia, Decreased Platelet Production, Hematologic Agents, Cardiovascular Agents, Cytochrome P-450 CYP1A2 Inhibitors, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP1A2 Substrates, Thrombocytosis, Vasodilating Agents, Antiplatelet agents, Platelet-reducing Agents	approved	1
DB01590	Everolimus	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Immunologic Factors, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, OATP1B3 inhibitors, Cytochrome P-450 CYP3A4 Substrates, Selective Immunosuppressants, Lactones, Anti-Bacterial Agents, Decreased Immunologic Activity, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Macrolides, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, mTOR Inhibitors, Antineoplastic Agents, mTOR Inhibitor Immunosuppressant, Myelosuppressive Agents, Polyketides, Protein Kinase Inhibitors, Cytochrome P-450 CYP3A Inhibitors, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors, Hyperglycemia-Associated Agents, Kinase Inhibitor	approved	1
DB00264	Metoprolol	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Amines, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Agents causing hyperkalemia, Adrenergic beta-Antagonists, Cardiovascular Agents, Hypotensive Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Adrenergic beta-1 Receptor Antagonists, Alcohols, Adrenergic Antagonists, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Antihypertensive Agents, Drugs causing inadvertant photosensitivity, Adrenergic Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Beta Blocking Agents, Selective, and Thiazides, Antihypertensive Agents Indicated for Hypertension, Amino Alcohols, Beta Blocking Agents and Thiazides, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, OCT2 Inhibitors, Beta blocking agents and calcium channel blockers, Beta Blocking Agents, Selective, Beta-Blockers (Beta1 Selective), Cytochrome P-450 CYP2D6 Substrates, Propanolamines	approved, investigational	2
DB01595	Nitrazepam	Drug	Psycholeptics, Tranquilizing Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, GABA Modulators, Benzodiazepines and benzodiazepine derivatives, Cytochrome P-450 CYP3A4 Substrates, Muscle Relaxants, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Benzazepines, Muscle Relaxants, Centrally Acting Agents, Hypnotics and Sedatives, Benzodiazepine hypnotics and sedatives, Cytochrome P-450 CYP2E1 Inhibitors, GABA Agents, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Anticonvulsants, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Benzodiazepinones, Anti-Anxiety Agents, Central Nervous System Agents	approved	3
DB00265	Crotamiton	Drug	Amines, Agrochemicals, Aniline Compounds, Pesticides, Scabicides and Pediculicides, Toxic Actions, Compounds used in a research, industrial, or household setting, Benzene Derivatives	approved	0
DB01594	Cinolazepam	Drug	Heterocyclic Compounds, Fused-Ring, Psycholeptics, Benzazepines, Nervous System, Central Nervous System Depressants, Benzodiazepines and benzodiazepine derivatives, Hypnotics and Sedatives, Benzodiazepine hypnotics and sedatives	experimental	2
DB00262	Carmustine	Drug	Cytochrome P-450 Substrates, Immunosuppressive Agents, Nitroso Compounds, Noxae, Nitrosoureas, Antineoplastic and Immunomodulating Agents, Alkylating Activity, Antineoplastic Agents, Cardiotoxic antineoplastic agents, Nitrosourea Compounds, Drugs that are Mainly Renally Excreted, Myelosuppressive Agents, Alkylating Drugs, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP1A2 Substrates, Toxic Actions, Antineoplastic Agents, Alkylating	approved, investigational	3
DB00263	Sulfisoxazole	Drug	QTc Prolonging Agents, Amines, Cytochrome P-450 Enzyme Inhibitors, Aniline Compounds, Genito Urinary System and Sex Hormones, Hypoglycemia-Associated Agents, Amides, Sulfanilamides, Anti-Infective Agents, Short-Acting Sulfonamides, SULFONAMIDES AND TRIMETHOPRIM, Anti-Bacterial Agents, Sulfur Compounds, Sulfonamide Antibacterial, Cytochrome P-450 CYP2C9 Inhibitors, Drugs causing inadvertant photosensitivity, Sulfones, Gynecological Antiinfectives and Antiseptics, Blood Glucose Lowering Agents, Antiinfectives for Systemic Use, Moderate Risk QTc-Prolonging Agents, Ophthalmologicals, Photosensitizing Agents, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Sulfonamides, Sensory Organs, Antibacterials for Systemic Use	approved, vet_approved	1
DB01593	Zinc	Drug	Zinc Compounds, Metals, Metals, Heavy, Minerals, Elements, Transition Elements, Trace Elements, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Micronutrients, Vasoprotectives, Metal cations, Physiological Phenomena, Replacement Preparations, Metal divalent cations, Food and Beverages, Laxatives, Copper Absorption Inhibitor, Growth Substances, Diet, Food, and Nutrition, Food	approved, investigational	124
DB00268	Ropinirole	Drug	Cytochrome P-450 Substrates, Nervous System, Hypotensive Agents, Antidepressive Agents, Nonergot-derivative Dopamine Receptor Agonists, Anti-Parkinson Drugs, Dopamine Agonists, Anti-Dyskinesia Agents, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Central Nervous System Depressants, Cytochrome P-450 CYP1A2 Substrates, Anti-Parkinson Agents (Dopamine Agonist), Central Nervous System Agents, Dopamine Agents	approved, investigational	4
DB01599	Probucol	Drug	QTc Prolonging Agents, Anticholesteremic Agents, Hypolipidemic Agents, Noxae, Protective Agents, Moderate Risk QTc-Prolonging Agents, Antioxidants, Lipid Modifying Agents, Lipid Modifying Agents, Plain, Lipid Regulating Agents, Phenols, Toxic Actions, Compounds used in a research, industrial, or household setting, Benzene Derivatives	approved, investigational	2
DB00269	Chlorotrianisene	Drug	Sex Hormones and Modulators of the Genital System, Antineoplastic Agents, Hormonal, Stilbenes, Hormones, Hormone Substitutes, and Hormone Antagonists, Estrogens, Non-Steroidal, Estrogens, Genito Urinary System and Sex Hormones, Antineoplastic Agents, Benzylidene Compounds, Natural and Semisynthetic Estrogens, Plain, Hormones, Benzene Derivatives	investigational, withdrawn	1
DB00266	Dicoumarol	Drug	Anticoagulants, Enzyme Inhibitors, Blood and Blood Forming Organs, Cytochrome P-450 Substrates, Uncoupling Agents, 4-Hydroxycoumarins, Coumarins, Hematologic Agents, Benzopyrans, Fibrinolytic Agents, Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index, Vitamin K Antagonists, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Narrow Therapeutic Index Drugs, Pyrans	approved	3
DB01598	Imipenem	Drug	Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Penem Antibacterial, Antiinfectives for Systemic Use, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Carbapenems, Thienamycins, Antibacterials for Systemic Use, Agents that reduce seizure threshold, Neurotoxic agents	approved	5
DB01597	Cilastatin	Drug	Renal Dehydropeptidase Inhibitor, Cycloparaffins, Enzyme Inhibitors, Dipeptidase Inhibitors, Protease Inhibitors, Cyclopropanes, OAT3/SLC22A8 Inhibitors, OAT1/SLC22A6 inhibitors	approved, investigational	1
DB00267	Cefmenoxime	Drug	Nephrotoxic agents, Third-Generation Cephalosporins, Cephacetrile, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Antibacterials for Systemic Use	approved	2
DB13570	Oxidized cellulose	Drug	Carbohydrates, Blood and Blood Forming Organs, Cellulose, Hematologic Agents, Coagulants, Biopolymers, Macromolecular Substances, Polysaccharides, Glucans, Local Hemostatics, Hemostatics, Polymers, Compounds used in a research, industrial, or household setting	experimental	0
DB13571	Pentamycin	Drug	Polyketides, Alkenes, Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Hydrocarbons, Acyclic, Antifungal Agents, Lactones	experimental	0
DB12240	Polatuzumab vedotin	Drug	Immunoglobulins, Cytochrome P-450 Substrates, Noxae, Antibodies, Amino Acids, Peptides, and Proteins, Cytochrome P-450 CYP3A4 Substrates, Immunoproteins, Proteins, Serum Globulins, Cytochrome P-450 CYP3A Substrates, Globulins, Blood Proteins, Toxic Actions	approved, investigational	1
DB12253	GDC-0810	Drug	Heterocyclic Compounds, Fused-Ring, Pyrazoles, Acids, Carbocyclic	investigational	0
DB13585	Aminoethyl nitrate	Drug	Anions, Acids, Noncarboxylic, Acids, Electrolytes, Ions, Vasodilators Used in Cardiac Diseases, Nitric Acid, Cardiac Therapy, Nitrogen Compounds	experimental	0
DB12252	PG-701	Drug	0	investigational	0
DB13586	Metandienone	Drug	Androgens for Topical Use, Hormones, Hormone Substitutes, and Hormone Antagonists, Dermatologicals, Androstadienes, Anabolic Agents, Androstenes, Hormones, Fused-Ring Compounds, Androstanes, Alimentary Tract and Metabolism, Anabolic Steroids, Anabolic Agents for Systemic Use, Androstan Derivatives, Steroids	experimental	0
DB13583	Mephenesin	Drug	Neuromuscular Agents, Central Nervous System Depressants, Musculo-Skeletal System, Muscle Relaxants, Centrally Acting Agents, Glycols, Central Nervous System Agents, Propylene Glycols, Muscle Relaxants, Alcohols, Peripheral Nervous System Agents	approved	0
DB12255	Vadadustat	Drug	Pyridines, Amino Acids, Peptides, and Proteins, Amino Acids	investigational	0
DB13584	Gallamine	Drug	Neuromuscular Agents, Amines, Ammonium Compounds, Quaternary Ammonium Compounds, Neuromuscular-Blocking Agents (Nondepolarizing), Onium Compounds, Muscle Relaxants, Nicotinic Antagonists, Peripheral Nervous System Agents, Anticholinergic Agents, Neurotransmitter Agents, Cholinergic Agents, Muscle Relaxants, Peripherally Acting Agents, Central Nervous System Depressants, Musculo-Skeletal System, Neuromuscular Blocking Agents, Nitrogen Compounds, Neurotoxic agents	experimental	0
DB12254	ABT-751	Drug	Sulfur Compounds, Amines, Aniline Compounds, Phenols, Amides, Benzene Derivatives, Sulfones	investigational	0
DB12257	Platinum	Drug	Cross-Linking Reagents, Metals, Laboratory Chemicals, Antineoplastic Agents, Metals, Heavy, Elements, Transition Elements, Platinum Compounds, Radiation-Sensitizing Agents, Indicators and Reagents, Compounds used in a research, industrial, or household setting, Chlorine Compounds, Nitrogen Compounds	investigational	0
DB12256	Bamosiran	Drug	0	investigational	0
DB12259	CG-200745	Drug	Amines, Hydroxy Acids, Hydroxylamines, Antineoplastic Agents, Histone Deacetylase Inhibitors	investigational	0
DB13587	Mesterolone	Drug	Androstanols, Sex Hormones and Modulators of the Genital System, Hormones, Hormone Substitutes, and Hormone Antagonists, Genito Urinary System and Sex Hormones, Anabolic Agents, Hormones, Fused-Ring Compounds, Gonadal Steroid Hormones, Androgens, Androstanes, 5-Androstanon (3) Derivatives, Testosterone Congeners, Gonadal Hormones, Steroids	experimental	0
DB12258	Abicipar Pegol	Drug	Proteins, Pegylated agents, Amino Acids, Peptides, and Proteins, Recombinant Proteins	investigational	0
DB13588	Naftidrofuryl	Drug	Neurotransmitter Agents, Serotonin Agents, Central Nervous System Depressants, Peripheral Vasodilators, Cardiovascular Agents, Furans, Serotonin Receptor Antagonists, Antidepressive Agents, Vasodilating Agents	experimental	0
DB00271	Diatrizoate	Drug	Carbohydrates, Benzoates, Acids, Carbocyclic, Roentgenography, Drugs that are Mainly Renally Excreted, Alcohols, Amino Sugars, Iodobenzoates, Iodinated Contrast Agents, Contrast Media, Diagnostic Uses of Chemicals, Radiographic Contrast Agent, Sugar Alcohols, Hexosamines, Triiodobenzoic Acids, Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting, X-Ray Contrast Activity, Benzene Derivatives	approved, vet_approved	0
DB00272	Betazole	Drug	Neurotransmitter Agents, Pyrazoles, Histamine Agonists, Tests for Gastric Secretion, Diagnostic Agents, Histamine Agents, Gastrointestinal Agents	approved	1
DB00270	Isradipine	Drug	Calcium Channel Blockers (Dihydropyridine), Dihydropyridine Derivatives, QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Agents causing hyperkalemia, Cytochrome P-450 CYP3A4 Inhibitors (moderate), BSEP/ABCB11 Substrates, Cardiovascular Agents, Hypotensive Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Calcium-Regulating Hormones and Agents, Potential QTc-Prolonging Agents, Antihypertensive Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Selective Calcium Channel Blockers With Mainly Vascular Effects, Antihypertensive Agents Indicated for Hypertension, Pyridines, Membrane Transport Modulators, Calcium Channel Blockers, Dihydropyridines, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors, Vasodilating Agents	approved, investigational	7
DB00275	Olmesartan	Drug	Antihypertensive Agents Indicated for Hypertension, BSEP/ABCB11 Inhibitors, Angiotensin II receptor blockers (ARBs) and diuretics, Angiotensin Receptor Antagonists, Agents causing hyperkalemia, Angiotensin II receptor blockers (ARBs) and calcium channel blockers, Cardiovascular Agents, Hypotensive Agents, OATP1B3 substrates, Tetrazoles, Angiotensin II receptor blockers (ARBs), plain, Imidazoles, Angiotensin II Antagonists and Calcium Channel Blockers, Agents Acting on the Renin-Angiotensin System, OATP1B1/SLCO1B1 Substrates, Angiotensin 2 Receptor Blocker, Antihypertensive Agents	approved, investigational	1
DB00276	Amsacrine	Drug	Immunosuppressive Agents, Acridines, Antineoplastic and Immunomodulating Agents, Laboratory Chemicals, Antineoplastic Agents, Cardiotoxic antineoplastic agents, Intercalating Agents, Myelosuppressive Agents, Heterocyclic Compounds, Fused-Ring, Narrow Therapeutic Index Drugs, Indicators and Reagents, Aminoacridines, P-glycoprotein inhibitors, Compounds used in a research, industrial, or household setting	approved, investigational	5
DB00273	Topiramate	Drug	Neuroprotective Agents, Decreased Central Nervous System Disorganized Electrical Activity, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Enzyme Inducing Antiepileptic Drugs, Drugs that are Mainly Renally Excreted, Monosaccharides, Cytochrome P-450 Enzyme Inducers, Miscellaneous Anticonvulsants, Carbohydrates, Hexoses, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inducers, Fructose, Ketoses, Cytochrome P-450 CYP3A4 Inducers (weak), Anticonvulsants, Anti-Obesity Agents, Central Nervous System Depressants, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Central Nervous System Agents	approved	9
DB00274	Cefmetazole	Drug	Nephrotoxic agents, Second-Generation Cephalosporins, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Cephamycins, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Antibacterials for Systemic Use	approved, investigational	6
DB00279	Liothyronine	Drug	Thyroid Products, Hormones, Hormone Substitutes, and Hormone Antagonists, OATP1B3 substrates, Hormones, Drugs that are Mainly Renally Excreted, Agents used to treat hypothyroidism, Thyroxine-binding globulin substrates, P-glycoprotein inducers, l-Triiodothyronine, UGT1A1 Substrates, OATP1B1/SLCO1B1 Substrates, Triiodothyronine, OAT3/SLC22A8 Inhibitors, Thyronines, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins	approved, vet_approved	3
DB00277	Theophylline	Drug	Purinergic P1 Receptor Antagonists, Enzyme Inhibitors, Cytochrome P-450 Substrates, Phosphodiesterase 5 Inhibitors, Cardiovascular Agents, Purinergic Agents, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index, Peripheral Nervous System Agents, Alkaloids, Purines, Xanthines and Adrenergics, Purinergic Antagonists, Xanthine derivatives, Cytochrome P-450 CYP2C8 Substrates, Purinones, Agents that reduce seizure threshold, Autonomic Agents, Phosphodiesterase Inhibitors, Cytochrome P-450 CYP2E1 Substrates, Anti-Asthmatic Agents, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Bronchodilator Agents, Respiratory Smooth Muscle Relaxants, Respiratory System Agents, Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Drugs for Obstructive Airway Diseases, Cytochrome P-450 CYP2D6 Substrates, Vasodilating Agents	approved	14
DB00278	Argatroban	Drug	Anticoagulants, Enzyme Inhibitors, Blood and Blood Forming Organs, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Protease Inhibitors, Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index, Hematologic Agents, Cytochrome P-450 CYP3A4 Substrates, Fibrinolytic Agents, Antithrombins, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Piperidines, Thrombin Inhibitors, Serine Protease Inhibitors	approved, investigational	1
DB13581	Rociverine	Drug	Anticholinergic Agents, Autonomic Agents, Cycloparaffins, Alimentary Tract and Metabolism, Acids, Carbocyclic, Agents producing tachycardia, Parasympatholytics, Drugs for Functional Gastrointestinal Disorders, Muscarinic Antagonists, Synthetic Anticholinergics, Esters With Tertiary Amino Group, Cyclohexanes, Peripheral Nervous System Agents	experimental	5
DB13582	Ferric (59Fe) citrate	Drug	Diagnostic Radiopharmaceuticals, Various Diagnostic Radiopharmaceuticals	experimental	0
DB12251	Moxaverine	Drug	Autonomic Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Opiate Alkaloids, Benzylisoquinolines, Alimentary Tract and Metabolism, Isoquinolines, Papaverine and Derivatives, Parasympatholytics, Drugs for Functional Gastrointestinal Disorders, Peripheral Nervous System Agents	investigational	0
DB12250	Cixutumumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Receptor, IGF Type 1, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Radiation-Sensitizing Agents, Immunoproteins	investigational	1
DB13580	Succinylsulfathiazole	Drug	Sulfur Compounds, Amines, Intestinal Antiinfectives, Alimentary Tract and Metabolism, Sulfonamides, Aniline Compounds, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Thiazoles, Amides, Sulfanilamides, Sulfones	experimental	0
DB13596	Oxycinchophen	Drug	Quinolines, Antiinflammatory and Antirheumatic Products, Musculo-Skeletal System, Specific Antirheumatic Agents	experimental	0
DB12264	Atevirdine	Drug	Enzyme Inhibitors, Nucleic Acid Synthesis Inhibitors, Anti-Retroviral Agents, Antiviral Agents, Reverse Transcriptase Inhibitors, Anti-Infective Agents	investigational	0
DB13597	Moroxydine	Drug	Antivirals for Systemic Use, Direct Acting Antivirals, Oxazines, Antiviral Agents, Antiinfectives for Systemic Use, Anti-Infective Agents	experimental	0
DB12263	Begacestat	Drug	Sulfur Compounds, Amyloid Precursor Protein Secretases, Amides, Sulfones	investigational	0
DB12266	Epofolate	Drug	Biological Factors, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Antineoplastic Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Pteridines, Lactones, Pigments, Biological, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Pterins, Cytochrome P-450 CYP3A4 Inhibitors	investigational	0
DB13595	Almasilate	Drug	Ions, Oxides, Minerals, Drugs that are Mainly Renally Excreted, Pharmaceutic Aids, Silicon Compounds, Aluminum and magnesium containing antacids, Anions, Gastric Acid Lowering Agents, Acids, Noncarboxylic, Acids, Alimentary Tract and Metabolism, Electrolytes, Drugs for Acid Related Disorders, Antacids, Oxygen Compounds	approved, experimental	0
DB12265	Fexinidazole	Drug	Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Imidazoles, Agents Against Leishmaniasis and Trypanosomiasis, Nitroimidazole Derivatives, Nitro Compounds	investigational	0
DB12268	Carmegliptin	Drug	Heterocyclic Compounds, Fused-Ring, Dipeptidyl Peptidase 4, Agents causing angioedema, Blood Glucose Lowering Agents, DPP-IV Inhibitors	investigational	0
DB12267	Brigatinib	Drug	Cytochrome P-450 Substrates, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, MATE inhibitors, MATE 1 Inhibitors, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Enzyme Inducers, Protein Kinase Inhibitors, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index, MATE 2 Inhibitors, Cytochrome P-450 CYP2C8 Substrates, Kinase Inhibitor	approved, investigational	9
DB13598	Diethyl ether	Drug	Anesthetics, Inhalation, Solvents, Anesthetics, General, Nervous System, Central Nervous System Depressants, Agents that produce hypertension, Ethyl Ethers, Central Nervous System Agents, Anesthetics, Ethers, Compounds used in a research, industrial, or household setting, Neurotoxic agents	experimental	0
DB13599	Difetarsone	Drug	Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Arsenicals	experimental	0
DB12269	PF-06273340	Drug	0	investigational	0
DB00282	Pamidronic acid	Drug	Nephrotoxic agents, Organophosphonates, Agents Causing Muscle Toxicity, Musculo-Skeletal System, Drugs for Treatment of Bone Diseases, Bone Density Conservation Agents, Antineoplastic Agents, Organophosphorus Compounds, Drugs Affecting Bone Structure and Mineralization, Bisphosphonates	approved	5
DB00283	Clemastine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Anti-Allergic Agents, Cytochrome P-450 Enzyme Inhibitors, Antihistamines for Topical Use, Dermatologicals, Neurotransmitter Agents, Histamine H1 Antagonists, Antipruritics, Incl. Antihistamines, Anesthetics, Etc., Histamine Antagonists, Photosensitizing Agents, Central Nervous System Depressants, Pyrrolidines, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Histamine Agents, Aminoalkyl Ethers, Antihistamines for Systemic Use, Antipruritics	approved, investigational	1
DB00280	Disopyramide	Drug	Highest Risk QTc-Prolonging Agents, Pyridines, QTc Prolonging Agents, Voltage-Gated Sodium Channel Blockers, Cytochrome P-450 Substrates, Hypoglycemia-Associated Agents, OCT1 inhibitors, Agents producing tachycardia, Cardiovascular Agents, Muscarinic Antagonists, Blood Glucose Lowering Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Membrane Transport Modulators, Anticholinergic Agents, Cytochrome P-450 CYP3A Substrates, OCT2 Inhibitors, Cytochrome P-450 CYP1A2 Substrates, Antiarrhythmics, Class I, Sodium Channel Blockers, Antiarrhythmics, Class Ia, Cardiac Therapy, Antiarrhythmic agents	approved	8
DB00281	Lidocaine	Drug	Voltage-Gated Sodium Channel Blockers, Cytochrome P-450 Substrates, Sensory System Agents, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Neuraxial Anesthetics, Otologicals, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Peripheral Nervous System Agents, Antipruritics and Local Anesthetics, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Substrates, Agents that reduce seizure threshold, Anesthetics, Local, Antiarrhythmic agents, Analgesics and Anesthetics, Cytochrome P-450 CYP2C18 Substrates, Cytochrome P-450 CYP3A5 Substrates, Local Anesthesia, Anesthetics for Topical Use, Anesthetics, Membrane Transport Modulators, Ophthalmologicals, Amide Local Anesthetic, Cytochrome P-450 CYP2A6 Substrates, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Sodium Channel Blockers, Antiarrhythmics, Class Ib, Cytochrome P-450 CYP1A2 Inhibitors (moderate), Cytochrome P-450 CYP2D6 Inhibitors, Amines, Nervous System, Aniline Compounds, Amides, Anilides, Cytochrome P-450 CYP1A2 Inhibitors, Vasoprotectives, Antipruritics, Incl. Antihistamines, Anesthetics, Etc., Antiarrhythmics, Class I, Dermatologicals, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Cytochrome P-450 CYP2C9 Substrates, Throat Preparations, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Central Nervous System Agents, Methemoglobinemia Associated Agents, P-glycoprotein inhibitors, Cardiac Therapy	approved, vet_approved	7
DB00286	Conjugated estrogens	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Estrogens, Genito Urinary System and Sex Hormones, Natural and Semisynthetic Estrogens, Plain, OATP1B3 substrates, Hormones, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, OAT3/SLC22A8 Substrates, Cytochrome P-450 CYP1A2 Inhibitors, Agents causing angioedema, Estradiol Congeners, COMT Substrates, Estrogens, Conjugated (USP), Gonadal Hormones, Cytochrome P-450 CYP1A2 Inhibitors (weak), OATP1B1/SLCO1B1 Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein substrates, Gonadal Steroid Hormones, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Substrates, Thyroxine-binding globulin inducers, Cytochrome P-450 CYP1A2 Substrates, OATP1B1/SLCO1B1 Substrates, OAT3/SLC22A8 Inhibitors	approved	2
DB00287	Travoprost	Drug	Inflammation Mediators, Fatty Acids, Antiglaucoma Preparations and Miotics, Prostaglandin analogs reducing intraocular pressure (IOP), Eicosanoids, Lipids, Ophthalmics, Prostaglandins, Synthetic, Ophthalmologicals, Fatty Acids, Unsaturated, Prostaglandins, Prostaglandins F, Synthetic, Antihypertensive Agents	approved	1
DB00284	Acarbose	Drug	Carbohydrates, Glycoside Hydrolase Inhibitors, Enzyme Inhibitors, Polysaccharides, Trisaccharides, Alimentary Tract and Metabolism, Hypoglycemia-Associated Agents, Drugs Used in Diabetes, Blood Glucose Lowering Agents, Oligosaccharides, Drugs that are Mainly Renally Excreted	approved, investigational	4
DB00285	Venlafaxine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Serotonin Agents, Cyclohexanols, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Hypoglycemia-Associated Agents, Lipids, Antidepressive Agents, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Phenethylamines, Drugs that are Mainly Renally Excreted, Alcohols, BCRP/ABCG2 Inducers, Cyclohexanes, Serotonin Modulators, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Norepinephrine Uptake Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Potential QTc-Prolonging Agents, Fatty Alcohols, Agents that reduce seizure threshold, Cycloparaffins, P-glycoprotein substrates, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Agents producing tachycardia, Antidepressive Agents, Second-Generation, Psychotropic Drugs, Membrane Transport Modulators, Cytochrome P-450 CYP2C9 Substrates, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Ethylamines, Hexanols, Central Nervous System Depressants, Neurotransmitter Uptake Inhibitors, Serotonin and Noradrenaline Reuptake Inhibitors, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (weak), Psychoanaleptics	approved	3
DB00288	Amcinonide	Drug	Corticosteroids, Dermatological Preparations, Cytochrome P-450 Substrates, Immunosuppressive Agents, Glucocorticoids, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Corticosteroids, Potent (Group III), Cytochrome P-450 CYP3A5 Inducers (strength unknown), Corticosteroid Hormone Receptor Agonists, Cytochrome P-450 CYP3A5 Inducers, Corticosteroids, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Cytochrome P-450 CYP3A4 Inducers, Dermatologicals, Cytochrome P-450 CYP3A Substrates, Pregnanes, Thyroxine-binding globulin inhibitors, Steroids, Fluorinated, Hyperglycemia-Associated Agents, Steroids	approved	2
DB00289	Atomoxetine	Drug	QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Psychostimulants, Agents Used for Adhd and Nootropics, Agents producing tachycardia, Miscellaneous Central Nervous System Agents, Drugs that are Mainly Renally Excreted, Membrane Transport Modulators, Cytochrome P-450 CYP2C19 Substrates, Neurotransmitter Agents, Central Nervous System Depressants, Norepinephrine Uptake Inhibitors, Neurotransmitter Uptake Inhibitors, Agents that produce hypertension, Potential QTc-Prolonging Agents, Cytochrome P-450 CYP2D6 Substrates, Adrenergic Agents, Norepinephrine Reuptake Inhibitor, Propylamines	approved	5
DB12260	Radiprodil	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Amides, Lipids, Acetates	investigational	0
DB13592	Etamiphylline	Drug	Autonomic Agents, Cytochrome P-450 Substrates, Anti-Asthmatic Agents, Bronchodilator Agents, Respiratory System Agents, Peripheral Nervous System Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Purines, Xanthines and Adrenergics, Cytochrome P-450 CYP1A2 Substrates, Drugs for Obstructive Airway Diseases, Xanthine derivatives, Purinones	experimental	0
DB13593	Zolimidine	Drug	Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Alimentary Tract and Metabolism, Drugs for Acid Related Disorders	experimental	0
DB12262	CRS-3123	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Methionine-tRNA Ligase, antagonists & inhibitors, Pyrans	investigational	0
DB13590	Calcium pangamate	Drug	Acids, Acyclic, Carbohydrates, Amines, Hydroxy Acids, Peptides, Gluconates, Amino Acids, Peptides, and Proteins, Mineral Supplements, Peptoids, Amino Acids, Calcium Salts, Alimentary Tract and Metabolism, Sugar Acids	experimental	0
DB13591	Metopimazine	Drug	Autonomic Agents, Antiemetics and Antinauseants, Alimentary Tract and Metabolism, Piperidines, Antiemetics, Central Nervous System Agents, Gastrointestinal Agents, Peripheral Nervous System Agents	experimental	0
DB12261	Ascrinvacumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB14850	Deleobuvir	Drug	Acids, Acyclic, Heterocyclic Compounds, Fused-Ring	investigational	0
DB14851	Relatlimab	Drug	0	investigational	0
DB13520	Metergoline	Drug	Ergot-derivative Dopamine Receptor Agonists, Serotonin Agents, Genito Urinary System and Sex Hormones, Serotonin Receptor Agonists, Antidepressive Agents, Ergolines, Dopamine Agonists, Ergot Alkaloids and Derivatives, Alkaloids, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Central Nervous System Depressants, Agents that produce hypertension, Prolactine Inhibitors, Dopamine Agents	approved	1
DB14854	TC-6987	Drug	0	investigational	0
DB13523	Veralipride	Drug	Psycholeptics, Tranquilizing Agents, Benzoates, Nervous System, Psychophysiologic Disorders, drug therapy, Acids, Carbocyclic, Benzamides and benzamide derivatives, Amides, Psychotropic Drugs, Antipsychotic Agents, Central Nervous System Depressants, Menopause, drug effects, Central Nervous System Agents, Benzene Derivatives, Neurotoxic agents	experimental	0
DB14855	2-(aminomethyl)phenol	Drug	Amines, Benzyl Compounds, Benzene Derivatives	investigational	0
DB13524	Propyphenazone	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Sensory System Agents, Nervous System, Anti-Inflammatory Agents, Pyrazoles, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Pyrazolones, Peripheral Nervous System Agents, Analgesics, Agents that produce hypertension, Central Nervous System Agents	experimental	0
DB14852	PRM-151	Drug	Proteins, Carbohydrates, Glycoconjugates, Acute-Phase Proteins, Blood Proteins, Multiprotein Complexes, Amino Acids, Peptides, and Proteins, Amyloid, Glycoproteins, Amyloidogenic Proteins, DNA-Binding Proteins, Macromolecular Substances	investigational	0
DB13521	Alipogene tiparvovec	Drug	Lipid Modifying Agents, Lipid Modifying Agents, Plain	approved, investigational	0
DB14853	Myrcludex B	Drug	0	investigational	0
DB13522	Mebicar	Drug	Tranquilizing Agents, Sensory System Agents, Analgesics, Nervous System, Central Nervous System Depressants, Anti-Anxiety Agents, Central Nervous System Agents, Psychotropic Drugs, Peripheral Nervous System Agents, Psychoanaleptics	experimental	0
DB14858	Tadekinig alfa	Drug	0	investigational	0
DB13527	Proglumetacin	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Acetic Acid Derivatives and Related Substances, Sensory System Agents, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Peripheral Nervous System Agents, Heterocyclic Compounds, Fused-Ring, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Musculo-Skeletal System, Agents that produce hypertension, Central Nervous System Agents, Indoles	experimental	0
DB14859	Fosifloxuridine nafalbenamide	Drug	0	investigational	0
DB13528	Chlormadinone	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, Reproductive Control Agents, Cytochrome P-450 CYP3A4 Substrates, Pregnadien Derivatives, Fused-Ring Compounds, Contraceptives, Oral, Cytochrome P-450 CYP3A Substrates, Contraceptives, Oral, Synthetic, Progestogens and Estrogens, Sequential Preparations, Progestins, Antiandrogens, Pregnanes, Combination Contraceptives (with Estrogen and derivatives), Hormone Antagonists, Hormonal Contraceptives for Systemic Use, Contraceptive Agents, Female, Progestin Contraceptives, Steroids, Steroids, Chlorinated	experimental	0
DB14856	PF-05089771	Drug	Sulfur Compounds, Phenols, Amides, Ethers, Benzene Derivatives, Sulfones	investigational	0
DB13525	Althea root	Drug	Cough and Cold Preparations, Expectorants	experimental	0
DB13526	Pentaerithrityl	Drug	Alimentary Tract and Metabolism, Osmotic Laxatives, Drugs for Constipation, Laxatives, Glycols, Alcohols	experimental	0
DB14857	Avadomide	Drug	Heterocyclic Compounds, Fused-Ring, Piperidines, Quinazolines	investigational	0
DB13529	Dobesilic acid	Drug	Arylsulfonates, Sulfur Acids, Arylsulfonic Acids, Hematologic Agents, Coagulants, Vasoprotectives, Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfonic Acids, Antivaricose Therapy, Hemostatics, Benzene Derivatives, Benzenesulfonates	investigational, experimental	0
DB01541	Boldenone	Drug	Androstanes, Testosterone and derivatives, Hormones, Hormone Substitutes, and Hormone Antagonists, Androstenols, Anabolic Agents, Androstenes, Testosterone Congeners, Hormones, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Steroids	illicit, vet_approved	1
DB02872	Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone	Drug	0	experimental	1
DB01540	17alpha-methyl-4-hydroxynandrolone	Drug	0	illicit	0
DB00210	Adapalene	Drug	Anti-Inflammatory Agents, Dermatologicals, Retinoids for Topical Use in Acne, Misc. Skin and Mucous Membrane Agents, Retinoids, Anti-Acne Preparations, Anti-Acne Preparations for Topical Use, Naphthalenes	approved	9
DB02871	3-Butylthiolane 1-Oxide	Drug	Sulfur Compounds, Alcohol Dehydrogenase, antagonists & inhibitors	experimental	1
DB02870	N-Allylaniline	Drug	0	experimental	1
DB02876	3-(4-carbamoyl-1-carboxy-2-methylsulfonyl-buta-1,3-dienylamino)-indolizine-2-carboxylic acid	Drug	0	experimental	1
DB01545	Ethyl loflazepate	Drug	Heterocyclic Compounds, Fused-Ring, Psycholeptics, Tranquilizing Agents, Benzazepines, Nervous System, Central Nervous System Depressants, Benzodiazepines and benzodiazepine derivatives, Anti-Anxiety Agents, Central Nervous System Agents, Psychotropic Drugs	illicit, experimental	2
DB00213	Pantoprazole	Drug	Benzimidazoles, Enzyme Inhibitors, Proton-pump Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors, Anti-Ulcer Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Sulfur Compounds, Alimentary Tract and Metabolism, Acid Reducers, Drugs for Acid Related Disorders, Gastrointestinal Agents, OATP1B1/SLCO1B1 Inhibitors, Pyridines, Proton Pump Inhibitors, P-glycoprotein substrates, BCRP/ABCG2 Inhibitors, Sulfoxides, Cytochrome P-450 CYP2C19 Substrates, Heterocyclic Compounds, Fused-Ring, Gastric Acid Lowering Agents, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Substrates, 2-Pyridinylmethylsulfinylbenzimidazoles, Cytochrome P-450 CYP2C19 Inhibitors (weak), OAT3/SLC22A8 Inhibitors, P-glycoprotein inhibitors	approved	2
DB02875	CRA_1802	Drug	0	experimental	1
DB01544	Flunitrazepam	Drug	Psycholeptics, Tranquilizing Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, GABA Modulators, Benzodiazepines and benzodiazepine derivatives, UGT2B7 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Muscle Relaxants, UGT1A3 Inhibitors, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Benzazepines, Muscle Relaxants, Centrally Acting Agents, Hypnotics and Sedatives, Benzodiazepine hypnotics and sedatives, Cytochrome P-450 CYP2E1 Inhibitors, GABA Agents, UGT1A1 Inhibitors, Psychotropic Drugs, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Cytochrome P-450 CYP2A6 Substrates, Benzodiazepinones, Anti-Anxiety Agents, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates	approved, illicit	2
DB00214	Torasemide	Drug	Antihypertensive Agents Indicated for Hypertension, Pyridines, High-Ceiling Diuretics, Cytochrome P-450 Substrates, Sodium Potassium Chloride Symporter Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Ototoxic agents, Cardiovascular Agents, Hypotensive Agents, Membrane Transport Modulators, Cytochrome P-450 CYP2C9 Substrates, Sulfur Compounds, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Sulfonamides, Cytochrome P-450 CYP2C9 Inhibitors, Diuretics, Natriuretic Agents, OATP1B1/SLCO1B1 Substrates, Antihypertensive Agents, Cytochrome P-450 CYP2C8 Substrates, Hyperglycemia-Associated Agents, Increased Diuresis at Loop of Henle, Non Potassium Sparing Diuretics, Sulfones	approved	2
DB00211	Midodrine	Drug	Autonomic Agents, Adrenergic alpha-Agonists, Amines, Cytochrome P-450 Substrates, Adrenergic alpha-1 Receptor Agonists, Agents producing tachycardia, Adrenergic and Dopaminergic Agents, Cardiovascular Agents, Amino Alcohols, Ethanolamines, Alcohols, Peripheral Nervous System Agents, Neurotransmitter Agents, Sympathomimetics, Vasoconstrictor Agents, Adrenergic Agonists, Cardiac Stimulants Excl. Cardiac Glycosides, Agents that produce hypertension, Cytochrome P-450 CYP2D6 Substrates, Cardiac Therapy, Adrenergic Agents, Bradycardia-Causing Agents	approved	3
DB01543	18-methyl-19-nortestosterone	Drug	Testosterone and derivatives	illicit, experimental	0
DB02873	1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One	Drug	0	experimental	1
DB00212	Remikiren	Drug	Renin-Inhibitors, Enzyme Inhibitors, Protease Inhibitors, Agents Acting on the Renin-Angiotensin System, Cardiovascular Agents, Antihypertensive Agents	experimental	1
DB01542	Allylprodine	Drug	0	illicit, experimental	0
DB01549	Rolicyclidine	Drug	Piperidines	illicit, experimental	2
DB00217	Bethanidine	Drug	Autonomic Agents, Adrenergic alpha-Agonists, Sympatholytics, Antiadrenergic Agents, Peripherally Acting, Agents producing tachycardia, Amidines, Cardiovascular Agents, Guanidines, Peripheral Nervous System Agents, Neurotransmitter Agents, Adrenergic alpha-2 Receptor Agonists, Adrenergic Agonists, Guanidine Derivatives, Agents that produce hypertension, Antihypertensive Agents, Adrenergic Agents	approved	3
DB01548	Diprenorphine	Drug	Opioid Antagonists, Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, Sensory System Agents, Central Nervous System Agents, Morphinans, Peripheral Nervous System Agents	illicit, vet_approved	4
DB02879	2,3-Di-O-Sulfo-Alpha-D-Glucopyranose	Drug	0	experimental	1
DB00218	Moxifloxacin	Drug	Fluoroquinolones, Quinolines, QTc Prolonging Agents, Quinolone Antimicrobial, Enzyme Inhibitors, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Antiinfectives for Systemic Use, Moderate Risk QTc-Prolonging Agents, Anti-Infective Agents, Quinolones, Cytochrome P-450 CYP1A2 Inhibitors, Ophthalmologicals, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Topoisomerase II Inhibitors, Sensory Organs, Antibacterials for Systemic Use, Cytochrome P-450 CYP1A2 Inhibitors (moderate)	approved, investigational	3
DB02878	3-(2-Aminoethyl)-4-(Aminomethyl)Heptanedioic Acid	Drug	0	experimental	1
DB01547	Drotebanol	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, Sensory System Agents, Analgesics, Morphine Derivatives, Narcotics, Central Nervous System Depressants, Central Nervous System Agents, Morphinans, Peripheral Nervous System Agents	illicit, experimental	0
DB00215	Citalopram	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Hypoglycemia-Associated Agents, Cytochrome P-450 CYP2C19 Inhibitors, Antidepressive Agents, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Benzofurans, Cytochrome P-450 CYP1A2 Inhibitors, Serotonin 5-HT2 Receptor Antagonists, Serotonin Modulators, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Nitriles, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Selective Serotonin Reuptake Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (weak), P-glycoprotein substrates, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Antidepressive Agents, Second-Generation, Psychotropic Drugs, Cytochrome P-450 CYP2C19 Substrates, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Neurotransmitter Uptake Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2C19 Inhibitors (weak), Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors, Vasodilating Agents, Cytochrome P-450 CYP3A4 Inhibitors (weak), Propylamines, Psychoanaleptics	approved	2
DB00216	Eletriptan	Drug	Serotonin 5-HT1 Receptor Agonists, Triptans, Amines, Cytochrome P-450 Substrates, Serotonin Agents, Nervous System, Cytochrome P-450 CYP3A Inducers, Selective Serotonin Agonists, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Antimigraine Preparations, Serotonin Modulators, Cytochrome P-450 Enzyme Inducers, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Serotonin 1d Receptor Agonists, Biogenic Amines, Indoles, Serotonin-1b and Serotonin-1d Receptor Agonist, Cytochrome P-450 CYP2A6 Inducers, P-glycoprotein substrates, Serotonin Receptor Agonists, Biogenic Monoamines, Serotonin 1b Receptor Agonists, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Agents that produce hypertension, Selective Serotonin 5-HT1 Receptor Agonists, Cytochrome P-450 CYP2D6 Substrates	approved, investigational	4
DB01546	Etryptamine	Drug	Heterocyclic Compounds, Fused-Ring, Amines, Stimulants, Biogenic Amines, Indoles, Biogenic Monoamines	illicit, investigational, withdrawn	0
DB02877	Arotinoid acid	Drug	Biological Factors, Cycloparaffins, Carotenoids, Alkenes, Acids, Carbocyclic, Hydrocarbons, Acyclic, Polyenes, Cyclohexenes, Terpenes, Benzene Derivatives, Cyclohexanes, Pigments, Biological	experimental	1
DB00219	Oxyphenonium	Drug	Autonomic Agents, Amines, Ammonium Compounds, Quaternary Ammonium Compounds, Agents producing tachycardia, Onium Compounds, Parasympatholytics, Muscarinic Antagonists, Peripheral Nervous System Agents, Anticholinergic Agents, Neurotransmitter Agents, Synthetic Anticholinergics, Quaternary Ammonium Compounds, Mydriatics, Cholinergic Agents, Alimentary Tract and Metabolism, Drugs for Functional Gastrointestinal Disorders, Nitrogen Compounds	approved	1
DB13530	Mepindolol	Drug	Amines, Cytochrome P-450 Substrates, Propanols, Agents causing hyperkalemia, Phenoxypropanolamines, Adrenergic beta-Antagonists, Amino Alcohols, Beta Blocking Agents, Non-Selective, Alcohols, Neurotransmitter Agents, Adrenergic Antagonists, Cytochrome P-450 CYP2D6 Substrates, Adrenergic Agents, Bradycardia-Causing Agents, Propanolamines	experimental	0
DB13531	Nicofetamide	Drug	Synthetic Antispasmodics, Amides With Tertiary Amines, Alimentary Tract and Metabolism, Drugs for Functional Gastrointestinal Disorders	experimental	0
DB14862	PF-06815345	Drug	0	investigational	0
DB12200	Tivantinib	Drug	Heterocyclic Compounds, Fused-Ring, Proto-Oncogene Proteins c-met, antagonists & inhibitors, Pyrrolidines	investigational	1
DB14860	Ensartinib	Drug	Enzyme Inhibitors, Protein Kinase Inhibitors, Antineoplastic Agents	investigational	0
DB13534	Gedocarnil	Drug	Psycholeptics, Nervous System, Central Nervous System Depressants, Hypnotics (Nonbenzodiazepine), Anti-Anxiety Agents, Hypnotics and Sedatives	experimental	0
DB14865	Human interleukin-2	Drug	Analgesics, Non-Narcotic, Biological Factors, Interleukin-2, Sensory System Agents, Cytokines, Peptides, Intercellular Signaling Peptides and Proteins, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Lymphokines, Peripheral Nervous System Agents, Proteins, Analgesics, Interleukin-2, antagonists & inhibitors, Interleukins, Central Nervous System Agents	investigational	0
DB12202	Zalutumumab	Drug	Proteins, Serum Globulins, Antineoplastic Agents, Immunological, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	1
DB12201	PF-03654746	Drug	Cycloparaffins, Histamine H3 Antagonists	investigational	0
DB14866	Amcasertib	Drug	0	investigational	0
DB13535	Nebacumab	Drug	Immunoglobulin M, Proteins, Serum Globulins, Immunoglobulins, Immune Sera and Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antiinfectives for Systemic Use, Immunoproteins	experimental	0
DB13532	Cyclopenthiazide	Drug	Sodium Chloride Symporter Inhibitors, Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Low-Ceiling Diuretics and Potassium-Sparing Agents, Amides, Cardiovascular Agents, Membrane Transport Modulators, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Benzothiadiazines, Sulfonamides, Diuretics, Natriuretic Agents, Antihypertensive Agents, Thiazides, Hyperglycemia-Associated Agents, Sulfones	approved	0
DB12204	Terbogrel	Drug	0	investigational	0
DB14864	Brolucizumab	Drug	Proteins, Serum Globulins, EENT Drugs, Miscellaneous, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Angiogenesis Inhibitors, Immunoproteins	approved, investigational	1
DB12203	Tozadenant	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Thiazoles	investigational	0
DB13533	Methylestrenolone	Drug	Sex Hormones and Modulators of the Genital System, Progesterone Congeners, Estranes, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, Progestins, Estren Derivatives, Fused-Ring Compounds, Steroids	experimental	0
DB14869	Remetinostat	Drug	0	investigational	0
DB12206	N-6022	Drug	Benzoates, Acids, Carbocyclic, Amides, Benzene Derivatives	investigational	0
DB13538	Guacetisal	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Antitussive Agents, Benzoates, Hydroxy Acids, Sensory System Agents, Nervous System, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Antirheumatic Agents, Hydroxybenzoates, Non COX-2 selective NSAIDS, Respiratory System Agents, Peripheral Nervous System Agents, Analgesics, Expectorants, Agents that produce hypertension, Phenols, Central Nervous System Agents, Salicylates, Salicylic Acid and Derivatives, Benzene Derivatives	experimental	0
DB12205	Ganitumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB13539	Iodoxamic acid	Drug	Iodobenzoates, Benzoates, Contrast Media, Diagnostic Uses of Chemicals, Acids, Carbocyclic, Watersoluble, Hepatotropic X-Ray Contrast Media, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting, Benzene Derivatives	experimental	0
DB13536	Broxyquinoline	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Quinoline Derivatives, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Intestinal Antiinfectives, Alimentary Tract and Metabolism, Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Hydroxyquinolines, Hydroxyquinoline Derivatives	experimental	0
DB12208	Iron isomaltoside 1000	Drug	Hematinics, Organometallic Compounds, Carbohydrates, Polysaccharides, Iron Compounds, Hematologic Agents, Oligosaccharides	approved, investigational	0
DB14867	Parsaclisib	Drug	0	investigational	0
DB13537	Gitoformate	Drug	Carbohydrates, Cardanolides, Cardiac Glycosides, Digitalis Glycosides, Glycosides, Cardenolides, Cardiac Therapy, Isomerism, Fused-Ring Compounds, Steroids	experimental	0
DB12207	Verdinexor	Drug	Acids, Acyclic, Acrylates, Amides	investigational	0
DB14868	AZD-8848	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purines, Ribonucleosides, Nucleic Acids, Nucleotides, and Nucleosides, Acids, Carbocyclic, Glycosides, Nucleosides, Purine Nucleosides	investigational	0
DB12209	Tirasemtiv	Drug	0	investigational	0
DB01552	Betameprodine	Drug	0	illicit, experimental	0
DB00220	Nelfinavir	Drug	Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Isoquinolines, Protease Inhibitors, Cytochrome P-450 CYP2C19 Inducers (strength unknown), OATP1B3 inhibitors, OCT1 inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (strong), BSEP/ABCB11 Substrates, UGT1A1 Inducers, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Cytochrome P-450 CYP3A4 Inhibitors (strong), Antivirals for Systemic Use, Direct Acting Antivirals, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C19 Inducers, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP3A7 Inhibitors (strong), Potential QTc-Prolonging Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), OATP1B1/SLCO1B1 Inhibitors, P-glycoprotein substrates, Cytochrome P-450 CYP3A5 Inhibitors, BCRP/ABCG2 Inhibitors, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Antiinfectives for Systemic Use, HIV Protease Inhibitors, Cytochrome P-450 CYP2C19 Substrates, P-glycoprotein inducers, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP3A7 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), P-glycoprotein inhibitors, Hyperglycemia-Associated Agents	approved	1
DB02883	2',3'-Dideoxycytidine-5'-Monophosphate	Drug	0	experimental	1
DB01551	Dihydrocodeine	Drug	Cytochrome P-450 Substrates, Sensory System Agents, Narcotics, Nervous System, Natural Opium Alkaloids, Semi-synthetic Opioids, Cytochrome P-450 CYP3A4 Substrates, Morphinans, Peripheral Nervous System Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, Analgesics, Cytochrome P-450 CYP3A Substrates, Morphine Derivatives, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Opioid Agonist, Opioids, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates	approved, illicit	0
DB02882	Cyanocinnoline	Drug	0	experimental	0
DB00221	Isoetharine	Drug	Autonomic Agents, Amines, Anti-Asthmatic Agents, Agents producing tachycardia, Bronchodilator Agents, Adrenergic beta-2 Receptor Agonists, Amino Alcohols, Respiratory System Agents, Alcohols, Peripheral Nervous System Agents, Adrenergic beta-Agonists, Neurotransmitter Agents, Adrenergic Agonists, Agents that produce hypertension, Adrenergic Agents	approved	2
DB01550	Fenproporex	Drug	Amines, Stimulants, Ethylamines, Phenethylamines, Drugs that are Mainly Renally Excreted	illicit, withdrawn, experimental	0
DB02881	4-(4-Hydroxy-3-Isopropylphenylthio)-2-Isopropylphenol	Drug	0	experimental	0
DB02880	N-[(1R)-1-(4-Bromophenyl)ethyl]-5-fluoro-2-hydroxybenzamide	Drug	0	experimental	0
DB01556	Chlorphentermine	Drug	Autonomic Agents, Amines, Ethylamines, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Sympathomimetics, Agents that produce hypertension, Amphetamines, Agents producing tachycardia, Phenethylamines, Peripheral Nervous System Agents	illicit, withdrawn	0
DB00224	Indinavir	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Protease Inhibitors, OCT1 inhibitors, BSEP/ABCB11 Substrates, Cytochrome P-450 CYP3A5 Inhibitors (weak), Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Cytochrome P-450 CYP3A4 Inhibitors (strong), Antivirals for Systemic Use, Direct Acting Antivirals, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), OATP1B1/SLCO1B1 Inhibitors, Pyridines, Cytochrome P-450 CYP3A7 Inhibitors (weak), Cytochrome P-450 CYP3A5 Substrates, P-glycoprotein substrates, Cytochrome P-450 CYP3A5 Inhibitors, UGT1A1 Inhibitors, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Antiinfectives for Systemic Use, HIV Protease Inhibitors, P-glycoprotein inducers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Cytochrome P-450 CYP3A7 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors, Hyperglycemia-Associated Agents	approved	1
DB02887	Stavudine triphosphate	Drug	Carbohydrates, Pyrimidines, Deoxyribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides, Pyrimidine Nucleotides	experimental	1
DB00225	Gadodiamide	Drug	Magnetic Resonance Imaging Contrast Media, Acids, Acyclic, Miscellaneous Therapeutic Agents, Amines, Fatty Acids, Injections, Intravenous, Lipids, Paramagnetic Contrast Agent, Polyamines, Acetates, Drugs that are Mainly Renally Excreted, Organometallic Compounds, Paramagnetic Contrast Media, Contrast Media, Diagnostic Uses of Chemicals, Magnetic Resonance Contrast Activity, Fatty Acids, Volatile, Compounds used in a research, industrial, or household setting	approved, investigational	0
DB01555	Alphacetylmethadol	Drug	Sensory System Agents, Analgesics, Ketones, Narcotics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Opioids, Central Nervous System Agents, Peripheral Nervous System Agents	illicit, experimental	0
DB01554	Bolandiol	Drug	Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, Estrenes, Testosterone Congeners, Hormones, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Steroids	illicit, experimental	0
DB02885	4-Imino-5-Methidyl-2-Trifluoromethylpyrimidine	Drug	0	experimental	1
DB00222	Glimepiride	Drug	Cytochrome P-450 Substrates, Immunosuppressive Agents, Hypoglycemia-Associated Agents, BSEP/ABCB11 Substrates, Cardiovascular Agents, Blood Glucose Lowering Agents, Cytochrome P-450 CYP2C9 Substrates, Sulfur Compounds, Alimentary Tract and Metabolism, Sulfonylureas, Drugs Used in Diabetes, Sulfones, Antiarrhythmic agents	approved	3
DB01553	Cloxazolam	Drug	Heterocyclic Compounds, Fused-Ring, Psycholeptics, Benzazepines, Nervous System, Central Nervous System Depressants, Benzodiazepines and benzodiazepine derivatives, Anti-Anxiety Agents	experimental	2
DB00223	Diflorasone	Drug	Corticosteroids, Dermatological Preparations, Pregnadienetriols, Corticosteroids, Immunosuppressive Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Dermatologicals, Hormones, Fused-Ring Compounds, Corticosteroids, Potent (Group III), Pregnanes, Steroids, Fluorinated, Corticosteroid Hormone Receptor Agonists, Steroids	approved	1
DB02884	3-Cyclohexyl-L-alanine	Drug	0	experimental	1
DB00228	Enflurane	Drug	Anesthetics, Inhalation, Anesthetics, General, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 Substrates, Nervous System, Central Nervous System Depressants, Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index, Methyl Ethers, Central Nervous System Agents, Anesthetics, Ethers, Agents that reduce seizure threshold	approved, investigational, vet_approved	7
DB01559	Clotiazepam	Drug	Cytochrome P-450 CYP2C19 Substrates, Psycholeptics, Cytochrome P-450 CYP2C18 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Nervous System, Central Nervous System Depressants, Benzodiazepines and benzodiazepine derivatives, Anti-Anxiety Agents, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP3A4 Substrates	approved, illicit	2
DB00229	Cefotiam	Drug	Nephrotoxic agents, Second-Generation Cephalosporins, Cephacetrile, Amides, Lactams, OAT1/SLC22A6 Substrates, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, OAT1/SLC22A6 inhibitors, OAT3/SLC22A8 Substrates, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, OAT3/SLC22A8 Inhibitors, Antibacterials for Systemic Use	approved, investigational	1
DB00226	Guanadrel	Drug	Adrenergic Antagonists, Amidines, Cardiovascular Agents, Antihypertensive Agents	approved	1
DB02889	4-O-(4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Beta-D-Lyxo-Hexopyranosyl)-Alpha-D-Erythro-Hexopyranose	Drug	0	experimental	1
DB01558	Bromazepam	Drug	Psycholeptics, Tranquilizing Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, GABA Modulators, Benzodiazepines and benzodiazepine derivatives, Muscle Relaxants, Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Benzazepines, Muscle Relaxants, Centrally Acting Agents, Hypnotics and Sedatives, Benzodiazepine hypnotics and sedatives, Cytochrome P-450 CYP2E1 Inhibitors, GABA Agents, Psychotropic Drugs, Cytochrome P-450 CYP2C19 Substrates, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Cytochrome P-450 CYP1A2 Substrates, Benzodiazepinones, Anti-Anxiety Agents, Central Nervous System Agents	approved, illicit, investigational	2
DB00227	Lovastatin	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (moderate), UGT1A3 substrates, BSEP/ABCB11 Substrates, Hypolipidemic Agents Indicated for Hyperlipidemia, Cytochrome P-450 CYP3A4 Substrates, Lipid Modifying Agents, UGT2B7 substrates, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Cytochrome P-450 CYP2C8 Substrates, Drugs causing inadvertant photosensitivity, Hydroxymethylglutaryl-CoA Reductase Inhibitors, OATP1B1/SLCO1B1 Inhibitors, Anticholesteremic Agents, Hypolipidemic Agents, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP2C19 Substrates, Lipid Regulating Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Agents Causing Muscle Toxicity, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), UGT1A1 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, OATP1B1/SLCO1B1 Substrates, P-glycoprotein inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (weak)	approved, investigational	3
DB02888	FKB-001	Drug	0	experimental	1
DB01557	α-Methylfentanyl	Drug	Street Drugs, Piperidines, Designer Drugs	illicit	0
DB14872	Lucerastat	Drug	Alkaloids, Carbohydrates, Imines, Imino Pyranoses, Piperidines, Imino Sugars	investigational	0
DB13541	Iprazochrome	Drug	Biological Factors, Serotonin Agents, Nervous System, Antidepressive Agents, Antimigraine Preparations, Pigments, Biological, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Quinones, Analgesics, Central Nervous System Depressants, Serotonin Receptor Antagonists, Indoles	experimental	0
DB14873	Enadenotucirev	Drug	0	investigational	0
DB13542	Bevonium	Drug	Analgesics, Non-Narcotic, Hydroxy Acids, Sensory System Agents, Anti-Inflammatory Agents, Acids, Carbocyclic, Antirheumatic Agents, Agents producing tachycardia, Muscarinic Antagonists, Peripheral Nervous System Agents, Anticholinergic Agents, Synthetic Anticholinergics, Quaternary Ammonium Compounds, Analgesics, Alimentary Tract and Metabolism, Diphenylacetic Acids, Phenylacetates, Drugs for Functional Gastrointestinal Disorders, Central Nervous System Agents	experimental	0
DB14870	PF-5190457	Drug	Azetines	investigational	0
DB12211	PSI-697	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, P-Selectin	investigational	0
DB14871	Xentuzumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB12210	AZD-6280	Drug	Heterocyclic Compounds, Fused-Ring, Receptors, Opioid, delta, agonists	investigational	0
DB13540	Isepamicin	Drug	Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Nephrotoxic agents, Carbohydrates, Anti-Bacterial Agents, Narrow Therapeutic Index Drugs, Aminoglycoside Antibacterials, Glycosides, Agents that produce neuromuscular block (indirect), Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use, Drugs that are Mainly Renally Excreted	experimental	0
DB13545	Isobromindione	Drug	Antigout Preparations, Musculo-Skeletal System, Preparations Increasing Uric Acid Excretion	experimental	0
DB12213	Etaracizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB14876	TAS-116	Drug	Benzoates, Acids, Carbocyclic, Amides, Benzene Derivatives	investigational	0
DB14877	Lintuzumab	Drug	Proteins, Serum Globulins, Antineoplastic Agents, Immunological, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB13546	Nizofenone	Drug	Neuroprotective Agents, QTc Prolonging Agents, Nervous System, Protective Agents, Psychostimulants, Agents Used for Adhd and Nootropics, Cardiovascular Agents, Central Nervous System Agents, Compounds used in a research, industrial, or household setting, Moderate Risk QTc-Prolonging Agents, Antiarrhythmic agents, Psychoanaleptics	experimental	0
DB12212	Landiolol	Drug	Oxazines, Cytochrome P-450 Substrates, Agents causing hyperkalemia, Adrenergic beta-Antagonists, Cardiovascular Agents, Neurotransmitter Agents, Adrenergic Antagonists, Beta Blocking Agents, Selective, Antihypertensive Agents, Cytochrome P-450 CYP2D6 Substrates, Adrenergic Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	investigational	0
DB13543	Mitobronitol	Drug	Alkylating Drugs, Carbohydrates, Noxae, Antineoplastic and Immunomodulating Agents, Sugar Alcohols, Antineoplastic Agents, Toxic Actions, Antineoplastic Agents, Alkylating, Alcohols	experimental	0
DB14874	Cergutuzumab amunaleukin	Drug	0	investigational	0
DB12214	Luseogliflozin	Drug	Carbohydrates, Sugar Alcohols, Alcohols	investigational	0
DB14875	AZD-4017	Drug	Pyridines, 11-beta-Hydroxysteroid Dehydrogenase Type 1, antagonists & inhibitors, Nicotinic Acids	investigational	0
DB13544	Ethenzamide	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Sensory System Agents, Nervous System, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Amides, Peripheral Nervous System Agents, Analgesics, Agents that produce hypertension, Central Nervous System Agents, Salicylic Acid and Derivatives	experimental	0
DB13549	4-dimethylaminophenol	Drug	Amines, Antidotes, Protective Agents, Aniline Compounds, Hydrogen Cyanide, Phenols, Compounds used in a research, industrial, or household setting, Benzene Derivatives	experimental	0
DB12216	Bergapten	Drug	Anti-Inflammatory Agents, Psoralens for Systemic Use, Dermatologicals, Coumarins, Benzopyrans, Radiation-Sensitizing Agents, Antipsoriatics, Heterocyclic Compounds, Fused-Ring, Photosensitizing agents used for phototherapy, Photosensitizing Agents, Antipsoriatics for Systemic Use, Furocoumarins, Pyrans	investigational	0
DB13547	Sulfatolamide	Drug	Sulfur Compounds, Amines, Gynecological Antiinfectives and Antiseptics, Sulfonamides, Aniline Compounds, Genito Urinary System and Sex Hormones, Amides, Sulfones	experimental	0
DB14878	Liafensine	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB12219	GSK-424887	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Amides, Lipids, Acetates	investigational	0
DB12218	Capivasertib	Drug	Proto-Oncogene Proteins c-akt, antagonists & inhibitors	investigational	0
DB14879	Cefiderocol	Drug	Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Amides, Lactams, beta-Lactams, Drugs that are Mainly Renally Excreted	approved, investigational	5
DB13548	Dibrompropamidine	Drug	Ophthalmologicals, Antiseptics and Disinfectants, Dermatologicals, Amidines, Biguanides and Amidines, Sensory Organs, Anti-Infective Agents, Anti-Infective Agents, Local	experimental	0
DB02890	6-hydroxyuridine-5'-phosphate	Drug	0	experimental	2
DB01563	Chloral hydrate	Drug	Psycholeptics, Nervous System, Central Nervous System Depressants, Ethylene Glycols, Glycols, Hypnotics and Sedatives, Central Nervous System Agents, Miscellaneous Anxiolytics Sedatives and Hypnotics, Drugs that are Mainly Renally Excreted, Alcohols	approved, illicit, investigational, vet_approved	0
DB00231	Temazepam	Drug	Tranquilizing Agents, Cytochrome P-450 Substrates, GABA Agents, GABA Modulators, Benzodiazepines and benzodiazepine derivatives, Cytochrome P-450 CYP3A4 Substrates, Muscle Relaxants, Psychotropic Drugs, Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Benzazepines, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Muscle Relaxants, Centrally Acting Agents, Anti-Anxiety Agents, Hypnotics and Sedatives, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2C8 Substrates, Benzodiazepine hypnotics and sedatives	approved, investigational	2
DB02894	Sulfamic Acid 2,3-O-(1-Methylethylidene)-4,5-O-Sulfonyl-Beta-Fructopyranose Ester	Drug	0	experimental	1
DB02893	D-Methionine	Drug	0	approved, investigational, experimental	2
DB01562	1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)	illicit, experimental	0
DB00232	Methyclothiazide	Drug	Increased Diuresis, Sodium Chloride Symporter Inhibitors, Amides, Cardiovascular Agents, Hypotensive Agents, Membrane Transport Modulators, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Photosensitizing Agents, Benzothiadiazines, Sulfonamides, Diuretics, Natriuretic Agents, Drugs causing inadvertant photosensitivity, Thiazides, Hyperglycemia-Associated Agents, Sulfones	withdrawn	4
DB01561	Androstanedione	Drug	0	illicit, experimental	2
DB02892	L-2-Amino-6-Methylene-Pimelic Acid	Drug	0	experimental	1
DB00230	Pregabalin	Drug	Acids, Acyclic, QTc Prolonging Agents, Tranquilizing Agents, Sensory System Agents, Nervous System, Hypoglycemia-Associated Agents, Amino Acids, Peptides, and Proteins, Muscle Relaxants, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Miscellaneous Anticonvulsants, Analgesics, Butyrates, Muscle Relaxants, Centrally Acting Agents, Potential QTc-Prolonging Agents, Agents causing angioedema, Bradycardia-Causing Agents, Antiarrhythmic agents, Aminobutyrates, Psychotropic Drugs, Amino Acids, Membrane Transport Modulators, Anticonvulsants, Central Nervous System Depressants, Anti-Anxiety Agents, Central Nervous System Agents, Vasodilating Agents	approved, investigational	1
DB02891	Tricyclazole	Drug	Sulfur Compounds	investigational, experimental	0
DB01560	Cathinone	Drug	Central Nervous System Stimulants, Central Nervous System Depressants, Central Nervous System Agents, Psychotropic Drugs	illicit	0
DB02898	(5R)-5-{[(2-Amino-3H-purin-6-yl)oxy]methyl}-2-pyrrolidinone	Drug	0	experimental	1
DB00235	Milrinone	Drug	Aminopyridines, Phosphodiesterase Inhibitors, Pyridines, Enzyme Inhibitors, Amines, Protective Agents, Phosphodiesterase 3 Inhibitors, Phosphodiesterase 5 Inhibitors, Hematologic Agents, Cardiovascular Agents, Drugs that are Mainly Renally Excreted, Cardiotonic Agents, Cardiac Stimulants Excl. Cardiac Glycosides, Vasodilating Agents, Cardiac Therapy, Compounds used in a research, industrial, or household setting	approved	1
DB01567	Fludiazepam	Drug	Psycholeptics, Tranquilizing Agents, Nervous System, Benzodiazepines and benzodiazepine derivatives, Muscle Relaxants, Psychotropic Drugs, Peripheral Nervous System Agents, Heterocyclic Compounds, Fused-Ring, Benzazepines, Central Nervous System Depressants, Muscle Relaxants, Centrally Acting Agents, Benzodiazepinones, Anti-Anxiety Agents, Central Nervous System Agents	illicit, experimental	16
DB02897	Acetylphosphate	Drug	0	experimental	2
DB01566	Methylenedioxyethamphetamine	Drug	Neurotransmitter Agents, Amines, Ethylamines, Sympathomimetics, Neurotransmitter Uptake Inhibitors, Amphetamines, Phenethylamines, Adrenergic Agents, Membrane Transport Modulators	illicit, experimental	0
DB00236	Pipobroman	Drug	Alkylating Drugs, Piperazines, Noxae, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Toxic Actions, Antineoplastic Agents, Alkylating	approved	1
DB01565	Dihydromorphine	Drug	Sensory System Agents, Narcotics, Semi-synthetic Opioids, Morphinans, Peripheral Nervous System Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, Analgesics, Morphine Derivatives, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Opioids, Central Nervous System Agents	illicit, experimental	5
DB00233	Aminosalicylic acid	Drug	Aminobenzoates, para-Aminobenzoates, Benzoates, Hydroxy Acids, Acids, Carbocyclic, Aminosalicylic Acids, Hydroxybenzoates, Antimycobacterials, Aminosalicylic Acid and Derivatives, Antiinfectives for Systemic Use, Anti-Infective Agents, Anti-Bacterial Agents, Drugs for Treatment of Tuberculosis, Phenols, Salicylates, Benzene Derivatives, Antituberculosis Agents	approved	4
DB02896	Methylthioinosine	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purines, Ribonucleosides, Sulfur Compounds, Nucleic Acids, Nucleotides, and Nucleosides, Thionucleosides, Thioinosine, Glycosides, Nucleosides, Purine Nucleosides	experimental	1
DB00234	Reboxetine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Oxazines, Adrenergic Uptake Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Morpholines, Psychotropic Drugs, Membrane Transport Modulators, Neurotransmitter Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Neurotransmitter Uptake Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Central Nervous System Agents, P-glycoprotein inhibitors, Adrenergic Agents, Cytochrome P-450 CYP2D6 Inhibitors (weak), Psychoanaleptics	approved, experimental	1
DB02895	3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol	Drug	0	experimental	1
DB01564	Calusterone	Drug	Androstanes, Testosterone and derivatives, Hormones, Hormone Substitutes, and Hormone Antagonists, Androstenols, Androstenes, Testosterone Congeners, Hormones, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Steroids	illicit, experimental	1
DB00239	Oxiconazole	Drug	Cytochrome P-450 Substrates, Gynecological Antiinfectives and Antiseptics, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Dermatologicals, Genito Urinary System and Sex Hormones, Antifungals for Dermatological Use, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Anti-Infective Agents, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 Enzyme Inducers, Azole Antifungals, Antifungals for Topical Use, Antifungal Agents, Imidazole and Triazole Derivatives, Imidazole Derivatives	approved	3
DB00237	Butabarbital	Drug	Anticholinergic Agents, Psycholeptics, Anticonvulsants, Pyrimidines, Nervous System, Central Nervous System Depressants, Pyrimidinones, Hypnotics and Sedatives, Central Nervous System Agents, Barbiturates, Nicotinic Antagonists, Drugs that are Mainly Renally Excreted	approved, illicit	11
DB01569	Formebolone	Drug	Androstanes, Testosterone and derivatives, Androstenols, Androstenes, Fused-Ring Compounds, Steroids	illicit, experimental	1
DB01568	Codeine-N-oxide	Drug	0	illicit, experimental	0
DB00238	Nevirapine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 Substrates, Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nonnucleoside Reverse Transcriptase Inhibitors, Cytochrome P-450 CYP3A Inducers, OCT1 inhibitors, Cytochrome P-450 CYP3A4 Substrates, Non-Nucleoside Reverse Transcriptase Inhibitors, Anti-Infective Agents, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Cytochrome P-450 CYP2B6 Inducers (strong), Cytochrome P-450 CYP1A2 Inhibitors, Antivirals for Systemic Use, Direct Acting Antivirals, Cytochrome P-450 Enzyme Inducers, Nucleic Acid Synthesis Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2B6 Inducers, Hepatotoxic Agents, Cytochrome P-450 CYP1A2 Inhibitors (weak), Pyridines, Cytochrome P-450 CYP3A5 Substrates, Chemically-Induced Disorders, Cytochrome P-450 CYP3A4 Inducers, Inducers of Drug Clearance, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Antiinfectives for Systemic Use, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A4 Inducers (weak), Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2A6 Substrates, Reverse Transcriptase Inhibitors, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2C9 Inducers, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2D6 Inhibitors (weak)	approved	1
DB02899	N-Carboxymethionine	Drug	0	experimental	7
DB14883	Lorecivivint	Drug	Heterocyclic Compounds, Fused-Ring, Anti-Inflammatory Agents, Pyrazoles	investigational	0
DB12220	ORG-25935	Drug	Naphthalenes	investigational	0
DB13552	Trifluperidol	Drug	Psycholeptics, Tranquilizing Agents, Ketones, Nervous System, Butyrophenones, Psychotropic Drugs, Neurotransmitter Agents, Antipsychotic Agents, Central Nervous System Depressants, Central Nervous System Agents, Butyrophenone Derivatives, Dopamine Antagonists, Dopamine Agents, Neurotoxic agents	experimental	0
DB14884	Imgatuzumab	Drug	0	investigational	0
DB13553	Carumonam	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amides, Lactams, Monobactams, beta-Lactams, Antiinfectives for Systemic Use, Antibacterials for Systemic Use	experimental	0
DB14881	Oliceridine	Drug	Sulfur Compounds, Ligands	investigational	0
DB13550	Bifemelane	Drug	Nervous System, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Antidepressive Agents, Central Nervous System Agents, Psychotropic Drugs, Benzene Derivatives, Psychoanaleptics	experimental	0
DB12222	Lurtotecan	Drug	Alkaloids, Antineoplastic Agents	investigational	0
DB13551	Cinchophen	Drug	Heterocyclic Compounds, Fused-Ring, Antigout Preparations, Musculo-Skeletal System, Preparations With No Effect on Uric Acid Metabolism	experimental	0
DB14882	CEP-9722	Drug	Heterocyclic Compounds, Fused-Ring, Phthalic Acids, Acids, Carbocyclic, Indoles, Imides, Isoindoles	investigational	0
DB12221	Canrenone	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Agents causing hyperkalemia, Diuretics, Natriuretic Agents, Pregnanes, Cardiovascular Agents, Hormone Antagonists, Potassium-Sparing Diuretics, Mineralocorticoid Receptor Antagonists, Fused-Ring Compounds, Steroids	investigational	0
DB12224	Oxothiazolidinecarboxylic acid	Drug	Acids, Acyclic, Amino Acids, Peptides, and Proteins, Amino Acids, Acidic, Amino Acids, Amino Acids, Cyclic, Sulfur Compounds, Pyrrolidinones, Amino Acids, Dicarboxylic, Imines, Thiazoles, Pyrrolidines, Glutamates, Imino Acids	investigational	0
DB14887	PF-04620110	Drug	Diacylglycerol O-Acyltransferase, Azepines	investigational	0
DB13556	Sulfamazone	Drug	Long-Acting Sulfonamides, SULFONAMIDES AND TRIMETHOPRIM, Sulfonamides, Antiinfectives for Systemic Use, Antibacterials for Systemic Use	experimental	0
DB12223	Squaric acid dibutyl ester	Drug	Allergens, Immunologic Factors, Cycloparaffins, Adjuvants, Immunologic	investigational	0
DB13557	Thiopropazate	Drug	Heterocyclic Compounds, Fused-Ring, Psycholeptics, Antipsychotic Agents, Sulfur Compounds, Nervous System, Central Nervous System Depressants, Phenothiazines With Piperazine Structure, Neurotoxic agents	experimental	0
DB14888	IQP-0528	Drug	Pyrimidines, Anti-HIV Agents	investigational	0
DB14885	PF-05180999	Drug	0	investigational	0
DB13554	Moperone	Drug	Psycholeptics, Antipsychotic Agents, Ketones, Nervous System, Central Nervous System Depressants, Butyrophenone Derivatives, Neurotoxic agents	experimental	0
DB12226	Terameprocol	Drug	Benzyl Compounds, Lignans, Phenols, Catechols, Benzene Derivatives	investigational	0
DB14886	BIO-11006	Drug	0	investigational	0
DB13555	Prajmaline	Drug	QTc Prolonging Agents, Cardiovascular Agents, Secologanin Tryptamine Alkaloids, Indole Alkaloids, Alkaloids, Heterocyclic Compounds, Fused-Ring, Antiarrhythmics, Class I, Potential QTc-Prolonging Agents, Indoles, Antiarrhythmics, Class Ia, Cardiac Therapy, Antiarrhythmic agents, Antiarrhythmics, Class Ic	experimental	0
DB12225	Beclabuvir	Drug	Heterocyclic Compounds, Fused-Ring, Antiviral Agents	investigational	0
DB12228	Telcagepant	Drug	0	investigational	3
DB12227	Tetulomab tetraxetan Lu-177	Drug	0	investigational	0
DB13558	Morclofone	Drug	Cough and Cold Preparations, Ketones, Benzene Derivatives	experimental	0
DB14889	Derazantinib	Drug	0	investigational	0
DB13559	Rimiterol	Drug	Adrenergic beta-Agonists, Adrenergics, Inhalants, Neurotransmitter Agents, Selective Beta 2-adrenergic Agonists, Adrenergic Agonists, Agents that produce hypertension, Phenols, Agents producing tachycardia, Drugs for Obstructive Airway Diseases, Adrenergic Agents, Benzene Derivatives	experimental	0
DB12229	Cerlapirdine	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Serotonin Agents, Central Nervous System Depressants, Pyrazoles, Serotonin Receptor Antagonists, Antidepressive Agents	investigational	0
DB01570	Ohmefentanyl	Drug	Sensory System Agents, Analgesics, Piperidines, Central Nervous System Agents, Peripheral Nervous System Agents	illicit	0
DB01574	Attapulgite	Drug	Antidotes, Intestinal Adsorbents, Alimentary Tract and Metabolism, Protective Agents, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Compounds used in a research, industrial, or household setting	approved, vet_approved	0
DB00242	Cladribine	Drug	Carbohydrates, Immunologic Factors, Ribonucleosides, Immunosuppressive Agents, Purine Antimetabolite, 2-Chloroadenosine, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Cardiotoxic antineoplastic agents, Deoxyadenosines, Purine Nucleosides, Antimetabolites, Selective Immunosuppressants, Myelosuppressive Agents, Heterocyclic Compounds, Fused-Ring, Purines, BCRP/ABCG2 Substrates, Narrow Therapeutic Index Drugs, Nucleic Acids, Nucleotides, and Nucleosides, Purine Analogues, Agents Causing Muscle Toxicity, Glycosides, Nucleosides, Deoxyribonucleosides	approved, investigational	10
DB01573	Benzylmorphine	Drug	0	illicit, experimental	0
DB00243	Ranolazine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, BSEP/ABCB11 Substrates, MATE inhibitors, Cardiovascular Agents, MATE 1 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Acetamides, Antianginal Agents, Piperazines, P-glycoprotein substrates, Moderate Risk QTc-Prolonging Agents, Membrane Transport Modulators, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, OCT2 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, MATE 2 Inhibitors, Cytochrome P-450 CYP2D6 Substrates, Sodium Channel Blockers, P-glycoprotein inhibitors, Vasodilating Agents, Cardiac Therapy, Cytochrome P-450 CYP2D6 Inhibitors (weak), Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved, investigational	6
DB00240	Alclometasone	Drug	Corticosteroids, Dermatological Preparations, Pregnadienetriols, Corticosteroids, Cytochrome P-450 Substrates, Immunosuppressive Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Dermatologicals, Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Ophthalmologicals, Corticosteroids, Moderately Potent (Group II), Cytochrome P-450 CYP3A Substrates, Pregnanes, Sensory Organs, Corticosteroid Hormone Receptor Agonists, Steroids	approved	1
DB01572	Methyl-1-testosterone	Drug	Testosterone and derivatives	illicit, experimental	0
DB01571	3-Methylfentanyl	Drug	Sensory System Agents, Analgesics, Piperidines, Central Nervous System Agents, Peripheral Nervous System Agents	illicit	3
DB00241	Butalbital	Drug	Psycholeptics, Nervous System, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Pyrimidinones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Nicotinic Antagonists, Anticholinergic Agents, Anticonvulsants, Cytochrome P-450 Enzyme Inducers, Pyrimidines, Central Nervous System Depressants, Hypnotics and Sedatives, Methemoglobinemia Associated Agents, Barbiturates	approved, illicit	11
DB01578	Metrizamide	Drug	Carbohydrates, Iodobenzoates, Benzoates, Contrast Media, Diagnostic Uses of Chemicals, Acids, Carbocyclic, Glycosides, Triiodobenzoic Acids, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting, Benzene Derivatives, Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media	experimental	0
DB00246	Ziprasidone	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Serotonin 5-HT1 Receptor Agonists, Highest Risk QTc-Prolonging Agents, Psycholeptics, QTc Prolonging Agents, Tranquilizing Agents, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Muscarinic Antagonists, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Anticholinergic Agents, Serotonin 5-HT2 Receptor Antagonists, Antipsychotic Agents, Histamine H1 Antagonists, Sulfur Compounds, Antipsychotic Agents (Second Generation Atypical), Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Adrenergic Antagonists, Adrenergic alpha-1 Receptor Antagonists, Dopamine Antagonists, Dopamine Agents, Neurotoxic agents, Cytochrome P-450 CYP3A5 Substrates, Adrenergic alpha-Antagonists, Indole Derivatives, Serotonin Receptor Agonists, Psychotropic Drugs, Neurotransmitter Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Agents that produce hypertension, Cytochrome P-450 CYP3A4 Inhibitors, Serotonin Receptor Antagonists, Central Nervous System Agents, Dopamine D2 Receptor Antagonists, Hyperglycemia-Associated Agents, Serotonin 5-HT1 Receptor Antagonists, Cytochrome P-450 CYP2D6 Inhibitors (weak)	approved	26
DB00247	Methysergide	Drug	Cytochrome P-450 Substrates, Serotonin Agents, Nervous System, Cardiovascular Agents, Lysergic Acid, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Ergolines, Antimigraine Preparations, Ergot Alkaloids and Derivatives, Serotonin 5-HT2 Receptor Antagonists, Alkaloids, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Analgesics, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Vasoconstrictor Agents, Agents that produce hypertension, Serotonin Receptor Antagonists	approved	8
DB01577	Metamfetamine	Drug	Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, Central Nervous System Stimulants, Adrenergic Uptake Inhibitors, Amines, Cytochrome P-450 Substrates, Nervous System, Increased Sympathetic Activity, Antidepressive Agents, Phenethylamines, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Adrenergic alpha-2 Receptor Agonists, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Appetite Suppression, Adrenergic Agents, Dopamine Agents, Dopamine Uptake Inhibitors, Autonomic Agents, Adrenergic alpha-Agonists, Psychostimulants, Agents Used for Adhd and Nootropics, Agents producing tachycardia, Central Nervous System Stimulation, Membrane Transport Modulators, Centrally Acting Sympathomimetics, Neurotransmitter Agents, Amphetamine Anorectic, Ethylamines, Sympathomimetics, Central Nervous System Depressants, Adrenergic Agonists, Neurotransmitter Uptake Inhibitors, Agents that produce hypertension, Amphetamines, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Psychoanaleptics	approved, illicit	11
DB01576	Dextroamphetamine	Drug	Central Nervous System Stimulants, Amines, Cytochrome P-450 Substrates, Nervous System, Psychostimulants, Agents Used for Adhd and Nootropics, Agents producing tachycardia, Phenethylamines, Central Nervous System Stimulation, Membrane Transport Modulators, Centrally Acting Sympathomimetics, Neurotransmitter Agents, Ethylamines, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Sympathomimetics, Neurotransmitter Uptake Inhibitors, Agents that produce hypertension, Amphetamines, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Dopamine Agents, Dopamine Uptake Inhibitors, Psychoanaleptics	approved, illicit	6
DB00244	Mesalazine	Drug	Aminosalicylate, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Anti-Inflammatory Agents, Agents causing hyperkalemia, Aminosalicylic Acids, Hydroxybenzoates, Non COX-2 selective NSAIDS, Intestinal Antiinflammatory Agents, Analgesics, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Agents that produce hypertension, Phenols, Salicylates, Benzene Derivatives	approved	8
DB00245	Benzatropine	Drug	QTc Prolonging Agents, Cytochrome P-450 Substrates, Nervous System, Muscarinic Antagonists, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Anticholinergic Agents, Alkaloids, Anti-Dyskinesia Agents, Histamine H1 Antagonists, Cholinergic Agents, Aza Compounds, Potential QTc-Prolonging Agents, Dopamine Agents, Dopamine Uptake Inhibitors, Agents producing tachycardia, Membrane Transport Modulators, Anti-Parkinson Drugs, Neurotransmitter Agents, Tropanes, Histamine Antagonists, Ethers of Tropine or Tropine Derivatives, Neurotransmitter Uptake Inhibitors, Histamine Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates	approved	5
DB01575	Kaolin	Drug	Antidiarrheals, Ions, Oxides, Minerals, Silicates, Silicon Compounds, Anions, Acids, Noncarboxylic, Intestinal Adsorbents, Metal cations, Acids, Alimentary Tract and Metabolism, Metal divalent cations, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Aluminium Compounds, Aluminum Silicates, Electrolytes, Oxygen Compounds, Gastrointestinal Agents	approved	0
DB00248	Cabergoline	Drug	Serotonin 5-HT1 Receptor Agonists, Ergot-derivative Dopamine Receptor Agonists, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Genito Urinary System and Sex Hormones, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Ergolines, Dopamine Agonists, Ergot Alkaloids and Derivatives, Alkaloids, Anti-Dyskinesia Agents, Serotonin Modulators, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Prolactine Inhibitors, Dopamine Agents, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Serotonin Receptor Agonists, Antineoplastic Agents, Anti-Parkinson Drugs, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Agents that produce hypertension, Cytochrome P-450 CYP3A4 Inhibitors, Central Nervous System Agents, Serotonin 5-HT2 Receptor Agonists	approved	21
DB00249	Idoxuridine	Drug	Carbohydrates, Ribonucleosides, Enzyme Inhibitors, Nucleoside Analog Antiviral, Pyrimidine Nucleosides, Deoxyuridine, Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors, Dermatologicals, Antiviral Agents, Antiinfectives for Systemic Use, Anti-Infective Agents, Ophthalmologicals, Antivirals for Systemic Use, Direct Acting Antivirals, Nucleic Acid Synthesis Inhibitors, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Deoxyribonucleosides, Sensory Organs	approved, investigational	2
DB01579	Phendimetrazine	Drug	Adrenergic alpha-Agonists, Central Nervous System Stimulants, Oxazines, Sympathomimetic Amine Anorectic, Adrenergic Agonists, Appetite Suppression, Increased Sympathetic Activity, Agents that produce hypertension, Adrenergic alpha-1 Receptor Agonists, Agents producing tachycardia, Central Nervous System Agents	approved, illicit	3
DB14880	Uteroglobin	Drug	Proteins, Amino Acids, Peptides, and Proteins, Secretoglobins	investigational	0
DB12275	Seviteronel	Drug	0	investigational	0
DB12274	Aducanumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB12277	Polihexanide	Drug	Disinfectants, Antiseptics and Disinfectants, Dermatologicals, Amidines, Biguanides and Amidines, Guanidines, Compounds used in a research, industrial, or household setting, Anti-Infective Agents	approved, investigational	0
DB12276	Apomine	Drug	Organophosphonates, Organophosphorus Compounds	investigational	0
DB12279	OBP-801	Drug	Peptides, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Histone Deacetylase Inhibitors	investigational	0
DB12278	Propiverine	Drug	Autonomic Agents, Cytochrome P-450 Substrates, Hydroxy Acids, Adrenergic alpha-Antagonists, Acids, Carbocyclic, Drugs for Urinary Frequency and Incontinence, Genito Urinary System and Sex Hormones, Urologicals, Agents producing tachycardia, Parasympatholytics, Muscarinic Antagonists, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Anticholinergic Agents, Urological Agents, Neurotransmitter Agents, Cholinergic Agents, Cytochrome P-450 CYP3A Substrates, Adrenergic Antagonists, Agents that produce hypertension, Diphenylacetic Acids, Phenylacetates, Adrenergic alpha-1 Receptor Antagonists	approved, investigational	7
DB00290	Bleomycin	Drug	Carbohydrates, Cytotoxic Antibiotics and Related Substances, Immunosuppressive Agents, Glycoconjugates, Peptides, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Cardiotoxic antineoplastic agents, Antibiotics, Antineoplastic, Cytoprotective Agent, Drugs that are Mainly Renally Excreted, Narrow Therapeutic Index Drugs, Glycopeptides	approved, investigational	3
DB00293	Raltitrexed	Drug	Enzyme Inhibitors, Immunosuppressive Agents, Noxae, Folic Acid Antagonists, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Thymidylate Synthase, antagonists & inhibitors, Antimetabolites, Myelosuppressive Agents, Heterocyclic Compounds, Fused-Ring, Folic Acid Analogues, Sulfur Compounds, Narrow Therapeutic Index Drugs, Toxic Actions	approved, investigational	2
DB00294	Etonogestrel	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Norsteroids, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, Reproductive Control Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Progesterone Congeners, Cytochrome P-450 CYP3A Substrates, Progestins, Combination Contraceptives (with Estrogen and derivatives), Norpregnenes, Hormonal Contraceptives for Systemic Use, Hyperglycemia-Associated Agents, Norpregnanes, Contraceptive Agents, Female, Intravaginal Contraceptives, Steroids	approved, investigational	1
DB00291	Chlorambucil	Drug	Immunosuppressive Agents, Noxae, Antineoplastic and Immunomodulating Agents, Nitrogen Mustard Analogues, Alkylating Activity, Antineoplastic Agents, Hydrocarbons, Halogenated, Mustard Compounds, Nitrogen Mustard Compounds, Myelosuppressive Agents, Alkylating Drugs, Narrow Therapeutic Index Drugs, Toxic Actions, Antineoplastic Agents, Alkylating, Agents that reduce seizure threshold	approved	1
DB00292	Etomidate	Drug	Adrenergic alpha-Agonists, Nervous System, Agents producing tachycardia, Anesthetics, Intravenous, Anesthetics, Drugs that are Mainly Renally Excreted, Adrenergic alpha-2 Receptor Agonists, Anesthetics, General, Imidazoles, Central Nervous System Depressants, Adrenergic Agonists, Agents that produce hypertension, Hypnotics and Sedatives, Central Nervous System Agents	approved	3
DB00297	Bupivacaine	Drug	Amines, Cytochrome P-450 Substrates, Sensory System Agents, Nervous System, Local Anesthesia, Neuraxial Anesthetics, Aniline Compounds, Amides, Hypotensive Agents, Anesthetics, Cytochrome P-450 CYP3A4 Substrates, Peripheral Nervous System Agents, Anilides, Cytochrome P-450 CYP2C19 Substrates, Amide Local Anesthetic, Cytochrome P-450 CYP3A Substrates, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Agents that reduce seizure threshold, Anesthetics, Local	approved, investigational	2
DB00298	Dapiprazole	Drug	Tranquilizing Agents, Adrenergic alpha-Antagonists, Antiglaucoma Preparations and Miotics, Ophthalmics, Ophthalmologicals, Neurotransmitter Agents, Antipsychotic Agents, Central Nervous System Depressants, Adrenergic Antagonists, Agents that produce hypertension, Adrenergic alpha-1 Receptor Antagonists, Central Nervous System Agents, Sensory Organs, Adrenergic Agents, Neurotoxic agents	approved	3
DB00295	Morphine	Drug	Cytochrome P-450 Substrates, Sensory System Agents, Nervous System, Neuraxial Anesthetics, UGT1A3 substrates, Hypotensive Agents, Cytochrome P-450 CYP3A4 Substrates, Opiate Agonists, Peripheral Nervous System Agents, Alkaloids, UGT2B7 substrates, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Opioids, Cytochrome P-450 CYP2C8 Substrates, Narcotics, P-glycoprotein substrates, Natural Opium Alkaloids, Anesthetics, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, High-risk opioids, Opiate Alkaloids, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Opioid Agonist, UGT1A1 Substrates, Central Nervous System Agents	approved, investigational	4
DB00296	Ropivacaine	Drug	Amines, Cytochrome P-450 Substrates, Sensory System Agents, Nervous System, Local Anesthesia, Neuraxial Anesthetics, Aniline Compounds, Amides, Hypotensive Agents, Anesthetics, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Anilides, Amide Local Anesthetic, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates, Anesthetics, Local	approved	1
DB00299	Penciclovir	Drug	Cytochrome P-450 Substrates, Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors, Dermatologicals, Antiviral Agents, Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor, Antiinfectives for Systemic Use, Anti-Infective Agents, Antivirals for Systemic Use, Direct Acting Antivirals, Heterocyclic Compounds, Fused-Ring, Purines, Nucleic Acid Synthesis Inhibitors, Cytochrome P-450 CYP1A2 Substrates, Reverse Transcriptase Inhibitors, Purinones	approved	2
DB12271	ORE-1001	Drug	Amino Acids, Essential, Amino Acids, Branched-Chain, Amino Acids, Peptides, and Proteins, Amino Acids	investigational	2
DB12270	Losmapimod	Drug	Cycloparaffins, Protein Kinase Inhibitors, p38 Mitogen-Activated Protein Kinases	investigational	0
DB12273	Ecopipam	Drug	Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Tranquilizing Agents, Antipsychotic Agents, Central Nervous System Depressants, Central Nervous System Agents, Dopamine Antagonists, Psychotropic Drugs, Dopamine Agents, Neurotoxic agents	investigational	0
DB12272	Vidupiprant	Drug	Sulfur Compounds, Acids, Carbocyclic, Amides, Sulfones	investigational	0
DB12286	Simendan	Drug	Hydrazines, Phosphodiesterase Inhibitors, QTc Prolonging Agents, Enzyme Inhibitors, Protective Agents, Phosphodiesterase 3 Inhibitors, Hydrazones, Cardiovascular Agents, Moderate Risk QTc-Prolonging Agents, Cardiotonic Agents, Pyridazines, Vasodilating Agents, Compounds used in a research, industrial, or household setting, Antiarrhythmic agents	investigational	0
DB12285	Verubecestat	Drug	Sulfur Compounds, Thiazines	investigational	1
DB12288	Piromelatine	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB12287	Talsaclidine	Drug	0	investigational	0
DB12289	Darexaban	Drug	Anticoagulants, Enzyme Inhibitors, Antithrombins, Benzoates, Factor Xa Inhibitors, Acids, Carbocyclic, Protease Inhibitors, Amides, Hematologic Agents, Serine Protease Inhibitors, Benzene Derivatives	investigational	0
DB12280	AZD-5423	Drug	Acids, Acyclic, Heterocyclic Compounds, Fused-Ring, Fatty Acids, Anti-Asthmatic Agents, Fatty Acids, Volatile, Pyrazoles, Amides, Lipids, Receptors, Glucocorticoid, agonists, Acetates	investigational	0
DB12282	Defactinib	Drug	Sulfur Compounds, Benzoates, Acids, Carbocyclic, Amides, Focal Adhesion Kinase 1, antagonists & inhibitors, Benzene Derivatives, Sulfones	investigational	0
DB12281	Luspatercept	Drug	Proteins, Serum Globulins, Immunoglobulins, Peptide Fragments, Globulins, Peptides, Immunoglobulin Constant Regions, Amino Acids, Peptides, and Proteins, Recombinant Proteins, Immunoglobulin Fragments, Immunoproteins	approved, investigational	0
DB12284	LY-2608204	Drug	0	investigational	0
DB12283	Balapiravir	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides	investigational	0
DB12297	GLPG-0187	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amides, Sulfones	investigational	0
DB12296	GS-5745	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB12299	Bavisant	Drug	Benzoates, Acids, Carbocyclic, Amides, Histamine H3 Antagonists, Benzene Derivatives	investigational	0
DB12298	5-(hydroxymethyl)-2-furaldehyde	Drug	0	investigational	0
DB12291	Tacedinaline	Drug	0	investigational	0
DB12290	Puerarin	Drug	Heterocyclic Compounds, Fused-Ring, Flavonoids, Benzopyrans, Cardiovascular Agents, Vasodilating Agents, Chromones, Pyrans	investigational	0
DB12293	Nefopam	Drug	Analgesics, Non-Narcotic, Azocines, Sensory System Agents, Analgesics, Nervous System, Central Nervous System Agents, Oxazocines, Peripheral Nervous System Agents	approved, investigational	0
DB12292	Barusiban	Drug	Peptides, Amino Acids, Peptides, and Proteins, Receptors, Oxytocin, antagonists & inhibitors	investigational	0
DB12295	Evodenoson	Drug	0	investigational	0
DB12294	Anrukinzumab	Drug	0	investigational	0
DB02902	3'-phospho-5'-adenylyl sulfate	Drug	0	experimental	1
DB02901	Stanolone	Drug	Androstanols, Sex Hormones and Modulators of the Genital System, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein substrates, Genito Urinary System and Sex Hormones, Hormones, Fused-Ring Compounds, Gonadal Steroid Hormones, Androgens, Androstanes, Testosterone and derivatives, Alimentary Tract and Metabolism, 5-Androstanon (3) Derivatives, Anabolic Steroids, Testosterone Congeners, Anabolic Agents for Systemic Use, Thyroxine-binding globulin inhibitors, Androstan Derivatives, Gonadal Hormones, Steroids	illicit, investigational	4
DB02900	alpha-D-mannose 6-phosphate	Drug	0	experimental	3
DB02906	(2s,4s)-Alpha-Campholinic Acid	Drug	0	experimental	1
DB02905	N7-(5'-Phospho-alpha-ribosyl)-2-hydroxypurine	Drug	0	experimental	1
DB02904	Beta-3-Serine	Drug	0	experimental	1
DB02903	1,3-bis-([[3-(4-{3-[3-nitro-5-(galactopyranosyloxy)-benzoylamino]-propyl}-piperazin-1-yl)-propylamino-3,4-dioxo-cyclobutenyl]-amino-ethyl]-amino-carbonyloxy)-2-amino-propane	Drug	0	experimental	1
DB14931	Cobomarsen	Drug	0	investigational	0
DB13600	Deltamethrin	Drug	Insecticides and Repellents, Antiparasitic Products, Insecticides and Repellents, Agrochemicals, Pyrethrines, Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents, Pesticides, Insecticides, Toxic Actions, Monoterpenes, Terpenes, Compounds used in a research, industrial, or household setting	experimental	0
DB13601	Oxiracetam	Drug	Nervous System, Central Nervous System Depressants, Psychostimulants, Agents Used for Adhd and Nootropics, Central Nervous System Agents, Psychotropic Drugs, Nootropic Agents, Psychoanaleptics	experimental	0
DB14932	Coleneuramide	Drug	Amino Sugars, Acids, Acyclic, Carbohydrates, Hydroxy Acids, Neuraminic Acids, Sugar Acids	investigational	0
DB14930	Alovudine F-18	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Antiviral Agents, Deoxyribonucleosides, Fluorine Radioisotopes, Anti-Infective Agents	investigational	0
DB14935	Serabelisib	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Oxazines	investigational	0
DB13604	Guanazodine	Drug	Guanidine Derivatives, Antiadrenergic Agents, Peripherally Acting, Amidines, Guanidines, Antihypertensive Agents	experimental	0
DB14936	Menaquinone 6	Drug	Fibrin Modulating Agents, Phytol, Hematologic Agents, Coagulants, Vitamins, Naphthalenes, Micronutrients, Quinones, Physiological Phenomena, Vitamins (Fat Soluble), Food and Beverages, Vitamin K 2, Naphthoquinones, Diterpenes, Hemostatics, Growth Substances, Terpenes, Diet, Food, and Nutrition, Food, Vitamin K	investigational	0
DB13605	Phenoperidine	Drug	Opioid Anesthetics, Sensory System Agents, Narcotics, Nervous System, Anesthetics, Peripheral Nervous System Agents, Anesthetics, General, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Piperidines, Opioids, Central Nervous System Agents, Isonipecotic Acids	experimental	0
DB13602	Promegestone	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Norsteroids, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, Cytochrome P-450 CYP3A4 Substrates, Pregnadien Derivatives, Norpregnadienes, Fused-Ring Compounds, Cytochrome P-450 CYP3A Substrates, Progestins, Norpregnanes, Steroids	experimental	0
DB14933	Nicotinamide riboside	Drug	Pyridines, Nicotinic Acids	investigational	0
DB14934	GDC-0927	Drug	0	investigational	0
DB13603	Pyrrolnitrin	Drug	Antifungals for Topical Use, Dermatologicals, Antifungals for Dermatological Use, Antifungal Agents, Anti-Infective Agents	experimental	0
DB13608	Tiocarlide	Drug	Drugs for Treatment of Tuberculosis, Antimycobacterials, Thiocarbamide Derivatives, Antiinfectives for Systemic Use	experimental	0
DB14939	Motixafortide	Drug	Amino Acids, Peptides, and Proteins	investigational	0
DB13609	Umifenovir	Drug	Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Experimental Unapproved Treatments for COVID-19, Antiviral Agents, UGT2B7 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Antiinfectives for Systemic Use, Antivirals for Systemic Use, Cytochrome P-450 CYP2C9 Substrates, Direct Acting Antivirals, Heterocyclic Compounds, Fused-Ring, UGT1A9 Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, UGT1A9 Substrates, Cytochrome P-450 CYP2D6 Substrates	investigational	0
DB13606	Phenazocine	Drug	Sensory System Agents, Narcotics, Nervous System, Morphinans, Peripheral Nervous System Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Benzomorphan Derivatives, Opioids, Benzomorphans, Central Nervous System Agents	experimental	0
DB14937	MK-8666	Drug	0	investigational	0
DB14938	Flurbiprofen axetil	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Acids, Acyclic, Fatty Acids, Sensory System Agents, Anti-Inflammatory Agents, Antirheumatic Agents, Lipids, Biphenyl Compounds, Peripheral Nervous System Agents, Analgesics, Fatty Acids, Volatile, Propionates, Central Nervous System Agents, Benzene Derivatives	investigational	0
DB13607	Picloxydine	Drug	Ophthalmologicals, Sensory Organs, Anti-Infective Agents	experimental	0
DB01622	Thioproperazine	Drug	Psycholeptics, Serotonin Agents, Adrenergic alpha-Antagonists, Nervous System, Phenothiazines, Antipsychotic Agents (First Generation Typical), Antidepressive Agents, Serotonin 5-HT2 Receptor Antagonists, Heterocyclic Compounds, Fused-Ring, Antipsychotic Agents, Sulfur Compounds, Central Nervous System Depressants, Adrenergic Antagonists, Agents that produce hypertension, Serotonin Receptor Antagonists, Adrenergic alpha-1 Receptor Antagonists, Dopamine Antagonists, Dopamine D2 Receptor Antagonists, Phenothiazines With Piperazine Structure, Serotonin 5-HT1 Receptor Antagonists, Neurotoxic agents	experimental	6
DB02953	2-Thiomethyl-3-Phenylpropanoic Acid	Drug	0	experimental	1
DB02952	2-aminoisobutyric acid	Drug	Acids, Acyclic, Fatty Acids, Butyrates, Fatty Acids, Volatile, Amino Acids, Branched-Chain, Amino Acids, Peptides, and Proteins, Lipids, Aminobutyrates, Isobutyrates, Amino Acids	experimental	2
DB01621	Pipotiazine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Psycholeptics, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Phenothiazines, Phenothiazines With Piperidine Structure, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C19 Substrates, Heterocyclic Compounds, Fused-Ring, Antipsychotic Agents, Sulfur Compounds, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Central Nervous System Depressants, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2D6 Substrates, Drugs causing inadvertant photosensitivity, Dopamine Antagonists, Dopamine D2 Receptor Antagonists, Hyperglycemia-Associated Agents, Neurotoxic agents	approved, investigational	4
DB01620	Pheniramine	Drug	Pyridines, QTc Prolonging Agents, Histamine H1 Antagonists, Anti-Allergic Agents, Antipruritics, Incl. Antihistamines, Anesthetics, Etc., Histamine Antagonists, Antihistamines for Topical Use, Dermatologicals, Potential QTc-Prolonging Agents, Histamine Agents, Antihistamines for Systemic Use, Antipruritics	approved	3
DB02951	3-Hydroxypyruvic Acid	Drug	Keto Acids	experimental	2
DB02950	Hymenialdisine	Drug	Interleukin-8, antagonists & inhibitors	experimental	3
DB01626	Pargyline	Drug	Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, Enzyme Inhibitors, Amines, Benzyl Compounds, MAO Inhibitors and Diuretics, Monoamine Oxidase Inhibitors, Cardiovascular Agents, Antidepressive Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Agents that produce hypertension, Benzylamines, Antihypertensive Agents, Benzene Derivatives, Agents that reduce seizure threshold	approved	2
DB02957	Orotidylic acid	Drug	Carbohydrates, Pyrimidines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Uracil Nucleotides, Nucleotides, Pyrimidine Nucleotides	experimental	0
DB02956	Pentasulfide-Sulfur	Drug	0	experimental	1
DB01625	Isopropamide	Drug	Anticholinergic Agents, Synthetic Anticholinergics, Quaternary Ammonium Compounds, Amines, Ammonium Compounds, Alimentary Tract and Metabolism, Agents producing tachycardia, Onium Compounds, Drugs for Functional Gastrointestinal Disorders, Muscarinic Antagonists, Nitrogen Compounds	approved, vet_approved	2
DB01624	Zuclopenthixol	Drug	Highest Risk QTc-Prolonging Agents, Psycholeptics, QTc Prolonging Agents, Tranquilizing Agents, Cytochrome P-450 Substrates, Serotonin Agents, Nervous System, Antipsychotic Agents (First Generation Typical), Antidepressive Agents, Thioxanthenes, Cytochrome P-450 CYP3A4 Substrates, Serotonin 5-HT2 Receptor Antagonists, Antipsychotic Agents, Histamine H1 Antagonists, Sulfur Compounds, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Adrenergic Antagonists, Adrenergic alpha-1 Receptor Antagonists, Thioxanthene Derivatives, Dopamine Antagonists, Dopamine Agents, Neurotoxic agents, Adrenergic alpha-Antagonists, Psychotropic Drugs, Xanthenes, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Agents that produce hypertension, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Dopamine D2 Receptor Antagonists	approved, investigational	7
DB02955	Ricinoleic Acid	Drug	Fatty Acids, Unsaturated, Complex Mixtures, Fatty Acids, Oils, Plant Preparations, Fats, Unsaturated, Biological Products, Oleic Acids, Lipids, Fatty Acids, Monounsaturated, Plant Oils, Fats	experimental	3
DB02954	(Carboxyhydroxyamino)Ethanoic Acid	Drug	0	experimental	2
DB01623	Thiothixene	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Psycholeptics, QTc Prolonging Agents, Tranquilizing Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Antipsychotic Agents (First Generation Typical), Thioxanthenes, Antipsychotic Agents, Sulfur Compounds, Potential QTc-Prolonging Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Drugs causing inadvertant photosensitivity, Thioxanthene Derivatives, Dopamine Antagonists, Dopamine Agents, Neurotoxic agents, Psychotropic Drugs, Xanthenes, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Photosensitizing Agents, Central Nervous System Depressants, Cytochrome P-450 CYP1A2 Substrates, Central Nervous System Agents, Dopamine D2 Receptor Antagonists	approved	3
DB01629	5-fluorouridine	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Thyroxine-binding globulin inducers, Fluorouracil and prodrugs, Glycosides, Nucleosides	experimental	2
DB02959	Oxitriptan	Drug	Amino Acids, Aromatic, Nervous System, Amino Acids, Essential, Tryptophan, Amino Acids, Peptides, and Proteins, Antidepressive Agents, Second-Generation, Antidepressive Agents, Psychotropic Drugs, Amino Acids, Amino Acids, Cyclic, Central Nervous System Depressants, Central Nervous System Agents, Psychoanaleptics	approved, investigational, nutraceutical	1
DB01628	Etoricoxib	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Nephrotoxic agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Sensory System Agents, Cyclooxygenase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Anti-Inflammatory Agents, Agents causing hyperkalemia, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Selective Cyclooxygenase 2 Inhibitors (NSAIDs), Peripheral Nervous System Agents, Sulfur Compounds, Antiinflammatory and Antirheumatic Products, Non-Steroids, COX-2 Inhibitors, Analgesics, Musculo-Skeletal System, Cytochrome P-450 CYP2C9 Inhibitors, Sulfones, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Pyridines, Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 CYP2E1 Inhibitors (weak), Antirheumatic Agents, Cytochrome P-450 CYP2C9 Substrates, Antiinflammatory and Antirheumatic Products, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Central Nervous System Agents, Cytochrome P-450 CYP2C19 Inhibitors (weak), Cytochrome P-450 CYP2D6 Inhibitors (weak)	approved, investigational	1
DB02958	Selenomethionine Selenoxide	Drug	Selenium Compounds	experimental	0
DB01627	Lincomycin	Drug	Carbohydrates, Enzyme Inhibitors, Macrolides, Lincosamides and Streptogramins, Agents that produce neuromuscular block (indirect), Antiinfectives for Systemic Use, Anti-Infective Agents, Anti-Bacterial Agents, Glycosides, Pyrrolidines, Lincosamides, Antibacterials for Systemic Use, Protein Synthesis Inhibitors, Neurotoxic agents	approved, vet_approved	1
DB13611	Chlormidazole	Drug	Heterocyclic Compounds, Fused-Ring, Antifungals for Topical Use, Dermatologicals, Antifungals for Dermatological Use, Imidazole and Triazole Derivatives	experimental	0
DB14942	BMS-986141	Drug	0	investigational	0
DB13612	Carbaspirin calcium	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Benzoates, Blood and Blood Forming Organs, Hydroxy Acids, Sensory System Agents, Nervous System, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Antirheumatic Agents, Hydroxybenzoates, Non COX-2 selective NSAIDS, Peripheral Nervous System Agents, Analgesics, Platelet Aggregation Inhibitors Excl. Heparin, Agents that produce hypertension, Phenols, Central Nervous System Agents, Salicylates, Salicylic Acid and Derivatives, Benzene Derivatives	investigational, experimental	0
DB14943	LGH-447	Drug	0	investigational	0
DB14940	Aspartyl-alanyl-diketopiperazine	Drug	Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins	investigational	0
DB13610	Flumedroxone	Drug	Pregnenediones, Hormones, Hormone Substitutes, and Hormone Antagonists, Nervous System, Hormones, Antimigraine Preparations, Corticosteroid Derivatives, Fused-Ring Compounds, Migraine Disorders, drug therapy, Gonadal Steroid Hormones, Progesterone Congeners, Analgesics, Pregnanes, Progesterone and Derivatives, Corpus Luteum Hormones, Gonadal Hormones, Pregnenes, Steroids	experimental	0
DB14941	BMS-817399	Drug	Amino Acids, Essential, Amino Acids, Branched-Chain, Amino Acids, Peptides, and Proteins, Amino Acids	investigational	0
DB14946	PCO-371	Drug	Imidazoles	investigational	0
DB13615	Mifamurtide	Drug	Acids, Acyclic, Carbohydrates, Immunologic Factors, Hydroxy Acids, Glycoconjugates, Peptides, Sugar Phosphates, Adjuvants, Immunologic, Antineoplastic and Immunomodulating Agents, Amino Acids, Peptides, and Proteins, Lipids, Phospholipids, Phosphatidic Acids, Muramic Acids, Glycerophospholipids, Alcohols, Amino Sugars, Glycerophosphates, Sugar Alcohols, Sugar Acids, Membrane Lipids, Triose Sugar Alcohols, Glycopeptides	approved, experimental	2
DB13616	Melagatran	Drug	Anticoagulants, Enzyme Inhibitors, Amines, Antithrombins, Blood and Blood Forming Organs, Benzyl Compounds, Protease Inhibitors, Azetines, Hematologic Agents, Serine Protease Inhibitors, Benzene Derivatives	experimental	0
DB14947	Bermekimab	Drug	Serum Globulins, Immunoglobulins, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Antibodies, Monoclonal	investigational	0
DB14944	Tarloxotinib	Drug	0	investigational	0
DB13613	Ticlatone	Drug	Sulfur Compounds, Antifungals for Topical Use, Dermatologicals, Antifungals for Dermatological Use	experimental	0
DB14945	Florbenazine F-18	Drug	0	investigational	0
DB13614	Metizoline	Drug	Nasal Preparations, Sympathomimetics, Plain	experimental	0
DB13619	Bornaprine	Drug	Anticholinergic Agents, Neurotransmitter Agents, Cholinergic Agents, Nervous System, Agents producing tachycardia, Muscarinic Antagonists, Tertiary Amines, Anti-Parkinson Drugs	experimental	0
DB13617	Clorexolone	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Sulfonamides, Diuretics, Amides, Low-Ceiling Diuretics, Excl. Thiazides, Sulfones	experimental	0
DB14948	BMS-986020	Drug	0	investigational	0
DB14949	AZD-7687	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Lipids	investigational	0
DB13618	Ipriflavone	Drug	Heterocyclic Compounds, Fused-Ring, Flavonoids, Musculo-Skeletal System, Drugs for Treatment of Bone Diseases, Benzopyrans, Drugs Affecting Bone Structure and Mineralization, Bone Remodeling, Chromones, Pyrans	experimental	0
DB02960	1-Carboxyethylaminomethyl-4-Aminomethylbenzene	Drug	0	experimental	0
DB02964	8,9,10-Trihydroxy-7-hydroxymethyl-2-thioxo-6-oxa-1,3-diaza-spiro[4.5]decan-4-one	Drug	0	experimental	1
DB00301	Flucloxacillin	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Amides, BSEP/ABCB11 Substrates, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Antiinfectives for Systemic Use, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Cytochrome P-450 Enzyme Inducers, Sulfur Compounds, Cytochrome P-450 CYP3A Substrates, Penicillins, Beta-Lactamase Resistant Penicillins, Antibacterials for Systemic Use	approved, investigational	1
DB01633	Deoxy-2-fluoro-beta-D-cellotrioside	Drug	0	investigational, experimental	1
DB00302	Tranexamic acid	Drug	Antifibrinolytic Agents, Cycloparaffins, Blood and Blood Forming Organs, Fibrin Modulating Agents, Acids, Carbocyclic, Hematologic Agents, Coagulants, Cyclohexanecarboxylic Acids, Hemostatics, Decreased Fibrinolysis, Amino Acids, Cyclohexanes	approved	1
DB01632	5-O-phosphono-alpha-D-ribofuranosyl diphosphate	Drug	Carbohydrates, Sugar Phosphates, Pentosephosphates	approved, investigational, experimental	6
DB02963	(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine	Drug	0	experimental	1
DB02962	Benzimidazole	Drug	Heterocyclic Compounds, Fused-Ring, Anthelmintics, Anti-Infective Agents, Antiparasitic Agents	investigational, experimental	1
DB01631	Methyl nonanoate	Drug	0	experimental	2
DB02961	Rhamnose	Drug	Carbohydrates, Deoxy Sugars, Rhamnose, metabolism	experimental	1
DB00300	Tenofovir disoproxil	Drug	Nephrotoxic agents, Tenofovir and prodrugs, P-glycoprotein substrates, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Organophosphorus Compounds, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Anti-Retroviral Agents, Antiviral Agents, OAT1/SLC22A6 Substrates, Anti-HIV Agents, Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, OAT3/SLC22A8 Substrates, Antivirals for Systemic Use, Direct Acting Antivirals, Heterocyclic Compounds, Fused-Ring, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors, Purines, Reverse Transcriptase Inhibitors, P-glycoprotein inhibitors	approved, investigational	2
DB01630	SC-74020	Drug	Sulfur Compounds, Amines, Hydroxy Acids, Hydroxylamines, Amides, Sulfones	experimental	1
DB02968	Penicillin G Acyl-Serine	Drug	Agents causing hyperkalemia	experimental	2
DB00305	Mitomycin	Drug	Cross-Linking Reagents, Enzyme Inhibitors, Cytotoxic Antibiotics and Related Substances, Immunosuppressive Agents, Noxae, Antineoplastic and Immunomodulating Agents, Alkylating Activity, Antineoplastic Agents, Cardiotoxic antineoplastic agents, Antibiotics, Antineoplastic, Myelosuppressive Agents, Alkylating Drugs, Heterocyclic Compounds, Fused-Ring, Mitomycins, Nucleic Acid Synthesis Inhibitors, Narrow Therapeutic Index Drugs, Indicators and Reagents, Toxic Actions, Indoles, Azirines, Compounds used in a research, industrial, or household setting, Indolequinones	approved	1
DB01637	3,7,11,15-tetramethyl-hexadecan-1-ol	Drug	0	investigational, experimental	0
DB02967	N-Ethylmaleimide	Drug	Compounds used in a research, industrial, or household setting	experimental	1
DB00306	Talbutal	Drug	Anticholinergic Agents, Psycholeptics, Pyrimidines, Nervous System, Central Nervous System Depressants, Barbiturates, Plain, Pyrimidinones, Hypnotics and Sedatives, Nicotinic Antagonists	approved, illicit	11
DB02966	Fluoro-Willardiine	Drug	0	experimental	1
DB00303	Ertapenem	Drug	Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Amides, Lactams, beta-Lactams, Carbapenems, Penem Antibacterial, Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use, Drugs that are Mainly Renally Excreted	approved, investigational	8
DB01635	2,2-Dimethylthiazolidine-4-Carboxylic Acid;(Dmt)Thiazolidine	Drug	0	experimental	0
DB01634	2-Oxy-4-Hydroxy-5-(2-Hydrazinopyridine)Phenylalanine	Drug	0	experimental	1
DB00304	Desogestrel	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, Hormones, UGT1A1 Inducers, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Contraceptives, Oral, Contraceptives, Oral, Synthetic, Progestogens and Estrogens, Sequential Preparations, Norpregnenes, Hormonal Contraceptives for Systemic Use, Norpregnanes, Contraceptive Agents, Female, Hormones, Hormone Substitutes, and Hormone Antagonists, Norsteroids, Reproductive Control Agents, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, Progestins, Combination Contraceptives (with Estrogen and derivatives), Hyperglycemia-Associated Agents, Progestin Contraceptives, Steroids	approved	2
DB02965	Ndelta-(N'-Sulphodiaminophosphinyl)-L-Ornithine	Drug	0	experimental	1
DB00309	Vindesine	Drug	Antineoplastic Agents, Phytogenic, Cytochrome P-450 Substrates, Immunosuppressive Agents, Tubulin Modulators, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Vinca Alkaloids, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Mitosis Modulators, Cardiotoxic antineoplastic agents, Cytochrome P-450 CYP3A4 Substrates, Secologanin Tryptamine Alkaloids, Indole Alkaloids, Myelosuppressive Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Antimitotic Agents, Indoles	approved, investigational	1
DB00307	Bexarotene	Drug	Cytochrome P-450 Substrates, Immunosuppressive Agents, Alkenes, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Cyclohexenes, Tetrahydronaphthalenes, Retinoids, Cytochrome P-450 CYP3A4 Substrates, Cyclohexanes, Cytochrome P-450 CYP3A4 Inducers (moderate), Cytochrome P-450 Enzyme Inducers, Carotenoids, Polyenes, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Compounds used in a research, industrial, or household setting, Biological Factors, Cycloparaffins, Cytochrome P-450 CYP2C8 Inhibitors, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A4 Inducers, Hydrocarbons, Acyclic, Antineoplastic Agents, Myelosuppressive Agents, Naphthalenes, Pigments, Biological, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, Terpenes	approved, investigational	3
DB01639	N-Methyl-Pyridoxal-5'-Phosphate	Drug	0	experimental	1
DB01638	Sorbitol	Drug	Blood and Blood Forming Organs, Flavoring Agents, Blood Substitutes and Perfusion Solutions, Irrigating Solutions, Drugs that are Mainly Renally Excreted, Alcohols, Physiological Phenomena, Alimentary Tract and Metabolism, Osmotic Laxatives, Food and Beverages, Food Ingredients, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Enemas, Food, Gastrointestinal Agents, Food Additives, Carbohydrates, Drugs for Constipation, Laboratory Chemicals, Pharmaceutic Aids, Sugar Alcohols, Indicators and Reagents, Laxatives, Tests for Bile Duct Patency, Pharmaceutical Preparations, Diagnostic Agents, Sweetening Agents	approved	0
DB00308	Ibutilide	Drug	Antiarrhythmics, Class III, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Sulfur Compounds, Amides, Cardiovascular Agents, Cardiac Therapy, Drugs that are Mainly Renally Excreted, Sulfones, Antiarrhythmic agents	approved	10
DB02969	5-(2-hydroxyethyl)-4-methylthiazole	Drug	Sulfur Compounds	experimental	1
DB14950	BMS-929075	Drug	0	investigational	0
DB14953	Firtecan pegol	Drug	Alkaloids, Ethylene Glycols, Glycols, Polymers, Compounds used in a research, industrial, or household setting, Alcohols, Macromolecular Substances	investigational	0
DB13622	Selenium (75Se) norcholesterol	Drug	Diagnostic Radiopharmaceuticals, Various Diagnostic Radiopharmaceuticals, Selenium Compounds	experimental	0
DB13623	Fabomotizole	Drug	Psycholeptics, Nervous System, Central Nervous System Depressants, Anti-Anxiety Agents	experimental	0
DB14954	PIK3CA	Drug	0	investigational	0
DB13620	Potassium gluconate	Drug	Potassium Salt, Alimentary Tract and Metabolism, Mineral Supplements	approved	0
DB14951	Etirinotecan pegol	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Topoisomerase Inhibitors, Ethylene Glycols, Antineoplastic and Immunomodulating Agents, Topoisomerase II Inhibitors, Antineoplastic Agents, Glycols, Polymers, Compounds used in a research, industrial, or household setting, Alcohols, Macromolecular Substances	investigational	0
DB13621	Tetragalacturonic acid hydroxymethylester	Drug	Blood and Blood Forming Organs, Local Hemostatics, Hemostatics	experimental	0
DB14952	Pamrevlumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB14957	MK-3577	Drug	0	investigational	0
DB13626	Aluminium glycinate	Drug	Alkalies, Hydroxides, Amino Acids, Peptides, and Proteins, Ions, Amino Acids, Aluminum and magnesium containing antacids, Anions, Gastric Acid Lowering Agents, Metal cations, Alimentary Tract and Metabolism, Metal divalent cations, Aluminium Compounds, Electrolytes, Drugs for Acid Related Disorders, Antacids	experimental	0
DB13627	Oxolinic acid	Drug	Fluoroquinolones, Quinolines, QTc Prolonging Agents, Enzyme Inhibitors, Renal Agents, Anti-Infective Agents, Urinary, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Antineoplastic Agents, 4-Quinolones, Antiinfectives for Systemic Use, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Anti-Infective Agents, Quinolones, Cytochrome P-450 CYP1A2 Inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Topoisomerase II Inhibitors, Potential QTc-Prolonging Agents, Antibacterials for Systemic Use	experimental	0
DB14958	Selicrelumab	Drug	0	investigational	0
DB14955	PF-04634817	Drug	Aza Compounds	investigational	0
DB13624	Methoxyphenamine	Drug	Amines, Adrenergics for Systemic Use, Agents producing tachycardia, Phenethylamines, Adrenergic beta-Agonists, Neurotransmitter Agents, Ethylamines, Non-selective Beta-adrenergic Agonists, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Sympathomimetics, Adrenergic Agonists, Agents that produce hypertension, Amphetamines, Drugs for Obstructive Airway Diseases, Adrenergic Agents	approved	0
DB14956	Davalintide	Drug	Amino Acids, Peptides, and Proteins	investigational	0
DB13625	Carbuterol	Drug	Adrenergics, Inhalants, Selective Beta 2-adrenergic Agonists, Amines, Adrenergics for Systemic Use, Drugs for Obstructive Airway Diseases, Amino Alcohols, Alcohols	experimental	0
DB13628	Ethyl hydroxybenzoate	Drug	Cell-mediated Immunity, Benzoates, Hydroxy Acids, Acids, Carbocyclic, Antifungals for Topical Use, Dermatologicals, Antifungals for Dermatological Use, Hydroxybenzoates, Phenols, Standardized Chemical Allergen, Benzene Derivatives, Increased Histamine Release	approved, experimental	0
DB14959	Opicinumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB13629	Mofebutazone	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Sensory System Agents, Anti-Inflammatory Agents, Pyrazoles, Agents causing hyperkalemia, Antirheumatic Agents, Antiinflammatory Preparations, Non-Steroids for Topical Use, Butylpyrazolidines, Topical Products for Joint and Muscular Pain, Pyrazolones, Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Musculo-Skeletal System, Agents that produce hypertension, Central Nervous System Agents	experimental	0
DB01640	6-(4-{[2-(3-iodobenzyl)-3-oxocyclohex-1-en-1-yl]amino}phenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one	Drug	0	experimental	1
DB02971	2-Amino-4-(2-Amino-Ethoxy)-Butyric Acid	Drug	0	experimental	0
DB02970	2-Propyl-Aniline	Drug	0	experimental	1
DB00312	Pentobarbital	Drug	Psycholeptics, Cytochrome P-450 Substrates, Nervous System, GABA Modulators, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP2A6 Inducers (strong), Drugs that are Mainly Renally Excreted, Anticholinergic Agents, Cytochrome P-450 CYP3A4 Inducers (strong), Cytochrome P-450 Enzyme Inducers, Pyrimidines, Hypnotics and Sedatives, Barbiturates, Cytochrome P-450 CYP2A6 Inducers, Cytochrome P-450 CYP3A Inducers (strong), GABA Agents, Cytochrome P-450 CYP3A4 Inducers, Pyrimidinones, Nicotinic Antagonists, Cytochrome P-450 CYP2C19 Substrates, Neurotransmitter Agents, Anticonvulsants, Central Nervous System Depressants, Barbiturates, Plain, Adjuvants, Anesthesia, Central Nervous System Agents	approved, investigational, vet_approved	13
DB02975	GE-2270A	Drug	Anti-Bacterial Agents, Sulfur Compounds, Peptides, Amino Acids, Peptides, and Proteins, Anti-Infective Agents	experimental	1
DB01644	3,6-dihydroxy-xanthene-9-propionic acid	Drug	0	experimental	1
DB02974	4-(4-Chlorophenyl)Imidazole	Drug	0	experimental	1
DB01643	Thymidine monophosphate	Drug	Thymine Nucleotides, Carbohydrates, Pyrimidines, Deoxyribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides, Pyrimidine Nucleotides	experimental	9
DB00313	Valproic acid	Drug	Acids, Acyclic, Tranquilizing Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, UGT1A3 substrates, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors (moderate), Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index, OAT3/SLC22A8 Substrates, UGT1A9 substrates with narrow therapeutic index, Miscellaneous Anticonvulsants, UGT2B7 substrates, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Pentanoic Acids, UGT2B7 substrates with narrow therapeutic index, Hepatotoxic Agents, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP2C8 Inhibitors, OAT1/SLC22A6 inhibitors, Cytochrome P-450 CYP2C19 Substrates, Neurotransmitter Agents, Valerates, Narrow Therapeutic Index Drugs, Photosensitizing Agents, Central Nervous System Depressants, Cytochrome P-450 CYP2A6 Substrates, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), UGT1A4 substrates, Cytochrome P-450 CYP2B6 Substrates, OAT3/SLC22A8 Inhibitors, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Decreased Central Nervous System Disorganized Electrical Activity, Enzyme Inhibitors, Fatty Acids, Nervous System, Antimanic Agents, Mood Stabilizer, Cytochrome P-450 CYP2C19 Inhibitors, Lipids, Anti-epileptic Agent, Fatty Acid Derivatives, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 Enzyme Inducers, Fatty Acids, Volatile, Cytochrome P-450 CYP2C9 Inhibitors, Drugs causing inadvertant photosensitivity, Cytochrome P-450 CYP2A6 Inducers, GABA Agents, Antineoplastic Agents, UGT1A1 Inhibitors, UGT1A6 substrate, OAT3/SLC22A8 Substrates with Narrow Therapeutic Index, Psychotropic Drugs, UGT1A1 substrates with narrow therapeutic index, UGT1A6 substrate with narrow therapeutic index, Cytochrome P-450 CYP2C9 Substrates, Anticonvulsants, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, UGT1A1 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, UGT1A3 substrates with narrow therapeutic index, UGT1A9 Substrates, Histone Deacetylase Inhibitors, Central Nervous System Agents, Methemoglobinemia Associated Agents	approved, investigational	9
DB02973	4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide	Drug	0	experimental	1
DB00310	Chlorthalidone	Drug	Phthalic Acids, Increased Diuresis, Sodium Chloride Symporter Inhibitors, Acids, Carbocyclic, Thiazide-like Diuretic, Amides, Cardiovascular Agents, Hypotensive Agents, Low-Ceiling Diuretics, Excl. Thiazides, Imides, Isoindoles, Sulfur Compounds, Diuretics, Antihypertensive Agents, Drugs causing inadvertant photosensitivity, Benzene Derivatives, Non Potassium Sparing Diuretics, Sulfones, Antihypertensive Agents Indicated for Hypertension, Ketones, Low-Ceiling Diuretics and Potassium-Sparing Agents, Membrane Transport Modulators, Heterocyclic Compounds, Fused-Ring, Photosensitizing Agents, Phthalimides, Sulfonamides, Benzophenones, Natriuretic Agents, Hyperglycemia-Associated Agents	approved	2
DB01642	methyl beta-D-glucopyranoside	Drug	Carbohydrates, Methylglycosides, Glycosides, Glucosides	experimental	3
DB01641	{(4Z)-2-[(1R,2R)-1-Amino-2-hydroxypropyl]-4-[(4-amino-1H-indol-3-yl)methylene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid	Drug	0	experimental	0
DB00311	Ethoxzolamide	Drug	Enzyme Inhibitors, Amides, Cardiovascular Agents, OAT1/SLC22A6 inhibitors, Heterocyclic Compounds, Fused-Ring, Carbonic Anhydrase Inhibitors, Sulfur Compounds, Sulfonamides, Thiazoles, Diuretics, Natriuretic Agents, Sulfones, Benzothiazoles	withdrawn	5
DB02972	1-Benzyl-(R)-Propylamine	Drug	0	experimental	1
DB02979	N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane	Drug	0	experimental	1
DB01648	Methyl 4-thio-beta-D-glucopyranoside	Drug	0	experimental	0
DB00316	Acetaminophen	Drug	Amines, Cytochrome P-450 Substrates, Sensory System Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Aniline Compounds, Cytochrome P-450 CYP3A Inducers, Amides, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Anilides, Cytochrome P-450 Enzyme Inducers, Analgesics, Analgesics, Non-Narcotic, Acetaminophen and Prodrugs, Cytochrome P-450 CYP2E1 Substrates, Miscellaneous Analgesics and Antipyretics, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inducers, UGT1A6 substrate, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, UGT1A1 Substrates, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2A6 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, UGT1A9 Substrates, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Methemoglobinemia Associated Agents, P-glycoprotein inhibitors, Antipyretics, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved	4
DB00317	Gefitinib	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Quinazolines, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP3A5 Substrates, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (weak), Kinase Inhibitor	approved, investigational	1
DB02978	Beta-Hydroxyleucine	Drug	Amino Acids, Essential, Amino Acids, Branched-Chain, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	0
DB01647	Daxalipram	Drug	0	experimental	1
DB02977	PNU177836	Drug	0	experimental	1
DB00314	Capreomycin	Drug	Nephrotoxic agents, Enzyme Inhibitors, Peptides, Amino Acids, Peptides, and Proteins, Antimycobacterials, Agents that produce neuromuscular block (indirect), Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Peptides, Cyclic, Anti-Bacterial Agents, Drugs for Treatment of Tuberculosis, Narrow Therapeutic Index Drugs, Antibiotics, Antitubercular, Aminoglycoside Antibacterials, Protein Synthesis Inhibitors, Antituberculosis Agents	approved	1
DB01646	N-Acetylmethionine	Drug	Amino Acids, Neutral, Sulfur Compounds, Amino Acids, Essential, Amino Acids, Sulfur, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	2
DB00315	Zolmitriptan	Drug	Serotonin 5-HT1 Receptor Agonists, Triptans, Amines, Cytochrome P-450 Substrates, Serotonin Agents, Nervous System, Selective Serotonin Agonists, Antidepressive Agents, Antimigraine Preparations, Serotonin Modulators, Analgesics, Oxazoles, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Serotonin 1d Receptor Agonists, Biogenic Amines, Indoles, Monoamine Oxidase A Substrates, Serotonin-1b and Serotonin-1d Receptor Agonist, Serotonin Receptor Agonists, Biogenic Monoamines, Serotonin 1b Receptor Agonists, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Central Nervous System Depressants, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Selective Serotonin 5-HT1 Receptor Agonists	approved, investigational	8
DB01645	Genistein	Drug	Enzyme Inhibitors, Phytoestrogens, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, Estrogens, Non-Steroidal, Cytochrome P-450 CYP3A Inducers, Hormones, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Anticarcinogenic Agents, Compounds used in a research, industrial, or household setting, Isoflavones, Cytochrome P-450 CYP1A2 Inhibitors (weak), OATP1B1/SLCO1B1 Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP2C8 Inhibitors, Protective Agents, Cytochrome P-450 CYP3A4 Inducers, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, Benzopyrans, Cytochrome P-450 CYP3A4 Inducers (weak), Heterocyclic Compounds, Fused-Ring, Flavonoids, Protein Kinase Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Substrates, P-glycoprotein inhibitors, Chromones, Pyrans	investigational	13
DB02976	Uridine-5'-diphosphate-2-deoxy-2-fluorogalactose	Drug	0	experimental	2
DB00318	Codeine	Drug	OCT1 substrates, Antitussive Agents, Cytochrome P-450 Substrates, Sensory System Agents, Nervous System, OCT1 inhibitors, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Morphinans, Opiate Agonists, Alkaloids, UGT2B7 substrates, Analgesics, Cough and Cold Preparations, Morphine Derivatives, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Opioids, Narcotics, Natural Opium Alkaloids, Respiratory System Agents, OAT1/SLC22A6 inhibitors, Heterocyclic Compounds, Fused-Ring, Opium Alkaloids and Derivatives, Phenanthrenes, Opiate Alkaloids, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Opioid Agonist, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates	approved, illicit	3
DB00319	Piperacillin	Drug	Penicillins With Extended Spectrum, Amides, Lactams, Agents that produce neuromuscular block (indirect), beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Penicillin G, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, OAT1/SLC22A6 inhibitors, OAT3/SLC22A8 Substrates, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Extended-spectrum Penicillins, Antibacterials for Systemic Use	approved	4
DB01649	7-methyl-GpppA	Drug	0	experimental	2
DB14960	Somatrogon	Drug	0	investigational	0
DB13630	Bibenzonium	Drug	Cough and Cold Preparations	experimental	0
DB14961	Seltorexant	Drug	0	investigational	0
DB14964	Narnatumab	Drug	0	investigational	0
DB13633	Mepartricin	Drug	Alkenes, Cytochrome P-450 Enzyme Inhibitors, Genito Urinary System and Sex Hormones, Antifungals for Dermatological Use, Urologicals, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Anti-Infective Agents, Lactones, Anti-Bacterial Agents, Antiinfectives and Antiseptics for Local Oral Treatment, Alimentary Tract and Metabolism, Antifungals for Topical Use, Polyenes, Antifungal Agents, Drugs Used in Benign Prostatic Hypertrophy, Antiprotozoals, Gynecological Antiinfectives and Antiseptics, Macrolides, Dermatologicals, Hydrocarbons, Acyclic, Urological Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Antiparasitic Agents, Stomatological Preparations	experimental	0
DB12301	Doravirine	Drug	Antivirals for Systemic Use, Direct Acting Antivirals, Pyridines, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor, Cytochrome P-450 CYP3A Substrates, Nonnucleoside Reverse Transcriptase Inhibitors, Antiviral Agents, Cytochrome P-450 CYP3A4 Substrates, Antiinfectives for Systemic Use, Non-Nucleoside Reverse Transcriptase Inhibitors	approved, investigational	1
DB14965	CTT-1057	Drug	0	investigational	0
DB13634	Pentifylline	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Purines, Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 Substrates, Peripheral Vasodilators, Purine Derivatives, Xanthine derivatives, Purinones	experimental	0
DB12300	P-nitrobiphenyl	Drug	0	approved, investigational, experimental	0
DB12303	Motolimod	Drug	Heterocyclic Compounds, Fused-Ring, Toll-Like Receptor 8, agonists	investigational	0
DB13631	Methoserpidine	Drug	Antiadrenergic Agents, Centrally Acting, Antihypertensive Agents, Secologanin Tryptamine Alkaloids	experimental	0
DB14962	Trastuzumab deruxtecan	Drug	Immunoglobulins, Cytochrome P-450 Substrates, Noxae, P-glycoprotein substrates, Antibodies, Amino Acids, Peptides, and Proteins, OATP1B3 substrates, Antibodies, Monoclonal, Cytochrome P-450 CYP3A4 Substrates, Immunoproteins, Proteins, Serum Globulins, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Substrates, Globulins, Blood Proteins, MATE 2 Substrates, Toxic Actions, MATE substrates	approved, investigational	2
DB14963	Konjac mannan	Drug	Carbohydrates, Polysaccharides, Laxatives, Plants, Gastrointestinal Agents	investigational	0
DB13632	Protiofate	Drug	Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones	experimental	0
DB12302	CP-724714	Drug	Heterocyclic Compounds, Fused-Ring, Receptor, ErbB-2, antagonists & inhibitors	investigational	0
DB14968	Bacillus calmette-guerin substrain tokyo 172-1 live antigen	Drug	0	investigational	0
DB13637	Tenitramine	Drug	Diamines, Amines, Antianginal Agents, Vasodilators Used in Cardiac Diseases, Polyamines, Vasodilating Agents, Cardiac Therapy, Organic Nitrates	experimental	0
DB12305	Dasotraline	Drug	Cycloparaffins, Amines, Naphthalenes	investigational	3
DB13638	Cefbuperazone	Drug	Nephrotoxic agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Second-Generation Cephalosporins, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Antibacterials for Systemic Use	experimental	0
DB14969	GTX-758	Drug	Benzoates, Acids, Carbocyclic, Amides, Benzene Derivatives	investigational	0
DB12304	Entolimod	Drug	Amino Acids, Peptides, and Proteins	investigational	0
DB14966	Venglustat	Drug	Acids, Acyclic	investigational	0
DB13635	Tiracizine	Drug	Heterocyclic Compounds, Fused-Ring, Cardiovascular Agents, Central Nervous System Agents, Cardiac Therapy, Antiarrhythmic agents	experimental	0
DB12307	Foretinib	Drug	Heterocyclic Compounds, Fused-Ring, Amines, Tyrosine Kinase Inhibitors, Aniline Compounds, Amides, Receptors, Vascular Endothelial Growth Factor, antagonists & inhibitors	investigational	2
DB13636	Etanautine	Drug	Anticholinergic Agents, Ethers, Chemically Close to Antihistamines, Nervous System, Agents producing tachycardia, Muscarinic Antagonists, Anti-Parkinson Drugs	experimental	0
DB14967	Margetuximab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB12306	Cipargamin	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB12309	GI-181771X	Drug	Heterocyclic Compounds, Fused-Ring, Benzazepines, Receptor, Cholecystokinin A, agonists	investigational	0
DB12308	Eltanolone	Drug	Central Nervous System Depressants, Pregnanes, Central Nervous System Agents, Anesthetics, Fused-Ring Compounds, Steroids	investigational	0
DB13639	Ferrous tartrate	Drug	Iron Bivalent, Oral Preparations, Antianemic Preparations, Blood and Blood Forming Organs, Iron Preparations	experimental	0
DB02982	Bombykol	Drug	Lipids, Alcohols	experimental	0
DB01651	Methyl 4,6-O-[(1R)-1-carboxyethylidene]-beta-D-galactopyranoside	Drug	0	experimental	1
DB01650	trans-2-hydroxycinnamic acid	Drug	OAT3/SLC22A8 Inhibitors	experimental	1
DB02981	Vitamin B6 Complexed with 2-Amino-Hexanoic Acid	Drug	0	experimental	1
DB00320	Dihydroergotamine	Drug	Serotonin 5-HT1 Receptor Agonists, Ergot-derivative Dopamine Receptor Agonists, Cytochrome P-450 Substrates, Sensory System Agents, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Antimigraine Preparations, Dopamine Agonists, Ergot Alkaloids and Derivatives, Peripheral Nervous System Agents, Ergotamines, Sympatholytic (Adrenergic Blocking) Agents, Alkaloids, Serotonin Modulators, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Adrenergic Antagonists, Adrenergic alpha-1 Receptor Antagonists, Dopamine Agents, Analgesics, Non-Narcotic, Adrenergic alpha-Antagonists, Ergotamine Derivative, Serotonin Receptor Agonists, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Vasoconstrictor Agents, Agents that produce hypertension, Cytochrome P-450 CYP3A4 Inhibitors, Central Nervous System Agents, Serotonin 5-HT2 Receptor Agonists, P-glycoprotein inhibitors	approved, investigational	4
DB02980	Thymidine-5'-(dithio)phosphate	Drug	0	experimental	1
DB01655	L-gulonic acid 6-phosphate	Drug	0	experimental	1
DB02986	N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide	Drug	0	experimental	1
DB00323	Tolcapone	Drug	Enzyme Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Ketones, Nervous System, Hypotensive Agents, Drugs that are Mainly Renally Excreted, Anti-Parkinson Drugs, Anti-Dyskinesia Agents, COMT Inhibitors, Central Nervous System Depressants, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors, Nitro Compounds, Benzophenones, Phenols, Nitrophenols, Central Nervous System Agents, Benzene Derivatives, Dopamine Agents	approved, withdrawn	1
DB00324	Fluorometholone	Drug	Corticosteroids, Dermatological Preparations, Cytochrome P-450 Substrates, Immunosuppressive Agents, Glucocorticoids, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Vasoprotectives, Corticosteroids, Moderately Potent (Group II), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Corticosteroid Hormone Receptor Agonists, Cytochrome P-450 CYP3A5 Inducers, Pregnadienediols, Anti-Allergic Agents, Corticosteroids, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Cytochrome P-450 CYP3A4 Inducers, Dermatologicals, Anti-Acne Preparations, Ophthalmologicals, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Cytochrome P-450 CYP3A Substrates, Pregnanes, Thyroxine-binding globulin inhibitors, Sensory Organs, Steroids, Fluorinated, Hyperglycemia-Associated Agents, Anti-Acne Preparations for Topical Use, Steroids	approved, investigational	1
DB02985	8-iodo-guanine	Drug	0	experimental	1
DB02984	4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline	Drug	0	experimental	1
DB00321	Amitriptyline	Drug	Cytochrome P-450 Substrates, Sensory System Agents, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Anticholinergic Agents, Serotonin 5-HT2 Receptor Antagonists, Tricyclics and Other Norepinephrine-reuptake Inhibitors, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Cytochrome P-450 CYP2C8 Substrates, Agents that reduce seizure threshold, Analgesics, Non-Narcotic, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP2C8 Inhibitors, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Agents producing tachycardia, Membrane Transport Modulators, Cytochrome P-450 CYP2C19 Substrates, Neurotransmitter Agents, Tertiary amine tricyclic antidepressants, Central Nervous System Depressants, Antidepressive Agents, Tricyclic, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), UGT1A4 substrates, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2D6 Inhibitors (weak), Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Adrenergic Uptake Inhibitors, Serotonin Agents, Cytochrome P-450 CYP2C19 Inhibitors, Muscarinic Antagonists, Antidepressive Agents, Serotonin Modulators, Histamine H1 Antagonists, Analgesics, Adrenergic Antagonists, Adrenergic alpha-1 Receptor Antagonists, Neurotoxic agents, Adrenergic alpha-Antagonists, P-glycoprotein substrates, UGT1A1 Inhibitors, Moderate Risk QTc-Prolonging Agents, Psychotropic Drugs, Cytochrome P-450 CYP2C9 Substrates, Non-Selective Monoamine Reuptake Inhibitors, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, UGT1A1 Substrates, Neurotransmitter Uptake Inhibitors, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Serotonin Receptor Antagonists, Central Nervous System Agents	approved	28
DB02983	Para-Mercury-Benzenesulfonic Acid	Drug	0	experimental	2
DB00322	Floxuridine	Drug	Carbohydrates, Ribonucleosides, Immunosuppressive Agents, Pyrimidine Nucleosides, Cytochrome P-450 Enzyme Inhibitors, Noxae, Cytochrome P-450 CYP2C9 Inhibitors (strong), Deoxyuridine, Antineoplastic and Immunomodulating Agents, Pyrimidine Analogues, Antineoplastic Agents, Antimetabolites, Drugs that are Mainly Renally Excreted, Myelosuppressive Agents, Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Thyroxine-binding globulin inducers, Cytochrome P-450 CYP2C9 Inhibitors, Glycosides, Nucleosides, Toxic Actions, Deoxyribonucleosides	approved	1
DB01652	4-hydroxybenzoyl-CoA	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Coenzymes, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Thioesters of coenzyme A, Enzymes and Coenzymes, Glycosides, Nucleotides, Adenine Nucleotides	experimental	2
DB00327	Hydromorphone	Drug	Cytochrome P-450 Substrates, Sensory System Agents, Nervous System, UGT1A3 substrates, Drugs that are Mainly Renally Excreted, Morphinans, Opiate Agonists, Peripheral Nervous System Agents, Alkaloids, UGT2B7 substrates, Analgesics, Morphine Derivatives, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Opioids, Narcotics, Natural Opium Alkaloids, Semi-synthetic Opioids, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, High-risk opioids, Opiate Alkaloids, Central Nervous System Depressants, Opioid Agonist, Central Nervous System Agents	approved, illicit	3
DB01659	3-(1,10-Phenanthrol-2-Yl)-L-Alanine	Drug	0	experimental	0
DB01658	1'-Deazo-Thiamin Diphosphate	Drug	0	experimental	0
DB00328	Indomethacin	Drug	Cytochrome P-450 Substrates, Immunosuppressive Agents, Sensory System Agents, Cyclooxygenase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Agents causing hyperkalemia, Hypoglycemia-Associated Agents, Non COX-2 selective NSAIDS, BSEP/ABCB11 Substrates, Cardiovascular Agents, UGT2B7 Inhibitors, Tocolytic Agents, OAT3/SLC22A8 Substrates, Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Non-Steroids, UGT2B7 substrates, Indoles, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, OATP1B1/SLCO1B1 Inhibitors, Acetic Acid Derivatives and Related Substances, Antirheumatic Agents, OAT1/SLC22A6 inhibitors, Cytochrome P-450 CYP2C19 Substrates, Ophthalmologicals, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Cytochrome P-450 CYP2C19 inhibitors (strength unknown), OAT3/SLC22A8 Inhibitors, Nephrotoxic agents, Enzyme Inhibitors, Anti-Inflammatory Agents, Cytochrome P-450 CYP2C19 Inhibitors, OAT1/SLC22A6 Substrates, Analgesics, Musculo-Skeletal System, P-glycoprotein substrates, UGT1A1 Inhibitors, Antiinflammatory Preparations, Non-Steroids for Topical Use, Topical Products for Joint and Muscular Pain, Myelosuppressive Agents, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Antigout Preparations, Antiinflammatory and Antirheumatic Products, UGT1A1 Substrates, Agents that produce hypertension, UGT1A9 Substrates, Central Nervous System Agents, Sensory Organs, P-glycoprotein inhibitors, Cardiac Therapy, Other Nonsteroidal Anti-inflammatory Agents	approved, investigational	9
DB02989	CRA_10972	Drug	0	experimental	1
DB01657	2-amino-3-[4-hydroxy-6-oxo-3-(2-phenyl-cyclopropylimino)-cyclohexa-1,4-dienyl]-propionic acid	Drug	0	experimental	1
DB02988	Imino-Tryptophan	Drug	0	experimental	1
DB00325	Nitroprusside	Drug	Iron Compounds, Cardiovascular Agents, Cyanides, Hypotensive Agents, Drugs that are Mainly Renally Excreted, Vasodilation, Nitric Oxide Donors, Organometallic Compounds, Anions, Antihypertensive Agents, Compounds used in a research, industrial, or household setting, Nitrogen Compounds, Ferricyanides, Laboratory Chemicals, Hydrogen Cyanide, Ions, Direct Vasodilators, Nitroferricyanide Derivatives, Ferric Compounds, Acids, Noncarboxylic, Acids, Arteriolar Smooth Muscle, Agents Acting On, Electrolytes, Indicators and Reagents, Methemoglobinemia Associated Agents, Vasodilating Agents	approved, investigational	1
DB01656	Roflumilast	Drug	Phosphodiesterase Inhibitors, Pyridines, Cycloparaffins, Amines, Benzoates, Cytochrome P-450 Substrates, Acids, Carbocyclic, Amides, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Agents to Treat Airway Disease, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Phosphodiesterase 4 Inhibitors, Drugs for Obstructive Airway Diseases, Benzene Derivatives	approved	4
DB00326	Calcium glucoheptonate	Drug	Calcium Salts, Acids, Acyclic, Carbohydrates, Hydroxy Acids, Alimentary Tract and Metabolism, Mineral Supplements, Supplements	approved	0
DB02987	Cysteine-S-acetamide	Drug	Amino Acids, Neutral, Sulfur Compounds, Amino Acids, Sulfur, Amino Acids, Peptides, and Proteins, Amino Acids, Sulfhydryl Compounds	experimental	2
DB02909	5-(2-Chlorophenyl)Furan-2-Carboxylic Acid	Drug	0	experimental	2
DB02908	RU78783	Drug	0	experimental	1
DB02907	2-Amino-Vinyl-Phosphate	Drug	0	experimental	1
DB02912	Propanoyl-CoA	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Coenzymes, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Thioesters of coenzyme A, Enzymes and Coenzymes, Glycosides, Nucleotides, Adenine Nucleotides	experimental	1
DB02911	2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine	Drug	0	experimental	1
DB02910	Octanoyl-Coenzyme A	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Coenzymes, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Thioesters of coenzyme A, Enzymes and Coenzymes, Glycosides, Nucleotides, Adenine Nucleotides	experimental	3
DB02917	N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide	Drug	0	experimental	1
DB02916	[(2r,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-3,4-Dihydroxytetrahydro-2-Furanyl]Methyl Sulfamate	Drug	0	experimental	0
DB02915	4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine	Drug	0	experimental	2
DB02914	Anhydrovitamin A	Drug	Biological Factors, Cycloparaffins, Carotenoids, Alkenes, Hydrocarbons, Acyclic, Polyenes, Cyclohexenes, Retinoids, Terpenes, Cyclohexanes, Pigments, Biological	experimental	0
DB02919	2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine	Drug	0	experimental	1
DB02918	Zardaverine	Drug	Autonomic Agents, Phosphodiesterase Inhibitors, Enzyme Inhibitors, Anti-Asthmatic Agents, Bronchodilator Agents, Respiratory System Agents, Peripheral Nervous System Agents	experimental	1
DB14902	JHU-75528 C-11	Drug	0	investigational	0
DB14903	Rovafovir etalafenamide	Drug	Heterocyclic Compounds, Fused-Ring, Purines	investigational	0
DB14900	ISO-1 F-18	Drug	0	investigational	0
DB14901	Inclisiran	Drug	Molecular Probes, RNA, Antisense, Antisense Elements (Genetics), Diagnostic Uses of Chemicals, Nucleic Acids, Nucleotides, and Nucleosides, RNA, RNA, Untranslated, Laboratory Chemicals, Nucleic Acid Probes, RNA, Small Untranslated, Compounds used in a research, industrial, or household setting, Nucleic Acids	investigational	0
DB14906	Adafosbuvir	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Glycosides, Nucleosides, Amino Acids, Peptides, and Proteins, Antiviral Agents, Amino Acids, Anti-Infective Agents	investigational	0
DB14907	Bevacizumab zirconium Zr-89	Drug	Immunoglobulins, Metals, Laboratory Chemicals, Antibodies, Amino Acids, Peptides, and Proteins, Metals, Heavy, Antibodies, Monoclonal, Elements, Transition Elements, Immunoproteins, Proteins, Serum Globulins, Antibodies, Monoclonal, Humanized, Diagnostic Uses of Chemicals, Globulins, Blood Proteins, Indicators and Reagents, Radiopharmaceuticals, Compounds used in a research, industrial, or household setting, Isotopes	investigational	0
DB14904	Pimasertib	Drug	Pyridines, Protein Kinase Inhibitors, Nicotinic Acids	investigational	0
DB14905	Emactuzumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB02920	Zn(Ii)-(20-Oxo-Protoporphyrin Ix)	Drug	0	experimental	0
DB02924	(4R)-limonene 1α,2α-epoxide	Drug	0	experimental	1
DB02923	Biphenyl-2,3-Diol	Drug	0	experimental	3
DB02922	Hexafluoroacetone Hydrate	Drug	Ketones, Hydrocarbons, Halogenated, Hydrocarbons, Fluorinated	experimental	0
DB02921	(South)-Methanocarba-Thymidine	Drug	0	experimental	1
DB02928	3-Amino-6-Hydroxy-Tyrosine	Drug	0	experimental	1
DB02927	Mixed Carbamic Phosphoric Acid Anhydride of 7,8-Diaminononanic Acid	Drug	0	experimental	1
DB02925	Piretanide	Drug	High-Ceiling Diuretics, Sulfur Compounds, Sodium Potassium Chloride Symporter Inhibitors, Gynecological Antiinfectives and Antiseptics, Sulfonamides, Genito Urinary System and Sex Hormones, Diuretics, Natriuretic Agents, Amides, Cardiovascular Agents, Membrane Transport Modulators, Sulfones	approved	1
DB02929	K201 free base	Drug	0	investigational, experimental	1
DB14910	Mirikizumab	Drug	0	investigational	0
DB14913	5-methyl-2'-fluoroarauracil F-18	Drug	0	investigational	0
DB14914	Flortaucipir F-18	Drug	Heterocyclic Compounds, Fused-Ring, Pyridines, Contrast Media, Diagnostic Uses of Chemicals, Indoles, Compounds used in a research, industrial, or household setting	approved, investigational	3
DB14911	Risuteganib	Drug	0	investigational	0
DB14912	Pegvorhyaluronidase alfa	Drug	0	investigational	0
DB14917	Ceralasertib	Drug	Sulfur Compounds	investigational	0
DB14918	Branaplam	Drug	0	investigational	0
DB14915	CODA-001	Drug	0	investigational	0
DB14916	Selonsertib	Drug	0	investigational	0
DB14908	Refanezumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Myelin-Associated Glycoprotein, antagonists & inhibitors, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB14909	Imetelstat	Drug	Carbohydrates, Enzyme Inhibitors, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Telomerase, antagonists & inhibitors, Nucleotides, Polynucleotides	investigational	0
DB01600	Tiaprofenic acid	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Acids, Acyclic, Fatty Acids, Sensory System Agents, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Lipids, Prostaglandin Antagonists, Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Photosensitizing Agents, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Fatty Acids, Volatile, Musculo-Skeletal System, Propionates, Agents that produce hypertension, Central Nervous System Agents, Other Nonsteroidal Anti-inflammatory Agents	approved	2
DB02931	CoA-s-acetyl tryptamine	Drug	0	experimental	1
DB02930	Adenosine 5'-[gamma-thio]triphosphate	Drug	Affinity Labels, Carbohydrates, Laboratory Chemicals, Nucleotides, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Indicators and Reagents, Adenine Nucleotides, Compounds used in a research, industrial, or household setting	experimental	14
DB02935	Diglyme	Drug	Glycols, Ethers, Alcohols	experimental	1
DB01604	Pivampicillin	Drug	Penicillins With Extended Spectrum, Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Penicillin G, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Antibacterials for Systemic Use	approved	1
DB02934	9-(6-deoxy-alpha-L-talofuranosyl)-6-methylpurine	Drug	0	experimental	1
DB01603	Meticillin	Drug	Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Beta-Lactamase Resistant Penicillins, Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use	approved, investigational	6
DB01602	Bacampicillin	Drug	Penicillins With Extended Spectrum, Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Penicillin G, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Antibacterials for Systemic Use	approved, investigational	1
DB02933	5'-Deoxy-5'-(Methylthio)-Tubercidin	Drug	0	experimental	2
DB02932	(R)-Bicalutamide	Drug	0	experimental	1
DB01601	Lopinavir	Drug	Nephrotoxic agents, QTc Prolonging Agents, BSEP/ABCB11 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Protease Inhibitors, OATP1B3 inhibitors, Cytochrome P-450 CYP2C19 Inhibitors, Experimental Unapproved Treatments for COVID-19, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Anti-Infective Agents, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strong), Antivirals for Systemic Use, Direct Acting Antivirals, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C9 Inhibitors, Potential QTc-Prolonging Agents, Cytochrome P-450 CYP2B6 Inhibitors (weak), OATP1B1/SLCO1B1 Inhibitors, Pyrimidinones, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Organic Anion Transporting Polypeptide 1B1 Inhibitors, Antiinfectives for Systemic Use, HIV Protease Inhibitors, P-glycoprotein inducers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors (weak), Cytochrome P-450 CYP2C9 Inducers, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), P-glycoprotein inhibitors, Hyperglycemia-Associated Agents, Cytochrome P-450 CYP2C9 Inhibitors (weak)	approved	1
DB01608	Periciazine	Drug	Psycholeptics, Adrenergic alpha-Antagonists, Nervous System, Phenothiazines, Antipsychotic Agents (First Generation Typical), Phenothiazines With Piperidine Structure, Heterocyclic Compounds, Fused-Ring, Antipsychotic Agents, Sulfur Compounds, Central Nervous System Depressants, Adrenergic Antagonists, Agents that produce hypertension, Adrenergic alpha-1 Receptor Antagonists, Dopamine Antagonists, Neurotoxic agents	approved, investigational	4
DB01607	Ticarcillin	Drug	Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Penicillins With Extended Spectrum, Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use	approved, investigational, vet_approved	1
DB02938	Heptanoic acid	Drug	0	investigational, experimental	1
DB02937	Gamma-Arsono-Beta, Gamma-Methyleneadenosine-5'-Diphosphate	Drug	0	experimental	2
DB01606	Tazobactam	Drug	Enzyme Inhibitors, Amides, Lactams, OAT1/SLC22A6 Substrates, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Anti-Infective Agents, OAT1/SLC22A6 inhibitors, OAT3/SLC22A8 Substrates, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Aza Compounds, Azabicyclo Compounds, beta-Lactamase Inhibitors, OAT3/SLC22A8 Inhibitors, Antibacterials for Systemic Use, Sulfones	approved	3
DB01605	Pivmecillinam	Drug	Renal Agents, Anti-Infective Agents, Urinary, Penicillins With Extended Spectrum, Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Antibacterials for Systemic Use	approved	1
DB02936	4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid	Drug	0	experimental	1
DB01609	Deferasirox	Drug	Benzoates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Acids, Carbocyclic, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, UGT1A1 Inhibitors, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), UGT1A3 Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 Enzyme Inducers, UGT1A9 Inhibitors, Iron Chelating Agents, Triazoles, UGT1A1 Substrates, Iron Chelating Activity, Sequestering Agents, Compounds used in a research, industrial, or household setting, Benzene Derivatives, Chelating Agents, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Heavy Metal Antagonists	approved, investigational	1
DB14920	Iboctadekin	Drug	0	investigational	0
DB14921	Mavacamten	Drug	Pyrimidines, Amines, Benzyl Compounds, Pyrimidinones, Benzene Derivatives	investigational	0
DB14924	PF-06651600	Drug	0	investigational	0
DB14925	Tenofovir exalidex	Drug	Heterocyclic Compounds, Fused-Ring, Purines, Organophosphorus Compounds	investigational	0
DB14922	Tislelizumab	Drug	0	investigational	0
DB14923	Satavaptan	Drug	Oxazines, Natriuretic Agents, Cardiovascular Agents, Antidiuretic Hormone Receptor Antagonists	investigational	0
DB14928	Lacnotuzumab	Drug	0	investigational	0
DB14929	Elsulfavirine	Drug	0	investigational	0
DB14926	Astuprotimut-R	Drug	0	investigational	0
DB14927	Amylopectin	Drug	Carbohydrates, Dietary Carbohydrates, Starch, Biopolymers, Macromolecular Substances, Polysaccharides, Physiological Phenomena, Food and Beverages, Glucans, Polymers, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food	investigational	0
DB14919	Rozanolixizumab	Drug	Proteins, Serum Globulins, Immunologic Factors, Immunoglobulins, Immunosuppressive Agents, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB01611	Hydroxychloroquine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Quinolines, QTc Prolonging Agents, Enzyme Inhibitors, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Antimalarials, Antirheumatic Agents, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Potential QTc-Prolonging Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2C8 Substrates, Drugs causing inadvertant photosensitivity, P-glycoprotein inhibitors, Antiparasitic Agents, Aminoquinolines	approved	4
DB02942	Inositol 1,3-Bisphosphate	Drug	Carbohydrates, Sugar Phosphates, Sugar Alcohols, Alcohols	experimental	1
DB01610	Valganciclovir	Drug	Nucleoside Analog Antiviral, Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors, Ganciclovir and prodrug, Antiviral Agents, Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Antivirals for Systemic Use, Direct Acting Antivirals, Heterocyclic Compounds, Fused-Ring, Purines, Ganciclovir, Nucleic Acid Synthesis Inhibitors, Nucleosides and Nucleotides, Purinones, Agents that reduce seizure threshold, Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor	approved, investigational	1
DB02941	3-(1-Aminoethyl)Nonanedioic Acid	Drug	0	experimental	1
DB02940	(4s)-2-[(1e)-1-Aminoprop-1-Enyl]-4,5-Dihydro-1,3-Thiazole-4-Carboxylic Acid	Drug	0	experimental	2
DB02946	Carpropamide	Drug	0	experimental	0
DB01615	Aceprometazine	Drug	QTc Prolonging Agents, Tranquilizing Agents, Phenothiazines, Moderate Risk QTc-Prolonging Agents, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Antipsychotic Agents, Histamine H1 Antagonists, Sulfur Compounds, Histamine Antagonists, Central Nervous System Depressants, Central Nervous System Agents, Dopamine Antagonists, Dopamine Agents, Neurotoxic agents	experimental	1
DB01614	Acepromazine	Drug	Psycholeptics, Tranquilizing Agents, Serotonin Agents, Nervous System, Antidepressive Agents, Serotonin 5-HT2 Receptor Antagonists, Antipsychotic Agents, Sulfur Compounds, Adrenergic Antagonists, Adrenergic alpha-1 Receptor Antagonists, Dopamine Antagonists, Dopamine Agents, Neurotoxic agents, Adrenergic alpha-Antagonists, Phenothiazines, Phenothiazines With Aliphatic Side-Chain, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Central Nervous System Depressants, Agents that produce hypertension, Serotonin Receptor Antagonists, Central Nervous System Agents, Dopamine D2 Receptor Antagonists, Serotonin 5-HT1 Receptor Antagonists	experimental, vet_approved	6
DB02945	alpha-L-iduronic acid	Drug	0	experimental	1
DB01613	Erythrityl tetranitrate	Drug	Carbohydrates, Antianginal Agents, Ions, Cardiovascular Agents, Nitrates, Organic Nitrates, Alcohols, Erythritol, Anions, Acids, Noncarboxylic, Acids, Sugar Alcohols, Electrolytes, Vasodilators Used in Cardiac Diseases, Nitric Acid, Vasodilating Agents, Cardiac Therapy, Nitrogen Compounds	approved, investigational, experimental	2
DB01612	Amyl Nitrite	Drug	Antianginal Agents, Antidotes, Nitrites, Ions, Cardiovascular Agents, Hypotensive Agents, Organic Nitrates, Anions, Acids, Noncarboxylic, Acids, Electrolytes, Methemoglobinemia Associated Agents, Vasodilating Agents, Nitrogen Compounds	approved	1
DB02943	N-(4-Aminobutanoyl)-S-(4-methoxybenzyl)-L-cysteinylglycine	Drug	0	experimental	1
DB01619	Phenindamine	Drug	Neurotransmitter Agents, Histamine H1 Antagonists, Histamine Antagonists, Histamine Agents, Antihistamines for Systemic Use	approved	1
DB01618	Molindone	Drug	Psycholeptics, Tranquilizing Agents, Nervous System, Indole Derivatives, Antipsychotic Agents (First Generation Typical), Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Antipsychotic Agents, Central Nervous System Depressants, Central Nervous System Agents, Indoles, Dopamine Antagonists, Dopamine D2 Receptor Antagonists, Neurotoxic agents	approved	4
DB02949	2-Acetyl-Protoporphyrin Ix	Drug	0	experimental	1
DB02948	Fosmidomycin	Drug	Organophosphonates, Anti-Bacterial Agents, Organophosphorus Compounds, Anti-Infective Agents	investigational, experimental	1
DB01616	Alverine	Drug	Autonomic Agents, Amines, Serotonin Agents, Alimentary Tract and Metabolism, Central Nervous System Depressants, Parasympatholytics, Drugs for Functional Gastrointestinal Disorders, Serotonin Receptor Antagonists, Antidepressive Agents, Serotonin 5-HT1 Receptor Antagonists, Peripheral Nervous System Agents	approved, investigational	1
DB02947	2-Fluoro-2'-Deoxyadenosine	Drug	0	experimental	1
DB11021	Equus caballus dander	Drug	Cell-mediated Immunity, Non-Standardized Animal Dander Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB13684	Omoconazole	Drug	Azole Antifungals, Gynecological Antiinfectives and Antiseptics, Antifungals for Topical Use, Dermatologicals, Genito Urinary System and Sex Hormones, Antifungals for Dermatological Use, Antifungal Agents, Imidazole and Triazole Derivatives, Imidazole Derivatives, Anti-Infective Agents	experimental	0
DB12352	Bizelesin	Drug	Alkylating Drugs, Cross-Linking Reagents, Heterocyclic Compounds, Fused-Ring, Noxae, Laboratory Chemicals, Antineoplastic Agents, Indicators and Reagents, Toxic Actions, Compounds used in a research, industrial, or household setting, Antineoplastic Agents, Alkylating	investigational	0
DB13685	Quingestanol	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Contraceptives, Postcoital, Norsteroids, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Contraceptives, Oral, Cytochrome P-450 CYP3A Substrates, Progestins, Combination Contraceptives (with Estrogen and derivatives), Hormonal Contraceptives for Systemic Use, Norpregnanes, Contraceptive Agents, Female, Progestin Contraceptives, Steroids	experimental	0
DB11020	Bos taurus dander	Drug	Cell-mediated Immunity, Non-Standardized Animal Dander Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB12351	Siagoside	Drug	Carbohydrates, Glycosphingolipids, Glycoconjugates, Glycolipids, Acidic Glycosphingolipids, Lipids, Membrane Lipids, Sphingolipids, Gangliosides	investigational	0
DB13682	Cefpirome	Drug	Fourth-Generation Cephalosporins, Nephrotoxic agents, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Antibacterials for Systemic Use	approved	0
DB12354	Imrecoxib	Drug	Gases, Anions, Sulfur Compounds, Acids, Noncarboxylic, Acids, Hydrogen Sulfide, Electrolytes, Ions	investigational	0
DB11023	Penicillium digitatum	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11022	Aspergillus nidulans	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB13683	Quinisocaine	Drug	Heterocyclic Compounds, Fused-Ring, Antipruritics, Incl. Antihistamines, Anesthetics, Etc., Sensory System Agents, Dermatologicals, Anesthetics for Topical Use, Central Nervous System Agents, Anesthetics, Anesthetics, Local, Peripheral Nervous System Agents	experimental	0
DB12353	Ulodesine	Drug	Carbohydrates, Pyrimidines, Imines, Pyrrolidines, Imino Sugars	investigational	0
DB11025	Dendryphiella vinosa	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB13688	Drisapersen	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Musculo-Skeletal System, Glycosides, Nucleotides, Polynucleotides	investigational, experimental	0
DB12356	Fletikumab	Drug	0	investigational	0
DB11024	Clonostachys rosea f. rosea	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB13689	Tacalcitol	Drug	Cholestanes, Secosteroids, Antipsoriatics for Topical Use, Psoriasis, Anti-Inflammatory Agents, Dermatologicals, Lipids, Antipsoriatics, Fused-Ring Compounds, Vitamins, Sterols, Vitamin D and Analogues, Vitamins (Fat Soluble), Membrane Lipids, Cholestenes, Ointments, Steroids	investigational, experimental	0
DB12355	Netazepide	Drug	Heterocyclic Compounds, Fused-Ring, Benzazepines, Receptors, Cholecystokinin, antagonists & inhibitors, Benzene Derivatives	investigational	0
DB12358	Enbucrilate	Drug	Acids, Acyclic, Acrylates, Cyanoacrylates, Equipment and Supplies, Nitriles, Surgical Equipment, Polymers, Tissue Adhesives, Compounds used in a research, industrial, or household setting, Surgical Fixation Devices, Macromolecular Substances	investigational	0
DB13686	Clometocillin	Drug	Anti-Bacterial Agents, Penicillins, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Beta-Lactamase Sensitive Penicillins, Antibacterials for Systemic Use	experimental	0
DB11027	Polistes annularis venom protein	Drug	Bee and Wasp Venom	approved	0
DB12357	BMS-863233	Drug	0	investigational	0
DB11026	Solenopsis richteri	Drug	Cell-mediated Immunity, Non-Standardized Insect Venom Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB13687	Niaprazine	Drug	Psycholeptics, Pyridines, Nervous System, Central Nervous System Depressants, Hypnotics and Sedatives, Nicotinic Acids	experimental	0
DB11029	Polistes metricus venom protein	Drug	Bee and Wasp Venom	approved	0
DB12359	BIIB021	Drug	Heterocyclic Compounds, Fused-Ring, Purines, HSP90 Heat-Shock Proteins, antagonists & inhibitors	investigational	0
DB11028	Polistes exclamans venom protein	Drug	Allergenic Extracts, Bee and Wasp Venom	approved	0
DB00370	Mirtazapine	Drug	QTc Prolonging Agents, Tranquilizing Agents, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Serotonin 5-HT2 Receptor Antagonists, Serotonin Modulators, Histamine H1 Antagonists, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Adrenergic Antagonists, Potential QTc-Prolonging Agents, Adrenergic Agents, Adrenergic alpha-Antagonists, Serotonin 5-HT3 Receptor Antagonists, Psychotropic Drugs, Antidepressive Agents, Tetracyclic, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Inhibitors, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Miscellaneous Antidepressants, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Anti-Anxiety Agents, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Adrenergic alpha-2 Receptor Antagonists, Histamine Agents, Cytochrome P-450 CYP3A4 Inhibitors (weak), Psychoanaleptics	approved	7
DB00371	Meprobamate	Drug	Acids, Acyclic, Psycholeptics, Tranquilizing Agents, Nervous System, Muscle Relaxants, Psychotropic Drugs, Peripheral Nervous System Agents, Central Nervous System Depressants, Muscle Relaxants, Centrally Acting Agents, Carbamates, Anti-Anxiety Agents, Hypnotics and Sedatives, Central Nervous System Agents	approved, illicit	7
DB00374	Treprostinil	Drug	Biological Factors, QTc Prolonging Agents, Autacoids, Inflammation Mediators, Blood and Blood Forming Organs, Cytochrome P-450 Substrates, Fatty Acids, Prostacycline Vasodilator, Eicosanoids, Lipids, Cardiovascular Agents, Prostacyclin Analogues, Vasodilation, Cytochrome P-450 CYP2C9 Substrates, Fatty Acids, Unsaturated, Prostaglandins, Platelet Aggregation Inhibitors Excl. Heparin, Potential QTc-Prolonging Agents, Prostaglandins I, Antihypertensive Agents, Vasodilating Agents	approved, investigational	3
DB00375	Colestipol	Drug	Hypolipidemic Agents, Amines, Hypolipidemic Agents Indicated for Hyperlipidemia, Polyamines, Bile-acid Binding Activity, Macromolecular Substances, Lipid Modifying Agents, Lipid Modifying Agents, Plain, Lipid Regulating Agents, Sequestering Agents, Anion Exchange Resins, Polymers, Bile Acid Sequestrants, Compounds used in a research, industrial, or household setting	approved	1
DB00372	Thiethylperazine	Drug	Autonomic Agents, Piperazines, Phenothiazines, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Antipsychotic Agents, Sulfur Compounds, Central Nervous System Depressants, Antiemetics, Central Nervous System Agents, Phenothiazine Derivatives, Antihistamines for Systemic Use, Dopamine Antagonists, Dopamine D2 Receptor Antagonists, Dopamine Agents, Gastrointestinal Agents, Neurotoxic agents	approved, withdrawn	1
DB00373	Timolol	Drug	QTc Prolonging Agents, Oxazines, Amines, Cytochrome P-450 Substrates, Agents causing hyperkalemia, Beta Blocking Agents, Non-Selective, and Thiazides, Adrenergic beta-Antagonists, Cardiovascular Agents, Hypotensive Agents, Drugs that are Mainly Renally Excreted, Alcohols, Sulfur Compounds, Adrenergic Antagonists, Thiazoles, Potential QTc-Prolonging Agents, Antihypertensive Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Thiadiazoles, Propanols, Antiglaucoma Preparations and Miotics, P-glycoprotein substrates, Amino Alcohols, Morpholines, Beta Blocking Agents and Thiazides, Beta Blocking Agents, Non-Selective, Cytochrome P-450 CYP2C19 Substrates, Ophthalmologicals, EENT Drugs, Miscellaneous, Cytochrome P-450 CYP2D6 Substrates, Propanolamines	approved	3
DB00378	Dydrogesterone	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, Hormones, Cytochrome P-450 CYP3A4 Substrates, Pregnadien Derivatives, Fused-Ring Compounds, Cytochrome P-450 CYP3A Substrates, Progestogens and Estrogens, Sequential Preparations, Progestins, Pregnanes, Steroids	approved, investigational, withdrawn	1
DB00379	Mexiletine	Drug	Cytochrome P-450 CYP2E1 Substrates, Voltage-Gated Sodium Channel Blockers, Amines, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Membrane Transport Modulators, Phenyl Ethers, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Phenols, Antiarrhythmics, Class I, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Sodium Channel Blockers, Antiarrhythmics, Class Ib, Ethers, Cardiac Therapy, Benzene Derivatives, Antiarrhythmic agents, Cytochrome P-450 CYP1A2 Inhibitors (moderate), Propylamines	approved, investigational	2
DB00376	Trihexyphenidyl	Drug	Anticholinergic Agents, Anti-Dyskinesia Agents, Neurotransmitter Agents, Cholinergic Agents, Nervous System, Piperidines, Agents producing tachycardia, Muscarinic Antagonists, Central Nervous System Agents, Tertiary Amines, Anti-Parkinson Drugs	approved	5
DB00377	Palonosetron	Drug	Autonomic Agents, Antiemetics and Antinauseants, Cytochrome P-450 Substrates, Serotonin Agents, Isoquinolines, Serotonin 5-HT3 Receptor Antagonists, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Serotonin 3 Receptor Antagonists, Cytochrome P-450 CYP3A Substrates, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Alimentary Tract and Metabolism, Central Nervous System Depressants, Cytochrome P-450 CYP1A2 Substrates, Antiemetics, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Quinuclidines, Gastrointestinal Agents	approved, investigational	1
DB13680	Naftazone	Drug	Quinones, Vasoprotectives, Capillary Stabilizing Agents, Hematologic Agents, Coagulants, Hemostatics, Naphthalenes	approved	0
DB13681	Butalamine	Drug	Oxazoles, Peripheral Vasodilators, Cardiovascular Agents, Vasodilating Agents	experimental	0
DB12350	Rostafuroxin	Drug	Androstanes, Fused-Ring Compounds, Steroids	investigational	0
DB12363	Dusigitumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB13695	Penthienate	Drug	Anticholinergic Agents, Synthetic Anticholinergics, Quaternary Ammonium Compounds, Amines, Ammonium Compounds, Alimentary Tract and Metabolism, Agents producing tachycardia, Onium Compounds, Drugs for Functional Gastrointestinal Disorders, Muscarinic Antagonists, Nitrogen Compounds	experimental	0
DB11032	Vespula squamosa venom protein	Drug	Cell-mediated Immunity, Bee and Wasp Venom, Increased IgG Production, Standardized Insect Venom Allergenic Extract, Increased Histamine Release	approved	0
DB11031	Vespula pensylvanica venom protein	Drug	Cell-mediated Immunity, Bee and Wasp Venom, Increased IgG Production, Standardized Insect Venom Allergenic Extract, Increased Histamine Release	approved	0
DB12362	Diaminopropanol tetraacetic acid	Drug	0	approved, investigational	0
DB13696	Bromochlorosalicylanilide	Drug	Antifungals for Topical Use, Dermatologicals, Antifungals for Dermatological Use	experimental	0
DB12365	Perzinfotel	Drug	Aza Compounds, Organophosphorus Compounds	investigational	0
DB11034	Influenza A virus A/Bolivia/559/2013 (H1N1) live (attenuated) antigen	Drug	0	approved, investigational	0
DB13693	Sulbenicillin	Drug	Penicillins With Extended Spectrum, Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Penicillin G, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Antibacterials for Systemic Use	experimental	0
DB13694	Distigmine	Drug	Neurotransmitter Agents, Pyridines, Enzyme Inhibitors, Cholinergic Agents, Cholinesterase Inhibitors, Nervous System, Parasympathomimetics	experimental	0
DB11033	Vespula vulgaris venom protein	Drug	Cell-mediated Immunity, Miscellaneous Therapeutic Agents, Allergenic Extracts, Bee and Wasp Venom, Increased IgG Production, Standardized Insect Venom Allergenic Extract, Increased Histamine Release	approved	0
DB12364	Betrixaban	Drug	Anticoagulants, Enzyme Inhibitors, Antithrombins, Benzoates, Factor Xa Inhibitors, P-glycoprotein substrates, Acids, Carbocyclic, Protease Inhibitors, Amides, Hematologic Agents, Serine Protease Inhibitors, Benzene Derivatives	approved, investigational	1
DB13699	Sulfathiourea	Drug	Short-Acting Sulfonamides, SULFONAMIDES AND TRIMETHOPRIM, Sulfur Compounds, Amines, Sulfonamides, Aniline Compounds, Amides, Antiinfectives for Systemic Use, Antibacterials for Systemic Use, Sulfones	experimental	0
DB11036	Influenza B virus B/Phuket/3073/2013 live (attenuated) antigen	Drug	0	approved	0
DB12367	Selurampanel	Drug	Heterocyclic Compounds, Fused-Ring, Quinazolines	investigational	0
DB12366	Vestronidase alfa	Drug	Enzymes, Alimentary Tract and Metabolism, Lysosomal beta Glucuronidase	approved, investigational	0
DB11035	Influenza A virus A/Switzerland/9715293/2013 (H3N2) live (attenuated) antigen	Drug	0	approved	0
DB11038	Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated)	Drug	Actively Acquired Immunity, Influenza Vaccines, Vaccines, Inactivated Influenza A Virus Vaccine	approved	0
DB12369	Sotrastaurin	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB13697	Ambazone	Drug	Throat Preparations, Amidines, Guanidines, Anti-Infective Agents, Local	experimental	0
DB11037	Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen	Drug	0	approved	0
DB13698	Ferrous carbonate	Drug	Iron Bivalent, Oral Preparations, Antianemic Preparations, Blood and Blood Forming Organs, Iron Preparations	experimental	0
DB12368	AZD-3839	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB11039	Influenza A virus A/Uruguay/716/2007(H3N2) hemagglutinin antigen (propiolactone inactivated)	Drug	0	approved	0
DB00381	Amlodipine	Drug	Calcium Channel Blockers (Dihydropyridine), Cytochrome P-450 CYP2D6 Inhibitors, Dihydropyridine Derivatives, QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Agents causing hyperkalemia, Calcium Channel Blockers and Diuretics, Cardiovascular Agents, Hypotensive Agents, Cytochrome P-450 CYP3A5 Inhibitors (weak), Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, ACE Inhibitors and Calcium Channel Blockers, Angiotensin II Antagonists and Calcium Channel Blockers, Calcium-Regulating Hormones and Agents, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Antihypertensive Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Selective Calcium Channel Blockers With Mainly Vascular Effects, Antihypertensive Agents Indicated for Hypertension, Pyridines, Antianginal Agents, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, Cytochrome P-450 CYP3A5 Inhibitors, Angiotensin II receptor blockers (ARBs) and calcium channel blockers, Membrane Transport Modulators, Calcium Channel Blockers, Dihydropyridines, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), P-glycoprotein inhibitors, Vasodilating Agents, Cytochrome P-450 CYP2D6 Inhibitors (weak)	approved	8
DB00382	Tacrine	Drug	Autonomic Agents, Enzyme Inhibitors, Cholinesterase Inhibitors, Cytochrome P-450 Substrates, Acridines, Nervous System, P-glycoprotein substrates, Parasympathomimetics, Peripheral Nervous System Agents, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cholinergic Agents, Agents Causing Muscle Toxicity, Anti-Dementia Drugs, Cytochrome P-450 CYP1A2 Substrates, Aminoacridines, Central Nervous System Agents, Nootropic Agents, Psychoanaleptics	approved, investigational, withdrawn	3
DB00380	Dexrazoxane	Drug	Enzyme Inhibitors, Miscellaneous Therapeutic Agents, Immunosuppressive Agents, Piperazines, Topoisomerase Inhibitors, Protective Agents, Cardiovascular Agents, Cytoprotective Agent, Diketopiperazines, Drugs that are Mainly Renally Excreted, Myelosuppressive Agents, Cardiotonic Agents, Topoisomerase II Inhibitors, Detoxifying Agents for Antineoplastic Treatment, Compounds used in a research, industrial, or household setting	approved, withdrawn	2
DB00385	Valrubicin	Drug	Carbohydrates, Anthracyclines, Enzyme Inhibitors, Cytotoxic Antibiotics and Related Substances, Topoisomerase Inhibitors, Antineoplastic and Immunomodulating Agents, Topoisomerase II Inhibitors, Naphthacenes, Antineoplastic Agents, Glycosides, Anthracyclines and Related Substances	approved	2
DB00383	Oxyphencyclimine	Drug	Anticholinergic Agents, Alimentary Tract and Metabolism, Agents producing tachycardia, Drugs for Functional Gastrointestinal Disorders, Muscarinic Antagonists, Synthetic Anticholinergics, Esters With Tertiary Amino Group	approved	3
DB00384	Triamterene	Drug	Nephrotoxic agents, Cytochrome P-450 Substrates, Increased Diuresis, Agents causing hyperkalemia, Decreased Renal K+ Excretion, Cardiovascular Agents, Hypotensive Agents, Potassium-Sparing Diuretics, Pteridines, Membrane Transport Modulators, Heterocyclic Compounds, Fused-Ring, Photosensitizing Agents, Cytochrome P-450 CYP1A2 Substrates, Diuretics, Natriuretic Agents, Epithelial Sodium Channel Blockers, Sodium Channel Blockers, Drugs causing inadvertant photosensitivity	approved	4
DB00389	Carbimazole	Drug	Thyroid Products, Imidazoles, Hormones, Hormone Substitutes, and Hormone Antagonists, Agents Causing Muscle Toxicity, Sulfur-Containing Imidazole Derivatives, Hormone Antagonists, Antithyroid agents, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins	approved, investigational	1
DB00387	Procyclidine	Drug	Anticholinergic Agents, Anti-Dyskinesia Agents, Neurotransmitter Agents, Cholinergic Agents, Nervous System, Pyrrolidines, Agents producing tachycardia, Muscarinic Antagonists, Central Nervous System Agents, Tertiary Amines, Anti-Parkinson Drugs	approved	4
DB00388	Phenylephrine	Drug	Amines, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Adrenergic alpha-1 Receptor Agonists, Cardiovascular Agents, Decongestants and Antiallergics, Alcohols, Peripheral Nervous System Agents, Sympathomimetic (Adrenergic) Agents, Cytochrome P-450 Enzyme Inducers, Nasal Preparations, Nasal Decongestants for Systemic Use, Monoamine Oxidase A Substrates, Compounds used in a research, industrial, or household setting, Adrenergic Agents, Sympathomimetics Used as Decongestants, Autonomic Agents, Sympathomimetics Excl. Antiglaucoma Preparations, Adrenergic alpha-Agonists, Mydriatics and Cycloplegics, Protective Agents, Nasal Decongestants, Agents producing tachycardia, Adrenergic and Dopaminergic Agents, Amino Alcohols, Ethanolamines, Respiratory System Agents, Cardiotonic Agents, Ophthalmologicals, Neurotransmitter Agents, Mydriatics, Sympathomimetics, Vasoconstrictor Agents, Adrenergic Agonists, Cardiac Stimulants Excl. Cardiac Glycosides, Sympathomimetics, Plain, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Inducers, Sensory Organs, Cardiac Therapy	approved	3
DB13691	Acetyldigoxin	Drug	Cardiac Glycosides, QTc Prolonging Agents, Digitalis Glycosides, Glycosides, Digoxin and derivatives, Potential QTc-Prolonging Agents, Cardiac Therapy, Compounds used in a research, industrial, or household setting, Antiarrhythmic agents	experimental	0
DB13692	Tretoquinol	Drug	Autonomic Agents, Adrenergics, Inhalants, Benzylisoquinolines, Adrenergics for Systemic Use, Anti-Asthmatic Agents, Isoquinolines, Agents producing tachycardia, Bronchodilator Agents, Respiratory System Agents, Peripheral Nervous System Agents, Adrenergic beta-Agonists, Alkaloids, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Selective Beta 2-adrenergic Agonists, Sympathomimetics, Adrenergic Agonists, Agents that produce hypertension, Drugs for Obstructive Airway Diseases, Adrenergic Agents	experimental	0
DB11030	Vespula germanica venom protein	Drug	Cell-mediated Immunity, Bee and Wasp Venom, Increased IgG Production, Standardized Insect Venom Allergenic Extract, Increased Histamine Release	approved	0
DB12361	Piclozotan	Drug	Serotonin 5-HT1 Receptor Agonists, Neurotransmitter Agents, Serotonin Agents, Central Nervous System Depressants, Serotonin Receptor Agonists, Agents that produce hypertension, Antidepressive Agents, Azepines	investigational	0
DB12360	PF-03654764	Drug	Cycloparaffins, Histamine H3 Antagonists	investigational	0
DB13690	Vinyl ether	Drug	Anesthetics, General, Alkenes, Nervous System, Central Nervous System Depressants, Hydrocarbons, Acyclic, Central Nervous System Agents, Anesthetics, Ethers	experimental	0
DB12374	Velmanase alfa	Drug	Enzymes, Alimentary Tract and Metabolism	investigational	0
DB11043	Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (propiolactone inactivated)	Drug	0	approved	0
DB12373	Isunakinra	Drug	Amino Acids, Peptides, and Proteins	investigational	0
DB11042	Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (propiolactone inactivated)	Drug	0	approved	0
DB12376	Ricolinostat	Drug	QTc Prolonging Agents, Enzyme Inhibitors, Amines, Hydroxy Acids, Hydroxylamines, Antineoplastic Agents, Histone Deacetylase Inhibitors, Moderate Risk QTc-Prolonging Agents	investigational	0
DB11045	Influenza A virus A/Texas/50/2012 X-223 (H3N2) antigen (propiolactone inactivated)	Drug	0	approved	0
DB12375	Oglemilast	Drug	0	investigational	0
DB11044	Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated)	Drug	Actively Acquired Immunity, Inactivated Influenza B Virus Vaccine, Influenza Vaccines, Vaccines	approved	0
DB11047	Influenza A virus A/Switzerland/9715293/2013 NIB-88 (H3N2) antigen (propiolactone inactivated)	Drug	0	approved	0
DB12378	Apricoxib	Drug	Sulfur Compounds, Amides, Sulfones	investigational	0
DB12377	Relebactam	Drug	Enzyme Inhibitors, MATE 2 Substrates, Aza Compounds, MATE 1 Substrates, beta-Lactamase Inhibitors, MATE substrates, OAT3/SLC22A8 Substrates	approved, investigational	5
DB11046	Influenza B virus B/Massachusetts/2/2012 BX-51B antigen (propiolactone inactivated)	Drug	0	approved	0
DB11048	Influenza A virus A/California/7/2009(H1N1)-like hemagglutinin antigen (propiolactone inactivated)	Drug	0	approved	0
DB12379	Indirubin	Drug	Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors, Coloring Agents, Antineoplastic Agents, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Antibiotics, Antineoplastic, Compounds used in a research, industrial, or household setting	investigational	2
DB00392	Profenamine	Drug	Cholinesterase Inhibitors, Nervous System, Agents producing tachycardia, Muscarinic Antagonists, Tertiary Amines, Anti-Parkinson Drugs, Anticholinergic Agents, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Sulfur Compounds, Cholinergic Agents, Adrenergic Antagonists, NMDA Receptor Antagonists, Histamine Agents, Adrenergic Agents	approved	3
DB00393	Nimodipine	Drug	Calcium Channel Blockers (Dihydropyridine), Dihydropyridine Derivatives, Selective Calcium Channel Blockers With Mainly Vascular Effects, Pyridines, QTc Prolonging Agents, Cytochrome P-450 Substrates, Agents causing hyperkalemia, Cardiovascular Agents, Hypotensive Agents, Cytochrome P-450 CYP3A4 Substrates, Nicotinic Acids, Moderate Risk QTc-Prolonging Agents, Membrane Transport Modulators, Calcium Channel Blockers, Dihydropyridines, Cytochrome P-450 CYP3A Substrates, Calcium-Regulating Hormones and Agents, Antihypertensive Agents, P-glycoprotein inhibitors, Vasodilating Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	approved, investigational	10
DB00390	Digoxin	Drug	QTc Prolonging Agents, Agents causing hyperkalemia, BSEP/ABCB11 Substrates, Digoxin and derivatives, Cardiovascular Agents, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, BSEP/ABCB11 Substrates with Narrow Therapeutic Index, Digoxin, antagonists & inhibitors, Glycosides, Cardenolides, Potential QTc-Prolonging Agents, P-glycoprotein substrates with narrow therapeutic index, Compounds used in a research, industrial, or household setting, Bradycardia-Causing Agents, Antiarrhythmic agents, Carbohydrates, Cardanolides, Cardiac Glycosides, OATP1B1/SLCO1B1 Inhibitors, P-glycoprotein substrates, Protective Agents, Digoxin, immunology, Cardiotonic Agents, Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, P-glycoprotein inducers, Narrow Therapeutic Index Drugs, Digitalis Glycosides, OATP1B1/SLCO1B1 Substrates, P-glycoprotein inhibitors, Cardiac Therapy	approved	1
DB00391	Sulpiride	Drug	Psycholeptics, QTc Prolonging Agents, Tranquilizing Agents, Benzoates, Cholinesterase Inhibitors, Nervous System, Acids, Carbocyclic, Benzamides and benzamide derivatives, Amides, Antidepressive Agents, Second-Generation, Antidepressive Agents, Moderate Risk QTc-Prolonging Agents, Psychotropic Drugs, Neurotransmitter Agents, Antipsychotic Agents, Central Nervous System Depressants, Central Nervous System Agents, Dopamine Antagonists, Dopamine D2 Receptor Antagonists, Benzene Derivatives, Dopamine Agents, Neurotoxic agents	approved, investigational	4
DB00396	Progesterone	Drug	OATP1B3 inducers, Progestin-containing Intrauterine Device, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Genito Urinary System and Sex Hormones, OCT1 inhibitors, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, BCRP/ABCG2 Inducers, Cytochrome P-450 CYP3A7 Inhibitors (strength unknown), Hormonal Contraceptives for Systemic Use, Gonadal Hormones, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP3A7 Inhibitors, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Progestins, Pregnanes, Cytochrome P-450 CYP2D6 Substrates, Pregnenes, Sex Hormones and Modulators of the Genital System, BSEP/ABCB11 Inhibitors, Pregnenediones, Cytochrome P-450 CYP2C19 Inhibitors, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2A6 Inducers, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein substrates, Progesterone, antagonists & inhibitors, BCRP/ABCG2 Inhibitors, Gonadal Steroid Hormones, P-glycoprotein inducers, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), OCT2 Inhibitors, Progesterone and Derivatives, P-glycoprotein inhibitors, Corpus Luteum Hormones, Hyperglycemia-Associated Agents, Steroids	approved, vet_approved	10
DB00397	Phenylpropanolamine	Drug	Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, Amines, Appetite Depressants, Cardiovascular Agents, Adrenergic beta-2 Receptor Agonists, Alcohols, Peripheral Nervous System Agents, Nasal Preparations, Nasal Decongestants for Systemic Use, Adrenergic Agents, Agents that reduce seizure threshold, Autonomic Agents, Adrenergic alpha-Agonists, Propanols, Nasal Decongestants, Agents producing tachycardia, Amino Alcohols, Respiratory System Agents, Adrenergic beta-Agonists, Neurotransmitter Agents, Sympathomimetics, Anti-Obesity Agents, Vasoconstrictor Agents, Adrenergic Agonists, Agents that produce hypertension, Propanolamines	approved, withdrawn, vet_approved	4
DB00394	Beclomethasone dipropionate	Drug	Corticosteroids, Dermatological Preparations, Cytochrome P-450 Substrates, Immunosuppressive Agents, Glucocorticoids, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, OATP1B3 inhibitors, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Intestinal Antiinflammatory Agents, Cytochrome P-450 Enzyme Inducers, Nasal Preparations, Corticosteroids, Potent (Group III), Alimentary Tract and Metabolism, Adrenals, Corticosteroids Acting Locally, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Corticosteroid Hormone Receptor Agonists, Cytochrome P-450 CYP3A5 Inducers, OATP1B1/SLCO1B1 Inhibitors, Pregnadienetriols, Corticosteroids, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Anti-Asthmatic Agents, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inducers, Dermatologicals, BCRP/ABCG2 Inhibitors, Respiratory System Agents, P-glycoprotein inducers, Agents to Treat Airway Disease, Cytochrome P-450 CYP3A Substrates, Pregnanes, Drugs for Obstructive Airway Diseases, Thyroxine-binding globulin inhibitors, Hyperglycemia-Associated Agents, Steroids, Steroids, Chlorinated	approved, investigational	1
DB00395	Carisoprodol	Drug	Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 Substrates, Central Nervous System Depressants, Musculo-Skeletal System, Muscle Relaxants, Centrally Acting Agents, Carbamic Acid Esters, Centrally-mediated Muscle Relaxation, Carbamates, Central Nervous System Agents, Muscle Relaxants	approved	5
DB00398	Sorafenib	Drug	Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Nicotinic Acids, Drugs that are Mainly Renally Excreted, UGT1A9 substrates with narrow therapeutic index, Cytochrome P-450 CYP2B6 Inhibitors (moderate), Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Substrates, P-glycoprotein substrates with narrow therapeutic index, Benzene Derivatives, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), OATP1B1/SLCO1B1 Inhibitors, Miscellaneous Therapeutic Agents, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP2C8 Inhibitors (strong), Protein Kinase Inhibitors, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Kinase Inhibitor, Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Enzyme Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (strong), Cytochrome P-450 CYP2C19 Inhibitors, Phenylurea Compounds, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors, Potential QTc-Prolonging Agents, Pyridines, P-glycoprotein substrates, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index, UGT1A1 Inhibitors, Vitamins, Myelosuppressive Agents, Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index, UGT1A9 Inhibitors, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, UGT1A9 Substrates, Vitamin B Complex, P-glycoprotein inhibitors	approved, investigational	10
DB00399	Zoledronic acid	Drug	Organophosphonates, Imidazoles, Musculo-Skeletal System, Drugs for Treatment of Bone Diseases, Bone Density Conservation Agents, Organophosphorus Compounds, Drugs Affecting Bone Structure and Mineralization, Bisphosphonates	approved	3
DB12370	Ipamorelin	Drug	Peptides, Amino Acids, Peptides, and Proteins	investigational	0
DB11041	Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)	Drug	Actively Acquired Immunity, Influenza Vaccines, Vaccines, Inactivated Influenza A Virus Vaccine	approved	0
DB12371	Siponimod	Drug	Cytochrome P-450 CYP2C9 Substrates, Receptors, Lysosphingolipid, antagonists & inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 CYP3A Substrates, Agents that produce hypertension, Azetines, Immunomodulatory Agents, Cytochrome P-450 CYP3A4 Substrates, Benzene Derivatives	approved, investigational	2
DB11040	Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated)	Drug	Actively Acquired Immunity, Inactivated Influenza B Virus Vaccine, Influenza Vaccines, Vaccines	approved	0
DB12385	10-hydroxycamptothecin	Drug	Alkaloids, Antineoplastic Agents, Phytogenic, Antineoplastic Agents	investigational	0
DB11054	Human cord blood hematopoietic progenitor cell	Drug	Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy	approved	0
DB12384	AR-67	Drug	Alkaloids	investigational	0
DB12387	OSI-027	Drug	0	investigational	0
DB11056	Stannous chloride	Drug	0	approved	0
DB12386	Bacillus calmette-guerin substrain danish 1331 live antigen	Drug	Live vaccines, Vaccines, Live Attenuated Bacillus Calmette-Guerin Vaccine	investigational	0
DB12389	Zamicastat	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Pyrans	investigational	0
DB11058	Petrolatum	Drug	Basic Ointments and Protectants, Dermatologicals, Ointment Bases, Pharmaceutical Preparations, Compounds used in a research, industrial, or household setting, Emollients, Pharmaceutic Aids	approved, investigational	0
DB12388	Evocalcet	Drug	0	investigational	0
DB11057	Mineral oil	Drug	Softener and Emollient Laxatives, Basic Ointments and Protectants, Alimentary Tract and Metabolism, Dermatologicals, Softeners, Emollients, Drugs for Constipation, Laxatives, Emollients	approved, vet_approved	0
DB11059	Carboxymethylcellulose	Drug	Carbohydrates, Cellulose, Anorexigenic Agents & Respiratory and CNS Stimulants, Carboxymethylcellulose Sodium, Artificial Tears, Biopolymers, Macromolecular Substances, EENT Drugs, Miscellaneous, Polysaccharides, Glucans, Laxatives, Bulk-Forming Laxatives, Polymers, Compounds used in a research, industrial, or household setting, Gastrointestinal Agents	approved, investigational	1
DB11050	Typhoid Vaccine Live	Drug	Inactivated Salmonella Typhi Vaccine, Live vaccines, Actively Acquired Immunity, Live Attenuated Salmonella Typhi Vaccine, Vaccines	approved	0
DB12381	Merestinib	Drug	Heterocyclic Compounds, Fused-Ring, Pyridines, Protein Kinase Inhibitors, Pyrazoles, Antineoplastic Agents, Nicotinic Acids	investigational	0
DB12380	GDC-0152	Drug	Cycloparaffins	investigational	0
DB12383	Cytochlor	Drug	0	investigational	0
DB11051	Azficel-T	Drug	Autologous Cultured Cell	approved, investigational	0
DB12382	R-306465	Drug	Enzyme Inhibitors, Sulfur Compounds, Amines, Hydroxy Acids, Hydroxylamines, Antineoplastic Agents, Histone Deacetylase Inhibitors	investigational	0
DB13640	Acetoxolone	Drug	Triterpenes, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Alimentary Tract and Metabolism, Pentacyclic Triterpenes, Drugs for Acid Related Disorders, Terpenes	experimental	0
DB14971	Iomazenil	Drug	Heterocyclic Compounds, Fused-Ring, Iodine Radioisotopes, Benzazepines, Benzodiazepinones	investigational	0
DB13641	Metisazone	Drug	Antivirals for Systemic Use, Direct Acting Antivirals, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Thiosemicarbazones, Semicarbazides, Antiviral Agents, Indoles, Semicarbazones, Antiinfectives for Systemic Use, Anti-Infective Agents	experimental	0
DB14972	Methamidophos	Drug	Sulfur Compounds, Agrochemicals, Pesticides, Organophosphorus Compounds, Insecticides, Toxic Actions, Compounds used in a research, industrial, or household setting	investigational	0
DB12310	Trehalose	Drug	Carbohydrates, Polysaccharides, Disaccharides, Glucans, Oligosaccharides, Polymers, Biopolymers, Compounds used in a research, industrial, or household setting, Macromolecular Substances	investigational	0
DB14970	Alobresib	Drug	0	investigational	0
DB14975	Voxelotor	Drug	Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Hematologic Agents, Cytochrome P-450 CYP2B6 Substrates, Aldehydes, Cytochrome P-450 CYP3A4 Substrates	approved, investigational	1
DB12312	ORG-25435	Drug	Benzene Derivatives	investigational	0
DB13644	Methylthiouracil	Drug	Pyrimidines, Thyroid Products, Hormones, Hormone Substitutes, and Hormone Antagonists, Pyrimidinones, Hormone Antagonists, Antithyroid agents, Thiouracil, Thiouracils, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins	experimental	0
DB12311	CP1-1189	Drug	Hydrocarbons, Acyclic, Alkanes	investigational	0
DB14976	Relacorilant	Drug	0	investigational	0
DB13645	Ethacizine	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Antiarrhythmics, Class I, Cardiovascular Agents, Central Nervous System Agents, Cardiac Therapy, Antiarrhythmic agents, Antiarrhythmics, Class Ic	experimental	0
DB12314	Chlorproguanil	Drug	Antiprotozoals, Biguanides, Antimalarials, Amidines, Guanidines, Anti-Infective Agents, Antiparasitic Agents	investigational	0
DB14973	Abrocitinib	Drug	0	investigational	0
DB13642	Pridinol	Drug	Central Nervous System Depressants, Musculo-Skeletal System, Muscle Relaxants, Centrally Acting Agents, Muscle Relaxants	experimental	0
DB12313	Dopexamine	Drug	Amines, Agents producing tachycardia, Catecholamines, Catechols, Adrenergic and Dopaminergic Agents, Cardiovascular Agents, Nonergot-derivative Dopamine Receptor Agonists, Biogenic Monoamines, Dopamine Agonists, Adrenergic beta-Agonists, Neurotransmitter Agents, Adrenergic Agonists, Cardiac Stimulants Excl. Cardiac Glycosides, Agents that produce hypertension, Biogenic Amines, Phenols, Vasodilating Agents, Cardiac Therapy, Adrenergic Agents, Benzene Derivatives, Dopamine Agents	approved, investigational	0
DB13643	Loprazolam	Drug	Heterocyclic Compounds, Fused-Ring, Psycholeptics, Tranquilizing Agents, Benzazepines, Nervous System, Central Nervous System Depressants, Benzodiazepines and benzodiazepine derivatives, Anti-Anxiety Agents, Hypnotics and Sedatives, Central Nervous System Agents, Psychotropic Drugs, Benzodiazepine hypnotics and sedatives	experimental	2
DB14974	Pimodivir	Drug	0	investigational	0
DB12316	9CUAB30	Drug	Fatty Acids, Lipids	investigational	0
DB13648	Alcuronium	Drug	Curare Alkaloids, Neuromuscular Agents, Amines, Ammonium Compounds, Benzylisoquinolines, Isoquinolines, Onium Compounds, Muscle Relaxants, Peripheral Nervous System Agents, Anticholinergic Agents, Alkaloids, Cholinergic Agents, Musculo-Skeletal System, Tetrahydroisoquinolines, Nitrogen Compounds, Quaternary Ammonium Compounds, Neuromuscular-Blocking Agents (Nondepolarizing), Toxiferine, Nicotinic Antagonists, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Muscle Relaxants, Peripherally Acting Agents, Central Nervous System Depressants, Neuromuscular Blocking Agents, Adjuvants, Anesthesia, Central Nervous System Agents	experimental	0
DB14979	Martinostat	Drug	Cycloparaffins, Amines, Hydroxy Acids, Hydroxylamines, Carbon Radioisotopes	investigational	0
DB13649	Proquazone	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Enzyme Inhibitors, Sensory System Agents, Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Peripheral Nervous System Agents, Heterocyclic Compounds, Fused-Ring, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Musculo-Skeletal System, Agents that produce hypertension, Central Nervous System Agents	experimental	0
DB12318	BMS-599626	Drug	Acids, Acyclic, ErbB Receptors, antagonists & inhibitors	investigational	0
DB14977	Padsevonil	Drug	0	investigational	0
DB13646	Saruplase	Drug	Anticoagulants, Biological Factors, Enzymes, Blood and Blood Forming Organs, Plasminogen Activators, Fibrin Modulating Agents, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Hematologic Agents, Cardiovascular Agents, Fibrinolytic Agents, Proteins, Blood Proteins, Serine Proteases, Hydrolases, Agents causing angioedema, Peptide Hydrolases, Enzyme Precursors, Serine Endopeptidases, Endopeptidases	experimental	0
DB13647	Semustine	Drug	Alkylating Drugs, Nitroso Compounds, Noxae, Nitrosoureas, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Toxic Actions, Nitrosourea Compounds, Antineoplastic Agents, Alkylating	investigational, experimental	0
DB12317	Vanucizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB14978	MIP-1095 I-131	Drug	0	investigational	0
DB12319	Benzbromarone	Drug	OATP1B1/SLCO1B1 Inhibitors, Renal Agents, Cytochrome P-450 Enzyme Inhibitors, Preparations Increasing Uric Acid Excretion, Antirheumatic Agents, BSEP/ABCB11 Substrates, Cytochrome P-450 CYP2C19 Inhibitors, Benzofurans, Heterocyclic Compounds, Fused-Ring, Antigout Preparations, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Musculo-Skeletal System, Uricosuric Agents, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2C19 inhibitors (strength unknown)	investigational, withdrawn	2
DB01662	Trans-O-Hydroxy-Alpha-Methyl Cinnamate	Drug	0	experimental	1
DB02993	8-Methyl-9-Oxoguanine	Drug	0	experimental	0
DB00330	Ethambutol	Drug	Diamines, Anti-Bacterial Agents, Amines, Drugs for Treatment of Tuberculosis, Antimycobacterials, Polyamines, Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Ethylenediamines, Antituberculosis Agents	approved	3
DB01661	1-(5-phospho-D-ribosyl)-ATP	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides, Adenine Nucleotides	experimental	1
DB00331	Metformin	Drug	OCT1 substrates, OCT2 Substrates, MATE 1 Substrates, Amidines, Guanidines, Blood Glucose Lowering Agents, Drugs that are Mainly Renally Excreted, Biguanides, Alimentary Tract and Metabolism, OCT2 Inhibitors, MATE 2 Substrates, Drugs Used in Diabetes, MATE substrates	approved	3
DB02992	1-Deoxy-6-O-Phosphono-1-[(Phosphonomethyl)Amino]-L-Threo-Hexitol	Drug	0	experimental	1
DB02991	S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea	Drug	0	experimental	1
DB02990	S-(2-Acetamidoethyl) hexadecanethioate	Drug	0	experimental	1
DB00334	Olanzapine	Drug	Psycholeptics, Tranquilizing Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Diazepines, Oxazepines, Thiazepines and Oxepines, Peripheral Nervous System Agents, Anticholinergic Agents, Serotonin 5-HT2 Receptor Antagonists, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Dopamine Antagonists, Agents producing tachycardia, Histamine H2 Antagonists, Neurotransmitter Agents, Central Nervous System Depressants, Antiemetics, UGT1A4 substrates, Cytochrome P-450 CYP2C19 Inhibitors (weak), Cytochrome P-450 CYP2D6 Substrates, Dopamine D2 Receptor Antagonists, Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Serotonin Agents, Nervous System, Cytochrome P-450 CYP2C19 Inhibitors, Hypotensive Agents, Muscarinic Antagonists, Antidepressive Agents, Antipsychotic Agents, Histamine H1 Antagonists, Antipsychotic Agents (Second Generation Atypical), Benzazepines, Cytochrome P-450 CYP2C9 Inhibitors, Adrenergic Antagonists, Potential QTc-Prolonging Agents, Adrenergic alpha-1 Receptor Antagonists, Gastrointestinal Agents, Autonomic Agents, Adrenergic alpha-Antagonists, P-glycoprotein substrates, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Histamine Antagonists, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Serotonin Receptor Antagonists, Central Nervous System Agents, Hyperglycemia-Associated Agents, Cytochrome P-450 CYP2C9 Inhibitors (weak), Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved, investigational	20
DB01666	D-Myo-Inositol-Hexasulphate	Drug	0	experimental	2
DB02996	2-(Thiomethylene)-4-Methylpentanoic Acid	Drug	0	experimental	1
DB01665	2H-Benzimidazol-2-amine	Drug	0	experimental	1
DB00335	Atenolol	Drug	Amines, Cytochrome P-450 Substrates, Sympatholytics, Agents causing hyperkalemia, Adrenergic beta-Antagonists, BSEP/ABCB11 Substrates, Cardiovascular Agents, Hypotensive Agents, Adrenergic beta-1 Receptor Antagonists, Alcohols, Peripheral Nervous System Agents, Adrenergic Antagonists, Antihypertensive Agents, Adrenergic Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Autonomic Agents, Beta Blocking Agents, Selective, and Thiazides, Antihypertensive Agents Indicated for Hypertension, QTc shortening agents, Amino Alcohols, Beta Blocking Agents and Thiazides, Beta blocking agents and calcium channel blockers, Beta Blocking Agents, Selective, Beta-Blockers (Beta1 Selective), Cytochrome P-450 CYP2D6 Substrates	approved	2
DB00332	Ipratropium	Drug	Autonomic Agents, Adrenergics, Inhalants, Solanaceous Alkaloids, Antimuscarinics Antispasmodics, Anti-Asthmatic Agents, Belladonna Alkaloids, Agents producing tachycardia, Muscarinic Antagonists, Bronchodilator Agents, Respiratory System Agents, Peripheral Nervous System Agents, Anticholinergic Agents, Alkaloids, Neurotransmitter Agents, Tropanes, Nasal Preparations, Agents to Treat Airway Disease, Cholinergic Agents, Aza Compounds, Azabicyclo Compounds, Drugs for Obstructive Airway Diseases, Atropine Derivatives	approved, experimental	3
DB02995	Cyclohexylammonium Ion	Drug	0	experimental	1
DB01664	(S)-DES-ME-AMPA	Drug	0	experimental	1
DB02994	Cacodylic acid	Drug	Organometallic Compounds, Herbicides, Agrochemicals, Arsenicals, Pesticides, Toxic Actions, Compounds used in a research, industrial, or household setting	experimental	4
DB01663	lambda-bis(2,2'-bipyridine)-(5-methyl-2-2'-bipyridine)-C9-adamantane ruthenium (II)	Drug	0	experimental	1
DB00333	Methadone	Drug	Cytochrome P-450 Substrates, Sensory System Agents, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Anticholinergic Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Diphenylpropylamine Derivatives, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP2C18 Substrates, Cytochrome P-450 CYP3A5 Substrates, Narcotics, Cytochrome P-450 CYP3A4 Inducers, Respiratory System Agents, Cytochrome P-450 CYP2C19 Substrates, Thyroxine-binding globulin inducers, Central Nervous System Depressants, Opioid Agonist, Drugs Used in Opioid Dependence, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2D6 Inhibitors, Antitussive Agents, QTc Prolonging Agents, Serotonin Agents, Nervous System, Antidepressive Agents, Opiate Agonists, Serotonin Modulators, Cytochrome P-450 Enzyme Inducers, Analgesics, Opioids, Cytochrome P-450 CYP2B6 Inducers, Ketones, Drugs Used in Addictive Disorders, Moderate Risk QTc-Prolonging Agents, Nicotinic Antagonists, Cytochrome P-450 CYP2C9 Substrates, High-risk opioids, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, NMDA Receptor Antagonists, Central Nervous System Agents, P-glycoprotein inhibitors	approved	8
DB00338	Omeprazole	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Benzimidazoles, Enzyme Inhibitors, Proton-pump Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Anti-Ulcer Agents, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 Enzyme Inducers, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Sulfur Compounds, Alimentary Tract and Metabolism, Acid Reducers, Cytochrome P-450 CYP2C8 Substrates, Drugs for Acid Related Disorders, Gastrointestinal Agents, Pyridines, Cytochrome P-450 CYP2C18 Substrates, Proton Pump Inhibitors, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inducers, BCRP/ABCG2 Inhibitors, Sulfoxides, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Gastric Acid Lowering Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP1A2 Inducers, 2-Pyridinylmethylsulfinylbenzimidazoles, Cytochrome P-450 CYP2C19 Inhibitors (weak), P-glycoprotein inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (weak)	approved, investigational, vet_approved	2
DB01669	Virginiamycin M1	Drug	Peptides, Cyclic, Anti-Bacterial Agents, Peptides, Streptogramins, Amino Acids, Peptides, and Proteins, Streptogramin Group A, Anti-Infective Agents	experimental	1
DB00339	Pyrazinamide	Drug	Cytochrome P-450 Substrates, Antimycobacterials, Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Pyrazines, Anti-Bacterial Agents, Drugs for Treatment of Tuberculosis, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Hepatotoxic Agents, Drugs causing inadvertant photosensitivity, Antituberculosis Agents	approved, investigational	1
DB00336	Nitrofural	Drug	Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Blood and Blood Forming Organs, Medicated Dressings, Antiseptics and Disinfectants, Dermatologicals, Otologicals, Nitrofurans, Blood Substitutes and Perfusion Solutions, Irrigating Solutions, Anti-Infective Agents, Ophthalmologicals, Medicated Dressings With Antiinfectives, Agents Against Leishmaniasis and Trypanosomiasis, Nitro Compounds, Nitrofuran Derivatives, Furans, Sensory Organs	approved, investigational, vet_approved	1
DB02999	Quisqualic acid	Drug	Neurotransmitter Agents, Oxadiazoles, Excitatory Amino Acid Agonists, Oxazoles, Amino Acids, Peptides, and Proteins, Excitatory Amino Acid Agents, Amino Acids	experimental	2
DB01668	Nanaomycin D	Drug	Quinones, Naphthalenes	experimental	1
DB01667	8-azaguanine	Drug	Heterocyclic Compounds, Fused-Ring, Purines, Cytochrome P-450 Substrates, Noxae, Aza Compounds, Cytochrome P-450 CYP1A2 Substrates, Antineoplastic Agents, Toxic Actions, Xanthine derivatives, Antimetabolites, Purinones	experimental	1
DB00337	Pimecrolimus	Drug	Agents for Dermatitis, Excluding Corticosteroids, Immunologic Factors, Enzyme Inhibitors, Cytochrome P-450 Substrates, Immunosuppressive Agents, Sensory System Agents, Cytochrome P-450 Enzyme Inhibitors, Anti-Inflammatory Agents, Calcineurin Inhibitor Immunosuppressant, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Misc. Skin and Mucous Membrane Agents, Cytochrome P-450 CYP3A4 Substrates, Lactones, Peripheral Nervous System Agents, Calcineurin Inhibitors, Anti-Bacterial Agents, Peptidylprolyl Isomerase, antagonists & inhibitors, Analgesics, Analgesics, Non-Narcotic, Dermatologicals, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Central Nervous System Agents	approved, investigational	2
DB02998	Metribolone	Drug	Estranes, Estrenes, Fused-Ring Compounds, Steroids	experimental	4
DB13651	Lorajmine	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, QTc Prolonging Agents, Antiarrhythmics, Class I, Potential QTc-Prolonging Agents, Cardiovascular Agents, Indoles, Antiarrhythmics, Class Ia, Cardiac Therapy, Secologanin Tryptamine Alkaloids, Antiarrhythmic agents, Indole Alkaloids	experimental	0
DB14982	Miransertib	Drug	Pyridines, Amines	investigational	0
DB13652	Bunaftine	Drug	Antiarrhythmics, Class III, QTc Prolonging Agents, Cardiovascular Agents, Cardiac Therapy, Moderate Risk QTc-Prolonging Agents, Antiarrhythmic agents, Naphthalenes	experimental	0
DB14983	Cimlanod	Drug	0	investigational	0
DB14980	AZD-6482	Drug	Aminobenzoates, Pyrimidines, Benzoates, Acids, Carbocyclic, Class Ia Phosphatidylinositol 3-Kinase, antagonists & inhibitors, Benzene Derivatives	investigational	0
DB12321	Ifetroban	Drug	Hematologic Agents, Antiplatelet agents	investigational	0
DB14981	Fytic acid	Drug	0	investigational	0
DB13650	Aloglutamol	Drug	Alkalies, Hydroxides, Ions, Propylene Glycols, Alcohols, Aluminum and magnesium containing antacids, Anions, Gastric Acid Lowering Agents, Metal cations, Alimentary Tract and Metabolism, Metal divalent cations, Aluminium Compounds, Electrolytes, Glycols, Drugs for Acid Related Disorders, Antacids	experimental	0
DB12320	Palovarotene	Drug	Benzylidene Compounds, Benzene Derivatives	investigational	0
DB14986	Linrodostat	Drug	Acids, Acyclic, Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Fatty Acids, Fatty Acids, Volatile, Amides, Lipids, Acetates	investigational	0
DB13655	Nikethamide	Drug	Pyridines, Central Nervous System Stimulants, Convulsants, Vitamin B Complex, Central Nervous System Agents, Nicotinic Acids, Respiratory System Agents, Vitamins	experimental	0
DB12323	Radotinib	Drug	Benzoates, Tyrosine Kinase Inhibitors, Acids, Carbocyclic, Amides, Benzene Derivatives	investigational	1
DB14987	Difamilast	Drug	0	investigational	0
DB13656	Eberconazole	Drug	Cycloparaffins, Antifungals for Topical Use, Dermatologicals, Antifungals for Dermatological Use, Imidazole and Triazole Derivatives	experimental	0
DB12322	GW-870086	Drug	Fused-Ring Compounds	investigational	0
DB14984	Casimersen	Drug	0	investigational	0
DB13653	Lorcainide	Drug	Acids, Acyclic, QTc Prolonging Agents, Fatty Acids, Amides, Lipids, Cardiovascular Agents, Acetates, Moderate Risk QTc-Prolonging Agents, Fatty Acids, Volatile, Antiarrhythmics, Class I, Acetamides, Cardiac Therapy, Benzene Derivatives, Antiarrhythmic agents, Antiarrhythmics, Class Ic	experimental	0
DB12325	Idasanutlin	Drug	Aminobenzoates, Benzoates, Acids, Carbocyclic, Proto-Oncogene Proteins c-mdm2, antagonists & inhibitors, Benzene Derivatives	investigational	0
DB13654	Montmorillonite	Drug	Antidotes, Protective Agents, Ions, Oxides, Minerals, Silicates, Silicon Compounds, Anions, Acids, Noncarboxylic, Intestinal Adsorbents, Metal cations, Acids, Alimentary Tract and Metabolism, Metal divalent cations, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Aluminium Compounds, Aluminum Silicates, Electrolytes, Compounds used in a research, industrial, or household setting, Oxygen Compounds	investigational, experimental	0
DB14985	Enarodustat	Drug	0	investigational	0
DB13659	Tenonitrozole	Drug	Antiparasitic Products, Insecticides and Repellents, Antiprotozoals	experimental	0
DB12327	Salvinorin A	Drug	Central Nervous System Depressants, Diterpenes, Central Nervous System Agents, Salvia, Terpenes, Hallucinogens, Psychotropic Drugs	investigational	0
DB12326	Antroquinonol	Drug	Quinones, Coenzymes, Enzymes and Coenzymes, Benzoquinones	investigational	0
DB14988	Dalantercept	Drug	Peptide Fragments, Receptors, Cytokine, Peptides, Protein-Serine-Threonine Kinases, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Receptors, Cell Surface, Recombinant Proteins, Immunoglobulin Fragments, Immunoproteins, Proteins, Activin Receptors, Receptors, Peptide, Phosphotransferases, Enzymes, Immunoglobulins, Receptors, Growth Factor, Transferases, Membrane Proteins, Serum Globulins, Globulins, Phosphotransferases (Alcohol Group Acceptor), Protein Kinases, Blood Proteins, Immunoglobulin Constant Regions, Receptors, Immunologic, Receptors, Transforming Growth Factor beta	investigational	0
DB12329	Eravacycline	Drug	Anti-Bacterial Agents, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Tetracyclines, Naphthacenes, Cytochrome P-450 CYP3A4 Substrates, Monoamine Oxidase A Substrates, Antiinfectives for Systemic Use, Antibacterials for Systemic Use	approved, investigational	1
DB13657	Benorilate	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Amines, Benzoates, Hydroxy Acids, Sensory System Agents, Nervous System, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Aniline Compounds, Antirheumatic Agents, Hydroxybenzoates, Non COX-2 selective NSAIDS, Amides, Peripheral Nervous System Agents, Anilides, Analgesics, Agents that produce hypertension, Phenols, Central Nervous System Agents, Salicylic Acid and Derivatives, Benzene Derivatives	approved	0
DB14989	Umbralisib	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB12328	Cantharidin	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Noxae, Toxic Actions, Benzofurans, Compounds used in a research, industrial, or household setting, Irritants	approved, investigational	2
DB13658	Hemoglobin raffimer	Drug	Blood and Blood Forming Organs, Blood Substitutes and Plasma Protein Fractions, Blood and Related Products, Blood Substitutes and Perfusion Solutions	investigational, experimental	0
DB01673	Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine	Drug	0	experimental	2
DB00341	Cetirizine	Drug	QTc Prolonging Agents, Anti-Allergic Agents, Piperazines, P-glycoprotein substrates, Drugs that are Mainly Renally Excreted, Histamine H1 Antagonists, Histamine H1 Antagonists, Non-Sedating, Piperazine Derivatives, Histamine Antagonists, Central Nervous System Depressants, Potential QTc-Prolonging Agents, Histamine Agents, P-glycoprotein inhibitors, Antihistamines for Systemic Use	approved	1
DB01672	2,3-Dihydroxy-Benzoic Acid	Drug	0	experimental	2
DB00342	Terfenadine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, BSEP/ABCB11 Substrates, Muscarinic Antagonists, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Anticholinergic Agents, Cytochrome P-450 CYP3A4 Inhibitors (strong), Cytochrome P-450 Enzyme Inducers, Histamine H1 Antagonists, Piperidines, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Antihistamines for Systemic Use, Benzene Derivatives, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Cytochrome P-450 CYP3A5 Substrates, Benzhydryl Compounds, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inducers, Neurotransmitter Agents, Histamine H1 Antagonists, Non-Sedating, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2D6 Substrates, Histamine Agents, P-glycoprotein inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (weak)	approved, withdrawn	7
DB01671	p-Hydroxymercuribenzoic acid	Drug	Organometallic Compounds, Enzyme Inhibitors, Benzoates, Hydroxy Acids, Acids, Carbocyclic, Protease Inhibitors, Hydroxybenzoates, Phenols, Mercuribenzoates, Phenylmercury Compounds, Benzene Derivatives, Organomercury Compounds	experimental	1
DB00340	Metixene	Drug	Anticholinergic Agents, Xanthenes, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Nervous System, Agents producing tachycardia, Muscarinic Antagonists, Tertiary Amines, Anti-Parkinson Drugs	approved	1
DB01670	Propyl acetate	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Lipids	experimental	1
DB00345	Aminohippuric acid	Drug	Aminobenzoates, para-Aminobenzoates, OATP1B1/SLCO1B1 Inhibitors, Benzoates, Acids, Carbocyclic, Benzamides and benzamide derivatives, Laboratory Chemicals, Tests for Renal Function and Ureteral Injuries, Amides, Aminohippuric Acids, OAT1/SLC22A6 Substrates, Hippurates, OAT1/SLC22A6 inhibitors, OAT3/SLC22A8 Substrates, OCT2 Inhibitors, Keto Acids, Indicators and Reagents, Diagnostic Agents, OAT3/SLC22A8 Inhibitors, Compounds used in a research, industrial, or household setting, Benzene Derivatives	approved, investigational	0
DB01677	Fumaric Acid	Drug	Acids, Acyclic, Antipsoriatics for Topical Use, Dermatologicals, Dicarboxylic Acids, Antipsoriatics	investigational, experimental	5
DB00346	Alfuzosin	Drug	QTc Prolonging Agents, Cytochrome P-450 Substrates, Adrenergic alpha-Antagonists, Genito Urinary System and Sex Hormones, Peripheral alpha-1 blockers, Urologicals, Cytochrome P-450 CYP3A4 Substrates, Selective Alfa-1-adrenergic Blocking Agents, Prostatic Hyperplasia, Urological Agents, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Adrenergic Antagonists, Potential QTc-Prolonging Agents, Adrenergic alpha-1 Receptor Antagonists, Drugs Used in Benign Prostatic Hypertrophy, Adrenergic Agents	approved, investigational	4
DB01676	Trinitrotoluene	Drug	Explosive Agents, Compounds used in a research, industrial, or household setting, Benzene Derivatives	experimental	1
DB00343	Diltiazem	Drug	QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Agents causing hyperkalemia, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Cardiovascular Agents, Hypotensive Agents, Miscellaneous Calcium-channel Blocking Agents, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A4 Inhibitors (strong), Cytochrome P-450 CYP3A7 Inhibitors (moderate), Vasoprotectives, Benzazepines, Calcium-Regulating Hormones and Agents, Cytochrome P-450 CYP3A7 Inhibitors (strong), Cytochrome P-450 CYP2C8 Inhibitors (moderate), Antihypertensive Agents, Cytochrome P-450 CYP2C8 Substrates, Drugs causing inadvertant photosensitivity, Bradycardia-Causing Agents, Selective Calcium Channel Blockers With Direct Cardiac Effects, Antiarrhythmic agents, Antihypertensive Agents Indicated for Hypertension, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, Cytochrome P-450 CYP3A5 Inhibitors, Moderate Risk QTc-Prolonging Agents, Membrane Transport Modulators, Cytochrome P-450 CYP2C19 Substrates, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Calcium Channel Blockers, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A5 Inhibitors (moderate), Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Cytochrome P-450 CYP3A7 Inhibitors, Benzothiazepine Derivatives, Cytochrome P-450 CYP3A4 Inhibitors, Calcium Channel Blockers (Nondihydropyridine), Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors, Vasodilating Agents	approved, investigational	2
DB01675	Methacrylyl-Coenzyme A	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Coenzymes, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Enzymes and Coenzymes, Glycosides, Nucleotides, Adenine Nucleotides	experimental	1
DB00344	Protriptyline	Drug	QTc Prolonging Agents, Adrenergic Uptake Inhibitors, Cytochrome P-450 Substrates, Serotonin Agents, Nervous System, Antidepressive Agents, Dibenzocycloheptenes, Serotonin Modulators, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Potential QTc-Prolonging Agents, Adrenergic Agents, Agents that reduce seizure threshold, Neurotoxic agents, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Benzocycloheptenes, Psychotropic Drugs, Membrane Transport Modulators, Neurotransmitter Agents, Non-Selective Monoamine Reuptake Inhibitors, Central Nervous System Depressants, Antidepressive Agents, Tricyclic, Neurotransmitter Uptake Inhibitors, Agents that produce hypertension, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors, Psychoanaleptics	approved	2
DB01674	[2-(1-Amino-2-Hydroxy-Propyl)-4-(4-Fluoro-1h-Indol-3-Ylmethyl)-5-Hydroxy-Imidazol-1-Yl]-Acetic Acid	Drug	0	experimental	0
DB00349	Clobazam	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Psycholeptics, Tranquilizing Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP3A Inducers, Benzodiazepines and benzodiazepine derivatives, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Cytochrome P-450 Enzyme Inducers, Benzazepines, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Cytochrome P-450 CYP2C18 Substrates, GABA Agents, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inducers, GABA Agonists, Psychotropic Drugs, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP3A4 Inducers (weak), GABA-A Receptor Agonists, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Anticonvulsants, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Anti-Anxiety Agents, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates	approved, illicit	2
DB01679	Propyl Trihydrogen Diphosphate	Drug	0	experimental	0
DB00347	Trimethadione	Drug	QTc Prolonging Agents, Cytochrome P-450 CYP2E1 Substrates, Decreased Central Nervous System Disorganized Electrical Activity, Cytochrome P-450 Substrates, Nervous System, Agents causing hyperkalemia, Cytochrome P-450 CYP3A4 Substrates, Oxazolidine Derivatives, Anti-epileptic Agent, Cytochrome P-450 CYP2C19 Substrates, Calcium Channel Blockers, Cytochrome P-450 CYP2C9 Substrates, Anticonvulsants, Cytochrome P-450 CYP3A Substrates, Oxazoles, Central Nervous System Depressants, Potential QTc-Prolonging Agents, Central Nervous System Agents, Cytochrome P-450 CYP2C8 Substrates, Bradycardia-Causing Agents, Antiarrhythmic agents	approved	1
DB01678	RU84687	Drug	0	experimental	1
DB00348	Nitisinone	Drug	Cycloparaffins, Enzyme Inhibitors, Benzoates, Hydroxyphenylpyruvate Dioxygenase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Ketones, Various Alimentary Tract and Metabolism Products, Acids, Carbocyclic, Other Miscellaneous Therapeutic Agents, 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor, 4-Hydroxyphenylpyruvate Dioxygenase, antagonists & inhibitors, Cyclohexanes, Alimentary Tract and Metabolism, Cytochrome P-450 CYP2C9 Inhibitors, Benzene Derivatives	approved, investigational	1
DB13662	Hexapropymate	Drug	Acids, Acyclic, Psycholeptics, Nervous System, Central Nervous System Depressants, Hypnotics and Sedatives	experimental	0
DB12330	Blisibimod	Drug	Proteins, Immunologic Factors, B-Cell Activating Factor, Amino Acids, Peptides, and Proteins, Recombinant Proteins	investigational	0
DB14993	Pyrotinib	Drug	Quinolines, Acids, Acyclic, Acrylates, Heterocyclic Compounds, Fused-Ring, Amides	investigational	0
DB13663	Clofenamide	Drug	Sulfonamides, Diuretics, Low-Ceiling Diuretics, Excl. Thiazides	experimental	0
DB14991	Nomacopan	Drug	0	investigational	0
DB13660	Propicillin	Drug	Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Beta-Lactamase Sensitive Penicillins, Anti-Infective Agents, Antibacterials for Systemic Use	experimental	0
DB11001	Influenza A virus A/South Australia/55/2014 (H3N2) antigen (MDCK cell derived, propiolactone inactivated)	Drug	0	approved	0
DB12332	Rucaparib	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, OATP1B3 inhibitors, OCT1 inhibitors, Cytochrome P-450 CYP2C19 Inhibitors, MATE inhibitors, MATE 1 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A7 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C8 Inhibitors (weak), Cytochrome P-450 CYP1A2 Inducers (moderate), Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Cytochrome P-450 CYP1A2 Inhibitors (weak), OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A5 Inhibitors, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, UGT1A1 Inhibitors, Poly(ADP-ribose) Polymerase Inhibitors, OAT1/SLC22A6 inhibitors, Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index, Heterocyclic Compounds, Fused-Ring, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP3A7 Inhibitors, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP1A2 Inducers, MATE 2 Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors (weak), Cytochrome P-450 CYP2D6 Substrates, OAT3/SLC22A8 Inhibitors, P-glycoprotein inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved, investigational	3
DB14992	Pegunigalsidase alfa	Drug	0	investigational	0
DB12331	Labetuzumab govitecan	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB11000	Influenza B virus B/Massachusetts/2/2012 antigen (MDCK cell derived, propiolactone inactivated)	Drug	0	approved	0
DB13661	Niridazole	Drug	Sulfur Compounds, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Imidazoles, Antitrematodals, Thiazoles, Anthelmintics, Antiplatyhelmintic Agents, Schistosomicides, Anti-Infective Agents, Antiparasitic Agents, Amebicides	experimental	0
DB11003	Anthrax vaccine	Drug	Live vaccines, Live Attenuated Bacillus Anthracis Vaccine, Actively Acquired Immunity, Vaccines, Attenuated, Anthrax Vaccines, Vaccines	approved	0
DB12334	Milataxel	Drug	Cycloparaffins, Taxoids, Cyclodecanes, Diterpenes, Terpenes	investigational	2
DB13666	Tiemonium iodide	Drug	Anticholinergic Agents, Synthetic Anticholinergics, Quaternary Ammonium Compounds, Oxazines, Alimentary Tract and Metabolism, Agents producing tachycardia, Drugs for Functional Gastrointestinal Disorders, Muscarinic Antagonists	experimental	0
DB14997	Pateclizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Arthritis, Rheumatoid, drug therapy, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Lymphotoxin-alpha, antagonists & inhibitors, Immunoproteins	investigational	0
DB13667	Cefozopran	Drug	Fourth-Generation Cephalosporins, Nephrotoxic agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Antibacterials for Systemic Use	experimental	0
DB12333	SPK-843	Drug	Alkenes, Hydrocarbons, Acyclic	investigational	0
DB11002	Influenza B virus B/Utah/9/2014 antigen (MDCK cell derived, propiolactone inactivated)	Drug	0	approved	0
DB14998	Olorinab	Drug	0	investigational	0
DB13664	Formocortal	Drug	Ophthalmologicals, Corticosteroids, Immunosuppressive Agents, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Sensory Organs	experimental	0
DB12336	GDC-0917	Drug	0	investigational	0
DB11005	Ulmus parvifolia pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB14995	NP-G2-044	Drug	0	investigational	0
DB14996	Sutimlimab	Drug	0	investigational	0
DB12335	Tanezumab	Drug	Immunoglobulins, Sensory System Agents, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins, Peripheral Nervous System Agents, Proteins, Serum Globulins, Analgesics, Globulins, Blood Proteins, Central Nervous System Agents, Receptor, Nerve Growth Factor, antagonists & inhibitors	investigational	0
DB11004	Betula pendula pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB13665	Fluanisone	Drug	Psycholeptics, Tranquilizing Agents, Antipsychotic Agents, Ketones, Nervous System, Central Nervous System Depressants, Hypnotics and Sedatives, Central Nervous System Agents, Butyrophenone Derivatives, Psychotropic Drugs, Neurotoxic agents	experimental	0
DB12338	Carisbamate	Drug	Acids, Acyclic, Anticonvulsants, Nervous System, Central Nervous System Depressants	investigational	0
DB11007	Cytisus scoparius flowering top	Drug	Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11006	Parkinsonia florida pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB12337	N-acetylsulfanilyl chloride	Drug	0	investigational	0
DB13668	Ipidacrine	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Cholinesterase Inhibitors, Nervous System, Anti-Dementia Drugs, Psychoanaleptics	experimental	0
DB14999	Human interferon beta	Drug	Proteins, Biological Factors, Immunologic Factors, Peptides, Interferons, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Experimental Unapproved Treatments for COVID-19, Anti-Infective Agents, Interferon Type I	approved, investigational	1
DB11009	Quahog, unspecified	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11008	Poultry	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB12339	Radezolid	Drug	Anti-Bacterial Agents, Oxazoles, Anti-Infective Agents	investigational	2
DB13669	Morpholine	Drug	Oxazines, Analgesics, Nervous System, Salicylic Acid and Derivatives	experimental	0
DB01684	1-Hydroxy-1-Thio-Glycerol	Drug	0	experimental	1
DB00352	Tioguanine	Drug	Heterocyclic Compounds, Fused-Ring, Purines, Thiopurine Analogs, Immunosuppressive Agents, Noxae, Purine Analogues, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Toxic Actions, Antimetabolites, Myelosuppressive Agents	approved	1
DB01683	Chymostatin	Drug	Enzyme Inhibitors, Peptides, Protease Inhibitors, Amino Acids, Peptides, and Proteins, Chymotrypsin, antagonists & inhibitors, Serine Protease Inhibitors	experimental	1
DB00353	Methylergometrine	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Genito Urinary System and Sex Hormones, Reproductive Control Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Ergolines, Uterotonic agents, Ergot Alkaloids and Derivatives, Alkaloids, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Agents that produce hypertension, Cytochrome P-450 CYP3A4 Inhibitors, Ergonovine, Dopamine Antagonists	approved	2
DB00350	Minoxidil	Drug	Antihypertensive Agents Indicated for Hypertension, Pyrimidine Derivatives, Dermatologicals, Cardiovascular Agents, Hypotensive Agents, Direct Vasodilators, Misc. Skin and Mucous Membrane Agents, Arteriolar Vasodilator, Pyrimidines, UGT1A1 Substrates, Piperidines, Arteriolar Smooth Muscle, Agents Acting On, Arteriolar Vasodilation, Antihypertensive Agents, Vasodilating Agents	approved, investigational	3
DB01682	6'-Methyl-Thiamin Diphosphate	Drug	0	experimental	0
DB00351	Megestrol acetate	Drug	Appetite Stimulants, Endocrine Therapy, Sex Hormones and Modulators of the Genital System, Central Nervous System Stimulants, Cytochrome P-450 Substrates, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, Megestrol, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Contraceptives, Oral, Hormones and Related Agents, Contraceptives, Oral, Synthetic, Progestogens and Estrogens, Sequential Preparations, Hormonal Contraceptives for Systemic Use, Contraceptive Agents, Female, Antineoplastic Agents, Hormonal, Pregnadienes, Antineoplastic and Immunomodulating Agents, Reproductive Control Agents, Antineoplastic Agents, Pregnadien Derivatives, Cytochrome P-450 CYP3A Substrates, Progestins, Pregnanes, Combination Contraceptives (with Estrogen and derivatives), Central Nervous System Agents, P-glycoprotein inhibitors, Hyperglycemia-Associated Agents, Progestin Contraceptives, Steroids	approved, investigational, vet_approved	2
DB01681	Benzene Hexacarboxylic Acid	Drug	Acids, Carbocyclic, Benzene Derivatives	experimental	1
DB00356	Chlorzoxazone	Drug	Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Oxazol, Thiazine, and Triazine Derivatives, Centrally-mediated Muscle Relaxation, Cytochrome P-450 CYP3A4 Substrates, Muscle Relaxants, Benzoxazoles, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Musculo-Skeletal System, Muscle Relaxants, Centrally Acting Agents, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2A6 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved	1
DB01688	P-Cresol	Drug	Phenols, Benzene Derivatives	experimental	1
DB00357	Aminoglutethimide	Drug	Endocrine Therapy, Antineoplastic Agents, Hormonal, Enzyme Inhibitors, Steroid Synthesis Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP2C19 Inducers (strength unknown), Antineoplastic Agents, Hormone Antagonists and Related Agents, Piperidones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Aromatase Inhibitors, Cytochrome P-450 Enzyme Inducers, Estrogen Antagonists, Cytochrome P-450 CYP2C19 Inducers, Piperidines, Hormone Antagonists	approved, investigational	2
DB01687	beta-Mannobiose	Drug	0	experimental	0
DB01686	N,N-dimethylarginine	Drug	Enzyme Inhibitors, Nitric Oxide Synthase, antagonists & inhibitors, Amino Acids, Basic, Amino Acids, Essential, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	2
DB00354	Buclizine	Drug	Anticholinergic Agents, Neurotransmitter Agents, QTc Prolonging Agents, Histamine H1 Antagonists, Piperazine Derivatives, Histamine Antagonists, Agents producing tachycardia, Potential QTc-Prolonging Agents, Muscarinic Antagonists, Histamine Agents, Antihistamines for Systemic Use	approved	2
DB00355	Aztreonam	Drug	Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Monobactam Antibacterial, Amides, Lactams, Monobactams, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use, Drugs that are Mainly Renally Excreted	approved	2
DB01685	Topiroxostat	Drug	Enzyme Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, BCRP/ABCG2 Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Drugs that are Mainly Renally Excreted, OAT1/SLC22A6 inhibitors, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, UGT1A9 Substrates, Cytochrome P-450 CYP2C8 Inhibitors (moderate), OAT3/SLC22A8 Inhibitors	experimental	1
DB00358	Mefloquine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Quinolines, QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Antimalarials, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Potential QTc-Prolonging Agents, Agents that reduce seizure threshold, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Cholinesterase Inhibitors, P-glycoprotein substrates, Methanolquinolines, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors, Antiparasitic Agents, Aminoquinolines, Cytochrome P-450 CYP2D6 Inhibitors (weak)	approved, investigational	3
DB01689	Inhibitor Idd 384	Drug	0	experimental	1
DB00359	Sulfadiazine	Drug	Coccidiostats, Amines, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Aniline Compounds, Genito Urinary System and Sex Hormones, Hypoglycemia-Associated Agents, Amides, Sulfanilamides, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, SULFONAMIDES AND TRIMETHOPRIM, Anti-Bacterial Agents, Sulfur Compounds, Sulfonamide Antibacterial, Cytochrome P-450 CYP2C9 Inhibitors, Intermediate-Acting Sulfonamides, Cytochrome P-450 CYP2C8 Substrates, Sulfones, Antiprotozoals, Gynecological Antiinfectives and Antiseptics, Blood Glucose Lowering Agents, Antiinfectives for Systemic Use, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Sulfonamides, Methemoglobinemia Associated Agents, Antibacterials for Systemic Use, Antiparasitic Agents	approved, investigational, vet_approved	1
DB14990	Bazlitoran	Drug	0	investigational	0
DB13673	Bekanamycin	Drug	Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Nephrotoxic agents, Carbohydrates, Anti-Bacterial Agents, Narrow Therapeutic Index Drugs, Aminoglycoside Antibacterials, Glycosides, Agents that produce neuromuscular block (indirect), Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use, Drugs that are Mainly Renally Excreted	experimental	0
DB11010	Cod, unspecified	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB12341	LY-2456302	Drug	Opioid Antagonists, Benzoates, Sensory System Agents, Acids, Carbocyclic, Amides, Central Nervous System Agents, Benzene Derivatives, Peripheral Nervous System Agents	investigational	0
DB12340	Navitoclax	Drug	Sulfur Compounds, Amines, Antineoplastic Agents, Amides, Sulfones	investigational	3
DB13674	Cridanimod	Drug	Heterocyclic Compounds, Fused-Ring, Immunologic Factors, Adjuvants, Immunologic, Antineoplastic and Immunomodulating Agents, Interferon Inducers	experimental	0
DB12343	Temocillin	Drug	Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Penicillins With Extended Spectrum, Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use	approved, investigational	0
DB13671	Sulbentine	Drug	Antifungals for Topical Use, Dermatologicals, Antifungals for Dermatological Use	experimental	0
DB12342	Ensituximab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB11011	Crab leg	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB13672	Dimethylaminopropionylphenothiazine	Drug	Synthetic Antispasmodics, Amides With Tertiary Amines, Alimentary Tract and Metabolism, Drugs for Functional Gastrointestinal Disorders	experimental	0
DB12345	MBX-2982	Drug	Sulfur Compounds	investigational	0
DB13677	Carboquone	Drug	Alkylating Drugs, Quinones, Aziridines, Noxae, Ethylene Imines, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Toxic Actions, Azirines, Benzoquinones, Antineoplastic Agents, Alkylating	experimental	0
DB11014	Salmon, unspecified	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB13678	Dihexyverine	Drug	Anticholinergic Agents, Alimentary Tract and Metabolism, Agents producing tachycardia, Drugs for Functional Gastrointestinal Disorders, Muscarinic Antagonists, Synthetic Anticholinergics, Esters With Tertiary Amino Group	experimental	0
DB12344	Fezakinumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Dermatologicals, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB13675	Metahexamide	Drug	Cytochrome P-450 CYP2C9 Substrates, Sulfur Compounds, Cytochrome P-450 Substrates, Alimentary Tract and Metabolism, Sulfonylureas, Drugs Used in Diabetes, Blood Glucose Lowering Agents, Sulfones	experimental	0
DB12347	CG-400549	Drug	Sulfur Compounds	investigational	0
DB13676	Mosapramine	Drug	Heterocyclic Compounds, Fused-Ring, Psycholeptics, Antipsychotic Agents, Nervous System, Central Nervous System Depressants, Neurotoxic agents	experimental	0
DB12346	Vatelizumab	Drug	0	investigational	0
DB11018	Canis lupus familiaris dander	Drug	Cell-mediated Immunity, Non-Standardized Animal Dander Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB12349	Dulanermin	Drug	Proteins, Biological Factors, Cytokines, Peptides, Intercellular Signaling Peptides and Proteins, Tumor Necrosis Factors, Amino Acids, Peptides, and Proteins, Recombinant Proteins	investigational	0
DB12348	5-amino-1,3,4-thiadiazole-2-thiol	Drug	Sulfur Compounds, Thiazoles	investigational	0
DB11017	Yeast	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased Histamine Release	approved	0
DB13679	Dexchlorpheniramine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Pyridines, QTc Prolonging Agents, Cytochrome P-450 Substrates, Substituted Alkylamines, Cytochrome P-450 Enzyme Inhibitors, Stereoisomerism, Moderate Risk QTc-Prolonging Agents, Neurotransmitter Agents, Histamine H1 Antagonists, Histamine Antagonists, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2D6 Substrates, Histamine Agents, Antihistamines for Systemic Use, Agents that reduce seizure threshold	investigational, experimental	0
DB11019	Cavia porcellus dander	Drug	Cell-mediated Immunity, Non-Standardized Animal Dander Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB01691	Indole Naphthyridinone	Drug	0	experimental	1
DB01690	Bis(Adenosine)-5'-Triphosphate	Drug	0	experimental	1
DB00360	Sapropterin	Drug	Biological Factors, Coenzymes, Amines, Various Alimentary Tract and Metabolism Products, Enzymes and Coenzymes, Other Miscellaneous Therapeutic Agents, Phenylalanine Hydroxylase Activators, Phenethylamines, Pteridines, Supplements, Pigments, Biological, Heterocyclic Compounds, Fused-Ring, Ethylamines, Pterins, Alimentary Tract and Metabolism, Breast Cancer Resistance Protein Inhibitors, Nitric Oxide Synthase, P-glycoprotein inhibitors, Dietary Supplements, Phenylalanine Hydroxylase Activator	approved, investigational	4
DB01695	N-Hydroxy-4-Phosphono-Butanamide	Drug	0	experimental	1
DB00363	Clozapine	Drug	Psycholeptics, Tranquilizing Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Diazepines, Oxazepines, Thiazepines and Oxepines, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Drugs that are Mainly Renally Excreted, Anticholinergic Agents, Serotonin 5-HT2 Receptor Antagonists, Cytochrome P-450 CYP2C8 Substrates, Dopamine Antagonists, Agents that reduce seizure threshold, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A4 Inducers, Agents producing tachycardia, Cytochrome P-450 CYP2C19 Substrates, Neurotransmitter Agents, Photosensitizing Agents, Central Nervous System Depressants, Cytochrome P-450 CYP2A6 Substrates, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), UGT1A4 substrates, Cytochrome P-450 CYP2C19 Inhibitors (weak), Cytochrome P-450 CYP2D6 Substrates, Dopamine D2 Receptor Antagonists, Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Serotonin Agents, Nervous System, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Cytochrome P-450 CYP2C19 Inhibitors, Hypotensive Agents, Muscarinic Antagonists, Antidepressive Agents, Cytochrome P-450 CYP1A2 Inhibitors, Antipsychotic Agents, Cytochrome P-450 Enzyme Inducers, Histamine H1 Antagonists, Antipsychotic Agents (Second Generation Atypical), Adrenergic Antagonists, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Adrenergic alpha-1 Receptor Antagonists, Drugs causing inadvertant photosensitivity, Neurotoxic agents, Adrenergic alpha-Antagonists, GABA Agents, P-glycoprotein substrates, Dibenzazepines, Moderate Risk QTc-Prolonging Agents, Psychotropic Drugs, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Serotonin Receptor Antagonists, Central Nervous System Agents, Hyperglycemia-Associated Agents, GABA Antagonists	approved	27
DB01694	D-tartaric acid	Drug	0	experimental	13
DB00364	Sucralfate	Drug	Carbohydrates, Anti-Ulcer Agents, Aluminum Complex, Protectants, Drugs that are Mainly Renally Excreted, Thioglycosides, Organometallic Compounds, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Sulfur Compounds, Metal cations, Alimentary Tract and Metabolism, Metal divalent cations, Glycosides, Aluminium Compounds, Drugs for Acid Related Disorders, Gastrointestinal Agents	approved	4
DB00361	Vinorelbine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Antineoplastic Agents, Phytogenic, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Tubulin Modulators, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Vinca Alkaloids, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Mitosis Modulators, Cardiotoxic antineoplastic agents, Cytochrome P-450 CYP3A4 Substrates, Secologanin Tryptamine Alkaloids, Indole Alkaloids, Myelosuppressive Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Antimitotic Agents, Indoles, Cytochrome P-450 CYP2D6 Inhibitors (weak), Neurotoxic agents	approved, investigational	1
DB00362	Anidulafungin	Drug	Peptides, Cyclic, Peptides, Antimycotics for Systemic Use, Echinocandins, Amino Acids, Peptides, and Proteins, Antifungal Agents, Antiinfectives for Systemic Use, Echinocandin Antifungal, Anti-Infective Agents	approved, investigational	1
DB01692	Dithioerythritol	Drug	Carbohydrates, Sulfur Compounds, Laboratory Chemicals, Sugar Alcohols, Glycosides, Indicators and Reagents, Compounds used in a research, industrial, or household setting, Alcohols, Sulfhydryl Reagents, Thioglycosides	experimental	3
DB01699	(4e)-4-Aminohex-4-Enoic Acid	Drug	0	experimental	1
DB00367	Levonorgestrel	Drug	Progestin-containing Intrauterine Device, Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Contraceptives, Oral, Contraceptives, Oral, Synthetic, Progestogens and Estrogens, Sequential Preparations, Norpregnenes, Hormonal Contraceptives for Systemic Use, Norpregnanes, Contraceptive Agents, Female, Cytochrome P-450 CYP3A5 Substrates, Contraceptives, Postcoital, Norsteroids, Reproductive Control Agents, Inhibit Ovum Fertilization, Cytochrome P-450 CYP3A Substrates, Progestins, Combination Contraceptives (with Estrogen and derivatives), Hyperglycemia-Associated Agents, Progestin Contraceptives, Steroids	approved, investigational	6
DB01698	Rutin	Drug	Flavonols, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Benzopyrans, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Heterocyclic Compounds, Fused-Ring, Vasoprotectives, Flavonoids, Cytochrome P-450 CYP3A Inhibitors, Capillary Stabilizing Agents, Cytochrome P-450 CYP3A4 Inhibitors, Chromones, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Pyrans	approved, investigational, experimental	2
DB00368	Norepinephrine	Drug	OCT1 substrates, Amines, OCT2 Substrates, Adrenergic alpha-1 Receptor Agonists, Cardiovascular Agents, Adrenergic beta-2 Receptor Agonists, Alcohols, Peripheral Nervous System Agents, Adrenergic alpha-2 Receptor Agonists, Adrenergic beta-1 Receptor Agonists, Alpha-and Beta-adrenergic Agonists, Biogenic Amines, COMT Substrates, Adrenergic Agents, Benzene Derivatives, Autonomic Agents, Adrenergic alpha-Agonists, Epinephrine and similars, Norepinephrine, antagonists & inhibitors, Agents producing tachycardia, Catecholamines, Catechols, Adrenergic and Dopaminergic Agents, Amino Alcohols, Ethanolamines, Biogenic Monoamines, Adrenergic beta-Agonists, Neurotransmitter Agents, Sympathomimetics, OCT2 Inhibitors, Vasoconstrictor Agents, Adrenergic Agonists, Cardiac Stimulants Excl. Cardiac Glycosides, Agents that produce hypertension, Phenols, Cardiac Therapy, Adrenergic beta-3 Receptor Agonists	approved	12
DB00365	Grepafloxacin	Drug	Fluoroquinolones, Quinolines, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, P-glycoprotein substrates, OAT1/SLC22A6 Substrates, Cytochrome P-450 CYP3A4 Substrates, Antiinfectives for Systemic Use, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Anti-Infective Agents, Quinolones, Cytochrome P-450 CYP1A2 Inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Cytochrome P-450 CYP3A Substrates, OCT2 Inhibitors, Topoisomerase II Inhibitors, Cytochrome P-450 CYP1A2 Substrates, P-glycoprotein inhibitors, Antibacterials for Systemic Use	approved, investigational, withdrawn	2
DB01697	beta-cellotriose	Drug	0	experimental	0
DB00366	Doxylamine	Drug	Autonomic Agents, Pyridines, QTc Prolonging Agents, Ethanolamine Derivatives, Agents producing tachycardia, Muscarinic Antagonists, Peripheral Nervous System Agents, Anticholinergic Agents, Neurotransmitter Agents, Histamine H1 Antagonists, Histamine Antagonists, Central Nervous System Depressants, Histamine Receptor Antagonists, Antiemetics, Potential QTc-Prolonging Agents, Central Nervous System Agents, Histamine Agents, Aminoalkyl Ethers, Antihistamines for Systemic Use, Gastrointestinal Agents	approved, vet_approved	3
DB00369	Cidofovir	Drug	Nephrotoxic agents, Enzyme Inhibitors, Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors, Pyrimidinones, Organophosphorus Compounds, Antiviral Agents, OAT1/SLC22A6 Substrates, Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, OAT1/SLC22A6 inhibitors, Organophosphonates, Antivirals for Systemic Use, Direct Acting Antivirals, Nucleic Acid Synthesis Inhibitors, Pyrimidines, Cytosine, Nucleosides and Nucleotides, Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor	approved	1
DB13670	Oxantel	Drug	Pyrimidines, Sulfur Compounds, Antiparasitic Products, Insecticides and Repellents, Thiophenes, Tetrahydropyrimidine Derivatives, Anthelmintics, Anti-Infective Agents, Antinematodal Agents, Antiparasitic Agents	experimental	0
DB12396	Fresolimumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB11065	Pancrelipase amylase	Drug	Enzymes, Amylases, Amylases, antagonists & inhibitors, Glycoside Hydrolases, alpha-Amylases, antagonists & inhibitors, Enzymes and Coenzymes, Hydrolases	approved	1
DB11064	Homosalate	Drug	Radiation-Protective Agents, Benzoates, Hydroxy Acids, Protective Agents, Acids, Carbocyclic, Dermatologicals, Hydroxybenzoates, Household Products, Phenols, Cosmetics, Sunscreen Agents, Compounds used in a research, industrial, or household setting, Benzene Derivatives	approved, investigational	3
DB12395	Esreboxetine	Drug	Oxazines, Adrenergic Uptake Inhibitors, Central Nervous System Depressants, Antidepressive Agents	investigational	0
DB12398	Naproxen etemesil	Drug	0	investigational	0
DB11067	Heme iron polypeptide	Drug	0	investigational	0
DB12397	DSM-265	Drug	0	investigational	0
DB11066	Pancrelipase protease	Drug	0	approved	1
DB11069	Schizochytrium DHA oil	Drug	0	experimental	0
DB11068	Selenic acid	Drug	Protective Agents, Mineral Supplements, Antioxidants, Trace Elements, Micronutrients, Physiological Phenomena, Alimentary Tract and Metabolism, Food and Beverages, Growth Substances, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food, Selenium Compounds	approved	0
DB12399	Polmacoxib	Drug	Anti-Inflammatory Agents, Non-Steroidal, Sulfur Compounds, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, COX-2 Inhibitors, Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Musculo-Skeletal System, Amides, Selective Cyclooxygenase 2 Inhibitors (NSAIDs), Sulfones	investigational	0
DB12390	MBX-8025	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, PPAR delta, agonists, Lipids	investigational	0
DB11061	Povidone	Drug	Alkenes, Hydrocarbons, Acyclic, Biomimetic Materials, Hematologic Agents, Vinyl Compounds, Artificial Tears, Pharmaceutic Aids, Macromolecular Substances, Plasma Substitutes, Pyrrolidinones, Polyenes, Polyvinyls, Pyrrolidines, Pharmaceutical Preparations, Blood Substitutes, Plastics, Polymers, Compounds used in a research, industrial, or household setting	approved	0
DB12392	Resminostat	Drug	Sulfur Compounds, Amines, Hydroxy Acids, Hydroxylamines, Amides, Sulfones	investigational	0
DB11060	Polyvinyl alcohol	Drug	EENT Drugs, Miscellaneous, Alkenes, Hydrocarbons, Acyclic, Polyenes, Polyvinyls, Vinyl Compounds, Plastics, Polymers, Artificial Tears, Compounds used in a research, industrial, or household setting, Alcohols, Macromolecular Substances	approved	0
DB12391	Sagopilone	Drug	Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Polyketides, Sulfur Compounds, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Cytochrome P-450 CYP3A4 Inhibitors, Thiazoles, Antineoplastic Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Lactones	investigational	0
DB12394	Eleclazine	Drug	Azepines	investigational	0
DB11063	Polysorbate 80	Drug	Surface-Active Agents, Excipients, Polyethylene Glycols, Artificial Tears, Pharmaceutic Aids, Alcohols, Drug Delivery Systems, Macromolecular Substances, Ethylene Glycols, Glycols, Pharmaceutical Preparations, Polymers, Compounds used in a research, industrial, or household setting, Pharmaceutical Vehicles	approved	0
DB11062	Octisalate	Drug	Radiation-Protective Agents, Benzoates, Hydroxy Acids, Protective Agents, Acids, Carbocyclic, Dermatologicals, Hydroxybenzoates, Household Products, Phenols, Cosmetics, Sunscreen Agents, Compounds used in a research, industrial, or household setting, Benzene Derivatives	approved, investigational	0
DB12393	Fanapanel	Drug	Heterocyclic Compounds, Fused-Ring, Organophosphorus Compounds	investigational	0
DB11075	Hypromellose	Drug	Carbohydrates, Other Diagnostics, Surgical Aids, Cellulose, Viscoelastic Substances, Artificial Tears, Biopolymers, Macromolecular Substances, Ophthalmologicals, EENT Drugs, Miscellaneous, Polysaccharides, Glucans, Sensory Organs, Polymers, Compounds used in a research, industrial, or household setting	approved	1
DB11077	Polyethylene glycol 400	Drug	EENT Drugs, Miscellaneous, Ethylene Glycols, Pegylated agents, Glycols, P-glycoprotein inhibitors, Polymers, Compounds used in a research, industrial, or household setting, Drugs that are Mainly Renally Excreted, Alcohols, Macromolecular Substances	approved	2
DB11079	Trolamine salicylate	Drug	Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Benzoates, Hydroxy Acids, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Hydroxybenzoates, Non COX-2 selective NSAIDS, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Phenols, Salicylates, Sunscreen Agents, Benzene Derivatives	approved	2
DB11072	Hydrogen fluoride	Drug	Acids, Noncarboxylic, Acids, Dental Agents, Fluorine Compounds	approved, investigational	0
DB11071	Phenyl salicylate	Drug	Benzoates, Hydroxy Acids, Acids, Carbocyclic, Genito Urinary System and Sex Hormones, Urologicals, Hydroxybenzoates, Phenols, Benzene Derivatives	approved	2
DB11074	Dimethicone	Drug	Basic Ointments and Protectants, Siloxanes, Scabicides and Pediculicides, Antifoaming Agents, Misc. Skin and Mucous Membrane Agents, Polymers, Compounds used in a research, industrial, or household setting, Organosilicon Compounds, Silicones, Silicon Compounds, Macromolecular Substances, Skin Barrier Activity	approved	0
DB11073	Cetylpyridinium	Drug	Surface-Active Agents, Pyridines, Blood and Blood Forming Organs, Pyridinium Compounds, Medicated Dressings, Mouthwashes and Gargles, Quaternary Ammonium Compounds, Antiseptics and Disinfectants, Dermatologicals, Blood Substitutes and Perfusion Solutions, Detergents, Irrigating Solutions, Anti-Infective Agents, Anti-Infective Agents, Local, Household Products, Medicated Dressings With Antiinfectives, Throat Preparations, Miscellaneous Anti-infectives, Compounds used in a research, industrial, or household setting	approved	0
DB11087	Pyrethrum extract	Drug	Agrochemicals, Pyrethrins, Pesticides, Insecticides, Toxic Actions, Monoterpenes, Terpenes, Compounds used in a research, industrial, or household setting	approved	1
DB11086	Cocoa butter	Drug	Physiological Phenomena, Antipruritics and Local Anesthetics, Food and Beverages, Lipids, Fats, Diet, Food, and Nutrition, Food	approved	0
DB11089	Docusate	Drug	Surface-Active Agents, Softener and Emollient Laxatives, Succinates, Alimentary Tract and Metabolism, Softeners, Emollients, Drugs for Constipation, Laxatives, Enemas	approved	0
DB11088	Shark liver oil	Drug	0	experimental	0
DB11081	Aluminum chloride	Drug	Astringents and Deodorants, Dermatologicals, Ions, Antiperspirants, Anti-Acne Preparations, Household Products, Anions, Acids, Noncarboxylic, Metal cations, Acids, Metal divalent cations, Chlorides, Dental Agents, Aluminium Compounds, Cosmetics, Electrolytes, Compounds used in a research, industrial, or household setting, Anti-Acne Preparations for Topical Use, Chlorine Compounds	approved, investigational	1
DB11080	Silver nitrate	Drug	Antiseptics and Disinfectants, Dermatologicals, Ions, Nitrates, Anti-Infective Agents, Anti-Infective Agents, Local, Anions, Acids, Noncarboxylic, Acids, Silver Compounds, Electrolytes, Nitric Acid, Nitrogen Compounds	approved, investigational	0
DB11082	Coal tar	Drug	Complex Mixtures, Keratoplastic Agents, Dermatologicals, Tars, Keratolytic Agents	approved	0
DB11085	Resorcinol	Drug	Ophthalmologicals, Dermatologicals, Phenols, Root Canal Filling Materials, Sensory Organs, Anti-Acne Preparations, Anti-Acne Preparations for Topical Use, Anti-Infective Agents, Benzene Derivatives, Drugs that are Mainly Renally Excreted	approved	1
DB11098	Potassium bicarbonate	Drug	Alkalies, Potassium Salt, Agents causing hyperkalemia, Ions, Carbonic Acid, Mineral Supplements, Carbon Compounds, Inorganic, Drugs that are Mainly Renally Excreted, Anions, Acids, Noncarboxylic, Acids, Alimentary Tract and Metabolism, Electrolytes, Carbonates	approved	1
DB11097	Plantago seed	Drug	Complex Mixtures, Plant Preparations, Plant Extracts, Biological Products, Herbs and Natural Products, Laxatives, Pharmaceutical Preparations, Bulk-Forming Laxatives, Gastrointestinal Agents	approved, investigational	0
DB11099	Crypthecodinium cohnii DHA oil	Drug	0	experimental	0
DB11090	Potassium nitrate	Drug	Potassium Salt, Anions, Explosive Agents, Acids, Noncarboxylic, Acids, Electrolytes, Ions, Nitric Acid, Compounds used in a research, industrial, or household setting, Drugs that are Mainly Renally Excreted, Nitrogen Compounds	approved	1
DB11092	Stannous fluoride	Drug	Alimentary Tract and Metabolism, Compounds used in a research, industrial, or household setting, Stomatological Preparations, Caries Prophylactic Agents	approved	0
DB11091	Hydrogen peroxide	Drug	Reactive Oxygen Species, Free Radicals, Noxae, Antiseptics and Disinfectants, Dermatologicals, Otologicals, Ions, Oxides, Anti-Infective Agents, Anti-Infective Agents, Local, Antifibrinolytic Agents, Anions, Antiinfectives and Antiseptics for Local Oral Treatment, Oxidants, Alimentary Tract and Metabolism, Electrolytes, Toxic Actions, Peroxides, Sensory Organs, Compounds used in a research, industrial, or household setting, Oxygen Compounds, Stomatological Preparations	approved, vet_approved	0
DB11094	Vitamin D	Drug	Secosteroids, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Vitamins, Micronutrients, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Physiological Phenomena, Cytochrome P-450 CYP3A Substrates, Vitamin D and Analogues, Vitamins (Fat Soluble), Food and Beverages, Bone Density Conservation Agents, Growth Substances, Diet, Food, and Nutrition, Food, Steroids	approved, nutraceutical, vet_approved	2
DB11093	Calcium citrate	Drug	Food Additives, Acids, Acyclic, Phosphate Binder, Calcium Compounds, Citrates, Blood Coagulation Factors, Mineral Supplements, Calcium Salts, Tricarboxylic Acids, Physiological Phenomena, Alimentary Tract and Metabolism, Food and Beverages, Food Ingredients, Polyvalent cation containing laxatives, antacids, oral supplements, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food	approved, investigational	33
DB11096	Meradimate	Drug	Aminobenzoates, Benzoates, Acids, Carbocyclic, Sunscreen Agents, Benzene Derivatives	approved	0
DB11095	Desirudin	Drug	Anticoagulants, Enzyme Inhibitors, Blood and Blood Forming Organs, Peptides, Fibrin Modulating Agents, Protease Inhibitors, Serpins, Amino Acids, Peptides, and Proteins, Hematologic Agents, Cardiovascular Agents, Proteins, Antithrombins, Thrombin Inhibitors, Antithrombin Proteins, Serine Protease Inhibitors	approved	0
DB13721	Cypermethrin	Drug	Insecticides and Repellents, Antiparasitic Products, Insecticides and Repellents, Agrochemicals, Pyrethrines, Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents, Pesticides, Insecticides, Toxic Actions, Monoterpenes, Terpenes, Compounds used in a research, industrial, or household setting	experimental	0
DB13722	Pirprofen	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Sensory System Agents, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Musculo-Skeletal System, Propionates, Agents that produce hypertension, Central Nervous System Agents	experimental	0
DB13720	Diphemanil	Drug	Anticholinergic Agents, Autonomic Agents, Synthetic Anticholinergics, Quaternary Ammonium Compounds, Alimentary Tract and Metabolism, Anti-Asthmatic Agents, Agents producing tachycardia, Parasympatholytics, Drugs for Functional Gastrointestinal Disorders, Muscarinic Antagonists, Bronchodilator Agents, Respiratory System Agents, Peripheral Nervous System Agents	approved, withdrawn, vet_approved	1
DB13725	Terodiline	Drug	Autonomic Agents, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Agents causing hyperkalemia, Drugs for Urinary Frequency and Incontinence, Genito Urinary System and Sex Hormones, Hydrocarbons, Acyclic, Urologicals, Alkanes, Parasympatholytics, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Butanes, Membrane Transport Modulators, Peripheral Nervous System Agents, Calcium Channel Blockers, Cytochrome P-450 CYP3A Substrates, Calcium-Regulating Hormones and Agents, Vasodilating Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	experimental	0
DB13726	Sulfaguanidine	Drug	Amines, Aniline Compounds, Amides, Amidines, Guanidines, Sulfanilamides, Anti-Infective Agents, Sulfur Compounds, Intestinal Antiinfectives, Alimentary Tract and Metabolism, Sulfonamides, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Sulfones	experimental	0
DB13723	Meldonium	Drug	Hydrazines, Immunologic Factors, Adjuvants, Immunologic, Cardiovascular Agents, Cardiac Therapy	experimental	0
DB13724	Nifuratel	Drug	Antiprotozoals, Oxazoles, Gynecological Antiinfectives and Antiseptics, Oxazolidinones, Genito Urinary System and Sex Hormones, Nitro Compounds, Nitrofurans, Antifungal Agents, Antitrichomonal Agents, Furans, Anti-Infective Agents, Antiparasitic Agents	experimental	0
DB13729	Camostat	Drug	Antifibrinolytic Agents, Enzyme Inhibitors, Blood and Blood Forming Organs, Protease Inhibitors, Amidines, Guanidines, Hemostatics, Proteinase Inhibitors, Serine Protease Inhibitors, Trypsin Inhibitors	experimental	4
DB13727	Azapetine	Drug	Heterocyclic Compounds, Fused-Ring, Peripheral Vasodilators	experimental	0
DB13728	Halometasone	Drug	Corticosteroids, Dermatological Preparations, Pregnadienetriols, Corticosteroids, Immunosuppressive Agents, Glucocorticoids, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Dermatologicals, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Corticosteroids, Potent (Group III), Pregnanes, Steroids, Fluorinated, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inducers, Steroids	experimental	0
DB00411	Carbamoylcholine	Drug	Amines, Ammonium Compounds, Sensory System Agents, Nervous System, Trimethyl Ammonium Compounds, Onium Compounds, Cardiovascular Agents, Alcohols, Peripheral Nervous System Agents, Cholinergic Agents, Analgesics, Choline Esters, Compounds used in a research, industrial, or household setting, Nitrogen Compounds, Analgesics, Non-Narcotic, Autonomic Agents, Cholinergic Agonists, Antiglaucoma Preparations and Miotics, Cholinergic Receptor Agonist, Protective Agents, Quaternary Ammonium Compounds, Parasympathomimetics, Miotics, Amino Alcohols, Ethanolamines, Parasympathomemetic (Cholinergic) Agents, Cardiotonic Agents, Ophthalmologicals, Neurotransmitter Agents, Central Nervous System Agents, Sensory Organs	approved	6
DB00412	Rosiglitazone	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Hypoglycemia-Associated Agents, BSEP/ABCB11 Substrates, Cytochrome P-450 CYP2A6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP2A6 Inhibitors (strength unknown), Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP1A2 Inhibitors, Sulfur Compounds, Alimentary Tract and Metabolism, Thiazoles, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Drugs Used in Diabetes, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Substrates, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Peroxisome Proliferator Receptor gamma Agonist, Peroxisome Proliferator-activated Receptor Activity, Blood Glucose Lowering Agents, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, Vasodilating Agents, Thiazolidinediones	approved, investigational	7
DB01742	(3r)-1-Acetyl-3-Methylpiperidine	Drug	0	experimental	1
DB01741	CRA_17693	Drug	0	experimental	1
DB00410	Mupirocin	Drug	Epoxy Compounds, Enzyme Inhibitors, Antibiotics for Topical Use, Fatty Acids, RNA Synthetase Inhibitor Antibacterial, Dermatologicals, Lipids, RNA Synthetase Inhibitors, Anti-Infective Agents, Anti-Bacterial Agents, Nasal Preparations, Ethers, Protein Synthesis Inhibitors, Ethers, Cyclic, Pyrans	approved, investigational, vet_approved	1
DB01740	4-butyl-5-propyl-1,3-selenazol-2-amine	Drug	Selenium Compounds	experimental	0
DB01747	Coprogen	Drug	Siderophores, Amines, Hydroxy Acids, Hydroxylamines	experimental	1
DB00415	Ampicillin	Drug	Penicillins With Extended Spectrum, Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Penicillin G, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Ophthalmologicals, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Sensory Organs, Aminopenicillins, Antibacterials for Systemic Use	approved, vet_approved	8
DB01746	D-Leucine	Drug	0	experimental	0
DB00416	Metocurine iodide	Drug	Neuromuscular Agents, Drugs, Chinese Herbal, Amines, Ammonium Compounds, Benzylisoquinolines, Isoquinolines, Quaternary Ammonium Compounds, Neuromuscular-Blocking Agents (Nondepolarizing), Onium Compounds, Nicotinic Antagonists, Peripheral Nervous System Agents, Anticholinergic Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Central Nervous System Depressants, Neuromuscular Blocking Agents, Tetrahydroisoquinolines, Nitrogen Compounds	approved, withdrawn	1
DB00413	Pramipexole	Drug	OCT1 substrates, Nervous System, OCT2 Substrates, Hypotensive Agents, Nonergot-derivative Dopamine Receptor Agonists, Drugs that are Mainly Renally Excreted, Anti-Parkinson Drugs, Dopamine Agonists, Antioxidants, Anti-Dyskinesia Agents, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Sulfur Compounds, Thiazoles, Anti-Parkinson Agents (Dopamine Agonist), Restless Legs Syndrome, Central Nervous System Agents, Benzothiazoles, Dopamine Agents	approved, investigational	5
DB01745	N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester	Drug	0	experimental	1
DB00414	Acetohexamide	Drug	Cytochrome P-450 CYP2C9 Substrates, Sulfur Compounds, Cytochrome P-450 Substrates, Alimentary Tract and Metabolism, Sulfonylureas, Drugs Used in Diabetes, Blood Glucose Lowering Agents, Sulfones	approved, investigational, withdrawn	1
DB01744	Camphor	Drug	Bornanes, Ketones, Plant Extracts, Anti-Infective Agents, Anti-Infective Agents, Local, Basic Lotions and Liniments, Complex Mixtures, Antipruritics and Local Anesthetics, Plant Preparations, Biological Products, Monoterpenes, Pharmaceutical Preparations, Terpenes, Cardiac Therapy, Norbornanes	approved	5
DB00419	Miglustat	Drug	Carbohydrates, Glycoside Hydrolase Inhibitors, Enzyme Inhibitors, Glucosylceramide Synthase Inhibitors, Imino Pyranoses, Various Alimentary Tract and Metabolism Products, Other Miscellaneous Therapeutic Agents, Anti-HIV Agents, Imino Sugars, Anti-Infective Agents, Alkaloids, Glucosylceramide Synthase Inhibitor, Imines, Alimentary Tract and Metabolism, Piperidines, Gaucher Disease	approved	1
DB01749	1,2-Dimethoxyethane	Drug	Ethers	experimental	0
DB00417	Phenoxymethylpenicillin	Drug	Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Beta-Lactamase Sensitive Penicillins, Penicillin G, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Aza Compounds, Azabicyclo Compounds, Natural Penicillins, Antibacterials for Systemic Use	approved, vet_approved	5
DB00418	Secobarbital	Drug	Psycholeptics, Cytochrome P-450 CYP2C8 Inducers, Nervous System, GABA Modulators, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Cytochrome P-450 CYP2C19 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP2C9 Inducers (strength unknown), Drugs that are Mainly Renally Excreted, Anticholinergic Agents, Cytochrome P-450 Enzyme Inducers, Pyrimidines, Cytochrome P-450 CYP2C19 Inducers, Hypnotics and Sedatives, Barbiturates, Cytochrome P-450 CYP2C8 Inducers (strong), GABA Agents, Cytochrome P-450 CYP3A4 Inducers, Pyrimidinones, Adjuvants, Nicotinic Antagonists, Neurotransmitter Agents, Anticonvulsants, Central Nervous System Depressants, Barbiturates, Plain, Cytochrome P-450 CYP1A2 Inducers, Adjuvants, Anesthesia, Central Nervous System Agents, Cytochrome P-450 CYP2C9 Inducers	approved, vet_approved	11
DB01748	N-Benzyl-4-Sulfamoyl-Benzamide	Drug	0	experimental	1
DB12400	Voxtalisib	Drug	Phosphatidylinositol 3-Kinase, antagonists & inhibitors, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amides, Sulfones	investigational	0
DB13732	Meglumine antimoniate	Drug	Amino Sugars, Carbohydrates, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Agents Against Leishmaniasis and Trypanosomiasis, Sugar Alcohols, Hexosamines, Antimony Compounds, Anti-Infective Agents, Antiparasitic Agents, Alcohols	investigational, experimental	0
DB13733	Methylpentynol	Drug	Psycholeptics, Nervous System, Central Nervous System Depressants, Lipids, Hypnotics and Sedatives, Fatty Alcohols, Alcohols	experimental	0
DB12402	Pumosetrag	Drug	0	investigational	0
DB13730	Nifurtoinol	Drug	Renal Agents, Anti-Infective Agents, Urinary, Nitro Compounds, Nitrofuran Derivatives, Nitrofurans, Furans, Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use	experimental	0
DB13731	Butamirate	Drug	Cough and Cold Preparations, Acids, Carbocyclic	experimental	0
DB12401	Bromperidol	Drug	Psycholeptics, Tranquilizing Agents, Antipsychotic Agents, Ketones, Nervous System, Central Nervous System Depressants, Central Nervous System Agents, Butyrophenone Derivatives, Butyrophenones, Psychotropic Drugs, Neurotoxic agents	approved, investigational	0
DB13736	Fenoxazoline	Drug	Nasal Preparations, Sympathomimetics, Plain	experimental	0
DB12404	Remimazolam	Drug	Heterocyclic Compounds, Fused-Ring, Benzazepines	investigational	0
DB12403	Samarium	Drug	Lanthanoid Series Elements, Metals, Elements, Metals, Rare Earth	investigational	0
DB13737	Cyclobarbital	Drug	Psycholeptics, Pyrimidines, Nervous System, Central Nervous System Depressants, Barbiturates, Plain, Pyrimidinones, Hypnotics and Sedatives	experimental	0
DB13734	Biphenylol	Drug	Antiseptics and Disinfectants, Dermatologicals, Phenol and Derivatives	experimental	0
DB12406	Lisofylline	Drug	Analgesics, Non-Narcotic, Immunologic Factors, Cytochrome P-450 Substrates, Sensory System Agents, Adjuvants, Immunologic, Anti-Inflammatory Agents, Antirheumatic Agents, Radiation-Sensitizing Agents, Peripheral Nervous System Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Purines, Analgesics, Cytochrome P-450 CYP1A2 Substrates, Xanthine derivatives, Central Nervous System Agents, Purinones	investigational	0
DB13735	Potassium Guaiacolsulfonate	Drug	Potassium Salt, Methyl Ethers, Phenols, Catechols, Ethers, Benzene Derivatives, Phenyl Ethers	experimental	0
DB12405	Triciribine	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides	investigational	0
DB12408	PF-03635659	Drug	Acids, Carbocyclic, Phenylacetates, Azetines, Receptor, Muscarinic M3, antagonists & inhibitors	investigational	0
DB12407	Iobitridol	Drug	Iodobenzoates, Benzoates, Contrast Media, Diagnostic Uses of Chemicals, Acids, Carbocyclic, Triiodobenzoic Acids, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting, Benzene Derivatives, Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media	approved, investigational	0
DB13738	Camylofin	Drug	Anticholinergic Agents, Autonomic Agents, Alimentary Tract and Metabolism, Agents producing tachycardia, Amino Acids, Peptides, and Proteins, Parasympatholytics, Drugs for Functional Gastrointestinal Disorders, Muscarinic Antagonists, Synthetic Anticholinergics, Esters With Tertiary Amino Group, Amino Acids, Peripheral Nervous System Agents	experimental	0
DB13739	Penamecillin	Drug	Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Beta-Lactamase Sensitive Penicillins, Antibacterials for Systemic Use	experimental	0
DB12409	Vatreptacog alfa	Drug	Biological Factors, Enzymes, Blood Coagulation Factors, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Factor VII, Proteins, Blood Proteins, Serine Proteases, Hydrolases, Peptide Hydrolases, Enzyme Precursors, Serine Endopeptidases, Endopeptidases	investigational	0
DB01750	1-naphthaleneacetic acid	Drug	Naphthalenes	experimental	1
DB01754	3,4-Dihydroxy-1-Methylquinolin-2(1h)-One	Drug	0	experimental	1
DB00422	Methylphenidate	Drug	Central Nervous System Stimulants, Nervous System, Acids, Carbocyclic, Methylphenidate and isomer, Respiratory and CNS Stimulants, Psychostimulants, Agents Used for Adhd and Nootropics, Central Nervous System Stimulation, Drugs that are Mainly Renally Excreted, Membrane Transport Modulators, Centrally Acting Sympathomimetics, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Neurotransmitter Uptake Inhibitors, Piperidines, Agents that produce hypertension, Phenylacetates, Central Nervous System Agents, Agents that reduce seizure threshold, Dopamine Agents, Dopamine Uptake Inhibitors, Psychoanaleptics	approved, investigational	3
DB01753	4-oxo-nicotinamide-adenine dinucleotide phosphate	Drug	0	experimental	1
DB00423	Methocarbamol	Drug	Acids, Acyclic, Phenylcarbamates, Centrally-mediated Muscle Relaxation, Methyl Ethers, Catechols, Muscle Relaxants, Peripheral Nervous System Agents, Phenyl Ethers, Central Nervous System Depressants, Musculo-Skeletal System, Muscle Relaxants, Centrally Acting Agents, Carbamic Acid Esters, Carbamates, Phenols, Central Nervous System Agents, Ethers, Benzene Derivatives	approved, vet_approved	1
DB01752	S-adenosyl-L-homocysteine	Drug	Carbohydrates, Ribonucleosides, Amino Acids, Sulfur, Amino Acids, Peptides, and Proteins, Purine Nucleosides, Amino Acids, Heterocyclic Compounds, Fused-Ring, Purines, Sulfur Compounds, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Homocysteine	experimental	36
DB00420	Promazine	Drug	Psycholeptics, Tranquilizing Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Peripheral Nervous System Agents, Anticholinergic Agents, Serotonin 5-HT2 Receptor Antagonists, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Dopamine Antagonists, Amino Acids, Essential, Agents producing tachycardia, Phenothiazines With Aliphatic Side-Chain, Cytochrome P-450 CYP2C19 Substrates, Neurotransmitter Agents, Central Nervous System Depressants, Antiemetics, Cytochrome P-450 CYP2D6 Substrates, Dopamine D2 Receptor Antagonists, QTc Prolonging Agents, Serotonin Agents, Nervous System, Amino Acids, Peptides, and Proteins, Antipsychotic Agents (First Generation Typical), Muscarinic Antagonists, Antidepressive Agents, Cytochrome P-450 CYP1A2 Inhibitors, Antipsychotic Agents, Histamine H1 Antagonists, Sulfur Compounds, Adrenergic Antagonists, Adrenergic alpha-1 Receptor Antagonists, Dopamine Agents, Gastrointestinal Agents, Neurotoxic agents, Autonomic Agents, Adrenergic alpha-Antagonists, Phenothiazines, Moderate Risk QTc-Prolonging Agents, Psychotropic Drugs, Amino Acids, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Agents that produce hypertension, Amino Acids, Branched-Chain, Cytochrome P-450 CYP1A2 Substrates, Serotonin Receptor Antagonists, Central Nervous System Agents	approved, vet_approved	6
DB01751	Tetraiodothyroacetic acid	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Thyroid Products, Hormones, Hormone Substitutes, and Hormone Antagonists, Amino Acids, Peptides, and Proteins, Hormones, Amino Acids	experimental	0
DB00421	Spironolactone	Drug	Antihypertensive Agents Indicated for Hypertension, Mineralocorticoid (Aldosterone) Receptor Antagonists, Cytochrome P-450 Enzyme Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP2C8 Inhibitors, Agents causing hyperkalemia, BSEP/ABCB11 Substrates, Cardiovascular Agents, Hypotensive Agents, Potassium-Sparing Diuretics, Fused-Ring Compounds, Lactones, P-glycoprotein inducers, Diuretics, Natriuretic Agents, Pregnanes, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Antihypertensive Agents, Hormone Antagonists, Mineralocorticoid Receptor Antagonists, Pregnenes, Steroids	approved	10
DB00426	Famciclovir	Drug	Enzyme Inhibitors, Cytochrome P-450 Substrates, Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors, Antiviral Agents, Cytochrome P-450 CYP3A4 Substrates, Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor, Antiinfectives for Systemic Use, Anti-Infective Agents, Ophthalmologicals, Antivirals for Systemic Use, Direct Acting Antivirals, Heterocyclic Compounds, Fused-Ring, Purines, Nucleic Acid Synthesis Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor, Sensory Organs, Nucleosides and Nucleotides	approved, investigational	1
DB01758	3-Iodo-Tyrosine	Drug	0	experimental	1
DB00427	Triprolidine	Drug	Neurotransmitter Agents, Pyridines, QTc Prolonging Agents, Histamine H1 Antagonists, Anti-Allergic Agents, Histamine Antagonists, Central Nervous System Depressants, Potential QTc-Prolonging Agents, Histamine Agents, Antihistamines for Systemic Use	approved	1
DB00424	Hyoscyamine	Drug	QTc Prolonging Agents, Solanaceous Alkaloids, Belladonna Alkaloids, Cardiovascular Agents, Muscarinic Antagonists, Peripheral Nervous System Agents, Anticholinergic Agents, Alkaloids, Cholinergic Agents, Alimentary Tract and Metabolism, Aza Compounds, Potential QTc-Prolonging Agents, Azabicyclo Compounds, Drugs for Functional Gastrointestinal Disorders, Belladonna Alkaloids, Tertiary Amines, Antiarrhythmic agents, Autonomic Agents, Anti-Asthmatic Agents, Agents producing tachycardia, Parasympatholytics, Bronchodilator Agents, Respiratory System Agents, Belladonna and Derivatives, Plain, Neurotransmitter Agents, Tropanes, Mydriatics, Adjuvants, Anesthesia, Central Nervous System Agents, Atropine Derivatives	approved	4
DB01756	4-phospho-L-threonic acid	Drug	0	experimental	1
DB00425	Zolpidem	Drug	gamma-Aminobutyric Acid-ergic Agonist, Psycholeptics, Pyridines, Cytochrome P-450 Substrates, GABA Agents, Nervous System, Sleep Aids, Pharmaceutical, GABA Agonists, Central Nervous System Depression, Cytochrome P-450 CYP3A4 Substrates, Miscellaneous Anxiolytics Sedatives and Hypnotics, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, GABA-A Receptor Agonists, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Cytochrome P-450 CYP1A2 Substrates, Hypnotics (Nonbenzodiazepine), Hypnotics and Sedatives, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Benzodiazepine hypnotics and sedatives	approved	4
DB01755	N-[Isoleucinyl]-N'-[adenosyl]-diaminosufone	Drug	0	experimental	1
DB00428	Streptozocin	Drug	Carbohydrates, Cytochrome P-450 CYP2E1 Inducers, Immunosuppressive Agents, Nitroso Compounds, Nitrosoureas, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Alkylating Activity, Antineoplastic Agents, Antibiotics, Antineoplastic, Nitrosourea Compounds, Myelosuppressive Agents, Alkylating Drugs, P-glycoprotein inducers, Cytochrome P-450 Enzyme Inducers, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP1A2 Inducers, Glycosides, Antineoplastic Agents, Alkylating, Cytochrome P-450 CYP2E1 Inducers (strength unknown)	approved, investigational	4
DB00429	Carboprost tromethamine	Drug	Biological Factors, Autacoids, Inflammation Mediators, Fatty Acids, Genito Urinary System and Sex Hormones, Reproductive Control Agents, Eicosanoids, Lipids, Abortifacient Agents, Nonsteroidal, Propylene Glycols, Uterotonic agents, Alcohols, Prostaglandins, Synthetic, Fatty Acids, Unsaturated, Prostaglandins, Abortifacient Agents, Prostaglandins F, Synthetic, Glycols, Pharmaceutical Preparations	approved	1
DB01759	Kojic acid	Drug	Antioxidants, Protective Agents, Mycotoxins, Compounds used in a research, industrial, or household setting, Pyrans	experimental	0
DB13740	Bemegride	Drug	Pyridines, Central Nervous System Stimulants, Convulsants, Pyridones, Central Nervous System Agents, Respiratory System Agents	experimental	0
DB13743	Sodium aurotiosulfate	Drug	Thiosulfates, Sulfur Acids, Gold Compounds, Antirheumatic Agents, Ions, Sulfates, Sulfuric Acids, Sodium Compounds, Anions, Sulfur Compounds, Acids, Noncarboxylic, Antiinflammatory and Antirheumatic Products, Acids, Gold Preparations, Musculo-Skeletal System, Osmotic Laxatives, Electrolytes, Laxatives, Specific Antirheumatic Agents	approved, experimental	0
DB12411	R-428	Drug	0	investigational	0
DB12410	Sabarubicin	Drug	Carbohydrates, Anthracyclines, Polysaccharides, Naphthacenes, Glycosides, Oligosaccharides	investigational	0
DB13744	Piromidic acid	Drug	Pyridines, QTc Prolonging Agents, Renal Agents, Anti-Infective Agents, Urinary, Cytochrome P-450 Enzyme Inhibitors, Nicotinic Acids, Antiinfectives for Systemic Use, Anti-Infective Agents, Quinolones, Cytochrome P-450 CYP1A2 Inhibitors, Anti-Bacterial Agents, Potential QTc-Prolonging Agents, Antibacterials for Systemic Use	experimental	0
DB12413	Indusatumab vedotin	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB13741	Ioglycamic acid	Drug	Iodobenzoates, Benzoates, Contrast Media, Diagnostic Uses of Chemicals, Acids, Carbocyclic, Triiodobenzoic Acids, Watersoluble, Hepatotropic X-Ray Contrast Media, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting, Benzene Derivatives	experimental	0
DB13742	Elcatonin	Drug	Calcitonin Preparations, Thyroid Products, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Amino Acids, Peptides, and Proteins, Calcium Homeostasis, Neuropeptides, Nerve Tissue Proteins, Hormones, Anti-Parathyroid Agents, Proteins, Peptide Hormones, Bone Density Conservation Agents, Calcium-Regulating Hormones and Agents, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins	experimental	0
DB12412	Gemigliptin	Drug	Diabetes Mellitus, Type 2, drug therapy, Alimentary Tract and Metabolism, Piperidines, Drugs Used in Diabetes, Agents causing angioedema, Blood Glucose Lowering Agents, DPP-IV Inhibitors	investigational	0
DB12415	Galeterone	Drug	Heterocyclic Compounds, Fused-Ring, Androstanes, Enzyme Inhibitors, Androstenes, Steroid 17-alpha-Hydroxylase, antagonists & inhibitors, Fused-Ring Compounds, Steroids	investigational	0
DB13747	Trolamine	Drug	Amines, Dermatologicals, Preparations for Treatment of Wounds and Ulcers, Amino Alcohols, Drugs that are Mainly Renally Excreted, Alcohols, Cicatrizants	approved	0
DB12414	Usistapide	Drug	0	investigational	0
DB13748	Tidiacic arginine	Drug	Liver Therapy, Alimentary Tract and Metabolism, Liver Therapy, Lipotropics, Bile and Liver Therapy	experimental	0
DB12417	Anagliptin	Drug	Enzyme Inhibitors, Protease Inhibitors, Agents causing angioedema, Blood Glucose Lowering Agents, DPP-IV Inhibitors	investigational	0
DB13745	Fazadinium bromide	Drug	Pyridines, Muscle Relaxants, Peripherally Acting Agents, Central Nervous System Depressants, Musculo-Skeletal System, Muscle Relaxants	experimental	0
DB12416	VTP-27999	Drug	Acids, Acyclic, Renin-Inhibitors, Agents Acting on the Renin-Angiotensin System	investigational	0
DB13746	Bioallethrin	Drug	Antiparasitic Products, Insecticides and Repellents, Cytochrome P-450 Substrates, Pyrethrins, Ectoparasiticides, Incl. Scabicides, Stereoisomerism, Agents causing hyperkalemia, Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents, Pesticides, Insecticides, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C19 Substrates, Calcium Channel Blockers, Cytochrome P-450 CYP2C9 Substrates, Agrochemicals, Cytochrome P-450 CYP3A Substrates, Pyrethrines, Incl. Synthetic Compounds, Toxic Actions, Monoterpenes, Cytochrome P-450 CYP2C8 Substrates, Terpenes, Compounds used in a research, industrial, or household setting, Bradycardia-Causing Agents, Antiarrhythmic agents	approved, experimental	6
DB12419	HSD-016	Drug	Alcohols	investigational	0
DB12418	Saccharin	Drug	Food Additives, Flavoring Agents, Pharmaceutic Aids, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Physiological Phenomena, Food and Beverages, Thiazoles, Food Ingredients, Pharmaceutical Preparations, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Benzothiazoles, Food, Sweetening Agents	investigational	1
DB13749	Magnesium gluconate	Drug	Acids, Acyclic, Carbohydrates, Hydroxy Acids, Metal cations, Alimentary Tract and Metabolism, Metal divalent cations, Sugar Acids, Mineral Supplements, Agents that produce neuromuscular block (indirect), Magnesium Compounds	approved, investigational	0
DB01761	4-[5-[2-(1-phenyl-ethylamino)-pyrimidin-4-yl]-1-methyl-4-(3-trifluoromethylphenyl)-1H-imidazol-2-yl]-piperidine	Drug	0	experimental	1
DB01760	2-Methoxy-3-Isopropylpyrazine	Drug	0	experimental	1
DB00430	Cefpiramide	Drug	Nephrotoxic agents, Third-Generation Cephalosporins, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Antibacterials for Systemic Use	approved	7
DB01765	(5-hydroxyindolo[1,2-a]quinazolin-7-yl)acetic acid	Drug	0	experimental	1
DB00433	Prochlorperazine	Drug	Psycholeptics, QTc Prolonging Agents, Tranquilizing Agents, Cytochrome P-450 Substrates, Nervous System, Schizophrenia, Antipsychotic Agents (First Generation Typical), Cytochrome P-450 CYP3A4 Substrates, Peripheral Nervous System Agents, Antipsychotic Agents, Sulfur Compounds, Drugs causing inadvertant photosensitivity, Dopamine Antagonists, Phenothiazines With Piperazine Structure, Dopamine Agents, Gastrointestinal Agents, Neurotoxic agents, Autonomic Agents, Phenothiazines, Moderate Risk QTc-Prolonging Agents, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Central Nervous System Depressants, Antiemetics, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Dopamine D2 Receptor Antagonists	approved, vet_approved	4
DB01764	Dalfopristin	Drug	Peptides, Cyclic, Anti-Bacterial Agents, Streptogramin Antibacterial, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Peptides, Cytochrome P-450 CYP3A4 Inhibitors, Streptogramins, Amino Acids, Peptides, and Proteins, Anti-Infective Agents, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved	1
DB00434	Cyproheptadine	Drug	QTc Prolonging Agents, Serotonin Agents, UGT1A3 substrates, Miscellaneous Derivatives, Muscarinic Antagonists, Antidepressive Agents, Dibenzocycloheptenes, Anticholinergic Agents, Serotonin 5-HT2 Receptor Antagonists, Histamine H1 Antagonists, Piperidines, Potential QTc-Prolonging Agents, Drugs causing inadvertant photosensitivity, Antihistamines for Systemic Use, Antipruritics, Agents that reduce seizure threshold, Gastrointestinal Agents, Anti-Allergic Agents, Dermatologicals, Agents producing tachycardia, Benzocycloheptenes, Neurotransmitter Agents, Histamine Antagonists, Photosensitizing Agents, Central Nervous System Depressants, Serotonin Receptor Antagonists, Histamine Agents	approved	7
DB00431	Lindane	Drug	Hydrocarbons, Chlorinated, Antiparasitic Products, Insecticides and Repellents, Agrochemicals, Ectoparasiticides, Incl. Scabicides, Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents, Pesticides, Hydrocarbons, Halogenated, Insecticides, Toxic Actions, Chlorine Containing Products, Compounds used in a research, industrial, or household setting, Agents that reduce seizure threshold	approved, withdrawn	10
DB01763	7-thionicotinamide-adenine-dinucleotide phosphate	Drug	0	experimental	1
DB00432	Trifluridine	Drug	Immunosuppressive Agents, Pyrimidine Analogues, OAT1/SLC22A6 Substrates, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, OAT3/SLC22A8 Substrates, Nucleic Acid Synthesis Inhibitors, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Carbohydrates, Nucleoside Analog Antiviral, Pyrimidine Nucleosides, Noxae, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Antiviral Agents, Antimetabolites, OAT1/SLC22A6 inhibitors, Ophthalmologicals, Nucleoside Metabolic Inhibitor, Nucleosides, Toxic Actions, Deoxyribonucleosides, Sensory Organs	approved, investigational	2
DB01762	Acetoacetic acid	Drug	Ketones, Keto Acids, Ketone Bodies	experimental	1
DB00437	Allopurinol	Drug	Enzyme Inhibitors, Protective Agents, Free Radical Scavengers, Preparations Inhibiting Uric Acid Production, Antimetabolites, Drugs that are Mainly Renally Excreted, OAT3/SLC22A8 Substrates, Antioxidants, Heterocyclic Compounds, Fused-Ring, Purines, Antigout Preparations, BCRP/ABCG2 Substrates, Musculo-Skeletal System, Uricosuric Agents, Xanthine Oxidase Inhibitors	approved	1
DB00438	Ceftazidime	Drug	Nephrotoxic agents, Third-Generation Cephalosporins, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, OAT1/SLC22A6 inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Cephaloridine, Antibacterials for Systemic Use	approved	9
DB01768	Methylumbelliferyl sialic acid	Drug	0	experimental	1
DB00435	Nitric Oxide	Drug	Cytochrome P-450 Enzyme Inhibitors, Nitroso Compounds, Free Radical Scavengers, Oxides, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Hypotensive Agents, Reactive Nitrogen Species, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Nitric Oxide, antagonists & inhibitors, Drugs that are Mainly Renally Excreted, Vasodilation, Peripheral Nervous System Agents, Antioxidants, Cytochrome P-450 CYP1A2 Inhibitors, Endothelium-Dependent Relaxing Factors, Anions, Compounds used in a research, industrial, or household setting, Nitrogen Compounds, Oxygen Compounds, Autonomic Agents, Free Radicals, Anti-Asthmatic Agents, Protective Agents, Ions, Bronchodilator Agents, Respiratory System Agents, Gases, Neurotransmitter Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Gasotransmitters, Nitrates and Nitrites, Electrolytes, Methemoglobinemia Associated Agents, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), Vasodilating Agents, Nitrogen Oxides	approved	3
DB01767	Hemi-Babim	Drug	0	experimental	2
DB00436	Bendroflumethiazide	Drug	Antihypertensive Agents Indicated for Hypertension, Increased Diuresis, Sodium Chloride Symporter Inhibitors, Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Low-Ceiling Diuretics and Potassium-Sparing Agents, Amides, Cardiovascular Agents, Hypotensive Agents, Membrane Transport Modulators, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Benzothiadiazines, Sulfonamides, Diuretics, Natriuretic Agents, Antihypertensive Agents, Thiazides, Hyperglycemia-Associated Agents, Bradycardia-Causing Agents, Sulfones	approved	5
DB01766	Beta-(2-Naphthyl)-Alanine	Drug	0	experimental	3
DB00439	Cerivastatin	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP2B6 Inducers (strength unknown), BSEP/ABCB11 Substrates, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Lipid Modifying Agents, Lipid Modifying Agents, Plain, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Substrates, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), OATP1B1/SLCO1B1 Inhibitors, Anticholesteremic Agents, Hypolipidemic Agents, Cytochrome P-450 CYP3A5 Substrates, Noxae, Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inducers, Lipid Regulating Agents, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), UGT1A1 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, OATP1B1/SLCO1B1 Substrates, Toxic Actions	approved, withdrawn	1
DB13750	Obidoxime	Drug	Oximes, Neurotransmitter Agents, Pyridines, Amines, Antidotes, Cholinergic Agents, Pyridinium Compounds, Cholinesterase Reactivators, Hydroxylamines, Enzyme Reactivators	experimental	0
DB13751	Glycyrrhizic acid	Drug	Triterpenes, Liver Therapy, Alimentary Tract and Metabolism, Anti-Inflammatory Agents, Pentacyclic Triterpenes, Liver Therapy, Lipotropics, BSEP/ABCB11 Substrates, Terpenes, Bile and Liver Therapy	approved, experimental	5
DB12420	Diazepinomicin	Drug	Heterocyclic Compounds, Fused-Ring, Terpenes	investigational	0
DB12422	Sulforaphane	Drug	Isocyanates, Sulfur Compounds, Protective Agents, Antineoplastic Agents, Anticarcinogenic Agents, Compounds used in a research, industrial, or household setting	investigational	0
DB13754	Mephenoxalone	Drug	Psycholeptics, Nervous System, Central Nervous System Depressants, Muscle Relaxants, Centrally Acting Agents, Anti-Anxiety Agents, Muscle Relaxants	experimental	0
DB13755	Iocarmic acid	Drug	Carbohydrates, Benzoates, Acids, Carbocyclic, Alcohols, Amino Sugars, Iodobenzoates, Contrast Media, Diagnostic Uses of Chemicals, Sugar Alcohols, Hexosamines, Triiodobenzoic Acids, Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting, Benzene Derivatives	experimental	0
DB12421	Somavaratan	Drug	0	investigational	0
DB13752	Tetramethrin	Drug	Insecticides and Repellents, Antiparasitic Products, Insecticides and Repellents, Agrochemicals, Pyrethrines, Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents, Pesticides, Insecticides, Toxic Actions, Monoterpenes, Terpenes, Compounds used in a research, industrial, or household setting	experimental	0
DB12424	MK-3207	Drug	Receptors, Calcitonin Gene-Related Peptide, antagonists & inhibitors	investigational	0
DB12423	Fozivudine Tidoxil	Drug	Carbohydrates, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Glycosides, Nucleosides, Deoxyribonucleosides, Dideoxynucleosides	investigational	0
DB13753	Cetiedil	Drug	Antisickling Agents, Peripheral Vasodilators, Hematologic Agents, Cardiovascular Agents, Vasodilating Agents	experimental	0
DB13758	Meclofenoxate	Drug	Acids, Acyclic, Neuroprotective Agents, Fatty Acids, Hydroxy Acids, Nervous System, Phenoxyacetates, Protective Agents, Psychostimulants, Agents Used for Adhd and Nootropics, Lipids, Acetates, Glycolates, Fatty Acids, Volatile, Central Nervous System Agents, Compounds used in a research, industrial, or household setting, Nootropic Agents, Psychoanaleptics	experimental	0
DB12426	Bitopertin	Drug	Sulfur Compounds	investigational	0
DB13759	Fenpiverinium	Drug	Anticholinergic Agents, Synthetic Anticholinergics, Quaternary Ammonium Compounds, Alimentary Tract and Metabolism, Agents producing tachycardia, Drugs for Functional Gastrointestinal Disorders, Muscarinic Antagonists	experimental	0
DB12425	Liothyronine I-131	Drug	Thyroxine-binding globulin substrates	investigational	0
DB13756	Peruvoside	Drug	Cardiotonic Agents, Carbohydrates, Cardanolides, Cardiac Glycosides, Protective Agents, Glycosides, Cardiovascular Agents, Cardiac Therapy, Compounds used in a research, industrial, or household setting, Fused-Ring Compounds, Steroids	experimental	0
DB12428	PAC-14028	Drug	Acids, Acyclic, Acrylates, Amides, TRPV Cation Channels, antagonists & inhibitors	investigational	0
DB13757	Epanolol	Drug	Acids, Acyclic, Amines, Cytochrome P-450 Substrates, Fatty Acids, Agents causing hyperkalemia, Adrenergic beta-Antagonists, Amides, Lipids, Cardiovascular Agents, Acetates, Alcohols, Peripheral Nervous System Agents, Fatty Acids, Volatile, Adrenergic Antagonists, Acetamides, Antihypertensive Agents, Adrenergic Agents, Benzene Derivatives, Bradycardia-Causing Agents, Autonomic Agents, Propanols, Amino Alcohols, Neurotransmitter Agents, Sympathomimetics, Beta Blocking Agents, Selective, Cytochrome P-450 CYP2D6 Substrates	experimental	0
DB12427	Orvepitant	Drug	Central Nervous System Depressants, Antidepressive Agents	investigational	0
DB12429	CI-1040	Drug	Benzoates, Acids, Carbocyclic, Amides, Calcium-Calmodulin-Dependent Protein Kinases, Benzene Derivatives	investigational	0
DB01772	3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione	Drug	0	experimental	1
DB00440	Trimethoprim	Drug	Enzyme Inhibitors, Renal Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Folic Acid Antagonists, Agents causing hyperkalemia, MATE 1 Substrates, MATE inhibitors, Antimycobacterials, MATE 1 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, SULFONAMIDES AND TRIMETHOPRIM, Pyrimidines, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Cytochrome P-450 CYP2C8 Substrates, Drugs causing inadvertant photosensitivity, MATE substrates, Anti-Infective Agents, Urinary, Antibiotics for Pneumocystis Pneumonia, Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, Trimethoprim and Derivatives, Antiinfectives for Systemic Use, P-glycoprotein inducers, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Agents Causing Muscle Toxicity, OCT2 Inhibitors, MATE 2 Substrates, Cytochrome P-450 CYP1A2 Substrates, MATE 2 Inhibitors, P-glycoprotein inhibitors, Antibacterials for Systemic Use	approved, vet_approved	1
DB01771	CRA_10991	Drug	0	experimental	1
DB00441	Gemcitabine	Drug	Immunologic Factors, Ribonucleosides, Enzyme Inhibitors, Immunosuppressive Agents, Pyrimidine Analogues, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Nucleic Acid Synthesis Inhibitors, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Carbohydrates, Pyrimidine Nucleosides, Noxae, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Antimetabolites, Radiation-Sensitizing Agents, Myelosuppressive Agents, Narrow Therapeutic Index Drugs, Nucleoside Metabolic Inhibitor, Ribonucleotide Reductases, antagonists & inhibitors, Nucleosides, Toxic Actions, Deoxyribonucleosides	approved	4
DB00444	Teniposide	Drug	Enzyme Inhibitors, Cytochrome P-450 Substrates, Immunosuppressive Agents, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Cardiotoxic antineoplastic agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Inhibitors, Topoisomerase II Inhibitors, Glycosides, Glucosides, Neurotoxic agents, Carbohydrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index, Myelosuppressive Agents, Cytochrome P-450 CYP2C19 Substrates, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (weak), Podophyllotoxin Derivatives	approved	1
DB01776	M-Cresol	Drug	Phenols, Benzene Derivatives	experimental	1
DB00445	Epirubicin	Drug	Anthracycline Topoisomerase Inhibitor, Carbohydrates, Anthracyclines, Enzyme Inhibitors, Cytotoxic Antibiotics and Related Substances, Immunosuppressive Agents, Topoisomerase Inhibitors, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Cardiotoxic antineoplastic agents, Antibiotics, Antineoplastic, Myelosuppressive Agents, UGT2B7 substrates, Topoisomerase II Inhibitors, UGT2B7 substrates with narrow therapeutic index, Naphthacenes, Glycosides, Hepatotoxic Agents, Anthracyclines and Related Substances	approved	2
DB01775	Dihydroxyacetone	Drug	Carbohydrates, Trioses, Ketoses, Monosaccharides	experimental	1
DB01774	Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester	Drug	0	experimental	1
DB00442	Entecavir	Drug	Cytochrome P-450 Substrates, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Antiviral Agents, Antiinfectives for Systemic Use, Anti-Infective Agents, Antivirals for Systemic Use, Direct Acting Antivirals, Heterocyclic Compounds, Fused-Ring, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors, Purines, Cytochrome P-450 CYP1A2 Substrates, Nucleoside Reverse Transcriptase Inhibitors, Nucleosides and Nucleotides, Purinones	approved, investigational	1
DB01773	4-[3-carboxymethyl-3-(4-phosphonooxy-benzyl)-ureido]-4-[(3-cyclohexyl-propyl)-methyl-carbamoyl]butyric acid	Drug	0	experimental	1
DB00443	Betamethasone	Drug	Corticosteroids, Dermatological Preparations, Cytochrome P-450 Substrates, Immunosuppressive Agents, Glucocorticoids, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Otologicals, Cytochrome P-450 CYP2C19 Inducers (strength unknown), Cytochrome P-450 CYP2B6 Inducers (strength unknown), Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Intestinal Antiinflammatory Agents, Nasal Preparations, Corticosteroids, Potent (Group III), Alimentary Tract and Metabolism, Cytochrome P-450 CYP2C19 Inducers, Corticosteroids Acting Locally, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Corticosteroid Hormone Receptor Agonists, Corticosteroids for Systemic Use, Pregnadienetriols, Corticosteroids, Corticosteroids for Systemic Use, Plain, Pregnadienes, Cytochrome P-450 CYP3A4 Inducers, Respiratory System Agents, Ophthalmologicals, Cytochrome P-450 CYP3A5 Inducers (weak), Pregnanes, Steroids, Fluorinated, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Cytochrome P-450 CYP2C8 Inducers, Anti-Inflammatory Agents, Ophthalmological and Otological Preparations, Fused-Ring Compounds, Vasoprotectives, Cytochrome P-450 Enzyme Inducers, Adrenals, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP2A6 Inducers, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein substrates, Dermatologicals, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Drugs for Obstructive Airway Diseases, Thyroxine-binding globulin inhibitors, Cytochrome P-450 CYP2C9 Inducers, Hyperglycemia-Associated Agents, Steroids	approved, vet_approved	1
DB00448	Lansoprazole	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Benzimidazoles, Proton-pump Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP2C19 Inhibitors, Inhibition Gastric Acid Secretion, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Anti-Ulcer Agents, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Cytochrome P-450 Enzyme Inducers, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Sulfur Compounds, Alimentary Tract and Metabolism, Acid Reducers, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2C8 Substrates, Drugs for Acid Related Disorders, Gastrointestinal Agents, Pyridines, Cytochrome P-450 CYP2C18 Substrates, Proton Pump Inhibitors, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inducers, BCRP/ABCG2 Inhibitors, Sulfoxides, Cytochrome P-450 CYP2C19 Inhibitors (strong), Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Gastric Acid Lowering Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2C9 Inducers, OAT3/SLC22A8 Inhibitors, P-glycoprotein inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (weak)	approved, investigational	2
DB00449	Dipivefrin	Drug	Amines, Adrenergic alpha-1 Receptor Agonists, Adrenergic beta-2 Receptor Agonists, Alcohols, Ophthalmics, Adrenergic alpha-2 Receptor Agonists, Adrenergic beta-1 Receptor Agonists, Biogenic Amines, Adrenergic Agents, Benzene Derivatives, Adrenergic alpha-Agonists, Antiglaucoma Preparations and Miotics, Catecholamines, Catechols, Amino Alcohols, Ethanolamines, Biogenic Monoamines, Ophthalmologicals, Adrenergic beta-Agonists, Neurotransmitter Agents, Mydriatics, Adrenergic Agonists, Sympathomimetics in Glaucoma Therapy, Phenols, Cholinesterase substrates, Sensory Organs, Adrenergic beta-3 Receptor Agonists	approved	5
DB01779	Glycerol 2-phosphate	Drug	Carbohydrates, Sugar Phosphates, Sugar Alcohols, Lipids, Membrane Lipids, Phospholipids, Triose Sugar Alcohols, Alcohols	experimental	1
DB00446	Chloramphenicol	Drug	Enzyme Inhibitors, Antibiotics for Topical Use, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Genito Urinary System and Sex Hormones, Otologicals, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Amphenicols, Ophthalmological and Otological Preparations, Anti-Infective Agents, Alcohols, Cytochrome P-450 CYP3A7 Inhibitors (strength unknown), Anti-Bacterial Agents, Antiinfectives for Treatment of Acne, Benzene Derivatives, Protein Synthesis Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Gynecological Antiinfectives and Antiseptics, Cytochrome P-450 CYP3A5 Inhibitors, Dermatologicals, Propylene Glycols, Anti-Acne Preparations, Antiinfectives for Systemic Use, Cytochrome P-450 CYP2C19 Inhibitors (strong), Myelosuppressive Agents, OAT1/SLC22A6 inhibitors, Ophthalmologicals, Nitrobenzenes, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A7 Inhibitors, Nitro Compounds, Cytochrome P-450 CYP3A4 Inhibitors, Glycols, Sensory Organs, Anti-Acne Preparations for Topical Use, Antibacterials for Systemic Use	approved, vet_approved	3
DB01778	8-Aminotheophylline	Drug	0	experimental	1
DB00447	Loracarbef	Drug	Nephrotoxic agents, Second-Generation Cephalosporins, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Antibacterials for Systemic Use	approved, investigational, withdrawn	2
DB01777	CoA-S-trimethylene-acetyl-tryptamine	Drug	0	experimental	1
DB01703	N-(2-ferrocenylethyl)maleimide	Drug	0	experimental	1
DB01702	2-(3,4-Dihydroxyphenyl)Acetic Acid	Drug	0	experimental	6
DB01701	1,2-Dichloro-Propane	Drug	0	experimental	1
DB01700	AICA ribonucleotide	Drug	Carbohydrates, Imidazoles, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Blood Glucose Lowering Agents, Nucleotides	investigational, experimental	1
DB01707	L-Alfa-Lysophosphatidylcholine, Lauroyl	Drug	0	experimental	0
DB01706	2-Bromo-6-chloro-purine	Drug	0	experimental	0
DB01705	Bis(5-Amidino-Benzimidazolyl)Methane	Drug	0	experimental	2
DB01704	2,4-Dihydroxy-Trans Cinnamic Acid	Drug	0	experimental	1
DB01709	2-phospho-D-glyceric acid	Drug	0	experimental	4
DB01708	Prasterone	Drug	Immunologic Factors, Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, 17-Ketosteroids, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, OATP1B3 substrates, Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 CYP3A7 Inhibitors (strength unknown), Alimentary Tract and Metabolism, Anabolic Agents for Systemic Use, Androgens and Estrogens, Androstan Derivatives, Gonadal Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Adjuvants, Immunologic, Androstenes, Ketosteroids, Gonadal Steroid Hormones, Androstanes, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Androstenols, Cytochrome P-450 CYP3A7 Inhibitors, Anabolic Steroids, OATP1B1/SLCO1B1 Substrates, Testosterone Congeners, Steroids	approved, investigational, nutraceutical	9
DB01710	Porphyrin Fe(III)	Drug	0	experimental	1
DB01714	Epsilon-N-methyllysine	Drug	Amino Acids, Basic, Amino Acids, Essential, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	0
DB01713	UDP-alpha-D-xylose	Drug	0	experimental	1
DB01712	(3R)-4-(p-toluenesulfonyl)-1,4-thiazane-3-carboxylicacid-L-phenylalanine ethyl ester	Drug	0	experimental	1
DB01711	2,3,4,5,6-Pentafluorobenzyl Alcohol	Drug	Benzyl Compounds, Benzene Derivatives, Alcohols	experimental	1
DB01718	Cetrimonium	Drug	Amines, Ammonium Compounds, Cetrimonium Compounds, Quaternary Ammonium Compounds, Antiseptics and Disinfectants, Dermatologicals, Trimethyl Ammonium Compounds, Medicated Shampoos, Onium Compounds, Anti-Infective Agents, Anti-Infective Agents, Local, Throat Preparations, Compounds used in a research, industrial, or household setting, Nitrogen Compounds, Miscellaneous Local Anti-infectives	approved	2
DB01717	Bis(Adenosine)-5'-Pentaphosphate	Drug	0	experimental	7
DB01716	2-propenyl-N-acetyl-neuramic acid	Drug	0	experimental	0
DB01715	7,8-Diamino-Nonanoic Acid	Drug	0	experimental	1
DB01719	Thio-Maltopentaose	Drug	0	experimental	1
DB13700	Protamine	Drug	Antidotes, Heparin Reversal Agent, Reversed Anticoagulation Activity, Heparin Binding Activity	investigational, experimental	0
DB13703	Gepefrine	Drug	Amines, Ethylamines, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Sympathomimetics, Cardiac Stimulants Excl. Cardiac Glycosides, Agents that produce hypertension, Amphetamines, Agents producing tachycardia, Adrenergic and Dopaminergic Agents, Cardiac Therapy, Phenethylamines	experimental	0
DB13704	Pristinamycin	Drug	Peptides, Cyclic, Anti-Bacterial Agents, Peptides, Macrolides, Lincosamides and Streptogramins, Streptogramins, Amino Acids, Peptides, and Proteins, Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use	investigational, experimental	0
DB13701	Ioglicic acid	Drug	Iodobenzoates, Benzoates, Contrast Media, Acids, Carbocyclic, Triiodobenzoic Acids, Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media, X-Ray Contrast Media, Iodinated, Benzene Derivatives	experimental	0
DB13702	Tibezonium iodide	Drug	Antiinfectives and Antiseptics for Local Oral Treatment, Alimentary Tract and Metabolism, Stomatological Preparations	experimental	0
DB13707	Sodium tartrate	Drug	Acids, Acyclic, Carbohydrates, Hydroxy Acids, Alimentary Tract and Metabolism, Osmotic Laxatives, Drugs for Constipation, Dicarboxylic Acids, Laxatives, Sugar Acids	approved	0
DB13708	Fenquizone	Drug	Heterocyclic Compounds, Fused-Ring, Sulfonamides, Diuretics, Natriuretic Agents, Cardiovascular Agents, Low-Ceiling Diuretics, Excl. Thiazides	experimental	0
DB13705	Decamethoxine	Drug	Anti-Bacterial Agents, Amines, Ammonium Compounds, Quaternary Ammonium Compounds, Antiseptics and Disinfectants, Dermatologicals, Bis-Trimethylammonium Compounds, Onium Compounds, Anti-Infective Agents, Anti-Infective Agents, Local, Nitrogen Compounds	experimental	0
DB13706	Eosin	Drug	Luminescent Agents, Spiro Compounds, Xanthenes, Heterocyclic Compounds, Fused-Ring, Antiseptics and Disinfectants, Coloring Agents, Dermatologicals, Laboratory Chemicals, Indicators and Reagents, Fluoresceins, Compounds used in a research, industrial, or household setting, Fluorescent Dyes	experimental	0
DB01721	N-[2-hydroxy-1-indanyl]-5-[(2-tertiarybutylaminocarbonyl)-4(benzo[1,3]dioxol-5-ylmethyl)-piperazino]-4-hydroxy-2-(1-phenylethyl)-pentanamide	Drug	0	experimental	1
DB01720	(2Z)-2-(Benzoylamino)-3-[4-(2-bromophenoxy)phenyl]acrylic acid	Drug	0	experimental	1
DB01725	2-{2-hydroxy-[1,1'-biphenyl]-3-yl}-1H-1,3-benzodiazole-5-carboximidamide	Drug	0	experimental	3
DB01724	L-Threoninol	Drug	0	experimental	0
DB01723	{3-[3-(3,4-Dimethoxy-Phenyl)-1-(1-{1-[2-(3,4,5-Trimethoxy-Phenyl)-Butyryl]-Piperidin-2yl}-Vinyloxy)-Propyl]-Phenoxy}-Acetic Acid	Drug	0	experimental	1
DB01729	1D-myo-inositol 1,3,4-trisphosphate	Drug	Carbohydrates, Sugar Phosphates, Sugar Alcohols, Alcohols	experimental	0
DB01728	1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine	Drug	Carbohydrates, Sugar Phosphates, Hematologic Agents, Lipids, Phospholipids, Phosphatidic Acids, Glycerophospholipids, Alcohols, Glycerophosphates, Sugar Alcohols, Membrane Lipids, Triose Sugar Alcohols, Antiplatelet agents	experimental	1
DB01727	Isocitric Acid	Drug	Acids, Acyclic, Tricarboxylic Acids, Citrates	experimental	6
DB01726	2-Aminophenol	Drug	Amines, Aniline Compounds, Phenols, Benzene Derivatives	experimental	1
DB13710	Metenolone	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, Anabolic Agents, Androstenes, Hormones, Fused-Ring Compounds, Gonadal Steroid Hormones, Androstanes, Alimentary Tract and Metabolism, Androstenols, Anabolic Steroids, Testosterone Congeners, Anabolic Agents for Systemic Use, Androstan Derivatives, Gonadal Hormones, Steroids	experimental	0
DB13711	Tritoqualine	Drug	Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Histamine Antagonists, Cholagogues and Choleretics, Histamine Agents, Antihistamines for Systemic Use	approved	0
DB13714	Xibornol	Drug	Monoterpenes, Terpenes, Antiinfectives for Systemic Use, Antibacterials for Systemic Use, Norbornanes	experimental	0
DB13715	Dilazep	Drug	Vasodilators Used in Cardiac Diseases, Cardiovascular Agents, Vasodilating Agents, Cardiac Therapy, Azepines	experimental	0
DB13712	Dixanthogen	Drug	Antiparasitic Products, Insecticides and Repellents, Ectoparasiticides, Incl. Scabicides, Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents, Ions, Sulfur Containing Products, Gases, Sulfides, Anions, Sulfur Compounds, Acids, Noncarboxylic, Acids, Hydrogen Sulfide, Electrolytes	experimental	0
DB13713	Quifenadine	Drug	Neurotransmitter Agents, Histamine Antagonists, Histamine Agents, Antihistamines for Systemic Use, Benzene Derivatives	experimental	0
DB13718	Hydroquinine	Drug	Autonomic Agents, Quinolines, Alkaloids, Heterocyclic Compounds, Fused-Ring, Cinchona Alkaloids, Musculo-Skeletal System, Parasympatholytics, Cardiovascular Agents, Quinuclidines, Antiarrhythmic agents, Peripheral Nervous System Agents	experimental	0
DB13719	Trolnitrate	Drug	Amines, Antianginal Agents, Ions, Amino Alcohols, Organic Nitrates, Alcohols, Anions, Acids, Noncarboxylic, Acids, Electrolytes, Vasodilators Used in Cardiac Diseases, Nitric Acid, Vasodilating Agents, Cardiac Therapy, Nitrogen Compounds	experimental	0
DB13716	Dibutylphthalate	Drug	Insecticides and Repellents, Phthalic Acids, Plasticizers, Antiparasitic Products, Insecticides and Repellents, Acids, Carbocyclic, Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents, Compounds used in a research, industrial, or household setting	experimental	0
DB13717	Phenothrin	Drug	Antiparasitic Products, Insecticides and Repellents, Agrochemicals, Ectoparasiticides, Incl. Scabicides, Pyrethrines, Incl. Synthetic Compounds, Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents, Pesticides, Insecticides, Toxic Actions, Monoterpenes, Terpenes, Compounds used in a research, industrial, or household setting	experimental	0
DB13709	Ciclonicate	Drug	Pyridines, Nicotinic Acid and Derivatives, Peripheral Vasodilators	experimental	0
DB00400	Griseofulvin	Drug	Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Dermatologicals, Antifungals for Dermatological Use, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Microtubule Inhibition, Decreased Mitosis, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Benzofurans, Anti-Infective Agents, Antifungals for Systemic Use, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 Enzyme Inducers, Antifungals for Topical Use, Cytochrome P-450 CYP1A2 Inducers, Antifungal Agents, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Tubulin Inhibiting Agent	approved, investigational, vet_approved	2
DB01732	(4R,5S,6S,7R)-1,3-dibenzyl-4,7-bis(phenoxymethyl)-5,6-dihydroxy-1,3 diazepan-2-one	Drug	0	experimental	1
DB00401	Nisoldipine	Drug	Calcium Channel Blockers (Dihydropyridine), Dihydropyridine Derivatives, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Agents causing hyperkalemia, Cardiovascular Agents, Hypotensive Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Calcium-Regulating Hormones and Agents, Antihypertensive Agents, Drugs causing inadvertant photosensitivity, Bradycardia-Causing Agents, Antiarrhythmic agents, Selective Calcium Channel Blockers With Mainly Vascular Effects, Antihypertensive Agents Indicated for Hypertension, Pyridines, Cytochrome P-450 CYP3A5 Substrates, Membrane Transport Modulators, Calcium Channel Blockers, Dihydropyridines, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Decreased Blood Pressure, P-glycoprotein inhibitors, Vasodilating Agents	approved	5
DB01731	(S)-wiskostatin	Drug	0	experimental	1
DB01736	[3-(Dodecanoylamino)Propyl](Hydroxy)Dimethylammonium	Drug	0	experimental	1
DB00404	Alprazolam	Drug	Psycholeptics, Tranquilizing Agents, Amines, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Nervous System, GABA Modulators, Benzodiazepines and benzodiazepine derivatives, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Alcohols, Triazolobenzodiazepines, Benzazepines, Biogenic Amines, Hypnotics and Sedatives, Benzene Derivatives, Cytochrome P-450 CYP3A5 Substrates, GABA Agents, Catechols, Amino Alcohols, Ethanolamines, Psychotropic Drugs, Biogenic Monoamines, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Phenols, Anti-Anxiety Agents, Central Nervous System Agents	approved, illicit, investigational	2
DB01735	3-Chloroalaninate	Drug	0	experimental	1
DB00405	Dexbrompheniramine	Drug	Neurotransmitter Agents, Pyridines, QTc Prolonging Agents, Histamine H1 Antagonists, Histamine Antagonists, Substituted Alkylamines, Central Nervous System Depressants, Potential QTc-Prolonging Agents, Histamine Agents, Antihistamines for Systemic Use	approved	1
DB00402	Eszopiclone	Drug	Psycholeptics, Pyridines, Cytochrome P-450 Substrates, Piperazines, Nervous System, Cytochrome P-450 CYP3A4 Substrates, Miscellaneous Anxiolytics Sedatives and Hypnotics, Muscle Relaxants, Drugs that are Mainly Renally Excreted, Pyrazines, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Central Nervous System Depressants, Muscle Relaxants, Centrally Acting Agents, Hypnotics (Nonbenzodiazepine), Hypnotics and Sedatives, Central Nervous System Agents, Cytochrome P-450 CYP2C8 Substrates, Drugs causing inadvertant photosensitivity, Benzodiazepine hypnotics and sedatives, Zopiclone and prodrugs	approved, investigational	5
DB01734	3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid	Drug	0	experimental	1
DB01733	L-Phospholactate	Drug	0	experimental	1
DB00403	Ceruletide	Drug	Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins, Tests for Bile Duct Patency, Diagnostic Agents	approved	1
DB00408	Loxapine	Drug	Psycholeptics, Tranquilizing Agents, Serotonin Agents, Nervous System, Dibenzoxazepines, Diazepines, Oxazepines, Thiazepines and Oxepines, Antipsychotic Agents (First Generation Typical), Antidepressive Agents, Serotonin 5-HT2 Receptor Antagonists, Antipsychotic Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Drugs causing inadvertant photosensitivity, Dopamine Antagonists, Dopamine Agents, Neurotoxic agents, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Photosensitizing Agents, Central Nervous System Depressants, Miscellaneous Antipsychotics, Serotonin Receptor Antagonists, Central Nervous System Agents, P-glycoprotein inhibitors, Dopamine D2 Receptor Antagonists	approved	33
DB00409	Remoxipride	Drug	Psycholeptics, Tranquilizing Agents, Benzoates, Cytochrome P-450 Substrates, Nervous System, Acids, Carbocyclic, Benzamides and benzamide derivatives, Amides, Psychotropic Drugs, Neurotransmitter Agents, Antipsychotic Agents, Bromobenzoates, Central Nervous System Depressants, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Dopamine Antagonists, Dopamine D2 Receptor Antagonists, Benzene Derivatives, Dopamine Agents, Neurotoxic agents	approved, withdrawn	5
DB01739	L-alloisoleucine	Drug	Amino Acids, Essential, Amino Acids, Branched-Chain, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	0
DB00406	Gentian violet cation	Drug	Amines, Gynecological Antiinfectives and Antiseptics, Aniline Compounds, Antifungals for Topical Use, Dermatologicals, Genito Urinary System and Sex Hormones, Miscellaneous Antifungals, Antifungals for Dermatological Use, Anti-Infective Agents, Anti-Infective Agents, Local	approved	1
DB01738	Phosphorylcolamine	Drug	Amines, Amino Alcohols, Alcohols	experimental	1
DB00407	Ardeparin	Drug	Anticoagulants, Carbohydrates, Polysaccharides, Glycosaminoglycans, Fibrin Modulating Agents, Heparin (Low Molecular Weight), Agents causing hyperkalemia, Heparin and similars, Hematologic Agents, Cardiovascular Agents	approved, investigational, withdrawn	2
DB01737	Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester	Drug	0	experimental	1
DB12473	Taurolidine	Drug	Alkanesulfonic Acids, Blood and Blood Forming Organs, Sulfur Acids, Hydrocarbons, Acyclic, Antineoplastic Agents, Alkanes, Thiazines, Blood Substitutes and Perfusion Solutions, Irrigating Solutions, Anti-Infective Agents, Anti-Infective Agents, Local, Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfonic Acids	approved, investigational	0
DB11142	Selenomethionine	Drug	Organoselenium Compounds, Amino Acids, Neutral, Sulfur Compounds, Amino Acids, Essential, Amino Acids, Sulfur, Amino Acids, Peptides, and Proteins, Amino Acids, Selenium Compounds	approved, investigational	0
DB12472	Levodropropizine	Drug	Antitussive Agents, Cough and Cold Preparations, Glycols, Central Nervous System Agents, Respiratory System Agents, Alcohols	investigational	0
DB11141	Manganese gluconate	Drug	Acids, Acyclic, Carbohydrates, Hydroxy Acids, Sugar Acids, Paramagnetic Contrast Agent	approved	0
DB12475	Biphenyl dimethyl dicarboxylate	Drug	0	investigational	0
DB11144	Hydrogenated palm kernel oil	Drug	0	experimental	0
DB11143	Cresol	Drug	Phenols, Standardized Chemical Allergen, Benzene Derivatives, Drugs that are Mainly Renally Excreted	approved	0
DB12474	Lynestrenol	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Contraceptives, Oral, Contraceptives, Oral, Synthetic, Progestogens and Estrogens, Sequential Preparations, Norpregnenes, Hormonal Contraceptives for Systemic Use, Norpregnanes, Contraceptive Agents, Female, Norsteroids, Reproductive Control Agents, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Progestins, Estren Derivatives, Combination Contraceptives (with Estrogen and derivatives), Progestin Contraceptives, Steroids	approved, investigational	0
DB12477	Perfluoro tert-butylcyclohexane	Drug	Hydrocarbons, Halogenated, Hydrocarbons, Fluorinated	investigational	0
DB11145	Oxyquinoline	Drug	Quinolines, Gynecological Antiinfectives and Antiseptics, Antiseptics and Disinfectants, Dermatologicals, Genito Urinary System and Sex Hormones, Hydroxyquinolines, Anti-Infective Agents, Local, Drugs that are Mainly Renally Excreted, Heterocyclic Compounds, Fused-Ring, Quinoline Derivatives, Throat Preparations, Antiinfectives and Antiseptics for Local Oral Treatment, Alimentary Tract and Metabolism, Stomatological Preparations	approved, vet_approved	0
DB12476	CPG-52852	Drug	0	investigational	0
DB12479	Zabofloxacin	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Quinolones	investigational	0
DB11148	Butamben	Drug	Aminobenzoates, para-Aminobenzoates, Benzoates, Sensory System Agents, Acids, Carbocyclic, Cholinesterase substrates, Central Nervous System Agents, Anesthetics, Benzene Derivatives, Drugs that are Mainly Renally Excreted, Anesthetics, Local, Peripheral Nervous System Agents	approved, withdrawn	4
DB11147	Aluminum zirconium pentachlorohydrate	Drug	0	approved	0
DB12478	Piribedil	Drug	Anti-Dyskinesia Agents, Neurotransmitter Agents, Piperazines, Nervous System, Anti-Parkinson Agents (Dopamine Agonist), Central Nervous System Agents, Nonergot-derivative Dopamine Receptor Agonists, Anti-Parkinson Drugs, Dopamine Agents, Dopamine Agonists	investigational	2
DB11149	Aluminum zirconium tetrachlorohydrex gly	Drug	0	approved	0
DB00491	Miglitol	Drug	Alkaloids, Carbohydrates, Glycoside Hydrolase Inhibitors, Enzyme Inhibitors, Imines, Imino Pyranoses, Alimentary Tract and Metabolism, Piperidines, Hypoglycemia-Associated Agents, Drugs Used in Diabetes, Blood Glucose Lowering Agents, Imino Sugars	approved	4
DB00492	Fosinopril	Drug	Acids, Acyclic, Enzyme Inhibitors, Agents causing hyperkalemia, Protease Inhibitors, Amino Acids, Peptides, and Proteins, Cardiovascular Agents, Hypotensive Agents, Drugs that are Mainly Renally Excreted, Imines, Angiotensin-Converting Enzyme Inhibitors, Agents Acting on the Renin-Angiotensin System, Agents causing angioedema, ACE Inhibitors and Diuretics, Antihypertensive Agents, Drugs causing inadvertant photosensitivity, Antihypertensive Agents Indicated for Hypertension, Phosphinic Acids, Organophosphorus Compounds, Phosphorus Compounds, Amino Acids, Phosphorus Acids, Amino Acids, Cyclic, Acids, Noncarboxylic, Acids, Photosensitizing Agents, Imino Acids	approved	1
DB00490	Buspirone	Drug	Psycholeptics, Tranquilizing Agents, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Piperazines, Cytochrome P-450 CYP3A7 Substrates, Nervous System, Cytochrome P-450 CYP3A4 Substrates, Miscellaneous Anxiolytics Sedatives and Hypnotics, Drugs that are Mainly Renally Excreted, Azaspirodecanedione Derivatives, Spiro Compounds, Neurotransmitter Agents, Pyrimidines, Cytochrome P-450 CYP3A Substrates, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Agents that produce hypertension, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors, Dopamine Antagonists, Dopamine D2 Receptor Antagonists	approved, investigational	5
DB00495	Zidovudine	Drug	Enzyme Inhibitors, Cytochrome P-450 Substrates, Immunosuppressive Agents, OAT1/SLC22A6 Substrates, UGT1A1 Inducers, Cytochrome P-450 CYP3A4 Substrates, Dideoxynucleosides, Anti-Infective Agents, OAT3/SLC22A8 Substrates, Antivirals for Systemic Use, Direct Acting Antivirals, Nucleic Acid Synthesis Inhibitors, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, UGT2B7 substrates, Glycosides, Cytochrome P-450 CYP2C8 Substrates, Nucleoside Reverse Transcriptase Inhibitors, Carbohydrates, Pyrimidine Nucleosides, Noxae, P-glycoprotein substrates, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Antiinfectives for Systemic Use, Antimetabolites, Myelosuppressive Agents, Cytochrome P-450 CYP2C9 Substrates, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, UGT1A1 Substrates, Cytochrome P-450 CYP2A6 Substrates, Nucleosides, Toxic Actions, Deoxyribonucleosides, Reverse Transcriptase Inhibitors, OAT3/SLC22A8 Inhibitors	approved	2
DB00496	Darifenacin	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Drugs for Urinary Frequency and Incontinence, Genito Urinary System and Sex Hormones, Urologicals, Agents producing tachycardia, Muscarinic Antagonists, Cytochrome P-450 CYP3A4 Substrates, Anticholinergic Agents, Urological Agents, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cholinergic Agents, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Cytochrome P-450 CYP2D6 Substrates	approved, investigational	5
DB00493	Cefotaxime	Drug	Nephrotoxic agents, Third-Generation Cephalosporins, Cephacetrile, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, OAT1/SLC22A6 inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, OAT3/SLC22A8 Inhibitors, Antibacterials for Systemic Use, Agents that reduce seizure threshold	approved	13
DB00494	Entacapone	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Anti-Parkinson Drugs, Anti-Dyskinesia Agents, COMT Inhibitors, Central Nervous System Depressants, Phenols, UGT1A9 Substrates, Central Nervous System Agents, Benzene Derivatives, Cytochrome P-450 CYP2D6 Inhibitors (weak), Dopamine Agents	approved, investigational	1
DB00499	Flutamide	Drug	Endocrine Therapy, Androgen Receptor Antagonists, Antineoplastic Agents, Hormonal, Amines, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Aniline Compounds, Antineoplastic and Immunomodulating Agents, Androgen Receptor Inhibitor, Antineoplastic Agents, Amides, Hormone Antagonists and Related Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Anilides, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Antiandrogens, Hormone Antagonists, Methemoglobinemia Associated Agents, Antiandrogens, non-steroidal	approved, investigational	3
DB00497	Oxycodone	Drug	Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Sensory System Agents, Narcotics, Nervous System, Natural Opium Alkaloids, Semi-synthetic Opioids, Cytochrome P-450 CYP3A4 Substrates, Morphinans, Opiate Agonists, Peripheral Nervous System Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, Analgesics, Cytochrome P-450 CYP3A Substrates, Morphine Derivatives, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Opioid Agonist, Opioids, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates	approved, illicit, investigational	3
DB00498	Phenindione	Drug	Anticoagulants, Blood and Blood Forming Organs, Narrow Therapeutic Index Drugs, Hematologic Agents, Indans, Indenes, Vitamin K Antagonists	approved, investigational	1
DB11140	Chromium Cr-51	Drug	Chromium Isotopes, Metals, Chromium, Radioisotopes, Metals, Heavy, Elements, Transition Elements, Isotopes	approved	0
DB12471	MK-3118	Drug	Carbohydrates, Terpenes	investigational	0
DB12470	Dexelvucitabine	Drug	Carbohydrates, Ribonucleosides, Enzyme Inhibitors, Pyrimidine Nucleosides, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Dideoxynucleosides, Anti-Infective Agents, Nucleic Acid Synthesis Inhibitors, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Deoxycytidine, HIV Reverse Transcriptase, Glycosides, Nucleosides, Deoxyribonucleosides, Reverse Transcriptase Inhibitors, Nucleoside Reverse Transcriptase Inhibitors	investigational	0
DB11153	Potassium hydroxide	Drug	Alkalies, Potassium Salt, Anions, Laboratory Chemicals, Electrolytes, Indicators and Reagents, Ions, Compounds used in a research, industrial, or household setting	approved	0
DB12484	Tetrahydrouridine	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Noxae, Glycosides, Nucleosides, Toxic Actions, Antimetabolites	investigational	0
DB12483	Copanlisib	Drug	Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, MATE inhibitors, Cytochrome P-450 CYP3A4 Substrates, Heterocyclic Compounds, Fused-Ring, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Substrates, MATE 2 Inhibitors, P-glycoprotein substrates with narrow therapeutic index, Kinase Inhibitor	approved, investigational	2
DB11152	Trichloroacetate	Drug	Hydrocarbons, Chlorinated, Acids, Acyclic, Fatty Acids, Noxae, Hydrocarbons, Halogenated, Lipids, Acetates, Chloroacetates, Fatty Acids, Volatile, Trichloroacetic Acid, Toxic Actions, Caustics, Compounds used in a research, industrial, or household setting	approved	0
DB11155	Triclocarban	Drug	Water Pollutants, Chemical, Amines, Environmental Pollutants, Aniline Compounds, Amides, Phenylurea Compounds, Anti-Infective Agents, Anti-Infective Agents, Local, Anilides, Toxic Actions, Water Pollutants, Benzene Derivatives, Miscellaneous Local Anti-infectives	approved	1
DB12486	Elobixibat	Drug	Sulfur Compounds, Oligopeptides, Peptides, Thiepins, Amino Acids, Peptides, and Proteins, Azepines	investigational	0
DB12485	Pimonidazole	Drug	Imidazoles, Nitro Compounds, Radiation-Sensitizing Agents	investigational	0
DB11154	Zinc citrate	Drug	Anticoagulants, Metal cations, Zinc Compounds, Metal divalent cations, Calculi Dissolution Agent, Copper Absorption Inhibitor	investigational	0
DB11157	Anthralin	Drug	Anthracenes, Antipsoriatics for Topical Use, Dermatologicals, Antracen Derivatives, Antipsoriatics	approved	3
DB11156	Pyrantel	Drug	Neuromuscular Agents, Antiparasitic Products, Insecticides and Repellents, Tetrahydropyrimidine Derivatives, Anthelmintics, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Pyrimidines, Sulfur Compounds, Thiophenes, Central Nervous System Depressants, Neuromuscular Blocking Agents, Neuromuscular Depolarizing Agents, Antinematodal Agents, Antiparasitic Agents	approved, vet_approved	2
DB12487	Promestriene	Drug	Sex Hormones and Modulators of the Genital System, Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, Estrenes, Estrogens, Genito Urinary System and Sex Hormones, Natural and Semisynthetic Estrogens, Plain, Hormones, Fused-Ring Compounds, Gonadal Steroid Hormones, Estradiol Congeners, Gonadal Hormones, Steroids	investigational	0
DB11159	Sodium sulfide	Drug	Gases, Anions, Sulfur Compounds, Acids, Noncarboxylic, Acids, Hydrogen Sulfide, Electrolytes, Ions	approved	0
DB12489	Mirvetuximab Soravtansine	Drug	Immunoglobulins, Cytochrome P-450 Enzyme Inhibitors, Noxae, Macrolides, Antibodies, Amides, Amino Acids, Peptides, and Proteins, Lactams, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Antibodies, Monoclonal, Immunoproteins, Lactones, Lactams, Macrocyclic, Proteins, Serum Globulins, Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Globulins, Blood Proteins, Cytochrome P-450 CYP3A4 Inhibitors, Toxic Actions	investigational	0
DB11158	Pectin	Drug	Food Additives, Carbohydrates, Plant Extracts, Biopolymers, Macromolecular Substances, Polysaccharides, Complex Mixtures, Intestinal Adsorbents, Physiological Phenomena, Plant Preparations, Alimentary Tract and Metabolism, Food and Beverages, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Biological Products, Food Ingredients, Pharmaceutical Preparations, Polymers, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food	approved, investigational, vet_approved	0
DB12480	Betulinic Acid	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Antineoplastic Agents, Phytogenic, Antiprotozoals, Sensory System Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Anti-Inflammatory Agents, Antimalarials, Antineoplastic Agents, Antirheumatic Agents, Non COX-2 selective NSAIDS, Prostaglandin Antagonists, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Anti-Infective Agents, Peripheral Nervous System Agents, Analgesics, Agents that produce hypertension, Central Nervous System Agents, Hormone Antagonists, Terpenes, Antiparasitic Agents	investigational	0
DB11151	Sodium hydroxide	Drug	Sodium Compounds, Alkalies, Anions, Hydroxides, Noxae, Electrolytes, Ions, Toxic Actions, Caustics, Compounds used in a research, industrial, or household setting	approved	0
DB12482	Acotiamide	Drug	Neurotransmitter Agents, Enzyme Inhibitors, Sulfur Compounds, Benzoates, Cholinergic Agents, Cholinesterase Inhibitors, Acids, Carbocyclic, Amides, Benzene Derivatives, Gastrointestinal Agents	investigational	0
DB11150	Barium sulfate	Drug	Sulfur Acids, Ions, Sulfates, Sulfuric Acids, Anions, Sulfur Compounds, Acids, Noncarboxylic, Contrast Media, Diagnostic Uses of Chemicals, Acids, Radiographic Contrast Agent, Barium Compounds, Electrolytes, X-Ray Contrast Media, Non-Iodinated, Compounds used in a research, industrial, or household setting, X-Ray Contrast Activity, Barium Sulfate Containing X-Ray Contrast Media	approved	0
DB12481	Barium	Drug	Metals, Metals, Alkaline Earth, Metals, Heavy, Elements	investigational	0
DB11164	Bicisate	Drug	Diagnostic Agents, Drugs that are Mainly Renally Excreted	approved, investigational	0
DB12495	Selepressin	Drug	Vasopressin and Analogues, Hormones, Hormone Substitutes, and Hormone Antagonists, Oligopeptides, Peptides, Pituitary Hormones, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Hormones, Receptors, Vasopressin, agonists, Proteins, Peptide Hormones, Pituitary Hormones, Posterior, Vasopressins	investigational	0
DB12494	SGI-1776	Drug	0	investigational	0
DB12497	Alagebrium	Drug	Sulfur Compounds	investigational	0
DB11166	Antithrombin Alfa	Drug	Anticoagulants, Recombinant Antithrombin, Factor Xa Inhibitors, Thrombin Inhibitors, Decreased Coagulation Factor Activity	approved, investigational	2
DB11165	Rosin	Drug	Cell-mediated Immunity, Complex Mixtures, Biological Products, Standardized Chemical Allergen, Tars, Plant Exudates, Pinus, Polymers, Biopolymers, Compounds used in a research, industrial, or household setting, Increased Histamine Release, Macromolecular Substances	approved	0
DB11168	Calcium threonate	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Blood Coagulation Factors, Lipids	approved	0
DB12499	Clascoterone	Drug	Acids, Acyclic, Fatty Acids, Pregnenediones, Hormones, Hormone Substitutes, and Hormone Antagonists, Adrenal Cortex Hormones, Lipids, Hormones, Fused-Ring Compounds, Hydroxycorticosteroids, Fatty Acids, Volatile, Pregnanes, 17-Hydroxycorticosteroids, Pregnenes, Steroids	investigational	0
DB12498	Mogamulizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Narrow Therapeutic Index Drugs, Globulins, Blood Proteins, Antineoplastic and Immunomodulating Agents, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	approved, investigational	1
DB11169	Ferrous asparto glycinate	Drug	0	approved	0
DB11160	Phenyltoloxamine	Drug	Benzene Derivatives	approved	1
DB12491	Fasiglifam	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds	investigational	0
DB12490	Forigerimod	Drug	Peptides, Amino Acids, Peptides, and Proteins, Ribonucleoprotein, U1 Small Nuclear	investigational	0
DB12493	PD-217014	Drug	Acids, Acyclic, Fatty Acids, Butyrates, Fatty Acids, Volatile, Amino Acids, Peptides, and Proteins, Ligands, Lipids, Aminobutyrates, Amino Acids	investigational	0
DB12492	Piritramide	Drug	Sensory System Agents, Analgesics, Narcotics, Nervous System, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Piperidines, Diphenylpropylamine Derivatives, Opioids, Central Nervous System Agents, Isonipecotic Acids, Peripheral Nervous System Agents	approved, investigational	0
DB11161	Polyethylene glycol 300	Drug	Ethylene Glycols, Glycols, Polymers, Compounds used in a research, industrial, or household setting, Alcohols, Macromolecular Substances	approved	0
DB11175	Zinc picolinate	Drug	Pyridines, Iron Chelating Agents, Metal cations, Zinc Compounds, Metal divalent cations, Sequestering Agents, Copper Absorption Inhibitor, Compounds used in a research, industrial, or household setting	investigational	0
DB11174	2-(l-menthoxy)ethanol	Drug	0	experimental	0
DB11176	Zeaxanthin	Drug	Xanthophylls, Biological Factors, Cycloparaffins, Carotenoids, Alkenes, Hydrocarbons, Acyclic, Polyenes, Cyclohexenes, Terpenes, Cyclohexanes, Pigments, Biological	approved, investigational	0
DB11179	Exametazime	Drug	Ketones	approved	0
DB11178	Polysorbate 20	Drug	Surface-Active Agents, Excipients, Polyethylene Glycols, Pharmaceutic Aids, Alcohols, Drug Delivery Systems, Macromolecular Substances, Ethylene Glycols, Glycols, Pharmaceutical Preparations, Polymers, Compounds used in a research, industrial, or household setting, Pharmaceutical Vehicles	approved	0
DB11171	Ferric sulfate	Drug	Hematinics, Organometallic Compounds, Parenteral Iron Replacement, Phosphate Binder, Iron Compounds	approved	0
DB11172	Sesame oil	Drug	Oils, Lipids, Dietary Fats, Unsaturated, Complex Mixtures, Physiological Phenomena, Plant Preparations, Fats, Unsaturated, Dietary Fats, Food and Beverages, Biological Products, Plant Oils, Fats, Diet, Food, and Nutrition, Food	investigational, nutraceutical	0
DB13761	Tilactase	Drug	Enzymes, beta-Galactosidase, antagonists & inhibitors, Glycoside Hydrolases, Alimentary Tract and Metabolism, beta-Galactosidase, Enzymes and Coenzymes, Antifoaming Agents, Digestives, Incl. Enzymes, Hydrolases, Enzyme Preparations, Galactosidases, Gastrointestinal Agents	approved, experimental	1
DB13762	Dexrabeprazole	Drug	Pyridines, Benzimidazoles, Enzyme Inhibitors, Cytochrome P-450 Substrates, Proton Pump Inhibitors, Sulfoxides, Anti-Ulcer Agents, Cytochrome P-450 CYP2C19 Substrates, Heterocyclic Compounds, Fused-Ring, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Gastric Acid Lowering Agents, Sulfur Compounds, Alimentary Tract and Metabolism, Acid Reducers, 2-Pyridinylmethylsulfinylbenzimidazoles, Drugs for Acid Related Disorders, Gastrointestinal Agents	experimental	0
DB11100	Allantoin	Drug	Basic Ointments and Protectants, Imidazoles, Dermatologicals, Herbs and Natural Products, Hydantoins, Imidazolidines, Thyroxine-binding globulin substrates	approved	0
DB12431	Muplestim	Drug	Interleukin-3, Biological Factors, Carbohydrates, Cytokines, Glycoconjugates, Peptides, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Glycoproteins, Hematopoietic Cell Growth Factors, Proteins, Interleukins, Colony-Stimulating Factors	investigational	0
DB13760	Niperotidine	Drug	Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Gastric Acid Lowering Agents, Histamine Antagonists, Alimentary Tract and Metabolism, Drugs for Acid Related Disorders, Histamine H2 Antagonists	investigational, experimental	0
DB13765	Mercuric chloride	Drug	Antiseptics and Disinfectants, Dermatologicals, Mercurial Products, Ions, Anti-Infective Agents, Anti-Infective Agents, Local, Anions, Acids, Noncarboxylic, Acids, Disinfectants, Chlorides, Electrolytes, Mercury Compounds, Compounds used in a research, industrial, or household setting, Chlorine Compounds	experimental	0
DB12433	SCH-900271	Drug	0	investigational	0
DB11102	N-acetyltyrosine	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Amino Acids, Peptides, and Proteins, Amino Acids, Drugs that are Mainly Renally Excreted	approved	0
DB13766	Lidoflazine	Drug	QTc Prolonging Agents, Cytochrome P-450 Substrates, Piperazines, Agents causing hyperkalemia, Non-Selective Calcium Channel Blockers, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Membrane Transport Modulators, Calcium Channel Blockers, Cytochrome P-450 CYP3A Substrates, Calcium-Regulating Hormones and Agents, Potential QTc-Prolonging Agents, Vasodilating Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	approved, experimental	0
DB12432	CC-401	Drug	JNK Mitogen-Activated Protein Kinases, antagonists & inhibitors, Pyrazoles	investigational	0
DB13763	Aurotioprol	Drug	Organometallic Compounds, Sulfur Compounds, Antiinflammatory and Antirheumatic Products, Gold Preparations, Musculo-Skeletal System, Antirheumatic Agents, Specific Antirheumatic Agents, Alcohols	experimental	0
DB12435	Tipelukast	Drug	0	investigational	0
DB11104	Sulfur hexafluoride	Drug	Other Diagnostics, Hydrofluoric Acid, Fluorine Compounds, Ions, Fluorides, Ultrasound Contrast Media, Gases, Anions, Sulfur Compounds, Acids, Noncarboxylic, Contrast Media, Acids, Electrolytes, Ultrasound Contrast Activity	approved	0
DB12434	Steviolbioside	Drug	Food Additives, Flavoring Agents, Pharmaceutic Aids, Physiological Phenomena, Food and Beverages, Diterpenes, Food Ingredients, Pharmaceutical Preparations, Terpenes, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Stevia, Food, Sweetening Agents	approved, investigational	0
DB13764	Monoxerutin	Drug	Vasoprotectives, Flavonoids, Capillary Stabilizing Agents	experimental	0
DB13769	Emetonium iodide	Drug	Anticholinergic Agents, Synthetic Anticholinergics, Quaternary Ammonium Compounds, Alimentary Tract and Metabolism, Agents producing tachycardia, Drugs for Functional Gastrointestinal Disorders, Muscarinic Antagonists	experimental	0
DB11105	Benzalkonium	Drug	Surface-Active Agents, Amines, Ammonium Compounds, Medicated Dressings, Quaternary Ammonium Compounds, Antiseptics and Disinfectants, Dermatologicals, Onium Compounds, Detergents, Anti-Infective Agents, Anti-Infective Agents, Local, Household Products, Pharmaceutic Aids, Benzalkonium Compounds, Preservatives, Pharmaceutical, Benzylammonium Compounds, Medicated Dressings With Antiinfectives, Throat Preparations, Pharmaceutical Preparations, Compounds used in a research, industrial, or household setting, Nitrogen Compounds, Miscellaneous Local Anti-infectives	approved, investigational	0
DB12436	Vofopitant	Drug	Autonomic Agents, Neurotransmitter Agents, Antiemetics, Central Nervous System Agents, Neurokinin-1 Receptor Antagonists, Gastrointestinal Agents, Peripheral Nervous System Agents	investigational	1
DB13767	Vorozole	Drug	Endocrine Therapy, Aromatase Inhibitors, Enzyme Inhibitors, Estrogen Antagonists, Steroid Synthesis Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Hormone Antagonists and Related Agents, Hormone Antagonists, Carbon Radioisotopes	experimental	0
DB11108	Aluminum sesquichlorohydrate	Drug	Alkalies, Anions, Acids, Noncarboxylic, Hydroxides, Metal cations, Acids, Metal divalent cations, Aluminium Compounds, Electrolytes, Ions, Chlorine Compounds	approved	0
DB12439	Ioforminol	Drug	Acids, Acyclic, Iodobenzoates, Benzoates, Iodine Radioisotopes, Acids, Carbocyclic, Amides, Formates, Benzene Derivatives	investigational	0
DB12438	Filociclovir	Drug	0	investigational	0
DB13768	Domiodol	Drug	Cough and Cold Preparations, Expectorants, Dioxoles	experimental	0
DB11107	Potassium bitartrate	Drug	Potassium Salt, Radiographic Contrast Agent	experimental	0
DB11109	Chlorine	Drug	Gases, Poisons, Noxae, Halogens, Toxic Actions, Elements, Compounds used in a research, industrial, or household setting	experimental	0
DB01783	Pantothenic acid	Drug	Alanine, Dermatologicals, Blood Coagulation Factors, Amino Acids, Peptides, and Proteins, Amino Acids, Imides, Vitamins, Micronutrients, Physiological Phenomena, Alimentary Tract and Metabolism, Food and Beverages, Vitamin B Complex, Preparations for Treatment of Wounds and Ulcers, Growth Substances, Diet, Food, and Nutrition, Cicatrizants, Food	approved, nutraceutical, vet_approved	1
DB00451	Levothyroxine	Drug	Amino Acids, Aromatic, OATP1B1/SLCO1B1 Inhibitors, Thyroid Products, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, OATP1B3 inhibitors, Amino Acids, Peptides, and Proteins, Hormones, Cytochrome P-450 CYP3A4 Substrates, Amino Acids, UGT1A1 substrates with narrow therapeutic index, Agents used to treat hypothyroidism, Thyroxine-binding globulin substrates, P-glycoprotein inducers, Amino Acids, Cyclic, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, UGT1A1 Substrates, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins	approved	4
DB01782	Pyrazolanthrone	Drug	0	experimental	4
DB00452	Framycetin	Drug	Nephrotoxic agents, Carbohydrates, Medicated Dressings, Dermatologicals, Agents that produce neuromuscular block (indirect), Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Ophthalmologicals, Anti-Bacterial Agents, Medicated Dressings With Antiinfectives, Nasal Preparations, Narrow Therapeutic Index Drugs, Aminoglycoside Antibacterials, Glycosides, Sensory Organs	approved	3
DB00450	Droperidol	Drug	Psycholeptics, QTc Prolonging Agents, Tranquilizing Agents, Benzimidazoles, Nervous System, Antipsychotic Agents (First Generation Typical), Butyrophenones, Peripheral Nervous System Agents, Antipsychotic Agents, Adrenergic Antagonists, Adrenergic alpha-1 Receptor Antagonists, Butyrophenone Derivatives, Dopamine Antagonists, Dopamine Agents, Gastrointestinal Agents, Neurotoxic agents, Autonomic Agents, Adrenergic alpha-Antagonists, Ketones, Miscellaneous Anxiolytics Sedatives and Hypnotics, Moderate Risk QTc-Prolonging Agents, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Central Nervous System Depressants, Agents that produce hypertension, Antiemetics, Adjuvants, Anesthesia, Central Nervous System Agents, Dopamine D2 Receptor Antagonists	approved, vet_approved	2
DB01780	Fusicoccin	Drug	Carbohydrates, Mycotoxins	experimental	1
DB00455	Loratadine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, BSEP/ABCB11 Substrates, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Dibenzocycloheptenes, Histamine H1 Antagonists, Piperidines, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Cytochrome P-450 CYP2C8 Substrates, Antihistamines for Systemic Use, Antipruritics, Anti-Allergic Agents, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, Dermatologicals, Benzocycloheptenes, Cytochrome P-450 CYP2C19 Substrates, Loratadine and prodrug, Cytochrome P-450 CYP2C9 Substrates, Neurotransmitter Agents, Histamine H1 Antagonists, Non-Sedating, Cytochrome P-450 CYP3A Inhibitors, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2C19 Inhibitors (weak), Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (weak), Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved, investigational	2
DB01786	D-Alanine	Drug	0	experimental	2
DB00456	Cefalotin	Drug	Nephrotoxic agents, Cephacetrile, Amides, Lactams, Thiazines, beta-Lactams, First-Generation Cephalosporins, Antiinfectives for Systemic Use, Anti-Infective Agents, OAT1/SLC22A6 inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, OAT3/SLC22A8 Inhibitors, Antibacterials for Systemic Use, Agents that reduce seizure threshold	approved, investigational, vet_approved	8
DB01785	Dimethylallyl Diphosphate	Drug	Terpenes	experimental	3
DB00453	Clomocycline	Drug	Anti-Bacterial Agents, Tetracyclines, Naphthacenes, Agents that produce neuromuscular block (indirect), Antiinfectives for Systemic Use, Antibacterials for Systemic Use	experimental	3
DB01784	4-Flourobenzenesulfonamide	Drug	0	experimental	1
DB00454	Meperidine	Drug	Cytochrome P-450 Substrates, Sensory System Agents, Serotonin Agents, Nervous System, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Antidepressive Agents, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Opiate Agonists, Peripheral Nervous System Agents, Serotonin Modulators, Cytochrome P-450 Enzyme Inducers, Phenylpiperidine opioids, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Piperidines, Opioids, Isonipecotic Acids, Agents that reduce seizure threshold, Narcotics, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inducers, Adjuvants, Cytochrome P-450 CYP2C19 Substrates, High-risk opioids, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Opioid Agonist, NMDA Receptor Antagonists, Cytochrome P-450 CYP1A2 Inducers, Adjuvants, Anesthesia, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates	approved	12
DB00459	Acitretin	Drug	Biological Factors, Cycloparaffins, Retinoids for Treatment of Psoriasis, Alkenes, Dermatologicals, Hydrocarbons, Acyclic, Cyclohexenes, Misc. Skin and Mucous Membrane Agents, Retinoids, Antipsoriatics, Cyclohexanes, Pigments, Biological, Carotenoids, Photosensitizing Agents, Antipsoriatics for Systemic Use, Polyenes, Hepatotoxic Agents, Drugs causing inadvertant photosensitivity, Keratolytic Agents, Terpenes	approved	8
DB01789	1-Amino-2,3-Dihydroxy-5-Hydroxymethyl Cyclohex-5-Ene	Drug	0	experimental	1
DB00457	Prazosin	Drug	OCT1 substrates, Antihypertensive Agents Indicated for Hypertension, Adrenergic alpha-Antagonists, OCT2 Substrates, P-glycoprotein substrates, OCT1 inhibitors, Peripheral alpha-1 blockers, Antiadrenergic Agents, Peripherally Acting, Cardiovascular Agents, Hypotensive Agents, Quinazolines, Heterocyclic Compounds, Fused-Ring, BCRP/ABCG2 Substrates, Adrenergic Antagonists, Alpha-Adrenoreceptor Antagonists and Diuretics, Adrenergic alpha-1 Receptor Antagonists, Antihypertensive Agents, P-glycoprotein inhibitors, Vasodilating Agents	approved	7
DB00458	Imipramine	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Drugs that are Mainly Renally Excreted, Anticholinergic Agents, Serotonin 5-HT2 Receptor Antagonists, Tricyclics and Other Norepinephrine-reuptake Inhibitors, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Adrenergic Agents, Agents that reduce seizure threshold, Cytochrome P-450 CYP2C18 Substrates, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Agents producing tachycardia, Membrane Transport Modulators, Cytochrome P-450 CYP2C19 Substrates, Neurotransmitter Agents, Tertiary amine tricyclic antidepressants, Central Nervous System Depressants, Antidepressive Agents, Tricyclic, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (moderate), Cytochrome P-450 CYP2D6 Inhibitors (weak), Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Adrenergic Uptake Inhibitors, Serotonin Agents, Nervous System, Cytochrome P-450 CYP2C19 Inhibitors, Hypotensive Agents, Muscarinic Antagonists, Antidepressive Agents, Cytochrome P-450 CYP1A2 Inhibitors, Serotonin Modulators, Histamine H1 Antagonists, Adrenergic Antagonists, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Adrenergic alpha-1 Receptor Antagonists, Neurotoxic agents, Adrenergic alpha-Antagonists, Cytochrome P-450 CYP2E1 Inhibitors, P-glycoprotein substrates, Dibenzazepines, Moderate Risk QTc-Prolonging Agents, Psychotropic Drugs, Cytochrome P-450 CYP2C19 Inhibitors (strong), Heterocyclic Compounds, Fused-Ring, Non-Selective Monoamine Reuptake Inhibitors, Cytochrome P-450 CYP3A Inhibitors, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, OCT2 Inhibitors, Neurotransmitter Uptake Inhibitors, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Serotonin Receptor Antagonists, Central Nervous System Agents, Psychoanaleptics	approved	24
DB01788	4-Imino-5-Methidyl-2-Methylpyrimidine	Drug	0	experimental	1
DB12440	Verdiperstat	Drug	Pyrimidines	investigational	0
DB13772	Rufloxacin	Drug	Fluoroquinolones, Quinolines, QTc Prolonging Agents, Enzyme Inhibitors, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Antiinfectives for Systemic Use, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Quinolones, Cytochrome P-450 CYP1A2 Inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Topoisomerase II Inhibitors, Potential QTc-Prolonging Agents, Antibacterials for Systemic Use	experimental	0
DB13773	Sulfamethoxypyridazine	Drug	Long-Acting Sulfonamides, Amines, Aniline Compounds, Amides, Sulfanilamides, Antiinfectives for Systemic Use, Anti-Infective Agents, SULFONAMIDES AND TRIMETHOPRIM, Anti-Bacterial Agents, Sulfur Compounds, Sulfonamide Antibacterial, Sulfonamides, Antibacterials for Systemic Use, Sulfones	experimental	0
DB13770	Vinylbital	Drug	Psycholeptics, Pyrimidines, Nervous System, Central Nervous System Depressants, Barbiturates, Plain, Pyrimidinones, Hypnotics and Sedatives	experimental	0
DB11111	Witch hazel	Drug	0	nutraceutical	0
DB12442	Alvespimycin	Drug	Quinones, HSP90 Heat-Shock Proteins, Amides, Lactams	investigational	1
DB12441	Tavilermide	Drug	0	investigational	0
DB13771	Ferric sodium citrate	Drug	Iron Trivalent, Oral Preparations, Antianemic Preparations, Blood and Blood Forming Organs, Iron Preparations	experimental	0
DB11110	Magnesium citrate	Drug	Acids, Acyclic, Blood and Blood Forming Organs, Citrates, Drugs for Constipation, Calculi Dissolution Agent, Laxatives, magnesium containing, Mineral Supplements, Agents that produce neuromuscular block (indirect), Blood Substitutes and Perfusion Solutions, Irrigating Solutions, Salt Solutions, Tricarboxylic Acids, Metal cations, Alimentary Tract and Metabolism, Metal divalent cations, Osmotic Laxatives, Laxatives, Gastrointestinal Agents, Magnesium Compounds	approved	0
DB13776	Ibacitabine	Drug	Dermatologicals, Antiviral Agents	experimental	0
DB11113	Castor oil	Drug	Oils, Drugs for Constipation, Lipids, Complex Mixtures, Plant Preparations, Alimentary Tract and Metabolism, Fats, Unsaturated, Biological Products, Laxatives, Contact Laxatives, Plant Oils, Fats, Gastrointestinal Agents	approved, investigational, nutraceutical, vet_approved	2
DB12444	Theanine	Drug	Amino Acids, Dicarboxylic, Amino Acids, Peptides, and Proteins, Amino Acids, Acidic, Amino Acids	investigational	0
DB12443	Sonedenoson	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purines, Ribonucleosides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Purine Nucleosides	investigational	0
DB11112	Lanolin	Drug	Basic Ointments and Protectants, Cosmetics, Lipids, Waxes, Compounds used in a research, industrial, or household setting, Household Products	approved	1
DB13777	Prenalterol	Drug	Autonomic Agents, Amines, Propanols, Protective Agents, Phenoxypropanolamines, Agents producing tachycardia, Adrenergic and Dopaminergic Agents, Cardiovascular Agents, Amino Alcohols, Alcohols, Peripheral Nervous System Agents, Cardiotonic Agents, Adrenergic beta-Agonists, Neurotransmitter Agents, Sympathomimetics, Adrenergic Agonists, Cardiac Stimulants Excl. Cardiac Glycosides, Adrenergic beta-1 Receptor Agonists, Agents that produce hypertension, Cardiac Therapy, Compounds used in a research, industrial, or household setting, Adrenergic Agents, Propanolamines	experimental	0
DB12446	Derenofylline	Drug	0	investigational	0
DB13774	Myristalkonium	Drug	Throat Preparations, Anti-Infective Agents, Local	experimental	0
DB11115	Ensulizole	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfur Acids, Sunscreen Agents	approved	0
DB13775	Tertatolol	Drug	Amines, Cytochrome P-450 Substrates, Propanols, Agents causing hyperkalemia, Adrenergic beta-Antagonists, Cardiovascular Agents, Amino Alcohols, Beta Blocking Agents, Non-Selective, Alcohols, Neurotransmitter Agents, Sulfur Compounds, Adrenergic Antagonists, Cytochrome P-450 CYP2D6 Substrates, Adrenergic Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	experimental	0
DB12445	Nitroaspirin	Drug	Nephrotoxic agents, Enzyme Inhibitors, Sensory System Agents, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Protease Inhibitors, Non COX-2 selective NSAIDS, Cardiovascular Agents, Peripheral Nervous System Agents, Analgesics, Salicylates, Antiplatelet agents, Benzene Derivatives, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Benzoates, Hydroxy Acids, Fibrin Modulating Agents, Antirheumatic Agents, Hydroxybenzoates, Hematologic Agents, Cysteine Proteinase Inhibitors, Agents that produce hypertension, Phenols, Central Nervous System Agents	investigational	1
DB11114	Eucalyptus oil	Drug	Complex Mixtures, Oils, Plant Preparations, Biological Products, Lipids, Plant Oils, Other Cold and Cough Preparations, Drugs that are Mainly Renally Excreted	approved	0
DB12448	Lifibrol	Drug	Benzoates, Hydroxy Acids, Acids, Carbocyclic, Phenols, Lipids, Benzene Derivatives, Fatty Alcohols, Alcohols	investigational	0
DB11117	Undecylenic acid	Drug	Fatty Acids, Unsaturated, Fatty Acids, Antifungals for Topical Use, Dermatologicals, Antifungals for Dermatological Use, Lipids, Fatty Acids, Monounsaturated	approved, investigational	0
DB12447	Nadifloxacin	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Enzyme Inhibitors, Topoisomerase Inhibitors, Antiinfectives for Treatment of Acne, Dermatologicals, Topoisomerase II Inhibitors, Anti-Acne Preparations, Anti-Acne Preparations for Topical Use, Anti-Infective Agents, Quinolones	investigational	0
DB11116	Aluminum zirconium trichlorohydrex gly	Drug	0	approved, experimental	0
DB11119	Sodium iodide	Drug	Sodium Compounds, Anions, Iodides, Iodine Compounds, Replacement Preparations, Electrolytes, Ions, Thyroid Diagnostic Radiopharmaceuticals	approved	0
DB13778	Cefazedone	Drug	Nephrotoxic agents, Amides, Lactams, Thiazines, beta-Lactams, First-Generation Cephalosporins, Antiinfectives for Systemic Use, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Antibacterials for Systemic Use	experimental	0
DB11118	Ammonia	Drug	Gases, Nitrogen Compounds	approved	0
DB12449	Tempol	Drug	Antioxidants, Drug Synergism, Radiation-Protective Agents, Neuroprotective Agents, Enzyme Inhibitors, Free Radicals, Protective Agents, Central Nervous System Agents, Spin Labels, Compounds used in a research, industrial, or household setting, Protein Synthesis Inhibitors	investigational	0
DB13779	Guanoclor	Drug	Guanidine Derivatives, Antiadrenergic Agents, Peripherally Acting, Amidines, Antihypertensive Agents	experimental	0
DB01790	(Rp)-cAMPS	Drug	Carbohydrates, Enzyme Inhibitors, Stereoisomerism, Nucleotides, Nucleotides, Cyclic, Cyclic AMP-Dependent Protein Kinases, agonists, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Protein Kinase Inhibitors, Ribonucleotides, Sulfur Compounds, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Adenine Nucleotides, Cyclic AMP-Dependent Protein Kinases, antagonists & inhibitors	experimental	1
DB00462	Methscopolamine bromide	Drug	Anticholinergic Agents, Agents producing tachycardia, Muscarinic Antagonists	approved	3
DB01794	bis(molybdopterin)tungsten cofactor	Drug	0	experimental	0
DB01793	SB-409513	Drug	0	experimental	1
DB00463	Metharbital	Drug	Anticholinergic Agents, Anticonvulsants, Pyrimidines, Nervous System, Central Nervous System Depressants, Pyrimidinones, Barbiturates and Derivatives, Nicotinic Antagonists	withdrawn	11
DB01792	Adenylyl-(3'-5')-uridine 3'-monophosphate	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Oligonucleotides, Glycosides, Nucleotides, Polynucleotides	experimental	1
DB00460	Verteporfin	Drug	Biological Factors, Dermatologicals, Photosensitizing Activity, Antineovascularisation Agents, Ocular Vascular Disorder Agents, Photoabsorption, Radiation-Sensitizing Agents, Pigments, Biological, Ophthalmologicals, EENT Drugs, Miscellaneous, Heterocyclic Compounds, Fused-Ring, Photosensitizing Agents, Photoenhancer, Sensory Organs, Porphyrins	approved, investigational	0
DB00461	Nabumetone	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cyclooxygenase Inhibitors, Ketones, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Selective Cyclooxygenase 2 Inhibitors (NSAIDs), Cytochrome P-450 CYP2C9 Substrates, Butanones, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, COX-2 Inhibitors, Analgesics, Photosensitizing Agents, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Musculo-Skeletal System, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Drugs causing inadvertant photosensitivity, Other Nonsteroidal Anti-inflammatory Agents	approved	2
DB01791	Piclamilast	Drug	Phosphodiesterase Inhibitors, Enzyme Inhibitors, Benzoates, Acids, Carbocyclic, Phosphodiesterase 4 Inhibitors, Amides, Benzene Derivatives	experimental	4
DB00466	Picrotoxin	Drug	Central Nervous System Stimulants, Cycloparaffins, Antidotes, GABA Agents, Protective Agents, Cyclohexanes, Lactones, Neurotransmitter Agents, Stimulants, Convulsants, Central Nervous System Agents, Compounds used in a research, industrial, or household setting, GABA Antagonists	experimental	5
DB01798	Ethyl Dihydrogen Diphosphate	Drug	0	experimental	0
DB00467	Enoxacin	Drug	Fluoroquinolones, Quinolines, QTc Prolonging Agents, Enzyme Inhibitors, Topoisomerase Inhibitors, Chemically-Induced Disorders, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (strong), Antiinfectives for Systemic Use, Anti-Infective Agents, Quinolones, Cytochrome P-450 CYP1A2 Inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Topoisomerase II Inhibitors, Potential QTc-Prolonging Agents, Antibacterials for Systemic Use	approved, investigational	3
DB01797	(2R)-2-(aminomethyl)-2,4-dihydroxy-5-oxo-3-(2-oxoethyl)-2,5-dihydro-1H-imidazol-3-ium	Drug	0	experimental	0
DB01796	Quinolinic Acid	Drug	Pyridines, Quinolinic Acids	experimental	2
DB00464	Sodium tetradecyl sulfate	Drug	Alkanesulfonic Acids, Surface-Active Agents, Sulfur Acids, Hydrocarbons, Acyclic, Alkanes, Lipids, Cardiovascular Agents, Sclerosing Agents for Local Injection, Pharmaceutical Solutions, Alcohols, Vasoprotectives, Sulfur Compounds, Acids, Noncarboxylic, Alkanesulfonates, Acids, Solutions, Sclerosing Solutions, Sulfonic Acids, Antivaricose Therapy, Pharmaceutical Preparations, Compounds used in a research, industrial, or household setting, Fatty Alcohols	approved, investigational	2
DB00465	Ketorolac	Drug	Nephrotoxic agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Agents causing hyperkalemia, Non COX-2 selective NSAIDS, Antiinflammatory and Antirheumatic Products, Non-Steroids, UGT2B7 substrates, Analgesics, Musculo-Skeletal System, Cytochrome P-450 CYP2C8 Substrates, Drugs causing inadvertant photosensitivity, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Sympathomimetics Excl. Antiglaucoma Preparations, Acetic Acid Derivatives and Related Substances, Mydriatics and Cycloplegics, Antirheumatic Agents, Ophthalmologicals, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Mydriatics, Antiinflammatory and Antirheumatic Products, Photosensitizing Agents, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Agents that produce hypertension, Sensory Organs, Other Nonsteroidal Anti-inflammatory Agents	approved	2
DB01795	Phenylboronic acid	Drug	Acids, Noncarboxylic, Acids, Boron Compounds	experimental	1
DB00468	Quinine	Drug	Neuromuscular Agents, Cytochrome P-450 Substrates, Sensory System Agents, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Hypoglycemia-Associated Agents, OCT1 inhibitors, Antimalarials, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Muscle Relaxants, Peripheral Nervous System Agents, Muscle Relaxants, Centrally Acting Agents, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Cytochrome P-450 CYP2C8 Substrates, Agents that reduce seizure threshold, Analgesics, Non-Narcotic, OATP1B1/SLCO1B1 Inhibitors, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP2C19 Substrates, Central Nervous System Depressants, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP2D6 Substrates, Antiparasitic Agents, Cytochrome P-450 CYP2D6 Inhibitors, OCT1 substrates, Quinolines, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Cytochrome P-450 CYP2C19 Inhibitors, Agents that produce neuromuscular block (indirect), Anti-Infective Agents, Cytochrome P-450 CYP1A2 Inhibitors, Alkaloids, Cytochrome P-450 Enzyme Inducers, Analgesics, Cinchona Alkaloids, Musculo-Skeletal System, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Quinuclidines, Cytochrome P-450 CYP2E1 Substrates, P-glycoprotein substrates, Blood Glucose Lowering Agents, Methanolquinolines, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Herbs (Hypotensive Properties), OCT2 Inhibitors, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Central Nervous System Agents, Methemoglobinemia Associated Agents, P-glycoprotein inhibitors	approved	3
DB00469	Tenoxicam	Drug	Nephrotoxic agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Oxicams, Sensory System Agents, Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Agents causing hyperkalemia, Non COX-2 selective NSAIDS, Peripheral Nervous System Agents, Sulfur Compounds, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Musculo-Skeletal System, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Antirheumatic Agents, Thiazines, Cytochrome P-450 CYP2C9 Substrates, Antiinflammatory and Antirheumatic Products, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Agents that produce hypertension, Central Nervous System Agents, OAT3/SLC22A8 Inhibitors, Other Nonsteroidal Anti-inflammatory Agents	approved	2
DB01799	4-Hydroxy-3-Methyl Butyl Diphosphate	Drug	0	experimental	1
DB11120	Turpentine	Drug	Solvents, Noxae, Oils, Lipids, Resins, Plant, Oils, Volatile, Plant Exudates, Biopolymers, Irritants, Macromolecular Substances, Complex Mixtures, Biological Products, Toxic Actions, Polymers, Compounds used in a research, industrial, or household setting	approved, experimental	1
DB13783	Acemetacin	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Acetic Acid Derivatives and Related Substances, Sensory System Agents, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Peripheral Nervous System Agents, Heterocyclic Compounds, Fused-Ring, Antigout Preparations, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, UGT2B7 substrates, Analgesics, Musculo-Skeletal System, Agents that produce hypertension, Central Nervous System Agents, Indoles	approved, investigational	2
DB12451	SCY-635	Drug	Peptides, Cyclic, Peptides, Amino Acids, Peptides, and Proteins	investigational	0
DB13784	Dixyrazine	Drug	Analgesics, Non-Narcotic, Autonomic Agents, Psycholeptics, Tranquilizing Agents, Sensory System Agents, Nervous System, Phenothiazines, Psychotropic Drugs, Peripheral Nervous System Agents, Heterocyclic Compounds, Fused-Ring, Antipsychotic Agents, Sulfur Compounds, Analgesics, Central Nervous System Depressants, Antiemetics, Central Nervous System Agents, Phenothiazines With Piperazine Structure, Gastrointestinal Agents, Neurotoxic agents	experimental	0
DB12450	Propyl Gallate	Drug	Antioxidants, Benzoates, Hydroxy Acids, Protective Agents, Acids, Carbocyclic, Gallic Acid, Hydroxybenzoates, Phenols, Compounds used in a research, industrial, or household setting, Benzene Derivatives	investigational	1
DB13781	Xamoterol	Drug	Oxazines, Amines, Propanols, Phenoxypropanolamines, Agents producing tachycardia, Amino Alcohols, Morpholines, Alcohols, Adrenergic beta-Agonists, Neurotransmitter Agents, Adrenergic Agonists, Cardiac Stimulants Excl. Cardiac Glycosides, Adrenergic beta-1 Receptor Agonists, Agents that produce hypertension, Cardiac Therapy, Adrenergic Agents, Propanolamines	approved	1
DB12453	Chlorine Dioxide	Drug	Anions, Disinfectants, Dental Disinfectants, Electrolytes, Ions, Compounds used in a research, industrial, or household setting, Anti-Infective Agents, Oxygen Compounds	investigational	0
DB11121	Chloroxylenol	Drug	Antiseptics and Disinfectants, Dermatologicals, Schistosomicides, Anti-Infective Agents, Anti-Infective Agents, Local, Drugs that are Mainly Renally Excreted, Disinfectants, Antiplatyhelmintic Agents, Compounds used in a research, industrial, or household setting, Antiparasitic Agents, Benzene Derivatives, Miscellaneous Local Anti-infectives, Phenol and Derivatives	approved	0
DB13782	Imipramine oxide	Drug	Nervous System, Dibenzazepines, Antidepressive Agents, Heterocyclic Compounds, Fused-Ring, Non-Selective Monoamine Reuptake Inhibitors, Narrow Therapeutic Index Drugs, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Antidepressive Agents, Tricyclic, Agents that produce hypertension, Agents that reduce seizure threshold, Neurotoxic agents, Psychoanaleptics	experimental	0
DB12452	Caprylic alcohol	Drug	Solvents, Lipids, Octanols, Compounds used in a research, industrial, or household setting, Fatty Alcohols, Alcohols	investigational	0
DB12455	Omadacycline	Drug	Anti-Bacterial Agents, P-glycoprotein substrates, Tetracyclines, Naphthacenes, Antiinfectives for Systemic Use, Antibacterials for Systemic Use	approved, investigational	6
DB11124	Racepinephrine	Drug	Amines, Adrenergic alpha-1 Receptor Agonists, Cardiovascular Agents, Adrenergic beta-2 Receptor Agonists, Alcohols, Peripheral Nervous System Agents, Adrenergic alpha-2 Receptor Agonists, Adrenergic beta-1 Receptor Agonists, Alpha-and Beta-adrenergic Agonists, Biogenic Amines, Adrenergic Agents, Benzene Derivatives, Autonomic Agents, Adrenergic alpha-Agonists, Anti-Asthmatic Agents, Epinephrine and similars, Agents producing tachycardia, Catecholamines, Catechols, Bronchodilator Agents, Amino Alcohols, Ethanolamines, Respiratory System Agents, Biogenic Monoamines, Adrenergic beta-Agonists, Neurotransmitter Agents, Mydriatics, Sympathomimetics, Vasoconstrictor Agents, Adrenergic Agonists, Agents that produce hypertension, Phenols, Adrenergic beta-3 Receptor Agonists	approved	9
DB13787	Tilidine	Drug	Cycloparaffins, Sensory System Agents, Narcotics, Nervous System, Acids, Carbocyclic, Cyclohexanes, Peripheral Nervous System Agents, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Opioids, Cyclohexanecarboxylic Acids, Central Nervous System Agents	experimental	0
DB12454	Zalypsis	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Isoquinolines	investigational	0
DB13788	Chlorbenzoxamine	Drug	Alimentary Tract and Metabolism, Drugs for Functional Gastrointestinal Disorders	experimental	0
DB11123	Hypochlorite	Drug	Reactive Oxygen Species, Free Radicals, Noxae, Antiseptics and Disinfectants, Dermatologicals, Ions, Oxides, Anti-Infective Agents, Sodium Compounds, Anions, Acids, Noncarboxylic, Acids, Disinfectants, Oxidants, Electrolytes, Toxic Actions, Compounds used in a research, industrial, or household setting, Chlorine Compounds, Oxygen Compounds, Miscellaneous Local Anti-infectives	approved	0
DB11126	Calcium gluconate	Drug	Acids, Acyclic, Carbohydrates, Hydroxy Acids, Phosphate Binder, Dermatologicals, Gluconates, Blood Coagulation Factors, Mineral Supplements, Minerals, Calcium Salts, Replacement Preparations, Alimentary Tract and Metabolism, Sugar Acids	approved, vet_approved	0
DB13785	Dropropizine	Drug	Antitussive Agents, Cough and Cold Preparations, Glycols, Central Nervous System Agents, Respiratory System Agents, Alcohols	experimental	0
DB12457	Rimegepant	Drug	OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, P-glycoprotein substrates, OATP1B3 inhibitors, MATE inhibitors, MATE 1 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Antimigraine Preparations, Cytochrome P-450 CYP2C9 Substrates, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Migraine Disorders, OCT2 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, OAT3/SLC22A8 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved, investigational	1
DB12456	Bococizumab	Drug	Anticholesteremic Agents, Hypolipidemic Agents, Immunoglobulins, Noxae, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Antimetabolites, Immunoproteins, Proteins, Serum Globulins, Lipid Regulating Agents, Globulins, Blood Proteins, Toxic Actions	investigational	0
DB11125	Benzethonium	Drug	Benzylammonium Compounds, Amines, Ammonium Compounds, Throat Preparations, Quaternary Ammonium Compounds, Antiseptics and Disinfectants, Dermatologicals, Onium Compounds, Anti-Infective Agents, Anti-Infective Agents, Local, Nitrogen Compounds, Miscellaneous Local Anti-infectives	approved	0
DB13786	Magnesium orotate	Drug	Pyrimidines, Metal cations, Alimentary Tract and Metabolism, Metal divalent cations, Pyrimidinones, Mineral Supplements, Agents that produce neuromuscular block (indirect), Magnesium Compounds	experimental	0
DB11128	Ammonium molybdate	Drug	Coloring Agents, Metals, Metals, Heavy, Elements, Transition Elements, Compounds used in a research, industrial, or household setting	experimental	0
DB12459	Belotecan	Drug	Alkaloids, Enzyme Inhibitors, Topoisomerase Inhibitors, Topoisomerase I Inhibitors, Antineoplastic Agents	investigational	0
DB11127	Selenious acid	Drug	Mineral Supplements, Minerals, Drugs that are Mainly Renally Excreted, Sodium Compounds, Trace Elements, Micronutrients, Physiological Phenomena, Replacement Preparations, Alimentary Tract and Metabolism, Food and Beverages, Growth Substances, Diet, Food, and Nutrition, Food, Selenium Compounds	approved, investigational	0
DB12458	Muscimol	Drug	Toxins, Biological, Biological Factors, GABA-A Receptor Agonists, Neurotransmitter Agents, GABA Agents, Oxazoles, GABA Agonists, Mycotoxins	investigational	3
DB13789	Aluminium acetotartrate	Drug	Otologicals, Sensory Organs, Anti-Infective Agents	experimental	0
DB11129	Carbamide peroxide	Drug	Tooth Bleaching Agents, Reactive Oxygen Species, Free Radicals, Noxae, Ions, Oxides, Bleaching Agents, Anti-Infective Agents, Anti-Infective Agents, Local, Anions, Oxidants, Electrolytes, Toxic Actions, Peroxides, Compounds used in a research, industrial, or household setting, Oxygen Compounds	approved	0
DB00470	Dronabinol	Drug	Analgesics, Non-Narcotic, Antiemetics and Antinauseants, Cytochrome P-450 Substrates, Sensory System Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, BCRP/ABCG2 Inhibitors, Agents producing tachycardia, Miscellaneous Antiemetics, Hormones, Cytochrome P-450 CYP3A4 Substrates, Hallucinogens, Psychotropic Drugs, Peripheral Nervous System Agents, Cytochrome P-450 CYP2C9 Substrates, Neurotransmitter Agents, Cannabinoid Receptor Agonists, Analgesics, Cytochrome P-450 CYP3A Substrates, Alimentary Tract and Metabolism, Cannabinoids and similars, Central Nervous System Depressants, Central Nervous System Agents, P-glycoprotein inhibitors, Terpenes	approved, illicit	2
DB00473	Hexylcaine	Drug	Cycloparaffins, Amines, Cyclohexanes	approved, withdrawn	2
DB00474	Methohexital	Drug	Psycholeptics, Cytochrome P-450 Substrates, Nervous System, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Pyrimidinones, Anesthetics, Intravenous, Anesthetics, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP2C19 Substrates, Anesthetics, General, Anticonvulsants, Cytochrome P-450 Enzyme Inducers, Pyrimidines, Central Nervous System Depressants, Barbiturates, Plain, Hypnotics and Sedatives, Central Nervous System Agents, Barbiturates	approved	1
DB00471	Montelukast	Drug	Acids, Acyclic, Cytochrome P-450 Substrates, Fatty Acids, Cytochrome P-450 Enzyme Inhibitors, Leukotriene Antagonists, Lipids, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Enzyme Inducers, Fatty Acids, Volatile, Hormone Antagonists, Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Hormones, Hormone Substitutes, and Hormone Antagonists, Anti-Asthmatic Agents, Cytochrome P-450 CYP2C8 Inhibitors, Respiratory System Agents, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Agents to Treat Airway Disease, Cytochrome P-450 CYP3A Substrates, Leukotriene Modifiers, Agents Causing Muscle Toxicity, Cytochrome P-450 CYP2A6 Substrates, Cytochrome P-450 CYP1A2 Inducers, Drugs for Obstructive Airway Diseases	approved	2
DB00472	Fluoxetine	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Hypoglycemia-Associated Agents, Cytochrome P-450 CYP2C9 Inhibitors (moderate), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Anticholinergic Agents, Serotonin 5-HT2 Receptor Antagonists, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Agents that reduce seizure threshold, Selective Serotonin Reuptake Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Chemically-Induced Disorders, Antidepressive Agents, Second-Generation, Membrane Transport Modulators, Cytochrome P-450 CYP2C19 Substrates, Neurotransmitter Agents, Central Nervous System Depressants, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2D6 Inhibitors (strong), Cytochrome P-450 CYP2D6 Inhibitors, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Enzyme Inhibitors, Amines, Serotonin Agents, Nervous System, Cytochrome P-450 CYP2C19 Inhibitors, Antidepressive Agents, Cytochrome P-450 CYP1A2 Inhibitors, Serotonin Modulators, Cytochrome P-450 CYP2C9 Inhibitors, Nicotinic Antagonists, Psychotropic Drugs, Cytochrome P-450 CYP2C19 Inhibitors (strong), Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Neurotransmitter Uptake Inhibitors, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Serotonin Receptor Antagonists, Central Nervous System Agents, P-glycoprotein inhibitors, Vasodilating Agents, Cytochrome P-450 CYP3A4 Inhibitors (weak), Propylamines, Psychoanaleptics	approved, vet_approved	7
DB00477	Chlorpromazine	Drug	Psycholeptics, Tranquilizing Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Anticholinergic Agents, Serotonin 5-HT2 Receptor Antagonists, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Dopamine Antagonists, Agents that reduce seizure threshold, Cytochrome P-450 CYP3A4 Inducers, Agents producing tachycardia, Phenothiazines With Aliphatic Side-Chain, Neurotransmitter Agents, Photosensitizing Agents, Central Nervous System Depressants, Antiemetics, Cytochrome P-450 CYP2D6 Substrates, Dopamine D2 Receptor Antagonists, Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, BSEP/ABCB11 Inhibitors, Serotonin Agents, Nervous System, Antipsychotic Agents (First Generation Typical), Hypotensive Agents, Muscarinic Antagonists, Antidepressive Agents, Antipsychotic Agents, Cytochrome P-450 Enzyme Inducers, Histamine H1 Antagonists, Sulfur Compounds, Adrenergic Antagonists, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Adrenergic alpha-1 Receptor Antagonists, Drugs causing inadvertant photosensitivity, Dopamine Agents, Gastrointestinal Agents, Neurotoxic agents, Autonomic Agents, Cholinesterase Inhibitors, Adrenergic alpha-Antagonists, Cytochrome P-450 CYP2E1 Inhibitors, P-glycoprotein substrates, Phenothiazines, Moderate Risk QTc-Prolonging Agents, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Serotonin Receptor Antagonists, Central Nervous System Agents, P-glycoprotein inhibitors, Hyperglycemia-Associated Agents, Serotonin 5-HT1 Receptor Antagonists	approved, investigational, vet_approved	24
DB00478	Rimantadine	Drug	Adamantanes, Cycloparaffins, Enzyme Inhibitors, Nucleic Acid Synthesis Inhibitors, M2 Protein Inhibitors, Influenza A M2 Protein Inhibitor, Antiviral Agents, Antiinfectives for Systemic Use, Anti-Infective Agents, Cyclic Amines	approved, investigational	1
DB00475	Chlordiazepoxide	Drug	Psycholeptics, Tranquilizing Agents, Cytochrome P-450 Substrates, Nervous System, GABA Modulators, Benzodiazepines and benzodiazepine derivatives, Nucleotides, Cytochrome P-450 CYP3A4 Substrates, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Benzazepines, Glycosides, Hypnotics and Sedatives, Pyrimidine Nucleotides, Carbohydrates, Cytosine Nucleotides, GABA Agents, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Ribonucleotides, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Anti-Anxiety Agents, Adjuvants, Anesthesia, Central Nervous System Agents	approved, illicit, investigational	2
DB00476	Duloxetine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 Substrates, Sensory System Agents, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Hypoglycemia-Associated Agents, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Serotonin Modulators, Sulfur Compounds, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Thiophenes, Norepinephrine Uptake Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Selective Serotonin Reuptake Inhibitors, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Agents producing tachycardia, Psychotropic Drugs, Membrane Transport Modulators, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Neurotransmitter Uptake Inhibitors, Serotonin and Noradrenaline Reuptake Inhibitors, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (weak), Psychoanaleptics	approved	3
DB00479	Amikacin	Drug	Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Nephrotoxic agents, Anti-Bacterial Agents, Narrow Therapeutic Index Drugs, Aminoglycoside Antibacterials, Glycosides, Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use, Drugs that are Mainly Renally Excreted	approved, investigational, vet_approved	1
DB13780	Aluminium clofibrate	Drug	Lipid Modifying Agents, Lipid Modifying Agents, Plain, Lipid Regulating Agents, Agents Causing Muscle Toxicity, Fibric Acids	experimental	0
DB12462	Ralinepag	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Lipids	investigational	0
DB13794	Dimethoxanate	Drug	Cough and Cold Preparations	experimental	0
DB11131	Capsicum oleoresin	Drug	Complex Mixtures, Plant Preparations, Biological Products, Pharmaceutical Preparations	approved	1
DB12461	GLPG-0492	Drug	Androgens, Imidazoles, Imidazolidines	investigational	0
DB11130	Opium	Drug	Antitussive Agents, Cytochrome P-450 Substrates, Sensory System Agents, Nervous System, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Opiate Agonists, Peripheral Nervous System Agents, Complex Mixtures, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Alimentary Tract and Metabolism, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Opioids, Biological Products, Gastrointestinal Agents, Narcotics, Antidiarrheals, Plant Extracts, Natural Opium Alkaloids, Antipropulsives, Respiratory System Agents, Cytochrome P-450 CYP3A Substrates, Plant Preparations, Central Nervous System Depressants, Pharmaceutical Preparations, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates	approved, illicit	3
DB13795	Brodimoprim	Drug	SULFONAMIDES AND TRIMETHOPRIM, Enzyme Inhibitors, Pyrimidines, Folic Acid Antagonists, Trimethoprim and Derivatives, Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use	experimental	0
DB11133	Omega-3 fatty acids	Drug	Fatty Acids, Oils, Lipids, Dietary Fats, Unsaturated, Phospholipids, Fatty Acids, Unsaturated, Physiological Phenomena, Dietary Fats, Food and Beverages, Fish Oils, Membrane Lipids, Fats, Fatty Acids, Omega-3, Diet, Food, and Nutrition, Food	approved, nutraceutical	3
DB13792	Clopamide	Drug	Sulfur Compounds, Sulfonamides, Piperidines, Diuretics, Natriuretic Agents, Amides, Cardiovascular Agents, Low-Ceiling Diuretics, Excl. Thiazides, Sulfones	experimental	0
DB12464	Bevenopran	Drug	0	investigational	0
DB12463	Semagacestat	Drug	Amino Acids, Peptides, and Proteins, Amino Acids, Amyloid Precursor Protein Secretases, antagonists & inhibitors	investigational	0
DB13793	Vinburnine	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Peripheral Vasodilators, Cardiovascular Agents, Indoles, Vasodilating Agents, Secologanin Tryptamine Alkaloids, Indole Alkaloids	experimental	0
DB11132	Silicon dioxide	Drug	Investigative Techniques, Colloids, Ions, Oxides, Minerals, Silicon Compounds, Anions, Acids, Noncarboxylic, Complex Mixtures, Acids, Electrolytes, Pharmaceutical Preparations, Compounds used in a research, industrial, or household setting, Dental Casting Investment, Hygroscopic Agents, Oxygen Compounds	approved	1
DB11135	Selenium	Drug	Protective Agents, Chalcogens, Mineral Supplements, Minerals, Elements, Drugs that are Mainly Renally Excreted, Antioxidants, Trace Elements, Micronutrients, Physiological Phenomena, Alimentary Tract and Metabolism, Food and Beverages, Polyvalent cation containing laxatives, antacids, oral supplements, Growth Substances, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food, Selenium Compounds	approved, investigational, vet_approved	0
DB13798	Demoxytocin	Drug	Oxytocin and Analogues, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pituitary Hormones, Reproductive Control Agents, Pituitary and Hypothalamic Hormones and Analogues, Amino Acids, Peptides, and Proteins, Hormones, Uterotonic agents, Peptide Hormones, Pituitary Hormones, Posterior, Posterior Pituitary Lobe Hormones, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins	experimental	0
DB12466	Favipiravir	Drug	Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Experimental Unapproved Treatments for COVID-19, OAT3/SLC22A8 Inhibitors, P-glycoprotein inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), OAT1/SLC22A6 inhibitors	approved, investigational	1
DB13799	Ethadione	Drug	Anticonvulsants, Nervous System, Central Nervous System Depressants, Oxazolidine Derivatives	experimental	0
DB12465	Ketanserin	Drug	Quinazolinones, Serotonin Agents, Hematologic Agents, Cardiovascular Agents, Antidepressive Agents, Quinazolines, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Piperidines, Serotonin Receptor Antagonists, Antihypertensive Agents, Antiplatelet agents	investigational	1
DB11134	Cupric oxide	Drug	Trace Elements, Micronutrients, Physiological Phenomena, Copper-containing Intrauterine Device, Food and Beverages, Metals, Metals, Heavy, Elements, Growth Substances, Transition Elements, Diet, Food, and Nutrition, Food	approved	0
DB13796	Dibunate	Drug	Cough and Cold Preparations	experimental	0
DB12468	Pf-04531083	Drug	0	investigational	0
DB11137	Molybdenum	Drug	Trace Elements, Micronutrients, Physiological Phenomena, Food and Beverages, Metals, Metals, Heavy, Elements, Growth Substances, Transition Elements, Diet, Food, and Nutrition, Food	approved	0
DB11136	Chromium	Drug	Cell-mediated Immunity, Metals, Standardized Chemical Allergen, Metals, Heavy, Minerals, Elements, Transition Elements, Drugs that are Mainly Renally Excreted, Trace Elements, Micronutrients, Physiological Phenomena, Food and Beverages, Chromium, Growth Substances, Diet, Food, and Nutrition, Food, Increased Histamine Release	approved	1
DB12467	TU-100	Drug	Quinones, Topoisomerase Inhibitors, DNA Topoisomerases, Type I, DNA Topoisomerases, Type II, Naphthalenes	investigational	0
DB13797	Iodocholesterol (131I)	Drug	Iodine (131I) Compounds, Diagnostic Radiopharmaceuticals	experimental	0
DB00480	Lenalidomide	Drug	Immunologic Factors, Phthalic Acids, Immunosuppressive Agents, P-glycoprotein substrates, Acids, Carbocyclic, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Growth Inhibitors, Angiogenesis Modulating Agents, Piperidones, Angiogenesis Inhibitors, Drugs that are Mainly Renally Excreted, Imides, Isoindoles, Myelosuppressive Agents, Heterocyclic Compounds, Fused-Ring, Phthalimides, Piperidines, Growth Substances, Thalidomide Analog	approved	4
DB00481	Raloxifene	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Enzyme Inhibitors, Genito Urinary System and Sex Hormones, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Estrogen Receptor Modulators, OATP1B3 substrates, Cytochrome P-450 CYP2B6 Inhibitors, Estrogen Agonist/Antagonist, Estrogen Antagonists, Stilbenes, Estrogen Agonist-antagonists, Bone Density Conservation Agents, Hormone Antagonists, Benzene Derivatives, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, Benzylidene Compounds, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Selective Estrogen Receptor Modulators, UGT1A1 Substrates, Cytochrome P-450 CYP2B6 Inhibitors (strong), Cytochrome P-450 CYP3A4 Inhibitors, OATP1B1/SLCO1B1 Substrates	approved, investigational	4
DB00484	Brimonidine	Drug	Adrenergic alpha-Agonists, Antiglaucoma Preparations and Miotics, Dermatologicals, Quinoxalines, Cardiovascular Agents, Hypotensive Agents, Misc. Skin and Mucous Membrane Agents, Ophthalmologicals, Heterocyclic Compounds, Fused-Ring, Adrenergic alpha-2 Receptor Agonists, Central Nervous System Depressants, Adrenergic Agonists, Sympathomimetics in Glaucoma Therapy, Sensory Organs, Adrenergic Agents	approved	3
DB00485	Dicloxacillin	Drug	Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Antiinfectives for Systemic Use, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Cytochrome P-450 Enzyme Inducers, Sulfur Compounds, Penicillins, Beta-Lactamase Resistant Penicillins, Antibacterials for Systemic Use	approved, investigational, vet_approved	6
DB00482	Celecoxib	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Nephrotoxic agents, BSEP/ABCB11 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 Substrates, Sensory System Agents, Cyclooxygenase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Anti-Inflammatory Agents, Agents causing hyperkalemia, Genito Urinary System and Sex Hormones, Amides, Cytochrome P-450 CYP3A4 Substrates, Selective Cyclooxygenase 2 Inhibitors (NSAIDs), Peripheral Nervous System Agents, Sulfur Compounds, Antiinflammatory and Antirheumatic Products, Non-Steroids, COX-2 Inhibitors, Analgesics, Musculo-Skeletal System, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Substrates, Drugs causing inadvertant photosensitivity, Sulfones, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Cyclooxygenase-2 (COX-2) Inhibitors, Gynecological Antiinfectives and Antiseptics, P-glycoprotein substrates, Pyrazoles, Antineoplastic and Immunomodulating Agents, Antirheumatic Agents, Cytochrome P-450 CYP2C9 Substrates, Antiinflammatory and Antirheumatic Products, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Sulfonamides, Agents that produce hypertension, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Methemoglobinemia Associated Agents	approved, investigational	5
DB00483	Gallamine triethiodide	Drug	Neuromuscular Agents, Amines, Ammonium Compounds, Cholinesterase Inhibitors, Quaternary Ammonium Compounds, Neuromuscular-Blocking Agents (Nondepolarizing), Agents producing tachycardia, Onium Compounds, Muscarinic Antagonists, Nicotinic Antagonists, Peripheral Nervous System Agents, Anticholinergic Agents, Neurotransmitter Agents, Cholinergic Agents, Central Nervous System Depressants, Neuromuscular Blocking Agents, Nitrogen Compounds	approved	5
DB00488	Altretamine	Drug	Alkylating Drugs, Triazines, Immunosuppressive Agents, Narrow Therapeutic Index Drugs, Noxae, Antineoplastic and Immunomodulating Agents, Alkylating Activity, Antineoplastic Agents, Toxic Actions, Antineoplastic Agents, Alkylating, Myelosuppressive Agents	approved	1
DB00489	Sotalol	Drug	Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Sympatholytics, Agents causing hyperkalemia, Beta Blocking Agents, Non-Selective, and Thiazides, Adrenergic beta-Antagonists, Cardiovascular Agents, Hypotensive Agents, Alcohols, Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index, Peripheral Nervous System Agents, Adrenergic Antagonists, Adrenergic Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Autonomic Agents, Amino Alcohols, Ethanolamines, Beta Blocking Agents and Thiazides, Beta Blocking Agents, Non-Selective, Cardiac Rhythm Alteration, Neurotransmitter Agents, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP2D6 Substrates	approved	3
DB00486	Nabilone	Drug	Autonomic Agents, Antiemetics and Antinauseants, Tranquilizing Agents, Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP2E1 Inhibitors (weak), Agents producing tachycardia, Hypotensive Agents, Miscellaneous Antiemetics, Cytochrome P-450 CYP2C9 Inhibitors (moderate), Psychotropic Drugs, Peripheral Nervous System Agents, Photosensitizing Agents, Alimentary Tract and Metabolism, Cannabinoids and similars, Central Nervous System Depressants, Cytochrome P-450 CYP2C9 Inhibitors, Antiemetics, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Central Nervous System Agents, Drugs causing inadvertant photosensitivity, Terpenes, Gastrointestinal Agents	approved, investigational	2
DB00487	Pefloxacin	Drug	Fluoroquinolones, Quinolines, QTc Prolonging Agents, Enzyme Inhibitors, Topoisomerase Inhibitors, Chemically-Induced Disorders, Cytochrome P-450 Enzyme Inhibitors, Antiinfectives for Systemic Use, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Anti-Infective Agents, Quinolones, Cytochrome P-450 CYP1A2 Inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Topoisomerase II Inhibitors, Potential QTc-Prolonging Agents, Antibacterials for Systemic Use	approved	4
DB13790	Fipexide	Drug	Nervous System, Psychostimulants, Agents Used for Adhd and Nootropics, Psychoanaleptics	experimental	0
DB13791	Penfluridol	Drug	Psycholeptics, QTc Prolonging Agents, Tranquilizing Agents, Cytochrome P-450 Substrates, Nervous System, Agents causing hyperkalemia, Cytochrome P-450 CYP3A4 Substrates, Moderate Risk QTc-Prolonging Agents, Psychotropic Drugs, Calcium Channel Blockers, Neurotransmitter Agents, Antipsychotic Agents, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Piperidines, Central Nervous System Agents, Diphenylbutylpiperidine Derivatives, Dopamine Antagonists, Dopamine D2 Receptor Antagonists, Bradycardia-Causing Agents, Antiarrhythmic agents, Dopamine Agents, Neurotoxic agents	experimental	0
DB12460	Conbercept	Drug	Proteins, Amino Acids, Peptides, and Proteins, Recombinant Proteins	investigational	0
DB11186	Pentoxyverine	Drug	Antitussive Agents, Cycloparaffins, Cough and Cold Preparations, Central Nervous System Agents, Respiratory System Agents	approved, investigational	5
DB11185	Sulisobenzone	Drug	Ketones, Sunscreen Agents, Benzene Derivatives, Drugs that are Mainly Renally Excreted	experimental	1
DB11188	1-(c14-c18 esteroyl)-2-docosahexanoyl-sn-glycero-3-phosphoethanolamine	Drug	0	experimental	0
DB11187	1-(c14-c18 esteroyl)-2-docosahexanoyl-sn-glycero-3-phosphocholine	Drug	0	experimental	0
DB11189	Magnesium glycinate	Drug	Osmotic Laxatives, Calculi Dissolution Agent, Laxatives, Agents that produce neuromuscular block (indirect)	approved	0
DB11180	Tetrofosmin	Drug	0	approved	0
DB11182	Rose bengal	Drug	Other Diagnostics, Coloring Agents, Laboratory Chemicals, Fluoresceins, Luminescent Agents, Ophthalmologicals, Spiro Compounds, Xanthenes, Heterocyclic Compounds, Fused-Ring, Indicators and Reagents, Diagnostic Agents, Sensory Organs, Compounds used in a research, industrial, or household setting, Colouring Agents, Fluorescent Dyes	approved, investigational	0
DB11181	Homatropine	Drug	Anticholinergic Agents, Autonomic Agents, Muscarinic Agonists, Ophthalmologicals, Alkaloids, Mydriatics and Cycloplegics, Aza Compounds, Parasympatholytics, Azabicyclo Compounds, Muscarinic Antagonists, Sensory Organs, Peripheral Nervous System Agents	approved	5
DB11184	Oftasceine	Drug	0	approved	0
DB11183	Light green SF yellowish	Drug	Arylsulfonates, Sulfur Compounds, Acids, Noncarboxylic, Amines, Ammonium Compounds, Acids, Sulfur Acids, Quaternary Ammonium Compounds, Sulfonic Acids, Arylsulfonic Acids, Onium Compounds, Nitrogen Compounds	approved, experimental	0
DB11197	Ferrous cysteine glycinate	Drug	0	approved	0
DB11199	Sage oil	Drug	Non-Standardized Food Allergenic Extract, Non-Standardized Plant Allergenic Extract, Agents that reduce seizure threshold	nutraceutical	0
DB11198	Peppermint oil	Drug	Autonomic Agents, Cytochrome P-450 Enzyme Inhibitors, Oils, Non-Standardized Plant Allergenic Extract, Antifoaming Agents, Herbs and Natural Products, Lipids, Parasympatholytics, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Oils, Volatile, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Peripheral Nervous System Agents, Cytochrome P-450 CYP1A2 Inhibitors, Non-Standardized Food Allergenic Extract, Complex Mixtures, Cytochrome P-450 CYP3A Inhibitors, Plant Preparations, Cytochrome P-450 CYP3A4 Inhibitors, Antiemetics, Biological Products, Central Nervous System Agents, Gastrointestinal Agents	approved, investigational	0
DB11191	Cobamamide	Drug	Heterocyclic Compounds, Fused-Ring, Coenzymes, Antianemic Preparations, Blood and Blood Forming Organs, Enzymes and Coenzymes, Vitamin B Complex, Corrinoids, Vitamins, VITAMIN B12 AND FOLIC ACID	approved	0
DB11190	Pantethine	Drug	Sulfur Compounds, Alimentary Tract and Metabolism, Vitamin B Complex, Vitamins, Sulfhydryl Compounds	approved, investigational	0
DB11193	Papain	Drug	Cysteine Endopeptidases, Enzymes, Cysteine Proteases, Papain, antagonists & inhibitors, Enzymes and Coenzymes, Hydrolases, Peptide Hydrolases, Endopeptidases, Gastrointestinal Agents	approved	1
DB11192	L-threonic acid	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Lipids	experimental	0
DB11195	Xylitol	Drug	Food Additives, Carbohydrates, Flavoring Agents, Pharmaceutic Aids, Alcohols, Physiological Phenomena, Food and Beverages, Sugar Alcohols, Food Ingredients, Pharmaceutical Preparations, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food, Sweetening Agents	investigational, experimental	5
DB01802	(4R)-7-Aza-7,8-dihydrolimonene	Drug	0	experimental	0
DB01800	4-Nitrocatechol sulfate	Drug	Phenols, Benzene Derivatives	experimental	2
DB01806	10-decarboxymethylaclacinomycin A	Drug	0	experimental	1
DB01805	Monoisopropylphosphorylserine	Drug	0	experimental	4
DB01804	2-Ammoniobut-3-Enoate, 2-Amino-3-Butenoate	Drug	0	experimental	1
DB01803	2-(Trimethylammonium)Ethyl Thiol	Drug	0	experimental	1
DB01809	1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine	Drug	0	experimental	2
DB01808	Thiarsahydroxy-Cysteine	Drug	0	experimental	1
DB01807	N-[(3Z)-5-Tert-butyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-ylidene]-N'-(4-chlorophenyl)urea	Drug	0	experimental	1
DB01813	Pyridoxyl-Glutamic Acid-5'-Monophosphate	Drug	0	experimental	2
DB01812	Adenosine 3',5'-diphosphate	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides, Adenine Nucleotides, Isomerism	experimental	12
DB01811	3h-Indole-5,6-Diol	Drug	0	experimental	1
DB01810	[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester	Drug	0	experimental	2
DB01817	Threonine-Aspartic Ester	Drug	0	experimental	1
DB01816	Castanospermine	Drug	Analgesics, Non-Narcotic, Glycoside Hydrolase Inhibitors, Immunologic Factors, Enzyme Inhibitors, Immunosuppressive Agents, Sensory System Agents, Anti-Inflammatory Agents, beta-Glucosidase, antagonists & inhibitors, Stereoisomerism, Peripheral Nervous System Agents, Heterocyclic Compounds, Fused-Ring, Analgesics, Glucosylceramidase, antagonists & inhibitors, Central Nervous System Agents	experimental	1
DB01815	Nz-(Dicarboxymethyl)Lysine	Drug	0	experimental	1
DB01814	2-Tridecanoyloxy-Pentadecanoic Acid	Drug	0	experimental	1
DB12510	Ozone	Drug	Oxidants, Photochemical, Gases, Noxae, Oxidants, Toxic Actions, Chalcogens, Elements, Compounds used in a research, industrial, or household setting	investigational	0
DB13842	Etofylline nicotinate	Drug	Peripheral Vasodilators, Purine Derivatives	experimental	0
DB13843	Cloprednol	Drug	Corticosteroids for Systemic Use, Corticosteroids, Immunosuppressive Agents, Corticosteroids for Systemic Use, Plain, Glucocorticoids, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Pregnanes, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Hyperglycemia-Associated Agents, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Cytochrome P-450 CYP3A5 Inducers, Pregnenes, Steroids	experimental	0
DB12512	Verucerfont	Drug	Receptors, Corticotropin-Releasing Hormone, antagonists & inhibitors, Oxazoles, Aza Compounds	investigational	0
DB13840	Hydroxyethylpromethazine	Drug	Phenothiazine Derivatives, Antihistamines for Systemic Use	experimental	0
DB13841	Clopenthixol	Drug	Psycholeptics, Tranquilizing Agents, Nervous System, Thioxanthenes, Psychotropic Drugs, Xanthenes, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Antipsychotic Agents, Sulfur Compounds, Central Nervous System Depressants, Central Nervous System Agents, Thioxanthene Derivatives, Dopamine Antagonists, Dopamine Agents, Neurotoxic agents	experimental	0
DB12511	Imiglitazar	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Lipids	investigational	0
DB13846	Pyrrobutamine	Drug	Antihistamines for Systemic Use	experimental	0
DB12514	Iofolastat I-123	Drug	Amino Acids, Dicarboxylic, Amino Acids, Peptides, and Proteins, Amino Acids, Acidic, Amino Acids	investigational	0
DB12513	Omaveloxolone	Drug	Terpenes	investigational	0
DB13847	Rhenium Re-186 sulfide	Drug	Anti-Inflammatory Agents, Therapeutic Radiopharmaceuticals	experimental	0
DB13844	Pipenzolate	Drug	Anticholinergic Agents, Synthetic Anticholinergics, Quaternary Ammonium Compounds, Alimentary Tract and Metabolism, Agents producing tachycardia, Drugs for Functional Gastrointestinal Disorders, Muscarinic Antagonists	experimental	0
DB13845	Etafenone	Drug	Ketones, Propiophenones, Vasodilators Used in Cardiac Diseases, Cardiovascular Agents, Vasodilating Agents, Cardiac Therapy	experimental	0
DB12515	9-aminocamptothecin	Drug	Alkaloids, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Antineoplastic Agents, Cytochrome P-450 CYP3A4 Substrates	investigational	0
DB12518	Raclopride	Drug	Tranquilizing Agents, Benzoates, Acids, Carbocyclic, Benzamides and benzamide derivatives, Amides, Psychotropic Drugs, Chlorobenzoates, Neurotransmitter Agents, Antipsychotic Agents, Central Nervous System Depressants, Central Nervous System Agents, Dopamine Antagonists, Dopamine D2 Receptor Antagonists, Benzene Derivatives, Dopamine Agents, Neurotoxic agents	investigational	1
DB12517	PF-00446687	Drug	Receptor, Melanocortin, Type 4, agonists	investigational	0
DB13848	Fluorodopa (18F)	Drug	Amino Acids, Aromatic, Amines, Phenylalanine, Amino Acids, Essential, Amino Acids, Peptides, and Proteins, Catecholamines, Catechols, Amino Acids, Amino Acids, Cyclic, Diagnostic Radiopharmaceuticals, Phenols, Fluorine Radioisotopes, Benzene Derivatives	approved, experimental	0
DB12519	Sarcosine	Drug	Peptides, Amino Acids, Peptides, and Proteins, N-substituted Glycines, Peptoids, Amino Acids	investigational	0
DB13849	Clofibride	Drug	Acids, Acyclic, Fatty Acids, Lipids, Isobutyrates, Phenyl Ethers, Lipid Modifying Agents, Lipid Modifying Agents, Plain, Lipid Regulating Agents, Butyrates, Agents Causing Muscle Toxicity, Fatty Acids, Volatile, Phenols, Clofibric Acid, Fibric Acids, Ethers, Benzene Derivatives	experimental	0
DB01860	Cordycepin Triphosphate	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Deoxyribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides, Adenine Nucleotides	experimental	1
DB00532	Mephenytoin	Drug	Decreased Central Nervous System Disorganized Electrical Activity, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP2C19 Inhibitors, Anti-epileptic Agent, Hydantoins, Imidazolidines, Thyroxine-binding globulin substrates, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Anticonvulsants, Imidazoles, Central Nervous System Depressants, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2C8 Substrates	approved, investigational, withdrawn	2
DB01864	5'-Guanosine-Diphosphate-Monothiophosphate	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Sulfur Compounds, Thionucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Guanine Nucleotides, Nucleotides, Guanosine Triphosphate	experimental	4
DB00533	Rofecoxib	Drug	Nephrotoxic agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Sensory System Agents, Cyclooxygenase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Anti-Inflammatory Agents, Agents causing hyperkalemia, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Selective Cyclooxygenase 2 Inhibitors (NSAIDs), Peripheral Nervous System Agents, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 Enzyme Inducers, Sulfur Compounds, Antiinflammatory and Antirheumatic Products, Non-Steroids, COX-2 Inhibitors, Analgesics, Cytochrome P-450 CYP2C8 Inhibitors (weak), Musculo-Skeletal System, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP1A2 Inhibitors (strong), Antirheumatic Agents, Cytochrome P-450 CYP2C9 Substrates, Antiinflammatory and Antirheumatic Products, Cytochrome P-450 CYP3A Substrates, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Central Nervous System Agents	approved, investigational, withdrawn	2
DB01863	Inositol 1,3,4,5-Tetrakisphosphate	Drug	Carbohydrates, Sugar Phosphates, Sugar Alcohols, Alcohols	experimental	8
DB00530	Erlotinib	Drug	Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Quinazolines, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C8 Substrates, P-glycoprotein substrates with narrow therapeutic index, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index, UGT1A1 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (strong), Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index, Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors, Kinase Inhibitor	approved, investigational	2
DB01862	Isopropyl beta-D-thiogalactopyranoside	Drug	Galactosides, Carbohydrates, Sulfur Compounds, Glycosides, Thiogalactosides, Thioglycosides	experimental	3
DB00531	Cyclophosphamide	Drug	Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 CYP3A Inducers, Nitrogen Mustard Analogues, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Hydrocarbons, Halogenated, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Anions, Cytochrome P-450 CYP2C8 Substrates, Phosphoramide Mustards, Cytochrome P-450 CYP2C18 Substrates, Cytochrome P-450 CYP3A5 Substrates, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A4 Inducers, Alkylating Activity, Antirheumatic Agents, Organophosphorus Compounds, Ions, Nitrogen Mustard Compounds, Phosphorus Compounds, Alkylating Drugs, Cytochrome P-450 CYP2C19 Substrates, Acids, Noncarboxylic, Narrow Therapeutic Index Drugs, Mutagens, Cytochrome P-450 CYP2A6 Substrates, Toxic Actions, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Immunologic Factors, Cytochrome P-450 CYP2C8 Inducers, Cardiotoxic antineoplastic agents, Cytochrome P-450 Enzyme Inducers, Phosphoramides, Cytochrome P-450 CYP2B6 Inducers, Antineoplastic Agents, Alkylating, Neurotoxic agents, Noxae, Antineoplastic Agents, Mustard Compounds, Myeloablative Agonists, Phosphorus Acids, Myelosuppressive Agents, Cytochrome P-450 CYP2C9 Substrates, Acids, Cytochrome P-450 CYP3A Substrates, Phosphoric Acids, Electrolytes, Methemoglobinemia Associated Agents	approved, investigational	2
DB01861	Uridine diphosphate glucose	Drug	Carbohydrates, Pyrimidines, Ribonucleotides, Deoxyribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Uridine Diphosphate, Glycosides, Nucleoside Diphosphate Sugars, Uracil Nucleotides, Uridine Diphosphate Sugars, Nucleotides, Pyrimidine Nucleotides	experimental	9
DB00536	Guanidine	Drug	Increased Acetylcholine Activity, OCT2 Inhibitors, MATE 2 Substrates, MATE 1 Substrates, OCT1 inhibitors, Amidines, Guanidines, OAT3/SLC22A8 Inhibitors, MATE substrates, Acetylcholine Releasing Agent	approved	7
DB01868	Glycyl-L-a-Aminopimelyl-E-(D-2-Aminoethyl)Phosphonate	Drug	0	experimental	1
DB00537	Ciprofloxacin	Drug	Fluoroquinolones, Quinolines, QTc Prolonging Agents, Enzyme Inhibitors, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Otologicals, MATE 1 Substrates, MATE inhibitors, MATE 1 Inhibitors, Ophthalmological and Otological Preparations, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Quinolones, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP3A7 Inhibitors (moderate), Anti-Bacterial Agents, Topoisomerase II Inhibitors, Drugs causing inadvertant photosensitivity, MATE substrates, Quinolone Antimicrobial, Chemically-Induced Disorders, P-glycoprotein substrates, Cytochrome P-450 CYP3A5 Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (strong), Antiinfectives for Systemic Use, Moderate Risk QTc-Prolonging Agents, Ophthalmologicals, Cytochrome P-450 CYP3A5 Inhibitors (moderate), Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Photosensitizing Agents, Agents Causing Muscle Toxicity, Cytochrome P-450 CYP3A7 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, MATE 2 Inhibitors, Sensory Organs, Antibacterials for Systemic Use	approved, investigational	11
DB00534	Chlormerodrin	Drug	Organometallic Compounds, Alkylmercury Compounds, Organomercury Compounds	approved, withdrawn	2
DB01866	RU79256	Drug	0	experimental	1
DB00535	Cefdinir	Drug	Third-Generation Cephalosporins, Lactams, OAT1/SLC22A6 Substrates, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, OAT3/SLC22A8 Substrates, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Aza Compounds, Azabicyclo Compounds, Antibacterials for Systemic Use	approved	4
DB01865	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	Drug	0	experimental	1
DB00538	Gadoversetamide	Drug	Magnetic Resonance Imaging Contrast Media, Other Diagnostics, Paramagnetic Contrast Media, Contrast Media, Diagnostic Uses of Chemicals, Magnetic Resonance Contrast Activity, Paramagnetic Contrast Agent, Compounds used in a research, industrial, or household setting, Gadolinium-based Contrast Agent	approved, investigational	0
DB00539	Toremifene	Drug	Endocrine Therapy, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Estrogen Receptor Modulators, Hormone Antagonists and Related Agents, Cytochrome P-450 CYP3A4 Substrates, Estrogen Agonist/Antagonist, Stilbenes, Bone Density Conservation Agents, Hormone Antagonists, Benzene Derivatives, Antineoplastic Agents, Hormonal, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Anti-Estrogens, Antineoplastic Agents, Benzylidene Compounds, Cytochrome P-450 CYP3A Inhibitors, Selective Estrogen Receptor Modulators, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors	approved, investigational	2
DB13850	Timepidium	Drug	Anticholinergic Agents, Synthetic Anticholinergics, Quaternary Ammonium Compounds, Alimentary Tract and Metabolism, Agents producing tachycardia, Drugs for Functional Gastrointestinal Disorders, Muscarinic Antagonists	experimental	0
DB13853	Anethole trithione	Drug	EENT Drugs, Miscellaneous, Sulfur Compounds, Various Alimentary Tract and Metabolism Products, Alimentary Tract and Metabolism, Methyl Ethers, Phenols, Ethers, Anisoles, Thiones, Benzene Derivatives, Gastrointestinal Agents, Phenyl Ethers	approved, experimental	0
DB12521	Methyl pyrrolidone	Drug	Noxae, Teratogens, Pyrrolidines, Toxic Actions, Polymers	investigational	0
DB12520	Plozalizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	1
DB13854	Gamolenic acid	Drug	Fatty Acids, Essential, Fatty Acids, Omega-6, Fatty Acids, Unsaturated, Fatty Acids, Dermatologicals, Lipids, Linolenic Acids, Agents that reduce seizure threshold	approved, investigational	0
DB12523	Mizolastine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, QTc Prolonging Agents, Histamine H1 Antagonists, Histamine H1 Antagonists, Non-Sedating, Histamine Antagonists, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Histamine Agents, Antihistamines for Systemic Use, Moderate Risk QTc-Prolonging Agents	approved, investigational	0
DB13851	Artemotil	Drug	Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Reactive Oxygen Species, Free Radicals, Antimalarials, Ions, Oxides, Schistosomicides, Anti-Infective Agents, Anions, Sesquiterpenes, Artemisinin and Derivatives, Plain, Electrolytes, Antiplatyhelmintic Agents, Peroxides, Terpenes, Antiparasitic Agents, Oxygen Compounds, Amebicides	approved	0
DB13852	Mefenorex	Drug	Autonomic Agents, Centrally Acting Antiobesity Products, Amines, Ethylamines, Sympathomimetics, Alimentary Tract and Metabolism, Agents that produce hypertension, Antiobesity Preparations, Excl. Diet Products, Agents producing tachycardia, Phenethylamines, Peripheral Nervous System Agents	experimental	0
DB12522	Toreforant	Drug	0	investigational	0
DB13857	Demegestone	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Norsteroids, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, Cytochrome P-450 CYP3A4 Substrates, Pregnadien Derivatives, Fused-Ring Compounds, Contraceptives, Oral, Progesterone Congeners, Cytochrome P-450 CYP3A Substrates, Progestins, Norpregnenes, Hormonal Contraceptives for Systemic Use, Norpregnanes, Contraceptive Agents, Female, Progestin Contraceptives, Steroids	experimental	1
DB12525	Molgramostim	Drug	Biological Factors, Carbohydrates, Cytokines, Glycoconjugates, Peptides, Adjuvants, Immunologic, Antineoplastic and Immunomodulating Agents, Intercellular Signaling Peptides and Proteins, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Glycoproteins, Hematopoietic Cell Growth Factors, Proteins, Colony-Stimulating Factors	investigational	0
DB13858	Dimazole	Drug	Sulfur Compounds, Antifungals for Topical Use, Dermatologicals, Antifungals for Dermatological Use	approved, withdrawn	0
DB12524	BI-671800	Drug	Benzoates, Acids, Carbocyclic, Amides, Benzene Derivatives	investigational	0
DB13855	Nifuroxazide	Drug	Benzoates, Hydroxy Acids, Intestinal Antiinfectives, Alimentary Tract and Metabolism, Acids, Carbocyclic, Nitro Compounds, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Phenols, Furans, Anti-Infective Agents, Benzene Derivatives	experimental	0
DB12527	Sofinicline	Drug	Aza Compounds	investigational	0
DB13856	Fluclorolone	Drug	Corticosteroids, Dermatological Preparations, Corticosteroids, Immunosuppressive Agents, Corticosteroids, Potent (Group III), Adrenal Cortex Hormones, Dermatologicals	experimental	0
DB12526	Batefenterol	Drug	Anticholinergic Agents, Quinolines, Acids, Acyclic, Adrenergic beta-Agonists, Heterocyclic Compounds, Fused-Ring, Adrenergic Agonists, Muscarinic Antagonists, Adrenergic beta-2 Receptor Agonists	investigational	0
DB12529	Nitrite	Drug	0	approved, investigational	0
DB12528	Glyceryl Trierucate	Drug	0	investigational	0
DB01871	[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester	Drug	0	experimental	2
DB00540	Nortriptyline	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Anticholinergic Agents, Serotonin 5-HT2 Receptor Antagonists, Tricyclics and Other Norepinephrine-reuptake Inhibitors, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Dopamine Antagonists, Adrenergic Agents, Agents that reduce seizure threshold, Cytochrome P-450 CYP3A5 Substrates, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Agents producing tachycardia, Benzocycloheptenes, Membrane Transport Modulators, Cytochrome P-450 CYP2C19 Substrates, Neurotransmitter Agents, Central Nervous System Depressants, Antidepressive Agents, Tricyclic, Cytochrome P-450 CYP2D6 Substrates, Dopamine D2 Receptor Antagonists, Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Adrenergic Uptake Inhibitors, Serotonin Agents, Nervous System, Muscarinic Antagonists, Antidepressive Agents, Dibenzocycloheptenes, Serotonin Modulators, Histamine H1 Antagonists, Adrenergic Antagonists, Potential QTc-Prolonging Agents, Adrenergic alpha-1 Receptor Antagonists, Neurotoxic agents, Adrenergic alpha-Antagonists, Cytochrome P-450 CYP2E1 Inhibitors, P-glycoprotein substrates, Psychotropic Drugs, Non-Selective Monoamine Reuptake Inhibitors, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Neurotransmitter Uptake Inhibitors, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Serotonin Receptor Antagonists, Central Nervous System Agents, Serotonin 5-HT1 Receptor Antagonists, Psychoanaleptics	approved	15
DB01870	1,4-dithio-alpha-D-glucopyranose	Drug	0	experimental	1
DB00543	Amoxapine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Adrenergic Uptake Inhibitors, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Dibenzoxazepines, Muscarinic Antagonists, Antidepressive Agents, Anticholinergic Agents, Serotonin 5-HT2 Receptor Antagonists, Serotonin Modulators, Antipsychotic Agents, Histamine H1 Antagonists, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Adrenergic Antagonists, Potential QTc-Prolonging Agents, Adrenergic alpha-1 Receptor Antagonists, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Dopamine Antagonists, Adrenergic Agents, Agents that reduce seizure threshold, Dopamine Agents, Neurotoxic agents, Adrenergic alpha-Antagonists, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Agents producing tachycardia, Psychotropic Drugs, Membrane Transport Modulators, Antidepressive Agents, Tetracyclic, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Non-Selective Monoamine Reuptake Inhibitors, Histamine Antagonists, Central Nervous System Depressants, Antidepressive Agents, Tricyclic, Neurotransmitter Uptake Inhibitors, Agents that produce hypertension, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors, Dopamine D2 Receptor Antagonists, Serotonin 5-HT1 Receptor Antagonists, Psychoanaleptics	approved	25
DB01875	8-azaxanthine	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Purines, Purinones	experimental	1
DB00544	Fluorouracil	Drug	Immunologic Factors, QTc Prolonging Agents, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Fluorouracil and prodrugs, Pyrimidine Analogues, Cardiotoxic antineoplastic agents, Misc. Skin and Mucous Membrane Agents, Nucleic Acid Synthesis Inhibitors, Pyrimidines, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2C8 Substrates, Drugs causing inadvertant photosensitivity, Noxae, Antineoplastic and Immunomodulating Agents, Pyrimidinones, Antineoplastic Agents, Antimetabolites, Moderate Risk QTc-Prolonging Agents, Myelosuppressive Agents, Fluoropyrimidines, BCRP/ABCG2 Substrates, Narrow Therapeutic Index Drugs, Photosensitizing Agents, Thyroxine-binding globulin inducers, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Nucleoside Metabolic Inhibitor, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2A6 Substrates, Toxic Actions	approved	3
DB01874	Tropinone	Drug	Alkaloids, Aza Compounds, Azabicyclo Compounds	experimental	0
DB01873	Epothilone D	Drug	Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Tubulin Modulators, Macrolides, Antimitotic Agents, Cytochrome P-450 CYP3A4 Inhibitors, Antineoplastic Agents, Mitosis Modulators, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Lactones	investigational	11
DB00541	Vincristine	Drug	Antineoplastic Agents, Phytogenic, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 CYP3A7 Substrates, Tubulin Modulators, Vinca Alkaloids, OATP1B3 inhibitors, Mitosis Modulators, BSEP/ABCB11 Substrates, Cardiotoxic antineoplastic agents, Cytochrome P-450 CYP3A4 Substrates, Indole Alkaloids, Alkaloids, BSEP/ABCB11 Substrates with Narrow Therapeutic Index, Indoles, P-glycoprotein substrates with narrow therapeutic index, Neurotoxic agents, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Secologanin Tryptamine Alkaloids, P-glycoprotein inducers, Heterocyclic Compounds, Fused-Ring, BCRP/ABCG2 Substrates, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Antimitotic Agents, P-glycoprotein inhibitors	approved, investigational	2
DB00542	Benazepril	Drug	Antihypertensive Agents Indicated for Hypertension, Enzyme Inhibitors, Agents causing hyperkalemia, Protease Inhibitors, Cardiovascular Agents, Hypotensive Agents, Heterocyclic Compounds, Fused-Ring, Photosensitizing Agents, Angiotensin-Converting Enzyme Inhibitors, Agents Acting on the Renin-Angiotensin System, Agents causing angioedema, ACE Inhibitors and Diuretics, Antihypertensive Agents, Decreased Blood Pressure, Drugs causing inadvertant photosensitivity	approved, investigational	1
DB01872	2-deoxy-2-acetamido-beta-D-galactose-4-sulfate	Drug	0	experimental	4
DB00547	Desoximetasone	Drug	Pregnadienediols, Corticosteroids, Dermatological Preparations, Pregnadienetriols, Corticosteroids, Immunosuppressive Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Dermatologicals, Hormones, Fused-Ring Compounds, Corticosteroids, Potent (Group III), Pregnanes, Steroids, Fluorinated, Corticosteroid Hormone Receptor Agonists, Steroids	approved	1
DB01879	(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid	Drug	0	experimental	1
DB00548	Azelaic acid	Drug	Acids, Acyclic, Dermatologicals, Decreased Sebaceous Gland Activity, Misc. Skin and Mucous Membrane Agents, Anti-Acne Preparations, Anti-Acne Preparations for Topical Use, Drugs that are Mainly Renally Excreted, Decreased Protein Synthesis	approved	5
DB01878	Benzophenone	Drug	Ketones, Photosensitizing Agents, Dermatologicals, Radiation-Sensitizing Agents, Benzene Derivatives	experimental	2
DB00545	Pyridostigmine	Drug	Neurotransmitter Agents, Pyridines, Cytochrome P-450 Enzyme Inducers, Enzyme Inhibitors, Cholinergic Agents, Cholinesterase Inhibitors, Nervous System, Pyridinium Compounds, Cytochrome P-450 CYP3A Inducers, Parasympathomimetics, Parasympathomemetic (Cholinergic) Agents	approved, investigational	3
DB01877	N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide	Drug	0	experimental	1
DB01876	Bis(5-Amidino-2-Benzimidazolyl)Methanone	Drug	0	experimental	1
DB00546	Adinazolam	Drug	Psycholeptics, Cytochrome P-450 Substrates, Nervous System, Benzodiazepines and benzodiazepine derivatives, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Psychotropic Drugs, Cytochrome P-450 CYP2C19 Substrates, Triazolobenzodiazepines, Heterocyclic Compounds, Fused-Ring, Benzazepines, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Anti-Anxiety Agents, Central Nervous System Agents	experimental	2
DB00549	Zafirlukast	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Leukotriene Antagonists, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inhibitors, Sulfur Compounds, Cytochrome P-450 CYP2C9 Inhibitors, Hormone Antagonists, Cytochrome P-450 CYP2C8 Substrates, Benzene Derivatives, Sulfones, Cytochrome P-450 CYP2E1 Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Anti-Asthmatic Agents, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (strong), Cytochrome P-450 CYP2E1 Inhibitors (weak), Respiratory System Agents, Cytochrome P-450 CYP2C19 Inhibitors (strong), Cytochrome P-450 CYP2C8 Inhibitors (strong), Cytochrome P-450 CYP2C9 Substrates, Agents to Treat Airway Disease, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Leukotriene Modifiers, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Drugs for Obstructive Airway Diseases	approved, investigational	1
DB13860	Imidazole salicylate	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Benzoates, Hydroxy Acids, Sensory System Agents, Nervous System, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Antirheumatic Agents, Hydroxybenzoates, Non COX-2 selective NSAIDS, Peripheral Nervous System Agents, Analgesics, Agents that produce hypertension, Phenols, Central Nervous System Agents, Salicylic Acid and Derivatives, Benzene Derivatives	experimental	0
DB13861	Iopentol	Drug	Iodobenzoates, Benzoates, Contrast Media, Diagnostic Uses of Chemicals, Acids, Carbocyclic, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting, Benzene Derivatives, Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media	experimental	0
DB12530	Inebilizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	approved, investigational	1
DB11201	Menthyl salicylate	Drug	0	approved	3
DB12532	Oxetacaine	Drug	Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Vasoprotectives, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Anesthetics, Anesthetics, Local	approved, investigational	1
DB13864	Hemoglobin crosfumaril	Drug	Benzoates, Blood and Blood Forming Organs, Hydroxy Acids, Blood Substitutes and Plasma Protein Fractions, Acids, Carbocyclic, Globins, Hydroxybenzoates, Amino Acids, Peptides, and Proteins, Blood Substitutes and Perfusion Solutions, Proteins, Blood Proteins, Blood and Related Products, Phenols, Hemeproteins, Blood Substitutes, Benzene Derivatives	experimental	0
DB11200	Aluminum zirconium octachlorohydrex gly	Drug	0	approved	1
DB13865	Dehydroemetine	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Isoquinolines	investigational	0
DB12531	Lobucavir	Drug	Enzyme Inhibitors, Cytochrome P-450 Substrates, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Purines, Nucleic Acid Synthesis Inhibitors, Cytochrome P-450 CYP1A2 Substrates, Reverse Transcriptase Inhibitors, Xanthine derivatives, Purinones	investigational	0
DB11203	Boron	Drug	Trace Elements, Micronutrients, Metalloids, Physiological Phenomena, Food and Beverages, Elements, Growth Substances, Diet, Food, and Nutrition, Food	experimental	0
DB12534	Mavrilimumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Antirheumatic Agents, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB13862	Magnesium phosphate	Drug	Blood and Blood Forming Organs, Ions, Agents that produce neuromuscular block (indirect), Blood Substitutes and Perfusion Solutions, Phosphorus Compounds, Electrolyte Solutions, Phosphorus Acids, Anions, Acids, Noncarboxylic, I.V. Solution Additives, Acids, Phosphoric Acids, Electrolytes	experimental	0
DB11202	N-alkyl ethylbenzyl dimethyl ammonium (C12-C14)	Drug	0	approved	0
DB12533	Cevipabulin	Drug	0	investigational	0
DB13863	Fosfructose	Drug	Carbohydrates, Immunologic Factors, Neuroprotective Agents, Sugar Phosphates, Protective Agents, Cardiovascular Agents, Hexosephosphates, Hexosediphosphates, Central Nervous System Agents, Fructosephosphates, Cardiac Therapy, Compounds used in a research, industrial, or household setting, Antiarrhythmic agents	experimental	0
DB13868	Adefovir	Drug	Nephrotoxic agents, Heterocyclic Compounds, Fused-Ring, Purines, Enzyme Inhibitors, Nucleic Acid Synthesis Inhibitors, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Organophosphorus Compounds, Antiviral Agents, Reverse Transcriptase Inhibitors, Nucleoside Reverse Transcriptase Inhibitors, Anti-Infective Agents	investigational	1
DB11205	Alcloxa	Drug	0	approved	0
DB12536	N-acetylmannosamine	Drug	Amino Sugars, Carbohydrates	investigational	0
DB13869	2-Methoxy-6-{(E)-[(4-methylphenyl)imino]methyl}phenol	Drug	Benzylidene Compounds, Benzene Derivatives	experimental	2
DB11204	Panthenol	Drug	Alanine, Amino Acids, Peptides, and Proteins, Vitamin B Complex, Wound Healing, Amino Acids, Imides, Vitamins	approved	0
DB12535	AC-430	Drug	0	investigational	0
DB12538	Nepadutant	Drug	Autonomic Agents, Peptides, Anti-Asthmatic Agents, Receptors, Tachykinin, antagonists & inhibitors, Amino Acids, Peptides, and Proteins, Bronchodilator Agents, Respiratory System Agents, Peripheral Nervous System Agents	investigational	0
DB11207	Amiloxate	Drug	Acids, Carbocyclic, Sunscreen Agents	approved	0
DB13866	Etynodiol	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Norsteroids, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 CYP3A Substrates, Progestins, Estren Derivatives, Norpregnenes, Hormonal Contraceptives for Systemic Use, Norpregnanes, Steroids	experimental	0
DB13867	Fluticasone	Drug	Corticosteroids, Dermatological Preparations, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Glucocorticoids, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Androstadienes, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Peripheral Nervous System Agents, Cytochrome P-450 Enzyme Inducers, Nasal Preparations, Corticosteroids, Potent (Group III), Cytochrome P-450 CYP3A5 Inducers (strength unknown), Corticosteroid Hormone Receptor Agonists, Cytochrome P-450 CYP3A5 Inducers, Autonomic Agents, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Anti-Allergic Agents, Corticosteroids, Cytochrome P-450 CYP3A5 Substrates, Anti-Asthmatic Agents, Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A5 Inhibitors, Dermatologicals, Androstenes, Bronchodilator Agents, Respiratory System Agents, Cytochrome P-450 CYP2C8 Inhibitors (strong), Androstanes, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Drugs for Obstructive Airway Diseases, Thyroxine-binding globulin inhibitors, Hyperglycemia-Associated Agents, Steroids	approved, experimental	4
DB11206	Bemotrizinol	Drug	Sunscreen Agents, Benzene Derivatives	approved	0
DB12537	Benzodiazepine	Drug	Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 Substrates, Benzazepines, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Benzodiazepines, antagonists & inhibitors, Benzodiazepines and benzodiazepine derivatives, Cytochrome P-450 CYP3A4 Substrates	approved, investigational	2
DB11209	Iron protein succinylate	Drug	Hematinics, Proteins, Acids, Acyclic, Ferric Compounds, Anemia, Hypochromic, drug therapy, Amino Acids, Peptides, and Proteins, Dicarboxylic Acids, Hematologic Agents	approved, investigational	0
DB12539	Oltipraz	Drug	Enzyme Inhibitors, Nucleic Acid Synthesis Inhibitors, Protective Agents, Anthelmintics, Antineoplastic Agents, Anticarcinogenic Agents, Antiplatyhelmintic Agents, Reverse Transcriptase Inhibitors, Schistosomicides, Compounds used in a research, industrial, or household setting, Anti-Infective Agents, Antiparasitic Agents	investigational	0
DB11208	Aluminum chlorohydrex propylene glycol	Drug	0	approved	0
DB01882	(2s)-2-Amino-4-(Methylsulfanyl)-1-Pyridin-2-Ylbutane-1,1-Diol	Drug	0	experimental	2
DB00550	Propylthiouracil	Drug	Thyroid Hormone Synthesis Inhibitors, Thyroid Products, Immunosuppressive Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Noxae, Pyrimidinones, Thiouracil, Thiouracils, Antimetabolites, Myelosuppressive Agents, Thyroid Hormone Synthesis Inhibitor, Pyrimidines, Agents Causing Muscle Toxicity, Toxic Actions, Hormone Antagonists, Antithyroid agents, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins	approved, investigational	1
DB00551	Acetohydroxamic acid	Drug	Enzyme Inhibitors, Amines, Hydroxy Acids, Urease Inhibitor, Genito Urinary System and Sex Hormones, Urease Inhibitors, Hydroxylamines, Urologicals	approved	2
DB01881	2-Methylpentane-1,2,4-Triol	Drug	0	experimental	1
DB01880	3,4-Dihydroxycinnamic Acid	Drug	Antioxidants, Protective Agents, Acids, Carbocyclic, Compounds used in a research, industrial, or household setting, Cinnamates	investigational, experimental	3
DB00554	Piroxicam	Drug	Nephrotoxic agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Oxicams, Sensory System Agents, Cyclooxygenase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Anti-Inflammatory Agents, Agents causing hyperkalemia, Non COX-2 selective NSAIDS, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Sulfur Compounds, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Musculo-Skeletal System, Cytochrome P-450 CYP2C8 Substrates, Drugs causing inadvertant photosensitivity, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Cytochrome P-450 CYP2C8 Inhibitors, Antirheumatic Agents, Thiazines, Antiinflammatory Preparations, Non-Steroids for Topical Use, Topical Products for Joint and Muscular Pain, OAT1/SLC22A6 inhibitors, Ophthalmologicals, Cytochrome P-450 CYP2C9 Substrates, Antiinflammatory and Antirheumatic Products, Photosensitizing Agents, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Agents that produce hypertension, Central Nervous System Agents, OAT3/SLC22A8 Inhibitors, Sensory Organs, Other Nonsteroidal Anti-inflammatory Agents	approved, investigational	2
DB00555	Lamotrigine	Drug	OCT1 substrates, Triazines, QTc Prolonging Agents, Tranquilizing Agents, Decreased Central Nervous System Disorganized Electrical Activity, Cytochrome P-450 Substrates, Nervous System, Agents causing hyperkalemia, UGT1A3 substrates, Mood Stabilizer, Muscarinic Antagonists, UGT1A1 Inducers, Cytochrome P-450 CYP3A4 Substrates, Anti-epileptic Agent, Drugs that are Mainly Renally Excreted, Anticholinergic Agents, Miscellaneous Anticonvulsants, Calcium-Regulating Hormones and Agents, Potential QTc-Prolonging Agents, Drugs causing inadvertant photosensitivity, Bradycardia-Causing Agents, Antiarrhythmic agents, P-glycoprotein substrates, Agents producing tachycardia, Psychotropic Drugs, Membrane Transport Modulators, Calcium Channel Blockers, Anticonvulsants, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Central Nervous System Depressants, OCT2 Inhibitors, UGT1A1 Substrates, UGT1A4 substrates, Central Nervous System Agents, Sodium Channel Blockers, P-glycoprotein inhibitors	approved, investigational	17
DB01885	D-Galctopyranosyl-1-On	Drug	0	experimental	1
DB01884	2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One	Drug	0	experimental	1
DB00552	Pentostatin	Drug	Carbohydrates, Ribonucleosides, Enzyme Inhibitors, Immunosuppressive Agents, Pyrimidine Nucleosides, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Cardiotoxic antineoplastic agents, Adenosine Deaminase Inhibitors, Coformycin, Drugs that are Mainly Renally Excreted, Myelosuppressive Agents, Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Nucleic Acid Synthesis Inhibitors, Pyrimidines, Narrow Therapeutic Index Drugs, Nucleic Acids, Nucleotides, and Nucleosides, Nucleoside Metabolic Inhibitor, Formycins, Glycosides, Nucleosides, Deoxyribonucleosides	approved, investigational	1
DB01883	N-(Sulfanylacetyl)Tyrosylprolylmethioninamide	Drug	0	experimental	1
DB00553	Methoxsalen	Drug	Cytochrome P-450 Enzyme Inhibitors, Psoralens for Systemic Use, Coloring Agents, Photoactivated Radical Generator, Psoralens for Topical Use, Cytochrome P-450 CYP2A6 Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP2A6 Inhibitors (strength unknown), Antipsoriatics, Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP1A2 Inhibitors, Compounds used in a research, industrial, or household setting, Cross-Linking Reagents, Antipsoriatics for Topical Use, Dermatologicals, Laboratory Chemicals, Photosensitizing Activity, Benzopyrans, Photoabsorption, Radiation-Sensitizing Agents, Heterocyclic Compounds, Fused-Ring, Photosensitizing agents used for phototherapy, Photosensitizing Agents, Antipsoriatics for Systemic Use, Indicators and Reagents, Furocoumarins, Pyrans	approved	1
DB00558	Zanamivir	Drug	Acids, Acyclic, Carbohydrates, Enzyme Inhibitors, Hydroxy Acids, Neuraminic Acids, Amidines, Antiviral Agents, Guanidines, Sialic Acids, Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Amino Sugars, Antivirals for Systemic Use, Direct Acting Antivirals, Sugar Acids, Neuraminidase Inhibitors, Pyrans	approved, investigational	3
DB01889	16,17-Androstene-3-Ol	Drug	0	experimental	1
DB00559	Bosentan	Drug	BSEP/ABCB11 Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Inducers, Genito Urinary System and Sex Hormones, Amides, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A4 Inducers (moderate), Cytochrome P-450 Enzyme Inducers, Pyrimidines, Sulfur Compounds, Hepatotoxic Agents, Antihypertensive Agents, Endothelin Receptor Antagonists, Sulfones, Cytochrome P-450 CYP2C9 Inducers (moderate), Gynecological Antiinfectives and Antiseptics, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, Antihypertensives for Pulmonary Arterial Hypertension, Sulfonamides, OATP1B1/SLCO1B1 Substrates, Cytochrome P-450 CYP2C9 Inducers, Vasodilating Agents	approved, investigational	2
DB00556	Perflutren	Drug	Other Diagnostics, QTc Prolonging Agents, Amino Acids, Peptides, and Proteins, Hydrocarbons, Halogenated, Ultrasound Contrast Media, Hydrocarbons, Fluorinated, Moderate Risk QTc-Prolonging Agents, Proteins, Microspheres, Contrast Media, Diagnostic Uses of Chemicals, Ultrasound Contrast Activity, Compounds used in a research, industrial, or household setting	approved	0
DB01888	4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]Pyrimidin-7-Ylamino]-N,N-Dimethylbenzenesulfonamide	Drug	0	experimental	1
DB00557	Hydroxyzine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Psycholeptics, QTc Prolonging Agents, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Piperazines, Cytochrome P-450 Enzyme Inhibitors, Diphenylmethane Derivatives, Nervous System, P-glycoprotein substrates, Dermatologicals, Cytochrome P-450 CYP3A4 Substrates, Miscellaneous Anxiolytics Sedatives and Hypnotics, Neurotransmitter Agents, Histamine H1 Antagonists, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Histamine Receptor Antagonists, Potential QTc-Prolonging Agents, Anti-Anxiety Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Histamine Agents, Antipruritics	approved	2
DB01887	N,N-[2,5-O-Dibenzyl-glucaryl]-DI-[1-amino-indan-2-OL]	Drug	0	experimental	2
DB13871	Albendazole oxide	Drug	Acids, Acyclic, Anticestodal Agents, Heterocyclic Compounds, Fused-Ring, Benzimidazoles, Anthelmintics, Carbamates, Antiplatyhelmintic Agents, Anti-Infective Agents, Antiparasitic Agents	experimental	0
DB13872	Lormetazepam	Drug	Heterocyclic Compounds, Fused-Ring, Psycholeptics, Benzazepines, Nervous System, Central Nervous System Depressants, Benzodiazepines and benzodiazepine derivatives, Benzodiazepinones, Hypnotics and Sedatives, Central Nervous System Agents	approved	2
DB12541	SAR-405838	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB11210	Ferrous bisglycinate	Drug	Organometallic Compounds, Iron Compounds, Amino Acids, Peptides, and Proteins, Amino Acids	approved	0
DB12540	Lecozotan	Drug	0	investigational	0
DB13875	Harmaline	Drug	Pyridines, Carbolines, Central Nervous System Stimulants, Enzyme Inhibitors, Monoamine Oxidase Inhibitors, Antidepressive Agents, Indole Alkaloids, Alkaloids, Heterocyclic Compounds, Fused-Ring, Harmala Alkaloids, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Agents that produce hypertension, Central Nervous System Agents, Indoles, Agents that reduce seizure threshold	experimental	1
DB12543	Samidorphan	Drug	Opioid Antagonists, Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, Sensory System Agents, Central Nervous System Agents, Morphinans, Peripheral Nervous System Agents	investigational	0
DB12542	GSK-356278	Drug	Sulfur Compounds, Oxazoles	investigational	0
DB13876	Brofaromine	Drug	Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, Enzyme Inhibitors, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Monoamine Oxidase Inhibitors, Antidepressive Agents	experimental	1
DB11211	Calcium sulfide	Drug	Gases, Anions, Sulfur Compounds, Acids, Noncarboxylic, Acids, Hydrogen Sulfide, Electrolytes, Ions, Anti-Infective Agents	experimental	0
DB13873	Fenofibric acid	Drug	Acids, Acyclic, Peroxisome Proliferator Receptor alpha Agonist, Anticholesteremic Agents, Hypolipidemic Agents, Fatty Acids, Ketones, Noxae, Hypolipidemic Agents Indicated for Hyperlipidemia, Lipids, Isobutyrates, Drugs that are Mainly Renally Excreted, Phenyl Ethers, Lipid Modifying Agents, Lipid Modifying Agents, Plain, Lipid Regulating Agents, Butyrates, Agents Causing Muscle Toxicity, Fatty Acids, Volatile, Benzophenones, Phenols, Toxic Actions, Fibric Acids, Ethers, Benzene Derivatives	approved	5
DB12545	Indobufen	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Enzyme Inhibitors, Blood and Blood Forming Organs, Sensory System Agents, Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Hematologic Agents, Peripheral Nervous System Agents, Heterocyclic Compounds, Fused-Ring, Analgesics, Platelet Aggregation Inhibitors Excl. Heparin, Agents that produce hypertension, Central Nervous System Agents, Antiplatelet agents	investigational	0
DB13874	Enasidenib	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, UGT1A3 substrates, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index, UGT1A9 substrates with narrow therapeutic index, UGT2B7 substrates, UGT2B7 substrates with narrow therapeutic index, Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Substrates, P-glycoprotein substrates with narrow therapeutic index, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index, Isocitrate Dehydrogenase 2 Inhibitor, OAT1/SLC22A6 inhibitors, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), UGT1A4 substrates, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, OAT3/SLC22A8 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors, Amines, Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index, OATP1B3 inhibitors, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2B6 Inducers, Pyridines, P-glycoprotein substrates, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, UGT1A1 Inhibitors, Isocitrate Dehydrogenase 2 Inhibitors, UGT1A1 substrates with narrow therapeutic index, Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C9 Substrates, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), OCT2 Inhibitors, UGT1A1 Substrates, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, UGT1A3 substrates with narrow therapeutic index, UGT1A9 Substrates, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), P-glycoprotein inhibitors	approved, investigational	1
DB13879	Glecaprevir	Drug	Antivirals for treatment of HCV infections, Cytochrome P-450 Enzyme Inhibitors, OATP1B3 inhibitors, Amides, OATP1B3 substrates, HCV NS3/4A Protease Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors, Antivirals for Systemic Use, Direct Acting Antivirals, Organic Anion Transporting Polypeptide 1B3 Inhibitors, Sulfur Compounds, Breast Cancer Resistance Protein Inhibitors, Sulfones, OATP1B1/SLCO1B1 Inhibitors, P-glycoprotein substrates, BCRP/ABCG2 Inhibitors, UGT1A1 Inhibitors, Antiviral Agents, Organic Anion Transporting Polypeptide 1B1 Inhibitors, Antiinfectives for Systemic Use, Heterocyclic Compounds, Fused-Ring, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, OATP1B1/SLCO1B1 Substrates, NS3/4A Protease Inhibitors, P-glycoprotein inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved, investigational	1
DB12547	LY-2886721	Drug	Heterocyclic Compounds, Fused-Ring, Pyridines	investigational	0
DB13877	Iniparib	Drug	Enzyme Inhibitors, Benzoates, Acids, Carbocyclic, Antineoplastic Agents, Amides, Poly(ADP-ribose) Polymerase Inhibitors, Benzene Derivatives	investigational	1
DB12549	Pyrazoloacridine	Drug	Heterocyclic Compounds, Fused-Ring, Laboratory Chemicals, Antineoplastic Agents, Indicators and Reagents, Intercalating Agents, Compounds used in a research, industrial, or household setting	investigational	0
DB11218	Tea tree oil	Drug	Complex Mixtures, Oils, Plant Preparations, Biological Products, Lipids, Oils, Volatile, Plant Oils, Anti-Infective Agents, Anti-Infective Agents, Local, Miscellaneous Local Anti-infectives	nutraceutical, experimental	0
DB11217	Arbutin	Drug	Carbohydrates, Glycosides, Glucosides	approved	1
DB12548	Sparsentan	Drug	0	investigational	2
DB13878	Pibrentasvir	Drug	OATP1B1/SLCO1B1 Inhibitors, Antivirals for treatment of HCV infections, Cytochrome P-450 Enzyme Inhibitors, P-glycoprotein substrates, OATP1B3 inhibitors, BCRP/ABCG2 Inhibitors, UGT1A1 Inhibitors, Antiviral Agents, Organic Anion Transporting Polypeptide 1B1 Inhibitors, Antiinfectives for Systemic Use, Cytochrome P-450 CYP1A2 Inhibitors, Antivirals for Systemic Use, Direct Acting Antivirals, Hepatitis C Virus NS5A Inhibitor, Heterocyclic Compounds, Fused-Ring, Organic Anion Transporting Polypeptide 1B3 Inhibitors, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Breast Cancer Resistance Protein Inhibitors, P-glycoprotein inhibitors	approved, investigational	1
DB11219	Enzacamene	Drug	Bornanes, Ketones, Monoterpenes, Sunscreen Agents, Terpenes, Norbornanes	approved	4
DB01893	N6-Benzyl Adenosine-5'-Diphosphate	Drug	0	experimental	1
DB00561	Doxapram	Drug	Central Nervous System Stimulants, Pyrrolidinones, Agents that produce hypertension, Pyrrolidines, Central Nervous System Agents, Respiratory System Agents, Increased Medullary Respiratory Drive	approved, vet_approved	2
DB00562	Benzthiazide	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Stimulants, Sodium Chloride Symporter Inhibitors, Gynecological Antiinfectives and Antiseptics, Sulfonamides, Genito Urinary System and Sex Hormones, Diuretics, Amides, Thiazides, Hyperglycemia-Associated Agents, Sulfones	approved	7
DB01892	Hyperforin	Drug	OATP1B1/SLCO1B1 Inhibitors, Phenols, Benzene Derivatives	nutraceutical	3
DB01891	Tl-3-093	Drug	0	experimental	2
DB01890	N,N-Bis(3-(D-gluconamido)propyl)deoxycholamide	Drug	0	experimental	2
DB00560	Tigecycline	Drug	Anti-Bacterial Agents, Enzyme Inhibitors, Glycylcyclines, Tetracyclines, Naphthacenes, Agents that produce neuromuscular block (indirect), Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use, Protein Synthesis Inhibitors	approved	6
DB00565	Cisatracurium	Drug	Neuromuscular Agents, Benzylisoquinolines, Isoquinolines, Neuromuscular-Blocking Agents (Nondepolarizing), Muscle Relaxants, Nicotinic Antagonists, Peripheral Nervous System Agents, Anticholinergic Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Neuromuscular Nondepolarizing Blockade, Muscle Relaxants, Peripherally Acting Agents, Central Nervous System Depressants, Musculo-Skeletal System, Neuromuscular Blocking Agents	approved	1
DB01897	2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride	Drug	0	experimental	1
DB01896	M-Aminophenylboronic Acid	Drug	0	experimental	1
DB00566	Succimer	Drug	Acids, Acyclic, Sulfur Compounds, Antidotes, Lead Chelator, Succinates, Protective Agents, Sequestering Agents, Dicarboxylic Acids, Compounds used in a research, industrial, or household setting, Lead Chelating Activity, Chelating Agents, Sulfhydryl Compounds	approved	4
DB01895	Aspartyl-Adenosine-5'-Monophosphate	Drug	0	experimental	1
DB00563	Methotrexate	Drug	Nephrotoxic agents, Immunologic Factors, Enzyme Inhibitors, Cytochrome P-450 Substrates, Immunosuppressive Agents, Folic Acid Antagonists, Cardiotoxic antineoplastic agents, OATP1B3 substrates, Cytochrome P-450 CYP3A4 Substrates, Pteridines, Drugs that are Mainly Renally Excreted, OAT3/SLC22A8 Substrates, Folic Acid Analogues, Nucleic Acid Synthesis Inhibitors, Pterins, Hepatotoxic Agents, Drugs causing inadvertant photosensitivity, Biological Factors, Noxae, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Dermatologicals, Reproductive Control Agents, Antineoplastic Agents, Antirheumatic Agents, Abortifacient Agents, Nonsteroidal, Antimetabolites, Myelosuppressive Agents, OAT1/SLC22A6 inhibitors, Pigments, Biological, Heterocyclic Compounds, Fused-Ring, BCRP/ABCG2 Substrates, Narrow Therapeutic Index Drugs, Abortifacient Agents, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Agents Causing Muscle Toxicity, OATP1B1/SLCO1B1 Substrates, Toxic Actions, OAT3/SLC22A8 Inhibitors	approved	3
DB00564	Carbamazepine	Drug	Cytochrome P-450 Substrates, Immunosuppressive Agents, Sensory System Agents, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Cardiovascular Agents, UGT1A1 Inducers, Cytochrome P-450 CYP2C19 Inducers (moderate), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inducers (strength unknown), Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP2B6 Inducers (strong), Peripheral Nervous System Agents, Carboxamide Derivatives, Cytochrome P-450 CYP3A4 Inducers (strong), Miscellaneous Anticonvulsants, UGT2B7 substrates, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Cytochrome P-450 CYP2C19 Inducers, Cytochrome P-450 CYP2C8 Substrates, UGT1A6 inducer, Analgesics, Non-Narcotic, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A Inducers (strong), Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A4 Inducers, Inducers of Drug Clearance, Membrane Transport Modulators, Central Nervous System Depressants, Cytochrome P-450 CYP1A2 Inducers (strong), Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inducers, Cytochrome P-450 CYP3A5 Inducers (strong), Cytochrome P-450 CYP2B6 Substrates, Sodium Channel Blockers, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Decreased Central Nervous System Disorganized Electrical Activity, Cytochrome P-450 CYP2C8 Inducers, Antimanic Agents, Mood Stabilizer, Cytochrome P-450 CYP2C19 Inhibitors, Enzyme Inducing Antiepileptic Drugs, Thyroxine-binding globulin substrates, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 Enzyme Inducers, Analgesics, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inducers, P-glycoprotein substrates, Dibenzazepines, Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index, Psychotropic Drugs, Myelosuppressive Agents, Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, P-glycoprotein inducers, Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index, Heterocyclic Compounds, Fused-Ring, Anticonvulsants, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Central Nervous System Agents, Cytochrome P-450 CYP2C9 Inducers	approved, investigational	3
DB00569	Fondaparinux	Drug	Anticoagulants, Carbohydrates, Enzyme Inhibitors, Blood and Blood Forming Organs, Factor Xa Inhibitors, Fibrin Modulating Agents, Protease Inhibitors, Hematologic Agents, Cardiovascular Agents, Oligosaccharides, Fibrinolytic Agents, Drugs that are Mainly Renally Excreted, Miscellaneous Anticoagulants, Polysaccharides, Antithrombins, Serine Protease Inhibitors	approved, investigational	2
DB00567	Cephalexin	Drug	Nephrotoxic agents, Cytochrome P-450 Substrates, MATE 1 Substrates, Amides, Lactams, OAT1/SLC22A6 Substrates, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, OAT3/SLC22A8 Substrates, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Aza Compounds, Azabicyclo Compounds, MATE substrates, Thiazines, beta-Lactams, First-Generation Cephalosporins, Antiinfectives for Systemic Use, OAT1/SLC22A6 inhibitors, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, OAT3/SLC22A8 Inhibitors, Antibacterials for Systemic Use	approved, investigational, vet_approved	5
DB01899	Nd1-Phosphonohistidine	Drug	0	experimental	1
DB01898	(2S,3S)-2-azanyl-3-methyl-pentanedioic acid	Drug	0	experimental	0
DB00568	Cinnarizine	Drug	QTc Prolonging Agents, Cytochrome P-450 Substrates, Nervous System, Agents causing hyperkalemia, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Histamine H1 Antagonists, Antivertigo Preparations, Calcium-Regulating Hormones and Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Piperazines, Moderate Risk QTc-Prolonging Agents, Membrane Transport Modulators, Calcium Channel Blockers, Cytochrome P-450 CYP2C9 Substrates, Neurotransmitter Agents, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2A6 Substrates, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Histamine Agents, Vasodilating Agents	approved, investigational	11
DB01819	Phosphoenolpyruvate	Drug	Hydroxy Acids	experimental	7
DB01818	O3-Sulfonylgalactose	Drug	0	experimental	1
DB13802	Epomediol	Drug	Liver Therapy, Alimentary Tract and Metabolism, Cholagogues and Choleretics, Liver Therapy, Lipotropics, Bile and Liver Therapy, Gastrointestinal Agents	experimental	0
DB13803	Xipamide	Drug	Sulfur Compounds, Sulfonamides, Diuretics, Natriuretic Agents, Amides, Cardiovascular Agents, Low-Ceiling Diuretics, Excl. Thiazides, Antihypertensive Agents, Sulfones	experimental	0
DB13800	Calcium levulinate	Drug	Calcium Salts, Enzyme Inhibitors, Alimentary Tract and Metabolism, Keto Acids, Mineral Supplements	approved, experimental	3
DB13801	Muzolimine	Drug	High-Ceiling Diuretics, Pyrazoles, Diuretics, Natriuretic Agents, Pyrazolone Derivatives, Cardiovascular Agents, Antihypertensive Agents	approved, withdrawn	0
DB13806	Linopirdine	Drug	Heterocyclic Compounds, Fused-Ring, Neuroprotective Agents, Nervous System, Protective Agents, Psychostimulants, Agents Used for Adhd and Nootropics, Cardiovascular Agents, Central Nervous System Agents, Potassium Channel Blockers, Compounds used in a research, industrial, or household setting, Membrane Transport Modulators, Psychoanaleptics	experimental	0
DB13807	Tisopurine	Drug	Heterocyclic Compounds, Fused-Ring, Purines, Antigout Preparations, Musculo-Skeletal System, Antirheumatic Agents, Preparations Inhibiting Uric Acid Production	experimental	0
DB13804	Benzylthiouracil	Drug	Pyrimidines, Thyroid Products, Pyrimidinones, Antithyroid agents, Thiouracils, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Uridine Phosphorylase, antagonists & inhibitors	experimental	0
DB13805	Reposal	Drug	Psycholeptics, Enzyme Inhibitors, Amines, Hydroxy Acids, Nervous System, Central Nervous System Depressants, Barbiturates, Plain, Hydroxylamines, Hypnotics and Sedatives, Benzene Derivatives	experimental	0
DB01820	2-{[4-(2-Acetylamino-2-pentylcarbamoyl-ethyl)-naphthalen-1-YL]-oxalyl-amino}-benzoic acid	Drug	0	experimental	1
DB01824	(3S)-Tetrahydro-3-furanyl {(2S,3S)-4-[(2S,4R)-4-{(1S,2R)-2-[(S)-amino(hydroxy)methoxy]-2,3-dihydro-1H-inden-1-yl}-2-benzyl-3-oxo-2-pyrrolidinyl]-3-hydroxy-1-phenyl-2-butanyl}carbamate	Drug	0	experimental	1
DB01823	Beta-D-Glucopyranose Spirohydantoin	Drug	0	experimental	1
DB01822	(4R,5R)-1,2-dithiane-4,5-diol	Drug	0	experimental	1
DB01821	L-N(omega)-Nitroarginine-2,4-L-diaminobutyric amide	Drug	0	experimental	2
DB01828	Methylamine	Drug	Amines	experimental	1
DB01827	2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide	Drug	0	experimental	1
DB01826	N-Butyl Isocyanide	Drug	0	experimental	4
DB01825	2-amino-8-methyl-4(1H)-quinazolinone	Drug	0	experimental	1
DB01829	Desulfo-coenzyme A	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Coenzymes, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Enzymes and Coenzymes, Glycosides, Nucleotides, Adenine Nucleotides	experimental	1
DB13810	Dimemorfan	Drug	Alkaloids, Antitussive Agents, Heterocyclic Compounds, Fused-Ring, Opium Alkaloids and Derivatives, Phenanthrenes, Opiate Alkaloids, Cough and Cold Preparations, Central Nervous System Agents, Respiratory System Agents	experimental	0
DB13813	Iodoform	Drug	Medicated Dressings With Antiinfectives, Medicated Dressings, Dermatologicals, Hydrocarbons, Halogenated, Miscellaneous Local Anti-infectives	approved, experimental, vet_approved	0
DB13814	Talampicillin	Drug	Penicillins With Extended Spectrum, Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Penicillin G, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Antibacterials for Systemic Use	experimental	0
DB13811	Oblimersen	Drug	Molecular Probes, Antisense Elements (Genetics), Carbohydrates, Oligonucleotides, Antisense, Antineoplastic and Immunomodulating Agents, Laboratory Chemicals, Oligonucleotides, Antineoplastic Agents, Nucleic Acid Probes, Nucleotides, Nucleic Acids, Polynucleotides, Sulfur Compounds, Diagnostic Uses of Chemicals, DNA, Antisense, Nucleic Acids, Nucleotides, and Nucleosides, DNA, Glycosides, Oligodeoxyribonucleotides, Antisense, Compounds used in a research, industrial, or household setting	investigational, experimental	0
DB13812	Bufylline	Drug	Autonomic Agents, Cytochrome P-450 Substrates, Anti-Asthmatic Agents, Cardiovascular Agents, Bronchodilator Agents, Respiratory System Agents, Peripheral Nervous System Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Purines, Cytochrome P-450 CYP1A2 Substrates, Drugs for Obstructive Airway Diseases, Xanthine derivatives, Vasodilating Agents, Purinones	experimental	0
DB13817	Carbromal	Drug	Psycholeptics, Nervous System, Central Nervous System Depressants, Hypnotics and Sedatives	experimental	0
DB13818	Bibrocathol	Drug	Ophthalmologicals, Phenols, Sensory Organs, Anti-Infective Agents, Benzene Derivatives	experimental	0
DB13815	Xenysalate	Drug	Dermatologicals, Medicated Shampoos	experimental	0
DB13816	Aspoxicillin	Drug	Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Penicillins With Extended Spectrum, Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Penicillin G, Antibacterials for Systemic Use	experimental	0
DB13808	Mebhydrolin	Drug	Heterocyclic Compounds, Fused-Ring, Pyridines, Indoles, Antihistamines for Systemic Use	experimental	0
DB13809	Paclitaxel poliglumex	Drug	Cycloparaffins, Peptides, Cyclodecanes, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Cardiotoxic antineoplastic agents, Amino Acids, Acidic, Amino Acids, Amino Acids, Dicarboxylic, Taxoids, Diterpenes, Glutamates, Terpenes	investigational, experimental	0
DB01831	Tryptophanyl-5'amp	Drug	0	experimental	2
DB00500	Tolmetin	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Acetic Acid Derivatives and Related Substances, Enzyme Inhibitors, Sensory System Agents, Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Antiinflammatory Preparations, Non-Steroids for Topical Use, Topical Products for Joint and Muscular Pain, OAT1/SLC22A6 inhibitors, Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Musculo-Skeletal System, Agents that produce hypertension, Central Nervous System Agents	approved	2
DB01830	AP-22408	Drug	0	experimental	1
DB01835	4R-Fluoro-N6-ethanimidoyl-L-lysine	Drug	0	experimental	1
DB00503	Ritonavir	Drug	Acids, Acyclic, Antivirals for treatment of HCV infections, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inhibitors (strong), BSEP/ABCB11 Substrates, Experimental Unapproved Treatments for COVID-19, UGT1A1 Inducers, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors (strong), Direct Acting Antivirals, Cytochrome P-450 CYP2C19 Inducers, Cytochrome P-450 CYP2C9 Inducers (weak), Cytochrome P-450 CYP2C8 Inhibitors (moderate), OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Chemically-Induced Disorders, Cytochrome P-450 CYP2C8 Inhibitors, Anti-Retroviral Agents, Anti-HIV Agents, Cytochrome P-450 CYP2C8 Inhibitors (strong), Cytochrome P-450 CYP3A7 Inhibitors, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inducers, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Cytochrome P-450 CYP2D6 Inhibitors (weak), Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, BSEP/ABCB11 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inducers, Protease Inhibitors, OATP1B3 inhibitors, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2B6 Inhibitors, Anti-Infective Agents, Cytochrome P-450 CYP1A2 Inhibitors, Antivirals for Systemic Use, Cytochrome P-450 Enzyme Inducers, Sulfur Compounds, Cytochrome P-450 CYP2B6 Inducers (weak), Breast Cancer Resistance Protein Inhibitors, Thiazoles, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Cytochrome P-450 CYP3A7 Inhibitors (strong), Potential QTc-Prolonging Agents, UDP Glucuronosyltransferases Inducers, P-glycoprotein substrates, Cytochrome P-450 CYP3A5 Inhibitors, BCRP/ABCG2 Inhibitors, Antiviral Agents, Antiinfectives for Systemic Use, HIV Protease Inhibitors, P-glycoprotein inducers, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2C9 Inducers, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), P-glycoprotein inhibitors, Hyperglycemia-Associated Agents	approved, investigational	2
DB00504	Levallorphan	Drug	Opioid Antagonists, Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, Sensory System Agents, Central Nervous System Agents, Morphinans, Peripheral Nervous System Agents	approved	1
DB01834	(9R,10R)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene	Drug	0	experimental	2
DB00501	Cimetidine	Drug	Cytochrome P-450 Enzyme Inhibitors, OCT1 inhibitors, MATE 1 Inhibitors, Anti-Ulcer Agents, Drugs that are Mainly Renally Excreted, OAT3/SLC22A8 Substrates, Cytochrome P-450 CYP3A7 Inhibitors (moderate), Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Alimentary Tract and Metabolism, Cytochrome P-450 CYP2C8 Inhibitors (weak), Acid Reducers, Drugs for Acid Related Disorders, MATE substrates, Chemically-Induced Disorders, Cytochrome P-450 CYP2C8 Inhibitors, Adjuvants, Histamine H2 Antagonists, OAT1/SLC22A6 inhibitors, Neurotransmitter Agents, Gastric Acid Lowering Agents, Cytochrome P-450 CYP3A7 Inhibitors, MATE 2 Substrates, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), MATE 2 Inhibitors, OAT3/SLC22A8 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (weak), Cytochrome P-450 CYP2D6 Inhibitors, OCT1 substrates, BSEP/ABCB11 Inhibitors, Enzyme Inhibitors, OCT2 Substrates, MATE 1 Substrates, Cytochrome P-450 CYP2C19 Inhibitors, MATE inhibitors, OAT1/SLC22A6 Substrates, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Gastrointestinal Agents, Cytochrome P-450 CYP1A2 Inhibitors (weak), Cytochrome P-450 CYP2E1 Inhibitors, P-glycoprotein substrates, Cytochrome P-450 CYP3A5 Inhibitors, Amidines, Guanidines, P-glycoprotein inducers, Cytochrome P-450 CYP3A5 Inhibitors (moderate), Cytochrome P-450 CYP3A Inhibitors, Histamine Antagonists, Imidazoles, Agents Causing Muscle Toxicity, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), OCT2 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Histamine Agents, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved, investigational	1
DB01833	Canavanine	Drug	Amino Acids, Peptides, and Proteins, Amino Acids	experimental	1
DB00502	Haloperidol	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Psycholeptics, QTc Prolonging Agents, Tranquilizing Agents, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Antipsychotic Agents (First Generation Typical), Butyrophenones, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Anti-Dyskinesia Agents, Antipsychotic Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Butyrophenone Derivatives, Drugs causing inadvertant photosensitivity, Dopamine Antagonists, Agents that reduce seizure threshold, Dopamine Agents, Gastrointestinal Agents, Neurotoxic agents, Autonomic Agents, Cytochrome P-450 CYP3A5 Substrates, Ketones, P-glycoprotein substrates, Moderate Risk QTc-Prolonging Agents, Psychotropic Drugs, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Neurotransmitter Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Central Nervous System Depressants, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, NMDA Receptor Antagonists, Antiemetics, UGT1A9 Substrates, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors, Dopamine D2 Receptor Antagonists, Hyperglycemia-Associated Agents	approved	18
DB01832	4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid	Drug	0	experimental	1
DB01839	Propylene glycol	Drug	Solvents, Pegylated agents, Glycols, Pharmaceutical Preparations, Propylene Glycols, Compounds used in a research, industrial, or household setting, Pharmaceutic Aids, Alcohols, Drug Delivery Systems, Pharmaceutical Vehicles	approved, investigational	1
DB00507	Nitazoxanide	Drug	Sulfur Compounds, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Anti-Infective Agents, Antiparasitic Agents	approved, investigational, vet_approved	1
DB01838	6,4'-Dihydroxy-3-Methyl-3',5'-Dibromoflavone	Drug	0	experimental	0
DB00508	Triflupromazine	Drug	Psycholeptics, Tranquilizing Agents, Serotonin Agents, Nervous System, Muscarinic Antagonists, Antidepressive Agents, Peripheral Nervous System Agents, Anticholinergic Agents, Serotonin 5-HT2 Receptor Antagonists, Antipsychotic Agents, Sulfur Compounds, Dopamine Antagonists, Dopamine Agents, Gastrointestinal Agents, Neurotoxic agents, Autonomic Agents, Cholinesterase Inhibitors, Phenothiazines, Agents producing tachycardia, Phenothiazines With Aliphatic Side-Chain, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Central Nervous System Depressants, Antiemetics, Serotonin Receptor Antagonists, Central Nervous System Agents, P-glycoprotein inhibitors, Dopamine D2 Receptor Antagonists	approved, vet_approved	5
DB01837	O-acetyl-L-serine	Drug	0	experimental	1
DB00505	Tridihexethyl	Drug	Anticholinergic Agents, Synthetic Anticholinergics, Quaternary Ammonium Compounds, Amines, Ammonium Compounds, Alimentary Tract and Metabolism, Agents producing tachycardia, Onium Compounds, Drugs for Functional Gastrointestinal Disorders, Muscarinic Antagonists, Nitrogen Compounds	withdrawn	3
DB01836	[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone	Drug	0	experimental	1
DB00509	Dextrothyroxine	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Lipid Modifying Agents, Lipid Modifying Agents, Plain, Hormones, Hormone Substitutes, and Hormone Antagonists, Amino Acids, Peptides, and Proteins, Hormones, Amino Acids	approved, investigational	3
DB13820	Oxomemazine	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Phenothiazine Derivatives, Antihistamines for Systemic Use	experimental	0
DB13821	Ceftezole	Drug	Nephrotoxic agents, Amides, Lactams, Thiazines, beta-Lactams, First-Generation Cephalosporins, Antiinfectives for Systemic Use, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Antibacterials for Systemic Use	experimental	0
DB13824	Enprostil	Drug	Biological Factors, Autacoids, Inflammation Mediators, Fatty Acids, Eicosanoids, Lipids, Anti-Ulcer Agents, Prostaglandins E, Synthetic, Prostaglandins, Synthetic, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Fatty Acids, Unsaturated, Prostaglandins, Alimentary Tract and Metabolism, Drugs for Acid Related Disorders, Gastrointestinal Agents	experimental	0
DB13825	Fedrilate	Drug	Cough and Cold Preparations	experimental	0
DB13822	Meprotixol	Drug	Cough and Cold Preparations	experimental	0
DB13823	Pipemidic acid	Drug	Fluoroquinolones, Cytochrome P-450 CYP1A2 Inhibitors (weak), Pyridines, QTc Prolonging Agents, Renal Agents, Anti-Infective Agents, Urinary, Piperazines, Cytochrome P-450 Enzyme Inhibitors, Nicotinic Acids, Antiinfectives for Systemic Use, Anti-Infective Agents, Cytochrome P-450 CYP1A2 Inhibitors, Anti-Bacterial Agents, Potential QTc-Prolonging Agents, Antibacterials for Systemic Use	experimental	0
DB13828	Cyfluthrin	Drug	Insecticides and Repellents, Antiparasitic Products, Insecticides and Repellents, Agrochemicals, Pyrethrines, Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents, Pesticides, Insecticides, Toxic Actions, Monoterpenes, Terpenes, Compounds used in a research, industrial, or household setting	experimental	0
DB13829	Calcium silicate	Drug	Calcium Compounds, Bone Substitutes, Ions, Oxides, Minerals, Silicon Compounds, Anions, Gastric Acid Lowering Agents, Acids, Noncarboxylic, Acids, Alimentary Tract and Metabolism, Electrolytes, Drugs for Acid Related Disorders, Antacids, Oxygen Compounds	experimental	0
DB13826	Etohexadiol	Drug	Solvents, Insecticides and Repellents, Antiparasitic Products, Insecticides and Repellents, Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents, Alcohols	experimental	0
DB13827	Indanazoline	Drug	Nasal Preparations, Sympathomimetics, Plain	experimental	0
DB13819	Proxazole	Drug	Oxazoles, Alimentary Tract and Metabolism, Drugs for Functional Gastrointestinal Disorders	experimental	0
DB01842	3'-Phosphate-Adenosine-5'-Diphosphate	Drug	0	experimental	2
DB00511	Acetyldigitoxin	Drug	Carbohydrates, Cardanolides, Cardiac Glycosides, Enzyme Inhibitors, Protective Agents, Cardiovascular Agents, Fused-Ring Compounds, Cardiotonic Agents, Digitalis Glycosides, Glycosides, Cardenolides, Cardiac Therapy, Compounds used in a research, industrial, or household setting, Antiarrhythmic agents, Steroids	approved	1
DB01841	4,6-Dideoxyglucose	Drug	0	experimental	5
DB01840	2-Deoxy-D-Glucitol 6-(E)-Vinylhomophosphonate	Drug	Carbohydrates, Sugar Alcohols, Myo-Inositol-1-Phosphate Synthase, antagonists & inhibitors, Alcohols	experimental	1
DB00514	Dextromethorphan	Drug	Antitussive Agents, Uncompetitive NMDA Receptor Antagonists, Cytochrome P-450 Substrates, Serotonin Agents, Sigma-1 Agonist, Cytochrome P-450 CYP3A7 Substrates, Nervous System, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Morphinans, Anticholinergic Agents, Alkaloids, Serotonin Modulators, Cough and Cold Preparations, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Excitatory Amino Acid Agents, Uncompetitive N-methyl-D-aspartate Receptor Antagonist, Cytochrome P-450 CYP3A5 Substrates, Narcotics, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Sigma-1 Receptor Agonists, Nicotinic Antagonists, Respiratory System Agents, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Opium Alkaloids and Derivatives, Phenanthrenes, Opiate Alkaloids, Cytochrome P-450 CYP3A Substrates, Expectorants, Central Nervous System Depressants, NMDA Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Excitatory Amino Acid Antagonists	approved	16
DB01846	Oxidized coenzyme A	Drug	0	experimental	2
DB00515	Cisplatin	Drug	Nephrotoxic agents, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, OCT2 Substrates, Cardiotoxic antineoplastic agents, Cytochrome P-450 CYP2B6 Inhibitors, Platinum Compounds, Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP2C9 Inhibitors, OCT2 substrates with narrow therapeutic index, Compounds used in a research, industrial, or household setting, Nitrogen Compounds, Cross-Linking Reagents, Cholinesterase Inhibitors, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Laboratory Chemicals, Antineoplastic Agents, Radiation-Sensitizing Agents, Myelosuppressive Agents, Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, BCRP/ABCG2 Substrates, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), OCT2 Inhibitors, Indicators and Reagents, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), Chlorine Compounds	approved	5
DB00512	Vancomycin	Drug	Nephrotoxic agents, Carbohydrates, Glycopeptide Antibacterials, Glycoconjugates, Peptides, Amino Acids, Peptides, and Proteins, Agents that produce neuromuscular block (indirect), Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Anti-Bacterial Agents, Narrow Therapeutic Index Drugs, Intestinal Antiinfectives, Alimentary Tract and Metabolism, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Glycopeptides, Antibacterials for Systemic Use	approved	1
DB01844	N,N-dimethylformamide	Drug	Acids, Acyclic, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 Substrates, Amides, Formates, Formamides	experimental	2
DB01843	(5S,7R,8S,9S,10R)-3-Amino-8,9,10-trihydroxy-7-(hydroxymethyl)-6-oxa-1,3-diazaspiro[4.5]decane-2,4-dione	Drug	0	experimental	1
DB00513	Aminocaproic acid	Drug	Acids, Acyclic, Blood and Blood Forming Organs, Fatty Acids, Fibrin Modulating Agents, Amino Acids, Peptides, and Proteins, Hematologic Agents, Lipids, Coagulants, Amino Acids, Antifibrinolytic Agents, Fatty Acids, Volatile, Caproates, Aminocaproates, Hemostatics, Decreased Fibrinolysis	approved, investigational	3
DB00518	Albendazole	Drug	Acids, Acyclic, Benzimidazoles, Cytochrome P-450 Substrates, Tubulin Modulators, Antihelminthic, Anthelmintics, Mitosis Modulators, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Benzimidazole Derivatives, Cytochrome P-450 Enzyme Inducers, Antinematodal Agents, Anticestodal Agents, Antiparasitic Products, Insecticides and Repellents, P-glycoprotein substrates, Cytochrome P-450 CYP2C19 Substrates, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Inducers (strong), Antimitotic Agents, Cytochrome P-450 CYP1A2 Substrates, Carbamates, Cytochrome P-450 CYP1A2 Inducers, Antiplatyhelmintic Agents, Antiparasitic Agents	approved, vet_approved	4
DB00519	Trandolapril	Drug	ACE Inhibitors and Calcium Channel Blockers, Antihypertensive Agents Indicated for Hypertension, Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors, Agents causing hyperkalemia, Protease Inhibitors, Agents Acting on the Renin-Angiotensin System, Agents causing angioedema, Cardiovascular Agents, Hypotensive Agents, Antihypertensive Agents	approved	1
DB01849	Dihydrouracil	Drug	Pyrimidines, Pyrimidinones	experimental	0
DB00516	Bentoquatam	Drug	Dermatologicals, Ions, Oxides, Minerals, Silicates, Silicon Compounds, Anions, Acids, Noncarboxylic, Metal cations, Acids, Metal divalent cations, Aluminium Compounds, Aluminum Silicates, Electrolytes, Oxygen Compounds	approved	0
DB01847	N-Carbamyl-D-Valine	Drug	0	experimental	1
DB00517	Anisotropine methylbromide	Drug	Anticholinergic Agents, Alkaloids, Neurotransmitter Agents, Cholinergic Agents, Aza Compounds, Agents producing tachycardia, Azabicyclo Compounds, Muscarinic Antagonists	approved	3
DB13831	Potassium permanganate	Drug	Potassium Salt, Antidotes, Antiseptics and Disinfectants, Dermatologicals, Laboratory Chemicals, Indicators and Reagents, Manganese Compounds, Compounds used in a research, industrial, or household setting, Potassium Compounds	investigational, experimental	0
DB13832	Ranimustine	Drug	Alkylating Drugs, Nitroso Compounds, Nitrosoureas, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents	experimental	0
DB12501	ABT-384	Drug	Cycloparaffins, 11-beta-Hydroxysteroid Dehydrogenase Type 1, antagonists & inhibitors	investigational	0
DB13830	Copper usnate	Drug	Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones	experimental	0
DB12500	Fedratinib	Drug	Cytochrome P-450 CYP2D6 Inhibitors, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, P-glycoprotein substrates, OATP1B3 inhibitors, BCRP/ABCG2 Inhibitors, Amides, MATE inhibitors, MATE 1 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C19 Substrates, Sulfur Compounds, Cytochrome P-450 CYP3A Substrates, MATE 2 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), P-glycoprotein inhibitors, Sulfones	approved, investigational	3
DB13835	Caroverine	Drug	Cytochrome P-450 Substrates, Agents causing hyperkalemia, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Membrane Transport Modulators, Calcium Channel Blockers, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Alimentary Tract and Metabolism, Calcium-Regulating Hormones and Agents, Drugs for Functional Gastrointestinal Disorders, Excitatory Amino Acid Agents, Vasodilating Agents, Excitatory Amino Acid Antagonists, Bradycardia-Causing Agents, Antiarrhythmic agents	experimental	0
DB13836	Metampicillin	Drug	Penicillins With Extended Spectrum, Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Penicillin G, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Antibacterials for Systemic Use	experimental	0
DB12505	E-7820	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amides, Sulfones	investigational	0
DB13833	Methylatropine	Drug	Autonomic Agents, Solanaceous Alkaloids, Belladonna Alkaloids, Parasympatholytics, Peripheral Nervous System Agents, Alkaloids, Belladonna and Derivatives, Plain, Tropanes, Belladonna Alkaloids, Semisynthetic, Quaternary Ammonium Compounds, Alimentary Tract and Metabolism, Aza Compounds, Azabicyclo Compounds, Drugs for Functional Gastrointestinal Disorders	experimental	0
DB13834	Phenylmercuric borate	Drug	Antiseptics and Disinfectants, Dermatologicals, Mercurial Products	experimental	0
DB12504	JNJ-40346527	Drug	0	investigational	0
DB12507	Atecegatran metoxil	Drug	Azetines	investigational	0
DB13839	Dipyrocetyl	Drug	Antiinflammatory and Antirheumatic Products, Analgesics, Nervous System, Musculo-Skeletal System, Salicylic Acid and Derivatives	experimental	0
DB12506	Fenamole	Drug	0	investigational	0
DB13837	Doxefazepam	Drug	Heterocyclic Compounds, Fused-Ring, Psycholeptics, Benzazepines, Nervous System, Central Nervous System Depressants, Benzodiazepines and benzodiazepine derivatives, Benzodiazepinones, Hypnotics and Sedatives	experimental	2
DB12509	Imeglimin	Drug	0	investigational	0
DB12508	E7107	Drug	0	investigational	0
DB13838	Noxytiolin	Drug	Sulfur Compounds, Blood and Blood Forming Organs, Thiourea, Blood Substitutes and Perfusion Solutions, Irrigating Solutions, Anti-Infective Agents, Anti-Infective Agents, Local	approved	0
DB00521	Carteolol	Drug	Quinolines, QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Sympatholytics, Agents causing hyperkalemia, Adrenergic beta-Antagonists, Cardiovascular Agents, Hypotensive Agents, Alcohols, Peripheral Nervous System Agents, Quinolones, Adrenergic Antagonists, Potential QTc-Prolonging Agents, Antihypertensive Agents, Adrenergic Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Autonomic Agents, Propanols, Antiglaucoma Preparations and Miotics, Phenoxypropanolamines, Amino Alcohols, Beta Blocking Agents, Non-Selective, Ophthalmologicals, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP2D6 Substrates, Sensory Organs, Propanolamines	approved	2
DB01853	Bacteriochlorophyll A	Drug	Proteins, Biological Factors, Chlorophyll, Heterocyclic Compounds, Fused-Ring, Bacteriochlorophylls, Amino Acids, Peptides, and Proteins, Metalloporphyrins, Photoreceptors, Microbial, Pigments, Biological, Porphyrins	experimental	2
DB01852	Kaempherol	Drug	0	experimental	1
DB00522	Bentiromide	Drug	Aminobenzoates, Benzoates, Acids, Carbocyclic, Laboratory Chemicals, Indicators and Reagents, Pancreatic Function Tests, Diagnostic Agents, Tests for Pancreatic Function, Compounds used in a research, industrial, or household setting, Benzene Derivatives	investigational, withdrawn	1
DB01851	Tetrabutylammonium Ion	Drug	0	experimental	2
DB00520	Caspofungin	Drug	OATP1B1/SLCO1B1 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Peptides, Antimycotics for Systemic Use, Amino Acids, Peptides, and Proteins, Lipids, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), OATP1B3 substrates, Antiinfectives for Systemic Use, Echinocandin Antifungal, Anti-Infective Agents, OAT1/SLC22A6 inhibitors, Peptides, Cyclic, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Echinocandins, OATP1B1/SLCO1B1 Substrates, Antifungal Agents, P-glycoprotein inhibitors, Lipopeptides	approved	1
DB01850	(2S,3S,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid	Drug	0	experimental	0
DB01857	Phosphoaspartate	Drug	0	experimental	2
DB00525	Tolnaftate	Drug	Acids, Acyclic, Sulfur Compounds, Antifungals for Topical Use, Dermatologicals, Antifungals for Dermatological Use, Carbamates, Antifungal Agents, Thiocarbamates, Anti-Infective Agents, Naphthalenes	approved, investigational, vet_approved	1
DB00526	Oxaliplatin	Drug	QTc Prolonging Agents, Immunosuppressive Agents, OCT2 Substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Moderate Risk QTc-Prolonging Agents, Platinum Compounds, Myelosuppressive Agents, Organometallic Compounds, BCRP/ABCG2 Substrates, Narrow Therapeutic Index Drugs, Coordination Complexes, OCT2 substrates with narrow therapeutic index	approved, investigational	1
DB01856	Pimelic Acid	Drug	0	experimental	1
DB01855	5-(Hydroxy-Methyl-Amino)-3-Methyl-Pyrrolidine-2-Carboxylic Acid	Drug	0	experimental	0
DB00523	Alitretinoin	Drug	Agents for Dermatitis, Excluding Corticosteroids, Biological Factors, Cycloparaffins, Alkenes, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Dermatologicals, Hydrocarbons, Acyclic, Antineoplastic Agents, Cyclohexenes, Misc. Skin and Mucous Membrane Agents, Retinoids, Vitamins, Cyclohexanes, Pigments, Biological, Vitamin A, Carotenoids, Vitamins (Fat Soluble), Polyenes, Terpenes, Tretinoin	approved, investigational	9
DB00524	Metolazone	Drug	Antihypertensive Agents Indicated for Hypertension, Quinazolinones, Increased Diuresis, Sodium Chloride Symporter Inhibitors, Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Low-Ceiling Diuretics and Potassium-Sparing Agents, Thiazide-like Diuretic, Amides, Cardiovascular Agents, Hypotensive Agents, Low-Ceiling Diuretics, Excl. Thiazides, Quinazolines, Drugs that are Mainly Renally Excreted, Membrane Transport Modulators, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Sulfonamides, Diuretics, Natriuretic Agents, Antihypertensive Agents, Hyperglycemia-Associated Agents, Non Potassium Sparing Diuretics, Sulfones	approved	1
DB01854	5-Bromonicotinamide	Drug	0	experimental	1
DB00529	Foscarnet	Drug	Nephrotoxic agents, Acids, Acyclic, QTc Prolonging Agents, Enzyme Inhibitors, Fatty Acids, Organophosphorus Compounds, Lipids, Phosphonic Acid Derivatives, Anti-Retroviral Agents, Antiviral Agents, Pyrophosphate Analog DNA Polymerase Inhibitor, Acetates, Antiinfectives for Systemic Use, Anti-Infective Agents, OAT1/SLC22A6 inhibitors, Organophosphonates, Antivirals for Systemic Use, Direct Acting Antivirals, Nucleic Acid Synthesis Inhibitors, Chelating Activity, Fatty Acids, Volatile, Potential QTc-Prolonging Agents, Reverse Transcriptase Inhibitors	approved	2
DB00527	Cinchocaine	Drug	Analgesics and Anesthetics, Quinolines, Cell-mediated Immunity, Cholinesterase Inhibitors, Sensory System Agents, Nervous System, Dermatologicals, Otologicals, Amides, Standardized Chemical Allergen, Anesthetics for Topical Use, Anesthetics, Peripheral Nervous System Agents, Ophthalmologicals, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Heterocyclic Compounds, Fused-Ring, Vasoprotectives, Antipruritics, Incl. Antihistamines, Anesthetics, Etc., Antipruritics and Local Anesthetics, Central Nervous System Agents, Sensory Organs, Anesthetics, Local, Increased Histamine Release	approved, vet_approved	3
DB01859	4-CDP-2-C-methyl-D-erythritol 2-phosphate	Drug	0	experimental	1
DB00528	Lercanidipine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Dihydropyridine Derivatives, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Agents causing hyperkalemia, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Hypotensive Agents, Cytochrome P-450 CYP3A4 Substrates, ACE Inhibitors and Calcium Channel Blockers, Calcium-Regulating Hormones and Agents, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Antihypertensive Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Bradycardia-Causing Agents, Antiarrhythmic agents, Selective Calcium Channel Blockers With Mainly Vascular Effects, Pyridines, Cytochrome P-450 CYP3A5 Substrates, Angiotensin II receptor blockers (ARBs) and calcium channel blockers, Membrane Transport Modulators, Calcium Channel Blockers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Cytochrome P-450 CYP3A4 Inhibitors, Vasodilating Agents	approved, investigational	1
DB01858	[1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate	Drug	0	experimental	1
DB12594	AZD-9056	Drug	Cycloparaffins, Benzoates, Acids, Carbocyclic, Amides, Benzene Derivatives	investigational	0
DB11263	Polydatin	Drug	Carbohydrates, Drugs, Chinese Herbal, Glycosides, Benzylidene Compounds, Benzene Derivatives	approved	0
DB12593	Apaziquone	Drug	Heterocyclic Compounds, Fused-Ring, Quinones, Antineoplastic Agents, Indoles, Azirines	investigational	0
DB11262	Bisoctrizole	Drug	Sunscreen Agents	approved	0
DB11265	Curcuma xanthorrhiza oil	Drug	0	nutraceutical	0
DB12596	Combretastatin	Drug	Antineoplastic Agents, Phytogenic, Stilbenes, Tubulin Modulators, Benzyl Compounds, Antimitotic Agents, Antineoplastic Agents, Mitosis Modulators, Benzylidene Compounds, Combretum, Benzene Derivatives	investigational	0
DB11264	Calcium glycerophosphate	Drug	0	approved	0
DB12595	Na-1	Drug	0	investigational	0
DB12598	Nafamostat	Drug	Analgesics, Non-Narcotic, OCT1 substrates, Anticoagulants, Immunologic Factors, Enzyme Inhibitors, Fibrinolysin, antagonists & inhibitors, Sensory System Agents, Anti-Inflammatory Agents, OCT2 Substrates, Protease Inhibitors, Antirheumatic Agents, Complement Inactivating Agents, Amidines, Hematologic Agents, Kallikreins, antagonists & inhibitors, Peripheral Nervous System Agents, Analgesics, Central Nervous System Agents, Serine Protease Inhibitors, Trypsin Inhibitors	investigational	6
DB11267	Triethoxycaprylylsilane	Drug	Quinones, Organosilicon Compounds, Silicon Compounds, Naphthalenes	experimental	0
DB11266	Sea salt	Drug	0	approved	0
DB12597	ABL-001	Drug	Pyridines, Nicotinic Acids	investigational	0
DB11269	Diethylamino hydroxybenzoyl hexyl benzoate	Drug	Amines, Ketones, Aniline Compounds, Phenols, Sunscreen Agents, Benzene Derivatives	approved	0
DB11268	Protocatechualdehyde	Drug	Anticoagulants, Phenols, Hematologic Agents, Aldehydes, Benzene Derivatives	experimental	0
DB12590	Indiplon	Drug	Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Sulfur Compounds, Benzazepines, GABA Agents, Central Nervous System Depressants, GABA Modulators, Hypnotics (Nonbenzodiazepine), Hypnotics and Sedatives, Central Nervous System Agents	investigational	0
DB11261	Atractylodes japonica root	Drug	0	approved	0
DB12592	EC-18	Drug	0	investigational	0
DB12591	BMS-911543	Drug	Heterocyclic Compounds, Fused-Ring, Janus Kinase 2, antagonists & inhibitors	investigational	0
DB11260	Diacetyl benzoyl lathyrol	Drug	0	approved	0
DB11274	Dihydro-alpha-ergocryptine	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates	approved	3
DB11273	Dihydroergocornine	Drug	Ergot-derivative Dopamine Receptor Agonists, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A4 Substrates, Dopamine Agonists, Ergot Alkaloids and Derivatives, Ergotamines, Alkaloids, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Agents that produce hypertension, Dopamine Agents	approved	3
DB11276	Pine needle oil (pinus mugo)	Drug	Herbs and Natural Products	experimental	0
DB11275	Epicriptine	Drug	Alkaloids	approved	1
DB11278	DL-Methylephedrine	Drug	Adrenergic alpha-2 Receptor Agonists, Adrenergic alpha-Agonists, Adrenergic Agonists, Agents that produce hypertension, Agents producing tachycardia, Drugs that are Mainly Renally Excreted	approved	4
DB11277	Aluminum zirconium pentachlorohydrex gly	Drug	0	approved	0
DB11279	Brilliant green cation	Drug	Amines, Ammonium Compounds, Coloring Agents, Onium Compounds, Compounds used in a research, industrial, or household setting, Anti-Infective Agents, Anti-Infective Agents, Local, Nitrogen Compounds	approved, vet_approved	0
DB11270	Atractylodes japonica root oil	Drug	0	approved	0
DB11272	Methyl undecenoyl leucinate	Drug	0	experimental	0
DB11271	Polysilicone-15	Drug	Sunscreen Agents	approved	0
DB11285	Ethyl ferulate	Drug	Acids, Carbocyclic, Cinnamates	approved, experimental	0
DB11284	DL-dimyristoylphosphatidylglycerol	Drug	Carbohydrates, Glycerophosphates, Sugar Phosphates, Sugar Alcohols, Lipids, Membrane Lipids, Phospholipids, Phosphatidic Acids, Triose Sugar Alcohols, Glycerophospholipids, Alcohols	approved	0
DB11286	Colloidal oatmeal	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved, nutraceutical	0
DB11289	Methicone (20 CST)	Drug	0	experimental	0
DB11288	Borneol	Drug	Perfume, Monoterpenes, Terpenes, Norbornanes	experimental	0
DB11281	Bismuth subcarbonate	Drug	Alkalies, Metals, Elements, Radioactive, Radioisotopes, Ions, Carbonic Acid, Metals, Heavy, Carbon Compounds, Inorganic, Elements, Anions, Acids, Noncarboxylic, Acids, Electrolytes, Isotopes, Bismuth containing drugs, Neurotoxic agents	experimental, vet_approved	0
DB11283	DL-dimyristoylphosphatidylcholine	Drug	Carbohydrates, Phosphatidylcholines, Sugar Phosphates, Laboratory Chemicals, Lipids, Phospholipids, Phosphatidic Acids, Glycerophospholipids, Alcohols, Glycerophosphates, Sugar Alcohols, Indicators and Reagents, Membrane Lipids, Triose Sugar Alcohols, Compounds used in a research, industrial, or household setting	approved	0
DB11282	Diethyltoluamide	Drug	Antiparasitic Products, Insecticides and Repellents, Benzoates, Protective Agents, Acids, Carbocyclic, Benzamides and benzamide derivatives, Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents, Pesticides, Amides, Insecticides and Repellents, Insect Repellents, Agrochemicals, Toxic Actions, Compounds used in a research, industrial, or household setting, Benzene Derivatives	approved	0
DB11296	Prezatide	Drug	Peptides, Amino Acids, Peptides, and Proteins, Growth Substances	experimental	0
DB11295	Trichophyton verrucosum	Drug	0	approved	0
DB11298	Thioredoxin	Drug	Proteins, Thioredoxins, antagonists & inhibitors, Amino Acids, Peptides, and Proteins, Thioredoxins	approved	0
DB11297	Palmitoyl oligopeptide	Drug	0	experimental	0
DB11299	Vanillyl butyl ether	Drug	0	approved	0
DB11290	Aluminium tristearate	Drug	0	experimental, vet_approved	0
DB11291	2-ethylhexyl benzoate	Drug	0	experimental	0
DB11294	Coccidioides immitis spherule	Drug	Cell-mediated Immunity, Skin Test Antigen	approved	4
DB11293	Rice bran oil	Drug	Complex Mixtures, Oils, Plant Preparations, Biological Products, Lipids, Plant Oils	approved	0
DB12550	Taladegib	Drug	Pyridazines	investigational	0
DB13882	Methyl nicotinate	Drug	Pyridines, Anti-Inflammatory Agents, Inflammation, Erythema, Nicotinic Acids	approved	0
DB13883	Coral snake (micrurus fulvius) immune globulin antivenin (equine)	Drug	0	approved, experimental	0
DB11221	Dioxybenzone	Drug	Ketones, Sunscreen Agents, Benzene Derivatives	approved	1
DB11220	Octacosanol	Drug	Lipids, Alcohols	nutraceutical	0
DB13881	Tisagenlecleucel	Drug	Membrane Proteins, Proteins, Receptors, Antigen, Receptors, Immunologic, Amino Acids, Peptides, and Proteins, Receptors, Cell Surface	approved, investigational	1
DB12551	Idazoxan	Drug	Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Imidazoles, Adrenergic alpha-Antagonists, Adrenergic Antagonists, Agents that produce hypertension, Dioxanes, Adrenergic alpha-2 Receptor Antagonists, Adrenergic Agents	investigational	0
DB11223	Tolu balsam	Drug	Complex Mixtures, Biological Products, Resins, Plant, Standardized Chemical Allergen, Plant Exudates, Polymers, Biopolymers, Compounds used in a research, industrial, or household setting, Macromolecular Substances	experimental	0
DB13886	Human cytomegalovirus immune globulin	Drug	Cytomegalovirus, Immunoglobulins, Immune Sera and Immunoglobulins, Immunoglobulin G, Immunoglobulin Isotypes, Antibodies, Amino Acids, Peptides, and Proteins, Antiinfectives for Systemic Use, Human Immunoglobulin G, Immunoproteins, Virus Neutralization, Proteins, Serum Globulins, Specific Immunoglobulins, Globulins, Blood Proteins, Passively Acquired Immunity, Immunization, Passive, Serum	approved	0
DB12554	Mebeverine	Drug	Autonomic Agents, Amines, Agents producing tachycardia, Parasympatholytics, Muscarinic Antagonists, Peripheral Nervous System Agents, Anticholinergic Agents, Ethylamines, Agents Causing Muscle Toxicity, Alimentary Tract and Metabolism, Drugs for Functional Gastrointestinal Disorders, Central Nervous System Agents, Synthetic Anticholinergics, Esters With Tertiary Amino Group	approved, investigational	0
DB12553	Fluocinolone	Drug	Pregnadienes, Adrenal Cortex Hormones, Pregnanes, Steroids, Fluorinated, Fused-Ring Compounds, Steroids	investigational	0
DB11222	Benzoin resin	Drug	Ericales, Plants, Complex Mixtures, Eukaryota, Plant Preparations, Styracaceae, Biological Products, Embryophyta, Pharmaceutical Preparations, Tracheophyta, Angiosperms, Streptophyta, Viridiplantae, Miscellaneous Local Anti-infectives	approved	0
DB13887	Meningococcal polysaccharide vaccine group W-135	Drug	Actively Acquired Immunity, Inactivated Meningococcal Vaccine	approved, investigational, experimental	0
DB11225	Peg-100 stearate	Drug	Pegylated agents	approved	0
DB12556	MK-5108	Drug	Cycloparaffins, Protein Kinase Inhibitors, Sulfur Compounds, Acids, Carbocyclic, Cyclohexanes	investigational	0
DB13884	Albutrepenonacog alfa	Drug	Proteins, Biological Factors, Albumins, Blood Proteins, Blood Coagulation Factors, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Enzyme Precursors, Hemostatics, Recombinant Proteins, Drugs that are Mainly Renally Excreted	approved	1
DB11224	Liquidambar styraciflua resin	Drug	0	experimental	0
DB13885	Ferric subsulfate	Drug	Phosphate Binder, Sulfur Acids, Iron Compounds, Hematologic Agents, Ions, Coagulants, Sulfuric Acids, Organometallic Compounds, Parenteral Iron Replacement, Anions, Sulfur Compounds, Acids, Noncarboxylic, Acids, Electrolytes, Hemostatics	approved, experimental	0
DB12555	Nelotanserin	Drug	Benzene Derivatives	investigational	1
DB12558	AEE-788	Drug	Heterocyclic Compounds, Fused-Ring, ErbB Receptors, antagonists & inhibitors, Receptors, Vascular Endothelial Growth Factor, antagonists & inhibitors	investigational	0
DB11227	Thermus thermophilus lysate	Drug	0	experimental	0
DB11226	Ethylhexyl methoxycrylene	Drug	0	approved, experimental	0
DB12557	FK-614	Drug	0	investigational	0
DB11229	Padimate A	Drug	Aminobenzoates, Benzoates, Acids, Carbocyclic, Benzene Derivatives	withdrawn, experimental	0
DB13888	Meningococcal polysaccharide vaccine group Y	Drug	Actively Acquired Immunity, Inactivated Meningococcal Vaccine	approved, investigational, experimental	0
DB13889	Meningococcal polysaccharide vaccine group A	Drug	Antigens, Biological Factors, Carbohydrates, Polysaccharides, Actively Acquired Immunity, Antigens, Bacterial, Inactivated Meningococcal Vaccine	approved, investigational, experimental	0
DB11228	Methylcellulose	Drug	Carbohydrates, Cellulose, Drugs for Constipation, Biopolymers, Macromolecular Substances, EENT Drugs, Miscellaneous, Polysaccharides, Alimentary Tract and Metabolism, Glucans, Laxatives, Bulk-Forming Laxatives, Polymers, Compounds used in a research, industrial, or household setting	approved	0
DB12559	EC-17	Drug	0	investigational	0
DB00572	Atropine	Drug	QTc Prolonging Agents, Solanaceous Alkaloids, Antimuscarinics Antispasmodics, Belladonna Alkaloids, BSEP/ABCB11 Substrates, Cardiovascular Agents, Muscarinic Antagonists, Peripheral Nervous System Agents, Anticholinergic Agents, Alkaloids, Cholinergic Agents, Alimentary Tract and Metabolism, Aza Compounds, Azabicyclo Compounds, Drugs for Functional Gastrointestinal Disorders, Belladonna Alkaloids, Tertiary Amines, Antiarrhythmic agents, Autonomic Agents, Mydriatics and Cycloplegics, Anti-Asthmatic Agents, Agents producing tachycardia, Parasympatholytics, Bronchodilator Agents, Moderate Risk QTc-Prolonging Agents, Respiratory System Agents, Ophthalmologicals, Belladonna and Derivatives, Plain, Neurotransmitter Agents, Tropanes, Mydriatics, Agents that produce hypertension, Adjuvants, Anesthesia, Central Nervous System Agents, Sensory Organs, Atropine Derivatives	approved, vet_approved	8
DB00573	Fenoprofen	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Enzyme Inhibitors, Sensory System Agents, Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Phenylpropionates, Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Musculo-Skeletal System, Propionates, Agents that produce hypertension, Central Nervous System Agents	approved	4
DB00570	Vinblastine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Antineoplastic Agents, Phytogenic, BSEP/ABCB11 Inhibitors, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Tubulin Modulators, Vinca Alkaloids, Cytochrome P-450 CYP3A Inducers, Mitosis Modulators, BSEP/ABCB11 Substrates, Cardiotoxic antineoplastic agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Indole Alkaloids, Alkaloids, BSEP/ABCB11 Substrates with Narrow Therapeutic Index, Cytochrome P-450 Enzyme Inducers, Indoles, P-glycoprotein substrates with narrow therapeutic index, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A4 Inducers, Antineoplastic Agents, Secologanin Tryptamine Alkaloids, Myelosuppressive Agents, P-glycoprotein inducers, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Antimitotic Agents, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (weak)	approved	6
DB00571	Propranolol	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Agents causing hyperkalemia, Beta Blocking Agents, Non-Selective, and Thiazides, Adrenergic beta-Antagonists, Cardiovascular Agents, Hypotensive Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Alcohols, Adrenergic Antagonists, Antihypertensive Agents, Adrenergic Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Antihypertensive Agents Indicated for Hypertension, Cytochrome P-450 CYP3A5 Substrates, Propanols, P-glycoprotein substrates, Phenoxypropanolamines, Amino Alcohols, Beta Blocking Agents and Thiazides, Beta Blocking Agents, Non-Selective, Moderate Risk QTc-Prolonging Agents, Naphthalenes, Cytochrome P-450 CYP2C19 Substrates, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, OCT2 Inhibitors, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors, Vasodilating Agents, Cytochrome P-450 CYP2D6 Inhibitors (weak), Propanolamines	approved, investigational	5
DB00576	Sulfamethizole	Drug	Amines, Blood and Blood Forming Organs, Cytochrome P-450 Enzyme Inhibitors, Aniline Compounds, Genito Urinary System and Sex Hormones, Amides, Blood Substitutes and Perfusion Solutions, Sulfanilamides, Irrigating Solutions, Anti-Infective Agents, Short-Acting Sulfonamides, SULFONAMIDES AND TRIMETHOPRIM, Sulfur Compounds, Cytochrome P-450 CYP2C9 Inhibitors, Thiazoles, Sulfones, Gynecological Antiinfectives and Antiseptics, Dermatologicals, Antiinfectives for Systemic Use, Ophthalmologicals, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Sulfonamides, Sensory Organs, Antibacterials for Systemic Use, Sulfathiazoles	approved, investigational, vet_approved	1
DB00577	Valaciclovir	Drug	Nephrotoxic agents, Acyclovir and prodrug, Prodrugs, Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors, Amino Acids, Essential, Amino Acids, Peptides, and Proteins, Antiviral Agents, Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor, Antiinfectives for Systemic Use, Amino Acids, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, OAT3/SLC22A8 Substrates, Antivirals for Systemic Use, Direct Acting Antivirals, Heterocyclic Compounds, Fused-Ring, Purines, Nucleic Acid Synthesis Inhibitors, Amino Acids, Branched-Chain, Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor, Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor, Nucleosides and Nucleotides, Purinones	approved, investigational	2
DB00574	Fenfluramine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Centrally Acting Antiobesity Products, Amines, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Serotonin Receptor Agonists, Antidepressive Agents, Phenethylamines, Membrane Transport Modulators, Neurotransmitter Agents, Stimulants, Ethylamines, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Alimentary Tract and Metabolism, Central Nervous System Depressants, Neurotransmitter Uptake Inhibitors, Antiobesity Preparations, Excl. Diet Products, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Serotonin 5-HT2 Receptor Agonists	approved, illicit, investigational, withdrawn	4
DB00575	Clonidine	Drug	Cytochrome P-450 Substrates, Sensory System Agents, Sympatholytics, Nervous System, Adrenergic alpha-1 Receptor Agonists, Cardiovascular Agents, Hypotensive Agents, Antiadrenergic Agents, Centrally Acting, Cytochrome P-450 CYP3A4 Substrates, Antimigraine Preparations, Peripheral Nervous System Agents, Adrenergic alpha-2 Receptor Agonists, Anesthetics, General, Analgesics, Imidazoline Receptor Agonists, Central Alpha-agonists, Antihypertensive Agents, Adrenergic Agents, Bradycardia-Causing Agents, Autonomic Agents, Antihypertensive Agents Indicated for Hypertension, Adrenergic alpha-Agonists, Cytochrome P-450 CYP3A5 Substrates, Antiglaucoma Preparations and Miotics, P-glycoprotein substrates, Agents producing tachycardia, Anesthetics, Ophthalmologicals, Neurotransmitter Agents, Imidazolines, Imidazoles, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Adrenergic Agonists, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Sympathomimetics in Glaucoma Therapy, Central alpha-2 Adrenergic Agonist, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Sensory Organs	approved	6
DB00578	Carbenicillin	Drug	Penicillins With Extended Spectrum, Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Penicillin G, Anti-Infective Agents, OAT1/SLC22A6 inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Antibacterials for Systemic Use	approved, investigational	1
DB00579	Mazindol	Drug	Central Nervous System Stimulants, Centrally Acting Antiobesity Products, Adrenergic Uptake Inhibitors, Serotonin Agents, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Anorexigenic Agents & Respiratory and CNS Stimulants, Antidepressive Agents, Membrane Transport Modulators, Isoindoles, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Serotonin Modulators, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Alimentary Tract and Metabolism, Central Nervous System Depressants, Neurotransmitter Uptake Inhibitors, Anorexigenic Agents & Respiratory and Cerebral Stimulants, Miscellaneous, Antiobesity Preparations, Excl. Diet Products, Central Nervous System Agents, Adrenergic Agents, Dopamine Agents, Dopamine Uptake Inhibitors	approved, investigational	4
DB11230	Magnesium Aluminum Silicate	Drug	Anions, Acids, Noncarboxylic, Acids, Electrolytes, Ions, Oxides, Agents that produce neuromuscular block (indirect), Minerals, Oxygen Compounds, Pharmaceutic Aids, Silicon Compounds	approved	0
DB12561	WNT-974	Drug	Enzyme Inhibitors	investigational	0
DB13893	Crotalus adamanteus antivenin	Drug	Passively Acquired Immunity, Venom Neutralization, Antivenin	approved, experimental	1
DB12560	Blosozumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB13894	Agkistrodon piscivorus antivenin	Drug	Passively Acquired Immunity, Venom Neutralization, Antivenin	approved, experimental	1
DB11232	Saccharide isomerate	Drug	0	approved	0
DB13891	Crotalus scutulatus antivenin	Drug	Passively Acquired Immunity, Venom Neutralization, Antivenin	approved, experimental	0
DB12563	MK-0686	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Acids, Carbocyclic, Amides, Lipids, Acetates, Benzene Derivatives	investigational	0
DB13892	Crotalus atrox antivenin	Drug	Passively Acquired Immunity, Venom Neutralization, Antivenin	approved, experimental	0
DB11231	Lycopene	Drug	Radiation-Protective Agents, Biological Factors, Cycloparaffins, Alkenes, Anti-Inflammatory Agents, Protective Agents, Hydrocarbons, Acyclic, Cyclohexenes, Cyclohexanes, Pigments, Biological, Antioxidants, Carotenoids, Polyenes, Anticarcinogenic Agents, Terpenes, Compounds used in a research, industrial, or household setting	approved, investigational	0
DB12562	Setipiprant	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB12565	Abexinostat	Drug	Heterocyclic Compounds, Fused-Ring, QTc Prolonging Agents, Enzyme Inhibitors, Amines, Hydroxy Acids, Hydroxylamines, Antineoplastic Agents, Histone Deacetylase Inhibitors, Moderate Risk QTc-Prolonging Agents	investigational	1
DB13897	Equine Botulinum Neurotoxin E Immune FAB2	Drug	0	approved, investigational, experimental	1
DB11234	Poliglusam	Drug	Carbohydrates, Anticholesteremic Agents, Hypolipidemic Agents, Noxae, Hematologic Agents, Chitin, Coagulants, Biopolymers, Macromolecular Substances, Lipid Regulating Agents, Polysaccharides, Sequestering Agents, Biocompatible Materials, Toxic Actions, Chitosan, Hemostatics, Polymers, Compounds used in a research, industrial, or household setting, Chelating Agents	experimental	0
DB12564	Gemcitabine elaidate	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Glycosides, Nucleosides, Deoxyribonucleosides	investigational	0
DB11233	Silver citrate	Drug	0	experimental	0
DB13898	Equine Botulinum Neurotoxin C Immune FAB2	Drug	0	approved, investigational, experimental	1
DB11236	Polyethylene glycol 3500	Drug	0	experimental	0
DB13895	Rhus Glabra Pollen	Drug	0	approved, experimental	0
DB12567	Camicinal	Drug	0	investigational	0
DB12566	Decernotinib	Drug	Heterocyclic Compounds, Fused-Ring, Amino Acids, Essential, Amino Acids, Branched-Chain, Amino Acids, Peptides, and Proteins, Amino Acids	investigational	0
DB13896	Talimogene laherparepvec	Drug	Antineoplastic Agents, Immunological, Simplexvirus, Complex Mixtures, DNA Viruses, Antineoplastic and Immunomodulating Agents, Herpesviridae, Alphaherpesvirinae, Antineoplastic Agents, Viruses	approved, investigational, experimental	3
DB11235	Thonzylamine	Drug	Antihistamines for Topical Use, Dermatologicals, Agents producing tachycardia, Muscarinic Antagonists, Anticholinergic Agents, Neurotransmitter Agents, Histamine H1 Antagonists, Nasal Preparations, Antipruritics, Incl. Antihistamines, Anesthetics, Etc., Histamine Antagonists, Antiallergic Agents, Excl. Corticosteroids, Histamine Agents, Antihistamines for Systemic Use, Substituted Ethylene Diamines	approved	6
DB12569	Tonapofylline	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Purines, Receptor, Adenosine A1, Purinones	investigational	1
DB11238	Borage oil	Drug	Fatty Acids, Omega-6, Fatty Acids, Oils, Antirheumatic Agents, Lipids, Dietary Fats, Unsaturated, Linolenic Acids, Fatty Acids, Essential, Fatty Acids, Unsaturated, Complex Mixtures, Plant Preparations, Biological Products, Agents that reduce seizure threshold	approved, investigational	0
DB12568	Tecemotide	Drug	Membrane Proteins, Proteins, Carbohydrates, Complex Mixtures, Glycoconjugates, Biological Products, Amino Acids, Peptides, and Proteins, Glycoproteins, Vaccines	investigational	0
DB11237	Trypsin	Drug	Enzymes, Blood and Blood Forming Organs, Musculo-Skeletal System, Dermatologicals, Enzymes and Coenzymes, Serine Proteases, Hydrolases, Peptide Hydrolases, Preparations for Treatment of Wounds and Ulcers, Serine Endopeptidases, Endopeptidases	approved, vet_approved	0
DB13899	Equine Botulinum Neurotoxin G Immune FAB2	Drug	0	approved, investigational, experimental	1
DB11239	Aluminum sulfate	Drug	Immunologic Factors, Sulfur Acids, Adjuvants, Immunologic, Ions, Sulfates, Sulfuric Acids, Anions, Sulfur Compounds, Acids, Noncarboxylic, Metal cations, Acids, Metal divalent cations, Aluminium Compounds, Electrolytes	approved	0
DB00580	Valdecoxib	Drug	Nephrotoxic agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Sensory System Agents, Cyclooxygenase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Anti-Inflammatory Agents, Agents causing hyperkalemia, Amides, Cytochrome P-450 CYP3A4 Substrates, Selective Cyclooxygenase 2 Inhibitors (NSAIDs), Peripheral Nervous System Agents, Sulfur Compounds, Antiinflammatory and Antirheumatic Products, Non-Steroids, COX-2 Inhibitors, Analgesics, Musculo-Skeletal System, Cytochrome P-450 CYP2C9 Inhibitors, Sulfones, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Antirheumatic Agents, Cytochrome P-450 CYP2C9 Substrates, Antiinflammatory and Antirheumatic Products, Cytochrome P-450 CYP3A Substrates, Agents that produce hypertension, UGT1A9 Substrates, Central Nervous System Agents, Cytochrome P-450 CYP2C9 Inhibitors (weak)	approved, investigational, withdrawn	3
DB00583	Levocarnitine	Drug	OATP1B1/SLCO1B1 Inhibitors, Amines, Ammonium Compounds, Quaternary Ammonium Compounds, Trimethyl Ammonium Compounds, Onium Compounds, Drugs that are Mainly Renally Excreted, Vitamins, OAT3/SLC22A8 Substrates, Alimentary Tract and Metabolism, Amino Acids and Derivatives, Caloric Agents, Vitamin B Complex, Dietary Supplements, Nitrogen Compounds, Carnitine Analog	approved, investigational	11
DB00584	Enalapril	Drug	Enzyme Inhibitors, Cytochrome P-450 Substrates, Oligopeptides, Peptides, Agents causing hyperkalemia, Protease Inhibitors, Amino Acids, Peptides, and Proteins, Cardiovascular Agents, Hypotensive Agents, ACE Inhibitors and Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Agents Acting on the Renin-Angiotensin System, Agents causing angioedema, ACE Inhibitors and Diuretics, Antihypertensive Agents, Drugs causing inadvertant photosensitivity, Antihypertensive Agents Indicated for Hypertension, OAT1/SLC22A6 inhibitors, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Agents Causing Muscle Toxicity, Dipeptides, OATP1B1/SLCO1B1 Substrates, OAT3/SLC22A8 Inhibitors, Decreased Blood Pressure, P-glycoprotein inhibitors	approved, vet_approved	1
DB00581	Lactulose	Drug	Carbohydrates, Disaccharides, Alimentary Tract and Metabolism, Osmotic Laxatives, Drugs for Constipation, Ammonia Detoxicants, Laxatives, Stimulation Large Intestine Fluid/Electrolyte Secretion, Acidifying Activity, Osmotic Activity, Gastrointestinal Agents	approved	1
DB00582	Voriconazole	Drug	QTc Prolonging Agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Antimycotics for Systemic Use, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Cytochrome P-450 CYP3A7 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors (strong), Cytochrome P-450 CYP3A7 Inhibitors (moderate), Triazoles, Cytochrome P-450 CYP2C9 Inhibitors, Potential QTc-Prolonging Agents, Antifungal Agents, Hormone Antagonists, Drugs causing inadvertant photosensitivity, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Triazole Derivatives, Steroid Synthesis Inhibitors, Chemically-Induced Disorders, Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP3A5 Inhibitors, Antiinfectives for Systemic Use, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A5 Inhibitors (moderate), Azole Antifungals, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Cytochrome P-450 CYP3A7 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors (weak), Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), 14-alpha Demethylase Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (weak)	approved	1
DB00587	Cinalukast	Drug	Sulfur Compounds	experimental	1
DB00588	Fluticasone propionate	Drug	Corticosteroids, Dermatological Preparations, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Androstadienes, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Peripheral Nervous System Agents, Corticosteroids, Potent (Group III), Adrenals, Autonomic Agents, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Anti-Allergic Agents, Corticosteroids, Cytochrome P-450 CYP3A5 Substrates, Anti-Asthmatic Agents, Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, Cytochrome P-450 CYP3A5 Inhibitors, Dermatologicals, Androstenes, Bronchodilator Agents, Respiratory System Agents, Cytochrome P-450 CYP2C8 Inhibitors (strong), Androstanes, Agents to Treat Airway Disease, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Cytochrome P-450 CYP3A4 Inhibitors, Thyroxine-binding globulin inhibitors, Steroids	approved	4
DB00585	Nizatidine	Drug	Cholinesterase Inhibitors, P-glycoprotein substrates, Anti-Ulcer Agents, Histamine H2 Antagonists, Neurotransmitter Agents, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Gastric Acid Lowering Agents, Sulfur Compounds, Histamine Antagonists, Agents Causing Muscle Toxicity, Alimentary Tract and Metabolism, Acid Reducers, Thiazoles, Drugs for Acid Related Disorders, Histamine Agents, Gastrointestinal Agents	approved	1
DB00586	Diclofenac	Drug	Cytochrome P-450 Substrates, Sensory System Agents, Cyclooxygenase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Acids, Carbocyclic, Agents causing hyperkalemia, UGT1A3 substrates, Non COX-2 selective NSAIDS, BSEP/ABCB11 Substrates, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Decreased Prostaglandin Production, Peripheral Nervous System Agents, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Antiinflammatory and Antirheumatic Products, Non-Steroids, UGT2B7 substrates, Agents causing angioedema, Cytochrome P-450 CYP2C8 Substrates, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, OATP1B1/SLCO1B1 Inhibitors, Acetic Acid Derivatives and Related Substances, Cytochrome P-450 CYP2C18 Substrates, Cyclooxygenase-2 (COX-2) Inhibitors, Antirheumatic Agents, OAT1/SLC22A6 inhibitors, Cytochrome P-450 CYP2C19 Substrates, Ophthalmologicals, Photosensitizing Agents, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Phenylacetates, Cytochrome P-450 CYP2B6 Substrates, OAT3/SLC22A8 Inhibitors, Nephrotoxic agents, Enzyme Inhibitors, Amines, Anti-Inflammatory Agents, Analgesics, Musculo-Skeletal System, Drugs causing inadvertant photosensitivity, Cytochrome P-450 CYP2E1 Inhibitors, Dermatologicals, Antiinflammatory Preparations, Non-Steroids for Topical Use, Topical Products for Joint and Muscular Pain, P-glycoprotein inducers, Cytochrome P-450 CYP2C9 Substrates, Antiinflammatory and Antirheumatic Products, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Ethylamines, UGT1A1 Substrates, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, UGT1A9 Substrates, Central Nervous System Agents, Sensory Organs, Other Nonsteroidal Anti-inflammatory Agents, Antimigraine Agents, Miscellaneous	approved, vet_approved	2
DB00589	Lisuride	Drug	Serotonin 5-HT1 Receptor Agonists, Ergot-derivative Dopamine Receptor Agonists, Cytochrome P-450 Substrates, Serotonin Agents, Nervous System, Genito Urinary System and Sex Hormones, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Ergolines, Antimigraine Preparations, Dopamine Agonists, Ergot Alkaloids and Derivatives, Serotonin 5-HT2 Receptor Antagonists, Alkaloids, Anti-Dyskinesia Agents, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Prolactine Inhibitors, Dopamine Antagonists, Dopamine Agents, Serotonin Receptor Agonists, Anti-Parkinson Drugs, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Agents that produce hypertension, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates	approved, investigational	15
DB13890	Meningococcal polysaccharide vaccine group C	Drug	Antigens, Biological Factors, Carbohydrates, Polysaccharides, Actively Acquired Immunity, Antigens, Bacterial, Neisseria meningitidis, Inactivated Meningococcal Vaccine	approved, investigational, experimental	0
DB12572	Pexacerfont	Drug	0	investigational	0
DB12571	Rimacalib	Drug	Enzyme Inhibitors, Oxazines, Protein Kinase Inhibitors	investigational	0
DB12574	LY-295501	Drug	Heterocyclic Compounds, Fused-Ring, Benzene Derivatives	investigational	0
DB11243	Ethyl macadamiate	Drug	0	approved	0
DB11242	Gelatin	Drug	Proteins, Scleroproteins, Amino Acids, Peptides, and Proteins	approved, vet_approved	0
DB12573	LY-2452473	Drug	Acids, Acyclic	investigational	0
DB12576	AZD-3043	Drug	Central Nervous System Depressants, Acids, Carbocyclic, Hypnotics and Sedatives	investigational	0
DB12575	Ronopterin	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Coenzymes, Nitric Oxide Synthase, antagonists & inhibitors, Pterins, Enzymes and Coenzymes, Pteridines, Pigments, Biological	investigational	0
DB11244	Cyclomethicone 5	Drug	Polymers, Compounds used in a research, industrial, or household setting, Organosilicon Compounds, Silicon Compounds, Macromolecular Substances	experimental	0
DB11247	Sambucus nigra flowering top	Drug	0	experimental	0
DB12578	Lexaptepid Pegol	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Anti-Inflammatory Agents, Oligonucleotides, Glycosides, Pegylated agents, Nucleotides, Polynucleotides	investigational	0
DB12577	Fosbretabulin	Drug	Antineoplastic Agents, Phytogenic, Antineoplastic Agents, Benzylidene Compounds, Benzene Derivatives	investigational	0
DB11246	Copper gluconate	Drug	Copper-containing Intrauterine Device	approved, investigational	0
DB12579	JNJ-37822681	Drug	Neurotransmitter Agents, Dopamine Antagonists, Dopamine D2 Receptor Antagonists, Dopamine Agents	investigational	1
DB11248	Zinc gluconate	Drug	Acids, Acyclic, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Carbohydrates, Vasoprotectives, Hydroxy Acids, Metal cations, Zinc Compounds, Alimentary Tract and Metabolism, Metal divalent cations, Sugar Acids, Copper Absorption Inhibitor, Mineral Supplements	approved, vet_approved	0
DB00590	Doxazosin	Drug	Antihypertensive Agents Indicated for Hypertension, Cytochrome P-450 Substrates, Adrenergic alpha-Antagonists, OCT1 inhibitors, Peripheral alpha-1 blockers, Antiadrenergic Agents, Peripherally Acting, Cardiovascular Agents, Hypotensive Agents, Quinazolines, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Adrenergic Antagonists, Adrenergic alpha-1 Receptor Antagonists, Antihypertensive Agents, Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors, Adrenergic Agents	approved	4
DB00591	Fluocinolone acetonide	Drug	Corticosteroids, Dermatological Preparations, Cytochrome P-450 Substrates, Immunosuppressive Agents, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Otologicals, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Vasoprotectives, Cytochrome P-450 Enzyme Inducers, Corticosteroid Hormone Receptor Agonists, Corticosteroids, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Cytochrome P-450 CYP3A4 Inducers, Dermatologicals, Ophthalmologicals, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Cytochrome P-450 CYP3A Substrates, Pregnanes, Steroids, Fluorinated, Steroids	approved, investigational, vet_approved	6
DB00594	Amiloride	Drug	Increased Diuresis, Agents causing hyperkalemia, Decreased Renal K+ Excretion, Cardiovascular Agents, Hypotensive Agents, Potassium-Sparing Diuretics, Membrane Transport Modulators, Pyrazines, OCT2 Inhibitors, Diuretics, Natriuretic Agents, Epithelial Sodium Channel Blockers, Acid Sensing Ion Channel Blockers, Sodium Channel Blockers	approved	9
DB00595	Oxytetracycline	Drug	Antibiotics for Topical Use, Gynecological Antiinfectives and Antiseptics, Dermatologicals, Genito Urinary System and Sex Hormones, Agents that produce neuromuscular block (indirect), Antiinfectives for Systemic Use, Anti-Infective Agents, OAT1/SLC22A6 inhibitors, OAT3/SLC22A8 Substrates, Ophthalmologicals, Anti-Bacterial Agents, Tetracyclines, Naphthacenes, OAT3/SLC22A8 Inhibitors, Sensory Organs, Antibacterials for Systemic Use	approved, investigational, vet_approved	3
DB00592	Piperazine	Drug	Piperazine and Derivatives, Antiparasitic Products, Insecticides and Repellents, Cytochrome P-450 Substrates, Piperazines, Anthelmintics, Cytochrome P-450 CYP2D6 Substrates, Hyperglycemia-Associated Agents, Anti-Infective Agents, Antinematodal Agents, Antiparasitic Agents	approved, vet_approved	1
DB00593	Ethosuximide	Drug	QTc Prolonging Agents, Cytochrome P-450 CYP2E1 Substrates, Decreased Central Nervous System Disorganized Electrical Activity, Cytochrome P-450 Substrates, Nervous System, Agents causing hyperkalemia, Cytochrome P-450 CYP3A4 Substrates, Anti-epileptic Agent, Imides, Calcium Channel Blockers, Anticonvulsants, Pyrrolidinones, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Succinimides, Pyrrolidines, Potential QTc-Prolonging Agents, Central Nervous System Agents, Succinimide Derivatives, Bradycardia-Causing Agents, Antiarrhythmic agents	approved	1
DB00598	Labetalol	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Alpha and Beta Blocking Agents and Thiazides, Amines, Cytochrome P-450 Substrates, Salicylamides, Cytochrome P-450 Enzyme Inhibitors, Agents causing hyperkalemia, Peripheral alpha-1 blockers, Adrenergic beta-Antagonists, Amides, Cardiovascular Agents, Hypotensive Agents, Drugs that are Mainly Renally Excreted, Alcohols, Peripheral Nervous System Agents, UGT2B7 substrates, Adrenergic Antagonists, Adrenergic alpha-1 Receptor Antagonists, Antihypertensive Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Adrenergic Agents, Bradycardia-Causing Agents, Autonomic Agents, Antihypertensive Agents Indicated for Hypertension, Adrenergic alpha-Antagonists, Agents producing tachycardia, Amino Alcohols, Ethanolamines, Beta Blocking Agents and Thiazides, Cytochrome P-450 CYP2C19 Substrates, Neurotransmitter Agents, Sympathomimetics, Alpha and Beta Blocking Agents, UGT1A1 Substrates, UGT1A9 Substrates, Cytochrome P-450 CYP2D6 Substrates, Vasodilating Agents	approved	3
DB00599	Thiopental	Drug	Psycholeptics, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, GABA Modulators, Cytochrome P-450 CYP3A Inducers, Anesthetics, Intravenous, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Hypotensive Agents, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Anticholinergic Agents, Anesthetics, General, Cytochrome P-450 Enzyme Inducers, Pyrimidines, Hypnotics and Sedatives, Barbiturates, GABA Agents, Cytochrome P-450 CYP3A4 Inducers, Pyrimidinones, Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index, Anesthetics, Nicotinic Antagonists, Cytochrome P-450 CYP2C19 Substrates, Neurotransmitter Agents, Anticonvulsants, Thiobarbiturates, Cytochrome P-450 CYP3A Inhibitors, Narrow Therapeutic Index Drugs, Central Nervous System Depressants, Barbiturates, Plain, Cytochrome P-450 CYP3A4 Inhibitors, Central Nervous System Agents	approved, vet_approved	12
DB00596	Ulobetasol	Drug	Corticosteroids, Dermatological Preparations, Pregnadienetriols, Corticosteroids, Immunosuppressive Agents, Pregnadienes, Psoriasis, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Dermatologicals, Cardiovascular Agents, Fused-Ring Compounds, Corticosteroids, Potent (Group III), Vasoconstrictor Agents, Pregnanes, Steroids, Fluorinated, Corticosteroid Hormone Receptor Agonists, Steroids	approved	1
DB00597	Gadoteridol	Drug	Magnetic Resonance Imaging Contrast Media, Lanthanoid Series Elements, Other Diagnostics, Metals, Paramagnetic Contrast Agent, Elements, Drugs that are Mainly Renally Excreted, Paramagnetic Contrast Media, Contrast Media, Diagnostic Uses of Chemicals, Magnetic Resonance Contrast Activity, Compounds used in a research, industrial, or household setting, Metals, Rare Earth	approved, investigational	0
DB12570	CC-223	Drug	0	investigational	0
DB12583	Maltodextrin	Drug	Carbohydrates	investigational	0
DB11252	Poloxamer 407	Drug	Surface-Active Agents, Excipients, Polyethylene Glycols, Pharmaceutic Aids, Alcohols, Drug Delivery Systems, Macromolecular Substances, Ethylene Glycols, Glycols, Pharmaceutical Preparations, Polymers, Compounds used in a research, industrial, or household setting, Pharmaceutical Vehicles	investigational	0
DB11251	Tocopherol	Drug	Cytochrome P-450 Substrates, Protective Agents, Benzopyrans, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Vitamins, Antioxidants, Heterocyclic Compounds, Fused-Ring, Micronutrients, Physiological Phenomena, Cytochrome P-450 CYP3A Substrates, Alimentary Tract and Metabolism, Vitamin E, Vitamins (Fat Soluble), Food and Beverages, Growth Substances, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food, Pyrans	approved, investigational	1
DB12582	Piperine	Drug	Enzyme Inhibitors, Alkenes, Chemically-Induced Disorders, Cytochrome P-450 Enzyme Inhibitors, Hydrocarbons, Acyclic, Amides, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Dioxoles, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Piper nigrum, Cytochrome P-450 CYP3A4 Inhibitors, UDPglucose 4-Epimerase, antagonists & inhibitors, P-glycoprotein inhibitors, Alkynes	investigational	1
DB12585	Ondelopran	Drug	Opioid Antagonists, Pyridines, Amines, Benzyl Compounds, Nicotinic Acids, Benzene Derivatives	investigational	0
DB11254	Hexylresorcinol	Drug	Throat Preparations, Miscellaneous Anti-infectives, Anthelmintics, Phenols, Resorcinols, Anti-Infective Agents, Anti-Infective Agents, Local, Antiparasitic Agents, Benzene Derivatives	approved	3
DB12584	Bimagrumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB11253	Xanthan gum	Drug	Food Additives, Antigens, Biological Factors, Carbohydrates, Antigens, Bacterial, Drug Carriers, Polysaccharides, Physiological Phenomena, Food and Beverages, Food Ingredients, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food	approved	0
DB12587	Razupenem	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amides, Lactams, beta-Lactams	investigational	0
DB11256	Levomefolic acid	Drug	Biological Factors, Coenzymes, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Amino Acids, Acidic, Pteridines, Amino Acids, Vitamins, Pigments, Biological, Heterocyclic Compounds, Fused-Ring, Amino Acids, Dicarboxylic, Pterins, Folic Acid and Derivatives, Vitamin B Complex	approved, investigational	0
DB11255	Chromium picolinate	Drug	Pyridines, Iron Chelating Agents, Sequestering Agents, Standardized Chemical Allergen, Compounds used in a research, industrial, or household setting	approved	0
DB12586	Anhydrovinblastine	Drug	0	investigational	0
DB12589	Dacetuzumab	Drug	Proteins, Serum Globulins, Antineoplastic Agents, Immunological, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	1
DB12588	AZD-1480	Drug	Janus Kinase 2, antagonists & inhibitors	investigational	0
DB11257	Fluoride ion	Drug	0	approved	0
DB11259	Diosmetin	Drug	Heterocyclic Compounds, Fused-Ring, Benzopyrans, Chromones, Pyrans	experimental	0
DB11250	Glyceryl monostearate	Drug	Lipids	experimental	0
DB12581	Ozarelix	Drug	Peptides, Amino Acids, Peptides, and Proteins	investigational	0
DB12580	Tradipitant	Drug	0	investigational	0
DB01901	Sucrosofate	Drug	Carbohydrates, Polysaccharides, Disaccharides, Anti-Ulcer Agents, Oligosaccharides, Gastrointestinal Agents	experimental	2
DB01905	2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine	Drug	0	experimental	2
DB01903	5-Bromo-2'-deoxyuridine 5'-(dihydrogen phosphate)	Drug	0	experimental	1
DB01902	1-Ethyl-Pyrrolidine-2,5-Dione	Drug	0	experimental	2
DB01909	Alpha-Cyclodextrin (Cyclohexa-Amylose)	Drug	0	experimental	1
DB01908	RU85493	Drug	0	experimental	1
DB01906	3-(5-amino-7-hydroxy-(1,2,3)triazolo(4,5-d)pyrimidin-2-yl)benzoic acid	Drug	Acids, Carbocyclic, Benzene Derivatives	experimental	1
DB01912	2,2':6',2''-Terpyridine Platinum(Ii)	Drug	0	experimental	2
DB01911	N-Methylmesoporphyrin	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Pigments, Biological, Porphyrins	experimental	1
DB01910	Sinefungin	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purines, Ribonucleosides, Antiprotozoals, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Antifungal Agents, Purine Nucleosides, Anti-Infective Agents, Antiparasitic Agents	experimental	4
DB01915	S-Hydroxycysteine	Drug	0	experimental	8
DB01914	D-glucose	Drug	Food Additives, Carbohydrates, Hexoses, Flavoring Agents, Glucose, Pharmaceutic Aids, Monosaccharides, Physiological Phenomena, Food and Beverages, Food Ingredients, Pharmaceutical Preparations, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food, Sweetening Agents	approved, investigational, vet_approved	0
DB01919	Pentanal	Drug	0	experimental	1
DB01918	[Methyltelluro]Acetate	Drug	0	experimental	1
DB01917	Putrescine	Drug	Diamines, Amines, Biogenic Amines, Putrescine, analogs & derivatives, Polyamines, Putrescine, antagonists & inhibitors, Biogenic Polyamines	experimental	5
DB13901	Equine Botulinum Neurotoxin F Immune FAB2	Drug	0	approved, investigational, experimental	1
DB13902	Equine Botulinum Neurotoxin D Immune FAB2	Drug	0	approved, investigational, experimental	1
DB13900	Equine Botulinum Neurotoxin A Immune FAB2	Drug	0	approved, investigational, experimental	1
DB13905	Scorpion (centruroides) immune Fab2 antivenin (equine)	Drug	Passively Acquired Immunity, Venom Neutralization, Antivenin	approved	0
DB13906	Aloe Vera Leaf	Drug	0	approved, experimental	1
DB13903	Equine Botulinum Neurotoxin B Immune FAB2	Drug	0	approved, investigational, experimental	1
DB13904	Cat dander extract	Drug	Allergenic Extracts	approved	0
DB01923	L-Xylulose 5-Phosphate	Drug	0	experimental	1
DB01922	Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam	Drug	0	experimental	1
DB01921	Xylose-derived lactam oxime	Drug	0	experimental	1
DB01920	1-O-[O-Nitrophenyl]-Beta-D-Galactopyranose	Drug	0	experimental	1
DB01927	Duroquinone	Drug	Quinones	experimental	1
DB01926	Carboxymycobactin S	Drug	0	experimental	1
DB01925	2'-Chloro-Biphenyl-2,3-Diol	Drug	0	experimental	1
DB01924	Benzhydroxamic Acid	Drug	Amines, Benzoates, Hydroxy Acids, Hydroxylamines	experimental	0
DB01929	5-Chloryl-2,4,6-Quinazolinetriamine	Drug	0	experimental	2
DB13912	Coumermycin A1	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Topoisomerase Inhibitors, Topoisomerase II Inhibitors, Antineoplastic Agents, Coumarins, Benzopyrans, Pyrans	experimental	0
DB13913	Belladonna	Drug	Antimuscarinics Antispasmodics	approved, experimental	0
DB13910	Valproate bismuth	Drug	EENT Drugs, Miscellaneous, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Bismuth containing drugs, Neurotoxic agents	approved	0
DB13911	Phloxine B	Drug	Luminescent Agents, Spiro Compounds, Xanthenes, Heterocyclic Compounds, Fused-Ring, Coloring Agents, Dental Agents, Laboratory Chemicals, Indicators and Reagents, Fluoresceins, Compounds used in a research, industrial, or household setting, Fluorescent Dyes	approved	0
DB13916	Toyocamycin	Drug	Carbohydrates, Ribonucleosides, Nucleic Acids, Nucleotides, and Nucleosides, Noxae, Antineoplastic Agents, Glycosides, Nucleosides, Toxic Actions, Antibiotics, Antineoplastic, Antimetabolites	experimental	0
DB13917	Deoxyepinephrine	Drug	Amines, Agents that produce hypertension, Biogenic Amines, Epinephrine and similars, Phenols, Catecholamines, Catechols, Amino Alcohols, Ethanolamines, Benzene Derivatives, Biogenic Monoamines, Alcohols	experimental	0
DB13914	Volixibat	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Lipid Regulating Agents, Sulfur Compounds	investigational, experimental	1
DB13915	Axicabtagene ciloleucel	Drug	Antigens, Differentiation, Isoantigens, Antigens, Biological Factors, Immunization, Investigative Techniques, Immunologic Techniques, Immunomodulation, Minor Histocompatibility Antigens, Antineoplastic Agents, Histocompatibility Antigens, Narrow Therapeutic Index Drugs, Antigens, Differentiation, B-Lymphocyte, Immunotherapy, Biomarkers, Immunization, Passive, Antigens, Surface, Antigens, CD	approved	1
DB13909	Bismuth subgallate	Drug	Benzoates, Hydroxy Acids, Antidiarrheals, Acids, Carbocyclic, Hydroxybenzoates, Hematologic Agents, Coagulants, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Antacids and Adsorbents, Phenols, Hemostatics, Benzene Derivatives, Bismuth containing drugs, Neurotoxic agents	approved	0
DB13907	Fusarium graminearum	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved, experimental	0
DB13908	Amylmetacresol	Drug	Miscellaneous Anti-infectives, Phenols, Benzene Derivatives	approved	1
DB01930	2,4-Dihydroxy-3,3-Dimethyl-Butyrate	Drug	0	experimental	1
DB00602	Ivermectin	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, OATP1B3 inhibitors, Scabicides and Pediculicides, Anthelmintics, Insecticides, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Lactones, Anti-Bacterial Agents, Cytochrome P-450 Enzyme Inducers, Pediculicides, Agrochemicals, Compounds used in a research, industrial, or household setting, Antinematodal Agents, OATP1B1/SLCO1B1 Inhibitors, Antiparasitic Products, Insecticides and Repellents, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inducers, Dermatologicals, Pesticides, Avermectines, P-glycoprotein inducers, Polyketides, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Toxic Actions, P-glycoprotein inhibitors, Antiparasitic Agents	approved, investigational, vet_approved	2
DB01934	Arylomycin A2	Drug	Peptides, Amino Acids, Peptides, and Proteins	experimental	1
DB01933	7-Hydroxystaurosporine	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Carbazoles, Enzyme Inhibitors, Protein Kinase Inhibitors, Antineoplastic Agents, Indoles, Protein Kinase C, antagonists & inhibitors, Indole Alkaloids	investigational, experimental	1
DB00603	Medroxyprogesterone acetate	Drug	Endocrine Therapy, Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Pregnenediones, Cytochrome P-450 Enzyme Inhibitors, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Genito Urinary System and Sex Hormones, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Contraceptives, Oral, Cytochrome P-450 Enzyme Inducers, Hormones and Related Agents, Pregnen (4) Derivatives, Progesterone Congeners, Contraceptives, Oral, Synthetic, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Hormonal Contraceptives for Systemic Use, Contraceptive Agents, Female, Gonadal Hormones, Antineoplastic Agents, Hormonal, Contraceptive Agents, Male, Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP2C8 Inhibitors, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A4 Inducers, Reproductive Control Agents, Antineoplastic Agents, Gonadal Steroid Hormones, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Progestins, Hydroxyprogesterones, Pregnanes, Progesterone and Derivatives, Combination Contraceptives (with Estrogen and derivatives), P-glycoprotein inhibitors, Corpus Luteum Hormones, Hyperglycemia-Associated Agents, Pregnenes, Progestin Contraceptives, Steroids	approved, investigational	4
DB01932	5-Methylpyrrole	Drug	0	experimental	1
DB00600	Monobenzone	Drug	alpha-Galactosidase, antagonists & inhibitors, Depigmenting Activity, Depigmenting Agents, Dermatologicals, Melanin Synthesis Inhibitors, Phenols, Benzene Derivatives	approved	1
DB01931	5,7-Dichlorokynurenic acid	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Xanthurenates, Excitatory Amino Acid Agents, Excitatory Amino Acid Antagonists, Hydroxyquinolines	experimental	1
DB00601	Linezolid	Drug	Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, Acids, Acyclic, Oxazolidinone Antibacterial, Enzyme Inhibitors, Fatty Acids, Immunosuppressive Agents, Serotonin Agents, Amides, Lipids, Antidepressive Agents, Acetates, Anti-Infective Agents, Serotonin Modulators, Anti-Bacterial Agents, Oxazoles, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Fatty Acids, Volatile, Acetamides, Protein Synthesis Inhibitors, Agents that reduce seizure threshold, Monoamine Oxidase Inhibitors, Antiinfectives for Systemic Use, Myelosuppressive Agents, Central Nervous System Depressants, Oxazolidinones, Agents that produce hypertension, Antibacterials for Systemic Use	approved, investigational	1
DB00606	Cyclothiazide	Drug	Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Amides, Cardiovascular Agents, OAT1/SLC22A6 inhibitors, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Sulfonamides, Diuretics, Natriuretic Agents, Antihypertensive Agents, Thiazides, Hyperglycemia-Associated Agents, Receptors, AMPA, Sulfones	approved	5
DB01938	L-Histidine Beta Naphthylamide	Drug	0	experimental	1
DB00607	Nafcillin	Drug	Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Antiinfectives for Systemic Use, Anti-Infective Agents, Cytochrome P-450 CYP3A4 Inducers (moderate), OAT1/SLC22A6 inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Cytochrome P-450 Enzyme Inducers, Sulfur Compounds, Penicillins, Beta-Lactamase Resistant Penicillins, Cytochrome P-450 CYP1A2 Inducers, Antibacterials for Systemic Use	approved, investigational	5
DB01937	Guanosine-2'-monophosphate	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Guanine Nucleotides, Nucleotides, Isomerism	experimental	1
DB00604	Cisapride	Drug	Aminobenzoates, Cytochrome P-450 CYP2D6 Inhibitors, para-Aminobenzoates, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Acids, Carbocyclic, Amides, Cytochrome P-450 CYP2C19 Inhibitors, Anti-Ulcer Agents, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Chlorobenzoates, Propulsives, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Alimentary Tract and Metabolism, Cytochrome P-450 CYP2C9 Inhibitors, Piperidines, Drugs for Functional Gastrointestinal Disorders, Cytochrome P-450 CYP2C8 Substrates, Benzene Derivatives, Gastrointestinal Agents, Benzoates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Serotonin Receptor Agonists, Benzamides and benzamide derivatives, Cytochrome P-450 CYP2C19 Inhibitors (moderate), Cytochrome P-450 CYP2C19 Substrates, Neurotransmitter Agents, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2A6 Substrates, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Inhibitors (strong)	approved, investigational, withdrawn	4
DB01936	alpha-D-arabinofuranose	Drug	0	investigational, experimental	1
DB01935	3-{[(1r)-1-Benzyl-2-Sulfanylethyl]Amino}-3-Oxopropanoic Acid	Drug	0	experimental	2
DB00605	Sulindac	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Acetic Acid Derivatives and Related Substances, Enzyme Inhibitors, Sensory System Agents, Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, OAT1/SLC22A6 inhibitors, Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Photosensitizing Agents, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Musculo-Skeletal System, Agents that produce hypertension, Indenes, Central Nervous System Agents, Drugs causing inadvertant photosensitivity, Other Nonsteroidal Anti-inflammatory Agents	approved, investigational	7
DB13960	Bronopol	Drug	Preservatives, Pharmaceutical, Cell-mediated Immunity, Laboratory Chemicals, Indicators and Reagents, Standardized Chemical Allergen, Glycols, Compounds used in a research, industrial, or household setting, Anti-Infective Agents, Anti-Infective Agents, Local, Drugs that are Mainly Renally Excreted, Alcohols, Increased Histamine Release	approved	1
DB11300	Thrombin	Drug	Biological Factors, Enzymes, Blood and Blood Forming Organs, Increased Coagulation Factor Activity, Thrombin, antagonists & inhibitors, Blood Coagulation Factors, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Hematologic Agents, Coagulants, Proteins, Blood Proteins, Local Hemostatics, Serine Proteases, Hydrolases, Peptide Hydrolases, Thrombin, analogs & derivatives, Hemostatics, Serine Endopeptidases, Endopeptidases	approved, investigational	10
DB13963	1,2-dichlorobenzene	Drug	Hydrocarbons, Chlorinated, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 Substrates, Agrochemicals, Pesticides, Hydrocarbons, Halogenated, Insecticides, Toxic Actions, Compounds used in a research, industrial, or household setting, Benzene Derivatives	experimental	0
DB12631	Aclerastide	Drug	Biological Factors, Autacoids, Inflammation Mediators, Hormones, Hormone Substitutes, and Hormone Antagonists, Oligopeptides, Peptides, Angiotensins, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Hormones, Proteins, Peptide Hormones	investigational	0
DB12630	Isopentyl 2-cyanoacrylate	Drug	0	investigational	0
DB13964	Peanut oil	Drug	Basic Ointments and Protectants, Complex Mixtures, Oils, Plant Preparations, Biological Products, Lipids, Plant Oils, Detergents	approved	0
DB11302	Hydrogenated soybean oil	Drug	0	experimental	0
DB13961	Fish oil	Drug	Calcium Channel Blockers, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Oils, Agents causing hyperkalemia, Fish Oils, Lipids, Cytochrome P-450 CYP3A4 Substrates, Vasodilating Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	approved, nutraceutical	11
DB12633	BMS-184476	Drug	Cycloparaffins, Cyclodecanes, Diterpenes, Terpenes	investigational	0
DB13962	Calcium saccharate	Drug	Replacement Preparations	approved, experimental	0
DB11301	Curcuma aromatica root oil	Drug	0	approved	0
DB12632	JNJ-41443532	Drug	Benzoates, Acids, Carbocyclic, Amides, Azetines, Benzene Derivatives	investigational	0
DB12635	Aleplasinin	Drug	0	investigational	0
DB11304	Phenoxyethanol	Drug	Glycols, Central Nervous System Agents, Anesthetics, Anti-Infective Agents, Anti-Infective Agents, Local, Drugs that are Mainly Renally Excreted, Alcohols	approved	0
DB13967	Patent Blue	Drug	Other Diagnostics, Amines, Aniline Compounds, Coloring Agents, Compounds used in a research, industrial, or household setting, Drugs that are Mainly Renally Excreted	approved	1
DB13968	Plasma protein fraction (human)	Drug	Proteins, Serum Albumin, Albumins, Plasma Substitutes, Globulins, Blood Proteins, Amino Acids, Peptides, and Proteins, Biomimetic Materials, Hematologic Agents, Blood Derivatives, Hemostatics, Blood Substitutes	approved	0
DB12634	Navicixizumab	Drug	0	investigational	0
DB11306	Bentonite	Drug	Antidotes, Protective Agents, Ions, Oxides, Minerals, Silicates, Silicon Compounds, Anions, Acids, Noncarboxylic, Metal cations, Acids, Metal divalent cations, Aluminium Compounds, Aluminum Silicates, Electrolytes, Compounds used in a research, industrial, or household setting, Oxygen Compounds	approved	0
DB12637	Onapristone	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, Reproductive Control Agents, Fertility Agents, Female, Antineoplastic Agents, Hormone Antagonists, Fused-Ring Compounds, Fertility Agents, Steroids	investigational	2
DB13965	Sarracenia Purpurea	Drug	Miscellaneous Analgesics and Antipyretics	approved, experimental	0
DB11305	Quaternium-18	Drug	0	experimental	0
DB13966	Isopropyl myristate	Drug	Fatty Acids, Scabicides and Pediculicides, Lipids, Myristic Acids	approved, experimental	0
DB12636	Samalizumab	Drug	0	investigational	0
DB12639	Telbermin	Drug	0	investigational	0
DB12638	PU-H71	Drug	Heterocyclic Compounds, Fused-Ring, Antineoplastic Agents, Dioxoles	investigational	0
DB13969	Quaternium-24	Drug	0	experimental	0
DB11309	Sulfuric acid	Drug	Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfur Acids	experimental	0
DB01981	3,6-Anhydro-2-(hydrogen sulfate)-alpha-D-galactopyranose	Drug	0	experimental	1
DB00650	Leucovorin	Drug	Enzymes and Coenzymes, Pteridines, OAT3/SLC22A8 Substrates, Physiological Phenomena, Pterins, Folic Acid and Derivatives, Tetrahydrofolates, Food and Beverages, Detoxifying Agents for Antineoplastic Treatment, Growth Substances, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food, Biological Factors, Coenzymes, Antidotes, Protective Agents, Vitamins, Pigments, Biological, Folate Analog, Heterocyclic Compounds, Fused-Ring, Micronutrients, Vitamin B Complex, Formyltetrahydrofolates, OAT3/SLC22A8 Inhibitors	approved	0
DB01980	Para-Iodo-D-Phenylalanine Hydroxamic Acid	Drug	0	experimental	1
DB01985	N-acetyl-L-arginine	Drug	Amino Acids, Basic, Amino Acids, Essential, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	1
DB00653	Magnesium sulfate	Drug	Blood and Blood Forming Organs, Sensory System Agents, Sulfur Acids, Agents causing hyperkalemia, Calculi Dissolution Agent, Cardiovascular Agents, Mineral Supplements, Agents that produce neuromuscular block (indirect), Blood Substitutes and Perfusion Solutions, Paramagnetic Contrast Agent, Sulfates, Electrolyte Solutions, Tocolytic Agents, Peripheral Nervous System Agents, Anions, Sulfur Compounds, I.V. Solution Additives, Metal cations, Miscellaneous Anticonvulsants, Analgesics, Replacement Preparations, Alimentary Tract and Metabolism, Osmotic Laxatives, Calcium-Regulating Hormones and Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Magnesium Salts, Dermatologicals, Reproductive Control Agents, Drugs for Constipation, Ions, Laxatives, magnesium containing, Anesthetics, Membrane Transport Modulators, Sulfuric Acids, Calcium Channel Blockers, Anticonvulsants, Acids, Noncarboxylic, Acids, Central Nervous System Depressants, Metal divalent cations, Electrolytes, Laxatives, Tests for Bile Duct Patency, Central Nervous System Agents, Diagnostic Agents, Vasodilating Agents, Magnesium Compounds	approved, investigational, vet_approved	1
DB00654	Latanoprost	Drug	Biological Factors, Autacoids, Fatty Acids, Antiglaucoma Preparations and Miotics, Prostaglandin analogs reducing intraocular pressure (IOP), Eicosanoids, Lipids, OAT1/SLC22A6 inhibitors, Prostaglandins, Synthetic, Ophthalmologicals, Fatty Acids, Unsaturated, Prostaglandins, Prostaglandins F, Synthetic, Antihypertensive Agents, OAT3/SLC22A8 Inhibitors, Sensory Organs	approved, investigational	1
DB01984	(4S)-5-[[(1S)-1-Carboxy-2-cyclohexylethyl]amino]-4-[[(2S)-2-[[(3R)-4-cyclohexyl-2-oxo-3-(phenylmethoxycarbonylamino)butanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-oxopentanoic acid	Drug	0	experimental	0
DB00651	Dyphylline	Drug	Autonomic Agents, Phosphodiesterase Inhibitors, Enzyme Inhibitors, Anti-Asthmatic Agents, Cardiovascular Agents, Bronchodilator Agents, Respiratory System Agents, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Purines, Xanthines and Adrenergics, Drugs for Obstructive Airway Diseases, Xanthine derivatives, Vasodilating Agents, Purinones	approved	6
DB01983	2(S)-Amino-6-Boronohexanoic Acid	Drug	0	experimental	1
DB00652	Pentazocine	Drug	Sensory System Agents, Narcotics, Nervous System, P-glycoprotein substrates, Morphinans, Peripheral Nervous System Agents, Opioid Antagonists, Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Benzomorphan Derivatives, Opioids, Benzomorphans, Adjuvants, Anesthesia, Central Nervous System Agents, Opiate Partial Agonists, Agents that reduce seizure threshold, Mixed Agonist / Antagonist Opioids, Partial Opioid Agonist/Antagonist	approved, vet_approved	3
DB01982	D-Mannuronic Acid	Drug	0	experimental	2
DB01989	Methyl N-{[(1R)-1-({1-[(benzyloxy)carbonyl]-L-prolyl-6-ammonio-L-norleucyl}amino)-2-phenylethyl](hydroxy)phosphoryl}-L-alanyl-L-prolinate	Drug	0	experimental	1
DB00657	Mecamylamine	Drug	Autonomic Agents, Antihypertensive Agents Indicated for Hypertension, Decreased Autonomic Ganglionic Activity, Ganglion Blockers, Cardiovascular Agents, Hypotensive Agents, Agents that produce neuromuscular block (indirect), Nicotinic Antagonists, Drugs that are Mainly Renally Excreted, Antiadrenergic Agents, Ganglion-Blocking, Peripheral Nervous System Agents, Anticholinergic Agents, Neurotransmitter Agents, Cholinergic Agents, Autonomic Ganglionic Blocker, Monoterpenes, Antihypertensive Agents, Terpenes, Norbornanes, Secondary and Tertiary Amines	approved, investigational	4
DB00658	Sevelamer	Drug	Lipid Regulating Agents, Phosphate Chelating Activity, Polystyrene Sulfonates, Amines, Phosphate Binder, Phosphate-removing Agents, Sequestering Agents, Drugs for Treatment of Hyperkalemia and Hyperphosphatemia, Polyamines, Bile Acid Sequestrants, Compounds used in a research, industrial, or household setting, Chelating Agents	approved	1
DB01988	6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine	Drug	0	experimental	1
DB01987	Cocarboxylase	Drug	Coenzymes, Enzymes and Coenzymes, Vitamins, Micronutrients, Pyrimidines, Sulfur Compounds, Physiological Phenomena, Food and Beverages, Thiazoles, Vitamin B Complex, Growth Substances, Diet, Food, and Nutrition, Food	approved, experimental	7
DB00655	Estrone	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, 17-Ketosteroids, Adrenal Cortex Hormones, Estrogens, Genito Urinary System and Sex Hormones, Natural and Semisynthetic Estrogens, Plain, Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, OAT3/SLC22A8 Substrates, Estradiol Congeners, Gonadal Hormones, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 CYP3A5 Substrates, Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein substrates, Estrenes, BCRP/ABCG2 Inhibitors, Ketosteroids, Gonadal Steroid Hormones, P-glycoprotein inducers, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, Thyroxine-binding globulin inducers, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2B6 Substrates, Steroids	approved	5
DB00656	Trazodone	Drug	Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Tranquilizing Agents, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Peripheral alpha-1 blockers, Antidepressive Agents, Antidepressive Agents, Triazolopyridine, Cytochrome P-450 CYP3A4 Substrates, Serotonin 5-HT2 Receptor Antagonists, Serotonin Modulators, Histamine H1 Antagonists, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Adrenergic Antagonists, Potential QTc-Prolonging Agents, Adrenergic alpha-1 Receptor Antagonists, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Agents that reduce seizure threshold, Selective Serotonin Reuptake Inhibitors, Pyridines, Cytochrome P-450 CYP3A5 Substrates, Piperazines, Adrenergic alpha-Antagonists, Pyridones, Antidepressive Agents, Second-Generation, Psychotropic Drugs, Membrane Transport Modulators, P-glycoprotein inducers, Neurotransmitter Agents, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Neurotransmitter Uptake Inhibitors, Agents that produce hypertension, Anti-Anxiety Agents, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Psychoanaleptics	approved, investigational	8
DB01986	3-Fluoro-2-Methyl-Aniline	Drug	0	experimental	1
DB00659	Acamprosate	Drug	Alkanesulfonic Acids, Alcohol Deterrents, Nervous System, Sulfur Acids, Hydrocarbons, Acyclic, Alkanes, Drugs Used in Alcohol Dependence, Miscellaneous Central Nervous System Agents, Drugs Used in Addictive Disorders, Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfonic Acids, Central Nervous System Agents	approved, investigational	3
DB13970	Dioctyldimonium	Drug	Amines, Ammonium Compounds, Onium Compounds, Nitrogen Compounds	approved, experimental	0
DB13971	Vanadium	Drug	Trace Elements, Micronutrients, Physiological Phenomena, Food and Beverages, Metals, Metals, Heavy, Elements, Growth Substances, Transition Elements, Diet, Food, and Nutrition, Food	approved, experimental	0
DB12640	CP-609754	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring	investigational	0
DB11311	Prothrombin	Drug	Proteins, Biological Factors, Increased Coagulation Activity, Blood Proteins, Blood Coagulation Factors, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Enzyme Precursors, Prothrombin, agonists	approved	4
DB12642	Olumacostat glasaretil	Drug	0	investigational	0
DB13974	Passiflora incarnata flower	Drug	Herbs and Natural Products	approved, experimental	0
DB12641	Tedatioxetine	Drug	0	investigational	0
DB13975	Black cohosh	Drug	Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors, Genito Urinary System and Sex Hormones, Cytochrome P-450 CYP3A4 Inhibitors, Herbs and Natural Products, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)	experimental	0
DB13972	Racemethionine	Drug	Amino Acids, Neutral, Sulfur Compounds, Amino Acids, Essential, Amino Acids, Sulfur, Amino Acids, Peptides, and Proteins, Amino Acids	approved, experimental	0
DB11313	Phenyl trimethicone	Drug	Polymers, Compounds used in a research, industrial, or household setting, Organosilicon Compounds, Silicon Compounds, Macromolecular Substances	experimental	0
DB12644	AZD-2066	Drug	0	investigational	0
DB11312	Protein C	Drug	Anticoagulants, Biological Factors, Enzymes, Blood and Blood Forming Organs, Glycoconjugates, Fibrin Modulating Agents, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Hematologic Agents, Cardiovascular Agents, Glycoproteins, Fibrinolytic Agents, Proteins, Blood Proteins, Decreased Coagulation Factor Activity, Enzyme Precursors, Blood Coagulation Factor Inhibitors	approved	2
DB12643	Nelivaptan	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB13973	Remestemcel-L	Drug	0	approved, investigational	0
DB11315	Methscopolamine	Drug	Autonomic Agents, Mydriatics and Cycloplegics, Agents producing tachycardia, Parasympatholytics, Muscarinic Antagonists, Peripheral Nervous System Agents, Anticholinergic Agents, Ophthalmologicals, Alkaloids, Belladonna and Derivatives, Plain, Synthetic Anticholinergics, Quaternary Ammonium Compounds, Tropanes, Belladonna Alkaloids, Semisynthetic, Quaternary Ammonium Compounds, Alimentary Tract and Metabolism, Aza Compounds, Azabicyclo Compounds, Drugs for Functional Gastrointestinal Disorders, Scopolamine Derivatives, Sensory Organs	approved	0
DB13978	Selisistat	Drug	Heterocyclic Compounds, Fused-Ring, Sirtuin 1, antagonists & inhibitors, Indoles	experimental	1
DB13979	Besilesomab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Radiopharmaceuticals, Immunoproteins	approved	1
DB12645	Givinostat	Drug	Acids, Acyclic, QTc Prolonging Agents, Antineoplastic Agents, Potential QTc-Prolonging Agents, Histone Deacetylase Inhibitors	investigational	0
DB12648	Nona-arginine	Drug	Furin, antagonists & inhibitors, Peptides, Amino Acids, Peptides, and Proteins	investigational	0
DB13976	Sulesomab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Diagnostic Radiopharmaceuticals, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Inflammation and Infection Detection, Immunoproteins, Technetium (99Mtc) Compounds	approved	0
DB13977	Potassium carbonate	Drug	Alkalies, Potassium Salt, Metals, Ions, Carbonic Acid, Carbon Compounds, Inorganic, Elements, Metals, Alkali, Metals, Light, Anions, Acids, Noncarboxylic, Acids, Electrolytes	approved	0
DB12647	Tocotrienol	Drug	Protective Agents, Benzopyrans, Vitamins, Antioxidants, Heterocyclic Compounds, Fused-Ring, Micronutrients, Physiological Phenomena, Vitamin E, Vitamins (Fat Soluble), Food and Beverages, Growth Substances, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food, Pyrans	investigational	0
DB12649	Ibipinabant	Drug	Neurotransmitter Agents, Sulfur Compounds, Hormones, Hormone Substitutes, and Hormone Antagonists, Cannabinoid Receptor Antagonists, Cannabinoids and similars, Receptor, Cannabinoid, CB1, antagonists & inhibitors, Agents producing tachycardia, Amides, Hormones, Sulfones	investigational	0
DB11318	1,2-Docosahexanoyl-sn-glycero-3-phosphoserine	Drug	0	experimental	0
DB01992	Coenzyme A	Drug	Carbohydrates, Coenzyme A, biosynthesis, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Coenzymes, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Enzymes and Coenzymes, Glycosides, Nucleotides, Adenine Nucleotides	investigational, nutraceutical	45
DB00660	Metaxalone	Drug	Oxazoles, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Muscle Relaxants, Centrally Acting Agents, Centrally-mediated Muscle Relaxation, Muscle Relaxants, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents	approved	0
DB01991	TU-514	Drug	Carbohydrates, Glycoconjugates, Lipids	experimental	1
DB00661	Verapamil	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, OCT1 inhibitors, Cardiovascular Agents, MATE 1 Inhibitors, Miscellaneous Calcium-channel Blocking Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Substrates, Antiarrhythmic agents, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Antihypertensive Agents Indicated for Hypertension, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP2C18 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP2C8 Inhibitors, Membrane Transport Modulators, Cytochrome P-450 CYP2C19 Substrates, Calcium Channel Blockers, Calcium Channel Blockers (Nondihydropyridine), MATE 2 Inhibitors, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Inhibitors (weak), Cytochrome P-450 CYP2D6 Inhibitors, OCT1 substrates, Amines, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Phenylalkylamine Derivatives, MATE inhibitors, Hypotensive Agents, ACE Inhibitors and Calcium Channel Blockers, Cytochrome P-450 CYP2C9 Inhibitors, Adrenergic Antagonists, Adrenergic alpha-1 Receptor Antagonists, Antihypertensive Agents, Bradycardia-Causing Agents, Selective Calcium Channel Blockers With Direct Cardiac Effects, Cytochrome P-450 CYP2E1 Substrates, Adrenergic alpha-Antagonists, P-glycoprotein substrates, Cytochrome P-450 CYP3A5 Inhibitors, Verapamil and analogues, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A5 Inhibitors (moderate), Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors, Vasodilating Agents, Cytochrome P-450 CYP2C9 Inhibitors (weak)	approved	11
DB01990	Cholesterol sulfate	Drug	Cholestanes, Enzyme Inhibitors, Protective Agents, Protease Inhibitors, Lipids, Fused-Ring Compounds, Sterols, Anticarcinogenic Agents, Membrane Lipids, Cholestenes, Compounds used in a research, industrial, or household setting, Serine Protease Inhibitors, Steroids	experimental	1
DB01996	3-Methylpyridine	Drug	Pyridines	experimental	2
DB00664	Sulfametopyrazine	Drug	Long-Acting Sulfonamides, Renal Agents, Amines, Anti-Infective Agents, Urinary, Antiprotozoals, Gynecological Antiinfectives and Antiseptics, Aniline Compounds, Genito Urinary System and Sex Hormones, Amides, Sulfanilamides, Antiinfectives for Systemic Use, Anti-Infective Agents, SULFONAMIDES AND TRIMETHOPRIM, Sulfur Compounds, Sulfonamides, Antibacterials for Systemic Use, Antiparasitic Agents, Sulfones	approved, withdrawn	1
DB01995	5-methylcytidine 5'-monophosphate	Drug	Carbohydrates, Pyrimidines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Cytosine Nucleotides, Glycosides, Nucleotides, Pyrimidine Nucleotides	experimental	0
DB00665	Nilutamide	Drug	Endocrine Therapy, Androgen Receptor Antagonists, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP2C8 Inhibitors, Antineoplastic and Immunomodulating Agents, Androgen Receptor Inhibitor, Antineoplastic Agents, Cytochrome P-450 CYP2C19 Inhibitors, Hormone Antagonists and Related Agents, Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP2C19 Substrates, Imidazoles, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors, Antiandrogens, Cytochrome P-450 CYP2C19 Inhibitors (weak), Hormone Antagonists, Antiandrogens, non-steroidal, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)	approved, investigational	1
DB01994	2-(Pyrido[1,2-E]Purin-4-Yl)Amino-Ethanol	Drug	0	experimental	0
DB00662	Trimethobenzamide	Drug	Autonomic Agents, Benzoates, Acids, Carbocyclic, Amides, Peripheral Nervous System Agents, Emesis Suppression, Central Nervous System Depressants, Antiemetics, Central Nervous System Agents, Aminoalkyl Ethers, Antihistamines for Systemic Use, Benzene Derivatives, Gastrointestinal Agents	approved, investigational	0
DB01993	N-(5'-Phosphopyridoxyl)-D-Alanine	Drug	0	experimental	1
DB00663	Flumethasone	Drug	Corticosteroids, Dermatological Preparations, Pregnadienetriols, Corticosteroids, Cytochrome P-450 Substrates, Immunosuppressive Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Dermatologicals, Otologicals, Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Corticosteroids, Moderately Potent (Group II), Cytochrome P-450 CYP3A Substrates, Pregnanes, Sensory Organs, Steroids, Fluorinated, Steroids	approved, vet_approved	1
DB00668	Epinephrine	Drug	Adrenergics, Inhalants, Cytochrome P-450 Enzyme Inhibitors, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Adrenergic beta-2 Receptor Agonists, Peripheral Nervous System Agents, Nasal Preparations, Dental Agents, Adrenergic beta-1 Receptor Agonists, Alpha-and Beta-adrenergic Agonists, Biogenic Amines, Local Hemostatics, COMT Substrates, Hemostatics, Adrenergic Agents, Benzene Derivatives, Adrenergic alpha-Agonists, Anti-Asthmatic Agents, Epinephrine and similars, Agents producing tachycardia, Catechols, Adrenergic and Dopaminergic Agents, Respiratory System Agents, Ophthalmologicals, Adrenergic beta-Agonists, Neurotransmitter Agents, Mydriatics, Sympathomimetics, Adrenergic Agonists, Cardiac Stimulants Excl. Cardiac Glycosides, Sympathomimetics, Plain, Sympathomimetics in Glaucoma Therapy, Adrenergic beta-3 Receptor Agonists, OCT1 substrates, Amines, OCT2 Substrates, Adrenergic alpha-1 Receptor Agonists, Sympathomimetic (Adrenergic) Agents, Adrenergic alpha-2 Receptor Agonists, Cytochrome P-450 CYP2C9 Inhibitors, Autonomic Agents, Antiglaucoma Preparations and Miotics, Catecholamines, Bronchodilator Agents, Biogenic Monoamines, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), OCT2 Inhibitors, Vasoconstrictor Agents, Agents that produce hypertension, Cytochrome P-450 CYP3A4 Inhibitors, Phenols, Drugs for Obstructive Airway Diseases, Cardiac Therapy, Hyperglycemia-Associated Agents, Stomatological Preparations	approved, vet_approved	8
DB00669	Sumatriptan	Drug	Serotonin 5-HT1 Receptor Agonists, Triptans, Amines, Serotonin Agents, Nervous System, Genito Urinary System and Sex Hormones, Selective Serotonin Agonists, Amides, Cardiovascular Agents, Antidepressive Agents, Antimigraine Preparations, Drugs that are Mainly Renally Excreted, Serotonin Modulators, Sulfur Compounds, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Serotonin 1d Receptor Agonists, Biogenic Amines, Indoles, Monoamine Oxidase A Substrates, Sulfones, Serotonin-1b and Serotonin-1d Receptor Agonist, P-glycoprotein substrates, Serotonin Receptor Agonists, Biogenic Monoamines, Serotonin 1b Receptor Agonists, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, BCRP/ABCG2 Substrates, Central Nervous System Depressants, Sulfonamides, Vasoconstrictor Agents, Agents that produce hypertension, Selective Serotonin 5-HT1 Receptor Agonists, OATP1B1/SLCO1B1 Substrates, Tryptamines	approved, investigational	4
DB01999	5,10,15,20-Tetrakis(4-Sulpfonatophenyl)-21h,23h-Porphine	Drug	0	experimental	0
DB00666	Nafarelin	Drug	Gonadotropins and Antigonadotropins, Hormones, Hormone Substitutes, and Hormone Antagonists, Oligopeptides, Peptides, Adrenal Cortex Hormones, Reproductive Control Agents, Fertility Agents, Female, Pituitary and Hypothalamic Hormones and Analogues, Gonadotropin Releasing Hormone Receptor Agonists, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Hormones, Pituitary Hormone-Releasing Hormones, Fertility Agents, Proteins, Peptide Hormones, Gonadotropin Releasing Hormone Receptor Agonist, Agents Causing Muscle Toxicity, Gonadotropin-releasing hormone agonist, Hypothalamic Hormones, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins	approved	2
DB01998	2-[3,4-Dihydroxy-2-Hydroxymethyl-5-(2-Hydroxy-Nonyl)-Tetrahydro-Furan-2-Yloxy]-6-Hydroxymethyl-Tetra Hydro-Pyran-3,4,5-Triol	Drug	0	experimental	1
DB01997	3-Bromo-7-Nitroindazole	Drug	Heterocyclic Compounds, Fused-Ring, Nitric Oxide Synthase, antagonists & inhibitors, Pyrazoles	experimental	3
DB13981	Nomegestrol acetate	Drug	Antineoplastic Agents, Hormonal, Cytochrome P-450 Substrates, Pregnadienes, Norsteroids, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Contraceptives, Oral, Progesterone Congeners, Cytochrome P-450 CYP3A Substrates, Progestins, Pregnanes, Combination Contraceptives (with Estrogen and derivatives), Hormonal Contraceptives for Systemic Use, Norpregnanes, Contraceptive Agents, Female, Progestin Contraceptives, Steroids	investigational	0
DB13982	Lutetium Lu-177	Drug	Lanthanoid Series Elements, Metals, Elements, Transition Elements, Isotopes, Metals, Rare Earth	approved	0
DB12651	Bardoxolone	Drug	0	investigational	1
DB12650	L-deprenyl-D2 C-11	Drug	0	investigational	0
DB13980	Copper Cu-64	Drug	0	approved	0
DB13985	Lutetium Lu 177 dotatate	Drug	Organometallic Compounds, Peptides, Cyclic, Peptides, Amino Acids, Peptides, and Proteins, Lutetium	approved, investigational	5
DB12652	Endothelin-1	Drug	Proteins, Biological Factors, Endothelins, Peptides, Intercellular Signaling Peptides and Proteins, Endothelin-1, antagonists & inhibitors, Amino Acids, Peptides, and Proteins	investigational	0
DB11321	Cod liver oil	Drug	Oils, Lipids, Dietary Fats, Unsaturated, Micronutrients, Physiological Phenomena, Fats, Unsaturated, Dietary Fats, Food and Beverages, Fish Oils, Fats, Growth Substances, Diet, Food, and Nutrition, Food	nutraceutical, vet_approved	0
DB13983	5,7,2′-trihydroxy-6,8-dimethoxyflavone	Drug	0	experimental	1
DB11324	Nonivamide	Drug	Solanaceous Alkaloids, Benzoates, Fatty Acids, Hydroxy Acids, Sensory System Agents, Alkenes, Acids, Carbocyclic, Hydrocarbons, Acyclic, Hydroxybenzoates, Amides, Catechols, Lipids, Fatty Acids, Monounsaturated, Peripheral Nervous System Agents, Phenyl Ethers, Polyunsaturated Alkamides, Alkaloids, Fatty Acids, Unsaturated, Nitric Oxide Synthase, antagonists & inhibitors, Phenols, Ethers, Hydroxybenzoate Ethers, Benzene Derivatives, Alkynes	investigational	1
DB12655	Patidegib	Drug	Alkaloids	investigational	0
DB13984	Cyclopropane	Drug	Cycloparaffins, Central Nervous System Depressants, Central Nervous System Agents, Anesthetics	experimental	0
DB11323	Glycol salicylate	Drug	Benzoates, Hydroxy Acids, Acids, Carbocyclic, Hydroxybenzoates, Phenols, Benzene Derivatives	approved	2
DB12654	GSK-376501	Drug	0	investigational	0
DB13989	Epitizide	Drug	Sodium Chloride Symporter Inhibitors, Diuretics, Low-Ceiling Diuretics and Potassium-Sparing Agents	experimental	0
DB12657	JNJ-42396302	Drug	0	investigational	0
DB11326	Boric acid	Drug	Acids, Noncarboxylic, Acids, Agrochemicals, Otologicals, Pesticides, Insecticides, Toxic Actions, Sensory Organs, Compounds used in a research, industrial, or household setting, Anti-Infective Agents, Boron Compounds	approved	0
DB09005	Batroxobin	Drug	Biological Factors, Enzymes, Viper Venoms, Blood and Blood Forming Organs, Fibrin Modulating Agents, Crotalid Venoms, Enzymes and Coenzymes, Hematologic Agents, Cardiovascular Agents, Coagulants, Toxins, Biological, Complex Mixtures, Venoms, Serine Proteases, Hydrolases, Peptide Hydrolases, Hemostatics, Serine Endopeptidases, Snake Venoms, Venombin A, Endopeptidases, Fluids and Secretions, Bodily Secretions	experimental	0
DB11325	Soy sterol	Drug	Biological Factors, Cholestanes, Phytochemicals, Sterols, Lipids, Membrane Lipids, Fused-Ring Compounds, Steroids	experimental	0
DB12656	Somatorelin	Drug	Tests for Pituitary Function, Diagnostic Agents	investigational	0
DB09006	Clinofibrate	Drug	Acids, Acyclic, Fatty Acids, Glycolates, Hydroxy Acids, Fatty Acids, Volatile, Lipids, Acetates	experimental	3
DB11328	Tetradecyl hydrogen sulfate (ester)	Drug	Drugs that are Mainly Renally Excreted	approved	1
DB13987	Strontium chloride	Drug	Strontium Radioisotopes, Metals, Metals, Alkaline Earth, Metals, Heavy, Elements, Drugs that are Mainly Renally Excreted	approved	0
DB12659	SJ-733	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB09003	Clocapramine	Drug	Heterocyclic Compounds, Fused-Ring	experimental	0
DB12658	AFN-1252	Drug	Heterocyclic Compounds, Fused-Ring, Pyrans	investigational	0
DB11327	Dipyrithione	Drug	0	approved	2
DB13988	SB-269970	Drug	Sulfur Compounds, Amides, Benzene Derivatives, Sulfones	investigational	1
DB09004	Clobutinol	Drug	Antitussive Agents, Amines, Cough and Cold Preparations, Central Nervous System Agents, Respiratory System Agents, Alcohols	withdrawn	0
DB09001	Barbexaclone	Drug	Anticonvulsants, Cytochrome P-450 Enzyme Inducers, Pyrimidines, Nervous System, Central Nervous System Depressants, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Pyrimidinones, Barbiturates and Derivatives, Barbiturates, Cytochrome P-450 CYP3A4 Inducers (strength unknown)	experimental	0
DB09002	Cloperastine	Drug	Cough and Cold Preparations	experimental	0
DB11329	C11-12 isoparaffin	Drug	0	approved	0
DB09000	Cyamemazine	Drug	Heterocyclic Compounds, Fused-Ring, Psycholeptics, Antipsychotic Agents, Sulfur Compounds, Nervous System, Photosensitizing Agents, Central Nervous System Depressants, Phenothiazines, Anti-Anxiety Agents, Phenothiazines With Aliphatic Side-Chain, Neurotoxic agents	experimental	0
DB00671	Cefixime	Drug	Third-Generation Cephalosporins, Cephacetrile, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Antibacterials for Systemic Use	approved, investigational	1
DB00672	Chlorpropamide	Drug	Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Sulfur Compounds, Cytochrome P-450 Substrates, Alimentary Tract and Metabolism, Hypoglycemia-Associated Agents, Sulfonylureas, Drugs Used in Diabetes, Blood Glucose Lowering Agents, Drugs that are Mainly Renally Excreted, Sulfones, OAT1/SLC22A6 inhibitors	approved, investigational	1
DB00670	Pirenzepine	Drug	Agents producing tachycardia, Muscarinic Antagonists, Anti-Ulcer Agents, Anticholinergic Agents, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Cholinergic Agents, Benzazepines, Alimentary Tract and Metabolism, Benzodiazepinones, Drugs for Acid Related Disorders, Gastrointestinal Agents	approved	1
DB00675	Tamoxifen	Drug	Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index, Estrogen Antagonists, Cytochrome P-450 CYP2B6 Inhibitors (moderate), Stilbenes, UGT2B7 substrates, UGT2B7 substrates with narrow therapeutic index, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Benzene Derivatives, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP2A6 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index, Anti-Estrogens, Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C19 Substrates, Narrow Therapeutic Index Drugs, Thyroxine-binding globulin inducers, Cytochrome P-450 CYP2A6 Substrates, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2D6 Inhibitors, Endocrine Therapy, QTc Prolonging Agents, BSEP/ABCB11 Inhibitors, Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index, Cardiotoxic antineoplastic agents, Estrogen Receptor Modulators, Hormone Antagonists and Related Agents, Cytochrome P-450 CYP2B6 Inhibitors, Estrogen Agonist/Antagonist, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C9 Inhibitors, Potential QTc-Prolonging Agents, Hormone Antagonists, Antineoplastic Agents, Hormonal, Cytochrome P-450 CYP2E1 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein substrates, Antineoplastic Agents, Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index, Benzylidene Compounds, P-glycoprotein inducers, Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C9 Substrates, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Selective Estrogen Receptor Modulators, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors	approved	10
DB09009	Articaine	Drug	Amide Local Anesthetic, Sulfur Compounds, Sensory System Agents, Nervous System, Thiophenes, Local Anesthesia, Amides, Central Nervous System Agents, Anesthetics, Hyperglycemia-Associated Agents, Anesthetics, Local, Peripheral Nervous System Agents	approved	0
DB00676	Benzyl benzoate	Drug	Acaricides, Antiparasitic Products, Insecticides and Repellents, Agrochemicals, Ectoparasiticides, Incl. Scabicides, Acids, Carbocyclic, Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents, Pesticides, Insecticides, Toxic Actions, Compounds used in a research, industrial, or household setting, Benzene Derivatives	approved	0
DB09007	Chlorphenoxamine	Drug	Amines, Antihistamines for Topical Use, Dermatologicals, Agents producing tachycardia, Muscarinic Antagonists, Anticholinergic Agents, Neurotransmitter Agents, Antipruritics, Incl. Antihistamines, Anesthetics, Etc., Cholinergic Agents, Histamine Antagonists, Histamine Agents, Aminoalkyl Ethers, Antihistamines for Systemic Use	withdrawn	0
DB00673	Aprepitant	Drug	Oxazines, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Cytochrome P-450 CYP3A7 Inhibitors (strength unknown), Peripheral Nervous System Agents, Cytochrome P-450 Enzyme Inducers, Alimentary Tract and Metabolism, Cytochrome P-450 CYP2C9 Inhibitors, Neurokinin 1 Antagonists, Substance P/Neurokinin-1 Receptor Antagonist, Neurokinin-1 Receptor Antagonists, Gastrointestinal Agents, Autonomic Agents, Antiemetics and Antinauseants, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A5 Inhibitors, Morpholines, Aprepitant and Prodrugs, Cytochrome P-450 CYP2C19 Substrates, Neurotransmitter Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP3A7 Inhibitors, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Antiemetics, Central Nervous System Agents, Cytochrome P-450 CYP2C19 Inhibitors (weak), Cytochrome P-450 CYP2C9 Inducers, Cytochrome P-450 CYP2C9 Inhibitors (weak)	approved, investigational	1
DB00674	Galantamine	Drug	QTc Prolonging Agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Nervous System, Cytochrome P-450 CYP3A4 Substrates, Peripheral Nervous System Agents, Alkaloids, Cholinergic Agents, Benzazepines, Anti-Dementia Drugs, Potential QTc-Prolonging Agents, Bradycardia-Causing Agents, Autonomic Agents, Cholinesterase Inhibitors, Parasympathomimetics, Parasympathomemetic (Cholinergic) Agents, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Amaryllidaceae Alkaloids, Cytochrome P-450 CYP3A Substrates, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors, Nootropic Agents, Psychoanaleptics	approved	4
DB09008	Cefaloridine	Drug	Nephrotoxic agents, Amides, Lactams, OAT1/SLC22A6 Substrates, Thiazines, beta-Lactams, First-Generation Cephalosporins, Antiinfectives for Systemic Use, Anti-Infective Agents, OAT3/SLC22A8 Substrates, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, OAT3/SLC22A8 Inhibitors, Antibacterials for Systemic Use	withdrawn, experimental	0
DB00679	Thioridazine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Highest Risk QTc-Prolonging Agents, Psycholeptics, QTc Prolonging Agents, Tranquilizing Agents, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Antipsychotic Agents (First Generation Typical), Hypotensive Agents, Antidepressive Agents, Phenothiazines With Piperidine Structure, Serotonin 5-HT2 Receptor Antagonists, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Antipsychotic Agents, Sulfur Compounds, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Adrenergic Antagonists, Adrenergic alpha-1 Receptor Antagonists, Drugs causing inadvertant photosensitivity, Dopamine Antagonists, Dopamine Agents, Neurotoxic agents, Adrenergic alpha-Antagonists, Cytochrome P-450 CYP2E1 Inhibitors, Phenothiazines, Psychotropic Drugs, Cytochrome P-450 CYP2C19 Substrates, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Photosensitizing Agents, Central Nervous System Depressants, Agents that produce hypertension, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2D6 Inhibitors (strong), Dopamine D2 Receptor Antagonists	approved, withdrawn	6
DB00677	Isoflurophate	Drug	Organophosphonates, Neurotransmitter Agents, Enzyme Inhibitors, Cholinergic Agents, Cholinesterase Inhibitors, Protease Inhibitors, Organophosphorus Compounds, Organofluorophosphonates, Ophthalmics	approved, investigational, withdrawn	3
DB00678	Losartan	Drug	QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Angiotensin Receptor Antagonists, Agents causing hyperkalemia, UGT1A3 substrates, BSEP/ABCB11 Substrates, Cytochrome P-450 CYP2C19 Inhibitors, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Hypotensive Agents, Tetrazoles, Cytochrome P-450 CYP3A4 Substrates, Angiotensin II Type 1 Receptor Blockers, UGT2B7 substrates, Agents Acting on the Renin-Angiotensin System, Potential QTc-Prolonging Agents, Agents causing angioedema, Antihypertensive Agents, Drugs causing inadvertant photosensitivity, Benzene Derivatives, Antiarrhythmic agents, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Antihypertensive Agents Indicated for Hypertension, Angiotensin II receptor blockers (ARBs) and diuretics, Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, Angiotensin II receptor blockers (ARBs) and calcium channel blockers, Angiotensin II receptor blockers (ARBs), plain, Biphenyl Compounds, OAT1/SLC22A6 inhibitors, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Inhibitors, Imidazoles, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, UGT1A1 Substrates, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Angiotensin II Type 2 Receptor Blockers, Angiotensin 2 Receptor Blocker, P-glycoprotein inhibitors	approved	1
DB12660	Samatasvir	Drug	Acids, Acyclic, Heterocyclic Compounds, Fused-Ring	investigational	0
DB13992	Azintamide	Drug	0	investigational	0
DB13993	MRK-409	Drug	Heterocyclic Compounds, Fused-Ring, Central Nervous System Depressants, Hydrocarbons, Halogenated, Anti-Anxiety Agents	experimental	0
DB13990	Dipropyl-4-hydroxytryptamine	Drug	0	experimental	0
DB12662	Naveglitazar	Drug	PPAR alpha, agonists, Acids, Carbocyclic, PPAR gamma, agonists	investigational	1
DB11331	1-Palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol))	Drug	0	approved, experimental	0
DB13991	Pipequaline	Drug	Heterocyclic Compounds, Fused-Ring, Central Nervous System Agents	experimental	0
DB11330	Factor IX Complex (Human)	Drug	Proteins, Biological Factors, Factor IX, Blood Proteins, Blood Coagulation Factors, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Enzyme Precursors	approved, investigational	0
DB12661	Urapidil	Drug	Serotonin Agents, Adrenergic alpha-Antagonists, Serotonin Receptor Agonists, Peripheral alpha-1 blockers, Antiadrenergic Agents, Peripherally Acting, Cardiovascular Agents, Antidepressive Agents, Neurotransmitter Agents, Central Nervous System Depressants, Adrenergic Antagonists, Agents that produce hypertension, Adrenergic alpha-1 Receptor Antagonists, Antihypertensive Agents, Vasodilating Agents, Adrenergic Agents	investigational	0
DB11333	Poloxamer 188	Drug	Surface-Active Agents, Excipients, Polyethylene Glycols, Pharmaceutic Aids, Alcohols, Drug Delivery Systems, Macromolecular Substances, Ethylene Glycols, Glycols, Pharmaceutical Preparations, Polymers, Compounds used in a research, industrial, or household setting, Pharmaceutical Vehicles	approved, investigational	0
DB13996	Magnesium acetate	Drug	Osmotic Laxatives, Calculi Dissolution Agent, Laxatives, Agents that produce neuromuscular block (indirect)	approved	1
DB12664	Indantadol	Drug	Amino Acids, Peptides, and Proteins, Indenes, Amino Acids	investigational	0
DB12663	Letrazuril	Drug	Nitriles	investigational	0
DB11332	Sinapultide	Drug	Amino Acids, Peptides, and Proteins, Pulmonary Surfactants	approved	1
DB13997	Baloxavir marboxil	Drug	Antivirals for Systemic Use, Direct Acting Antivirals, Enzyme Inhibitors, Sulfur Compounds, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, UGT1A3 substrates, Antiviral Agents, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents	approved, investigational	1
DB12666	Emapunil	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB11335	Ascorbyl glucoside	Drug	Acids, Acyclic, Carbohydrates, Hydroxy Acids, Sugar Acids	experimental	0
DB13994	AZD-7325	Drug	Heterocyclic Compounds, Fused-Ring, GABA Modulators	investigational	2
DB13995	Ferric pyrophosphate citrate	Drug	Parenteral Iron Replacement, Enzymes, Phosphate Binder, Enzymes and Coenzymes, Hydrolases, Peptide Hydrolases, Phosphate salts	approved, investigational	4
DB12665	Isoquercetin	Drug	Carbohydrates, Flavonols, Heterocyclic Compounds, Fused-Ring, Flavonoids, Glycosides, Benzopyrans, Chromones, Pyrans	investigational	0
DB11337	Zeatin	Drug	Cytokinins, Heterocyclic Compounds, Fused-Ring, Purines, Growth Substances, Plant Growth Regulators	experimental	0
DB12668	Metenkefalin	Drug	Receptors, Opioid, mu, agonists, Experimental Unapproved Treatments for COVID-19, Neuropeptides, Receptors, Opioid, delta, agonists	investigational	2
DB09016	Butriptyline	Drug	QTc Prolonging Agents, Tranquilizing Agents, Serotonin Agents, Nervous System, Antidepressive Agents, Benzocycloheptenes, Moderate Risk QTc-Prolonging Agents, Psychotropic Drugs, Serotonin 5-HT2 Receptor Antagonists, Histamine H1 Antagonists, Non-Selective Monoamine Reuptake Inhibitors, Histamine Antagonists, Narrow Therapeutic Index Drugs, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Tertiary amine tricyclic antidepressants, Central Nervous System Depressants, Antidepressive Agents, Tricyclic, Agents that produce hypertension, Anti-Anxiety Agents, Serotonin Receptor Antagonists, Central Nervous System Agents, Agents that reduce seizure threshold, Neurotoxic agents, Psychoanaleptics	approved	3
DB12667	Protionamide	Drug	Pyridines, Anti-Bacterial Agents, Drugs for Treatment of Tuberculosis, Antimycobacterials, Thiocarbamide Derivatives, Antiinfectives for Systemic Use, Anti-Infective Agents, Isonicotinic Acids, Antituberculosis Agents	approved, investigational	0
DB11336	Kinetin	Drug	Cytokinins, Heterocyclic Compounds, Fused-Ring, Purines, Growth Substances, Plant Growth Regulators	approved	0
DB09017	Brotizolam	Drug	Psycholeptics, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Nervous System, Central Nervous System Depressants, Benzodiazepines and benzodiazepine derivatives, Hypnotics and Sedatives, Central Nervous System Agents, Cytochrome P-450 CYP3A4 Substrates, Benzodiazepine hypnotics and sedatives	investigational, withdrawn	2
DB09014	Captodiame	Drug	Serotonin 5-HT2 Receptor Antagonists, Psycholeptics, Serotonin Agents, Diphenylmethane Derivatives, Nervous System, Central Nervous System Depressants, Anti-Anxiety Agents, Serotonin Receptor Antagonists, Antidepressive Agents	experimental	3
DB13998	Lonoctocog alfa	Drug	Hemostatics	approved, investigational	11
DB13999	Moroctocog alfa	Drug	Proteins, Biological Factors, Blood Proteins, Blood Coagulation Factors, Amino Acids, Peptides, and Proteins, Hemostatics, Recombinant Proteins	approved	11
DB09015	Canrenoic acid	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Agents causing hyperkalemia, Diuretics, Natriuretic Agents, Pregnanes, Cardiovascular Agents, Hormone Antagonists, Potassium-Sparing Diuretics, Mineralocorticoid Receptor Antagonists, Fused-Ring Compounds, Steroids	approved, withdrawn	0
DB12669	4SC-203	Drug	0	investigational	0
DB11338	Clove oil	Drug	Complex Mixtures, Oils, Plant Preparations, Biological Products, Lipids, Plant Oils, Drugs that are Mainly Renally Excreted	approved, nutraceutical	4
DB09012	Carbazochrome	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Blood and Blood Forming Organs, Hematologic Agents, Coagulants, Hemostatics, Indoles, Pigments, Biological	withdrawn, experimental	0
DB09013	Befunolol	Drug	Amines, Cytochrome P-450 Substrates, Propanols, Antiglaucoma Preparations and Miotics, Agents causing hyperkalemia, Adrenergic beta-Antagonists, Amino Alcohols, Alcohols, Ophthalmologicals, Adrenergic beta-Agonists, Neurotransmitter Agents, Adrenergic Agonists, Adrenergic Antagonists, Cytochrome P-450 CYP2D6 Substrates, Sensory Organs, Adrenergic Agents, Bradycardia-Causing Agents	experimental	2
DB09010	Carmofur	Drug	Fluoropyrimidines, Pyrimidines, Antineoplastic and Immunomodulating Agents, Pyrimidine Analogues, Pyrimidinones, Antineoplastic Agents, Antimetabolites	withdrawn	0
DB09011	Beclamide	Drug	Acids, Acyclic, Anticonvulsants, Fatty Acids, Nervous System, Central Nervous System Depressants, Fatty Acids, Volatile, Lipids	experimental	0
DB00682	Warfarin	Drug	Blood and Blood Forming Organs, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Cytochrome P-450 Enzyme Inducers, Agrochemicals, Vitamin K Inhibitors, Cytochrome P-450 CYP2C9 Inducers (weak), Cytochrome P-450 CYP2C8 Substrates, Compounds used in a research, industrial, or household setting, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Anticoagulants, Rodenticides, Cytochrome P-450 CYP2C18 Substrates, 4-Hydroxycoumarins, Cytochrome P-450 CYP2C18 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A4 Inducers, Pesticides, Coumarins, Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index, Hematologic Agents, Vitamin K Antagonists, Cytochrome P-450 CYP2C19 Substrates, Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A4 Inducers (weak), Heterocyclic Compounds, Fused-Ring, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Toxic Actions, Cytochrome P-450 CYP2C9 Inducers, Pyrans	approved	2
DB00683	Midazolam	Drug	Psycholeptics, Tranquilizing Agents, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, GABA Modulators, Benzodiazepines and benzodiazepine derivatives, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Triazolobenzodiazepines, Hypnotics and Sedatives, Benzodiazepine hypnotics and sedatives, Cytochrome P-450 CYP3A5 Substrates, GABA Agents, Anesthetics, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Cytochrome P-450 CYP3A4 Inhibitors, UGT1A4 substrates, Anti-Anxiety Agents, Adjuvants, Anesthesia, Central Nervous System Agents	approved, illicit	2
DB00680	Moricizine	Drug	QTc Prolonging Agents, Oxazines, Voltage-Gated Sodium Channel Blockers, Phenothiazines, Cardiovascular Agents, Morpholines, Membrane Transport Modulators, Heterocyclic Compounds, Fused-Ring, Antipsychotic Agents, Sulfur Compounds, Central Nervous System Depressants, Antiarrhythmics, Class I, Potential QTc-Prolonging Agents, Sodium Channel Blockers, Cardiac Therapy, Antiarrhythmic agents, Antiarrhythmics, Class Ic, Neurotoxic agents	approved, investigational, withdrawn	1
DB00681	Amphotericin B	Drug	Nephrotoxic agents, Cytochrome P-450 Enzyme Inhibitors, Investigative Techniques, Antimycotics for Systemic Use, Genito Urinary System and Sex Hormones, Polyene Antifungal, Biomimetic Materials, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Hypotensive Agents, Lipid-based Polyene Antifungal, Anti-Infective Agents, Drug Carriers, Drug Delivery Systems, Lactones, Anti-Bacterial Agents, Antiinfectives and Antiseptics for Local Oral Treatment, Intestinal Antiinfectives, Alimentary Tract and Metabolism, Polyenes, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Glycosides, Antifungal Agents, Compounds used in a research, industrial, or household setting, Agents that reduce seizure threshold, Amebicides, Carbohydrates, Antiprotozoals, Gynecological Antiinfectives and Antiseptics, Membranes, Artificial, Antiinfectives for Systemic Use, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Narrow Therapeutic Index Drugs, Agents Causing Muscle Toxicity, Cytochrome P-450 CYP3A4 Inhibitors, Pharmaceutical Preparations, Liposomes, Antiparasitic Agents, Stomatological Preparations	approved, investigational	1
DB00686	Pentosan polysulfate	Drug	Anticoagulants, Carbohydrates, Miscellaneous Therapeutic Agents, Glycosaminoglycans, Sulfur Acids, Genito Urinary System and Sex Hormones, Urologicals, Hematologic Agents, Sulfuric Acids, Vasoprotectives, Polysaccharides, Sulfur Compounds, Acids, Noncarboxylic, Acids, Photosensitizing Agents, Antivaricose Therapy, Drugs causing inadvertant photosensitivity	approved	3
DB00687	Fludrocortisone	Drug	Corticosteroids for Systemic Use, Corticosteroids, Cytochrome P-450 Substrates, Immunosuppressive Agents, Corticosteroids for Systemic Use, Plain, Hormones, Hormone Substitutes, and Hormone Antagonists, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Hydroxycorticosteroids, Cytochrome P-450 CYP3A Substrates, Adrenals, Mineralocorticoids, 11-Hydroxycorticosteroids, 17-Hydroxycorticosteroids, Hyperglycemia-Associated Agents, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Pregnenes, Steroids	approved, investigational	2
DB09018	Bromopride	Drug	Aminobenzoates, para-Aminobenzoates, Acids, Carbocyclic, Amides, Chlorobenzoates, Peripheral Nervous System Agents, Phenyl Ethers, Propulsives, Alimentary Tract and Metabolism, Drugs for Functional Gastrointestinal Disorders, Ethers, Dopamine Antagonists, Hydroxybenzoate Ethers, Benzene Derivatives, Dopamine Agents, Gastrointestinal Agents, Autonomic Agents, Benzoates, Hydroxy Acids, Benzamides and benzamide derivatives, Hydroxybenzoates, Neurotransmitter Agents, Antiemetics, Phenols, Central Nervous System Agents, Dopamine D2 Receptor Antagonists	investigational	1
DB00684	Tobramycin	Drug	Nephrotoxic agents, Carbohydrates, Agents that produce neuromuscular block (indirect), Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Ophthalmologicals, Anti-Bacterial Agents, Narrow Therapeutic Index Drugs, Aminoglycoside Antibacterials, Glycosides, Nebramycin, Sensory Organs, Antibacterials for Systemic Use	approved, investigational	2
DB09019	Bromhexine	Drug	Cycloparaffins, Amines, Cough and Cold Preparations, Expectorants, Aniline Compounds, Cyclohexylamines, Respiratory System Agents, Cyclohexanes	approved	0
DB00685	Trovafloxacin	Drug	Fluoroquinolones, Quinolines, Cytochrome P-450 CYP1A2 Inhibitors (weak), Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Enzyme Inhibitors, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Antiinfectives for Systemic Use, Anti-Infective Agents, Quinolones, Cytochrome P-450 CYP1A2 Inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Photosensitizing Agents, Topoisomerase II Inhibitors, Drugs causing inadvertant photosensitivity, Antibacterials for Systemic Use	approved, investigational, withdrawn	3
DB00688	Mycophenolate mofetil	Drug	Immunologic Factors, Cytochrome P-450 Substrates, Fatty Acids, Immunosuppressive Agents, Lipids, OATP1B3 substrates, Cytochrome P-450 CYP3A4 Substrates, Antimetabolite Immunosuppressant, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Anti-Bacterial Agents, UGT2B7 substrates, Antibiotics, Antitubercular, Mycophenolic Acid and Prodrugs, Cytochrome P-450 CYP2C8 Substrates, Antituberculosis Agents, Cytochrome P-450 CYP3A5 Substrates, P-glycoprotein substrates, IMP Dehydrogenase, antagonists & inhibitors, Antibiotics, Antineoplastic, UGT1A6 substrate, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, UGT1A1 Substrates, OATP1B1/SLCO1B1 Substrates, UGT1A9 Substrates	approved, investigational	3
DB00689	Cephaloglycin	Drug	Nephrotoxic agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Amides, Lactams, Thiazines, beta-Lactams, Anti-Infective Agents	approved	1
DB00608	Chloroquine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Quinolines, QTc Prolonging Agents, Cytochrome P-450 Substrates, Sensory System Agents, Cytochrome P-450 Enzyme Inhibitors, Anti-Inflammatory Agents, Antimalarials, Experimental Unapproved Treatments for COVID-19, Agents that produce neuromuscular block (indirect), Cytochrome P-450 CYP3A4 Substrates, Filaricides, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Analgesics, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Cytochrome P-450 CYP2C8 Substrates, Drugs causing inadvertant photosensitivity, Antinematodal Agents, Agents that reduce seizure threshold, Amebicides, Analgesics, Non-Narcotic, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Cytochrome P-450 CYP3A5 Substrates, P-glycoprotein substrates, Antirheumatic Agents, Moderate Risk QTc-Prolonging Agents, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Agents Causing Muscle Toxicity, alpha-Galactosidase, antagonists & inhibitors, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Methemoglobinemia Associated Agents, P-glycoprotein inhibitors, Antiparasitic Agents, Aminoquinolines	approved, investigational, vet_approved	7
DB01939	5-Amidino-Benzimidazole	Drug	0	experimental	1
DB00609	Ethionamide	Drug	Pyridines, Hypolipidemic Agents, Noxae, Antimycobacterials, Thiocarbamide Derivatives, Antiinfectives for Systemic Use, Anti-Infective Agents, Lipid Regulating Agents, Anti-Bacterial Agents, Fatty Acid Synthesis Inhibitors, Drugs for Treatment of Tuberculosis, Photosensitizing Agents, Toxic Actions, Drugs causing inadvertant photosensitivity, Isonicotinic Acids, Antituberculosis Agents	approved	2
DB13920	Valopicitabine	Drug	Carbohydrates, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides	experimental	0
DB13923	Emicizumab	Drug	Immunoglobulins, Blood and Blood Forming Organs, Blood Coagulation Factors, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins, Proteins, Serum Globulins, Globulins, Blood Proteins, Hemostatics, Antihemorrhagic Agents, Miscellaneous	approved, investigational	2
DB13924	Varicella Zoster Vaccine (Recombinant)	Drug	Vaccines	approved, investigational	0
DB13921	2'-C-methylcytidine	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Glycosides, Nucleosides, Deoxyribonucleosides	experimental	0
DB13927	anle138b	Drug	Heterocyclic Compounds, Fused-Ring, Dioxoles	experimental	0
DB13928	Semaglutide	Drug	Glucagon-like Peptide-1 (GLP-1) Agonists, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Gastrointestinal Hormones, Pancreatic Hormones, Glucagon-like peptide-1 (GLP-1) analogues, Amino Acids, Peptides, and Proteins, Blood Glucose Lowering Agents, GLP-1 Agonists, Hormones, Proteins, Peptide Hormones, Alimentary Tract and Metabolism, Incretin Mimetics, Drugs Used in Diabetes	approved, investigational	1
DB13925	Dotatate gallium Ga-68	Drug	Peptides, Cyclic, Peptides, Gallium Radioisotopes, Radioactive Diagnostic Agent, Amino Acids, Peptides, and Proteins, Positron Emitting Activity	approved, investigational	1
DB13926	Cenegermin	Drug	Ophthalmologicals, Sensory Organs	approved, investigational	1
DB13918	Diclofop-methyl	Drug	Phenols, Ethers, Benzene Derivatives, Phenyl Ethers	experimental	0
DB13919	Candesartan	Drug	OATP1B1/SLCO1B1 Inhibitors, Angiotensin II receptor blockers (ARBs) and diuretics, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Angiotensin Receptor Antagonists, Cytochrome P-450 CYP2C8 Inhibitors, Agents causing hyperkalemia, UGT1A3 substrates, Angiotensin II receptor blockers (ARBs) and calcium channel blockers, Cardiovascular Agents, Angiotensin II receptor blockers (ARBs), plain, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP2C8 Inhibitors (weak), Cytochrome P-450 CYP2C9 Inhibitors, Agents Acting on the Renin-Angiotensin System, Angiotensin II Type 2 Receptor Blockers, Angiotensin 2 Receptor Blocker, Antihypertensive Agents, P-glycoprotein inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (weak), Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)	experimental	1
DB01941	LG-100268	Drug	Pyridines, Ligands, Naphthalenes	experimental	1
DB01940	Balanol Analog 2	Drug	0	experimental	1
DB00610	Metaraminol	Drug	Autonomic Agents, Adrenergic alpha-Agonists, Amines, Propanols, Adrenergic alpha-1 Receptor Agonists, Agents producing tachycardia, Adrenergic and Dopaminergic Agents, Cardiovascular Agents, Amino Alcohols, Alcohols, Peripheral Nervous System Agents, Neurotransmitter Agents, Sympathomimetics, Vasoconstrictor Agents, Adrenergic Agonists, Cardiac Stimulants Excl. Cardiac Glycosides, Agents that produce hypertension, Cardiac Therapy, Adrenergic Agents, Propanolamines	approved, investigational	1
DB00613	Amodiaquine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Quinolines, QTc Prolonging Agents, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Antimalarials, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors, Potential QTc-Prolonging Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Substrates, P-glycoprotein inhibitors, Antiparasitic Agents, Aminoquinolines	approved, investigational	2
DB01945	4-Carbamoyl-1-Beta-D-Ribofuranosyl-Imidazolium-5-Olate-5'-Phosphate	Drug	0	experimental	0
DB00614	Furazolidone	Drug	Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, Enzyme Inhibitors, Renal Agents, Anti-Infective Agents, Urinary, Antiprotozoals, Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Nitrofurans, Monoamine Oxidase Inhibitors, Antitrichomonal Agents, Antidepressive Agents, Anti-Infective Agents, Anti-Infective Agents, Local, Oxazoles, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Oxazolidinones, Nitro Compounds, Agents that produce hypertension, Furans, Antiparasitic Agents, Agents that reduce seizure threshold	experimental, vet_approved	1
DB01944	(S)-blebbistatin	Drug	0	experimental	1
DB00611	Butorphanol	Drug	Antitussive Agents, Sensory System Agents, Narcotics, Nervous System, Respiratory System Agents, Opioid Agonist/Antagonist, Morphinans, Peripheral Nervous System Agents, Opioid Antagonists, Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Morphinan Derivatives, Opioids, Central Nervous System Agents, Opiate Partial Agonists, Mixed Agonist / Antagonist Opioids	approved, illicit, vet_approved	3
DB01942	Formic acid	Drug	Acids, Acyclic, Blood Coagulation Factors, Hemostatics	investigational, experimental	50
DB00612	Bisoprolol	Drug	Amines, Cytochrome P-450 Substrates, Sympatholytics, Agents causing hyperkalemia, Adrenergic beta-Antagonists, Cardiovascular Agents, Hypotensive Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Adrenergic beta-1 Receptor Antagonists, Alcohols, Peripheral Nervous System Agents, Adrenergic Antagonists, Antihypertensive Agents, Adrenergic Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Autonomic Agents, Beta Blocking Agents, Selective, and Thiazides, Antihypertensive Agents Indicated for Hypertension, Propanols, P-glycoprotein substrates, Phenoxypropanolamines, Amino Alcohols, Beta Blocking Agents and Thiazides, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Beta blocking agents and calcium channel blockers, Beta Blocking Agents, Selective, Beta-Blockers (Beta1 Selective), P-glycoprotein inhibitors, Propanolamines	approved	2
DB00617	Paramethadione	Drug	Cytochrome P-450 CYP2C9 Substrates, Anticonvulsants, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Nervous System, Central Nervous System Depressants, Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP3A4 Substrates, Oxazolidine Derivatives	approved	1
DB01949	2-Amino-N,3,3-Trimethylbutanamide	Drug	0	experimental	1
DB01948	1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One	Drug	0	experimental	1
DB00618	Demeclocycline	Drug	Anti-Bacterial Agents, Antibiotics for Topical Use, Photosensitizing Agents, Tetracyclines, Dermatologicals, Naphthacenes, Agents that produce neuromuscular block (indirect), Drugs causing inadvertant photosensitivity, Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use	approved	2
DB01947	RU78262	Drug	0	experimental	1
DB00615	Rifabutin	Drug	Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Inducers, Amides, Lactams, Antimycobacterials, Cytochrome P-450 CYP2C19 Inducers (moderate), Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Rifamycins, Anti-Infective Agents, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Lactams, Macrocyclic, Anti-Bacterial Agents, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C19 Inducers, Antibiotics, Antitubercular, Cytochrome P-450 CYP2B6 Inducers (weak), Cytochrome P-450 CYP2B6 Inducers, Rifamycin Antimycobacterial, Antituberculosis Agents, Cytochrome P-450 CYP3A4 Inducers, Antiinfectives for Systemic Use, Cytochrome P-450 CYP2C8 Inducers (weak), P-glycoprotein inducers, Cytochrome P-450 CYP3A4 Inducers (weak), Heterocyclic Compounds, Fused-Ring, Drugs for Treatment of Tuberculosis, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inducers	approved, investigational	5
DB01946	Bisindolylmaleimide VIII	Drug	Acids, Acyclic, Heterocyclic Compounds, Fused-Ring, Maleates, Enzyme Inhibitors, Dicarboxylic Acids, Hematologic Agents, Antiplatelet agents, Imides, Protein Kinase C, antagonists & inhibitors	experimental	2
DB00616	Candoxatril	Drug	Acids, Acyclic, Enzyme Inhibitors, Fatty Acids, Prodrugs, Fatty Acids, Volatile, Protease Inhibitors, Lipids, Cardiovascular Agents, Indenes, Antihypertensive Agents, Neprilysin, antagonists & inhibitors	experimental	2
DB00619	Imatinib	Drug	Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, Acids, Carbocyclic, BSEP/ABCB11 Substrates, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors (moderate), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A7 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Substrates, Benzene Derivatives, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Antineoplastic and Immunomodulating Agents, Benzamides and benzamide derivatives, Cytochrome P-450 CYP2C19 Substrates, Protein Kinase Inhibitors, Photosensitizing Agents, Cytochrome P-450 CYP3A7 Inhibitors, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2D6 Inhibitors (weak), Kinase Inhibitor, Cytochrome P-450 CYP2D6 Inhibitors, OCT1 substrates, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Enzyme Inhibitors, Amides, Cardiotoxic antineoplastic agents, Pyrimidines, Cytochrome P-450 CYP2C9 Inhibitors, Drugs causing inadvertant photosensitivity, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Benzoates, Piperazines, P-glycoprotein substrates, Cytochrome P-450 CYP3A5 Inhibitors, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, Myelosuppressive Agents, Cytochrome P-450 CYP2C9 Substrates, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), OCT2 Inhibitors, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors	approved	9
DB13930	Ulixertinib	Drug	Pyridines, Amines	investigational	2
DB13931	Netarsudil	Drug	Ophthalmologicals, Alanine, Antiglaucoma Preparations and Miotics, Acids, Carbocyclic, Amino Acids, Peptides, and Proteins, Rho Kinase Inhibitors, Rho Kinase Inhibitor, Sensory Organs, Amino Acids, Benzene Derivatives	approved	3
DB13934	Ligandrol	Drug	0	investigational	1
DB12602	Pentetreotide	Drug	Acids, Acyclic, Amines, Fatty Acids, Peptides, Amino Acids, Peptides, and Proteins, Lipids, Neuropeptides, Hormones, Polyamines, Acetates, Proteins, Peptide Hormones, Fatty Acids, Volatile, Pituitary Hormone Release Inhibiting Hormones, Radiopharmaceuticals, Compounds used in a research, industrial, or household setting, Hormones, Hormone Substitutes, and Hormone Antagonists, Pancreatic Hormones, Laboratory Chemicals, Nerve Tissue Proteins, Peptides, Cyclic, Diagnostic Uses of Chemicals, Hypothalamic Hormones, Indicators and Reagents, Terbium, Indium Radioisotopes	approved, investigational	0
DB13935	AC-262536	Drug	Aza Compounds	experimental	0
DB12601	Sonolisib	Drug	Fused-Ring Compounds, Steroids	investigational	0
DB12604	Sisomicin	Drug	Nephrotoxic agents, Carbohydrates, Enzyme Inhibitors, Agents that produce neuromuscular block (indirect), Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Gentamicins, Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Anti-Bacterial Agents, Narrow Therapeutic Index Drugs, Aminoglycoside Antibacterials, Glycosides, Antibacterials for Systemic Use, Protein Synthesis Inhibitors	investigational	0
DB13932	Voretigene neparvovec	Drug	0	approved	1
DB13933	Nonacog beta pegol	Drug	Biological Factors, Blood Coagulation Factors, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Alcohols, Macromolecular Substances, Proteins, Blood Proteins, Ethylene Glycols, Pegylated agents, Glycols, Enzyme Precursors, Hemostatics, Polymers, Compounds used in a research, industrial, or household setting	approved, investigational	3
DB13938	S-40503	Drug	Heterocyclic Compounds, Fused-Ring	experimental	0
DB12606	Netivudine	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Arabinonucleosides, Glycosides, Nucleosides	investigational	0
DB13939	RAD-140	Drug	Oxazoles	investigational, experimental	0
DB12605	Etripamil	Drug	0	investigational	0
DB12608	Emixustat	Drug	Amines, Propanols, Phenols, Amino Alcohols, Ethers, Benzene Derivatives, Alcohols	investigational	0
DB13936	JNJ-28330835	Drug	0	experimental	0
DB12607	Diridavumab	Drug	0	investigational	0
DB13937	LGD-3303	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring	experimental	0
DB13929	Relcovaptan	Drug	Heterocyclic Compounds, Fused-Ring, Hormones, Hormone Substitutes, and Hormone Antagonists, Hematologic Agents, Hormone Antagonists, Antiplatelet agents	investigational	2
DB01952	1,N6-Ethenoadenine	Drug	0	experimental	1
DB00620	Triamcinolone	Drug	Immunologic Factors, Corticosteroids, Dermatological Preparations, Enzyme Inhibitors, Cytochrome P-450 Substrates, Immunosuppressive Agents, Protein-Lysine 6-Oxidase, antagonists & inhibitors, Cytochrome P-450 CYP3A7 Substrates, Glucocorticoids, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Corticosteroids for Local Oral Treatment, Fused-Ring Compounds, Vasoprotectives, Corticosteroids, Moderately Potent (Group II), Cytochrome P-450 Enzyme Inducers, Nasal Preparations, Alimentary Tract and Metabolism, Adrenals, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Corticosteroid Hormone Receptor Agonists, Cytochrome P-450 CYP3A5 Inducers, Corticosteroids for Systemic Use, Corticosteroids, Cytochrome P-450 CYP3A5 Substrates, Corticosteroids for Systemic Use, Plain, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Cytochrome P-450 CYP3A4 Inducers, Dermatologicals, Cytochrome P-450 CYP3A7 Inducers, Ophthalmologicals, Agents to Treat Airway Disease, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Pregnanes, Drugs for Obstructive Airway Diseases, Thyroxine-binding globulin inhibitors, Sensory Organs, Steroids, Fluorinated, Hyperglycemia-Associated Agents, Cytochrome P-450 CYP3A7 Inducers (strength unknown), Steroids	approved, vet_approved	1
DB00621	Oxandrolone	Drug	Androstanols, Cytochrome P-450 Enzyme Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Anabolic Agents, Hormones, Fused-Ring Compounds, Androgens, Androstanes, Alimentary Tract and Metabolism, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors, Anabolic Steroids, Anabolic Agents for Systemic Use, Thyroxine-binding globulin inhibitors, Androstan Derivatives, Steroids	approved, investigational	1
DB01951	Gpi-1046	Drug	0	experimental	1
DB01950	AR-AO-14418	Drug	Glycogen Synthase Kinase 3, antagonists & inhibitors, Sulfur Compounds	experimental	1
DB00624	Testosterone	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 CYP3A Inducers, Genito Urinary System and Sex Hormones, OATP1B3 substrates, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Testosterone and derivatives, 3-Oxoandrosten (4) Derivatives, Androgens and Estrogens, Cytochrome P-450 CYP2C8 Substrates, Gonadal Hormones, Cytochrome P-450 CYP3A5 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP3A4 Inducers, Androstenes, Gonadal Steroid Hormones, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Androgens, Androstanes, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Substrates, Androstenols, OAT3/SLC22A8 Inducers, Testosterone Congeners, Thyroxine-binding globulin inhibitors, Cytochrome P-450 CYP2B6 Substrates, P-glycoprotein inhibitors, Steroids	approved, investigational	3
DB01956	Taurine	Drug	Alkanesulfonic Acids, Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfur Acids, Hydrocarbons, Acyclic, Sulfonic Acids, Alkanes	approved, nutraceutical	8
DB01955	1,4-Butanediol	Drug	Glycols, Alcohols	experimental	5
DB00625	Efavirenz	Drug	Cytochrome P-450 Substrates, Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor, Cytochrome P-450 Enzyme Inhibitors, Nonnucleoside Reverse Transcriptase Inhibitors, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP2C19 Inducers (strength unknown), OCT1 inhibitors, Cytochrome P-450 CYP2B6 Inducers (strength unknown), BSEP/ABCB11 Substrates, Cytochrome P-450 CYP2C9 Inhibitors (moderate), UGT1A1 Inducers, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inducers (moderate), Cytochrome P-450 CYP3A4 Inhibitors (strong), Direct Acting Antivirals, Nucleic Acid Synthesis Inhibitors, Cytochrome P-450 CYP2C19 Inducers, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Chemically-Induced Disorders, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Inducers, Inducers of Drug Clearance, Anti-Retroviral Agents, Cytochrome P-450 CYP2C19 Inhibitors (moderate), Cytochrome P-450 CYP3A7 Inducers (moderate), Central Nervous System Depressants, Reverse Transcriptase Inhibitors, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Enzyme Inhibitors, Oxazines, Cytochrome P-450 CYP2C19 Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors, Anti-Infective Agents, Cytochrome P-450 CYP1A2 Inhibitors, Antivirals for Systemic Use, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (moderate), Antiviral Agents, Antiinfectives for Systemic Use, Moderate Risk QTc-Prolonging Agents, Cytochrome P-450 CYP3A7 Inducers, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors	approved, investigational	1
DB00622	Nicardipine	Drug	Calcium Channel Blockers (Dihydropyridine), Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Agents causing hyperkalemia, Cytochrome P-450 CYP2B6 Inducers (strength unknown), BSEP/ABCB11 Substrates, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Anticholinergic Agents, Calcium-Regulating Hormones and Agents, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Cytochrome P-450 CYP2C8 Substrates, Antiarrhythmic agents, Selective Calcium Channel Blockers With Mainly Vascular Effects, Antihypertensive Agents Indicated for Hypertension, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Agents producing tachycardia, Membrane Transport Modulators, Calcium Channel Blockers, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP2D6 Inhibitors, Dihydropyridine Derivatives, QTc Prolonging Agents, Cytochrome P-450 CYP2C9 Inhibitors (strong), Cytochrome P-450 CYP3A4 Inhibitors (moderate), Cytochrome P-450 CYP2C19 Inhibitors, Hypotensive Agents, Muscarinic Antagonists, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C9 Inhibitors, Adrenergic Antagonists, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Potential QTc-Prolonging Agents, Adrenergic alpha-1 Receptor Antagonists, Antihypertensive Agents, Bradycardia-Causing Agents, Pyridines, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Adrenergic alpha-Antagonists, P-glycoprotein substrates, Cytochrome P-450 CYP3A5 Inhibitors, Dihydropyridines, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors, Vasodilating Agents	approved, investigational	15
DB01954	Rolipram	Drug	Phosphodiesterase Inhibitors, Enzyme Inhibitors, Pyrrolidinones, Central Nervous System Depressants, Phosphodiesterase 4 Inhibitors, Pyrrolidines, Antidepressive Agents, Central Nervous System Agents, Psychotropic Drugs	investigational	2
DB01953	Inhibitor of P38 Kinase	Drug	0	experimental	1
DB00623	Fluphenazine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Psycholeptics, Tranquilizing Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Antipsychotic Agents (First Generation Typical), Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Antipsychotic Agents, Sulfur Compounds, Drugs causing inadvertant photosensitivity, Dopamine Antagonists, Phenothiazines With Piperazine Structure, Agents that reduce seizure threshold, Dopamine Agents, Neurotoxic agents, Prodrugs, Cytochrome P-450 CYP2E1 Inhibitors, Phenothiazines, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Photosensitizing Agents, Central Nervous System Depressants, Central Nervous System Agents, P-glycoprotein inhibitors, Delayed-Action Preparations, Dopamine D2 Receptor Antagonists, Cytochrome P-450 CYP2D6 Inhibitors (weak)	approved	6
DB00628	Clorazepic acid	Drug	Tranquilizing Agents, Cytochrome P-450 Substrates, GABA Agents, GABA Modulators, Benzodiazepines and benzodiazepine derivatives, Cytochrome P-450 CYP3A4 Substrates, Psychotropic Drugs, Drugs that are Mainly Renally Excreted, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Anticonvulsants, Benzazepines, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Anti-Anxiety Agents, Central Nervous System Agents	approved, illicit	2
DB01959	3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester	Drug	0	experimental	2
DB00629	Guanabenz	Drug	Adrenergic alpha-Agonists, Cytochrome P-450 Substrates, Agents producing tachycardia, Amidines, Cardiovascular Agents, Guanidines, Neurotransmitter Agents, Adrenergic alpha-2 Receptor Agonists, Adrenergic Agonists, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Central alpha-2 Adrenergic Agonist, Antihypertensive Agents, Adrenergic Agents	approved, investigational	2
DB01958	5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine	Drug	0	experimental	2
DB00626	Bacitracin	Drug	Nephrotoxic agents, Antibiotics for Topical Use, Benzoates, Hydroxy Acids, Peptides, Acids, Carbocyclic, Dermatologicals, Hydroxybenzoates, Amino Acids, Peptides, and Proteins, Antiinfectives for Systemic Use, Anti-Infective Agents, Anti-Infective Agents, Local, Peptides, Cyclic, Anti-Bacterial Agents, Throat Preparations, Bacitracins, Decreased Cell Wall Synthesis & Repair, Phenols, Antibacterials for Systemic Use, Benzene Derivatives	approved, vet_approved	3
DB01957	3-Chlorophenol	Drug	Hydrocarbons, Chlorinated, Phenols, Hydrocarbons, Halogenated, Chlorobenzenes, Benzene Derivatives	experimental	1
DB00627	Niacin	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Hypolipidemic Agents Indicated for Hyperlipidemia, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Nicotinic Acids, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Lipid Modifying Agents, Lipid Modifying Agents, Plain, Physiological Phenomena, Food and Beverages, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Growth Substances, Diet, Food, and Nutrition, Food, Pyridines, Hypolipidemic Agents, Cytochrome P-450 CYP2E1 Inhibitors, Noxae, Vitamins, Lipid Regulating Agents, Micronutrients, Cytochrome P-450 CYP3A Inhibitors, Agents Causing Muscle Toxicity, Nicotinic Acid and Derivatives, Cytochrome P-450 CYP3A4 Inhibitors, Peripheral Vasodilators, Miscellaneous Antilipemic Agents, Toxic Actions, Vitamin B Complex, Thyroxine-binding globulin inhibitors, Vasodilating Agents, Hyperglycemia-Associated Agents	approved, investigational, nutraceutical	4
DB13941	Piperaquine	Drug	Cytochrome P-450 CYP2B6 Inhibitors (weak), Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Cytochrome P-450 CYP2E1 Inducers, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Antimalarials, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Antiparasitic Agents, Cytochrome P-450 CYP2E1 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors (weak)	investigational, experimental	0
DB12611	PF-477736	Drug	Heterocyclic Compounds, Fused-Ring, Benzazepines	investigational	0
DB13940	2,5-Dimethoxy-4-ethylthioamphetamine	Drug	Amines, Serotonin Agents, Serotonin Receptor Agonists, Agents producing tachycardia, Antidepressive Agents, Phenethylamines, Ethylamines, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Sympathomimetics, Central Nervous System Depressants, Agents that produce hypertension, Amphetamines, Serotonin 5-HT2 Receptor Agonists	experimental	2
DB12610	Ebselen	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Neuroprotective Agents, Enzyme Inhibitors, Sensory System Agents, Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Protective Agents, Antirheumatic Agents, Anti-Ulcer Agents, Peripheral Nervous System Agents, Antioxidants, Analgesics, Agents that produce hypertension, Central Nervous System Agents, Compounds used in a research, industrial, or household setting, Gastrointestinal Agents, Selenium Compounds	investigational	1
DB12613	Davunetide	Drug	Peptides, Amino Acids, Peptides, and Proteins	investigational	0
DB13946	Testosterone undecanoate	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Testosterone and derivatives, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2C8 Substrates, Gonadal Hormones, Cytochrome P-450 CYP3A5 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP3A4 Inducers, Androstenes, Gonadal Steroid Hormones, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Androgens, Androstanes, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Androstenols, Cytochrome P-450 CYP3A4 Inhibitors, OAT3/SLC22A8 Inducers, Testosterone Congeners, Thyroxine-binding globulin inhibitors, Cytochrome P-450 CYP2B6 Substrates, P-glycoprotein inhibitors, Steroids	approved, investigational	3
DB12612	Ozanimod	Drug	BCRP/ABCG2 Substrates, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 CYP3A Substrates, Oxazoles, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Indenes, Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP3A4 Substrates, Selective Immunosuppressants	approved, investigational	2
DB13943	Testosterone cypionate	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Anabolic Agents, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Testosterone and derivatives, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2C8 Substrates, Gonadal Hormones, Cytochrome P-450 CYP3A5 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP3A4 Inducers, Androstenes, Gonadal Steroid Hormones, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Androgens, Androstanes, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Androstenols, Cytochrome P-450 CYP3A4 Inhibitors, OAT3/SLC22A8 Inducers, Testosterone Congeners, Thyroxine-binding globulin inhibitors, Cytochrome P-450 CYP2B6 Substrates, P-glycoprotein inhibitors, Delayed-Action Preparations, Steroids	approved	3
DB12615	Plazomicin	Drug	Nephrotoxic agents, Carbohydrates, MATE inhibitors, MATE 1 Inhibitors, Agents that produce neuromuscular block (indirect), Drugs that are Mainly Renally Excreted, Gentamicins, Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Anti-Bacterial Agents, Narrow Therapeutic Index Drugs, Aminoglycoside Antibacterials, Glycosides, MATE 2 Inhibitors	approved, investigational	2
DB12614	Reparixin	Drug	Sulfur Compounds, Amides, Sulfones	investigational	0
DB13944	Testosterone enanthate	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Testosterone and derivatives, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2C8 Substrates, Hormonal Contraceptives for Systemic Use, Gonadal Hormones, Contraceptive Agents, Male, Cytochrome P-450 CYP3A5 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP3A4 Inducers, Androstenes, Gonadal Steroid Hormones, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Androgens, Androstanes, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Androstenols, Cytochrome P-450 CYP3A4 Inhibitors, OAT3/SLC22A8 Inducers, Testosterone Congeners, Thyroxine-binding globulin inhibitors, Cytochrome P-450 CYP2B6 Substrates, P-glycoprotein inhibitors, Steroids	approved	3
DB13949	Ferric cation	Drug	Parenteral Iron Replacement, Phosphate Chelating Activity, Phosphate Binder, Iron Compounds, Polyvalent cation containing laxatives, antacids, oral supplements	approved	2
DB12617	Mizoribine	Drug	Analgesics, Non-Narcotic, Carbohydrates, Immunologic Factors, Enzyme Inhibitors, Antiprotozoals, Immunosuppressive Agents, Sensory System Agents, Anti-Inflammatory Agents, IMP Dehydrogenase, antagonists & inhibitors, Antimalarials, Antineoplastic Agents, Antirheumatic Agents, Antibiotics, Antineoplastic, Anti-Infective Agents, Peripheral Nervous System Agents, Nucleic Acids, Nucleotides, and Nucleosides, Analgesics, Glycosides, Nucleosides, Central Nervous System Agents, Antiparasitic Agents	investigational	0
DB12616	Sprifermin	Drug	Proteins, Biological Factors, Peptides, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins	investigational	0
DB12619	BMS-188797	Drug	Cycloparaffins, Cyclodecanes, Diterpenes, Terpenes	investigational	0
DB13947	Testosterone enantate benzilic acid hydrazone	Drug	Androstanes, Testosterone and derivatives, Hormones, Hormone Substitutes, and Hormone Antagonists, Androstenols, Androstenes, Testosterone Congeners, Hormones, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Steroids	approved, experimental	0
DB13948	N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine	Drug	Serotonin Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Serotonin Receptor Agonists, Antidepressive Agents, Serotonin 5-HT2 Receptor Agonists	experimental	1
DB12618	Apocynin	Drug	Analgesics, Non-Narcotic, Antioxidants, Enzyme Inhibitors, Sensory System Agents, Analgesics, Ketones, Anti-Inflammatory Agents, Protective Agents, Antirheumatic Agents, Central Nervous System Agents, Compounds used in a research, industrial, or household setting, Peripheral Nervous System Agents	investigational	0
DB12609	Tovetumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB00631	Clofarabine	Drug	Immunosuppressive Agents, Hypotensive Agents, Nucleotides, Drugs that are Mainly Renally Excreted, OAT3/SLC22A8 Substrates, Purine Nucleotides, Purines, Nucleic Acid Synthesis Inhibitors, Nucleic Acids, Nucleotides, and Nucleosides, Purine Analogues, Glycosides, OCT2 substrates with narrow therapeutic index, Carbohydrates, Arabinonucleosides, Noxae, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Antimetabolites, OAT3/SLC22A8 Substrates with Narrow Therapeutic Index, Myelosuppressive Agents, Heterocyclic Compounds, Fused-Ring, Ribonucleotides, BCRP/ABCG2 Substrates, Nucleoside Metabolic Inhibitor, Nucleosides, Toxic Actions, Adenine Nucleotides	approved, investigational	3
DB01963	Phenylethane Boronic Acid	Drug	Acids, Noncarboxylic, Acids, Boron Compounds	experimental	1
DB00632	Docosanol	Drug	Dermatologicals, Lipids, Antiviral Agents, Anti-Infective Agents, Alcohols	approved, investigational	2
DB01962	Phosphonotyrosine	Drug	0	experimental	3
DB01961	Cytidine 3'-monophosphate	Drug	0	experimental	1
DB00630	Alendronic acid	Drug	Organophosphonates, Agents Causing Muscle Toxicity, Musculo-Skeletal System, Drugs for Treatment of Bone Diseases, Bone Density Conservation Agents, Organophosphorus Compounds, Drugs Affecting Bone Structure and Mineralization, Bisphosphonates	approved	6
DB01960	7-methyl-7,8-dihydroguanosine-5'-diphosphate	Drug	0	experimental	3
DB01967	N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide	Drug	0	experimental	2
DB00635	Prednisone	Drug	Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 Substrates, Immunosuppressive Agents, Glucocorticoids, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP2C19 Inducers (strength unknown), Cytochrome P-450 CYP2B6 Inducers (strength unknown), Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Intestinal Antiinflammatory Agents, Cytochrome P-450 Enzyme Inducers, Alimentary Tract and Metabolism, Cytochrome P-450 CYP2C19 Inducers, Adrenals, Corticosteroids Acting Locally, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Corticosteroid Hormone Receptor Agonists, Cytochrome P-450 CYP3A5 Inducers, Pregnadienediols, Corticosteroids for Systemic Use, Antineoplastic Agents, Hormonal, Corticosteroids, Corticosteroids for Systemic Use, Plain, Cytochrome P-450 CYP2A6 Inducers, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inducers, Antineoplastic Agents, P-glycoprotein inducers, Cytochrome P-450 CYP3A Substrates, Pregnanes, Thyroxine-binding globulin inhibitors, Cytochrome P-450 CYP2C9 Inducers, Prednisolone and Prodrugs, P-glycoprotein inhibitors, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Hyperglycemia-Associated Agents, Steroids	approved, vet_approved	1
DB00636	Clofibrate	Drug	Acids, Acyclic, Cytochrome P-450 Substrates, Fatty Acids, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Lipids, Cytochrome P-450 CYP2A6 Inhibitors, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2A6 Inhibitors (strength unknown), Phenyl Ethers, Lipid Modifying Agents, Lipid Modifying Agents, Plain, Cytochrome P-450 Enzyme Inducers, Butyrates, Fatty Acids, Volatile, Fibric Acids, Ethers, Benzene Derivatives, Cytochrome P-450 CYP2E1 Inducers (strength unknown), Anticholesteremic Agents, Hypolipidemic Agents, Cytochrome P-450 CYP2E1 Inducers, Noxae, Cytochrome P-450 CYP3A4 Inducers, Isobutyrates, Lipid Regulating Agents, Cytochrome P-450 CYP3A Substrates, Thyroxine-binding globulin inducers, Agents Causing Muscle Toxicity, Phenols, Toxic Actions, Clofibric Acid	approved, investigational	1
DB01966	Di-Stearoyl-3-Sn-Phosphatidylethanolamine	Drug	0	experimental	1
DB00633	Dexmedetomidine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Psycholeptics, Cytochrome P-450 Substrates, Sensory System Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Hypotensive Agents, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Cytochrome P-450 CYP1A2 Inhibitors, Adrenergic alpha-2 Receptor Agonists, Anesthetics, General, Analgesics, Hypnotics and Sedatives, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Adrenergic Agents, Bradycardia-Causing Agents, Analgesics, Non-Narcotic, Adrenergic alpha-Agonists, Cytochrome P-450 CYP2E1 Substrates, Agents producing tachycardia, Anesthetics, Miscellaneous Anxiolytics Sedatives and Hypnotics, Neurotransmitter Agents, Imidazoles, Central Nervous System Depressants, Adrenergic Agonists, Agents that produce hypertension, Central alpha-2 Adrenergic Agonist, Central Nervous System Agents	approved, vet_approved	1
DB01965	2'-Deoxyuridine 5'-alpha,beta-imido-triphosphate	Drug	0	experimental	2
DB01964	AL5424	Drug	0	experimental	1
DB00634	Sulfacetamide	Drug	Renal Agents, Amines, Anti-Infective Agents, Urinary, Gynecological Antiinfectives and Antiseptics, Aniline Compounds, Dermatologicals, Genito Urinary System and Sex Hormones, Amides, Sulfanilamides, Anti-Acne Preparations, Anti-Infective Agents, Anti-Infective Agents, Local, Ophthalmologicals, Anti-Bacterial Agents, Sulfur Compounds, Sulfonamide Antibacterial, Sulfonamides, Antiinfectives for Treatment of Acne, Sensory Organs, Anti-Acne Preparations for Topical Use, Sulfones	approved	3
DB00639	Butoconazole	Drug	Azole Antifungals, Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Antifungal Agents, Antifungal Agents (Vaginal), Imidazole Derivatives, Anti-Infective Agents	approved	1
DB00637	Astemizole	Drug	Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Benzimidazoles, Anti-Allergic Agents, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, BSEP/ABCB11 Substrates, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Histamine H1 Antagonists, Histamine H1 Antagonists, Non-Sedating, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2D6 Substrates, Histamine Agents, P-glycoprotein inhibitors, Antihistamines for Systemic Use	approved, withdrawn	4
DB01969	Trifluoroacetonyl coenzyme A	Drug	0	experimental	1
DB01968	2-Thioethenamine	Drug	0	experimental	1
DB00638	Inulin	Drug	Carbohydrates, Dietary Carbohydrates, Fructans, Starch, Tests for Renal Function and Ureteral Injuries, Biopolymers, Macromolecular Substances, Polysaccharides, Physiological Phenomena, Food and Beverages, Glucans, Diagnostic Agents, Polymers, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food	approved, investigational, nutraceutical	1
DB12620	Nerve Growth Factor	Drug	Proteins, Biological Factors, Peptides, Nerve Growth Factors, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Nerve Tissue Proteins	investigational	0
DB13952	Estradiol acetate	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Estrogens, OCT1 inhibitors, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C8 Substrates, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Substrates, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inducers, BCRP/ABCG2 Inhibitors, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, Thyroxine-binding globulin inducers, OCT2 Inhibitors, UGT1A1 Substrates, Cytochrome P-450 CYP1A2 Substrates	approved, investigational, vet_approved	10
DB13953	Estradiol benzoate	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Estrogens, OCT1 inhibitors, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Fused-Ring Compounds, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 Enzyme Inducers, Estradiol Congeners, Cytochrome P-450 CYP2C8 Substrates, Hormonal Contraceptives for Systemic Use, Gonadal Hormones, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inducers, Estrenes, Reproductive Control Agents, BCRP/ABCG2 Inhibitors, Gonadal Steroid Hormones, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, OCT2 Inhibitors, UGT1A1 Substrates, Cytochrome P-450 CYP1A2 Substrates, Steroids	approved, investigational, vet_approved	10
DB13950	WIN 55212-2	Drug	Oxazines, Cytochrome P-450 Substrates, Sensory System Agents, Cytochrome P-450 Enzyme Inhibitors, Cannabinoid Receptor Antagonists, Agents causing hyperkalemia, Agents producing tachycardia, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Membrane Transport Modulators, Peripheral Nervous System Agents, Calcium Channel Blockers, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Analgesics, Cytochrome P-450 CYP3A Substrates, Cannabinoids and similars, Receptor, Cannabinoid, CB1, antagonists & inhibitors, Calcium-Regulating Hormones and Agents, Cytochrome P-450 CYP3A4 Inhibitors, Central Nervous System Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	experimental	0
DB12622	Lupeol	Drug	Triterpenes, Anti-Inflammatory Agents, Terpenes	investigational	0
DB13951	Stanolone acetate	Drug	Testosterone and derivatives, P-glycoprotein substrates	experimental	4
DB12621	ST-101	Drug	Indenes	investigational	0
DB12624	Octenidine	Drug	Throat Preparations, Gynecological Antiinfectives and Antiseptics, Quaternary Ammonium Compounds, Antiseptics and Disinfectants, Dermatologicals, Genito Urinary System and Sex Hormones, Anti-Infective Agents, Anti-Infective Agents, Local	investigational	0
DB13956	Estradiol valerate	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Estrogens, OCT1 inhibitors, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 Enzyme Inducers, Estradiol Congeners, Cytochrome P-450 CYP2C8 Substrates, Hormonal Contraceptives for Systemic Use, Contraceptive Agents, Female, Gonadal Hormones, Estrogen Contraceptives, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inducers, Estrenes, BCRP/ABCG2 Inhibitors, Estradiol, agonists, Gonadal Steroid Hormones, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, Thyroxine-binding globulin inducers, OCT2 Inhibitors, UGT1A1 Substrates, Cytochrome P-450 CYP1A2 Substrates, Steroids	approved, investigational, vet_approved	10
DB12623	Taprenepag	Drug	Acids, Acyclic, Sulfur Compounds, Fatty Acids, Fatty Acids, Volatile, Receptors, Prostaglandin E, EP2 Subtype, agonists, Amides, Lipids, Sulfones	investigational	0
DB13957	J147	Drug	Heptanes, Diarylheptanoids, Hydrocarbons, Acyclic, Phenols, Alkanes, Catechols, Benzene Derivatives	experimental	0
DB12626	Senrebotase	Drug	0	investigational	0
DB13954	Estradiol cypionate	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Estrogens, OCT1 inhibitors, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 Enzyme Inducers, Estradiol Congeners, Cytochrome P-450 CYP2C8 Substrates, Hormonal Contraceptives for Systemic Use, Contraceptive Agents, Female, Gonadal Hormones, Estrogen Contraceptives, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inducers, Estrenes, Reproductive Control Agents, BCRP/ABCG2 Inhibitors, Gonadal Steroid Hormones, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, Thyroxine-binding globulin inducers, OCT2 Inhibitors, UGT1A1 Substrates, Cytochrome P-450 CYP1A2 Substrates, Steroids	approved, investigational, vet_approved	10
DB13955	Estradiol dienanthate	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, OCT1 inhibitors, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 Enzyme Inducers, Estradiol Congeners, Cytochrome P-450 CYP2C8 Substrates, Gonadal Hormones, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inducers, Estrenes, BCRP/ABCG2 Inhibitors, Gonadal Steroid Hormones, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, OCT2 Inhibitors, UGT1A1 Substrates, Cytochrome P-450 CYP1A2 Substrates, Steroids	approved, investigational, vet_approved	10
DB12625	Evogliptin	Drug	Alimentary Tract and Metabolism, Dipeptidyl Peptidase 4, Drugs Used in Diabetes, Agents causing angioedema, Blood Glucose Lowering Agents, DPP-IV Inhibitors	investigational	0
DB12628	Methyl-D9-choline	Drug	0	investigational	0
DB12627	GSK-1292263	Drug	0	investigational	0
DB13958	Trestolone acetate	Drug	Estranes, Testosterone and derivatives, Hormones, Hormone Substitutes, and Hormone Antagonists, Estrenes, Testosterone Congeners, Hormones, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Steroids	experimental	0
DB13959	Medium-chain triglycerides	Drug	0	approved	0
DB12629	3,5-diiodothyropropionic acid	Drug	Amino Acids, Aromatic, Acids, Acyclic, Thyroid Products, Cytochrome P-450 Substrates, Fatty Acids, Hormones, Hormone Substitutes, and Hormone Antagonists, Amino Acids, Peptides, and Proteins, Lipids, Hormones, Cytochrome P-450 CYP3A4 Substrates, Amino Acids, Amino Acids, Cyclic, Cytochrome P-450 CYP3A Substrates, Fatty Acids, Volatile, Thyronines	investigational	0
DB01970	Hg9a-9, Nonanoyl-N-Hydroxyethylglucamide	Drug	0	experimental	1
DB01974	2-Amino-3-[5-(Amino-Carboxy-Methyl)-2,3-Dihydro-Isoxazol-3-Ylsulfanyl]-Propionic Acid	Drug	0	experimental	0
DB00642	Pemetrexed	Drug	Enzyme Inhibitors, Cytochrome P-450 Substrates, Immunosuppressive Agents, Folic Acid Antagonists, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Amino Acids, Acidic, Antimetabolites, Amino Acids, Drugs that are Mainly Renally Excreted, Myelosuppressive Agents, OAT3/SLC22A8 Substrates, Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Heterocyclic Compounds, Fused-Ring, Purines, Folic Acid Analogues, Nucleic Acid Synthesis Inhibitors, Narrow Therapeutic Index Drugs, Amino Acids, Dicarboxylic, Cytochrome P-450 CYP1A2 Substrates, Glutamates, Purinones	approved, investigational	4
DB01973	O-Benzylsulfonyl-Serine	Drug	0	experimental	5
DB00643	Mebendazole	Drug	Acids, Acyclic, Benzimidazoles, Antiparasitic Products, Insecticides and Repellents, Cytochrome P-450 Substrates, Tubulin Modulators, Antihelminthic, Anthelmintics, Mitosis Modulators, Anti-Infective Agents, Benzimidazole Derivatives, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Substrates, Antimitotic Agents, Carbamates, Antinematodal Agents, Antiparasitic Agents	approved, vet_approved	2
DB00640	Adenosine	Drug	QTc Prolonging Agents, Ribonucleosides, Sensory System Agents, Alkenes, Cyclohexenes, Enzymes and Coenzymes, Cardiovascular Agents, Purinergic Agents, Adenosine, antagonists & inhibitors, Cyclohexanes, Peripheral Nervous System Agents, Purines, Nucleic Acids, Nucleotides, and Nucleosides, Analgesics, Polyenes, Glycosides, Class IV Antiarrythmics, Purinergic P1 Receptor Agonists, Antiarrhythmic agents, Biological Factors, Carbohydrates, Enzymes, Cycloparaffins, Miscellaneous Therapeutic Agents, Hydrocarbons, Acyclic, Agents producing tachycardia, Purine Nucleosides, Moderate Risk QTc-Prolonging Agents, Antiarrhythmics, Class V, Pigments, Biological, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Purinergic Agonists, Nucleosides, Miscellaneous Cardiac Drugs, Central Nervous System Agents, Oxidoreductases, Terpenes, Vasodilating Agents, Cardiac Therapy	approved, investigational	4
DB01972	Guanosine-5'-Monophosphate	Drug	0	experimental	14
DB01971	trans-urocanic acid	Drug	Acids, Acyclic, Acrylates, Imidazoles	experimental	1
DB00641	Simvastatin	Drug	Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, UGT1A3 substrates, Cytochrome P-450 CYP2B6 Inducers (strength unknown), BSEP/ABCB11 Substrates, Hypolipidemic Agents Indicated for Hyperlipidemia, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Lipid Modifying Agents, Lipid Modifying Agents, Plain, Cytochrome P-450 Enzyme Inducers, UGT2B7 substrates, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2C8 Substrates, Drugs causing inadvertant photosensitivity, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Cytochrome P-450 CYP2B6 Inhibitors (weak), OATP1B1/SLCO1B1 Inhibitors, Anticholesteremic Agents, Hypolipidemic Agents, Cytochrome P-450 CYP3A5 Substrates, Noxae, Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, Naphthalenes, Cytochrome P-450 CYP2C19 Substrates, Lipid Regulating Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Agents Causing Muscle Toxicity, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), UGT1A1 Substrates, OATP1B1/SLCO1B1 Substrates, Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors	approved	3
DB00646	Nystatin	Drug	OATP1B1/SLCO1B1 Inhibitors, Gynecological Antiinfectives and Antiseptics, Dermatologicals, Genito Urinary System and Sex Hormones, Antifungals for Dermatological Use, OATP1B3 inhibitors, Polyene Antifungal, Anti-Infective Agents, Ionophores, Membrane Transport Modulators, Lactones, Polyketides, Intestinal Antiinfectives, Alimentary Tract and Metabolism, Antifungals for Topical Use, Polyenes, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Antifungal Agents, Antifungal Agents (Vaginal), Compounds used in a research, industrial, or household setting	approved, vet_approved	1
DB01978	7,9-Dimethylguanine	Drug	Heterocyclic Compounds, Fused-Ring, Purines, Xanthine derivatives, Purinones	experimental	1
DB00647	Dextropropoxyphene	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Acids, Acyclic, Cytochrome P-450 Substrates, Fatty Acids, Sensory System Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Lipids, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Peripheral Nervous System Agents, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Fatty Acids, Volatile, Diphenylpropylamine Derivatives, Opioids, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Agents that reduce seizure threshold, Narcotics, High-risk opioids, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Opioid Agonist, Propionates, Cytochrome P-450 CYP3A4 Inhibitors, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates	approved, illicit, investigational, withdrawn	4
DB01977	6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine	Drug	0	experimental	1
DB01976	Aminoanthracene	Drug	0	experimental	0
DB00644	Gonadorelin	Drug	Gonadotropins and Antigonadotropins, Gonadotropin-Releasing Hormone, antagonists & inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Oligopeptides, Peptides, Adrenal Cortex Hormones, Pituitary and Hypothalamic Hormones and Analogues, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Hormones, Tests for Fertility Disturbances, Pituitary Hormone-Releasing Hormones, Proteins, Peptide Hormones, Gonadotropin-releasing hormone agonist, Gonadotropin-Releasing Hormone, agonists, Hypothalamic Hormones, Diagnostic Agents, Pituitary Function, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins	approved, investigational, vet_approved	2
DB00645	Dyclonine	Drug	Sensory System Agents, Throat Preparations, Ketones, Nervous System, Central Nervous System Depressants, Central Nervous System Agents, Anesthetics, Anesthetics, Local, Peripheral Nervous System Agents	approved	1
DB01975	AMPCPR	Drug	0	experimental	2
DB00648	Mitotane	Drug	Hydrocarbons, Chlorinated, Antineoplastic Agents, Hormonal, Cytochrome P-450 CYP3A Inducers (strong), Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Antineoplastic Agents, Hydrocarbons, Halogenated, Cytochrome P-450 CYP3A4 Inducers (strong), Cytochrome P-450 Enzyme Inducers, Narrow Therapeutic Index Drugs, Thyroxine-binding globulin inducers, P-glycoprotein inhibitors	approved	5
DB00649	Stavudine	Drug	Enzyme Inhibitors, OAT1/SLC22A6 Substrates, Dideoxynucleosides, Anti-Infective Agents, Antivirals for Systemic Use, Direct Acting Antivirals, Nucleic Acid Synthesis Inhibitors, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleoside Reverse Transcriptase Inhibitors, Neurotoxic agents, Carbohydrates, Pyrimidine Nucleosides, Noxae, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Antiinfectives for Systemic Use, Antimetabolites, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors, Agents Causing Muscle Toxicity, Nucleosides, Toxic Actions, Deoxyribonucleosides, Reverse Transcriptase Inhibitors	approved, investigational	1
DB01979	Methyl alpha-D-mannoside	Drug	0	experimental	1
DB09063	Ceritinib	Drug	QTc Prolonging Agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, Receptor Protein-Tyrosine Kinases, antagonists & inhibitors, Cytochrome P-450 CYP3A4 Substrates, Sulfur Compounds, Cytochrome P-450 CYP2C9 Inhibitors, P-glycoprotein substrates with narrow therapeutic index, Bradycardia-Causing Agents, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Moderate Risk QTc-Prolonging Agents, Protein Kinase Inhibitors, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Hyperglycemia-Associated Agents, Cytochrome P-450 CYP3A4 Inhibitors (weak), Kinase Inhibitor	approved	1
DB09064	Ciprofibrate	Drug	Acids, Acyclic, Hypolipidemic Agents, Peroxisome Proliferators, Fatty Acids, Noxae, Lipids, Isobutyrates, Phenyl Ethers, Lipid Modifying Agents, Lipid Modifying Agents, Plain, Lipid Regulating Agents, Carcinogens, Butyrates, Agents Causing Muscle Toxicity, Fatty Acids, Volatile, Phenols, Toxic Actions, Fibric Acids, Ethers, Benzene Derivatives	approved, investigational	1
DB11383	Carbomycin	Drug	Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Lactones	vet_approved	0
DB11386	Chlorobutanol	Drug	Antiemetics and Antinauseants, Preservatives, Pharmaceutical, Chlorohydrins, Alimentary Tract and Metabolism, Lipids, Pharmaceutical Preparations, Butanols, Compounds used in a research, industrial, or household setting, Fatty Alcohols, Pharmaceutic Aids, Alcohols	approved, investigational, vet_approved	1
DB09061	Cannabidiol	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Serotonin 5-HT1 Receptor Agonists, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP3A7 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inhibitors, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A5 Inhibitors, Serotonin Receptor Agonists, BCRP/ABCG2 Inhibitors, Agents producing tachycardia, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Anticonvulsants, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cannabinoids and similars, Central Nervous System Depressants, Cytochrome P-450 CYP3A7 Inhibitors, Agents that produce hypertension, Cytochrome P-450 CYP2D6 Substrates, Serotonin 5-HT2 Receptor Agonists, Terpenes	approved, investigational	44
DB09062	Cefminox	Drug	Nephrotoxic agents, Second-Generation Cephalosporins, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Antibacterials for Systemic Use	experimental	0
DB11385	Cefalonium	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amides, Lactams, Thiazines, beta-Lactams	experimental, vet_approved	0
DB11387	Chloroform	Drug	Hydrocarbons, Chlorinated, Solvents, Anesthetics, General, Nervous System, Trihalomethanes, Hydrocarbons, Halogenated, Anesthetics, Compounds used in a research, industrial, or household setting	approved, vet_approved	0
DB09060	Avibactam	Drug	Enzyme Inhibitors, Aza Compounds, beta-Lactamase Inhibitors, Anti-Infective Agents, OAT3/SLC22A8 Substrates	approved	10
DB11389	Clorsulon	Drug	Sulfur Compounds, Amines, Sulfonamides, Aniline Compounds, Anthelmintics, Amides, Antiplatyhelmintic Agents, Anti-Infective Agents, Antiparasitic Agents, Sulfones	vet_approved	0
DB09069	Trimetazidine	Drug	Piperazines, Cardiovascular Agents, Vasodilating Agents, Cardiac Therapy	approved, investigational	1
DB09067	Corticorelin ovine triflutate	Drug	Proteins, Peptide Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Hypothalamic Hormones, Amino Acids, Peptides, and Proteins, Neuropeptides, Tests for Pituitary Function, Nerve Tissue Proteins, Diagnostic Agents, Hormones, Pituitary Hormone-Releasing Hormones	approved	1
DB09068	Vortioxetine	Drug	Serotonin 5-HT1 Receptor Agonists, Tranquilizing Agents, Cytochrome P-450 Substrates, Serotonin Agents, Nervous System, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Serotonin Modulators, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP3A5 Substrates, Piperazines, Serotonin Receptor Agonists, Serotonin 5-HT3 Receptor Antagonists, Psychotropic Drugs, Membrane Transport Modulators, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Neurotransmitter Uptake Inhibitors, Agents that produce hypertension, Cytochrome P-450 CYP2A6 Substrates, Anti-Anxiety Agents, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Serotonin 5-HT1 Receptor Antagonists, Psychoanaleptics	approved, investigational	7
DB09065	Cobicistat	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Acids, Acyclic, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, OATP1B3 inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (strong), Other Miscellaneous Therapeutic Agents, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Cytochrome P-450 CYP3A4 Inhibitors (strong), Organic Anion Transporting Polypeptide 1B3 Inhibitors, Sulfur Compounds, Breast Cancer Resistance Protein Inhibitors, Thiazoles, Cytochrome P-450 CYP3A7 Inhibitors (strong), OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Chemically-Induced Disorders, Cytochrome P-450 CYP3A5 Inhibitors, BCRP/ABCG2 Inhibitors, Anti-HIV Agents, Organic Anion Transporting Polypeptide 1B1 Inhibitors, Antiinfectives for Systemic Use, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A7 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Carbamates, P-glycoprotein inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (weak)	approved	0
DB09066	Corifollitropin alfa	Drug	Sex Hormones and Modulators of the Genital System, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pituitary Hormones, Genito Urinary System and Sex Hormones, Amino Acids, Peptides, and Proteins, Gonadotropins, Follicle Stimulating Hormone, Hormones, Recombinant Proteins, Drugs that are Mainly Renally Excreted, Gonadotropins, Pituitary, Peptide Hormones, Pituitary Hormones, Anterior	approved, investigational	1
DB11380	Cambendazole	Drug	Heterocyclic Compounds, Fused-Ring, Benzimidazoles, Anthelmintics, Anti-Infective Agents, Antinematodal Agents, Antiparasitic Agents	experimental, vet_approved	0
DB11382	Carbarsone	Drug	Organometallic Compounds, Arsenicals	vet_approved	0
DB11395	Deracoxib	Drug	Sulfur Compounds, Amides, Sulfones	vet_approved	0
DB09074	Olaparib	Drug	Enzyme Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Poly(ADP-ribose) Polymerase Inhibitors, Myelosuppressive Agents, Pyridazines, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2B6 Inducers, P-glycoprotein inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved	3
DB11394	Decoquinate	Drug	Quinolines, Coccidiostats, Heterocyclic Compounds, Fused-Ring, Antiprotozoals, Hydroxyquinolines, Anti-Infective Agents, Antiparasitic Agents	experimental, vet_approved	0
DB09075	Edoxaban	Drug	Anticoagulants, Enzyme Inhibitors, Sulfur Compounds, Antithrombins, Blood and Blood Forming Organs, Factor Xa Inhibitors, P-glycoprotein substrates, Protease Inhibitors, Hematologic Agents, Fibrinolytic Agents, Serine Protease Inhibitors, Drugs that are Mainly Renally Excreted	approved	1
DB09072	Sodium oxybate	Drug	Acids, Acyclic, Fatty Acids, Hydroxy Acids, Nervous System, Anesthetics, Intravenous, Lipids, Miscellaneous Central Nervous System Agents, Anesthetics, Hydroxybutyrates, Anesthetics, General, Butyrates, Central Nervous System Depressants, Fatty Acids, Volatile, Adjuvants, Anesthesia, Central Nervous System Agents	approved	0
DB11397	Dichlorvos	Drug	QTc Prolonging Agents, Enzyme Inhibitors, Cholinesterase Inhibitors, Pesticides, Anthelmintics, Organophosphorus Compounds, Insecticides, Anti-Infective Agents, Organophosphates, Neurotransmitter Agents, Cholinergic Agents, Agrochemicals, Potential QTc-Prolonging Agents, Toxic Actions, Compounds used in a research, industrial, or household setting, Antiparasitic Agents	vet_approved	2
DB09073	Palbociclib	Drug	Enzyme Inhibitors, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Cyclin-Dependent Kinases, antagonists & inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, OCT1 inhibitors, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Myelosuppressive Agents, Protein Kinase Inhibitors, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (weak), Kinase Inhibitor	approved, investigational	2
DB11396	Dichlorophen	Drug	Hydrocarbons, Chlorinated, Anticestodal Agents, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Anthelmintics, Hydrocarbons, Halogenated, Chlorophenols, Chlorobenzenes, Anti-Infective Agents, Phenols, Antiplatyhelmintic Agents, Antiparasitic Agents, Benzene Derivatives, Anticestodals	experimental, vet_approved	0
DB09070	Tibolone	Drug	Sex Hormones and Modulators of the Genital System, Antineoplastic Agents, Hormonal, Hormones, Hormone Substitutes, and Hormone Antagonists, Norsteroids, Estrogens, Genito Urinary System and Sex Hormones, Anabolic Agents, Cardiovascular Agents, Estrogen Receptor Modulators, Hormones, Fused-Ring Compounds, Hormone Antagonists, Norpregnanes, Steroids	approved, investigational	1
DB11399	Dirlotapide	Drug	Acids, Acyclic, Heterocyclic Compounds, Fused-Ring	investigational, vet_approved	0
DB09071	Tasimelteon	Drug	Psycholeptics, Receptors, Melatonin, agonists, Cycloparaffins, Melatonin Receptor Agonists, Cytochrome P-450 Substrates, Nervous System, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Cytochrome P-450 CYP1A2 Substrates, Hypnotics and Sedatives	approved, investigational	2
DB11398	Diclazuril	Drug	Coccidiostats, Antiprotozoals, Anti-Infective Agents, Antiparasitic Agents	investigational, vet_approved	0
DB09078	Lenvatinib	Drug	Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, BSEP/ABCB11 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Benzene Derivatives, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A4 Inducers, Antineoplastic Agents, Moderate Risk QTc-Prolonging Agents, OAT1/SLC22A6 inhibitors, Cytochrome P-450 CYP3A4 Inducers (weak), Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), OCT2 Inhibitors, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Receptor Tyrosine Kinase Inhibitors, OAT3/SLC22A8 Inhibitors, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors (weak), Kinase Inhibitor	approved, investigational	10
DB09079	Nintedanib	Drug	OCT1 substrates, Enzyme Inhibitors, Cytochrome P-450 Substrates, Tyrosine Kinase Inhibitors, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, OCT1 inhibitors, Antineoplastic Agents, Cytochrome P-450 CYP3A4 Substrates, Antifibrotic Agents, Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, UGT1A1 Substrates, P-glycoprotein inhibitors, Kinase Inhibitor	approved	12
DB09076	Umeclidinium	Drug	Anticholinergic Agents, Adrenergics, Inhalants, Agents to Treat Airway Disease, Antimuscarinics Antispasmodics, Cytochrome P-450 Substrates, P-glycoprotein substrates, Agents producing tachycardia, Drugs for Obstructive Airway Diseases, Muscarinic Antagonists, Cytochrome P-450 CYP2D6 Substrates, Pulmonary Disease, Chronic Obstructive, drug therapy	approved	5
DB09077	Dinutuximab	Drug	Immunoglobulins, Immunosuppressive Agents, Antineoplastic and Immunomodulating Agents, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Hypotensive Agents, Antibodies, Monoclonal, Immunoproteins, Myelosuppressive Agents, Glycolipid Disialoganglioside-directed Antibody Interactions, Proteins, Serum Globulins, Narrow Therapeutic Index Drugs, Globulins, Glycolipid Disialoganglioside-directed Antibody, Blood Proteins	approved, investigational	1
DB11390	Coumaphos	Drug	Organothiophosphorus Compounds, QTc Prolonging Agents, Enzyme Inhibitors, Anthelmintics, Insecticides, Anti-Infective Agents, Organophosphates, Sulfur Compounds, Cholinergic Agents, Agrochemicals, Organothiophosphates, Potential QTc-Prolonging Agents, Compounds used in a research, industrial, or household setting, Antinematodal Agents, Cholinesterase Inhibitors, Pesticides, Coumarins, Organophosphorus Compounds, Benzopyrans, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Narrow Therapeutic Index Drugs, Toxic Actions, Umbelliferones, Antiparasitic Agents, Pyrans	vet_approved	0
DB11393	Danofloxacin	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Anti-Infective Agents, Quinolones	experimental, vet_approved	0
DB10061	Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine	Drug	0	approved	0
DB11392	Cythioate	Drug	Sulfur Compounds, Agrochemicals, Pesticides, Organophosphorus Compounds, Insecticides, Toxic Actions, Compounds used in a research, industrial, or household setting	vet_approved	0
DB10062	Rabies virus inactivated antigen, B	Drug	Inactivated Rabies Virus Vaccine, Immune Sera and Immunoglobulins, Immune Sera, Actively Acquired Immunity, Rabies Vaccines, Vaccines, Antiinfectives for Systemic Use	approved	0
DB09085	Tetracaine	Drug	Aminobenzoates, para-Aminobenzoates, Benzoates, Sensory System Agents, Nervous System, Local Anesthesia, Acids, Carbocyclic, Dermatologicals, Anesthetics for Topical Use, Ester Local Anesthetic, Anesthetics, Peripheral Nervous System Agents, Ophthalmologicals, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Vasoprotectives, Anesthetics, General, Antipruritics, Incl. Antihistamines, Anesthetics, Etc., Antipruritics and Local Anesthetics, Dental Agents, Esters of Aminobenzoic Acid, Central Nervous System Agents, Sensory Organs, Benzene Derivatives, Anesthetics, Local	approved, vet_approved	3
DB09086	Eugenol	Drug	Solvents, Cell-mediated Immunity, Acids, Carbocyclic, Caffeic Acids, Standardized Chemical Allergen, Compounds used in a research, industrial, or household setting, Anti-Infective Agents, Cinnamates, Increased Histamine Release	approved	4
DB10076	Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen	Drug	Inactivated Haemophilus Influenzae B Vaccine, Actively Acquired Immunity, Influenza Vaccines, Vaccines	approved, investigational	0
DB09083	Ivabradine	Drug	Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Cytochrome P-450 Substrates, Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Heterocyclic Compounds, Fused-Ring, Benzazepines, Cytochrome P-450 CYP3A Substrates, Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker, Miscellaneous Cardiac Drugs, Cardiac Therapy, Bradycardia-Causing Agents	approved	1
DB09084	Benzydamine	Drug	Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Antiinflammatory Products for Vaginal Administration, Anti-Inflammatory Agents, Mouthwashes and Gargles, Pyrazoles, Agents causing hyperkalemia, Genito Urinary System and Sex Hormones, Indazoles, Non COX-2 selective NSAIDS, Antiinflammatory Preparations, Non-Steroids for Topical Use, Topical Products for Joint and Muscular Pain, Drugs that are Mainly Renally Excreted, Heterocyclic Compounds, Fused-Ring, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Throat Preparations, Alimentary Tract and Metabolism, Musculo-Skeletal System, Agents that produce hypertension, Stomatological Preparations	approved	0
DB09081	Idebenone	Drug	Antioxidants, Quinones, Coenzymes, Nervous System, Protective Agents, Psychostimulants, Agents Used for Adhd and Nootropics, Enzymes and Coenzymes, Benzoquinones, Compounds used in a research, industrial, or household setting, Drugs that are Mainly Renally Excreted, Psychoanaleptics	approved, investigational	0
DB09082	Vilanterol	Drug	Hydrocarbons, Chlorinated, Adrenergics, Inhalants, QTc Prolonging Agents, Cytochrome P-450 Substrates, Immunosuppressive Agents, Benzyl Compounds, Agents producing tachycardia, Hydrocarbons, Halogenated, Adrenergic beta-2 Receptor Agonists, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Alcohols, Adrenergic beta-Agonists, Agents to Treat Airway Disease, Cytochrome P-450 CYP3A Substrates, Adrenergic Agonists, Agents that produce hypertension, Potential QTc-Prolonging Agents, Drugs for Obstructive Airway Diseases, Benzene Derivatives	approved	1
DB09080	Olodaterol	Drug	Autonomic Agents, Adrenergics, Inhalants, QTc Prolonging Agents, Oxazines, Cytochrome P-450 Substrates, Anti-Asthmatic Agents, Agents producing tachycardia, Bronchodilator Agents, Adrenergic beta-2 Receptor Agonists, Respiratory System Agents, Peripheral Nervous System Agents, Adrenergic beta-Agonists, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Selective Beta 2-adrenergic Agonists, Agents to Treat Airway Disease, Adrenergic Agonists, Adrenergic beta-1 Receptor Agonists, Agents that produce hypertension, Potential QTc-Prolonging Agents, Drugs for Obstructive Airway Diseases, Cytochrome P-450 CYP2C8 Substrates	approved	1
DB09089	Trimebutine	Drug	QTc Prolonging Agents, Antimuscarinics Antispasmodics, Cytochrome P-450 Substrates, Acids, Carbocyclic, Agents causing hyperkalemia, Muscarinic Antagonists, Prokinetic Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Phenyl Ethers, Anticholinergic Agents, Alimentary Tract and Metabolism, Potential QTc-Prolonging Agents, Drugs for Functional Gastrointestinal Disorders, Ethers, Hydroxybenzoate Ethers, Synthetic Anticholinergics, Esters With Tertiary Amino Group, Benzene Derivatives, Bradycardia-Causing Agents, Antiarrhythmic agents, Gastrointestinal Agents, Autonomic Agents, Benzoates, Hydroxy Acids, Hydroxybenzoates, Agents producing tachycardia, Parasympatholytics, Calcium Channel Blockers, Cytochrome P-450 CYP3A Substrates, Phenols	approved	8
DB09087	Potassium alum	Drug	Immunologic Factors, Potassium Salt, Sulfur Acids, Adjuvants, Immunologic, Ions, Sulfates, Sulfuric Acids, Anions, Sulfur Compounds, Acids, Noncarboxylic, Metal cations, Acids, Metal divalent cations, Aluminium Compounds, Electrolytes	approved	0
DB09088	Amylocaine	Drug	Acids, Carbocyclic, Benzene Derivatives	approved, withdrawn	1
DB09096	Benzoyl peroxide	Drug	Nitrogen Binding Agent, Benzoates, Acids, Carbocyclic, Dermatologicals, Peroxides, Keratolytic Agents, Anti-Acne Preparations, Anti-Acne Preparations for Topical Use, Benzene Derivatives	approved	0
DB09097	Quinagolide	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Miscellaneous Therapeutic Agents, Genito Urinary System and Sex Hormones, Dopamine D2 Receptor Agonists, Prolactine Inhibitors, Dopamine Agents, Dopamine Agonists	approved, investigational	2
DB09094	Podophyllin	Drug	Antineoplastic Agents, Phytogenic, Noxae, Plant Extracts, Dermatologicals, Antineoplastic Agents, Misc. Skin and Mucous Membrane Agents, Complex Mixtures, Plant Preparations, Biological Products, Toxic Actions, Pharmaceutical Preparations, Caustics, Keratolytic Agents, Compounds used in a research, industrial, or household setting	approved	0
DB09095	Difluocortolone	Drug	Corticosteroids, Dermatological Preparations, Cytochrome P-450 Substrates, Immunosuppressive Agents, Glucocorticoids, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Corticosteroids, Potent (Group III), Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inducers, Pregnadienediols, Corticosteroids, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Cytochrome P-450 CYP3A4 Inducers, Dermatologicals, Cytochrome P-450 CYP3A Substrates, Pregnanes, Steroids, Fluorinated, Hyperglycemia-Associated Agents, Steroids	approved, investigational, withdrawn	2
DB09092	Xanthinol	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Purines, Pyridines, Peripheral Vasodilators, Purine Derivatives, Cardiovascular Agents, Nicotinic Acids, Vasodilating Agents, Purinones	approved, withdrawn	6
DB09093	Chlortetracycline	Drug	Enzyme Inhibitors, Antibiotics for Topical Use, Antiprotozoals, Dermatologicals, Agents that produce neuromuscular block (indirect), Antiinfectives for Systemic Use, Anti-Infective Agents, Ophthalmologicals, Anti-Bacterial Agents, Antiinfectives and Antiseptics for Local Oral Treatment, Alimentary Tract and Metabolism, Tetracyclines, Naphthacenes, Sensory Organs, Antibacterials for Systemic Use, Antiparasitic Agents, Protein Synthesis Inhibitors, Stomatological Preparations	approved, investigational, vet_approved	6
DB09090	Pinaverium	Drug	Autonomic Agents, QTc Prolonging Agents, Oxazines, Cytochrome P-450 Substrates, Agents causing hyperkalemia, Parasympatholytics, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Membrane Transport Modulators, Peripheral Nervous System Agents, Calcium Channel Blockers, Cytochrome P-450 CYP3A Substrates, Alimentary Tract and Metabolism, Miscellaneous GI Drugs, Calcium-Regulating Hormones and Agents, Potential QTc-Prolonging Agents, Drugs for Functional Gastrointestinal Disorders, Vasodilating Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	approved	1
DB09091	Tixocortol	Drug	Cell-mediated Immunity, Anti-Allergic Agents, Corticosteroids, Immunosuppressive Agents, Pregnenediones, Hormones, Hormone Substitutes, and Hormone Antagonists, Adrenal Cortex Hormones, Standardized Chemical Allergen, Hormones, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Hydroxycorticosteroids, Intestinal Antiinflammatory Agents, Nasal Preparations, Alimentary Tract and Metabolism, Corticosteroids Acting Locally, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Pregnanes, 11-Hydroxycorticosteroids, 17-Hydroxycorticosteroids, Increased Histamine Release, Pregnenes, Steroids	approved, withdrawn	2
DB09098	Somatrem	Drug	Anterior Pituitary Lobe Hormones and Analogues, Somatropin and Somatropin Agonists, Peptide Hormones, Growth Hormone, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pituitary Hormones, Pituitary and Hypothalamic Hormones and Analogues, Amino Acids, Peptides, and Proteins, Hormones, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Pituitary Hormones, Anterior	approved, investigational, withdrawn	2
DB09099	Somatostatin	Drug	Cytochrome P-450 Enzyme Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, P-glycoprotein substrates, Pancreatic Hormones, Pituitary and Hypothalamic Hormones and Analogues, Somatostatin, agonists, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Hormones, Proteins, Peptide Hormones, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Hypothalamic Hormones, Pituitary Hormone Release Inhibiting Hormones, Somatostatin and Analogues, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved, investigational	5
DB12671	Beloranib	Drug	Cycloparaffins, Acids, Carbocyclic, Antineoplastic Agents, Growth Inhibitors, Angiogenesis Modulating Agents, Ethers, Growth Substances, Terpenes, Angiogenesis Inhibitors, Ethers, Cyclic	investigational	0
DB11340	Ubiquinol	Drug	Quinones, Coenzymes, Enzymes and Coenzymes, Benzoquinones	approved, investigational	0
DB09020	Bisacodyl	Drug	Alimentary Tract and Metabolism, Cresols, Drugs for Constipation, Phenols, Laxatives, Stimulation Large Intestine Fluid/Electrolyte Secretion, Contact Laxatives, Increased Large Intestinal Motility, Benzene Derivatives, Enemas, Gastrointestinal Agents	approved	0
DB12670	Rolofylline	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Purines, Diuretics, Natriuretic Agents, Cardiovascular Agents, Purinones	investigational	1
DB11342	Aluminum oxide	Drug	Anions, Aluminum Oxides, Metal cations, Metal divalent cations, Dermatologicals, Aluminium Compounds, Electrolytes, Ions, Oxides, Anti-Acne Preparations, Anti-Acne Preparations for Topical Use, Oxygen Compounds	approved	0
DB12673	ATX-914	Drug	Heterocyclic Compounds, Fused-Ring, Quinazolines	investigational	0
DB12672	Icaritin	Drug	Heterocyclic Compounds, Fused-Ring, Benzopyrans, Chromones, Pyrans	investigational	0
DB11341	Ichthammol	Drug	Amines, Ammonium Compounds, Dermatologicals, Onium Compounds, Nitrogen Compounds	approved	0
DB12675	PF-04995274	Drug	0	investigational	0
DB11344	(+)-menthol	Drug	0	experimental	0
DB12674	Lurbinectedin	Drug	Heterocyclic Compounds, Fused-Ring, OATP1B1/SLCO1B1 Inhibitors, Pyridines, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, P-glycoprotein substrates, OATP1B3 inhibitors, OCT1 inhibitors, Indoles, Cytochrome P-450 CYP3A4 Substrates, P-glycoprotein inhibitors	approved, investigational	1
DB11343	Silanol	Drug	Organosilicon Compounds, Silicon Compounds	approved	0
DB11346	Rubidium	Drug	Metals, Metals, Heavy, Elements, Metals, Alkali	approved, investigational	0
DB12677	Soblidotin	Drug	Peptides, Antineoplastic Agents, Amino Acids, Peptides, and Proteins	investigational	0
DB11345	(S)-camphor	Drug	0	experimental	4
DB12676	Modufolin	Drug	0	investigational	0
DB11348	Calcium Phosphate	Drug	Calcium Compounds, Blood Coagulation Factors, Ions, Mineral Supplements, Ceramics, Phosphorus Compounds, Phosphate salts, Phosphorus Acids, Calcium Salts, Anions, Acids, Noncarboxylic, Acids, Phosphoric Acids, Alimentary Tract and Metabolism, Biocompatible Materials, Electrolytes, Compounds used in a research, industrial, or household setting	approved	33
DB09027	Ledipasvir	Drug	Antivirals for Systemic Use, Direct Acting Antivirals, Hepatitis C Virus NS5A Inhibitor, Heterocyclic Compounds, Fused-Ring, Antivirals for treatment of HCV infections, P-glycoprotein substrates, Breast Cancer Resistance Protein Inhibitors, Antiviral Agents, P-glycoprotein inhibitors, Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted	approved	1
DB12679	WP 1066	Drug	0	investigational	0
DB12678	Relamorelin	Drug	Peptides, Amino Acids, Peptides, and Proteins	investigational	0
DB09028	Cytisine	Drug	Drugs Used in Nicotine Dependence, Heterocyclic Compounds, Fused-Ring, Nicotine, antagonists & inhibitors, Nervous System, Drugs Used in Addictive Disorders	experimental	5
DB11347	Bacillus subtilis	Drug	0	experimental	0
DB09026	Aliskiren	Drug	Acids, Acyclic, Antihypertensive Agents Indicated for Hypertension, Renin-Inhibitors, Cytochrome P-450 Substrates, P-glycoprotein substrates, Agents causing hyperkalemia, Methyl Ethers, Dicarboxylic Acids, Hypotensive Agents, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A Substrates, Agents Acting on the Renin-Angiotensin System, Antihypertensive Agents, Ethers, Benzene Derivatives	approved, investigational	1
DB11349	Cetyl ethylhexanoate	Drug	0	experimental	0
DB09023	Benactyzine	Drug	Autonomic Agents, Hydroxy Acids, Acids, Carbocyclic, Benzilates, Agents producing tachycardia, Parasympatholytics, Muscarinic Antagonists, Antidepressive Agents, Psychotropic Drugs, Peripheral Nervous System Agents, Anticholinergic Agents, Neurotransmitter Agents, Cholinergic Agents, Central Nervous System Depressants, Diphenylacetic Acids, Phenylacetates, Central Nervous System Agents	withdrawn	0
DB00690	Flurazepam	Drug	Psycholeptics, Tranquilizing Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, GABA Modulators, Benzodiazepines and benzodiazepine derivatives, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Benzazepines, Hypnotics and Sedatives, Cytochrome P-450 CYP2E1 Inhibitors, GABA Agents, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, OCT2 Inhibitors, Cytochrome P-450 CYP2A6 Substrates, Benzodiazepinones, Anti-Anxiety Agents, Central Nervous System Agents, P-glycoprotein inhibitors	approved, illicit, investigational	2
DB09021	Benzoctamine	Drug	Dibenzo-Bicyclo-Octadiene Derivatives, Psycholeptics, Nervous System, Central Nervous System Depressants, Anti-Anxiety Agents	experimental	0
DB09022	Benfluorex	Drug	Lipid Regulating Agents, Hypolipidemic Agents, Amines, Appetite Depressants, Ethylamines, Noxae, Alimentary Tract and Metabolism, Anti-Obesity Agents, Drugs Used in Diabetes, Toxic Actions, Blood Glucose Lowering Agents, Phenethylamines	investigational, withdrawn	0
DB00693	Fluorescein	Drug	Other Diagnostics, Ocular Disorders, Coloring Agents, Laboratory Chemicals, Diagnostic Dye, BSEP/ABCB11 Substrates, Fluoresceins, OAT1/SLC22A6 Substrates, OAT1/SLC22A6 inhibitors, OAT3/SLC22A8 Substrates, Luminescent Agents, Ophthalmologicals, Spiro Compounds, Xanthenes, Heterocyclic Compounds, Fused-Ring, Contrast Media, Diagnostic Uses of Chemicals, Indicators and Reagents, Diagnostic Agents, Sensory Organs, Compounds used in a research, industrial, or household setting, Colouring Agents, Fluorescent Dyes	approved	2
DB00694	Daunorubicin	Drug	Anthracycline Topoisomerase Inhibitor, Anthracyclines, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytotoxic Antibiotics and Related Substances, Immunosuppressive Agents, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, BSEP/ABCB11 Substrates, Cardiotoxic antineoplastic agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Enzyme Inducers, Topoisomerase II Inhibitors, Naphthacenes, Glycosides, P-glycoprotein substrates with narrow therapeutic index, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inducers, Carbohydrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Antibiotics, Antineoplastic, Myelosuppressive Agents, P-glycoprotein inducers, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors, Anthracyclines and Related Substances	approved	3
DB00691	Moexipril	Drug	Antihypertensive Agents Indicated for Hypertension, QTc Prolonging Agents, Enzyme Inhibitors, Isoquinolines, Agents causing hyperkalemia, Protease Inhibitors, Cardiovascular Agents, Hypotensive Agents, Heterocyclic Compounds, Fused-Ring, Photosensitizing Agents, Angiotensin-Converting Enzyme Inhibitors, Agents Acting on the Renin-Angiotensin System, Potential QTc-Prolonging Agents, Agents causing angioedema, ACE Inhibitors and Diuretics, Antihypertensive Agents, Drugs causing inadvertant photosensitivity	approved	1
DB00692	Phentolamine	Drug	Antidotes, Adrenergic alpha-Antagonists, Peripheral alpha-1 blockers, Cardiovascular Agents, Hypotensive Agents, Non-selective Alfa-adrenergic Blocking Agents, Drugs that are Mainly Renally Excreted, Sympatholytic (Adrenergic Blocking) Agents, Neurotransmitter Agents, Imidazoles, Adrenergic Antagonists, Agents that produce hypertension, Peripheral Vasodilators, Adrenergic alpha-1 Receptor Antagonists, Antihypertensive Agents, Vasodilating Agents, Adrenergic Agents, Imidazoline Derivatives	approved	4
DB00697	Tizanidine	Drug	Neuromuscular Agents, QTc Prolonging Agents, Cytochrome P-450 Substrates, Sensory System Agents, Hypotensive Agents, Muscle Relaxants, Adrenergic alpha-2 Receptor Agonists, Analgesics, Musculo-Skeletal System, Muscle Relaxants, Centrally Acting Agents, Potential QTc-Prolonging Agents, Adrenergic Agents, Bradycardia-Causing Agents, Autonomic Agents, Adrenergic alpha-Agonists, Agents producing tachycardia, Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index, Neurotransmitter Agents, Anticonvulsants, Imidazolines, Imidazoles, Central Nervous System Depressants, Adrenergic Agonists, Cytochrome P-450 CYP1A2 Substrates, Central alpha-2 Adrenergic Agonist, Central Nervous System Agents	approved, investigational	3
DB00698	Nitrofurantoin	Drug	Renal Agents, Anti-Infective Agents, Urinary, Nitrofuran Antibacterial, P-glycoprotein substrates, Agents causing hyperkalemia, Nitrofurans, BSEP/ABCB11 Substrates, Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Thyroxine-binding globulin substrates, Anti-Bacterial Agents, BCRP/ABCG2 Substrates, Nitro Compounds, Nitrofuran Derivatives, Furans, Methemoglobinemia Associated Agents, Antibacterials for Systemic Use	approved, vet_approved	3
DB09029	Secukinumab	Drug	Interleukin-17, antagonists & inhibitors, Psoriasis, drug therapy, Interleukin-17A Antagonist, Immunoglobulins, Immunosuppressive Agents, Antineoplastic and Immunomodulating Agents, Antibodies, Amino Acids, Peptides, and Proteins, Agents reducing cytokine levels, Misc. Skin and Mucous Membrane Agents, Interleukin Inhibitors, Immunoproteins, Proteins, Serum Globulins, Globulins, Blood Proteins	approved	1
DB00695	Furosemide	Drug	Aminobenzoates, Nephrotoxic agents, High-Ceiling Diuretics, Amines, Sodium Potassium Chloride Symporter Inhibitors, Acids, Carbocyclic, Aniline Compounds, Amides, Ototoxic agents, Cardiovascular Agents, Hypotensive Agents, Sulfanilamides, Drugs that are Mainly Renally Excreted, Thyroxine-binding globulin substrates, High-Ceiling Diuretics and Potassium-Sparing Agents, Sulfur Compounds, Diuretics, Antihypertensive Agents, Drugs causing inadvertant photosensitivity, Benzene Derivatives, Non Potassium Sparing Diuretics, Sulfones, Antihypertensive Agents Indicated for Hypertension, Benzoates, Membrane Transport Modulators, OAT1/SLC22A6 inhibitors, Photosensitizing Agents, Sulfonamides, UGT1A1 Substrates, Natriuretic Agents, OAT3/SLC22A8 Inhibitors, Hyperglycemia-Associated Agents, Increased Diuresis at Loop of Henle	approved, vet_approved	3
DB00696	Ergotamine	Drug	Serotonin 5-HT1 Receptor Agonists, Cytochrome P-450 Substrates, Sensory System Agents, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Antimigraine Preparations, Uterotonic agents, Ergot Alkaloids and Derivatives, Peripheral Nervous System Agents, Cytochrome P-450 CYP3A4 Inhibitors (strong), Ergotamines, Sympatholytic (Adrenergic Blocking) Agents, Alkaloids, Serotonin Modulators, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Adrenergic Antagonists, Adrenergic alpha-1 Receptor Antagonists, Adrenergic Agents, Analgesics, Non-Narcotic, Adrenergic alpha-Antagonists, Ergotamine Derivative, Reproductive Control Agents, Serotonin Receptor Agonists, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Vasoconstrictor Agents, Agents that produce hypertension, Cytochrome P-450 CYP3A4 Inhibitors, Central Nervous System Agents, Serotonin 5-HT2 Receptor Agonists, P-glycoprotein inhibitors	approved	14
DB00699	Nicergoline	Drug	Cytochrome P-450 Substrates, Adrenergic alpha-Antagonists, Cardiovascular Agents, Ergolines, Ergot Alkaloids and Derivatives, Alkaloids, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Adrenergic Antagonists, Agents that produce hypertension, Peripheral Vasodilators, Adrenergic alpha-1 Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Vasodilating Agents, Adrenergic Agents, Nootropic Agents	approved, investigational	1
DB12682	Mubritinib	Drug	0	investigational	0
DB09030	Vorapaxar	Drug	Receptor, PAR-1, antagonists & inhibitors, Anticoagulants, Blood and Blood Forming Organs, Cytochrome P-450 Substrates, Receptors, Thrombin, antagonists & inhibitors, Protease-activated Receptor-1 Antagonists, Hematologic Agents, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Platelet Aggregation Inhibitors Excl. Heparin, Protease-activated Receptor-1 Antagonist, P-glycoprotein inhibitors, Antiplatelet agents	approved	1
DB11350	Cocamidopropyl betaine	Drug	Surface-Active Agents, Amines, Ammonium Compounds, Quaternary Ammonium Compounds, Trimethyl Ammonium Compounds, Onium Compounds, Compounds used in a research, industrial, or household setting, Nitrogen Compounds	experimental	0
DB12681	Salirasib	Drug	Enzyme Inhibitors, Benzoates, Hydroxy Acids, Acids, Carbocyclic, Antineoplastic Agents, Hydroxybenzoates, Lipids, Alcohols, Sesquiterpenes, Phenols, Terpenes, Benzene Derivatives, Fatty Alcohols, Calcium-Calmodulin-Dependent Protein Kinases, antagonists & inhibitors	investigational	0
DB09031	Miltefosine	Drug	Amines, Ammonium Compounds, Antileishmanial, Antiprotozoals, Quaternary Ammonium Compounds, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Trimethyl Ammonium Compounds, Onium Compounds, Amino Alcohols, Ethanolamines, Anti-Infective Agents, Alcohols, Narrow Therapeutic Index Drugs, Antifungal Agents, Antiparasitic Agents, Nitrogen Compounds	approved, investigational	1
DB12684	Aviscumine	Drug	Biological Factors, Enzymes, Immunologic Factors, Adjuvants, Immunologic, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Ribosome Inactivating Proteins, Proteins, Plant Lectins, Complex Mixtures, Glycoside Hydrolases, Biological Products, Lectins, Hydrolases, N-Glycosyl Hydrolases, Plant Proteins	investigational	0
DB11352	Ascorbyl phosphate	Drug	Vitamin C and analogues, Vitamins	approved	0
DB12683	Lumretuzumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB12686	PHA-793887	Drug	Cyclin-Dependent Kinases, antagonists & inhibitors	investigational	0
DB11355	Propolis wax	Drug	0	approved	0
DB12685	K-134	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB11357	Linseed oil	Drug	Complex Mixtures, Oils, Plant Preparations, Fats, Unsaturated, Biological Products, Lipids, Plant Oils, Fats	approved, investigational	0
DB12688	Moxetumomab Pasudotox	Drug	Proteins, Immunotoxins, Narrow Therapeutic Index Drugs, Antineoplastic Agents, Amino Acids, Peptides, and Proteins	approved, investigational	2
DB11356	Polyquaternium-10 (400 cps at 2%)	Drug	0	approved	0
DB12687	Vesatolimod	Drug	Heterocyclic Compounds, Fused-Ring, Toll-Like Receptor 7, agonists, Antiviral Agents, Anti-Infective Agents	investigational	0
DB09038	Empagliflozin	Drug	P-glycoprotein substrates, UGT1A3 substrates, Sodium-Glucose Transporter 2 Inhibitors, Hypotensive Agents, OATP1B3 substrates, Blood Glucose Lowering Agents, Sodium-glucose co-transporter 2 (SGLT2) inhibitors, Drugs that are Mainly Renally Excreted, OAT3/SLC22A8 Substrates, BCRP/ABCG2 Substrates, UGT2B7 substrates, Alimentary Tract and Metabolism, Glycosides, OATP1B1/SLCO1B1 Substrates, UGT1A9 Substrates, Drugs Used in Diabetes, Benzene Derivatives	approved	1
DB11359	Guaiacol	Drug	Methyl Ethers, Phenols, Catechols, Ethers, Benzene Derivatives, Phenyl Ethers	approved	1
DB12689	Azeliragon	Drug	0	investigational	0
DB09039	Eliglustat	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Glucosylceramide Synthase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Various Alimentary Tract and Metabolism Products, P-glycoprotein substrates, Other Miscellaneous Therapeutic Agents, Cytochrome P-450 CYP3A4 Substrates, Glucosylceramide Synthase Inhibitor, Cytochrome P-450 CYP3A Substrates, Alimentary Tract and Metabolism, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2D6 Substrates, Gaucher Disease, P-glycoprotein inhibitors	approved	1
DB11358	Evening primrose oil	Drug	Fatty Acids, Omega-6, Fatty Acids, Sensory System Agents, Anti-Inflammatory Agents, Lipids, Dietary Fats, Unsaturated, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Fatty Acids, Essential, Complex Mixtures, Analgesics, Biological Products, Oenothera biennis, Agents that reduce seizure threshold, Analgesics, Non-Narcotic, Hypolipidemic Agents, Noxae, Oils, Dermatologicals, Antirheumatic Agents, Linolenic Acids, Lipid Regulating Agents, Fatty Acids, Unsaturated, Plant Preparations, Toxic Actions, Central Nervous System Agents	investigational, nutraceutical	0
DB09036	Siltuximab	Drug	Immunoglobulins, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Agents reducing cytokine levels, Interleukin Inhibitors, Immunoproteins, Interleukin-6 Antagonist, Proteins, Serum Globulins, Cytochrome P-450 CYP3A4 Inducers (weak), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A Inhibitors, Globulins, Blood Proteins, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved, investigational	1
DB09037	Pembrolizumab	Drug	Immunoglobulins, Antineoplastic and Immunomodulating Agents, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins, Proteins, Serum Globulins, Antineoplastic Agents, Immunological, Globulins, Blood Proteins, Programmed Death Receptor-1 Blocking Antibody, Programmed Death Receptor-1-directed Antibody Interactions	approved	1
DB09034	Suvorexant	Drug	Psycholeptics, Orexin Receptor Antagonists, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Sleep Aids, Pharmaceutical, Cytochrome P-450 CYP3A4 Substrates, Miscellaneous Anxiolytics Sedatives and Hypnotics, Neurotransmitter Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Hypnotics and Sedatives, Central Nervous System Agents, P-glycoprotein inhibitors	approved, investigational	2
DB09035	Nivolumab	Drug	Immunoglobulins, Adjuvants, Immunologic, Antineoplastic and Immunomodulating Agents, Immunoglobulin G, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins, Proteins, Serum Globulins, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, Globulins, Blood Proteins, Programmed Death Receptor-1 Blocking Antibody, Programmed Death Receptor-1-directed Antibody Interactions	approved	1
DB09033	Vedolizumab	Drug	Immunoglobulins, Immunosuppressive Agents, Antineoplastic and Immunomodulating Agents, Antibodies, Integrin Receptor Antagonist, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Selective Immunosuppressants, Immunoproteins, Proteins, Serum Globulins, Globulins, Blood Proteins, Miscellaneous GI Drugs, Gastrointestinal Agents	approved	2
DB12680	Intepirdine	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds	investigational	0
DB11362	Selexipag	Drug	Acids, Acyclic, Blood and Blood Forming Organs, Cytochrome P-450 Substrates, Fatty Acids, Prodrugs, P-glycoprotein substrates, Receptors, Prostaglandin, agonists, Amides, Lipids, Prostacyclin Receptor Agonists, Cardiovascular Agents, OATP1B3 substrates, Cytochrome P-450 CYP3A4 Substrates, Acetates, Prostacyclin Receptor Agonist, Cytochrome P-450 CYP3A Substrates, Platelet Aggregation Inhibitors Excl. Heparin, Fatty Acids, Volatile, OATP1B1/SLCO1B1 Substrates, Antihypertensive Agents, Cytochrome P-450 CYP2C8 Substrates, Vasodilating Agents	approved	1
DB09041	Tavaborole	Drug	Antifungals for Topical Use, Dermatologicals, Antifungals for Dermatological Use, Antifungal Agents, Anti-Infective Agents, Protein Synthesis Inhibitors, Oxaborole Antifungal	approved, investigational	1
DB12693	Ritanserin	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Selective Serotonin Reuptake Inhibitors, Tranquilizing Agents, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Hypoglycemia-Associated Agents, Pyrimidinones, Antidepressive Agents, Second-Generation, Antidepressive Agents, Psychotropic Drugs, Neurotransmitter Agents, Serotonin Modulators, Antipsychotic Agents, Pyrimidines, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Piperidines, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Anti-Anxiety Agents, Serotonin Receptor Antagonists, Central Nervous System Agents, Neurotoxic agents	investigational	1
DB11361	Betula pendula tar oil	Drug	0	nutraceutical	0
DB12692	Gusperimus	Drug	Radiation-Protective Agents, Immunologic Factors, Immunosuppressive Agents, Protective Agents, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Amidines, Antibiotics, Antineoplastic, Compounds used in a research, industrial, or household setting, Selective Immunosuppressants	investigational	0
DB09042	Tedizolid phosphate	Drug	Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, Oxazolidinone Antibacterial, Immunosuppressive Agents, Serotonin Agents, Organophosphorus Compounds, Antidepressive Agents, Anti-Infective Agents, Myelosuppressive Agents, Serotonin Modulators, Anti-Bacterial Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Oxazolidinones	approved	1
DB11364	Pidotimod	Drug	Acids, Acyclic, Immunologic Factors, Adjuvants, Immunologic, Antineoplastic and Immunomodulating Agents, Amino Acids, Peptides, and Proteins, Amino Acids, Acidic, Amino Acids, Drugs that are Mainly Renally Excreted, Amino Acids, Cyclic, Sulfur Compounds, Pyrrolidinones, Amino Acids, Dicarboxylic, Imines, Thiazoles, Pyrrolidines, Glutamates, Imino Acids	experimental	0
DB12695	Phenethyl Isothiocyanate	Drug	Isocyanates, Carcinogens, Enzyme Inhibitors, Sulfur Compounds, Noxae, Protective Agents, Antineoplastic Agents, Toxic Actions, Anticarcinogenic Agents, Compounds used in a research, industrial, or household setting, Aldehyde Dehydrogenase, antagonists & inhibitors	investigational	45
DB12694	CE-326597	Drug	Heterocyclic Compounds, Fused-Ring, Benzazepines	investigational	0
DB09040	Efinaconazole	Drug	Azole Antifungals, Antifungals for Topical Use, Dermatologicals, Antifungals for Dermatological Use, Antifungal Agents, Imidazole and Triazole Derivatives, Anti-Infective Agents	approved	1
DB11363	Alectinib	Drug	Cytochrome P-450 Substrates, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors, Cytochrome P-450 CYP3A Substrates, Indoles, P-glycoprotein inhibitors, Kinase Inhibitor	approved, investigational	1
DB11366	Roquinimex	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Immunologic Factors, Adjuvants, Immunologic, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Growth Inhibitors, Angiogenesis Modulating Agents, Growth Substances, Angiogenesis Inhibitors	investigational	0
DB12697	Methylselenocysteine	Drug	Amino Acids, Neutral, Cysteine, Protective Agents, Amino Acids, Sulfur, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Amino Acids, Organoselenium Compounds, Sulfur Compounds, Anticarcinogenic Agents, Compounds used in a research, industrial, or household setting, Selenium Compounds, Sulfhydryl Compounds	investigational	0
DB12696	BMS-582949	Drug	Mitogen-Activated Protein Kinase 14, antagonists & inhibitors	investigational	0
DB11365	Sennosides	Drug	Anthracenes, Plant Extracts, Drugs for Constipation, Herbs and Natural Products, Quinones, Complex Mixtures, Plant Preparations, Alimentary Tract and Metabolism, Anthraquinones, Biological Products, Laxatives, Contact Laxatives, Pharmaceutical Preparations, Gastrointestinal Agents	experimental	2
DB12699	Balugrastim	Drug	Biological Factors, Carbohydrates, Cytokines, Glycoconjugates, Peptides, Adjuvants, Immunologic, Antineoplastic and Immunomodulating Agents, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Glycoproteins, Recombinant Proteins, Hematopoietic Cell Growth Factors, Proteins, Serum Albumin, Albumins, Blood Proteins, Colony-Stimulating Factors	investigational	0
DB11368	Chlorophetanol	Drug	Antifungals for Topical Use, Dermatologicals, Antifungals for Dermatological Use	experimental	0
DB12698	Ibalizumab	Drug	Immunoglobulins, HIV Fusion Inhibitors, Antibodies, Amino Acids, Peptides, and Proteins, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Antiinfectives for Systemic Use, Anti-Infective Agents, Immunoproteins, Proteins, Serum Globulins, Antivirals for Systemic Use, Direct Acting Antivirals, Globulins, Blood Proteins	approved, investigational	3
DB11367	Cefroxadine	Drug	Nephrotoxic agents, Amides, Lactams, Thiazines, beta-Lactams, First-Generation Cephalosporins, Antiinfectives for Systemic Use, Drugs that are Mainly Renally Excreted, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Antibacterials for Systemic Use	withdrawn	1
DB09049	Naloxegol	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 Substrates, Sensory System Agents, Cytochrome P-450 Enzyme Inhibitors, Peripheral Opioid Receptor Antagonists, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Alcohols, Peripheral Nervous System Agents, Alkaloids, Alimentary Tract and Metabolism, Ethylene Glycols, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Polymers, Compounds used in a research, industrial, or household setting, Narcotics, Drugs for Constipation, Macromolecular Substances, Opioid Antagonists, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, Cytochrome P-450 CYP3A Substrates, Miscellaneous GI Drugs, Glycols, Central Nervous System Agents, Cytochrome P-450 CYP2C19 Inhibitors (weak)	approved	1
DB09047	Finafloxacin	Drug	Fluoroquinolones, Quinolines, Quinolone Antimicrobial, Enzyme Inhibitors, Renal Agents, Anti-Infective Agents, Urinary, Topoisomerase Inhibitors, Antineoplastic Agents, Anti-Infective Agents, Quinolones, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Topoisomerase II Inhibitors	approved, investigational	3
DB09048	Netupitant	Drug	Cytochrome P-450 Substrates, Netupitant and prodrug, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Breast Cancer Resistance Protein Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Neurokinin 1 Antagonists, Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors, Substance P/Neurokinin-1 Receptor Antagonist	approved, investigational	1
DB09045	Dulaglutide	Drug	Peptide Fragments, Peptides, Glucagon-like peptide-1 (GLP-1) analogues, Amino Acids, Peptides, and Proteins, Hormones, Recombinant Proteins, Immunoglobulin Fragments, Immunoproteins, Proteins, Peptide Hormones, Alimentary Tract and Metabolism, Incretin Mimetics, Protein Precursors, Drugs Used in Diabetes, Proglucagon, Immunoglobulins, Glucagon-like Peptide-1 (GLP-1) Agonists, Hormones, Hormone Substitutes, and Hormone Antagonists, Gastrointestinal Hormones, Pancreatic Hormones, Blood Glucose Lowering Agents, GLP-1 Agonists, Serum Globulins, Globulins, Blood Proteins, Immunoglobulin Constant Regions	approved, investigational	1
DB09046	Metreleptin	Drug	Biological Factors, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Intercellular Signaling Peptides and Proteins, Obesity, drug therapy, Amino Acids, Peptides, and Proteins, Hormones, Adipokines, Proteins, Peptide Hormones, Alimentary Tract and Metabolism, Amino Acids and Derivatives, Analogs/Derivatives, Leptin Analog	approved	1
DB09043	Albiglutide	Drug	Glucagon-like Peptide-1 (GLP-1) Agonists, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Gastrointestinal Hormones, Pancreatic Hormones, Glucagon-like peptide-1 (GLP-1) analogues, Amino Acids, Peptides, and Proteins, Blood Glucose Lowering Agents, GLP-1 Agonists, Hormones, Recombinant Proteins, Incretins, Proteins, Peptide Hormones, Glucagon-Like Peptides, Alimentary Tract and Metabolism, Protein Precursors, Drugs Used in Diabetes, Proglucagon	approved	1
DB12691	UK-432097	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purines, Ribonucleosides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Purine Nucleosides, Adenosine A2 Receptor Agonists	investigational	0
DB11360	Lactobacillus plantarum	Drug	0	approved, investigational	0
DB12690	LY-2584702	Drug	Ribosomal Protein S6 Kinases, 70-kDa, antagonists & inhibitors	investigational	0
DB11373	Amitraz	Drug	Adrenergic alpha-Agonists, Amines, Protective Agents, Aniline Compounds, Pesticides, Agents producing tachycardia, Insecticides, Pesticide Synergists, Neurotransmitter Agents, Adrenergic alpha-2 Receptor Agonists, Insect Repellents, Agrochemicals, Adrenergic Agonists, Agents that produce hypertension, Toxic Actions, Compounds used in a research, industrial, or household setting, Adrenergic Agents, Benzene Derivatives	experimental, vet_approved	0
DB09052	Blinatumomab	Drug	Immunoglobulins, Immunosuppressive Agents, Antineoplastic and Immunomodulating Agents, CD3-directed Antibody Interactions, Antibodies, Antineoplastic Agents, Amides, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins, Myelosuppressive Agents, Proteins, Serum Globulins, Sulfur Compounds, Narrow Therapeutic Index Drugs, Globulins, Blood Proteins, Bispecific CD19-directed CD3-directed T Cell Engager, CD19-directed Antibody Interactions, Monoterpenes, CD3 Receptor Agonists, Terpenes, Norbornanes, Sulfones	approved, investigational	2
DB11372	Altrenogest	Drug	Progesterone Congeners, Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, Adrenal Cortex Hormones, Estrenes, Progestins, Hormones, Fused-Ring Compounds, Steroids	vet_approved	0
DB09053	Ibrutinib	Drug	Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Immunosuppressive Agents, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Cytochrome P-450 CYP3A4 Substrates, Myelosuppressive Agents, Protein Kinase Inhibitors, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2D6 Substrates, Kinase Inhibitor	approved	1
DB11375	Avilamycin	Drug	Carbohydrates, Anti-Bacterial Agents, Polysaccharides, Growth Substances, Anti-Infective Agents	vet_approved	0
DB09050	Ceftolozane	Drug	Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Aza Compounds, Amides, Azabicyclo Compounds, Thiazines, beta-Lactams, Anti-Infective Agents, Drugs that are Mainly Renally Excreted	approved, investigational	5
DB09051	Elosulfase alfa	Drug	Enzymes, Alimentary Tract and Metabolism, Enzymes and Coenzymes, Sulfatases, Carbon-Oxygen Lyases, Hydrolases, Esterases, Lyases, Recombinant Proteins, Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme, Polysaccharide-Lyases, Chondroitinases and Chondroitin Lyases	approved, investigational	0
DB11377	Bambermycins	Drug	Antigens, Biological Factors, Carbohydrates, Anti-Bacterial Agents, Polysaccharides, Polysaccharides, Bacterial, Antigens, Bacterial, Anti-Infective Agents	vet_approved	0
DB11376	Azaperone	Drug	Tranquilizing Agents, Ketones, Antipsychotic Agents (First Generation Typical), Butyrophenones, Psychotropic Drugs, Neurotransmitter Agents, Antipsychotic Agents, Central Nervous System Depressants, Hypnotics and Sedatives, Central Nervous System Agents, Dopamine Antagonists, Dopamine D2 Receptor Antagonists, Dopamine Agents, Neurotoxic agents	investigational, vet_approved	0
DB11379	Butonate	Drug	Organophosphorus Compounds	experimental, vet_approved	0
DB11378	Buquinolate	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring	experimental, vet_approved	0
DB09059	Atosiban	Drug	Peptide Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pituitary Hormones, Genito Urinary System and Sex Hormones, Reproductive Control Agents, Amino Acids, Peptides, and Proteins, Pituitary Hormones, Posterior, Hormone Antagonists, Hormones, Tocolytic Agents	approved, investigational	4
DB09056	Amorolfine	Drug	Oxazines, Antifungals for Topical Use, Dermatologicals, Antifungals for Dermatological Use, Antifungal Agents, Anti-Infective Agents	approved, investigational	0
DB09057	Anthrax immune globulin human	Drug	Serum Globulins, Immunoglobulins, Serum, Vaccines	approved	1
DB09054	Idelalisib	Drug	Enzyme Inhibitors, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, OATP1B3 inhibitors, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP2C19 Inhibitors, Class Ia Phosphatidylinositol 3-Kinase, antagonists & inhibitors, Quinazolines, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A7 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors (strong), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C8 Inhibitors (weak), Cytochrome P-450 CYP2B6 Inducers, Hepatotoxic Agents, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), UGT1A4 Inhibitors, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A5 Inhibitors, Antineoplastic Agents, Heterocyclic Compounds, Fused-Ring, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A7 Inhibitors, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, UGT1A4 substrates, P-glycoprotein inhibitors, Kinase Inhibitor	approved	1
DB09055	Acipimox	Drug	Lipid Modifying Agents, Lipid Modifying Agents, Plain, Lipid Regulating Agents, Hypolipidemic Agents, Noxae, Agents Causing Muscle Toxicity, Nicotinic Acid and Derivatives, Toxic Actions	approved, investigational	0
DB11371	Alfaxalone	Drug	Anesthetics, General, Nervous System, Central Nervous System Depressants, Pregnanes, Central Nervous System Agents, Anesthetics, Fused-Ring Compounds, Steroids	vet_approved	0
DB00701	Amprenavir	Drug	Acids, Acyclic, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Protease Inhibitors, Amides, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Antivirals for Systemic Use, Direct Acting Antivirals, Cytochrome P-450 Enzyme Inducers, Sulfur Compounds, Antibiotics, Antitubercular, Sulfones, Antituberculosis Agents, Cytochrome P-450 CYP2B6 Inhibitors (weak), OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Substrates, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inducers, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Antiinfectives for Systemic Use, HIV Protease Inhibitors, P-glycoprotein inducers, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Amprenavir and Prodrugs, Cytochrome P-450 CYP2D6 Substrates	approved, investigational	1
DB00702	Icodextrin	Drug	Carbohydrates, Polysaccharides, Solutions, Dialysis Solutions, Glucans, Pharmaceutical Preparations, Polymers, Biopolymers, Compounds used in a research, industrial, or household setting, Pharmaceutical Solutions, Macromolecular Substances	approved, investigational	0
DB00700	Eplerenone	Drug	Antihypertensive Agents Indicated for Hypertension, Mineralocorticoid (Aldosterone) Receptor Antagonists, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Agents causing hyperkalemia, Cardiovascular Agents, Hypotensive Agents, Cytochrome P-450 CYP3A4 Substrates, Potassium-Sparing Diuretics, Fused-Ring Compounds, Lactones, Cytochrome P-450 CYP3A Substrates, Diuretics, Natriuretic Agents, Pregnanes, Antihypertensive Agents, Hormone Antagonists, Mineralocorticoid Receptor Antagonists, Pregnenes, Steroids	approved	1
DB00705	Delavirdine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 Substrates, Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor, Cytochrome P-450 Enzyme Inhibitors, Nonnucleoside Reverse Transcriptase Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (strong), Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Non-Nucleoside Reverse Transcriptase Inhibitors, Anti-Infective Agents, Cytochrome P-450 CYP3A7 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors (strong), Antivirals for Systemic Use, Direct Acting Antivirals, Nucleic Acid Synthesis Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Indoles, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Piperazines, Cytochrome P-450 CYP3A5 Inhibitors, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Antiinfectives for Systemic Use, Cytochrome P-450 CYP2C19 Inhibitors (strong), Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A7 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Reverse Transcriptase Inhibitors, Cytochrome P-450 CYP2D6 Substrates	approved	1
DB00706	Tamsulosin	Drug	Cytochrome P-450 Substrates, Adrenergic alpha-Antagonists, Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Peripheral alpha-1 blockers, Urologicals, Amides, Hypotensive Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Selective Alfa-1-adrenergic Blocking Agents, Urological Agents, Neurotransmitter Agents, Sulfur Compounds, Cytochrome P-450 CYP3A Substrates, Sulfonamides, Adrenergic Antagonists, Adrenergic alpha-1 Receptor Antagonists, Cytochrome P-450 CYP2D6 Substrates, Drugs Used in Benign Prostatic Hypertrophy, Adrenergic Agents, Sulfones	approved, investigational	3
DB00703	Methazolamide	Drug	Thiadiazoles, Enzyme Inhibitors, Antiglaucoma Preparations and Miotics, Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Cardiovascular Agents, Hypotensive Agents, OAT1/SLC22A6 inhibitors, Ophthalmologicals, Carbonic Anhydrase Inhibitors, Sulfur Compounds, Photosensitizing Agents, Sulfonamides, Thiazoles, Diuretics, Natriuretic Agents, Sensory Organs, Drugs causing inadvertant photosensitivity	approved	5
DB00704	Naltrexone	Drug	Centrally Acting Antiobesity Products, Alcohol Deterrents, Sensory System Agents, Narcotics, Nervous System, Natural Opium Alkaloids, Drugs Used in Alcohol Dependence, Drugs Used in Addictive Disorders, Opiate Antagonists, Morphinans, Peripheral Nervous System Agents, Opioid Antagonists, Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Agents Causing Muscle Toxicity, Alimentary Tract and Metabolism, UGT1A1 Substrates, Opioids, Antiobesity Preparations, Excl. Diet Products, Central Nervous System Agents	approved, investigational, vet_approved	4
DB00709	Lamivudine	Drug	OCT1 substrates, Ribonucleosides, Enzyme Inhibitors, OCT2 Substrates, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, OAT1/SLC22A6 Substrates, Dideoxynucleosides, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Antivirals for Systemic Use, Direct Acting Antivirals, Nucleic Acid Synthesis Inhibitors, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleoside Reverse Transcriptase Inhibitors, Carbohydrates, Pyrimidine Nucleosides, P-glycoprotein substrates, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Antiinfectives for Systemic Use, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors, BCRP/ABCG2 Substrates, Deoxycytidine, Agents Causing Muscle Toxicity, Nucleosides, Deoxyribonucleosides, Reverse Transcriptase Inhibitors	approved, investigational	3
DB00707	Porfimer sodium	Drug	Biological Factors, Antineoplastic and Immunomodulating Agents, Dermatologicals, Photoactivated Radical Generator, Sensitizers Used in Photodynamic/radiation Therapy, Antineoplastic Agents, Photosensitizing Activity, Photoabsorption, Hematoporphyrin Derivative, Radiation-Sensitizing Agents, Hematoporphyrins, Pigments, Biological, Heterocyclic Compounds, Fused-Ring, Photosensitizing agents used for phototherapy, Photosensitizing Agents, Porphyrins	approved, investigational	2
DB00708	Sufentanil	Drug	Cytochrome P-450 Substrates, Sensory System Agents, Nervous System, Neuraxial Anesthetics, Anesthetics, Intravenous, Hypotensive Agents, Cytochrome P-450 CYP3A4 Substrates, Opiate Agonists, Peripheral Nervous System Agents, Anesthetics, General, Phenylpiperidine opioids, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Piperidines, Opioids, Bradycardia-Causing Agents, Fentanyl and fentanyl analogues, Opioid Anesthetics, Narcotics, Anesthetics, High-risk opioids, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Opioid Agonist, Agents that produce hypertension, Adjuvants, Anesthesia, Central Nervous System Agents, Opioids, Anilidopiperidine	approved, investigational	3
DB00712	Flurbiprofen	Drug	Nephrotoxic agents, Acids, Acyclic, Enzyme Inhibitors, Cytochrome P-450 Substrates, Fatty Acids, Sensory System Agents, Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Agents causing hyperkalemia, UGT1A3 substrates, Non COX-2 selective NSAIDS, Lipids, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Non-Steroids, UGT2B7 substrates, Analgesics, Fatty Acids, Volatile, Musculo-Skeletal System, Drugs causing inadvertant photosensitivity, Benzene Derivatives, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Antirheumatic Agents, UGT1A1 Inhibitors, Antiinflammatory Preparations, Non-Steroids for Topical Use, Biphenyl Compounds, Topical Products for Joint and Muscular Pain, OAT1/SLC22A6 inhibitors, Ophthalmologicals, Cytochrome P-450 CYP2C9 Substrates, Antiinflammatory and Antirheumatic Products, Throat Preparations, Photosensitizing Agents, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), UGT1A1 Substrates, Propionates, Agents that produce hypertension, UGT1A9 Substrates, Central Nervous System Agents, Sensory Organs, Other Nonsteroidal Anti-inflammatory Agents	approved, investigational	2
DB00713	Oxacillin	Drug	Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Beta-Lactamase Resistant Penicillins, Antibacterials for Systemic Use	approved, investigational	9
DB00710	Ibandronate	Drug	Organophosphonates, QTc Prolonging Agents, Agents Causing Muscle Toxicity, Musculo-Skeletal System, Drugs for Treatment of Bone Diseases, Bone Density Conservation Agents, Organophosphorus Compounds, Potential QTc-Prolonging Agents, Drugs Affecting Bone Structure and Mineralization, Bisphosphonates	approved, investigational	3
DB00711	Diethylcarbamazine	Drug	Acids, Acyclic, Piperazine and Derivatives, Enzyme Inhibitors, Antiparasitic Products, Insecticides and Repellents, Cholinesterase Inhibitors, Piperazines, Antihelminthic, Anthelmintics, Filaricides, Anti-Infective Agents, Carbamates, Lipoxygenase Inhibitors, Antinematodal Agents, Antiparasitic Agents	approved, investigational, vet_approved	2
DB00716	Nedocromil	Drug	Quinolines, Anti-Allergic Agents, Anti-Asthmatic Agents, Anti-Inflammatory Agents, 4-Quinolones, Respiratory System Agents, Decongestants and Antiallergics, Drugs that are Mainly Renally Excreted, Quinolones, Ophthalmologicals, Heterocyclic Compounds, Fused-Ring, Nasal Preparations, Decreased Histamine Release, Antiallergic Agents, Excl. Corticosteroids, Drugs for Obstructive Airway Diseases, Mast Cell Stabilizers, Respiratory Agents, Miscellaneous, Sensory Organs	approved, investigational	5
DB00717	Norethisterone	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, Cytochrome P-450 CYP2C19 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Contraceptives, Oral, Cytochrome P-450 Enzyme Inducers, Contraceptives, Oral, Synthetic, Cytochrome P-450 CYP2C19 Inducers, Progestogens and Estrogens, Sequential Preparations, Norpregnenes, Hormonal Contraceptives for Systemic Use, Contraceptive Agents, Female, Cytochrome P-450 CYP3A5 Substrates, Norsteroids, Reproductive Control Agents, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2A6 Substrates, Progestins, Estren Derivatives, Combination Contraceptives (with Estrogen and derivatives), P-glycoprotein inhibitors, Hyperglycemia-Associated Agents, Progestin Contraceptives, Steroids	approved	3
DB00714	Apomorphine	Drug	QTc Prolonging Agents, Benzylisoquinolines, Cytochrome P-450 Substrates, Serotonin Agents, Nervous System, Isoquinolines, Genito Urinary System and Sex Hormones, Urologicals, Hypotensive Agents, Antidepressive Agents, Dopamine Agonists, Opiate Agonists, Peripheral Nervous System Agents, Alkaloids, Emetics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Anti-Parkinson Agents (Dopamine Agonist), Potential QTc-Prolonging Agents, COMT Substrates, Cytochrome P-450 CYP2C8 Substrates, Dopamine Agents, Gastrointestinal Agents, Autonomic Agents, Cytochrome P-450 CYP3A5 Substrates, Nonergot-derivative Dopamine Receptor Agonists, Anti-Parkinson Drugs, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Drugs Used in Erectile Dysfunction, Aporphines, Central Nervous System Depressants, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates	approved, investigational	14
DB00715	Paroxetine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Hypoglycemia-Associated Agents, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Muscarinic Antagonists, Antidepressive Agents, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Anticholinergic Agents, Cytochrome P-450 CYP1A2 Inhibitors, Serotonin Modulators, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Cytochrome P-450 CYP2C9 Inhibitors, Piperidines, Drugs causing inadvertant photosensitivity, Selective Serotonin Reuptake Inhibitors, Agents producing tachycardia, Antidepressive Agents, Second-Generation, Psychotropic Drugs, Membrane Transport Modulators, Cytochrome P-450 CYP2C19 Substrates, Neurotransmitter Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Central Nervous System Depressants, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Neurotransmitter Uptake Inhibitors, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), Cytochrome P-450 CYP2D6 Inhibitors (strong), P-glycoprotein inhibitors, Psychoanaleptics	approved, investigational	12
DB00718	Adefovir dipivoxil	Drug	Nephrotoxic agents, Enzyme Inhibitors, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Organophosphorus Compounds, Antiviral Agents, OAT1/SLC22A6 Substrates, Antiinfectives for Systemic Use, Anti-Infective Agents, OAT1/SLC22A6 inhibitors, Antivirals for Systemic Use, Direct Acting Antivirals, Heterocyclic Compounds, Fused-Ring, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors, Purines, Nucleic Acid Synthesis Inhibitors, Reverse Transcriptase Inhibitors, Nucleosides and Nucleotides	approved, investigational	1
DB00719	Azatadine	Drug	QTc Prolonging Agents, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Benzocycloheptenes, Dibenzocycloheptenes, Neurotransmitter Agents, Cytochrome P-450 Enzyme Inducers, Histamine H1 Antagonists, Histamine Antagonists, Piperidines, Potential QTc-Prolonging Agents, Histamine Agents, Antihistamines for Systemic Use, Agents that reduce seizure threshold	approved	1
DB12701	Intetumumab	Drug	Proteins, Serum Globulins, Antineoplastic Agents, Immunological, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB12700	Solamargine	Drug	Alkaloids	investigational	0
DB12703	Omipalisib	Drug	Phosphatidylinositol 3-Kinases, antagonists & inhibitors, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amides, Sulfones	investigational	0
DB12702	Velusetrag	Drug	Aza Compounds	investigational	1
DB12705	Cenerimod	Drug	0	investigational	0
DB12704	Spiradoline	Drug	Sensory System Agents, Analgesics, Diuretics, Natriuretic Agents, Receptors, Opioid, kappa, agonists, Cardiovascular Agents, Central Nervous System Agents, Antiarrhythmic agents, Peripheral Nervous System Agents	investigational	0
DB12707	AR-42	Drug	0	investigational	0
DB12706	Seletalisib	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB00720	Clodronic acid	Drug	Organophosphonates, Musculo-Skeletal System, Drugs for Treatment of Bone Diseases, Bone Density Conservation Agents, Organophosphorus Compounds, Drugs Affecting Bone Structure and Mineralization, Bisphosphonates	approved, investigational, vet_approved	4
DB00723	Methoxamine	Drug	Autonomic Agents, Adrenergic alpha-Agonists, Amines, Propanols, Adrenergic alpha-1 Receptor Agonists, Agents producing tachycardia, Adrenergic and Dopaminergic Agents, Cardiovascular Agents, Amino Alcohols, Phenethylamines, Alcohols, Peripheral Nervous System Agents, Neurotransmitter Agents, Ethylamines, Sympathomimetics, Vasoconstrictor Agents, Adrenergic Agonists, Cardiac Stimulants Excl. Cardiac Glycosides, Agents that produce hypertension, Cardiac Therapy, Adrenergic Agents, Propanolamines	approved, investigational	3
DB00724	Imiquimod	Drug	Quinolines, Immunologic Factors, Cytochrome P-450 Substrates, Immunosuppressive Agents, Adjuvants, Immunologic, Dermatologicals, Antineoplastic Agents, Increased Cytokine Production, Misc. Skin and Mucous Membrane Agents, Cytochrome P-450 CYP3A4 Substrates, Increased Cytokine Activity, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Substrates, Interferon Inducers, Aminoquinolines	approved, investigational	2
DB00721	Procaine	Drug	Aminobenzoates, para-Aminobenzoates, Sensory System Agents, Nervous System, Acids, Carbocyclic, Antidepressive Agents, Peripheral Nervous System Agents, Anticholinergic Agents, Vasoprotectives, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Benzene Derivatives, Agents that reduce seizure threshold, Anesthetics, Local, Benzoates, Cholinesterase Inhibitors, Monoamine Oxidase Inhibitors, Anesthetics, Nicotinic Antagonists, Ophthalmologicals, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Central Nervous System Depressants, Esters of Aminobenzoic Acid, NMDA Receptor Antagonists, Cholinesterase substrates, Central Nervous System Agents, Sensory Organs	approved, investigational, vet_approved	11
DB00722	Lisinopril	Drug	Antihypertensive Agents Indicated for Hypertension, Enzyme Inhibitors, Oligopeptides, Peptides, Protective Agents, Agents causing hyperkalemia, Protease Inhibitors, Amino Acids, Peptides, and Proteins, Cardiovascular Agents, Hypotensive Agents, Drugs that are Mainly Renally Excreted, Cardiotonic Agents, ACE Inhibitors and Calcium Channel Blockers, Lipid Modifying Agents, Photosensitizing Agents, Angiotensin-Converting Enzyme Inhibitors, Agents Acting on the Renin-Angiotensin System, Dipeptides, Agents causing angioedema, ACE Inhibitors and Diuretics, Antihypertensive Agents, Drugs causing inadvertant photosensitivity, Compounds used in a research, industrial, or household setting	approved, investigational	2
DB00727	Nitroglycerin	Drug	Explosive Agents, Antianginal Agents, Cardiovascular Agents, Hypotensive Agents, Organic Nitrates, Vasodilation, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Vasoprotectives, Nitrate Vasodilator, Nitro Compounds, Nitrates and Nitrites, Vasodilators Used in Cardiac Diseases, Antihypertensive Agents, Methemoglobinemia Associated Agents, Vasodilating Agents, Cardiac Therapy, Compounds used in a research, industrial, or household setting	approved, investigational	1
DB00728	Rocuronium	Drug	Neuromuscular Agents, OCT1 substrates, Androstanols, Neuromuscular-Blocking Agents (Nondepolarizing), OCT1 inhibitors, Agents producing tachycardia, Muscarinic Antagonists, Muscle Relaxants, Nicotinic Antagonists, Fused-Ring Compounds, Peripheral Nervous System Agents, Anticholinergic Agents, Androstanes, Neuromuscular Nondepolarizing Blockade, Muscle Relaxants, Peripherally Acting Agents, Central Nervous System Depressants, Musculo-Skeletal System, Neuromuscular Blocking Agents, Steroids	approved	3
DB00725	Homatropine methylbromide	Drug	Anticholinergic Agents, Muscarinic Agonists, Alkaloids, Alimentary Tract and Metabolism, Aza Compounds, Agents producing tachycardia, Azabicyclo Compounds, Drugs for Functional Gastrointestinal Disorders, Muscarinic Antagonists	approved	5
DB00726	Trimipramine	Drug	QTc Prolonging Agents, Adrenergic Uptake Inhibitors, Cytochrome P-450 Substrates, Serotonin Agents, Nervous System, Antidepressive Agents, Serotonin 5-HT2 Receptor Antagonists, Tricyclics and Other Norepinephrine-reuptake Inhibitors, Serotonin Modulators, Histamine H1 Antagonists, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Adrenergic Antagonists, Potential QTc-Prolonging Agents, Adrenergic alpha-1 Receptor Antagonists, Adrenergic Agents, Agents that reduce seizure threshold, Neurotoxic agents, Adrenergic alpha-Antagonists, P-glycoprotein substrates, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Dibenzazepines, Psychotropic Drugs, Membrane Transport Modulators, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Non-Selective Monoamine Reuptake Inhibitors, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Tertiary amine tricyclic antidepressants, Central Nervous System Depressants, Antidepressive Agents, Tricyclic, Neurotransmitter Uptake Inhibitors, Agents that produce hypertension, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Serotonin 5-HT1 Receptor Antagonists, Psychoanaleptics	approved	18
DB12750	N-omega-nitro-L-arginine methyl ester	Drug	Enzyme Inhibitors, Arginine, Amino Acids, Basic, Amino Acids, Essential, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, Amino Acids	investigational	0
DB11421	Imidacloprid	Drug	Neurotransmitter Agents, Cholinergic Agents, Agrochemicals, Pesticides, Insecticides, Toxic Actions, Compounds used in a research, industrial, or household setting	vet_approved	1
DB12752	Bucindolol	Drug	Autonomic Agents, Amines, Cytochrome P-450 Substrates, Propanols, Adrenergic alpha-Antagonists, Agents causing hyperkalemia, Adrenergic beta-Antagonists, Cardiovascular Agents, Amino Alcohols, Alcohols, Peripheral Nervous System Agents, Neurotransmitter Agents, Sympathomimetics, Adrenergic Antagonists, Adrenergic alpha-1 Receptor Antagonists, Cytochrome P-450 CYP2D6 Substrates, Vasodilating Agents, Adrenergic Agents, Bradycardia-Causing Agents	investigational	0
DB12751	Malic acid	Drug	Acids, Acyclic, Hydroxy Acids, Dicarboxylic Acids	investigational	0
DB11420	Squalane	Drug	Triterpenes, Alkenes, Hydrocarbons, Acyclic, Polyenes, Terpenes	experimental, vet_approved	0
DB12754	Iodide	Drug	0	approved, experimental	0
DB11423	Lasalocid	Drug	Coccidiostats, Anti-Bacterial Agents, Antiprotozoals, Furans, Compounds used in a research, industrial, or household setting, Anti-Infective Agents, Antiparasitic Agents, Ionophores, Membrane Transport Modulators	vet_approved	0
DB12753	Racivir	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Deoxycytidine, Glycosides, Nucleosides, Antiviral Agents, Deoxyribonucleosides, Dideoxynucleosides, Anti-Infective Agents	investigational	0
DB12756	TAK-901	Drug	Heterocyclic Compounds, Fused-Ring, Pyridines, Protein Kinase Inhibitors, Sulfur Compounds, Indoles	investigational	0
DB09104	Magnesium hydroxide	Drug	Hydroxides, Genito Urinary System and Sex Hormones, Urologicals, Calculi Dissolution Agent, Agents that produce neuromuscular block (indirect), Drugs that are Mainly Renally Excreted, Aluminum and magnesium containing antacids, Anions, Basic Ointments and Protectants, Metal cations, Alimentary Tract and Metabolism, Osmotic Laxatives, Drugs for Acid Related Disorders, Gastrointestinal Agents, Magnesium Salts, Alkalies, Ions, Laxatives, magnesium containing, Antacids and Adsorbents, Gastric Acid Lowering Agents, Metal divalent cations, Emollients Demulcents and Protectants, Electrolytes, Laxatives, Antacids, Magnesium Compounds	approved, investigational	0
DB11425	Luprostiol	Drug	Biological Factors, Autacoids, Fatty Acids, Unsaturated, Inflammation Mediators, Prostaglandins, Fatty Acids, Eicosanoids, Lipids, Prostaglandins, Synthetic	experimental, vet_approved	0
DB09105	Asfotase alfa	Drug	Enzyme Replacement Therapy, Enzymes, Immunoglobulins, Immunoglobulin Isotypes, Antibodies, Enzymes and Coenzymes, Tissue-nonspecific Alkaline Phosphatase, Amino Acids, Peptides, and Proteins, Hypophosphatasia, drug therapy, Esterases, Recombinant Proteins, Immunoproteins, Proteins, Serum Globulins, Phosphoric Monoester Hydrolases, Globulins, Alimentary Tract and Metabolism, Blood Proteins, Hydrolases	approved, investigational	2
DB11424	Lufenuron	Drug	Benzoates, Agrochemicals, Acids, Carbocyclic, Pesticides, Amides, Insecticides, Toxic Actions, Chitin, antagonists & inhibitors, Compounds used in a research, industrial, or household setting, Benzene Derivatives	experimental, vet_approved	0
DB12755	Zoptarelin doxorubicin	Drug	Carbohydrates, Anthracyclines, Hormones, Hormone Substitutes, and Hormone Antagonists, Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Hormones, Pituitary Hormone-Releasing Hormones, Proteins, Peptide Hormones, Hypothalamic Hormones, Naphthacenes, Glycosides	investigational	0
DB12758	Atreleuton	Drug	Enzyme Inhibitors, Lipoxygenase Inhibitors	investigational	0
DB09102	Daclatasvir	Drug	OATP1B1/SLCO1B1 Inhibitors, Antivirals for treatment of HCV infections, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, P-glycoprotein substrates, OATP1B3 inhibitors, BCRP/ABCG2 Inhibitors, HCV Replication Complex Inhibitors, Antiviral Agents, Organic Anion Transporting Polypeptide 1B1 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Antiinfectives for Systemic Use, Antivirals for Systemic Use, Direct Acting Antivirals, Hepatitis C Virus NS5A Inhibitor, Organic Anion Transporting Polypeptide 1B3 Inhibitors, Cytochrome P-450 CYP3A Substrates, Breast Cancer Resistance Protein Inhibitors, P-glycoprotein inhibitors	approved, investigational	1
DB11427	Maropitant	Drug	Autonomic Agents, Antiemetics, Central Nervous System Agents, Benzene Derivatives, Gastrointestinal Agents, Peripheral Nervous System Agents	vet_approved	0
DB12757	Pelitrexol	Drug	Sulfur Compounds	investigational	0
DB11426	Marbofloxacin	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Anti-Infective Agents, Quinolones	vet_approved	0
DB09103	Ancestim	Drug	Proteins, Biological Factors, Cytokines, Peptides, Adjuvants, Immunologic, Antineoplastic and Immunomodulating Agents, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Drugs that are Mainly Renally Excreted, Colony-Stimulating Factors, Hematopoietic Cell Growth Factors	approved, investigational, withdrawn	1
DB11429	Mibolerone	Drug	Estranes, Testosterone and derivatives, Hormones, Hormone Substitutes, and Hormone Antagonists, Estrenes, Testosterone Congeners, Hormones, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Steroids	vet_approved	1
DB09100	Thyroid, porcine	Drug	Thyroid Products, Agents used to treat hypothyroidism	approved	2
DB11428	Medetomidine	Drug	Analgesics, Non-Narcotic, Adrenergic alpha-Agonists, Sensory System Agents, Agents producing tachycardia, Peripheral Nervous System Agents, Neurotransmitter Agents, Adrenergic alpha-2 Receptor Agonists, Imidazoles, Analgesics, Central Nervous System Depressants, Adrenergic Agonists, Agents that produce hypertension, Hypnotics and Sedatives, Central Nervous System Agents, Adrenergic Agents	experimental, vet_approved	0
DB09101	Elvitegravir	Drug	Quinolines, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Antiviral Agents, Cytochrome P-450 CYP3A4 Substrates, Antiinfectives for Systemic Use, HIV Integrase Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strong), Antivirals for Systemic Use, Direct Acting Antivirals, Heterocyclic Compounds, Fused-Ring, HIV Integrase, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, UGT1A1 Substrates, Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2C9 Inducers	approved	1
DB12759	Suptavumab	Drug	0	investigational	0
DB00770	Alprostadil	Drug	Prostaglandin E1 Agonist, Fatty Acids, Genito Urinary System and Sex Hormones, Urologicals, Eicosanoids, Lipids, Cardiovascular Agents, Fatty Acids, Monounsaturated, OAT1/SLC22A6 Substrates, OAT3/SLC22A8 Substrates, Prostaglandins, Synthetic, Genitourinary Arterial Vasodilation, Prostaglandins, Biological Factors, Autacoids, Inflammation Mediators, Miscellaneous Vasodilatating Agents, Prostaglandin Receptor Agonists, Hematologic Agents, Venous Vasodilation, OAT1/SLC22A6 inhibitors, Urological Agents, Fatty Acids, Unsaturated, Drugs Used in Erectile Dysfunction, Prostaglandins E, Vasodilating Agents, Cardiac Therapy	approved, investigational	3
DB00771	Clidinium	Drug	Autonomic Agents, GI Motility Alteration, Hydroxy Acids, Acids, Carbocyclic, Benzilates, Agents producing tachycardia, Parasympatholytics, Muscarinic Antagonists, Peripheral Nervous System Agents, Anticholinergic Agents, Alimentary Tract and Metabolism, Central Nervous System Depressants, Digestive/GI System Activity Alteration, Diphenylacetic Acids, Phenylacetates, Decreased Parasympathetic Acetylcholine Activity, Drugs for Functional Gastrointestinal Disorders, Quinuclidines	approved	1
DB00774	Hydroflumethiazide	Drug	Increased Diuresis, Sodium Chloride Symporter Inhibitors, Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Amides, Cardiovascular Agents, Hypotensive Agents, Membrane Transport Modulators, OAT1/SLC22A6 inhibitors, OAT3/SLC22A8 Substrates, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Photosensitizing Agents, Benzothiadiazines, Sulfonamides, Diuretics, Natriuretic Agents, Antihypertensive Agents, OAT3/SLC22A8 Inhibitors, Drugs causing inadvertant photosensitivity, Thiazides, Sulfones	approved, investigational, withdrawn	9
DB09108	Simoctocog alfa	Drug	0	approved	1
DB00775	Tirofiban	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Blood and Blood Forming Organs, Platelet Aggregation Inhibitors Excl. Heparin, Decreased Platelet Aggregation, Fibrin Modulating Agents, Amino Acids, Peptides, and Proteins, Hematologic Agents, Cardiovascular Agents, Amino Acids, Antiplatelet agents, Drugs that are Mainly Renally Excreted	approved	2
DB09109	Turoctocog alfa	Drug	Proteins, Biological Factors, Blood Proteins, Blood Coagulation Factors, Amino Acids, Peptides, and Proteins, Hemostatics, Recombinant Proteins	approved, investigational	3
DB09106	Hydroxyethyl Starch	Drug	Blood and Blood Forming Organs, Dietary Carbohydrates, Increased Intravascular Volume, Biomimetic Materials, Blood Substitutes and Perfusion Solutions, Biopolymers, Drugs that are Mainly Renally Excreted, Polysaccharides, Physiological Phenomena, Replacement Preparations, Food and Beverages, Blood and Related Products, Blood Substitutes, Polymers, Compounds used in a research, industrial, or household setting, Osmotic Activity, Diet, Food, and Nutrition, Food, Carbohydrates, Blood Substitutes and Plasma Protein Fractions, Starch, Hematologic Agents, Macromolecular Substances, Plasma Substitutes, Glucans	approved	0
DB00772	Malathion	Drug	Organothiophosphorus Compounds, QTc Prolonging Agents, Enzyme Inhibitors, Antiparasitic Products, Insecticides and Repellents, Cholinesterase Inhibitors, Cytochrome P-450 Substrates, Ectoparasiticides, Incl. Scabicides, Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents, Pesticides, Organophosphorus Compounds, Insecticides, Organophosphates, Neurotransmitter Agents, Sulfur Compounds, Cholinergic Agents, Agrochemicals, Cytochrome P-450 CYP1A2 Substrates, Organothiophosphates, Potential QTc-Prolonging Agents, Toxic Actions, Cytochrome P-450 CYP2B6 Substrates, Compounds used in a research, industrial, or household setting	approved, investigational	1
DB09107	Methoxy polyethylene glycol-epoetin beta	Drug	Hematinics, Biological Factors, Carbohydrates, Blood and Blood Forming Organs, Cytokines, Glycoconjugates, Peptides, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Glycoproteins, Erythropoiesis-Stimulating Agents, Alcohols, Hematopoietic Cell Growth Factors, Macromolecular Substances, Proteins, Increased Erythroid Cell Production, Antianemic Preparations, Ethylene Glycols, Pegylated agents, Glycols, Polymers, Compounds used in a research, industrial, or household setting, Colony-Stimulating Factors	approved	1
DB00773	Etoposide	Drug	Antineoplastic Agents, Phytogenic, Enzyme Inhibitors, Cytochrome P-450 Substrates, Immunosuppressive Agents, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Podophyllotoxin, Cytochrome P-450 CYP3A Inducers, Lignans, Cardiotoxic antineoplastic agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Tetrahydronaphthalenes, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Enzyme Inducers, Topoisomerase II Inhibitors, Glycosides, P-glycoprotein substrates with narrow therapeutic index, Benzene Derivatives, Glucosides, Carbohydrates, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 CYP3A5 Substrates, Benzyl Compounds, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index, Antineoplastic Agents, Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index, UGT1A1 substrates with narrow therapeutic index, Myelosuppressive Agents, Naphthalenes, Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, UGT1A1 Substrates, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors, Podophyllotoxin Derivatives	approved	2
DB00778	Roxithromycin	Drug	OATP1B1/SLCO1B1 Inhibitors, QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Erythromycin and similars, Macrolides, Lincosamides and Streptogramins, OATP1B3 inhibitors, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Antiinfectives for Systemic Use, Moderate Risk QTc-Prolonging Agents, Anti-Infective Agents, Lactones, Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), Antibacterials for Systemic Use, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved, investigational, withdrawn	2
DB00779	Nalidixic acid	Drug	Fluoroquinolones, Quinolines, QTc Prolonging Agents, Enzyme Inhibitors, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Naphthyridines, 4-Quinolones, Antiinfectives for Systemic Use, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Moderate Risk QTc-Prolonging Agents, Anti-Infective Agents, OAT1/SLC22A6 inhibitors, Quinolones, Cytochrome P-450 CYP1A2 Inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Photosensitizing Agents, Topoisomerase II Inhibitors, Drugs causing inadvertant photosensitivity, Antibacterials for Systemic Use, Agents that reduce seizure threshold	approved, investigational	1
DB00776	Oxcarbazepine	Drug	Decreased Central Nervous System Disorganized Electrical Activity, Voltage-Gated Sodium Channel Blockers, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inducers (strength unknown), Enzyme Inducing Antiepileptic Drugs, Anti-epileptic Agent, Carboxamide Derivatives, Cytochrome P-450 Enzyme Inducers, Miscellaneous Anticonvulsants, Drugs causing inadvertant photosensitivity, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A5 Inhibitors, Dibenzazepines, Membrane Transport Modulators, P-glycoprotein inducers, Heterocyclic Compounds, Fused-Ring, Anticonvulsants, Cytochrome P-450 CYP3A Inhibitors, Photosensitizing Agents, Central Nervous System Depressants, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Central Nervous System Agents, Sodium Channel Blockers	approved	1
DB00777	Propiomazine	Drug	Psycholeptics, Serotonin Agents, Adrenergic alpha-Antagonists, Nervous System, Agents producing tachycardia, Muscarinic Antagonists, Antidepressive Agents, Anticholinergic Agents, Serotonin 5-HT2 Receptor Antagonists, Heterocyclic Compounds, Fused-Ring, Histamine H1 Antagonists, Sulfur Compounds, Histamine Antagonists, Central Nervous System Depressants, Adrenergic Antagonists, Agents that produce hypertension, Hypnotics and Sedatives, Serotonin Receptor Antagonists, Adrenergic alpha-1 Receptor Antagonists, Dopamine Antagonists, Dopamine D2 Receptor Antagonists	approved	6
DB11430	Monensin	Drug	Acids, Acyclic, Coccidiostats, Enzyme Inhibitors, Antiprotozoals, Fatty Acids, Uncoupling Agents, P-glycoprotein substrates, Lipids, Proton Ionophores, Anti-Infective Agents, Ionophores, Membrane Transport Modulators, Sodium Ionophores, Valerates, Fatty Acids, Volatile, Furans, P-glycoprotein inhibitors, Compounds used in a research, industrial, or household setting, Antiparasitic Agents	experimental, vet_approved	0
DB12761	Timcodar	Drug	0	investigational	0
DB12760	GW-493838	Drug	0	investigational	0
DB11432	Narasin	Drug	Coccidiostats, Anti-Bacterial Agents, Antiprotozoals, Anti-Infective Agents, Antiparasitic Agents, Ionophores	experimental, vet_approved	0
DB12763	MK-1496	Drug	0	investigational	0
DB11431	Moxidectin	Drug	Polyketides, Agrochemicals, Pesticides, Anthelmintics, Insecticides, Toxic Actions, Compounds used in a research, industrial, or household setting, Anti-Infective Agents, Antinematodal Agents, Antiparasitic Agents, Lactones	approved, investigational, vet_approved	3
DB12762	Rabacfosadine	Drug	Heterocyclic Compounds, Fused-Ring, Amino Acids, Peptides, and Proteins, Amino Acids	investigational	0
DB12765	Methyl isocyanate	Drug	Antisickling Agents, Hematologic Agents	investigational	0
DB11433	Nequinate	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring	vet_approved	0
DB12764	ABC-294640	Drug	Cycloparaffins	investigational	0
DB09115	Diiodohydroxyquinoline	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Quinoline Derivatives, Antiprotozoals, Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Hydroxyquinolines, Anti-Infective Agents, Antiparasitic Agents, Amebicides	approved	0
DB12767	Gaxilose	Drug	Carbohydrates, Polysaccharides, Oligosaccharides	approved, investigational	0
DB11436	Nifurpirinol	Drug	Nitro Compounds, Furans	experimental, vet_approved	0
DB12766	Cicletanine	Drug	QTc Prolonging Agents, Diuretics, Natriuretic Agents, Potential QTc-Prolonging Agents, Cardiovascular Agents, Low-Ceiling Diuretics, Excl. Thiazides, Antihypertensive Agents, Antiarrhythmic agents	investigational	0
DB09116	Calcium carbimide	Drug	Nervous System, Drugs Used in Alcohol Dependence, Drugs Used in Addictive Disorders	approved, withdrawn	1
DB09113	Poractant alfa	Drug	Surface-Active Agents, Surfactant Activity, Complex Mixtures, Alveolar Surface Tension Reduction, Lipids, Membrane Lipids, Respiratory System Agents, Bradycardia-Causing Agents, Pulmonary Surfactants	approved	0
DB11438	Nitenpyram	Drug	Agrochemicals, Pesticides, Insecticides, Toxic Actions, Compounds used in a research, industrial, or household setting	experimental, vet_approved	0
DB12769	Lometrexol	Drug	Biological Factors, Coenzymes, Enzyme Inhibitors, Noxae, Folic Acid Antagonists, Antineoplastic Agents, Enzymes and Coenzymes, Antimetabolites, Pteridines, Pigments, Biological, Heterocyclic Compounds, Fused-Ring, Folic Acid Analogues, Pterins, Toxic Actions	investigational	1
DB11437	Nitarsone	Drug	Organometallic Compounds	vet_approved	0
DB09114	Colfosceril palmitate	Drug	Carbohydrates, Phosphatidylcholines, Sugar Phosphates, Lipids, Phospholipids, Phosphatidic Acids, Glycerophospholipids, Pulmonary Surfactants, Alcohols, Glycerophosphates, Sugar Alcohols, Lung Surfactants, Membrane Lipids, Triose Sugar Alcohols	approved, investigational, withdrawn	0
DB12768	BCG vaccine	Drug	Immunologic Factors, Live vaccines, Complex Mixtures, Adjuvants, Immunologic, Tuberculosis Vaccines, Antineoplastic and Immunomodulating Agents, Biological Products, Vaccines, Bacterial Vaccines, Live Attenuated Bacillus Calmette-Guerin Vaccine	investigational	0
DB09111	Pentastarch	Drug	Carbohydrates, Dietary Carbohydrates, Increased Intravascular Volume, Starch, Biomimetic Materials, Hematologic Agents, Biopolymers, Drugs that are Mainly Renally Excreted, Macromolecular Substances, Polysaccharides, Physiological Phenomena, Plasma Substitutes, Food and Beverages, Glucans, Blood Substitutes, Polymers, Compounds used in a research, industrial, or household setting, Osmotic Activity, Diet, Food, and Nutrition, Food	approved, investigational	0
DB09112	Nitrous acid	Drug	Food Additives, Antidotes, Nitrites, Laboratory Chemicals, Ions, Hypotensive Agents, Sodium Compounds, Anions, Acids, Noncarboxylic, Physiological Phenomena, Acids, Food and Beverages, Food Ingredients, Electrolytes, Indicators and Reagents, Food Preservatives, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Nitrogen Compounds, Food	approved, investigational	3
DB09110	Coenzyme M	Drug	Alkanesulfonic Acids, Mesna, Sulfur Acids, Protective Agents, Hydrocarbons, Acyclic, Alkanes, Cytoprotective Agent, Sulfur Compounds, Acids, Noncarboxylic, Alkanesulfonates, Acids, Cough and Cold Preparations, Expectorants, Sulfonic Acids, Detoxifying Agents for Antineoplastic Treatment, Compounds used in a research, industrial, or household setting, Sulfhydryl Compounds	approved, investigational	0
DB00781	Polymyxin B	Drug	Peptides, Antimicrobial Cationic Peptides, Otologicals, Amino Acids, Peptides, and Proteins, Antiinfectives for Systemic Use, Ophthalmological and Otological Preparations, Anti-Infective Agents, Ophthalmologicals, Peptides, Cyclic, Proteins, Anti-Bacterial Agents, Intestinal Antiinfectives, Alimentary Tract and Metabolism, Polymyxin-class Antibacterial, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Pore Forming Cytotoxic Proteins, Sensory Organs, Lipopeptides, Antibacterials for Systemic Use, Neurotoxic agents, Polymyxins	approved, vet_approved	1
DB00782	Propantheline	Drug	Amines, Ammonium Compounds, Quaternary Ammonium Compounds, Agents producing tachycardia, Onium Compounds, Muscarinic Antagonists, Anti-Ulcer Agents, Drugs that are Mainly Renally Excreted, Anticholinergic Agents, Xanthenes, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Synthetic Anticholinergics, Quaternary Ammonium Compounds, Cholinergic Agents, Alimentary Tract and Metabolism, Drugs for Functional Gastrointestinal Disorders, Nitrogen Compounds, Gastrointestinal Agents	approved	1
DB00780	Phenelzine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Enzyme Inhibitors, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Hypotensive Agents, Antidepressive Agents, Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP3A7 Inhibitors (strength unknown), Monoamine Oxidase Inhibitors, Non-Selective, Serotonin Modulators, Cytochrome P-450 Enzyme Inducers, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Monoamine Oxidase A Substrates, Agents that reduce seizure threshold, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Cytochrome P-450 CYP2E1 Inducers (strength unknown), Hydrazines, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Cytochrome P-450 CYP2E1 Inducers, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors, Monoamine Oxidase Inhibitors, Psychotropic Drugs, Cytochrome P-450 CYP3A Inhibitors, Central Nervous System Depressants, Cytochrome P-450 CYP3A7 Inhibitors, Agents that produce hypertension, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Central Nervous System Agents, Psychoanaleptics	approved	7
DB00785	Cryptenamine	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Veratrum Alkaloids, Cevanes, Cardiovascular Agents, Antihypertensive Agents	approved	2
DB09119	Eslicarbazepine acetate	Drug	Voltage-Gated Sodium Channel Blockers, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP2C19 Inhibitors, Cardiovascular Agents, Cytochrome P-450 CYP2C19 Inhibitors (moderate), Membrane Transport Modulators, Carboxamide Derivatives, Cytochrome P-450 CYP3A4 Inducers (weak), Heterocyclic Compounds, Fused-Ring, Anticonvulsants, Cytochrome P-450 Enzyme Inducers, Eslicarbazepine and prodrugs, Central Nervous System Depressants, UGT1A1 Substrates, Central Nervous System Agents, Sodium Channel Blockers	approved	1
DB00786	Marimastat	Drug	Enzyme Inhibitors, Amines, Hydroxy Acids, Hydroxylamines, Metalloendopeptidases, antagonists & inhibitors	investigational	23
DB00783	Estradiol	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Adrenal Cortex Hormones, Estrogens, Genito Urinary System and Sex Hormones, Natural and Semisynthetic Estrogens, Plain, Hormones, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Antiandrogens and Estrogens, OAT3/SLC22A8 Substrates, Cytochrome P-450 CYP1A2 Inhibitors, Contraceptives, Oral, Progestogens and Estrogens, Sequential Preparations, Androgens and Estrogens, Estradiol Congeners, COMT Substrates, Cytochrome P-450 CYP2C8 Substrates, Hormonal Contraceptives for Systemic Use, Contraceptive Agents, Female, Gonadal Hormones, Estrogen Contraceptives, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein substrates, Estrenes, Estrogens, agonists, BCRP/ABCG2 Inhibitors, Estradiol, agonists, Gonadal Steroid Hormones, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, Thyroxine-binding globulin inducers, OCT2 Inhibitors, UGT1A1 Substrates, Cytochrome P-450 CYP1A2 Substrates, Intravaginal Contraceptives, Steroids	approved, investigational, vet_approved	7
DB09117	Paraldehyde	Drug	Psycholeptics, Anticonvulsants, Nervous System, Central Nervous System Depressants, Hypnotics and Sedatives, Central Nervous System Agents, Acetaldehyde	approved, investigational	0
DB00784	Mefenamic acid	Drug	Aminobenzoates, Nephrotoxic agents, Enzyme Inhibitors, Amines, Cytochrome P-450 Substrates, Sensory System Agents, Cyclooxygenase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, ortho-Aminobenzoates, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Aniline Compounds, Peripheral Nervous System Agents, Fenamates, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Musculo-Skeletal System, Drugs causing inadvertant photosensitivity, Benzene Derivatives, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Benzoates, Cytochrome P-450 CYP2C8 Inhibitors, Antirheumatic Agents, Cytochrome P-450 CYP2C9 Substrates, UGT1A9 Inhibitors, Antiinflammatory and Antirheumatic Products, Photosensitizing Agents, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Agents that produce hypertension, Central Nervous System Agents, Other Nonsteroidal Anti-inflammatory Agents	approved	2
DB09118	Stiripentol	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP2C19 Inhibitors (strong), Dioxoles, Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP3A4 Inhibitors (strong), Anticonvulsants, Cytochrome P-450 CYP3A Inhibitors, Miscellaneous Anticonvulsants, Photosensitizing Agents, Central Nervous System Depressants, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Drugs causing inadvertant photosensitivity	approved	3
DB00789	Gadopentetic acid	Drug	Magnetic Resonance Imaging Contrast Media, Acids, Acyclic, Miscellaneous Therapeutic Agents, Amines, Fatty Acids, Lipids, Paramagnetic Contrast Agent, Polyamines, Acetates, Drugs that are Mainly Renally Excreted, Organometallic Compounds, Paramagnetic Contrast Media, Contrast Media, Diagnostic Uses of Chemicals, Magnetic Resonance Contrast Activity, Fatty Acids, Volatile, Compounds used in a research, industrial, or household setting	approved	1
DB00787	Acyclovir	Drug	Nephrotoxic agents, OCT1 substrates, Acyclovir and prodrug, Cytochrome P-450 Substrates, MATE 1 Substrates, OCT1 inhibitors, OAT1/SLC22A6 Substrates, Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, OAT3/SLC22A8 Substrates, Antivirals for Systemic Use, Direct Acting Antivirals, Purines, Nucleic Acid Synthesis Inhibitors, Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor, Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor, MATE substrates, Nucleosides and Nucleotides, Purinones, Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors, Dermatologicals, Antiviral Agents, Antiinfectives for Systemic Use, OAT1/SLC22A6 inhibitors, Ophthalmologicals, Heterocyclic Compounds, Fused-Ring, MATE 2 Substrates, Cytochrome P-450 CYP1A2 Substrates, OAT3/SLC22A8 Inhibitors, Sensory Organs	approved	3
DB00788	Naproxen	Drug	Nephrotoxic agents, Antiinflammatory Products for Vaginal Administration, Enzyme Inhibitors, Cytochrome P-450 Substrates, Sensory System Agents, Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Agents causing hyperkalemia, Genito Urinary System and Sex Hormones, UGT1A3 substrates, Non COX-2 selective NSAIDS, BSEP/ABCB11 Substrates, Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Non-Steroids, UGT2B7 substrates, Analgesics, Musculo-Skeletal System, Cytochrome P-450 CYP2C8 Substrates, Drugs causing inadvertant photosensitivity, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Antirheumatic Agents, Antiinflammatory Preparations, Non-Steroids for Topical Use, Naphthaleneacetic Acids, Topical Products for Joint and Muscular Pain, UGT1A6 substrate, Naphthalenes, OAT1/SLC22A6 inhibitors, Cytochrome P-450 CYP2C9 Substrates, Antigout Preparations, Antiinflammatory and Antirheumatic Products, Photosensitizing Agents, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), UGT1A1 Substrates, Propionates, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, UGT1A9 Substrates, Central Nervous System Agents, P-glycoprotein inhibitors, Other Nonsteroidal Anti-inflammatory Agents	approved, vet_approved	3
DB12770	Lafutidine	Drug	Acids, Acyclic, Fatty Acids, Amides, Lipids, Anti-Ulcer Agents, Histamine H2 Antagonists, Acetates, Neurotransmitter Agents, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Gastric Acid Lowering Agents, Histamine Antagonists, Alimentary Tract and Metabolism, Fatty Acids, Volatile, Drugs for Acid Related Disorders, Histamine Agents, Gastrointestinal Agents	investigational	0
DB12771	Hydroxytyrosol	Drug	Antioxidants, Protective Agents, Hematologic Agents, Compounds used in a research, industrial, or household setting, Anti-Infective Agents, Antiplatelet agents, Alcohols	investigational	0
DB11440	Norgestomet	Drug	Progesterone Congeners, Pregnanes, Fused-Ring Compounds, Pregnenes, Steroids	vet_approved	0
DB11443	Orbifloxacin	Drug	Cytochrome P-450 CYP1A2 Inhibitors, Fluoroquinolones, Quinolines, Heterocyclic Compounds, Fused-Ring, QTc Prolonging Agents, Anti-Bacterial Agents, Cytochrome P-450 Enzyme Inhibitors, Potential QTc-Prolonging Agents, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Quinolones	vet_approved	0
DB12774	AZD-8055	Drug	Oxazines	investigational	0
DB11442	Oleandomycin	Drug	Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Cytochrome P-450 CYP3A4 Inhibitors, Macrolides, Lincosamides and Streptogramins, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use, Lactones	vet_approved	0
DB12773	Sifalimumab	Drug	Proteins, Serum Globulins, Immunologic Factors, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	1
DB12776	E-6005	Drug	Heterocyclic Compounds, Fused-Ring, Phosphodiesterase Inhibitors, Acids, Carbocyclic, Phosphodiesterase 4 Inhibitors, Antipruritics	investigational	0
DB12775	Abituzumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB12778	Rivipansel	Drug	Carbohydrates, Glycoconjugates, Lipids	investigational	0
DB11447	Phenothiazine	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Antiprotozoals, Anti-Infective Agents, Antiparasitic Agents, Agents that reduce seizure threshold	experimental, vet_approved	1
DB09126	Chorionic Gonadotropin (Human)	Drug	Sex Hormones and Modulators of the Genital System, Gonadotropins and Antigonadotropins, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Genito Urinary System and Sex Hormones, Reproductive Control Agents, Amino Acids, Peptides, and Proteins, Gonadotropins, Hormones, Chorionic Gonadotropin, Pregnancy Proteins, Proteins, Peptide Hormones, Placental Hormones	approved, vet_approved	1
DB12777	Somatoprim	Drug	Proteins, Peptide Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pancreatic Hormones, Hypothalamic Hormones, Pituitary Hormone Release Inhibiting Hormones, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Hormones	investigational	0
DB11446	Oxfendazole	Drug	Heterocyclic Compounds, Fused-Ring, Benzimidazoles, Anthelmintics, Anti-Infective Agents, Antinematodal Agents, Antiparasitic Agents	investigational, vet_approved	0
DB09124	Medrogestone	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Pregnadienes, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, Cytochrome P-450 CYP3A4 Substrates, Pregnadien Derivatives, Fused-Ring Compounds, Cytochrome P-450 CYP3A Substrates, Progestogens and Estrogens, Sequential Preparations, Progestins, Pregnanes, Steroids	approved, withdrawn	1
DB11449	Phthalofyne	Drug	0	experimental, vet_approved	0
DB11448	Phosmet	Drug	Organothiophosphorus Compounds, QTc Prolonging Agents, Phthalic Acids, Acids, Carbocyclic, Pesticides, Organophosphorus Compounds, Insecticides, Imides, Isoindoles, Organophosphates, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Agrochemicals, Phthalimides, Organothiophosphates, Potential QTc-Prolonging Agents, Toxic Actions, Compounds used in a research, industrial, or household setting	vet_approved	0
DB09125	Potassium citrate	Drug	Acids, Acyclic, Anticoagulants, Potassium Salt, Alkalinizing Activity, Agents causing hyperkalemia, Citrates, Citric Acid Derivatives, Calculi Dissolution Agent, Cardiovascular Agents, Mineral Supplements, Respiratory System Agents, Metabolic Alkalinizer, Tricarboxylic Acids, Urinary Alkalinisers, Expectorants, Replacement Preparations, Alimentary Tract and Metabolism, Diuretics, Natriuretic Agents	approved, investigational, vet_approved	0
DB12779	Higenamine	Drug	Analgesics, Non-Narcotic, Sensory System Agents, Anti-Inflammatory Agents, Fibrin Modulating Agents, Isoquinolines, Protective Agents, Antirheumatic Agents, Agents producing tachycardia, Hematologic Agents, Cardiovascular Agents, Peripheral Nervous System Agents, Cardiotonic Agents, Adrenergic beta-Agonists, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Analgesics, Adrenergic Agonists, Agents that produce hypertension, Central Nervous System Agents, Compounds used in a research, industrial, or household setting, Adrenergic Agents	investigational	0
DB09122	Peginterferon beta-1a	Drug	Biological Factors, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Cytokines, Peptides, Adjuvants, Immunologic, Interferons, Antineoplastic and Immunomodulating Agents, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Interferon Type I, Alcohols, Macromolecular Substances, Myelosuppressive Agents, Cytochrome P-450 CYP1A2 Inhibitors, Proteins, Ethylene Glycols, Pegylated agents, Glycols, Polymers, Compounds used in a research, industrial, or household setting	approved	0
DB09123	Dienogest	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, Hormones, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Contraceptives, Oral, Progestogens and Estrogens, Sequential Preparations, Hormone Antagonists, Hormonal Contraceptives for Systemic Use, Contraceptive Agents, Female, Gonadal Hormones, Antineoplastic Agents, Hormonal, Contraceptive Agents, Male, Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, Estrenes, Reproductive Control Agents, Antineoplastic Agents, Pregnadien Derivatives, Gonadal Steroid Hormones, Cytochrome P-450 CYP3A Substrates, Progestins, Testosterone Congeners, Combination Contraceptives (with Estrogen and derivatives), Hyperglycemia-Associated Agents, Progestin Contraceptives, Steroids	approved	2
DB09120	Zucapsaicin	Drug	Solanaceous Alkaloids, Fatty Acids, Alkenes, Cytochrome P-450 Enzyme Inhibitors, Amides, Cytochrome P-450 CYP2C19 Inhibitors, Lipids, Fatty Acids, Monounsaturated, Cytochrome P-450 CYP1A2 Inhibitors, Polyunsaturated Alkamides, Alkaloids, Musculo-Skeletal System, Cytochrome P-450 CYP2C9 Inhibitors, Benzene Derivatives, Alkynes, Capsaicin and Similar Agents, Cytochrome P-450 CYP2E1 Inhibitors, Hydrocarbons, Acyclic, Cytochrome P-450 CYP2E1 Inhibitors (weak), Catechols, Cytochrome P-450 CYP2C19 Inhibitors (moderate), Topical Products for Joint and Muscular Pain, Fatty Acids, Unsaturated, Phenols, Other Nonsteroidal Anti-inflammatory Agents, Cytochrome P-450 CYP2C9 Inhibitors (weak), Cytochrome P-450 CYP1A2 Inhibitors (moderate)	approved, investigational	1
DB09121	Aurothioglucose	Drug	Organogold Compounds, Organometallic Compounds, Antiinflammatory and Antirheumatic Products, Gold Preparations, Musculo-Skeletal System, Antirheumatic Agents, Specific Antirheumatic Agents, Drugs that are Mainly Renally Excreted	approved, withdrawn	3
DB00792	Tripelennamine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Aminopyridines, Pyridines, Amines, Anti-Allergic Agents, Cytochrome P-450 Enzyme Inhibitors, Antihistamines for Topical Use, Dermatologicals, Polyamines, Ethylenediamine Derivatives, Ethylenediamines, Diamines, Neurotransmitter Agents, Histamine H1 Antagonists, Antipruritics, Incl. Antihistamines, Anesthetics, Etc., Histamine Antagonists, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Histamine Agents, Antihistamines for Systemic Use, Substituted Ethylene Diamines	approved, vet_approved	1
DB00793	Haloprogin	Drug	Antifungals for Topical Use, Dermatologicals, Antifungals for Dermatological Use, Phenols, Antifungal Agents, Ethers, Anti-Infective Agents, Benzene Derivatives	approved, withdrawn	0
DB00790	Perindopril	Drug	Antihypertensive Agents Indicated for Hypertension, Enzyme Inhibitors, Cholinesterase Inhibitors, Agents causing hyperkalemia, Protease Inhibitors, Cardiovascular Agents, Hypotensive Agents, Drugs that are Mainly Renally Excreted, ACE Inhibitors and Calcium Channel Blockers, Heterocyclic Compounds, Fused-Ring, Lipid Modifying Agents, Angiotensin-Converting Enzyme Inhibitors, Agents Acting on the Renin-Angiotensin System, Agents causing angioedema, ACE Inhibitors and Diuretics, Antihypertensive Agents, Indoles	approved	2
DB00791	Uracil mustard	Drug	Noxae, Nitrosoureas, Antineoplastic and Immunomodulating Agents, Pyrimidinones, Antineoplastic Agents, Hydrocarbons, Halogenated, Mustard Compounds, Nitrogen Mustard Compounds, Alkylating Drugs, Pyrimidines, Narrow Therapeutic Index Drugs, Toxic Actions, Antineoplastic Agents, Alkylating	approved	1
DB00796	Candesartan cilexetil	Drug	Antihypertensive Agents Indicated for Hypertension, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Angiotensin Receptor Antagonists, Cytochrome P-450 CYP2C8 Inhibitors, Agents causing hyperkalemia, UGT1A3 substrates, Cardiovascular Agents, Hypotensive Agents, Cytochrome P-450 CYP2C8 Inhibitors (strong), Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Agents Acting on the Renin-Angiotensin System, Angiotensin II Antagonists and Diuretics, Angiotensin 2 Receptor Blocker, Antihypertensive Agents, P-glycoprotein inhibitors, Benzene Derivatives	approved	1
DB00797	Tolazoline	Drug	Adrenergic alpha-Antagonists, Peripheral alpha-1 blockers, Cardiovascular Agents, Hypotensive Agents, Topical Products for Joint and Muscular Pain, Neurotransmitter Agents, Imidazolines, Imidazoles, Musculo-Skeletal System, Adrenergic Antagonists, Agents that produce hypertension, Peripheral Vasodilators, Adrenergic alpha-1 Receptor Antagonists, Antihypertensive Agents, Vasodilating Agents, Adrenergic Agents, Imidazoline Derivatives	approved, vet_approved	6
DB09128	Brexpiprazole	Drug	Quinolines, Serotonin 5-HT1 Receptor Agonists, Psycholeptics, Cytochrome P-450 Substrates, Serotonin Agents, Nervous System, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Dopamine Agonists, Serotonin 5-HT2 Receptor Antagonists, Antipsychotic Agents, Sulfur Compounds, Antipsychotic Agents (Second Generation Atypical), Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Adrenergic Antagonists, Adrenergic alpha-1 Receptor Antagonists, Dopamine Agents, Neurotoxic agents, Adrenergic alpha-Antagonists, Serotonin Receptor Agonists, Dopamine D2 Receptor Agonists, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Agents that produce hypertension, Serotonin Receptor Antagonists, Cytochrome P-450 CYP2D6 Substrates, Hyperglycemia-Associated Agents	approved, investigational	5
DB00794	Primidone	Drug	Psycholeptics, Decreased Central Nervous System Disorganized Electrical Activity, Cytochrome P-450 Substrates, Nervous System, GABA Modulators, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Cytochrome P-450 CYP2C19 Inducers (strength unknown), Barbiturates and Derivatives, UGT1A1 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Enzyme Inducing Antiepileptic Drugs, Anti-epileptic Agent, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Anticholinergic Agents, Cytochrome P-450 CYP3A4 Inducers (strong), Cytochrome P-450 Enzyme Inducers, Pyrimidines, Cytochrome P-450 CYP2C19 Inducers, Hypnotics and Sedatives, Barbiturates, Cytochrome P-450 CYP2E1 Inducers (strength unknown), Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 CYP2E1 Inducers, Cytochrome P-450 CYP3A Inducers (strong), GABA Agents, Cytochrome P-450 CYP3A4 Inducers, Pyrimidinones, Nicotinic Antagonists, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Neurotransmitter Agents, Anticonvulsants, Central Nervous System Depressants, Cytochrome P-450 CYP1A2 Inducers (strong), Cytochrome P-450 CYP1A2 Inducers, Phenobarbital and similars, Central Nervous System Agents, Cytochrome P-450 CYP2C9 Inducers	approved, vet_approved	11
DB09129	Chromic chloride	Drug	Antioxidants, Anions, Acids, Noncarboxylic, Acids, Replacement Preparations, Protective Agents, Electrolytes, Ions, Minerals, Compounds used in a research, industrial, or household setting, Chlorine Compounds, Drugs that are Mainly Renally Excreted	approved	1
DB00795	Sulfasalazine	Drug	Aminosalicylate, Nephrotoxic agents, Immunosuppressive Agents, Sensory System Agents, Anti-Inflammatory Agents, Agents causing hyperkalemia, Genito Urinary System and Sex Hormones, OATP1B3 inhibitors, Non COX-2 selective NSAIDS, Amides, Anti-Infective Agents, Peripheral Nervous System Agents, Intestinal Antiinflammatory Agents, Sulfur Compounds, Analgesics, Alimentary Tract and Metabolism, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Salicylates, Sulfones, Gastrointestinal Agents, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, OATP1B1/SLCO1B1 Inhibitors, Gynecological Antiinfectives and Antiseptics, Antirheumatic Agents, BCRP/ABCG2 Inhibitors, BCRP/ABCG2 Substrates, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Sulfonamides, Agents that produce hypertension, Central Nervous System Agents, Methemoglobinemia Associated Agents	approved	10
DB00798	Gentamicin	Drug	Nephrotoxic agents, Carbohydrates, Enzyme Inhibitors, Antibiotics for Topical Use, Dermatologicals, Otologicals, Agents that produce neuromuscular block (indirect), Antiinfectives for Systemic Use, Ophthalmological and Otological Preparations, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Gentamicins, OAT1/SLC22A6 inhibitors, Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Ophthalmologicals, Anti-Bacterial Agents, Narrow Therapeutic Index Drugs, alpha-Galactosidase, antagonists & inhibitors, Aminoglycoside Antibacterials, Glycosides, Sensory Organs, Antibacterials for Systemic Use, Protein Synthesis Inhibitors	approved, vet_approved	5
DB00799	Tazarotene	Drug	Pyridines, Cytochrome P-450 Substrates, Prodrugs, Antipsoriatics for Topical Use, Noxae, Teratogens, Dermatologicals, Misc. Skin and Mucous Membrane Agents, Retinoids, Antipsoriatics, Toxic Actions, Cytochrome P-450 CYP2C8 Substrates, Keratolytic Agents	approved, investigational	4
DB12781	Balaglitazone	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Thiazoles, Blood Glucose Lowering Agents, Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP3A4 Substrates, Thiazolidinediones, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)	investigational	0
DB11450	Pimobendan	Drug	Cardiotonic Agents, Phosphodiesterase Inhibitors, Enzyme Inhibitors, Cytochrome P-450 Substrates, Protective Agents, Cytochrome P-450 CYP1A2 Substrates, Cardiovascular Agents, Vasodilating Agents, Compounds used in a research, industrial, or household setting	vet_approved	0
DB09130	Copper	Drug	Copper-containing Intrauterine Device, Metals, Metals, Heavy, Minerals, Decreased Embryonic Implantation, Elements, Transition Elements, Inhibit Ovum Fertilization, Trace Elements, Micronutrients, Physiological Phenomena, Decreased Sperm Motility, Replacement Preparations, Food and Beverages, Growth Substances, Diet, Food, and Nutrition, Food	approved, investigational	147
DB12780	Quinfamide	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB11452	Ponazuril	Drug	0	vet_approved	0
DB12783	Benserazide	Drug	Anti-Dyskinesia Agents, Hydrazines, Neurotransmitter Agents, Enzyme Inhibitors, Aromatic L-amino Acid Decarboxylase Inhibitors, Central Nervous System Agents, Drugs that are Mainly Renally Excreted, Anti-Parkinson Drugs, Dopamine Agents	approved, investigational	1
DB12782	SCH-486757	Drug	Aza Compounds	investigational	0
DB11451	Poloxalene	Drug	Surface-Active Agents, Disinfectants, Polyethylene Glycols, Ethylene Glycols, Glycols, Polymers, Compounds used in a research, industrial, or household setting, Anti-Infective Agents, Alcohols, Gastrointestinal Agents, Macromolecular Substances	investigational, vet_approved	0
DB11454	Prostalene	Drug	Biological Factors, Autacoids, Fatty Acids, Unsaturated, Inflammation Mediators, Prostaglandins, Fatty Acids, Eicosanoids, Lipids, Prostaglandins F, Synthetic, Prostaglandins, Synthetic	vet_approved	0
DB12785	Furaprevir	Drug	0	investigational	0
DB11453	Pradofloxacin	Drug	Fluoroquinolones, Quinolines, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Fluoroquinolone Antibacterial, Quinolones	vet_approved	0
DB12784	NS-018	Drug	0	investigational	0
DB11456	Ronnel	Drug	Sulfur Compounds, Organophosphorus Compounds	experimental, vet_approved	0
DB12787	Norethandrolone	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, Alimentary Tract and Metabolism, Norsteroids, Anabolic Steroids, Anabolic Agents, Anabolic Agents for Systemic Use, Hormones, Norpregnenes, Norpregnanes, Fused-Ring Compounds, Androstan Derivatives, Steroids	investigational	0
DB12786	Alvircept Sudotox	Drug	0	investigational	0
DB11455	Robenacoxib	Drug	Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Amines, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Aniline Compounds, Agents that produce hypertension, Selective Cyclooxygenase 2 Inhibitors (NSAIDs)	experimental, vet_approved	1
DB09137	Technetium Tc-99m mebrofenin	Drug	Acids, Acyclic, Hepatic and Reticulo Endothelial System, Laboratory Chemicals, Amino Acids, Peptides, and Proteins, Radiopharmaceutical Activity, OATP1B3 substrates, Amino Acids, Drugs that are Mainly Renally Excreted, Organometallic Compounds, Amino Acids, Cyclic, Diagnostic Uses of Chemicals, Imines, Diagnostic Radiopharmaceuticals, OATP1B1/SLCO1B1 Substrates, Radioactive Diagnostic Agent, Indicators and Reagents, Radiopharmaceuticals, Compounds used in a research, industrial, or household setting, Technetium (99Mtc) Compounds	approved	0
DB11458	Roxarsone	Drug	Organometallic Compounds, Coccidiostats, Anti-Bacterial Agents, Antiprotozoals, Arsenicals, Anti-Infective Agents, Antiparasitic Agents	vet_approved	0
DB12789	Dinoprost	Drug	Biological Factors, Autacoids, Inflammation Mediators, Fatty Acids, Genito Urinary System and Sex Hormones, Reproductive Control Agents, Eicosanoids, Lipids, Abortifacient Agents, Nonsteroidal, Uterotonic agents, Fatty Acids, Unsaturated, Prostaglandins, Abortifacient Agents, Prostaglandins F	approved, investigational	1
DB11457	Rotenone	Drug	Enzyme Inhibitors, Uncoupling Agents, Pesticides, Insecticides, Benzopyrans, Heterocyclic Compounds, Fused-Ring, Flavonoids, Agrochemicals, Toxic Actions, Compounds used in a research, industrial, or household setting, Chromones, Isoflavones, Pyrans	vet_approved	0
DB12788	Glucagon-like peptide II	Drug	0	investigational	0
DB09138	Technetium Tc-99m medronate	Drug	Organotechnetium Compounds, Laboratory Chemicals, Organophosphorus Compounds, Radiopharmaceutical Activity, Organometallic Compounds, Organophosphonates, Diagnostic Uses of Chemicals, Diagnostic Radiopharmaceuticals, Radioactive Diagnostic Agent, Indicators and Reagents, Skeleton, Radiopharmaceuticals, Compounds used in a research, industrial, or household setting, Technetium (99Mtc) Compounds	approved	0
DB09135	Ioxilan	Drug	Benzoates, Acids, Carbocyclic, Drugs that are Mainly Renally Excreted, Iodobenzoates, Iodinated Contrast Agents, Contrast Media, Diagnostic Uses of Chemicals, Radiographic Contrast Agent, Triiodobenzoic Acids, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting, X-Ray Contrast Activity, Benzene Derivatives, Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media	approved	0
DB09136	Isosulfan blue	Drug	Amines, Aniline Compounds, Coloring Agents, Compounds used in a research, industrial, or household setting, Drugs that are Mainly Renally Excreted	approved	0
DB11459	Selamectin	Drug	Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Anti-Infective Agents, Antiparasitic Agents, Lactones	vet_approved	0
DB09133	Iothalamic acid	Drug	Carbohydrates, Benzoates, Acids, Carbocyclic, Roentgenography, Drugs that are Mainly Renally Excreted, Alcohols, Amino Sugars, Iodobenzoates, Contrast Media, Diagnostic Uses of Chemicals, Radiographic Contrast Agent, Sugar Alcohols, Hexosamines, Triiodobenzoic Acids, Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting, X-Ray Contrast Activity, Benzene Derivatives	approved	0
DB09134	Ioversol	Drug	Benzoates, Acids, Carbocyclic, Roentgenography, Drugs that are Mainly Renally Excreted, Iodobenzoates, Iodinated Contrast Agents, Contrast Media, Diagnostic Uses of Chemicals, Radiographic Contrast Agent, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting, X-Ray Contrast Activity, Benzene Derivatives, Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media	approved	0
DB09131	Cupric Chloride	Drug	Metals, Metals, Heavy, Elements, Transition Elements	approved, investigational	2
DB09132	Gadoteric acid	Drug	Magnetic Resonance Imaging Contrast Media, Carbohydrates, Roentgenography, Drugs that are Mainly Renally Excreted, Alcohols, Amino Sugars, Paramagnetic Contrast Media, Contrast Media, Diagnostic Uses of Chemicals, Sequestering Agents, Sugar Alcohols, Hexosamines, Compounds used in a research, industrial, or household setting, Chelating Agents, Gadolinium-based Contrast Agent	approved	0
DB09139	Technetium Tc-99m oxidronate	Drug	Organometallic Compounds, Organophosphonates, Diagnostic Radiopharmaceuticals, Organophosphorus Compounds, Radioactive Diagnostic Agent, Radiopharmaceutical Activity, Skeleton, Drugs that are Mainly Renally Excreted, Technetium (99Mtc) Compounds	approved	0
DB12710	Perazine	Drug	Psycholeptics, Tranquilizing Agents, Nervous System, Phenothiazines, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Antipsychotic Agents, Sulfur Compounds, Central Nervous System Depressants, Central Nervous System Agents, Dopamine Antagonists, Phenothiazines With Piperazine Structure, Dopamine Agents, Neurotoxic agents	approved, investigational	0
DB12712	Pilsicainide	Drug	Anilides, QTc Prolonging Agents, Amines, Aniline Compounds, Amides, BSEP/ABCB11 Substrates, Potential QTc-Prolonging Agents, Cardiovascular Agents, Sodium Channel Blockers, Acetanilides, Membrane Transport Modulators, Antiarrhythmic agents	investigational	0
DB12711	LTX-109	Drug	Peptides, Peptidomimetics, Amino Acids, Peptides, and Proteins	investigational	0
DB12714	Nerispirdine	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB12713	Sotagliflozin	Drug	Carbohydrates, Sodium-Glucose Transporter 2 Inhibitors, Blood Glucose Lowering Agents, Sodium-Glucose Transporter 1, antagonists & inhibitors	investigational	0
DB12716	NB-001	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Enzyme Inhibitors, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides, Adenine Nucleotides, Adenylyl Cyclase Inhibitors	investigational	0
DB12715	MSX-122	Drug	Receptors, CXCR4, antagonists & inhibitors	investigational	0
DB12718	Carlumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB12717	Mibampator	Drug	Sulfur Compounds, Amides, Benzene Derivatives, Sulfones	investigational	0
DB12709	Tributyrin	Drug	Glycerides, Lipids	investigational	0
DB12708	Sulprostone	Drug	Biological Factors, Autacoids, Inflammation Mediators, Fatty Acids, Menstruation-Inducing Agents, Genito Urinary System and Sex Hormones, Reproductive Control Agents, Eicosanoids, Lipids, Abortifacient Agents, Nonsteroidal, Uterotonic agents, Fatty Acids, Unsaturated, Prostaglandins, Abortifacient Agents, Prostaglandins E	investigational	0
DB00730	Thiabendazole	Drug	Benzimidazoles, Antiparasitic Products, Insecticides and Repellents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Antihelminthic, Dermatologicals, Antifungals for Dermatological Use, Anthelmintics, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Benzimidazole Derivatives, Cytochrome P-450 CYP1A2 Inhibitors, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Antifungals for Topical Use, Cytochrome P-450 CYP1A2 Substrates, Thiazoles, Imidazole and Triazole Derivatives, Antinematodal Agents, Antiparasitic Agents	approved, vet_approved	1
DB00731	Nateglinide	Drug	Amino Acids, Aromatic, Glinide, Cycloparaffins, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Potassium Channel Antagonists, Cytochrome P-450 CYP3A7 Substrates, Phenylalanine, Amino Acids, Essential, Hypoglycemia-Associated Agents, Amino Acids, Peptides, and Proteins, Blood Glucose Lowering Agents, Cytochrome P-450 CYP3A4 Substrates, Amino Acids, Drugs that are Mainly Renally Excreted, Cyclohexanes, OAT1/SLC22A6 inhibitors, Amino Acids, Cyclic, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, Alimentary Tract and Metabolism, UGT1A9 Substrates, Drugs Used in Diabetes, Cytochrome P-450 CYP2D6 Substrates	approved, investigational	2
DB00734	Risperidone	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Psycholeptics, QTc Prolonging Agents, Tranquilizing Agents, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Serotonin 5-HT2 Receptor Antagonists, Antipsychotic Agents, Histamine H1 Antagonists, Pyrimidines, Antipsychotic Agents (Second Generation Atypical), Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Adrenergic Antagonists, Potential QTc-Prolonging Agents, Adrenergic alpha-1 Receptor Antagonists, Dopamine Antagonists, Agents that reduce seizure threshold, Dopamine Agents, Neurotoxic agents, Cytochrome P-450 CYP3A5 Substrates, Adrenergic alpha-Antagonists, P-glycoprotein substrates, Pyrimidinones, Psychotropic Drugs, Neurotransmitter Agents, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Agents that produce hypertension, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Dopamine D2 Receptor Antagonists, Hyperglycemia-Associated Agents, Serotonin 5-HT1 Receptor Antagonists, Cytochrome P-450 CYP2D6 Inhibitors (weak)	approved, investigational	13
DB00735	Naftifine	Drug	Allylamine Antifungal, Amines, Alkenes, Antifungals for Topical Use, Dermatologicals, Hydrocarbons, Acyclic, Antifungals for Dermatological Use, Antifungal Agents, Anti-Infective Agents, Allyl Compounds	approved	1
DB00732	Atracurium besylate	Drug	Neuromuscular Agents, Benzylisoquinolines, Isoquinolines, Neuromuscular-Blocking Agents (Nondepolarizing), Nicotinic Antagonists, Peripheral Nervous System Agents, Anticholinergic Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cholinergic Agents, Miscellaneous Skeletal Muscle Relaxants, Central Nervous System Depressants, Neuromuscular Blocking Agents	approved	1
DB00733	Pralidoxime	Drug	Oximes, Neurotransmitter Agents, Amines, Antidotes, Cholinergic Agents, Cholinesterase Reactivators, Protective Agents, Hydroxylamines, Enzyme Reactivators, Compounds used in a research, industrial, or household setting, Drugs that are Mainly Renally Excreted	approved, vet_approved	2
DB00738	Pentamidine	Drug	Miscellaneous Antiprotozoals, Nephrotoxic agents, QTc Prolonging Agents, Benzamidines, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Antibiotics for Pneumocystis Pneumonia, Agents causing hyperkalemia, Hypoglycemia-Associated Agents, Amidines, Blood Glucose Lowering Agents, Moderate Risk QTc-Prolonging Agents, Anti-Infective Agents, Cytochrome P-450 CYP2C19 Substrates, Agents Against Leishmaniasis and Trypanosomiasis, Cytochrome P-450 CYP3A Substrates, Trypanocidal Agents, Antifungal Agents, Cytochrome P-450 CYP2D6 Substrates, Hyperglycemia-Associated Agents, Antiparasitic Agents	approved, investigational	2
DB00739	Hetacillin	Drug	Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Penicillins With Extended Spectrum, Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Antibacterials for Systemic Use	approved, withdrawn, vet_approved	5
DB00736	Esomeprazole	Drug	Benzimidazoles, Enzyme Inhibitors, Proton-pump Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors, Anti-Ulcer Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Sulfur Compounds, Antiinflammatory and Antirheumatic Products, Non-Steroids, Alimentary Tract and Metabolism, Musculo-Skeletal System, Acid Reducers, Drugs causing inadvertant photosensitivity, Drugs for Acid Related Disorders, Gastrointestinal Agents, Pyridines, Proton Pump Inhibitors, P-glycoprotein substrates, Sulfoxides, Cytochrome P-450 CYP2C19 Substrates, Heterocyclic Compounds, Fused-Ring, Gastric Acid Lowering Agents, Antiinflammatory and Antirheumatic Products, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Propionates, 2-Pyridinylmethylsulfinylbenzimidazoles, Cytochrome P-450 CYP2C19 Inhibitors (weak), OAT3/SLC22A8 Inhibitors, P-glycoprotein inhibitors	approved, investigational	2
DB00737	Meclizine	Drug	Autonomic Agents, Anti-Allergic Agents, Cytochrome P-450 Substrates, Piperazines, Benzhydryl Compounds, Peripheral Nervous System Agents, Neurotransmitter Agents, Histamine H1 Antagonists, Piperazine Derivatives, Emesis Suppression, Histamine Antagonists, Antivertigo Preparations, Central Nervous System Depressants, Antiemetics, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Histamine Agents, Antihistamines for Systemic Use, Benzene Derivatives, Gastrointestinal Agents	approved	2
DB12721	RO-5028442	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB12720	Nivocasan	Drug	0	investigational	0
DB12722	N-sulfoglucosamine sulfohydrolase recombinant	Drug	0	investigational	0
DB12725	TD-8954	Drug	Heterocyclic Compounds, Fused-Ring, Serotonin Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Serotonin Receptor Agonists, Antidepressive Agents, Serotonin 5-HT4 Receptor Agonists	investigational	0
DB12724	AZD-7295	Drug	0	investigational	0
DB12727	Perfosfamide	Drug	Organophosphorus Compounds, Hydrocarbons, Halogenated, Ions, Mustard Compounds, Nitrogen Mustard Compounds, Phosphorus Compounds, Phosphorus Acids, Anions, Acids, Noncarboxylic, Acids, Phosphoric Acids, Phosphoramides, Electrolytes, Phosphoramide Mustards	investigational	0
DB12726	Monteplase	Drug	Anticoagulants, Biological Factors, Enzymes, Fibrin Modulating Agents, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Hematologic Agents, Cardiovascular Agents, Fibrinolytic Agents, Proteins, Blood Proteins, Serine Proteases, Hydrolases, Peptide Hydrolases, Serine Endopeptidases, Endopeptidases	investigational	0
DB12729	ASP-3026	Drug	Sulfur Compounds	investigational	0
DB12728	Fenpropidin	Drug	Fungicides, Industrial, Agrochemicals, Pesticides, Toxic Actions, Compounds used in a research, industrial, or household setting	approved, experimental	0
DB12719	Turofexorate isopropyl	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB00741	Hydrocortisone	Drug	Corticosteroids, Dermatological Preparations, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 CYP3A7 Substrates, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Otologicals, Cytochrome P-450 CYP2C19 Inducers (strength unknown), Cytochrome P-450 CYP2B6 Inducers (strength unknown), Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Corticosteroids for Local Oral Treatment, Cytochrome P-450 CYP2C9 Inducers (strength unknown), OAT3/SLC22A8 Substrates, Intestinal Antiinflammatory Agents, Nasal Preparations, Alimentary Tract and Metabolism, Cytochrome P-450 CYP2C19 Inducers, Corticosteroids Acting Locally, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, 11-Hydroxycorticosteroids, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Corticosteroid Hormone Receptor Agonists, Corticosteroids for Systemic Use, Corticosteroids, Cytochrome P-450 CYP3A5 Substrates, Corticosteroids for Systemic Use, Plain, Corticosteroids, Weak (Group I), Cytochrome P-450 CYP3A4 Inducers, Hydroxycorticosteroids, Ophthalmologicals, Pregnanes, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Pregnenes, Cytochrome P-450 CYP2C8 Inducers, Pregnenediones, Anti-Inflammatory Agents, Ophthalmological and Otological Preparations, Fused-Ring Compounds, Vasoprotectives, Cytochrome P-450 Enzyme Inducers, Adrenals, Cytochrome P-450 CYP2B6 Inducers, 17-Hydroxycorticosteroids, Cytochrome P-450 CYP2A6 Inducers, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein substrates, Dermatologicals, Hydrocortisone and derivatives, P-glycoprotein inducers, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inducers, Sensory Organs, Hyperglycemia-Associated Agents, Stomatological Preparations, Steroids	approved, vet_approved	2
DB00742	Mannitol	Drug	Nephrotoxic agents, Blood and Blood Forming Organs, Increased Diuresis, Solutions Producing Osmotic Diuresis, Agents causing hyperkalemia, Flavoring Agents, Cardiovascular Agents, Hypotensive Agents, Blood Substitutes and Perfusion Solutions, Irrigating Solutions, Drugs that are Mainly Renally Excreted, Alcohols, Physiological Phenomena, Cough and Cold Preparations, Alimentary Tract and Metabolism, Osmotic Laxatives, Food and Beverages, Diuretics, Food Ingredients, Compounds used in a research, industrial, or household setting, Osmotic Activity, Diet, Food, and Nutrition, Food, Food Additives, Carbohydrates, P-glycoprotein substrates, Drugs for Constipation, i.v. Solutions, Pharmaceutic Aids, Kidney Function, Diuretics, Osmotic, Expectorants, Sugar Alcohols, Natriuretic Agents, Laxatives, Pharmaceutical Preparations, Sweetening Agents	approved, investigational	0
DB00740	Riluzole	Drug	Neuroprotective Agents, Cytochrome P-450 Substrates, Nervous System, Protective Agents, Miscellaneous Central Nervous System Agents, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Anticonvulsants, Sulfur Compounds, BCRP/ABCG2 Substrates, Central Nervous System Depressants, Cytochrome P-450 CYP1A2 Substrates, Thiazoles, Central Nervous System Agents, Excitatory Amino Acid Agents, Compounds used in a research, industrial, or household setting, Excitatory Amino Acid Antagonists, Benzothiazoles	approved, investigational	2
DB00745	Modafinil	Drug	Wakefulness-Promoting Agents, Central Nervous System Stimulants, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP3A Inducers, Increased Sympathetic Activity, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (weak), Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inducers (moderate), Cytochrome P-450 Enzyme Inducers, Stimulants, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2B6 Inducers, Benzene Derivatives, Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Inducers (moderate), Benzhydryl Compounds, Chemically-Induced Disorders, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A5 Inhibitors, Psychostimulants, Agents Used for Adhd and Nootropics, Sympathomimetic-like Agent, Central Nervous System Stimulation, Centrally Acting Sympathomimetics, Cytochrome P-450 CYP3A4 Inducers (weak), Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inducers, Cytochrome P-450 CYP3A5 Inducers (weak), Central Nervous System Agents, Cytochrome P-450 CYP2C9 Inducers, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), Psychoanaleptics	approved, investigational	2
DB00746	Deferoxamine	Drug	Siderophores, Amines, Hydroxy Acids, Iron Chelating Agents, Hydroxylamines, Iron Chelating Activity, Sequestering Agents, Compounds used in a research, industrial, or household setting, Chelating Agents, Hydroxamic Acids, Heavy Metal Antagonists	approved, investigational	3
DB00743	Gadobenic acid	Drug	Magnetic Resonance Imaging Contrast Media, Carbohydrates, Other Diagnostics, QTc Prolonging Agents, Paramagnetic Contrast Agent, Moderate Risk QTc-Prolonging Agents, Drugs that are Mainly Renally Excreted, Alcohols, Amino Sugars, Paramagnetic Contrast Media, Contrast Media, Diagnostic Uses of Chemicals, Magnetic Resonance Contrast Activity, Sugar Alcohols, Hexosamines, Compounds used in a research, industrial, or household setting, Gadolinium-based Contrast Agent	approved, investigational	0
DB00744	Zileuton	Drug	Analgesics, Non-Narcotic, Enzyme Inhibitors, Cytochrome P-450 Substrates, Sensory System Agents, Cytochrome P-450 Enzyme Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Anti-Inflammatory Agents, Leukotriene Antagonists, Cytochrome P-450 CYP3A4 Substrates, Peripheral Nervous System Agents, Cytochrome P-450 CYP2C9 Substrates, Agents to Treat Airway Disease, Cytochrome P-450 CYP3A Inhibitors, Analgesics, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, UGT1A9 Substrates, Central Nervous System Agents, Hormone Antagonists, Decreased Leukotriene Production, Lipoxygenase Inhibitors	approved, investigational, withdrawn	1
DB00749	Etodolac	Drug	Nephrotoxic agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Sensory System Agents, Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Agents causing hyperkalemia, UGT1A3 substrates, Drugs that are Mainly Renally Excreted, Selective Cyclooxygenase 2 Inhibitors (NSAIDs), Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Non-Steroids, COX-2 Inhibitors, UGT2B7 substrates, Analgesics, Musculo-Skeletal System, Indoles, Drugs causing inadvertant photosensitivity, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Acetic Acid Derivatives and Related Substances, Antirheumatic Agents, OAT1/SLC22A6 inhibitors, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Antiinflammatory and Antirheumatic Products, Photosensitizing Agents, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Agents that produce hypertension, UGT1A9 Substrates, Central Nervous System Agents, Other Nonsteroidal Anti-inflammatory Agents, Indoleacetic Acids	approved, investigational, vet_approved	3
DB00747	Scopolamine	Drug	Psycholeptics, Solanaceous Alkaloids, Antimuscarinics Antispasmodics, Nervous System, Belladonna Alkaloids, Muscarinic Antagonists, Peripheral Nervous System Agents, Anticholinergic Agents, Alkaloids, Cholinergic Agents, Alimentary Tract and Metabolism, Aza Compounds, Azabicyclo Compounds, Hypnotics and Sedatives, Scopolamine Derivatives, Gastrointestinal Agents, Autonomic Agents, Antiemetics and Antinauseants, Mydriatics and Cycloplegics, Adjuvants, Agents producing tachycardia, Ophthalmologicals, Neurotransmitter Agents, Tropanes, Mydriatics, Central Nervous System Depressants, Antiemetics, Adjuvants, Anesthesia, Central Nervous System Agents, Sensory Organs, P-glycoprotein inhibitors	approved, investigational	8
DB00748	Carbinoxamine	Drug	QTc Prolonging Agents, Cytochrome P-450 Substrates, Moderate Risk QTc-Prolonging Agents, Neurotransmitter Agents, Histamine H1 Antagonists, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Central Nervous System Depressants, Drugs causing inadvertant photosensitivity, Histamine Agents, Aminoalkyl Ethers, Antihistamines for Systemic Use	approved	1
DB12730	Dolastatin 10	Drug	Peptides, Cyclic, Peptides, Tubulin Modulators, Antimitotic Agents, Antineoplastic Agents, Mitosis Modulators, Amino Acids, Peptides, and Proteins	investigational	0
DB12732	Firategrast	Drug	Proteins, Serum Globulins, Globulins, Anti-Inflammatory Agents, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB11401	Efrotomycin	Drug	Pyridines, Anti-Bacterial Agents, Anti-Infective Agents	vet_approved	0
DB11400	Doramectin	Drug	Tranquilizing Agents, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Pesticides, Anthelmintics, Insecticides, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Anti-Infective Agents, Lactones, Anti-Bacterial Agents, Anticonvulsants, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Agrochemicals, Central Nervous System Depressants, Cytochrome P-450 CYP3A4 Inhibitors, Toxic Actions, Anti-Anxiety Agents, Central Nervous System Agents, Compounds used in a research, industrial, or household setting, Antiparasitic Agents	vet_approved	0
DB12731	Daporinad	Drug	Acids, Acyclic, Acrylates, Amides	investigational	1
DB12734	Demcizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB11403	Emodepside	Drug	Peptides, Cyclic, Peptides, Amino Acids, Peptides, and Proteins, Anti-Infective Agents, Antiparasitic Agents	investigational, vet_approved	0
DB12733	Dipraglurant	Drug	0	investigational	1
DB12736	Etanidazole	Drug	Imidazoles, Nitro Compounds, Antineoplastic Agents, Nitroimidazoles, Radiation-Sensitizing Agents	investigational	0
DB11405	Eprinomectin	Drug	Cytochrome P-450 Enzyme Inhibitors, Macrolides, Pesticides, Anthelmintics, Insecticides, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Anti-Infective Agents, Lactones, Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Agrochemicals, Cytochrome P-450 CYP3A4 Inhibitors, Toxic Actions, Compounds used in a research, industrial, or household setting, Antiparasitic Agents	vet_approved	0
DB11404	Enrofloxacin	Drug	Cytochrome P-450 CYP1A2 Inhibitors, Fluoroquinolones, Quinolines, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Anti-Infective Agents, Quinolones	vet_approved	0
DB12738	Tiplimotide	Drug	Membrane Proteins, Proteins, Peptides, Myelin Proteins, Amino Acids, Peptides, and Proteins, Nerve Tissue Proteins	investigational	0
DB12737	Brontictuzumab	Drug	0	investigational	0
DB11409	Febantel	Drug	Antiprotozoals, Anthelmintics, Amidines, Anti-Infective Agents, Antiparasitic Agents	experimental, vet_approved	0
DB11408	Famphur	Drug	Organothiophosphorus Compounds, QTc Prolonging Agents, Sulfur Compounds, Agrochemicals, Pesticides, Organophosphorus Compounds, Insecticides, Potential QTc-Prolonging Agents, Toxic Actions, Compounds used in a research, industrial, or household setting, Organophosphates	vet_approved	0
DB12739	Bindarit	Drug	Acids, Acyclic, Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Fatty Acids, Anti-Inflammatory Agents, Fatty Acids, Volatile, Pyrazoles, Lipids, Protein Synthesis Inhibitors	investigational	0
DB00752	Tranylcypromine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, Tranquilizing Agents, Enzyme Inhibitors, Amines, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2A6 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Hypotensive Agents, Antidepressive Agents, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Monoamine Oxidase Inhibitors, Non-Selective, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP2A6 Inhibitors (strong), Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Serotonin Modulators, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Agents that reduce seizure threshold, Cytochrome P-450 CYP2E1 Inhibitors, Monoamine Oxidase Inhibitors, Psychotropic Drugs, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Agents that produce hypertension, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Anti-Anxiety Agents, Central Nervous System Agents, Propylamines, Psychoanaleptics	approved, investigational	2
DB00753	Isoflurane	Drug	QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Hydrocarbons, Halogenated, Hypotensive Agents, Cytochrome P-450 CYP2B6 Inhibitors, Anticholinergic Agents, Anesthetics, General, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2B6 Inducers, Potential QTc-Prolonging Agents, Ethers, Agents that reduce seizure threshold, Anesthetics, Inhalation, Cytochrome P-450 CYP2E1 Substrates, Methyl Ethers, Anesthetics, Nicotinic Antagonists, Central Nervous System Depressants, Agents that produce hypertension, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)	approved, vet_approved	10
DB00750	Prilocaine	Drug	Amines, Sensory System Agents, Nervous System, Local Anesthesia, Aniline Compounds, Amides, Anesthetics, Peripheral Nervous System Agents, Anilides, Amide Local Anesthetic, Central Nervous System Agents, Methemoglobinemia Associated Agents, Anesthetics, Local	approved	1
DB00751	Epinastine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Decongestants and Antiallergics, Ophthalmics, Serotonin 5-HT2 Receptor Antagonists, Histamine H1 Antagonists, Decreased Histamine Release, Acid Reducers, Potential QTc-Prolonging Agents, Histamine H1 Inhibitors, P-glycoprotein substrates, Histamine H2 Antagonists, Ophthalmologicals, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Serotonin Receptor Antagonists, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Sensory Organs, Histamine Agents, Cytochrome P-450 CYP2D6 Inhibitors (weak)	approved, investigational	6
DB00756	Hexachlorophene	Drug	Hydrocarbons, Chlorinated, Antiseptics and Disinfectants, Dermatologicals, Hydrocarbons, Halogenated, Chlorophenols, Chlorobenzenes, Anti-Infective Agents, Anti-Infective Agents, Local, Photosensitizing Agents, Phenols, Drugs causing inadvertant photosensitivity, Benzene Derivatives, Phenol and Derivatives	approved, withdrawn	4
DB00757	Dolasetron	Drug	Autonomic Agents, Antiemetics and Antinauseants, QTc Prolonging Agents, Cytochrome P-450 Substrates, Serotonin Agents, Serotonin 5-HT3 Receptor Antagonists, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Moderate Risk QTc-Prolonging Agents, Peripheral Nervous System Agents, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Serotonin 3 Receptor Antagonists, Cytochrome P-450 CYP3A Substrates, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Alimentary Tract and Metabolism, Central Nervous System Depressants, Antiemetics, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Gastrointestinal Agents	approved, investigational	1
DB00754	Ethotoin	Drug	Decreased Central Nervous System Disorganized Electrical Activity, Voltage-Gated Sodium Channel Blockers, Nervous System, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Anti-epileptic Agent, Hydantoins, Imidazolidines, Membrane Transport Modulators, Thyroxine-binding globulin substrates, Anticonvulsants, Cytochrome P-450 Enzyme Inducers, Imidazoles, Central Nervous System Depressants, Central Nervous System Agents, Sodium Channel Blockers	approved	2
DB00755	Tretinoin	Drug	Cytochrome P-450 Substrates, Immunosuppressive Agents, Alkenes, Cytochrome P-450 CYP3A7 Substrates, Retinoids for Topical Use in Acne, Cyclohexenes, Cardiotoxic antineoplastic agents, Hypotensive Agents, Retinoids, Cytochrome P-450 CYP3A4 Substrates, Cell Stimulants and Proliferants, Cyclohexanes, Vitamin A, Carotenoids, Polyenes, Cytochrome P-450 CYP2C8 Substrates, Keratolytic Agents, Tretinoin, Biological Factors, Cycloparaffins, Cytochrome P-450 CYP2C18 Substrates, Cytochrome P-450 CYP3A5 Substrates, Antineoplastic and Immunomodulating Agents, Dermatologicals, Hydrocarbons, Acyclic, Antineoplastic Agents, Anti-Acne Preparations, Vitamins, Pigments, Biological, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, Vitamins (Fat Soluble), Cytochrome P-450 CYP2A6 Substrates, Cytochrome P-450 CYP2B6 Substrates, Terpenes, Anti-Acne Preparations for Topical Use	approved, investigational, nutraceutical	18
DB00758	Clopidogrel	Drug	Blood and Blood Forming Organs, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, OCT1 inhibitors, Purinergic Agents, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Sulfur Compounds, Cytochrome P-450 CYP2B6 Inhibitors (moderate), Thiophenes, Cytochrome P-450 CYP2C9 Inhibitors, Purinergic Antagonists, Antiplatelet agents, Pyridines, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, Purinergic P2 Receptor Antagonists, Thienopyridines, Hematologic Agents, Cytochrome P-450 CYP2C8 Inhibitors (strong), Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Platelet Aggregation Inhibitors Excl. Heparin, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Decreased Platelet Aggregation, OCT2 Inhibitors, Cytochrome P-450 CYP1A2 Substrates, Purinergic P2Y Receptor Antagonists, Cytochrome P-450 CYP2B6 Substrates, P2Y12 Platelet Inhibitor	approved	1
DB00759	Tetracycline	Drug	Enzyme Inhibitors, Antibiotics for Topical Use, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Tetracycline, antagonists & inhibitors, Otologicals, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Agents that produce neuromuscular block (indirect), Cytochrome P-450 CYP3A4 Substrates, Ophthalmological and Otological Preparations, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, OAT3/SLC22A8 Substrates, Anti-Bacterial Agents, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Antiinfectives and Antiseptics for Local Oral Treatment, Alimentary Tract and Metabolism, Naphthacenes, Drugs causing inadvertant photosensitivity, Drugs for Acid Related Disorders, Protein Synthesis Inhibitors, Dermatologicals, Antiinfectives for Systemic Use, OAT1/SLC22A6 inhibitors, Ophthalmologicals, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Tetracyclines, Cytochrome P-450 CYP3A4 Inhibitors, OAT3/SLC22A8 Inhibitors, Sensory Organs, Antibacterials for Systemic Use, Stomatological Preparations	approved, vet_approved	9
DB11410	Fenbendazole	Drug	Acids, Acyclic, Heterocyclic Compounds, Fused-Ring, Benzimidazoles, Antiparasitic Products, Insecticides and Repellents, Anthelmintics, Carbamates, Anti-Infective Agents, Antinematodal Agents, Antiparasitic Agents, Benzimidazole Derivatives	vet_approved	0
DB12741	DTP-348	Drug	0	investigational	0
DB12740	CC-115	Drug	0	investigational	0
DB11412	Fenthion	Drug	Organothiophosphorus Compounds, QTc Prolonging Agents, Enzyme Inhibitors, Cholinesterase Inhibitors, Pesticides, Organophosphorus Compounds, Insecticides, Organophosphates, Neurotransmitter Agents, Sulfur Compounds, Cholinergic Agents, Agrochemicals, Organothiophosphates, Potential QTc-Prolonging Agents, Toxic Actions, Compounds used in a research, industrial, or household setting	vet_approved	0
DB12743	Z-160	Drug	0	investigational	0
DB11411	Fenprostalene	Drug	Biological Factors, Autacoids, Fatty Acids, Unsaturated, Inflammation Mediators, Prostaglandins, Fatty Acids, Abortifacient Agents, Reproductive Control Agents, Eicosanoids, Lipids, Abortifacient Agents, Nonsteroidal, Prostaglandins, Synthetic	vet_approved	0
DB12742	Amuvatinib	Drug	0	investigational	6
DB12745	GSK-690693	Drug	Oxazoles	investigational	0
DB11413	Florfenicol	Drug	Anti-Bacterial Agents, Nitrobenzenes, Nitro Compounds, Glycols, Propylene Glycols, Anti-Infective Agents, Benzene Derivatives, Alcohols	experimental, vet_approved	0
DB12744	CGI-1842	Drug	Receptor, EphB4, antagonists & inhibitors, Heterocyclic Compounds, Fused-Ring, Benzene Derivatives	investigational	0
DB12747	Tertomotide	Drug	0	investigational	1
DB11416	Gamithromycin	Drug	Anti-Bacterial Agents, Polyketides, Anti-Infective Agents, Lactones	vet_approved	0
DB12746	AKN-028	Drug	0	investigational	0
DB12749	Butylphthalide	Drug	Heterocyclic Compounds, Fused-Ring, Neuroprotective Agents, Drugs, Chinese Herbal, Protective Agents, Hematologic Agents, Central Nervous System Agents, Compounds used in a research, industrial, or household setting, Antiplatelet agents	investigational	0
DB11417	Gleptoferron	Drug	Acids, Acyclic, Carbohydrates, Hydroxy Acids, Iron Compounds, Biopolymers, Macromolecular Substances, Organometallic Compounds, Ferric Compounds, Polysaccharides, Dextrans, Glucans, Pharmaceutical Preparations, Polymers, Compounds used in a research, industrial, or household setting	vet_approved	0
DB12748	LTX-315	Drug	Peptides, Amino Acids, Peptides, and Proteins	investigational	0
DB11419	Haloxon	Drug	Heterocyclic Compounds, Fused-Ring, Coumarins, Benzopyrans, Pyrans	vet_approved	0
DB00760	Meropenem	Drug	Amides, Lactams, beta-Lactams, Penem Antibacterial, Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Carbapenems, Thienamycins, Antibacterials for Systemic Use	approved, investigational	1
DB00763	Methimazole	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Thyroid Hormone Synthesis Inhibitors, Thyroid Products, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2A6 Inhibitors, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Drugs that are Mainly Renally Excreted, Thyroid Hormone Synthesis Inhibitor, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strong), Sulfur Compounds, Cytochrome P-450 CYP2C9 Inhibitors, Sulfur-Containing Imidazole Derivatives, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Hormone Antagonists, Antithyroid agents, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Cytochrome P-450 CYP2E1 Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP2E1 Inhibitors (weak), Myelosuppressive Agents, Cytochrome P-450 CYP3A Inhibitors, Imidazoles, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2B6 Inhibitors (strong), Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2A6 Inhibitors (weak), Cytochrome P-450 CYP2D6 Inhibitors (weak), Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved	1
DB00764	Mometasone	Drug	Corticosteroids, Dermatological Preparations, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Glucocorticoids, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Nasal Preparations, Corticosteroids, Potent (Group III), Adrenals, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Corticosteroid Hormone Receptor Agonists, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Cytochrome P-450 CYP3A5 Inducers, Pregnadienediols, Anti-Allergic Agents, Corticosteroids, Pregnadienes, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Inducers, Dermatologicals, Cytochrome P-450 CYP3A Substrates, Pregnanes, Drugs for Obstructive Airway Diseases, Thyroxine-binding globulin inhibitors, Hyperglycemia-Associated Agents, Steroids	experimental	2
DB00761	Potassium chloride	Drug	Potassium Salt, Blood and Blood Forming Organs, Agents causing hyperkalemia, Ions, Mineral Supplements, Blood Substitutes and Perfusion Solutions, Minerals, Hemodialysis Solution, Electrolyte Solutions, Potassium Compounds, Drugs that are Mainly Renally Excreted, Anions, Acids, Noncarboxylic, I.V. Solution Additives, Acids, Replacement Preparations, Alimentary Tract and Metabolism, Chlorides, Electrolytes, Chlorine Compounds	approved, withdrawn	6
DB00762	Irinotecan	Drug	Enzyme Inhibitors, Cytochrome P-450 Substrates, Immunosuppressive Agents, Topoisomerase Inhibitors, Cytochrome P-450 CYP3A7 Substrates, Topoisomerase I Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Alkaloids, Polysaccharides, Carbohydrates, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Disaccharides, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Oligosaccharides, Myelosuppressive Agents, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Substrates, UGT1A1 Substrates, UGT1A9 Substrates, Cholinesterase substrates, Pharmaceutical Preparations, Cytochrome P-450 CYP2B6 Substrates	approved, investigational	2
DB00767	Benzquinamide	Drug	Anticholinergic Agents, Heterocyclic Compounds, Fused-Ring, Histamine H1 Antagonists, Histamine Antagonists, Agents producing tachycardia, Muscarinic Antagonists, P-glycoprotein inhibitors	withdrawn	6
DB00768	Olopatadine	Drug	QTc Prolonging Agents, Cytochrome P-450 Substrates, Sensory System Agents, Anti-Inflammatory Agents, Cytochrome P-450 CYP3A4 Substrates, Decongestants and Antiallergics, Peripheral Nervous System Agents, Histamine H1 Antagonists, Nasal Preparations, Decreased Histamine Release, Antiallergic Agents, Excl. Corticosteroids, Histamine H1 Inhibitors, Dibenzoxepins, Anti-Allergic Agents, P-glycoprotein substrates, Ophthalmologicals, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Histamine H1 Antagonists, Non-Sedating, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Mast Cell Stabilizers, Antihistamine Drugs, Central Nervous System Agents, Sensory Organs, Histamine Agents	approved	8
DB00765	Metyrosine	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Methyltyrosines, Tyrosine Hydroxylase Inhibitors, Enzyme Inhibitors, Catecholamine Synthesis Inhibitor, Amino Acids, Peptides, and Proteins, Antihypertensive Agents, Amino Acids	approved	1
DB00766	Clavulanic acid	Drug	Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Enzyme Inhibitors, Lactams, beta-Lactamase Inhibitors, beta-Lactams, Anti-Infective Agents	approved, vet_approved	1
DB00769	Hydrocortamate	Drug	Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown)	approved	1
DB09184	Edivoxetine	Drug	Oxazines, Adrenergic Uptake Inhibitors, Central Nervous System Depressants, Antidepressive Agents, Alcohols	investigational	0
DB09185	Viloxazine	Drug	Cytochrome P-450 CYP1A2 Inhibitors (weak), Oxazines, Adrenergic Uptake Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Antidepressive Agents, Second-Generation, Antidepressive Agents, Morpholines, Psychotropic Drugs, Drugs that are Mainly Renally Excreted, Membrane Transport Modulators, Cytochrome P-450 CYP1A2 Inhibitors, Neurotransmitter Agents, Central Nervous System Depressants, Neurotransmitter Uptake Inhibitors, Central Nervous System Agents, Adrenergic Agents, Psychoanaleptics	approved, investigational, withdrawn	1
DB09182	Benzylfentanyl	Drug	Piperidines	illicit	0
DB09183	Dasabuvir	Drug	Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor, Antivirals for treatment of HCV infections, Cytochrome P-450 Substrates, P-glycoprotein substrates, Pyrimidinones, BCRP/ABCG2 Inhibitors, Amides, UGT1A1 Inhibitors, Antiviral Agents, Cytochrome P-450 CYP3A4 Substrates, Antiinfectives for Systemic Use, RNA Replicase Inhibitors, Antivirals for Systemic Use, Direct Acting Antivirals, Pyrimidines, Sulfur Compounds, Cytochrome P-450 CYP3A Substrates, Breast Cancer Resistance Protein Inhibitors, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2C8 Substrates, Sulfones	approved	1
DB09180	Thienylfentanyl	Drug	0	illicit	0
DB09181	Trefentanil	Drug	0	experimental	0
DB09188	Amedalin	Drug	0	experimental	0
DB09189	Daledalin	Drug	Heterocyclic Compounds, Fused-Ring	experimental	0
DB09186	Nisoxetine	Drug	Adrenergic Uptake Inhibitors, Amines, Central Nervous System Depressants, Norepinephrine, antagonists & inhibitors, Antidepressive Agents, Propylamines	experimental	1
DB09187	Lortalamine	Drug	Heterocyclic Compounds, Fused-Ring, Adrenergic Uptake Inhibitors, Central Nervous System Depressants, Antidepressive Agents, Pyrans	experimental	0
DB09195	Lorpiprazole	Drug	Serotonin Modulators, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Antidepressive Agents, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted	approved	6
DB09196	Lubazodone	Drug	Oxazines	experimental	0
DB09193	CP-39,332	Drug	0	experimental	0
DB09194	Etoperidone	Drug	Pyridines, Piperazines, Serotonin Agents, Nervous System, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Pyridones, Antidepressive Agents, Drugs that are Mainly Renally Excreted, Serotonin 5-HT2 Receptor Antagonists, Serotonin Modulators, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Serotonin Receptor Antagonists, Psychoanaleptics	withdrawn	6
DB09191	Talsupram	Drug	Sulfur Compounds	experimental	0
DB09192	Tandamine	Drug	Heterocyclic Compounds, Fused-Ring	experimental	0
DB09190	Talopram	Drug	Heterocyclic Compounds, Fused-Ring, Adrenergic Uptake Inhibitors, Amines, Central Nervous System Depressants, Antidepressive Agents, Carbon Radioisotopes	experimental	0
DB09199	Netoglitazone	Drug	Sulfur Compounds, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Thiazoles, Blood Glucose Lowering Agents, Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP3A4 Substrates, Thiazolidinediones, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)	experimental	0
DB09197	Mepiprazole	Drug	0	experimental	0
DB09198	Lobeglitazone	Drug	OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors, Blood Glucose Lowering Agents, PPAR gamma, agonists, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors, Sulfur Compounds, Cytochrome P-450 CYP3A Substrates, PPAR alpha, agonists, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Thiazoles, Cytochrome P-450 CYP2C8 Substrates, Thiazolidinediones, Cytochrome P-450 CYP1A2 Inhibitors (moderate), Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)	experimental	1
DB11461	Sulfachlorpyridazine	Drug	Renal Agents, Sulfur Compounds, Amines, Anti-Infective Agents, Urinary, Sulfonamides, Aniline Compounds, Amides, Sulfanilamides, Anti-Infective Agents, Sulfones	vet_approved	0
DB09140	Oxygen	Drug	Gases, Miscellaneous Therapeutic Agents, Medical Gases, Other Miscellaneous Therapeutic Agents, Chalcogens, Elements	approved, vet_approved	2
DB12792	Boscalid	Drug	Pyridines, Nicotinic Acids, Benzene Derivatives	approved, experimental	0
DB11460	Squalene	Drug	Triterpenes, Alkenes, Hydrocarbons, Acyclic, Polyenes, Terpenes	vet_approved	0
DB12791	Laninamivir	Drug	Neuraminidase, antagonists & inhibitors, Acids, Acyclic, Carbohydrates, Hydroxy Acids, Neuraminic Acids, Amidines, Antiviral Agents, Guanidines, Sialic Acids, Anti-Infective Agents, Amino Sugars, Sugar Acids, Pyrans	investigational	0
DB09141	Protamine sulfate	Drug	Heparin Antagonists, Proteins, Nucleoproteins, Heparin Reversal Agent, Antiheparin Agents, Amino Acids, Peptides, and Proteins, Hematologic Agents, Nuclear Proteins	approved	2
DB12794	p-Quaterphenyl	Drug	0	investigational	0
DB11463	Sulfanitran	Drug	Sulfur Compounds, Amines, Sulfonamides, Aniline Compounds, Amides, Sulfones	vet_approved	0
DB12793	Condoliase	Drug	0	investigational	0
DB11462	Sulfaethoxypyridazine	Drug	Sulfur Compounds, Amines, Sulfonamides, Aniline Compounds, Amides, Sulfanilamides, Sulfones	vet_approved	0
DB12796	MRX-I	Drug	0	investigational	0
DB12795	CMX-2043	Drug	Coenzymes, Sulfur Compounds, Fatty Acids, Oligopeptides, Peptides, Thiophenes, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Lipids	investigational	0
DB11464	Sulfaquinoxaline	Drug	Sulfur Compounds, Amines, Antiprotozoals, Sulfonamides, Aniline Compounds, Amides, Sulfanilamides, Anti-Infective Agents, Antiparasitic Agents, Sulfones	vet_approved	0
DB11467	Thiostrepton	Drug	Peptides, Cyclic, Anti-Bacterial Agents, Peptides, Amino Acids, Peptides, and Proteins, Anti-Infective Agents	vet_approved	0
DB12798	Relenopride	Drug	Acids, Acyclic, Benzoates, Acids, Carbocyclic, Amides, Benzene Derivatives	investigational	0
DB11466	Tepoxalin	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Immunologic Factors, Immunosuppressive Agents, Sensory System Agents, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Peripheral Nervous System Agents, Analgesics, Agents that produce hypertension, Central Nervous System Agents	vet_approved	0
DB12797	Ecromeximab	Drug	Proteins, Serum Globulins, Antineoplastic Agents, Immunological, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB09148	Florbetaben (18F)	Drug	Amines, Central Nervous System, Diagnostic Radiopharmaceuticals, Radioactive Diagnostic Agent, Benzylidene Compounds, Fluorine Radioisotopes, Benzene Derivatives, Drugs that are Mainly Renally Excreted, Positron Emitting Activity	approved	1
DB11468	Tiamulin	Drug	Anti-Bacterial Agents, Terpenes, Anti-Infective Agents	vet_approved	0
DB09149	Florbetapir (18F)	Drug	Amines, Central Nervous System, Diagnostic Radiopharmaceuticals, Radioactive Diagnostic Agent, Glycols, Fluorine Radioisotopes, Drugs that are Mainly Renally Excreted, Positron Emitting Activity, Alcohols	approved, investigational	1
DB12799	Laniquidar	Drug	Heterocyclic Compounds, Fused-Ring, Drug Resistance, Multiple, ATP Binding Cassette Transporter, Subfamily B, Member 1, antagonists & inhibitors, P-glycoprotein inhibitors, Carbon Radioisotopes	investigational	0
DB09146	Iron sucrose	Drug	Acids, Acyclic, Carbohydrates, Iron Trivalent, Oral Preparations, Hydroxy Acids, Phosphate Binder, Disaccharides, Iron Compounds, Oligosaccharides, Organometallic Compounds, Ferric Compounds, Polysaccharides, Phosphate-removing Agents, Drugs for Treatment of Hyperkalemia and Hyperphosphatemia, Iron Preparations, Sugar Acids, Pharmaceutical Preparations	approved	0
DB09147	Ferric pyrophosphate	Drug	Phosphate Binder, Iron Compounds, Metals, Ions, Metals, Heavy, Elements, Phosphorus Compounds, Transition Elements, Polyphosphates, Phosphate salts, Phosphorus Acids, Parenteral Iron Replacement, Anions, Acids, Noncarboxylic, Acids, Phosphoric Acids, Electrolytes	experimental	3
DB09144	Uridine triacetate	Drug	Acids, Acyclic, Carbohydrates, Ribonucleosides, Fatty Acids, Pyrimidine Nucleosides, Pyrimidine Analog, Various Alimentary Tract and Metabolism Products, Lipids, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Alimentary Tract and Metabolism, Fatty Acids, Volatile, Glycosides, Nucleosides	approved, investigational	0
DB09145	Water	Drug	EENT Drugs, Miscellaneous, Other Miscellaneous Therapeutic Agents, Irrigating Solutions, Oxygen Compounds, Diluents	approved	0
DB09142	Sincalide	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Gastrointestinal Hormones, Amino Acids, Peptides, and Proteins, Tests for Bile Duct Patency, OATP1B3 substrates, Diagnostic Agents, Hormones, Cholecystokinin Analog, Gallbladder Function	approved	0
DB09143	Sonidegib	Drug	Cytochrome P-450 Substrates, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Antineoplastic and Immunomodulating Agents, Hedgehog Pathway Inhibitor, Antineoplastic Agents, Smoothened Receptor Antagonists, Cytochrome P-450 CYP3A4 Substrates, Benzene Derivatives	approved, investigational	1
DB09151	Flutemetamol (18F)	Drug	Amines, Laboratory Chemicals, Radiopharmaceutical Activity, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Central Nervous System, Contrast Media, Diagnostic Uses of Chemicals, Thiazoles, Diagnostic Radiopharmaceuticals, Radioactive Diagnostic Agent, Indicators and Reagents, Radiopharmaceuticals, Compounds used in a research, industrial, or household setting	approved, investigational	1
DB11472	Tioxidazole	Drug	Sulfur Compounds	vet_approved	0
DB11471	Tilmicosin	Drug	Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Anti-Infective Agents, Lactones	investigational, vet_approved	0
DB09152	Nitrogen	Drug	Gases, Miscellaneous Therapeutic Agents, Medical Gases, Other Miscellaneous Therapeutic Agents, Elements	approved, vet_approved	0
DB11474	Tulathromycin A	Drug	Carbohydrates, Anti-Bacterial Agents, Polysaccharides, Oligosaccharides, Anti-Infective Agents	vet_approved	0
DB11473	Metrifonate	Drug	Enzyme Inhibitors, Antiparasitic Products, Insecticides and Repellents, Cholinesterase Inhibitors, Pesticides, Anthelmintics, Organophosphorus Compounds, Insecticides, Anti-Infective Agents, Organophosphonates, Neurotransmitter Agents, Cholinergic Agents, Agrochemicals, Antitrematodals, Toxic Actions, Organophosphorous Compounds, Compounds used in a research, industrial, or household setting, Antiparasitic Agents	vet_approved	0
DB11476	Virginiamycin	Drug	Peptides, Cyclic, Anti-Bacterial Agents, Enzyme Inhibitors, Antibiotics for Topical Use, Peptides, Dermatologicals, Streptogramins, Amino Acids, Peptides, and Proteins, Anti-Infective Agents, Protein Synthesis Inhibitors	vet_approved	0
DB11475	Tylosin	Drug	Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Anti-Infective Agents, Lactones	vet_approved	0
DB11478	Zeranol	Drug	Toxins, Biological, Biological Factors, Hormones, Hormone Substitutes, and Hormone Antagonists, Estrogens, Non-Steroidal, Estrogens, Mycotoxins, Phenols, Zearalenone, Hormones, Resorcinols, Benzene Derivatives, Lactones	experimental, vet_approved	2
DB11477	Xylazine	Drug	Neuromuscular Agents, Adrenergic alpha-Agonists, Sensory System Agents, Agents producing tachycardia, Thiazines, Muscle Relaxants, Peripheral Nervous System Agents, Neurotransmitter Agents, Adrenergic alpha-2 Receptor Agonists, Sulfur Compounds, Analgesics, Central Nervous System Depressants, Adrenergic Agonists, Muscle Relaxants, Centrally Acting Agents, Agents that produce hypertension, Hypnotics and Sedatives, Central Nervous System Agents, Adrenergic Agents	vet_approved	1
DB11479	Zilpaterol	Drug	Heterocyclic Compounds, Fused-Ring, Receptors, Adrenergic, beta, Organosilicon Compounds	vet_approved	0
DB09157	Carbon dioxide	Drug	Other Diagnostics, Miscellaneous Therapeutic Agents, Other Miscellaneous Therapeutic Agents, Ions, Oxides, Carbon Compounds, Inorganic, Gases, Anions, Radiographic Contrast Agent, Medical Gases, Electrolytes, X-Ray Contrast Activity, Oxygen Compounds	approved, investigational, vet_approved	0
DB09158	Trypan blue free acid	Drug	Arylsulfonates, Ocular Disorders, Sulfur Acids, Coloring Agents, Arylsulfonic Acids, Diagnostic Dye, Naphthalenes, Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfonic Acids, Azo Compounds, Compounds used in a research, industrial, or household setting, Naphthalenesulfonates	approved	0
DB09155	Helium	Drug	Gases, Miscellaneous Therapeutic Agents, Medical Gases, Other Miscellaneous Therapeutic Agents, Elements, Noble Gases	approved, investigational, vet_approved	0
DB09156	Iopromide	Drug	Benzoates, Acids, Carbocyclic, Roentgenography, Drugs that are Mainly Renally Excreted, Iodobenzoates, Iodinated Contrast Agents, Contrast Media, Diagnostic Uses of Chemicals, Radiographic Contrast Agent, Triiodobenzoic Acids, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting, X-Ray Contrast Activity, Benzene Derivatives, Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media	approved	0
DB09153	Sodium chloride	Drug	Miscellaneous Therapeutic Agents, Blood and Blood Forming Organs, Other Miscellaneous Therapeutic Agents, Ions, Mineral Supplements, Blood Substitutes and Perfusion Solutions, Irrigating Solutions, Electrolyte Solutions, Salt Solutions, Sodium Compounds, EENT Drugs, Miscellaneous, Anions, Acids, Noncarboxylic, I.V. Solution Additives, Acids, Replacement Preparations, Sodium, Alimentary Tract and Metabolism, Chlorides, Electrolytes, Respiratory Agents, Miscellaneous, Chlorine Compounds, Diluents	approved, vet_approved	0
DB09154	Sodium citrate	Drug	Acids, Acyclic, Blood and Blood Forming Organs, Calculi Dissolution Agent, Blood Substitutes and Perfusion Solutions, Irrigating Solutions, Miscellaneous Anticoagulants, Tricarboxylic Acids, Physiological Phenomena, Food and Beverages, Food Ingredients, Buffers, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food, Neurotoxic agents, Food Additives, Anticoagulants, Citrates, Laboratory Chemicals, Citric Acid Derivatives, Hematologic Agents, Salt Solutions, Antacids and Adsorbents, Urinary Alkalinisers, Miscellaneous GI Drugs, Food Preservatives	approved, investigational	0
DB11470	Tildipirosin	Drug	Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Lactones	vet_approved	0
DB11482	Balsam of Peru	Drug	Cell-mediated Immunity, Complex Mixtures, Biological Products, Resins, Plant, Standardized Chemical Allergen, Plant Exudates, Polymers, Biopolymers, Compounds used in a research, industrial, or household setting, Increased Histamine Release, Macromolecular Substances	nutraceutical, vet_approved	0
DB09163	Technetium Tc-99m exametazime	Drug	Organotechnetium Compounds, Oximes, Amines, Hydroxylamines, Laboratory Chemicals, Radiopharmaceutical Activity, Drugs that are Mainly Renally Excreted, Organometallic Compounds, Central Nervous System, Diagnostic Uses of Chemicals, Diagnostic Radiopharmaceuticals, Radioactive Diagnostic Agent, Indicators and Reagents, Radiopharmaceuticals, Compounds used in a research, industrial, or household setting, Technetium (99Mtc) Compounds	approved	0
DB09160	Technetium Tc-99m tetrofosmin	Drug	Organometallic Compounds, Diagnostic Uses of Chemicals, Laboratory Chemicals, Diagnostic Radiopharmaceuticals, Radioactive Diagnostic Agent, Indicators and Reagents, Radiopharmaceutical Activity, Radiopharmaceuticals, Compounds used in a research, industrial, or household setting, Technetium (99Mtc) Compounds	approved	0
DB11485	Ceftiofur	Drug	Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Amides, Lactams, Thiazines, beta-Lactams, Anti-Infective Agents	vet_approved	0
DB09161	Technetium Tc-99m sestamibi	Drug	Organotechnetium Compounds, P-glycoprotein substrates, Laboratory Chemicals, Radiopharmaceutical Activity, Organometallic Compounds, Diagnostic Uses of Chemicals, Diagnostic Radiopharmaceuticals, Radioactive Diagnostic Agent, Indicators and Reagents, Nitriles, Radiopharmaceuticals, Compounds used in a research, industrial, or household setting, Technetium (99Mtc) Compounds	approved, investigational	0
DB11487	Dexamethasone isonicotinate	Drug	Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Glucocorticoids, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inducers, Pregnadienetriols, Anti-Allergic Agents, Corticosteroids, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Pregnanes, Steroids, Fluorinated, Hyperglycemia-Associated Agents, Steroids	vet_approved	0
DB09168	4-Phenylfentanyl	Drug	0	illicit	0
DB09169	3-Allylfentanyl	Drug	Piperidines	illicit	0
DB09166	Etizolam	Drug	Psycholeptics, Tranquilizing Agents, Cytochrome P-450 CYP2C18 Substrates, Cytochrome P-450 Substrates, Nervous System, Benzodiazepines and benzodiazepine derivatives, Cytochrome P-450 CYP3A4 Substrates, Muscle Relaxants, Psychotropic Drugs, Cytochrome P-450 CYP2C19 Substrates, Heterocyclic Compounds, Fused-Ring, Benzazepines, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Muscle Relaxants, Centrally Acting Agents, Benzodiazepinones, Anti-Anxiety Agents, Hypnotics and Sedatives, Central Nervous System Agents, Benzodiazepine hypnotics and sedatives	experimental	3
DB09167	Dosulepin	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index, Anticholinergic Agents, Serotonin 5-HT2 Receptor Antagonists, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Adrenergic Agents, Agents that reduce seizure threshold, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Agents producing tachycardia, Membrane Transport Modulators, Neurotransmitter Agents, Narrow Therapeutic Index Drugs, Tertiary amine tricyclic antidepressants, Central Nervous System Depressants, Antidepressive Agents, Tricyclic, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (moderate), Cytochrome P-450 CYP2D6 Inhibitors (weak), Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Adrenergic Uptake Inhibitors, Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index, Serotonin Agents, Nervous System, Cytochrome P-450 CYP2C19 Inhibitors, Muscarinic Antagonists, Antidepressive Agents, Cytochrome P-450 CYP1A2 Inhibitors, Serotonin Modulators, Histamine H1 Antagonists, Sulfur Compounds, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Potential QTc-Prolonging Agents, Neurotoxic agents, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Non-Selective Monoamine Reuptake Inhibitors, Histamine Antagonists, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Thiepins, Neurotransmitter Uptake Inhibitors, Agents that produce hypertension, Dibenzothiepins, Serotonin Receptor Antagonists, Central Nervous System Agents, Psychoanaleptics	approved	12
DB09164	Technetium Tc-99m disofenin	Drug	Organotechnetium Compounds, Hepatic and Reticulo Endothelial System, Laboratory Chemicals, Amino Acids, Peptides, and Proteins, Radiopharmaceutical Activity, Amino Acids, Drugs that are Mainly Renally Excreted, Organometallic Compounds, Amino Acids, Cyclic, Diagnostic Uses of Chemicals, Imines, Diagnostic Radiopharmaceuticals, Radioactive Diagnostic Agent, Indicators and Reagents, Imino Acids, Radiopharmaceuticals, Compounds used in a research, industrial, or household setting, Technetium (99Mtc) Compounds	approved	0
DB09165	Technetium Tc-99m pyrophosphate	Drug	Laboratory Chemicals, Ions, Radiopharmaceutical Activity, Phosphorus Compounds, Polyphosphates, Drugs that are Mainly Renally Excreted, Phosphate salts, Phosphorus Acids, Anions, Acids, Noncarboxylic, Diagnostic Uses of Chemicals, Acids, Phosphoric Acids, Diagnostic Radiopharmaceuticals, Radioactive Diagnostic Agent, Electrolytes, Indicators and Reagents, Skeleton, Diphosphates, Radiopharmaceuticals, Technetium Compounds, Compounds used in a research, industrial, or household setting, Technetium (99Mtc) Compounds	approved	2
DB11481	Atipamezole	Drug	Neurotransmitter Agents, Adrenergic alpha-Antagonists, Adrenergic Antagonists, Agents that produce hypertension, Adrenergic alpha-2 Receptor Antagonists, Adrenergic Agents	investigational, vet_approved	0
DB11480	Zoalene	Drug	Coccidiostats, Antiprotozoals, Benzoates, Acids, Carbocyclic, Benzamides and benzamide derivatives, Amides, Anti-Infective Agents, Antiparasitic Agents, Benzene Derivatives	experimental, vet_approved	0
DB09173	Butyrfentanyl	Drug	Street Drugs, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Piperidines, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP3A4 Substrates	illicit	3
DB09174	Lofentanil	Drug	Sensory System Agents, Analgesics, Narcotics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Piperidines, Opioids, Central Nervous System Agents, Peripheral Nervous System Agents	illicit	0
DB11493	Sodium tripolyphosphate	Drug	Anions, Acids, Noncarboxylic, Acids, Phosphoric Acids, Electrolytes, Ions, Phosphorus Compounds, Phosphate salts, Phosphorus Acids	vet_approved	0
DB09171	β-Methylfentanyl	Drug	0	illicit	0
DB11496	2-mercaptobenzothiazole	Drug	Heterocyclic Compounds, Fused-Ring, Cell-mediated Immunity, Sulfur Compounds, Thiazoles, Standardized Chemical Allergen, Anti-Infective Agents, Increased Histamine Release	approved, experimental, vet_approved	1
DB09172	Brifentanil	Drug	Piperidines	illicit	0
DB11495	(S)-methoprene	Drug	0	vet_approved	0
DB09170	β-Hydroxythiofentanyl	Drug	0	illicit	0
DB11497	Sulfotep	Drug	Sulfur Compounds, Organophosphorus Compounds	experimental, vet_approved	0
DB11499	Amphomycin	Drug	Anti-Bacterial Agents, Peptides, Amino Acids, Peptides, and Proteins, Lipids, Anti-Infective Agents	vet_approved	0
DB09179	R-30490	Drug	Piperidines	experimental	0
DB09177	p-Fluorofentanyl	Drug	0	illicit	0
DB09178	Phenaridine	Drug	Aminopyridines, Pyridines, Amines	illicit	0
DB09175	Mirfentanil	Drug	Piperidines	experimental	0
DB11490	Nalorphine	Drug	Opioid Antagonists, Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, Antidotes, Sensory System Agents, Semi-synthetic Opioids, Central Nervous System Agents, Morphinans, Peripheral Nervous System Agents	experimental, vet_approved	0
DB11491	Sarafloxacin	Drug	Cytochrome P-450 CYP1A2 Inhibitors, Fluoroquinolones, Quinolines, Heterocyclic Compounds, Fused-Ring, QTc Prolonging Agents, Anti-Bacterial Agents, Cytochrome P-450 Enzyme Inhibitors, Potential QTc-Prolonging Agents, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Quinolones	withdrawn, vet_approved	0
DB00808	Indapamide	Drug	QTc Prolonging Agents, Cytochrome P-450 Substrates, Increased Diuresis, Sodium Chloride Symporter Inhibitors, Genito Urinary System and Sex Hormones, Thiazide-like Diuretic, Amides, Cardiovascular Agents, Hypotensive Agents, Low-Ceiling Diuretics, Excl. Thiazides, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Lipid Modifying Agents, Sulfur Compounds, Diuretics, Potential QTc-Prolonging Agents, Antihypertensive Agents, Indoles, Drugs causing inadvertant photosensitivity, Non Potassium Sparing Diuretics, Sulfones, Antihypertensive Agents Indicated for Hypertension, Membrane Transport Modulators, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Sulfonamides, Natriuretic Agents, Hyperglycemia-Associated Agents	approved	1
DB00809	Tropicamide	Drug	Anticholinergic Agents, Autonomic Agents, Ophthalmologicals, Neurotransmitter Agents, Pyridines, Mydriatics, Cholinergic Agents, Mydriatics and Cycloplegics, Muscarinic Antagonists, Sensory Organs, Peripheral Nervous System Agents	approved, investigational	4
DB00806	Pentoxifylline	Drug	Radiation-Protective Agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Phosphodiesterase 5 Inhibitors, Free Radical Scavengers, Cardiovascular Agents, Drugs that are Mainly Renally Excreted, Antioxidants, Alkaloids, Purines, Xanthine derivatives, Compounds used in a research, industrial, or household setting, Antiplatelet agents, Purinones, Hematologic Activity Alteration, Phosphodiesterase Inhibitors, Protective Agents, Hematologic Agents, Hemorrheologic Agents, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP1A2 Substrates, Peripheral Vasodilators, Purine Derivatives, Blood Viscosity Reducer, Drugs for Obstructive Airway Diseases, Vasodilating Agents	approved, investigational	4
DB00807	Proparacaine	Drug	Aminobenzoates, para-Aminobenzoates, Benzoates, Hydroxy Acids, Sensory System Agents, Local Anesthesia, Acids, Carbocyclic, Hydroxybenzoates, Anesthetics, Isomerism, Peripheral Nervous System Agents, Phenyl Ethers, Ophthalmologicals, Phenols, Central Nervous System Agents, Sensory Organs, Ethers, Hydroxybenzoate Ethers, Benzene Derivatives, Anesthetics, Local	approved, vet_approved	1
DB00811	Ribavirin	Drug	Carbohydrates, Ribonucleosides, Antivirals for treatment of HCV infections, Nucleoside Analog Antiviral, Noxae, Antiviral Agents, Antiinfectives for Systemic Use, Antimetabolites, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Antivirals for Systemic Use, Direct Acting Antivirals, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Toxic Actions, Nucleosides and Nucleotides	approved	5
DB00812	Phenylbutazone	Drug	Nephrotoxic agents, Cytochrome P-450 Substrates, Sensory System Agents, Cytochrome P-450 Enzyme Inhibitors, Anti-Inflammatory Agents, Agents causing hyperkalemia, Cytochrome P-450 CYP3A Inducers, Non COX-2 selective NSAIDS, Butylpyrazolidines, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Pyrazolones, Peripheral Nervous System Agents, Cytochrome P-450 Enzyme Inducers, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Musculo-Skeletal System, Cytochrome P-450 CYP2C9 Inhibitors, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Pyrazoles, Cytochrome P-450 CYP3A4 Inducers, Antirheumatic Agents, Antiinflammatory Preparations, Non-Steroids for Topical Use, Topical Products for Joint and Muscular Pain, OAT1/SLC22A6 inhibitors, Cytochrome P-450 CYP2C9 Substrates, Antiinflammatory and Antirheumatic Products, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Agents that produce hypertension, Central Nervous System Agents, OAT3/SLC22A8 Inhibitors	approved, vet_approved	3
DB00810	Biperiden	Drug	Autonomic Agents, Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Agents producing tachycardia, Parasympatholytics, Muscarinic Antagonists, Nicotinic Antagonists, Tertiary Amines, Anti-Parkinson Drugs, Peripheral Nervous System Agents, Anticholinergic Agents, Anti-Dyskinesia Agents, Neurotransmitter Agents, Cholinergic Agents, Piperidines, Aza Compounds, Azabicyclo Compounds, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)	approved, investigational	1
DB00815	Sodium lauryl sulfate	Drug	Alkanesulfonic Acids, Surface-Active Agents, Sulfur Acids, Hydrocarbons, Acyclic, Alkanes, Lipids, Alcohols, Sulfur Compounds, Acids, Noncarboxylic, Alkanesulfonates, Acids, Sulfonic Acids, Dodecanol, Compounds used in a research, industrial, or household setting, Fatty Alcohols, Sulfones	experimental	0
DB00816	Orciprenaline	Drug	Adrenergics, Inhalants, Amines, Adrenergic beta-2 Receptor Agonists, Tocolytic Agents, Alcohols, Peripheral Nervous System Agents, Selective Beta 2-adrenergic Agonists, Non-selective Beta-adrenergic Agonists, Adrenergic Agents, Benzene Derivatives, Autonomic Agents, Adrenergics for Systemic Use, Anti-Asthmatic Agents, Reproductive Control Agents, Agents producing tachycardia, Catecholamines, Catechols, Bronchodilator Agents, Amino Alcohols, Ethanolamines, Respiratory System Agents, Adrenergic beta-Agonists, Neurotransmitter Agents, Agents to Treat Airway Disease, Sympathomimetics, Adrenergic Agonists, Agents that produce hypertension, Phenols, Drugs for Obstructive Airway Diseases	approved	1
DB00813	Fentanyl	Drug	Cytochrome P-450 Substrates, Sensory System Agents, Serotonin Agents, Cytochrome P-450 CYP3A7 Substrates, Nervous System, Neuraxial Anesthetics, Anesthetics, Intravenous, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Opiate Agonists, Peripheral Nervous System Agents, Serotonin Modulators, Anesthetics, General, Phenylpiperidine opioids, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Piperidines, Opioids, Bradycardia-Causing Agents, Agents that reduce seizure threshold, Fentanyl and fentanyl analogues, Opioid Anesthetics, Cytochrome P-450 CYP3A5 Substrates, Narcotics, Adjuvants, Anesthetics, High-risk opioids, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Opioid Agonist, Agents that produce hypertension, Adjuvants, Anesthesia, Central Nervous System Agents, P-glycoprotein inhibitors, Opioids, Anilidopiperidine	approved, illicit, investigational, vet_approved	4
DB00814	Meloxicam	Drug	Nephrotoxic agents, Cytochrome P-450 Substrates, Oxicams, Sensory System Agents, Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Agents causing hyperkalemia, Cytochrome P-450 CYP3A4 Substrates, Selective Cyclooxygenase 2 Inhibitors (NSAIDs), Peripheral Nervous System Agents, Sulfur Compounds, Antiinflammatory and Antirheumatic Products, Non-Steroids, COX-2 Inhibitors, Analgesics, Musculo-Skeletal System, Thiazoles, Cytochrome P-450 CYP2C8 Substrates, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Antirheumatic Agents, Thiazines, Cytochrome P-450 CYP2C9 Substrates, Antiinflammatory and Antirheumatic Products, Cytochrome P-450 CYP3A Substrates, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Agents that produce hypertension, Other Nonsteroidal Anti-inflammatory Agents	approved, vet_approved	2
DB00819	Acetazolamide	Drug	Enzyme Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Genito Urinary System and Sex Hormones, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Carbonic Anhydrase Inhibitors, Sulfur Compounds, Thiazoles, Diuretics, Drugs causing inadvertant photosensitivity, Thiadiazoles, Antiglaucoma Preparations and Miotics, Gynecological Antiinfectives and Antiseptics, Antiglaucoma Agents, OAT1/SLC22A6 inhibitors, Ophthalmologicals, Anticonvulsants, Cytochrome P-450 CYP3A Inhibitors, Photosensitizing Agents, Central Nervous System Depressants, Sulfonamides, Cytochrome P-450 CYP3A4 Inhibitors, Natriuretic Agents, Central Nervous System Agents, Sensory Organs	approved, vet_approved	8
DB00817	Rosoxacin	Drug	Cytochrome P-450 CYP1A2 Inhibitors, Fluoroquinolones, Quinolines, Heterocyclic Compounds, Fused-Ring, QTc Prolonging Agents, Anti-Bacterial Agents, Cytochrome P-450 Enzyme Inhibitors, Potential QTc-Prolonging Agents, Antiinfectives for Systemic Use, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Anti-Infective Agents, Antibacterials for Systemic Use	approved, investigational	2
DB00818	Propofol	Drug	QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Anesthetics, Intravenous, Hypotensive Agents, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Miscellaneous General Anesthetics, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Anesthetics, General, Potential QTc-Prolonging Agents, Hypnotics and Sedatives, Cytochrome P-450 CYP2C8 Substrates, Benzene Derivatives, Agents that reduce seizure threshold, Cytochrome P-450 CYP2C18 Substrates, Cytochrome P-450 CYP2E1 Inhibitors, UGT1A1 Inhibitors, Anesthetics, UGT1A6 substrate, Cytochrome P-450 CYP2C19 Substrates, P-glycoprotein inducers, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Inhibitors, Agents Causing Muscle Toxicity, Central Nervous System Depressants, UGT1A1 Substrates, Agents that produce hypertension, Cytochrome P-450 CYP3A4 Inhibitors, Phenols, UGT1A9 Substrates, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved, investigational, vet_approved	5
DB12800	CHF-6001	Drug	Aminobenzoates, Sulfur Compounds, Benzoates, Acids, Carbocyclic, Amides, Benzene Derivatives, Sulfones	investigational	0
DB12802	Picropodophyllin	Drug	Podophyllum, Benzyl Compounds, Lignans, Tetrahydronaphthalenes, Insulin-Like Growth Factor I, Benzene Derivatives, Naphthalenes	investigational	0
DB12804	Daniquidone	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB12803	Dichloroisoproterenol	Drug	Amines, Phenols, Catecholamines, Catechols, Amino Alcohols, Ethanolamines, Benzene Derivatives, Alcohols	investigational	0
DB12806	GSK-1004723	Drug	Pyridazines, Histamine H1 Antagonists, Histamine Antagonists	investigational	0
DB12805	Ataciguat	Drug	Aminobenzoates, Sulfur Compounds, Benzoates, Enzyme Activators, Acids, Carbocyclic, Amides, Benzene Derivatives, Sulfones	investigational	0
DB00822	Disulfiram	Drug	Acids, Acyclic, QTc Prolonging Agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Disulfides, Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents, BSEP/ABCB11 Substrates, Drugs Used in Alcohol Dependence, Acetyl Aldehyde Dehydrogenase Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Sulfides, Anions, Sulfur Compounds, Potential QTc-Prolonging Agents, Aldehyde Dehydrogenase Inhibitor, Agents that reduce seizure threshold, Alcohol Deterrents, Antiparasitic Products, Insecticides and Repellents, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP2E1 Inhibitors, Ectoparasiticides, Incl. Scabicides, Ions, Drugs Used in Addictive Disorders, Sulfur Containing Products, Thiocarbamates, Gases, Acids, Noncarboxylic, Acids, Cytochrome P-450 CYP3A Substrates, Carbamates, Hydrogen Sulfide, Electrolytes, Central Nervous System Agents	approved	2
DB00823	Ethynodiol diacetate	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Norsteroids, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, Reproductive Control Agents, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Contraceptives, Oral, Cytochrome P-450 CYP3A Substrates, Contraceptives, Oral, Synthetic, Progestins, Combination Contraceptives (with Estrogen and derivatives), Norpregnenes, Hormonal Contraceptives for Systemic Use, Hyperglycemia-Associated Agents, Norpregnanes, Contraceptive Agents, Female, Progestin Contraceptives, Steroids	approved	2
DB00820	Tadalafil	Drug	Phosphodiesterase Inhibitors, Pyridines, Carbolines, Enzyme Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Genito Urinary System and Sex Hormones, Phosphodiesterase 5 Inhibitors, Urologicals, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Urological Agents, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Substrates, Drugs Used in Erectile Dysfunction, Antihypertensives for Pulmonary Arterial Hypertension, Antihypertensive Agents, Indoles, Vasodilating Agents	approved, investigational	2
DB00821	Carprofen	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Sensory System Agents, Anti-Inflammatory Agents, Agents causing hyperkalemia, Dermatologicals, Antirheumatic Agents, Radiation-Sensitizing Agents, Selective Cyclooxygenase 2 Inhibitors (NSAIDs), OAT1/SLC22A6 inhibitors, Peripheral Nervous System Agents, Heterocyclic Compounds, Fused-Ring, Analgesics, Photosensitizing Agents, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Agents that produce hypertension, Central Nervous System Agents, Indoles	approved, withdrawn, vet_approved	2
DB00826	Natamycin	Drug	Cytochrome P-450 Enzyme Inhibitors, Gynecological Antiinfectives and Antiseptics, Dermatologicals, Genito Urinary System and Sex Hormones, Antifungals for Dermatological Use, Polyene Antifungal, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Anti-Infective Agents, Anti-Infective Agents, Local, Lactones, Ophthalmologicals, Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Antiinfectives and Antiseptics for Local Oral Treatment, Intestinal Antiinfectives, Alimentary Tract and Metabolism, Antifungals for Topical Use, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Cytochrome P-450 CYP3A4 Inhibitors, Antifungal Agents, Polyene Antimicrobial, Sensory Organs, Stomatological Preparations	approved	1
DB00827	Cinoxacin	Drug	Fluoroquinolones, QTc Prolonging Agents, Enzyme Inhibitors, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Antiinfectives for Systemic Use, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Moderate Risk QTc-Prolonging Agents, Anti-Infective Agents, OAT1/SLC22A6 inhibitors, Cytochrome P-450 CYP1A2 Inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Topoisomerase II Inhibitors, Antibacterials for Systemic Use	approved, investigational, withdrawn	2
DB00824	Enprofylline	Drug	Autonomic Agents, Purinergic P1 Receptor Antagonists, Anti-Asthmatic Agents, Bronchodilator Agents, Purinergic Agents, Adenosine A2 Receptor Antagonists, Respiratory System Agents, Peripheral Nervous System Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Purines, Purinergic Antagonists, Purinones	approved, experimental	6
DB00825	Levomenthol	Drug	QTc Prolonging Agents, Cytochrome P-450 Substrates, Cyclohexanols, Agents causing hyperkalemia, Lipids, Cytochrome P-450 CYP3A4 Substrates, Alcohols, Cyclohexanes, Antipruritics and Local Anesthetics, Potential QTc-Prolonging Agents, Monoterpenes, Other Cold and Cough Preparations, Antipruritics, Bradycardia-Causing Agents, Fatty Alcohols, Antiarrhythmic agents, Cycloparaffins, Dermatologicals, Herbs and Natural Products, Calcium Channel Blockers, EENT Drugs, Miscellaneous, Basic Lotions and Liniments, Cytochrome P-450 CYP3A Substrates, Hexanols, Other Analgesics, Terpenes, Vasodilating Agents	approved	5
DB00828	Fosfomycin	Drug	Organophosphonates, Anti-Bacterial Agents, Anti-Infective Agents, Urinary, Organophosphorus Compounds, Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use, Drugs that are Mainly Renally Excreted	approved	1
DB00829	Diazepam	Drug	Psycholeptics, Tranquilizing Agents, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, GABA Modulators, Benzodiazepines and benzodiazepine derivatives, Anesthetics, Intravenous, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Muscle Relaxants, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Anesthetics, General, Benzazepines, Muscle Relaxants, Centrally Acting Agents, Hypnotics and Sedatives, Cytochrome P-450 CYP2C8 Substrates, Benzodiazepine hypnotics and sedatives, Autonomic Agents, Cytochrome P-450 CYP2C18 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP2E1 Inhibitors, GABA Agents, P-glycoprotein substrates, Anesthetics, Psychotropic Drugs, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Anticonvulsants, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Benzodiazepinones, Anti-Anxiety Agents, Adjuvants, Anesthesia, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates	approved, illicit, investigational, vet_approved	2
DB12810	AN-2718	Drug	0	investigational	0
DB12813	Radium Ra-223	Drug	Metals, Elements, Radioactive, Metals, Alkaline Earth, Radioisotopes, Metals, Heavy, Elements, Isotopes	investigational	0
DB12812	Palomid 529	Drug	Heterocyclic Compounds, Fused-Ring, Pyrans	investigational	0
DB12815	Crotedumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB12814	Cepeginterferon alfa-2B	Drug	Cytochrome P-450 CYP1A2 Inhibitors, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Adjuvants, Immunologic, Interferons, Antineoplastic and Immunomodulating Agents, Pegylated agents, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Myelosuppressive Agents	investigational	0
DB12817	Zoliflodacin	Drug	Pyrimidines, Pyrimidinones	investigational	0
DB12816	Terpinen-4-ol	Drug	0	investigational	0
DB12808	Trifarotene	Drug	Cytochrome P-450 Substrates, Alkenes, Dermatologicals, Retinoids for Topical Use in Acne, Misc. Skin and Mucous Membrane Agents, Cytochrome P-450 CYP3A4 Substrates, Anti-Acne Preparations, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, Polyenes, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2C8 Substrates, Anti-Acne Preparations for Topical Use	approved, investigational	3
DB12807	Naptumomab Estafenatox	Drug	Proteins, Serum Globulins, Toxins, Biological, Biological Factors, Immunoglobulins, Globulins, Noxae, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Toxic Actions, Immunoproteins	investigational	0
DB12809	BK-MDA	Drug	0	investigational	0
DB00830	Phenmetrazine	Drug	Autonomic Agents, Central Nervous System Stimulants, Oxazines, Appetite Depressants, Sympathomimetics, Anti-Obesity Agents, Agents that produce hypertension, Agents producing tachycardia, Central Nervous System Agents, Morpholines, Peripheral Nervous System Agents	approved, illicit	2
DB00833	Cefaclor	Drug	Nephrotoxic agents, Second-Generation Cephalosporins, Amides, BSEP/ABCB11 Substrates, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, OAT3/SLC22A8 Substrates, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, OAT3/SLC22A8 Inhibitors, Antibacterials for Systemic Use	approved	2
DB00834	Mifepristone	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Menstruation-Inducing Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Genito Urinary System and Sex Hormones, Hypoglycemia-Associated Agents, BSEP/ABCB11 Substrates, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors (moderate), Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A7 Inhibitors (strength unknown), Contraceptives, Oral, Synthetic, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Hormonal Contraceptives for Systemic Use, Contraceptive Agents, Female, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Inducers, Reproductive Control Agents, Cytochrome P-450 CYP3A7 Inhibitors, Progestational Hormone Receptor Antagonists, Cytochrome P-450 CYP2D6 Inhibitors, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Sex Hormones and Modulators of the Genital System, OATP1B3 inhibitors, Fused-Ring Compounds, Abortifacient Agents, Steroidal, Contraceptives, Oral, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C9 Inhibitors, Hormone Antagonists, Estranes, Contraceptives, Postcoital, Hormones, Hormone Substitutes, and Hormone Antagonists, Progesterone Receptor Modulators, Estrenes, Blood Glucose Lowering Agents, P-glycoprotein inducers, Cytochrome P-450 CYP3A Inhibitors, Abortifacient Agents, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Luteolytic Agents, Progestin Antagonist, P-glycoprotein inhibitors, Steroids	approved, investigational	4
DB00831	Trifluoperazine	Drug	Psycholeptics, Tranquilizing Agents, Cytochrome P-450 Substrates, Nervous System, Antipsychotic Agents (First Generation Typical), Peripheral Nervous System Agents, Antipsychotic Agents, Sulfur Compounds, Adrenergic Antagonists, Adrenergic alpha-1 Receptor Antagonists, Drugs causing inadvertant photosensitivity, Dopamine Antagonists, Phenothiazines With Piperazine Structure, Dopamine Agents, Gastrointestinal Agents, Neurotoxic agents, Autonomic Agents, Adrenergic alpha-Antagonists, P-glycoprotein substrates, Phenothiazines, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Photosensitizing Agents, Central Nervous System Depressants, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Antiemetics, UGT1A4 substrates, Central Nervous System Agents, P-glycoprotein inhibitors, Dopamine D2 Receptor Antagonists	approved, investigational	6
DB00832	Phensuximide	Drug	Anticonvulsants, Pyrrolidinones, Nervous System, Central Nervous System Depressants, Pyrrolidines, Succinimide Derivatives, Imides	approved	0
DB00837	Progabide	Drug	Acids, Acyclic, Fatty Acids, GABA Agents, Nervous System, GABA Agonists, Amino Acids, Peptides, and Proteins, Lipids, Antidepressive Agents, Aminobutyrates, Psychotropic Drugs, Amino Acids, Anti-Parkinson Drugs, Fatty Acid Derivatives, Anti-Dyskinesia Agents, Neurotransmitter Agents, Anticonvulsants, Butyrates, Central Nervous System Depressants, Fatty Acids, Volatile, Central Nervous System Agents	experimental	2
DB00838	Clocortolone	Drug	Pregnadienediols, Corticosteroids, Dermatological Preparations, Corticosteroids, Immunosuppressive Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Dermatologicals, Hormones, Fused-Ring Compounds, Corticosteroids, Moderately Potent (Group II), Pregnanes, Steroids, Fluorinated, Corticosteroid Hormone Receptor Agonists, Steroids	approved	1
DB00835	Brompheniramine	Drug	Pyridines, QTc Prolonging Agents, Anti-Allergic Agents, Cytochrome P-450 Substrates, Substituted Alkylamines, Agents producing tachycardia, Muscarinic Antagonists, Anticholinergic Agents, Neurotransmitter Agents, Histamine H1 Antagonists, Histamine Antagonists, Photosensitizing Agents, Central Nervous System Depressants, Propylamine Derivatives, Potential QTc-Prolonging Agents, Cytochrome P-450 CYP2B6 Substrates, Histamine Agents, Antihistamines for Systemic Use	approved	6
DB00836	Loperamide	Drug	QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Antidiarrheals, P-glycoprotein substrates, Agents causing hyperkalemia, Antipropulsives, Cytochrome P-450 CYP3A4 Substrates, Moderate Risk QTc-Prolonging Agents, Cytochrome P-450 CYP3A4 Inhibitors (strong), Calcium Channel Blockers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Alimentary Tract and Metabolism, Opioid Agonist, Piperidines, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2C8 Substrates, Bradycardia-Causing Agents, Antiarrhythmic agents, Gastrointestinal Agents	approved	7
DB00839	Tolazamide	Drug	Cytochrome P-450 CYP2C9 Substrates, Sulfur Compounds, Cytochrome P-450 Substrates, Alimentary Tract and Metabolism, Hypoglycemia-Associated Agents, Sulfonylureas, Drugs Used in Diabetes, Blood Glucose Lowering Agents, Drugs that are Mainly Renally Excreted, Sulfones	approved, investigational	1
DB12820	Concizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB12822	Pancreatic Polypeptide	Drug	Proteins, Peptide Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pancreatic Hormones, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Hormones, Gastrointestinal Agents	investigational	0
DB12821	Perflubutane	Drug	Iron Compounds, Metals, Hydrocarbons, Halogenated, Ions, Metals, Heavy, Elements, Hydrocarbons, Fluorinated, Transition Elements, Organometallic Compounds, Anions, Contrast Media, Diagnostic Uses of Chemicals, Electrolytes, Compounds used in a research, industrial, or household setting, Oxygen Compounds	approved, investigational	0
DB12824	Monalizumab	Drug	0	investigational	0
DB12823	Tecarfarin	Drug	Heterocyclic Compounds, Fused-Ring, Acids, Carbocyclic, Coumarins, Benzopyrans, Benzene Derivatives, Pyrans	investigational	0
DB12826	Depatuxizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB12825	Lefamulin	Drug	QTc Prolonging Agents, Sulfur Compounds, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Substrates, Acetates	approved, investigational	1
DB12827	Indoximod	Drug	Amino Acids, Aromatic, Tryptophan Oxygenase, antagonists & inhibitors, Amino Acids, Cyclic, Amino Acids, Essential, Amino Acids, Peptides, and Proteins, Amino Acids	investigational	0
DB12819	GSI-136	Drug	0	investigational	0
DB12818	NM-3	Drug	0	investigational	0
DB00840	Hydroxypropyl cellulose	Drug	Carbohydrates, Polysaccharides, Glucans, Demulcent, Polymers, Artificial Tears, Biopolymers, Compounds used in a research, industrial, or household setting, Demulcent Activity, Macromolecular Substances, Ophthalmics	approved	0
DB00841	Dobutamine	Drug	Amines, Adrenergic alpha-1 Receptor Agonists, Cardiovascular Agents, Selective Beta 1-adrenergic Agonists, Adrenergic beta-2 Receptor Agonists, Phenethylamines, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Sympathomimetic (Adrenergic) Agents, Adrenergic beta-1 Receptor Agonists, COMT Substrates, Compounds used in a research, industrial, or household setting, Adrenergic Agents, Benzene Derivatives, Autonomic Agents, Adrenergic alpha-Agonists, Protective Agents, Agents producing tachycardia, Catecholamines, Catechols, Adrenergic and Dopaminergic Agents, Cardiotonic Agents, Adrenergic beta-Agonists, Neurotransmitter Agents, Ethylamines, Sympathomimetics, Adrenergic Agonists, Cardiac Stimulants Excl. Cardiac Glycosides, Agents that produce hypertension, Phenols, Cardiac Therapy	approved	4
DB00844	Nalbuphine	Drug	Sensory System Agents, Narcotics, Nervous System, Semi-synthetic Opioids, Opioid Agonist/Antagonist, Morphinans, Peripheral Nervous System Agents, Opioid Antagonists, Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Morphinan Derivatives, Opioids, Central Nervous System Agents, Opiate Partial Agonists, Mixed Agonist / Antagonist Opioids	approved	3
DB00845	Clofazimine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, BSEP/ABCB11 Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Anti-Inflammatory Agents, Cytochrome P-450 CYP3A Inducers, Antimycobacterials, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Anti-Infective Agents, Anti-Bacterial Agents, Cytochrome P-450 Enzyme Inducers, Potential QTc-Prolonging Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Drugs causing inadvertant photosensitivity, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A5 Inhibitors, BCRP/ABCG2 Inhibitors, Antiinfectives for Systemic Use, Drugs for Treatment of Lepra, Leprostatic Agents, Cytochrome P-450 CYP3A4 Inducers (weak), Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors, Phenazines	approved, investigational	2
DB00842	Oxazepam	Drug	Psycholeptics, Tranquilizing Agents, GABA Agents, Nervous System, GABA Modulators, Benzodiazepines and benzodiazepine derivatives, Psychotropic Drugs, Drugs that are Mainly Renally Excreted, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, UGT2B7 substrates, Benzazepines, Central Nervous System Depressants, Benzodiazepinones, UGT1A9 Substrates, Anti-Anxiety Agents, Hypnotics and Sedatives, Central Nervous System Agents, Benzodiazepine hypnotics and sedatives	approved	2
DB00843	Donepezil	Drug	QTc Prolonging Agents, Enzyme Inhibitors, Cholinesterase Inhibitors, Cytochrome P-450 Substrates, Nervous System, Indans, Cytochrome P-450 CYP3A4 Substrates, Parasympathomemetic (Cholinergic) Agents, Muscle Relaxants, Cytochrome P-450 CYP2C9 Substrates, Neurotransmitter Agents, BCRP/ABCG2 Substrates, Cholinergic Agents, Cytochrome P-450 CYP3A Substrates, Anti-Dementia Drugs, Central Nervous System Depressants, Muscle Relaxants, Centrally Acting Agents, Piperidines, Indenes, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Bradycardia-Causing Agents, Nootropic Agents, Psychoanaleptics	approved	8
DB00848	Levamisole	Drug	Immunologic Factors, Antiparasitic Products, Insecticides and Repellents, Adjuvants, Immunologic, Anthelmintics, Antirheumatic Agents, Anti-Infective Agents, Imidazothiazole Derivatives, Sulfur Compounds, Imidazoles, Thiazoles, Levamisole, analogs & derivatives, Antinematodal Agents, Antiparasitic Agents	approved, investigational, withdrawn, vet_approved	6
DB00849	Methylphenobarbital	Drug	Psycholeptics, Cytochrome P-450 Substrates, GABA Agents, Nervous System, GABA Modulators, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Pyrimidinones, Barbiturates and Derivatives, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Nicotinic Antagonists, Anticholinergic Agents, Cytochrome P-450 CYP2C19 Substrates, Neurotransmitter Agents, Anticonvulsants, Cytochrome P-450 Enzyme Inducers, Pyrimidines, Central Nervous System Depressants, Phenobarbital and similars, Hypnotics and Sedatives, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates, Barbiturates	approved	11
DB00846	Flurandrenolide	Drug	Corticosteroids, Dermatological Preparations, Corticosteroids, Cytochrome P-450 Substrates, Immunosuppressive Agents, Pregnenediones, Hormones, Hormone Substitutes, and Hormone Antagonists, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Dermatologicals, Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Corticosteroids, Potent (Group III), Cytochrome P-450 CYP3A Substrates, Pregnanes, Steroids, Fluorinated, Corticosteroid Hormone Receptor Agonists, Pregnenes, Steroids	approved	1
DB00847	Cysteamine	Drug	Cystine Disulfide Reduction, Amines, Other Miscellaneous Therapeutic Agents, Cystine Depleting Agents, Ophthalmics, Ophthalmologicals, EENT Drugs, Miscellaneous, Sulfur Compounds, Ethylamines, Alimentary Tract and Metabolism, Amino Acids and Derivatives, Mercaptoethylamines, Sensory Organs, Sulfhydryl Compounds	approved, investigational	3
DB00800	Fenoldopam	Drug	Antihypertensive Agents Indicated for Hypertension, Adrenergic and Dopaminergic Agents, Cardiovascular Agents, Hypotensive Agents, Drugs that are Mainly Renally Excreted, Dopamine Agonists, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Benzazepines, Cardiac Stimulants Excl. Cardiac Glycosides, Antihypertensive Agents, Dopamine D1 Receptor Agonists, Vasodilating Agents, Cardiac Therapy, Dopamine Agents	approved	8
DB00801	Halazepam	Drug	Heterocyclic Compounds, Fused-Ring, Psycholeptics, Tranquilizing Agents, Benzazepines, Nervous System, Central Nervous System Depressants, Benzodiazepines and benzodiazepine derivatives, Anti-Anxiety Agents, Central Nervous System Agents, Psychotropic Drugs	approved, illicit, withdrawn	2
DB00804	Dicyclomine	Drug	Autonomic Agents, Cycloparaffins, Antimuscarinics Antispasmodics, Acids, Carbocyclic, Agents producing tachycardia, Parasympatholytics, Muscarinic Antagonists, Drugs that are Mainly Renally Excreted, Cyclohexanes, Peripheral Nervous System Agents, Anticholinergic Agents, Neurotransmitter Agents, Cholinergic Agents, Alimentary Tract and Metabolism, Cyclohexanecarboxylic Acids, Drugs for Functional Gastrointestinal Disorders, Synthetic Anticholinergics, Esters With Tertiary Amino Group	approved	2
DB00805	Minaprine	Drug	Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, Central Nervous System Stimulants, Cholinesterase Inhibitors, Cytochrome P-450 Substrates, Nervous System, Monoamine Oxidase Inhibitors, Antidepressive Agents, Psychotropic Drugs, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Agents that produce hypertension, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Agents that reduce seizure threshold, Psychoanaleptics	approved	9
DB00802	Alfentanil	Drug	Cytochrome P-450 Substrates, Sensory System Agents, Cytochrome P-450 CYP3A7 Substrates, Nervous System, Anesthetics, Intravenous, Cytochrome P-450 CYP3A4 Substrates, Opiate Agonists, Peripheral Nervous System Agents, Anesthetics, General, Phenylpiperidine opioids, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Piperidines, Opioids, Bradycardia-Causing Agents, Fentanyl and fentanyl analogues, Opioid Anesthetics, Cytochrome P-450 CYP3A5 Substrates, Narcotics, Anesthetics, High-risk opioids, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Opioid Agonist, Agents that produce hypertension, Central Nervous System Agents, P-glycoprotein inhibitors, Opioids, Anilidopiperidine	approved, illicit	1
DB00803	Colistin	Drug	Nephrotoxic agents, Peptides, Antimicrobial Cationic Peptides, Amino Acids, Peptides, and Proteins, Lipids, Agents that produce neuromuscular block (indirect), Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Membrane Proteins, Peptides, Cyclic, Proteins, Anti-Bacterial Agents, Intestinal Antiinfectives, Alimentary Tract and Metabolism, Aminoglycoside Antibacterials, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Pore Forming Cytotoxic Proteins, Lipopeptides, Antibacterials for Systemic Use, Polymyxins	approved	1
DB11540	Propiopromazine	Drug	Heterocyclic Compounds, Fused-Ring, Antipsychotic Agents, Sulfur Compounds, Central Nervous System Depressants, Phenothiazines, Neurotoxic agents	experimental, vet_approved	0
DB12871	Burlulipase	Drug	0	investigational	0
DB12870	Buthionine Sulfoximine	Drug	Radiation-Protective Agents, Amino Acids, Neutral, Enzyme Inhibitors, Noxae, Protective Agents, Amino Acids, Essential, Amino Acids, Sulfur, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antimetabolites, Radiation-Sensitizing Agents, Amino Acids, Sulfur Compounds, Toxic Actions, Compounds used in a research, industrial, or household setting	investigational	0
DB12873	Dianhydrogalactitol	Drug	Alkylating Drugs, Carbohydrates, Galactitol, Noxae, Sugar Alcohols, Antineoplastic Agents, Toxic Actions, Antineoplastic Agents, Alkylating, Alcohols	investigational	0
DB11541	Ractopamine	Drug	Adrenergic beta-Agonists, Neurotransmitter Agents, Amines, Ethylamines, Adrenergic Agonists, Agents that produce hypertension, Agents producing tachycardia, Growth Substances, Adrenergic Agents	vet_approved	1
DB12872	Vonicog Alfa	Drug	0	approved, investigational	2
DB12875	Mavatrep	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB11544	Salinomycin	Drug	Coccidiostats, Anti-Bacterial Agents, Antiprotozoals, P-glycoprotein inhibitors, Anti-Infective Agents, Antiparasitic Agents, Ionophores	vet_approved	0
DB12874	Quizartinib	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Thiazoles, Benzene Derivatives	investigational	1
DB11543	Romifidine	Drug	Neurotransmitter Agents, Adrenergic alpha-2 Receptor Agonists, Adrenergic alpha-Agonists, Central Nervous System Depressants, Adrenergic Agonists, Agents that produce hypertension, Agents producing tachycardia, Hypnotics and Sedatives, Central Nervous System Agents, Anesthetics, Adrenergic Agents	vet_approved	0
DB09225	Zotepine	Drug	Psycholeptics, Tranquilizing Agents, Cytochrome P-450 Substrates, Serotonin Agents, Nervous System, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Psychotropic Drugs, Serotonin 5-HT2 Receptor Antagonists, Heterocyclic Compounds, Fused-Ring, Antipsychotic Agents, Sulfur Compounds, Antipsychotic Agents (Second Generation Atypical), Cytochrome P-450 CYP3A Substrates, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Thiepins, Cytochrome P-450 CYP1A2 Substrates, Serotonin Receptor Antagonists, Central Nervous System Agents, Dopamine Antagonists, Dopamine D2 Receptor Antagonists, Neurotoxic agents	approved, investigational, withdrawn	7
DB12877	Oxatomide	Drug	Neurotransmitter Agents, QTc Prolonging Agents, Histamine H1 Antagonists, Piperazine Derivatives, Anti-Allergic Agents, Histamine Antagonists, Anti-Asthmatic Agents, Histamine Agents, Antihistamines for Systemic Use, Moderate Risk QTc-Prolonging Agents, Respiratory System Agents	approved, investigational	0
DB11545	Semduramicin	Drug	Furans, Ionophores, Pyrans	vet_approved	0
DB09226	Brilaroxazine	Drug	Neurotransmitter Agents, Tranquilizing Agents, Antipsychotic Agents, Antipsychotic Agents (Second Generation Atypical), Serotonin Agents, Central Nervous System Depressants, Antidepressive Agents, Central Nervous System Agents, Psychotropic Drugs, Neurotoxic agents	investigational	0
DB12876	GS-9256	Drug	Acids, Noncarboxylic, Acids, Peptides, Organophosphorus Compounds, Amino Acids, Peptides, and Proteins, Phosphorus Compounds, Phosphorus Acids	investigational	0
DB12879	Omigapil	Drug	Ethers, Ethers, Cyclic	investigational	0
DB09223	Blonanserin	Drug	Cytochrome P-450 Substrates, Serotonin Agents, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Serotonin 5-HT2 Receptor Antagonists, Antipsychotic Agents, Antipsychotic Agents (Second Generation Atypical), Cytochrome P-450 CYP3A Substrates, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Serotonin Receptor Antagonists, Dopamine Antagonists, Dopamine D2 Receptor Antagonists, Neurotoxic agents	investigational	3
DB11547	Sulfabromomethazine	Drug	0	vet_approved	0
DB12878	AV-101	Drug	Amino Acids, Peptides, and Proteins, Amino Acids, Sweetening Agents	investigational	0
DB09224	Melperone	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Psycholeptics, QTc Prolonging Agents, Tranquilizing Agents, Cytochrome P-450 Enzyme Inhibitors, Ketones, Nervous System, Moderate Risk QTc-Prolonging Agents, Psychotropic Drugs, Drugs that are Mainly Renally Excreted, Antipsychotic Agents, Antipsychotic Agents (Second Generation Atypical), Central Nervous System Depressants, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Butyrophenone Derivatives, Dopamine Antagonists, Dopamine D2 Receptor Antagonists, Antiarrhythmic agents, Neurotoxic agents	investigational	1
DB09221	Polaprezinc	Drug	Proteins, Metal cations, Zinc Compounds, Oligopeptides, Peptides, Metal divalent cations, Dipeptides, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Anti-Ulcer Agents, Gastrointestinal Agents	experimental	8
DB09222	Fibrinogen human	Drug	Proteins, Biological Factors, Blood and Blood Forming Organs, Increased Coagulation Activity, Acute-Phase Proteins, Blood Proteins, Blood Coagulation Factors, Fibrinogen, Protein Precursors, Amino Acids, Peptides, and Proteins, Hemostatics	approved	0
DB11549	Tiletamine	Drug	Cycloparaffins, Ketones, Anesthetics, Intravenous, Anesthetics, Cyclohexanes, Anesthetics, General, Anticonvulsants, Sulfur Compounds, Thiophenes, Central Nervous System Depressants, Central Nervous System Agents, Anesthetics, Dissociative, Cyclohexanones	vet_approved	0
DB09220	Nicorandil	Drug	Pyridines, Agents causing hyperkalemia, Ions, Cardiovascular Agents, Nitrates, Nicotinic Acids, Drugs that are Mainly Renally Excreted, Micronutrients, Anions, Acids, Noncarboxylic, Physiological Phenomena, Acids, Food and Beverages, Electrolytes, Vasodilators Used in Cardiac Diseases, Antihypertensive Agents, Growth Substances, Nitric Acid, Vasodilating Agents, Cardiac Therapy, Diet, Food, and Nutrition, Nitrogen Compounds, Antiarrhythmic agents, Food	approved, investigational	1
DB00891	Sulfapyridine	Drug	Amines, Cytochrome P-450 Enzyme Inhibitors, Gynecological Antiinfectives and Antiseptics, Aniline Compounds, Dermatologicals, Genito Urinary System and Sex Hormones, Amides, Sulfanilamides, Antiinfectives for Systemic Use, Anti-Infective Agents, Short-Acting Sulfonamides, SULFONAMIDES AND TRIMETHOPRIM, Sulfur Compounds, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Sulfonamides, Cytochrome P-450 CYP2C9 Inhibitors, Methemoglobinemia Associated Agents, Antibacterials for Systemic Use, Sulfones	approved	1
DB00892	Oxybuprocaine	Drug	Aminobenzoates, para-Aminobenzoates, Benzoates, Sensory System Agents, Acids, Carbocyclic, Dermatologicals, Anesthetics for Topical Use, Anesthetics, Peripheral Nervous System Agents, Ophthalmologicals, Antipruritics, Incl. Antihistamines, Anesthetics, Etc., Cholinesterase substrates, Central Nervous System Agents, Sensory Organs, Benzene Derivatives, Anesthetics, Local	approved, investigational	1
DB00890	Dienestrol	Drug	Sex Hormones and Modulators of the Genital System, Hormones, Hormone Substitutes, and Hormone Antagonists, Estrogens, Non-Steroidal, Estrogens, Genito Urinary System and Sex Hormones, Synthetic Estrogens, Plain, Phenols, Hormones, Benzene Derivatives	approved, investigational	2
DB00895	Benzylpenicilloyl polylysine	Drug	Acids, Acyclic, Fatty Acids, Drug Hypersensitivity, Amides, Lactams, Lipids, beta-Lactams, Acetates, Antiinfectives for Systemic Use, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Fatty Acids, Volatile, Penicillins, Acetamides, Antibacterials for Systemic Use, Benzene Derivatives	approved	2
DB09229	Aranidipine	Drug	Calcium Channel Blockers, Pyridines, QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Agents causing hyperkalemia, Potential QTc-Prolonging Agents, Cytochrome P-450 CYP3A4 Substrates, Vasodilating Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	experimental	5
DB00896	Rimexolone	Drug	Cytochrome P-450 Substrates, Immunosuppressive Agents, Glucocorticoids, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 CYP3A4 Inducers (strong), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Corticosteroid Hormone Receptor Agonists, Cytochrome P-450 CYP3A5 Inducers, Corticosteroids, Corticosteroids for Systemic Use, Plain, Cytochrome P-450 CYP3A Inducers (strong), Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP3A4 Inducers, Ophthalmologicals, Cytochrome P-450 CYP3A Substrates, Pregnanes, Thyroxine-binding globulin inhibitors, Sensory Organs, Hyperglycemia-Associated Agents, Steroids	approved	1
DB09227	Barnidipine	Drug	Dihydropyridine Derivatives, Selective Calcium Channel Blockers With Mainly Vascular Effects, Pyridines, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Agents causing hyperkalemia, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Cardiovascular Agents, Hypotensive Agents, Cytochrome P-450 CYP3A4 Substrates, Membrane Transport Modulators, Calcium Channel Blockers, Dihydropyridines, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Calcium-Regulating Hormones and Agents, Cytochrome P-450 CYP3A4 Inhibitors, Vasodilating Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	experimental	1
DB00893	Iron Dextran	Drug	Hematinics, Carbohydrates, Phosphate Binder, Iron Compounds, Hematologic Agents, Biopolymers, Supplements, Macromolecular Substances, Organometallic Compounds, Parenteral Iron Replacement, Ferric Compounds, Polysaccharides, Dextrans, Glucans, Polymers, Compounds used in a research, industrial, or household setting	approved, vet_approved	4
DB00894	Testolactone	Drug	Aromatase Inhibitors, Androstanes, Antineoplastic Agents, Hormonal, Androstadienes, Androstenes, Antineoplastic Agents, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Homosteroids, Steroids	approved, investigational	1
DB09228	Conestat alfa	Drug	C1 inhibitors, Blood and Blood Forming Organs, Protease Inhibitors, Drugs Used in Hereditary Angioedema	approved, investigational	7
DB00899	Remifentanil	Drug	Acids, Acyclic, Fatty Acids, Sensory System Agents, Nervous System, Anesthetics, Intravenous, Lipids, Hypotensive Agents, Opiate Agonists, Peripheral Nervous System Agents, Anesthetics, General, Phenylpiperidine opioids, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Fatty Acids, Volatile, Piperidines, Opioids, Hypnotics and Sedatives, Bradycardia-Causing Agents, Fentanyl and fentanyl analogues, Opioid Anesthetics, Narcotics, Agents producing tachycardia, Anesthetics, High-risk opioids, Central Nervous System Depressants, Opioid Agonist, Propionates, Agents that produce hypertension, Central Nervous System Agents, Opioids, Anilidopiperidine	approved	3
DB00897	Triazolam	Drug	Psycholeptics, Tranquilizing Agents, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, GABA Modulators, Benzodiazepines and benzodiazepine derivatives, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Triazolobenzodiazepines, Benzazepines, Hypnotics and Sedatives, Benzodiazepine hypnotics and sedatives, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Cytochrome P-450 CYP3A5 Substrates, GABA Agents, Cytochrome P-450 CYP2C8 Inhibitors, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Central Nervous System Depressants, Anti-Anxiety Agents, Adjuvants, Anesthesia, Central Nervous System Agents	approved, investigational	2
DB00898	Ethanol	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Anti-Infective Agents, Local, Alcohols, Nerve Depressants, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C9 Inhibitors, Compounds used in a research, industrial, or household setting, Neurotoxic agents, Solvents, Cytochrome P-450 CYP2E1 Substrates, Miscellaneous Therapeutic Agents, Antidotes, Cytochrome P-450 CYP2E1 Inducers, Antiseptics and Disinfectants, Cytochrome P-450 CYP3A4 Inducers, Dermatologicals, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Central Nervous System Depressants, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, NMDA Receptor Antagonists, Cytochrome P-450 CYP2E1 Inducers (moderate), Central Nervous System Agents, Cytochrome P-450 CYP2C19 Inhibitors (weak), Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors (weak), Miscellaneous Local Anti-infectives	approved	52
DB12880	Interleukin-10	Drug	Proteins, Biological Factors, Cytokines, Interleukins, Peptides, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins	investigational	0
DB12882	Ombrabulin	Drug	Amino Acids, Neutral, Amino Acids, Peptides, and Proteins, Amino Acids	investigational	0
DB11551	Trenbolone	Drug	Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, Estrenes, Anabolic Agents, Hormones, Fused-Ring Compounds, Steroids	vet_approved	0
DB12881	Indole-3-carbinol	Drug	Heterocyclic Compounds, Fused-Ring, Protective Agents, Antineoplastic Agents, Anticarcinogenic Agents, Compounds used in a research, industrial, or household setting	investigational	0
DB12884	Lavoltidine	Drug	Neurotransmitter Agents, Gastric Acid Lowering Agents, Histamine Antagonists, Histamine Agents, Histamine H2 Antagonists	investigational	0
DB12883	Eltoprazine	Drug	Neurotransmitter Agents, Serotonin Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Serotonin Receptor Agonists, Antidepressive Agents	investigational	0
DB11552	Tricaine	Drug	Benzoates, Central Nervous System Depressants, Acids, Carbocyclic, Central Nervous System Agents, Anesthetics, Benzene Derivatives	vet_approved	0
DB11555	Zolazepam	Drug	Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Tranquilizing Agents, GABA Agents, Central Nervous System Depressants, GABA Modulators, Anti-Anxiety Agents, Central Nervous System Agents, Psychotropic Drugs	vet_approved	0
DB12886	GSK-1521498	Drug	Receptors, Opioid, mu, Indenes	investigational	0
DB11554	Tylvalosin	Drug	Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Lactones	vet_approved	0
DB12885	CF-102	Drug	0	investigational	0
DB12888	Ezutromid	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB09236	Lacidipine	Drug	Dihydropyridine Derivatives, Selective Calcium Channel Blockers With Mainly Vascular Effects, Pyridines, QTc Prolonging Agents, Cytochrome P-450 Substrates, Agents causing hyperkalemia, Cardiovascular Agents, Hypotensive Agents, Cytochrome P-450 CYP3A4 Substrates, Membrane Transport Modulators, Calcium Channel Blockers, Cytochrome P-450 CYP3A Substrates, Mutagens, Calcium-Regulating Hormones and Agents, Potential QTc-Prolonging Agents, Antihypertensive Agents, Vasodilating Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	approved, investigational	1
DB11556	Detomidine	Drug	Adrenergic alpha-Agonists, Sensory System Agents, Agents producing tachycardia, Peripheral Nervous System Agents, Neurotransmitter Agents, Adrenergic alpha-2 Receptor Agonists, Analgesics, Central Nervous System Depressants, Adrenergic Agonists, Agents that produce hypertension, Hypnotics and Sedatives, Central Nervous System Agents, Adrenergic Agents	vet_approved	0
DB12887	Tazemetostat	Drug	Pyridines, Benzoates, Cytochrome P-450 Substrates, P-glycoprotein substrates, Amides, MATE inhibitors, MATE 1 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, MATE 2 Inhibitors, Benzene Derivatives	approved, investigational	2
DB09237	Levamlodipine	Drug	Antihypertensive Agents Indicated for Hypertension, Pyridines, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A7 Substrates, P-glycoprotein substrates, Antihypertensive Agents, Cytochrome P-450 CYP3A4 Substrates, Nicotinic Acids	approved, investigational	4
DB09234	Darodipine	Drug	Pyridines, Cytochrome P-450 Substrates, Agents causing hyperkalemia, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Membrane Transport Modulators, Calcium Channel Blockers, Dihydropyridines, Cytochrome P-450 CYP3A Substrates, Calcium-Regulating Hormones and Agents, Vasodilating Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	experimental	0
DB11558	Toluene	Drug	Solvents, Compounds used in a research, industrial, or household setting, Benzene Derivatives	vet_approved	0
DB12889	Velneperit	Drug	0	investigational	0
DB09235	Efonidipine	Drug	QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Agents causing hyperkalemia, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Hypotensive Agents, Cytochrome P-450 CYP3A4 Substrates, Calcium-Regulating Hormones and Agents, Diuretics, Potential QTc-Prolonging Agents, Antihypertensive Agents, Benzene Derivatives, Bradycardia-Causing Agents, Antiarrhythmic agents, Pyridines, Membrane Transport Modulators, Calcium Channel Blockers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Nitro Compounds, Cytochrome P-450 CYP3A4 Inhibitors, Natriuretic Agents, Phenols, Vasodilating Agents	experimental	2
DB09232	Cilnidipine	Drug	Dihydropyridine Derivatives, Selective Calcium Channel Blockers With Mainly Vascular Effects, Pyridines, Cytochrome P-450 Substrates, Agents causing hyperkalemia, Cardiovascular Agents, Hypotensive Agents, Cytochrome P-450 CYP3A4 Substrates, Membrane Transport Modulators, Calcium Channel Blockers, Cytochrome P-450 CYP3A Substrates, Calcium-Regulating Hormones and Agents, Vasodilating Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	investigational	2
DB09233	Cronidipine	Drug	0	experimental	0
DB09230	Azelnidipine	Drug	Acids, Acyclic, Pyridines, Cytochrome P-450 Substrates, Agents causing hyperkalemia, Amino Acids, Peptides, and Proteins, Azetines, Cytochrome P-450 CYP3A4 Substrates, Amino Acids, Amino Acids, Cyclic, Calcium Channel Blockers, Cytochrome P-450 CYP3A Substrates, Imines, Imino Acids, Vasodilating Agents, Azetidines, Bradycardia-Causing Agents, Antiarrhythmic agents	investigational	1
DB09231	Benidipine	Drug	Dihydropyridine Derivatives, Selective Calcium Channel Blockers With Mainly Vascular Effects, Pyridines, QTc Prolonging Agents, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Agents causing hyperkalemia, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Moderate Risk QTc-Prolonging Agents, Membrane Transport Modulators, Calcium Channel Blockers, Dihydropyridines, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Calcium-Regulating Hormones and Agents, Cytochrome P-450 CYP3A4 Inhibitors, Vasodilating Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	experimental	3
DB09238	Manidipine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Dihydropyridine Derivatives, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Agents causing hyperkalemia, Cytochrome P-450 CYP2C19 Inhibitors, Cardiovascular Agents, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, ACE Inhibitors and Calcium Channel Blockers, Cytochrome P-450 CYP2C9 Inhibitors, Calcium-Regulating Hormones and Agents, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Antihypertensive Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Selective Calcium Channel Blockers With Mainly Vascular Effects, Cytochrome P-450 CYP2B6 Inhibitors (weak), Pyridines, Membrane Transport Modulators, Calcium Channel Blockers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors (weak), Vasodilating Agents, Cytochrome P-450 CYP2D6 Inhibitors (weak), Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved, investigational	2
DB09239	Niguldipine	Drug	Pyridines, QTc Prolonging Agents, Cytochrome P-450 Substrates, Adrenergic alpha-Antagonists, Agents causing hyperkalemia, Antineoplastic Agents, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Membrane Transport Modulators, Calcium Channel Blockers, Cytochrome P-450 CYP3A Substrates, Adrenergic Antagonists, Calcium-Regulating Hormones and Agents, Potential QTc-Prolonging Agents, Adrenergic alpha-1 Receptor Antagonists, Antihypertensive Agents, P-glycoprotein inhibitors, Vasodilating Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	experimental	1
DB11560	Lesinurad	Drug	Acids, Acyclic, Renal Agents, Cytochrome P-450 Substrates, Fatty Acids, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Preparations Increasing Uric Acid Excretion, Antirheumatic Agents, Lipids, Urate Transporter 1 Inhibitors, Acetates, Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A4 Inducers (weak), Urate Transporter 1 Inhibitor, Antigout Preparations, Cytochrome P-450 Enzyme Inducers, Sulfur Compounds, Fatty Acids, Volatile, Musculo-Skeletal System, Uricosuric Agents, Sulfhydryl Compounds	approved, investigational	2
DB12891	Ozanezumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB09240	Niludipine	Drug	Pyridines, Cytochrome P-450 Substrates, Agents causing hyperkalemia, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Membrane Transport Modulators, Calcium Channel Blockers, Dihydropyridines, Cytochrome P-450 CYP3A Substrates, Calcium-Regulating Hormones and Agents, Vasodilating Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	experimental	0
DB12890	Dihydrexidine	Drug	Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Nonergot-derivative Dopamine Receptor Agonists, Dopamine Agents, Dopamine Agonists	investigational	1
DB12893	Sacituzumab govitecan	Drug	Immunoglobulins, Noxae, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins, Proteins, Serum Globulins, Alkaloids, Globulins, Blood Proteins, UGT1A1 Substrates, Toxic Actions	approved, investigational	3
DB11562	Bicuculline	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Central Nervous System Stimulants, Benzylisoquinolines, GABA Agents, GABA-A Receptor Antagonists, Isoquinolines, Convulsants, Central Nervous System Agents, GABA Antagonists	experimental	0
DB12892	MGB-BP-3	Drug	0	investigational	0
DB11561	Aminacrine	Drug	Acridines, Noxae, Antiseptics and Disinfectants, Coloring Agents, Dermatologicals, Laboratory Chemicals, Anti-Infective Agents, Anti-Infective Agents, Local, Acridine Derivatives, Luminescent Agents, Heterocyclic Compounds, Fused-Ring, Mutagens, Indicators and Reagents, Toxic Actions, Aminoacridines, Compounds used in a research, industrial, or household setting, Fluorescent Dyes	experimental	0
DB12895	TD-139	Drug	0	investigational	0
DB11564	Insulin argine	Drug	Blood Glucose Lowering Agents, Insulin	experimental	0
DB11563	Sebelipase alfa	Drug	Enzymes, Alimentary Tract and Metabolism, Carboxylic Ester Hydrolases, Enzymes and Coenzymes, Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme, Hydrolases, Wolman Disease, drug therapy, Esterases, Cholesterol Ester Storage Disease, drug therapy, Hydrolytic Lysosomal Triacylglycerol-specific Enzyme	approved, investigational	0
DB12894	Raluridine	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Deoxyribonucleosides	investigational	0
DB12897	MK-7622	Drug	0	investigational	0
DB12896	PSI-352938	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides	investigational	0
DB11568	Insulin tregopil	Drug	Cytochrome P-450 Enzyme Inducers, Insulin, Short-Acting, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Cytochrome P-450 CYP1A2 Inducers, Blood Glucose Lowering Agents, Insulin	investigational	0
DB09247	Iproclozide	Drug	Acids, Acyclic, Fatty Acids, Hydroxy Acids, Nervous System, Central Nervous System Depressants, Fatty Acids, Volatile, Lipids, Antidepressive Agents, Acetates, Psychoanaleptics	withdrawn	0
DB12899	TT-301	Drug	0	investigational	0
DB12898	Calcitonin eel	Drug	0	investigational	0
DB09248	Mebanazine	Drug	Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Agents that produce hypertension, Monoamine Oxidase Inhibitors, Antidepressive Agents, Agents that reduce seizure threshold	withdrawn	0
DB11567	Insulin peglispro	Drug	Insulin, Long-Acting, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pancreatic Hormones, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Amino Acids, Peptides, and Proteins, Blood Glucose Lowering Agents, Hormones, Insulin, Alcohols, Macromolecular Substances, Cytochrome P-450 Enzyme Inducers, Peptide Hormones, Ethylene Glycols, Cytochrome P-450 CYP1A2 Inducers, Pegylated agents, Glycols, Polymers, Compounds used in a research, industrial, or household setting	investigational	0
DB09245	Toloxatone	Drug	Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, Enzyme Inhibitors, Monoamine Oxidase A Inhibitors, Nervous System, Monoamine Oxidase Inhibitors, Antidepressive Agents, Psychotropic Drugs, Drugs that are Mainly Renally Excreted, Oxazoles, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Agents that produce hypertension, Central Nervous System Agents, Agents that reduce seizure threshold, Psychoanaleptics	experimental	1
DB09246	Benmoxin	Drug	Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Agents that produce hypertension, Monoamine Oxidase Inhibitors, Antidepressive Agents, Agents that reduce seizure threshold	withdrawn	0
DB11569	Ixekizumab	Drug	Interleukin-17A Antagonist, Immunoglobulins, Immunosuppressive Agents, Antineoplastic and Immunomodulating Agents, Dermatologicals, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Misc. Skin and Mucous Membrane Agents, Interleukin Inhibitors, Immunoproteins, Proteins, Serum Globulins, Globulins, Blood Proteins, Interleukin-17	approved, investigational	1
DB09243	Hydracarbazine	Drug	Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Agents that produce hypertension, Monoamine Oxidase Inhibitors, Antidepressive Agents, Agents that reduce seizure threshold	experimental	0
DB09244	Pirlindole	Drug	Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, Enzyme Inhibitors, Serotonin Agents, Monoamine Oxidase Inhibitors, Antidepressive Agents, Psychotropic Drugs, Drugs that are Mainly Renally Excreted, Heterocyclic Compounds, Fused-Ring, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Agents that produce hypertension, Serotonin Receptor Antagonists, Central Nervous System Agents, Indoles, Serotonin 5-HT1 Receptor Antagonists, Agents that reduce seizure threshold	experimental	3
DB09241	Methylene blue	Drug	Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), MATE 1 Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Drugs that are Mainly Renally Excreted, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Agents that reduce seizure threshold, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Miscellaneous Therapeutic Agents, Antidotes, Cytochrome P-450 CYP2C8 Inhibitors, Tests for Gastric Secretion, Photosensitizing Agents, Central Nervous System Depressants, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inducers, MATE 2 Inhibitors, Oxidation-Reduction Agent, Cytochrome P-450 CYP2D6 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors, MATE inhibitors, Antidepressive Agents, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors, Antipsychotic Agents, Cytochrome P-450 Enzyme Inducers, Sulfur Compounds, Cytochrome P-450 CYP2C9 Inhibitors, Drugs causing inadvertant photosensitivity, Neurotoxic agents, UGT1A4 Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), P-glycoprotein substrates, Phenothiazines, Cytochrome P-450 CYP3A5 Inhibitors, Monoamine Oxidase Inhibitors, Heterocyclic Compounds, Fused-Ring, UGT1A9 Inhibitors, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), OCT2 Inhibitors, Agents that produce hypertension, Cytochrome P-450 CYP3A4 Inhibitors, Gastric Function, Diagnostic Agents, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), P-glycoprotein inhibitors	approved, investigational	2
DB09242	Moxonidine	Drug	Adrenergic alpha-2 Receptor Agonists, Adrenergic alpha-Agonists, Sympatholytics, Adrenergic Agonists, Agents that produce hypertension, Imidazoline Receptor Agonists, Agents producing tachycardia, Cardiovascular Agents, Hypotensive Agents, Antiadrenergic Agents, Centrally Acting, Antihypertensive Agents	approved, investigational	2
DB09249	Octamoxin	Drug	Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Agents that produce hypertension, Monoamine Oxidase Inhibitors, Antidepressive Agents, Agents that reduce seizure threshold	withdrawn	0
DB09250	Pheniprazine	Drug	Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Agents that produce hypertension, Monoamine Oxidase Inhibitors, Antidepressive Agents, Agents that reduce seizure threshold	withdrawn	0
DB11571	Human thrombin	Drug	Increased Coagulation Factor Activity, Blood Coagulation Factors	approved	8
DB11570	Padimate O	Drug	Aminobenzoates, Radiation-Protective Agents, Benzoates, Protective Agents, Acids, Carbocyclic, Dermatologicals, Cosmetics, Sunscreen Agents, Compounds used in a research, industrial, or household setting, Benzene Derivatives, Household Products	approved	0
DB09251	Phenoxypropazine	Drug	Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Agents that produce hypertension, Monoamine Oxidase Inhibitors, Antidepressive Agents, Agents that reduce seizure threshold	withdrawn	0
DB11573	Aluminum chlorohydrate	Drug	Medicated Dressings With Antiinfectives, Medicated Dressings, Musculo-Skeletal System, Astringents and Deodorants, Dermatologicals, Drugs for Treatment of Bone Diseases, Drugs Affecting Bone Structure and Mineralization	approved	0
DB11572	Thrombin alfa	Drug	Biological Factors, Enzymes, Increased Coagulation Factor Activity, Blood Coagulation Factors, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Hemorrhage, Proteins, Blood Proteins, Serine Proteases, Hydrolases, Peptide Hydrolases, Hemostatics, Serine Endopeptidases, Endopeptidases	approved	5
DB11575	Grazoprevir	Drug	Antivirals for treatment of HCV infections, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, P-glycoprotein substrates, Antiviral Agents, OATP1B3 substrates, Cytochrome P-450 CYP3A4 Substrates, HCV NS3/4A Protease Inhibitors, Antiinfectives for Systemic Use, Anti-Infective Agents, Antivirals for Systemic Use, Direct Acting Antivirals, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Breast Cancer Resistance Protein Inhibitors, OATP1B1/SLCO1B1 Substrates, NS3/4A Protease Inhibitors	approved	1
DB11574	Elbasvir	Drug	Antivirals for treatment of HCV infections, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, P-glycoprotein substrates, Cytochrome P-450 CYP3A5 Inhibitors, Experimental Unapproved Treatments for COVID-19, Antiviral Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Antiinfectives for Systemic Use, Cytochrome P-450 CYP3A7 Inhibitors (strength unknown), Antivirals for Systemic Use, Direct Acting Antivirals, Hepatitis C Virus NS5A Inhibitor, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A7 Inhibitors, Breast Cancer Resistance Protein Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors	approved	1
DB11577	Indigotindisulfonic acid	Drug	Kidney Function, Heterocyclic Compounds, Fused-Ring, Coloring Agents, Tests for Renal Function and Ureteral Injuries, Diagnostic Agents, Indoles, Compounds used in a research, industrial, or household setting, Drugs that are Mainly Renally Excreted	approved	2
DB11576	Ferric oxide	Drug	Magnetic Resonance Imaging Contrast Media, Organometallic Compounds, Contrast Media, Iron Compounds, Superparamagnetic Contrast Media	experimental	0
DB11579	Light Mineral Oil	Drug	Basic Ointments and Protectants	approved	0
DB09258	Bemiparin	Drug	Anticoagulants, Carbohydrates, Polysaccharides, Blood and Blood Forming Organs, Glycosaminoglycans, Heparin (Low Molecular Weight), Agents causing hyperkalemia, Heparin and similars, Hematologic Agents	approved, investigational	3
DB11578	Hard fat	Drug	Suppositories, Pharmaceutical Vehicles	approved	0
DB09259	Reviparin	Drug	Anticoagulants, Carbohydrates, Polysaccharides, Blood and Blood Forming Organs, Glycosaminoglycans, Fibrin Modulating Agents, Heparin (Low Molecular Weight), Agents causing hyperkalemia, Heparin and similars, Hematologic Agents, Cardiovascular Agents	approved, investigational	0
DB09256	Tegafur	Drug	Cytochrome P-450 Substrates, Fluorouracil and prodrugs, Pyrimidine Analogues, Drugs that are Mainly Renally Excreted, Pyrimidines, Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 CYP3A5 Substrates, Noxae, Cytochrome P-450 CYP2A6 Substrates with a Narrow Therapeutic Index, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index, Pyrimidinones, Antineoplastic Agents, Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index, Antimetabolites, Fluoropyrimidines, Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Thyroxine-binding globulin inducers, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2A6 Substrates, Toxic Actions	approved, investigational	1
DB09257	Gimeracil	Drug	Drugs that are Mainly Renally Excreted	approved	1
DB09254	Caroxazone	Drug	Acids, Acyclic, Fatty Acids, Monoamine Oxidase Inhibitors, Amides, Lipids, Antidepressive Agents, Acetates, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Fatty Acids, Volatile, Agents that produce hypertension, Acetamides, Benzene Derivatives, Agents that reduce seizure threshold	withdrawn	0
DB09255	Dextran	Drug	Anticoagulants, Carbohydrates, Blood and Blood Forming Organs, Increased Intravascular Volume, Blood Substitutes and Plasma Protein Fractions, Biomimetic Materials, Hematologic Agents, Blood Substitutes and Perfusion Solutions, Biopolymers, Drugs that are Mainly Renally Excreted, Macromolecular Substances, Polysaccharides, Dextrans, Plasma Substitutes, Glucans, Blood and Related Products, Blood Substitutes, Polymers, Compounds used in a research, industrial, or household setting, Osmotic Activity	approved, investigational, vet_approved	0
DB09252	Pivhydrazine	Drug	Acids, Acyclic, Fatty Acids, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Fatty Acids, Volatile, Agents that produce hypertension, Monoamine Oxidase Inhibitors, Lipids, Antidepressive Agents, Agents that reduce seizure threshold	withdrawn	0
DB09253	Safrazine	Drug	Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Agents that produce hypertension, Monoamine Oxidase Inhibitors, Antidepressive Agents, Agents that reduce seizure threshold, Monoamine Oxidase Inhibitors, Non-Selective	withdrawn	0
DB12831	Gabexate	Drug	Anticoagulants, Enzyme Inhibitors, Protease Inhibitors, Amidines, Hematologic Agents, Guanidines, Serine Protease Inhibitors	investigational	3
DB12830	Cebranopadol	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB12833	Tandospirone	Drug	Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Tranquilizing Agents, Serotonin Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Serotonin Receptor Agonists, Anti-Anxiety Agents, Antidepressive Agents, Central Nervous System Agents, Psychotropic Drugs	investigational	0
DB11502	Butacaine	Drug	Benzoates, Sensory System Agents, Acids, Carbocyclic, Central Nervous System Agents, Anesthetics, Benzene Derivatives, Anesthetics, Local, Peripheral Nervous System Agents	vet_approved	0
DB12832	Prednimustine	Drug	Pregnadienetriols, Noxae, Pregnadienes, Antineoplastic and Immunomodulating Agents, Nitrogen Mustard Analogues, Antineoplastic Agents, Hydrocarbons, Halogenated, Mustard Compounds, Nitrogen Mustard Compounds, Fused-Ring Compounds, Alkylating Drugs, Pregnanes, Toxic Actions, Antineoplastic Agents, Alkylating, Steroids	investigational	0
DB11501	Bunamidine	Drug	Anthelmintics, Anti-Infective Agents, Antiparasitic Agents	vet_approved	0
DB11504	Caramiphen	Drug	Cycloparaffins	experimental, vet_approved	0
DB12835	Olipudase alfa	Drug	Proteins, Enzymes, Phosphoric Diester Hydrolases, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Hydrolases, Esterases	investigational	0
DB12834	Secnidazole	Drug	Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Imidazoles, Nitroimidazole Antimicrobial, Nitroimidazole Derivatives, Nitro Compounds, Antiinfectives for Systemic Use, Nitroimidazoles, Anti-Infective Agents, Antibacterials for Systemic Use, Antiparasitic Agents	approved	0
DB12837	UK-500001	Drug	0	investigational	0
DB12836	Grapiprant	Drug	Sulfur Compounds, P-glycoprotein substrates, Amides, Sulfones	investigational, vet_approved	1
DB12839	Pegvaliase	Drug	Proteins, Enzymes, Carbon-Nitrogen Lyases, Enzymes and Coenzymes, Pegylated agents, Amino Acids, Peptides, and Proteins, Ammonia-Lyases, Lyases	approved, investigational	0
DB12838	Tetrasul	Drug	Hydrocarbons, Chlorinated, Hydrocarbons, Halogenated, Benzene Derivatives	investigational	0
DB11507	Cloprostenol	Drug	Biological Factors, Autacoids, Inflammation Mediators, Fatty Acids, Adrenal Cortex Hormones, Reproductive Control Agents, Eicosanoids, Lipids, Prostaglandins, Synthetic, Fatty Acids, Unsaturated, Prostaglandins, Abortifacient Agents, Prostaglandins F, Synthetic, Luteolytic Agents, Hormonal Contraceptives for Systemic Use	vet_approved	0
DB12829	Amithiozone	Drug	Anti-Bacterial Agents, Sulfur Compounds, Drugs for Treatment of Tuberculosis, Thiosemicarbazones, Semicarbazides, Antimycobacterials, Semicarbazones, Antiinfectives for Systemic Use, Anti-Infective Agents, Antituberculosis Agents	investigational	0
DB00851	Dacarbazine	Drug	Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 Substrates, Immunosuppressive Agents, Noxae, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index, Alkylating Activity, Antineoplastic Agents, Drugs that are Mainly Renally Excreted, Triazenes, Myelosuppressive Agents, Alkylating Drugs, Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index, Imidazoles, Cytochrome P-450 CYP1A2 Substrates, Toxic Actions, Antineoplastic Agents, Alkylating	approved, investigational	3
DB00852	Pseudoephedrine	Drug	Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, Amines, Adrenergic alpha-1 Receptor Agonists, Cardiovascular Agents, Phenethylamines, Alcohols, Peripheral Nervous System Agents, Sympathomimetic (Adrenergic) Agents, Adrenergic alpha-2 Receptor Agonists, Nasal Preparations, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Nasal Decongestants for Systemic Use, Alpha-and Beta-adrenergic Agonists, Autonomic Agents, Adrenergic alpha-Agonists, Propanols, Anti-Asthmatic Agents, Nasal Decongestants, Agents producing tachycardia, Norepinephrine Releasing Agent, Bronchodilator Agents, Amino Alcohols, Respiratory System Agents, Adrenergic beta-Agonists, Ethylamines, Sympathomimetics, Vasoconstrictor Agents, Adrenergic Agonists, Agents that produce hypertension, Amphetamines, Hyperglycemia-Associated Agents, Propanolamines	approved	12
DB00850	Perphenazine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Psycholeptics, Tranquilizing Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Antipsychotic Agents (First Generation Typical), Cytochrome P-450 CYP3A4 Substrates, Antipsychotic Agents, Sulfur Compounds, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Substrates, Drugs causing inadvertant photosensitivity, Dopamine Antagonists, Phenothiazines With Piperazine Structure, Dopamine Agents, Neurotoxic agents, Cytochrome P-450 CYP2C18 Substrates, Phenothiazines, Psychotropic Drugs, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Central Nervous System Depressants, Cytochrome P-450 CYP1A2 Substrates, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Dopamine D2 Receptor Antagonists	approved	3
DB00855	Aminolevulinic acid	Drug	Peptides, Antineoplastic and Immunomodulating Agents, Dermatologicals, Sensitizers Used in Photodynamic/radiation Therapy, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Misc. Skin and Mucous Membrane Agents, Porphyrin Precursor, Radiation-Sensitizing Agents, Amino Acids, Proteins, Photosensitizing agents used for phototherapy, Opioid Peptides, Photosensitizing Agents, Keto Acids, Enkephalins, Levulinic Acids	approved	1
DB00856	Chlorphenesin	Drug	Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Dermatologicals, Antifungals for Dermatological Use, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Propylene Glycols, Muscle Relaxants, Alcohols, Peripheral Nervous System Agents, Cytochrome P-450 Enzyme Inducers, Central Nervous System Depressants, Antifungals for Topical Use, Muscle Relaxants, Centrally Acting Agents, Glycols, Central Nervous System Agents	approved, experimental	0
DB00853	Temozolomide	Drug	Immunosuppressive Agents, Noxae, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A Inducers, Alkylating Activity, Antineoplastic Agents, Drugs that are Mainly Renally Excreted, Triazenes, Myelosuppressive Agents, Alkylating Drugs, Cytochrome P-450 Enzyme Inducers, Imidazoles, Narrow Therapeutic Index Drugs, Toxic Actions, Antineoplastic Agents, Alkylating	approved, investigational	1
DB00854	Levorphanol	Drug	Sensory System Agents, Narcotics, Morphinans, Peripheral Nervous System Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Opioid Agonist, Opioids, Central Nervous System Agents	approved	3
DB00859	Penicillamine	Drug	Antidotes, Immunosuppressive Agents, Protective Agents, Amino Acids, Sulfur, Antirheumatic Agents, Amino Acids, Peptides, and Proteins, Amino Acids, Myelosuppressive Agents, Sulfur Compounds, Antiinflammatory and Antirheumatic Products, Agents Causing Muscle Toxicity, Musculo-Skeletal System, Sequestering Agents, OATP1B1/SLCO1B1 Substrates, Penicillamine and Similar Agents, Specific Antirheumatic Agents, Compounds used in a research, industrial, or household setting, Chelating Agents, Heavy Metal Antagonists	approved	1
DB00857	Terbinafine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Allylamine Antifungal, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Antifungals for Dermatological Use, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C8 Inhibitors (weak), Antifungals for Topical Use, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Antifungal Agents, Cytochrome P-450 CYP2C8 Substrates, Allylamines, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Inducers, Dermatologicals, Naphthalenes, Antifungals for Systemic Use, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Cytochrome P-450 CYP1A2 Substrates	approved, investigational, vet_approved	2
DB00858	Drostanolone	Drug	Androstanes, Fused-Ring Compounds, Steroids	illicit	1
DB12840	Pirnabine	Drug	Peptide Hormones, Enzyme Activators, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Guanylyl Cyclase C Agonists, Receptors, Guanylate Cyclase-Coupled, agonists, Amino Acids, Peptides, and Proteins, Hormones, Gastrointestinal Agents	investigational	0
DB11511	Difloxacin	Drug	Cytochrome P-450 CYP1A2 Inhibitors, Fluoroquinolones, Quinolines, Heterocyclic Compounds, Fused-Ring, QTc Prolonging Agents, Anti-Bacterial Agents, Cytochrome P-450 Enzyme Inhibitors, Potential QTc-Prolonging Agents, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Quinolones	vet_approved	0
DB12842	Pegamotecan	Drug	Alkaloids, Ethylene Glycols, Pegylated agents, Glycols, Polymers, Compounds used in a research, industrial, or household setting, Alcohols, Macromolecular Substances	investigational	0
DB11510	Deslorelin	Drug	Enzyme Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Oligopeptides, Peptides, Adrenal Cortex Hormones, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Alcohol Dehydrogenase, antagonists & inhibitors, Hormones, Pituitary Hormone-Releasing Hormones, Proteins, Peptide Hormones, Gonadotropin-releasing hormone agonist, Hypothalamic Hormones	investigational, vet_approved	0
DB12841	Glial growth factor 2	Drug	0	investigational	0
DB11513	Diperodon	Drug	0	vet_approved	0
DB12844	Rontalizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB12843	Oleandrin	Drug	Carbohydrates, Cardanolides, Cardiac Glycosides, Glycosides, Fused-Ring Compounds, Steroids	investigational, experimental	0
DB11512	Dihydrostreptomycin	Drug	Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Nephrotoxic agents, Ophthalmologicals, Carbohydrates, Anti-Bacterial Agents, Narrow Therapeutic Index Drugs, Aminoglycoside Antibacterials, Glycosides, Agents that produce neuromuscular block (indirect), Sensory Organs, Anti-Infective Agents, Drugs that are Mainly Renally Excreted	approved, investigational, withdrawn, vet_approved	0
DB12846	Reproterol	Drug	Adrenergics, Inhalants, Amines, Alcohols, Peripheral Nervous System Agents, Alkaloids, Purines, Selective Beta 2-adrenergic Agonists, Adrenergic Agents, Benzene Derivatives, Purinones, Autonomic Agents, Adrenergics for Systemic Use, Anti-Asthmatic Agents, Agents producing tachycardia, Catecholamines, Catechols, Bronchodilator Agents, Amino Alcohols, Ethanolamines, Respiratory System Agents, Adrenergic beta-Agonists, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Adrenergic Agonists, Agents that produce hypertension, Phenols, Drugs for Obstructive Airway Diseases, Pharmaceutical Preparations	investigational	0
DB12845	Amatuximab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	1
DB12848	PF-04217903	Drug	0	investigational	0
DB11517	Etymemazine	Drug	0	experimental, vet_approved	0
DB12847	Pyroxamide	Drug	Pyridines, Amines, Hydroxy Acids, Hydroxylamines	investigational	0
DB11516	Dithiazanine	Drug	Coloring Agents, Laboratory Chemicals, Anthelmintics, Anti-Infective Agents, Luminescent Agents, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Thiazoles, Indicators and Reagents, Compounds used in a research, industrial, or household setting, Antinematodal Agents, Antiparasitic Agents, Fluorescent Dyes, Benzothiazoles	vet_approved	0
DB11519	Fluprostenol	Drug	Biological Factors, Autacoids, Fatty Acids, Unsaturated, Inflammation Mediators, Prostaglandins, Fatty Acids, Abortifacient Agents, Reproductive Control Agents, Eicosanoids, Lipids, Luteolytic Agents, Prostaglandins, Synthetic	vet_approved	0
DB12849	Clazakizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB11518	Flunixin	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Pyridines, Sensory System Agents, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Veterinary Drugs, Nicotinic Acids, Peripheral Nervous System Agents, Analgesics, Agents that produce hypertension, Central Nervous System Agents, Antipyretics	vet_approved	0
DB11509	Cupric glycinate	Drug	Amino Acids, Peptides, and Proteins, Amino Acids	vet_approved	0
DB00862	Vardenafil	Drug	Phosphodiesterase Inhibitors, QTc Prolonging Agents, Enzyme Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Piperazines, P-glycoprotein substrates, Genito Urinary System and Sex Hormones, Phosphodiesterase 5 Inhibitors, Urologicals, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Urological Agents, Imidazoles, Cytochrome P-450 CYP3A Substrates, Drugs Used in Erectile Dysfunction, Potential QTc-Prolonging Agents, P-glycoprotein inhibitors, Vasodilating Agents	approved	3
DB00863	Ranitidine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, OCT1 substrates, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, OCT2 Substrates, OCT1 inhibitors, OAT1/SLC22A6 Substrates, Anti-Ulcer Agents, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Drugs that are Mainly Renally Excreted, OAT3/SLC22A8 Substrates, Cytochrome P-450 CYP1A2 Inhibitors, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Alimentary Tract and Metabolism, Acid Reducers, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Drugs for Acid Related Disorders, Gastrointestinal Agents, Cholinesterase Inhibitors, P-glycoprotein substrates, Histamine H2 Antagonists, OAT1/SLC22A6 inhibitors, Gastric Acid Lowering Agents, Cytochrome P-450 CYP3A Inhibitors, Histamine Antagonists, Agents Causing Muscle Toxicity, OCT2 Inhibitors, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Furans, P-glycoprotein inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved, withdrawn	2
DB00860	Prednisolone	Drug	Corticosteroids, Dermatological Preparations, Cytochrome P-450 Substrates, Immunosuppressive Agents, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Otologicals, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Corticosteroids for Local Oral Treatment, Ophthalmological and Otological Preparations, Fused-Ring Compounds, Intestinal Antiinflammatory Agents, Vasoprotectives, Cytochrome P-450 Enzyme Inducers, Nasal Preparations, Alimentary Tract and Metabolism, Adrenals, Corticosteroids Acting Locally, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Corticosteroid Hormone Receptor Agonists, Corticosteroids for Systemic Use, Antineoplastic Agents, Hormonal, Pregnadienetriols, Antidotes, Corticosteroids, Corticosteroids for Systemic Use, Plain, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Corticosteroids, Weak (Group I), P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inducers, Dermatologicals, Antineoplastic Agents, Ophthalmologicals, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Cytochrome P-450 CYP3A Substrates, Pregnanes, Prednisolone and Prodrugs, Sensory Organs, Hyperglycemia-Associated Agents, Stomatological Preparations, Steroids	approved, vet_approved	1
DB00861	Diflunisal	Drug	Nephrotoxic agents, Enzyme Inhibitors, Sensory System Agents, Cyclooxygenase Inhibitors, Nervous System, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Non COX-2 selective NSAIDS, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Analgesics, Salicylates, Drugs causing inadvertant photosensitivity, Benzene Derivatives, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Benzoates, Hydroxy Acids, Antirheumatic Agents, Hydroxybenzoates, OAT1/SLC22A6 inhibitors, UGT1A9 Inhibitors, Photosensitizing Agents, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Agents that produce hypertension, Phenols, Central Nervous System Agents, Salicylic Acid and Derivatives, Other Nonsteroidal Anti-inflammatory Agents	approved, investigational	2
DB00866	Alprenolol	Drug	Amines, Cytochrome P-450 Substrates, Serotonin Agents, Sympatholytics, Agents causing hyperkalemia, Adrenergic beta-Antagonists, Cardiovascular Agents, Antidepressive Agents, Alcohols, Peripheral Nervous System Agents, Adrenergic Antagonists, Antihypertensive Agents, Adrenergic Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Autonomic Agents, Propanols, Phenoxypropanolamines, Amino Alcohols, Beta Blocking Agents, Non-Selective, Neurotransmitter Agents, Central Nervous System Depressants, Serotonin Receptor Antagonists, Cytochrome P-450 CYP2D6 Substrates, Serotonin 5-HT1 Receptor Antagonists, Propanolamines	withdrawn, experimental	4
DB00867	Ritodrine	Drug	Autonomic Agents, Amines, Propanols, Genito Urinary System and Sex Hormones, Reproductive Control Agents, Sympathomimetics, Labour Repressants, Agents producing tachycardia, Adrenergic beta-2 Receptor Agonists, Amino Alcohols, Phenethylamines, Tocolytic Agents, Alcohols, Peripheral Nervous System Agents, Adrenergic beta-Agonists, Neurotransmitter Agents, Ethylamines, Sympathomimetics, Adrenergic Agonists, Agents that produce hypertension, Adrenergic Agents, Propanolamines	approved, investigational	1
DB00864	Tacrolimus	Drug	Agents for Dermatitis, Excluding Corticosteroids, Nephrotoxic agents, Immunologic Factors, QTc Prolonging Agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Calcineurin Inhibitor Immunosuppressant, Agents causing hyperkalemia, Misc. Skin and Mucous Membrane Agents, Cytochrome P-450 CYP3A4 Substrates, Lactones, Calcineurin Inhibitors, Anti-Bacterial Agents, Potential QTc-Prolonging Agents, Drugs causing inadvertant photosensitivity, P-glycoprotein substrates with narrow therapeutic index, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Dermatologicals, Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index, Myelosuppressive Agents, P-glycoprotein inducers, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Agents Causing Muscle Toxicity, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors, Hyperglycemia-Associated Agents, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved, investigational	1
DB00865	Benzphetamine	Drug	Central Nervous System Stimulants, Adrenergic Uptake Inhibitors, Amines, Cytochrome P-450 Substrates, Increased Sympathetic Activity, Adrenergic alpha-1 Receptor Agonists, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Phenethylamines, Peripheral Nervous System Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Appetite Suppression, Adrenergic Agents, Dopamine Agents, Dopamine Uptake Inhibitors, Autonomic Agents, Adrenergic alpha-Agonists, Sympathomimetic Amine Anorectic, Agents producing tachycardia, Membrane Transport Modulators, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Ethylamines, Sympathomimetics, Central Nervous System Depressants, Adrenergic Agonists, Neurotransmitter Uptake Inhibitors, Agents that produce hypertension, Amphetamines, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates	approved, illicit	4
DB00868	Benzonatate	Drug	Antitussive Agents, Non-narcotic Antitussive, Amines, Cough and Cold Preparations, Hydrocarbons, Acyclic, Alkanes, Decreased Tracheobronchial Stretch Receptor Activity, Cholinesterase substrates, Central Nervous System Agents, Respiratory System Agents, Butanes	approved	1
DB00869	Dorzolamide	Drug	Cytochrome P-450 CYP2E1 Substrates, Enzyme Inhibitors, Intraocular Pressure, drug effects, Cytochrome P-450 Substrates, Antiglaucoma Preparations and Miotics, Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Amides, Cardiovascular Agents, Drugs that are Mainly Renally Excreted, Ophthalmologicals, Cytochrome P-450 CYP2C9 Substrates, Carbonic Anhydrase Inhibitors, Sulfur Compounds, Cytochrome P-450 CYP3A Substrates, Sulfonamides, Diuretics, Antihypertensive Agents, Sensory Organs, Sulfones	approved	4
DB11520	Hygromycin B	Drug	Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Nephrotoxic agents, Carbohydrates, Anti-Bacterial Agents, Narrow Therapeutic Index Drugs, Aminoglycoside Antibacterials, Anthelmintics, Glycosides, Agents that produce neuromuscular block (indirect), Anti-Infective Agents, Antiparasitic Agents, Drugs that are Mainly Renally Excreted	vet_approved	0
DB12851	Miravirsen	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides, Polynucleotides	investigational	0
DB12850	Etalocib	Drug	Acids, Carbocyclic, Benzene Derivatives	investigational	0
DB11522	Isoflupredone	Drug	Pregnadienetriols, Pregnadienes, Pregnanes, Steroids, Fluorinated, Fused-Ring Compounds, Steroids	vet_approved	0
DB12853	DA-6886	Drug	Benzoates, Acids, Carbocyclic, Amides, Benzene Derivatives	investigational	0
DB11521	Imidocarb	Drug	Anilides, Amines, Antiprotozoals, Aniline Compounds, Amides, Phenylurea Compounds, Carbanilides, Anti-Infective Agents, Antiparasitic Agents, Benzene Derivatives	vet_approved	0
DB12852	MK-0752	Drug	Acids, Acyclic, Sulfur Compounds, Fatty Acids, Fatty Acids, Volatile, Lipids, Amyloid Precursor Protein Secretases, antagonists & inhibitors	investigational	0
DB12855	Apricitabine	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Glycosides, Nucleosides, Deoxyribonucleosides	investigational	1
DB09203	Synephrine	Drug	Amines, Cardiovascular Agents, Decongestants and Antiallergics, Alcohols, Peripheral Nervous System Agents, Biogenic Amines, Adrenergic Agents, Sympathomimetics Used as Decongestants, Autonomic Agents, Adrenergic alpha-Agonists, Nasal Decongestants, Agents producing tachycardia, Adrenergic and Dopaminergic Agents, Amino Alcohols, Ethanolamines, Respiratory System Agents, Biogenic Monoamines, Ophthalmologicals, Neurotransmitter Agents, Sympathomimetics, Vasoconstrictor Agents, Adrenergic Agonists, Cardiac Stimulants Excl. Cardiac Glycosides, Agents that produce hypertension, Sensory Organs, Cardiac Therapy	experimental	1
DB12854	BMS-908662	Drug	0	investigational	0
DB09204	Arotinolol	Drug	Amines, Cytochrome P-450 Substrates, Propanols, Agents causing hyperkalemia, Adrenergic beta-Antagonists, Hypotensive Agents, Amino Alcohols, Drugs that are Mainly Renally Excreted, Alcohols, Neurotransmitter Agents, Adrenergic Antagonists, Cytochrome P-450 CYP2D6 Substrates, Adrenergic Agents, Bradycardia-Causing Agents	investigational	3
DB09201	Ciglitazone	Drug	Sulfur Compounds, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Thiazoles, Blood Glucose Lowering Agents, Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP3A4 Substrates, Thiazolidinediones, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)	experimental	1
DB11526	Masitinib	Drug	Protein Kinase Inhibitors, Sulfur Compounds, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents	investigational, vet_approved	0
DB12857	NVP-LEQ-506	Drug	0	investigational	0
DB09202	Cirazoline	Drug	Neurotransmitter Agents, Adrenergic alpha-Agonists, Vasoconstrictor Agents, Adrenergic Agonists, Agents that produce hypertension, Adrenergic alpha-1 Receptor Agonists, Nasal Decongestants, Agents producing tachycardia, Cardiovascular Agents, Respiratory System Agents, Adrenergic Agents	experimental	4
DB12856	Timonacic	Drug	0	investigational	0
DB11525	Maduramicin	Drug	Anti-Bacterial Agents, Anti-Infective Agents, Ionophores	vet_approved	0
DB12859	Tantalum	Drug	Metals, Metals, Heavy, Elements, Transition Elements	investigational	0
DB09200	Rivoglitazone	Drug	Sulfur Compounds, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Thiazoles, Blood Glucose Lowering Agents, Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP3A4 Substrates, Thiazolidinediones, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)	investigational, experimental	0
DB12858	LY-377604	Drug	0	investigational	0
DB11529	Melengestrol	Drug	Corticosteroids for Systemic Use, Corticosteroids, Cytochrome P-450 Substrates, Immunosuppressive Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Adrenal Cortex Hormones, Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 CYP3A Substrates, Pregnanes, Steroids	vet_approved	0
DB00870	Suprofen	Drug	Nephrotoxic agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Sensory System Agents, Cyclooxygenase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Non COX-2 selective NSAIDS, Phenylpropionates, Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Non-Steroids, UGT2B7 substrates, Analgesics, Musculo-Skeletal System, Cytochrome P-450 CYP2C9 Inhibitors, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Antirheumatic Agents, Cytochrome P-450 CYP2C9 Substrates, Antiinflammatory and Antirheumatic Products, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), UGT1A1 Substrates, Propionates	approved, withdrawn	2
DB09209	Pholcodine	Drug	Antitussive Agents, Oxazines, Sensory System Agents, Respiratory System Agents, Drugs that are Mainly Renally Excreted, Morphinans, Peripheral Nervous System Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Opium Alkaloids and Derivatives, Phenanthrenes, Opiate Alkaloids, Analgesics, Cough and Cold Preparations, Morphine Derivatives, Central Nervous System Agents	approved, illicit	3
DB00873	Loteprednol	Drug	Ophthalmologicals, Androstanes, Anti-Allergic Agents, Corticosteroids, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Androstadienes, Androstenes, Sensory Organs, Fused-Ring Compounds, Corticosteroid Hormone Receptor Agonists, Steroids	approved, experimental	0
DB09207	AS-8112	Drug	Neurotransmitter Agents, Dopamine Antagonists, Dopamine D2 Receptor Antagonists, Dopamine Agents	experimental	3
DB09208	Pegloticase	Drug	Enzymes, Enzymes and Coenzymes, Enzymes, Immobilized, Alcohols, Macromolecular Substances, Antigout Preparations, Ethylene Glycols, Musculo-Skeletal System, Pegylated agents, Glycols, Oxidoreductases, Polymers, Compounds used in a research, industrial, or household setting, Uric Acid-specific Enzyme	approved, investigational	1
DB00874	Guaifenesin	Drug	Cough and Cold Preparations, Expectorants, Methyl Ethers, Phenols, Catechols, Ethers, Respiratory System Agents, Benzene Derivatives, Phenyl Ethers	approved, investigational, vet_approved	1
DB00871	Terbutaline	Drug	Adrenergics, Inhalants, QTc Prolonging Agents, Amines, Adrenergic beta-2 Receptor Agonists, Tocolytic Agents, Drugs that are Mainly Renally Excreted, Alcohols, Peripheral Nervous System Agents, Selective Beta 2-adrenergic Agonists, Potential QTc-Prolonging Agents, Adrenergic Agents, Autonomic Agents, Cholinesterase Inhibitors, Adrenergics for Systemic Use, Anti-Asthmatic Agents, Reproductive Control Agents, Agents producing tachycardia, Bronchodilator Agents, Amino Alcohols, Ethanolamines, Respiratory System Agents, Adrenergic beta-Agonists, Neurotransmitter Agents, Agents to Treat Airway Disease, Sympathomimetics, Adrenergic Agonists, Agents that produce hypertension, Drugs for Obstructive Airway Diseases	approved	3
DB09205	Moxisylyte	Drug	Autonomic Agents, Amines, Dimethylamines, Sympatholytics, Adrenergic alpha-Antagonists, Genito Urinary System and Sex Hormones, Miotics, Urologicals, Cardiovascular Agents, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Neurotransmitter Agents, Drugs Used in Erectile Dysfunction, Adrenergic Antagonists, Agents that produce hypertension, Peripheral Vasodilators, Cholinesterase substrates, Methylamines, Vasodilating Agents, Adrenergic Agents	approved, investigational	1
DB09206	Trimazosin	Drug	Neurotransmitter Agents, Adrenergic alpha-Antagonists, Adrenergic Antagonists, Peripheral alpha-1 blockers, Antiadrenergic Agents, Peripherally Acting, Cardiovascular Agents, Adrenergic alpha-1 Receptor Antagonists, Antihypertensive Agents, Vasodilating Agents, Adrenergic Agents	experimental	0
DB00872	Conivaptan	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cardiovascular Agents, Hypotensive Agents, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A4 Inhibitors (strong), Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Diuretics, Natriuretic Agents, Antidiuretic Hormone Receptor Antagonists, P-glycoprotein inhibitors	approved, investigational	2
DB00877	Sirolimus	Drug	Immunologic Factors, Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 CYP3A7 Substrates, Sirolimus and Prodrugs, Cytochrome P-450 CYP3A4 Substrates, Selective Immunosuppressants, Anti-Infective Agents, Lactones, Anti-Bacterial Agents, Decreased Immunologic Activity, Agents causing angioedema, Antifungal Agents, P-glycoprotein substrates with narrow therapeutic index, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Macrolides, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, mTOR Inhibitors, Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index, mTOR Inhibitor Immunosuppressant, Antibiotics, Antineoplastic, Myelosuppressive Agents, Ophthalmologicals, P-glycoprotein inducers, Polyketides, Protein Kinase Inhibitors, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Sensory Organs, P-glycoprotein inhibitors, Hyperglycemia-Associated Agents, Kinase Inhibitor	approved, investigational	3
DB00878	Chlorhexidine	Drug	Medicated Dressings, Otologicals, Irrigating Solutions, Ophthalmological and Otological Preparations, Anti-Infective Agents, Anti-Infective Agents, Local, Medicated Dressings With Antiinfectives, Biguanides, Antiinfectives and Antiseptics for Local Oral Treatment, Disinfectants, Alimentary Tract and Metabolism, Dental Agents, Biguanides and Amidines, Compounds used in a research, industrial, or household setting, Mouthwashes, Antiseptics and Disinfectants, Dermatologicals, Amidines, Guanidines, Household Products, Decreased Cell Wall Integrity, Ophthalmologicals, Throat Preparations, Miscellaneous Anti-infectives, Sensory Organs, Stomatological Preparations, Miscellaneous Local Anti-infectives	approved, vet_approved	1
DB00875	Flupentixol	Drug	Highest Risk QTc-Prolonging Agents, Psycholeptics, QTc Prolonging Agents, Tranquilizing Agents, Serotonin Agents, Nervous System, Antipsychotic Agents (First Generation Typical), Muscarinic Antagonists, Antidepressive Agents, Thioxanthenes, Anticholinergic Agents, Serotonin 5-HT2 Receptor Antagonists, Antipsychotic Agents, Sulfur Compounds, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Adrenergic Antagonists, Adrenergic alpha-1 Receptor Antagonists, Drugs causing inadvertant photosensitivity, Thioxanthene Derivatives, Dopamine Antagonists, Dopamine Agents, Neurotoxic agents, Piperazines, Adrenergic alpha-Antagonists, P-glycoprotein substrates, Agents producing tachycardia, Psychotropic Drugs, Xanthenes, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Photosensitizing Agents, Central Nervous System Depressants, Agents that produce hypertension, Serotonin Receptor Antagonists, Central Nervous System Agents, P-glycoprotein inhibitors, Dopamine D2 Receptor Antagonists	approved, investigational, withdrawn	5
DB00876	Eprosartan	Drug	Acids, Acyclic, Antihypertensive Agents Indicated for Hypertension, Angiotensin II receptor blockers (ARBs) and diuretics, Angiotensin Receptor Antagonists, Agents causing hyperkalemia, Cardiovascular Agents, Hypotensive Agents, Angiotensin II receptor blockers (ARBs), plain, Angiotensin II Type 1 Receptor Blockers, Sulfur Compounds, Agents Causing Muscle Toxicity, Agents Acting on the Renin-Angiotensin System, Agents causing angioedema, Angiotensin 2 Receptor Blocker, Antihypertensive Agents	approved	1
DB00879	Emtricitabine	Drug	Ribonucleosides, Enzyme Inhibitors, MATE 1 Substrates, Dideoxynucleosides, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Antivirals for Systemic Use, Direct Acting Antivirals, Nucleic Acid Synthesis Inhibitors, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, MATE substrates, Nucleoside Reverse Transcriptase Inhibitors, Carbohydrates, Pyrimidine Nucleosides, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Antiinfectives for Systemic Use, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors, Deoxycytidine, Nucleosides, Deoxyribonucleosides, Reverse Transcriptase Inhibitors	approved, investigational	1
DB12860	Actinium	Drug	Metals, Elements, Radioactive, Radioisotopes, Actinoid Series Elements, Metals, Heavy, Elements, Isotopes	investigational	0
DB12862	Glucose Oxidase	Drug	Alcohol Oxidoreductases, Enzymes, Enzymes and Coenzymes, Oxidoreductases	investigational	0
DB11530	Metoserpate	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Indoles, Indole Alkaloids	vet_approved	0
DB12861	Rimeporide	Drug	0	investigational	0
DB12864	Melarsoprol	Drug	Organometallic Compounds, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Agents Against Leishmaniasis and Trypanosomiasis, Arsenicals, Trypanocidal Agents, Anti-Infective Agents, Antiparasitic Agents	investigational	0
DB12863	Sivelestat	Drug	Enzyme Inhibitors, Sulfur Compounds, Protease Inhibitors, Amides, Amino Acids, Peptides, and Proteins, Serine Protease Inhibitors, Amino Acids, Sulfones	investigational	0
DB09214	Dexketoprofen	Drug	Nephrotoxic agents, Sensory System Agents, Nervous System, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Non COX-2 selective NSAIDS, Phenylpropionates, Drugs that are Mainly Renally Excreted, Alcohols, Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Musculo-Skeletal System, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Antirheumatic Agents, Antiinflammatory Preparations, Non-Steroids for Topical Use, Propylene Glycols, Topical Products for Joint and Muscular Pain, Antiinflammatory and Antirheumatic Products, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Propionates, Agents that produce hypertension, Glycols, Central Nervous System Agents	approved, investigational	2
DB12866	Pradigastat	Drug	Acids, Acyclic, Pyridines, Amines, Fatty Acids, Fatty Acids, Volatile, Lipids, OAT3/SLC22A8 Inhibitors	investigational	0
DB11534	Butyl chloride	Drug	Hydrocarbons, Acyclic, Alkanes	vet_approved	0
DB12865	Etelcalcetide	Drug	Calcium-sensing Receptor Agonist, Amino Acids, Peptides, and Proteins, Calcium Homeostasis, Increased Calcium-sensing Receptor Sensitivity, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Anti-Parathyroid Agents	approved, investigational	1
DB09215	Droxicam	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Oxicams, Sensory System Agents, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Musculo-Skeletal System, Agents that produce hypertension, Central Nervous System Agents	withdrawn	2
DB12868	Intoplicine	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB09212	Loxoprofen	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Sensory System Agents, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Peripheral Nervous System Agents, UGT2B7 substrates, Analgesics, Agents that produce hypertension, Central Nervous System Agents	approved	2
DB11537	Pirlimycin	Drug	Carbohydrates, Anti-Bacterial Agents, Glycosides, Pyrrolidines, Lincosamides, Neurotoxic agents	vet_approved	0
DB12867	Benperidol	Drug	Psycholeptics, Tranquilizing Agents, Ketones, Nervous System, Butyrophenones, Psychotropic Drugs, Neurotransmitter Agents, Antipsychotic Agents, Central Nervous System Depressants, Central Nervous System Agents, Butyrophenone Derivatives, Dopamine Antagonists, Dopamine Agents, Neurotoxic agents	approved, investigational	0
DB09213	Dexibuprofen	Drug	Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Cytochrome P-450 Substrates, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, UGT1A3 substrates, Non COX-2 selective NSAIDS, Phenylpropionates, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, UGT2B7 substrates, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Musculo-Skeletal System, UGT1A1 Substrates, Propionates, Agents that produce hypertension, UGT1A9 Substrates, Cytochrome P-450 CYP2C8 Substrates	approved, investigational	12
DB09210	Piracetam	Drug	Acids, Acyclic, Neuroprotective Agents, Fatty Acids, Nervous System, Protective Agents, Psychostimulants, Agents Used for Adhd and Nootropics, Amides, Lipids, Acetates, Drugs that are Mainly Renally Excreted, Pyrrolidinones, Fatty Acids, Volatile, Pyrrolidines, Acetamides, Central Nervous System Agents, Compounds used in a research, industrial, or household setting, Nootropic Agents, Psychoanaleptics	approved, investigational	0
DB09211	Limaprost	Drug	Biological Factors, Autacoids, Fatty Acids, Unsaturated, Inflammation Mediators, Prostaglandins, Fatty Acids, Prostaglandins E, Eicosanoids, Lipids, Fatty Acids, Monounsaturated	investigational	4
DB12869	Eliprodil	Drug	Neuroprotective Agents, Neurotransmitter Agents, Protective Agents, Receptors, Neurotransmitter, Central Nervous System Agents, Excitatory Amino Acid Agents, Compounds used in a research, industrial, or household setting, Excitatory Amino Acid Antagonists	investigational	0
DB00880	Chlorothiazide	Drug	Increased Diuresis, Sodium Chloride Symporter Inhibitors, Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Amides, Cardiovascular Agents, Hypotensive Agents, Membrane Transport Modulators, OAT1/SLC22A6 inhibitors, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Photosensitizing Agents, Benzothiadiazines, Sulfonamides, Diuretics, Natriuretic Agents, Antihypertensive Agents, Drugs causing inadvertant photosensitivity, Thiazides, Hyperglycemia-Associated Agents, Sulfones	approved, vet_approved	3
DB00881	Quinapril	Drug	Antihypertensive Agents Indicated for Hypertension, Enzyme Inhibitors, Isoquinolines, Agents causing hyperkalemia, Protease Inhibitors, Cardiovascular Agents, Hypotensive Agents, OAT3/SLC22A8 Substrates, Heterocyclic Compounds, Fused-Ring, Angiotensin-Converting Enzyme Inhibitors, Agents Acting on the Renin-Angiotensin System, Agents causing angioedema, ACE Inhibitors and Diuretics, Antihypertensive Agents, Tetrahydroisoquinolines	approved, investigational	1
DB00884	Risedronic acid	Drug	Organophosphonates, Pyridines, Agents Causing Muscle Toxicity, Musculo-Skeletal System, Drugs for Treatment of Bone Diseases, Bone Density Conservation Agents, Calcium-Regulating Hormones and Agents, Organophosphorus Compounds, Cardiovascular Agents, Drugs Affecting Bone Structure and Mineralization, Bisphosphonates, Membrane Transport Modulators	approved, investigational	2
DB09218	Clonixin	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Pyridines, Sensory System Agents, Anti-Inflammatory Agents, Agents causing hyperkalemia, Amino Acids, Essential, Amino Acids, Diamino, Antirheumatic Agents, Non COX-2 selective NSAIDS, Amino Acids, Peptides, and Proteins, Nicotinic Acids, Amino Acids, Peripheral Nervous System Agents, Analgesics, Amino Acids, Basic, Agents that produce hypertension, Central Nervous System Agents	experimental	0
DB09219	Bisoxatin	Drug	Alimentary Tract and Metabolism, Drugs for Constipation, Laxatives, Contact Laxatives, Drugs that are Mainly Renally Excreted	approved	0
DB00885	Pemirolast	Drug	Neurotransmitter Agents, Pyrimidines, Decreased Histamine Release, Mast Cell Stabilizers, Histamine Agents, Ophthalmics	approved, investigational	0
DB09216	Tolfenamic acid	Drug	Aminobenzoates, Nephrotoxic agents, Cytochrome P-450 Substrates, Sensory System Agents, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Non COX-2 selective NSAIDS, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Peripheral Nervous System Agents, Fenamates, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Musculo-Skeletal System, Calcium-Regulating Hormones and Agents, Hormone Antagonists, Benzene Derivatives, Bradycardia-Causing Agents, Antiarrhythmic agents, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Benzoates, Hormones, Hormone Substitutes, and Hormone Antagonists, Antirheumatic Agents, Prostaglandin Antagonists, Membrane Transport Modulators, Migraine Disorders, drug therapy, Calcium Channel Blockers, Neurotransmitter Agents, Antiinflammatory and Antirheumatic Products, Cytochrome P-450 CYP3A Substrates, Agents that produce hypertension, Central Nervous System Agents	approved, investigational	2
DB00882	Clomifene	Drug	Sex Hormones and Modulators of the Genital System, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein substrates, Genito Urinary System and Sex Hormones, Reproductive Control Agents, Fertility Agents, Female, Benzylidene Compounds, Estrogen Receptor Modulators, Clomiphene, Ovulation Stimulants, Synthetic, Fertility Agents, Estrogen Agonist/Antagonist, Estrogen Antagonists, Selective Estrogen Receptor Modulators, Stilbenes, Estrogen Agonist-antagonists, Hormone Antagonists, Benzene Derivatives	approved, investigational	2
DB09217	Firocoxib	Drug	Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Sulfur Compounds, Anti-Inflammatory Agents, Agents causing hyperkalemia, Agents that produce hypertension, Furans, Selective Cyclooxygenase 2 Inhibitors (NSAIDs), Lactones	experimental, vet_approved	1
DB00883	Isosorbide dinitrate	Drug	Carbohydrates, Antianginal Agents, Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Cardiovascular Agents, Hypotensive Agents, Organic Nitrates, Vasodilation, Alcohols, Nitric Oxide Donors, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Vasoprotectives, Nitrate Vasodilator, Nitrates and Nitrites, Sugar Alcohols, Vasodilators Used in Cardiac Diseases, Methemoglobinemia Associated Agents, Vasodilating Agents, Cardiac Therapy	approved, investigational	1
DB00888	Mechlorethamine	Drug	Cholinesterase Inhibitors, Immunosuppressive Agents, Noxae, Antineoplastic and Immunomodulating Agents, Nitrogen Mustard Analogues, Alkylating Activity, Antineoplastic Agents, Cardiotoxic antineoplastic agents, Hydrocarbons, Halogenated, Mustard Compounds, Nitrogen Mustard Compounds, Irritants, Myelosuppressive Agents, Alkylating Drugs, Poisons, Narrow Therapeutic Index Drugs, Toxic Actions, Compounds used in a research, industrial, or household setting, Antineoplastic Agents, Alkylating	approved, investigational	1
DB00889	Granisetron	Drug	QTc Prolonging Agents, Cytochrome P-450 Substrates, Serotonin Agents, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Peripheral Nervous System Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Alimentary Tract and Metabolism, Aza Compounds, Azabicyclo Compounds, Gastrointestinal Agents, Autonomic Agents, Antiemetics and Antinauseants, Pyrazoles, Indazoles, Serotonin 5-HT3 Receptor Antagonists, Moderate Risk QTc-Prolonging Agents, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Serotonin 3 Receptor Antagonists, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Antiemetics, Serotonin Receptor Antagonists, Central Nervous System Agents	approved, investigational	1
DB00886	Omapatrilat	Drug	Enzyme Inhibitors, Agents causing hyperkalemia, Protease Inhibitors, Cardiovascular Agents, Azepines, Metalloendopeptidases, antagonists & inhibitors, Vasopeptidase Inhibitors, Sulfur Compounds, Angiotensin-Converting Enzyme Inhibitors, Thiepins, Agents that produce hypertension, Agents Acting on the Renin-Angiotensin System, Agents causing angioedema, Antihypertensive Agents	investigational	2
DB00887	Bumetanide	Drug	Aminobenzoates, Nephrotoxic agents, High-Ceiling Diuretics, Sodium Potassium Chloride Symporter Inhibitors, Acids, Carbocyclic, Genito Urinary System and Sex Hormones, Amides, Cardiovascular Agents, Hypotensive Agents, Drugs that are Mainly Renally Excreted, OAT3/SLC22A8 Substrates, High-Ceiling Diuretics and Potassium-Sparing Agents, Sulfur Compounds, Diuretics, Drugs causing inadvertant photosensitivity, Benzene Derivatives, Non Potassium Sparing Diuretics, Sulfones, Benzoates, Gynecological Antiinfectives and Antiseptics, meta-Aminobenzoates, Membrane Transport Modulators, OAT1/SLC22A6 inhibitors, Photosensitizing Agents, Agents Causing Muscle Toxicity, Sulfonamides, Natriuretic Agents, OAT3/SLC22A8 Inhibitors, Hyperglycemia-Associated Agents, Increased Diuresis at Loop of Henle	approved	5
DB10294	Streptococcus pneumoniae type 3 capsular polysaccharide diphtheria crm197 protein conjugate antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved	0
DB10295	Streptococcus pneumoniae type 5 capsular polysaccharide diphtheria crm197 protein conjugate antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved	0
DB10296	Streptococcus pneumoniae type 6a capsular polysaccharide diphtheria crm197 protein conjugate antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved, investigational	0
DB10297	Streptococcus pneumoniae type 7f capsular polysaccharide diphtheria crm197 protein conjugate antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved	0
DB10298	Streptococcus pneumoniae type 19a capsular polysaccharide diphtheria crm197 protein conjugate antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved	0
DB10299	Human papillomavirus type 6 L1 capsid protein antigen	Drug	Actively Acquired Immunity, Inactivated Human Papillomavirus Vaccine	approved, investigational	0
DB10290	Streptococcus pneumoniae type 18c capsular polysaccharide diphtheria crm197 protein conjugate antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved	0
DB10291	Streptococcus pneumoniae type 19f capsular polysaccharide diphtheria crm197 protein conjugate antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved	0
DB10292	Streptococcus pneumoniae type 23f capsular polysaccharide diphtheria crm197 protein conjugate antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved	0
DB10293	Streptococcus pneumoniae type 1 capsular polysaccharide diphtheria crm197 protein conjugate antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved	0
DB09261	Certoparin	Drug	Anticoagulants, Carbohydrates, Polysaccharides, Glycosaminoglycans, Heparin (Low Molecular Weight), Agents causing hyperkalemia, Heparin and similars, Hematologic Agents	approved, investigational	0
DB11582	Thiocolchicoside	Drug	Alkaloids, Central Nervous System Depressants, Musculo-Skeletal System, Muscle Relaxants, Centrally Acting Agents, Muscle Relaxants	experimental	3
DB09262	Imidafenacin	Drug	Anticholinergic Agents, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Agents producing tachycardia, UGT1A4 substrates, Muscarinic Antagonists, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted	investigational	3
DB11581	Venetoclax	Drug	OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Antineoplastic Agents, BCRP/ABCG2 Inhibitors, Amides, Cytochrome P-450 CYP3A4 Substrates, Increased Cellular Death, Sulfur Compounds, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, BCL-2 Inhibitor, P-glycoprotein inhibitors, P-glycoprotein substrates with narrow therapeutic index, Sulfones	approved, investigational	1
DB11584	Pipradrol	Drug	Nervous System, Psychostimulants, Agents Used for Adhd and Nootropics, Psychoanaleptics	approved	1
DB11583	Cetalkonium	Drug	Surface-Active Agents, Amines, Ammonium Compounds, Lipids, Onium Compounds, Compounds used in a research, industrial, or household setting, Anti-Infective Agents, Anti-Infective Agents, Local, Nitrogen Compounds, Alcohols	approved	0
DB09260	Parnaparin	Drug	Anticoagulants, Carbohydrates, Polysaccharides, Blood and Blood Forming Organs, Glycosaminoglycans, Fibrin Modulating Agents, Heparin (Low Molecular Weight), Agents causing hyperkalemia, Heparin and similars, Hematologic Agents, Cardiovascular Agents	approved, investigational	0
DB11586	Asunaprevir	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Antivirals for treatment of HCV infections, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Protease Inhibitors, OATP1B3 inhibitors, Amides, Cytochrome P-450 CYP3A4 Substrates, HCV Protease Inhibitors, Antivirals for Systemic Use, Direct Acting Antivirals, Cytochrome P-450 Enzyme Inducers, Sulfur Compounds, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Sulfones, Cytochrome P-450 CYP3A5 Inducers, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Substrates, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inducers, Antiviral Agents, Antiinfectives for Systemic Use, HIV Protease Inhibitors, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A4 Inducers (weak), Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2A6 Substrates, Cytochrome P-450 CYP3A5 Inducers (weak), OATP1B1/SLCO1B1 Substrates, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors	approved, investigational, withdrawn	1
DB11585	Drometrizole trisiloxane	Drug	Polymers, Compounds used in a research, industrial, or household setting, Organosilicon Compounds, Silicon Compounds, Macromolecular Substances	approved	0
DB11588	Carbon monoxide	Drug	Gases, Neurotransmitter Agents, Anions, Noxae, Gasotransmitters, Electrolytes, Ions, Oxides, Toxic Actions, Carbon Compounds, Inorganic, Oxygen Compounds	approved, investigational	2
DB11587	Etafedrine	Drug	Amines, Propanols, Agents producing tachycardia, Adrenergic beta-2 Receptor Agonists, Amino Alcohols, Phenethylamines, Drugs that are Mainly Renally Excreted, Alcohols, Adrenergic beta-Agonists, Ethylamines, Adrenergic Agonists, Agents that produce hypertension, Propanolamines	approved	1
DB09269	Phenylacetic acid	Drug	Nitrogen Binding Agent, Urea Cycle Disorder Agents, Noxae, Acids, Carbocyclic, Toxic Actions, Ammonium Ion Binding Activity	approved	0
DB11589	Neon	Drug	Gases, Elements, Noble Gases	approved, investigational	0
DB09267	Strontium ranelate	Drug	Strontium, Sulfur Compounds, Musculo-Skeletal System, Drugs for Treatment of Bone Diseases, Bone Density Conservation Agents, Drugs Affecting Bone Structure and Mineralization	approved, withdrawn	0
DB09268	Picosulfuric acid	Drug	Acids, Acyclic, Pyridines, Tricarboxylic Acids, Alimentary Tract and Metabolism, Drugs for Constipation, Laxatives, Contact Laxatives, Drugs that are Mainly Renally Excreted, Gastrointestinal Agents	approved	0
DB09265	Lixisenatide	Drug	Glucagon-like Peptide-1 (GLP-1) Agonists, Alimentary Tract and Metabolism, Incretin Mimetics, Glucagon-like peptide-1 (GLP-1) analogues, Amino Acids, Peptides, and Proteins, Drugs Used in Diabetes, Blood Glucose Lowering Agents, GLP-1 Agonists, Drugs that are Mainly Renally Excreted	approved	1
DB09266	Technetium Tc-99m tilmanocept	Drug	Tumour Detection, Diagnostic Radiopharmaceuticals, Radioactive Diagnostic Agent, Radiopharmaceutical Activity, Technetium (99Mtc) Compounds	approved, investigational	1
DB09263	Patiromer	Drug	Potassium Binder, Potassium Ion Binding Activity, Compounds used in a research, industrial, or household setting, Potassium-removing Agents, Macromolecular Substances	approved, investigational	1
DB09264	Idarucizumab	Drug	Immunoglobulins, Antidotes, Humanized Monoclonal Antibody Fragment, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Drugs that are Mainly Renally Excreted, Immunoproteins, Proteins, Serum Globulins, Antibodies, Monoclonal, Humanized, Globulins, Blood Proteins, Antihemorrhagic Agents, Miscellaneous	approved	0
DB11580	Ravulizumab	Drug	Immunologic Factors, Immunoglobulins, Immunosuppressive Agents, Complement Inactivator Proteins, Antibodies, Complement Inactivating Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins, Proteins, Serum Globulins, Antibodies, Monoclonal, Humanized, Globulins, Blood Proteins	approved, investigational	1
DB09272	Eluxadoline	Drug	Amino Acids, Aromatic, OATP1B1/SLCO1B1 Inhibitors, Amino Acids, Essential, Amino Acids, Peptides, and Proteins, Antipropulsives, Amino Acids, OAT3/SLC22A8 Substrates, Opioid Antagonists, Amino Acids, Cyclic, Receptors, Opioid, mu, agonists, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Alimentary Tract and Metabolism, Miscellaneous GI Drugs, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Opioids, OATP1B1/SLCO1B1 Substrates, Gastrointestinal Agents, Mixed Agonist / Antagonist Opioids, Receptors, Opioid, delta, antagonists & inhibitors	approved, investigational	3
DB11593	Isatoic anhydride	Drug	Anti-Bacterial Agents, Enzyme Inhibitors, beta-Lactamase Inhibitors, Anti-Infective Agents	experimental	0
DB09273	Doxofylline	Drug	Autonomic Agents, Antitussive Agents, Phosphodiesterase Inhibitors, Enzyme Inhibitors, Cytochrome P-450 Substrates, Anti-Asthmatic Agents, Phosphodiesterase 5 Inhibitors, Agents producing tachycardia, Bronchodilator Agents, Adrenergic beta-2 Receptor Agonists, Respiratory System Agents, Peripheral Nervous System Agents, Adrenergic beta-Agonists, Alkaloids, Heterocyclic Compounds, Fused-Ring, Purines, Adrenergic Agonists, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Drugs for Obstructive Airway Diseases, Xanthine derivatives, Central Nervous System Agents, Vasodilating Agents, Purinones	experimental	3
DB11592	Nitrocefin	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Laboratory Chemicals, Amides, Indicators and Reagents, Lactams, Thiazines, beta-Lactams, Compounds used in a research, industrial, or household setting	experimental	0
DB09270	Ubidecarenone	Drug	Coenzymes, P-glycoprotein substrates, Hypoglycemia-Associated Agents, Enzymes and Coenzymes, Benzoquinones, Vitamins, Micronutrients, Quinones, Other Nutritional Agents, Physiological Phenomena, Agents Causing Muscle Toxicity, Food and Beverages, Growth Substances, Cardiac Therapy, Diet, Food, and Nutrition, Electron Transport Chain Complex Proteins, Food	approved, investigational, nutraceutical	2
DB11595	Atezolizumab	Drug	Immunoglobulins, Antineoplastic and Immunomodulating Agents, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins, Proteins, Serum Globulins, Antibodies, Monoclonal, Humanized, Globulins, Blood Proteins, Programmed Death Receptor-1 Blocking Antibody, Programmed Death Receptor-1-directed Antibody Interactions	approved, investigational	1
DB09271	Cimetropium	Drug	Autonomic Agents, Alkaloids, Belladonna and Derivatives, Plain, Tropanes, Belladonna Alkaloids, Semisynthetic, Quaternary Ammonium Compounds, Alimentary Tract and Metabolism, Aza Compounds, Parasympatholytics, Azabicyclo Compounds, Drugs for Functional Gastrointestinal Disorders, Peripheral Nervous System Agents	investigational, experimental	0
DB11594	Domiphen	Drug	Amines, Ammonium Compounds, Antiinfectives and Antiseptics for Local Oral Treatment, Alimentary Tract and Metabolism, Miscellaneous Anti-infectives, Onium Compounds, Nitrogen Compounds, Stomatological Preparations, Miscellaneous Local Anti-infectives	approved, experimental	0
DB11597	Human Rho(D) immune globulin	Drug	Endogenous Antigen Neutralization, Passively Acquired Immunity, Serum, Human Immunoglobulin G	approved, investigational	1
DB11596	Levoleucovorin	Drug	Biological Factors, Coenzymes, Antidotes, Protective Agents, Enzymes and Coenzymes, Pteridines, Vitamins, Pigments, Biological, Folate Analog, Heterocyclic Compounds, Fused-Ring, Folic Acid Analogues, Pterins, Folic Acid and Derivatives, Tetrahydrofolates, Detoxifying Agents for Antineoplastic Treatment, Vitamin B Complex, Formyltetrahydrofolates, Compounds used in a research, industrial, or household setting	approved, investigational	1
DB11599	Starch, corn	Drug	Carbohydrates, Dietary Carbohydrates, Starch, Biopolymers, Macromolecular Substances, Polysaccharides, Physiological Phenomena, Food and Beverages, Glucans, Polymers, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food	approved, nutraceutical	0
DB11598	Antithrombin III human	Drug	Anticoagulants, Biological Factors, Carbohydrates, Enzyme Inhibitors, Blood and Blood Forming Organs, Glycosaminoglycans, Peptides, Serpins, Amino Acids, Peptides, and Proteins, Hematologic Agents, Oligosaccharides, Drugs that are Mainly Renally Excreted, Proteins, Serum Globulins, Alpha-Globulins, Antithrombin III, agonists, Polysaccharides, Antithrombins, Globulins, Antithrombin III, Blood Proteins, Antithrombin Proteins, Blood Coagulation Factor Inhibitors, Serine Protease Inhibitors	approved	1
DB09278	Activated charcoal	Drug	Antidotes, Charcoal Preparations, Protective Agents, Antifoaming Agents, Ions, Elements, Carbon, Antacids and Adsorbents, Microspheres, Anions, Intestinal Adsorbents, Adsorption, Alimentary Tract and Metabolism, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Electrolytes, Compounds used in a research, industrial, or household setting, Oxygen Compounds	approved	0
DB09279	Fimasartan	Drug	Angiotensin II receptor blockers (ARBs) and diuretics, BCRP/ABCG2 Substrates, Angiotensin Receptor Antagonists, Agents causing hyperkalemia, Agents Acting on the Renin-Angiotensin System, OATP1B1/SLCO1B1 Substrates, Hypotensive Agents, Angiotensin II receptor blockers (ARBs), plain, Benzene Derivatives	investigational	1
DB09276	Sodium aurothiomalate	Drug	Acids, Acyclic, Hydroxy Acids, Gold Compounds, Antirheumatic Agents, Dicarboxylic Acids, UGT1A1 Inhibitors, Drugs that are Mainly Renally Excreted, Organogold Compounds, Organometallic Compounds, Sulfur Compounds, Antiinflammatory and Antirheumatic Products, Gold Preparations, Musculo-Skeletal System, Specific Antirheumatic Agents, Malates, Thiomalates, Sulfhydryl Compounds	approved, investigational	0
DB09277	Choline C 11	Drug	Drugs that are Mainly Renally Excreted	approved, investigational	0
DB09274	Artesunate	Drug	Acids, Acyclic, Cytochrome P-450 Substrates, Reactive Oxygen Species, Anthelmintics, Antimalarials, Oxides, Schistosomicides, Anti-Infective Agents, Anions, UGT2B7 substrates, Peroxides, Oxygen Compounds, OATP1B1/SLCO1B1 Inhibitors, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Free Radicals, P-glycoprotein substrates, Antineoplastic Agents, Dicarboxylic Acids, Ions, Antiviral Agents, BCRP/ABCG2 Substrates, Artemisinins, Cytochrome P-450 CYP2A6 Substrates, Artemisinin and Derivatives, Plain, UGT1A9 Substrates, Electrolytes, Antiplatyhelmintic Agents, OAT3/SLC22A8 Inhibitors, Terpenes, Antiparasitic Agents	approved, investigational	1
DB09275	Bismuth subcitrate potassium	Drug	Bismuth containing drugs, Neurotoxic agents	approved, investigational	1
DB11591	Bilastine	Drug	Heterocyclic Compounds, Fused-Ring, QTc Prolonging Agents, Histamine H1 Antagonists, Histamine H1 Antagonists, Non-Sedating, Histamine Antagonists, Potential QTc-Prolonging Agents, Antihistamines for Systemic Use	approved, investigational	1
DB11590	Thimerosal	Drug	Cell-mediated Immunity, Antiseptics and Disinfectants, Dermatologicals, Mercurial Products, Standardized Chemical Allergen, Pharmaceutic Aids, Organomercury Compounds, Organometallic Compounds, Preservatives, Pharmaceutical, Pharmaceutical Preparations, Compounds used in a research, industrial, or household setting, Alkylmercury Compounds, Ethylmercury Compounds, Increased Histamine Release	approved	3
DB09283	Trapidil	Drug	Phosphodiesterase Inhibitors, Enzyme Inhibitors, Pyrimidines, Triazoles, Hematologic Agents, Vasodilators Used in Cardiac Diseases, Cardiovascular Agents, Vasodilating Agents, Cardiac Therapy, Antiplatelet agents	experimental	2
DB09284	Imolamine	Drug	Oxazoles, Vasodilators Used in Cardiac Diseases, Cardiovascular Agents, Vasodilating Agents, Cardiac Therapy	investigational	0
DB09281	Magnesium trisilicate	Drug	Calculi Dissolution Agent, Ions, Oxides, Agents that produce neuromuscular block (indirect), Minerals, Silicates, Drugs that are Mainly Renally Excreted, Silicon Compounds, Aluminum and magnesium containing antacids, Anions, Gastric Acid Lowering Agents, Acids, Noncarboxylic, Metal cations, Acids, Metal divalent cations, Osmotic Laxatives, Electrolytes, Laxatives, Antacids, Oxygen Compounds, Gastrointestinal Agents, Magnesium Compounds	approved	0
DB09282	Molsidomine	Drug	Nitric Oxide Donors, Oxadiazoles, Oxazines, Oxazoles, Sydnones, Vasodilators Used in Cardiac Diseases, Cardiovascular Agents, Morpholines, Vasodilating Agents, Cardiac Therapy	approved, investigational	1
DB10276	Rotavirus vaccine	Drug	Actively Acquired Immunity, Viral Vaccines, Vaccines, Live Attenuated Rotavirus Vaccine, Live Rotavirus Vaccine, Antiinfectives for Systemic Use, Rota Virus Diarrhea Vaccines	approved	0
DB09280	Lumacaftor	Drug	Pyridines, Amines, Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 CYP3A Inducers (strong), Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP2C19 Inducers (strength unknown), Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP2C9 Inducers (strength unknown), Dioxoles, P-glycoprotein inducers, Cytochrome P-450 CYP3A4 Inducers (strong), Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C19 Inducers, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2C9 Inducers, P-glycoprotein inhibitors, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)	approved	1
DB09289	Tianeptine	Drug	Cytochrome P-450 Substrates, Serotonin Agents, Nervous System, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Psychotropic Drugs, Azepines, Serotonin Modulators, Sulfur Compounds, Narrow Therapeutic Index Drugs, Analgesics, Cytochrome P-450 CYP3A Substrates, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Agents Causing Muscle Toxicity, Central Nervous System Depressants, Thiepins, Antidepressive Agents, Tricyclic, Agents that produce hypertension, Central Nervous System Agents, Agents that reduce seizure threshold, Neurotoxic agents, Psychoanaleptics	investigational	4
DB09287	Polyethylene glycol	Drug	Surface-Active Agents, Solvents, Excipients, Polyethylene Glycols, Drugs for Constipation, Stimulation Large Intestine Fluid/Electrolyte Secretion, Pharmaceutic Aids, Alcohols, Drug Delivery Systems, Macromolecular Substances, Alimentary Tract and Metabolism, Ethylene Glycols, Osmotic Laxatives, Pegylated agents, Electrolytes, Laxatives, Glycols, Pharmaceutical Preparations, P-glycoprotein inhibitors, Polymers, Compounds used in a research, industrial, or household setting, Osmotic Activity, Gastrointestinal Agents, Pharmaceutical Vehicles	approved, vet_approved	0
DB09288	Propacetamol	Drug	Nephrotoxic agents, Amines, Cytochrome P-450 Substrates, Sensory System Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Anti-Inflammatory Agents, Agents causing hyperkalemia, Aniline Compounds, Cytochrome P-450 CYP3A Inducers, Non COX-2 selective NSAIDS, Amides, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Anilides, Cytochrome P-450 Enzyme Inducers, Analgesics, Cytochrome P-450 CYP2C8 Substrates, Acetanilides, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Acetaminophen and Prodrugs, Cytochrome P-450 CYP2E1 Substrates, Prodrugs, Cytochrome P-450 CYP3A4 Inducers, Antirheumatic Agents, UGT1A6 substrate, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, UGT1A1 Substrates, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2A6 Substrates, UGT1A9 Substrates, Cholinesterase substrates, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates	experimental	4
DB09285	Morniflumate	Drug	Aminobenzoates, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Pyridines, Amines, Benzoates, ortho-Aminobenzoates, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Aniline Compounds, Nicotinic Acids, Fenamates, UGT1A9 Inhibitors, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Musculo-Skeletal System, Agents that produce hypertension, Benzene Derivatives	experimental	4
DB09286	Pipamperone	Drug	Psycholeptics, Tranquilizing Agents, Serotonin Agents, Ketones, Nervous System, Hypotensive Agents, Antidepressive Agents, Psychotropic Drugs, Neurotransmitter Agents, Antipsychotic Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Serotonin Receptor Antagonists, Central Nervous System Agents, Butyrophenone Derivatives, Dopamine Antagonists, Dopamine D2 Receptor Antagonists, Neurotoxic agents	investigational	8
DB10283	Rabies virus inactivated antigen, A	Drug	Inactivated Rabies Virus Vaccine, Immune Sera and Immunoglobulins, Immune Sera, Actively Acquired Immunity, Rabies Vaccines, Vaccines, Antiinfectives for Systemic Use	approved, investigational	0
DB10284	Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen	Drug	0	approved	0
DB09295	Talniflumate	Drug	Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Heterocyclic Compounds, Fused-Ring, Niflumic Acid and Prodrugs, Anti-Inflammatory Agents, Agents causing hyperkalemia, Agents that produce hypertension, Selective Cyclooxygenase 2 Inhibitors (NSAIDs)	experimental	3
DB09292	Sacubitril	Drug	Acids, Acyclic, OATP1B1/SLCO1B1 Inhibitors, Fatty Acids, OATP1B3 inhibitors, Amino Acids, Peptides, and Proteins, Lipids, Hypotensive Agents, Amino Acids, Drugs that are Mainly Renally Excreted, Neprilysin, antagonists & inhibitors, Neprilysin Inhibitor, Butyrates, Fatty Acids, Volatile, Agents causing angioedema	approved	1
DB10285	Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen	Drug	0	approved	0
DB10286	Streptococcus pneumoniae type 4 capsular polysaccharide diphtheria crm197 protein conjugate antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved, investigational	0
DB09293	Iodide I-131	Drug	Radioactive Therapeutic Agent, Therapeutic Radiopharmaceuticals, Iodine (131I) Compounds, Diagnostic Radiopharmaceuticals, Radiopharmaceutical Activity, Thyroid Diagnostic Radiopharmaceuticals	approved, investigational	0
DB10287	Streptococcus pneumoniae type 6b capsular polysaccharide diphtheria crm197 protein conjugate antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved	0
DB09290	Ramosetron	Drug	Autonomic Agents, Cytochrome P-450 Substrates, Serotonin Agents, Antidepressive Agents, Peripheral Nervous System Agents, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Central Nervous System Depressants, Cytochrome P-450 CYP1A2 Substrates, Antiemetics, Serotonin Receptor Antagonists, Central Nervous System Agents, Gastrointestinal Agents	investigational	1
DB10288	Streptococcus pneumoniae type 9v capsular polysaccharide diphtheria crm197 protein conjugate antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved	0
DB09291	Rolapitant	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Antiemetics and Antinauseants, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, BCRP/ABCG2 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Alimentary Tract and Metabolism, Breast Cancer Resistance Protein Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Neurokinin 1 Antagonists, P-glycoprotein inhibitors, Substance P/Neurokinin-1 Receptor Antagonist, Neurokinin-1 Receptor Antagonists	approved, investigational	1
DB10289	Streptococcus pneumoniae type 14 capsular polysaccharide diphtheria crm197 protein conjugate antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved	0
DB09298	Silibinin	Drug	OATP1B1/SLCO1B1 Inhibitors, Antineoplastic Agents, Phytogenic, Benzyl Compounds, Protective Agents, Lignans, OATP1B3 inhibitors, Antineoplastic Agents, UGT1A1 Inhibitors, Benzopyrans, OAT1/SLC22A6 Substrates, OAT1/SLC22A6 inhibitors, OAT3/SLC22A8 Substrates, Heterocyclic Compounds, Fused-Ring, Flavonoids, Flavonolignans, Compounds used in a research, industrial, or household setting, Benzene Derivatives, Chromones, Pyrans	investigational, experimental	0
DB09299	Tenofovir alafenamide	Drug	Nephrotoxic agents, Cytochrome P-450 Substrates, Tenofovir and prodrugs, P-glycoprotein substrates, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Antiviral Agents, OAT1/SLC22A6 Substrates, OATP1B3 substrates, Cytochrome P-450 CYP3A4 Substrates, Antiinfectives for Systemic Use, OAT3/SLC22A8 Substrates, Antivirals for Systemic Use, Direct Acting Antivirals, Heterocyclic Compounds, Fused-Ring, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors, Purines, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, OATP1B1/SLCO1B1 Substrates	approved	3
DB09296	Ombitasvir	Drug	Acids, Acyclic, Antivirals for treatment of HCV infections, Amines, Cytochrome P-450 Substrates, P-glycoprotein substrates, Aniline Compounds, Amides, UGT1A1 Inhibitors, Antiviral Agents, Antiinfectives for Systemic Use, Antivirals for Systemic Use, Direct Acting Antivirals, Hepatitis C Virus NS5A Inhibitor, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP2C8 Substrates	approved, investigational	1
DB09297	Paritaprevir	Drug	OATP1B1/SLCO1B1 Inhibitors, Antivirals for treatment of HCV infections, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, P-glycoprotein substrates, OATP1B3 inhibitors, BCRP/ABCG2 Inhibitors, UGT1A1 Inhibitors, Antiviral Agents, OATP1B3 substrates, Organic Anion Transporting Polypeptide 1B1 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, HCV NS3/4A Protease Inhibitors, Antiinfectives for Systemic Use, Antivirals for Systemic Use, Direct Acting Antivirals, Organic Anion Transporting Polypeptide 1B3 Inhibitors, Cytochrome P-450 CYP3A Substrates, Breast Cancer Resistance Protein Inhibitors, OATP1B1/SLCO1B1 Substrates, NS3/4A Protease Inhibitors, P-glycoprotein inhibitors	approved, investigational	1
DB00929	Misoprostol	Drug	Fatty Acids, Genito Urinary System and Sex Hormones, Eicosanoids, Lipids, Anti-Ulcer Agents, Uterotonic agents, Prostaglandins E, Synthetic, Prostaglandins, Synthetic, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Prostaglandins, Antiinflammatory and Antirheumatic Products, Non-Steroids, Alimentary Tract and Metabolism, Musculo-Skeletal System, Drugs causing inadvertant photosensitivity, Drugs for Acid Related Disorders, Gastrointestinal Agents, Biological Factors, Autacoids, Inflammation Mediators, Reproductive Control Agents, Abortifacient Agents, Nonsteroidal, Fatty Acids, Unsaturated, Antiinflammatory and Antirheumatic Products, Abortifacient Agents, Photosensitizing Agents, Propionates, Prostaglandin E1 Analog	approved	4
DB00927	Famotidine	Drug	Cytochrome P-450 CYP1A2 Inhibitors (weak), QTc Prolonging Agents, Cytochrome P-450 Enzyme Inhibitors, MATE inhibitors, MATE 1 Inhibitors, Anti-Ulcer Agents, Histamine H2 Antagonists, OAT3/SLC22A8 Substrates, Cytochrome P-450 CYP1A2 Inhibitors, Neurotransmitter Agents, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Gastric Acid Lowering Agents, Sulfur Compounds, Histamine Antagonists, Alimentary Tract and Metabolism, OCT2 Inhibitors, Acid Reducers, Thiazoles, Potential QTc-Prolonging Agents, OAT3/SLC22A8 Inhibitors, Drugs for Acid Related Disorders, Histamine Agents, Gastrointestinal Agents	approved	1
DB00928	Azacitidine	Drug	Carbohydrates, Ribonucleosides, Enzyme Inhibitors, Immunosuppressive Agents, Pyrimidine Nucleosides, Noxae, Antineoplastic and Immunomodulating Agents, Pyrimidine Analogues, Antineoplastic Agents, Antimetabolites, Drugs that are Mainly Renally Excreted, Myelosuppressive Agents, Nucleic Acid Synthesis Inhibitors, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Nucleoside Metabolic Inhibitor, Aza Compounds, Glycosides, Nucleosides, Toxic Actions	approved, investigational	3
DB12910	Emicerfont	Drug	Corticotropin-Releasing Hormone, antagonists & inhibitors	investigational	0
DB12912	Nolatrexed	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Noxae, Folic Acid Antagonists, Antineoplastic Agents, Thymidylate Synthase, antagonists & inhibitors, Toxic Actions, Antimetabolites	investigational	0
DB12911	Nicoboxil	Drug	Pyridines, Drugs that are Mainly Renally Excreted	approved, investigational	0
DB12914	MGL-3196	Drug	Pyrimidines, Pyrimidinones	investigational	0
DB12916	Mitolactol	Drug	Alkylating Drugs, Carbohydrates, Galactitol, Noxae, Sugar Alcohols, Antineoplastic Agents, Toxic Actions, Antineoplastic Agents, Alkylating, Alcohols	investigational	0
DB12915	Corticorelin acetate	Drug	0	investigational	0
DB12907	Mannose	Drug	Carbohydrates, Hexoses, Monosaccharides	investigational	0
DB12906	LY-2334737	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Glycosides, Nucleosides, Deoxyribonucleosides	investigational	0
DB12909	Factor XIII (human)	Drug	Increased Fibrin Polymerization Activity, Acyltransferases, Biological Factors, Enzymes, Transferases, Blood Coagulation Factors, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Factor XIII, antagonists & inhibitors, Aminoacyltransferases, Proteins, Increased Coagulation Activity, Blood Proteins, Factor XIIIa, antagonists & inhibitors, Transglutaminases, Hemostatics	approved, investigational	0
DB12908	Denenicokin	Drug	0	investigational	0
DB00932	Tipranavir	Drug	Cytochrome P-450 CYP2D6 Inhibitors, BSEP/ABCB11 Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Protease Inhibitors, OATP1B3 inhibitors, BSEP/ABCB11 Substrates, Cytochrome P-450 CYP2C19 Inhibitors, UGT1A1 Inducers, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Cytochrome P-450 CYP3A4 Inhibitors (strong), Antivirals for Systemic Use, Direct Acting Antivirals, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Hepatotoxic Agents, Drugs causing inadvertant photosensitivity, OATP1B1/SLCO1B1 Inhibitors, P-glycoprotein substrates, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Antiinfectives for Systemic Use, HIV Protease Inhibitors, Cytochrome P-450 CYP2C19 Substrates, P-glycoprotein inducers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors (weak), Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors, Hyperglycemia-Associated Agents, Pyrans	approved, investigational	1
DB00933	Mesoridazine	Drug	Psycholeptics, QTc Prolonging Agents, Tranquilizing Agents, Cytochrome P-450 Substrates, Serotonin Agents, Nervous System, Antipsychotic Agents (First Generation Typical), Antidepressive Agents, Phenothiazines With Piperidine Structure, Serotonin 5-HT2 Receptor Antagonists, Antipsychotic Agents, Sulfur Compounds, Dopamine Antagonists, Dopamine Agents, Neurotoxic agents, Phenothiazines, Moderate Risk QTc-Prolonging Agents, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Central Nervous System Depressants, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Dopamine D2 Receptor Antagonists	approved, investigational	2
DB00930	Colesevelam	Drug	Anticholesteremic Agents, Hypolipidemic Agents, Amines, Alkenes, Noxae, Hydrocarbons, Acyclic, Hypolipidemic Agents Indicated for Hyperlipidemia, Allylamine, Bile-acid Binding Activity, Allyl Compounds, Lipid Modifying Agents, Lipid Modifying Agents, Plain, Lipid Regulating Agents, Toxic Actions, Bile Acid Sequestrants	approved	1
DB00931	Metacycline	Drug	Anti-Bacterial Agents, Tetracyclines, Naphthacenes, Agents that produce neuromuscular block (indirect), Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use	approved, investigational	1
DB00936	Salicylic acid	Drug	Nephrotoxic agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Sensory System Agents, Cyclooxygenase Inhibitors, Nervous System, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Antifungals for Dermatological Use, Non COX-2 selective NSAIDS, Anti-Infective Agents, Peripheral Nervous System Agents, Analgesics, Antifungals for Topical Use, Sclerosing Solutions, Antifungal Agents, Salicylates, Keratolytic Agents, Benzene Derivatives, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nitrogen Binding Agent, Benzoates, Hydroxy Acids, Dermatologicals, Hydroxybenzoates, OAT1/SLC22A6 inhibitors, Ophthalmologicals, Cytochrome P-450 CYP2C9 Substrates, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Agents that produce hypertension, Phenols, Central Nervous System Agents, OAT3/SLC22A8 Inhibitors, Sensory Organs, Salicylic Acid and Derivatives	approved, investigational, vet_approved	3
DB00937	Diethylpropion	Drug	Centrally Acting Antiobesity Products, Amines, Appetite Depressants, Sympathomimetic Amine Anorectic, Increased Sympathetic Activity, Agents producing tachycardia, Stimulants, Ethylamines, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Sympathomimetics, Alimentary Tract and Metabolism, Anti-Obesity Agents, Central Nervous System Depressants, Appetite Suppression, Agents that produce hypertension, Amphetamines, Antiobesity Preparations, Excl. Diet Products	approved, illicit	2
DB00934	Maprotiline	Drug	Anthracenes, QTc Prolonging Agents, Adrenergic Uptake Inhibitors, Cytochrome P-450 Substrates, Serotonin Agents, Nervous System, Muscarinic Antagonists, Antidepressive Agents, Drugs that are Mainly Renally Excreted, Anticholinergic Agents, Tricyclics and Other Norepinephrine-reuptake Inhibitors, Serotonin Modulators, Histamine H1 Antagonists, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Potential QTc-Prolonging Agents, Adrenergic Agents, Agents that reduce seizure threshold, Agents producing tachycardia, Antidepressive Agents, Second-Generation, Psychotropic Drugs, Membrane Transport Modulators, Antidepressive Agents, Tetracyclic, Neurotransmitter Agents, Non-Selective Monoamine Reuptake Inhibitors, Histamine Antagonists, Central Nervous System Depressants, Neurotransmitter Uptake Inhibitors, Cytochrome P-450 CYP1A2 Substrates, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Psychoanaleptics	approved, investigational	13
DB00935	Oxymetazoline	Drug	Autonomic Agents, Adrenergic alpha-Agonists, Increased Sympathetic Activity, Vasoconstriction, Adrenergic alpha-1 Receptor Agonists, Nasal Decongestants, Agents producing tachycardia, Cardiovascular Agents, Respiratory System Agents, Decongestants and Antiallergics, Peripheral Nervous System Agents, Ophthalmologicals, Neurotransmitter Agents, Adrenergic alpha-2 Receptor Agonists, Nasal Preparations, Imidazoles, Sympathomimetics, Vasoconstrictor Agents, Adrenergic Agonists, Sympathomimetics, Plain, Agents that produce hypertension, Sensory Organs, Adrenergic Agents, Sympathomimetics Used as Decongestants	approved, investigational	6
DB00938	Salmeterol	Drug	OCT1 substrates, Adrenergics, Inhalants, QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, OCT1 inhibitors, Adrenergic beta-2 Receptor Agonists, Cytochrome P-450 CYP3A4 Substrates, Phenethylamines, Alcohols, Peripheral Nervous System Agents, Sympathomimetic (Adrenergic) Agents, Selective Beta 2-adrenergic Agonists, Potential QTc-Prolonging Agents, Adrenergic Agents, Autonomic Agents, Cytochrome P-450 CYP3A5 Substrates, Anti-Asthmatic Agents, Cytochrome P-450 CYP2C8 Inhibitors, Agents producing tachycardia, Bronchodilator Agents, Amino Alcohols, Ethanolamines, Respiratory System Agents, Cytochrome P-450 CYP2C8 Inhibitors (strong), Adrenergic beta-Agonists, Neurotransmitter Agents, Agents to Treat Airway Disease, Cytochrome P-450 CYP3A Substrates, Ethylamines, Agents Causing Muscle Toxicity, OCT2 Inhibitors, Adrenergic Agonists, Agents that produce hypertension, Drugs for Obstructive Airway Diseases	approved	3
DB00939	Meclofenamic acid	Drug	Aminobenzoates, Nephrotoxic agents, Enzyme Inhibitors, Amines, Sensory System Agents, Cyclooxygenase Inhibitors, ortho-Aminobenzoates, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Aniline Compounds, Non COX-2 selective NSAIDS, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Thyroxine-binding globulin substrates, Fenamates, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Musculo-Skeletal System, Benzene Derivatives, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Benzoates, Antirheumatic Agents, Antiinflammatory Preparations, Non-Steroids for Topical Use, Topical Products for Joint and Muscular Pain, OAT1/SLC22A6 inhibitors, Antiinflammatory and Antirheumatic Products, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Agents that produce hypertension, Central Nervous System Agents	approved, vet_approved	5
DB12921	Chlorsulfaquinoxaline	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amines, Sulfonamides, Aniline Compounds, Amides, Sulfones	investigational	0
DB12920	Pinometostat	Drug	Heterocyclic Compounds, Fused-Ring, Antineoplastic Agents	investigational	0
DB12923	Gallopamil	Drug	QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Agents causing hyperkalemia, Phenylalkylamine Derivatives, Cardiovascular Agents, Verapamil and analogues, Cytochrome P-450 CYP3A4 Substrates, Phenethylamines, Membrane Transport Modulators, Calcium Channel Blockers, Cytochrome P-450 CYP3A Substrates, Ethylamines, Calcium-Regulating Hormones and Agents, Potential QTc-Prolonging Agents, P-glycoprotein inhibitors, Vasodilating Agents, Bradycardia-Causing Agents, Selective Calcium Channel Blockers With Direct Cardiac Effects, Antiarrhythmic agents	investigational	0
DB12925	Crolibulin	Drug	Heterocyclic Compounds, Fused-Ring, Pyrans	investigational	0
DB12924	Ozenoxacin	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Pyridines, Quinolone Antimicrobial, Anti-Bacterial Agents, Amines, Antibiotics for Topical Use, Dermatologicals	approved, investigational	2
DB12927	Theodrenaline	Drug	Amines, Cytochrome P-450 Substrates, Epinephrine and similars, Catecholamines, Catechols, Adrenergic and Dopaminergic Agents, Cardiovascular Agents, Amino Alcohols, Ethanolamines, Biogenic Monoamines, Alcohols, Alkaloids, Heterocyclic Compounds, Fused-Ring, Purines, Cardiac Stimulants Excl. Cardiac Glycosides, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Biogenic Amines, Phenols, Xanthine derivatives, Cardiac Therapy, Benzene Derivatives, Purinones	investigational	0
DB12926	Cafedrine	Drug	Amines, Cytochrome P-450 Substrates, Propanols, Adrenergic and Dopaminergic Agents, Cardiovascular Agents, Amino Alcohols, Alcohols, Alkaloids, Heterocyclic Compounds, Fused-Ring, Purines, Cardiac Stimulants Excl. Cardiac Glycosides, Cytochrome P-450 CYP1A2 Substrates, Xanthine derivatives, Vasodilating Agents, Cardiac Therapy, Purinones, Propanolamines	investigational	0
DB12917	Bimekizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB12919	T-62	Drug	0	investigational	0
DB00940	Methantheline	Drug	Amines, Ammonium Compounds, Quaternary Ammonium Compounds, Agents producing tachycardia, Onium Compounds, Muscarinic Antagonists, Histamine H2 Antagonists, Anticholinergic Agents, Neurotransmitter Agents, Synthetic Anticholinergics, Quaternary Ammonium Compounds, Gastric Acid Lowering Agents, Cholinergic Agents, Histamine Antagonists, Alimentary Tract and Metabolism, Acid Reducers, Drugs for Functional Gastrointestinal Disorders, Nitrogen Compounds	approved, investigational	6
DB00943	Zalcitabine	Drug	Ribonucleosides, Enzyme Inhibitors, OAT1/SLC22A6 Substrates, Dideoxynucleosides, Anti-Infective Agents, Antivirals for Systemic Use, Direct Acting Antivirals, Nucleic Acid Synthesis Inhibitors, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleoside Reverse Transcriptase Inhibitors, Carbohydrates, Pyrimidine Nucleosides, Noxae, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Antiinfectives for Systemic Use, Antimetabolites, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors, Deoxycytidine, Nucleosides, Toxic Actions, Deoxyribonucleosides, Reverse Transcriptase Inhibitors	approved, investigational	1
DB00944	Demecarium	Drug	Ophthalmologicals, Neurotransmitter Agents, Enzyme Inhibitors, Amines, Ammonium Compounds, Cholinergic Agents, Cholinesterase Inhibitors, Antiglaucoma Preparations and Miotics, Parasympathomimetics, Onium Compounds, Sensory Organs, Nitrogen Compounds	approved	2
DB00941	Hexafluronium	Drug	Amines, Ammonium Compounds, Cholinesterase Inhibitors, Quaternary Ammonium Compounds, Onium Compounds, Muscle Relaxants, Nicotinic Antagonists, Anticholinergic Agents, Neurotransmitter Agents, Cholinergic Agents, Muscle Relaxants, Peripherally Acting Agents, Central Nervous System Depressants, Musculo-Skeletal System, Bis-Trimethylammonium Compounds, Nitrogen Compounds	approved	1
DB00942	Cycrimine	Drug	Anticholinergic Agents, Agents producing tachycardia, Muscarinic Antagonists	approved	1
DB00947	Fulvestrant	Drug	Endocrine Therapy, Antineoplastic Agents, Hormonal, Cytochrome P-450 Substrates, Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, Antineoplastic and Immunomodulating Agents, Estrenes, Anti-Estrogens, Antineoplastic Agents, Hormone Antagonists and Related Agents, Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Gonadal Steroid Hormones, Estrogen Antagonists, Selective Estrogen Receptor Modulators, Cytochrome P-450 CYP3A Substrates, UGT1A1 Substrates, Estrogen Receptor Antagonists, Estradiol Congeners, Hormone Antagonists, Gonadal Hormones, Steroids	approved, investigational	1
DB00948	Mezlocillin	Drug	Penicillins With Extended Spectrum, Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Penicillin G, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Antibacterials for Systemic Use	approved, investigational	3
DB00945	Acetylsalicylic acid	Drug	Nephrotoxic agents, Blood and Blood Forming Organs, Cytochrome P-450 Substrates, Sensory System Agents, Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Cytochrome P-450 CYP2C19 Inducers (strength unknown), Non COX-2 selective NSAIDS, Cardiovascular Agents, Drugs that are Mainly Renally Excreted, Decreased Prostaglandin Production, Peripheral Nervous System Agents, Cytochrome P-450 Enzyme Inducers, Analgesics, Alimentary Tract and Metabolism, Cytochrome P-450 CYP2C19 Inducers, Musculo-Skeletal System, Agents causing angioedema, Salicylates, Antiplatelet agents, Benzene Derivatives, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Anticoagulants, P-glycoprotein substrates, Hydroxybenzoates, Hematologic Agents, UGT1A6 substrate, OAT1/SLC22A6 inhibitors, P-glycoprotein inducers, Cytochrome P-450 CYP2C9 Substrates, Antiinflammatory and Antirheumatic Products, Platelet Aggregation Inhibitors Excl. Heparin, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Decreased Platelet Aggregation, Agents that produce hypertension, OAT3/SLC22A8 Inhibitors, Salicylic Acid and Derivatives, Stomatological Preparations, Antipyretics	approved, vet_approved	18
DB00946	Phenprocoumon	Drug	Anticoagulants, Blood and Blood Forming Organs, Cytochrome P-450 Substrates, 4-Hydroxycoumarins, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Coumarins, Hematologic Agents, Benzopyrans, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index, Vitamin K Antagonists, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Vitamin K Inhibitors, Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C8 Substrates, Pyrans	approved, investigational	1
DB00949	Felbamate	Drug	Acids, Acyclic, QTc Prolonging Agents, Decreased Central Nervous System Disorganized Electrical Activity, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP3A Inducers, Phenylcarbamates, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (moderate), Cytochrome P-450 CYP3A4 Substrates, Anti-epileptic Agent, Alcohols, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C9 Inhibitors, Potential QTc-Prolonging Agents, Excitatory Amino Acid Agents, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 CYP3A4 Inducers, Propylene Glycols, Cytochrome P-450 CYP3A4 Inducers (weak), Neurotransmitter Agents, Anticonvulsants, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), NMDA Receptor Antagonists, Carbamates, Glycols, Central Nervous System Agents, Excitatory Amino Acid Antagonists	approved	2
DB12930	Opipramol	Drug	Cytochrome P-450 Substrates, Nervous System, Dibenzazepines, Antidepressive Agents, Psychotropic Drugs, Membrane Transport Modulators, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Non-Selective Monoamine Reuptake Inhibitors, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Antidepressive Agents, Tricyclic, Neurotransmitter Uptake Inhibitors, Agents that produce hypertension, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Adrenergic Agents, Agents that reduce seizure threshold, Neurotoxic agents, Psychoanaleptics	investigational	0
DB12932	Merotocin	Drug	0	investigational	0
DB11601	Tuberculin purified protein derivative	Drug	Antigens, Biological Factors, Cell-mediated Immunity, Tuberculosis, Laboratory Chemicals, Indicators and Reagents, Antigens, Bacterial, Antihistamine Drugs, Tuberculin, Skin Test Antigen, Compounds used in a research, industrial, or household setting, Tuberculosis Skin Test	approved	1
DB12931	Fenobam	Drug	0	investigational	0
DB11600	Beeswax	Drug	Lipids, Bees	approved	0
DB12934	Granotapide	Drug	Acids, Acyclic, Benzoates, Acids, Carbocyclic, Amides, Dicarboxylic Acids, Benzene Derivatives	investigational	0
DB11603	Human rabies virus immune globulin	Drug	Rabies Vaccines, Serum, Vaccines	approved	1
DB12933	RO-4987655	Drug	Benzoates, Acids, Carbocyclic, Amides, Benzene Derivatives	investigational	0
DB11602	Hydroxyethyl cellulose	Drug	Carbohydrates, Polysaccharides, Glucans, Ophthalmic Solutions, Polymers, Biopolymers, Compounds used in a research, industrial, or household setting, Macromolecular Substances, Saliva, Artificial	approved	0
DB11605	Myrrh	Drug	0	approved	3
DB11604	Tetanus Immune Globulin	Drug	Serum Globulins, Specific Immunoglobulins, Immunoglobulins, Immune Sera and Immunoglobulins, Serum, Antiinfectives for Systemic Use	approved	1
DB12935	Remogliflozin etabonate	Drug	Carbohydrates, Glycosides, Sodium-Glucose Transporter 2 Inhibitors, Blood Glucose Lowering Agents	investigational	0
DB11607	Efmoroctocog alfa	Drug	Hemostatics	approved, investigational	1
DB12938	Isoxaflutole	Drug	Membrane Proteins, Proteins, Neoplasm Proteins, Amino Acids, Peptides, and Proteins, Tumor Suppressor Proteins	approved, investigational, experimental	0
DB12937	Quercetin-3'-O-phosphate	Drug	0	investigational	0
DB11606	Susoctocog alfa	Drug	Blood and Blood Forming Organs, Blood Coagulation Factors, Hemostatics	approved, investigational	1
DB12929	JNJ-39220675	Drug	Histamine H3 Antagonists	investigational	0
DB12928	GET-73	Drug	0	investigational	0
DB00950	Fexofenadine	Drug	Anti-Allergic Agents, Benzhydryl Compounds, P-glycoprotein substrates, OATP1B3 substrates, OAT3/SLC22A8 Substrates, Neurotransmitter Agents, Histamine H1 Antagonists, Histamine H1 Antagonists, Non-Sedating, Histamine Antagonists, Piperidines, OATP1B1/SLCO1B1 Substrates, Histamine Agents, Antihistamines for Systemic Use, Benzene Derivatives	approved, investigational	1
DB00951	Isoniazid	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Cytochrome P-450 CYP2C19 Inhibitors, Antimycobacterials, Cytochrome P-450 CYP2A6 Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP2A6 Inhibitors (strength unknown), Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP1A2 Inhibitors, Anti-Bacterial Agents, Cytochrome P-450 Enzyme Inducers, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Cytochrome P-450 CYP2C9 Inhibitors, Hepatotoxic Agents, Agents that reduce seizure threshold, Antituberculosis Agents, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Cytochrome P-450 CYP2E1 Inducers (strength unknown), Hydrazines, Pyridines, Cytochrome P-450 CYP2E1 Substrates, Hypolipidemic Agents, Cytochrome P-450 CYP2E1 Inducers, Cytochrome P-450 CYP2E1 Inhibitors, Noxae, Cytochrome P-450 CYP2C8 Inhibitors, Hydrazides, Antiinfectives for Systemic Use, Cytochrome P-450 CYP2C19 Inhibitors (strong), Lipid Regulating Agents, Fatty Acid Synthesis Inhibitors, Cytochrome P-450 CYP3A Inhibitors, Drugs for Treatment of Tuberculosis, Agents Causing Muscle Toxicity, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2E1 Inhibitors (moderate), Toxic Actions, Cytochrome P-450 CYP2C19 Inhibitors (weak), Isonicotinic Acids, Cytochrome P-450 CYP2D6 Inhibitors (weak)	approved, investigational	7
DB00954	Dirithromycin	Drug	Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Cytochrome P-450 CYP3A4 Inhibitors, Macrolides, Lincosamides and Streptogramins, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use, Lactones	experimental	1
DB00955	Netilmicin	Drug	Nephrotoxic agents, Carbohydrates, Enzyme Inhibitors, Agents that produce neuromuscular block (indirect), Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Gentamicins, Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Ophthalmologicals, Anti-Bacterial Agents, Narrow Therapeutic Index Drugs, Aminoglycoside Antibacterials, Glycosides, Sensory Organs, Antibacterials for Systemic Use, Protein Synthesis Inhibitors	approved, investigational	2
DB00952	Naratriptan	Drug	Serotonin 5-HT1 Receptor Agonists, Triptans, Amines, Serotonin Agents, Nervous System, Selective Serotonin Agonists, Cardiovascular Agents, Antidepressive Agents, Antimigraine Preparations, Serotonin Modulators, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Serotonin 1d Receptor Agonists, Biogenic Amines, Indoles, Monoamine Oxidase A Substrates, Serotonin-1b and Serotonin-1d Receptor Agonist, Serotonin Receptor Agonists, Biogenic Monoamines, Serotonin 1b Receptor Agonists, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Central Nervous System Depressants, Vasoconstrictor Agents, Agents that produce hypertension, Selective Serotonin 5-HT1 Receptor Agonists	approved, investigational	4
DB00953	Rizatriptan	Drug	Serotonin 5-HT1 Receptor Agonists, Triptans, Amines, Serotonin Agents, Nervous System, Selective Serotonin Agonists, Antidepressive Agents, Antimigraine Preparations, Drugs that are Mainly Renally Excreted, Serotonin Modulators, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Serotonin 1d Receptor Agonists, Biogenic Amines, Indoles, Monoamine Oxidase A Substrates, Serotonin-1b and Serotonin-1d Receptor Agonist, Serotonin Receptor Agonists, Biogenic Monoamines, Serotonin 1b Receptor Agonists, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Central Nervous System Depressants, Migraine Disorders, Agents that produce hypertension, Selective Serotonin 5-HT1 Receptor Agonists	approved	3
DB00958	Carboplatin	Drug	Nephrotoxic agents, Cross-Linking Reagents, Immunosuppressive Agents, Antineoplastic and Immunomodulating Agents, Laboratory Chemicals, Antineoplastic Agents, Platinum Compounds, Drugs that are Mainly Renally Excreted, Myelosuppressive Agents, Organometallic Compounds, BCRP/ABCG2 Substrates, Narrow Therapeutic Index Drugs, Indicators and Reagents, Compounds used in a research, industrial, or household setting	approved	1
DB00959	Methylprednisolone	Drug	Neuroprotective Agents, Corticosteroids, Dermatological Preparations, Cytochrome P-450 Substrates, Immunosuppressive Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP2C19 Inducers (strength unknown), Cytochrome P-450 CYP2B6 Inducers (strength unknown), Experimental Unapproved Treatments for COVID-19, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Peripheral Nervous System Agents, Cytochrome P-450 CYP2C19 Inducers, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Corticosteroid Hormone Receptor Agonists, Corticosteroids for Systemic Use, Pregnadienetriols, Corticosteroids, Corticosteroids for Systemic Use, Plain, Pregnadienes, Corticosteroids, Weak (Group I), Protective Agents, Cytochrome P-450 CYP3A4 Inducers, Ophthalmologicals, Antiemetics, Pregnanes, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Cytochrome P-450 CYP2C8 Inducers, Anti-Inflammatory Agents, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Adrenals, Cytochrome P-450 CYP2B6 Inducers, Compounds used in a research, industrial, or household setting, Gastrointestinal Agents, Autonomic Agents, Cytochrome P-450 CYP2A6 Inducers, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein substrates, Dermatologicals, Antineoplastic Agents, Anti-Acne Preparations, P-glycoprotein inducers, Cytochrome P-450 CYP3A Substrates, Central Nervous System Agents, Cytochrome P-450 CYP2C9 Inducers, Sensory Organs, Hyperglycemia-Associated Agents, Anti-Acne Preparations for Topical Use, Steroids	approved, vet_approved	2
DB00956	Hydrocodone	Drug	Antitussive Agents, Cytochrome P-450 Substrates, Sensory System Agents, Cytochrome P-450 CYP3A4 Substrates, Morphinans, Peripheral Nervous System Agents, Alkaloids, Analgesics, Cough and Cold Preparations, Morphine Derivatives, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Opioids, Narcotics, Semi-synthetic Opioids, Respiratory System Agents, Cytochrome P-450 CYP2C19 Substrates, Heterocyclic Compounds, Fused-Ring, Opium Alkaloids and Derivatives, Opiate Alkaloids, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Opioid Agonist, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates	approved, illicit, investigational	3
DB00957	Norgestimate	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Genito Urinary System and Sex Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Contraceptives, Oral, Cytochrome P-450 Enzyme Inducers, Contraceptives, Oral, Synthetic, Progestogens and Estrogens, Sequential Preparations, Norpregnenes, Hormonal Contraceptives for Systemic Use, Norpregnanes, Contraceptive Agents, Female, Norsteroids, Cytochrome P-450 CYP3A4 Inducers, Reproductive Control Agents, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, UGT1A1 Substrates, Progestins, Combination Contraceptives (with Estrogen and derivatives), Cytochrome P-450 CYP2B6 Substrates, P-glycoprotein inhibitors, Hyperglycemia-Associated Agents, Progestin Contraceptives, Steroids	approved, investigational	3
DB11610	Oxilofrine	Drug	Amines, Propanols, Ethylamines, Amino Alcohols, Phenethylamines, Alcohols, Propanolamines	approved	0
DB12941	Darolutamide	Drug	OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 Substrates, P-glycoprotein substrates, OATP1B3 inhibitors, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Substrates, UGT1A1 Substrates, Antiandrogens, UGT1A9 Substrates, Antiandrogens, non-steroidal	approved, investigational	2
DB12940	Helium He-3	Drug	Gases, Elements, Noble Gases	investigational	0
DB12943	Milatuzumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB11611	Lifitegrast	Drug	Amino Acids, Aromatic, Cytochrome P-450 Enzyme Inhibitors, Anti-Inflammatory Agents, Amino Acids, Essential, Amino Acids, Peptides, and Proteins, Amino Acids, Pharmaceutical Solutions, Lymphocyte Function-Associated Antigen-1 Antagonist, Ophthalmologicals, Amino Acids, Cyclic, Sulfur Compounds, Lymphocyte Function-Associated Antigen-1, Solutions, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors, Ophthalmic Solutions, Anti-inflammatory Agents, Miscellaneous, Pharmaceutical Preparations, Sensory Organs, Compounds used in a research, industrial, or household setting, Lymphocyte Function-Associated Antigen-1 Antagonists	approved	1
DB12942	Lactitol	Drug	Food Additives, Carbohydrates, Drugs for Constipation, Flavoring Agents, Pharmaceutic Aids, Alcohols, Alimentary Tract and Metabolism, Osmotic Laxatives, Food and Beverages, Food Ingredients, Laxatives, Pharmaceutical Preparations, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food, Gastrointestinal Agents, Sweetening Agents	approved, investigational	0
DB11614	Rupatadine	Drug	QTc Prolonging Agents, Cytochrome P-450 Substrates, Platelet Activating Factor, antagonists & inhibitors, Cytochrome P-450 CYP3A4 Substrates, Benzocycloheptenes, Dibenzocycloheptenes, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Histamine H1 Antagonists, Histamine H1 Antagonists, Non-Sedating, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Piperidines, Potential QTc-Prolonging Agents, Cytochrome P-450 CYP2D6 Substrates, Antihistamines for Systemic Use	approved	2
DB12945	Dihydralazine	Drug	Cytochrome P-450 CYP1A2 Inhibitors, Pyridazines, Phthalazines, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Hydrazinophthalazine Derivatives, Arteriolar Smooth Muscle, Agents Acting On, Cytochrome P-450 CYP1A2 Substrates, Cardiovascular Agents, Antihypertensive Agents, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Hydrazinophthalazine Derivatives and Diuretics	approved, experimental	0
DB12944	Phloroglucinol	Drug	Alimentary Tract and Metabolism, Laboratory Chemicals, Phenols, Indicators and Reagents, Drugs for Functional Gastrointestinal Disorders, Compounds used in a research, industrial, or household setting, Benzene Derivatives	investigational	0
DB11613	Velpatasvir	Drug	Acids, Acyclic, OATP1B1/SLCO1B1 Inhibitors, Antivirals for treatment of HCV infections, Cytochrome P-450 Substrates, P-glycoprotein substrates, OATP1B3 inhibitors, BCRP/ABCG2 Inhibitors, Organic Anion Transporting Polypeptide 2B1 Inhibitors, Antiviral Agents, Organic Anion Transporting Polypeptide 1B1 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Antiinfectives for Systemic Use, Anti-Infective Agents, Antivirals for Systemic Use, Direct Acting Antivirals, Hepatitis C Virus NS5A Inhibitor, Heterocyclic Compounds, Fused-Ring, Organic Anion Transporting Polypeptide 1B3 Inhibitors, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Substrates, Breast Cancer Resistance Protein Inhibitors, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2C8 Substrates, P-glycoprotein inhibitors	approved, investigational	1
DB12947	Doxifluridine	Drug	Appetite Stimulants, Carbohydrates, Immunologic Factors, Ribonucleosides, Central Nervous System Stimulants, Immunosuppressive Agents, Pyrimidine Nucleosides, Noxae, Deoxyuridine, Fluorouracil and prodrugs, Antineoplastic Agents, Antimetabolites, Isomerism, Fluoropyrimidines, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Toxic Actions, Deoxyribonucleosides, Central Nervous System Agents	investigational	0
DB11616	Pirarubicin	Drug	Carbohydrates, Anthracyclines, Cytotoxic Antibiotics and Related Substances, Immunosuppressive Agents, Antineoplastic and Immunomodulating Agents, Naphthacenes, Antineoplastic Agents, Glycosides, Anthracyclines and Related Substances	investigational	0
DB12946	8-cyclopentyl-1,3-dipropylxanthine	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Purinergic P1 Receptor Antagonists, Purines, Adenosine A1 Receptor Antagonists, Purinergic Antagonists, Purinergic Agents, Purinones	investigational	0
DB12949	PF-03382792	Drug	0	investigational	0
DB11618	Zorubicin	Drug	Carbohydrates, Anthracyclines, Cytotoxic Antibiotics and Related Substances, Antineoplastic and Immunomodulating Agents, Naphthacenes, Antineoplastic Agents, Glycosides, Antibiotics, Antineoplastic, Anthracyclines and Related Substances	experimental	0
DB12948	Didox	Drug	Enzyme Inhibitors, Amines, Hydroxy Acids, Ribonucleotide Reductases, antagonists & inhibitors, Hydroxylamines, Antineoplastic Agents	investigational	0
DB11617	Aclarubicin	Drug	Carbohydrates, Anthracyclines, Enzyme Inhibitors, Cytotoxic Antibiotics and Related Substances, Topoisomerase Inhibitors, Antineoplastic and Immunomodulating Agents, Topoisomerase II Inhibitors, Naphthacenes, Antineoplastic Agents, Glycosides, Antibiotics, Antineoplastic, Anthracyclines and Related Substances	investigational	0
DB11609	Normethadone	Drug	Antitussive Agents, Sensory System Agents, Ketones, Narcotics, Respiratory System Agents, Peripheral Nervous System Agents, Opium Alkaloids and Derivatives, Analgesics, Cough and Cold Preparations, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Opioids, Central Nervous System Agents	approved, illicit	0
DB12939	Nikkomycin Z	Drug	Carbohydrates, Enzyme Inhibitors, Glycosides, Antifungal Agents, Anti-Infective Agents	investigational	0
DB11608	Eftrenonacog alfa	Drug	Biological Factors, Immunoglobulins, Peptide Fragments, Peptides, Blood Coagulation Factors, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Recombinant Proteins, Immunoglobulin Fragments, Immunoproteins, Proteins, Serum Globulins, Globulins, Blood Proteins, Immunoglobulin Constant Regions, Enzyme Precursors, Hemostatics	approved, investigational	0
DB00961	Mepivacaine	Drug	Amide Local Anesthetic, Sensory System Agents, Nervous System, Local Anesthesia, Piperidines, Amides, Central Nervous System Agents, Anesthetics, Drugs that are Mainly Renally Excreted, Anesthetics, Local, Peripheral Nervous System Agents	approved, vet_approved	1
DB00962	Zaleplon	Drug	Acids, Acyclic, Psycholeptics, Cytochrome P-450 Substrates, Fatty Acids, Cytochrome P-450 CYP3A7 Substrates, Nervous System, GABA Modulators, Amides, Lipids, Cytochrome P-450 CYP3A4 Substrates, Acetates, Drugs that are Mainly Renally Excreted, gamma-Aminobutyric Acid A Receptor Agonist, Fatty Acids, Volatile, Hypnotics and Sedatives, Benzodiazepine hypnotics and sedatives, Cytochrome P-450 CYP3A5 Substrates, GABA Agents, GABA Agonists, Central Nervous System Depression, Miscellaneous Anxiolytics Sedatives and Hypnotics, GABA-A Receptor Agonists, Neurotransmitter Agents, Anticonvulsants, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Hypnotics (Nonbenzodiazepine), Central Nervous System Agents	approved, illicit, investigational	1
DB00960	Pindolol	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Amines, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Agents causing hyperkalemia, Adrenergic beta-Antagonists, Cardiovascular Agents, Hypotensive Agents, Antidepressive Agents, Drugs that are Mainly Renally Excreted, Alcohols, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Adrenergic Antagonists, Antihypertensive Agents, Adrenergic Agents, Bradycardia-Causing Agents, Antihypertensive Agents Indicated for Hypertension, Propanols, Phenoxypropanolamines, Amino Alcohols, Beta Blocking Agents, Non-Selective, Neurotransmitter Agents, Central Nervous System Depressants, Serotonin Receptor Antagonists, Cytochrome P-450 CYP2D6 Substrates, Vasodilating Agents, Serotonin 5-HT1 Receptor Antagonists, Cytochrome P-450 CYP2D6 Inhibitors (weak), Propanolamines	approved, investigational	5
DB00965	Ethiodized oil	Drug	Oils, Iodized Oil, Lipids, Roentgenography, Iodinated Contrast Agents, Complex Mixtures, Contrast Media, Diagnostic Uses of Chemicals, Plant Preparations, Radiographic Contrast Agent, Biological Products, Plant Oils, Compounds used in a research, industrial, or household setting, X-Ray Contrast Activity	approved, investigational	0
DB00966	Telmisartan	Drug	Benzimidazoles, Cytochrome P-450 Enzyme Inhibitors, Angiotensin Receptor Antagonists, Agents causing hyperkalemia, UGT1A3 substrates, BSEP/ABCB11 Substrates, Cytochrome P-450 CYP2C19 Inhibitors, Cardiovascular Agents, Hypotensive Agents, Angiotensin II Type 1 Receptor Blockers, Agents Acting on the Renin-Angiotensin System, Agents causing angioedema, Antihypertensive Agents, Benzene Derivatives, Antihypertensive Agents Indicated for Hypertension, Angiotensin II receptor blockers (ARBs) and diuretics, Angiotensin II receptor blockers (ARBs) and calcium channel blockers, BCRP/ABCG2 Inhibitors, Angiotensin II receptor blockers (ARBs), plain, Biphenyl Compounds, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Angiotensin II Type 2 Receptor Blockers, Angiotensin 2 Receptor Blocker, P-glycoprotein inhibitors	approved, investigational	2
DB00963	Bromfenac	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Sensory System Agents, Cyclooxygenase Inhibitors, Ketones, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Hydrocarbons, Halogenated, Selective Cyclooxygenase 2 Inhibitors (NSAIDs), Peripheral Nervous System Agents, Ophthalmologicals, Analgesics, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Central Nervous System Agents, Sensory Organs, Hydrocarbons, Brominated, Benzene Derivatives	approved	2
DB00964	Apraclonidine	Drug	Adrenergic alpha-Agonists, Cytochrome P-450 Substrates, Antiglaucoma Preparations and Miotics, Adrenergic alpha-1 Receptor Agonists, Hypotensive Agents, Ophthalmics, Ophthalmologicals, EENT Drugs, Miscellaneous, Neurotransmitter Agents, Adrenergic alpha-2 Receptor Agonists, Imidazolines, Imidazoles, Adrenergic Agonists, Sympathomimetics in Glaucoma Therapy, Cytochrome P-450 CYP2D6 Substrates, Sensory Organs, Adrenergic Agents	approved	3
DB00969	Alosetron	Drug	Pyridines, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Serotonin 5-HT3 Receptor Antagonists, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Serotonin 3 Receptor Antagonists, Cytochrome P-450 CYP3A Substrates, Alimentary Tract and Metabolism, Central Nervous System Depressants, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2E1 Inhibitors (moderate), Drugs for Functional Gastrointestinal Disorders, Serotonin Receptor Antagonists, Indoles, Cytochrome P-450 CYP1A2 Inhibitors (moderate), Gastrointestinal Agents	approved, withdrawn	1
DB00967	Desloratadine	Drug	QTc Prolonging Agents, Benzocycloheptenes, Dibenzocycloheptenes, Moderate Risk QTc-Prolonging Agents, Anticholinergic Agents, Loratadine and prodrug, Neurotransmitter Agents, Histamine H1 Antagonists, Histamine H1 Antagonists, Non-Sedating, Cholinergic Agents, Histamine Antagonists, Central Nervous System Depressants, Piperidines, Histamine Agents, P-glycoprotein inhibitors, Antihistamines for Systemic Use	approved, investigational	1
DB00968	Methyldopa	Drug	Enzyme Inhibitors, Amines, Sympatholytics, Amino Acids, Peptides, and Proteins, Cardiovascular Agents, Hypotensive Agents, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Adrenergic alpha-2 Receptor Agonists, Central Alpha-agonists, Antihypertensive Agents, COMT Substrates, Adrenergic Agents, Benzene Derivatives, Bradycardia-Causing Agents, Amino Acids, Aromatic, Autonomic Agents, Dihydroxyphenylalanine, Antihypertensive Agents Indicated for Hypertension, Adrenergic alpha-Agonists, Aromatic L-amino Acid Decarboxylase Inhibitors, Phenylalanine, Amino Acids, Essential, Catecholamines, Catechols, Amino Acids, Amino Acids, Cyclic, Neurotransmitter Agents, Agents Causing Muscle Toxicity, Adrenergic Agonists, Phenols, Central alpha-2 Adrenergic Agonist	approved	2
DB00900	Didanosine	Drug	Ribonucleosides, Enzyme Inhibitors, OAT1/SLC22A6 Substrates, Dideoxynucleosides, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Antivirals for Systemic Use, Direct Acting Antivirals, Purines, Nucleic Acid Synthesis Inhibitors, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleoside Reverse Transcriptase Inhibitors, Neurotoxic agents, Carbohydrates, Noxae, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Purine Nucleosides, Antiinfectives for Systemic Use, Antimetabolites, Heterocyclic Compounds, Fused-Ring, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors, Nucleosides, Toxic Actions, Deoxyribonucleosides, Reverse Transcriptase Inhibitors	approved	2
DB00903	Etacrynic acid	Drug	Nephrotoxic agents, Acids, Acyclic, Enzyme Inhibitors, High-Ceiling Diuretics, Fatty Acids, Hydroxy Acids, Sodium Potassium Chloride Symporter Inhibitors, Phenoxyacetates, Lipids, Ototoxic agents, Cardiovascular Agents, Hypotensive Agents, Agents that produce neuromuscular block (indirect), Acetates, OAT1/SLC22A6 inhibitors, Glycolates, Fatty Acids, Volatile, Aryloxyacetic Acid Derivatives, Diuretics, Natriuretic Agents, Hyperglycemia-Associated Agents, Increased Diuresis at Loop of Henle, Non Potassium Sparing Diuretics	approved, investigational	4
DB00904	Ondansetron	Drug	QTc Prolonging Agents, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Peripheral Nervous System Agents, Cytochrome P-450 CYP1A2 Inhibitors, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Indoles, Antiemetics and Antinauseants, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 CYP3A5 Substrates, Serotonin 5-HT3 Receptor Antagonists, Moderate Risk QTc-Prolonging Agents, Psychotropic Drugs, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Carbazoles, Serotonin 3 Receptor Antagonists, Imidazoles, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Cytochrome P-450 CYP1A2 Substrates, Antiemetics, Anti-Anxiety Agents, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates	approved	5
DB00901	Bitolterol	Drug	Autonomic Agents, Adrenergics, Inhalants, Amines, Anti-Asthmatic Agents, Agents producing tachycardia, Bronchodilator Agents, Adrenergic beta-2 Receptor Agonists, Amino Alcohols, Respiratory System Agents, Alcohols, Peripheral Nervous System Agents, Adrenergic beta-Agonists, Neurotransmitter Agents, Selective Beta 2-adrenergic Agonists, Adrenergic Agonists, Agents that produce hypertension, Drugs for Obstructive Airway Diseases, Adrenergic Agents	withdrawn	1
DB00902	Methdilazine	Drug	Heterocyclic Compounds, Fused-Ring, Histamine H1 Antagonists, Sulfur Compounds, Histamine Antagonists, Phenothiazine Derivatives, Antihistamines for Systemic Use, Agents that reduce seizure threshold	approved	1
DB00907	Cocaine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Cytochrome P-450 Substrates, Sensory System Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Otologicals, Cardiovascular Agents, Muscarinic Antagonists, Esters of Benzoic Acid, Cytochrome P-450 CYP3A4 Substrates, Peripheral Nervous System Agents, Anticholinergic Agents, Alkaloids, Cocaine, antagonists & inhibitors, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Aza Compounds, Azabicyclo Compounds, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Agents that reduce seizure threshold, Anesthetics, Local, Dopamine Agents, Dopamine Uptake Inhibitors, Analgesics and Anesthetics, Agents producing tachycardia, Anesthetics, Membrane Transport Modulators, Ophthalmologicals, Neurotransmitter Agents, Tropanes, Throat Preparations, Cytochrome P-450 CYP3A Substrates, OCT2 Inhibitors, Vasoconstrictor Agents, Neurotransmitter Uptake Inhibitors, Cholinesterase substrates, Central Nervous System Agents, Sensory Organs	approved, illicit	8
DB00908	Quinidine	Drug	Voltage-Gated Sodium Channel Blockers, Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, OCT1 inhibitors, Antimalarials, Cardiovascular Agents, Cytochrome P-450 CYP2C9 Inhibitors (moderate), Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index, Anticholinergic Agents, Complex Mixtures, Cytochrome P-450 CYP2C8 Inhibitors (weak), P-glycoprotein substrates with narrow therapeutic index, Polymers, Adrenergic Agents, Agents that reduce seizure threshold, Antiarrhythmic agents, Carbohydrates, OATP1B1/SLCO1B1 Inhibitors, Antiprotozoals, Chemically-Induced Disorders, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index, Agents producing tachycardia, Membrane Transport Modulators, Cytochrome P-450 CYP2C8 Inducers (weak), Neurotransmitter Agents, Narrow Therapeutic Index Drugs, Photosensitizing Agents, Pharmaceutical Preparations, Cytochrome P-450 CYP2D6 Substrates, OAT3/SLC22A8 Inhibitors, Sodium Channel Blockers, Cytochrome P-450 CYP2D6 Inhibitors (strong), Antiarrhythmics, Class Ia, Antiparasitic Agents, Cytochrome P-450 CYP2D6 Inhibitors, Quinolines, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, BSEP/ABCB11 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inducers, Muscarinic Antagonists, Agents that produce neuromuscular block (indirect), Cytochrome P-450 CYP2B6 Inhibitors, Biopolymers, Anti-Infective Agents, Cytochrome P-450 CYP1A2 Inhibitors, Alkaloids, Cytochrome P-450 Enzyme Inducers, Polysaccharides, Cholinergic Agents, Cinchona Alkaloids, Cytochrome P-450 CYP2C9 Inhibitors, Adrenergic Antagonists, Biological Products, Antiarrhythmics, Class I, Adrenergic alpha-1 Receptor Antagonists, Drugs causing inadvertant photosensitivity, Compounds used in a research, industrial, or household setting, Quinuclidines, Cytochrome P-450 CYP2E1 Substrates, Adrenergic alpha-Antagonists, P-glycoprotein substrates, Plant Extracts, Cytochrome P-450 CYP1A2 Inhibitors (strong), Macromolecular Substances, Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Plant Preparations, OCT2 Inhibitors, Agents that produce hypertension, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), P-glycoprotein inhibitors, Cardiac Therapy, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved, investigational	7
DB00905	Bimatoprost	Drug	Biological Factors, Autacoids, Inflammation Mediators, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Fatty Acids, Antiglaucoma Preparations and Miotics, Prostaglandin analogs reducing intraocular pressure (IOP), Eicosanoids, Amides, Lipids, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Prostaglandins, Synthetic, Ophthalmologicals, Fatty Acids, Unsaturated, Prostaglandins, Cytochrome P-450 CYP3A Substrates, Prostaglandins F, Synthetic, Antihypertensive Agents, Sensory Organs	approved, investigational	3
DB00906	Tiagabine	Drug	Nipecotic Acids, Decreased Central Nervous System Disorganized Electrical Activity, Cytochrome P-450 Substrates, GABA Agents, Nervous System, Cytochrome P-450 CYP3A4 Substrates, Anti-epileptic Agent, Membrane Transport Modulators, Fatty Acid Derivatives, Neurotransmitter Agents, Anticonvulsants, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, UGT1A1 Substrates, Neurotransmitter Uptake Inhibitors, Piperidines, Central Nervous System Agents, GABA Uptake Inhibitors	approved, investigational	1
DB00909	Zonisamide	Drug	Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, QTc Prolonging Agents, Decreased Central Nervous System Disorganized Electrical Activity, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Agents causing hyperkalemia, Genito Urinary System and Sex Hormones, Amides, Cytochrome P-450 CYP2C19 Inhibitors, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Anti-epileptic Agent, Drugs that are Mainly Renally Excreted, Carbonic Anhydrase Inhibitors, Sulfur Compounds, Calcium-Regulating Hormones and Agents, Diuretics, Isoxazoles, Potential QTc-Prolonging Agents, Compounds used in a research, industrial, or household setting, Bradycardia-Causing Agents, Sulfones, Antiarrhythmic agents, Cytochrome P-450 CYP3A5 Substrates, Gynecological Antiinfectives and Antiseptics, Membrane Transport Modulators, Cytochrome P-450 CYP2C19 Substrates, Calcium Channel Blockers, Anticonvulsants, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Sulfonamides, UGT1A1 Substrates, Central Nervous System Agents, Cytochrome P-450 CYP2C19 Inhibitors (weak), P-glycoprotein inhibitors	approved, investigational	31
DB00910	Paricalcitol	Drug	Cholestanes, Secosteroids, Cytochrome P-450 Substrates, Calcium Homeostasis, Lipids, Cytochrome P-450 CYP3A4 Substrates, Anti-Parathyroid Agents, Fused-Ring Compounds, Vitamins, Cytochrome P-450 CYP3A Substrates, Sterols, Vitamin D and Analogues, Vitamins (Fat Soluble), Bone Density Conservation Agents, UGT1A4 substrates, Membrane Lipids, Cholestenes, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Steroids	approved, investigational	1
DB00911	Tinidazole	Drug	Cytochrome P-450 Substrates, Genito Urinary System and Sex Hormones, BSEP/ABCB11 Substrates, Antitrichomonal Agents, Cytochrome P-450 CYP3A4 Substrates, Nitroimidazoles, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Anti-Bacterial Agents, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Nitroimidazole Antimicrobial, Alimentary Tract and Metabolism, Nitroimidazole Derivatives, Drugs for Acid Related Disorders, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Noxae, Gynecological Antiinfectives and Antiseptics, Antiinfectives for Systemic Use, Alkylating Drugs, Imidazoles, Cytochrome P-450 CYP3A Substrates, Nitro Compounds, Toxic Actions, Imidazole Derivatives, Antibacterials for Systemic Use, Antiparasitic Agents	approved, investigational	1
DB00914	Phenformin	Drug	OCT1 substrates, Biguanides, Cytochrome P-450 Substrates, Alimentary Tract and Metabolism, OCT2 Inhibitors, OCT1 inhibitors, Amidines, Drugs Used in Diabetes, Guanidines, Blood Glucose Lowering Agents, Cytochrome P-450 CYP2D6 Substrates	approved, investigational, withdrawn	2
DB00915	Amantadine	Drug	Adamantane Derivatives, OCT1 substrates, QTc Prolonging Agents, Sensory System Agents, Nervous System, OCT2 Substrates, OCT1 inhibitors, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Anticholinergic Agents, Anti-Dyskinesia Agents, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, M2 Protein Inhibitors, Potential QTc-Prolonging Agents, Dopamine Agents, Analgesics, Non-Narcotic, Adamantanes, Cycloparaffins, Influenza A M2 Protein Inhibitor, Antiviral Agents, Nicotinic Antagonists, Anti-Parkinson Drugs, Neurotransmitter Agents, OCT2 Inhibitors, NMDA Receptor Antagonists, Central Nervous System Agents	approved	6
DB00912	Repaglinide	Drug	Acids, Acyclic, Glinide, Cytochrome P-450 Substrates, Potassium Channel Antagonists, Stereoisomerism, Hypoglycemia-Associated Agents, BSEP/ABCB11 Substrates, Blood Glucose Lowering Agents, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A Substrates, Alimentary Tract and Metabolism, OATP1B1/SLCO1B1 Substrates, Drugs Used in Diabetes, Meglitinides, Cytochrome P-450 CYP2C8 Substrates	approved, investigational	2
DB00913	Anileridine	Drug	Anesthetics, General, Opioid Anesthetics, Nervous System, Piperidines, Anesthetics	approved, illicit	1
DB00918	Almotriptan	Drug	Serotonin 5-HT1 Receptor Agonists, Triptans, Amines, Cytochrome P-450 Substrates, Serotonin Agents, Nervous System, Selective Serotonin Agonists, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Antimigraine Preparations, Drugs that are Mainly Renally Excreted, Serotonin Modulators, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Serotonin 1d Receptor Agonists, Biogenic Amines, Indoles, Cytochrome P-450 CYP2C8 Substrates, Monoamine Oxidase A Substrates, Serotonin-1b and Serotonin-1d Receptor Agonist, Cytochrome P-450 CYP2E1 Substrates, Serotonin Receptor Agonists, Biogenic Monoamines, Serotonin 1b Receptor Agonists, Cytochrome P-450 CYP2C19 Substrates, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Migraine Disorders, Agents that produce hypertension, Selective Serotonin 5-HT1 Receptor Agonists, Cytochrome P-450 CYP2D6 Substrates	approved, investigational	2
DB00919	Spectinomycin	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Glycosides, Dioxanes, Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use	approved, investigational, vet_approved	1
DB00916	Metronidazole	Drug	Miscellaneous Antiprotozoals, QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Genito Urinary System and Sex Hormones, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Nitroimidazoles, Anti-Infective Agents, Anti-Bacterial Agents, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Antiinfectives and Antiseptics for Local Oral Treatment, Nitroimidazole Antimicrobial, Alimentary Tract and Metabolism, Nitroimidazole Derivatives, Cytochrome P-450 CYP2C9 Inhibitors, Potential QTc-Prolonging Agents, Drugs for Acid Related Disorders, Agents that reduce seizure threshold, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP2C8 Inhibitors, Gynecological Antiinfectives and Antiseptics, Dermatologicals, Antiinfectives for Systemic Use, Cytochrome P-450 CYP3A Inhibitors, Imidazoles, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), UGT1A1 Substrates, Nitro Compounds, Cytochrome P-450 CYP2A6 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Imidazole Derivatives, P-glycoprotein inhibitors, Antibacterials for Systemic Use, Antiparasitic Agents, Stomatological Preparations, Miscellaneous Local Anti-infectives	approved	3
DB00917	Dinoprostone	Drug	Biological Factors, Autacoids, Inflammation Mediators, Fatty Acids, Genito Urinary System and Sex Hormones, Reproductive Control Agents, OCT1 inhibitors, Eicosanoids, Lipids, OAT1/SLC22A6 Substrates, Uterotonic agents, OAT1/SLC22A6 inhibitors, OAT3/SLC22A8 Substrates, Prostaglandins, Synthetic, Fatty Acids, Unsaturated, Prostaglandins, Dinoprostone, antagonists & inhibitors, OCT2 Inhibitors, Prostaglandins E, OATP1B1/SLCO1B1 Substrates, OAT3/SLC22A8 Inhibitors	approved	5
DB12901	Fiacitabine	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Arabinonucleosides, Antineoplastic Agents, Glycosides, Nucleosides, Antiviral Agents, Anti-Infective Agents	investigational	0
DB12900	Irdabisant	Drug	Receptors, Histamine H3	investigational	0
DB12903	DEBIO-1347	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB12902	Trofosfamide	Drug	Immunologic Factors, Immunosuppressive Agents, Noxae, Antineoplastic and Immunomodulating Agents, Nitrogen Mustard Analogues, Antineoplastic Agents, Organophosphorus Compounds, Hydrocarbons, Halogenated, Ions, Mustard Compounds, Nitrogen Mustard Compounds, Phosphorus Compounds, Phosphorus Acids, Alkylating Drugs, Anions, Acids, Noncarboxylic, Acids, Mutagens, Phosphoric Acids, Phosphoramides, Electrolytes, Toxic Actions, Antineoplastic Agents, Alkylating, Phosphoramide Mustards	investigational	0
DB12905	Samarium Sm-153	Drug	Lanthanoid Series Elements, Metals, Elements, Isotopes, Metals, Rare Earth	investigational	0
DB12904	ZSTK-474	Drug	0	investigational	0
DB00921	Buprenorphine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 Substrates, Sensory System Agents, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Morphinans, Opiate Agonists, Peripheral Nervous System Agents, Alkaloids, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Opioids, Cytochrome P-450 CYP2C8 Substrates, Oripavine Derivatives, Cytochrome P-450 CYP2C18 Substrates, Cytochrome P-450 CYP3A5 Substrates, Narcotics, BCRP/ABCG2 Inhibitors, Drugs Used in Addictive Disorders, Opioid Antagonists, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, UGT1A1 Substrates, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Drugs Used in Opioid Dependence, UGT1A9 Substrates, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors, Opiate Partial Agonists, Cytochrome P-450 CYP2D6 Inhibitors (weak), Cytochrome P-450 CYP3A4 Inhibitors (weak), Mixed Agonist / Antagonist Opioids	approved, illicit, investigational, vet_approved	4
DB00922	Levosimendan	Drug	Hydrazines, Phosphodiesterase Inhibitors, QTc Prolonging Agents, Enzyme Inhibitors, Protective Agents, Phosphodiesterase 3 Inhibitors, Hydrazones, Cardiovascular Agents, Hypotensive Agents, Moderate Risk QTc-Prolonging Agents, Cardiotonic Agents, Pyridazines, Cardiac Stimulants Excl. Cardiac Glycosides, Vasodilating Agents, Cardiac Therapy, Compounds used in a research, industrial, or household setting, Antiarrhythmic agents	approved, investigational	4
DB00920	Ketotifen	Drug	Histamine H1 Inhibitors, Other Antihistamines, QTc Prolonging Agents, Anti-Allergic Agents, Dermatologicals, Decongestants and Antiallergics, Ophthalmologicals, Neurotransmitter Agents, Histamine H1 Antagonists, Sulfur Compounds, Histamine Antagonists, Thiophenes, Piperidines, Potential QTc-Prolonging Agents, Antihistamine Drugs, Sensory Organs, Histamine Agents, Antihistamines for Systemic Use, Antipruritics	approved	2
DB00925	Phenoxybenzamine	Drug	Amines, Adrenergic alpha-Antagonists, OCT1 inhibitors, Peripheral alpha-1 blockers, Cardiovascular Agents, Hypotensive Agents, Neurotransmitter Agents, Ethylamines, OCT2 Inhibitors, Adrenergic Antagonists, Agents that produce hypertension, Peripheral Vasodilators, Adrenergic alpha-1 Receptor Antagonists, Antihypertensive Agents, Vasodilating Agents, Adrenergic Agents	approved	8
DB00926	Etretinate	Drug	Biological Factors, Cycloparaffins, Retinoids for Treatment of Psoriasis, Alkenes, Dermatologicals, Hydrocarbons, Acyclic, Cyclohexenes, Retinoids, Antipsoriatics, Cyclohexanes, Pigments, Biological, Carotenoids, Photosensitizing Agents, Antipsoriatics for Systemic Use, Polyenes, Drugs causing inadvertant photosensitivity, Keratolytic Agents, Terpenes	withdrawn	6
DB00923	Ceforanide	Drug	Nephrotoxic agents, Second-Generation Cephalosporins, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Antibacterials for Systemic Use	approved	1
DB00924	Cyclobenzaprine	Drug	Tranquilizing Agents, Cytochrome P-450 Substrates, Centrally-mediated Muscle Relaxation, Cytochrome P-450 CYP3A4 Substrates, Benzocycloheptenes, Dibenzocycloheptenes, Muscle Relaxants, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Musculo-Skeletal System, Muscle Relaxants, Centrally Acting Agents, Cytochrome P-450 CYP1A2 Substrates, UGT1A4 substrates, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Drugs causing inadvertant photosensitivity, Agents that reduce seizure threshold, Neurotoxic agents	approved	9
DB12990	Icosabutate	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Lipids	investigational	0
DB11661	Eptacog alfa pegol (activated)	Drug	Pegylated agents	investigational	0
DB12992	Bleomycin A6	Drug	Carbohydrates, Glycoconjugates, Peptides, Amino Acids, Peptides, and Proteins, Glycopeptides	investigational	0
DB11660	Latanoprostene bunod	Drug	Biological Factors, Autacoids, Fatty Acids, Unsaturated, Inflammation Mediators, Prostaglandins, Fatty Acids, Prostaglandin analogs reducing intraocular pressure (IOP), Eicosanoids, Lipids, Drugs that are Mainly Renally Excreted, Prostaglandins, Synthetic	approved, investigational	1
DB12991	Deoxyspergualin	Drug	Radiation-Protective Agents, Immunologic Factors, Immunosuppressive Agents, Protective Agents, Antineoplastic Agents, Amidines, Antibiotics, Antineoplastic, Compounds used in a research, industrial, or household setting	investigational	0
DB10330	Streptococcus pneumoniae type 11a capsular polysaccharide antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved, investigational	0
DB10331	Streptococcus pneumoniae type 12f capsular polysaccharide antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved, investigational	0
DB12994	MIP-1095 I-123	Drug	0	investigational	0
DB11663	Pictilisib	Drug	Phosphatidylinositol 3-Kinases, antagonists & inhibitors, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Pyrazoles, Amides, Sulfones	investigational	0
DB11662	Rabusertib	Drug	Protein Kinase Inhibitors, Antineoplastic Agents, Benzene Derivatives	investigational	0
DB10332	Streptococcus pneumoniae type 14 capsular polysaccharide antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved, investigational	0
DB12993	Berkelium	Drug	Metals, Elements, Radioactive, Radioisotopes, Actinoid Series Elements, Metals, Heavy, Elements, Isotopes	investigational	0
DB12996	Acteoside	Drug	Carbohydrates, Immunologic Factors, Antineoplastic Agents, Phytogenic, Immunosuppressive Agents, Protective Agents, Antineoplastic Agents, Anti-Infective Agents, Antioxidants, Verbenaceae, Sequestering Agents, Glycosides, Compounds used in a research, industrial, or household setting, Benzene Derivatives, Chelating Agents	investigational	0
DB11665	BMS-690514	Drug	Carbon Radioisotopes	investigational	0
DB10333	Streptococcus pneumoniae type 15b capsular polysaccharide antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved, investigational	0
DB10334	Streptococcus pneumoniae type 17f capsular polysaccharide antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved, investigational	0
DB11664	Psilocybin	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Amines, Central Nervous System Depressants, Biogenic Amines, Central Nervous System Agents, Indoles, Tryptamines, Hallucinogens, Psychotropic Drugs, Biogenic Monoamines, Indole Alkaloids	investigational	0
DB11667	2'-cyano-2'-deoxy-1-(beta-D-arabinofuranosyl)cytosine	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Arabinonucleosides, Glycosides, Nucleosides	investigational	0
DB09346	Metrizoic acid	Drug	Iodobenzoates, Benzoates, Contrast Media, Diagnostic Uses of Chemicals, Radiographic Contrast Agent, Acids, Carbocyclic, Triiodobenzoic Acids, Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting, X-Ray Contrast Activity, Benzene Derivatives	approved	0
DB12998	PF-00217830	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB08015	(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime	Drug	0	experimental	1
DB10335	Streptococcus pneumoniae type 18c capsular polysaccharide antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved, investigational	0
DB10336	Streptococcus pneumoniae type 19f capsular polysaccharide antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved, investigational	0
DB09347	Acetrizoic acid	Drug	Aminobenzoates, Iodobenzoates, Benzoates, Contrast Media, Diagnostic Uses of Chemicals, Acids, Carbocyclic, meta-Aminobenzoates, Triiodobenzoic Acids, Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting, Benzene Derivatives	withdrawn	0
DB12997	Brilacidin	Drug	Amidines	investigational	0
DB11666	Buparlisib	Drug	Phosphatidylinositol 3-Kinase, antagonists & inhibitors, Pyridines, Oxazines, Amines	investigational	0
DB08016	4-(6-CHLORO-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL) BUTYL PHOSPHATE	Drug	0	experimental	1
DB10337	Streptococcus pneumoniae type 19a capsular polysaccharide antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved, investigational	0
DB08013	(METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE	Drug	0	experimental	2
DB11669	Ortataxel	Drug	Cycloparaffins, Cyclodecanes, Antineoplastic Agents, Diterpenes, Terpenes	investigational	0
DB09344	Invert sugar	Drug	Food Additives, Carbohydrates, Hexoses, Flavoring Agents, Sclerosing Agents for Local Injection, Drugs that are Mainly Renally Excreted, Pharmaceutic Aids, Ketoses, Monosaccharides, Vasoprotectives, Cariogenic Agents, Physiological Phenomena, Food and Beverages, Antivaricose Therapy, Food Ingredients, Pharmaceutical Preparations, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food, Sweetening Agents	experimental	0
DB09345	Pramocaine	Drug	Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Vasoprotectives, Oxazines, Antipruritics, Incl. Antihistamines, Anesthetics, Etc., Sensory System Agents, Antipruritics and Local Anesthetics, Dermatologicals, Anesthetics for Topical Use, Central Nervous System Agents, Anesthetics, Anesthetics, Local, Peripheral Nervous System Agents	approved	1
DB08014	(METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE	Drug	0	experimental	2
DB10338	Streptococcus pneumoniae type 20 capsular polysaccharide antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved, investigational	0
DB11668	Rusalatide acetate	Drug	Biological Factors, Enzymes, Peptides, Blood Coagulation Factors, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Wound Healing, Proteins, Blood Proteins, Serine Proteases, Hydrolases, Peptide Hydrolases, Serine Endopeptidases, Endopeptidases	investigational	0
DB12999	MK-6186	Drug	0	investigational	0
DB08011	(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime	Drug	0	experimental	1
DB09342	Propoxycaine	Drug	Aminobenzoates, para-Aminobenzoates, Benzoates, Hydroxy Acids, Sensory System Agents, Acids, Carbocyclic, Hydroxybenzoates, Anesthetics, Peripheral Nervous System Agents, Phenyl Ethers, Phenols, Central Nervous System Agents, Ethers, Hydroxybenzoate Ethers, Benzene Derivatives, Anesthetics, Local	approved	1
DB10339	Streptococcus pneumoniae type 22f capsular polysaccharide antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved, investigational	0
DB09343	Tipiracil	Drug	Pyrimidines, Thymidine Phosphorylase Inhibitor, OCT2 Substrates, MATE 1 Substrates, Pyrimidinones, OCT2 substrates with narrow therapeutic index, MATE substrates	approved, investigational	1
DB08012	Pirodavir	Drug	Antiviral Agents	experimental	2
DB09340	Tyropanoic acid	Drug	Contrast Media, Watersoluble, Hepatotropic X-Ray Contrast Media, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting	approved	0
DB09341	Dextrose, unspecified form	Drug	Miscellaneous Therapeutic Agents, Caloric Agents, Cardiac Function, Diabetes Mellitus, Hemodialysis Solution, Compounds used in a research, industrial, or household setting	approved, vet_approved	0
DB08010	(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime	Drug	0	experimental	1
DB08019	N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine	Drug	0	experimental	2
DB09348	Propiolactone	Drug	Disinfectants, Compounds used in a research, industrial, or household setting, Anti-Infective Agents, Lactones	approved, withdrawn	1
DB08017	3-METHOXY-6-[4-(3-METHYLPHENYL)-1-PIPERAZINYL]PYRIDAZINE	Drug	0	experimental	2
DB09349	Gastric intrinsic factor	Drug	Proteins, Carbohydrates, Glycoconjugates, Intrinsic Factor, Amino Acids, Peptides, and Proteins, Mucoproteins, Glycoproteins	approved, experimental	0
DB08018	N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE	Drug	0	experimental	2
DB11670	SP-8203	Drug	Heterocyclic Compounds, Fused-Ring, Quinazolines	investigational	0
DB09350	Piperonyl butoxide	Drug	Pesticide Synergists, Heterocyclic Compounds, Fused-Ring, Benzodioxoles, Agrochemicals, Pesticides, Toxic Actions, Compounds used in a research, industrial, or household setting, Dioxoles, Drugs that are Mainly Renally Excreted	approved, vet_approved	0
DB10340	Streptococcus pneumoniae type 23f capsular polysaccharide antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved, investigational	0
DB11672	Curcumin	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Enzyme Inhibitors, Sensory System Agents, Cytochrome P-450 Enzyme Inhibitors, Anti-Inflammatory Agents, Cytochrome P-450 CYP2C9 Inhibitors (strong), Coloring Agents, Diarylheptanoids, Alkanes, Cytochrome P-450 CYP2B6 Inhibitors, Peripheral Nervous System Agents, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strong), Cytochrome P-450 CYP2B6 Inhibitors (moderate), Analgesics, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Compounds used in a research, industrial, or household setting, Benzene Derivatives, Analgesics, Non-Narcotic, Heptanes, P-glycoprotein substrates, Hydrocarbons, Acyclic, Antineoplastic Agents, Antirheumatic Agents, Catechols, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Phenols, Central Nervous System Agents, P-glycoprotein inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (moderate)	approved, investigational, experimental	5
DB10341	Streptococcus pneumoniae type 33f capsular polysaccharide antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved, investigational	0
DB11671	AZD-4877	Drug	Pyrimidines, Benzoates, Acids, Carbocyclic, Amides, Benzene Derivatives	investigational	0
DB11674	Equol	Drug	Heterocyclic Compounds, Fused-Ring, Flavonoids, Phytoestrogens, Hormones, Hormone Substitutes, and Hormone Antagonists, Estrogens, Non-Steroidal, Estrogens, Benzopyrans, Hormones, Chromones, Isoflavones, Pyrans	investigational	2
DB10342	Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen	Drug	Inactivated Haemophilus Influenzae B Vaccine, Actively Acquired Immunity, Influenza Vaccines, Vaccines	approved, investigational	0
DB10343	Bacillus calmette-guerin substrain tice live antigen	Drug	Live vaccines, Actively Acquired Immunity, Vaccines, Increased Macrophage Proliferation, Live Attenuated Bacillus Calmette-Guerin Vaccine, Increased Immunologically Active Molecule Activity, Live Attenuated Bacillus Calmette-Guerin Immunotherapy	approved	0
DB11673	Pyridoxamine	Drug	Micronutrients, Pyridines, Physiological Phenomena, Food and Beverages, Vitamin B Complex, Growth Substances, Diet, Food, and Nutrition, Picolines, Vitamins, Food	investigational	0
DB10344	Ginger	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Herbs and Natural Products, Increased Histamine Release	approved	0
DB11676	Galidesivir	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purines, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Experimental Unapproved Treatments for COVID-19, Purine-Nucleoside Phosphorylase, antagonists & inhibitors	investigational	1
DB10345	House dust	Drug	Cell-mediated Immunity, Increased IgG Production, Non-Standardized House Dust Allergenic Extract, Increased Histamine Release	approved	0
DB11675	Mosapride	Drug	Oxazines, Benzoates, Serotonin Agents, Acids, Carbocyclic, Serotonin Receptor Agonists, Amides, Anti-Ulcer Agents, Antidepressive Agents, Neurotransmitter Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Benzene Derivatives, Gastrointestinal Agents	investigational	0
DB11678	Treosulfan	Drug	Alkanesulfonic Acids, Butylene Glycols, Noxae, Sulfur Acids, Antineoplastic and Immunomodulating Agents, Hydrocarbons, Acyclic, Antineoplastic Agents, Alkanes, Alcohols, Alkylating Drugs, Sulfur Compounds, Acids, Noncarboxylic, Alkanesulfonates, Acids, Sulfonic Acids, Toxic Actions, Glycols, Mesylates, Antineoplastic Agents, Alkylating	investigational	0
DB08026	2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide	Drug	0	experimental	1
DB09357	Dexpanthenol	Drug	Alanine, Dermatologicals, Amino Acids, Peptides, and Proteins, Wound Healing, Amino Acids, Drugs that are Mainly Renally Excreted, Imides, Vitamins, Ophthalmologicals, Alimentary Tract and Metabolism, Vitamin B Complex, Preparations for Treatment of Wounds and Ulcers, Sensory Organs, Cicatrizants	approved	0
DB10346	Acacia longifolia pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08027	CAP-1	Drug	0	experimental	1
DB11677	Triheptanoin	Drug	Glycerides, Lipids	approved, investigational	0
DB09355	Sulfabenzamide	Drug	Sulfur Compounds, Amides, Sulfones	approved	0
DB10348	Fraxinus americana pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08024	1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE	Drug	0	experimental	1
DB10349	Paspalum notatum pollen	Drug	Cell-mediated Immunity, Grass Pollen Allergen Extracts, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08025	N-{2'-[(4-FLUOROPHENYL)AMINO]-4,4'-BIPYRIDIN-2-YL}-4-METHOXYCYCLOHEXANECARBOXAMIDE	Drug	0	experimental	1
DB11679	Fruquintinib	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB09353	Octasulfur	Drug	Chalcogens, Elements, Keratolytic Agents	approved	0
DB08022	(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile	Drug	0	experimental	1
DB08023	N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine	Drug	0	experimental	1
DB08020	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	Drug	0	experimental	2
DB09351	Levobetaxolol	Drug	Cytochrome P-450 Substrates, Agents causing hyperkalemia, Adrenergic Antagonists, Adrenergic beta-Antagonists, Cytochrome P-450 CYP2D6 Substrates, Bradycardia-Causing Agents	approved, investigational	1
DB08021	5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide	Drug	0	experimental	1
DB09352	Hydroxyamphetamine	Drug	Autonomic Agents, Mydriatics, Amines, Ethylamines, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Sympathomimetics, Adrenergic Agonists, Amphetamines, Phenethylamines, Peripheral Nervous System Agents	approved	0
DB08028	BUT-3-ENYL-[5-(4-CHLORO-PHENYL)-3,6-DIHYDRO-[1,3,4]THIADIAZIN-2-YLIDENE]-AMINE	Drug	0	experimental	1
DB08029	N~2~-(biphenyl-4-ylsulfonyl)-N-hydroxy-N~2~-(2-hydroxyethyl)glycinamide	Drug	0	experimental	1
DB11681	Tofimilast	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB11680	Ficlatuzumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB08030	3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide	Drug	0	experimental	1
DB10350	Fagus grandifolia pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10351	Cynodon dactylon pollen	Drug	Cell-mediated Immunity, Standardized Pollen Allergenic Extract, Grass Pollen Allergen Extracts, Allergenic Extracts, Increased IgG Production, Increased Histamine Release	approved	0
DB11683	PF-06282999	Drug	Acids, Acyclic, Pyrimidines, Fatty Acids, Fatty Acids, Volatile, Amides, Lipids, Acetates	investigational	0
DB10352	Betula lenta pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11682	Daprodustat	Drug	Pyrimidines, Pyrimidinones, Amino Acids, Peptides, and Proteins, Amino Acids	investigational	0
DB11685	Figitumumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB10353	Poa annua pollen	Drug	Cell-mediated Immunity, Grass Pollen Allergen Extracts, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10354	Acer negundo pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11684	APR-246	Drug	0	investigational	0
DB10355	Bromus inermis pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11687	E-6201	Drug	0	investigational	0
DB11686	Iferanserin	Drug	Serotonin Agents, Central Nervous System Depressants, Acids, Carbocyclic, Serotonin Receptor Antagonists, Antidepressive Agents	investigational	0
DB10356	Xanthium strumarium pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10357	Zea mays pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11689	Selumetinib	Drug	Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Tyrosine Kinase Inhibitors, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Substrates, UGT1A1 Substrates, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2C8 Substrates	approved, investigational	2
DB08037	MK-0731	Drug	0	experimental	1
DB09369	Polyestradiol phosphate	Drug	Endocrine Therapy, Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, Antineoplastic and Immunomodulating Agents, Estrenes, Estrogens, Hormones, Fused-Ring Compounds, Gonadal Steroid Hormones, Hormones and Related Agents, Estradiol Congeners, Gonadal Hormones, Steroids	approved	1
DB11688	2-chloroethyl-3-sarcosinamide-1-nitrosourea	Drug	Nitroso Compounds, Antineoplastic Agents, Nitrosourea Compounds	investigational	0
DB08038	L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide	Drug	0	experimental	1
DB10359	Rumex acetosella pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08035	1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE	Drug	0	experimental	1
DB09366	Propyliodone	Drug	Pyridines, Contrast Media, Diagnostic Uses of Chemicals, Non-Watersoluble X-Ray Contrast Media, Iodopyridones, Pyridones, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting	approved	0
DB08036	6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one	Drug	0	experimental	1
DB08033	(5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE	Drug	0	experimental	1
DB09364	Procaine merethoxylline	Drug	0	approved	0
DB08034	(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE	Drug	0	experimental	1
DB08031	N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE	Drug	0	experimental	1
DB08032	N,N-DIETHYL-2-[(2-THIENYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE	Drug	0	experimental	1
DB09363	Rauwolfia serpentina root	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Antiadrenergic Agents, Centrally Acting, Antihypertensive Agents, Indoles, Secologanin Tryptamine Alkaloids, Indole Alkaloids	investigational	1
DB08039	(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE	Drug	0	experimental	2
DB10360	Rumex crispus pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08040	Kelatorphan	Drug	Sensory System Agents, Analgesics, Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins, Central Nervous System Agents, Peripheral Nervous System Agents	experimental	1
DB09371	Norethynodrel	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Norsteroids, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, Reproductive Control Agents, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Contraceptives, Oral, Cytochrome P-450 CYP3A Substrates, Contraceptives, Oral, Synthetic, Progestins, Combination Contraceptives (with Estrogen and derivatives), Norpregnenes, Hormonal Contraceptives for Systemic Use, Norpregnanes, Contraceptive Agents, Female, Progestin Contraceptives, Steroids	approved	3
DB11692	Pavinetant	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amides, Receptors, Neurokinin-3, antagonists & inhibitors, Sulfones	investigational	1
DB08041	3-BENZYLOXYCARBONYLAMINO-2-HYDROXY-4-PHENYL-BUTYRIC ACID	Drug	0	experimental	1
DB09372	Tannic acid	Drug	Compounds used in a research, industrial, or household setting	approved	0
DB10361	Ulmus americana pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11691	Naldemedine	Drug	Opioid Antagonists, Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, Peripheral Opioid Receptor Antagonists, Alimentary Tract and Metabolism, UGT1A3 substrates, Drugs for Constipation, Drugs that are Mainly Renally Excreted, Morphinans	approved, investigational	3
DB11694	Ilorasertib	Drug	Pyridines, Enzyme Inhibitors, Protein Kinase Inhibitors, Amines, Antineoplastic Agents, Benzene Derivatives	investigational	0
DB10362	Ulmus pumila pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10363	Corylus americana pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB09370	Sodium phosphate P 32	Drug	Narrow Therapeutic Index Drugs, Therapeutic Radiopharmaceuticals, Antineoplastic Agents, Radioactive Diagnostic Agent, Diagnostic Agents, Various Therapeutic Radiopharmaceuticals	approved	0
DB11693	Voclosporin	Drug	Peptides, Cyclic, Calcineurin Inhibitors, Immunosuppressive Agents, Peptides, Cyclosporins, Antineoplastic and Immunomodulating Agents, Amino Acids, Peptides, and Proteins	investigational	2
DB10364	Carya ovata pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11696	Racecadotril	Drug	Enzyme Inhibitors, Peptides, Antidiarrheals, Protease Inhibitors, Amino Acids, Sulfur, Amino Acids, Peptides, and Proteins, N-substituted Glycines, Peptoids, Amino Acids, Neprilysin, antagonists & inhibitors, Sulfur Compounds, Alimentary Tract and Metabolism, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Gastrointestinal Agents	investigational	0
DB10365	Sorghum halepense pollen	Drug	Cell-mediated Immunity, Grass Pollen Allergen Extracts, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11695	Carnosine	Drug	Proteins, Oligopeptides, Peptides, Dipeptides, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins	investigational	0
DB11698	Ipragliflozin	Drug	Carbohydrates, Sulfur Compounds, Alimentary Tract and Metabolism, Glycosides, Drugs Used in Diabetes, Sodium-Glucose Transporter 2 Inhibitors, Blood Glucose Lowering Agents, Sodium-glucose co-transporter 2 (SGLT2) inhibitors	investigational	0
DB10366	Poa pratensis pollen	Drug	Cell-mediated Immunity, Standardized Pollen Allergenic Extract, Grass Pollen Allergen Extracts, Allergenic Extracts, Increased IgG Production, Increased Histamine Release	approved	0
DB11697	Pacritinib	Drug	Janus Kinase 2, antagonists & inhibitors, fms-Like Tyrosine Kinase 3, antagonists & inhibitors, Tyrosine Kinase Inhibitors	investigational	0
DB09379	Sutilain	Drug	Enzymes, Enzymes and Coenzymes, Serine Proteases, Hydrolases, Peptide Hydrolases, Serine Endopeptidases, Endopeptidases	approved, withdrawn	0
DB08048	4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL	Drug	0	experimental	2
DB10368	Chenopodium album pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11699	Tropisetron	Drug	Autonomic Agents, Antiemetics and Antinauseants, Serotonin Agents, Serotonin 5-HT3 Receptor Antagonists, Antidepressive Agents, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Alimentary Tract and Metabolism, Central Nervous System Depressants, Antiemetics, Serotonin Receptor Antagonists, Central Nervous System Agents, Indoles, Antiarrhythmic agents, Gastrointestinal Agents	approved, investigational	1
DB10369	Acer saccharum pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08049	7,8-dihydroxy-4-phenyl-2H-chromen-2-one	Drug	0	experimental	1
DB08046	2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide	Drug	0	experimental	1
DB09377	Undecoylium chloride iodine complex	Drug	0	approved	0
DB09378	Fluprednisolone	Drug	Corticosteroids for Systemic Use, Pregnadienetriols, Corticosteroids, Cytochrome P-450 Substrates, Immunosuppressive Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 CYP3A Substrates, Pregnanes, Steroids, Fluorinated, Steroids	approved	0
DB08047	4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol	Drug	0	experimental	2
DB09375	Chymotrypsin	Drug	Ophthalmologicals, Enzymes, Blood and Blood Forming Organs, Surgical Aids, Enzymes and Coenzymes, Serine Proteases, Chymotrypsin, antagonists & inhibitors, Hydrolases, Peptide Hydrolases, Sensory Organs, Serine Endopeptidases, Endopeptidases	approved, vet_approved	0
DB08044	ABT-341	Drug	Enzyme Inhibitors, Protease Inhibitors, Benzene Derivatives	experimental	1
DB09376	Lapyrium	Drug	Pyridines	approved	0
DB08045	4-{4-[4-(3-AMINOPROPOXY)PHENYL]-1H-PYRAZOL-5-YL}-6-CHLOROBENZENE-1,3-DIOL	Drug	0	experimental	1
DB08042	N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine	Drug	0	experimental	1
DB09373	Trolamine polypeptide oleate condensate	Drug	0	approved, vet_approved	0
DB08043	1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA	Drug	0	experimental	1
DB09374	Indocyanine green acid form	Drug	Coloring Agents, Cardiac Function, Diagnostic Dye, BSEP/ABCB11 Substrates, Roentgenography, Liver Function, Compounds used in a research, industrial, or household setting	approved, investigational	0
DB11690	Vonapanitase	Drug	Proteins, Enzymes, Enzymes and Coenzymes, Serine Proteases, Amino Acids, Peptides, and Proteins, Hydrolases, Peptide Hydrolases, Recombinant Proteins, Serine Endopeptidases, Endopeptidases	investigational	0
DB12950	Albusomatropin	Drug	Growth Hormone, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pituitary Hormones, Amino Acids, Peptides, and Proteins, Hormones, Recombinant Proteins, Proteins, Peptide Hormones, Serum Albumin, Albumins, Blood Proteins, Pituitary Hormones, Anterior	investigational	0
DB11621	Human Varicella-Zoster Immune Globulin	Drug	Immunoglobulins, Antibodies, Amino Acids, Peptides, and Proteins, Hemic and Immune Systems, Herpesvirus 3, Human, Blood, Immunoproteins, Proteins, Serum Globulins, Complex Mixtures, Globulins, Blood Proteins, Biological Products, Immunization, Passive, Serum, Body Fluids, Fluids and Secretions	approved	0
DB12952	Methylprednisone	Drug	Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates	approved, investigational	0
DB12951	Pivagabine	Drug	Acids, Acyclic, Fatty Acids, Butyrates, Nervous System, Central Nervous System Depressants, Fatty Acids, Volatile, Amino Acids, Peptides, and Proteins, Lipids, Antidepressive Agents, Aminobutyrates, Amino Acids, Psychoanaleptics	investigational	0
DB11620	Neridronic Acid	Drug	Organophosphonates, Organophosphorus Compounds	investigational, experimental	0
DB12954	Terizidone	Drug	Drugs for Treatment of Tuberculosis, Oxazoles, Antimycobacterials, Antiinfectives for Systemic Use	approved, investigational	0
DB09302	Alirocumab	Drug	Hypolipidemic Agents, Immunoglobulins, Antibodies, Amino Acids, Peptides, and Proteins, Hypolipidemic Agents Indicated for Hyperlipidemia, Antibodies, Monoclonal, Immunoproteins, Hypercholesterolemia, drug therapy, Proteins, Serum Globulins, Lipid Modifying Agents, Lipid Modifying Agents, Plain, Globulins, Blood Proteins, PCSK9 Inhibitor, Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Inhibitors	approved	1
DB11623	Candoxatrilat	Drug	Cycloparaffins, Enzyme Inhibitors, Acids, Carbocyclic, Protease Inhibitors, Neprilysin, antagonists & inhibitors, Cyclohexanes	experimental	1
DB12953	Disitertide	Drug	0	investigational	0
DB09303	Evolocumab	Drug	Anticholesteremic Agents, Hypolipidemic Agents, Immunoglobulins, Noxae, Antibodies, Amino Acids, Peptides, and Proteins, Hypolipidemic Agents Indicated for Hyperlipidemia, Antibodies, Monoclonal, Antimetabolites, Immunoproteins, Proteins, Serum Globulins, Lipid Modifying Agents, Lipid Modifying Agents, Plain, Lipid Regulating Agents, Globulins, Blood Proteins, PCSK9 Inhibitor, Toxic Actions, Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Inhibitors	approved	0
DB11622	Dehydrocholic acid	Drug	Cholagogues and Choleretics, Laxatives, Bile Acids and Salts, Cholanes, Cholic Acids, Fused-Ring Compounds, Gastrointestinal Agents, Steroids	approved, investigational	0
DB09300	Butylscopolamine	Drug	Autonomic Agents, Amines, Ammonium Compounds, Antimuscarinics Antispasmodics, Quaternary Ammonium Compounds, Agents producing tachycardia, Onium Compounds, Parasympatholytics, Muscarinic Antagonists, Peripheral Nervous System Agents, Anticholinergic Agents, Alkaloids, Belladonna and Derivatives, Plain, Neurotransmitter Agents, Tropanes, Belladonna Alkaloids, Semisynthetic, Quaternary Ammonium Compounds, Cholinergic Agents, Alimentary Tract and Metabolism, Aza Compounds, Azabicyclo Compounds, Drugs for Functional Gastrointestinal Disorders, Scopolamine Derivatives, Nitrogen Compounds	approved, investigational, vet_approved	2
DB11625	Perflenapent	Drug	Contrast Media, Diagnostic Uses of Chemicals, Hydrocarbons, Halogenated, Ultrasound Contrast Media, Hydrocarbons, Fluorinated, Compounds used in a research, industrial, or household setting	investigational, withdrawn	0
DB12956	Vantictumab	Drug	0	investigational	0
DB11624	Epoetin delta	Drug	Proteins, Biological Factors, Carbohydrates, Cytokines, Glycoconjugates, Peptides, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Glycoproteins, Colony-Stimulating Factors, Hematopoietic Cell Growth Factors	approved, investigational, withdrawn	0
DB12955	Delparantag	Drug	0	investigational	0
DB09301	Chondroitin sulfate	Drug	Carbohydrates, Polysaccharides, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Glycosaminoglycans, Musculo-Skeletal System, Chondroitin, Drugs that are Mainly Renally Excreted	approved, investigational, nutraceutical	4
DB11627	Hepatitis B Vaccine (Recombinant)	Drug	Antigens, Biological Factors, Hepatitis Antigens, Hepatitis B Surface Antigens, drug effects, Antigens, Viral, Actively Acquired Immunity, Inactivated Hepatitis B Virus Vaccine, Vaccines, Hepatitis B Surface Antigens, Hepatitis B Antigens	approved, withdrawn	0
DB12958	Prothipendyl	Drug	Psycholeptics, Antipsychotic Agents, Sulfur Compounds, Nervous System, Central Nervous System Depressants, Neurotoxic agents	investigational	0
DB11626	Tasonermin	Drug	Adjuvants, Immunologic, Antineoplastic and Immunomodulating Agents	approved	2
DB12957	5-fluoro-2'-deoxycytidine	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Glycosides, Nucleosides, Deoxyribonucleosides	investigational	0
DB11629	Laropiprant	Drug	Heterocyclic Compounds, Fused-Ring	approved, investigational, withdrawn	0
DB12959	IOWH-032	Drug	0	investigational	0
DB11628	Depreotide	Drug	Peptides, Amino Acids, Peptides, and Proteins	withdrawn	0
DB11619	Gestrinone	Drug	Norpregnatrienes, Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Norsteroids, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, Reproductive Control Agents, Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Contraceptives, Oral, Cytochrome P-450 CYP3A Substrates, Progestins, Antigonadotropins and Similar Agents, Hormonal Contraceptives for Systemic Use, Norpregnanes, Contraceptive Agents, Female, Progestin Contraceptives, Steroids	approved	6
DB09308	Solithromycin	Drug	Ketolides, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Macrolides, Lincosamides and Streptogramins, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Antiinfectives for Systemic Use, Anti-Infective Agents, Lactones, Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Antibacterials for Systemic Use	investigational	0
DB09309	Kitasamycin	Drug	Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Leucomycins, Anti-Infective Agents, Lactones	experimental	0
DB09306	Metralindole	Drug	Heterocyclic Compounds, Fused-Ring, Pyridines, Indoles	experimental	0
DB00972	Azelastine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2A6 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2A6 Inhibitors (strength unknown), Decongestants and Antiallergics, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Histamine H1 Antagonists, Nasal Preparations, Antiallergic Agents, Excl. Corticosteroids, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Substrates, Antihistamines for Systemic Use, Autonomic Agents, Anti-Allergic Agents, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP2E1 Inhibitors, Respiratory System Agents, Cytochrome P-450 CYP2C19 Substrates, Ophthalmologicals, Pyridazines, Cytochrome P-450 CYP2C9 Substrates, Neurotransmitter Agents, Histamine H1 Antagonists, Non-Sedating, Cytochrome P-450 CYP3A Inhibitors, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2A6 Substrates, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2D6 Substrates, Sensory Organs, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), Histamine Agents, P-glycoprotein inhibitors	approved	4
DB00973	Ezetimibe	Drug	Anticholesteremic Agents, Hypolipidemic Agents, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Decreased Cholesterol Absorption, P-glycoprotein substrates, UGT1A3 substrates, Azetines, BSEP/ABCB11 Substrates, Hypolipidemic Agents Indicated for Hyperlipidemia, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Dietary Cholesterol Absorption Inhibitor, Lipid Modifying Agents, Lipid Modifying Agents, Plain, Lipid Regulating Agents, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, UGT2B7 substrates, UGT1A1 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, OATP1B1/SLCO1B1 Substrates, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)	approved	3
DB09307	Oxaprotiline	Drug	Antidepressive Agents, Tetracyclic, Anthracenes, Narrow Therapeutic Index Drugs, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Antidepressive Agents, Tricyclic, Agents that produce hypertension, Antidepressive Agents, Central Nervous System Agents, Psychotropic Drugs, Agents that reduce seizure threshold, Neurotoxic agents	experimental	0
DB00970	Dactinomycin	Drug	Actinomycin, Enzyme Inhibitors, Cytotoxic Antibiotics and Related Substances, Immunosuppressive Agents, Peptides, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibiotics, Antineoplastic, Anti-Infective Agents, Myelosuppressive Agents, Peptides, Cyclic, Heterocyclic Compounds, Fused-Ring, Nucleic Acid Synthesis Inhibitors, BCRP/ABCG2 Substrates, Actinomycines, P-glycoprotein inhibitors, P-glycoprotein substrates with narrow therapeutic index, Protein Synthesis Inhibitors	approved, investigational	2
DB09304	Setiptiline	Drug	Antidepressive Agents, Tetracyclic, Heterocyclic Compounds, Fused-Ring, Dibenzazepines	experimental	2
DB09305	Aptazapine	Drug	Antidepressive Agents, Tetracyclic, Heterocyclic Compounds, Fused-Ring, Benzazepines	experimental	0
DB00971	Selenium Sulfide	Drug	Antifungals for Topical Use, Dermatologicals, Antifungals for Dermatological Use, Selenium Compounds	approved	0
DB00976	Telithromycin	Drug	QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Lincosamides and Streptogramins, OATP1B3 inhibitors, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Cytochrome P-450 CYP3A7 Inhibitors (strength unknown), Lactones, Cytochrome P-450 CYP3A4 Inhibitors (strong), Anti-Bacterial Agents, Protein Synthesis Inhibitors, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Cytochrome P-450 CYP3A5 Substrates, Ketolides, Macrolides, Cytochrome P-450 CYP3A5 Inhibitors, Erythromycin and similars, Antiinfectives for Systemic Use, Moderate Risk QTc-Prolonging Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A7 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, RNA, Ribosomal, 23S, Antibacterials for Systemic Use, Ketolide Antibacterial	approved	1
DB00977	Ethinylestradiol	Drug	Endocrine Therapy, Sex Hormones and Modulators of the Genital System, BSEP/ABCB11 Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Adrenal Cortex Hormones, Estrogens, Genito Urinary System and Sex Hormones, Cytochrome P-450 CYP2C19 Inhibitors, Natural and Semisynthetic Estrogens, Plain, Hormones, UGT1A1 Inducers, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Contraceptives, Oral, Hormones and Related Agents, UGT2B7 substrates, Progestogens and Estrogens, Sequential Preparations, BSEP/ABCB11 inducers, Estradiol Congeners, COMT Substrates, Cytochrome P-450 CYP2C8 Substrates, Hormonal Contraceptives for Systemic Use, Norpregnanes, Contraceptive Agents, Female, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Gonadal Hormones, Norpregnatrienes, Estrogen Contraceptives, Cytochrome P-450 CYP3A5 Substrates, Contraceptives, Postcoital, Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP2C8 Inhibitors, Norsteroids, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Estrogenic Steroids, Alkylated, Gonadal Steroid Hormones, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, Thyroxine-binding globulin inducers, UGT1A1 Substrates, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), UGT1A9 Substrates, UGT1A4 substrates, Hyperglycemia-Associated Agents, Steroids	approved	2
DB00974	Edetic acid	Drug	Acids, Acyclic, Amines, Fatty Acids, Polyamines, Acetates, Ethylenediamines, Diamines, Calcium Chelating Activity, Physiological Phenomena, Fatty Acids, Volatile, Food and Beverages, Sequestering Agents, Food Ingredients, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food, Heavy Metal Antagonists, Food Additives, Anticoagulants, Hematologic Agents, Calcium Chelating Agents, Lead Chelator, Decreased Coagulation Factor Activity, Lead Chelating Activity, Chelating Agents	approved, vet_approved	3
DB00975	Dipyridamole	Drug	Anticoagulants, OATP1B1/SLCO1B1 Inhibitors, Phosphodiesterase Inhibitors, Enzyme Inhibitors, Miscellaneous Vasodilatating Agents, Blood and Blood Forming Organs, P-glycoprotein substrates, OATP1B3 inhibitors, Phosphodiesterase 5 Inhibitors, BSEP/ABCB11 Substrates, Hematologic Agents, Cardiovascular Agents, Hypotensive Agents, Pyrimidines, Platelet Aggregation Inhibitors Excl. Heparin, Decreased Platelet Aggregation, P-glycoprotein inhibitors, Vasodilating Agents, Antiplatelet agents	approved	6
DB00978	Lomefloxacin	Drug	Fluoroquinolones, Quinolines, QTc Prolonging Agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Antiinfectives for Systemic Use, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Moderate Risk QTc-Prolonging Agents, Anti-Infective Agents, Quinolones, Cytochrome P-450 CYP1A2 Inhibitors, Ophthalmologicals, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Photosensitizing Agents, Topoisomerase II Inhibitors, Cytochrome P-450 CYP1A2 Substrates, Sensory Organs, Drugs causing inadvertant photosensitivity, Antibacterials for Systemic Use	approved, investigational	3
DB00979	Cyclopentolate	Drug	Autonomic Agents, Mydriatics and Cycloplegics, Acids, Carbocyclic, Parasympatholytics, Muscarinic Antagonists, Peripheral Nervous System Agents, Anticholinergic Agents, Ophthalmologicals, Neurotransmitter Agents, Mydriatics, Cholinergic Agents, Phenylacetates, Cholinesterase substrates, Sensory Organs	approved	1
DB11630	Temoporfin	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Narrow Therapeutic Index Drugs, Photosensitizing Agents, Antineoplastic and Immunomodulating Agents, Dermatologicals, Sensitizers Used in Photodynamic/radiation Therapy, Antineoplastic Agents, Radiation-Sensitizing Agents, Pigments, Biological, Porphyrins	approved, investigational	0
DB12961	Leukotriene B4	Drug	Fatty Acids, Essential, Biological Factors, Arachidonic Acids, Autacoids, Fatty Acids, Unsaturated, Inflammation Mediators, Fatty Acids, Leukotrienes, Eicosanoids, Lipids, Leukotriene B4, antagonists & inhibitors	investigational	3
DB12960	INCB-9471	Drug	Receptors, CCR4, antagonists & inhibitors	investigational	1
DB11632	Opicapone	Drug	Enzyme Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP2C19 Inducers (strength unknown), Anti-Parkinson Drugs, Anti-Dyskinesia Agents, Cytochrome P-450 Enzyme Inducers, COMT Inhibitors, Oxazoles, Cytochrome P-450 CYP2C19 Inducers, Cytochrome P-450 CYP2C8 Inhibitors (weak), Central Nervous System Agents, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Dopamine Agents	approved, investigational	1
DB12963	CCX-354	Drug	0	investigational	0
DB10300	Human papillomavirus type 11 L1 capsid protein antigen	Drug	Actively Acquired Immunity, Inactivated Human Papillomavirus Vaccine	approved	0
DB10301	Human papillomavirus type 16 L1 capsid protein antigen	Drug	Actively Acquired Immunity, Inactivated Human Papillomavirus Vaccine	approved, investigational	0
DB11631	Eptotermin Alfa	Drug	Proteins, Biological Factors, Peptides, Musculo-Skeletal System, Drugs for Treatment of Bone Diseases, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, TGF-beta Superfamily Proteins, Bone Morphogenetic Proteins, Drugs Affecting Bone Structure and Mineralization	approved, investigational, withdrawn	0
DB12962	CP-547632	Drug	Sulfur Compounds	investigational	0
DB10302	Human papillomavirus type 18 L1 capsid protein antigen	Drug	Actively Acquired Immunity, Inactivated Human Papillomavirus Vaccine	approved, investigational	0
DB11634	Colestilan chloride	Drug	Drugs for Treatment of Hyperkalemia and Hyperphosphatemia, Fused-Ring Compounds, Steroids	approved, investigational, withdrawn	0
DB12965	Silver	Drug	Silver Compounds, Antiseptics and Disinfectants, Dermatologicals, Metals, Metals, Heavy, Elements, Transition Elements	approved, investigational	4
DB09313	Ioxaglic acid	Drug	Iodobenzoates, Benzoates, Contrast Media, Diagnostic Uses of Chemicals, Radiographic Contrast Agent, Acids, Carbocyclic, Triiodobenzoic Acids, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting, X-Ray Contrast Activity, Benzene Derivatives, Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media	approved, investigational	0
DB09314	Technetium Tc-99m pertechnetate	Drug	Diagnostic Uses of Chemicals, Laboratory Chemicals, Diagnostic Radiopharmaceuticals, Radioactive Diagnostic Agent, Indicators and Reagents, Radiopharmaceutical Activity, Thyroid Diagnostic Radiopharmaceuticals, Radiopharmaceuticals, Technetium Compounds, Compounds used in a research, industrial, or household setting	approved, investigational	0
DB12964	Lerisetron	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB11633	Isavuconazole	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Antimycotics for Systemic Use, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2B6 Inducers (weak), Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2B6 Inducers, Antifungal Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Triazole Derivatives, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Isavuconazole and Prodrugs, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A5 Inhibitors, BCRP/ABCG2 Inhibitors, Antiinfectives for Systemic Use, Cytochrome P-450 CYP3A5 Inhibitors (moderate), UGT1A9 Inhibitors, Azole Antifungals, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), OCT2 Inhibitors, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2C9 Inducers, P-glycoprotein inhibitors, Cytochrome P-450 CYP2C8 Inducers (strength unknown)	approved, investigational	10
DB09311	Polycarbophil	Drug	Antidiarrheals, Laxatives, Bulk-Forming Laxatives, Plastics, Polymers, Compounds used in a research, industrial, or household setting, Dental Materials, Drug Carriers, Gastrointestinal Agents, Macromolecular Substances, Resins, Synthetic	experimental	0
DB11636	Nomegestrol	Drug	Sex Hormones and Modulators of the Genital System, Antineoplastic Agents, Hormonal, Cytochrome P-450 Substrates, Pregnadienes, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, Cytochrome P-450 CYP3A4 Substrates, Pregnadien Derivatives, Fused-Ring Compounds, Progesterone Congeners, Cytochrome P-450 CYP3A Substrates, Progestogens and Estrogens, Sequential Preparations, Progestins, Pregnanes, Hormonal Contraceptives for Systemic Use, Steroids	approved	0
DB12967	Mitoguazone	Drug	Enzyme Inhibitors, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Amidines, Guanidines	investigational	0
DB11635	Tocofersolan	Drug	Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Alimentary Tract and Metabolism, Vitamin E, Vitamins (Fat Soluble), Benzopyrans, Cytochrome P-450 CYP3A4 Substrates, Compounds used in a research, industrial, or household setting, Vitamins, Drug Carriers, Pyrans	approved	1
DB09312	Antilymphocyte immunoglobulin (horse)	Drug	Antibody-Surface Protein Interactions, Serum Globulins, Immunoglobulins, Miscellaneous Therapeutic Agents, Immunosuppressive Agents, Lymphocyte Function Alteration, Antineoplastic and Immunomodulating Agents, Immunoglobulin G, Increased T Lymphocyte Destruction, Selective Immunosuppressants	approved, investigational	0
DB12966	Falnidamol	Drug	0	investigational	0
DB11638	Artenimol	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Reactive Oxygen Species, Cytochrome P-450 Enzyme Inhibitors, Free Radicals, Antimalarials, Cytochrome P-450 CYP2C19 Inhibitors, Ions, Oxides, Anti-Infective Agents, Artemisia, Anions, UGT2B7 substrates, Sesquiterpenes, Artemisinin and Derivatives, Plain, UGT1A9 Substrates, Electrolytes, Peroxides, Cytochrome P-450 CYP2C19 Inhibitors (weak), Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Terpenes, Antiparasitic Agents, Oxygen Compounds	investigational, experimental	191
DB12969	Methylinositol	Drug	Carbohydrates, Sugar Alcohols, Alcohols	investigational	0
DB09310	Catridecacog	Drug	Blood and Blood Forming Organs, Blood Coagulation Factors, Hemostatics	approved	1
DB12968	DONU	Drug	Nitroso Compounds	investigational	0
DB11637	Delamanid	Drug	QTc Prolonging Agents, Cytochrome P-450 Substrates, Drugs for Treatment of Tuberculosis, Imidazoles, Cytochrome P-450 CYP3A Substrates, Nitro Compounds, Antimycobacterials, Cytochrome P-450 CYP3A4 Substrates, Antiinfectives for Systemic Use, Moderate Risk QTc-Prolonging Agents	approved, investigational	0
DB11639	Dibotermin alfa	Drug	Proteins, Biological Factors, Peptides, Musculo-Skeletal System, Drugs for Treatment of Bone Diseases, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, TGF-beta Superfamily Proteins, Bone Morphogenetic Proteins, Drugs Affecting Bone Structure and Mineralization	approved, investigational	2
DB00980	Ramelteon	Drug	Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Psycholeptics, Melatonin Receptor Agonists, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Nervous System, Central Nervous System Depressants, Cytochrome P-450 CYP1A2 Substrates, Hypnotics and Sedatives, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted	approved, investigational	2
DB09319	Carindacillin	Drug	Penicillins With Extended Spectrum, Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Penicillin G, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Antibacterials for Systemic Use	approved, investigational	1
DB00983	Formoterol	Drug	OCT1 substrates, Adrenergics, Inhalants, QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, OCT1 inhibitors, Adrenergic beta-2 Receptor Agonists, Alcohols, Selective Beta 2-adrenergic Agonists, UGT2B7 substrates, Potential QTc-Prolonging Agents, Adrenergic Agents, Autonomic Agents, Anti-Asthmatic Agents, Agents producing tachycardia, Bronchodilator Agents, Amino Alcohols, Ethanolamines, Respiratory System Agents, Cytochrome P-450 CYP2C19 Substrates, Adrenergic beta-Agonists, Cytochrome P-450 CYP2C9 Substrates, Agents to Treat Airway Disease, Adrenergic Agonists, Agents that produce hypertension, Cytochrome P-450 CYP2A6 Substrates, UGT1A9 Substrates, Drugs for Obstructive Airway Diseases, Cytochrome P-450 CYP2D6 Substrates	approved, investigational	3
DB09317	Synthetic Conjugated Estrogens, A	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Thyroxine-binding globulin inducers, Estrogens, Hormones, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Gonadal Hormones, Gonadal Steroid Hormones	approved	1
DB00984	Nandrolone phenpropionate	Drug	Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, Estrenes, Anabolic Agents, Hormones, Fused-Ring Compounds, Gonadal Steroid Hormones, Androgens, Testosterone Congeners, Thyroxine-binding globulin inhibitors, Nandrolone and esters, Gonadal Hormones, Steroids	approved, illicit, investigational	1
DB09318	Synthetic Conjugated Estrogens, B	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Thyroxine-binding globulin inducers, Estrogens, Hormones, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Gonadal Hormones, Gonadal Steroid Hormones	approved	1
DB00981	Physostigmine	Drug	Autonomic Agents, Acids, Acyclic, Enzyme Inhibitors, Antidotes, Cholinesterase Inhibitors, Antiglaucoma Preparations and Miotics, Parasympathomimetics, Phenylcarbamates, Miotics, Indole Alkaloids, Peripheral Nervous System Agents, Ophthalmologicals, Alkaloids, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cholinergic Agents, Carbamates, Indoles, Sensory Organs	approved, investigational	3
DB09315	Xenon-133	Drug	Gases, Xenon Isotopes, Xenon, Diagnostic Radiopharmaceuticals, Radioisotopes, Radiopharmaceutical Activity, Elements, Isotopes, Inhalation Diagnostic Agent, Noble Gases	approved	0
DB09316	Thallous Chloride	Drug	Metals, Radioactive Diagnostic Agent, Metals, Heavy, Elements	approved	0
DB00982	Isotretinoin	Drug	Cytochrome P-450 Substrates, Alkenes, Teratogens, Retinoids for Topical Use in Acne, Cyclohexenes, Misc. Skin and Mucous Membrane Agents, Retinoids, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Cyclohexanes, Anti-Acne Preparations for Systemic Use, Carotenoids, Polyenes, Drugs causing inadvertant photosensitivity, Biological Factors, Cycloparaffins, Noxae, Retinoids for Treatment of Acne, Dermatologicals, Hydrocarbons, Acyclic, Anti-Acne Preparations, Pigments, Biological, Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Agents Causing Muscle Toxicity, Toxic Actions, Terpenes, Anti-Acne Preparations for Topical Use	approved	2
DB00987	Cytarabine	Drug	OCT1 substrates, Immunologic Factors, Ribonucleosides, Cytochrome P-450 Substrates, Immunosuppressive Agents, Pyrimidine Analogues, Cardiotoxic antineoplastic agents, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Nucleic Acid Synthesis Inhibitors, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Carbohydrates, Pyrimidine Nucleosides, Arabinonucleosides, Noxae, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Antimetabolites, Myelosuppressive Agents, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Nucleoside Metabolic Inhibitor, Nucleosides, Toxic Actions	approved, investigational	2
DB00988	Dopamine	Drug	OCT1 substrates, Amines, OCT2 Substrates, Cardiovascular Agents, Selective Beta 1-adrenergic Agonists, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Biogenic Amines, COMT Substrates, Dopamine, metabolism, Monoamine Oxidase A Substrates, Compounds used in a research, industrial, or household setting, Benzene Derivatives, Dopamine Agents, Autonomic Agents, Protective Agents, Agents producing tachycardia, Catecholamines, Catechols, Adrenergic and Dopaminergic Agents, Biogenic Monoamines, Cardiotonic Agents, Neurotransmitter Agents, Sympathomimetics, OCT2 Inhibitors, Cardiac Stimulants Excl. Cardiac Glycosides, Agents that produce hypertension, Phenols, Cardiac Therapy	approved	16
DB00985	Dimenhydrinate	Drug	Autonomic Agents, QTc Prolonging Agents, Amines, Benzhydryl Compounds, Ethanolamine Derivatives, Moderate Risk QTc-Prolonging Agents, Peripheral Nervous System Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Purines, Histamine H1 Antagonists, Histamine Antagonists, Ethylamines, Central Nervous System Depressants, Antiemetics, Pharmaceutical Preparations, Central Nervous System Agents, Histamine Agents, Benzene Derivatives, Purinones, Gastrointestinal Agents	approved	1
DB00986	Glycopyrronium	Drug	Adrenergics, Inhalants, Amines, Ammonium Compounds, Antimuscarinics Antispasmodics, Quaternary Ammonium Compounds, Agents producing tachycardia, Onium Compounds, Muscarinic Antagonists, Anticholinergic Agents, Neurotransmitter Agents, Synthetic Anticholinergics, Quaternary Ammonium Compounds, Cholinergic Agents, Alimentary Tract and Metabolism, Pyrrolidines, Drugs for Functional Gastrointestinal Disorders, Drugs for Obstructive Airway Diseases, Adjuvants, Anesthesia, Central Nervous System Agents, Nitrogen Compounds	approved, investigational, vet_approved	3
DB00989	Rivastigmine	Drug	Acids, Acyclic, Neuroprotective Agents, Enzyme Inhibitors, Cholinesterase Inhibitors, Cytochrome P-450 Substrates, Nervous System, Protective Agents, Phenylcarbamates, Parasympathomemetic (Cholinergic) Agents, Neurotransmitter Agents, Cholinergic Agents, Cytochrome P-450 CYP3A Substrates, Anti-Dementia Drugs, Carbamates, Central Nervous System Agents, Compounds used in a research, industrial, or household setting, Bradycardia-Causing Agents, Psychoanaleptics	approved, investigational	2
DB12970	Levoglucose	Drug	Compounds used in a research, industrial, or household setting	investigational	0
DB12972	Sepranolone	Drug	Pregnanes, Central Nervous System Agents, Anesthetics, Fused-Ring Compounds, Steroids	investigational	0
DB11641	Vinflunine	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Vinca Alkaloids, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Cytochrome P-450 CYP3A4 Substrates, Secologanin Tryptamine Alkaloids, Indole Alkaloids, Alkaloids, Heterocyclic Compounds, Fused-Ring, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Indoles, P-glycoprotein substrates with narrow therapeutic index	approved, investigational	1
DB12971	Pactimibe	Drug	Heterocyclic Compounds, Fused-Ring, Sterol O-Acyltransferase, antagonists & inhibitors, Indoles	investigational	0
DB10310	Human papillomavirus type 31 L1 capsid protein antigen	Drug	0	approved	0
DB11640	Amifampridine	Drug	Aminopyridines, Pyridines, QTc Prolonging Agents, Amines, Iodine Radioisotopes, Potassium Channel Antagonists, Nervous System, Cardiovascular Agents, Potassium Channel Blockers, Moderate Risk QTc-Prolonging Agents, Membrane Transport Modulators, Peripheral Nervous System Agents	approved, investigational	1
DB11643	Recombinant Cholera Toxin B Subunit	Drug	Biological Factors, Enzymes, Immunologic Factors, Noxae, Adjuvants, Immunologic, Enterotoxins, Transferases, Glycosyltransferases, Enzymes and Coenzymes, Toxins, Biological, Poisons, Bacterial Toxins, ADP Ribose Transferases, Cholera Toxin, Toxic Actions, Compounds used in a research, industrial, or household setting, Pentosyltransferases	approved	0
DB10311	Human papillomavirus type 33 L1 capsid protein antigen	Drug	0	approved	0
DB12974	Roniciclib	Drug	Sulfur Compounds	investigational	0
DB12973	Serlopitant	Drug	Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Neurokinin-1 Receptor Antagonists	investigational	0
DB10312	Human papillomavirus type 45 L1 capsid protein antigen	Drug	0	approved	0
DB11642	Pitolisant	Drug	Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP1A2 Inducers (strength unknown), OCT1 inhibitors, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Receptors, Histamine H3, Drugs causing inadvertant photosensitivity, Cytochrome P-450 CYP3A4 Inducers, Moderate Risk QTc-Prolonging Agents, Cytochrome P-450 CYP3A4 Inducers (weak), Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Cytochrome P-450 CYP1A2 Inducers, Cytochrome P-450 CYP2D6 Substrates	approved, investigational	2
DB09324	Sulbactam	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Sulfur Compounds, Amides, Lactams, beta-Lactamase Inhibitors, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use, Drugs that are Mainly Renally Excreted	approved	1
DB11645	PF-4191834	Drug	Gases, Anions, Sulfur Compounds, Acids, Noncarboxylic, Acids, Hydrogen Sulfide, Electrolytes, Ions	investigational	0
DB12976	Robatumumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB10313	Human papillomavirus type 52 L1 capsid protein antigen	Drug	0	approved	0
DB12975	Pyronaridine	Drug	Heterocyclic Compounds, Fused-Ring, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Antimalarials, Anti-Infective Agents, Antiparasitic Agents	investigational	0
DB11644	Tafamidis	Drug	Heterocyclic Compounds, Fused-Ring, Immunologic Factors, Hormones, Hormone Substitutes, and Hormone Antagonists, Nervous System, Anti-Inflammatory Agents, BCRP/ABCG2 Inhibitors, Miscellaneous Cardiac Drugs, OAT3/SLC22A8 Inhibitors, Fused-Ring Compounds, OAT1/SLC22A6 inhibitors	approved, investigational	1
DB09325	Sodium fluoride	Drug	Cariostatic Agents, Miscellaneous Therapeutic Agents, Mouthwashes and Gargles, Protective Agents, Fluorine Compounds, Ions, Mineral Supplements, Fluorides, Drugs that are Mainly Renally Excreted, Caries Prophylactic Agents, Sodium Compounds, Anions, Alimentary Tract and Metabolism, Dental Agents, Compounds used in a research, industrial, or household setting, Stomatological Preparations	approved	1
DB10314	Human papillomavirus type 58 L1 capsid protein antigen	Drug	0	approved	0
DB10315	Measles virus strain enders' attenuated edmonston live antigen	Drug	Actively Acquired Immunity, Live Attenuated Measles Virus Vaccine	approved, investigational	0
DB11647	Incyclinide	Drug	Naphthacenes	investigational	0
DB12978	Pexidartinib	Drug	Amines, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP3A Inducers, OATP1B3 inhibitors, Cytochrome P-450 CYP2B6 Inducers (strength unknown), MATE inhibitors, MATE 1 Inhibitors, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2B6 Inducers, Hepatotoxic Agents, OATP1B1/SLCO1B1 Inhibitors, Pyridines, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A4 Inducers, Antineoplastic Agents, UGT1A1 Inhibitors, Cytochrome P-450 CYP3A4 Inducers (weak), Cytochrome P-450 CYP3A Inhibitors, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, MATE 2 Inhibitors, UGT1A4 substrates, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved, investigational	4
DB09322	Zinc sulfate	Drug	Zinc Compounds, Sulfur Acids, Dermatologicals, Ions, Mineral Supplements, Minerals, Misc. Skin and Mucous Membrane Agents, Sulfates, Sulfuric Acids, Astringents, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Vasoprotectives, Anions, Sulfur Compounds, Acids, Noncarboxylic, Metal cations, Acids, Alimentary Tract and Metabolism, Metal divalent cations, Electrolytes, Copper Absorption Inhibitor	approved, investigational	0
DB11646	Conatumumab	Drug	Proteins, Serum Globulins, Antineoplastic Agents, Immunological, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB12977	Simenepag isopropyl	Drug	0	investigational	0
DB10316	Mumps virus strain B level jeryl lynn live antigen	Drug	Actively Acquired Immunity, Live Mumps Virus Vaccine	approved, investigational	0
DB11649	Lersivirine	Drug	RNA-Directed DNA Polymerase	investigational	0
DB10317	Rubella virus vaccine	Drug	Live Attenuated Rubella Virus Vaccine, Live vaccines, Actively Acquired Immunity, Viral Vaccines, Vaccines, Antiinfectives for Systemic Use, Rubella Vaccines	approved, investigational	0
DB09320	Procaine benzylpenicillin	Drug	Aminobenzoates, para-Aminobenzoates, Benzoates, Acids, Carbocyclic, Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Beta-Lactamase Sensitive Penicillins, Penicillin G, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Antibacterials for Systemic Use, Benzene Derivatives	approved, vet_approved	0
DB09321	Zinc oxide	Drug	Radiation-Protective Agents, Zinc Compounds, Protective Agents, Dermatologicals, Ions, Oxides, Household Products, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Vasoprotectives, Anions, Basic Ointments and Protectants, Metal cations, Metal divalent cations, Basic Powders and Demulcents, Cosmetics, Electrolytes, Copper Absorption Inhibitor, Sunscreen Agents, Compounds used in a research, industrial, or household setting, Oxygen Compounds	approved	0
DB10318	Varicella Zoster Vaccine (Live/attenuated)	Drug	Live vaccines, Complex Mixtures, Actively Acquired Immunity, Viral Vaccines, Herpesvirus Vaccines, Biological Products, Live Attenuated Herpes Zoster Virus Vaccine, Varicella Zoster Vaccines, Vaccines, Live Attenuated Varicella Zoster Virus Vaccine, Antiinfectives for Systemic Use	approved	0
DB12979	Nepicastat	Drug	Dopamine beta-Hydroxylase, antagonists & inhibitors, Sulfur Compounds	investigational	0
DB11648	Afuresertib	Drug	Sulfur Compounds, Amines, Polyamines	investigational	0
DB10319	Streptococcus pneumoniae type 1 capsular polysaccharide antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved	0
DB00990	Exemestane	Drug	Endocrine Therapy, Enzyme Inhibitors, Cytochrome P-450 Substrates, Steroid Synthesis Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Antineoplastic and Immunomodulating Agents, Androstenes, Antineoplastic Agents, Hormone Antagonists and Related Agents, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Aromatase Inhibitors, Androstanes, Estrogen Antagonists, Cytochrome P-450 CYP3A Substrates, Hormone Antagonists, Steroids	approved, investigational	1
DB00991	Oxaprozin	Drug	Nephrotoxic agents, Acids, Acyclic, Enzyme Inhibitors, Fatty Acids, Sensory System Agents, Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Agents causing hyperkalemia, Non COX-2 selective NSAIDS, Lipids, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Oxazoles, Fatty Acids, Volatile, Musculo-Skeletal System, Drugs causing inadvertant photosensitivity, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Antirheumatic Agents, Antiinflammatory and Antirheumatic Products, Photosensitizing Agents, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Propionates, Agents that produce hypertension, Central Nervous System Agents, Other Nonsteroidal Anti-inflammatory Agents	approved	2
DB00994	Neomycin	Drug	Nephrotoxic agents, Enzyme Inhibitors, Antibiotics for Topical Use, Blood and Blood Forming Organs, Otologicals, Ototoxic agents, Agents that produce neuromuscular block (indirect), Blood Substitutes and Perfusion Solutions, Irrigating Solutions, Ophthalmological and Otological Preparations, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Anti-Bacterial Agents, Antiinfectives and Antiseptics for Local Oral Treatment, Intestinal Antiinfectives, Alimentary Tract and Metabolism, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Glycosides, Protein Synthesis Inhibitors, Neurotoxic agents, Carbohydrates, Dermatologicals, Antiinfectives for Systemic Use, Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Ophthalmologicals, Narrow Therapeutic Index Drugs, Throat Preparations, Aminoglycoside Antibacterials, Sensory Organs, Antibacterials for Systemic Use, Stomatological Preparations	approved, vet_approved	3
DB09328	Vayarin	Drug	Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 Enzyme Inhibitors	approved, investigational	0
DB00995	Auranofin	Drug	Organogold Compounds, Organometallic Compounds, Antiinflammatory and Antirheumatic Products, Gold Preparations, Gold Compounds, Musculo-Skeletal System, Antirheumatic Agents, Specific Antirheumatic Agents, Drugs that are Mainly Renally Excreted	approved, investigational	2
DB09329	Antihemophilic Factor (Recombinant), PEGylated	Drug	Biological Factors, Blood Coagulation Factors, Amino Acids, Peptides, and Proteins, Recombinant Proteins, Drugs that are Mainly Renally Excreted, Alcohols, Macromolecular Substances, Proteins, Blood Proteins, Ethylene Glycols, Pegylated agents, Glycols, Hemostatics, Polymers, Compounds used in a research, industrial, or household setting	approved, investigational	1
DB09326	Ammonia N-13	Drug	Radioactive Diagnostic Agent, Radiopharmaceutical Activity	approved	0
DB00992	Methyl aminolevulinate	Drug	Antineoplastic and Immunomodulating Agents, Dermatologicals, Sensitizers Used in Photodynamic/radiation Therapy, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Misc. Skin and Mucous Membrane Agents, Porphyrin Precursor, Photochemotherapy, Radiation-Sensitizing Agents, Amino Acids, Photosensitizing agents used for phototherapy, Photosensitizing Agents, Keto Acids, Levulinic Acids	approved, investigational	0
DB09327	Tegafur-uracil	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 CYP2A6 Substrates	approved, investigational	4
DB00993	Azathioprine	Drug	Carbohydrates, Immunologic Factors, Thiopurine Analogs, Cytochrome P-450 Substrates, Immunosuppressive Agents, Purine Antimetabolite, Noxae, P-glycoprotein substrates, Thionucleosides, Antineoplastic and Immunomodulating Agents, Antirheumatic Agents, Antimetabolites, Drugs that are Mainly Renally Excreted, Heterocyclic Compounds, Fused-Ring, Purines, Nucleic Acid Synthesis Inhibitors, Sulfur Compounds, Nucleic Acids, Nucleotides, and Nucleosides, Cytochrome P-450 CYP1A2 Substrates, Glycosides, Nucleosides, Toxic Actions, Sulfhydryl Compounds	approved	1
DB00998	Frovatriptan	Drug	Serotonin 5-HT1 Receptor Agonists, Triptans, Amines, Cytochrome P-450 Substrates, Serotonin Agents, Nervous System, Selective Serotonin Agonists, Antidepressive Agents, Antimigraine Preparations, Serotonin Modulators, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Serotonin 1d Receptor Agonists, Biogenic Amines, Indoles, Serotonin-1b and Serotonin-1d Receptor Agonist, Serotonin Receptor Agonists, Biogenic Monoamines, Serotonin 1b Receptor Agonists, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Central Nervous System Depressants, Migraine Disorders, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Selective Serotonin 5-HT1 Receptor Agonists	approved, investigational	2
DB00999	Hydrochlorothiazide	Drug	Nephrotoxic agents, QTc Prolonging Agents, Increased Diuresis, Sodium Chloride Symporter Inhibitors, Genito Urinary System and Sex Hormones, Amides, Cardiovascular Agents, Hypotensive Agents, OAT3/SLC22A8 Substrates, Sulfur Compounds, Benzothiadiazines, Diuretics, Potential QTc-Prolonging Agents, Antihypertensive Agents, Drugs causing inadvertant photosensitivity, Thiazides, Non Potassium Sparing Diuretics, Sulfones, Antihypertensive Agents Indicated for Hypertension, Gynecological Antiinfectives and Antiseptics, Low-Ceiling Diuretics and Potassium-Sparing Agents, Membrane Transport Modulators, OAT1/SLC22A6 inhibitors, Heterocyclic Compounds, Fused-Ring, Photosensitizing Agents, Sulfonamides, Natriuretic Agents, Hyperglycemia-Associated Agents	approved, vet_approved	2
DB00996	Gabapentin	Drug	Acids, Acyclic, Tranquilizing Agents, Decreased Central Nervous System Disorganized Electrical Activity, Amines, Sensory System Agents, Nervous System, Acids, Carbocyclic, Amino Acids, Peptides, and Proteins, Gabapentin and Prodrugs, Anti-epileptic Agent, Cyclohexanes, Peripheral Nervous System Agents, Miscellaneous Anticonvulsants, Analgesics, Butyrates, Drugs causing inadvertant photosensitivity, Cycloparaffins, Aminobutyrates, Psychotropic Drugs, Amino Acids, Neurotransmitter Agents, Anticonvulsants, Photosensitizing Agents, Central Nervous System Depressants, Cyclohexanecarboxylic Acids, Central Nervous System Agents	approved, investigational	6
DB00997	Doxorubicin	Drug	Anthracycline Topoisomerase Inhibitor, Cytochrome P-450 CYP2D6 Inhibitors, Anthracyclines, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytotoxic Antibiotics and Related Substances, Immunosuppressive Agents, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, BSEP/ABCB11 Substrates, Cardiotoxic antineoplastic agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, BSEP/ABCB11 Substrates with Narrow Therapeutic Index, Topoisomerase II Inhibitors, Naphthacenes, Glycosides, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Drugs causing inadvertant photosensitivity, P-glycoprotein substrates with narrow therapeutic index, Carbohydrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Antibiotics, Antineoplastic, Myelosuppressive Agents, P-glycoprotein inducers, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), P-glycoprotein inhibitors, Anthracyclines and Related Substances	approved, investigational	3
DB12981	XL-888	Drug	Acids, Carbocyclic, Aza Compounds, HSP90 Heat-Shock Proteins, antagonists & inhibitors	investigational	0
DB11650	HT-0712	Drug	Piperidines	investigational	0
DB12980	CHS-828	Drug	Anions, Acids, Noncarboxylic, Acids, Hydrogen Cyanide, Amidines, Electrolytes, Ions, Nitrogen Compounds	investigational	0
DB10320	Streptococcus pneumoniae type 2 capsular polysaccharide antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved, investigational	0
DB11652	Tucatinib	Drug	BCRP/ABCG2 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Tyrosine Kinase Inhibitors, OCT2 Inhibitors, P-glycoprotein substrates, MATE 2 Inhibitors, MATE inhibitors, MATE 1 Inhibitors, Cytochrome P-450 CYP2C8 Substrates	approved, investigational	2
DB12983	Phthalocyanine	Drug	Heterocyclic Compounds, Fused-Ring, Radiation-Sensitizing Agents, Pigments, Biological	investigational	0
DB10321	Streptococcus pneumoniae type 3 capsular polysaccharide antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved, investigational	0
DB11651	Dactolisib	Drug	Heterocyclic Compounds, Fused-Ring, Antineoplastic Agents	investigational	0
DB12982	Silicon	Drug	Trace Elements, Micronutrients, Metalloids, Physiological Phenomena, Food and Beverages, Minerals, Elements, Growth Substances, Diet, Food, and Nutrition, Food	approved, investigational	0
DB12985	Quisinostat	Drug	Amines, Hydroxy Acids, Hydroxylamines	investigational	0
DB11654	T-2000	Drug	0	investigational	0
DB10322	Streptococcus pneumoniae type 4 capsular polysaccharide antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved, investigational	0
DB11653	Bremelanotide	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pituitary Hormones, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Hormones, Proteins, Peptide Hormones, Melanocyte-Stimulating Hormones, Hypothalamic Hormones, Protein Precursors, Receptor, Melanocortin, Type 3, agonists, Melanocortins, Receptor, Melanocortin, Type 4, agonists, Pituitary Hormones, Anterior, Pro-Opiomelanocortin	approved, investigational	5
DB12984	Larotaxel	Drug	Cycloparaffins, Cyclodecanes, Diterpenes, Terpenes	investigational	0
DB10323	Streptococcus pneumoniae type 5 capsular polysaccharide antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved, investigational	0
DB09335	Alatrofloxacin	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Topoisomerase Inhibitors, Topoisomerase II Inhibitors, Anti-Infective Agents, Quinolones	approved, withdrawn	0
DB12987	Penclomedine	Drug	Pyridines, Antineoplastic Agents	investigational	0
DB10324	Streptococcus pneumoniae type 6b capsular polysaccharide antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved, investigational	0
DB11656	Rebamipide	Drug	Quinolines, Enzyme Inhibitors, Protective Agents, Amino Acids, Peptides, and Proteins, Anti-Ulcer Agents, Amino Acids, Antioxidants, Heterocyclic Compounds, Fused-Ring, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Alimentary Tract and Metabolism, Drugs for Acid Related Disorders, Compounds used in a research, industrial, or household setting, Gastrointestinal Agents	investigational	0
DB08004	(2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol	Drug	0	experimental	1
DB12986	VS-5584	Drug	Heterocyclic Compounds, Fused-Ring, Oxazines	investigational	0
DB09336	Technetium Tc-99m nofetumomab merpentan	Drug	0	approved, withdrawn	2
DB08005	4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide	Drug	0	experimental	1
DB10325	Streptococcus pneumoniae type 7f capsular polysaccharide antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved, investigational	0
DB11655	Evacetrapib	Drug	Heterocyclic Compounds, Fused-Ring, Lipid Regulating Agents, Anticholesteremic Agents, Hypolipidemic Agents, Benzazepines, Noxae, Toxic Actions, Cholesterol Ester Transfer Proteins, antagonists & inhibitors	investigational	0
DB10326	Streptococcus pneumoniae type 8 capsular polysaccharide antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved, investigational	0
DB12989	Neosaxitoxin	Drug	Neuromuscular Agents, Biological Factors, Pesticides, Insecticides, Marine Toxins, Peripheral Nervous System Agents, Toxins, Biological, Heterocyclic Compounds, Fused-Ring, Purines, Agrochemicals, Central Nervous System Depressants, Neuromuscular Blocking Agents, Toxic Actions, Compounds used in a research, industrial, or household setting	investigational	0
DB11658	QAV-680	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB09333	Iopodic acid	Drug	Contrast Media, Diagnostic Uses of Chemicals, Iodobenzenes, Hydrocarbons, Halogenated, Watersoluble, Hepatotropic X-Ray Contrast Media, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting, Benzene Derivatives, Hydrocarbons, Iodinated	approved, investigational, withdrawn	1
DB08003	ISOTHIAZOLIDINONE ANALOG	Drug	0	experimental	1
DB11657	Tabalumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, B-Cell Activating Factor, antagonists & inhibitors, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB09334	Seractide acetate	Drug	0	approved	1
DB12988	LY-518674	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Lipids	investigational	0
DB10327	Streptococcus pneumoniae type 9n capsular polysaccharide antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved, investigational	0
DB10328	Streptococcus pneumoniae type 9v capsular polysaccharide antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved, investigational	0
DB08000	2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE	Drug	0	experimental	1
DB09331	Daratumumab	Drug	Immunoglobulins, Antineoplastic and Immunomodulating Agents, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins, Proteins, Serum Globulins, CD38-directed Antibody Interactions, Narrow Therapeutic Index Drugs, Globulins, Blood Proteins, CD38-directed Cytolytic Antibody	approved	1
DB11659	Indium	Drug	Anions, Acids, Noncarboxylic, Acids, Metals, Electrolytes, Ions, Metals, Heavy, Elements, Nitric Acid, Indium Radioisotopes, Nitrogen Compounds	investigational	0
DB10329	Streptococcus pneumoniae type 10a capsular polysaccharide antigen	Drug	Actively Acquired Immunity, Inactivated Pneumococcal Vaccine	approved, investigational	0
DB08001	5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID	Drug	0	experimental	1
DB09332	Kappadione	Drug	0	approved	7
DB09330	Osimertinib	Drug	Acids, Acyclic, Enzyme Inhibitors, Amines, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Amides, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Enzyme Inducers, Breast Cancer Resistance Protein Inhibitors, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A4 Inducers, Antineoplastic Agents, Acrylates, Protein Kinase Inhibitors, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP1A2 Inducers, Cytochrome P-450 CYP3A4 Inhibitors (weak), Kinase Inhibitor	approved	1
DB09339	Indium In-111 imciromab pentetate	Drug	Diagnostic Radiopharmaceuticals	withdrawn	0
DB08008	5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine	Drug	0	experimental	1
DB08009	SU-11652	Drug	Heterocyclic Compounds, Fused-Ring	experimental	1
DB08006	N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine	Drug	0	experimental	1
DB09337	Medical air	Drug	Medical Gases, Other Miscellaneous Therapeutic Agents	approved, vet_approved	0
DB08007	(2R)-3-{[(BENZYLAMINO)CARBONYL]AMINO}-2-HYDROXYPROPANOIC ACID	Drug	0	experimental	1
DB09338	Mersalyl	Drug	Organometallic Compounds, Enzyme Inhibitors, Diuretics, Low-Ceiling Diuretics, Excl. Thiazides, Mercurial Diuretics, Drugs that are Mainly Renally Excreted, Alkylmercury Compounds, Organomercury Compounds	experimental	3
DB08095	3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA	Drug	0	experimental	1
DB08096	8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM	Drug	0	experimental	1
DB08093	3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE	Drug	0	experimental	1
DB08094	RO-4584820	Drug	0	investigational	1
DB08091	3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE	Drug	0	experimental	1
DB08092	3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide	Drug	0	experimental	1
DB08090	(3Z,5S,6R,7S,8R,8aR)-3-(octylimino)hexahydro[1,3]oxazolo[3,4-a]pyridine-5,6,7,8-tetrol	Drug	0	experimental	1
DB08099	6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine	Drug	0	experimental	1
DB08097	2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE	Drug	0	experimental	1
DB08098	{[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid	Drug	0	experimental	1
DB09382	Iodohippurate sodium I-131	Drug	Diagnostic Radiopharmaceuticals, Renal System	approved	0
DB08051	(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE	Drug	0	experimental	1
DB10371	Prosopis juliflora pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB09383	Meprednisone	Drug	Pregnadienediols, Corticosteroids for Systemic Use, Corticosteroids, Cytochrome P-450 Substrates, Immunosuppressive Agents, Corticosteroids for Systemic Use, Plain, Glucocorticoids, Pregnadienes, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A Substrates, Pregnanes, Thyroxine-binding globulin inhibitors, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Hyperglycemia-Associated Agents, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Cytochrome P-450 CYP3A5 Inducers, Steroids	approved, investigational	0
DB10372	Artemisia vulgaris pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased Histamine Release	approved	0
DB08052	PP-121	Drug	0	experimental	1
DB10373	Morus rubra pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB09380	Sodium chromate Cr-51	Drug	Radioactive Diagnostic Agent	approved	0
DB10374	Quercus agrifolia pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB09381	Esterified estrogens	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Thyroxine-binding globulin inducers, Estrogens, Cytochrome P-450 CYP3A4 Substrates	approved	0
DB08050	5-phenyl-2-keto-valeric acid	Drug	0	experimental	1
DB10375	Quercus virginiana pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10376	Quercus alba pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10377	Avena sativa pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10378	Olea europaea pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10379	Dactylis glomerata pollen	Drug	Cell-mediated Immunity, Standardized Pollen Allergenic Extract, Grass Pollen Allergen Extracts, Allergenic Extracts, Increased IgG Production, Increased Histamine Release	approved	0
DB08059	Wortmannin	Drug	Immunologic Factors, Enzyme Inhibitors, Immunosuppressive Agents, Serotonin Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Androstadienes, Androstenes, Antidepressive Agents, Radiation-Sensitizing Agents, Anti-Infective Agents, Fused-Ring Compounds, Androstanes, Protein Kinase Inhibitors, Central Nervous System Depressants, Insulin Antagonists, Antifungal Agents, Serotonin Receptor Antagonists, Hormone Antagonists, Steroids	experimental	4
DB08057	N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine	Drug	0	experimental	1
DB09389	Norgestrel	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Contraceptives, Postcoital, Norsteroids, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, Reproductive Control Agents, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Contraceptives, Oral, Cytochrome P-450 CYP3A Substrates, Contraceptives, Oral, Synthetic, Progestogens and Estrogens, Sequential Preparations, Progestins, Combination Contraceptives (with Estrogen and derivatives), Norpregnenes, Hormonal Contraceptives for Systemic Use, Norpregnanes, Contraceptive Agents, Female, Progestin Contraceptives, Steroids	approved	3
DB08058	4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one	Drug	0	experimental	1
DB08055	N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine	Drug	0	experimental	1
DB08056	N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine	Drug	0	experimental	1
DB08053	1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	Drug	0	experimental	1
DB09385	Cyanocobalamin Co-57	Drug	Radioactive Diagnostic Agent, Radiopharmaceutical Activity	approved	0
DB08054	1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine	Drug	0	experimental	1
DB10370	Festuca pratensis pollen	Drug	Cell-mediated Immunity, Standardized Pollen Allergenic Extract, Grass Pollen Allergen Extracts, Allergenic Extracts, Increased IgG Production, Increased Histamine Release	approved	0
DB08062	3-(4-CHLOROPHENYL)-5-(METHYLTHIO)-4H-1,2,4-TRIAZOLE	Drug	0	experimental	1
DB09393	Amino acids	Drug	Blood and Blood Forming Organs, Amino Acids, Peptides, and Proteins, Blood Substitutes and Perfusion Solutions, Solutions for Parenteral Nutrition, Amino Acid Hypertonic Solution, Amino Acids, i.v. Solutions	investigational	0
DB10382	Plantago lanceolata pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10383	Populus alba pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08063	1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE	Drug	0	experimental	2
DB09394	Phosphoric acid	Drug	Acids, Noncarboxylic, Acids, Acid Etching, Dental, Phosphorus Compounds, Compounds used in a research, industrial, or household setting, Dental Materials, Drugs that are Mainly Renally Excreted, Phosphorus Acids	approved	0
DB10384	Ambrosia acanthicarpa pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased Histamine Release	approved	0
DB08060	4-(2-AMINOPHENYL)-4-OXOBUTANOIC ACID	Drug	0	experimental	1
DB08061	4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE	Drug	0	experimental	1
DB10385	Ambrosia artemisiifolia pollen	Drug	Cell-mediated Immunity, Standardized Pollen Allergenic Extract, Allergenic Extracts, Increased IgG Production, Increased Histamine Release	approved	0
DB10386	Ambrosia trifida pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased Histamine Release	approved	0
DB10387	Ambrosia psilostachya pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased Histamine Release	approved	0
DB10388	Salsola kali pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10389	Lolium perenne pollen	Drug	Cell-mediated Immunity, Standardized Pollen Allergenic Extract, Grass Pollen Allergen Extracts, Allergenic Extracts, Increased IgG Production, Increased Histamine Release	approved	0
DB08068	N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-	Drug	0	experimental	1
DB08069	4-AMINO-5-(2-METHYLPHENYL)-2,4-DIHYDRO-3H-1,2,4-TRIAZOLE-3-THIONE	Drug	0	experimental	1
DB08066	N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE	Drug	0	experimental	2
DB09397	Technetium Tc-99m sulfur colloid	Drug	Sulfur Compounds, Diagnostic Uses of Chemicals, Hepatic and Reticulo Endothelial System, Laboratory Chemicals, Diagnostic Radiopharmaceuticals, Radioactive Diagnostic Agent, Technetium (99Mtc), Particles and Colloids, Indicators and Reagents, Radiopharmaceutical Activity, Radiopharmaceuticals, Technetium Compounds, Compounds used in a research, industrial, or household setting	approved, investigational	0
DB08067	4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM	Drug	0	experimental	1
DB09398	Fluoride ion F-18	Drug	Tumour Detection, Diagnostic Radiopharmaceuticals, Radioactive Diagnostic Agent, Radiopharmaceutical Activity	approved	0
DB08064	N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA	Drug	0	experimental	1
DB09395	Sodium acetate	Drug	Acids, Acyclic, Blood and Blood Forming Organs, Fatty Acids, I.V. Solution Additives, Replacement Preparations, Fatty Acids, Volatile, Lipids, Blood Substitutes and Perfusion Solutions, Acetates, Electrolyte Solutions, Drugs that are Mainly Renally Excreted	approved, investigational	0
DB08065	2-(1H-pyrazol-3-yl)-1H-benzimidazole	Drug	0	experimental	1
DB10380	Carya illinoinensis pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10381	Amaranthus retroflexus pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased Histamine Release	approved	0
DB10393	Platanus racemosa pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08073	(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE	Drug	0	experimental	4
DB08074	3-(3-Methyl-2-buten-1-yl)-3H-purin-6-amine	Drug	0	experimental	1
DB10394	Phleum pratense pollen	Drug	Cell-mediated Immunity, Complex Mixtures, Standardized Pollen Allergenic Extract, Grass Pollen Allergen Extracts, Allergenic Extracts, Biological Products, Increased IgG Production, Increased Histamine Release	approved, investigational	0
DB08071	(2S)-1-methyl-2-[(2S,4R)-2-methyl-4-phenylpentyl]piperidine	Drug	0	experimental	1
DB10395	Holcus lanatus pollen	Drug	Cell-mediated Immunity, Grass Pollen Allergen Extracts, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08072	4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE	Drug	0	experimental	1
DB10396	Juglans nigra pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10397	Juglans californica pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10398	Salix nigra pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08070	2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE	Drug	0	experimental	2
DB10399	Felis catus skin	Drug	Cell-mediated Immunity, Allergenic Extracts, Standardized Animal Skin Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08079	AMG-208	Drug	0	investigational	1
DB08077	2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID	Drug	0	experimental	2
DB08078	{4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy}acetic acid	Drug	0	experimental	1
DB08075	4-(2-amino-1,3-thiazol-4-yl)pyrimidin-2-amine	Drug	0	experimental	1
DB08076	4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine	Drug	0	experimental	1
DB10390	Artemisia tridentata pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased Histamine Release	approved	0
DB10391	Atriplex wrightii pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10392	Platanus occidentalis pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08084	IDD594	Drug	Acids, Acyclic, Sulfur Compounds, Fatty Acids, Fatty Acids, Volatile, Amides, Lipids, Aldehyde Reductase, antagonists & inhibitors	experimental	1
DB08085	1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE	Drug	0	experimental	1
DB08082	N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE	Drug	0	experimental	1
DB08083	2-(1,3-thiazol-4-yl)-1H-benzimidazole-5-sulfonamide	Drug	0	experimental	1
DB08080	Latrunculin B	Drug	Sulfur Compounds, Porifera, Thiazoles, Marine Toxins	experimental	3
DB08081	3-OXO-OCTANOIC ACID (2-OXO-TETRAHYDRO-FURAN-3-YL)-AMIDE	Drug	0	experimental	3
DB08088	2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile	Drug	0	experimental	1
DB08089	LGD-2226	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring	experimental	1
DB08086	N-[12-(1H-imidazol-1-yl)dodecanoyl]-L-leucine	Drug	0	experimental	1
DB08087	4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE	Drug	0	experimental	1
DB11700	Setmelanotide	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pituitary Hormones, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Hormones, Proteins, Peptide Hormones, Melanocyte-Stimulating Hormones, Anti-Obesity Agents, Hypothalamic Hormones, Protein Precursors, Melanocortins, Receptor, Melanocortin, Type 4, agonists, Pituitary Hormones, Anterior, Pro-Opiomelanocortin	investigational	0
DB11702	Antineoplaston A10	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Piperidines, Amides, Lipids, Acetamides, Acetates, Benzene Derivatives	investigational	0
DB11701	Amenamevir	Drug	Oxazoles	investigational	0
DB11704	Adomeglivant	Drug	Benzene Derivatives	investigational	0
DB11703	Acalabrutinib	Drug	Benzoates, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Acids, Carbocyclic, Cytochrome P-450 CYP3A5 Inhibitors, Antineoplastic Agents, Amides, Cytochrome P-450 CYP3A5 Inhibitors (weak), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Benzene Derivatives, Cytochrome P-450 CYP3A4 Inhibitors (weak), Kinase Inhibitor	approved, investigational	1
DB11706	Raxatrigine	Drug	Acids, Acyclic, Amino Acids, Cyclic, Imines, Phenols, Amino Acids, Peptides, and Proteins, Ethers, Imino Acids, Amino Acids, Benzene Derivatives	investigational	0
DB11705	Iomeprol	Drug	Iodobenzoates, Benzoates, Contrast Media, Diagnostic Uses of Chemicals, Acids, Carbocyclic, Triiodobenzoic Acids, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting, Benzene Derivatives, Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media	approved, investigational	0
DB11711	Navarixin	Drug	Cycloparaffins, Receptors, Interleukin-8B, antagonists & inhibitors, Benzoates, Acids, Carbocyclic, Receptors, Interleukin-8A, antagonists & inhibitors, Amides, Benzene Derivatives	investigational	0
DB11710	Trigonellamide	Drug	Pyridines, Nicotinic Acids	investigational	0
DB11713	Ruzasvir	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Antiviral Agents, Anti-Infective Agents	investigational	0
DB11712	Tezacaftor	Drug	Heterocyclic Compounds, Fused-Ring, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Substrates, P-glycoprotein inhibitors, Dioxoles	approved, investigational	1
DB11715	Bapineuzumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB11714	Durvalumab	Drug	Immunoglobulins, Programmed Death Ligand-1-directed Antibody Interactions, Antineoplastic and Immunomodulating Agents, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibiotics, Antineoplastic, Antibodies, Monoclonal, Immunoproteins, Proteins, Serum Globulins, Antineoplastic Agents, Immunological, Narrow Therapeutic Index Drugs, Globulins, Blood Proteins, Programmed Death Ligand-1 Blocker, Programmed Death Ligand-1 Antagonists	approved, investigational	1
DB11717	Epacadostat	Drug	Sulfur Compounds, Amines, Antineoplastic and Immunomodulating Agents, Hydroxylamines, Antineoplastic Agents, Amides, Sulfones	investigational	0
DB11716	Misonidazole	Drug	Antiprotozoals, Imidazoles, Nitro Compounds, Antineoplastic Agents, Nitroimidazoles, Radiation-Sensitizing Agents, Anti-Infective Agents, Antiparasitic Agents	investigational	0
DB11708	Peficitinib	Drug	Immunologic Factors, Pyridines, Cycloparaffins, Enzyme Inhibitors, Immunosuppressive Agents, Nicotinic Acids	investigational	0
DB11707	Olaptesed Pegol	Drug	Pegylated agents	investigational	0
DB11709	Acetyl hexapeptide-3	Drug	Peptides, Amino Acids, Peptides, and Proteins	investigational	0
DB11720	Angiotensin 1-7	Drug	Biological Factors, Autacoids, Inflammation Mediators, Hormones, Hormone Substitutes, and Hormone Antagonists, Oligopeptides, Peptides, Angiotensins, Amino Acids, Peptides, and Proteins, Neuropeptides, Cardiovascular Agents, Nerve Tissue Proteins, Hormones, Proteins, Peptide Hormones, Antihypertensive Agents, Vasodilating Agents	investigational	0
DB09401	Isosorbide	Drug	Carbohydrates, Antianginal Agents, Contraceptive Agents, Male, Noxae, Adrenal Cortex Hormones, Reproductive Control Agents, Cardiovascular Agents, Organic Nitrates, Alcohols, Diuretics, Osmotic, Sesquiterpenes, Sugar Alcohols, Diuretics, Natriuretic Agents, Toxic Actions, Terpenes, Vasodilating Agents, Hormonal Contraceptives for Systemic Use	approved, investigational	3
DB11721	Mitoglitazone	Drug	Sulfur Compounds, Thiazoles	investigational	0
DB11724	Bombesin	Drug	Biological Factors, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Amphibian Venoms, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Hormones, Bombesin, antagonists & inhibitors, Proteins, Toxins, Biological, Neurotransmitter Agents, Peptide Hormones, Complex Mixtures, Venoms, Fluids and Secretions, Bodily Secretions	investigational	0
DB09400	Selenomethionine Se-75	Drug	Selenium Compounds	approved	0
DB11723	Dutogliptin	Drug	Acids, Noncarboxylic, Acids, Agents causing angioedema, Blood Glucose Lowering Agents, Boron Compounds, DPP-IV Inhibitors	investigational	1
DB11726	Encenicline	Drug	Sulfur Compounds, Nicotinic Agonists	investigational	1
DB11725	Latrepirdine	Drug	Heterocyclic Compounds, Fused-Ring, Alzheimer Disease	investigational	0
DB11727	Endostar	Drug	Angiogenic Proteins, Biological Factors, Angiostatic Proteins, Collagen Type XVIII, Peptides, Intercellular Signaling Peptides and Proteins, Antineoplastic Agents, Non-Fibrillar Collagens, Amino Acids, Peptides, and Proteins, Growth Inhibitors, Angiogenesis Modulating Agents, Recombinant Proteins, Angiogenesis Inhibitors, Biopolymers, Macromolecular Substances, Proteins, Scleroproteins, Extracellular Matrix Proteins, Collagen, Growth Substances, Polymers, Compounds used in a research, industrial, or household setting	investigational	0
DB11719	UK-390957	Drug	0	investigational	0
DB09409	Magnesium acetate tetrahydrate	Drug	Osmotic Laxatives, Calculi Dissolution Agent, Laxatives, Agents that produce neuromuscular block (indirect)	approved	1
DB11718	Encorafenib	Drug	Acids, Acyclic, QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Amides, Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A4 Substrates, Moderate Risk QTc-Prolonging Agents, Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C19 Substrates, Protein Kinase Inhibitors, Sulfur Compounds, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2D6 Substrates, Sulfones	approved, investigational	2
DB09407	Magnesium chloride	Drug	Blood and Blood Forming Organs, Calculi Dissolution Agent, Ions, Mineral Supplements, Agents that produce neuromuscular block (indirect), Blood Substitutes and Perfusion Solutions, Minerals, Hemodialysis Solution, Electrolyte Solutions, Drugs that are Mainly Renally Excreted, Anions, Acids, Noncarboxylic, I.V. Solution Additives, Metal cations, Acids, Alimentary Tract and Metabolism, Metal divalent cations, Chlorides, Electrolytes, Chlorine Compounds, Magnesium Compounds	approved	0
DB09403	Iocetamic acid	Drug	Contrast Media, Hydrocarbons, Halogenated, Watersoluble, Hepatotropic X-Ray Contrast Media, X-Ray Contrast Media, Iodinated, Benzene Derivatives, Hydrocarbons, Iodinated	approved	0
DB11731	Depatuxizumab mafodotin	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Noxae, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Toxic Actions, Antibodies, Monoclonal, Immunoproteins	investigational	2
DB11730	Ribociclib	Drug	Highest Risk QTc-Prolonging Agents, Pyridines, QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A4 Inhibitors (strong), Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Kinase Inhibitor	approved, investigational	2
DB10400	Dermatophagoides farinae	Drug	Allergens, Cell-mediated Immunity, Allergenic Extracts, Increased IgG Production, Standardized Insect Allergenic Extract, Increased Histamine Release	approved	0
DB10401	Dermatophagoides pteronyssinus	Drug	Allergens, Cell-mediated Immunity, Allergenic Extracts, Increased IgG Production, Standardized Insect Allergenic Extract, Increased Histamine Release	approved	0
DB09413	Monopotassium phosphate	Drug	Cariostatic Agents, Potassium Salt, Protective Agents, Laboratory Chemicals, Ions, Phosphorus Compounds, Phosphate salts, Phosphorus Acids, Anions, Acids, Noncarboxylic, Acids, Phosphoric Acids, Replacement Preparations, Osmotic Laxatives, Electrolytes, Laxatives, Buffers, Compounds used in a research, industrial, or household setting, Dental Materials	approved, investigational, vet_approved	0
DB11732	Lasmiditan	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, P-glycoprotein substrates, OCT1 inhibitors, BCRP/ABCG2 Inhibitors, Amides, MATE inhibitors, MATE 1 Inhibitors, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, MATE 2 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), P-glycoprotein inhibitors	approved, investigational	1
DB11735	Galactose	Drug	Carbohydrates, Contrast Media, Tests for Liver Functional Capacity, Hexoses, Diagnostic Agents, Ultrasound Contrast Media, Monosaccharides	approved, investigational	0
DB10403	Agrostis gigantea pollen	Drug	Cell-mediated Immunity, Standardized Pollen Allergenic Extract, Grass Pollen Allergen Extracts, Allergenic Extracts, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10404	Anthoxanthum odoratum pollen	Drug	Cell-mediated Immunity, Standardized Pollen Allergenic Extract, Grass Pollen Allergen Extracts, Allergenic Extracts, Increased IgG Production, Increased Histamine Release	approved	0
DB11734	Fedovapagon	Drug	0	investigational	0
DB11737	Icotinib	Drug	Cytochrome P-450 CYP3A5 Inducers (moderate), Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Tyrosine Kinase Inhibitors, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A Inducers, Antineoplastic Agents, Cytochrome P-450 CYP3A4 Substrates, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 Enzyme Inducers, Protein Kinase Inhibitors, Crown Compounds, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A5 Inducers (weak), Ethers, Cytochrome P-450 CYP3A5 Inducers, Ethers, Cyclic	investigational, experimental	1
DB11736	PF-00489791	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amides, Sulfones	investigational	0
DB10406	Bos taurus skin	Drug	Cell-mediated Immunity, Non-Standardized Animal Skin Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11739	Vonoprazan	Drug	Sulfur Compounds, Amides, Sulfones	investigational	0
DB11738	Rilmenidine	Drug	Autonomic Agents, Adrenergic alpha-Agonists, Sympatholytics, Agents producing tachycardia, Cardiovascular Agents, Antiadrenergic Agents, Centrally Acting, Peripheral Nervous System Agents, Neurotransmitter Agents, Adrenergic alpha-2 Receptor Agonists, Oxazoles, Adrenergic Agonists, Agents that produce hypertension, Imidazoline Receptor Agonists, Antihypertensive Agents, Adrenergic Agents	approved, investigational	1
DB10408	Cotton seed	Drug	Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11729	GSK-2330672	Drug	Sulfur Compounds, Amines, Thiepins, Azepines	investigational	0
DB09418	Potassium perchlorate	Drug	Potassium Salt, Thyroid Products, Acids, Noncarboxylic, Acids, Antithyroid agents, Perchlorates, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Chlorine Compounds, Drugs that are Mainly Renally Excreted	approved, investigational	1
DB09419	Xylose	Drug	Carbohydrates, Pentoses, Monosaccharides	approved	0
DB09414	Dipotassium phosphate	Drug	Cariostatic Agents, Potassium Salt, Protective Agents, Laboratory Chemicals, Ions, Phosphorus Compounds, Phosphate salts, Phosphorus Acids, Anions, Acids, Noncarboxylic, Acids, Phosphoric Acids, Osmotic Laxatives, Electrolytes, Laxatives, Buffers, Compounds used in a research, industrial, or household setting, Dental Materials	approved	0
DB11780	Allicin	Drug	Hypolipidemic Agents, Noxae, Sulfur Acids, Protective Agents, Free Radical Scavengers, Blood Glucose Lowering Agents, Anti-Infective Agents, Antioxidants, Lipid Regulating Agents, Sulfur Compounds, Acids, Noncarboxylic, Acids, Toxic Actions, Compounds used in a research, industrial, or household setting	investigational	0
DB09460	Sodium carbonate	Drug	Alkalies, Anions, Acids, Noncarboxylic, Acids, Electrolytes, Ions, Carbonic Acid, Carbon Compounds, Inorganic	approved	4
DB11782	Birinapant	Drug	Heterocyclic Compounds, Fused-Ring, Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins	investigational	0
DB10450	Aspergillus terreus	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10451	Acacia	Drug	Carbohydrates, Plant Gums, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Plant Exudates, Biopolymers, Macromolecular Substances, Polysaccharides, Complex Mixtures, Biological Products, Polymers, Compounds used in a research, industrial, or household setting, Increased IgG Production, Increased Histamine Release	approved	0
DB11781	Tosedostat	Drug	Enzyme Inhibitors, Amines, Hydroxy Acids, Hydroxylamines, Amino Acids, Peptides, and Proteins, Amino Acids	investigational	2
DB11784	NRX-1074	Drug	0	investigational	0
DB10452	Ailanthus altissima pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10453	Alnus incana subsp. rugosa pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11783	Imidapril	Drug	Enzyme Inhibitors, Imidazoles, Angiotensin-Converting Enzyme Inhibitors, Agents causing hyperkalemia, Protease Inhibitors, Agents Acting on the Renin-Angiotensin System, Agents causing angioedema, Cardiovascular Agents, Hypotensive Agents, Antihypertensive Agents	investigational	0
DB10454	Medicago sativa pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11786	Pefcalcitol	Drug	0	investigational	0
DB11785	Anisodamine	Drug	QTc Prolonging Agents, Cytochrome P-450 Substrates, Sensory System Agents, Anti-Inflammatory Agents, Agents causing hyperkalemia, Adrenergic beta-Antagonists, Free Radical Scavengers, Cardiovascular Agents, Anti-Ulcer Agents, Peripheral Nervous System Agents, Antioxidants, Alkaloids, Analgesics, Adrenergic Antagonists, Potential QTc-Prolonging Agents, Compounds used in a research, industrial, or household setting, Adrenergic Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Gastrointestinal Agents, Analgesics, Non-Narcotic, Autonomic Agents, Drugs, Chinese Herbal, Protective Agents, Antirheumatic Agents, Agents producing tachycardia, Parasympatholytics, Neurotransmitter Agents, Adrenergic Agonists, Agents that produce hypertension, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Vasodilating Agents	investigational	0
DB10455	Fraxinus velutina pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11788	Neuropeptide Y	Drug	Proteins, Neuropeptide Y, drug effects, Peptides, Neuropeptide Y, antagonists & inhibitors, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins	approved, investigational	0
DB10456	Populus tremuloides pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08136	4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide	Drug	0	experimental	1
DB10457	Morella cerifera pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11787	Ralimetinib	Drug	Mitogen-Activated Protein Kinase 14, antagonists & inhibitors	investigational	0
DB08137	(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide	Drug	0	experimental	1
DB10458	Betula nigra pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08134	4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide	Drug	0	experimental	1
DB11789	Hyodeoxycholic Acid	Drug	Bile Acids and Salts, Cholanes, Cholic Acids, Fused-Ring Compounds, Steroids	investigational	0
DB10459	Amaranthus palmeri pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased Histamine Release	approved	0
DB08135	N-phenyl-1H-pyrazole-3-carboxamide	Drug	0	experimental	1
DB08132	5-hydroxynaphthalene-1-sulfonamide	Drug	0	experimental	1
DB08133	N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide	Drug	0	experimental	1
DB09461	Xenon Xe-127	Drug	Gases, Xenon Isotopes, Xenon, Radioactive Diagnostic Agent, Radioisotopes, Radiopharmaceutical Activity, Elements, Isotopes, Inhalation Diagnostic Agent, Noble Gases	approved	0
DB08130	N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine	Drug	0	experimental	1
DB08131	2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-3-METHYL-BUTYRIC ACID	Drug	0	experimental	1
DB09462	Glycerin	Drug	Carbohydrates, Other Diagnostics, Solvents, Cell-mediated Immunity, Cytochrome P-450 CYP2E1 Inducers, Protective Agents, Drugs for Constipation, Irrigating Solutions, Non-Standardized Chemical Allergen, Alcohols, Cytochrome P-450 Enzyme Inducers, Basic Ointments and Protectants, Alimentary Tract and Metabolism, Osmotic Laxatives, Sugar Alcohols, Laxatives, Other Cold and Cough Preparations, Triose Sugar Alcohols, Compounds used in a research, industrial, or household setting, Increased IgG Production, Cryoprotective Agents, Cytochrome P-450 CYP2E1 Inducers (strength unknown), Enemas, Increased Histamine Release	approved, investigational	14
DB08138	{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide	Drug	0	experimental	1
DB08139	5-chloro-7-[(1-methylethyl)amino]pyrazolo[1,5-a]pyrimidine-3-carbonitrile	Drug	0	experimental	1
DB11791	Capmatinib	Drug	Benzoates, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, P-glycoprotein substrates, Acids, Carbocyclic, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, Amides, MATE inhibitors, MATE 1 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP3A Substrates, MATE 2 Inhibitors, Benzene Derivatives	approved, investigational	1
DB08140	5-[(4-AMINOCYCLOHEXYL)AMINO]-7-(PROPAN-2-YLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBONITRILE	Drug	0	experimental	1
DB10460	Juniperus ashei pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11790	Radafaxine	Drug	Ketones, Propiophenones	investigational	0
DB10461	Juniperus virginiana pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11793	Niraparib	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Narrow Therapeutic Index Drugs, Pyrazoles, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Poly(ADP-ribose) Polymerase Inhibitors	approved, investigational	2
DB11792	Mirodenafil	Drug	Phosphodiesterase Inhibitors, Enzyme Inhibitors, Pyrimidines, Sulfur Compounds, Phosphodiesterase 5 Inhibitors, Amides, Vasodilating Agents, Sulfones	investigational	0
DB10462	Xanthium strumarium var. canadense pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11795	GSK-2636771	Drug	Enzyme Inhibitors, Oxazines, Protein Kinase Inhibitors, Antineoplastic Agents	investigational	0
DB10463	Populus deltoides pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10464	Populus fremontii pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11794	Berzosertib	Drug	0	investigational	0
DB10465	Populus deltoides subsp. monilifera pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11797	Aceneuramic acid	Drug	Musculo-Skeletal System	investigational	0
DB10466	Cupressus arizonica pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11796	Fostemsavir	Drug	Organophosphorus Compounds	investigational	0
DB10467	Taxodium distichum pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08147	4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid	Drug	0	experimental	1
DB11799	Bictegravir	Drug	Antivirals for Systemic Use, Direct Acting Antivirals, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, UGT1A1 Substrates, MATE inhibitors, Antiviral Agents, MATE 1 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Antiinfectives for Systemic Use	approved, investigational	2
DB11798	Tanzisertib	Drug	Heterocyclic Compounds, Fused-Ring, Cycloparaffins, Hexanols, JNK Mitogen-Activated Protein Kinases, antagonists & inhibitors, Lipids, Fatty Alcohols, Alcohols, Carbon Radioisotopes, Cyclohexanes	investigational	0
DB08148	1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine	Drug	0	experimental	2
DB10468	Eupatorium capillifolium pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB09479	Rubidium Rb-82	Drug	Radioactive Diagnostic Agent, Radiopharmaceutical Activity	approved, investigational	0
DB10469	Ulmus crassifolia pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08145	6-(2,6-DIMETHOXYPHENYL)PYRIDO[2,3-D]PYRIMIDINE-2,7-DIAMINE	Drug	0	experimental	1
DB09477	Enalaprilat	Drug	Antihypertensive Agents Indicated for Hypertension, Enzyme Inhibitors, Oligopeptides, Peptides, Agents causing hyperkalemia, Protease Inhibitors, Amino Acids, Peptides, and Proteins, Cardiovascular Agents, Hypotensive Agents, Drugs that are Mainly Renally Excreted, Photosensitizing Agents, Angiotensin-Converting Enzyme Inhibitors, Agents Acting on the Renin-Angiotensin System, Dipeptides, Agents causing angioedema, Antihypertensive Agents, Decreased Blood Pressure, Drugs causing inadvertant photosensitivity	approved	2
DB08146	7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine	Drug	0	experimental	1
DB08143	5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE	Drug	0	experimental	1
DB08144	6-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine	Drug	0	experimental	1
DB09472	Sodium sulfate	Drug	Sulfur Acids, Drugs for Constipation, Ions, Mineral Supplements, Drugs that are Mainly Renally Excreted, Sulfuric Acids, Anions, Sulfur Compounds, Acids, Noncarboxylic, Acids, Sodium, Alimentary Tract and Metabolism, Osmotic Laxatives, Electrolytes, Laxatives, Gastrointestinal Agents	approved, vet_approved	2
DB08141	4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide	Drug	0	experimental	1
DB08142	AT-7519	Drug	Cyclin-Dependent Kinases, antagonists & inhibitors	investigational	2
DB09473	Indium In-111 oxyquinoline	Drug	Radioactive Diagnostic Agent, Radiopharmaceutical Activity	approved	0
DB08149	1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine	Drug	0	experimental	2
DB08150	4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium	Drug	0	experimental	2
DB10470	Eucalyptus globulus pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB09481	Magnesium carbonate	Drug	Metals, Calculi Dissolution Agent, Agents that produce neuromuscular block (indirect), Bleaching Agents, Elements, Drugs that are Mainly Renally Excreted, Aluminum and magnesium containing antacids, Metals, Light, Metal cations, Oxidants, Alimentary Tract and Metabolism, Osmotic Laxatives, Drugs for Treatment of Hyperkalemia and Hyperphosphatemia, Drugs for Acid Related Disorders, Compounds used in a research, industrial, or household setting, Hygroscopic Agents, Noxae, Drugs for Constipation, Laxatives, magnesium containing, Gastric Acid Lowering Agents, Metal divalent cations, Metals, Alkaline Earth, Laxatives, Toxic Actions, Antacids, Magnesium Compounds	approved, investigational	1
DB08151	(5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol	Drug	0	experimental	1
DB10471	Solidago canadensis pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10472	Celtis occidentalis pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10473	Juniperus californica pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB09480	Iofetamine I-123	Drug	Iodine (123I) Compounds, Amines, Laboratory Chemicals, Agents producing tachycardia, Phenethylamines, Central Nervous System, Diagnostic Uses of Chemicals, Ethylamines, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Sympathomimetics, Agents that produce hypertension, Amphetamines, Diagnostic Radiopharmaceuticals, Indicators and Reagents, Radiopharmaceuticals, Compounds used in a research, industrial, or household setting	approved	0
DB10474	Robinia pseudoacacia pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10475	Acer rubrum pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08158	2,4-DINITROPHENYL 2-DEOXY-2-FLUORO-BETA-D-MANNOPYRANOSIDE	Drug	0	experimental	1
DB10478	Melaleuca quinquenervia pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10479	Chenopodium ambrosioides pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08159	4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE	Drug	0	experimental	1
DB08156	3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID	Drug	0	experimental	2
DB09487	Iotrolan	Drug	Iodobenzoates, Benzoates, Contrast Media, Diagnostic Uses of Chemicals, Acids, Carbocyclic, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting, Benzene Derivatives, Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media	approved	0
DB08157	ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE	Drug	0	experimental	2
DB09488	Acrivastine	Drug	Neurotransmitter Agents, Pyridines, QTc Prolonging Agents, Histamine H1 Antagonists, Histamine H1 Antagonists, Non-Sedating, Histamine Antagonists, Potential QTc-Prolonging Agents, Histamine Agents, Antihistamines for Systemic Use, Drugs that are Mainly Renally Excreted	approved	1
DB08154	3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile	Drug	0	experimental	1
DB08155	N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE	Drug	0	experimental	2
DB09483	Potassium lactate	Drug	Potassium Salt, Blood and Blood Forming Organs, I.V. Solution Additives, Laxatives, Blood Substitutes and Perfusion Solutions, Electrolyte Solutions	approved	0
DB08152	{(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate	Drug	0	experimental	1
DB08153	(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE	Drug	0	experimental	1
DB09484	Sodium fluorophosphate	Drug	Cariostatic Agents, Toothpastes, Protective Agents, Hydrofluoric Acid, Fluorine Compounds, Ions, Mineral Supplements, Fluorides, Phosphorus Compounds, Phosphorus Acids, Caries Prophylactic Agents, Anions, Acids, Noncarboxylic, Acids, Phosphoric Acids, Alimentary Tract and Metabolism, Osmotic Laxatives, Dental Agents, Electrolytes, Laxatives, Compounds used in a research, industrial, or household setting, Stomatological Preparations	approved	0
DB10481	Quercus rubra pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08161	(S)-2-(MERCAPTOMETHYL)-5-PHENYLPENTANOIC ACID	Drug	0	experimental	1
DB09493	Technetium Tc-99m red blood cells	Drug	Radioactive Diagnostic Agent, Radiopharmaceutical Activity	approved	0
DB08162	Fasudil	Drug	Enzyme Inhibitors, Piperazines, Isoquinolines, Amides, Cardiovascular Agents, Membrane Transport Modulators, Calcium Channel Blockers, Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors, Sulfur Compounds, Sulfonamides, Calcium-Regulating Hormones and Agents, Peripheral Vasodilators, Vasodilating Agents, Sulfones, Antiarrhythmic agents	investigational	4
DB10482	Syagrus romanzoffiana pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10483	Schinus molle pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB09490	Indium In-111 chloride	Drug	Radioactive Diagnostic Agent, Radiopharmaceutical Activity	approved	0
DB08160	(2S)-2-AMINO-4-(METHYLSULFANYL)-1-(1,3-THIAZOL-2-YL)BUTANE-1,1-DIOL	Drug	0	experimental	1
DB10484	Amaranthus spinosus pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased Histamine Release	approved	0
DB10485	Casuarina equisetifolia pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10486	Pinus strobus pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10487	Pinus echinata pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10488	Ligustrum vulgare pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08169	(2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide	Drug	0	experimental	1
DB10489	Elymus repens pollen	Drug	Cell-mediated Immunity, Grass Pollen Allergen Extracts, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB09498	Strontium chloride Sr-89	Drug	Radioactive Therapeutic Agent, Pain Palliation (Bone Seeking Agents), Strontium Radioisotopes, Therapeutic Radiopharmaceuticals, Metals, Metals, Alkaline Earth, Metals, Heavy, Elements, Various Pain Palliation Radiopharmaceuticals	approved, investigational	0
DB08167	Methylthioninium	Drug	Oxidation-Reduction Activity, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Oxidation-Reduction Agent	investigational, experimental	2
DB08168	Coumarin 120	Drug	Heterocyclic Compounds, Fused-Ring, Laboratory Chemicals, Indicators and Reagents, Benzopyrans, Compounds used in a research, industrial, or household setting, Pyrans	experimental	3
DB09499	Thiosulfuric acid	Drug	Antidotes, Sulfur Acids, Protective Agents, Ions, Minerals, Sulfates, Anti-Infective Agents, Sulfuric Acids, Antioxidants, Anions, Sulfur Compounds, Acids, Noncarboxylic, Acids, Sequestering Agents, Electrolytes, Compounds used in a research, industrial, or household setting, Chelating Agents, Antituberculosis Agents	approved, investigational	0
DB09496	Octinoxate	Drug	Radiation-Protective Agents, Protectives Against UV-Radiation for Topical Use, Protectives Against UV-Radiation, Protective Agents, Acids, Carbocyclic, Dermatologicals, Cosmetics, Sunscreen Agents, Compounds used in a research, industrial, or household setting, Emollients and Protectives, Drugs that are Mainly Renally Excreted, Household Products	approved, investigational	0
DB08165	indane-5-sulfonamide	Drug	0	experimental	1
DB08166	(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile	Drug	0	experimental	1
DB08163	5'-{[4-(aminooxy)butyl](methyl)amino}-5'-deoxy-8-ethenyladenosine	Drug	0	experimental	1
DB09494	Cetyl alcohol	Drug	Lipids, Drugs that are Mainly Renally Excreted, Alcohols	approved	0
DB08164	(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE	Drug	0	experimental	1
DB09495	Avobenzone	Drug	Radiation-Protective Agents, Ketones, Protective Agents, Dermatologicals, Cosmetics, Sunscreen Agents, Compounds used in a research, industrial, or household setting, Household Products	approved, investigational	0
DB10480	Morus alba pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11740	MK-1775	Drug	Enzyme Inhibitors	investigational	1
DB10410	Equus caballus skin	Drug	Cell-mediated Immunity, Non-Standardized Animal Skin Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11742	Ebastine	Drug	Neurotransmitter Agents, QTc Prolonging Agents, Histamine H1 Antagonists, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 Substrates, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Ketones, Potential QTc-Prolonging Agents, Cytochrome P-450 CYP3A4 Substrates, Histamine Agents, Antihistamines for Systemic Use	approved, investigational	0
DB11741	Famitinib	Drug	Heterocyclic Compounds, Fused-Ring, Receptor Protein-Tyrosine Kinases, antagonists & inhibitors	investigational	0
DB10411	Ceiba pentandra fiber	Drug	Cell-mediated Immunity, Non-Standardized Plant Fiber Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10412	Mus musculus skin	Drug	Cell-mediated Immunity, Non-Standardized Animal Skin Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11744	Epetraborole	Drug	Anti-Bacterial Agents, Leucine-tRNA Ligase, antagonists & inhibitors	investigational	0
DB09423	Technetium Tc-99m polyphosphate	Drug	Anions, Acids, Noncarboxylic, Acids, Phosphoric Acids, Electrolytes, Ions, Phosphorus Compounds, Phosphate salts, Phosphorus Acids	approved	0
DB11743	Ipatasertib	Drug	Proto-Oncogene Proteins c-akt, antagonists & inhibitors	investigational	0
DB10413	Orris	Drug	Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11746	Onartuzumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB09421	Protirelin	Drug	Thyrotropin-Releasing Hormone, Thyroid Products, Hormones, Hormone Substitutes, and Hormone Antagonists, Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins, Neuropeptides, Tests for Thyreoidea Function, Nerve Tissue Proteins, Hormones, Pituitary Hormone-Releasing Hormones, Proteins, Peptide Hormones, Hypothalamic Hormones, Diagnostic Agents	approved, investigational	1
DB11745	Otenabant	Drug	Heterocyclic Compounds, Fused-Ring, Cannabinoid Receptor Antagonists, Cannabinoids and similars, Receptor, Cannabinoid, CB1, antagonists & inhibitors	investigational	1
DB09422	Soybean oil	Drug	Oils, Lipid Emulsion, Lipids, Dietary Fats, Unsaturated, Complex Mixtures, Physiological Phenomena, Plant Preparations, Fats, Unsaturated, Dietary Fats, Food and Beverages, Caloric Agents, Biological Products, Plant Oils, Fats, Diet, Food, and Nutrition, Food	approved	1
DB10415	Rabbit	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved, investigational	0
DB11748	Benfotiamine	Drug	Immunologic Factors, Pyrimidines, Sulfur Compounds, Adjuvants, Immunologic, Alimentary Tract and Metabolism, Sequestering Agents, Thiazoles, Vitamin B Complex, Compounds used in a research, industrial, or household setting, Vitamins	approved, experimental	0
DB10416	Cavia porcellus skin	Drug	Cell-mediated Immunity, Non-Standardized Animal Skin Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB09420	Iodide I-123	Drug	Halogens, Diagnostic Radiopharmaceuticals, Radioactive Diagnostic Agent, Radioisotopes, Radiopharmaceutical Activity, Iodine Isotopes, Thyroid Diagnostic Radiopharmaceuticals, Elements, Isotopes	approved	0
DB10417	Periplaneta americana	Drug	Cell-mediated Immunity, Non-Standardized Insect Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11747	Barasertib	Drug	Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors, Organophosphorus Compounds	investigational	0
DB10418	Blatella germanica	Drug	Allergens, Cell-mediated Immunity, Non-Standardized Insect Allergenic Extract, Increased IgG Production, Insect Proteins, Increased Histamine Release	approved	0
DB11749	(R)-Praziquantel	Drug	0	investigational	0
DB10419	Solenopsis invicta	Drug	Cell-mediated Immunity, Non-Standardized Insect Venom Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10409	Canis lupus familiaris skin	Drug	Cell-mediated Immunity, Non-Standardized Animal Skin Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB09429	Albumin iodinated I-125 serum	Drug	Radioactive Diagnostic Agent, Radiopharmaceutical Activity	approved	0
DB09425	Indium In-111 pentetate	Drug	Central Nervous System, Lead Chelator, Diagnostic Radiopharmaceuticals, Radioactive Diagnostic Agent, Radiopharmaceutical Activity	approved	0
DB11751	Cabotegravir	Drug	Pyridines, Anti-HIV Agents, OAT3/SLC22A8 Inhibitors, OAT1/SLC22A6 inhibitors	investigational	0
DB10420	Gallus gallus feather	Drug	Cell-mediated Immunity, Non-Standardized Feather Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11750	Clobetasol	Drug	Corticosteroids, Dermatological Preparations, Cytochrome P-450 Substrates, Immunosuppressive Agents, Glucocorticoids, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Corticosteroids, Very Potent (Group IV), Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Corticosteroid Hormone Receptor Agonists, Cytochrome P-450 CYP3A5 Inducers, Pregnadienetriols, Corticosteroids, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Cytochrome P-450 CYP3A4 Inducers, Dermatologicals, Cytochrome P-450 CYP3A Substrates, Pregnanes, Thyroxine-binding globulin inhibitors, Steroids, Fluorinated, Hyperglycemia-Associated Agents, Steroids	approved, investigational, experimental	0
DB10421	Anas platyrhynchos feather	Drug	Cell-mediated Immunity, Non-Standardized Feather Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11753	Rifamycin	Drug	Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Otologicals, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), MATE 1 Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inducers (strong), Cytochrome P-450 CYP2C19 Inducers, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A Inducers (strong), Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Inducers, Antirheumatic Agents, Ophthalmologicals, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Inducers (strength unknown), Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 CYP2C8 Inducers, OATP1B3 inhibitors, Amides, Cytochrome P-450 CYP2C19 Inhibitors, Lactams, MATE inhibitors, Antimycobacterials, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP2C19 Inducers (strong), Rifamycins, Anti-Infective Agents, Cytochrome P-450 CYP1A2 Inhibitors, Lactams, Macrocyclic, Anti-Bacterial Agents, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2B6 Inducers, P-glycoprotein substrates, Antiinfectives for Systemic Use, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Drugs for Treatment of Tuberculosis, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2C9 Inducers, Sensory Organs, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), P-glycoprotein inhibitors	approved, investigational	3
DB10422	Anser anser feather	Drug	Cell-mediated Immunity, Non-Standardized Feather Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11752	Bryostatin 1	Drug	Immunologic Factors, Anti-Bacterial Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Adjuvants, Immunologic, Macrolides, Cytochrome P-450 CYP3A4 Inhibitors, Antineoplastic Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Enzyme Activation, Lactones	investigational	9
DB11755	Tetrahydrocannabivarin	Drug	Serotonin 5-HT1 Receptor Agonists, Serotonin Agents, Central Nervous System Depressants, Serotonin Receptor Agonists, Agents that produce hypertension, Antidepressive Agents	investigational	7
DB08103	2,6-dibromo-4-phenoxyphenol	Drug	0	experimental	0
DB10423	Acremonium strictum	Drug	0	approved	0
DB10424	Alternaria alternata	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08104	N-(3,5-dibromo-4-hydroxyphenyl)benzamide	Drug	0	experimental	0
DB11754	Lirilumab	Drug	0	investigational	0
DB11757	Istradefylline	Drug	OATP1B1/SLCO1B1 Inhibitors, Purinergic P1 Receptor Antagonists, Cytochrome P-450 CYP2C18 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, OATP1B3 inhibitors, BCRP/ABCG2 Inhibitors, MATE inhibitors, MATE 1 Inhibitors, Purinergic Agents, Adenosine A2 Receptor Antagonists, Cytochrome P-450 CYP3A4 Substrates, OAT1/SLC22A6 inhibitors, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, MATE 2 Inhibitors, Purinergic Antagonists, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2C8 Substrates, P-glycoprotein inhibitors	approved, investigational	2
DB10425	Aspergillus fumigatus	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased Histamine Release	approved	0
DB08101	2,6-dibromo-4-[(E)-2-phenylethenyl]phenol	Drug	0	experimental	0
DB11756	Solanezumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB08102	3,5-dibromobiphenyl-4-ol	Drug	0	experimental	0
DB10426	Aspergillus niger var. niger	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10427	Aureobasidium pullulans var. pullutans	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB09430	Albumin iodinated I-131 serum	Drug	Radiopharmaceutical Activity	approved	0
DB11759	Pevonedistat	Drug	Cycloparaffins, Enzyme Inhibitors	investigational	0
DB11758	Cenicriviroc	Drug	Receptors, CCR2, antagonists & inhibitors, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Anti-Infective Agents, CCR5 Receptor Antagonists	investigational	0
DB10428	Botrytis cinerea	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08100	2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol	Drug	0	experimental	0
DB10429	Candida albicans	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08109	(1S,4R,7AR)-4-BUTOXY-1-[(1R)-1-FORMYLPROPYL]-2,4,5,6,7,7A-HEXAHYDRO-1H-ISOINDOLE-3-CARBOXYLIC ACID	Drug	0	experimental	1
DB08107	N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID	Drug	0	experimental	1
DB08108	N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID	Drug	0	experimental	1
DB08105	N-[(6-butoxynaphthalen-2-yl)sulfonyl]-L-glutamic acid	Drug	0	experimental	1
DB08106	N-[(6-butoxynaphthalen-2-yl)sulfonyl]-D-glutamic acid	Drug	0	experimental	1
DB11760	Talazoparib	Drug	Pyridazines, Enzyme Inhibitors, BCRP/ABCG2 Substrates, Narrow Therapeutic Index Drugs, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, P-glycoprotein substrates with narrow therapeutic index, Poly(ADP-ribose) Polymerase Inhibitors	approved, investigational	2
DB10430	Chaetomium globosum	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11762	Marizomib	Drug	0	investigational	0
DB10431	Cladosporium cladosporioides	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11761	Tenapanor	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates	approved, investigational	1
DB10432	Cladosporium sphaerospermum	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11764	Spebrutinib	Drug	Acids, Acyclic, Acrylates, Protein Kinase Inhibitors, Amides	investigational	0
DB11763	Momelotinib	Drug	Enzyme Inhibitors, Protein Kinase Inhibitors, Benzoates, Acids, Carbocyclic, Amides, Benzene Derivatives	investigational	0
DB10433	Cochliobolus sativus	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11766	AZD-1305	Drug	Acids, Acyclic, Aza Compounds	investigational	0
DB10434	Epicoccum nigrum	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08114	5-benzyl-1,3-thiazol-2-amine	Drug	0	experimental	2
DB10435	Fusarium oxysporum vasinfectum	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB09446	Safflower oil	Drug	Oils, Lipids, Dietary Fats, Unsaturated, Complex Mixtures, Physiological Phenomena, Plant Preparations, Fats, Unsaturated, Dietary Fats, Food and Beverages, Biological Products, Plant Oils, Fats, Diet, Food, and Nutrition, Food	approved, investigational	0
DB11765	PF-04991532	Drug	Pyridines, Enzyme Inhibitors, Glucokinase, antagonists & inhibitors	investigational	0
DB08115	2-aminoethyl naphthalen-1-ylacetate	Drug	0	experimental	1
DB11768	Zytron	Drug	Sulfur Compounds, Amines, Organophosphorus Compounds	approved, investigational	0
DB10436	Helminthosporium solani	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB09443	Krypton Kr 81m	Drug	Diagnostic Radiopharmaceuticals	approved	0
DB08112	N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID	Drug	0	experimental	1
DB11767	Sarilumab	Drug	Immunoglobulins, Biologics for Rheumatoid Arthritis Treatment, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Antibodies, Antirheumatic Agents, Interleukin-6 Receptor Antagonist, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Disease-modifying Antirheumatic Agents, Interleukin Inhibitors, Immunoproteins, Proteins, Serum Globulins, Cytochrome P-450 CYP3A4 Inducers (weak), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A Inhibitors, Globulins, Blood Proteins, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved, investigational	6
DB10437	Mucor plumbeus	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08113	3-pyridin-4-yl-1H-indazole	Drug	0	experimental	2
DB10438	Neurospora intermedia	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08110	(1R,4S,7AS)-1-(1-FORMYLPROP-1-EN-1-YL)-4-METHOXY-2,4,5,6,7,7A-HEXAHYDRO-1H-ISOINDOLE-3-CARBOXYLIC ACID	Drug	0	experimental	1
DB11769	Funapide	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB10439	Penicillium chrysogenum var. chrysogenum	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08111	4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol	Drug	0	experimental	1
DB09449	Sodium phosphate, monobasic	Drug	Potassium Salt, Ions, Phosphorus Compounds, Phosphate salts, Phosphorus Acids, Anions, Acids, Noncarboxylic, Acids, Phosphoric Acids, Osmotic Laxatives, Electrolytes, Laxatives, Urinary Acidifying Agents, Agents that reduce seizure threshold	approved	0
DB08118	2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide	Drug	0	experimental	1
DB08119	1,1,1-TRIFLUORO-3-((N-ACETYL)-L-LEUCYLAMIDO)-4-PHENYL-BUTAN-2-ONE(N-ACETYL-L-LEUCYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)	Drug	0	experimental	1
DB08116	(3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine	Drug	0	experimental	1
DB09447	Technetium Tc-99m albumin colloid	Drug	Radioactive Diagnostic Agent, Radiopharmaceutical Activity	approved, experimental	0
DB11771	Tremelimumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB11770	Talinolol	Drug	QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Propanols, P-glycoprotein substrates, Agents causing hyperkalemia, Adrenergic beta-Antagonists, Cardiovascular Agents, Amino Alcohols, Alcohols, Neurotransmitter Agents, Adrenergic Antagonists, Beta Blocking Agents, Selective, Potential QTc-Prolonging Agents, Antihypertensive Agents, Cytochrome P-450 CYP2D6 Substrates, Adrenergic Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	investigational	0
DB10440	Phoma exigua var. exigua	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11773	BMS-903452	Drug	Pyridines, Sulfur Compounds	investigational	0
DB10441	Rhizopus arrhizus var. arrhizus	Drug	Allergens, Cell-mediated Immunity, Fungal Proteins, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10442	Rhodotorula rubra	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11772	Pilaralisib	Drug	Phosphatidylinositol 3-Kinase, antagonists & inhibitors, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amides, Sulfones	investigational	1
DB10443	Ustilago maydis	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11775	PF-03758309	Drug	p21-Activated Kinases, antagonists & inhibitors	investigational	0
DB11774	Pazufloxacin	Drug	Fluoroquinolones, Quinolines, QTc Prolonging Agents, Enzyme Inhibitors, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Antiinfectives for Systemic Use, Anti-Infective Agents, Quinolones, Cytochrome P-450 CYP1A2 Inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Topoisomerase II Inhibitors, Potential QTc-Prolonging Agents, Antibacterials for Systemic Use, Antituberculosis Agents, Cytochrome P-450 CYP1A2 Inhibitors (moderate)	investigational	0
DB10444	Ustilago tritici	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10445	Stemphylium solani	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11777	Cenderitide	Drug	Toxins, Biological, Biological Factors, Peptide Hormones, Complex Mixtures, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Venoms, Amino Acids, Peptides, and Proteins, Hormones, Fluids and Secretions, Bodily Secretions	investigational	0
DB08125	4-{[(2-Oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]amino}-N-(1,3-thiazol-2-yl)benzenesulfonamide	Drug	0	experimental	1
DB09456	Insulin beef	Drug	Cytochrome P-450 Enzyme Inducers, Insulin, Short-Acting, Alimentary Tract and Metabolism, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Cytochrome P-450 CYP1A2 Inducers, Drugs Used in Diabetes, Insulins and Analogues for Injection, Fast-Acting, Blood Glucose Lowering Agents, Insulin	approved	0
DB11776	Brodalumab	Drug	Immunoglobulins, Immunosuppressive Agents, Antineoplastic and Immunomodulating Agents, Dermatologicals, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Misc. Skin and Mucous Membrane Agents, Interleukin Inhibitors, Immunoproteins, Proteins, Serum Globulins, Globulins, Blood Proteins, Interleukin 17 Receptor A Antagonists, Interleukin-17 Receptor A Antagonist	approved, investigational	0
DB08126	3-{[4-([amino(imino)methyl]aminosulfonyl)anilino]methylene}-2-oxo-2,3-dihydro-1H-indole	Drug	0	experimental	1
DB10446	Trichophyton mentagrophytes	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11779	Danoprevir	Drug	Cytochrome P-450 CYP3A4 Inhibitors (strong), Sulfur Compounds, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Amides, Sulfones	investigational	1
DB10447	Saccharomyces cerevisiae	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08123	N-methyl-{4-[2-(7-oxo-6,7-dihydro-8H-[1,3]thiazolo[5,4-e]indol-8-ylidene)hydrazino]phenyl}methanesulfonamide	Drug	0	experimental	1
DB08124	3-{[(2,2-dioxido-1,3-dihydro-2-benzothien-5-yl)amino]methylene}-5-(1,3-oxazol-5-yl)-1,3-dihydro-2H-indol-2-one	Drug	0	experimental	1
DB11778	Danusertib	Drug	Protein Kinase Inhibitors, Benzoates, Acids, Carbocyclic, Amides, Benzene Derivatives	investigational	0
DB10448	Aspergillus oryzae	Drug	0	approved	0
DB10449	Aspergillus repens	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08121	(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid	Drug	0	experimental	1
DB08122	N-Methyl-4-{[(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]amino}benzenesulfonamide	Drug	0	experimental	1
DB08120	6,8-DIMERCAPTO-OCTANOIC ACID AMIDE	Drug	0	experimental	1
DB08129	(1R)-2-amino-1-[3-(trifluoromethyl)phenyl]ethanol	Drug	0	experimental	1
DB08127	1,3,3-trimethyl-2-[(1E,3E)-3-methylpenta-1,3-dien-1-yl]cyclohexene	Drug	0	experimental	0
DB09459	L-tartaric acid	Drug	Acids, Acyclic, Carbohydrates, Urinary Alkalinisers, Hydroxy Acids, Dicarboxylic Acids, Sugar Acids, Chelating Agents	experimental	0
DB08128	(1S,4R,9S)-5-(trifluoromethyl)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-9-amine	Drug	0	experimental	1
DB08172	(2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide	Drug	0	experimental	1
DB08173	5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE	Drug	0	experimental	1
DB10493	Artemisia frigida pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased Histamine Release	approved	0
DB10494	Distichlis spicata pollen	Drug	Cell-mediated Immunity, Grass Pollen Allergen Extracts, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08170	(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE	Drug	0	experimental	1
DB10495	Liquidambar styraciflua pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08171	11-MERCAPTOUNDECANOIC ACID	Drug	Sulfur Compounds, Lipids	experimental	1
DB10496	Juglans regia pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10497	Amaranthus tuberculatus pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10498	Triticum aestivum pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10499	Felis catus hair	Drug	Cell-mediated Immunity, Allergenic Extracts, Standardized Animal Hair Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08178	4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine	Drug	0	experimental	2
DB08179	methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate	Drug	0	experimental	1
DB08176	(1Z)-4-(4-FLUOROPHENYL)-2-METHYLIDENEBUTAN-1-IMINE	Drug	0	experimental	1
DB08177	(E)-3-(5((5-(4-CHLOROPHENYL)FURAN-2-YL)METHYLENE)-4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)PROPANOIC ACID	Drug	0	experimental	1
DB08174	5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE	Drug	0	experimental	1
DB08175	(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID	Drug	0	experimental	3
DB10490	Ambrosia tenuifolia pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased Histamine Release	approved	0
DB10491	Ambrosia bidentata pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased Histamine Release	approved	0
DB08184	2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE	Drug	0	experimental	1
DB08181	2-((3'-METHYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID	Drug	0	experimental	1
DB08182	4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine	Drug	0	experimental	2
DB08180	2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE	Drug	0	experimental	2
DB08187	N-Methylphenylalanyl-N-[(trans-4-aminocyclohexyl)methyl]-L-prolinamide	Drug	0	experimental	1
DB08188	Emivirine	Drug	Enzyme Inhibitors, Nucleic Acid Synthesis Inhibitors, Pyrimidines, Pyrimidinones, Anti-Retroviral Agents, Antiviral Agents, Reverse Transcriptase Inhibitors, Anti-Infective Agents	investigational	1
DB08185	2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	Drug	0	experimental	27
DB08186	(3E)-4-(1-METHYL-1H-INDOL-3-YL)BUT-3-EN-2-ONE	Drug	0	experimental	1
DB08194	4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine	Drug	0	experimental	1
DB08195	(1R)-2-[(CYANOMETHYL)AMINO]-1-({[2-(DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)-2-OXOETHYL MORPHOLINE-4-CARBOXYLATE	Drug	0	experimental	1
DB08192	2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE	Drug	0	experimental	1
DB08193	2-(3-NITROPHENYL)ACETIC ACID	Drug	0	experimental	1
DB08190	N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide	Drug	0	experimental	1
DB08191	4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid	Drug	0	experimental	1
DB08198	[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE	Drug	0	experimental	1
DB08199	N-[(BENZYLOXY)CARBONYL]-L-CYSTEINYLGLYCINE	Drug	0	experimental	1
DB08196	2-((3',5'-DIMETHOXY-4'-HYDROXYPHENYL)AZO)BENZOIC ACID	Drug	0	experimental	1
DB08197	(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime	Drug	0	experimental	1
DB11821	Danegaptide	Drug	Acids, Acyclic, Amino Acids, Cyclic, Benzoates, Imines, Oligopeptides, Peptides, Acids, Carbocyclic, Amides, Amino Acids, Peptides, and Proteins, Imino Acids, Amino Acids, Benzene Derivatives	investigational	0
DB09501	Ferric ammonium citrate	Drug	Magnetic Resonance Imaging Contrast Media, Organometallic Compounds, Paramagnetic Contrast Media, Amines, Ammonium Compounds, Contrast Media, Iron Compounds, Onium Compounds, Nitrogen Compounds	approved, experimental	0
DB11820	Nifurtimox	Drug	Sulfur Compounds, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Agents Against Leishmaniasis and Trypanosomiasis, Nitro Compounds, Trypanocidal Agents, Nitrofuran Derivatives, Nitrofurans, Furans, Thiazines, Anti-Infective Agents, Antiparasitic Agents	investigational	0
DB11823	Esketamine	Drug	Cycloparaffins, Cytochrome P-450 Substrates, Nervous System, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Agents producing tachycardia, Antidepressive Agents, Anesthetics, Cytochrome P-450 CYP3A4 Substrates, Psychotropic Drugs, Cyclohexanes, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A4 Inducers (weak), Anesthetics, General, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Cytochrome P-450 CYP2B6 Inducers (weak), Cytochrome P-450 CYP2B6 Inducers, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates	approved, investigational	5
DB11822	TMC-647055	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amides, Sulfones	investigational	0
DB11825	Mirogabalin	Drug	0	investigational	0
DB11824	Tofogliflozin	Drug	Carbohydrates, Glycosides, Sodium-Glucose Transporter 2 Inhibitors, Blood Glucose Lowering Agents, Benzene Derivatives	investigational	0
DB11827	Ertugliflozin	Drug	P-glycoprotein substrates, Sodium-Glucose Transporter 2 Inhibitors, UGT1A1 Inhibitors, Blood Glucose Lowering Agents, Sodium-glucose co-transporter 2 (SGLT2) inhibitors, BCRP/ABCG2 Substrates, UGT2B7 substrates, Alimentary Tract and Metabolism, Diuretics, UGT1A9 Substrates, Drugs Used in Diabetes, Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors, UGT1A4 Inhibitors	approved, investigational	1
DB11826	Lampalizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Peptide Fragments, Globulins, Peptides, Blood Proteins, Amino Acids, Peptides, and Proteins, Immunoglobulin Fragments, Immunoproteins	investigational	0
DB11818	Retosiban	Drug	0	investigational	0
DB09508	Ferumoxides	Drug	Carbohydrates, Iron Compounds, Minerals, Nanostructures, Biopolymers, Magnets, Macromolecular Substances, Nanoparticles, Organometallic Compounds, Ferric Compounds, Ferrous Compounds, Ferrosoferric Oxide, Polysaccharides, Contrast Media, Diagnostic Uses of Chemicals, Glucans, Polymers, Compounds used in a research, industrial, or household setting, Suspensions, Metal Nanoparticles	approved	0
DB11817	Baricitinib	Drug	Cytochrome P-450 Substrates, Immunosuppressive Agents, Janus Kinase Inhibitor, OATP1B3 inhibitors, Amides, Azetines, MATE inhibitors, Cytochrome P-450 CYP3A4 Substrates, Selective Immunosuppressants, Drugs that are Mainly Renally Excreted, OAT3/SLC22A8 Substrates, Sulfur Compounds, MATE substrates, Sulfones, Janus Kinase Inhibitors, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, BCRP/ABCG2 Inhibitors, OAT1/SLC22A6 inhibitors, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Substrates, MATE 2 Substrates with a Narrow Therapeutic Index, OCT2 Inhibitors, MATE 2 Substrates, MATE 2 Inhibitors, OAT3/SLC22A8 Inhibitors	approved, investigational	4
DB11819	ASP-4058	Drug	Heterocyclic Compounds, Fused-Ring, Oxazoles	investigational	0
DB09507	Ferumoxsil	Drug	Magnetic Resonance Imaging Contrast Media, Investigative Techniques, Iron Compounds, Colloids, Superparamagnetic Contrast Media, Minerals, Nanostructures, Magnets, Silicon Compounds, Macromolecular Substances, Nanoparticles, Organometallic Compounds, Ferric Compounds, Ferrous Compounds, Ferrosoferric Oxide, Complex Mixtures, Contrast Media, Pharmaceutical Preparations, Polymers, Compounds used in a research, industrial, or household setting, Organosilicon Compounds, Metal Nanoparticles	approved, experimental	0
DB09502	Fludeoxyglucose (18F)	Drug	Carbohydrates, Deoxy Sugars, Laboratory Chemicals, Radiopharmaceutical Activity, Deoxyglucose, Drugs that are Mainly Renally Excreted, Diagnostic Uses of Chemicals, Tumour Detection, Diagnostic Radiopharmaceuticals, Radioactive Diagnostic Agent, Indicators and Reagents, Radiopharmaceuticals, Compounds used in a research, industrial, or household setting	approved, investigational	0
DB11830	Mocetinostat	Drug	QTc Prolonging Agents, Enzyme Inhibitors, Benzoates, Acids, Carbocyclic, Antineoplastic Agents, Amides, Histone Deacetylase Inhibitors, Moderate Risk QTc-Prolonging Agents, Benzene Derivatives	investigational	3
DB11832	Crenolanib	Drug	Heterocyclic Compounds, Fused-Ring, Receptor, Platelet-Derived Growth Factor alpha, antagonists & inhibitors, Receptor, Platelet-Derived Growth Factor beta, antagonists & inhibitors, Tyrosine Kinase Inhibitors, Antineoplastic Agents	investigational	0
DB09511	Talc	Drug	Ions, Oxides, Minerals, Silicates, Antiperspirants, Household Products, Silicon Compounds, Anions, Acids, Noncarboxylic, Metal cations, Acids, Metal divalent cations, Cosmetics, Electrolytes, Compounds used in a research, industrial, or household setting, Oxygen Compounds, Magnesium Compounds	approved	0
DB10500	Almond	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB10501	Apple	Drug	Non-Standardized Food Allergenic Extract, Increased Histamine Release	approved	0
DB11831	Dinitrochlorobenzene	Drug	Hydrocarbons, Chlorinated, Antigens, Biological Factors, Noxae, Laboratory Chemicals, Hydrocarbons, Halogenated, Haptens, Epitopes, Chlorobenzenes, Irritants, Nitrobenzenes, Nitro Compounds, Dinitrobenzenes, Indicators and Reagents, Toxic Actions, Compounds used in a research, industrial, or household setting, Benzene Derivatives	investigational	2
DB09512	Simethicone	Drug	Surface-Active Agents, Siloxanes, Dermatologicals, Antifoaming Agents, Polymers, Compounds used in a research, industrial, or household setting, Organosilicon Compounds, Silicones, Emollients, Silicon Compounds, Dimethylpolysiloxanes, Macromolecular Substances	approved	0
DB10502	Apricot	Drug	Non-Standardized Food Allergenic Extract, Increased Histamine Release	approved	0
DB11834	Guselkumab	Drug	Immunoglobulins, Immunosuppressive Agents, Interleukin-23 Antagonist, Antineoplastic and Immunomodulating Agents, Antibodies, Amino Acids, Peptides, and Proteins, Misc. Skin and Mucous Membrane Agents, Interleukin Inhibitors, Immunoproteins, Proteins, Serum Globulins, Globulins, Blood Proteins	approved, investigational	1
DB10503	Asparagus	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11833	Basimglurant	Drug	0	investigational	0
DB09510	Urea C-13	Drug	Helicobacter pylori Diagnostic	approved	1
DB11836	Sapanisertib	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB10504	Avocado	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11835	Indium In-111 pentetreotide	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pancreatic Hormones, Amino Acids, Peptides, and Proteins, Neuropeptides, Radiopharmaceutical Activity, Nerve Tissue Proteins, Hormones, Indium (111In) Compounds, Proteins, Peptide Hormones, Tumour Detection, Hypothalamic Hormones, Pituitary Hormone Release Inhibiting Hormones, Diagnostic Radiopharmaceuticals, Radioactive Diagnostic Agent, Indium Radioisotopes	approved, investigational	0
DB10505	Banana	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11838	Revamilast	Drug	0	investigational	0
DB10506	Barley	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11837	Osilodrostat	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, OCT1 inhibitors, Cytochrome P-450 CYP2C19 Inhibitors, MATE inhibitors, MATE 1 Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (weak), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), UGT2B7 substrates, Cytochrome P-450 CYP11B2, antagonists & inhibitors, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors, OAT1/SLC22A6 inhibitors, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, OCT2 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, UGT1A4 substrates, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2C19 Inhibitors (weak), Cytochrome P-450 CYP2D6 Substrates, OAT3/SLC22A8 Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (moderate), Cytochrome P-450 CYP2D6 Inhibitors (weak), Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved, investigational	2
DB11829	Ruboxistaurin	Drug	Acids, Acyclic, Heterocyclic Compounds, Fused-Ring, Maleates, Enzyme Inhibitors, Dicarboxylic Acids, Imides, Protein Kinase C, antagonists & inhibitors	investigational	0
DB11828	Neratinib	Drug	Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Cytochrome P-450 CYP3A4 Substrates, P-glycoprotein inhibitors, Kinase Inhibitor	approved, investigational	1
DB09517	Sodium ferric gluconate complex	Drug	Parenteral Iron Replacement, Phosphate Binder, Iron Preparations	approved	3
DB09516	Mequinol	Drug	Skin Lightening Agent, Lentigo, Protective Agents, Dermatologicals, Melanin Synthesis Inhibitors, Methyl Ethers, Phenyl Ethers, Antioxidants, Depigmenting Activity, Phenols, Ethers, Compounds used in a research, industrial, or household setting, Benzene Derivatives	approved	0
DB09513	Urea C-14	Drug	0	approved	1
DB11841	Entinostat	Drug	QTc Prolonging Agents, Enzyme Inhibitors, Benzoates, Acids, Carbocyclic, Antineoplastic Agents, Amides, Histone Deacetylase Inhibitors, Moderate Risk QTc-Prolonging Agents, Benzene Derivatives	investigational	0
DB10510	Brazil nut	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11840	Dalotuzumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB10511	Broccoli	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11843	PF-04958242	Drug	Sulfur Compounds, Amides, Sulfones	investigational	0
DB10512	Buckwheat	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11842	Angiotensin II	Drug	Biological Factors, Autacoids, Inflammation Mediators, Angiotensin II, antagonists & inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Oligopeptides, Peptides, Vasoconstriction, Angiotensins, Amino Acids, Peptides, and Proteins, Neuropeptides, Cardiovascular Agents, Nerve Tissue Proteins, Hormones, Proteins, Peptide Hormones, Vasoconstrictor Agents, Cardiac Stimulants Excl. Cardiac Glycosides, Cardiac Therapy	approved, investigational	1
DB11845	Lucitanib	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB10513	Cabbage	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11844	Pritelivir	Drug	Enzyme Inhibitors, Sulfur Compounds, Antiviral Agents, Anti-Infective Agents	investigational	0
DB10514	Cantaloupe	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11847	Cadazolid	Drug	Oxazoles	investigational	0
DB10515	Carrot	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11846	Creatinine	Drug	Imidazoles	investigational	0
DB10516	Casein	Drug	Cell-mediated Immunity, Amino Acids, Peptides, and Proteins, Proteins, Non-Standardized Food Allergenic Extract, Milk components, Physiological Phenomena, Milk Proteins, Caseins, Dietary Proteins, Phosphoproteins, Food and Beverages, Sequestering Agents, Beverages, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Fluids and Secretions, Bodily Secretions, Dairy Products, Food, Increased Histamine Release	approved	0
DB11849	Emibetuzumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB10517	Celery	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11848	Mannose 6-phosphate	Drug	0	investigational	0
DB10518	Cherry	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB10508	String bean	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11839	PZ-128	Drug	0	investigational	0
DB10509	Beef	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB09526	Hydroquinone	Drug	Radiation-Protective Agents, Noxae, Protective Agents, Dermatologicals, Melanin Synthesis Inhibitors, Antioxidants, Mutagens, Depigmenting Activity, Depigmenting Agents, Melanin Synthesis Inhibitor, Phenols, Toxic Actions, Compounds used in a research, industrial, or household setting, Benzene Derivatives	approved, investigational	1
DB09527	Secretin porcine	Drug	Proteins, Peptide Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Gastrointestinal Hormones, Amino Acids, Peptides, and Proteins, Neuropeptides, Secretin, Nerve Tissue Proteins, Hormones, Gastrointestinal Agents	approved	0
DB11850	Ublituximab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Leukemia, Lymphocytic, Chronic, B-Cell, drug therapy, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB10520	Cinnamon	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11852	Tegobuvir	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB11851	Bafetinib	Drug	Enzyme Inhibitors, Protein Kinase Inhibitors	investigational	0
DB08202	4-({[(4-METHYLPIPERAZIN-1-YL)AMINO]CARBONOTHIOYL}AMINO)BENZENESULFONAMIDE	Drug	0	experimental	1
DB11854	Astodrimer	Drug	Investigative Techniques, Peptides, Amino Acids, Essential, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, Nanostructures, Amino Acids, Drug Carriers, Drug Delivery Systems, Macromolecular Substances, Nanoparticles, Lysine, Amino Acids, Basic, Pharmaceutical Preparations, Polymers, Compounds used in a research, industrial, or household setting	investigational	1
DB09534	Ecamsule	Drug	Radiation-Protective Agents, Sulfur Acids, Protective Agents, Dermatologicals, Household Products, Sulfur Compounds, Acids, Noncarboxylic, Acids, Cosmetics, Monoterpenes, Sunscreen Agents, Terpenes, Compounds used in a research, industrial, or household setting, Norbornanes	approved	0
DB11853	Relugolix	Drug	Pyrimidines, Receptors, LHRH, antagonists & inhibitors, Benzene Derivatives	investigational	0
DB08203	7-[2-METHOXY-1-(METHOXYMETHYL)ETHYL]-7H-PYRROLO[3,2-F] QUINAZOLINE-1,3-DIAMINE	Drug	0	experimental	1
DB10523	Coconut	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB08200	(1R)-menthyl hexyl phosphonate group	Drug	0	experimental	1
DB09531	Perflexane	Drug	Hydrocarbons, Halogenated, Ultrasound Contrast Activity, Diagnostic Agents, Ultrasound Contrast Media, Hydrocarbons, Fluorinated	approved	0
DB11856	Ligelizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB11855	Revefenacin	Drug	Anticholinergic Agents, BCRP/ABCG2 Substrates, Cytochrome P-450 Substrates, P-glycoprotein substrates, OATP1B1/SLCO1B1 Substrates, Amides, Muscarinic Antagonists, OATP1B3 substrates, Bronchodilator Agents, Cytochrome P-450 CYP2D6 Substrates, Benzene Derivatives	approved, investigational	1
DB09532	Secretin human	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Gastrointestinal Hormones, Amino Acids, Peptides, and Proteins, Neuropeptides, Secretin, Nerve Tissue Proteins, Hormones, Proteins, Peptide Hormones, Diagnostic Agents, Tests for Pancreatic Function, Gastrointestinal Agents	approved	1
DB08201	(1S)-menthyl hexyl phosphonate group	Drug	0	experimental	1
DB10525	Coffee bean	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB10526	Red king crab	Drug	0	approved	0
DB11858	Leukotriene D4	Drug	Fatty Acids, Essential, SRS-A, Biological Factors, Arachidonic Acids, Autacoids, Fatty Acids, Unsaturated, Inflammation Mediators, Fatty Acids, Leukotrienes, Eicosanoids, Lipids	investigational	2
DB11857	Seribantumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB10527	Cucumber	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB10528	Egg white	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB10529	Egg	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11859	Brexanolone	Drug	Dietary Carbohydrates, Pregnenediones, GABA Modulators, Cyclodextrins, Hormones, Biopolymers, Fused-Ring Compounds, Polysaccharides, Progesterone Congeners, Physiological Phenomena, Food and Beverages, Dextrins, Polymers, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food, Gonadal Hormones, Carbohydrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Starch, Anesthetics, Gonadal Steroid Hormones, Macromolecular Substances, Anticonvulsants, Central Nervous System Depressants, Glucans, Pregnanes, Pharmaceutical Preparations, Central Nervous System Agents, Corpus Luteum Hormones, Pregnenes, Steroids	approved, investigational	1
DB10519	Chicken	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB09539	Omega-3-acid ethyl esters	Drug	Biological Factors, Autacoids, Inflammation Mediators, Fatty Acids, Oils, Eicosanoids, Lipids, Dietary Fats, Unsaturated, Fatty Acids, Unsaturated, Physiological Phenomena, Dietary Fats, Food and Beverages, Fish Oils, Pharmaceutical Preparations, Fats, Fatty Acids, Omega-3, Diet, Food, and Nutrition, Food, Nootropic Agents	approved, investigational	1
DB08208	2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE	Drug	0	experimental	1
DB08209	Methyl red	Drug	Coloring Agents, Compounds used in a research, industrial, or household setting	experimental	1
DB09537	Iodine povacrylex	Drug	0	approved	0
DB08206	4-(1,3-BENZOXAZOL-2-YL)-2,6-DIBROMOPHENOL	Drug	0	experimental	0
DB08207	2-(3,5-DIMETHYLPHENYL)-1,3-BENZOXAZOLE	Drug	0	experimental	0
DB08204	3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE	Drug	0	experimental	1
DB09535	Octocrylene	Drug	Acids, Acyclic, Sunscreen Agents	approved, investigational	2
DB08205	4-(1,3-BENZOXAZOL-2-YL)-2,6-DIMETHYLPHENOL	Drug	0	experimental	0
DB09536	Titanium dioxide	Drug	Radiation-Protective Agents, Water Pollutants, Chemical, Protective Agents, Astringents and Deodorants, Coloring Agents, Dermatologicals, Metals, Elements, Transition Elements, Radiation-Sensitizing Agents, Household Products, Metals, Light, Photosensitizing Agents, Biocompatible Materials, Cosmetics, Sunscreen Agents, Compounds used in a research, industrial, or household setting	approved	1
DB11801	Rapastinel	Drug	Peptides, Amino Acids, Peptides, and Proteins	investigational	0
DB11800	Tivozanib	Drug	Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Receptors, Vascular Endothelial Growth Factor, antagonists & inhibitors, Benzene Derivatives	investigational	0
DB11803	Sirukumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Immunosuppressive Agents, Globulins, Blood Proteins, Antineoplastic and Immunomodulating Agents, Antibodies, Amino Acids, Peptides, and Proteins, Interleukin Inhibitors, Immunoproteins	investigational	0
DB11805	Saracatinib	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Antineoplastic Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Dioxoles	investigational	0
DB11804	AZD-5672	Drug	Acids, Acyclic, Fatty Acids, Amides, Lipids, Anti-HIV Agents, Acetates, Anti-Infective Agents, Sulfur Compounds, Fatty Acids, Volatile, Acetamides, Benzene Derivatives, Sulfones, CCR5 Receptor Antagonists	investigational	0
DB11810	Etarfolatide	Drug	0	investigational	0
DB11812	Talaporfin	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Photosensitizing Agents, Dermatologicals, Antineoplastic Agents, Radiation-Sensitizing Agents, Pigments, Biological	investigational	0
DB11811	Arhalofenate	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Acids, Carbocyclic, Amides, Lipids, Acetates	investigational	1
DB11814	PF-03882845	Drug	Heterocyclic Compounds, Fused-Ring, Pyrazoles	investigational	0
DB11813	Mipsagargin	Drug	0	investigational	0
DB11816	Omecamtiv Mecarbil	Drug	0	investigational	0
DB11815	Tilarginine	Drug	Enzyme Inhibitors, Nitric Oxide Synthase, antagonists & inhibitors, Arginine, Amino Acids, Basic, Amino Acids, Essential, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, Amino Acids	approved, investigational	0
DB11807	Dexmecamylamine	Drug	0	investigational	0
DB11806	VTP-194204	Drug	Fatty Acids, Ligands, Lipids, Naphthalenes	investigational	0
DB11809	Artefenomel	Drug	Anions, Cycloparaffins, Antiprotozoals, Reactive Oxygen Species, Free Radicals, Antimalarials, Electrolytes, Ions, Oxides, Anti-Infective Agents, Antiparasitic Agents, Oxygen Compounds	investigational	0
DB11808	Faldaprevir	Drug	Antivirals for Systemic Use, Direct Acting Antivirals, Antivirals for treatment of HCV infections, Sulfur Compounds, Peptides, Protease Inhibitors, Amino Acids, Peptides, and Proteins, Antiviral Agents, Antiinfectives for Systemic Use	investigational	0
DB10570	Squash	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB08250	(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE	Drug	0	experimental	1
DB10571	Strawberry	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB10572	Corn	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB10573	Tomato	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB10574	Tuna	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB10575	Turkey	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved, investigational	0
DB10576	Vanilla	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB08257	4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID	Drug	0	experimental	1
DB10577	English walnut	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB08258	6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID	Drug	0	experimental	1
DB10578	Watermelon	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB08255	(3AR,5R,6S,7R,7AR)-5-(HYDROXYMETHYL)-2-PROPYL-5,6,7,7A-TETRAHYDRO-3AH-PYRANO[3,2-D][1,3]THIAZOLE-6,7-DIOL	Drug	0	experimental	1
DB10579	Wheat	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB08256	N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE	Drug	0	experimental	1
DB08253	NAM NAPTHYLAMINOALANINE	Drug	0	experimental	1
DB08254	2-Naphthalenesulfonic acid	Drug	Arylsulfonates, Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfur Acids, Sulfonic Acids, Arylsulfonic Acids, Naphthalenes	experimental	2
DB08251	4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID	Drug	0	experimental	1
DB08252	2-((4'-HYDROXYNAPHTHYL)-AZO)BENZOIC ACID	Drug	0	experimental	1
DB08259	7-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEPTANOIC ACID	Drug	0	experimental	1
DB10580	Tea leaf	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved, investigational	0
DB08260	(1S,2R,3S,4R,5R)-2,3,4-trihydroxy-N-octyl-6-oxa-8-azabicyclo[3.2.1]octane-8-carbothioamide	Drug	0	experimental	1
DB08261	2-hydroxy-7-methoxy-5-methyl-naphthalene-1-carboxylic acid meso-2,5-dihydroxy-cyclopent-3-enyl ester	Drug	0	experimental	1
DB10581	Khuskia oryzae	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10582	Artemisia annua pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased Histamine Release	approved	0
DB10583	Clostridium tetani toxoid antigen (formaldehyde inactivated)	Drug	Toxoids, Complex Mixtures, Actively Acquired Immunity, Inactivated Clostridium Tetani Vaccine, Biological Products, Vaccines, Bacterial Vaccines, Antiinfectives for Systemic Use, Tetanus Vaccines	approved	0
DB10584	Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)	Drug	Toxoids, Complex Mixtures, Actively Acquired Immunity, Biological Products, Diphtheria Vaccines, Vaccines, Bacterial Vaccines, Diphtheria, Antiinfectives for Systemic Use, Inactivated Corynebacterium Diphtheriae Vaccine	approved, investigational	0
DB08268	6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE	Drug	0	experimental	1
DB08266	Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate	Drug	0	experimental	5
DB08267	6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one	Drug	0	experimental	1
DB08264	(1R, 2S)-cis 1,2 dihydroxy-1,2-dihydronaphthalene	Drug	0	experimental	2
DB08265	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	Drug	0	experimental	1
DB08262	2,6-dicarboxynaphthalene	Drug	0	experimental	2
DB08263	N-(carboxycarbonyl)-D-phenylalanine	Drug	0	experimental	1
DB08271	N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID	Drug	0	experimental	4
DB08272	(4S)-4-(2-NAPHTHYLMETHYL)-D-GLUTAMIC ACID	Drug	0	experimental	1
DB08270	N-(2-AMINOETHYL)-N~2~-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE	Drug	0	experimental	1
DB10596	Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (UV, formaldehyde inactivated)	Drug	0	approved	0
DB10597	Influenza A virus A/Switzerland/9715293/2013 NIB-88 (H3N2) antigen (UV, formaldehyde inactivated)	Drug	0	approved	0
DB10598	Influenza B virus B/Brisbane/60/2008 antigen (UV, formaldehyde inactivated)	Drug	0	approved	0
DB10599	Influenza B virus B/Phuket/3073/2013 antigen (UV, formaldehyde inactivated)	Drug	0	approved	0
DB08279	3-{ISOPROPYL[(TRANS-4-METHYLCYCLOHEXYL)CARBONYL]AMINO}-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID	Drug	0	experimental	1
DB08277	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	Drug	0	experimental	1
DB08278	1-(2-cyclopropylethyl)-3-(1,1-dioxo-2H-1,2,4-benzothiadiazin-3-yl)-6-fluoro-4-hydroxy-2(1H)-quinolinone	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Thiazines, RNA Replicase, antagonists & inhibitors	experimental	1
DB08275	N-DODECANOYL-L-TYROSINE	Drug	0	experimental	1
DB08276	trifluoro-[hydroxy-[hydroxy-[2-(N-methyl-2-nitro-anilino)ethoxy]phosphoryl]oxy-phosphoryl]oxy-beryllium(1-)	Drug	0	experimental	1
DB08273	4-HYDROXY-5-IODO-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION	Drug	0	experimental	2
DB08274	6,7,8,9-TETRAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOHEPTA[B]PYRAN-2-ONE	Drug	0	experimental	1
DB08282	O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-chlorophenyl)thiocarbamate	Drug	0	experimental	1
DB08283	(2R,3R,4R,5S)-2-(HYDROXYMETHYL)-1-NONYLPIPERIDINE-3,4,5-TRIOL	Drug	0	experimental	1
DB08280	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	Drug	0	experimental	1
DB08281	O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-bromophenyl)thiocarbamate	Drug	0	experimental	1
DB08288	CYCLOHEXYL-NORSTATINE	Drug	0	experimental	0
DB08289	N-(PARA-GLUTARAMIDOPHENYL-ETHYL)-PIPERIDINIUM-N-OXIDE	Drug	0	experimental	1
DB08286	1-Naphthoxyacetic acid	Drug	Acids, Acyclic, Fatty Acids, Hydroxy Acids, Fatty Acids, Volatile, Lipids, Acetates	experimental	2
DB08287	(1R,2R)-N-(2-Aminoethyl)-2-{[(4-methoxyphenyl)sulfonyl]methyl}cyclohexanecarboxamide	Drug	0	experimental	1
DB08284	O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-iodophenyl)thiocarbamate	Drug	0	experimental	1
DB08285	(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol	Drug	0	experimental	2
DB11861	Litronesib	Drug	Sulfur Compounds, Thiazoles, Amides, Sulfones	investigational	0
DB11860	Aramchol	Drug	Bile Acids and Salts, Cholanes, Fused-Ring Compounds, Steroids	investigational	0
DB10530	Egg yolk	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB10531	Flounder	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11863	Alvelestat	Drug	Pyridines, Sulfur Compounds, Leukocyte Elastase, antagonists & inhibitors	investigational	0
DB10532	Garlic	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Herbs and Natural Products, Increased Histamine Release	approved, nutraceutical	0
DB11862	Landogrozumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB11865	Brivanib alaninate	Drug	Amino Acids, Peptides, and Proteins, Amino Acids	investigational	0
DB08213	1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE	Drug	0	experimental	1
DB10533	Grape	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11864	Preladenant	Drug	0	investigational	0
DB08214	4-(1H-IMIDAZOL-1-YL)PHENOL	Drug	0	experimental	1
DB10534	Grapefruit	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB08211	5-bromo-3-(pyrrolidin-1-ylsulfonyl)-1H-indole-2-carboxamide	Drug	0	experimental	1
DB11867	JNJ-39393406	Drug	0	investigational	0
DB10535	Karaya gum	Drug	Carbohydrates, Plant Gums, Cell-mediated Immunity, Equipment and Supplies, Drugs for Constipation, Plant Exudates, Surgical Equipment, Biopolymers, Surgical Fixation Devices, Macromolecular Substances, Non-Standardized Food Allergenic Extract, Polysaccharides, Complex Mixtures, Alimentary Tract and Metabolism, Biological Products, Laxatives, Bulk-Forming Laxatives, Polymers, Tissue Adhesives, Compounds used in a research, industrial, or household setting, Increased IgG Production, Increased Histamine Release	approved	0
DB08212	1-[2-(3-ACETYL-2-HYDROXY-6-METHOXY-PHENYL)-CYCLOPROPYL]-3-(5-CYANO-PYRIDIN-2-YL)-THIOUREA	Drug	0	experimental	1
DB09543	Methyl salicylate	Drug	Benzoates, Hydroxy Acids, Oils, Acids, Carbocyclic, Antirheumatic Agents, Hydroxybenzoates, Lipids, Complex Mixtures, Fixatives, Plant Preparations, Biological Products, Gaultheria, Phenols, Pharmaceutical Preparations, Salicylates, Betula, Compounds used in a research, industrial, or household setting, Benzene Derivatives	approved, vet_approved	0
DB11866	Romosozumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Musculo-Skeletal System, Bone Anabolic Agents, Drugs for Treatment of Bone Diseases, Antibodies, Amino Acids, Peptides, and Proteins, Drugs Affecting Bone Structure and Mineralization, Immunoproteins	approved, investigational	1
DB10536	Honeydew melon	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB10537	Lamb	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11869	Valspodar	Drug	Peptides, Cyclic, OATP1B1/SLCO1B1 Inhibitors, ATP Binding Cassette Transporter, Subfamily B, Member 1, Peptides, Drug Resistance, Multiple, P-glycoprotein substrates, OATP1B3 inhibitors, Amino Acids, Peptides, and Proteins, P-glycoprotein inhibitors	investigational	0
DB11868	Etiracetam	Drug	Acids, Acyclic, Fatty Acids, Amides, Lipids, Acetates, Anticonvulsants, Pyrrolidinones, Central Nervous System Depressants, Fatty Acids, Volatile, Pyrrolidines, Acetamides, Central Nervous System Agents, Nootropic Agents	investigational	0
DB08210	2-AMINO-4-FLUORO-5-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]-N-(1,3-THIAZOL-2-YL)BENZAMIDE	Drug	0	experimental	1
DB10538	Lemon	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved, investigational	0
DB10539	Lettuce	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB08219	4-Methyl-5-[(2Z)-2-{[4-(4-morpholinyl)phenyl]imino}-2,5-dihydro-4-pyrimidinyl]-1,3-thiazol-2-amine	Drug	0	experimental	2
DB08217	S-[(1-Hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate	Drug	0	experimental	4
DB08218	HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM	Drug	0	experimental	2
DB09546	Iobenguane sulfate I-123	Drug	Radioactive Diagnostic Agent, Radiopharmaceutical Activity, Drugs that are Mainly Renally Excreted	approved, investigational	0
DB08215	Terbutryn	Drug	Herbicides, Agrochemicals, Pesticides, Toxic Actions, Compounds used in a research, industrial, or household setting	experimental	7
DB08216	2-((3'-TERTBUTYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID	Drug	0	experimental	1
DB11870	RG-4733	Drug	Heterocyclic Compounds, Fused-Ring, Amyloid Precursor Protein Secretases, antagonists & inhibitors	investigational	0
DB11872	ZD-6126	Drug	0	investigational	0
DB10540	Lima bean	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB10541	Lobster	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11871	PF-00610355	Drug	Acids, Acyclic, Fatty Acids, Agents producing tachycardia, Amides, Lipids, Adrenergic beta-2 Receptor Agonists, Acetates, Adrenergic beta-Agonists, Sulfur Compounds, Fatty Acids, Volatile, Adrenergic Agonists, Agents that produce hypertension, Acetamides, Benzene Derivatives, Sulfones	investigational	0
DB10542	Goat milk	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11874	Crocin	Drug	Biological Factors, Cycloparaffins, Alkenes, Hydrocarbons, Acyclic, Polyenes, Cyclohexenes, Terpenes, Condiments, Cyclohexanes, Pigments, Biological	investigational	0
DB11873	Verinurad	Drug	Acids, Acyclic, Antigout Preparations, Fatty Acids, Fatty Acids, Volatile, Antirheumatic Agents, Lipids	investigational	0
DB10543	Cow milk	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11876	Alanyl glutamine	Drug	Blood and Blood Forming Organs, I.V. Solution Additives, Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins, Blood Substitutes and Perfusion Solutions, Amino Acids	investigational	0
DB08224	(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL	Drug	0	experimental	1
DB10544	Cultivated mushroom	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB09555	Dexchlorpheniramine maleate	Drug	Cytochrome P-450 CYP2D6 Inhibitors, OCT1 substrates, Pyridines, QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Stereoisomerism, OCT1 inhibitors, Cytochrome P-450 CYP3A4 Substrates, Moderate Risk QTc-Prolonging Agents, Neurotransmitter Agents, Histamine H1 Antagonists, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, OCT2 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2D6 Substrates, Histamine Agents, Agents that reduce seizure threshold	approved	1
DB10545	Mustard seed	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11875	3,3'-diindolylmethane	Drug	Heterocyclic Compounds, Fused-Ring, Protective Agents, Anticarcinogenic Agents, Compounds used in a research, industrial, or household setting	investigational	0
DB11878	Filibuvir	Drug	RNA Replicase, antagonists & inhibitors, Pyrans	investigational	0
DB10546	Oat	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB08222	METHOXYUNDECYLPHOSPHINIC ACID	Drug	0	experimental	2
DB08223	N-{(1S,2R)-1-BENZYL-3-[(CYCLOPROPYLMETHYL)(2-FURYLSULFONYL)AMINO]-2-HYDROXYPROPYL}-N'-METHYLSUCCINAMIDE	Drug	0	experimental	0
DB11877	Basmisanil	Drug	0	investigational	0
DB10547	Black olive	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB10548	Onion	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB09551	Desoxyribonuclease	Drug	Endodeoxyribonucleases, Enzymes, Blood and Blood Forming Organs, Deoxyribonuclease I, Deoxyribonuclease I, antagonists & inhibitors, Endonucleases, Enzymes and Coenzymes, Hydrolases, Esterases, Deoxyribonucleases	approved	0
DB08220	(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid	Drug	0	experimental	2
DB08221	N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE	Drug	0	experimental	1
DB11879	Dusquetide	Drug	Peptides, Amino Acids, Peptides, and Proteins	investigational	0
DB09552	Thonzonium	Drug	Amines, Ammonium Compounds, Onium Compounds, Nitrogen Compounds	approved	1
DB10549	Orange	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB08228	5,8-dimethoxy-1,4-dimethylquinolin-2(1H)-one	Drug	0	experimental	1
DB09559	Necitumumab	Drug	Immunoglobulins, Antineoplastic and Immunomodulating Agents, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, HER1 Antagonists, Immunoproteins, Proteins, Serum Globulins, Antineoplastic Agents, Immunological, ErbB Receptors, antagonists & inhibitors, Narrow Therapeutic Index Drugs, Globulins, Blood Proteins, Epidermal Growth Factor Receptor Antagonist	approved, investigational	1
DB08229	[N-(3-dibenzylcarbamoyl-oxiranecarbonyl)-hydrazino]-acetic acid	Drug	0	experimental	1
DB08226	Myxopyronin B	Drug	DNA-Directed RNA Polymerases, antagonists & inhibitors	experimental	5
DB08227	1-(1-HYDROXY-2,2,6,6-TETRAMETHYLPIPERIDIN-4-YL)PYRROLIDINE-2,5-DIONE	Drug	0	experimental	1
DB11881	AUY922	Drug	Phenols, HSP90 Heat-Shock Proteins, antagonists & inhibitors, Benzene Derivatives	investigational	0
DB10550	Oyster	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11880	Acridine Carboxamide	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Topoisomerase Inhibitors, Topoisomerase II Inhibitors, Antineoplastic Agents	investigational	0
DB11883	SB-705498	Drug	TRPV Cation Channels, antagonists & inhibitors	investigational	0
DB10551	Pea	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB10552	Peach	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11882	BPC-157	Drug	Peptides, Amino Acids, Peptides, and Proteins, Anti-Ulcer Agents, Gastrointestinal Agents	investigational	0
DB10553	Peanut	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11885	Anlotinib	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB10554	Pear	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11884	Vadastuximab Talirine	Drug	Proteins, Serum Globulins, Heterocyclic Compounds, Fused-Ring, Immunoglobulins, Benzazepines, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB08235	N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide	Drug	0	experimental	7
DB10555	Pecan	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11886	Infigratinib	Drug	Antineoplastic Agents, Receptor, Fibroblast Growth Factor, Type 1, antagonists & inhibitors, Benzene Derivatives	investigational	0
DB10556	Green bell pepper	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB09567	Olive oil	Drug	Oils, Lipid Emulsion, Lipids, Dietary Fats, Unsaturated, Complex Mixtures, Physiological Phenomena, Plant Preparations, Fats, Unsaturated, Dietary Fats, Food and Beverages, Biological Products, Plant Oils, Fats, Diet, Food, and Nutrition, Food	approved	0
DB08236	(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one	Drug	0	experimental	7
DB11889	Lanicemine	Drug	Amines, Ethylamines, Central Nervous System Depressants, Receptors, N-Methyl-D-Aspartate, antagonists & inhibitors, Antidepressive Agents	investigational	0
DB09564	Insulin degludec	Drug	Insulin, Long-Acting, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pancreatic Hormones, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Amino Acids, Peptides, and Proteins, Blood Glucose Lowering Agents, Hormones, Insulin, Cytochrome P-450 Enzyme Inducers, Peptide Hormones, Alimentary Tract and Metabolism, Long-acting Insulins, Cytochrome P-450 CYP1A2 Inducers, Drugs Used in Diabetes, Insulin Analog	approved	2
DB08233	6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE	Drug	0	experimental	2
DB10557	Black pepper	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11888	Laninamivir octanoate	Drug	Neuraminidase, antagonists & inhibitors, Acids, Acyclic, Carbohydrates, Hydroxy Acids, Neuraminic Acids, Amidines, Antiviral Agents, Guanidines, Sialic Acids, Anti-Infective Agents, Amino Sugars, Sugar Acids, Pyrans	investigational	0
DB08234	5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine	Drug	0	experimental	4
DB10558	Pineapple	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB10559	Pistachio	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB08231	Myristic acid	Drug	Fatty Acids, Lipids, Myristic Acids	experimental	45
DB08232	[5-(5-Amino-1H-pyrrolo[3,2-b]pyridin-2-yl)-6-hydroxy-3'-nitro-3-biphenylyl]acetic acid	Drug	0	experimental	2
DB09563	Choline C-11	Drug	Radioactive Diagnostic Agent, Radiopharmaceutical Activity	approved	0
DB08230	Tricetin	Drug	Antioxidants, Biological Factors, Carbohydrates, Heterocyclic Compounds, Fused-Ring, Flavonoids, Protective Agents, Glycosides, Benzopyrans, Compounds used in a research, industrial, or household setting, Chromones, Pigments, Biological, Pyrans	experimental	1
DB09561	Sodium glycerophosphate	Drug	Carbohydrates, Blood and Blood Forming Organs, Sugar Phosphates, Lipids, Phospholipids, Blood Substitutes and Perfusion Solutions, Electrolyte Solutions, Phosphate salts, Alcohols, I.V. Solution Additives, Sugar Alcohols, Membrane Lipids, Triose Sugar Alcohols	approved	0
DB08239	(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE	Drug	0	experimental	1
DB09568	Omega-3-carboxylic acids	Drug	Fatty Acids, Omega-3	approved, investigational	6
DB08237	2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate)	Drug	0	experimental	1
DB08238	5-aminonaphthalene-2-sulfonic acid	Drug	0	experimental	1
DB11890	Cilengitide	Drug	Toxins, Biological, Biological Factors, Complex Mixtures, Venoms, Fluids and Secretions, Bodily Secretions	investigational	0
DB09570	Ixazomib	Drug	Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Antineoplastic and Immunomodulating Agents, Protease Inhibitors, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A4 Substrates, Amino Acids, Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2C8 Substrates, Proteasome Inhibitors	approved, investigational	0
DB10560	Plum	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11892	Prulifloxacin	Drug	Fluoroquinolones, Quinolines, QTc Prolonging Agents, Enzyme Inhibitors, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Antiinfectives for Systemic Use, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Anti-Infective Agents, Dioxoles, Quinolones, Cytochrome P-450 CYP1A2 Inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Topoisomerase II Inhibitors, Potential QTc-Prolonging Agents, Antibacterials for Systemic Use	investigational	0
DB10561	Pork	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11891	CUDC-907	Drug	Phosphatidylinositol 3-Kinase, antagonists & inhibitors, QTc Prolonging Agents, Oxazines, Antineoplastic Agents, Potential QTc-Prolonging Agents, Histone Deacetylase Inhibitors	investigational	0
DB11894	Efatutazone	Drug	Sulfur Compounds, Thiazoles, Antineoplastic Agents, PPAR gamma, antagonists & inhibitors	investigational	0
DB10562	Potato	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11893	Avagacestat	Drug	Sulfur Compounds, Oxazoles, Amides, Sulfones, Amyloid Precursor Protein Secretases, antagonists & inhibitors	investigational	0
DB10563	Rice	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11896	Gedatolisib	Drug	Enzyme Inhibitors, Oxazines, Protein Kinase Inhibitors	investigational	0
DB10564	Rye	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11895	Lenomorelin	Drug	Peptide Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Amino Acids, Peptides, and Proteins, Hormones	investigational	0
DB10566	Sesame seed	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB08246	(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE	Drug	0	experimental	1
DB11898	2,4-thiazolidinedione	Drug	Sulfur Compounds, Thiazoles, Ligands, Blood Glucose Lowering Agents	investigational	0
DB10567	Shrimp	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB08247	6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE	Drug	0	experimental	1
DB08244	(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE	Drug	0	experimental	1
DB10568	Soybean	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11899	MK-8776	Drug	0	investigational	0
DB10569	Spinach	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB08245	1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-5-NITRO-1H-INDOLE	Drug	0	experimental	1
DB08242	N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide	Drug	0	experimental	1
DB08240	N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE	Drug	0	experimental	1
DB09571	Levmetamfetamine	Drug	0	approved	0
DB08241	4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE	Drug	0	experimental	2
DB08248	3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE	Drug	0	experimental	2
DB08249	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	Drug	0	experimental	4
DB08293	(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE	Drug	0	experimental	1
DB08294	2-(4-HYDROXY-3-NITROPHENYL)ACETIC ACID	Drug	0	experimental	2
DB08291	N-(3-AMINOPROPYL)-2-NITROBENZENAMINE	Drug	0	experimental	1
DB08292	(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE	Drug	0	experimental	1
DB08299	4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid	Drug	0	experimental	3
DB08297	ORTHONITROPHENYL-BETA-D-FUCOPYRANOSIDE	Drug	0	experimental	1
DB08295	4-HYDROXY-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION	Drug	0	experimental	2
DB08296	5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID	Drug	0	experimental	1
DB11940	Triapine	Drug	Sulfur Compounds, Semicarbazides, Semicarbazones	investigational	0
DB11942	Selinexor	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, OATP1B3 inhibitors, Cytochrome P-450 CYP3A4 Substrates	approved, investigational	1
DB10610	Duck	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11941	Tasisulam	Drug	Sulfur Compounds, Benzoates, Acids, Carbocyclic, Amides, Benzene Derivatives, Sulfones	investigational	0
DB10611	Allergenic extract- beef liver	Drug	0	approved	0
DB11944	Ingavirin	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Lipids, Antiviral Agents, Anti-Infective Agents	investigational	0
DB10612	Veal	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB10613	Bluefish	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11943	Delafloxacin	Drug	Fluoroquinolones, Quinolines, QTc Prolonging Agents, Cytochrome P-450 CYP2E1 Inducers, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, UGT1A3 substrates, Fluoroquinolone Antibacterial, Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Quinolones, Cytochrome P-450 CYP3A4 Inducers (weak), Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Cytochrome P-450 Enzyme Inducers, BCRP/ABCG2 Substrates, UGT1A1 Substrates, Cytochrome P-450 CYP2C9 Inducers (weak), Cytochrome P-450 CYP2E1 Inducers (weak), Potential QTc-Prolonging Agents, Cytochrome P-450 CYP2C9 Inducers, Antibacterials for Systemic Use	approved, investigational	2
DB10614	Common carp	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11946	AZD-1981	Drug	0	investigational	0
DB10615	Haddock	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11945	Avelumab	Drug	Immunoglobulins, Programmed Death Ligand-1-directed Antibody Interactions, Antineoplastic and Immunomodulating Agents, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins, Proteins, Serum Globulins, Globulins, Blood Proteins, Programmed Death Ligand-1 Blocker, Programmed Death Ligand-1 Antagonists	approved, investigational	1
DB11948	Lapachone	Drug	Quinones, Enzyme Inhibitors, Nucleic Acid Synthesis Inhibitors, Anti-Retroviral Agents, Antiviral Agents, Reverse Transcriptase Inhibitors, Radiation-Sensitizing Agents, Anti-Infective Agents, Naphthalenes	investigational	1
DB10616	Pacific halibut	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11947	Pridopidine	Drug	0	investigational	0
DB10617	Herring	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11939	Henagliflozin	Drug	0	investigational	0
DB10607	Oryctolagus cuniculus skin	Drug	Cell-mediated Immunity, Non-Standardized Animal Skin Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11938	Difelikefalin	Drug	0	investigational	0
DB10608	Rattus norvegicus skin	Drug	Cell-mediated Immunity, Non-Standardized Animal Skin Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10609	Bombyx mori fiber	Drug	Cell-mediated Immunity, Non-Standardized Insect Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11951	Lemborexant	Drug	Orexin Receptor Antagonists, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, P-glycoprotein substrates, Sleep Aids, Pharmaceutical, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Sleep Initiation and Maintenance Disorders, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Cytochrome P-450 CYP2B6 Inducers	approved, investigational	2
DB10620	Red snapper	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11950	Teneligliptin	Drug	Sulfur Compounds, Thiazoles, Agents causing angioedema, Blood Glucose Lowering Agents, DPP-IV Inhibitors	investigational	0
DB08301	N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE	Drug	0	experimental	1
DB11953	PF-04447943	Drug	Phosphodiesterase Inhibitors, Pyrimidines	investigational	0
DB10621	Atlantic salmon	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB08302	3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid	Drug	0	experimental	1
DB10622	European pilchard	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11952	Duvelisib	Drug	Phosphatidylinositol 3-Kinases, antagonists & inhibitors, Heterocyclic Compounds, Fused-Ring, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Substrates	approved, investigational	2
DB11955	Avotermin	Drug	Proteins, Biological Factors, Cytokines, Peptides, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, TGF-beta Superfamily Proteins, Transforming Growth Factor beta	investigational	0
DB10623	Scallop	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11954	Lomibuvir	Drug	Cycloparaffins, Sulfur Compounds, Hexanols, Lipids, Fatty Alcohols, Alcohols, Cyclohexanes	investigational	0
DB08300	1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine	Drug	0	experimental	1
DB10624	Smelt	Drug	0	approved	0
DB11957	Idalopirdine	Drug	Heterocyclic Compounds, Fused-Ring, Amines, Serotonin Agents, Benzyl Compounds, Central Nervous System Depressants, Serotonin Receptor Antagonists, Antidepressive Agents, Benzene Derivatives	investigational	0
DB10625	Swordfish	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11956	Delanzomib	Drug	Amino Acids, Neutral, Enzyme Inhibitors, Acids, Noncarboxylic, Acids, Amino Acids, Essential, Protease Inhibitors, Amino Acids, Peptides, and Proteins, Proteasome Inhibitors, Amino Acids, Boron Compounds	investigational	0
DB10626	Trout	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11959	Crenezumab	Drug	Proteins, Serum Globulins, Alzheimer Disease, drug therapy, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB10627	White fish	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11958	Brivanib	Drug	Amino Acids, Peptides, and Proteins, Amino Acids	investigational	0
DB10628	Blackberry	Drug	0	approved	0
DB08309	3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL	Drug	0	experimental	2
DB10618	Mackerel	Drug	0	approved	0
DB11949	Vestipitant	Drug	Neurotransmitter Agents, Hydrocarbons, Halogenated, Hydrocarbons, Fluorinated, Benzene Derivatives, Neurokinin-1 Receptor Antagonists	investigational	1
DB10619	Northern pike	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB08307	2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE	Drug	0	experimental	1
DB08308	SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER	Drug	0	experimental	1
DB08305	(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide	Drug	0	experimental	1
DB08306	3-[(3-Nitrophenyl)sulfamoyl]-2-thiophenecarboxylic acid	Drug	0	experimental	1
DB08303	(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide	Drug	0	experimental	1
DB08304	(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide	Drug	0	experimental	1
DB11960	Carboxyamidotriazole	Drug	Calcium Channel Blockers, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Agents causing hyperkalemia, Calcium-Regulating Hormones and Agents, Antineoplastic Agents, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Bradycardia-Causing Agents, Membrane Transport Modulators, Antiarrhythmic agents	investigational	0
DB11962	GSK-1059615	Drug	0	investigational	0
DB10630	Sour cherry	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB11961	AZD-1236	Drug	0	investigational	0
DB10631	Cranberry	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved, investigational	0
DB08312	6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE	Drug	0	experimental	1
DB11964	Ilaprazole	Drug	Heterocyclic Compounds, Fused-Ring, Pyridines, Benzimidazoles, Gastric Acid Lowering Agents, Sulfur Compounds, Proton Pump Inhibitors, Sulfoxides, Anti-Ulcer Agents	investigational	0
DB10632	Date	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB11963	Dacomitinib	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, OCT1 inhibitors, Quinazolines, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates with narrow therapeutic index, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, UGT1A1 Inhibitors, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2D6 Inhibitors (strong), P-glycoprotein inhibitors	approved, investigational	1
DB08313	Nocodazole	Drug	Heterocyclic Compounds, Fused-Ring, Benzimidazoles, Tubulin Modulators, Antimitotic Agents, Antineoplastic Agents, Mitosis Modulators	experimental	1
DB10633	Fig	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB10634	Wine grape	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB08310	N-[(2R)-2-{[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl}hexyl]-N-hydroxyformamide	Drug	0	experimental	1
DB11966	BMS-986094	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Guanine Nucleotides, Nucleotides	investigational	0
DB11965	SJG-136	Drug	Heterocyclic Compounds, Fused-Ring, Benzazepines	investigational	0
DB10635	Lime (citrus)	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11968	MK-7145	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB10636	Raspberry	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11967	Binimetinib	Drug	Cytochrome P-450 CYP2C19 Substrates, Heterocyclic Compounds, Fused-Ring, MAP Kinase Kinase 1, antagonists & inhibitors, Protein Kinase Inhibitors, Cytochrome P-450 Substrates, UGT1A1 Substrates, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP1A2 Substrates, Antineoplastic Agents, P-glycoprotein substrates with narrow therapeutic index, MAP Kinase Kinase 2, antagonists & inhibitors, UGT1A1 substrates with narrow therapeutic index	approved, investigational	5
DB10637	Tangerine	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB10638	Artichoke	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB10639	Kidney bean	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB11969	Uprosertib	Drug	Amines, Polyamines	investigational	0
DB10629	Blueberry	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB08318	6-(2-phenoxyethoxy)-1,3,5-triazine-2,4-diamine	Drug	0	experimental	1
DB08319	2'-HYDROXY-1,1'-BIPHENYL-2-SULFINIC ACID	Drug	0	experimental	1
DB08316	4-amino-7,7-dimethyl-7,8-dihydroquinazolin-5(6H)-one	Drug	0	experimental	1
DB08317	5-methyl-6-phenylquinazoline-2,4-diamine	Drug	0	experimental	1
DB08314	(2-AMINO-1,3-OXAZOL-5-YL)-(3-BROMOPHENYL)METHANONE	Drug	0	experimental	1
DB08315	2-AMINO-N,N-BIS(PHENYLMETHYL)-1,3-OXAZOLE-5-CARBOXAMIDE	Drug	0	experimental	1
DB11971	Vilaprisan	Drug	Fused-Ring Compounds	investigational	0
DB10640	Beet	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB11970	Burixafor	Drug	0	investigational	0
DB11973	Tesevatinib	Drug	Receptor, EphB4, antagonists & inhibitors, Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Protein Kinase Inhibitors, ErbB Receptors, antagonists & inhibitors, Tyrosine Kinase Inhibitors, Receptor, ErbB-2, antagonists & inhibitors, Aza Compounds, Antineoplastic Agents, Vascular Endothelial Growth Factor Receptor-2, antagonists & inhibitors	investigational	3
DB10641	Kiwi fruit	Drug	0	approved	0
DB11972	Rilotumumab	Drug	Proteins, Serum Globulins, Antineoplastic Agents, Immunological, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB10642	Brussels sprout	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB11975	TAK-448	Drug	Proteins, Biological Factors, Peptides, Intercellular Signaling Peptides and Proteins, Neoplasm Proteins, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Tumor Suppressor Proteins	investigational	0
DB08323	3-OXO-N-[(3S)-2-OXOPYRROLIDIN-3-YL]DODECANAMIDE	Drug	0	experimental	1
DB10643	Cauliflower	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB11974	PF-04691502	Drug	Phosphatidylinositol 3-Kinases, antagonists & inhibitors, Pyridines	investigational	0
DB10644	Eggplant	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB08324	N-3-OXO-DODECANOYL-L-HOMOSERINE LACTONE	Drug	0	experimental	1
DB08321	(1S,2S,3R,6R)-4-(hydroxymethyl)-6-(octylamino)cyclohex-4-ene-1,2,3-triol	Drug	0	experimental	1
DB11977	Golvatinib	Drug	Pyridines, Amines, Vascular Endothelial Growth Factor Receptor-2, antagonists & inhibitors	investigational	0
DB10645	Lentil	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB11976	Anifrolumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB08322	2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID	Drug	0	experimental	1
DB10646	Green olive	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB11979	Elagolix	Drug	Gonadotropin-releasing Hormone Antagonists, Cytochrome P-450 Substrates, P-glycoprotein substrates, UGT1A1 Substrates, OATP1B1/SLCO1B1 Substrates, Antigonadotropins and Similar Agents, Hydrocarbons, Halogenated, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2C8 Substrates, P-glycoprotein inhibitors	approved, investigational	1
DB10647	Parsley	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11978	Glasdegib	Drug	Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Cytochrome P-450 Substrates, P-glycoprotein substrates, Hedgehog Pathway Inhibitor, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, MATE inhibitors, MATE 1 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Heterocyclic Compounds, Fused-Ring, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Substrates, Smoothened Receptor Antagonists, UGT1A9 Substrates, MATE 2 Inhibitors, Cytochrome P-450 CYP2C8 Substrates, P-glycoprotein inhibitors, Benzene Derivatives	approved, investigational	1
DB08320	DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE	Drug	0	experimental	2
DB10648	Sweet potato	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB08329	Sulthiame	Drug	Anticonvulsants, Sulfur Compounds, Nervous System, Central Nervous System Depressants, Central Nervous System Agents	experimental	1
DB08327	Homogentisic acid	Drug	Acids, Carbocyclic, Phenylacetates	experimental	1
DB08328	PANTOTHENYL-AMINOETHANOL-11-PIVALIC ACID	Drug	0	experimental	1
DB08325	2-({6-[(3-Chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)ethanol	Drug	0	experimental	2
DB08326	2-(6-HYDROXY-1,3-BENZOTHIAZOL-2-YL)-1,3-THIAZOL-4(5H)-ONE	Drug	0	experimental	1
DB11900	OC-459	Drug	Heterocyclic Compounds, Fused-Ring, Indoles	investigational	0
DB11902	Gisadenafil	Drug	Pyrimidines, Sulfur Compounds, Cyclic Nucleotide Phosphodiesterases, Type 5, Amides, Sulfones	investigational	0
DB11901	Apalutamide	Drug	Endocrine Therapy, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Inducers, MATE inhibitors, Hormone Antagonists and Related Agents, MATE 1 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C19 Inducers (strong), Drugs that are Mainly Renally Excreted, BCRP/ABCG2 Inducers, Cytochrome P-450 CYP3A4 Inducers (strong), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C19 Inducers, Cytochrome P-450 CYP2C9 Inducers (weak), Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP3A Inducers (strong), Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A4 Inducers, Antineoplastic Agents, Imidazolidines, P-glycoprotein inducers, Imidazoles, Cytochrome P-450 CYP3A Substrates, OCT2 Inhibitors, Antiandrogens, MATE 2 Inhibitors, Cytochrome P-450 CYP2C9 Inducers, OAT3/SLC22A8 Inhibitors, OATP1B1/SLCO1B1 Inducers, Prostatic Neoplasms, drug therapy	approved, investigational	2
DB11904	Flumatinib	Drug	Pyridines, Enzyme Inhibitors, Protein Kinase Inhibitors, Amines, Benzoates, Tyrosine Kinase Inhibitors, Acids, Carbocyclic, Amides, Benzene Derivatives	investigational	0
DB11903	GW842166	Drug	Cannabinoid Receptor Agonists, Receptor, Cannabinoid, CB2, agonists, Cannabinoids and similars, Agents producing tachycardia	investigational	0
DB11911	Galunisertib	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB11910	MK-0249	Drug	Heterocyclic Compounds, Fused-Ring, Quinazolines	investigational	0
DB11913	LY-2090314	Drug	Glycogen Synthase Kinase 3, antagonists & inhibitors, Acids, Acyclic, Heterocyclic Compounds, Fused-Ring, Maleates, Dicarboxylic Acids, Imides	investigational	0
DB11912	Lanopepden	Drug	Anti-Bacterial Agents, Enzyme Inhibitors, Amines, Hydroxy Acids, Hydroxylamines	investigational	0
DB11915	Valbenazine	Drug	Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Nervous System, Amino Acids, Essential, Vesicular Monoamine Transporter 2 Inhibitor, Amino Acids, Peptides, and Proteins, Cytochrome P-450 CYP3A4 Substrates, Amino Acids, Drugs that are Mainly Renally Excreted, Vesicular Monoamine Transporter 2 Inhibitors, Heterocyclic Compounds, Fused-Ring, Quinolizines, Cytochrome P-450 CYP3A Substrates, Amino Acids, Branched-Chain, Cytochrome P-450 CYP2D6 Substrates	approved, investigational	1
DB11914	Lebrikizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	2
DB11906	Acyline	Drug	Gonadotropin-Releasing Hormone, antagonists & inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Amino Acids, Peptides, and Proteins, Hormone Antagonists	investigational	0
DB11905	Sutezolid	Drug	Acids, Acyclic, Fatty Acids, Oxazoles, Tuberculosis, Pulmonary, drug therapy, Fatty Acids, Volatile, Amides, Lipids, Acetates	investigational	0
DB11907	Rociletinib	Drug	Acids, Acyclic, Acrylates, Protein Kinase Inhibitors, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Amides	investigational	0
DB11909	Varespladib	Drug	Acids, Acyclic, Heterocyclic Compounds, Fused-Ring, Phospholipases A, antagonists & inhibitors, Enzyme Inhibitors, Fatty Acids, Fatty Acids, Volatile, Lipids, Phospholipase A2 Inhibitors	investigational	0
DB11920	Lesogaberan	Drug	GABA-A Receptor Agonists, Neurotransmitter Agents, Acids, Noncarboxylic, Amines, Acids, GABA Agents, GABA Agonists, Organophosphorus Compounds, Phosphorus Compounds, Phosphorus Acids, Gastrointestinal Agents	investigational	0
DB11922	Danirixin	Drug	Sulfur Compounds	investigational	0
DB11921	Deflazacort	Drug	Corticosteroids for Systemic Use, Corticosteroids, Cytochrome P-450 Substrates, Immunosuppressive Agents, Corticosteroids for Systemic Use, Plain, Glucocorticoids, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Hyperglycemia-Associated Agents, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Corticosteroid Hormone Receptor Agonists, Cytochrome P-450 CYP3A5 Inducers, Steroids	approved, investigational	1
DB11924	Safingol	Drug	Enzyme Inhibitors, Amines, Glycols, Amino Alcohols, Protein Kinase C, antagonists & inhibitors, Alcohols	investigational	0
DB11923	Decoglurant	Drug	0	investigational	0
DB11926	Tesidolumab	Drug	0	investigational	0
DB11925	Vistusertib	Drug	Oxazines, Protein Kinase Inhibitors	investigational	0
DB11917	Vatiquinone	Drug	Quinones, Coenzymes, Enzymes and Coenzymes, Benzoquinones	investigational	0
DB11916	Indium In-111	Drug	0	investigational	0
DB11919	6-O-benzylguanine	Drug	Heterocyclic Compounds, Fused-Ring, Purines, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Antineoplastic Agents, Xanthine derivatives, Cytochrome P-450 CYP3A4 Substrates, Purinones	investigational	0
DB11918	Guadecitabine	Drug	Carbohydrates, Immunologic Factors, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Aza Compounds, Antineoplastic Agents, Glycosides, Nucleosides	investigational	0
DB11930	Varlilumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB10600	Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated)	Drug	Influenza Vaccines, Vaccines, Inactivated Influenza A Virus Vaccine	approved	0
DB10601	Influenza A virus A/South Australia/55/2014 IVR-175 (H3N2) antigen (propiolactone inactivated)	Drug	0	approved	0
DB11933	Riboprine	Drug	0	investigational	0
DB10602	Influenza B virus B/Phuket/3073/2013 antigen (propiolactone inactivated)	Drug	0	approved	0
DB11932	Abametapir	Drug	0	investigational	0
DB11935	Flomoxef	Drug	Nephrotoxic agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Second-Generation Cephalosporins, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Antibacterials for Systemic Use	investigational	0
DB10603	Meriones unguiculatus skin	Drug	Cell-mediated Immunity, Non-Standardized Animal Skin Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10604	Capra hircus skin	Drug	Cell-mediated Immunity, Non-Standardized Animal Skin Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11934	Epelsiban	Drug	Oxazines, Piperazines	investigational	0
DB11937	Kynurenic Acid	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Xanthurenates, Excitatory Amino Acid Agents, Excitatory Amino Acid Antagonists, Hydroxyquinolines	investigational	2
DB10605	Mesocricetus auratus skin	Drug	Cell-mediated Immunity, Non-Standardized Animal Skin Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11936	Bempedoic acid	Drug	Acids, Acyclic, Lipid Regulating Agents, OATP1B1/SLCO1B1 Inhibitors, Enzyme Inhibitors, Hypolipidemic Agents, UGT2B7 substrates, OATP1B3 inhibitors, Hypolipidemic Agents Indicated for Hyperlipidemia, OATP1B3 substrates	approved, investigational	1
DB10606	Sus scrofa skin	Drug	Cell-mediated Immunity, Non-Standardized Animal Skin Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB11928	Vosoritide	Drug	Natriuretic Peptides, Peptide Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Amino Acids, Peptides, and Proteins, Hormones	investigational	0
DB11927	Lodenafil carbonate	Drug	Alkalies, Anions, Acids, Noncarboxylic, Acids, Electrolytes, Ions, Carbonic Acid, Carbon Compounds, Inorganic	investigational	0
DB11929	Vaniprevir	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB10690	Ctenocephalides canis	Drug	Cell-mediated Immunity, Non-Standardized Insect Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08370	S-(4-BROMOBENZYL)CYSTEINE	Drug	0	experimental	1
DB08371	p-Benzoyl-L-phenylalanine	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Ketones, Amino Acids, Essential, Amino Acids, Peptides, and Proteins, Amino Acids, Benzene Derivatives	experimental	2
DB10691	Aedes taeniorhynchus	Drug	Cell-mediated Immunity, Non-Standardized Insect Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB07040	2-amino-7-fluoro-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxamide	Drug	0	experimental	1
DB10693	Ctenocephalides felis	Drug	Cell-mediated Immunity, Non-Standardized Insect Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10694	Aspergillus flavus	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased Histamine Release	approved	0
DB10695	Eurotium herbariorum	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10696	Trichothecium roseum	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10697	Curvularia inaequalis	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08378	4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID	Drug	0	experimental	3
DB07046	2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide	Drug	0	experimental	1
DB10698	Fusarium compactum	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08379	6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one	Drug	0	experimental	1
DB07045	(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol	Drug	0	experimental	2
DB10699	Geotrichum candidum	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB07048	N-[(2R)-5-(aminosulfonyl)-2,3-dihydro-1H-inden-2-yl]-2-propylpentanamide	Drug	0	experimental	1
DB08376	(2R)-3-(phosphonooxy)propane-1,2-diyl diheptanoate	Drug	0	experimental	1
DB07047	2',4'-DICHLORO-4-HYDROXY-1,1'-BIPHENYL-3-CARBOXYLIC ACID	Drug	0	experimental	0
DB08377	N-[4-(4-nitrophenylphospho)butanoyl]-D-alanine	Drug	0	experimental	1
DB07042	7-amino-2-tert-butyl-4-{[2-(1H-imidazol-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidine-6-carboxamide	Drug	0	experimental	1
DB08374	Phenylalanylmethylchloride	Drug	0	experimental	1
DB07041	N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide	Drug	0	experimental	2
DB08375	(2R)-2-[(1R)-1-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-2-oxoethyl]-5-methylidene-2H-1,3-thiazine-4-carboxylic acid	Drug	0	experimental	3
DB07044	3-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide	Drug	0	experimental	1
DB08372	1-[2-(4-ETHOXY-3-FLUOROPYRIDIN-2-YL)ETHYL]-3-(5-METHYLPYRIDIN-2-YL)THIOUREA	Drug	0	experimental	2
DB07043	7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide	Drug	0	experimental	1
DB08373	4,4'-BIS([H]METHYLSULFONYL)-2,2',5,5'-TETRACHLOROBIPHENYL	Drug	0	experimental	1
DB07049	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	Drug	0	experimental	1
DB08382	Gosogliptin	Drug	Diabetes Mellitus, Type 2, drug therapy, Agents causing angioedema, Blood Glucose Lowering Agents, DPP-IV Inhibitors	investigational	1
DB07051	3,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER	Drug	0	experimental	1
DB07050	5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide	Drug	0	experimental	1
DB08389	6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE	Drug	0	experimental	1
DB07057	(3S)-1-(2-hydroxyphenyl)-5-oxopyrrolidine-3-carboxylic acid	Drug	0	experimental	1
DB07056	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	Drug	0	experimental	1
DB07059	N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE	Drug	0	experimental	1
DB08387	Mardepodect	Drug	Heterocyclic Compounds, Fused-Ring	investigational	1
DB07058	5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione	Drug	0	experimental	1
DB08388	5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE	Drug	0	experimental	1
DB07053	2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID	Drug	0	experimental	1
DB08385	4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid	Drug	0	experimental	1
DB07052	5'-S-ethyl-5'-thioadenosine	Drug	0	experimental	1
DB08386	2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline	Drug	0	experimental	1
DB07055	2-[2-(1H-tetrazol-5-yl)ethyl]-1H-isoindole-1,3(2H)-dione	Drug	0	experimental	1
DB08383	4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole	Drug	0	experimental	1
DB07054	(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL	Drug	0	experimental	1
DB08384	2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline	Drug	0	experimental	1
DB07060	3-(INDOL-3-YL) LACTATE	Drug	0	experimental	2
DB08392	2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL	Drug	0	experimental	1
DB08393	2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL	Drug	0	experimental	1
DB07062	N-{3-[4-Hydroxy-1-(3-methylbutyl)-2-oxo-1,2-dihydropyrrolo[1,2-b]pyridazin-3-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl}methanesulfonamide	Drug	0	experimental	1
DB08390	(6S)-6-CYCLOPENTYL-6-[2-(3-FLUORO-4-ISOPROPOXYPHENYL)ETHYL]-4-HYDROXY-5,6-DIHYDRO-2H-PYRAN-2-ONE	Drug	0	experimental	1
DB07061	1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL	Drug	0	experimental	1
DB08391	PQ-10	Drug	0	experimental	1
DB07068	(4-{4-[(TERT-BUTOXYCARBONYL)AMINO]-2,2-BIS(ETHOXYCARBONYL)BUTYL}PHENYL)SULFAMIC ACID	Drug	0	experimental	1
DB07067	(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE	Drug	0	experimental	1
DB08398	2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine	Drug	Carcinogens, Mutagens, Noxae, Toxic Actions	investigational	2
DB07069	m-Hydroxyhippuric acid	Drug	Benzoates, Acids, Carbocyclic, Keto Acids, Benzamides and benzamide derivatives, Amides, Benzene Derivatives	experimental	1
DB08399	Piceatannol	Drug	Tyrosine Kinase Inhibitors, Benzylidene Compounds, Benzene Derivatives	experimental	3
DB08396	4-{[(Z)-(5-oxo-2-phenyl-1,3-oxazol-4(5H)-ylidene)methyl]amino}butanoic acid	Drug	0	experimental	1
DB07064	(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE	Drug	0	experimental	1
DB07063	Lidorestat	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Indoles, Aldehyde Reductase, antagonists & inhibitors	investigational	1
DB08397	6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID	Drug	0	experimental	1
DB08394	PARA-NITROPHENYLPHOSPHONOBUTANOYL-GLYCINE	Drug	0	experimental	1
DB07066	2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE	Drug	0	experimental	1
DB08395	2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE	Drug	0	experimental	1
DB07065	5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine	Drug	0	experimental	1
DB07071	(R)-1-(4-(4-(Hydroxymethyl)-1,3,2-dioxaborolan-2-YL)phenethyl)guanidine	Drug	0	experimental	1
DB07070	(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid	Drug	0	experimental	1
DB07073	5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one	Drug	0	experimental	1
DB07072	(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE	Drug	0	experimental	1
DB07079	3-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}propane-1-thiol	Drug	0	experimental	1
DB07078	(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE	Drug	0	experimental	1
DB07075	3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE	Drug	0	experimental	1
DB07074	6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER	Drug	0	experimental	1
DB07077	(R)-1-(4-(4-(Hydroxymethyl)-1,3,2-dioxaborolan-2-YL)phenyl)guanidine	Drug	0	experimental	1
DB07076	6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE	Drug	0	experimental	1
DB11980	Carbon Black	Drug	0	investigational	0
DB10650	Raphanus sativus	Drug	0	approved	0
DB11982	GDC-0623	Drug	Pyridines, Nicotinic Acids	investigational	0
DB10651	Rhubarb	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB11981	Elamipretide	Drug	Peptides, Amino Acids, Peptides, and Proteins	investigational	0
DB11984	Letaxaban	Drug	Anticoagulants, Enzyme Inhibitors, Pyrimidines, Sulfur Compounds, Antithrombins, Factor Xa Inhibitors, Protease Inhibitors, Hematologic Agents, Serine Protease Inhibitors	investigational	0
DB10652	Turnip	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB11983	Placulumab	Drug	0	investigational	0
DB10653	Cashew	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB08334	3-FLUORO-4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME	Drug	0	experimental	1
DB11986	Entrectinib	Drug	QTc Prolonging Agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Pyrazoles, Antineoplastic Agents, Amides, Cytochrome P-450 CYP3A4 Substrates, Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors, Cytochrome P-450 CYP3A Substrates, P-glycoprotein inhibitors, P-glycoprotein substrates with narrow therapeutic index, Benzene Derivatives	approved, investigational	6
DB07002	4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile	Drug	0	experimental	1
DB10654	Hazelnut	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11985	Dapaconazole	Drug	0	investigational	0
DB08335	4-HYDROXYBENZALDEHYDE O-(3,3-DIMETHYLBUTANOYL)OXIME	Drug	0	experimental	1
DB10655	Macadamia nut	Drug	0	approved	0
DB07001	(3S,5E)-3-propyl-3,4-dihydrothieno[2,3-f][1,4]oxazepin-5(2H)-imine	Drug	0	experimental	1
DB11988	Ocrelizumab	Drug	Immunologic Factors, Immunoglobulins, Immunosuppressive Agents, Antineoplastic and Immunomodulating Agents, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Selective Immunosuppressants, Immunoproteins, Proteins, Serum Globulins, Antibodies, Monoclonal, Humanized, CD20-directed Cytolytic Antibody, Globulins, Blood Proteins, CD20-directed Antibody Interactions, Immunomodulatory Agents	approved, investigational	1
DB10656	Nectarine	Drug	0	approved	0
DB08332	9-(2-carboxyethyl)-10-methylanthracene endoperoxide	Drug	0	experimental	1
DB07004	2-[(5-hex-1-yn-1-ylfuran-2-yl)carbonyl]-N-methylhydrazinecarbothioamide	Drug	0	experimental	1
DB10657	Mango	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11987	GSK-2018682	Drug	Heterocyclic Compounds, Fused-Ring, Oxazoles	investigational	0
DB08333	4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME	Drug	0	experimental	1
DB07003	(2S)-2-methyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine	Drug	0	experimental	1
DB08330	METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE	Drug	0	experimental	10
DB10658	Papaya	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Herbs and Natural Products, Increased Histamine Release	approved	0
DB10659	Leek	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB08331	N-1H-imidazol-2-yl-N'-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine	Drug	0	experimental	1
DB11989	Benznidazole	Drug	Immunologic Factors, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Noxae, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Imidazoles, Agents Against Leishmaniasis and Trypanosomiasis, Mutagens, Nitroimidazole Derivatives, Nitro Compounds, Trypanocidal Agents, Toxic Actions, Antiparasitic Agents	approved, investigational	0
DB07000	N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide	Drug	0	experimental	1
DB07009	2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL	Drug	0	experimental	2
DB08338	19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one	Drug	0	experimental	1
DB07006	9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE	Drug	0	experimental	1
DB08339	PD-166326	Drug	0	experimental	1
DB07005	D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide	Drug	0	experimental	1
DB07008	4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE	Drug	0	experimental	1
DB08336	2-Methyl-2-propanyl [(1R)-2-methyl-1-(1,3,4-oxadiazol-2-yl)propyl]carbamate	Drug	0	experimental	1
DB07007	(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine	Drug	0	experimental	1
DB08337	2-Methyl-2-propanyl [(1S)-2-methyl-1-(1,3,4-oxadiazol-2-yl)propyl]carbamate	Drug	0	experimental	1
DB11991	Oprozomib	Drug	Peptides, Amino Acids, Peptides, and Proteins	investigational	0
DB11990	MK-0812	Drug	0	investigational	0
DB10660	Okra	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB10661	Parsnip	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11993	PF-03463275	Drug	Aza Compounds, Glycine Plasma Membrane Transport Proteins, antagonists & inhibitors	investigational	0
DB10662	Chickpea	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB11992	Omarigliptin	Drug	Heterocyclic Compounds, Fused-Ring, Agents causing angioedema, Blood Glucose Lowering Agents, DPP-IV Inhibitors	investigational	0
DB11995	Avatrombopag	Drug	Cytochrome P-450 Enzyme Inducers, Receptors, Thrombopoietin, agonists, Sulfur Compounds, Blood and Blood Forming Organs, Cytochrome P-450 CYP2C8 Inducers, P-glycoprotein substrates, BCRP/ABCG2 Inhibitors, Cytochrome P-450 CYP2C9 Inducers (weak), Cytochrome P-450 CYP2C9 Inducers, Hemostatics, OAT3/SLC22A8 Inhibitors, Cytochrome P-450 CYP2C8 Inducers (weak)	approved, investigational	3
DB10663	Black-eyed pea	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB11994	Diacerein	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Anthracenes, Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Anti-Inflammatory Agents, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Quinones, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Musculo-Skeletal System, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)	approved, investigational	9
DB10664	Watercress	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB11997	Interleukin-7	Drug	Proteins, Biological Factors, Cytokines, Interleukins, Peptides, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins	investigational	0
DB08345	4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	Drug	0	experimental	1
DB07013	TERT-BUTYL 4-({[4-(BUT-2-YN-1-YLAMINO)PHENYL]SULFONYL}METHYL)-4-[(HYDROXYAMINO)CARBONYL]PIPERIDINE-1-CARBOXYLATE	Drug	0	experimental	1
DB07012	6-AMINO-3,7-DIHYDRO-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE	Drug	0	experimental	1
DB11996	Thymopentin	Drug	Thymopoietins, Immunologic Factors, Hormones, Hormone Substitutes, and Hormone Antagonists, Adjuvants, Immunologic, Antineoplastic and Immunomodulating Agents, Thymus Hormones, Hormones	investigational	0
DB10666	Arabica coffee bean	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB08346	(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE	Drug	0	experimental	1
DB07015	(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine	Drug	0	experimental	1
DB11999	Vosaroxin	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents	investigational	0
DB10667	Tragacanth	Drug	Carbohydrates, Plant Gums, Cell-mediated Immunity, Excipients, Non-Standardized Plant Allergenic Extract, Plant Exudates, Biopolymers, Pharmaceutic Aids, Drug Delivery Systems, Macromolecular Substances, Non-Standardized Food Allergenic Extract, Polysaccharides, Complex Mixtures, Biological Products, Pharmaceutical Preparations, Polymers, Compounds used in a research, industrial, or household setting, Increased IgG Production, Increased Histamine Release, Pharmaceutical Vehicles	approved	0
DB11998	Sorivudine	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Arabinonucleosides, Glycosides, Nucleosides, Antiviral Agents, Anti-Infective Agents	investigational	0
DB07014	2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole	Drug	0	experimental	1
DB08344	4-chloro-N-(3-methoxypropyl)-N-[(3S)-1-(2-phenylethyl)piperidin-3-yl]benzamide	Drug	0	experimental	1
DB08341	4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide	Drug	0	experimental	1
DB10669	Allspice	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB08342	S-palmitoyl-L-cysteine	Drug	0	experimental	6
DB07011	(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE	Drug	0	experimental	1
DB08340	N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE	Drug	0	experimental	1
DB07010	N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	Drug	0	experimental	2
DB07017	(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one	Drug	0	experimental	1
DB08349	N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide	Drug	0	experimental	1
DB07016	(3R)-8-(dioxidosulfanyl)-3-methyl-1,2,3,4-tetrahydroquinoline	Drug	0	experimental	1
DB07019	N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1~7,11~]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE	Drug	0	experimental	1
DB08347	4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile	Drug	0	experimental	1
DB08348	N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE	Drug	0	experimental	5
DB07018	5-ETHYL-3-[(2-METHOXYETHYL)METHYLAMINO]-6-METHYL-4-(3-METHYLBENZYL)PYRIDIN-2(1H)-ONE	Drug	0	experimental	1
DB10670	Laurus nobilis	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB10671	Caraway seed	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB10672	Clove	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB10673	Dill	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB10674	Horseradish	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB10675	Licorice	Drug	0	approved	0
DB10676	Nutmeg	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB07024	2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE	Drug	0	experimental	1
DB08356	4-[4-(4-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl]benzene-1,3-diol	Drug	0	experimental	1
DB07023	(1R)-2-[(Diaminomethylene)amino]-1-{4-[(4R)-4-(hydroxymethyl)-1,3,2-dioxaborolan-2-yl]phenyl}ethyl nicotinate	Drug	0	experimental	1
DB08357	Diethylene glycol diethyl ether	Drug	0	experimental	3
DB10677	Oregano	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB10678	Paprika	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB07026	(1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE	Drug	0	experimental	1
DB08354	2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	Drug	0	experimental	1
DB10679	White pepper	Drug	0	approved	0
DB08355	1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid	Drug	0	experimental	2
DB07025	3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE	Drug	0	experimental	1
DB08352	6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine	Drug	0	experimental	1
DB07020	N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide	Drug	0	experimental	1
DB08353	2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	Drug	0	experimental	1
DB07022	3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate	Drug	0	experimental	1
DB08350	5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE	Drug	0	experimental	1
DB08351	N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide	Drug	0	experimental	1
DB07021	(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine	Drug	0	experimental	1
DB07028	(2-{[(4-BROMO-2-FLUOROBENZYL)AMINO]CARBONYL}-5-CHLOROPHENOXY)ACETIC ACID	Drug	0	experimental	1
DB07027	D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide	Drug	0	experimental	1
DB08358	2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE	Drug	0	experimental	2
DB08359	2-PHENYLAMINO-4-METHYL-5-ACETYL THIAZOLE	Drug	0	experimental	1
DB07029	4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE	Drug	0	experimental	1
DB08360	2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	Drug	0	experimental	1
DB10681	Poppy seed	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB10683	Spearmint	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB10685	Wheat bran	Drug	0	approved	0
DB10686	American chestnut	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB08367	(R)-2-(FORMYLOXY)-3-(PHOSPHONOOXY)PROPYL PENTANOATE	Drug	0	experimental	1
DB07035	(2E)-3-{3-[(5-ETHYL-3-IODO-6-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-4-YL)OXY]PHENYL}ACRYLONITRILE	Drug	0	experimental	1
DB10687	Hops	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Herbs and Natural Products, Increased Histamine Release	approved	0
DB07034	2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID	Drug	0	experimental	1
DB10688	Musca domestica	Drug	Cell-mediated Immunity, Non-Standardized Insect Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08368	OCTANE-1,3,5,7-TETRACARBOXYLIC ACID	Drug	0	experimental	1
DB07037	(2S)-1-AMINO-3-[(5-NITROQUINOLIN-8-YL)AMINO]PROPAN-2-OL	Drug	0	experimental	1
DB08365	8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide	Drug	0	experimental	1
DB07036	(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol	Drug	0	experimental	1
DB08366	3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid	Drug	0	experimental	1
DB07031	3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid	Drug	Biological Factors, Cycloparaffins, Carotenoids, Alkenes, Hydrocarbons, Acyclic, Polyenes, Cyclohexenes, Terpenes, Cyclohexanes, Pigments, Biological	experimental	1
DB08363	1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine	Drug	0	experimental	1
DB08364	1-{[(1E)-(3-HYDROXY-2-METHYL-5-{[(TRIHYDROXY-LAMBDA^5^-PHOSPHANYL)OXY]METHYL}PYRIDIN-4-YL)METHYLIDENE]AMINO}UNDECAN-2-ONE	Drug	0	experimental	1
DB07030	(5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID	Drug	0	experimental	1
DB07033	5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE	Drug	0	experimental	1
DB08361	2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide	Drug	0	experimental	1
DB07032	2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL	Drug	0	experimental	1
DB08362	N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE	Drug	0	experimental	1
DB07039	(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide	Drug	0	experimental	1
DB07038	2-(cyclohexylamino)benzoic acid	Drug	0	experimental	1
DB08369	1-(biphenyl-4-ylmethyl)-1H-imidazole	Drug	0	experimental	1
DB07082	1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL	Drug	0	experimental	1
DB07081	(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE	Drug	0	experimental	1
DB07084	N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide	Drug	0	experimental	1
DB07083	beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide	Drug	0	experimental	1
DB07080	TO-901317	Drug	Sulfur Compounds, Amides, Hydrocarbons, Halogenated, Sulfones	experimental	6
DB07089	N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide	Drug	0	experimental	1
DB07086	4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL	Drug	0	experimental	2
DB07085	2-{[N-(2-ACETYL-5-CHLORO-4-FLUOROPHENYL)GLYCYL]AMINO}BENZOIC ACID	Drug	0	experimental	1
DB07088	(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide	Drug	0	experimental	2
DB07087	4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL	Drug	0	experimental	2
DB07093	{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID	Drug	0	experimental	1
DB07092	(2S,3S)-3-AMINO-4-(3,3-DIFLUOROPYRROLIDIN-1-YL)-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YLCYCLOHEXYL)BUTANAMIDE	Drug	0	experimental	1
DB07095	(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide	Drug	0	experimental	2
DB07094	1-(2,2'-bithiophen-5-yl)methanamine	Drug	0	experimental	1
DB07091	(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide	Drug	0	experimental	2
DB07090	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Drug	0	experimental	1
DB07097	4-tert-butyl-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide	Drug	0	experimental	1
DB07096	6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE	Drug	0	experimental	1
DB07099	N-[4-(benzyloxy)phenyl]glycinamide	Drug	0	experimental	1
DB07098	4-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide	Drug	0	experimental	1
DB10730	Juniperus osteosperma pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08411	N-[4-(4-nitrophenylphospho)butanoyl]-L-alanine	Drug	0	experimental	1
DB10731	Juniperus occidentalis pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08412	6-{4-[HYDROXY-(4-NITRO-PHENOXY)-PHOSPHORYL]-BUTYRYLAMINO}-HEXANOIC ACID	Drug	0	experimental	1
DB10732	Tilia americana pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10733	Mangifera indica pollen	Drug	0	approved	0
DB10734	Acer macrophyllum pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08410	PARA-NITROBENZYL GLUTARYL GLYCINIC ACID	Drug	0	experimental	1
DB10735	Acer saccharinum pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10736	Broussonetia papyrifera pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10737	Quercus velutina pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10738	Quercus macrocarpa pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08419	(1S)-1-(PHENOXYMETHYL)PROPYL METHYLPHOSPHONOCHLORIDOATE	Drug	0	experimental	1
DB10728	Juniperus pinchotii pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10729	Juniperus scopulorum pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08418	(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate	Drug	0	experimental	1
DB08416	(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE	Drug	0	experimental	1
DB08413	METHYL-PHOSPHONIC ACID MONO-(4-NITRO-PHENYL) ESTER	Drug	0	experimental	2
DB08414	PNU-142721	Drug	0	experimental	1
DB10740	Quercus gambelii pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10741	Quercus lobata pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08422	[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE	Drug	0	experimental	1
DB10742	Quercus nigra pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10743	Citrus sinensis pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08423	[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE	Drug	0	experimental	1
DB10744	Pinus taeda pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08420	1-{[1-(2-AMINO-3-PHENYL-PROPIONYL)-PYRROLIDINE-2-CARBONYL]-AMINO}-2-(3-CYANO-PHENYL)-ETHANEBORONIC ACID	Drug	0	experimental	1
DB08421	PIPERIDINE-2-CARBOXYLIC ACID TERT-BUTYLAMIDE	Drug	0	experimental	1
DB10745	Pinus palustris pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10746	Pinus ponderosa pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10747	Pinus elliottii pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10748	Pinus virginiana pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10749	Pinus monticola pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10739	Quercus kelloggii pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08428	3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL	Drug	0	experimental	2
DB08429	N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide	Drug	0	experimental	1
DB08426	THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE	Drug	0	experimental	1
DB08427	Prephenic acid	Drug	Cycloparaffins, Acids, Carbocyclic, Cyclohexanes	experimental	1
DB08424	[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE	Drug	0	experimental	1
DB10750	Populus nigra pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10751	Elaeagnus angustifolia pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10752	Salix lasiolepis pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB07101	PD-0325901	Drug	Amines, Benzoates, Acids, Carbocyclic, Aniline Compounds, Amides, Benzene Derivatives	investigational	1
DB10753	Salix discolor pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08433	phenyl ethenesulfonate	Drug	0	experimental	1
DB07100	4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL	Drug	0	experimental	1
DB08434	2-METHYLCARBAMOYL-3-(4-PHOSPHONOOXY-PHENYL)-CYCLOPROPANECARBOXYLIC ACID	Drug	0	experimental	1
DB10754	Populus balsamifera subsp. trichocarpa pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08431	[(3R,4S)-4-HYDROXY-3-METHYL-2-OXOHEXYL]PHOSPHONIC ACID	Drug	0	experimental	1
DB10755	Taraxacum officinale pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB07103	2-(4-METHYLPHENOXY)ETHYLPHOSPHINATE	Drug	0	experimental	1
DB08432	THYMIDINE-5'-THIOPHOSPHATE	Drug	0	experimental	1
DB10756	Atriplex polycarpa pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB07102	(2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid	Drug	0	experimental	1
DB10757	Baccharis halimifolia pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08430	PARA-NITROPHENYL 1-THIO-BETA-D-GLUCOPYRANOSIDE	Drug	0	experimental	1
DB10758	Hymenoclea salsola pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased Histamine Release	approved	0
DB10759	Allenrolfea occidentalis pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB07109	Isoferulic acid	Drug	Acids, Carbocyclic	experimental	1
DB07108	4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID	Drug	0	experimental	1
DB08439	Parecoxib	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Sensory System Agents, Cyclooxygenase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Cytochrome P-450 CYP3A4 Substrates, Selective Cyclooxygenase 2 Inhibitors (NSAIDs), Peripheral Nervous System Agents, Cytochrome P-450 CYP2C9 Substrates, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, COX-2 Inhibitors, Analgesics, Cytochrome P-450 CYP3A Substrates, Musculo-Skeletal System, Cytochrome P-450 CYP2C9 Inhibitors, Agents that produce hypertension, Central Nervous System Agents	approved	2
DB08437	Puromycin	Drug	Nephrotoxic agents, Ribonucleosides, Enzyme Inhibitors, Acids, Carbocyclic, Agents that produce neuromuscular block (indirect), Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Purines, Anti-Bacterial Agents, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Protein Synthesis Inhibitors, Carbohydrates, Antiprotozoals, Noxae, Antineoplastic Agents, Purine Nucleosides, Antimetabolites, Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Heterocyclic Compounds, Fused-Ring, Narrow Therapeutic Index Drugs, Trypanocidal Agents, Aminoglycoside Antibacterials, Nucleosides, Toxic Actions, Antiparasitic Agents, Cinnamates	experimental	13
DB07105	2-[2-(4-Chloro-Phenylsulfanyl)-Acetylamino]-3-(4-Guanidino-Phenyl)-Propionamide	Drug	0	experimental	1
DB07104	4-amino-N-[4-(benzyloxy)phenyl]butanamide	Drug	0	experimental	1
DB08438	(2E,4R,5S)-2,3,4,5-TETRAHYDROXY-6-(PALMITOYLOXY)HEX-2-ENOIC ACID	Drug	0	experimental	1
DB08435	(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid	Drug	0	experimental	1
DB07107	(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE	Drug	0	experimental	2
DB07106	SKF-91488	Drug	Histamine N-Methyltransferase, antagonists & inhibitors, Neurotransmitter Agents, Sulfur Compounds, Histamine Agonists, Thiourea, Histamine Agents	experimental	1
DB08436	8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-	Drug	0	experimental	1
DB10760	Atriplex lentiformis pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10761	Artemisia douglasiana pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10762	Artemisia ludoviciana pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased Histamine Release	approved	0
DB10763	Urtica dioica pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB07112	N-[(4-HYDROXY-8-IODOISOQUINOLIN-3-YL)CARBONYL]GLYCINE	Drug	0	experimental	1
DB10764	Iva axillaris pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08444	3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile	Drug	0	experimental	1
DB07111	(4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid	Drug	0	experimental	1
DB10765	Ambrosia deltoidea pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased Histamine Release	approved	0
DB08445	(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE	Drug	0	experimental	1
DB08442	4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol	Drug	0	experimental	1
DB07114	4-[(METHYLSULFONYL)AMINO]BENZOIC ACID	Drug	0	experimental	1
DB10766	Sarcobatus vermiculatus pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10767	Atriplex canescens pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB07113	(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE	Drug	0	experimental	1
DB08443	2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol	Drug	0	experimental	1
DB10768	Artemisia absinthium pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased Histamine Release	approved	0
DB08440	N-1,10-phenanthrolin-5-ylacetamide	Drug	0	experimental	1
DB08441	6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE	Drug	0	experimental	1
DB10769	Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated)	Drug	Actively Acquired Immunity, Vaccines, Inactivated Japanese Encephalitis Virus Vaccine	approved	0
DB07110	4-(4-FLUOROBENZYL)PIPERIDINE	Drug	0	experimental	1
DB07119	1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL	Drug	0	experimental	2
DB07116	1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE	Drug	0	experimental	1
DB08448	(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol	Drug	0	experimental	1
DB07115	N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide	Drug	0	experimental	1
DB08449	2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid	Drug	0	experimental	1
DB08446	3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile	Drug	0	experimental	1
DB07118	Hymecromone	Drug	Heterocyclic Compounds, Fused-Ring, Narrow Therapeutic Index Drugs, Alimentary Tract and Metabolism, Laboratory Chemicals, Coumarins, Indicators and Reagents, Benzopyrans, Bile Therapy, Compounds used in a research, industrial, or household setting, Umbelliferones, Bile and Liver Therapy, Pyrans	investigational, experimental	1
DB08447	3-{3-[(DIMETHYLAMINO)METHYL]-1H-INDOL-7-YL}PROPAN-1-OL	Drug	0	experimental	1
DB07117	5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE	Drug	0	experimental	1
DB10700	Phoma glomerata	Drug	0	approved	0
DB10701	Rhodotorula mucilaginosa	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10702	Stemphylium sarciniforme	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10703	Trichoderma harzianum	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10704	Ustilago avenae	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10705	Tilletia caries	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10710	Tobacco leaf	Drug	Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10711	Corcorus capsularis fiber	Drug	Cell-mediated Immunity, Non-Standardized Plant Fiber Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10712	Agave sisalana fiber	Drug	Cell-mediated Immunity, Non-Standardized Plant Fiber Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10713	Poa compressa pollen	Drug	Cell-mediated Immunity, Grass Pollen Allergen Extracts, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10714	Phalaris arundinacea pollen	Drug	Cell-mediated Immunity, Grass Pollen Allergen Extracts, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10715	Bouteloua gracilis pollen	Drug	Cell-mediated Immunity, Grass Pollen Allergen Extracts, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10716	Urochloa mutica pollen	Drug	Cell-mediated Immunity, Grass Pollen Allergen Extracts, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10706	Puccinia graminis	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10707	Cotton	Drug	Cell-mediated Immunity, Non-Standardized Plant Fiber Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10708	Flax seed	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08400	4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid	Drug	0	experimental	1
DB10720	Acacia baileyana pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10721	Alnus rubra pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08401	(2E)-2-({(2S)-2-CARBOXY-2-[(PHENOXYACETYL)AMINO]ETHOXY}IMINO)PENTANEDIOIC ACID	Drug	0	experimental	1
DB10722	Alnus rhombifolia pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10723	Fraxinus latifolia pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10724	Betula populifolia pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10725	Tamarix gallica pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10727	Juniperus monosperma pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08408	(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl 2,2-dimethylpropanoate	Drug	0	experimental	1
DB10717	Secale cereale pollen	Drug	Cell-mediated Immunity, Grass Pollen Allergen Extracts, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10718	Leymus condensatus pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08409	4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE	Drug	0	experimental	2
DB10719	Pascopyrum smithii pollen	Drug	Cell-mediated Immunity, Grass Pollen Allergen Extracts, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08406	[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE	Drug	0	experimental	1
DB08407	Platensimycin	Drug	Cycloparaffins, Hypolipidemic Agents, Amines, Benzoates, Noxae, Acids, Carbocyclic, Aniline Compounds, Amides, Antimetabolites, Anti-Infective Agents, Lipid Regulating Agents, Fatty Acid Synthesis Inhibitors, 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase, Toxic Actions, Benzene Derivatives	experimental	1
DB08404	S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEXANETHIOATE	Drug	0	experimental	1
DB08405	S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEPTANETHIOATE	Drug	0	experimental	1
DB08402	2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID	Drug	0	experimental	3
DB08403	METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID	Drug	0	experimental	2
DB08491	N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE	Drug	0	experimental	1
DB08492	(2E)-3-(2-OCT-1-YN-1-YLPHENYL)ACRYLIC ACID	Drug	0	experimental	1
DB07161	5-phenyl-1H-indazol-3-amine	Drug	0	experimental	1
DB08490	CTS-1027	Drug	Amines, Hydroxy Acids, Hydroxylamines	investigational, experimental	1
DB07160	N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCINE	Drug	0	experimental	1
DB07167	5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE	Drug	0	experimental	1
DB08499	N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide	Drug	0	experimental	1
DB07169	5R-(3,4-DICHLOROPHENYLMETHYL)-3-(2-THIOPHENESULFONYLAMINO)-4-OXO-2-THIONOTHIAZOLIDINE	Drug	0	experimental	1
DB08497	(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate	Drug	0	experimental	1
DB08498	(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate	Drug	0	experimental	1
DB07168	[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile	Drug	0	experimental	1
DB07163	5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE	Drug	0	experimental	1
DB08495	4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE	Drug	0	experimental	1
DB08496	(R)-warfarin	Drug	Cytochrome P-450 CYP2C19 Substrates, Anticoagulants, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP2C18 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP3A4 Substrates, Vitamin K Antagonists	experimental	0
DB07162	4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide	Drug	0	experimental	1
DB07165	N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE	Drug	0	experimental	1
DB08493	5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID	Drug	0	experimental	1
DB08494	S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate	Drug	0	experimental	1
DB07164	N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine	Drug	0	experimental	2
DB07170	5'-FLUORO-2',5'-DIDEOXYADENOSINE	Drug	0	experimental	1
DB07172	(5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid	Drug	0	experimental	1
DB07171	5-(2-hydroxyethyl)nonane-1,9-diol	Drug	0	experimental	1
DB07178	5-PENTYL-2-PHENOXYPHENOL	Drug	0	experimental	1
DB07177	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	Drug	0	experimental	2
DB07179	3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide	Drug	0	experimental	1
DB07174	6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-4-(3-METHOXYPROPYL)-2,2-DIMETHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE	Drug	0	experimental	1
DB07173	7-(5-DEOXY-BETA-D-RIBOFURANOSYL)-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE	Drug	0	experimental	1
DB07176	1-Naphthylamine-5-sulfonic acid	Drug	Arylsulfonates, Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfur Acids, Sulfonic Acids, Arylsulfonic Acids, Naphthalenes	experimental	0
DB07175	N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide	Drug	0	experimental	1
DB07181	4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide	Drug	0	experimental	1
DB07180	5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H-pyrrole-3-carboxamide	Drug	0	experimental	1
DB07183	N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide	Drug	0	experimental	1
DB07182	(2S)-2-(3-Carbamimidamidophenyl)-3-[hydroxy(3-phenylpropyl)phosphoryl]propanoic acid	Drug	0	experimental	1
DB07189	(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid	Drug	0	experimental	1
DB07188	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Drug	0	experimental	1
DB07185	2-{[(4-CHLOROPHENOXY)ACETYL]AMINO}BENZOIC ACID	Drug	0	experimental	1
DB07184	6-(cyclohexylsulfanyl)-1-(ethoxymethyl)-5-(1-methylethyl)pyrimidine-2,4(1H,3H)-dione	Drug	0	experimental	1
DB07187	CP-744809	Drug	0	experimental	1
DB07186	4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE	Drug	0	experimental	2
DB07192	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Drug	0	experimental	1
DB07194	2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide	Drug	0	experimental	1
DB07193	(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine	Drug	0	experimental	1
DB07190	3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide	Drug	0	experimental	1
DB07199	(2S,4S,5R)-1-(4-TERT-BUTYLBENZOYL)-2-ISOBUTYL-5-(1,3-THIAZOL-2-YL)PYRROLIDINE-2,4-DICARBOXYLIC ACID	Drug	0	experimental	2
DB07196	N-methyl-1-(2-thiophen-2-ylphenyl)methanamine	Drug	0	experimental	1
DB07195	4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL	Drug	0	experimental	2
DB07198	5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE	Drug	0	experimental	2
DB07197	4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID	Drug	0	experimental	1
DB10770	Foreskin fibroblast (neonatal)	Drug	Allogeneic Cultured Cell Scaffold	approved	11
DB10771	Bovine type I collagen	Drug	Allogeneic Cultured Cell Scaffold	approved	0
DB10772	Foreskin keratinocyte (neonatal)	Drug	Allogeneic Cultured Cell Scaffold	approved	12
DB10773	Influenza A virus A/California/7/2009 (H1N1) recombinant hemagglutinin antigen	Drug	0	approved	0
DB10774	Influenza A virus A/Victoria/361/2011 (H3N2) recombinant hemagglutinin antigen	Drug	0	approved	0
DB08455	Ro 12-7310	Drug	Biological Factors, Cycloparaffins, Carotenoids, Alkenes, Hydrocarbons, Acyclic, Polyenes, Cyclohexenes, Retinoids, Terpenes, Cyclohexanes, Pigments, Biological	experimental	0
DB10775	Influenza B virus B/Wisconsin/1/2010 recombinant hemagglutinin antigen	Drug	0	approved	0
DB07123	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	Drug	0	experimental	1
DB08456	S-[(1-Hydroxy-2,2,5,5-tetramethyl-4-phenyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate	Drug	0	experimental	1
DB07122	1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine	Drug	0	experimental	1
DB10776	Influenza A virus A/Texas/50/2012 (H3N2) recombinant hemagglutinin antigen	Drug	0	approved	0
DB07125	4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid	Drug	0	experimental	1
DB08453	2-Nonyl-4-quinolinol 1-oxide	Drug	0	experimental	18
DB10777	Influenza B virus B/Massachusetts/2/2012 recombinant hemagglutinin antigen	Drug	0	approved	0
DB08454	N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE	Drug	0	experimental	1
DB07124	(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE	Drug	0	experimental	1
DB10778	Influenza A virus A/Switzerland/9715293/2013 (H3N2) recombinant hemagglutinin antigen	Drug	0	approved	0
DB08451	N-(QUINOLIN-8-YL)METHANESULFONAMIDE	Drug	0	experimental	1
DB10779	Influenza B virus B/Phuket/3073/2013 recombinant hemagglutinin antigen	Drug	0	approved	0
DB07121	4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE	Drug	0	experimental	1
DB08450	N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine	Drug	0	experimental	1
DB07120	3-Carbamimidamido-1,1-diphenylurea	Drug	0	experimental	1
DB07127	{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID	Drug	0	experimental	1
DB08459	3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile	Drug	0	experimental	1
DB07126	O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE	Drug	0	experimental	2
DB07129	(2R)-1-(2,6-dimethylphenoxy)propan-2-amine	Drug	0	experimental	1
DB08457	4-(3,5-DIMETHYLPHENOXY)-5-(FURAN-2-YLMETHYLSULFANYLMETHYL)-3-IODO-6-METHYLPYRIDIN-2(1H)-ONE	Drug	0	experimental	1
DB07128	N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE	Drug	0	experimental	1
DB08458	(4-BROMOPHENYL)[4-({(2E)-4-[CYCLOPROPYL(METHYL)AMINO]BUT-2-ENYL}OXY)PHENYL]METHANONE	Drug	0	experimental	1
DB10780	Influenza B virus B/Hubei-Wujiagang/158/2009 BX-39 antigen (propiolactone inactivated)	Drug	0	approved	0
DB10781	Influenza A virus A/Christchurch/16/2010 NIB-74 (H1N1) antigen (propiolactone inactivated)	Drug	0	approved	0
DB10782	Influenza A virus A/Victoria/361/2011 IVR-165 (H3N2) antigen (propiolactone inactivated)	Drug	0	approved	0
DB10783	Neisseria meningitidis serogroup b nhba fusion protein antigen	Drug	0	approved	0
DB10784	Neisseria meningitidis serogroup b fhbp fusion protein antigen	Drug	0	approved	0
DB10785	Neisseria meningitidis serogroup b nada protein antigen	Drug	0	approved	0
DB07134	5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE	Drug	0	experimental	1
DB10786	Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle	Drug	0	approved	0
DB08466	5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol	Drug	0	experimental	1
DB10787	Bordetella pertussis toxoid antigen (glutaraldehyde inactivated)	Drug	Actively Acquired Immunity, Inactivated Bordetella Pertussis Vaccine	approved, investigational	0
DB08467	6-(2,3,4,5,6,7-HEXAHYDRO-2,4,4-TRIMETHYL-1-METYLENEINDEN-2-YL)-3-METHYLHEXA-2,4-DIENOIC ACID	Drug	0	experimental	0
DB07133	D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide	Drug	0	experimental	1
DB07136	BX-528	Drug	0	experimental	1
DB08464	METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE	Drug	0	experimental	2
DB10788	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated)	Drug	Actively Acquired Immunity, Inactivated Bordetella Pertussis Vaccine	approved, investigational	0
DB07135	(2S,3S)-3-AMINO-4-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-5-YLCYCLOHEXYL)BUTANAMIDE	Drug	0	experimental	1
DB10789	Bordetella pertussis pertactin antigen	Drug	Membrane Proteins, Proteins, Toxins, Biological, Biological Factors, Bordetella bronchiseptica, Bacterial Toxins, Amino Acids, Peptides, and Proteins, Bordetella pertussis, Virulence Factors, Bacterial Proteins	approved, investigational	0
DB08465	2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE	Drug	0	experimental	2
DB08462	N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE	Drug	0	experimental	1
DB07130	4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID	Drug	0	experimental	1
DB08463	(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol	Drug	0	experimental	2
DB07132	1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA	Drug	0	experimental	1
DB08460	MK-4965	Drug	HIV Reverse Transcriptase, antagonists & inhibitors	experimental	1
DB07131	(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide	Drug	0	experimental	2
DB08461	3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL	Drug	0	experimental	1
DB07138	Neflamapimod	Drug	0	investigational	1
DB07137	(2S)-N-[(3E)-5-Cyclopropyl-3H-pyrazol-3-ylidene]-2-[4-(2-oxo-1-imidazolidinyl)phenyl]propanamide	Drug	0	experimental	2
DB07139	3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid	Drug	0	experimental	1
DB08469	tert-butyl 4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate	Drug	0	experimental	1
DB08470	3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole	Drug	0	experimental	1
DB10790	Bordetella pertussis fimbriae 2/3 antigen	Drug	Actively Acquired Immunity, Inactivated Bordetella Pertussis Vaccine	approved, investigational	0
DB10791	Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (formaldehyde inactivated)	Drug	0	approved, investigational	0
DB10792	Influenza A virus A/Switzerland/9715293/2013 NIB-88 (H3N2) antigen (formaldehyde inactivated)	Drug	0	approved, investigational	0
DB10793	Influenza B virus B/Phuket/3073/2013 antigen (formaldehyde inactivated)	Drug	0	approved, investigational	0
DB10794	Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated)	Drug	Actively Acquired Immunity, Inactivated Influenza B Virus Vaccine, Influenza Vaccines, Vaccines	approved	0
DB10795	Poliovirus type 1 antigen (formaldehyde inactivated)	Drug	Actively Acquired Immunity, Inactivated Poliovirus Vaccine	approved, investigational	0
DB10796	Poliovirus type 2 antigen (formaldehyde inactivated)	Drug	Actively Acquired Immunity, Inactivated Poliovirus Vaccine	approved, investigational	0
DB10797	Poliovirus type 3 antigen (formaldehyde inactivated)	Drug	Actively Acquired Immunity, Inactivated Poliovirus Vaccine	approved, investigational	0
DB07145	(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE	Drug	0	experimental	1
DB08478	N-[2-Chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide	Drug	0	experimental	1
DB10798	Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen	Drug	Actively Acquired Immunity, Inactivated Meningococcal Vaccine	approved, investigational	0
DB07144	5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine	Drug	0	experimental	1
DB07147	methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate	Drug	0	experimental	1
DB10799	Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen	Drug	Actively Acquired Immunity, Inactivated Meningococcal Vaccine	approved	0
DB08475	[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl hydrogen hex-5-enylphosphonate	Drug	0	experimental	1
DB08476	3-AMINO-AZACYCLOTRIDECAN-2-ONE	Drug	0	experimental	1
DB07146	2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE	Drug	0	experimental	1
DB07141	5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine	Drug	0	experimental	1
DB08473	Dichlororibofuranosylbenzimidazole	Drug	Carbohydrates, Ribonucleosides, Enzyme Inhibitors, Nucleic Acid Synthesis Inhibitors, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides	experimental	1
DB08474	3-(CARBOXYAMIDE(2-CARBOXYAMIDE-2-TERTBUTYLETHYL))PENTAN	Drug	0	experimental	1
DB07140	5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine	Drug	0	experimental	2
DB07143	D-phenylalanyl-N-benzyl-L-prolinamide	Drug	0	experimental	1
DB08471	1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine	Drug	0	experimental	1
DB08472	(R)-Fluoxetine	Drug	0	experimental	1
DB07142	5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine	Drug	0	experimental	2
DB07149	(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one	Drug	0	experimental	1
DB07148	(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one	Drug	0	experimental	1
DB08479	N-(3,5-dimethoxyphenyl)imidodicarbonimidic diamide	Drug	0	experimental	1
DB08480	4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN	Drug	0	experimental	1
DB08481	4-Methyl-N-[5-(5-methyl-furan-2-ylmethylene)-4-oxo-thiazolidin-2-ylidene]-benzenesulfonamide	Drug	0	experimental	1
DB07150	4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME	Drug	0	experimental	2
DB07156	(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione	Drug	0	experimental	1
DB08488	4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE	Drug	0	experimental	1
DB08489	N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE	Drug	0	experimental	1
DB07155	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	Drug	0	experimental	1
DB08486	Efaproxiral	Drug	Acids, Acyclic, Amines, Antisickling Agents, Fatty Acids, Photosensitizing Agents, Fatty Acids, Volatile, Antineoplastic and Immunomodulating Agents, Sensitizers Used in Photodynamic/radiation Therapy, Antineoplastic Agents, Hematologic Agents, Lipids, Radiation-Sensitizing Agents	investigational	2
DB07158	5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE	Drug	0	experimental	1
DB08487	3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE	Drug	0	experimental	1
DB07157	(5R,6S,8S)-8-[3-(AMINOMETHYL)PHENYL]-6-HYDROXY-5-ISOPROPYL-3-OXO-1-PHENYL-2,7-DIOXA-4-AZA-6-PHOSPHANONAN-9-OIC ACID 6-OXIDE	Drug	0	experimental	1
DB07152	N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide	Drug	0	experimental	1
DB08484	4-AMINO-N-[(2-SULFANYLETHYL)CARBAMOYL]BENZENESULFONAMIDE	Drug	0	experimental	1
DB07151	4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one	Drug	0	experimental	1
DB08485	(1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID	Drug	0	experimental	1
DB08482	[[1-[N-HYDROXY-ACETAMIDYL]-3-METHYL-BUTYL]-CARBONYL-LEUCINYL]-ALANINE ETHYL ESTER	Drug	0	experimental	1
DB07154	(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE	Drug	0	experimental	1
DB07153	6-methyl-5-[3-methyl-3-(3,4,5-trimethoxyphenyl)but-1-yn-1-yl]pyrimidine-2,4-diamine	Drug	0	experimental	1
DB07159	Tamatinib	Drug	0	investigational, experimental	1
DB10800	Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen	Drug	Actively Acquired Immunity, Inactivated Meningococcal Vaccine	approved	0
DB10801	Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen	Drug	Actively Acquired Immunity, Inactivated Meningococcal Vaccine	approved	0
DB10802	Influenza A virus A/California/7/2009(H1N1)-like antigen (formaldehyde inactivated)	Drug	0	approved	0
DB10803	Typhoid Vi polysaccharide vaccine	Drug	Inactivated Salmonella Typhi Vaccine, Actively Acquired Immunity, Vaccines	approved	0
DB10804	Bacillus calmette-guerin substrain connaught live antigen	Drug	Live vaccines, Vaccines, Live Attenuated Bacillus Calmette-Guerin Vaccine	approved, investigational	0
DB10850	Verticillium albo-atrum	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10851	White catfish	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB07200	(2S,4S,5R)-2-ISOBUTYL-5-(2-THIENYL)-1-[4-(TRIFLUOROMETHYL)BENZOYL]PYRROLIDINE-2,4-DICARBOXYLIC ACID	Drug	0	experimental	2
DB10852	Carob	Drug	Carbohydrates, Cell-mediated Immunity, Antidiarrheals, Non-Standardized Plant Allergenic Extract, Plant Exudates, Biopolymers, Macromolecular Substances, Non-Standardized Food Allergenic Extract, Polysaccharides, Complex Mixtures, Biological Products, Polymers, Compounds used in a research, industrial, or household setting, Gastrointestinal Agents, Increased Histamine Release	approved	0
DB08532	6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine	Drug	0	experimental	1
DB10853	Sweet cherry	Drug	0	approved	0
DB08533	3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine	Drug	0	experimental	1
DB07202	6-CHLORO-3-(3-METHYLISOXAZOL-5-YL)-4-PHENYLQUINOLIN-2(1H)-ONE	Drug	0	experimental	1
DB08530	7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE	Drug	0	experimental	1
DB08531	5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	Drug	0	experimental	1
DB07201	(2S)-3-[(9H-fluoren-9-ylideneamino)oxy]-2-methylpropanoic acid	Drug	0	experimental	0
DB10855	Opilio crab	Drug	0	approved	0
DB10856	Bos taurus hair	Drug	Cell-mediated Immunity, Non-Standardized Animal Hair Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10857	Serinus canaria feather	Drug	Cell-mediated Immunity, Non-Standardized Feather Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10858	Melilotus albus pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10859	Melilotus officinalis pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10849	Tetracoccosporium paxianum	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB07208	(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid	Drug	0	experimental	1
DB07207	2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE	Drug	0	experimental	2
DB08538	N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine	Drug	0	experimental	1
DB08539	3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	Drug	0	experimental	1
DB07209	(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid	Drug	0	experimental	1
DB08536	3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine	Drug	0	experimental	1
DB07204	(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE	Drug	0	experimental	2
DB07203	6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE	Drug	0	experimental	2
DB08537	3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine	Drug	0	experimental	1
DB08534	5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	Drug	0	experimental	1
DB07206	6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE	Drug	0	experimental	1
DB07205	N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	Drug	0	experimental	1
DB08535	3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	Drug	0	experimental	1
DB10860	Typha latifolia pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10861	Atlantic cod	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB10862	Red currant	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB07211	(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE	Drug	0	experimental	2
DB08543	1-[2-HYDROXY-3-(4-CYCLOHEXYL-PHENOXY)-PROPYL]-4-(2-PYRIDYL)-PIPERAZINE	Drug	0	experimental	1
DB08544	(S)-Fluoxetine	Drug	0	experimental	1
DB10864	Cumin	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB07210	3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	Drug	0	experimental	1
DB10865	Cladosporium herbarum	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB07213	(5-{3-[5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL]-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL	Drug	0	experimental	1
DB08541	[(3S)-9-hydroxy-1-methyl-10-oxo-4,10-dihydro-3H-benzo[g]isochromen-3-yl]acetic acid	Drug	0	experimental	1
DB08542	3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione	Drug	0	experimental	1
DB10866	Acheta domesticus	Drug	Cell-mediated Immunity, Non-Standardized Insect Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB07212	N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE	Drug	0	experimental	1
DB10867	Canis lupus familiaris hair	Drug	Cell-mediated Immunity, Non-Standardized Animal Hair Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10868	Odocoileus virginianus hair	Drug	0	approved	0
DB08540	2-[4-(2H-1,4-BENZOTHIAZINE-3-YL)-PIPERAZINE-1-LY]-1,3-THIAZOLE-4-CARBOXYLIC ACID ETHYLESTER	Drug	0	experimental	1
DB10869	Grain mill dust	Drug	0	approved	0
DB07219	BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE	Drug	0	experimental	1
DB07218	6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE	Drug	0	experimental	2
DB08549	(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER	Drug	0	experimental	1
DB08547	PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE	Drug	0	experimental	1
DB07215	GW-590735	Drug	Acids, Acyclic, Sulfur Compounds, Fatty Acids, Fatty Acids, Volatile, Lipids	investigational	2
DB08548	[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl hydrogen hex-5-enylphosphonate	Drug	0	experimental	1
DB07217	N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide	Drug	0	experimental	1
DB09876	Clostridium tetani	Drug	0	approved	0
DB08545	(1S)-1-Phenylethyl (4-acetamidobenzyl)phosphonate	Drug	0	experimental	1
DB07216	(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE	Drug	0	experimental	2
DB09877	Corynebacterium diphtheriae	Drug	0	approved, investigational	0
DB08546	4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE	Drug	0	experimental	1
DB10870	Epidermophyton floccosum	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10871	Ambrosia dumosa pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased Histamine Release	approved	0
DB10872	Ambrosia confertiflora pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10873	Sporisorium cruentum	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10874	Goose	Drug	0	approved	0
DB08554	N-(3-carboxypropanoyl)-L-norvaline	Drug	0	experimental	2
DB07222	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	Drug	0	experimental	1
DB07221	(2,2-DIPHOSPHONOETHYL)(DODECYL)DIMETHYLPHOSPHONIUM	Drug	0	experimental	1
DB08555	1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline	Drug	0	experimental	1
DB10875	Concord grape	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB07224	N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE	Drug	0	experimental	1
DB08552	(1R)-1-(2-thienylacetylamino)-1-phenylmethylboronic acid	Drug	0	experimental	1
DB10876	Capra hircus hair	Drug	Cell-mediated Immunity, Non-Standardized Animal Hair Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10877	Cavia porcellus hair	Drug	Cell-mediated Immunity, Non-Standardized Animal Hair Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB07223	METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE	Drug	0	experimental	1
DB08553	(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime	Drug	0	experimental	1
DB08550	7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Isoquinolines, Monoamine Oxidase Inhibitors, Antidepressive Agents, Phenylethanolamine N-Methyltransferase, antagonists & inhibitors	experimental	1
DB08551	3-{(R)-(Dihydroxyboryl)[(2-thienylacetyl)amino]methyl}benzoic acid	Drug	0	experimental	3
DB10879	Arrhenatherum elatius pollen	Drug	Cell-mediated Immunity, Grass Pollen Allergen Extracts, Non-Standardized Pollen Allergenic Extract, Increased Histamine Release	approved	0
DB07220	N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE	Drug	0	experimental	1
DB07229	3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE	Drug	0	experimental	1
DB08558	2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL	Drug	0	experimental	4
DB07226	N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE	Drug	0	experimental	1
DB08559	N-[(2S,4S,6R)-2-(dihydroxymethyl)-4-hydroxy-3,3-dimethyl-7-oxo-4lambda~4~-thia-1-azabicyclo[3.2.0]hept-6-yl]-2-phenylacetamide	Drug	0	experimental	1
DB07225	N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE	Drug	0	experimental	1
DB07228	1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA	Drug	0	experimental	1
DB08556	5'-ACETYL-4-{[(2,4-DIMETHYLPHENYL)SULFONYL]AMINO}-2,2'-BITHIOPHENE-5-CARBOXYLIC ACID	Drug	0	experimental	1
DB07227	L-778123	Drug	0	experimental	3
DB08557	2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide	Drug	0	experimental	1
DB10880	Equus caballus hair	Drug	Cell-mediated Immunity, Non-Standardized Animal Hair Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10881	Sus scrofa hair	Drug	Cell-mediated Immunity, Non-Standardized Animal Hair Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10882	Carya cordiformis pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10883	Carya glabra pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10884	Millet seed	Drug	0	approved	0
DB08565	L-1-naphthyl-2-acetamido-ethane boronic acid	Drug	0	experimental	1
DB10885	Mustard greens	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB07233	N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan	Drug	0	experimental	1
DB08566	D-1-naphthyl-2-acetamido-ethane boronic acid	Drug	0	experimental	1
DB07232	Veliparib	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Antineoplastic Agents, Poly(ADP-ribose) Polymerase Inhibitors	investigational	2
DB10886	Quercus muehlenbergii pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB07235	N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE	Drug	0	experimental	1
DB10887	Quercus palustris pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08564	(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide	Drug	0	experimental	1
DB07234	3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione	Drug	0	experimental	1
DB10888	Quercus stellata pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10889	Quercus garryana pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08561	BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE	Drug	0	experimental	1
DB08562	4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID	Drug	0	experimental	3
DB07231	N-({(2S,3S)-3-[(BENZYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINE	Drug	0	experimental	1
DB07230	3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE	Drug	0	experimental	2
DB08560	3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE	Drug	0	experimental	1
DB07237	{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone	Drug	0	experimental	1
DB08569	3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE	Drug	0	experimental	2
DB07236	3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL	Drug	0	experimental	2
DB07239	7-(aminomethyl)-6-(2-chlorophenyl)-1-methyl-1H-benzimidazole-5-carbonitrile	Drug	0	experimental	1
DB08568	A-674563	Drug	Heterocyclic Compounds, Fused-Ring, Pyrazoles	experimental	2
DB07238	Nesbuvir	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amides, Sulfones	investigational	2
DB10810	Penicillium expansum	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10811	Penicillium italicum	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10812	Penicillium roqueforti	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10813	Phoma destructiva	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10814	Rhizopus stolonifer	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10815	Fraxinus pennsylvanica pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10805	Yellow Fever Vaccine	Drug	Live Attenuated Yellow Fever Virus Vaccine, Live vaccines, Complex Mixtures, Actively Acquired Immunity, Viral Vaccines, Yellow Fever Vaccines, Biological Products, Vaccines, Antiinfectives for Systemic Use	approved, investigational	0
DB10806	Fusarium oxysporum	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10807	Candida tropicalis	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10808	Mucor racemosus	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10809	Penicillium camemberti	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08500	(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol	Drug	0	experimental	1
DB10820	Hypomyces perniciosus	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10821	Neurospora crassa	Drug	0	approved	0
DB10822	Paecilomyces variotii	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10823	Microascus brevicaulis	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10824	Colletotrichum coccodes	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10825	Pleospora herbarum	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10826	Streptomyces griseus	Drug	Cell-mediated Immunity, Non-Standardized Bacterial Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10816	Atriplex confertifolia pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08507	N-[[2-METHYL-4-HYDROXYCARBAMOYL]BUT-4-YL-N]-BENZYL-P-[PHENYL]-P-[METHYL]PHOSPHINAMID	Drug	0	experimental	1
DB10817	Passalora fulva	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08508	N-BENZOYL-D-ALANINE	Drug	Amino Acids, Peptides, and Proteins, Amino Acids	experimental	1
DB08505	methyl 4-bromo-N-[8-(hydroxyamino)-8-oxooctanoyl]-L-phenylalaninate	Drug	0	experimental	1
DB10818	Cochliobolus spicifer	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08506	N-{(2S)-3-[(1R)-1-aminoethyl](hydroxy)phosphoryl-2-benzylpropanoyl}-L-phenylalanine	Drug	0	experimental	1
DB10819	Myrothecium verrucaria	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08503	(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol	Drug	0	experimental	1
DB08504	6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM	Drug	0	experimental	1
DB08501	DIETHYL PROPANE-1,3-DIYLBISCARBAMATE	Drug	0	experimental	1
DB08502	Capravirine	Drug	Enzyme Inhibitors, Cytochrome P-450 Substrates, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Cytochrome P-450 CYP3A4 Substrates, Non-Nucleoside Reverse Transcriptase Inhibitors, Anti-Infective Agents, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Nucleic Acid Synthesis Inhibitors, Cytochrome P-450 CYP3A Substrates, Reverse Transcriptase Inhibitors, Cytochrome P-450 CYP2C8 Substrates	investigational	1
DB08509	1-[6-(2-CHLORO-4-METHYXYPHENOXY)-HEXYL]-IMIDAZOLE	Drug	0	experimental	1
DB08510	5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE	Drug	0	experimental	1
DB10830	Mung bean	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB10831	Betula papyrifera pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08511	6-amino-2-methyl-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one	Drug	0	experimental	1
DB10832	Betula occidentalis pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10833	Betula alleghaniensis pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10834	Ustilago cynodontis	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10835	Ustilago nuda hordei	Drug	Allergens, Cell-mediated Immunity, Fungal Proteins, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10836	Bromus secalinus pollen	Drug	Cell-mediated Immunity, Grass Pollen Allergen Extracts, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10837	Beta vulgaris pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10827	Trichoderma viride	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08519	N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine	Drug	0	experimental	1
DB10828	Trichophyton schoenleinii	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08516	(S)-(+)-2-[4-(FLUOROBENZYLOXY-BENZYLAMINO)PROPIONAMIDE]	Drug	0	experimental	1
DB10829	Basil	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB08517	Sakuranetin	Drug	Heterocyclic Compounds, Fused-Ring, Benzopyrans, Chromones, Pyrans	experimental	1
DB08514	6-amino-2-[(thiophen-2-ylmethyl)amino]-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one	Drug	0	experimental	1
DB08515	(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE	Drug	0	experimental	14
DB08512	6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one	Drug	0	experimental	1
DB08513	[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID	Drug	0	experimental	3
DB10840	Acrothecium robustum	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08521	4-[4-(4-Fluorophenyl)-2-[4-[(R)-methylsulfinyl]phenyl]-1H-imidazol-5-yl]pyridine	Drug	0	experimental	2
DB10841	Humicola grisea	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08522	4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE	Drug	0	experimental	1
DB10842	Microsporum audouinii	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10843	Microsporum canis	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10844	Apiospora montagnei	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased Histamine Release	approved	0
DB08520	(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE	Drug	0	experimental	1
DB10845	Phycomyces blakesleeanus	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10846	Sporotrichum pruinosum	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10847	Stachybotrys chartarum	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10848	Syncephalastrum racemosum	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08529	(6E,11E)-HEPTADECA-6,11-DIENE-9,9-DIYLBIS(PHOSPHONIC ACID)	Drug	0	experimental	1
DB10838	Chenopodium botrys pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10839	Mycocladus corymbiferus	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08527	1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE	Drug	0	experimental	2
DB08528	2-AMINO-6-(3,5-DIMETHYLPHENYL)SULFONYLBENZONITRILE	Drug	0	experimental	1
DB08525	HYDROXY[3-(6-METHYLPYRIDIN-2-YL)PROPYL]FORMAMIDE	Drug	0	experimental	1
DB08526	CARBOBENZYLOXY-(L)-LEUCINYL-(L)LEUCINYL METHOXYMETHYLKETONE	Drug	0	experimental	1
DB08523	[HYDROXY(3-PHENYLPROPYL)AMINO]METHANOL	Drug	0	experimental	2
DB08524	2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE	Drug	0	experimental	1
DB07280	5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE	Drug	0	experimental	1
DB07282	3-({[(1Z)-(2-methoxyphenyl)methylidene]amino}oxy)propanoic acid	Drug	0	experimental	0
DB07281	N~3~-BENZYLPYRIDINE-2,3-DIAMINE	Drug	0	experimental	1
DB07288	N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide	Drug	0	experimental	1
DB07287	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	Drug	0	experimental	1
DB07289	5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID	Drug	0	experimental	1
DB07284	N~3~-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE	Drug	0	experimental	1
DB07283	9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid	Drug	0	experimental	0
DB07286	BMS-564929	Drug	0	experimental	1
DB07285	(3R)-4,4-DIFLUORO-3-[(4-METHOXYPHENYL)SULFONYL]BUTANOIC ACID	Drug	0	experimental	1
DB07291	5-amino-1-(4-chlorophenyl)-1H-pyrazole-4-carbonitrile	Drug	0	experimental	1
DB07290	(2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDE	Drug	0	experimental	1
DB07293	benzyl (2-oxopropyl)carbamate	Drug	0	experimental	1
DB07292	4-(2-amino-1,3-thiazol-4-yl)phenol	Drug	0	experimental	1
DB07299	4-METHYL-PENTANOIC ACID {1-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYLCARBAMOYL]-2-METHYL-PROPYL}-AMIDE	Drug	0	experimental	1
DB07298	3-(CARBOXYMETHOXY)THIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID	Drug	0	experimental	1
DB07295	2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID	Drug	0	experimental	1
DB07294	3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid	Drug	0	experimental	1
DB07297	5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE	Drug	0	experimental	1
DB07296	(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE	Drug	0	experimental	1
DB10890	Red bell pepper	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB10891	Perch	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB10892	Pumpkin	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB10893	Melopsittacus undulatus feather	Drug	Cell-mediated Immunity, Non-Standardized Feather Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10894	Pinus contorta pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10895	Pinus sylvestris pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08576	1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)-2-(METHYLAMINO)ETHANONE	Drug	0	experimental	1
DB07244	5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE	Drug	0	experimental	2
DB10896	Pinus rigida pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB07243	(3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLATE	Drug	0	experimental	1
DB10897	Capsicum	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB08577	3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE	Drug	0	experimental	1
DB08574	(5R)-2-sulfanyl-5-[4-(trifluoromethyl)benzyl]-1,3-thiazol-4(5H)-one	Drug	0	experimental	1
DB10898	Oryctolagus cuniculus hair	Drug	Cell-mediated Immunity, Non-Standardized Animal Hair Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB07246	(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE	Drug	0	experimental	1
DB10899	Sequoia sempervirens pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08575	2-[(1S)-1-BENZYL-2-SULFANYLETHYL]-1H-IMIDAZO[4,5-C]PYRIDIN-5-IUM	Drug	0	experimental	1
DB07245	6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE	Drug	0	experimental	1
DB07240	3-[(9H-fluoren-9-ylideneamino)oxy]propanoic acid	Drug	0	experimental	0
DB08572	4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE	Drug	0	experimental	2
DB08573	3-[(4-CHLOROANILINO)SULFONYL]THIOPHENE-2-CARBOXYLIC ACID	Drug	0	experimental	1
DB07242	(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile	Drug	0	experimental	2
DB08570	4-(ACETYLAMINO)-3-HYDROXY-5-NITROBENZOIC ACID	Drug	Neuraminidase, antagonists & inhibitors, Benzoates, Acids, Carbocyclic, Benzene Derivatives	experimental	2
DB07241	7-carboxy-5-hydroxy-12,13-dihydro-6H-indolo[2,3-a]pyrrolo[3,4-c]carbazole	Drug	0	experimental	1
DB08571	4-(ACETYLAMINO)-5-AMINO-3-HYDROXYBENZOIC ACID	Drug	0	experimental	1
DB07248	7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE	Drug	0	experimental	1
DB07247	[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA	Drug	0	experimental	2
DB08578	4-[(5-bromopyridin-2-yl)amino]-4-oxobutanoic acid	Drug	0	experimental	1
DB08579	4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}aniline	Drug	0	experimental	1
DB07249	N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine	Drug	0	experimental	1
DB08580	4-bromo-2-{[(2R)-2-(2-chlorobenzyl)pyrrolidin-1-yl]carbonyl}aniline	Drug	0	experimental	1
DB07255	N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE	Drug	0	experimental	1
DB08587	Sinapic acid	Drug	Acids, Carbocyclic, Laboratory Chemicals, Indicators and Reagents, Compounds used in a research, industrial, or household setting, Cinnamates	experimental	1
DB08588	2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE	Drug	0	experimental	1
DB07254	N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE	Drug	0	experimental	1
DB08585	S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] hexanethioate	Drug	0	experimental	1
DB07257	4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione	Drug	0	experimental	1
DB07256	3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE	Drug	0	experimental	1
DB08586	S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] octanethioate	Drug	0	experimental	1
DB07251	N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE	Drug	0	experimental	1
DB08583	2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide	Drug	0	experimental	1
DB07250	N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE	Drug	0	experimental	1
DB07253	N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine	Drug	0	experimental	1
DB08581	4-[(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)amino]-4-oxobutanoic acid	Drug	0	experimental	1
DB08582	N-(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)-4-morpholin-4-yl-4-oxobutanamide	Drug	0	experimental	1
DB07252	3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide	Drug	0	experimental	1
DB07259	1-(4-thiophen-2-ylphenyl)methanamine	Drug	0	experimental	1
DB07258	(R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol	Drug	0	experimental	1
DB08589	SYRINGATE	Drug	0	experimental	1
DB08590	1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE	Drug	0	experimental	1
DB08591	5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE	Drug	0	experimental	1
DB07260	N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline	Drug	0	experimental	1
DB07266	AKI-001	Drug	Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors	experimental	1
DB08598	R-82913	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Nucleic Acid Synthesis Inhibitors, Benzazepines, HIV Reverse Transcriptase, antagonists & inhibitors, Anti-Retroviral Agents, Antiviral Agents, Reverse Transcriptase Inhibitors, Anti-HIV Agents, Anti-Infective Agents	experimental	2
DB07265	3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID	Drug	0	experimental	1
DB08599	N-[(4-methoxyphenyl)sulfonyl]-D-alanine	Drug	0	experimental	1
DB07268	2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE	Drug	0	experimental	1
DB08596	5'-deoxy-5'-piperidin-1-ylthymidine	Drug	0	experimental	1
DB07267	2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine	Drug	0	experimental	1
DB08597	Dorsomorphin	Drug	Enzyme Inhibitors, Protein Kinase Inhibitors, AMP-Activated Protein Kinases, antagonists & inhibitors	experimental	2
DB07262	1-{[N-(1-Imino-guanidino-methyl)]sulfanylmethyl}-3-trifluoromethyl-benzene	Drug	0	experimental	1
DB08594	TERT-BUTYL 2-CYANO-2-METHYLHYDRAZINECARBOXYLATE	Drug	0	experimental	1
DB07261	THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE	Drug	0	experimental	1
DB08595	4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL	Drug	0	experimental	2
DB07264	(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	Drug	0	experimental	1
DB08593	1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE	Drug	0	experimental	1
DB07263	[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid	Drug	0	experimental	1
DB07269	(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-METHYLPROPYL](HYDROXY)PHOSPHORYL]PROPANOIC ACID	Drug	0	experimental	1
DB07271	4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one	Drug	0	experimental	1
DB07270	N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE	Drug	0	experimental	1
DB07277	2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE	Drug	0	experimental	2
DB07276	5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE	Drug	0	experimental	2
DB07279	N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE	Drug	0	experimental	1
DB07278	GW-813893	Drug	Anticoagulants, Enzyme Inhibitors, Sulfur Compounds, Antithrombins, Factor Xa Inhibitors, Protease Inhibitors, Pyrrolidines, Amides, Hematologic Agents, Serine Protease Inhibitors, Sulfones	experimental	2
DB07273	1-[(2-AMINO-4-CHLORO-5-METHYLPHENYL)SULFONYL]-L-PROLINE	Drug	0	experimental	1
DB07272	N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE	Drug	0	experimental	2
DB07275	3-(1,1-dioxido-4H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1-(3-methylbutyl)quinolin-2(1H)-one	Drug	0	experimental	1
DB07274	N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide	Drug	0	experimental	1
DB10900	Rumex obtusifolius pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10901	Rumex altissimus pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10902	Rumex salicifolius var. mexicanus pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10903	Sitotroga cerealella	Drug	0	approved	0
DB10910	Helianthus annuus pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10911	Carpinus caroliniana pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10912	Picea pungens pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10913	Starch, tapioca	Drug	0	approved	0
DB10914	Larix occidentalis pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10904	English sole	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB10905	Safflower	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB10906	Sugarcane	Drug	0	approved	0
DB10907	Sunflower seed	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB10908	Platanus hybrida pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10909	Artemisia californica pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased Histamine Release	approved	0
DB10921	Artemisia dracunculus pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10922	Pinus banksiana pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10923	Pinus resinosa pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10924	Pinus nigra pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10925	Pinus thunbergii pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08606	(3R,4S)-1-[(4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)METHYL]-4-[(METHYLSULFANYL)METHYL]PYRROLIDIN-3-OL	Drug	0	experimental	1
DB10915	Trichophyton rubrum	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08607	(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE	Drug	0	experimental	1
DB10916	Salix lucida ssp. lasiandra pollen	Drug	0	approved	0
DB08604	Triclosan	Drug	Hypolipidemic Agents, Noxae, Medicated Dressings, Antiseptics and Disinfectants, Dermatologicals, Anti-Infective Agents, Anti-Infective Agents, Local, Phenyl Ethers, Lipid Regulating Agents, Fatty Acid Synthesis Inhibitors, Medicated Dressings With Antiinfectives, Phenols, Toxic Actions, Ethers, Benzene Derivatives, Miscellaneous Local Anti-infectives, Phenol and Derivatives	approved, investigational	10
DB10917	Juniperus virginiana	Drug	Oils, Lipids, Plant Oils	approved	0
DB08605	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	Drug	0	experimental	2
DB10918	Venison	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB08602	3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one	Drug	0	experimental	1
DB10919	Black walnut	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB08603	N-[(1S)-5-amino-1-(chloroacetyl)pentyl]-4-methylbenzenesulfonamide	Drug	0	experimental	1
DB08600	Tivirapine	Drug	0	experimental	1
DB08601	Tributyltin	Drug	Organometallic Compounds, Organotin Compounds	experimental	2
DB08608	4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE	Drug	0	experimental	1
DB08609	(2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide	Drug	0	experimental	1
DB10970	Trichophyton tonsurans	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10971	Mycogone nigra	Drug	0	approved	0
DB10972	Absidia capillata	Drug	0	approved	0
DB10973	Thermomyces lanuginosus	Drug	0	approved	0
DB07321	2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE	Drug	0	experimental	1
DB08653	Tryptamine	Drug	Heterocyclic Compounds, Fused-Ring, Amines, Biogenic Amines, Indoles, Biogenic Monoamines	experimental	2
DB07320	4-(6-{[(4-METHYLCYCLOHEXYL)AMINO]METHYL}-1,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)BENZOIC ACID	Drug	0	experimental	1
DB08654	TRANS-(1S,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL	Drug	0	experimental	1
DB10974	Trichosporon cutaneum	Drug	0	approved	0
DB07323	2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID	Drug	0	experimental	1
DB10975	Tanacetum cinerariifolium flower	Drug	Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08651	3'-THIO-THYMIDINE-5'-PHOSPHATE	Drug	0	experimental	2
DB08652	Indoleacetamide	Drug	Heterocyclic Compounds, Fused-Ring, Indoles	experimental	2
DB10976	Largemouth bass	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB07322	2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID	Drug	0	experimental	1
DB10977	Cocoa	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB10979	Blue crab	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB07329	1-[N-4'-NITROBENZYL-N-4'-CARBOXYBUTYLAMINO]METHYLPHOSPHONIC ACID	Drug	0	experimental	1
DB07328	METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE	Drug	0	experimental	1
DB08659	2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide	Drug	0	experimental	1
DB08657	2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID	Drug	Sulfur Compounds	experimental	1
DB07325	N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE	Drug	0	experimental	1
DB07324	3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE	Drug	0	experimental	1
DB08658	ETHYL HYDROGEN DIETHYLAMIDOPHOSPHATE	Drug	0	experimental	1
DB07327	R-95845	Drug	Acids, Acyclic, Fatty Acids, Ketones, Fatty Acids, Volatile, Amides, Lipids, Acetates	experimental	2
DB08655	9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE	Drug	0	experimental	1
DB07326	6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide	Drug	0	experimental	1
DB08656	5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide	Drug	0	experimental	1
DB10980	Barley malt	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB10981	Radish	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB10982	Sage	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB10983	Thyme	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased IgG Production, Increased Histamine Release	approved	0
DB07332	ALPHA-(2,6-DICHLOROPHENYL)-ALPHA-(2-ACETYL-5-METHYLANILINO)ACETAMIDE	Drug	0	experimental	2
DB08664	({3-[1-(4-Hydroxy-2-oxo-2H-chromen-3-yl)-propyl]-phenylcarbamoyl}-methyl)-carbamic acid tert-butyl ester	Drug	0	experimental	1
DB10984	Peppermint	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Herbs and Natural Products, Increased Histamine Release	approved	0
DB08665	6,11-DIHYDRO-11-ETHYL-6-METHYL-9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN-5-ONE	Drug	0	experimental	1
DB07331	p-Nitrophenylacetic acid	Drug	Acids, Carbocyclic	experimental	1
DB10985	Ulmus rubra pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08662	3-[1-(4-BROMO-PHENYL)-2-METHYL-PROPYL]-4-HYDROXY-CHROMEN-2-ONE	Drug	0	experimental	1
DB07334	N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE	Drug	0	experimental	1
DB10986	Pseudotsuga menziesii pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10987	Carya laciniosa pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08663	4-HYDROXY-7-METHOXY-3-(1-PHENYL-PROPYL)-CHROMEN-2-ONE	Drug	0	experimental	1
DB07333	N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE	Drug	0	experimental	1
DB08660	Quinalizarin	Drug	Anthracenes, Quinones	experimental	1
DB10988	Maclura pomifera pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10989	Hepatitis A Vaccine	Drug	Actively Acquired Immunity, Vaccines, Inactivated Hepatitis A Virus Vaccine	approved	1
DB08661	1-(2,5-dideoxy-5-pyrrolidin-1-yl-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione	Drug	0	experimental	1
DB07330	A-620223	Drug	0	experimental	1
DB07339	(3S)-3-hydroxy-1-methyl-2,3-dihydro-1H-indole-5,6-dione	Drug	0	experimental	1
DB06005	Adomiparin	Drug	0	investigational	0
DB07336	4-[3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL]-2-METHOXYPHENOL	Drug	0	experimental	1
DB08668	3-(5-Amino-3-imino-3H-pyrazol-4-ylazo)-benzoic acid	Drug	0	experimental	1
DB07335	3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL	Drug	0	experimental	2
DB08669	METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-METHYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE	Drug	0	experimental	1
DB08666	5-imino-4-(3-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine	Drug	0	experimental	1
DB07338	Acifluorfen	Drug	Herbicides, Enzyme Inhibitors, Benzoates, Agrochemicals, Acids, Carbocyclic, Pesticides, Toxic Actions, Compounds used in a research, industrial, or household setting, Benzene Derivatives	experimental	2
DB08667	4-(4-fluoro-phenylazo)-5-imino-5H-pyrazol-3-ylamine	Drug	0	experimental	1
DB07337	4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE	Drug	0	experimental	1
DB10990	Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen	Drug	Inactivated Haemophilus Influenzae B Vaccine, Haemophilus Vaccines, Actively Acquired Immunity, Vaccines, Inactivated, Influenza Vaccines, Vaccines	approved, investigational	0
DB10991	Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)	Drug	Actively Acquired Immunity, Inactivated Bordetella Pertussis Vaccine	approved	0
DB10992	Bordetella pertussis pertactin antigen (formaldehyde inactivated)	Drug	Actively Acquired Immunity, Inactivated Bordetella Pertussis Vaccine	approved	0
DB10994	Human papillomavirus type 16 L1 capsid protein residues 2-471 antigen	Drug	0	approved, investigational	0
DB07343	4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE	Drug	0	experimental	1
DB10995	Human papillomavirus type 18 l1 capsid protein residues 2-472 antigen	Drug	0	approved, investigational	0
DB08675	(5Z)-7-{(1R,4S,5R,6R)-6-[(1E)-1-Octen-1-yl]-2,3-diazabicyclo[2.2.1]hept-2-en-5-yl}-5-heptenoic acid	Drug	0	experimental	1
DB10996	Influenza A virus A/Christchurch/16/2010 NIB-74XP (H1N1) antigen (formaldehyde inactivated)	Drug	0	approved	0
DB06011	AMG-222	Drug	Agents causing angioedema, Blood Glucose Lowering Agents, Benzocycloheptenes, DPP-IV Inhibitors	investigational	1
DB08676	(20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE	Drug	0	experimental	2
DB07342	1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone	Drug	Cycloparaffins, Heme Oxygenase-1, antagonists & inhibitors	experimental	1
DB10997	Autologous cultured chondrocytes	Drug	Autologous Cultured Cell	approved, investigational	0
DB07345	4-(2-aminoethyl)-2-cyclohexylphenol	Drug	0	experimental	1
DB08673	4-[(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINO]BENZENESULFONAMIDE	Drug	0	experimental	1
DB06014	Eteplirsen	Drug	Carbohydrates, Oxazines, Nucleic Acids, Nucleotides, and Nucleosides, Oligonucleotides, Antisense, Musculo-Skeletal System, Oligonucleotides, Glycosides, Nucleotides, Morpholines, Polynucleotides	approved, investigational	1
DB06013	Aldoxorubicin	Drug	Carbohydrates, Hydrazines, Anthracyclines, Naphthacenes, Antineoplastic Agents, Glycosides, Cardiotoxic antineoplastic agents	investigational	1
DB08674	(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE	Drug	0	experimental	2
DB07344	3,6,9,12,15-PENTAOXAHEPTADECAN-1-OL	Drug	0	experimental	1
DB10998	Influenza A virus A/Brisbane/10/2010 (H1N1) antigen (MDCK cell derived, propiolactone inactivated)	Drug	0	approved, investigational	0
DB08671	5-Imino-4-(2-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine	Drug	0	experimental	1
DB10999	Influenza A virus A/Texas/50/2012 X-223A (H3N2) antigen (MDCK cell derived, propiolactone inactivated)	Drug	0	approved	0
DB08672	4-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDE	Drug	0	experimental	1
DB07341	octyl 3-amino-3-deoxy-2-O-(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)-beta-D-galactopyranoside	Drug	0	experimental	1
DB07340	Reversine	Drug	Heterocyclic Compounds, Fused-Ring, Oxazines, Protein Kinase Inhibitors	experimental	2
DB08670	METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-ISOPROPYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE	Drug	0	experimental	1
DB06016	Cariprazine	Drug	Serotonin 5-HT1 Receptor Agonists, Psycholeptics, Tranquilizing Agents, Cytochrome P-450 Substrates, Serotonin Agents, Nervous System, Serotonin Receptor Agonists, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Psychotropic Drugs, Serotonin 5-HT2 Receptor Antagonists, Antipsychotic Agents, Histamine H1 Antagonists, Antipsychotic Agents (Second Generation Atypical), Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Agents that produce hypertension, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Neurotoxic agents	approved, investigational	6
DB07347	4-(2-Aminoethyl)Benzenesulfonyl Fluoride	Drug	Enzyme Inhibitors, Sulfur Compounds, Serine Protease Inhibitors, Trypsin Inhibitors	experimental	2
DB07346	4-(2-aminoethyl)-2-ethylphenol	Drug	0	experimental	1
DB08677	N-(5-Isopropyl-thiazol-2-YL)-2-pyridin-3-YL-acetamide	Drug	0	experimental	1
DB07349	(1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE	Drug	0	experimental	4
DB08678	(4-ETHYLPHENYL)SULFAMIC ACID	Drug	0	experimental	1
DB07348	Brefeldin A	Drug	Anti-Bacterial Agents, Enzyme Inhibitors, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), P-glycoprotein inhibitors, Anti-Infective Agents, Protein Synthesis Inhibitors, Lactones	experimental	2
DB08686	5,6,7,8,9,10-HEXAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOOCTA[B]PYRAN-2-ONE	Drug	0	experimental	1
DB07354	2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM	Drug	0	experimental	1
DB07353	4-(2,5-DIAMINO-5-HYDROXY-PENTYL)-PHENOL	Drug	0	experimental	1
DB06022	GlycoPEG-GCSF	Drug	Pegylated agents	investigational	0
DB08687	FG-2216	Drug	0	investigational	2
DB08684	O-Decyl Hydrogen Thiocarbonate	Drug	0	experimental	1
DB07356	(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE	Drug	0	experimental	1
DB07355	3-(heptyloxy)benzoic acid	Drug	0	experimental	1
DB08685	1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine	Drug	0	experimental	1
DB08682	1-METHYL ETHYL 1-CHLORO-5-[[(5,6DIHYDRO-2-METHYL-1,4-OXATHIIN-3-YL)CARBONYL]AMINO]BENZOATE	Drug	0	experimental	1
DB07350	(2E)-N-hydroxy-3-[1-methyl-4-(phenylacetyl)-1H-pyrrol-2-yl]prop-2-enamide	Drug	0	experimental	1
DB08683	REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE	Drug	0	experimental	1
DB06021	AV-412	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Protein Kinase Inhibitors, ErbB Receptors, antagonists & inhibitors, Receptor, ErbB-2, antagonists & inhibitors, Antineoplastic Agents	investigational	2
DB08680	N-{3-[(E)-(tert-butoxyimino)methyl]-4-chlorophenyl}-2-methylfuran-3-carbimidothioic acid	Drug	0	experimental	1
DB07352	Apigenin	Drug	Heterocyclic Compounds, Fused-Ring, Flavonoids, Flavones, Benzopyrans, Chromones, Pyrans	experimental	1
DB08681	1-METHYL ETHYL 2-CHLORO-5-[[[(1-METHYLETHOXY)THIOOXO]METHYL]AMINO]-BENZOATE	Drug	0	experimental	1
DB07351	O-(((1R)-((N-(PHENYL-METHOXY-CARBONYL)-ALANYL)-AMINO)METHYL)HYDROXYPHOSPHINYL)3-L-PHENYLLACTATE	Drug	0	experimental	1
DB07358	2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide	Drug	0	experimental	1
DB07357	4-AMINO-2-HEXYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL	Drug	0	experimental	1
DB08688	2-Undecanone	Drug	0	experimental	1
DB08689	Ubiquinone Q1	Drug	Quinones, Coenzymes, Enzymes and Coenzymes, Benzoquinones	experimental	13
DB07359	3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide	Drug	0	experimental	1
DB10930	Amaranthus retroflexus whole	Drug	Non-Standardized Pollen Allergenic Extract	approved	0
DB08610	N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE	Drug	0	experimental	1
DB10932	Cephalosporium roseum	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10933	Cochliobolus lunatus	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10934	Haematonectria haematococca	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10935	Chrysonilia sitophila	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10936	Pleospora betae	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08617	4-(2,2,2-TRIFLUOROETHYL)-L-PHENYLALANINE	Drug	0	experimental	1
DB10926	Carya tomentosa pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08618	3-(HYDROXY-PHENYL-PHOSPHINOYLOXY)-8-METHYL-8-AZA-BICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID METHYL ESTER	Drug	0	experimental	1
DB10927	Iva annua pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08615	2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM	Drug	0	experimental	1
DB10928	Bassia scoparia pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10929	Cyclachaena xanthifolia pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08613	2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL	Drug	0	experimental	1
DB08614	3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE	Drug	0	experimental	1
DB08611	2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL	Drug	0	experimental	1
DB08612	1,1,1-TRIFLUORO-3-(OCTYLTHIO)ACETONE	Drug	0	experimental	1
DB08619	Testosterone succinate	Drug	Androstanes, Testosterone and derivatives, Hormones, Hormone Substitutes, and Hormone Antagonists, Androstenols, Androstenes, Testosterone Congeners, Thyroxine-binding globulin inhibitors, Hormones, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Steroids	experimental	1
DB08620	Thiacloprid	Drug	Sulfur Compounds, Agrochemicals, Pesticides, Insecticides, Toxic Actions, Compounds used in a research, industrial, or household setting	experimental	1
DB10940	Acacia pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08621	Thiamphenicol	Drug	Anti-Bacterial Agents, Nitrobenzenes, Nitro Compounds, Glycols, Propylene Glycols, Amphenicols, Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use, Benzene Derivatives, Alcohols	investigational, experimental	1
DB10941	Bassia hyssopifolia pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10942	Brassica rapa pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10943	Callistemon citrinus pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10945	Dicoria canescens pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10946	Krascheninnikovia lanata pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10947	Ambrosia ambrosioides pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased Histamine Release	approved	0
DB10937	Puccinia striiformis var. striiformis	Drug	0	approved	0
DB08628	(5R)-5-[(1E)-BUTA-1,3-DIENYL]-4-HYDROXY-3,5-DIMETHYLTHIOPHEN-2(5H)-ONE	Drug	0	experimental	1
DB08629	N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE	Drug	0	experimental	3
DB10939	Pleospora tarda	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08626	Thiorphan	Drug	Enzyme Inhibitors, Sulfur Compounds, Peptides, Protease Inhibitors, Amino Acids, Sulfur, Amino Acids, Peptides, and Proteins, N-substituted Glycines, Peptoids, Amino Acids	experimental	1
DB08627	(5R)-4-HYDROXY-3,5-DIMETHYL-5-[(1E,3E)-2-METHYLPENTA-1,3-DIENYL]THIOPHEN-2(5H)-ONE	Drug	0	experimental	1
DB08624	1-[(4S)-4-amino-5-(1,3-benzothiazol-2-yl)-5-oxopentyl]guanidine	Drug	0	experimental	2
DB08622	4-(4-CHLORO-PHENYL)-1-{3-[2-(4-FLUORO-PHENYL)-[1,3]DITHIOLAN-2-YL]-PROPYL}-PIPERIDIN-4-OL	Drug	0	experimental	1
DB08623	2-[CARBOXY-(2-THIOPHEN-2-YL-ACETYLAMINO)-METHYL]-5-METHYLENE-5,6-DIHYDRO-2H-[1,3]THIAZINE-4-CARBOXYLIC ACID	Drug	0	experimental	1
DB10950	Phoenix dactylifera pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08631	N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE	Drug	0	experimental	1
DB08632	Trimesic acid	Drug	Acids, Acyclic	experimental	2
DB10952	Quercus dumosa pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB07301	Carbazole	Drug	Heterocyclic Compounds, Fused-Ring, Carcinogens, Noxae, Toxic Actions, Indoles	experimental	2
DB10953	Suaeda moquinii pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10954	Tilia cordata pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB07300	2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine	Drug	0	experimental	1
DB10955	Apis mellifera venom	Drug	Miscellaneous Therapeutic Agents, Allergenic Extracts, Bee and Wasp Venom	approved	0
DB10956	Vespula maculifrons venom protein	Drug	Cell-mediated Immunity, Bee and Wasp Venom, Increased IgG Production, Standardized Insect Venom Allergenic Extract, Increased Histamine Release	approved	0
DB10957	Dolichovespula arenaria venom protein	Drug	Cell-mediated Immunity, Miscellaneous Therapeutic Agents, Allergenic Extracts, Bee and Wasp Venom, Increased IgG Production, Standardized Insect Venom Allergenic Extract, Increased Histamine Release	approved	0
DB10958	Dolichovespula maculata venom protein	Drug	Cell-mediated Immunity, Miscellaneous Therapeutic Agents, Allergenic Extracts, Bee and Wasp Venom, Increased IgG Production, Standardized Insect Venom Allergenic Extract, Increased Histamine Release	approved	0
DB07307	N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide	Drug	0	experimental	1
DB10948	Ambrosia chamissonis pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased Histamine Release	approved	0
DB08639	Dapivirine	Drug	Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, HIV Reverse Transcriptase, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Anti-Infective Agents	investigational	1
DB07306	ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE	Drug	0	experimental	1
DB10949	Koeleria macrantha pollen	Drug	Cell-mediated Immunity, Grass Pollen Allergen Extracts, Allergenic Extracts, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB07309	5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID	Drug	0	experimental	1
DB08637	4-(2-METHOXYPHENYL)-2-OXOBUT-3-ENOIC ACID	Drug	0	experimental	1
DB07308	5-(2-CHLOROBENZYL)-2-FUROIC ACID	Drug	0	experimental	1
DB08638	1-hydroperoxy-L-tryptophan	Drug	0	experimental	1
DB08635	N-(TRANS-4'-NITRO-4-STILBENYL)-N-METHYL-5-AMINO-PENTANOIC ACID	Drug	0	experimental	1
DB07303	N~3~-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE	Drug	0	experimental	1
DB08636	2-Hydroxybenzalpyruvate	Drug	Acids, Carbocyclic	experimental	1
DB07302	9(S)-HODE	Drug	0	experimental	1
DB08633	TNP-470	Drug	Cycloparaffins, Sesquiterpenes, Antineoplastic Agents, Growth Inhibitors, Angiogenesis Modulating Agents, Antibiotics, Antineoplastic, Growth Substances, Terpenes, Angiogenesis Inhibitors, Cyclohexanes	investigational	1
DB07305	5-(2-CHLORO-4-NITROPHENYL)-2-FUROIC ACID	Drug	0	experimental	1
DB08634	6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL	Drug	0	experimental	1
DB07304	5-[2-(TRIFLUOROMETHOXY)PHENYL]-2-FUROIC ACID	Drug	0	experimental	1
DB10961	Hordeum vulgare pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08642	(2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}-1,2,5,6,7,8-hexahydroquinazoline-2,4-diamine	Drug	0	experimental	1
DB10962	Agrostis stolonifera pollen	Drug	Cell-mediated Immunity, Grass Pollen Allergen Extracts, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB07310	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	Drug	0	experimental	1
DB10963	Phalaris minor pollen	Drug	Cell-mediated Immunity, Grass Pollen Allergen Extracts, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08643	2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER	Drug	0	experimental	1
DB10964	Lolium perenne subsp. multiflorum pollen	Drug	Cell-mediated Immunity, Grass Pollen Allergen Extracts, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB08640	(2S,3S)-3-FORMYL-2-({[(4-METHYLPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID	Drug	0	experimental	1
DB07312	2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE	Drug	0	experimental	1
DB08641	(2S,3S)-3-FORMYL-2-({[(4-NITROPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID	Drug	0	experimental	1
DB07311	18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE	Drug	0	experimental	1
DB10965	Sorghum bicolor subsp. bicolor pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10966	Sorghum bicolor subsp. drummondii pollen	Drug	Cell-mediated Immunity, Grass Pollen Allergen Extracts, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10967	Amphiachyris dracunculoides pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10968	Iva angustifolia pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10969	Neurospora sitophila	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB10959	Polistes fuscatus venom protein	Drug	Cell-mediated Immunity, Allergenic Extracts, Bee and Wasp Venom, Increased IgG Production, Standardized Insect Venom Allergenic Extract, Increased Histamine Release	approved	0
DB07318	N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE	Drug	0	experimental	1
DB07317	(3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one	Drug	0	experimental	1
DB08648	(1R,3S,5S,8R)-8-Hydroxy-2-oxabicyclo[3.3.1]non-6-ene-3,5-dicarboxylic acid	Drug	0	experimental	3
DB08649	(1S)-1-AMINO-2-(1H-INDOL-3-YL)ETHANOL	Drug	0	experimental	2
DB07319	6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE	Drug	0	experimental	1
DB08646	TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL	Drug	0	experimental	7
DB07314	1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA	Drug	0	experimental	1
DB08647	TRAZEOLIDE	Drug	0	experimental	1
DB07313	5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID	Drug	0	experimental	1
DB08644	{1-[2-(1-FORMYL-PROPYL)-3-METHANESULFONYLAMINO-PYRROLIDINE-1-CARBONYL]-2-METHYL-PROPYL}-CARBAMIC ACID TERT-BUTYL ESTER	Drug	0	experimental	1
DB07316	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	Drug	0	experimental	1
DB08645	6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE	Drug	0	experimental	1
DB07315	5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide	Drug	0	experimental	1
DB06070	SNX-5422	Drug	Heterocyclic Compounds, Fused-Ring, Benzoates, Pyrazoles, Acids, Carbocyclic, Amides, Benzene Derivatives	investigational	2
DB06071	DTS-201	Drug	Carbohydrates, Anthracyclines, Naphthacenes, Glycosides	investigational	0
DB06077	Lumateperone	Drug	Cytochrome P-450 Substrates, Serotonin Agents, Dopamine D2 Receptor Agonists, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Dopamine Agonists, Serotonin Modulators, Antipsychotic Agents, Antipsychotic Agents (Second Generation Atypical), Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, UGT1A1 Substrates, Cytochrome P-450 CYP1A2 Substrates, UGT1A4 substrates, Serotonin Receptor Antagonists, Cytochrome P-450 CYP2C8 Substrates, Dopamine Antagonists, Neurotoxic agents	approved, investigational	5
DB06073	CTS-21166	Drug	0	investigational	1
DB06075	Linsitinib	Drug	0	investigational	1
DB06081	Caplacizumab	Drug	Amino Acid Sequence, Immunoglobulins, Peptide Fragments, Blood and Blood Forming Organs, Peptides, Amino Acids, Peptides, and Proteins, Immunoglobulin Fragments, Immunoproteins, Proteins, Serum Globulins, Globulins, Blood Proteins, von Willebrand Factor, antagonists & inhibitors, Immunoglobulin Variable Region, Immunoglobulin Fab Fragments, Antiplatelet agents	approved, investigational	1
DB06080	ABT-869	Drug	Heterocyclic Compounds, Fused-Ring, Pyrazoles, Receptor Protein-Tyrosine Kinases, antagonists & inhibitors, Benzene Derivatives	investigational	6
DB06083	Tapinarof	Drug	Phenols, Benzylidene Compounds, Benzene Derivatives	investigational	4
DB06082	PX-478	Drug	Acids, Carbocyclic, Hydrocarbons, Halogenated	investigational	1
DB06089	ICA-105665	Drug	0	investigational	5
DB06087	Friulimicin B	Drug	Amino Acids, Peptides, and Proteins	investigational	0
DB06091	Evofosfamide	Drug	Organophosphorus Compounds, Hydrocarbons, Halogenated, Ions, Mustard Compounds, Nitrogen Mustard Compounds, Phosphorus Compounds, Phosphorus Acids, Anions, Acids, Noncarboxylic, Imidazoles, Acids, Phosphoric Acids, Nitro Compounds, Phosphoramides, Electrolytes	investigational	0
DB06094	Apatorsen	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides, Polynucleotides	investigational	1
DB06093	ABT-560	Drug	0	investigational	0
DB06090	Bradanicline	Drug	Heterocyclic Compounds, Fused-Ring, Receptors, Nicotinic	investigational	1
DB06096	NXN-188	Drug	0	investigational	3
DB06098	PRLX 93936	Drug	0	investigational	2
DB06097	GSK-923295	Drug	0	investigational	1
DB08690	Ubiquinone Q2	Drug	Coenzymes, Antidotes, Protective Agents, Enzymes and Coenzymes, Benzoquinones, Vitamins, Lipid Regulating Agents, Micronutrients, Quinones, Physiological Phenomena, Food and Beverages, Growth Substances, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Electron Transport Chain Complex Proteins, Food	experimental	25
DB07365	1-Naphthyl-L-alanine	Drug	0	experimental	2
DB08697	4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide	Drug	0	experimental	1
DB08698	1-[(3S)-5-PHENYL-3-THIOPHEN-2-YL-3H-1,4-BENZODIAZEPIN-2-YL]AZETIDIN-3-OL	Drug	0	experimental	1
DB07364	6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE	Drug	0	experimental	2
DB07367	(3Z,5S,6R,7S,8S,8aR)-3-(octylimino)hexahydro[1,3]oxazolo[3,4-a]pyridine-5,6,7,8-tetrol	Drug	0	experimental	1
DB08695	3-(4-nitrophenyl)-1H-pyrazole	Drug	0	experimental	1
DB07366	2-[N'-(4-AMINO-BUTYL)-HYDRAZINOCARBONYL]-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER	Drug	0	experimental	1
DB08693	L-1-(4-chlorophenyl)-2-(acetamido)ethane boronic acid	Drug	0	experimental	1
DB08694	Variolin B	Drug	Alkaloids	experimental	2
DB07360	1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea	Drug	0	experimental	1
DB07363	THIOPHENE-2,5-DISULFONIC ACID 2-AMIDE-5-(4-METHYL-BENZYLAMIDE)	Drug	0	experimental	1
DB08691	ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate	Drug	0	experimental	2
DB08692	D-1-(4-chlorophenyl)-2-(acetamido)ethane boronic acid	Drug	0	experimental	1
DB07362	1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea	Drug	0	experimental	1
DB07369	N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide	Drug	0	experimental	1
DB07368	4-(METHYLSULFONYL)BENZENECARBOXIMIDAMIDE	Drug	0	experimental	1
DB08699	1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	Drug	0	experimental	1
DB06039	PA-1050040	Drug	0	investigational	1
DB07370	(3Z,5S,6R,7S,8R,8aS)-3-(octylimino)hexahydro[1,3]thiazolo[3,4-a]pyridine-5,6,7,8-tetrol	Drug	0	experimental	1
DB07376	5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID)	Drug	0	experimental	2
DB06045	Trofinetide	Drug	Peptides, Amino Acids, Peptides, and Proteins	investigational	0
DB07375	Etiocholanedione	Drug	0	experimental	4
DB07378	4-AMINO-2-OCTYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL	Drug	0	experimental	1
DB07377	N'-((2S,3R)-3-AMINO-2-HYDROXY-5-(ISOPROPYLSULFANYL)PENTANOYL)-N-3-CHLOROBENZOYL HYDRAZIDE	Drug	0	experimental	1
DB07371	3-(10-methyl-9-anthryl)propanoic acid	Drug	0	experimental	1
DB06040	Filanesib	Drug	Sulfur Compounds, Antimitotic Agents, Thiazoles, Antineoplastic Agents, Mitosis Modulators	investigational	1
DB06043	Olaratumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antineoplastic and Immunomodulating Agents, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	approved, investigational	1
DB07374	Anisomycin	Drug	Anti-Bacterial Agents, Enzyme Inhibitors, Nucleic Acid Synthesis Inhibitors, Antiprotozoals, Pyrrolidines, Anti-Infective Agents, Antiparasitic Agents, Protein Synthesis Inhibitors	experimental	13
DB07373	Boldione	Drug	Androstanes, Androstenes, Fused-Ring Compounds, Steroids	experimental	1
DB06042	ZEN-012	Drug	0	investigational	6
DB06049	IPH 2101	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB07379	(2S)-2-({6-[(3-Amino-5-chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methyl-1-butanol	Drug	0	experimental	2
DB06050	TB-402	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	1
DB07381	(S)-atrolactic acid	Drug	0	experimental	1
DB07380	1,1,1-TRIFLUORO-3-ACETAMIDO-4-PHENYL BUTAN-2-ONE(N-ACETYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)	Drug	0	experimental	1
DB07387	3-(BUTYLSULPHONYL)-PROPANOIC ACID	Drug	0	experimental	1
DB06058	XTL-6865	Drug	0	investigational	1
DB07389	N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE	Drug	0	experimental	1
DB07388	ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE	Drug	0	experimental	2
DB07383	N-(1-BENZYL-3,3,3-TRIFLUORO-2,2-DIHYDROXY-PROPYL)-ACETAMIDE	Drug	0	experimental	1
DB07382	N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine	Drug	0	experimental	1
DB07385	3-(HYDROXYMETHYL)-1-METHYL-5-(2-METHYLAZIRIDIN-1-YL)-2-PHENYL-1H-INDOLE-4,7-DIONE	Drug	0	experimental	1
DB07384	1-ACETYL-2-CARBOXYPIPERIDINE	Drug	0	experimental	3
DB07390	2-[3-(5-Mercapto-[1,3,4]thiadiazol-2-yl)-ureido]-N-methyl-3-phenyl-propionamide	Drug	Enzyme Inhibitors, Sulfur Compounds, Protease Inhibitors, Thiazoles, Matrix Metalloproteinase Inhibitors	experimental	1
DB07392	Atrazine	Drug	Triazines, Herbicides, Agrochemicals, Pesticides, Toxic Actions, Compounds used in a research, industrial, or household setting	experimental	4
DB06061	AZD-8330	Drug	Pyridines, Protein Kinase Inhibitors	investigational	1
DB07391	(2S)-2-AMINO-1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)PROPAN-1-ONE	Drug	0	experimental	1
DB07398	2-[(CYCLOPROPYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE	Drug	0	experimental	1
DB07397	(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide	Drug	0	experimental	1
DB06069	XMT-1001	Drug	Alkaloids, Acetals, Compounds used in a research, industrial, or household setting, Macromolecular Substances	investigational	1
DB06063	CAM-2029	Drug	0	investigational	0
DB07394	AUROVERTIN B	Drug	Pyrans	experimental	3
DB07393	2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE	Drug	0	experimental	1
DB07396	AVE-2865	Drug	0	experimental	1
DB07395	4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid	Drug	0	experimental	1
DB06064	KAI-1455	Drug	0	investigational	1
DB08705	6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE	Drug	0	experimental	1
DB08706	(2S)-({(5Z)-5-[(5-Ethyl-2-furyl)methylene]-4-oxo-4,5-dihydro-1,3-thiazol-2-yl}amino)(4-fluorophenyl)acetic acid	Drug	0	experimental	1
DB08703	12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one	Drug	0	experimental	1
DB08704	[[(3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(pentanoylamino)oxan-2-ylidene]amino] N-phenylcarbamate	Drug	0	experimental	1
DB08701	2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE	Drug	0	experimental	2
DB08702	2,5-DIPHENYLFURAN-3,4-DICARBOXYLIC ACID	Drug	0	experimental	1
DB08709	2,3-diphenyl-1H-indole-7-carboxylic acid	Drug	0	experimental	1
DB08707	4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine	Drug	0	experimental	1
DB08708	N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine	Drug	0	experimental	1
DB08717	[(2S)-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-2-yl]acetic acid	Drug	0	experimental	1
DB08714	2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[4-METHYL-2H-TETRAZOL-2-YL]-PHENOL	Drug	0	experimental	1
DB08715	2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2-METHYL-4-ISOXAZOLYL]-PHENOL	Drug	0	experimental	1
DB08712	11-[(MERCAPTOCARBONYL)OXY]UNDECANOIC ACID	Drug	0	experimental	1
DB08713	2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2N-METHYL-2H-TETRAZOL-5-YL]-PHENOL	Drug	0	experimental	1
DB08710	(5Z)-5-[(5-ethylfuran-2-yl)methylidene]-2-[[(S)-(4-fluorophenyl)-(2H-tetrazol-5-yl)methyl]amino]-1,3-thiazol-4-one	Drug	0	experimental	1
DB08711	Methyl vanillate	Drug	Benzoates, Hydroxy Acids, Acids, Carbocyclic, Hydroxybenzoates, Phenols, Ethers, Hydroxybenzoate Ethers, Benzene Derivatives, Phenyl Ethers	experimental	1
DB08718	4-(3-ethylthiophen-2-yl)benzene-1,2-diol	Drug	0	experimental	1
DB08719	5-(5-(6-CHLORO-4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE	Drug	0	experimental	1
DB08720	5-(5-(4-(4,5-dihydro-2-oxazoly)phenoxy)pentyl)-3-methyl osoxazole	Drug	0	experimental	1
DB08727	3-Methyl-5-(7-{4-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]phenoxy}heptyl)-1,2-oxazole	Drug	0	experimental	1
DB08728	5-(3-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)propyl)-3-methyl isoxazole	Drug	0	experimental	2
DB08725	(S)-5-(7-(4-(4-Ethyl-4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methylisoxazole	Drug	0	experimental	1
DB08726	5-(7-(4-(4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole	Drug	0	experimental	3
DB08723	WIN-54954	Drug	0	experimental	2
DB08724	5-(5-(4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)pentyl)-3-methyl isoxazole	Drug	0	experimental	1
DB08721	5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole	Drug	0	experimental	1
DB08722	5-(7-(6-chloro-4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole	Drug	0	experimental	1
DB08729	5-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide	Drug	0	experimental	1
DB06111	AB192	Drug	Acids, Acyclic, Amino Acids, Cyclic, Imines, Organophosphorus Compounds, Amino Acids, Peptides, and Proteins, Imino Acids, Amino Acids, Dipeptidyl-Peptidases and Tripeptidyl-Peptidases, antagonists & inhibitors	experimental	0
DB08774	1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine	Drug	0	experimental	1
DB07441	3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID	Drug	0	experimental	2
DB08775	Benzoyl-tyrosine-alanine-fluoro-methyl ketone	Drug	0	experimental	1
DB08772	Zopolrestat	Drug	Pyridazines, Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Sulfur Compounds, Aldose Reductase Inhibitors, Thiazoles, Blood Glucose Lowering Agents, Aldehyde Reductase, antagonists & inhibitors	experimental	2
DB07444	6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE	Drug	0	experimental	1
DB06112	3,4-Methylenedioxy-N-isopropylamphetamine	Drug	0	investigational	0
DB08773	2-(4-hydroxyphenyl)benzo[b]thiophen-6-ol	Drug	0	experimental	2
DB07443	(2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide	Drug	0	experimental	1
DB08770	4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol	Drug	0	experimental	1
DB08771	(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one	Drug	0	experimental	1
DB07440	4-TERT-BUTYLBENZENESULFONIC ACID	Drug	0	experimental	1
DB06119	Cenobamate	Drug	Voltage-Gated Sodium Channel Blockers, Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, GABA Modulators, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Enzyme Inducers, UGT2B7 substrates, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A5 Inhibitors, Cytochrome P-450 CYP2C19 Substrates, Anticonvulsants, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Cytochrome P-450 CYP2A6 Substrates, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Inducers (strength unknown)	approved, investigational	0
DB07449	N-[(1S)-1-(aminocarbonyl)-4-(ethanimidoylamino)butyl]benzamide	Drug	0	experimental	1
DB08778	[4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone	Drug	0	experimental	1
DB07446	N-(biphenyl-4-ylsulfonyl)-D-leucine	Drug	0	experimental	1
DB07445	N'-[(1E)-(3,5-DIBROMO-2,4-DIHYDROXYPHENYL)METHYLENE]NICOTINOHYDRAZIDE	Drug	0	experimental	1
DB08779	2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol	Drug	0	experimental	1
DB06117	1alpha,24S-Dihydroxyvitamin D2	Drug	Cholestanes, Secosteroids, Sterols, Vitamin D and Analogues, Vitamins (Fat Soluble), Lipids, Membrane Lipids, Cholestenes, Fused-Ring Compounds, Vitamins, Steroids	investigational	0
DB07448	(2S)-3-[(R)-[(1S)-1-amino-3-phenylpropyl](hydroxy)phosphoryl]-2-benzylpropanoic acid	Drug	0	experimental	1
DB08776	N-(4-OXO-5,6,7,8-TETRAHYDRO-4H-[1,3]THIAZOLO[5,4-C]AZEPIN-2-YL)ACETAMIDE	Drug	0	experimental	1
DB06116	Eldelumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Chemokine CXCL10, Immunoproteins	investigational	1
DB07447	5beta-dihydrotestosterone	Drug	Testosterone and derivatives	experimental	1
DB08777	5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE	Drug	0	experimental	1
DB08785	4-Methylcoumarin	Drug	0	experimental	1
DB07453	alpha-Naphthoflavone	Drug	Heterocyclic Compounds, Fused-Ring, Flavonoids, Benzopyrans, Chromones, Pyrans	experimental	1
DB08786	4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine	Drug	0	experimental	1
DB07452	2,6-diamino-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one	Drug	0	experimental	1
DB07455	N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide	Drug	0	experimental	1
DB08783	(4-{(2S)-2-[(tert-butoxycarbonyl)amino]-3-methoxy-3-oxopropyl}phenyl)methaneseleninic acid	Drug	Selenium Compounds	experimental	1
DB06124	L-aminocarnityl-succinyl-leucyl-argininal-diethylacetal	Drug	0	investigational	1
DB08784	2-(4-CHLORO-PHENYLAMINO)-NICOTINIC ACID	Drug	0	experimental	1
DB07454	(R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE	Drug	0	experimental	1
DB08781	1-[(2S)-4-(5-BROMO-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL]METHANAMINE	Drug	0	experimental	1
DB08782	4-(2-AMINOETHYL)BENZENESULFONAMIDE	Drug	Sulfur Compounds, Amides, Sulfones	experimental	1
DB07451	1-(5-BROMO-PYRIDIN-2-YL)-3-[2-(6-FLUORO-2-HYDROXY-3-PROPIONYL-PHENYL)-CYCLOPROPYL]-UREA	Drug	0	experimental	1
DB08780	6-MORPHOLIN-4-YL-9H-PURINE	Drug	0	experimental	1
DB07450	(R)-minalrestat	Drug	0	experimental	1
DB06129	SVV-001	Drug	0	investigational	0
DB07457	3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE	Drug	0	experimental	1
DB08789	2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE	Drug	0	experimental	1
DB07456	3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione	Drug	0	experimental	1
DB08787	4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine	Drug	0	experimental	1
DB07459	4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE	Drug	0	experimental	1
DB08788	3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE	Drug	0	experimental	1
DB06127	Bisegliptin	Drug	Agents causing angioedema, Blood Glucose Lowering Agents, DPP-IV Inhibitors	investigational	1
DB07458	3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione	Drug	0	experimental	1
DB08796	Pipazethate	Drug	Antitussive Agents, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Cough and Cold Preparations, Amides, Central Nervous System Agents, Respiratory System Agents, Sulfones	experimental	0
DB07464	1(R)-1-ACETAMIDO-2-(3-CARBOXY-2-HYDROXYPHENYL)ETHYL BORONIC ACID	Drug	0	experimental	1
DB06133	Dimethylcurcumin	Drug	0	investigational	1
DB07463	(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(butylsulfanyl)methyl]pyrrolidin-3-ol	Drug	0	experimental	1
DB08797	Salicylamide	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Benzoates, Sensory System Agents, Cyclooxygenase Inhibitors, Nervous System, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Amides, Peripheral Nervous System Agents, Analgesics, Agents that produce hypertension, Ligands, Central Nervous System Agents, Salicylic Acid and Derivatives, Benzene Derivatives	approved	0
DB07466	(1R)-2-PHENYLACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACID	Drug	0	experimental	1
DB08794	Ethyl biscoumacetate	Drug	Anticoagulants, Heterocyclic Compounds, Fused-Ring, Blood and Blood Forming Organs, Cytochrome P-450 Substrates, 4-Hydroxycoumarins, Cytochrome P-450 CYP3A Substrates, Coumarins, Hematologic Agents, Benzopyrans, Cytochrome P-450 CYP3A4 Substrates, Pyrans, Vitamin K Antagonists	withdrawn	0
DB07465	(1S,3S,5S)-2-{(2S)-2-amino-2-[(1R,3S,5R,7S)-3-hydroxytricyclo[3.3.1.1~3,7~]dec-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carbonitrile	Drug	0	experimental	1
DB06134	SNS-314	Drug	Protein Kinase Inhibitors, Sulfur Compounds, Benzene Derivatives	investigational	2
DB08795	Azidocillin	Drug	Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Beta-Lactamase Sensitive Penicillins, Antibacterials for Systemic Use	experimental	5
DB07460	2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE	Drug	0	experimental	1
DB08792	Diloxanide	Drug	Dichloroacetamide Derivatives, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Anti-Infective Agents, Antiparasitic Agents, Amebicides	experimental	0
DB08790	1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID	Drug	0	experimental	1
DB07462	(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE	Drug	0	experimental	1
DB08791	1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE	Drug	0	experimental	1
DB07461	3-AMINO-3-BENZYL-9-CARBOXAMIDE[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE	Drug	0	experimental	1
DB06130	FAV-201	Drug	0	investigational	0
DB06137	KX-01	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Amides, Lipids, Acetates	investigational	1
DB07468	(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one	Drug	0	experimental	1
DB07467	(S)-Indapamide	Drug	0	experimental	1
DB08798	Sulfamoxole	Drug	Amines, Cytochrome P-450 Enzyme Inhibitors, Aniline Compounds, Amides, Sulfanilamides, Antiinfectives for Systemic Use, Anti-Infective Agents, SULFONAMIDES AND TRIMETHOPRIM, Sulfur Compounds, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Sulfonamides, Cytochrome P-450 CYP2C9 Inhibitors, Intermediate-Acting Sulfonamides, Antibacterials for Systemic Use, Sulfones	experimental	1
DB08799	Antazoline	Drug	Neurotransmitter Agents, QTc Prolonging Agents, Histamine H1 Antagonists, Nasal Preparations, Anti-Allergic Agents, Histamine Antagonists, Imidazoles, Antiallergic Agents, Excl. Corticosteroids, Histamine Agents, Antihistamines for Systemic Use, Moderate Risk QTc-Prolonging Agents	approved	1
DB07469	(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one	Drug	0	experimental	1
DB06138	IRL-1620	Drug	Proteins, Biological Factors, Peptides, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins	investigational	1
DB06144	Sertindole	Drug	Psycholeptics, Tranquilizing Agents, Cytochrome P-450 Substrates, Serotonin Agents, Nervous System, Indole Derivatives, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Psychotropic Drugs, Serotonin 5-HT2 Receptor Antagonists, Heterocyclic Compounds, Fused-Ring, Antipsychotic Agents, Antipsychotic Agents (Second Generation Atypical), Cytochrome P-450 CYP3A Substrates, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Dopamine Antagonists, Dopamine D2 Receptor Antagonists, Neurotoxic agents	approved, investigational, withdrawn	8
DB07474	3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE	Drug	0	experimental	1
DB07477	Felbinac	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Sensory System Agents, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Antiinflammatory Preparations, Non-Steroids for Topical Use, Topical Products for Joint and Muscular Pain, Peripheral Nervous System Agents, Analgesics, Musculo-Skeletal System, Agents that produce hypertension, Central Nervous System Agents	experimental	1
DB07476	N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE	Drug	0	experimental	1
DB06145	Spiramycin	Drug	Carbohydrates, Coccidiostats, Antiprotozoals, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Macrolides, Lincosamides and Streptogramins, Antiinfectives for Systemic Use, Anti-Infective Agents, Lactones, Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Glycosides, Leucomycins, Antibacterials for Systemic Use, Antiparasitic Agents	approved	1
DB07471	5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE	Drug	0	experimental	2
DB06140	SUVN-502	Drug	Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents	investigational	1
DB07470	(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one	Drug	0	experimental	1
DB07473	(R)-(+) 5(9BH)-OXO-9B-PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-3-CARBOXYLIC ACID METHYL ESTER	Drug	0	experimental	1
DB07472	(R)-(+)9B-(3-METHYL)PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-5(9BH)-ONE	Drug	0	experimental	1
DB06148	Mianserin	Drug	Cytochrome P-450 Substrates, Serotonin Agents, Nervous System, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Serotonin 5-HT2 Receptor Antagonists, Serotonin Modulators, Histamine H1 Antagonists, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Dopamine Antagonists, Adrenergic Agents, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Dibenzazepines, Antidepressive Agents, Second-Generation, Psychotropic Drugs, Antidepressive Agents, Tetracyclic, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Histamine Agents, Dopamine D2 Receptor Antagonists, Psychoanaleptics	approved, investigational	20
DB07479	(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL	Drug	0	experimental	1
DB06147	Sulfathiazole	Drug	Amines, Gynecological Antiinfectives and Antiseptics, Aniline Compounds, Dermatologicals, Genito Urinary System and Sex Hormones, Amides, Sulfanilamides, Antiinfectives for Systemic Use, Anti-Infective Agents, Short-Acting Sulfonamides, SULFONAMIDES AND TRIMETHOPRIM, Sulfur Compounds, Sulfonamides, Thiazoles, Antibacterials for Systemic Use, Sulfones, Sulfathiazoles	approved, vet_approved	1
DB07478	3,4-Biphenyldiol	Drug	0	experimental	1
DB06149	Teicoplanin	Drug	Carbohydrates, Glycopeptide Antibacterials, Glycoconjugates, Peptides, Amino Acids, Peptides, and Proteins, Lipids, Antiinfectives for Systemic Use, Lipoglycopeptides, Anti-Infective Agents, Anti-Bacterial Agents, Glycopeptides, Lipopeptides, Antibacterials for Systemic Use	approved, investigational	1
DB08730	3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE	Drug	0	experimental	1
DB08731	2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid	Drug	0	experimental	1
DB07400	1-ETHOXYCARBONYL-D-PHE-PRO-2(4-AMINOBUTYL)HYDRAZINE	Drug	0	experimental	1
DB08738	1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one	Drug	0	experimental	1
DB07406	(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE	Drug	0	experimental	1
DB08739	2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione	Drug	0	experimental	1
DB07405	1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE	Drug	0	experimental	1
DB07408	5-(2-NITROPHENYL)-2-FUROIC ACID	Drug	0	experimental	1
DB08736	S,R-Warfarin alcohol	Drug	0	experimental	0
DB08737	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL	Drug	0	experimental	1
DB07407	5-(2-METHOXYPHENYL)-2-FUROIC ACID	Drug	0	experimental	1
DB08734	6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE	Drug	0	experimental	1
DB07402	Azapropazone	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Triazines, Renal Agents, Sensory System Agents, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Peripheral Nervous System Agents, Antigout Preparations, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Musculo-Skeletal System, Uricosuric Agents, Agents that produce hypertension, Central Nervous System Agents	withdrawn	0
DB08735	R,S-Warfarin alcohol	Drug	0	experimental	0
DB07401	Azoxystrobin	Drug	Fungicides, Industrial, Acids, Acyclic, Acrylates, Methacrylates, Electron Transport Complex III	experimental	10
DB07404	BPH-608	Drug	0	experimental	1
DB08732	NALPHA-[(BENZYLOXY)CARBONYL]-N-[(1R)-4-HYDROXY-1-METHYL-2-OXOBUTYL]-L-PHENYLALANINAMIDE	Drug	0	experimental	2
DB07403	4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE	Drug	0	experimental	1
DB08733	(2R,3R)-N^1^-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-N^4^-HYDROXY-2-(2-METHYLPROPYL)-3-{[(1,3-THIAZOL-2-YLCARBONYL)AMINO]METHYL}BUTANEDIAMIDE	Drug	0	experimental	1
DB07409	(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID	Drug	0	experimental	1
DB08741	5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine	Drug	0	experimental	1
DB08742	1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)	Drug	0	experimental	2
DB07411	PHENYLALANINE BORONIC ACID	Drug	0	experimental	1
DB07410	[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID	Drug	0	experimental	2
DB08740	CYCLOHEXYLMETHYL-2,3-DIHYDROXY-5-METHYL-HEXYLAMIDE	Drug	0	experimental	1
DB08749	3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE	Drug	0	experimental	1
DB07416	(2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE	Drug	0	experimental	3
DB08747	(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one	Drug	0	experimental	1
DB07419	S-23	Drug	Heterocyclic Compounds, Fused-Ring, Amines, Isoquinolines, Aniline Compounds, Amides	experimental	1
DB07418	bis(4-nitrophenyl) hydrogen phosphate	Drug	0	experimental	1
DB08748	4-(Dimethylamino)benzoic acid	Drug	Aminobenzoates, Benzoates, Acids, Carbocyclic, Benzene Derivatives	experimental	2
DB07413	5'-S-[2-(decylamino)ethyl]-5'-thioadenosine	Drug	0	experimental	1
DB08745	4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE	Drug	0	experimental	1
DB07412	1-biphenyl-2-ylmethanamine	Drug	0	experimental	1
DB08746	1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE	Drug	0	experimental	1
DB08743	2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE	Drug	0	experimental	1
DB07415	4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine	Drug	0	experimental	1
DB08744	Casimiroin	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Aromatase, Quinone Reductases, antagonists & inhibitors, Dioxoles	experimental	1
DB07414	(5S)-1-benzyl-3-(1,1-dioxido-1,2-benzisothiazol-3-yl)-4-hydroxy-5-(1-methylethyl)-1,5-dihydro-2H-pyrrol-2-one	Drug	0	experimental	1
DB08752	N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide	Drug	0	experimental	1
DB07420	(1R)-4-(3-phenoxyphenyl)-1-phosphonobutane-1-sulfonic acid	Drug	0	experimental	1
DB08753	4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE	Drug	0	experimental	1
DB08750	1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE	Drug	0	experimental	1
DB07422	(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide	Drug	0	experimental	1
DB08751	N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE	Drug	0	experimental	1
DB07421	4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile	Drug	0	experimental	1
DB07428	4-[(5-methoxy-2-methylphenoxy)methyl]pyridine	Drug	0	experimental	2
DB07427	2-[(2-methoxy-5-methylphenoxy)methyl]pyridine	Drug	0	experimental	2
DB08758	IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE	Drug	0	experimental	1
DB08759	[(3R,4S,5S,7R)-4,8-DIHYDROXY-3,5,7-TRIMETHYL-2-OXOOCTYL]PHOSPHONIC ACID	Drug	0	experimental	1
DB07429	2-({[4-bromo-3-(diethylsulfamoyl)phenyl]carbonyl}amino)benzoic acid	Drug	0	experimental	1
DB08756	Y-27632	Drug	Neuromuscular Agents, Enzyme Inhibitors, Central Nervous System Depressants, Muscle Relaxants, Centrally Acting Agents, Cardiovascular Agents, Antihypertensive Agents, Central Nervous System Agents, Muscle Relaxants, Peripheral Nervous System Agents	experimental	4
DB07424	Tripotassium (1R)-4-biphenyl-4-yl-1-phosphonatobutane-1-sulfonate	Drug	0	experimental	1
DB08757	5-(2-chlorophenyl)furan-2-carbohydrazide	Drug	0	experimental	1
DB07423	Andarine	Drug	Acids, Acyclic, Amines, Fatty Acids, Fatty Acids, Volatile, Aniline Compounds, Phenols, Amides, Lipids, Acetates, Benzene Derivatives	experimental	1
DB08754	N-Caffeoyltyramine	Drug	Amines, Acids, Carbocyclic, Biogenic Amines, Biogenic Monoamines, Cinnamates	experimental	1
DB07426	[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)	Drug	0	experimental	1
DB08755	N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide	Drug	0	experimental	1
DB07425	Sobetirome	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Lipids, Benzene Derivatives	investigational	2
DB08763	[N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHANE-PHOSPHONATE	Drug	0	experimental	1
DB07431	(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one	Drug	0	experimental	2
DB07430	(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one	Drug	0	experimental	1
DB07433	(TERT-BUTYLOXYCARBONYL)-ALANYL-AMINO ETHYL-FORMAMIDE	Drug	0	experimental	1
DB08761	(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione	Drug	0	experimental	1
DB07432	[[(3R,4R,5S,6R)-3-(butanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] N-phenylcarbamate	Drug	0	experimental	2
DB08762	O-(((1R)-((N-PHENYLMETHOXYCARBONYL-L-ALANYL)AMINO)ETHYL)HYDROXYPHOSPHONO)-L-BENZYLACETIC ACID	Drug	0	experimental	1
DB06101	IMC-1C11	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	3
DB08760	(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid	Drug	0	experimental	1
DB07439	1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE-2,4(1H,3H)-DIONE	Drug	0	experimental	1
DB06109	YKP-1358	Drug	Serotonin 5-HT2 Receptor Antagonists, Neurotransmitter Agents, Serotonin Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Serotonin Receptor Antagonists, Antidepressive Agents, Dopamine Antagonists, Dopamine D2 Receptor Antagonists, Dopamine Agents	investigational	2
DB08767	2-(4-METHOXYPHENYL)ACETAMIDE	Drug	0	experimental	2
DB07435	1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE	Drug	0	experimental	2
DB07434	HONH-BENZYLMALONYL-L-ALANYLGLYCINE-P-NITROANILIDE	Drug	0	experimental	1
DB08768	N(6)-dimethylallyladenine	Drug	Carbohydrates, Cytokinins, Heterocyclic Compounds, Fused-Ring, Purines, Ribonucleosides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Vitamin B Complex, Purine Nucleosides, Vitamins	experimental	1
DB06103	VX-148	Drug	Benzene Derivatives	investigational	2
DB08765	6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE	Drug	0	experimental	2
DB07437	5-Benzylacyclouridine	Drug	Enzyme Inhibitors, Pyrimidines, Pyrimidinones, Uridine Phosphorylase, antagonists & inhibitors	experimental	2
DB06106	AIT-034	Drug	0	investigational	0
DB07436	N-(1-PHENYL-PROPYL)-FORMAMIDE	Drug	0	experimental	1
DB08766	Zofenoprilat	Drug	Acids, Acyclic, Amino Acids, Cyclic, Imines, Amino Acids, Peptides, and Proteins, Imino Acids, Amino Acids	experimental	1
DB06191	Zosuquidar	Drug	Heterocyclic Compounds, Fused-Ring, Drug Resistance, Multiple, P-glycoprotein inhibitors, Benzocycloheptenes	investigational	1
DB06190	Solabegron	Drug	Adrenergic beta-Agonists, Neurotransmitter Agents, Amines, Acids, Carbocyclic, Adrenergic Agonists, Agents that produce hypertension, Agents producing tachycardia, Adrenergic Agents, Adrenergic beta-3 Receptor Agonists, Benzene Derivatives	investigational	1
DB06193	Pixantrone	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Cytotoxic Antibiotics and Related Substances, Narrow Therapeutic Index Drugs, Topoisomerase Inhibitors, Antineoplastic and Immunomodulating Agents, Topoisomerase II Inhibitors, Antineoplastic Agents, Anthracyclines and Related Substances	approved, investigational	0
DB06192	Nimotuzumab	Drug	Proteins, Serum Globulins, Antineoplastic Agents, Immunological, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB06199	Atrasentan	Drug	Heterocyclic Compounds, Fused-Ring, Benzodioxoles, Endothelin A Receptor Antagonists, Antineoplastic Agents, OATP1B1/SLCO1B1 Substrates, Pyrrolidines, Dioxoles, Endothelin Receptor Antagonists	investigational	1
DB06198	Alovudine	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Antiviral Agents, Deoxyribonucleosides, Fluorine Radioisotopes, Anti-Infective Agents	investigational	0
DB06195	Seliciclib	Drug	Heterocyclic Compounds, Fused-Ring, Purines, Enzyme Inhibitors, Protein Kinase Inhibitors, Antineoplastic Agents, Anti-Infective Agents	investigational	7
DB06194	Elocalcitol	Drug	Cholestanes, Secosteroids, Sterols, Vitamin D and Analogues, Vitamins (Fat Soluble), Lipids, Membrane Lipids, Cholestenes, Fused-Ring Compounds, Vitamins, Steroids	investigational	1
DB06197	Bimosiamose	Drug	Carbohydrates, Hexoses, Hydrocarbons, Acyclic, Alkanes, Benzene Derivatives, Monosaccharides	investigational	0
DB06196	Icatibant	Drug	Immunologic Factors, Blood and Blood Forming Organs, Sensory System Agents, Oligopeptides, Peptides, Anti-Inflammatory Agents, Kinins, Amino Acids, Peptides, and Proteins, Neuropeptides, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Proteins, Analgesics, Bradykinin Receptor Antagonists, Agents causing angioedema, Analgesics, Non-Narcotic, Biological Factors, Autacoids, Inflammation Mediators, Intercellular Signaling Peptides and Proteins, Antirheumatic Agents, Complement Inactivating Agents, Nerve Tissue Proteins, Bradykinin B2 Receptor Antagonists, Central Nervous System Agents, Drugs Used in Hereditary Angioedema	approved, investigational	2
DB07480	4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN	Drug	0	experimental	1
DB06155	Rimonabant	Drug	Cytochrome P-450 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Cannabinoid Receptor Antagonists, Pyrazoles, Agents producing tachycardia, Hormones, Cytochrome P-450 CYP3A4 Substrates, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Alimentary Tract and Metabolism, Anti-Obesity Agents, Cannabinoids and similars, Receptor, Cannabinoid, CB1, antagonists & inhibitors, Piperidines, Antiobesity Preparations, Excl. Diet Products	approved, investigational	2
DB07486	3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline	Drug	0	experimental	1
DB06154	Pentaerythritol tetranitrate	Drug	Carbohydrates, Antianginal Agents, Fibrin Modulating Agents, Hematologic Agents, Cardiovascular Agents, Propylene Glycols, Drugs that are Mainly Renally Excreted, Organic Nitrates, Alcohols, Polysaccharides, Vasodilators Used in Cardiac Diseases, Glycols, Vasodilating Agents, Cardiac Therapy	approved	3
DB07485	Bisphenol Z	Drug	Cycloparaffins, Benzene Derivatives	experimental	1
DB06157	Istaroxime	Drug	Androstanols, Androstanes, Hormones, Hormone Substitutes, and Hormone Antagonists, 17-Ketosteroids, Adrenal Cortex Hormones, Hormones, Ketosteroids, Fused-Ring Compounds, Sodium-Potassium-Exchanging ATPase, antagonists & inhibitors, Gonadal Hormones, Gonadal Steroid Hormones, Steroids	investigational	2
DB07488	{4-Amino-2-[(4-methoxyphenyl)amino]-1,3-thiazol-5-yl}(4-methoxyphenyl)methanone	Drug	0	experimental	1
DB07487	(6-METHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL)METHYLPHOSPHINATE	Drug	0	experimental	1
DB06156	Tesofensine	Drug	Biogenic Monoamines, antagonists & inhibitors	investigational	3
DB06151	Acetylcysteine	Drug	Amino Acids, Neutral, OATP1B1/SLCO1B1 Inhibitors, Cysteine, Antidotes, Protective Agents, Decreased Respiratory Secretion Viscosity, Amino Acids, Sulfur, Amino Acids, Peptides, and Proteins, Free Radical Scavengers, Respiratory System Agents, Amino Acids, Anti-Infective Agents, Antioxidants, Ophthalmologicals, Reduction Activity, Sulfur Compounds, Cough and Cold Preparations, Expectorants, Antidote for Acetaminophen Overdose, Sensory Organs, Increased Glutathione Concentration, Compounds used in a research, industrial, or household setting, Sulfhydryl Compounds	approved, investigational	11
DB07482	(2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-L-PROLINAMIDE	Drug	0	experimental	1
DB07481	tert-butyl [(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl]carbamate	Drug	0	experimental	1
DB06150	Sulfadimethoxine	Drug	Long-Acting Sulfonamides, Amines, Cytochrome P-450 Enzyme Inhibitors, Gynecological Antiinfectives and Antiseptics, Aniline Compounds, Genito Urinary System and Sex Hormones, Amides, Sulfanilamides, Antiinfectives for Systemic Use, Anti-Infective Agents, SULFONAMIDES AND TRIMETHOPRIM, Sulfur Compounds, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Sulfonamides, Cytochrome P-450 CYP2C9 Inhibitors, Antibacterials for Systemic Use, Sulfones	approved, vet_approved	0
DB06153	Pizotifen	Drug	Sensory System Agents, Serotonin Agents, Nervous System, Muscarinic Antagonists, Antidepressive Agents, Antimigraine Preparations, Peripheral Nervous System Agents, Anticholinergic Agents, Serotonin 5-HT2 Receptor Antagonists, Histamine H1 Antagonists, Sulfur Compounds, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Thiophenes, Adrenergic Antagonists, Adrenergic alpha-1 Receptor Antagonists, Analgesics, Non-Narcotic, Adrenergic alpha-Antagonists, Agents producing tachycardia, Psychotropic Drugs, Neurotransmitter Agents, Histamine Antagonists, Central Nervous System Depressants, Agents that produce hypertension, Serotonin Receptor Antagonists, Central Nervous System Agents, Antimigraine Agents, Miscellaneous, Serotonin 5-HT1 Receptor Antagonists	approved	16
DB07484	(2R)-4,4-dihydroxy-5-nitro-2-(phenylmethyl)pentanoic acid	Drug	0	experimental	1
DB06152	Nylidrin	Drug	Amines, Cytochrome P-450 Substrates, Agents causing hyperkalemia, Genito Urinary System and Sex Hormones, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Phenethylamines, Tocolytic Agents, Alcohols, Peripheral Nervous System Agents, 2-Amino-1-Phenylethanol Derivatives, Adrenergic Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Autonomic Agents, Miscellaneous Vasodilatating Agents, Propanols, Reproductive Control Agents, Sympathomimetics, Labour Repressants, Agents producing tachycardia, Amino Alcohols, Adrenergic beta-Agonists, Calcium Channel Blockers, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Ethylamines, Sympathomimetics, Adrenergic Agonists, Agents that produce hypertension, Peripheral Vasodilators, Vasodilating Agents, Propanolamines	approved	2
DB07483	1,1'-BIPHENYL-2-SULFINIC ACID	Drug	0	experimental	1
DB06159	Rubitecan	Drug	Alkaloids, Enzyme Inhibitors, Topoisomerase Inhibitors, Topoisomerase I Inhibitors, Antineoplastic Agents	investigational	1
DB07489	4-Amino-2-[(3-chlorophenyl)amino]-5-(4-fluorobenzoyl)-1,3-thiazol-3-ium	Drug	0	experimental	1
DB06160	Garenoxacin	Drug	Fluoroquinolones, Quinolines, QTc Prolonging Agents, Enzyme Inhibitors, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Antineoplastic Agents, Antiinfectives for Systemic Use, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Moderate Risk QTc-Prolonging Agents, Anti-Infective Agents, Quinolones, Cytochrome P-450 CYP1A2 Inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Topoisomerase II Inhibitors, Antibacterials for Systemic Use	investigational	0
DB07491	5-amino-2,4,6-tribromobenzene-1,3-dicarboxylic acid	Drug	0	experimental	1
DB07490	2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL	Drug	0	experimental	4
DB07497	5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL	Drug	0	experimental	3
DB06166	Fosdevirine	Drug	Heterocyclic Compounds, Fused-Ring, Acids, Noncarboxylic, Acids, Organophosphorus Compounds, Phosphorus Compounds, Phosphorus Acids	investigational	0
DB07496	1,3-diphenylurea	Drug	0	experimental	1
DB07499	N-(4-{[amino(imino)methyl]amino}butyl)-2,4'-bi-1,3-thiazole-4-carboxamide	Drug	0	experimental	1
DB06168	Canakinumab	Drug	Immunoglobulins, Immunosuppressive Agents, Antineoplastic and Immunomodulating Agents, Antibodies, Amino Acids, Peptides, and Proteins, Agents reducing cytokine levels, Interleukin Inhibitors, Immunoproteins, Proteins, Serum Globulins, Globulins, Blood Proteins, Interleukin-1beta, antagonists & inhibitors	approved, investigational	1
DB07498	4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID	Drug	0	experimental	1
DB06162	Lumiliximab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	1
DB07493	5-Bromoindirubin	Drug	0	experimental	1
DB06161	Opebacan	Drug	0	investigational	0
DB07492	Bromamphenicol	Drug	Nitrobenzenes, Nitro Compounds, Glycols, Propylene Glycols, Benzene Derivatives, Alcohols	experimental	1
DB07495	5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE	Drug	0	experimental	1
DB06163	Plevitrexed	Drug	Heterocyclic Compounds, Fused-Ring, Antineoplastic Agents	investigational	0
DB07494	(3-EXO)-3-(10,11-DIHYDRO-5H-DIBENZO[A,D][7]ANNULEN-5-YLOXY)-8,8-DIMETHYL-8-AZONIABICYCLO[3.2.1]OCTANE	Drug	0	experimental	1
DB06169	Indibulin	Drug	Acids, Acyclic, Heterocyclic Compounds, Fused-Ring, Fatty Acids, Fatty Acids, Volatile, Amides, Lipids, Acetates	investigational	0
DB06171	Paclitaxel trevatide	Drug	Cycloparaffins, Taxoids, Cyclodecanes, Antineoplastic Agents, Diterpenes, Amino Acids, Peptides, and Proteins, Cardiotoxic antineoplastic agents, Terpenes	investigational	0
DB06177	Glufosfamide	Drug	Carbohydrates, Oxazines, Hexoses, Organophosphorus Compounds, Hydrocarbons, Halogenated, Ions, Mustard Compounds, Nitrogen Mustard Compounds, Phosphorus Compounds, Phosphorus Acids, Monosaccharides, Anions, Acids, Noncarboxylic, Acids, Phosphoric Acids, Phosphoramides, Electrolytes, Phosphoramide Mustards	investigational	0
DB06176	Romidepsin	Drug	Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Peptides, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, OATP1B3 substrates, Antibiotics, Antineoplastic, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C19 Substrates, Peptides, Cyclic, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Histone Deacetylase Inhibitors, Cytochrome P-450 CYP2B6 Substrates	approved, investigational	5
DB06179	Darinaparsin	Drug	Organometallic Compounds, Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins	investigational	0
DB06178	Talotrexin	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Amino Acids, Basic, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, Pteridines, Amino Acids, Pigments, Biological	investigational	0
DB06174	Noscapine	Drug	Antitussive Agents, Cytochrome P-450 Enzyme Inhibitors, Isoquinolines, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Respiratory System Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Opium Alkaloids and Derivatives, Opiate Alkaloids, Cytochrome P-450 CYP3A Inhibitors, Cough and Cold Preparations, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Central Nervous System Agents	approved, investigational	1
DB06180	TG1024	Drug	0	investigational	0
DB06182	Talabostat	Drug	Acids, Noncarboxylic, Acids, Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins, Boron Compounds, Dipeptidyl-Peptidases and Tripeptidyl-Peptidases, antagonists & inhibitors	investigational	0
DB06181	IMO-2055	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Antineoplastic Agents, Glycosides, Nucleotides, Toll-Like Receptor 9, agonists, Polynucleotides	investigational	0
DB06188	Ispinesib	Drug	Heterocyclic Compounds, Fused-Ring, Benzoates, Acids, Carbocyclic, Amides, Benzene Derivatives	investigational	0
DB06187	Valtorcitabine	Drug	0	investigational	0
DB06184	AEG35156	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides, Polynucleotides	investigational	1
DB06186	Ipilimumab	Drug	Immunoglobulins, Adjuvants, Immunologic, Antineoplastic and Immunomodulating Agents, Immunoglobulin G, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, CTLA-4-directed Blocking Antibody, Antibodies, Monoclonal, Drugs that are Mainly Renally Excreted, Immunoproteins, Proteins, Serum Globulins, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, Narrow Therapeutic Index Drugs, Globulins, Blood Proteins, Increased T Lymphocyte Activation, CTLA-4-directed Antibody Interactions	approved	1
DB06185	Forodesine	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purines, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Purine-Nucleoside Phosphorylase, antagonists & inhibitors	investigational	1
DB08815	Lurasidone	Drug	Psycholeptics, QTc Prolonging Agents, Tranquilizing Agents, Cytochrome P-450 Substrates, Serotonin Agents, Nervous System, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Isoindoles, Serotonin 5-HT2 Receptor Antagonists, Antipsychotic Agents, Sulfur Compounds, Antipsychotic Agents (Second Generation Atypical), Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Adrenergic Antagonists, Thiazoles, Potential QTc-Prolonging Agents, Dopamine Antagonists, Adrenergic Agents, Dopamine Agents, Neurotoxic agents, Adrenergic alpha-Antagonists, Indole Derivatives, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Agents that produce hypertension, Serotonin Receptor Antagonists, Central Nervous System Agents, Adrenergic alpha-2 Receptor Antagonists, Dopamine D2 Receptor Antagonists, Hyperglycemia-Associated Agents, Serotonin 5-HT1 Receptor Antagonists	approved, investigational	6
DB08816	Ticagrelor	Drug	Ribonucleosides, Blood and Blood Forming Organs, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Purinergic Agents, Cytochrome P-450 CYP3A4 Substrates, Phenylalanine Hydroxylase Activators, Purines, Nucleic Acids, Nucleotides, and Nucleosides, Cytochrome P-450 CYP2C9 Inhibitors, Glycosides, Purinergic Antagonists, Antiplatelet agents, Anticoagulants, Carbohydrates, P-glycoprotein substrates, Cytochrome P-450 CYP3A5 Inhibitors, Purinergic P2 Receptor Antagonists, Hematologic Agents, Purine Nucleosides, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Platelet Aggregation Inhibitors Excl. Heparin, Decreased Platelet Aggregation, Cytochrome P-450 CYP3A4 Inhibitors, Nucleosides, Purinergic P2Y Receptor Antagonists, P-glycoprotein inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (weak), P2Y12 Platelet Inhibitor	approved	1
DB08813	Nadroparin	Drug	Anticoagulants, Carbohydrates, Polysaccharides, Blood and Blood Forming Organs, Glycosaminoglycans, Fibrin Modulating Agents, Heparin (Low Molecular Weight), Agents causing hyperkalemia, Heparin and similars, Hematologic Agents, Cardiovascular Agents	approved, investigational	4
DB08814	Triflusal	Drug	Anticoagulants, Benzoates, Blood and Blood Forming Organs, Hydroxy Acids, Platelet Aggregation Inhibitors Excl. Heparin, Acids, Carbocyclic, Hydroxybenzoates, Phenols, Hematologic Agents, Antiplatelet agents, Benzene Derivatives	approved, investigational	4
DB08811	Tofisopam	Drug	Psycholeptics, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Stereoisomerism, Benzodiazepines and benzodiazepine derivatives, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Antidepressive Agents, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Benzazepines, Central Nervous System Depressants, Cytochrome P-450 CYP3A4 Inhibitors, Anti-Anxiety Agents, Central Nervous System Agents	experimental	4
DB08810	Cinitapride	Drug	Serotonin 5-HT1 Receptor Agonists, Benzoates, Serotonin Agents, Acids, Carbocyclic, Serotonin Receptor Agonists, Amides, Anti-Ulcer Agents, Antidepressive Agents, Serotonin 5-HT2 Receptor Antagonists, Propulsives, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Alimentary Tract and Metabolism, Central Nervous System Depressants, Agents that produce hypertension, Drugs for Functional Gastrointestinal Disorders, Serotonin Receptor Antagonists, Benzene Derivatives, Gastrointestinal Agents	investigational	3
DB08819	Tafluprost	Drug	Biological Factors, Autacoids, Inflammation Mediators, Fatty Acids, Prostaglandin Receptor Agonists, Antiglaucoma Preparations and Miotics, Prostaglandin analogs reducing intraocular pressure (IOP), Eicosanoids, Lipids, Ophthalmics, Prostaglandins, Synthetic, Ophthalmologicals, Fatty Acids, Unsaturated, Prostaglandins, Increased Prostaglandin Activity, Sensory Organs	approved	1
DB08818	Hyaluronic acid	Drug	Carbohydrates, Immunologic Factors, Glycosaminoglycans, Lubricants, Surgical Aids, Adjuvants, Immunologic, Protective Agents, Dermatologicals, Viscoelastic Substances, Ophthalmologicals, Viscosupplements, Nasal Preparations, Polysaccharides, Musculo-Skeletal System, Preparations for Treatment of Wounds and Ulcers, Sensory Organs, Compounds used in a research, industrial, or household setting, Cicatrizants	approved, vet_approved	15
DB08826	Deferiprone	Drug	Pyridines, Iron Chelating Agents, Iron Chelating Activity, Sequestering Agents, Pyridones, UGT1A6 substrate, Compounds used in a research, industrial, or household setting, Chelating Agents, Drugs that are Mainly Renally Excreted, Heavy Metal Antagonists	approved	0
DB08827	Lomitapide	Drug	Hypolipidemic Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Hypolipidemic Agents Indicated for Hyperlipidemia, Cytochrome P-450 CYP3A4 Substrates, Heterocyclic Compounds, Fused-Ring, Lipid Modifying Agents, Lipid Modifying Agents, Plain, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Microsomal Triglyceride Transfer Protein Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Hepatotoxic Agents, Microsomal Triglyceride Transfer Protein Inhibitor, Miscellaneous Antilipemic Agents, P-glycoprotein inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved, investigational	1
DB08824	Ioflupane I-123	Drug	Iodine (123I) Compounds, Iodine Radioisotopes, Radiopharmaceutical Activity, Drugs that are Mainly Renally Excreted, Alkaloids, Tropanes, Central Nervous System, Diagnostic Uses of Chemicals, Aza Compounds, Diagnostic Radiopharmaceuticals, Radioactive Diagnostic Agent, Azabicyclo Compounds, Fluorine Radioisotopes, Carbon Radioisotopes	approved	0
DB08822	Azilsartan medoxomil	Drug	Antihypertensive Agents Indicated for Hypertension, Angiotensin II receptor blockers (ARBs) and diuretics, Angiotensin Receptor Antagonists, Agents causing hyperkalemia, Hypotensive Agents, Angiotensin II receptor blockers (ARBs), plain, Angiotensin II Type 1 Receptor Blockers, Heterocyclic Compounds, Fused-Ring, Oxazoles, Agents Acting on the Renin-Angiotensin System, Agents causing angioedema, Angiotensin 2 Receptor Blocker, Antihypertensive Agents, Decreased Blood Pressure	approved, investigational	1
DB08823	Spinosad	Drug	Polyketides, Pediculicides, Agrochemicals, Pesticides, Insecticides, Toxic Actions, Pharmaceutical Preparations, Compounds used in a research, industrial, or household setting, Lactones	approved, investigational, vet_approved	0
DB08820	Ivacaftor	Drug	Quinolines, Amines, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Aniline Compounds, Chloride Channel Activation Potentiators, Cytochrome P-450 CYP3A4 Substrates, Membrane Transport Modulators, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors, Chloride Channel Agonists, Cytochrome P-450 CYP3A4 Inhibitors, Phenols, P-glycoprotein inhibitors, Cystic Fibrosis Transmembrane Conductance Regulator Potentiators, Benzene Derivatives, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved	1
DB08828	Vismodegib	Drug	Amines, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, Aniline Compounds, Antineoplastic and Immunomodulating Agents, Hedgehog Pathway Inhibitor, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, Amides, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Smoothened Receptor Antagonists, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)	approved, investigational	1
DB08830	Dehydroascorbic acid	Drug	Acids, Acyclic, Carbohydrates, Hydroxy Acids, Vitamins, Lactones, Micronutrients, Physiological Phenomena, Food and Beverages, Vitamin C and analogues, Sugar Acids, Urinary Acidifying Agents, Growth Substances, Diet, Food, and Nutrition, Food	experimental	0
DB08837	Tetraethylammonium	Drug	Amines, Ammonium Compounds, OCT2 Substrates, Quaternary Ammonium Compounds, Ganglion Blockers, MATE 1 Substrates, Onium Compounds, Cardiovascular Agents, Membrane Transport Modulators, MATE 2 Substrates, Potassium Channel Blockers, Tetraethylammonium Compounds, MATE substrates, Nitrogen Compounds	investigational, experimental	4
DB07505	N-({(3R,4R)-4-[(benzyloxy)methyl]pyrrolidin-3-yl}methyl)-N-(2-methylpropyl)benzenesulfonamide	Drug	0	experimental	1
DB07504	(2R)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol	Drug	0	experimental	1
DB08838	Agmatine	Drug	OCT1 substrates, Cytochrome P-450 Substrates, OCT2 Substrates, Agents causing hyperkalemia, Amidines, Guanidines, Cytochrome P-450 CYP3A4 Substrates, Nicotinic Antagonists, Anticholinergic Agents, Calcium Channel Blockers, Cytochrome P-450 CYP3A Substrates, NMDA Receptor Antagonists, Vasodilating Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	experimental	7
DB07507	2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione	Drug	0	experimental	1
DB08835	Spaglumic Acid	Drug	Ophthalmologicals, Nasal Preparations, Antiallergic Agents, Excl. Corticosteroids, Mast Cell Stabilizers, Sensory Organs, Decongestants and Antiallergics	experimental	1
DB07506	L-BENZYLSUCCINIC ACID	Drug	0	experimental	3
DB08836	Temocapril	Drug	Enzyme Inhibitors, Sulfur Compounds, Angiotensin-Converting Enzyme Inhibitors, Thiepins, Agents causing hyperkalemia, Protease Inhibitors, Agents Acting on the Renin-Angiotensin System, OATP1B1/SLCO1B1 Substrates, Agents causing angioedema, Cardiovascular Agents, Antihypertensive Agents, Azepines	investigational, experimental	1
DB08833	Taurochenodeoxycholic acid	Drug	Alkanesulfonic Acids, Surface-Active Agents, Cytochrome P-450 Substrates, Sulfur Acids, Hydrocarbons, Acyclic, Alkanes, Cytochrome P-450 CYP3A4 Substrates, Detergents, Bile Acids and Salts, Cholic Acids, Fused-Ring Compounds, Household Products, Sulfur Compounds, Acids, Noncarboxylic, Acids, Cytochrome P-450 CYP3A Substrates, Sulfonic Acids, Cholagogues and Choleretics, Cholanes, Compounds used in a research, industrial, or household setting, Taurodeoxycholic Acid, Gastrointestinal Agents, Steroids	experimental	0
DB07501	(2S)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol	Drug	0	experimental	1
DB07500	(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one	Drug	0	experimental	1
DB08834	Tauroursodeoxycholic acid	Drug	Alkanesulfonic Acids, Sulfur Acids, Hydrocarbons, Acyclic, Alkanes, Bile Acids and Salts, Cholic Acids, Isomerism, Anti-Infective Agents, Fused-Ring Compounds, Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfonic Acids, Cholagogues and Choleretics, Cholanes, Taurodeoxycholic Acid, Gastrointestinal Agents, Steroids	investigational, experimental	0
DB08831	2-deoxyglucose	Drug	Antimetabolites	investigational, experimental	0
DB07503	(5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE	Drug	0	experimental	1
DB07502	4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol	Drug	0	experimental	1
DB07509	difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron	Drug	0	experimental	1
DB07508	4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE	Drug	0	experimental	1
DB08839	Serotonin	Drug	Viper Venoms, Amines, Serotonin Agents, Enzymes and Coenzymes, Antidepressive Agents, Toxins, Biological, Complex Mixtures, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Biogenic Amines, Serine Proteases, Indoles, Snake Venoms, Fluids and Secretions, Bodily Secretions, Biological Factors, Enzymes, Autacoids, Inflammation Mediators, Serotonin Receptor Agonists, Biogenic Monoamines, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Central Nervous System Depressants, Venoms, Hydrolases, Peptide Hydrolases, Tryptamines, Endopeptidases	investigational, nutraceutical	5
DB08840	N-methylnicotinamide	Drug	Pyridines, Preparations for Biliary Tract Therapy, Alimentary Tract and Metabolism, MATE 2 Substrates, MATE 1 Substrates, Bile Therapy, Nicotinic Acids, MATE substrates, Drugs that are Mainly Renally Excreted, Bile and Liver Therapy	experimental	0
DB08841	Tyramine	Drug	Autonomic Agents, Neurotransmitter Agents, Amines, Sympathomimetics, Neurotransmitter Uptake Inhibitors, Agents that produce hypertension, Biogenic Amines, Agents producing tachycardia, Adrenergic Agents, Biogenic Monoamines, Membrane Transport Modulators, Peripheral Nervous System Agents	investigational, nutraceutical	0
DB07510	3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid	Drug	0	experimental	1
DB07516	(2Z,4E)-3-chloro-2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid	Drug	0	experimental	1
DB08848	Guvacine	Drug	Pyridines	experimental	4
DB07515	1-(2-{[(6-amino-2-methylpyridin-3-yl)methyl]amino}ethyl)-6-chloro-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-1,4-dihydropyrazin-2-ol	Drug	0	experimental	1
DB08849	Nipecotic acid	Drug	Piperidines	experimental	0
DB08846	Ellagic acid	Drug	Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Benzopyrans, OAT1/SLC22A6 Substrates, OAT1/SLC22A6 inhibitors, OAT3/SLC22A8 Substrates, Pyrans	investigational	17
DB07518	(2R)-2-ETHYL-1-HEXANESULFONIC ACID	Drug	0	experimental	1
DB07517	3-CARBOXY-4-METHYL-5-PROPYL-2-FURANPROPIONIC	Drug	0	experimental	0
DB08847	Hydroxyproline	Drug	Acids, Acyclic, Amino Acids, Cyclic, Imines, Amino Acids, Peptides, and Proteins, Imino Acids, Amino Acids	experimental	0
DB07512	7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE	Drug	0	experimental	1
DB08844	Uric acid	Drug	Antioxidants, Alkaloids, Heterocyclic Compounds, Fused-Ring, Purines, Protective Agents, Xanthine derivatives, Compounds used in a research, industrial, or household setting, Purinones	investigational	1
DB07511	4-(4-methyl-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzonitrile	Drug	0	experimental	1
DB08845	Oxogluric acid	Drug	Acids, Acyclic, Glutarates, Keto Acids, Dicarboxylic Acids, Ketoglutaric Acids	investigational, nutraceutical, experimental	1
DB08842	Acetylcarnitine	Drug	Amines, Ammonium Compounds, Nervous System, Quaternary Ammonium Compounds, Psychostimulants, Agents Used for Adhd and Nootropics, Trimethyl Ammonium Compounds, Onium Compounds, Micronutrients, Physiological Phenomena, Food and Beverages, Central Nervous System Agents, Growth Substances, Diet, Food, and Nutrition, Nitrogen Compounds, Food, Nootropic Agents, Psychoanaleptics	approved, investigational	0
DB07514	3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one	Drug	0	experimental	1
DB08843	GS 0573	Drug	Heterocyclic Compounds, Fused-Ring, Immunologic Factors, Purines, Anti-Infective Agents	investigational	0
DB07513	7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE	Drug	0	experimental	1
DB07519	(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one	Drug	0	experimental	1
DB08804	Nandrolone decanoate	Drug	Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, Estrenes, Anabolic Agents, Hormones, Fused-Ring Compounds, Gonadal Steroid Hormones, Androgens, Bone Density Conservation Agents, Testosterone Congeners, Thyroxine-binding globulin inhibitors, Nandrolone and esters, Gonadal Hormones, Steroids	approved, illicit	1
DB08805	Metiamide	Drug	Neurotransmitter Agents, Gastric Acid Lowering Agents, Sulfur Compounds, Histamine Antagonists, Acid Reducers, Thiourea, Anti-Ulcer Agents, Histamine Agents, Histamine H2 Antagonists, Gastrointestinal Agents	experimental	1
DB08802	Isothipendyl	Drug	Neurotransmitter Agents, Histamine H1 Antagonists, Sulfur Compounds, Antipruritics, Incl. Antihistamines, Anesthetics, Etc., Histamine Antagonists, Antihistamines for Topical Use, Dermatologicals, Histamine Agents, Phenothiazine Derivatives, Antihistamines for Systemic Use	experimental	1
DB08803	Tymazoline	Drug	Nasal Preparations, Sympathomimetics, Plain	experimental	0
DB08800	Chloropyramine	Drug	Diamines, Neurotransmitter Agents, Histamine H1 Antagonists, Amines, Antipruritics, Incl. Antihistamines, Anesthetics, Etc., Histamine Antagonists, Antihistamines for Topical Use, Dermatologicals, Histamine Agents, Polyamines, Antihistamines for Systemic Use, Substituted Ethylene Diamines	experimental	1
DB08801	Dimetindene	Drug	Pyridines, Anti-Allergic Agents, Substituted Alkylamines, Antihistamines for Topical Use, Dermatologicals, Agents producing tachycardia, Muscarinic Antagonists, Anticholinergic Agents, Neurotransmitter Agents, Histamine H1 Antagonists, Antipruritics, Incl. Antihistamines, Anesthetics, Etc., Histamine Antagonists, Indenes, Histamine Agents, Antihistamines for Systemic Use, Antipruritics	approved, investigational	2
DB08808	Bupranolol	Drug	QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Propanols, Agents causing hyperkalemia, Phenoxypropanolamines, Adrenergic beta-Antagonists, Cardiovascular Agents, Amino Alcohols, Beta Blocking Agents, Non-Selective, Alcohols, Neurotransmitter Agents, Adrenergic Antagonists, Potential QTc-Prolonging Agents, Antihypertensive Agents, Cytochrome P-450 CYP2D6 Substrates, Adrenergic Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Propanolamines	experimental	3
DB08809	Dichloroacetic acid	Drug	Chloroacetates, Hydrocarbons, Chlorinated, Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Hydrocarbons, Halogenated, Lipids, Acetates	approved, investigational	2
DB08806	Roxatidine acetate	Drug	Neurotransmitter Agents, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Gastric Acid Lowering Agents, Histamine Antagonists, Alimentary Tract and Metabolism, Acid Reducers, Anti-Ulcer Agents, Drugs for Acid Related Disorders, Histamine Agents, Histamine H2 Antagonists, Gastrointestinal Agents	experimental	1
DB08807	Bopindolol	Drug	Amines, Cytochrome P-450 Substrates, Propanols, Agents causing hyperkalemia, Phenoxypropanolamines, Adrenergic beta-Antagonists, Amino Alcohols, Beta Blocking Agents, Non-Selective, Alcohols, Neurotransmitter Agents, Adrenergic Antagonists, Cytochrome P-450 CYP2D6 Substrates, Adrenergic Agents, Bradycardia-Causing Agents, Propanolamines	experimental	5
DB07563	1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine	Drug	0	experimental	1
DB08895	Tofacitinib	Drug	Enzyme Inhibitors, Biologics for Rheumatoid Arthritis Treatment, Cytochrome P-450 Substrates, Immunosuppressive Agents, Janus Kinase Inhibitor, Antineoplastic and Immunomodulating Agents, Antirheumatic Agents, Cytochrome P-450 CYP3A4 Substrates, Disease-modifying Antirheumatic Agents, Selective Immunosuppressants, Myelosuppressive Agents, Cytochrome P-450 CYP2C19 Substrates, Janus Kinase 3, antagonists & inhibitors, Protein Kinase Inhibitors, Cytochrome P-450 CYP3A Substrates, Bradycardia-Causing Agents, Janus Kinase Inhibitors	approved, investigational	4
DB06231	Caldaret	Drug	Arylsulfonates, Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfur Acids, Sulfonic Acids, Arylsulfonic Acids, Benzene Derivatives	investigational	1
DB08896	Regorafenib	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Inhibitors, Hepatotoxic Agents, Benzene Derivatives, Bradycardia-Causing Agents, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, UGT1A1 Inhibitors, Protein Kinase Inhibitors, UGT1A9 Inhibitors, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, UGT1A9 Substrates, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), P-glycoprotein inhibitors, Kinase Inhibitor	approved	18
DB07562	N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE	Drug	0	experimental	2
DB06234	Maribavir	Drug	Antivirals for Systemic Use, Carbohydrates, Direct Acting Antivirals, Heterocyclic Compounds, Fused-Ring, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Antiviral Agents, Antiinfectives for Systemic Use, Anti-Infective Agents	investigational	2
DB08893	Mirabegron	Drug	Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Aniline Compounds, Drugs for Urinary Frequency and Incontinence, Genito Urinary System and Sex Hormones, Urologicals, Amides, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Anilides, Sulfur Compounds, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Potential QTc-Prolonging Agents, Adrenergic Agents, P-glycoprotein substrates, Agents producing tachycardia, Urological Agents, Adrenergic beta-Agonists, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Adrenergic Agonists, Agents that produce hypertension, Cholinesterase substrates, Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors, Adrenergic beta-3 Receptor Agonists, Selective Beta 3-adrenergic Agonists	approved	1
DB07565	Chloramphenicol succinate	Drug	Anti-Bacterial Agents, Nitrobenzenes, Narrow Therapeutic Index Drugs, P-glycoprotein substrates, Nitro Compounds, Glycols, Propylene Glycols, Anti-Infective Agents, Benzene Derivatives, Alcohols	approved	1
DB06233	Ridaforolimus	Drug	Anti-Bacterial Agents, Polyketides, Protein Kinase Inhibitors, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A4 Inhibitors, Antineoplastic Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Lactones	investigational	1
DB08894	Peginesatide	Drug	Blood and Blood Forming Organs, Amino Acids, Peptides, and Proteins, Erythropoiesis-Stimulating Agents, Drugs that are Mainly Renally Excreted, Alcohols, Macromolecular Substances, Increased Erythroid Cell Production, Antianemic Preparations, Ethylene Glycols, Pegylated agents, Glycols, Polymers, Compounds used in a research, industrial, or household setting	approved, investigational	1
DB07564	6-amino-2-[(2-morpholin-4-ylethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one	Drug	0	experimental	1
DB08891	Arbaclofen	Drug	0	investigational	2
DB08892	Arbaclofen Placarbil	Drug	Neuromuscular Agents, Acids, Acyclic, Fatty Acids, GABA Agents, GABA Agonists, Amino Acids, Peptides, and Proteins, Lipids, Aminobutyrates, Muscle Relaxants, Amino Acids, Peripheral Nervous System Agents, Neurotransmitter Agents, Butyrates, Central Nervous System Depressants, Fatty Acids, Volatile, Muscle Relaxants, Centrally Acting Agents, GABA-B Receptor Agonists, Central Nervous System Agents	investigational	2
DB06230	Nalmefene	Drug	Neuroprotective Agents, Appetite Depressants, Sensory System Agents, Nervous System, UGT1A3 substrates, Drugs Used in Alcohol Dependence, Drugs Used in Addictive Disorders, Drugs that are Mainly Renally Excreted, Morphinans, Peripheral Nervous System Agents, Opioid Antagonists, Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, UGT2B7 substrates, Central Nervous System Agents, Antipruritics	approved, investigational, withdrawn	3
DB07561	(2Z)-2-cyano-N-(3'-ethoxybiphenyl-4-yl)-3-hydroxybut-2-enamide	Drug	0	experimental	1
DB08890	Linaclotide	Drug	Guanylate Cyclase-C Agonist, Enzyme Activators, Alimentary Tract and Metabolism, Guanylyl Cyclase C Agonists, Miscellaneous GI Drugs, Drugs for Constipation, Amino Acids, Peptides, and Proteins, Laxatives, Gastrointestinal Agents, Guanylate Cyclase Activators	approved	1
DB07560	N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide	Drug	0	experimental	1
DB06239	Tipapkinogene sovacivec	Drug	0	investigational	0
DB06236	Elvucitabine	Drug	Carbohydrates, Ribonucleosides, Enzyme Inhibitors, Pyrimidine Nucleosides, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Dideoxynucleosides, Anti-Infective Agents, Nucleic Acid Synthesis Inhibitors, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Deoxycytidine, HIV Reverse Transcriptase, Glycosides, Nucleosides, Deoxyribonucleosides, Reverse Transcriptase Inhibitors, Nucleoside Reverse Transcriptase Inhibitors	investigational	0
DB07567	(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL	Drug	0	experimental	1
DB08899	Enzalutamide	Drug	Endocrine Therapy, Androgen Receptor Antagonists, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Hormone Antagonists and Related Agents, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP2C19 Inducers (moderate), Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Thyroxine-binding globulin substrates, Cytochrome P-450 CYP3A4 Inducers (strong), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C19 Inducers, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP2C9 Inducers (moderate), Cytochrome P-450 CYP3A Inducers (strong), Cytochrome P-450 CYP2C8 Inhibitors, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A4 Inducers, Androgen Receptor Inhibitor, Antineoplastic Agents, Hydantoins, Imidazolidines, Cytochrome P-450 CYP2C9 Substrates, Imidazoles, Cytochrome P-450 CYP3A Substrates, Antiandrogens, Cytochrome P-450 CYP3A5 Inducers (strong), Cytochrome P-450 CYP2C9 Inducers, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), P-glycoprotein inhibitors, Antiandrogens, non-steroidal	approved	1
DB06235	Vadimezan	Drug	Xanthenes, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 Substrates, UGT2B7 substrates, Cytochrome P-450 CYP1A2 Substrates, Antineoplastic Agents, UGT1A9 Substrates	investigational	0
DB08897	Aclidinium	Drug	Anticholinergic Agents, Adrenergics, Inhalants, Alkaloids, Agents to Treat Airway Disease, Antimuscarinics Antispasmodics, Aza Compounds, Agents producing tachycardia, Azabicyclo Compounds, Cholinesterase substrates, Drugs for Obstructive Airway Diseases, Muscarinic Antagonists, Drugs that are Mainly Renally Excreted	approved	5
DB07569	CIS-4-METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE	Drug	0	experimental	1
DB06237	Avanafil	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Drugs Used in Erectile Dysfunction, Cyclic Nucleotide Phosphodiesterases, Type 5, Genito Urinary System and Sex Hormones, Phosphodiesterase 5 Inhibitors, Urologicals, Cytochrome P-450 CYP3A4 Substrates, Vasodilating Agents	approved	1
DB08898	Glucarpidase	Drug	Proteins, Enzymes, Exopeptidases, Detoxifying Agents for Antineoplastic Treatment, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Hydrolases, Peptide Hydrolases, gamma-Glutamyl Hydrolase, antagonists & inhibitors, Carboxypeptidases	approved, investigational	1
DB07568	(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE	Drug	0	experimental	1
DB06243	Eflornithine	Drug	Enzyme Inhibitors, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Decarboxylase Inhibitors, Dermatologicals, Amino Acids, Diamino, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Decarboxylase Inhibitor, Misc. Skin and Mucous Membrane Agents, Amino Acids, Anti-Infective Agents, Ornithine Decarboxylase Inhibitors, Agents Against Leishmaniasis and Trypanosomiasis, Amino Acids, Basic, Trypanocidal Agents, Antiparasitic Agents	approved, withdrawn	1
DB07574	2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE	Drug	0	experimental	5
DB07573	(2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol	Drug	0	experimental	1
DB06245	Lanoteplase	Drug	Biological Factors, Enzymes, Plasminogen Activators, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Proteins, Blood Proteins, Serine Proteases, Hydrolases, Agents causing angioedema, Peptide Hydrolases, Serine Endopeptidases, Endopeptidases	investigational	17
DB06244	Trafermin	Drug	Proteins, Biological Factors, Peptides, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Cardiovascular Agents, Fibroblast Growth Factors	investigational	0
DB07575	2,4-DIAMINO-1,5-DIPHENYL-3-HYDROXYPENTANE	Drug	0	experimental	1
DB07570	3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID	Drug	0	experimental	1
DB06241	Clenoliximab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, CD4 Antigens, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	1
DB07572	3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate	Drug	0	experimental	1
DB06240	Tariquidar	Drug	Heterocyclic Compounds, Fused-Ring, Drug Resistance, Multiple, P-glycoprotein inhibitors	investigational	1
DB07571	N~2~-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)-2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]-L-LEUCINAMIDE	Drug	0	experimental	1
DB06247	CX516	Drug	Receptors, AMPA	investigational	1
DB07578	CP-94707	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, HIV Reverse Transcriptase, antagonists & inhibitors, Thiazoles	experimental	1
DB06246	Exisulind	Drug	Analgesics, Non-Narcotic, Enzyme Inhibitors, Sensory System Agents, Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Protective Agents, Antineoplastic Agents, Antirheumatic Agents, Peripheral Nervous System Agents, Analgesics, Anticarcinogenic Agents, Indenes, Central Nervous System Agents, Compounds used in a research, industrial, or household setting	investigational	7
DB07577	2,4-Diamino-5-phenyl-6-ethylpyrimidine	Drug	0	experimental	1
DB06249	Arzoxifene	Drug	Sulfur Compounds	approved, investigational	2
DB06248	Amelubant	Drug	Acids, Acyclic, Receptors, Leukotriene B4, antagonists & inhibitors	investigational	2
DB07579	Bis-1,2-{[(Z)-2-carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane	Drug	0	experimental	1
DB07585	5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine	Drug	0	experimental	2
DB06253	Thioctic acid tromethamine	Drug	0	investigational	0
DB07584	N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine	Drug	0	experimental	2
DB06256	rPSGL-Ig	Drug	0	investigational	0
DB07587	N-(1-CYANOCYCLOPROPYL)-3-({[(2S)-5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE	Drug	0	experimental	1
DB07586	5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE	Drug	0	experimental	1
DB06255	Incadronic acid	Drug	Organophosphonates, Bone Density Conservation Agents, Antineoplastic Agents, Organophosphorus Compounds, Bisphosphonates	experimental	4
DB06250	Fluasterone	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, 17-Ketosteroids, Adrenal Cortex Hormones, Androstenes, Hormones, Ketosteroids, Fused-Ring Compounds, Gonadal Steroid Hormones, Androstanes, Androstenols, Testosterone Congeners, Gonadal Hormones, Steroids	investigational	0
DB07581	5-AMINO-6-CYCLOHEXYL-4-HYDROXY-2-ISOPROPYL-HEXANOIC ACID	Drug	0	experimental	1
DB07580	BIS-1,2-{[(Z)-2CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBONYL}-PIPERAZINE	Drug	0	experimental	1
DB07583	(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE	Drug	0	experimental	2
DB06251	Dersalazine	Drug	Benzoates, Hydroxy Acids, Platelet Activating Factor, antagonists & inhibitors, Acids, Carbocyclic, Hydroxybenzoates, Phenols, Salicylates, Benzene Derivatives	investigational	0
DB07582	N-[(2R,3S)-1-((2S)-2-{[(CYCLOPENTYLAMINO)CARBONYL]AMINO}-3-METHYLBUTANOYL)-2-(1-FORMYL-1-CYCLOBUTYL)PYRROLIDINYL]CYCLOPROPANECARBOXAMIDE	Drug	0	experimental	2
DB07589	N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE	Drug	0	experimental	1
DB06258	Bimoclomol	Drug	0	investigational	1
DB06257	HE-2200	Drug	Androstanes, Androstenes, Fused-Ring Compounds, Steroids	investigational	0
DB07588	3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID	Drug	0	experimental	1
DB07590	S-[3-(3,4-DICHLOROPHENYL)-3-OXOPROPYL]-L-CYSTEINE	Drug	0	experimental	1
DB07596	(17beta)-17-(cyanomethyl)-2-methoxyestra-1(10),2,4-trien-3-yl sulfamate	Drug	0	experimental	1
DB06264	Tolperisone	Drug	Neuromuscular Agents, Pyridines, Cytochrome P-450 Substrates, Ketones, Topical Products for Joint and Muscular Pain, Muscle Relaxants, Peripheral Nervous System Agents, Central Nervous System Depressants, Musculo-Skeletal System, Muscle Relaxants, Centrally Acting Agents, Cytochrome P-450 CYP1A2 Substrates, Propiophenones, Central Nervous System Agents	investigational	0
DB07595	(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE	Drug	0	experimental	1
DB06267	Udenafil	Drug	Phosphodiesterase Inhibitors, Enzyme Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Genito Urinary System and Sex Hormones, Phosphodiesterase 5 Inhibitors, Urologicals, Amides, Cytochrome P-450 CYP3A4 Substrates, Sulfur Compounds, Cytochrome P-450 CYP3A Substrates, Drugs Used in Erectile Dysfunction, Vasodilating Agents, Sulfones	approved, investigational	1
DB07598	2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE	Drug	0	experimental	1
DB07597	CIS-(1R,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL	Drug	0	experimental	1
DB06266	Lonidamine	Drug	Antispermatogenic Agents, Antiprotozoals, Contraceptive Agents, Male, Noxae, Pyrazoles, Adrenal Cortex Hormones, Antineoplastic and Immunomodulating Agents, Reproductive Control Agents, Antineoplastic Agents, Radiation-Sensitizing Agents, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Trypanocidal Agents, Toxic Actions, Hormonal Contraceptives for Systemic Use, Antiparasitic Agents	investigational	2
DB07592	(2R)-3-Methyl-1-phenyl-2-butanyl [(2S)-1-oxo-2-hexanyl]carbamate	Drug	0	experimental	1
DB06261	Hexaminolevulinate	Drug	Other Diagnostics, Photosensitizing Agents, Keto Acids, Levulinic Acids, Amino Acids, Peptides, and Proteins, Amino Acids, Carbon Radioisotopes	approved	0
DB06260	Aviptadil	Drug	Erectile Dysfunction, Proteins, Peptide Hormones, Imidazoles, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Gastrointestinal Hormones, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Pharmaceutical Preparations, Hormones	experimental	0
DB07591	N1-CYCLOPENTYL-N2-(THIAZOL-2-YL)OXALAMIDE	Drug	0	experimental	1
DB06263	Amrubicin	Drug	Carbohydrates, Cytotoxic Antibiotics and Related Substances, Antineoplastic and Immunomodulating Agents, Naphthacenes, Antineoplastic Agents, Glycosides, Anthracyclines and Related Substances	investigational	2
DB07594	CCT-018159	Drug	Heterocyclic Compounds, Fused-Ring	experimental	2
DB07593	1-(PHENYLMETHYL)CYCLOPENTYL[(1S)-1-FORMYLPENTYL]CARBAMATE	Drug	0	experimental	1
DB06262	Droxidopa	Drug	Amines, Adrenergic alpha-1 Receptor Agonists, Amino Acids, Peptides, and Proteins, Adrenergic beta-2 Receptor Agonists, Drugs that are Mainly Renally Excreted, Alcohols, Anti-Dyskinesia Agents, Adrenergic alpha-2 Receptor Agonists, Increased Blood Pressure, Adrenergic beta-1 Receptor Agonists, Biogenic Amines, Benzene Derivatives, Amino Acids, Neutral, Adrenergic alpha-Agonists, Epinephrine and similars, Agents producing tachycardia, Catecholamines, Catechols, Adrenergic and Dopaminergic Agents, Amino Alcohols, Ethanolamines, Amino Acids, Biogenic Monoamines, Adrenergic beta-Agonists, Adrenergic Agonists, Cardiac Stimulants Excl. Cardiac Glycosides, Agents that produce hypertension, Phenols, Central Nervous System Agents, Cardiac Therapy, Adrenergic beta-3 Receptor Agonists	approved, investigational	10
DB07599	[(2-AMINO-ALPHA-METHOXYIMINO-4-THIAZOLYLACETYL)AMINO]METHYLBORONIC ACID	Drug	0	experimental	1
DB06268	Sitaxentan	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Substrates, Sulfur Compounds, Cytochrome P-450 CYP3A Inhibitors, Antihypertensives for Pulmonary Arterial Hypertension, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Antihypertensive Agents, Cytochrome P-450 CYP2C19 Inhibitors (weak), Endothelin Receptor Antagonists	approved, investigational, withdrawn	2
DB07521	(3Z,6S)-6-Chloro-1-(2-{[(5-chloro-1-benzothiophen-3-yl)methyl]amino}ethyl)-3-({2-[(2R)-2-piperidinyl]ethyl}imino)-2-piperazinol	Drug	0	experimental	1
DB07520	N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE	Drug	0	experimental	1
DB07527	N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]-4-METHOXY-2,3,6-TRIMETHYLBENZENESULFONAMIDE	Drug	0	experimental	1
DB07526	N-[4-({[5-(DIMETHYLAMINO)-1-NAPHTHYL]SULFONYL}AMINO)BUTYL]-3-SULFANYLPROPANAMIDE	Drug	0	experimental	1
DB08857	Bamet-UD2	Drug	Organometallic Compounds, Bile Acids and Salts, Cholanes, Cholic Acids, Fused-Ring Compounds, Steroids	experimental	0
DB07529	(5E)-2-Amino-5-(2-pyridinylmethylene)-1,3-thiazol-4(5H)-one	Drug	0	experimental	1
DB08858	cis-Diamminechlorocholylglycinateplatinum(II)	Drug	Organometallic Compounds, Bile Acids and Salts, Cholanes, Fused-Ring Compounds, Steroids	experimental	0
DB07528	3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one	Drug	0	experimental	1
DB08855	Leukotriene C4	Drug	Fatty Acids, Essential, SRS-A, Biological Factors, Arachidonic Acids, Autacoids, Fatty Acids, Unsaturated, Inflammation Mediators, Fatty Acids, Leukotrienes, Eicosanoids, Lipids	investigational, experimental	3
DB08856	DADLE	Drug	Proteins, Opioid Peptides, Enkephalin, Leucine, Peptides, Enkephalins, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins	experimental	0
DB07522	N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]NAPHTHALENE-2-SULFONAMIDE	Drug	0	experimental	1
DB07525	3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine	Drug	0	experimental	1
DB07524	N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine	Drug	0	experimental	1
DB07530	(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol	Drug	0	experimental	2
DB08862	Cholecystokinin	Drug	OATP1B1/SLCO1B1 Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Gastrointestinal Hormones, Amino Acids, Peptides, and Proteins, OATP1B3 substrates, Hormones, Cholecystokinin, agonists, Cholecystokinin, antagonists & inhibitors, Cholagogues and Choleretics, OATP1B1/SLCO1B1 Substrates, Diagnostic Agents, Tests for Pancreatic Function, Gastrointestinal Agents	approved, investigational	6
DB06201	Rufinamide	Drug	Voltage-Gated Sodium Channel Blockers, Cytochrome P-450 Substrates, Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP2E1 Inhibitors (weak), Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Membrane Transport Modulators, Carboxamide Derivatives, Cytochrome P-450 CYP3A4 Inducers (weak), Anticonvulsants, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Miscellaneous Anticonvulsants, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Central Nervous System Agents, Sodium Channel Blockers	approved	2
DB08860	Pitavastatin	Drug	OATP1B1/SLCO1B1 Inhibitors, Anticholesteremic Agents, Enzyme Inhibitors, Hypolipidemic Agents, Cytochrome P-450 Substrates, P-glycoprotein substrates, UGT1A3 substrates, BSEP/ABCB11 Substrates, Hypolipidemic Agents Indicated for Hyperlipidemia, OATP1B3 substrates, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Lipid Modifying Agents, Lipid Modifying Agents, Plain, Lipid Regulating Agents, BCRP/ABCG2 Substrates, UGT2B7 substrates, Agents Causing Muscle Toxicity, OATP1B1/SLCO1B1 Substrates, Toxic Actions, Cytochrome P-450 CYP2C8 Substrates, Hydroxymethylglutaryl-CoA Reductase Inhibitors	approved	2
DB07532	N-hexanoyl-L-homoserine	Drug	0	experimental	0
DB06200	Tedisamil	Drug	Cardiotonic Agents, Antiarrhythmics, Class III, QTc Prolonging Agents, Cycloparaffins, Protective Agents, Cardiovascular Agents, Cardiac Therapy, Compounds used in a research, industrial, or household setting, Moderate Risk QTc-Prolonging Agents, Antiarrhythmic agents	investigational	0
DB08861	DPDPE	Drug	Sensory System Agents, Narcotics, Peptides, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Peripheral Nervous System Agents, Proteins, Neurotransmitter Agents, Opioid Peptides, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Enkephalins, Opioids, Central Nervous System Agents	experimental	0
DB07531	4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE	Drug	0	experimental	1
DB07538	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE	Drug	0	experimental	2
DB06207	Silodosin	Drug	Cytochrome P-450 Substrates, Adrenergic alpha-Antagonists, P-glycoprotein substrates, Genito Urinary System and Sex Hormones, Peripheral alpha-1 blockers, Urologicals, Cytochrome P-450 CYP3A4 Substrates, Selective Alfa-1-adrenergic Blocking Agents, Urological Agents, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, UGT2B7 substrates, Cytochrome P-450 CYP3A Substrates, Adrenergic Antagonists, Adrenergic alpha-1 Receptor Antagonists, Drugs Used in Benign Prostatic Hypertrophy, Adrenergic Agents	approved	3
DB07537	N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide	Drug	0	experimental	1
DB06206	Sugammadex	Drug	Carbohydrates, Antidotes, Dietary Carbohydrates, gamma-Cyclodextrins, Starch, Cyclodextrins, Biopolymers, Macromolecular Substances, Polysaccharides, Physiological Phenomena, Food and Beverages, Glucans, Dextrins, Polymers, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food	approved	0
DB08868	Fingolimod	Drug	Immunologic Factors, QTc Prolonging Agents, Cytochrome P-450 CYP2E1 Substrates, Amines, Cytochrome P-450 Substrates, Immunosuppressive Agents, Antineoplastic and Immunomodulating Agents, Experimental Unapproved Treatments for COVID-19, Amino Alcohols, Propylene Glycols, Selective Immunosuppressants, Alcohols, P-glycoprotein inducers, Sphingosine 1-phosphate Receptor Modulator, Glycols, Immunomodulatory Agents, P-glycoprotein inhibitors, Bradycardia-Causing Agents	approved, investigational	5
DB06209	Prasugrel	Drug	Anticoagulants, Blood and Blood Forming Organs, Cytochrome P-450 Substrates, Piperazines, Hematologic Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Sulfur Compounds, Cytochrome P-450 CYP3A Substrates, Platelet Aggregation Inhibitors Excl. Heparin, Thiophenes, Decreased Platelet Aggregation, Purinergic P2Y Receptor Antagonists, Cytochrome P-450 CYP2B6 Substrates, Antiplatelet agents, P2Y12 Platelet Inhibitor	approved	1
DB07539	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID	Drug	0	experimental	2
DB08869	Tesamorelin	Drug	Somatropin and Somatropin Agonists, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pituitary and Hypothalamic Hormones and Analogues, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Hormones, Pituitary Hormone-Releasing Hormones, Growth Hormone-Releasing Hormone, Proteins, Anterior Pituitary Lobe Hormones and Analogues, Peptide Hormones, Hypothalamic Hormones, Somatotropin Agonists, Growth Hormone Releasing Factor Analog, Lipodystrophy, Growth Substances, Increased GHRH Activity, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins	approved, investigational	1
DB06203	Alogliptin	Drug	Enzyme Inhibitors, Cytochrome P-450 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Protease Inhibitors, Pyrimidinones, Blood Glucose Lowering Agents, Hormones, Cytochrome P-450 CYP3A4 Substrates, DPP-IV Inhibitors, Drugs that are Mainly Renally Excreted, Incretins, Pyrimidines, Cytochrome P-450 CYP3A Substrates, Alimentary Tract and Metabolism, Drugs Used in Diabetes, Agents causing angioedema, Cytochrome P-450 CYP2D6 Substrates	approved	1
DB07534	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE	Drug	0	experimental	2
DB06202	Lasofoxifene	Drug	Sex Hormones and Modulators of the Genital System, Selective Estrogen Receptor Modulators, Genito Urinary System and Sex Hormones, Naphthalenes	approved, investigational	3
DB08867	Ulipristal	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Contraceptives, Postcoital, Norsteroids, Progesterone Receptor Modulators, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, Reproductive Control Agents, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Selective Progesterone Receptor Modulators, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Progesterone Agonist/Antagonist, Hormonal Contraceptives for Systemic Use, Norpregnanes, Contraceptive Agents, Female, Steroids	approved	3
DB07533	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE	Drug	0	experimental	2
DB07536	N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide	Drug	0	experimental	1
DB08864	Rilpivirine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor, Cytochrome P-450 Enzyme Inhibitors, Nonnucleoside Reverse Transcriptase Inhibitors, OATP1B3 inhibitors, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Non-Nucleoside Reverse Transcriptase Inhibitors, Anti-Infective Agents, Antivirals for Systemic Use, Direct Acting Antivirals, Nucleic Acid Synthesis Inhibitors, Pyrimidines, Nitriles, Potential QTc-Prolonging Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), OATP1B1/SLCO1B1 Inhibitors, BCRP/ABCG2 Inhibitors, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Antiinfectives for Systemic Use, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2B6 Inhibitors (strong), Cytochrome P-450 CYP3A4 Inhibitors, Reverse Transcriptase Inhibitors, P-glycoprotein inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved	2
DB06205	Hyaluronidase (human recombinant)	Drug	Enzymes, Blood and Blood Forming Organs, Glycoside Hydrolases, Enzymes and Coenzymes, Carbon-Oxygen Lyases, Hydrolases, Lyases, Polysaccharide-Lyases, Hyaluronoglucosaminidase, antagonists & inhibitors	approved, investigational	2
DB06204	Tapentadol	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Adrenergic Uptake Inhibitors, Cytochrome P-450 Substrates, Sensory System Agents, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Antidepressive Agents, Opiate Agonists, Peripheral Nervous System Agents, Serotonin Modulators, UGT2B7 substrates, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Opioids, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Adrenergic Agents, Benzene Derivatives, Narcotics, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Membrane Transport Modulators, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Neurotransmitter Agents, Central Nervous System Depressants, Opioid Agonist, Neurotransmitter Uptake Inhibitors, Phenols, UGT1A9 Substrates, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates	approved	6
DB08865	Crizotinib	Drug	Aminopyridines, QTc Prolonging Agents, Enzyme Inhibitors, Amines, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Piperidines, P-glycoprotein substrates with narrow therapeutic index, Bradycardia-Causing Agents, Pyridines, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A5 Inhibitors, Antineoplastic Agents, Moderate Risk QTc-Prolonging Agents, Protein Kinase Inhibitors, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, OCT2 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Organic Cation Transporter 1 Inhibitors, Receptor Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), P-glycoprotein inhibitors, Kinase Inhibitor	approved	2
DB07535	2-amino-6-[2-(1H-indol-6-yl)ethyl]pyrimidin-4(3H)-one	Drug	0	experimental	1
DB08873	Boceprevir	Drug	Acids, Acyclic, Antivirals for treatment of HCV infections, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Protease Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (strong), Amino Acids, Peptides, and Proteins, Cytochrome P-450 CYP3A4 Substrates, HCV NS3/4A Protease Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strong), Antivirals for Systemic Use, Direct Acting Antivirals, Imines, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A5 Inhibitors, Antiviral Agents, Antiinfectives for Systemic Use, Amino Acids, Amino Acids, Cyclic, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, NS3/4A Protease Inhibitors, Imino Acids, P-glycoprotein inhibitors	approved, withdrawn	1
DB06210	Eltrombopag	Drug	Blood and Blood Forming Organs, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Acids, Carbocyclic, UGT1A3 substrates, UGT2B7 Inhibitors, Increased Platelet Production, Thrombopoietin Receptor Agonist, UGT1A3 Inhibitors, Increased Megakaryocyte Maturation, Breast Cancer Resistance Protein Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Hemostatics, Cytochrome P-450 CYP2C8 Substrates, Benzene Derivatives, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), UGT1A4 Inhibitors, Hematinics, OATP1B1/SLCO1B1 Inhibitors, Thrombopoietin Receptor Agonists, Cytochrome P-450 CYP2C8 Inhibitors, BCRP/ABCG2 Inhibitors, UGT1A1 Inhibitors, Organic Anion Transporting Polypeptide 1B1 Inhibitors, UGT2B15 Inhibitors, UGT1A9 Inhibitors, UGT1A1 Substrates, Cytochrome P-450 CYP1A2 Substrates, UGT1A6 Inhibitors	approved	1
DB07541	4-(dihydroxyboranyl)-2-({[4-(phenylsulfonyl)thiophen-2-yl]sulfonyl}amino)benzoic acid	Drug	0	experimental	1
DB07540	4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE	Drug	0	experimental	1
DB08874	Fidaxomicin	Drug	Other Macrolides, Carbohydrates, Cytochrome P-450 Enzyme Inhibitors, Macrolides, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Anti-Infective Agents, Lactones, Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Intestinal Antiinfectives, Alimentary Tract and Metabolism, Macrolide Antibacterial, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Cytochrome P-450 CYP3A4 Inhibitors	approved	1
DB06212	Tolvaptan	Drug	Cytochrome P-450 Substrates, P-glycoprotein substrates, Agents causing hyperkalemia, Vasopressin V2 Receptor Antagonists, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Heterocyclic Compounds, Fused-Ring, Benzazepines, Cytochrome P-450 CYP3A Substrates, Diuretics, Natriuretic Agents, Antidiuretic Hormone Receptor Antagonists, P-glycoprotein inhibitors, Vasopressin V2 Receptor Antagonist	approved	2
DB08871	Eribulin	Drug	Microtubule Inhibitors, QTc Prolonging Agents, Immunosuppressive Agents, Narrow Therapeutic Index Drugs, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Microtubule Inhibition, Potential QTc-Prolonging Agents, Myelosuppressive Agents	approved, investigational	2
DB07543	(S)-carazolol	Drug	0	experimental	2
DB08872	Gabapentin enacarbil	Drug	Acids, Acyclic, Fatty Acids, Butyrates, Central Nervous System Depressants, Fatty Acids, Volatile, Amino Acids, Peptides, and Proteins, Gabapentin and Prodrugs, Lipids, Aminobutyrates, Anti-epileptic Agent, Amino Acids, Drugs that are Mainly Renally Excreted	approved, investigational	2
DB07542	5-AMINO-6-CYCLOHEXYL-4-HYDROXY-2-ISOBUTYL-HEXANOIC ACID	Drug	0	experimental	1
DB06211	Doripenem	Drug	Amides, Lactams, beta-Lactams, Penem Antibacterial, Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, OAT3/SLC22A8 Substrates, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Carbapenems, Antibacterials for Systemic Use	approved, investigational	5
DB08870	Brentuximab vedotin	Drug	Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Antibodies, CD30-directed Antibody Interactions, Amino Acids, Peptides, and Proteins, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Immunoproteins, Proteins, CD30-directed Immunoconjugate, P-glycoprotein substrates with narrow therapeutic index, Immunoglobulins, Noxae, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Microtubule Inhibition, Antibodies, Monoclonal, Serum Globulins, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Globulins, Blood Proteins, Cytochrome P-450 CYP3A4 Inhibitors, Toxic Actions	approved, investigational	1
DB06218	Lacosamide	Drug	Acids, Acyclic, Decreased Central Nervous System Disorganized Electrical Activity, Voltage-Gated Sodium Channel Blockers, Cytochrome P-450 Substrates, Fatty Acids, Nervous System, Alkanes, Amides, Lipids, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Acetates, Anti-epileptic Agent, Miscellaneous Anticonvulsants, Fatty Acids, Volatile, Acetamides, Bradycardia-Causing Agents, Hydrocarbons, Acyclic, Membrane Transport Modulators, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Anticonvulsants, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Central Nervous System Agents, Sodium Channel Blockers	approved	3
DB07549	2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE	Drug	0	experimental	1
DB06217	Vernakalant	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Antiarrhythmics, Class III, QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Methyl Ethers, Phenyl Ethers, Phenols, Potential QTc-Prolonging Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2D6 Substrates, Ethers, Cardiac Therapy, Benzene Derivatives, Antiarrhythmic agents	approved, investigational	4
DB07548	2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE	Drug	0	experimental	1
DB08879	Belimumab	Drug	Immunologic Factors, Immunoglobulins, Immunosuppressive Agents, Antineoplastic and Immunomodulating Agents, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, B Lymphocyte Stimulator-specific Inhibitor, Selective Immunosuppressants, Immunoproteins, Decreased B Lymphocyte Activation, Proteins, Serum Globulins, Globulins, Blood Proteins, B Lymphocyte Stimulator-directed Antibody Interactions	approved	1
DB06219	Dalbavancin	Drug	Carbohydrates, Glycopeptide Antibacterials, Glycoconjugates, Peptides, Amino Acids, Peptides, and Proteins, Lipids, Antiinfectives for Systemic Use, Lipoglycopeptides, Anti-Infective Agents, Lipoglycopeptide Antibacterial, Anti-Bacterial Agents, Glycopeptides, Lipopeptides, Antibacterials for Systemic Use	approved, investigational	1
DB07545	N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE	Drug	0	experimental	1
DB08877	Ruxolitinib	Drug	Cytochrome P-450 Substrates, Immunosuppressive Agents, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Janus Kinases, antagonists & inhibitors, Myelosuppressive Agents, Protein Kinase Inhibitors, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Kinase Inhibitor	approved	2
DB06213	Regadenoson	Drug	Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Purinergic Agonists, Purinergic Agents, Purinergic P1 Receptor Agonists, Cardiac Therapy, Adenosine A2 Receptor Agonists	approved, investigational	1
DB07544	N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE	Drug	0	experimental	1
DB08878	Aminopterin	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Pterins, Folic Acid Antagonists, Pteridines, Pigments, Biological	investigational, withdrawn	0
DB07547	5-(4-CYANOPHENYL)-3-{[(2-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID	Drug	0	experimental	1
DB06216	Asenapine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Highest Risk QTc-Prolonging Agents, Psycholeptics, QTc Prolonging Agents, Tranquilizing Agents, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Diazepines, Oxazepines, Thiazepines and Oxepines, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Antipsychotic Agents, Histamine H1 Antagonists, Antipsychotic Agents (Second Generation Atypical), Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Acid Reducers, Adrenergic Antagonists, Adrenergic alpha-1 Receptor Antagonists, Dopamine Antagonists, Neurotoxic agents, Adrenergic alpha-Antagonists, Serotonin Receptor Agonists, Histamine H2 Antagonists, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, UGT1A4 substrates, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Dopamine D2 Receptor Antagonists, Hyperglycemia-Associated Agents, Cytochrome P-450 CYP2D6 Inhibitors (weak)	approved	20
DB08875	Cabozantinib	Drug	Amines, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Aniline Compounds, Antineoplastic and Immunomodulating Agents, Receptor Protein-Tyrosine Kinases, antagonists & inhibitors, Antineoplastic Agents, Amides, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Substrates, Protein Kinase Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C8 Inhibitors (weak), Kinase Inhibitor	approved, investigational	3
DB06215	Ferumoxytol	Drug	Hematinics, Iron Compounds, Hematologic Agents, Minerals, Paramagnetic Contrast Agent, Parenteral Nutrition Solutions, Pharmaceutical Solutions, Organometallic Compounds, Parenteral Iron Replacement, Ferric Compounds, Ferrous Compounds, Magnetic Resonance Contrast Activity, Solutions, Pharmaceutical Preparations, Compounds used in a research, industrial, or household setting	approved, investigational	0
DB07546	[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid	Drug	0	experimental	1
DB08876	Taliglucerase alfa	Drug	Glucosidases, Enzyme Replacement Therapy, Enzymes, Glycoside Hydrolases, Alimentary Tract and Metabolism, Enzymes and Coenzymes, Hydrolases, Gaucher Disease, Recombinant Proteins, Hydrolytic Lysosomal Glucocerebroside-specific Enzyme	approved, investigational	1
DB08884	Gadoxetic acid	Drug	Magnetic Resonance Imaging Contrast Media, Acids, Acyclic, Other Diagnostics, Amines, Fatty Acids, Lipids, OATP1B3 substrates, Paramagnetic Contrast Agent, Polyamines, Acetates, Organometallic Compounds, Paramagnetic Contrast Media, Contrast Media, Diagnostic Uses of Chemicals, Magnetic Resonance Contrast Activity, Fatty Acids, Volatile, OATP1B1/SLCO1B1 Substrates, Compounds used in a research, industrial, or household setting, Gadolinium-based Contrast Agent	approved	0
DB07552	(2R)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile	Drug	0	experimental	4
DB08885	Aflibercept	Drug	Enzymes, Vascular Endothelial Growth Factor Inhibitor, Antineoplastic and Immunomodulating Agents, Receptors, Growth Factor, Transferases, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Receptors, Cell Surface, Antineovascularisation Agents, Ocular Vascular Disorder Agents, Recombinant Proteins, Receptor Protein-Tyrosine Kinases, Vascular Endothelial Growth Factor Inhibitors, Ophthalmics, Membrane Proteins, Ophthalmologicals, Proteins, EENT Drugs, Miscellaneous, Phosphotransferases (Alcohol Group Acceptor), Protein Kinases, Receptors, Peptide, Sensory Organs, Protein-Tyrosine Kinases, Phosphotransferases	approved	3
DB07551	(2S)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile	Drug	0	experimental	4
DB08882	Linagliptin	Drug	Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, OCT2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Protease Inhibitors, OCT1 inhibitors, Hormones, Quinazolines, Cytochrome P-450 CYP3A4 Substrates, DPP-IV Inhibitors, Purines, Alimentary Tract and Metabolism, Drugs Used in Diabetes, Agents causing angioedema, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein substrates, Blood Glucose Lowering Agents, Incretins, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, OCT2 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors	approved	1
DB07553	9,9,9-TRIFLUORO-8-OXO-N-PHENYLNONANAMIDE	Drug	0	experimental	1
DB08883	Perampanel	Drug	Pyridines, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Nervous System, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Receptors, AMPA, antagonists & inhibitors, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Anticonvulsants, Cytochrome P-450 Enzyme Inducers, Miscellaneous Anticonvulsants, Cytochrome P-450 CYP3A Substrates, AMPA Receptor Antagonists, Central Nervous System Depressants, Cytochrome P-450 CYP2B6 Inducers (weak), Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2B6 Inducers, Noncompetitive AMPA Glutamate Receptor Antagonist, Cytochrome P-450 CYP2B6 Substrates	approved	1
DB08880	Teriflunomide	Drug	Dihydroorotate Dehydrogenase Inhibitors, Acids, Acyclic, Immunologic Factors, Amines, Fatty Acids, Immunosuppressive Agents, Sensory System Agents, Cytochrome P-450 Enzyme Inhibitors, Anti-Inflammatory Agents, Aniline Compounds, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Lipids, Selective Immunosuppressants, Peripheral Nervous System Agents, Cytochrome P-450 Enzyme Inducers, Analgesics, Butyrates, Pyrimidine Synthesis Inhibitor, Fatty Acids, Volatile, Hepatotoxic Agents, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Immunomodulatory Agents, Cytochrome P-450 CYP1A2 Inducers (weak), Benzene Derivatives, Analgesics, Non-Narcotic, OATP1B1/SLCO1B1 Inhibitors, Hydroxy Acids, Cytochrome P-450 CYP2C8 Inhibitors, Antineoplastic and Immunomodulating Agents, Antirheumatic Agents, BCRP/ABCG2 Inhibitors, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP1A2 Inducers, Central Nervous System Agents, OAT3/SLC22A8 Inhibitors	approved	1
DB08881	Vemurafenib	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP3A Inducers, Genito Urinary System and Sex Hormones, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Amides, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 Enzyme Inducers, Sulfur Compounds, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2B6 Inducers, Indoles, Drugs causing inadvertant photosensitivity, P-glycoprotein substrates with narrow therapeutic index, Sulfones, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Gynecological Antiinfectives and Antiseptics, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A4 Inducers, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors, BCRP/ABCG2 Substrates, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Sulfonamides, P-glycoprotein inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (moderate), Cytochrome P-450 CYP2D6 Inhibitors (weak), Kinase Inhibitor	approved	1
DB07550	2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE	Drug	0	experimental	1
DB06229	Ocaperidone	Drug	Pyrimidines	investigational	11
DB07559	(2Z)-2-cyano-N-(2,2'-dichlorobiphenyl-4-yl)-3-hydroxybut-2-enamide	Drug	0	experimental	1
DB06228	Rivaroxaban	Drug	Anticoagulants, Enzyme Inhibitors, Oxazines, Blood and Blood Forming Organs, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Factor Xa Inhibitors, P-glycoprotein substrates, Protease Inhibitors, Hematologic Agents, Cytochrome P-450 CYP3A4 Substrates, Morpholines, Drugs that are Mainly Renally Excreted, Sulfur Compounds, Antithrombins, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Substrates, Thiophenes, Serine Protease Inhibitors	approved	1
DB06225	HMR4011	Drug	0	investigational	0
DB07556	CGS-27023	Drug	Enzyme Inhibitors, Sulfur Compounds, Amines, Hydroxy Acids, Protease Inhibitors, Hydroxylamines, Matrix Metalloproteinase Inhibitors, Amides, Serine Protease Inhibitors, Sulfones, Metalloendopeptidases, antagonists & inhibitors	experimental	2
DB08888	Ocriplasmin	Drug	Enzymes, Peptides, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Ophthalmics, Ophthalmologicals, EENT Drugs, Miscellaneous, Serine Proteases, Hydrolases, Peptide Hydrolases, Sensory Organs, Serine Endopeptidases, Endopeptidases	approved	3
DB06224	Alicaforsen	Drug	Carbohydrates, Immunologic Factors, Nucleic Acids, Nucleotides, and Nucleosides, Oligonucleotides, Glycosides, Nucleotides, Gastrointestinal Agents, Polynucleotides	investigational	0
DB08889	Carfilzomib	Drug	Immunosuppressive Agents, Peptides, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, P-glycoprotein inhibitors, P-glycoprotein substrates with narrow therapeutic index, Proteasome Inhibitors, Myelosuppressive Agents	approved, investigational	6
DB07555	Hydroxy(oxo)(2-{(1S)-2,2,2-trifluoro-1-[2-(trimethylarsonio)ethoxy]ethyl}phenyl)ammonium	Drug	0	experimental	1
DB08886	Asparaginase Erwinia chrysanthemi	Drug	Narrow Therapeutic Index Drugs, Antineoplastic Agents, Asparagine-specific Enzyme, Thyroxine-binding globulin inhibitors, Asparaginase	approved, investigational	0
DB07558	acetylleucyl-leucyl-norleucinal	Drug	Enzyme Inhibitors, Oligopeptides, Peptides, Cysteine Proteinase Inhibitors, Protease Inhibitors, Amino Acids, Peptides, and Proteins, Calpain, antagonists & inhibitors, NF-kappa B, antagonists & inhibitors	experimental	1
DB06226	Nelipepimut-S	Drug	0	investigational	2
DB07557	3,20-Pregnanedione	Drug	0	experimental	4
DB08887	Icosapent ethyl	Drug	Biological Factors, Autacoids, Hypolipidemic Agents, Inflammation Mediators, Fatty Acids, Oils, Eicosanoids, Hematologic Agents, Lipids, Dietary Fats, Unsaturated, Fatty Acids, Unsaturated, Physiological Phenomena, Dietary Fats, Food and Beverages, Fish Oils, Miscellaneous Antilipemic Agents, Fats, Fatty Acids, Omega-3, Antiplatelet agents, Diet, Food, and Nutrition, Food	approved, investigational, nutraceutical	0
DB06270	MAHDL01	Drug	0	investigational	0
DB06276	Tanomastat	Drug	Acids, Carbocyclic, Matrix Metalloproteinases, Benzene Derivatives	investigational	0
DB06272	Maxacalcitol	Drug	Cholestanes, Secosteroids, Protective Agents, Dermatologicals, Antineoplastic Agents, Lipids, Fused-Ring Compounds, Vitamins, Sterols, Vitamin D and Analogues, Vitamins (Fat Soluble), Anticarcinogenic Agents, Membrane Lipids, Cholestenes, Compounds used in a research, industrial, or household setting, Steroids	investigational	0
DB06271	Sulodexide	Drug	Anticoagulants, Carbohydrates, Hypolipidemic Agents, Blood and Blood Forming Organs, Noxae, Fibrin Modulating Agents, Heparin Group, Agents causing hyperkalemia, Hematologic Agents, Cardiovascular Agents, Fibrinolytic Agents, Lipid Regulating Agents, Polysaccharides, Heparin and similars, Toxic Actions	approved, investigational	2
DB06274	Alvimopan	Drug	Opioid Antagonists, Receptors, Opioid, mu, antagonists & inhibitors, Peripheral Opioid Receptor Antagonists, Alimentary Tract and Metabolism, Drugs for Constipation, Gastrointestinal Agents	approved, investigational	3
DB06273	Tocilizumab	Drug	Immunoglobulins, Biologics for Rheumatoid Arthritis Treatment, Immunosuppressive Agents, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Antibodies, Antirheumatic Agents, Interleukin-6 Receptor Antagonist, Amino Acids, Peptides, and Proteins, Experimental Unapproved Treatments for COVID-19, Agents reducing cytokine levels, Antibodies, Monoclonal, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Disease-modifying Antirheumatic Agents, Interleukin Inhibitors, Immunoproteins, Proteins, Serum Globulins, Cytochrome P-450 CYP3A4 Inducers (weak), Cytochrome P-450 Enzyme Inducers, Globulins, Blood Proteins	approved	1
DB06281	Torcetrapib	Drug	Blood Pressure, Heterocyclic Compounds, Fused-Ring, Lipid Regulating Agents, Anticholesteremic Agents, Hypolipidemic Agents, Noxae, Toxic Actions, Cholesterol Ester Transfer Proteins	investigational	1
DB06280	Senicapoc	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Amides, Lipids, Acetates, Benzene Derivatives	investigational	0
DB06287	Temsirolimus	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Sirolimus and Prodrugs, Cytochrome P-450 CYP3A4 Substrates, Lactones, Anti-Bacterial Agents, Agents causing angioedema, P-glycoprotein substrates with narrow therapeutic index, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Macrolides, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A5 Inhibitors, mTOR Inhibitors, Antineoplastic Agents, Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index, Myelosuppressive Agents, Polyketides, Protein Kinase Inhibitors, Cytochrome P-450 CYP3A Inhibitors, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, P-glycoprotein inhibitors, Hyperglycemia-Associated Agents, Cytochrome P-450 CYP2D6 Inhibitors (weak), Kinase Inhibitor	approved	1
DB06288	Amisulpride	Drug	Psycholeptics, QTc Prolonging Agents, Tranquilizing Agents, Benzoates, Nervous System, Acids, Carbocyclic, Benzamides and benzamide derivatives, Amides, Antidepressive Agents, Second-Generation, Antidepressive Agents, Psychotropic Drugs, Neurotransmitter Agents, Antipsychotic Agents, Antipsychotic Agents (Second Generation Atypical), Central Nervous System Depressants, Potential QTc-Prolonging Agents, Central Nervous System Agents, Dopamine Antagonists, Dopamine D2 Receptor Antagonists, Benzene Derivatives, Dopamine Agents, Neurotoxic agents	approved, investigational	4
DB06283	Ziconotide	Drug	Mollusk Venoms, Neuroprotective Agents, Sensory System Agents, Nervous System, Peripheral Nervous System Agents, Toxins, Biological, Complex Mixtures, Analgesics, Calcium Channels, N-Type, Calcium-Regulating Hormones and Agents, Compounds used in a research, industrial, or household setting, Fluids and Secretions, Antiarrhythmic agents, Analgesics, Non-Narcotic, Protective Agents, Membrane Transport Modulators, Marine Toxins, Calcium Channel Blockers, N-Calcium Channel Receptor Antagonists, Narrow Therapeutic Index Drugs, Central Nervous System Depressants, Venoms, Central Nervous System Agents, Vasodilating Agents, Conotoxins	approved	2
DB06282	Levocetirizine	Drug	QTc Prolonging Agents, Cytochrome P-450 Substrates, Piperazines, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Neurotransmitter Agents, Histamine H1 Antagonists, Histamine H1 Antagonists, Non-Sedating, Piperazine Derivatives, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Potential QTc-Prolonging Agents, Histamine Agents, Antihistamines for Systemic Use	approved	1
DB06285	Teriparatide	Drug	Thyroid Products, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Bone Anabolic Agents, Amino Acids, Peptides, and Proteins, Calcium Homeostasis, Hormones, Parathyroid Agents, Peptide Hormones, Bone Density Conservation Agents, Calcium-Regulating Hormones and Agents, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Parathyroid Hormones and Analogues	approved, investigational	1
DB06290	Simeprevir	Drug	Antivirals for treatment of HCV infections, BSEP/ABCB11 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Genito Urinary System and Sex Hormones, Protease Inhibitors, OATP1B3 inhibitors, Amides, OATP1B3 substrates, Cytochrome P-450 CYP3A4 Substrates, HCV NS3/4A Protease Inhibitors, HCV Protease Inhibitors, Anti-Infective Agents, Cytochrome P-450 CYP1A2 Inhibitors, Antivirals for Systemic Use, Direct Acting Antivirals, Organic Anion Transporting Polypeptide 1B3 Inhibitors, Sulfur Compounds, Drugs causing inadvertant photosensitivity, Sulfones, OATP1B1/SLCO1B1 Inhibitors, Gynecological Antiinfectives and Antiseptics, P-glycoprotein substrates, BCRP/ABCG2 Inhibitors, Antiviral Agents, Organic Anion Transporting Polypeptide 1B1 Inhibitors, Antiinfectives for Systemic Use, Heterocyclic Compounds, Fused-Ring, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Sulfonamides, Cytochrome P-450 CYP3A4 Inhibitors, OATP1B1/SLCO1B1 Substrates, NS3/4A Protease Inhibitors, P-glycoprotein inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (moderate)	approved	1
DB06292	Dapagliflozin	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Hypotensive Agents, Sodium-glucose co-transporter 2 (SGLT2) inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inhibitors, UGT2B7 substrates, Alimentary Tract and Metabolism, Diuretics, Glycosides, Drugs Used in Diabetes, Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors, Benzene Derivatives, Carbohydrates, P-glycoprotein substrates, Sodium-Glucose Transporter 2 Inhibitors, Blood Glucose Lowering Agents, Sodium-Glucose Transport Proteins, antagonists & inhibitors, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2A6 Substrates, UGT1A9 Substrates, Cytochrome P-450 CYP2D6 Substrates	approved	1
DB06297	LX-2931	Drug	Amines, Hydroxylamines	investigational	0
DB06299	Hydronidone	Drug	Pyridines	investigational	0
DB06294	Semuloparin	Drug	Anticoagulants, Carbohydrates, Polysaccharides, Glycosaminoglycans, Fibrin Modulating Agents, Heparin and similars, Hematologic Agents, Cardiovascular Agents	investigational	0
DB06293	Pegnivacogin	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Oligonucleotides, Glycosides, Pegylated agents, Nucleotides, Factor IXa, antagonists & inhibitors, Polynucleotides	investigational	0
DB06295	Pramiconazole	Drug	0	investigational	0
DB08936	Chlorcyclizine	Drug	QTc Prolonging Agents, Histamine H1 Antagonists, Piperazine Derivatives, Histamine Antagonists, Potential QTc-Prolonging Agents, Antihistamines for Systemic Use	approved	1
DB07604	(6AR,11AS,11BR)-10-ACETYL-9-HYDROXY-7,7-DIMETHYL-2,6,6A,7,11A,11B-HEXAHYDRO-11H-PYRROLO[1',2':2,3]ISOINDOLO[4,5,6-CD]INDOL-11-ONE	Drug	0	experimental	1
DB07603	N-hexanoyl-L-homocysteine	Drug	0	experimental	0
DB08937	TAS-102	Drug	Carbohydrates, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Glycosides, Nucleosides, Deoxyribonucleosides, Pharmaceutical Preparations	investigational	0
DB08934	Sofosbuvir	Drug	Carbohydrates, Ribonucleosides, Antivirals for treatment of HCV infections, Pyrimidine Nucleosides, P-glycoprotein substrates, Antiviral Agents, Uracil Nucleotides, Nucleotides, Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, RNA Replicase Inhibitors, Antivirals for Systemic Use, Direct Acting Antivirals, Pyrimidines, Ribonucleotides, BCRP/ABCG2 Substrates, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Pyrimidine Nucleotides, Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor	approved	1
DB07606	6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE	Drug	0	experimental	1
DB08935	Obinutuzumab	Drug	Immunoglobulins, Antigens, CD20, Immunosuppressive Agents, Antineoplastic and Immunomodulating Agents, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Hypotensive Agents, Antibodies, Monoclonal, Immunoproteins, Myelosuppressive Agents, Proteins, Serum Globulins, Antineoplastic Agents, Immunological, CD20-directed Cytolytic Antibody, Globulins, Blood Proteins, CD20-directed Antibody Interactions	approved, investigational	1
DB07605	2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE	Drug	0	experimental	1
DB08932	Macitentan	Drug	Cytochrome P-450 Substrates, Amides, Endothelin B Receptor Antagonists, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP2C19 Substrates, Sulfur Compounds, Cytochrome P-450 CYP3A Substrates, Antihypertensives for Pulmonary Arterial Hypertension, Endothelin A Receptor Antagonists, Antihypertensive Agents, Vasodilating Agents, Endothelin Receptor Antagonists, Sulfones	approved	2
DB08933	Luliconazole	Drug	Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Dermatologicals, Antifungals for Dermatological Use, Cytochrome P-450 CYP2C19 Inhibitors, Anti-Infective Agents, Azole Antifungals, Cytochrome P-450 CYP3A Inhibitors, Antifungals for Topical Use, Cytochrome P-450 CYP3A4 Inhibitors, Antifungal Agents, Imidazole and Triazole Derivatives, Cytochrome P-450 CYP2C19 Inhibitors (weak)	approved	1
DB08930	Dolutegravir	Drug	Enzyme Inhibitors, P-glycoprotein substrates, UGT1A3 substrates, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Multidrug and Toxin Extrusion Transporter 1 Inhibitors, Antiinfectives for Systemic Use, Anti-Infective Agents, HIV Integrase Inhibitors, OAT1/SLC22A6 inhibitors, Antivirals for Systemic Use, Direct Acting Antivirals, Heterocyclic Compounds, Fused-Ring, BCRP/ABCG2 Substrates, OCT2 Inhibitors, UGT1A1 Substrates, Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor, UGT1A9 Substrates, Integrase Inhibitors, OAT3/SLC22A8 Inhibitors, Miscellaneous Antiretrovirals*	approved	1
DB07602	S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE	Drug	0	experimental	1
DB08931	Riociguat	Drug	Cytochrome P-450 Substrates, Guanylate Cyclase Stimulators, Hypotensive Agents, Cytochrome P-450 CYP3A4 Substrates, Soluble Guanylate Cyclase Stimulator, BCRP/ABCG2 Substrates, Enzyme Activators, Cytochrome P-450 CYP3A Substrates, Guanylate Cyclase, Antihypertensives for Pulmonary Arterial Hypertension, Antihypertensive Agents, Cytochrome P-450 CYP2C8 Substrates, Vasodilating Agents	approved	1
DB07601	4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol	Drug	0	experimental	1
DB07608	N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide	Drug	0	experimental	1
DB07607	4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE	Drug	0	experimental	1
DB08938	Magaldrate	Drug	Alkalies, Hydroxides, Ions, Antacids With Antiflatulents, Aluminum and magnesium containing antacids, Anions, Gastric Acid Lowering Agents, Metal cations, Alimentary Tract and Metabolism, Metal divalent cations, Aluminium Compounds, Electrolytes, Drugs for Acid Related Disorders, Antacids, Gastrointestinal Agents, Magnesium Compounds	approved, withdrawn	0
DB07609	N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	Drug	0	experimental	1
DB08939	Letosteine	Drug	Sulfur Compounds, Cough and Cold Preparations, Expectorants, Thiazoles, Respiratory System Agents	experimental	0
DB08940	Kebuzone	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Sensory System Agents, Anti-Inflammatory Agents, Pyrazoles, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Butylpyrazolidines, Pyrazolones, Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Musculo-Skeletal System, Agents that produce hypertension, Central Nervous System Agents	experimental	0
DB08947	Iopamidol	Drug	Benzoates, Acids, Carbocyclic, Roentgenography, Iodobenzoates, Iodinated Contrast Agents, Contrast Media, Diagnostic Uses of Chemicals, Radiographic Contrast Agent, Triiodobenzoic Acids, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting, X-Ray Contrast Activity, Benzene Derivatives, Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media	approved	0
DB07615	Tranilast	Drug	Aminobenzoates, Cytochrome P-450 Substrates, Sensory System Agents, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Peripheral Nervous System Agents, Analgesics, Calcium-Regulating Hormones and Agents, Antiplatelet agents, Benzene Derivatives, Bradycardia-Causing Agents, Antiarrhythmic agents, Analgesics, Non-Narcotic, Anti-Allergic Agents, Benzoates, Antirheumatic Agents, Hematologic Agents, Membrane Transport Modulators, Calcium Channel Blockers, Cytochrome P-450 CYP2C9 Substrates, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Central Nervous System Agents, Histamine Agents	investigational	1
DB08948	Iodamide	Drug	Iodobenzoates, Benzoates, Contrast Media, Diagnostic Uses of Chemicals, Acids, Carbocyclic, Triiodobenzoic Acids, Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting, Benzene Derivatives	withdrawn	0
DB07614	PHENYL-5-(1H-PYRAZOL-3-YL)-1,3-THIAZOLE	Drug	0	experimental	1
DB07617	N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	Drug	0	experimental	1
DB08945	Iotroxic acid	Drug	Iodobenzoates, Benzoates, Contrast Media, Diagnostic Uses of Chemicals, Acids, Carbocyclic, Triiodobenzoic Acids, Watersoluble, Hepatotropic X-Ray Contrast Media, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting, Benzene Derivatives	withdrawn, experimental	0
DB08946	Iopanoic acid	Drug	Contrast Media, Diagnostic Uses of Chemicals, Iodobenzenes, Hydrocarbons, Halogenated, Watersoluble, Hepatotropic X-Ray Contrast Media, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting, Benzene Derivatives, Hydrocarbons, Iodinated	approved, withdrawn	0
DB07616	4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid	Drug	0	experimental	1
DB07611	DECANE-1-THIOL	Drug	0	experimental	1
DB08943	Isoconazole	Drug	Azole Antifungals, Imidazoles, Gynecological Antiinfectives and Antiseptics, Antifungals for Topical Use, Dermatologicals, Genito Urinary System and Sex Hormones, Antifungals for Dermatological Use, Antifungal Agents, Imidazole and Triazole Derivatives, Imidazole Derivatives, Ointments, Anti-Infective Agents	approved	0
DB07610	1,2-Dihydroxynaphthalene	Drug	Naphthalenes	experimental	1
DB08944	Isoaminile	Drug	Antitussive Agents, Cough and Cold Preparations, Nitriles, Central Nervous System Agents, Respiratory System Agents	approved, withdrawn	0
DB07613	3-phenyl-5-(1H-pyrazol-3-yl)isoxazole	Drug	0	experimental	1
DB08941	Isoxsuprine	Drug	Autonomic Agents, Amines, Propanols, Reproductive Control Agents, Agents producing tachycardia, Cardiovascular Agents, Hypotensive Agents, Amino Alcohols, Phenethylamines, Tocolytic Agents, Alcohols, Peripheral Nervous System Agents, Adrenergic beta-Agonists, Neurotransmitter Agents, 2-Amino-1-Phenylethanol Derivatives, Ethylamines, Sympathomimetics, Adrenergic Agonists, Agents that produce hypertension, Peripheral Vasodilators, Vasodilating Agents, Adrenergic Agents, Propanolamines	approved, withdrawn	0
DB07612	6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE	Drug	0	experimental	1
DB08942	Isoxicam	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Sensory System Agents, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Thiazines, Peripheral Nervous System Agents, Sulfur Compounds, Analgesics, Agents that produce hypertension, Central Nervous System Agents	approved, withdrawn	0
DB07619	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	Drug	0	experimental	1
DB07618	2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE	Drug	0	experimental	1
DB08949	Inositol nicotinate	Drug	Pyridines, Other Nutritional Agents, Nicotinic Acid and Derivatives, Peripheral Vasodilators, Vitamin B Complex, Cardiovascular Agents, Vasodilating Agents, Vitamins	approved, withdrawn	2
DB08950	Indoramin	Drug	Benzoates, Adrenergic alpha-Antagonists, Acids, Carbocyclic, Benzamides and benzamide derivatives, Peripheral alpha-1 blockers, Antiadrenergic Agents, Peripherally Acting, Amides, Cardiovascular Agents, Hypotensive Agents, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Piperidines, Adrenergic Antagonists, Agents that produce hypertension, Adrenergic alpha-1 Receptor Antagonists, Antihypertensive Agents, Indoles, Adrenergic Agents, Benzene Derivatives	approved, withdrawn	1
DB08951	Indoprofen	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Enzyme Inhibitors, Sensory System Agents, Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Phenylpropionates, Isoindoles, Peripheral Nervous System Agents, Heterocyclic Compounds, Fused-Ring, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Musculo-Skeletal System, Propionates, Agents that produce hypertension, Central Nervous System Agents	withdrawn	0
DB07620	2-[(2,4-DICHLORO-5-METHYLPHENYL)SULFONYL]-1,3-DINITRO-5-(TRIFLUOROMETHYL)BENZENE	Drug	0	experimental	2
DB07626	4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide	Drug	0	experimental	1
DB08958	Hexetidine	Drug	Pyrimidines, Antiinfectives and Antiseptics for Local Oral Treatment, Alimentary Tract and Metabolism, Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Antifungal Agents, Anti-Infective Agents, Anti-Infective Agents, Local, Stomatological Preparations	approved, investigational	0
DB07625	4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide	Drug	0	experimental	1
DB07628	6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one	Drug	0	experimental	1
DB08956	Hydroxydione	Drug	Pregnanes, Fused-Ring Compounds, Steroids	investigational, withdrawn	0
DB08957	Hexoprenaline	Drug	Autonomic Agents, Adrenergics, Inhalants, Amines, Adrenergics for Systemic Use, Anti-Asthmatic Agents, Reproductive Control Agents, Agents producing tachycardia, Bronchodilator Agents, Adrenergic beta-2 Receptor Agonists, Phenethylamines, Respiratory System Agents, Tocolytic Agents, Peripheral Nervous System Agents, Adrenergic beta-Agonists, Neurotransmitter Agents, Selective Beta 2-adrenergic Agonists, Ethylamines, Adrenergic Agonists, Agents that produce hypertension, Drugs for Obstructive Airway Diseases, Adrenergic Agents	withdrawn, experimental	0
DB07627	(2S)-4-METHYL-2-(3-PHENYLTHIOUREIDO)-N-((3S)-TETRAHYDRO-2-HYDROXY-3-FURANYL)PENTANAMIDE	Drug	0	experimental	1
DB07622	1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA	Drug	0	experimental	1
DB08954	Ifenprodil	Drug	Adrenergic alpha-Antagonists, Receptors, N-Methyl-D-Aspartate, Cardiovascular Agents, Anti-Parkinson Drugs, Neurotransmitter Agents, Anticonvulsants, Central Nervous System Depressants, Adrenergic Antagonists, Agents that produce hypertension, NMDA Receptor Antagonists, Peripheral Vasodilators, Excitatory Amino Acid Agents, Vasodilating Agents, Excitatory Amino Acid Antagonists, Adrenergic Agents	approved, investigational, withdrawn	2
DB08955	Ibuproxam	Drug	Nephrotoxic agents, Acids, Acyclic, Amines, Fatty Acids, Sensory System Agents, Anti-Inflammatory Agents, Agents causing hyperkalemia, Hydroxylamines, Non COX-2 selective NSAIDS, Amides, Lipids, Acetates, Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Fatty Acids, Volatile, Musculo-Skeletal System, Acetamides, Benzene Derivatives, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Hydroxy Acids, Antirheumatic Agents, Antiinflammatory and Antirheumatic Products, Propionates, Agents that produce hypertension, Central Nervous System Agents	withdrawn	0
DB07621	(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	Drug	0	experimental	1
DB07624	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	Drug	0	experimental	1
DB08952	Indenolol	Drug	QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Propanols, Agents causing hyperkalemia, Adrenergic beta-Antagonists, Cardiovascular Agents, Amino Alcohols, Moderate Risk QTc-Prolonging Agents, Alcohols, Neurotransmitter Agents, Adrenergic Antagonists, Potential QTc-Prolonging Agents, Antihypertensive Agents, Cytochrome P-450 CYP2D6 Substrates, Vasodilating Agents, Adrenergic Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	withdrawn	0
DB08953	Indalpine	Drug	Selective Serotonin Reuptake Inhibitors, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Hypoglycemia-Associated Agents, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Psychotropic Drugs, Membrane Transport Modulators, Neurotransmitter Agents, Serotonin Modulators, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Neurotransmitter Uptake Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Central Nervous System Agents	investigational, withdrawn	0
DB07623	4,4'-DIPYRIDYL DISULFIDE	Drug	Gases, Sulfides, Anions, Sulfur Compounds, Acids, Noncarboxylic, Acids, Hydrogen Sulfide, Electrolytes, Ions, Sulfhydryl Reagents	experimental	1
DB07629	N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE	Drug	0	experimental	1
DB08961	Azosemide	Drug	Sulfur Compounds, Amines, Sodium Potassium Chloride Symporter Inhibitors, Sulfonamides, Aniline Compounds, Diuretics, Natriuretic Agents, Amides, Cardiovascular Agents, Sulfones	investigational	0
DB08962	Glibornuride	Drug	Cytochrome P-450 CYP2C9 Substrates, Sulfur Compounds, Cytochrome P-450 Substrates, Alimentary Tract and Metabolism, Sulfonylureas, Drugs Used in Diabetes, Blood Glucose Lowering Agents, Sulfones	investigational, withdrawn	0
DB07631	Lauryldimethylbetaine	Drug	Amines, Ammonium Compounds, Quaternary Ammonium Compounds, Trimethyl Ammonium Compounds, Onium Compounds, Nitrogen Compounds	experimental	1
DB08960	Hexamethonium	Drug	Autonomic Agents, Amines, Ammonium Compounds, Quaternary Ammonium Compounds, Ganglion Blockers, Onium Compounds, Cardiovascular Agents, Muscle Relaxants, Nicotinic Antagonists, Peripheral Nervous System Agents, Anticholinergic Agents, Neurotransmitter Agents, Cholinergic Agents, Muscle Relaxants, Peripherally Acting Agents, Central Nervous System Depressants, Bis-Trimethylammonium Compounds, Hexamethonium Compounds, Antihypertensive Agents, Nitrogen Compounds	experimental	1
DB07630	N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE	Drug	0	experimental	1
DB07637	Dibromotyrosine	Drug	Thyroid Products, Antithyroid agents, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins	experimental	1
DB08969	Flurothyl	Drug	Central Nervous System Stimulants, Convulsants, Ethyl Ethers, Central Nervous System Agents, Ethers	withdrawn	0
DB06306	Onalespib	Drug	Heterocyclic Compounds, Fused-Ring, Benzoates, Acids, Carbocyclic, Amides, HSP90 Heat-Shock Proteins, antagonists & inhibitors, Benzene Derivatives	investigational	0
DB06305	Sonepcizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB07636	5-Heptyl-6-hydroxy-1,3-benzothiazole-4,7-dione	Drug	0	experimental	5
DB08967	Dimetotiazine	Drug	Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Histamine H1 Antagonists, Sulfur Compounds, Histamine Antagonists, Analgesics, Nervous System, Histamine Agents, Antimigraine Preparations	approved	0
DB07639	3-(7-DIAMINOMETHYL-NAPHTHALEN-2-YL)-PROPIONIC ACID ETHYL ESTER	Drug	0	experimental	1
DB06307	Apoptone	Drug	Androstanes, Fused-Ring Compounds, Steroids	investigational	1
DB08968	Fominoben	Drug	Antitussive Agents, Oxazines, Central Nervous System Agents, Respiratory System Agents	withdrawn, experimental	0
DB07638	(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	Drug	0	experimental	2
DB06302	Glesatinib	Drug	Acids, Acyclic, Fatty Acids, Tyrosine Kinase Inhibitors, Fatty Acids, Volatile, Amides, Lipids, Acetamides, Acetates, Benzene Derivatives	investigational	0
DB08965	Fusafungine	Drug	Peptides, Cyclic, Anti-Bacterial Agents, Throat Preparations, Peptides, Amino Acids, Peptides, and Proteins, Anti-Infective Agents	approved, withdrawn	0
DB07633	octyl 3-deoxy-2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-xylo-hexopyranoside	Drug	0	experimental	1
DB07632	5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide	Drug	0	experimental	1
DB08966	Fursultiamine	Drug	Micronutrients, Pyrimidines, Sulfur Compounds, Physiological Phenomena, Food and Beverages, Thiazoles, Vitamin B Complex, Growth Substances, Diet, Food, and Nutrition, Vitamins, Food	approved	0
DB07635	4,4'-Dihydroxybenzophenone	Drug	0	experimental	1
DB06304	BIIB015	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Noxae, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Toxic Actions, Immunoproteins	investigational	0
DB07634	(2,6-Dimethylphenoxy)acetic acid	Drug	0	experimental	1
DB06303	Otilimab	Drug	0	investigational	0
DB08964	Gemeprost	Drug	Biological Factors, Autacoids, Inflammation Mediators, Fatty Acids, Genito Urinary System and Sex Hormones, Reproductive Control Agents, Eicosanoids, Lipids, Fatty Acids, Monounsaturated, Abortifacient Agents, Nonsteroidal, Uterotonic agents, Drugs that are Mainly Renally Excreted, Prostaglandins E, Synthetic, Fatty Acids, Unsaturated, Prostaglandins, Abortifacient Agents, Prostaglandins E	approved, withdrawn	2
DB06309	Refametinib	Drug	Sulfur Compounds, Amines, Aniline Compounds, Amides, Sulfones	investigational	0
DB08903	Bedaquiline	Drug	Quinolines, QTc Prolonging Agents, Cytochrome P-450 Substrates, Antimycobacterials, Cytochrome P-450 CYP3A4 Substrates, Antiinfectives for Systemic Use, Moderate Risk QTc-Prolonging Agents, Anti-Infective Agents, Diarylquinoline Antimycobacterial, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Drugs for Treatment of Tuberculosis, Cytochrome P-450 CYP3A Substrates, Mycobacterium tuberculosis, Antituberculosis Agents	approved	1
DB08904	Certolizumab pegol	Drug	Immunologic Factors, Peptide Fragments, Immunosuppressive Agents, Peptides, Antibodies, Amino Acids, Peptides, and Proteins, Disease-modifying Antirheumatic Agents, Drugs that are Mainly Renally Excreted, Alcohols, Immunoglobulin Fragments, Immunoproteins, Proteins, Antibodies, Monoclonal, Humanized, Ethylene Glycols, Tumor Necrosis Factor Receptor Blocking Activity, Immunoglobulin Fab Fragments, Polymers, Immunoglobulins, Biologics for Rheumatoid Arthritis Treatment, Polyethylene Glycols, Tumor Necrosis Factor Alpha (TNF-α) Inhibitors, Antineoplastic and Immunomodulating Agents, Antirheumatic Agents, Agents reducing cytokine levels, Antibodies, Monoclonal, Macromolecular Substances, Serum Globulins, Globulins, Pegylated agents, Glycols, Tumor Necrosis Factor Blocker	approved	1
DB08901	Ponatinib	Drug	Enzyme Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Myelosuppressive Agents, Protein Kinase Inhibitors, BCRP/ABCG2 Substrates, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Hepatotoxic Agents, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2C8 Substrates, P-glycoprotein inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Kinase Inhibitor	approved, investigational	15
DB08902	Raxibacumab	Drug	Anthrax Protective Antigen-directed Antibody Interactions, Immunoglobulins, Immune Sera and Immunoglobulins, Antibodies, Amino Acids, Peptides, and Proteins, Antiinfectives for Systemic Use, Immunoproteins, Proteins, Serum Globulins, Specific Immunoglobulins, Globulins, Blood Proteins, Anthrax Protective Antigen-directed Antibody	approved	1
DB08900	Teduglutide	Drug	Radiation-Protective Agents, Glucagon-Like Peptide 2, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Various Alimentary Tract and Metabolism Products, Gastrointestinal Hormones, Pancreatic Hormones, Protective Agents, Amino Acids, Peptides, and Proteins, Hormones, GLP-2 Analog, Drugs that are Mainly Renally Excreted, Proteins, Peptide Hormones, Glucagon-Like Peptides, Alimentary Tract and Metabolism, Glucagon-like Peptide-2 (GLP-2) Agonists, Miscellaneous GI Drugs, Protein Precursors, Analogs/Derivatives, Compounds used in a research, industrial, or household setting, Gastrointestinal Agents, Proglucagon	approved	1
DB08909	Glycerol phenylbutyrate	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Nitrogen Binding Agent, Carbohydrates, Cytochrome P-450 Enzyme Inhibitors, Various Alimentary Tract and Metabolism Products, Acids, Carbocyclic, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Drugs that are Mainly Renally Excreted, Alcohols, Cytochrome P-450 CYP3A4 Inducers (weak), Cytochrome P-450 Enzyme Inducers, Urea Cycle Disorder Agents, Alimentary Tract and Metabolism, Sugar Alcohols, Cytochrome P-450 CYP2D6 Inhibitors (strong), Triose Sugar Alcohols	approved	0
DB08907	Canagliflozin	Drug	Cytochrome P-450 Substrates, P-glycoprotein substrates, Agents causing hyperkalemia, Hypotensive Agents, Blood Glucose Lowering Agents, Sodium-glucose co-transporter 2 (SGLT2) inhibitors, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Sulfur Compounds, Cytochrome P-450 CYP3A Substrates, Thiophenes, Alimentary Tract and Metabolism, Diuretics, UGT1A9 Substrates, Drugs Used in Diabetes, Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors, P-glycoprotein inhibitors, Glucosides	approved	1
DB08908	Dimethyl fumarate	Drug	Acids, Acyclic, Fumarates, Immunologic Factors, Immunosuppressive Agents, Antineoplastic and Immunomodulating Agents, Dermatologicals, Dicarboxylic Acids, Miscellaneous Central Nervous System Agents, Radiation-Sensitizing Agents	approved, investigational	2
DB08905	Formestane	Drug	Endocrine Therapy, Enzyme Inhibitors, 17-Ketosteroids, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Hormone Antagonists and Related Agents, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Estrogen Antagonists, Hormone Antagonists, Gonadal Hormones, Steroid Synthesis Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A4 Inducers, Androstenes, Antineoplastic Agents, Ketosteroids, Gonadal Steroid Hormones, Aromatase Inhibitors, Androstanes, Testosterone Congeners, Steroids	approved, investigational, withdrawn	0
DB08906	Fluticasone furoate	Drug	Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Glucocorticoids, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Nasal Preparations, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inducers, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Corticosteroids, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A5 Inhibitors, Androstenes, Cytochrome P-450 CYP2C8 Inhibitors (strong), Androstanes, Agents to Treat Airway Disease, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Drugs for Obstructive Airway Diseases, Thyroxine-binding globulin inhibitors, Hyperglycemia-Associated Agents, Steroids	approved	3
DB08915	Aleglitazar	Drug	Sulfur Compounds	investigational	3
DB08912	Dabrafenib	Drug	QTc Prolonging Agents, Enzyme Inhibitors, Amines, Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Hydroxylamines, OATP1B3 inhibitors, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A4 Inducers (moderate), Cytochrome P-450 CYP2C9 Inducers (strong), Cytochrome P-450 Enzyme Inducers, Organic Anion Transporting Polypeptide 1B3 Inhibitors, Cytochrome P-450 CYP2C19 Inducers, Breast Cancer Resistance Protein Inhibitors, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index, Potential QTc-Prolonging Agents, Cytochrome P-450 CYP2C8 Substrates, Drugs causing inadvertant photosensitivity, P-glycoprotein substrates with narrow therapeutic index, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A4 Inducers, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, Organic Anion Transporting Polypeptide 1B1 Inhibitors, Cytochrome P-450 CYP2C8 Inducers (weak), Cytochrome P-450 CYP2C8 Inhibitors (strong), OAT1/SLC22A6 inhibitors, Protein Kinase Inhibitors, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Organic Anion Transporter 1 Inhibitors, Cytochrome P-450 CYP2C9 Inducers, OAT3/SLC22A8 Inhibitors, Proto-Oncogene Proteins B-raf, antagonists & inhibitors, Hyperglycemia-Associated Agents, Kinase Inhibitor	approved, investigational	5
DB08913	Radium Ra 223 dichloride	Drug	Metals, Radioactive alpha-Particle Emitting Therapeutic Agent, Antineoplastic Agents, Elements, Radioactive, Metals, Alkaline Earth, Radioisotopes, Metals, Heavy, Elements, Isotopes	approved, investigational	0
DB08910	Pomalidomide	Drug	Immunologic Factors, Phthalic Acids, Cytochrome P-450 Substrates, Immunosuppressive Agents, Acids, Carbocyclic, Growth Inhibitors, Angiogenesis Modulating Agents, Piperidones, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Imides, Isoindoles, Piperidines, Growth Substances, Thalidomide Analog, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Angiogenesis Inhibitors, Myelosuppressive Agents, Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Phthalimides, Cytochrome P-450 CYP1A2 Substrates	approved	3
DB08911	Trametinib	Drug	Pyridines, Enzyme Inhibitors, MAP Kinase Kinase 1, antagonists & inhibitors, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Antineoplastic Agents, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Drugs that are Mainly Renally Excreted, MAP Kinase Kinase 2, antagonists & inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (strong), Cytochrome P-450 Enzyme Inducers, Protein Kinase Inhibitors, Pyrimidines, Narrow Therapeutic Index Drugs, Kinase Inhibitor	approved	2
DB08918	Levomilnacipran	Drug	Adrenergic Uptake Inhibitors, Cytochrome P-450 Substrates, Serotonin Agents, Hypoglycemia-Associated Agents, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Serotonin Modulators, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Norepinephrine Uptake Inhibitors, Cytochrome P-450 CYP2C8 Substrates, Selective Serotonin Reuptake Inhibitors, Cycloparaffins, P-glycoprotein substrates, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Cyclopropanes, Agents producing tachycardia, Psychotropic Drugs, Membrane Transport Modulators, Cytochrome P-450 CYP2C19 Substrates, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Miscellaneous Antidepressants, Neurotransmitter Uptake Inhibitors, Serotonin and Noradrenaline Reuptake Inhibitors, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates	approved, investigational	2
DB08916	Afatinib	Drug	Enzyme Inhibitors, Tyrosine Kinase Inhibitors, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, Amides, Quinazolines, Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors, BCRP/ABCG2 Substrates, P-glycoprotein inhibitors, Kinase Inhibitor	approved	3
DB08917	Ferric carboxymaltose	Drug	Carbohydrates, Phosphate Binder, Disaccharides, Iron Compounds, Oligosaccharides, Biopolymers, Macromolecular Substances, Organometallic Compounds, Parenteral Iron Replacement, Polysaccharides, Glucans, Polymers, Compounds used in a research, industrial, or household setting	approved	0
DB08925	Adrafinil	Drug	Adrenergic alpha-Agonists, Amines, Hydroxy Acids, Nervous System, Hydroxylamines, Psychostimulants, Agents Used for Adhd and Nootropics, Sympathomimetic-like Agent, Agents producing tachycardia, Neurotransmitter Agents, Adrenergic Agonists, Agents that produce hypertension, Adrenergic Agents, Psychoanaleptics	withdrawn	0
DB08926	Acediasulfone	Drug	Sulfur Compounds	experimental	0
DB08924	Amfecloral	Drug	0	experimental	0
DB08921	(4R)-limonene	Drug	Cycloparaffins, Cyclohexenes, Monoterpenes, Terpenes, Cyclohexanes	investigational	0
DB08922	Perospirone	Drug	Tranquilizing Agents, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A4 Substrates, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Antipsychotic Agents, Sulfur Compounds, Antipsychotic Agents (Second Generation Atypical), Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2C8 Substrates, Dopamine Antagonists, Dopamine D2 Receptor Antagonists, Neurotoxic agents	experimental	6
DB08927	Amperozide	Drug	Serotonin 5-HT2 Receptor Antagonists, Neurotransmitter Agents, Tranquilizing Agents, Antipsychotic Agents, Serotonin Agents, Central Nervous System Depressants, Serotonin Receptor Antagonists, Antidepressive Agents, Central Nervous System Agents, Psychotropic Drugs, Neurotoxic agents	experimental	1
DB08928	Arsthinol	Drug	Organometallic Compounds, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Arsenicals	experimental	0
DB05021	EMZ702	Drug	0	investigational	0
DB07684	5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID	Drug	0	experimental	1
DB05022	Amonafide	Drug	Enzyme Inhibitors, Isoquinolines, Laboratory Chemicals, Antineoplastic Agents, Intercalating Agents, Piperidones, Anti-Infective Agents, Imides, Naphthalenes, Heterocyclic Compounds, Fused-Ring, Piperidines, Indicators and Reagents, Compounds used in a research, industrial, or household setting	investigational	2
DB07683	N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine	Drug	0	experimental	1
DB07686	4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE	Drug	0	experimental	1
DB06355	ACY001	Drug	0	investigational	0
DB05023	ATL1101	Drug	0	investigational	1
DB07685	4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE	Drug	0	experimental	1
DB05024	CTA018	Drug	0	investigational	2
DB06354	Tezampanel	Drug	Heterocyclic Compounds, Fused-Ring, Receptors, AMPA, antagonists & inhibitors	investigational	2
DB07680	[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID	Drug	0	experimental	1
DB07681	DODECANESULFONATE ION	Drug	0	experimental	1
DB05020	Besifovir dipivoxil	Drug	Heterocyclic Compounds, Fused-Ring, Purines, Organophosphorus Compounds, Xanthine derivatives, Purinones	investigational	1
DB06350	Elinogrel	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amides, Quinazolines, Sulfones	investigational	1
DB05029	Lancovutide	Drug	Membrane Proteins, Proteins, Peptides, Amino Acids, Peptides, and Proteins, Pore Forming Cytotoxic Proteins, Bacterial Proteins	investigational	0
DB07688	4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE	Drug	0	experimental	2
DB05025	Arimoclomol	Drug	Amines	investigational	1
DB06356	TRC093	Drug	0	investigational	1
DB07687	4-({5-[(4-AMINOCYCLOHEXYL)AMINO][1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL}AMINO)BENZENESULFONAMIDE	Drug	0	experimental	1
DB05027	DG041	Drug	0	investigational	0
DB06358	Iclaprim	Drug	SULFONAMIDES AND TRIMETHOPRIM, Enzyme Inhibitors, Folic Acid Antagonists, Trimethoprim and Derivatives, Antiinfectives for Systemic Use, Antibacterials for Systemic Use	investigational	1
DB07689	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	Drug	0	experimental	1
DB07695	N-(3,5-dibromo-4-hydroxyphenyl)-4-hydroxy-3,5-dimethylbenzamide	Drug	0	experimental	0
DB05032	REV131	Drug	Proteins, Amino Acids, Peptides, and Proteins	investigational	1
DB06364	XR5944	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB07694	2,5-dichloro-N-(3,5-dibromo-4-hydroxyphenyl)benzamide	Drug	0	experimental	0
DB05033	INCB7839	Drug	0	investigational	1
DB07697	1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine	Drug	0	experimental	1
DB05034	Ularitide	Drug	Autonomic Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Anti-Asthmatic Agents, Amino Acids, Peptides, and Proteins, Cardiovascular Agents, Bronchodilator Agents, Hormones, Respiratory System Agents, Peripheral Nervous System Agents, Natriuretic Peptides, Peptide Hormones, Diuretics, Natriuretic Agents	investigational	1
DB06366	Pertuzumab	Drug	Immunoglobulins, Antineoplastic and Immunomodulating Agents, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Breast Neoplasms, HER2/Neu/cerbB2 Antagonists, Immunoproteins, Proteins, Serum Globulins, Antineoplastic Agents, Immunological, Globulins, Blood Proteins, Receptor, ErbB-2, antagonists & inhibitors, HER2 Receptor Antagonist	approved	1
DB06365	Sapacitabine	Drug	Carbohydrates, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidinones, Antineoplastic Agents, Glycosides, Nucleosides	investigational	0
DB07696	methyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate	Drug	0	experimental	1
DB05035	Eprotirome	Drug	Amines, Aniline Compounds, Amides	investigational	2
DB06360	Lucatumumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Multiple Myeloma, drug therapy, Antibodies, Monoclonal, Immunoproteins	investigational	1
DB07691	2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid	Drug	0	experimental	1
DB06362	Becatecarin	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Glycosides, Indoles	investigational	2
DB07693	N-(3,5-dibromo-4-hydroxyphenyl)-2,6-dimethylbenzamide	Drug	0	experimental	0
DB07692	1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine	Drug	0	experimental	1
DB06361	rsPSMA Vaccine	Drug	0	approved, investigational	0
DB06368	Alamifovir	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB05036	Grn163l	Drug	0	investigational	4
DB06367	Relacatib	Drug	Sulfur Compounds	investigational	1
DB07698	3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine	Drug	0	experimental	1
DB05038	Anatibant	Drug	Heterocyclic Compounds, Fused-Ring, Bradykinin Receptor Antagonists	investigational	1
DB05039	Indacaterol	Drug	Quinolines, Adrenergics, Inhalants, QTc Prolonging Agents, Cytochrome P-450 Substrates, P-glycoprotein substrates, Agents producing tachycardia, Adrenergic beta-2 Receptor Agonists, Cytochrome P-450 CYP3A4 Substrates, Adrenergic beta-Agonists, Heterocyclic Compounds, Fused-Ring, Selective Beta 2-adrenergic Agonists, Agents to Treat Airway Disease, Cytochrome P-450 CYP3A Substrates, UGT1A1 Substrates, Adrenergic Agonists, Agents that produce hypertension, Potential QTc-Prolonging Agents, Drugs for Obstructive Airway Diseases, Indenes	approved	1
DB05043	GSK159797	Drug	0	investigational	0
DB06374	Elacestrant	Drug	Naphthalenes	investigational	1
DB05044	PSN357	Drug	0	investigational	1
DB05045	Obinepitide	Drug	0	investigational	2
DB06376	CHGN111	Drug	0	investigational	1
DB05046	V1003	Drug	0	investigational	2
DB06371	Siplizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	1
DB05040	MVA3000	Drug	0	investigational	0
DB06370	Indisulam	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Antineoplastic Agents, Amides, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Carbonic Anhydrase Inhibitors, Sulfur Compounds, Cytochrome P-450 CYP3A Inhibitors, Sulfonamides, Cytochrome P-450 CYP3A4 Inhibitors, Diuretics, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Sulfones	investigational	0
DB06372	Rilonacept	Drug	Proteins, Interleukin-1 Receptor Accessory Protein, Immunosuppressive Agents, Anti-Inflammatory Agents, Antineoplastic and Immunomodulating Agents, Amino Acids, Peptides, and Proteins, Agents reducing cytokine levels, Receptors, Interleukin-1 Type I, Recombinant Proteins, Interleukin Inhibitors	approved, investigational	3
DB05042	SGS518	Drug	0	investigational	1
DB05047	CX717	Drug	0	illicit, investigational	5
DB06379	Calcitonin gene-related peptide	Drug	Proteins, Calcitonin Gene-Related Peptide, analogs & derivatives, Peptides, Amino Acids, Peptides, and Proteins, Neuropeptides, Cardiovascular Agents, Nerve Tissue Proteins, Calcitonin Gene-Related Peptide, antagonists & inhibitors, Vasodilating Agents	investigational	0
DB05048	Cannabinor	Drug	Terpenes	investigational	0
DB05049	DDP733	Drug	0	investigational	1
DB05054	AN0128	Drug	Boron Compounds	investigational	0
DB05055	RG2417	Drug	0	investigational	0
DB05056	EGS21	Drug	0	investigational	0
DB05057	Erdosteine	Drug	Acids, Acyclic, Sulfur Compounds, Fatty Acids, Cough and Cold Preparations, Expectorants, Fatty Acids, Volatile, Lipids, Acetates, Respiratory System Agents, Sulfhydryl Compounds	approved, investigational	0
DB05050	ADL5859	Drug	Heterocyclic Compounds, Fused-Ring, Benzoates, Acids, Carbocyclic, Receptors, Opioid, delta, Amides, Benzene Derivatives, Pyrans	investigational	1
DB05051	BZL101	Drug	Complex Mixtures, Scutellaria, Plant Preparations, Biological Products, Pharmaceutical Preparations	investigational	0
DB05052	MF101	Drug	0	investigational	1
DB05053	MB-07803	Drug	0	investigational	1
DB05059	ILY101	Drug	0	investigational	0
DB07640	2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione	Drug	0	experimental	2
DB08972	Flumequine	Drug	Fluoroquinolones, Quinolines, QTc Prolonging Agents, Enzyme Inhibitors, Renal Agents, Anti-Infective Agents, Urinary, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Antineoplastic Agents, Antiinfectives for Systemic Use, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Anti-Infective Agents, Quinolones, Cytochrome P-450 CYP1A2 Inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Topoisomerase II Inhibitors, Potential QTc-Prolonging Agents, Antibacterials for Systemic Use	withdrawn	0
DB08973	Fluclorolone acetonide	Drug	Pregnadienes, Pregnanes, Fused-Ring Compounds, Steroids	approved, withdrawn	0
DB07642	5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine	Drug	0	experimental	1
DB08970	Fluprednidene	Drug	Corticosteroids, Dermatological Preparations, Corticosteroids, Cytochrome P-450 Substrates, Immunosuppressive Agents, Glucocorticoids, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Dermatologicals, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Corticosteroids, Moderately Potent (Group II), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Hyperglycemia-Associated Agents, Cytochrome P-450 CYP3A5 Inducers	experimental	0
DB06311	Darapladib	Drug	Enzyme Inhibitors, Pyrimidines, Amines, Hydroxylamines, Phospholipase A2 Inhibitors	investigational	1
DB06310	Motavizumab	Drug	Proteins, Serum Globulins, Specific Immunoglobulins, Immunoglobulins, Immune Sera and Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Antiinfectives for Systemic Use, Immunoproteins	investigational	0
DB08971	Fluocortolone	Drug	Corticosteroids, Dermatological Preparations, Cytochrome P-450 Substrates, Immunosuppressive Agents, Glucocorticoids, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Vasoprotectives, Cytochrome P-450 Enzyme Inducers, Corticosteroids, Potent (Group III), Cytochrome P-450 CYP3A5 Inducers (strength unknown), Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Cytochrome P-450 CYP3A5 Inducers, Pregnadienediols, Corticosteroids, Corticosteroids for Systemic Use, Plain, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Cytochrome P-450 CYP3A4 Inducers, Dermatologicals, Ophthalmologicals, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Cytochrome P-450 CYP3A Substrates, Pregnanes, Sensory Organs, Steroids, Fluorinated, Hyperglycemia-Associated Agents, Steroids	approved, withdrawn	0
DB07641	Decyl(dimethyl)phosphine oxide	Drug	Organophosphorus Compounds, Phosphorus Compounds	experimental	1
DB07648	(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL	Drug	0	experimental	1
DB06317	Elotuzumab	Drug	Immunoglobulins, Antineoplastic and Immunomodulating Agents, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, SLAMF7-directed Immunostimulatory Antibody, Antibodies, Monoclonal, Immunoproteins, Proteins, Serum Globulins, SLAMF7-directed Antibody Interactions, Narrow Therapeutic Index Drugs, Globulins, Blood Proteins	approved	1
DB07647	(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL	Drug	0	experimental	1
DB08978	Fentonium	Drug	Alkaloids, Belladonna and Derivatives, Plain, Tropanes, Belladonna Alkaloids, Semisynthetic, Quaternary Ammonium Compounds, Solanaceous Alkaloids, Alimentary Tract and Metabolism, Belladonna Alkaloids, Aza Compounds, Azabicyclo Compounds, Drugs for Functional Gastrointestinal Disorders	withdrawn	0
DB07649	(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(benzylsulfanyl)methyl]pyrrolidin-3-ol	Drug	0	experimental	1
DB06318	AVE9633	Drug	Immunoglobulins, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Antibodies, Amides, Amino Acids, Peptides, and Proteins, Lactams, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Antibodies, Monoclonal, Immunoproteins, Lactones, Lactams, Macrocyclic, Proteins, Serum Globulins, Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Globulins, Blood Proteins, Cytochrome P-450 CYP3A4 Inhibitors	investigational	1
DB08979	Fenspiride	Drug	Autonomic Agents, Anti-Asthmatic Agents, Drugs for Obstructive Airway Diseases, Bronchodilator Agents, Respiratory System Agents, Asthma, Peripheral Nervous System Agents	experimental	0
DB06313	BNC105	Drug	Heterocyclic Compounds, Fused-Ring, Methyl Ethers, Phenols, Ethers, Benzene Derivatives, Phenyl Ethers	investigational	0
DB07644	5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine	Drug	0	experimental	1
DB08976	Floctafenine	Drug	Aminobenzoates, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Miscellaneous Analgesics and Antipyretics, Benzoates, Sensory System Agents, Nervous System, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Peripheral Nervous System Agents, Analgesics, Agents that produce hypertension, Central Nervous System Agents, Benzene Derivatives	approved, withdrawn	0
DB07643	5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine	Drug	0	experimental	1
DB07646	UNDECYLAMINE-N,N-DIMETHYL-N-OXIDE	Drug	0	experimental	3
DB08974	Flubendazole	Drug	Acids, Acyclic, Heterocyclic Compounds, Fused-Ring, Benzimidazoles, Antiparasitic Products, Insecticides and Repellents, Anthelmintics, Carbamates, Anti-Infective Agents, Antinematodal Agents, Antiparasitic Agents, Benzimidazole Derivatives	withdrawn, experimental	0
DB06314	SGX-523	Drug	0	investigational	1
DB08975	Florantyrone	Drug	0	withdrawn	0
DB07645	Sebacic acid	Drug	Acids, Acyclic, Fatty Acids, Lipids	experimental	2
DB07651	N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE	Drug	0	experimental	1
DB08983	Etofibrate	Drug	Acids, Acyclic, Anticholesteremic Agents, Hypolipidemic Agents, Fatty Acids, Noxae, Lipids, Isobutyrates, Phenyl Ethers, Lipid Modifying Agents, Lipid Modifying Agents, Plain, Lipid Regulating Agents, Butyrates, Agents Causing Muscle Toxicity, Fatty Acids, Volatile, Phenols, Toxic Actions, Fibric Acids, Ethers, Benzene Derivatives	experimental	0
DB07650	Decyl formate	Drug	0	experimental	1
DB08984	Etofenamate	Drug	Aminobenzoates, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Amines, Benzoates, Sensory System Agents, ortho-Aminobenzoates, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Aniline Compounds, Antirheumatic Agents, Non COX-2 selective NSAIDS, Antiinflammatory Preparations, Non-Steroids for Topical Use, Topical Products for Joint and Muscular Pain, Peripheral Nervous System Agents, Thyroxine-binding globulin substrates, Fenamates, Analgesics, Musculo-Skeletal System, Agents that produce hypertension, Central Nervous System Agents, Benzene Derivatives	experimental	0
DB07653	N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE	Drug	0	experimental	1
DB08981	Fenbufen	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Enzyme Inhibitors, Sensory System Agents, Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Musculo-Skeletal System, Propionates, Agents that produce hypertension, Central Nervous System Agents	approved	0
DB06322	Carotuximab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	1
DB06321	R-348	Drug	0	investigational	1
DB07652	1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE	Drug	0	experimental	2
DB08982	Etozoline	Drug	0	experimental	0
DB08980	Fendiline	Drug	QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Agents causing hyperkalemia, Phenylalkylamine Derivatives, Non-Selective Calcium Channel Blockers, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Moderate Risk QTc-Prolonging Agents, Phenethylamines, Membrane Transport Modulators, Calcium Channel Blockers, Cytochrome P-450 CYP3A Substrates, Ethylamines, Calcium-Regulating Hormones and Agents, Vasodilating Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	withdrawn	0
DB07659	AC-(D)PHE-PRO-BOROHOMOLYS-OH	Drug	0	experimental	1
DB06328	Methoxyamine	Drug	Amines	investigational	1
DB07658	AC-(D)Phe-pro-borolys-OH	Drug	0	experimental	1
DB08989	Etamivan	Drug	Benzoates, Acids, Carbocyclic, Amides, Respiratory System Agents, Benzene Derivatives	withdrawn	0
DB08987	Etidocaine	Drug	Anilides, Amines, Sensory System Agents, Nervous System, Aniline Compounds, Amides, Central Nervous System Agents, Anesthetics, Acetanilides, Anesthetics, Local, Peripheral Nervous System Agents	approved	0
DB06324	XmAb 2513	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	1
DB07655	3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE	Drug	0	experimental	1
DB08988	Ethoheptazine	Drug	0	approved, withdrawn	0
DB07654	(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC	Drug	0	experimental	1
DB06323	AZX-100	Drug	Proteins, Molecular Chaperones, Heat-Shock Proteins, Amino Acids, Peptides, and Proteins	investigational	0
DB07657	PHOSPHONIC ACID 2-DODECANOYLAMINO-HEXYL ESTER PROPYL ESTER	Drug	0	experimental	1
DB08985	Etilefrine	Drug	Autonomic Agents, Adrenergic alpha-Agonists, Amines, Protective Agents, Agents producing tachycardia, Adrenergic and Dopaminergic Agents, Cardiovascular Agents, Amino Alcohols, Ethanolamines, Alcohols, Peripheral Nervous System Agents, Cardiotonic Agents, Adrenergic beta-Agonists, Neurotransmitter Agents, Sympathomimetics, Vasoconstrictor Agents, Adrenergic Agonists, Cardiac Stimulants Excl. Cardiac Glycosides, Adrenergic beta-1 Receptor Agonists, Agents that produce hypertension, Cardiac Therapy, Compounds used in a research, industrial, or household setting, Adrenergic Agents	withdrawn	0
DB06326	Latiglutenase	Drug	Enzymes, Enzymes and Coenzymes, Hydrolases, Celiac Disease, drug therapy	investigational	0
DB06325	Pegpleranib	Drug	Pegylated agents	investigational	1
DB08986	Etifoxine	Drug	Psycholeptics, Tranquilizing Agents, Nervous System, Central Nervous System Depressants, Anti-Anxiety Agents, Central Nervous System Agents, Psychotropic Drugs	investigational, withdrawn	0
DB08994	Ditazole	Drug	Anticoagulants, Blood and Blood Forming Organs, Platelet Aggregation Inhibitors Excl. Heparin	withdrawn, experimental	0
DB07662	PD-168393	Drug	Heterocyclic Compounds, Fused-Ring	experimental	2
DB06331	4-O-Demethylpenclomedine	Drug	Pyridines	investigational	1
DB05000	AeroLEF	Drug	0	investigational	0
DB07661	1,6-Naphthalenediol	Drug	Naphthalenes	experimental	1
DB08995	Diosmin	Drug	Heterocyclic Compounds, Fused-Ring, Vasoprotectives, Flavonoids, Flavones, Capillary Stabilizing Agents, Benzopyrans, Chromones, Pyrans	approved, investigational	1
DB07664	K-00546	Drug	0	experimental	5
DB08992	Eperisone	Drug	Autonomic Agents, Neuromuscular Agents, QTc Prolonging Agents, Cytochrome P-450 Substrates, Ketones, Agents causing hyperkalemia, Parasympatholytics, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Moderate Risk QTc-Prolonging Agents, Muscle Relaxants, Membrane Transport Modulators, Peripheral Nervous System Agents, Calcium Channel Blockers, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Musculo-Skeletal System, Muscle Relaxants, Centrally Acting Agents, Calcium-Regulating Hormones and Agents, Central Nervous System Agents, Vasodilating Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	investigational	0
DB05001	PSN9301	Drug	0	investigational	1
DB06333	Trodusquemine	Drug	Diamines, Amines, Biogenic Amines, Polyamines, Fused-Ring Compounds, Biogenic Polyamines, Steroids	investigational	3
DB08993	Enviomycin	Drug	Peptides, Cyclic, Anti-Bacterial Agents, Peptides, Antibiotics, Antitubercular, Amino Acids, Peptides, and Proteins, Anti-Infective Agents, Antituberculosis Agents	experimental	0
DB07663	2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID	Drug	0	experimental	1
DB08990	Eprazinone	Drug	Cough and Cold Preparations, Expectorants, Ketones, Respiratory System Agents	withdrawn, experimental	0
DB08991	Epirizole	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Sensory System Agents, Anti-Inflammatory Agents, Pyrazoles, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Peripheral Nervous System Agents, Pyrimidines, Analgesics, Agents that produce hypertension, Central Nervous System Agents	experimental	0
DB07660	AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH	Drug	0	experimental	1
DB07669	2,3-Dimethyl-1,4-naphthoquinone	Drug	Quinones, Naphthalenes	experimental	3
DB05009	Apadenoson	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purines, Cycloparaffins, Nucleic Acids, Nucleotides, and Nucleosides, Acids, Carbocyclic, Hydrocarbons, Acyclic, Glycosides, Nucleosides, Adenosine A2 Receptor Agonists, Cyclohexanes	investigational	1
DB08998	Demexiptiline	Drug	Benzocycloheptenes	experimental	0
DB06335	Saxagliptin	Drug	Cycloparaffins, Enzyme Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Oligopeptides, Peptides, Protease Inhibitors, Hypoglycemia-Associated Agents, Amino Acids, Peptides, and Proteins, Blood Glucose Lowering Agents, Hormones, Cytochrome P-450 CYP3A4 Substrates, DPP-IV Inhibitors, Drugs that are Mainly Renally Excreted, OAT3/SLC22A8 Substrates, Incretins, Cytochrome P-450 CYP3A Substrates, Alimentary Tract and Metabolism, Drugs Used in Diabetes, Agents causing angioedema	approved	1
DB05003	Imexon	Drug	Ketones	investigational	2
DB07666	(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE	Drug	0	experimental	1
DB05004	Peptide YY (3-36)	Drug	Peptide Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Gastrointestinal Hormones, Amino Acids, Peptides, and Proteins, Hormones	investigational	4
DB07665	N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide	Drug	0	experimental	1
DB08999	Cyclopentamine	Drug	Cycloparaffins, Nasal Preparations, Ganglion Blockers, Sympathomimetics, Plain	withdrawn	0
DB06334	Tucidinostat	Drug	Pyridines, QTc Prolonging Agents, Amines, Benzoates, Acids, Carbocyclic, Antineoplastic Agents, Amides, Histone Deacetylase Inhibitors, Moderate Risk QTc-Prolonging Agents, Benzene Derivatives	investigational	0
DB08996	Dimetacrine	Drug	Heterocyclic Compounds, Fused-Ring, Non-Selective Monoamine Reuptake Inhibitors, Nervous System, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Antidepressive Agents, Tricyclic, Agents that produce hypertension, Antidepressive Agents, Drugs that are Mainly Renally Excreted, Agents that reduce seizure threshold, Neurotoxic agents, Psychoanaleptics	withdrawn, experimental	1
DB07668	3-(4-DIETHYLAMINO-2-HYDROXY-PHENYL)-2-METHYL-PROPIONIC ACID	Drug	0	experimental	1
DB07667	2-((3',5'-DIMETHYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID	Drug	0	experimental	1
DB08997	Dexetimide	Drug	Autonomic Agents, Nervous System, Agents producing tachycardia, Parasympatholytics, Muscarinic Antagonists, Piperidones, Tertiary Amines, Anti-Parkinson Drugs, Peripheral Nervous System Agents, Anticholinergic Agents, Anti-Dyskinesia Agents, Neurotransmitter Agents, Cholinergic Agents, Piperidines, Central Nervous System Agents	withdrawn	0
DB06336	Elsiglutide	Drug	0	investigational	0
DB05006	Adecatumumab	Drug	Antigens, Biological Factors, Carbohydrates, Immunoglobulins, Glycoconjugates, Antibodies, Amino Acids, Peptides, and Proteins, Glycoproteins, Immunoproteins, Membrane Proteins, Proteins, Serum Globulins, Globulins, Blood Proteins, Antigens, Surface, Membrane Glycoproteins	investigational	0
DB06342	Coltuximab ravtansine	Drug	Immunoglobulins, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Antibodies, Amides, Amino Acids, Peptides, and Proteins, Lactams, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Antibodies, Monoclonal, Immunoproteins, Lactones, Lactams, Macrocyclic, Proteins, Serum Globulins, Immunotoxins, Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Globulins, Blood Proteins, Cytochrome P-450 CYP3A4 Inhibitors	investigational	1
DB05010	SGS-742	Drug	Neuroprotective Agents, Neurotransmitter Agents, GABA Agents, Protective Agents, Central Nervous System Agents, Compounds used in a research, industrial, or household setting, GABA Antagonists	investigational	2
DB07673	(2S)-2-Methyl-3-phenylpropanoic acid	Drug	0	experimental	1
DB07672	TRANS-2-(DIMETHYLPHENYLSILYL)-PIPERIDINE-N-OXIDE	Drug	0	experimental	1
DB05011	Taberminogene vadenovec	Drug	0	investigational	0
DB05012	XEN2174	Drug	Amino Acids, Peptides, and Proteins	investigational	1
DB07675	(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID	Drug	0	experimental	1
DB05013	Ingenol mebutate	Drug	Increased Cellular Death, Dermatologicals, Misc. Skin and Mucous Membrane Agents, Terpenes, Cell Death Inducer	approved	2
DB06343	Teprotumumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Antibodies, Amino Acids, Peptides, and Proteins, Ototoxic agents, Antibodies, Monoclonal, Hyperglycemia-Associated Agents, Immunoproteins	approved, investigational	1
DB07674	O,O-DIETHYL HYDROGEN THIOPHOSPHATE	Drug	0	experimental	1
DB07671	2-[1-METHYLHEXYL]-4,6-DINITROPHENOL	Drug	0	experimental	4
DB07670	N,4-Dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide	Drug	0	experimental	1
DB05018	Migalastat	Drug	Alkaloids, Carbohydrates, Imines, Imino Pyranoses, Various Alimentary Tract and Metabolism Products, Alimentary Tract and Metabolism, UGT1A1 Substrates, Piperidines, Other Miscellaneous Therapeutic Agents, Imino Sugars, Drugs that are Mainly Renally Excreted	approved, investigational	1
DB05019	LC16M8	Drug	0	investigational	0
DB07677	2-methyl-3,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one	Drug	0	experimental	1
DB05014	XL999	Drug	0	investigational	6
DB06346	Fiboflapon	Drug	Acids, Acyclic, Asthma, drug therapy, Heterocyclic Compounds, Fused-Ring, Valerates, Fatty Acids, Fatty Acids, Volatile, Lipids	investigational	1
DB06345	AR-9281	Drug	Cycloparaffins, Epoxide Hydrolases, antagonists & inhibitors	investigational	1
DB07676	3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one	Drug	0	experimental	2
DB05015	Belinostat	Drug	Enzyme Inhibitors, Amines, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Hydroxylamines, Amides, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 Enzyme Inducers, Sulfur Compounds, Cytochrome P-450 CYP2C8 Inhibitors (weak), Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP1A2 Inducers (weak), Sulfones, Hydroxy Acids, Cytochrome P-450 CYP2A6 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, UGT1A1 substrates with narrow therapeutic index, Myelosuppressive Agents, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), UGT1A1 Substrates, Cytochrome P-450 CYP2A6 Substrates, Cytochrome P-450 CYP1A2 Inducers, Histone Deacetylase Inhibitors	approved, investigational	1
DB05016	Ataluren	Drug	Oxazoles, Musculo-Skeletal System, OATP1B3 inhibitors, UGT1A9 Substrates, OAT3/SLC22A8 Inhibitors, OAT1/SLC22A6 inhibitors	approved, investigational	0
DB07679	(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid	Drug	0	experimental	1
DB06347	Cenisertib	Drug	Monoterpenes, Terpenes	investigational	1
DB07678	(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL	Drug	0	experimental	2
DB05017	YSIL6	Drug	0	investigational	2
DB05060	R1626	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides	investigational	1
DB06397	Nicaraven	Drug	Antioxidants, Pyridines, Protective Agents, Nicotinic Acids, Compounds used in a research, industrial, or household setting	investigational	0
DB06399	Atacicept	Drug	Proteins, Amino Acids, Peptides, and Proteins, Recombinant Proteins	investigational	0
DB05068	ATG002	Drug	0	investigational	0
DB06393	Xaliproden	Drug	Neurotransmitter Agents, Nervous System	investigational	1
DB05061	GFT14	Drug	0	investigational	0
DB06395	Abafungin	Drug	Sulfur Compounds, Azole Antifungals, Antifungal Agents	investigational	0
DB05063	Mitoquinone	Drug	Quinones, Coenzymes, Enzymes and Coenzymes, Benzoquinones	investigational	0
DB06394	Riferminogene pecaplasmid	Drug	0	investigational	0
DB05064	INCB13739	Drug	Sulfur Compounds, 11-beta-Hydroxysteroid Dehydrogenase Type 1, antagonists & inhibitors, Amides, Sulfones	investigational	1
DB05069	ATG003	Drug	0	investigational	2
DB05070	ADX10059	Drug	0	investigational	1
DB05071	ACE393	Drug	0	investigational	0
DB05076	Fenretinide	Drug	Biological Factors, Cycloparaffins, Alkenes, Protective Agents, Hydrocarbons, Acyclic, Antineoplastic Agents, Cyclohexenes, Retinoids, Cyclohexanes, Pigments, Biological, Carotenoids, Polyenes, Anticarcinogenic Agents, Terpenes, Compounds used in a research, industrial, or household setting	investigational	0
DB05077	SLV319	Drug	Sulfur Compounds, Cannabinoid Receptor Antagonists, Cannabinoids and similars, Receptor, Cannabinoid, CB1, antagonists & inhibitors, Agents producing tachycardia, Amides, Sulfones	investigational	1
DB05078	AER001	Drug	0	investigational	2
DB05079	HY10275	Drug	0	investigational	2
DB05072	AV608	Drug	0	investigational	1
DB05075	TG-100801	Drug	Benzene Derivatives	investigational	4
DB05080	OBE101	Drug	0	investigational	2
DB05081	JB991	Drug	0	investigational	0
DB05082	ARX201	Drug	0	investigational	0
DB05087	Ganaxolone	Drug	Pregnanes, Fused-Ring Compounds, Steroids	investigational	6
DB05088	Tetrathiomolybdate	Drug	Enzyme Inhibitors, Adenosine Triphosphatases, antagonists & inhibitors, Metals, Antineoplastic Agents, Growth Inhibitors, Metals, Heavy, Angiogenesis Modulating Agents, Elements, Transition Elements, Sequestering Agents, Growth Substances, Compounds used in a research, industrial, or household setting, Chelating Agents	investigational	1
DB05089	VPM4001	Drug	0	investigational	0
DB05084	Abaloparatide	Drug	Biological Factors, Thyroid Products, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Intercellular Signaling Peptides and Proteins, Parathyroid Hormone-Related Protein, Amino Acids, Peptides, and Proteins, Hormones, Proteins, Peptide Hormones, Bone Density Conservation Agents, Analogs/Derivatives, Parathyroid Hormones and Analogues	approved, investigational	1
DB05085	TM30339	Drug	0	investigational	1
DB05090	FP0011	Drug	0	investigational	0
DB05091	M0002	Drug	0	investigational	1
DB05092	CDP323	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Integrin alpha4, Amino Acids, Essential, Amino Acids, Peptides, and Proteins, Amino Acids	investigational	1
DB05093	AX200	Drug	0	investigational	0
DB05098	Leptin	Drug	Proteins, Biological Factors, Peptide Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Hormones, Adipokines	investigational	1
DB05099	Ancrod	Drug	Anticoagulants, Biological Factors, Enzymes, Viper Venoms, Blood and Blood Forming Organs, Fibrin Modulating Agents, Crotalid Venoms, Enzymes and Coenzymes, Hematologic Agents, Cardiovascular Agents, Fibrinolytic Agents, Toxins, Biological, Complex Mixtures, Venoms, Serine Proteases, Hydrolases, Peptide Hydrolases, Serine Endopeptidases, Snake Venoms, Venombin A, Endopeptidases, Fluids and Secretions, Bodily Secretions	approved, investigational	1
DB05095	Cimicoxib	Drug	Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Sulfur Compounds, Anti-Inflammatory Agents, Agents causing hyperkalemia, Agents that produce hypertension, Amides, Selective Cyclooxygenase 2 Inhibitors (NSAIDs), Sulfones	investigational	1
DB05096	LY2140023	Drug	Amino Acids, Peptides, and Proteins	investigational	2
DB05097	Labetuzumab	Drug	Proteins, Serum Globulins, Antineoplastic Agents, Immunological, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	1
DB07724	Indeglitazar	Drug	0	experimental	4
DB07726	t-Butylhydroquinone	Drug	Antioxidants, Calcium-Transporting ATPases, antagonists & inhibitors, Enzyme Inhibitors, Protective Agents, Phenols, Compounds used in a research, industrial, or household setting, Benzene Derivatives	experimental	2
DB07721	DIETHYL 4-METHOXYPHENYL PHOSPHATE	Drug	0	experimental	1
DB07720	Epibatidine	Drug	Analgesics, Non-Narcotic, Neurotransmitter Agents, Cholinergic Agents, Sensory System Agents, Analgesics, Cholinergic Agonists, Nicotinic Agonists, Central Nervous System Agents, Peripheral Nervous System Agents	experimental	7
DB07723	3-(5-methoxy-1H-indol-3-yl)propanoic acid	Drug	0	experimental	1
DB07722	3-(4-NITRO-PHENOXY)-PROPAN-1-OL	Drug	0	experimental	1
DB07729	3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide	Drug	0	experimental	1
DB07728	2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE	Drug	0	experimental	2
DB07730	5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE	Drug	0	experimental	1
DB07736	(2S)-4-(4-fluorobenzyl)-N-(2-sulfanylethyl)piperazine-2-carboxamide	Drug	0	experimental	1
DB06405	Eprodisate	Drug	Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfur Acids, Hydrocarbons, Acyclic, Alkanes	investigational	0
DB06404	Human C1-esterase inhibitor	Drug	Carbohydrates, Immunologic Factors, Enzyme Inhibitors, Blood and Blood Forming Organs, Complement Inactivator Proteins, Glycoconjugates, Peptides, Protease Inhibitors, Serpins, Complement Inactivating Agents, Amino Acids, Peptides, and Proteins, Glycoproteins, Complement C1 Inactivator Proteins, Immunoproteins, Complement System Proteins, Proteins, C1 inhibitors, Kallikrein Inhibitors, Blood Proteins, Drugs Used in Hereditary Angioedema, Serine Protease Inhibitors, Decreased Vascular Permeability	approved	7
DB07735	N-[1-(2,6-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide	Drug	0	experimental	1
DB07738	N-[1-(5-bromo-2,3-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide	Drug	0	experimental	1
DB07737	(2S)-4-(4-fluorobenzyl)-N-(3-sulfanylpropyl)piperazine-2-carboxamide	Drug	0	experimental	1
DB06406	Idraparinux	Drug	Anticoagulants, Carbohydrates, Enzyme Inhibitors, Polysaccharides, Antithrombins, Factor Xa Inhibitors, Protease Inhibitors, Hematologic Agents, Serine Protease Inhibitors	investigational	1
DB07732	2-[(2-NAPHTHYLSULFONYL)AMINO]ETHYL DIHYDROGEN PHOSPHATE	Drug	0	experimental	2
DB06401	Bazedoxifene	Drug	Estrogen Agonist/Antagonist, Heterocyclic Compounds, Fused-Ring, Sex Hormones and Modulators of the Genital System, Selective Estrogen Receptor Modulators, Hormones, Hormone Substitutes, and Hormone Antagonists, UGT1A1 Substrates, Genito Urinary System and Sex Hormones, Bone Density Conservation Agents, Estrogen Receptor Modulators, Hormone Antagonists	approved, investigational	2
DB07731	CAN-508	Drug	Cyclin-Dependent Kinase 9, antagonists & inhibitors	experimental	1
DB06400	Vitespen	Drug	Proteins, Molecular Chaperones, Complex Mixtures, Biological Products, Amino Acids, Peptides, and Proteins, Vaccines	investigational	0
DB06403	Ambrisentan	Drug	Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, P-glycoprotein substrates, Acids, Carbocyclic, UGT1A3 substrates, Hypertension, Pulmonary, Cardiovascular Agents, OATP1B3 substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C19 Substrates, UGT2B7 substrates, Cytochrome P-450 CYP3A Substrates, Antihypertensives for Pulmonary Arterial Hypertension, OATP1B1/SLCO1B1 Substrates, UGT1A9 Substrates, Antihypertensive Agents, Vasodilating Agents, Endothelin Receptor Antagonists	approved, investigational	2
DB07734	N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide	Drug	0	experimental	1
DB07733	1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE	Drug	0	experimental	1
DB06402	Telavancin	Drug	Carbohydrates, QTc Prolonging Agents, Glycopeptide Antibacterials, Glycoconjugates, Peptides, Amino Acids, Peptides, and Proteins, Lipids, Antiinfectives for Systemic Use, Moderate Risk QTc-Prolonging Agents, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Lipoglycopeptide Antibacterial, Anti-Bacterial Agents, Glycosides, Glycopeptides, Lipopeptides, Antibacterials for Systemic Use	approved	0
DB06409	Morphine glucuronide	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, Morphinans	investigational	3
DB07739	(3R)-3-(FLUOROMETHYL)-7-(THIOMORPHOLIN-4-YLSULFONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE	Drug	0	experimental	1
DB06408	Taribavirin	Drug	Carbohydrates, Ribonucleosides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Antiviral Agents, Purine-Nucleoside Phosphorylase, antagonists & inhibitors, Anti-Infective Agents	investigational	6
DB06410	Doxercalciferol	Drug	Cholestanes, Secosteroids, Calcium Homeostasis, Lipids, Anti-Parathyroid Agents, Fused-Ring Compounds, Vitamins, Micronutrients, Physiological Phenomena, Sterols, Vitamin D and Analogues, Vitamins (Fat Soluble), Food and Beverages, Bone Density Conservation Agents, Membrane Lipids, Cholestenes, Growth Substances, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Diet, Food, and Nutrition, Food, Steroids	approved	1
DB07741	4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE	Drug	0	experimental	1
DB07740	(7R,12R,13R)-13-formyl-12,14-dihydroxy-3,5,7-trimethyltetradeca-2,4-dienoic acid	Drug	0	experimental	1
DB07747	(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE	Drug	0	experimental	1
DB06415	Calfactant	Drug	Surface-Active Agents, Surfactant Activity, Complex Mixtures, Alveolar Surface Tension Reduction, Respiratory System Agents, Bradycardia-Causing Agents, Pulmonary Surfactants	approved	0
DB07746	3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID	Drug	0	experimental	1
DB07749	2-ACETYLAMINO-4-METHYL-PENTANOIC ACID (1-FORMYL-2-PHENYL-ETHYL)-AMIDE	Drug	0	experimental	1
DB07748	2-({[4-(TRIFLUOROMETHOXY)PHENYL]SULFONYL}AMINO)ETHYL DIHYDROGEN PHOSPHATE	Drug	0	experimental	2
DB07743	S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE	Drug	0	experimental	2
DB06412	Oxymetholone	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Androstanols, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Cytochrome P-450 Enzyme Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP3A5 Inhibitors, Anabolic Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Hormones, Fused-Ring Compounds, Cytochrome P-450 CYP3A7 Inhibitors (strength unknown), Androgens, Androstanes, Cytochrome P-450 CYP3A Inhibitors, Alimentary Tract and Metabolism, Cytochrome P-450 CYP3A7 Inhibitors, Anabolic Steroids, Cytochrome P-450 CYP3A4 Inhibitors, Anabolic Agents for Systemic Use, Thyroxine-binding globulin inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Androstan Derivatives, Steroids	approved, illicit	2
DB07742	N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE	Drug	0	experimental	1
DB07745	2-{[4-(TRIFLUOROMETHOXY)BENZOYL]AMINO}ETHYL DIHYDROGEN PHOSPHATE	Drug	0	experimental	2
DB06414	Etravirine	Drug	Enzyme Inhibitors, Cytochrome P-450 Substrates, Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor, Cytochrome P-450 Enzyme Inhibitors, Nonnucleoside Reverse Transcriptase Inhibitors, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Non-Nucleoside Reverse Transcriptase Inhibitors, Anti-Infective Agents, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inducers (moderate), Antivirals for Systemic Use, Direct Acting Antivirals, Cytochrome P-450 Enzyme Inducers, Nucleic Acid Synthesis Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP3A4 Inducers, Anti-Retroviral Agents, Antiviral Agents, Antiinfectives for Systemic Use, Cytochrome P-450 CYP2C19 Substrates, P-glycoprotein inducers, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Reverse Transcriptase Inhibitors, Cytochrome P-450 CYP2C9 Inducers	approved	2
DB07744	Z-Val-Ala-Asp fluoromethyl ketone	Drug	Neuroprotective Agents, Enzyme Inhibitors, Protective Agents, Cysteine Proteinase Inhibitors, Protease Inhibitors, Amino Acids, Peptides, and Proteins, Central Nervous System Agents, Caspase Inhibitors, Compounds used in a research, industrial, or household setting, Amino Acids	experimental	1
DB06413	Armodafinil	Drug	Wakefulness-Promoting Agents, Central Nervous System Stimulants, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Benzene Derivatives, Cytochrome P-450 CYP3A5 Inducers, Benzhydryl Compounds, Chemically-Induced Disorders, Cytochrome P-450 CYP3A4 Inducers, Psychostimulants, Agents Used for Adhd and Nootropics, Cytochrome P-450 CYP2C19 Inhibitors (moderate), Centrally Acting Sympathomimetics, Cytochrome P-450 CYP3A4 Inducers (weak), Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inducers, Central Nervous System Agents, Psychoanaleptics	approved, investigational	1
DB06419	Cethromycin	Drug	Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Macrolides, P-glycoprotein substrates, Erythromycin and similars, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Lactones, Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, RNA, Ribosomal, 23S, P-glycoprotein inhibitors, Protein Synthesis Inhibitors	investigational	1
DB07750	(2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol	Drug	0	experimental	1
DB06421	Declopramide	Drug	Aminobenzoates, para-Aminobenzoates, Benzoates, Acids, Carbocyclic, Benzamides and benzamide derivatives, Amides, Benzene Derivatives	investigational	3
DB07751	(2S)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol	Drug	0	experimental	1
DB06420	Annamycin	Drug	Carbohydrates, Anthracyclines, Naphthacenes, Antineoplastic Agents, Glycosides, Antibiotics, Antineoplastic, P-glycoprotein inhibitors	investigational	2
DB07758	5-(2,5-DICHLOROPHENYL)-2-FUROIC ACID	Drug	0	experimental	1
DB07757	(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one	Drug	0	experimental	1
DB06429	Talnetant	Drug	Heterocyclic Compounds, Fused-Ring, Receptors, Neurokinin-3, antagonists & inhibitors	investigational	1
DB07759	5-[2-(TRIFLUOROMETHYL)PHENYL]-2-FUROIC ACID	Drug	0	experimental	1
DB07754	DCFBC	Drug	0	experimental	1
DB06423	Endostatin	Drug	Angiogenic Proteins, Biological Factors, Angiostatic Proteins, Collagen Type XVIII, Peptides, Intercellular Signaling Peptides and Proteins, Antineoplastic Agents, Non-Fibrillar Collagens, Amino Acids, Peptides, and Proteins, Growth Inhibitors, Angiogenesis Modulating Agents, Angiogenesis Inhibitors, Biopolymers, Macromolecular Substances, Proteins, Scleroproteins, Extracellular Matrix Proteins, Collagen, Growth Substances, Polymers, Compounds used in a research, industrial, or household setting	investigational	5
DB06422	Ticalopride	Drug	Aminobenzoates, para-Aminobenzoates, Benzoates, Acids, Carbocyclic, Piperidines, Benzamides and benzamide derivatives, Amides, Benzene Derivatives, Chlorobenzoates	investigational	2
DB07753	3',5'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID	Drug	0	experimental	0
DB07756	1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL	Drug	0	experimental	1
DB07755	(2S)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol	Drug	0	experimental	1
DB07703	(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	Drug	0	experimental	1
DB07702	17alpha-Estriol	Drug	0	experimental	2
DB07705	(S)-econazole	Drug	0	experimental	2
DB07704	6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE	Drug	0	experimental	1
DB07701	1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE	Drug	0	experimental	1
DB07700	3-carboxamido-1,3,5(10)-estratrien-17(R)-spiro-2'(5',5'-dimethyl-6'oxo)tetrahydropyran	Drug	0	experimental	1
DB07707	(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL	Drug	0	experimental	2
DB07706	2-Hydroxyestradiol	Drug	Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, Estrenes, Estrogens, Catechol, Estradiol Congeners, COMT Substrates, Hormones, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Steroids	experimental	1
DB07708	3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL	Drug	0	experimental	2
DB07714	6-(3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)HEXANOIC ACID	Drug	0	experimental	1
DB07713	(1S)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid	Drug	0	experimental	1
DB07716	(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL	Drug	0	experimental	1
DB07715	Emodin	Drug	Anthracenes, Enzyme Inhibitors, Plant Extracts, Cascara, Quinones, Protein Kinase Inhibitors, Complex Mixtures, Plant Preparations, Anthraquinones, Biological Products, Laxatives, Pharmaceutical Preparations, Gastrointestinal Agents	investigational	4
DB07710	PHENYLALANYLAMINODI(ETHYLOXY)ETHYL BENZENESULFONAMIDEAMINOCARBONYLBENZENESULFONAMIDE	Drug	0	experimental	1
DB07712	3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL	Drug	0	experimental	2
DB07711	(2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol	Drug	0	experimental	1
DB07718	4-Hydroxyphenylpyruvic acid	Drug	Pyruvates, Acids, Carbocyclic, Keto Acids	experimental	3
DB07717	(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE	Drug	0	experimental	1
DB07719	[(3R)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid	Drug	0	experimental	1
DB05142	ND7001	Drug	0	investigational	2
DB06474	Sibrotuzumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	1
DB05143	OXI-4503	Drug	Anions, Acids, Noncarboxylic, Acids, Phosphoric Acids, Electrolytes, Ions, Benzylidene Compounds, Phosphorus Compounds, Polyphosphates, Benzene Derivatives, Phosphate salts, Phosphorus Acids	investigational	0
DB05144	PEV3A	Drug	Vaccines	investigational	0
DB05145	TH0318	Drug	0	investigational	0
DB06475	Ruplizumab	Drug	0	investigational	1
DB06470	Clomethiazole	Drug	Neuroprotective Agents, Psycholeptics, Cytochrome P-450 Substrates, GABA Agents, Nervous System, GABA Modulators, Protective Agents, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C19 Substrates, Neurotransmitter Agents, Anticonvulsants, Sulfur Compounds, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Cytochrome P-450 CYP2A6 Substrates, Thiazoles, Hypnotics and Sedatives, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates, Compounds used in a research, industrial, or household setting	investigational	1
DB06472	Fradafiban	Drug	Benzene Derivatives, Platelet Glycoprotein GPIIb-IIIa Complex, antagonists & inhibitors	investigational	2
DB05140	RAV12	Drug	0	investigational	0
DB05141	LY2181308	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides, Polynucleotides	investigational	1
DB06471	Naxifylline	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Purinergic P1 Receptor Antagonists, Purines, Adenosine A1 Receptor Antagonists, Purinergic Antagonists, Purinergic Agents, Purinones	investigational	1
DB06478	Porfiromycin	Drug	Heterocyclic Compounds, Fused-Ring, Quinones, Mitomycins, Antineoplastic Agents, Antibiotics, Antineoplastic, Indoles, Azirines, Indolequinones	investigational	0
DB05146	XL820	Drug	0	investigational	4
DB06477	Sumanirole	Drug	Heterocyclic Compounds, Fused-Ring	investigational	3
DB05147	CYT997	Drug	0	investigational	15
DB05148	CG0070	Drug	0	investigational	0
DB06479	Propentofylline	Drug	Neuroprotective Agents, Cytochrome P-450 Substrates, Nervous System, Protective Agents, Psychostimulants, Agents Used for Adhd and Nootropics, Anti-Ulcer Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Purines, Cytochrome P-450 CYP1A2 Substrates, Xanthine derivatives, Central Nervous System Agents, Compounds used in a research, industrial, or household setting, Purinones, Psychoanaleptics	investigational	1
DB05149	XL844	Drug	0	investigational	2
DB06485	Ropidoxuridine	Drug	0	investigational	0
DB05154	Pretomanid	Drug	Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 Substrates, Imidazoles, Cytochrome P-450 CYP3A Substrates, Nitro Compounds, OAT3/SLC22A8 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Antituberculosis Agents	approved	5
DB05155	CR665	Drug	Proteins, Peptides, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins	investigational	1
DB05156	SL017	Drug	0	investigational	0
DB06486	Enzastaurin	Drug	Heterocyclic Compounds, Fused-Ring	investigational	8
DB06481	Manitimus	Drug	Hydrocarbons, Acyclic	investigational	1
DB05150	CAD106	Drug	0	investigational	1
DB06480	Prucalopride	Drug	Cytochrome P-450 Substrates, P-glycoprotein substrates, Drugs for Constipation, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Alimentary Tract and Metabolism, Miscellaneous GI Drugs, Laxatives, Gastrointestinal Agents	approved	1
DB05151	TST10088	Drug	0	investigational	0
DB06482	ALGRX 1207	Drug	0	investigational	0
DB05152	NGX267	Drug	Muscarinic Agonists, Neurotransmitter Agents, Sulfur Compounds, Cholinergic Agents, Cholinergic Agonists	investigational	1
DB06489	Liatermin	Drug	0	investigational	0
DB05157	KC706	Drug	0	investigational	4
DB05158	PM02734	Drug	Peptides, Cyclic, Peptides, Amino Acids, Peptides, and Proteins	investigational	0
DB05159	CCX915	Drug	0	investigational	1
DB06496	Dextrin 2-sulfate	Drug	Carbohydrates, Dietary Carbohydrates, Starch, Biopolymers, Macromolecular Substances, Polysaccharides, Physiological Phenomena, Food and Beverages, Glucans, Polymers, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food	investigational	0
DB05164	CMLVAX100	Drug	0	investigational	1
DB06495	Onercept	Drug	Membrane Proteins, Proteins, Receptors, Cytokine, Polyethylene Glycols, Receptors, Tumor Necrosis Factor, Receptors, Immunologic, Amino Acids, Peptides, and Proteins, Receptors, Cell Surface, Receptors, Death Domain, Recombinant Proteins	investigational	1
DB05165	LY2275796	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides, Polynucleotides	investigational	1
DB06498	L523S	Drug	0	investigational	0
DB05166	APD668	Drug	0	investigational	1
DB06497	Aplaviroc	Drug	HIV Fusion Inhibitors, Acids, Carbocyclic, Benzene Derivatives	investigational	1
DB05167	PDPSC18	Drug	0	investigational	0
DB06492	Mirococept	Drug	0	investigational	1
DB05160	Topsalysin	Drug	Membrane Proteins, Proteins, Toxins, Biological, Biological Factors, Amino Acids, Peptides, and Proteins	investigational	0
DB05161	Elafin	Drug	Proteins, Enzyme Inhibitors, Proteinase Inhibitory Proteins, Secretory, Peptides, Protease Inhibitors, Amino Acids, Peptides, and Proteins	investigational	2
DB06494	Sufugolix	Drug	0	investigational	1
DB06493	Velafermin	Drug	Proteins, Biological Factors, Peptides, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins	investigational	0
DB05163	PV903	Drug	0	investigational	0
DB05168	Vintafolide	Drug	Alkaloids, Biological Factors, Heterocyclic Compounds, Fused-Ring, Pterins, Vinca Alkaloids, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Indoles, Pteridines, Secologanin Tryptamine Alkaloids, Indole Alkaloids, Pigments, Biological	investigational	3
DB06499	Furaprofen	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB05169	AT9283	Drug	Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors	investigational	2
DB05170	Benzimate	Drug	0	investigational	0
DB05177	DG051	Drug	0	investigational	1
DB05178	DLO6001	Drug	0	investigational	0
DB05171	E-2012	Drug	Amyloid Precursor Protein Secretases	investigational	2
DB05172	AT3022	Drug	0	investigational	0
DB05173	PTC299	Drug	Analgesics, Non-Narcotic, Enzyme Inhibitors, Sulfur Compounds, Sensory System Agents, Analgesics, Anti-Inflammatory Agents, Antirheumatic Agents, Central Nervous System Agents, Peripheral Nervous System Agents	investigational	0
DB05174	CX501	Drug	0	investigational	0
DB05179	DLO6002	Drug	0	investigational	0
DB07761	(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol	Drug	0	experimental	1
DB07760	3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid	Drug	0	experimental	1
DB07763	(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE	Drug	0	experimental	10
DB05100	Prinomastat	Drug	Enzyme Inhibitors, Protease Inhibitors, Matrix Metalloproteinase Inhibitors	investigational	0
DB07762	4-(N-ACETYLAMINO)-3-[N-(2-ETHYLBUTANOYLAMINO)]BENZOIC ACID	Drug	0	experimental	1
DB06431	Evernimicin	Drug	Carbohydrates, Glycosides	investigational	0
DB05101	Matuzumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	1
DB07769	S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE	Drug	0	experimental	1
DB05106	IR208	Drug	0	investigational	0
DB07768	Epitestosterone	Drug	Androstanes, Hormones, Hormone Substitutes, and Hormone Antagonists, Androstenols, Androstenes, Testosterone Congeners, Hormones, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Steroids	experimental	2
DB05107	16-Bromoepiandrosterone	Drug	Androstanols, Androstanes, Hormones, Hormone Substitutes, and Hormone Antagonists, 17-Ketosteroids, Adrenal Cortex Hormones, Testosterone Congeners, Hormones, Ketosteroids, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Steroids	investigational	1
DB06437	Tifacogin	Drug	Amino Acids, Peptides, and Proteins	investigational	0
DB05108	EHT899	Drug	0	investigational	0
DB05109	Trabectedin	Drug	Cytochrome P-450 Substrates, Immunosuppressive Agents, Isoquinolines, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index, Tetrahydroisoquinolines, Antineoplastic Agents, Alkylating, Cytochrome P-450 CYP2E1 Substrates, Noxae, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index, Alkylating Activity, Antineoplastic Agents, Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index, Dioxoles, Myelosuppressive Agents, Alkylating Drugs, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Toxic Actions, Cytochrome P-450 CYP2D6 Substrates	approved, investigational	1
DB06439	Tyloxapol	Drug	Surface-Active Agents, Cough and Cold Preparations, Expectorants, Ethylene Glycols, Glycols, Detergents, Polymers, Compounds used in a research, industrial, or household setting, Household Products, Alcohols, Macromolecular Substances	approved, investigational	1
DB07765	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	Drug	0	experimental	1
DB06434	Repifermin	Drug	Proteins, Biological Factors, Peptides, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Fibroblast Growth Factors	investigational	0
DB05102	Rupintrivir	Drug	Enzyme Inhibitors, Protease Inhibitors, Pyrrolidines, Antiviral Agents, Anti-Infective Agents	investigational	1
DB05103	AN-9	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Lipids	investigational	0
DB07764	Fluorescin	Drug	0	experimental	1
DB06433	Tezacitabine	Drug	Ribonucleoside Diphosphate Reductase, antagonists & inhibitors, Carbohydrates, Ribonucleosides, Enzyme Inhibitors, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Antineoplastic Agents, Glycosides, Nucleosides, Deoxyribonucleosides, Radiation-Sensitizing Agents	investigational	1
DB05104	Asimadoline	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Amides, Lipids, Acetates	investigational	1
DB07767	Ferulic acid	Drug	Analgesics, Non-Narcotic, Anticoagulants, Sensory System Agents, Anti-Inflammatory Agents, Protective Agents, Acids, Carbocyclic, Laboratory Chemicals, Antirheumatic Agents, Free Radical Scavengers, Hematologic Agents, Cardiovascular Agents, Plants, Peripheral Nervous System Agents, Antioxidants, Analgesics, Cholagogues and Choleretics, Indicators and Reagents, Antihypertensive Agents, Central Nervous System Agents, Compounds used in a research, industrial, or household setting, Cinnamates, Gastrointestinal Agents	experimental	4
DB06436	Semaxanib	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Protein Kinase Inhibitors, Antineoplastic Agents, Growth Inhibitors, Angiogenesis Modulating Agents, Growth Substances, Angiogenesis Inhibitors	investigational	1
DB05105	Pleconaril	Drug	Antivirals for Systemic Use, Common Cold, drug therapy, Direct Acting Antivirals, Oxazoles, Antiviral Agents, Antiinfectives for Systemic Use, Anti-Infective Agents	investigational	1
DB06435	Tarazepide	Drug	Heterocyclic Compounds, Fused-Ring, Benzazepines	investigational	0
DB07766	(2Z,3E)-2,3'-biindole-2',3(1H,1'H)-dione 3-{O-[(3R)-3,4-dihydroxybutyl]oxime}	Drug	0	experimental	2
DB07772	(1R)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid	Drug	0	experimental	1
DB06441	Cangrelor	Drug	Anticoagulants, Carbohydrates, Blood and Blood Forming Organs, Purinergic P2 Receptor Antagonists, Hematologic Agents, Nucleotides, Purinergic Agents, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Purine Nucleotides, Purines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Platelet Aggregation Inhibitors Excl. Heparin, Decreased Platelet Aggregation, Glycosides, Purinergic P2Y Receptor Antagonists, Purinergic Antagonists, Adenine Nucleotides, Antiplatelet agents, P2Y12 Platelet Inhibitor	approved	1
DB07771	[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID	Drug	0	experimental	3
DB05110	VIR201	Drug	0	investigational	1
DB06440	Ravuconazole	Drug	Sulfur Compounds, Azole Antifungals, Antifungal Agents	investigational	0
DB05111	Fontolizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	1
DB07773	5-FLUOROINDOLE PROPANOL PHOSPHATE	Drug	0	experimental	2
DB05112	AP5280	Drug	Organometallic Compounds, Acids, Acyclic, Acrylates, Amides, Drug Delivery Systems	investigational	0
DB06442	Avasimibe	Drug	Acids, Acyclic, Fatty Acids, Chemically-Induced Disorders, Cytochrome P-450 Enzyme Inhibitors, Sulfur Acids, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP2C19 Inhibitors, Lipids, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inducers (moderate), Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 Enzyme Inducers, Sulfur Compounds, Acids, Noncarboxylic, Acids, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Fatty Acids, Volatile, Arteriosclerosis, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2C19 inhibitors (strength unknown)	investigational	1
DB07770	5-(4-FLUOROPHENYL)-3-{[(4-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID	Drug	0	experimental	1
DB05117	IGN301	Drug	0	investigational	0
DB06449	Ilodecakin	Drug	0	investigational	0
DB06448	Lonafarnib	Drug	Enzyme Inhibitors, P-glycoprotein inhibitors	investigational	2
DB07779	N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE	Drug	0	experimental	1
DB05118	R1204	Drug	0	investigational	0
DB05119	Rilapladib	Drug	Quinolines, Acids, Acyclic, Heterocyclic Compounds, Fused-Ring, Fatty Acids, Fatty Acids, Volatile, Amides, Lipids, Acetates	investigational	1
DB06445	Diethylnorspermine	Drug	Diamines, Amines, Antineoplastic Agents, Biogenic Amines, Cardiovascular Agents, Antihypertensive Agents, Polyamines, Biogenic Polyamines	investigational	0
DB07776	Flavone	Drug	Heterocyclic Compounds, Fused-Ring, Flavonoids, Flavones, Benzopyrans, Chromones, Pyrans	approved, experimental	4
DB05113	105AD7	Drug	0	investigational	0
DB06444	Dexanabinol	Drug	Autonomic Agents, Neuroprotective Agents, Protective Agents, Cardiovascular Agents, Peripheral Nervous System Agents, Neurotransmitter Agents, Cannabinoids and similars, Antiemetics, Central Nervous System Agents, Excitatory Amino Acid Agents, Terpenes, Compounds used in a research, industrial, or household setting, Excitatory Amino Acid Antagonists, Gastrointestinal Agents	investigational	1
DB07775	3',5'-DIBROMO-2',4,4',6'-TETRAHYDROXY AURONE	Drug	0	experimental	0
DB05114	EHC18	Drug	0	investigational	0
DB05115	NN344	Drug	Insulin, Long-Acting, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pancreatic Hormones, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Amino Acids, Peptides, and Proteins, Blood Glucose Lowering Agents, Hormones, Insulin, Proteins, Cytochrome P-450 Enzyme Inducers, Peptide Hormones, Protein Precursors, Cytochrome P-450 CYP1A2 Inducers	investigational	1
DB07778	(S)-famoxadone	Drug	0	experimental	10
DB06447	E5531	Drug	Toxins, Biological, Antigens, Biological Factors, Carbohydrates, Polysaccharides, Glycoconjugates, Polysaccharides, Bacterial, Bacterial Toxins, Endotoxins, Lipids, Antigens, Bacterial, Lipopolysaccharides	investigational	1
DB05116	Thymectacin	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Deoxyuridine, Glycosides, Nucleosides, Deoxyribonucleosides, Nucleotides	investigational	1
DB06446	Dotarizine	Drug	Cytochrome P-450 Substrates, Serotonin Agents, Agents causing hyperkalemia, Cardiovascular Agents, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Membrane Transport Modulators, Calcium Channel Blockers, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Calcium-Regulating Hormones and Agents, Serotonin Receptor Antagonists, Vasodilating Agents, Benzene Derivatives, Bradycardia-Causing Agents, Antiarrhythmic agents	investigational	4
DB05120	AT1391	Drug	0	investigational	1
DB07783	1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE	Drug	0	experimental	1
DB06451	Aprinocarsen	Drug	Carbohydrates, Sulfur Compounds, Nucleic Acids, Nucleotides, and Nucleosides, Oligonucleotides, Glycosides, Nucleotides, Protein Kinase C, antagonists & inhibitors, Polynucleotides	investigational	1
DB05121	1D09C3	Drug	0	investigational	1
DB07782	4-AMINO-2-TRIFLUOROMETHYL-5-HYDROXYMETHYLPYRIMIDINE PYROPHOSPHATE	Drug	0	experimental	1
DB05122	R1295	Drug	0	investigational	3
DB06454	Sarizotan	Drug	0	investigational	3
DB07785	1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE	Drug	0	experimental	1
DB06453	Mirostipen	Drug	0	investigational	0
DB07784	[4-(4-ACETYLAMINO-PHENYL)-3,5-DIOXO-4-AZA-TRICYCLO[5.2.2.0 2,6]UNDEC-1-YLCARBAMOYLOXY]-ACETIC ACID	Drug	0	experimental	1
DB05123	Gemcabene	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Lipids	investigational	0
DB07781	N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-NITRILOMETHYL-PYRIDYL]-THIOUREA	Drug	0	experimental	1
DB07780	Farnesyl diphosphate	Drug	QTc Prolonging Agents, Organophosphorus Compounds, Potential QTc-Prolonging Agents, Terpenes, Organophosphates	experimental	11
DB05128	Aminocandin	Drug	Peptides, Amino Acids, Peptides, and Proteins, Lipids, Echinocandin Antifungal	investigational	0
DB05129	Elsamitrucin	Drug	Carbohydrates, Antineoplastic Agents, Glycosides, Antibiotics, Antineoplastic	investigational	3
DB05124	ARC183	Drug	0	investigational	0
DB07787	5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE	Drug	0	experimental	1
DB05125	SC12267	Drug	0	investigational	1
DB06455	Meclinertant	Drug	Receptors, Neurotensin, antagonists & inhibitors, Heterocyclic Compounds, Fused-Ring	investigational	0
DB07786	1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE	Drug	0	experimental	1
DB06458	Remacemide	Drug	Acids, Acyclic, Neuroprotective Agents, Fatty Acids, Cytochrome P-450 Enzyme Inhibitors, Protective Agents, Amides, Lipids, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Acetates, Anticonvulsants, Cytochrome P-450 CYP3A Inhibitors, Central Nervous System Depressants, Fatty Acids, Volatile, Cytochrome P-450 CYP3A4 Inhibitors, Central Nervous System Agents, Compounds used in a research, industrial, or household setting	investigational	0
DB07789	1-[5-Methyl-2-(trifluoromethyl)furan-3-yl]-3-[5-[2-[[6-(1H-1,2,4-triazol-5-ylamino)pyrimidin-4-yl]amino]ethyl]-1,3-thiazol-2-yl]urea	Drug	0	experimental	1
DB05126	PYM50018	Drug	0	investigational	0
DB05127	ANA971	Drug	0	investigational	1
DB06457	Tecastemizole	Drug	Heterocyclic Compounds, Fused-Ring	investigational	1
DB07788	(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE	Drug	0	experimental	1
DB07794	5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE	Drug	0	experimental	1
DB06463	IR502	Drug	0	investigational	0
DB05131	TTP889	Drug	0	investigational	1
DB07793	(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE	Drug	0	experimental	1
DB06462	Mitumomab	Drug	0	investigational	0
DB05132	ND1251	Drug	0	investigational	0
DB05133	VP025	Drug	0	investigational	1
DB07796	(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE	Drug	0	experimental	1
DB06465	FK-960	Drug	Benzoates, Acids, Carbocyclic, Amides, Benzene Derivatives	investigational	0
DB07795	Fisetin	Drug	Heterocyclic Compounds, Fused-Ring, Benzopyrans, Chromones, Pyrans	experimental	2
DB05134	Tanespimycin	Drug	Quinones, Protein-Serine-Threonine Kinases, antagonists & inhibitors, Amides, Lactams, HSP90 Heat-Shock Proteins, antagonists & inhibitors	investigational	2
DB06464	IR501	Drug	0	investigational	0
DB07790	N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE	Drug	0	experimental	1
DB07792	(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE	Drug	0	experimental	1
DB06461	Squalamine	Drug	Cholestanes, Hydroxy Acids, Protective Agents, Antineoplastic Agents, Growth Inhibitors, Angiogenesis Modulating Agents, Angiogenesis Inhibitors, Anti-Infective Agents, Fused-Ring Compounds, Anti-Bacterial Agents, Anticarcinogenic Agents, Growth Substances, Compounds used in a research, industrial, or household setting, Steroids	investigational	0
DB07791	4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE	Drug	0	experimental	1
DB06460	Enrasentan	Drug	Indenes, Endothelin Receptor Antagonists	investigational	2
DB05130	INCB3284	Drug	Benzoates, Acids, Carbocyclic, Amides, Amino Acids, Peptides, and Proteins, Amino Acids, Benzene Derivatives	investigational	1
DB05139	CR002	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	1
DB05135	Vibriolysin	Drug	0	investigational	0
DB06467	Apolizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB07798	(3R)-3-(FLUOROMETHYL)-N-(3,3,3-TRIFLUOROPROPYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE	Drug	0	experimental	1
DB05136	Bavituximab	Drug	Proteins, Serum Globulins, Antineoplastic Agents, Immunological, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB07797	N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-CHLORO-PYRIDYL]-THIOUREA	Drug	0	experimental	1
DB05137	Lobeline	Drug	Autonomic Agents, Alkaloids, Neurotransmitter Agents, Cholinergic Agents, Cholinergic Agonists, Nicotinic Agonists, Piperidines, Ganglionic Stimulants, Respiratory System Agents, Peripheral Nervous System Agents	investigational	3
DB06469	Lestaurtinib	Drug	Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Indoles	investigational	1
DB06468	Cariporide	Drug	QTc Prolonging Agents, Sulfur Compounds, Amidines, Potential QTc-Prolonging Agents, Cardiovascular Agents, Antiarrhythmic agents	investigational	1
DB05138	AdPEDF	Drug	0	investigational	0
DB05180	LX6171	Drug	0	investigational	0
DB05181	BTA798	Drug	0	investigational	0
DB05186	SQ-109	Drug	Diamines, Cycloparaffins, Amines, Polyamines	investigational	0
DB05187	Elafibranor	Drug	Acids, Acyclic, Fatty Acids, Ketones, PPAR delta, agonists, Lipids, Benzopyrans, Heterocyclic Compounds, Fused-Ring, Flavonoids, PPAR alpha, agonists, Fatty Acids, Volatile, Propiophenones, Chromones, Pyrans	investigational	3
DB05188	KD3010	Drug	Sulfur Compounds, Amides, PPAR delta, antagonists & inhibitors, Sulfones	investigational	1
DB05189	EPC2407	Drug	Heterocyclic Compounds, Fused-Ring, Pyrans	investigational	0
DB05182	AS1409	Drug	0	investigational	0
DB05183	MLN0415	Drug	0	investigational	1
DB05184	XL228	Drug	0	investigational	4
DB05185	TRO19622	Drug	Cholestanes, Cholestenes, Fused-Ring Compounds, Steroids	investigational	0
DB05190	XL281	Drug	0	investigational	2
DB05191	Atl146e	Drug	Heterocyclic Compounds, Fused-Ring, Cycloparaffins, Acids, Carbocyclic, Adenosine A2 Receptor Agonists, Cyclohexanes	investigational	1
DB05192	MB07811	Drug	Organophosphorus Compounds	investigational	1
DB05197	Sofalcone	Drug	Heterocyclic Compounds, Fused-Ring, Flavonoids, Ketones, Propiophenones, Benzopyrans, Anti-Ulcer Agents, Chromones, Gastrointestinal Agents, Pyrans	investigational	0
DB05198	CYC116	Drug	Protein Kinase Inhibitors, Sulfur Compounds	investigational	2
DB05199	LX1031	Drug	Amino Acids, Aromatic, Tryptophan Hydroxylase, antagonists & inhibitors, Amino Acids, Cyclic, Amino Acids, Essential, Amino Acids, Peptides, and Proteins, Amino Acids, Benzene Derivatives	investigational	1
DB05194	KB002	Drug	0	investigational	3
DB05195	ADC4022	Drug	0	investigational	0
DB05196	ACR325	Drug	0	investigational	0
DB07840	(E)-[4-(3,5-Difluorophenyl)-3H-pyrrolo[2,3-b]pyridin-3-ylidene](3-methoxyphenyl)methanol	Drug	0	experimental	1
DB06515	Resiniferatoxin	Drug	Neurotoxins, TRPV Cation Channels, Terpenes	investigational	1
DB07846	(3,4,8b-Trimethyl-3-oxido-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-3-ium-7-yl) N-(2-ethylphenyl)carbamate	Drug	0	experimental	1
DB07845	2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide	Drug	0	experimental	1
DB07848	5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide	Drug	0	experimental	1
DB07847	6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE	Drug	0	experimental	1
DB07842	(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid	Drug	0	experimental	1
DB06511	AMGN-0007	Drug	Membrane Proteins, Proteins, Tumor Necrosis Factor Decoy Receptors, Receptors, Cytokine, Receptors, Tumor Necrosis Factor, Receptors, Immunologic, Amino Acids, Peptides, and Proteins, Receptors, Cell Surface	investigational	1
DB07841	Geranylgeranyl diphosphate	Drug	QTc Prolonging Agents, Organophosphorus Compounds, Potential QTc-Prolonging Agents, Terpenes, Phosphate salts, Organophosphates	experimental	7
DB06510	Muraglitazar	Drug	Cytochrome P-450 Substrates, PPAR alpha, agonists, UGT1A1 Substrates, UGT1A3 substrates, Cytochrome P-450 CYP1A2 Substrates, Amino Acids, Peptides, and Proteins, PPAR gamma, agonists, Cytochrome P-450 CYP2C8 Substrates, Amino Acids	investigational	2
DB07844	6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE	Drug	0	experimental	1
DB07843	5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE	Drug	0	experimental	1
DB06512	Deramciclane	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Tranquilizing Agents, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Antidepressive Agents, Psychotropic Drugs, Serotonin 5-HT2 Receptor Antagonists, Neurotransmitter Agents, Anticonvulsants, Central Nervous System Depressants, Anti-Anxiety Agents, Monoterpenes, Serotonin Receptor Antagonists, Central Nervous System Agents, Terpenes, Norbornanes, Cytochrome P-450 CYP2D6 Inhibitors (weak)	investigational	2
DB06519	Edaglitazone	Drug	Sulfur Compounds	investigational	0
DB07849	S-NONYL-CYSTEINE	Drug	0	experimental	1
DB06518	R-1487	Drug	Pyridines, Mitogen-Activated Protein Kinase 14, antagonists & inhibitors	investigational	1
DB07851	(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE	Drug	0	experimental	1
DB07850	(1R,2S)-2-(5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)cyclohexanecarboxylic acid	Drug	0	experimental	1
DB07857	(2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine	Drug	0	experimental	2
DB06525	Ganstigmine	Drug	Acids, Acyclic, Carbamates	investigational	1
DB07856	6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE	Drug	0	experimental	2
DB07859	4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE	Drug	0	experimental	4
DB06527	Tramiprosate	Drug	Alkanesulfonic Acids, Carbohydrates, GABA Agents, Sulfur Acids, GABA Agonists, Hydrocarbons, Acyclic, Alkanes, Neurotransmitter Agents, Anticonvulsants, Sulfur Compounds, Acids, Noncarboxylic, Acids, Central Nervous System Depressants, Sulfonic Acids, Central Nervous System Agents	investigational	0
DB07858	(2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine	Drug	0	experimental	2
DB07853	2-[4-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]iminocyclohexa-2,5-dien-1-yl]acetonitrile	Drug	0	experimental	3
DB06521	Ertiprotafib	Drug	Sulfur Compounds, Acids, Carbocyclic	investigational	4
DB07852	1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID	Drug	0	experimental	2
DB07855	(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE	Drug	0	experimental	2
DB07854	N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE	Drug	0	experimental	2
DB06523	Levovirin	Drug	0	investigational	0
DB06529	Ocinaplon	Drug	Central Nervous System Depressants, Hypnotics (Nonbenzodiazepine), Hypnotics and Sedatives	investigational	0
DB07860	(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE	Drug	0	experimental	2
DB07862	7-(1-ETHYL-PROPYL)-7H-PYRROLO-[3,2-F]QUINAZOLINE-1,3-DIAMINE	Drug	0	experimental	1
DB05200	AT2220	Drug	0	investigational	1
DB07861	(2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide	Drug	0	experimental	1
DB06530	Resiquimod	Drug	0	investigational	2
DB07868	6-CHLORO-4-(CYCLOHEXYLSULFANYL)-3-PROPYLQUINOLIN-2(1H)-ONE	Drug	0	experimental	1
DB05205	CX157	Drug	0	investigational	1
DB06536	Tesaglitazar	Drug	Alkanesulfonic Acids, Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfur Acids, Acids, Carbocyclic, Hydrocarbons, Acyclic, Sulfonic Acids, Alkanes	investigational	2
DB07867	6-CHLORO-4-(CYCLOHEXYLOXY)-3-PROPYLQUINOLIN-2(1H)-ONE	Drug	0	experimental	1
DB05207	SD118	Drug	0	investigational	2
DB07869	6-Chloro-4-[(R)-cyclohexylsulfinyl]-3-propyl-2(1H)-quinolinone	Drug	0	experimental	1
DB06538	Robalzotan	Drug	Heterocyclic Compounds, Fused-Ring, Pyrans	investigational	1
DB07864	4-[(CYCLOPROPYLETHYNYL)OXY]-6-FLUORO-3-ISOPROPYLQUINOLIN-2(1H)-ONE	Drug	0	experimental	1
DB05201	V24343	Drug	0	investigational	1
DB06533	Ragaglitazar	Drug	Acids, Carbocyclic	investigational	2
DB07863	2-chloro-5-nitro-N-phenylbenzamide	Drug	0	experimental	3
DB05202	Egaptivon pegol	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Oligonucleotides, Glycosides, Pegylated agents, Nucleotides, Polynucleotides	investigational	2
DB06532	Pafuramidine	Drug	Antiprotozoals, Trypanocidal Agents, Amidines, Anti-Infective Agents, Antiparasitic Agents	investigational	0
DB06535	Etilevodopa	Drug	Amino Acids, Aromatic, Dihydroxyphenylalanine, Amines, Nervous System, Phenylalanine, Amino Acids, Essential, Amino Acids, Peptides, and Proteins, Catecholamines, Catechols, Amino Acids, Anti-Parkinson Drugs, Amino Acids, Cyclic, Phenols, Benzene Derivatives, Dopa and Dopa Derivatives, Dopamine Agents	investigational	0
DB05203	SPP1148	Drug	0	investigational	2
DB07866	(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	Drug	0	experimental	1
DB06534	Thrombopoietin	Drug	Proteins, Biological Factors, Carbohydrates, Cytokines, Glycoconjugates, Peptides, Intercellular Signaling Peptides and Proteins, Thrombopoietin, antagonists & inhibitors, Amino Acids, Peptides, and Proteins, Glycoproteins, Colony-Stimulating Factors, Hematopoietic Cell Growth Factors	investigational	1
DB07865	3-(1H-tetrazol-5-ylamino)cyclohex-2-en-1-one	Drug	0	experimental	1
DB05204	XL418	Drug	0	investigational	1
DB05209	Rozrolimupab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Immunoglobulin Isotypes, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	1
DB07871	6-CHLORO-4-(CYCLOHEXYLOXY)-3-ISOPROPYLQUINOLIN-2(1H)-ONE	Drug	0	experimental	1
DB07870	Haloxyfop-P	Drug	0	experimental	1
DB05210	SF1126	Drug	Heterocyclic Compounds, Fused-Ring, Peptides, Amino Acids, Peptides, and Proteins, Benzopyrans, Pyrans	investigational	5
DB07873	Lauryl alcohol diphosphonic acid	Drug	0	experimental	1
DB07872	5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide	Drug	0	experimental	1
DB05211	PS386113	Drug	0	investigational	0
DB07879	N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide	Drug	0	experimental	1
DB06548	Minodronic acid	Drug	Organophosphonates, Organophosphorus Compounds	investigational	2
DB05217	GMX1777	Drug	Amidines	investigational	1
DB07878	N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE	Drug	0	experimental	1
DB05218	PN0621	Drug	0	investigational	1
DB06549	Labradimil	Drug	Proteins, Biological Factors, Autacoids, Inflammation Mediators, Oligopeptides, Peptides, Intercellular Signaling Peptides and Proteins, Kinins, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins	investigational	1
DB05219	Crisaborole	Drug	Agents for Dermatitis, Excluding Corticosteroids, Cytochrome P-450 CYP2B6 Inhibitors (weak), Phosphodiesterase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Anti-Inflammatory Agents, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors, Dermatologicals, Phosphodiesterase 4 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Cytochrome P-450 CYP2C9 Inhibitors (moderate), Cytochrome P-450 CYP2B6 Inhibitors	approved, investigational	4
DB05212	HE3286	Drug	Cytochrome P-450 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, 17-Ketosteroids, Adrenal Cortex Hormones, Androstenes, Hormones, Ketosteroids, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Gonadal Steroid Hormones, Androstanes, Cytochrome P-450 CYP3A Substrates, Androstenols, Gonadal Hormones, Steroids	investigational	2
DB07875	5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide	Drug	0	experimental	1
DB07874	(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one	Drug	0	experimental	1
DB06543	Astaxanthin	Drug	Anticoagulants, Biological Factors, Cycloparaffins, Carotenoids, Alkenes, Hydrocarbons, Acyclic, Polyenes, Cyclohexenes, Fibrinolytic Agents, Terpenes, Cyclohexanes, Pigments, Biological	investigational	1
DB07877	8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE	Drug	0	experimental	2
DB05214	KD7040	Drug	0	investigational	1
DB06545	Gavilimomab	Drug	0	investigational	0
DB07876	(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE	Drug	0	experimental	3
DB07802	3,8-DIBROMO-7-HYDROXY-4-METHYL-2H-CHROMEN-2-ONE	Drug	0	experimental	1
DB07801	N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide	Drug	0	experimental	1
DB07804	5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE	Drug	0	experimental	1
DB07803	2-phenyl-1H-imidazole-4-carboxylic acid	Drug	0	experimental	1
DB07800	N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE	Drug	0	experimental	1
DB07809	4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE	Drug	0	experimental	1
DB07806	(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID	Drug	0	experimental	1
DB07805	3-CHLORO-2,2-DIMETHYL-N-[4-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE	Drug	0	experimental	1
DB07808	(1S,2R)-2-[(2,5-difluorophenyl)carbamoyl]cyclopropanecarboxylic acid	Drug	0	experimental	1
DB07807	(3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL	Drug	0	experimental	1
DB07813	GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE	Drug	0	experimental	1
DB07812	N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide	Drug	0	experimental	2
DB07815	Gibberellin A4	Drug	Diterpenes, Kaurane, Diterpenes, Terpenes	experimental	1
DB07814	Gibberellic acid	Drug	Diterpenes, Kaurane, Diterpenes, Growth Substances, Terpenes, Plant Growth Regulators	experimental	1
DB07811	N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide	Drug	0	experimental	1
DB07810	Phloretin	Drug	Heterocyclic Compounds, Fused-Ring, Flavonoids, Ketones, Hydroxypropiophenone, Phloroglucinol, Phenols, Propiophenones, Benzopyrans, Benzene Derivatives, Chromones, Pyrans	experimental	1
DB07817	1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea	Drug	0	experimental	2
DB07816	N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID	Drug	0	experimental	1
DB07819	(2E)-3-(4-CHLOROPHENYL)-N-HYDROXYACRYLAMIDE	Drug	0	experimental	2
DB07818	(2E)-3-(2,4-DICHLOROPHENYL)-N-HYDROXYACRYLAMIDE	Drug	0	experimental	2
DB07824	4-ethyl-5-methyl-2-(1H-tetrazol-5-yl)-1,2-dihydro-3H-pyrazol-3-one	Drug	0	experimental	2
DB07823	(2S)-2-[(3aR,4R,7S,7aS)-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl]propanoic acid	Drug	0	experimental	2
DB07826	2-[4-chloro-2-(phenylcarbonyl)phenoxy]-N-phenylacetamide	Drug	0	experimental	1
DB07825	(3S)-1-(4-acetylphenyl)-5-oxopyrrolidine-3-carboxylic acid	Drug	0	experimental	1
DB07820	6-(3',5'-DIMETHYLBENZYL)-1-ETHOXYMETHYL-5-ISOPROPYLURACIL	Drug	0	experimental	1
DB07821	(1R)-1,2,2-trimethylpropyl (R)-methylphosphinate	Drug	0	experimental	3
DB07827	4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID	Drug	0	experimental	1
DB07829	4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE	Drug	0	experimental	1
DB06504	S-8510	Drug	Heterocyclic Compounds, Fused-Ring, Benzazepines	investigational	0
DB07835	N~3~-cyclopropyl-N~4~'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide	Drug	0	experimental	1
DB07834	N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide	Drug	0	experimental	1
DB06503	MLN2222	Drug	0	investigational	1
DB06506	Repinotan	Drug	Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Sulfur Compounds, Cytochrome P-450 Substrates, Cytochrome P-450 CYP2D6 Substrates, Pyrans	investigational	1
DB07837	[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid	Drug	0	experimental	1
DB07836	1-DECYL-3-TRIFLUORO ETHYL-SN-GLYCERO-2-PHOSPHOMETHANOL	Drug	0	experimental	1
DB07831	2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE	Drug	0	experimental	1
DB07830	(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE	Drug	0	experimental	1
DB07833	N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide	Drug	0	experimental	1
DB07832	4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde	Drug	0	experimental	1
DB07839	N~2~-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE	Drug	0	experimental	1
DB06508	GW-559090	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Amino Acids, Essential, Amino Acids, Peptides, and Proteins, Amino Acids	investigational	0
DB07838	(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE	Drug	0	experimental	1
DB06595	Midostaurin	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Cytochrome P-450 CYP2C19 Inducers (strength unknown), Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors (strong), Cytochrome P-450 CYP3A4 Inducers (strong), Cytochrome P-450 CYP2C19 Inducers, Indoles, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Cytochrome P-450 CYP3A Inducers (strong), Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A4 Inducers, Carbazoles, Protein Kinase Inhibitors, Receptor Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP1A2 Inducers, Cytochrome P-450 CYP2C19 Inhibitors (weak), Cytochrome P-450 CYP2D6 Inhibitors (strong), Cytochrome P-450 CYP2C8 Inducers (strength unknown), Kinase Inhibitor, Cytochrome P-450 CYP2D6 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 CYP2C19 Inhibitors, Indole Alkaloids, Cytochrome P-450 CYP1A2 Inhibitors, Alkaloids, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2E1 Inhibitors (strong), Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (strong), Antineoplastic Agents, Cytochrome P-450 CYP3A7 Inducers, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2C9 Inducers, Protein Kinase C, antagonists & inhibitors, Cytochrome P-450 CYP3A7 Inducers (strength unknown)	approved, investigational	6
DB05263	Caprospinol	Drug	Acids, Acyclic, Cholestanes, Fatty Acids, Fatty Acids, Volatile, Lipids, Fused-Ring Compounds, Steroids	investigational	0
DB05264	NPI 32101	Drug	0	investigational	1
DB06594	Agomelatine	Drug	Acids, Acyclic, Cytochrome P-450 Substrates, Fatty Acids, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Melatonin, agonists, Amides, Lipids, Antidepressive Agents, Acetates, Serotonin 5-HT2 Receptor Antagonists, Central Nervous System Depressants, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Fatty Acids, Volatile, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP1A2 Substrates, Serotonin Receptor Antagonists, Central Nervous System Agents, Psychoanaleptics	approved, investigational	3
DB06597	Estradiol sulfamate	Drug	Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, Estrenes, Steryl-Sulfatase, antagonists & inhibitors, Amides, Hormones, Fused-Ring Compounds, Gonadal Steroid Hormones, Sulfur Compounds, Estradiol Congeners, Sulfones, Gonadal Hormones, Steroids	investigational	0
DB05265	Ecabet	Drug	Enzyme Inhibitors, Protective Agents, Protease Inhibitors, Antineoplastic Agents, Anti-Ulcer Agents, Anti-Infective Agents, Phenanthrenes, Diterpenes, Pepsin A, antagonists & inhibitors, Anticarcinogenic Agents, Terpenes, Compounds used in a research, industrial, or household setting, Gastrointestinal Agents	investigational	2
DB05266	Ibudilast	Drug	Autonomic Agents, Phosphodiesterase Inhibitors, Enzyme Inhibitors, Anti-Asthmatic Agents, Leukotriene Antagonists, Phosphodiesterase 5 Inhibitors, Hematologic Agents, Cardiovascular Agents, Bronchodilator Agents, Respiratory System Agents, Peripheral Nervous System Agents, Drugs for Obstructive Airway Diseases, Vasodilating Agents, Antiplatelet agents	investigational	5
DB05260	Gallium nitrate	Drug	Immunosuppressive Agents, Metals, Calcium-Regulating Hormones and Agents, Antineoplastic Agents, Metals, Heavy, Bone Resorption Inhibition, Elements, Calcium Resorption Inhibitor	approved, investigational	6
DB06590	Ceftaroline fosamil	Drug	Nephrotoxic agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use	approved, investigational	0
DB06592	Pegargiminase	Drug	Enzymes, Ethylene Glycols, Enzymes and Coenzymes, Glycols, Polymers, Compounds used in a research, industrial, or household setting, Alcohols, Macromolecular Substances	investigational	0
DB05262	Oxypurinol	Drug	Enzyme Inhibitors, Pyrimidines, Pyrazoles, Xanthine Oxidase Inhibitors	investigational	1
DB06599	Lexatumumab	Drug	Proteins, Serum Globulins, Immunologic Factors, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Receptors, TNF-Related Apoptosis-Inducing Ligand, Immunoproteins	investigational	1
DB05268	iCo-007	Drug	0	investigational	1
DB06598	Brostallicin	Drug	Amidines	investigational	0
DB05276	Hepatitis B Immune Globulin	Drug	Proteins, Serum Globulins, Globulins, Blood Proteins, Passively Acquired Immunity, Human Immunoglobulin, Immunization, Passive, Amino Acids, Peptides, and Proteins, Serum, Immunoproteins, Virus Neutralization	approved, investigational	1
DB05271	Rotigotine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Serotonin 5-HT1 Receptor Agonists, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Serotonin Receptor Agonists, Hypotensive Agents, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Nonergot-derivative Dopamine Receptor Agonists, Anti-Parkinson Drugs, Dopamine Agonists, Naphthalenes, Neurotransmitter Agents, Sulfur Compounds, Cytochrome P-450 CYP3A Substrates, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Agents that produce hypertension, Anti-Parkinson Agents (Dopamine Agonist), Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2D6 Substrates, Dopamine Agents	approved	7
DB05273	Samarium (153Sm) lexidronam	Drug	Analgesics, Non-Narcotic, Radioactive Therapeutic Agent, Pain Palliation (Bone Seeking Agents), Sensory System Agents, Analgesics, Therapeutic Radiopharmaceuticals, Radioisotopes, Radiopharmaceutical Activity, Central Nervous System Agents, Various Pain Palliation Radiopharmaceuticals, Peripheral Nervous System Agents	approved, investigational	0
DB05285	SB-249553	Drug	0	investigational	0
DB05288	Anecortave acetate	Drug	Hydroxycorticosteroids, Pregnenediones, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Pregnanes, 11-Hydroxycorticosteroids, Hormones, 17-Hydroxycorticosteroids, Angiogenesis Inhibitors, Fused-Ring Compounds, Pregnenes, Steroids	investigational	0
DB05282	MCC	Drug	0	investigational	1
DB05284	CA4P	Drug	0	investigational	1
DB05289	Tarenflurbil	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Propionates, Lipids, Biphenyl Compounds, Benzene Derivatives	investigational	1
DB05290	SPP 301	Drug	0	investigational	1
DB05296	Motexafin lutetium	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Photosensitizing Agents, Dermatologicals, Radiation-Sensitizing Agents, Pigments, Biological, Porphyrins	investigational	0
DB05297	Paclitaxel docosahexaenoic acid	Drug	Cycloparaffins, Taxoids, Cyclodecanes, Diterpenes, Terpenes	investigational	1
DB05298	Tetomilast	Drug	Sulfur Compounds	investigational	1
DB05299	keyhole limpet hemocyanin	Drug	Proteins, Antigens, Biological Factors, Immunologic Factors, Arthropod Proteins, Adjuvants, Immunologic, Amino Acids, Peptides, and Proteins, Haptens, Mollusca, Metalloproteins, Pigments, Biological	approved, investigational	1
DB05292	IDM-1	Drug	0	investigational	0
DB05293	IDM-2	Drug	0	investigational	0
DB05294	Vandetanib	Drug	Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Cytochrome P-450 Substrates, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, OCT2 Inhibitors, Drugs causing inadvertant photosensitivity, P-glycoprotein inhibitors, Kinase Inhibitor	approved	5
DB05295	Eldecalcitol	Drug	Secosteroids, Vitamin D and Analogues, Vitamins (Fat Soluble), Bone Density Conservation Agents, Fused-Ring Compounds, Vitamins, Steroids	investigational	1
DB07882	4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID	Drug	0	experimental	1
DB07881	N-{[2-({[1-(4-CARBOXYBUTANOYL)AMINO]-2-PHENYLETHYL}-HYDROXYPHOSPHINYL)OXY]ACETYL}-2-PHENYLETHYLAMINE	Drug	0	experimental	1
DB05220	Alisertib	Drug	Protein Kinase Inhibitors	investigational	1
DB06550	Bivatuzumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	1
DB07884	Opaviraline	Drug	Heterocyclic Compounds, Fused-Ring, Antiviral Agents, Non-Nucleoside Reverse Transcriptase Inhibitors	experimental	1
DB05222	KB001	Drug	0	investigational	1
DB07883	(2-AMINO-3-PHENYL-BICYCLO[2.2.1]HEPT-2-YL)-PHENYL-METHANONE	Drug	0	experimental	1
DB06552	rNAPc2	Drug	0	investigational	3
DB07880	2-((4'-HYDROXYPHENYL)-AZO)BENZOIC ACID	Drug	0	experimental	1
DB06559	Lanimostim	Drug	0	investigational	0
DB05227	APD791	Drug	Serotonin 5-HT2 Receptor Antagonists, Neurotransmitter Agents, Oxazines, Benzoates, Serotonin Agents, Central Nervous System Depressants, Acids, Carbocyclic, Amides, Serotonin Receptor Antagonists, Antidepressive Agents, Benzene Derivatives	investigational	1
DB05228	RDEA806	Drug	0	investigational	1
DB06558	Tezosentan	Drug	Receptors, Endothelin, Cardiovascular Agents, Vasodilating Agents	investigational	2
DB07889	(2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol	Drug	0	experimental	1
DB05229	Beraprost	Drug	Anticoagulants, Biological Factors, Autacoids, Inflammation Mediators, Blood and Blood Forming Organs, Cytochrome P-450 Substrates, Fatty Acids, Eicosanoids, Hematologic Agents, Lipids, Cardiovascular Agents, Fatty Acids, Unsaturated, Prostaglandins, Platelet Aggregation Inhibitors Excl. Heparin, Prostaglandins I, Cytochrome P-450 CYP2C8 Substrates, Vasodilating Agents, Antiplatelet agents, Cryoprotective Agents	investigational	1
DB05223	Pracinostat	Drug	Heterocyclic Compounds, Fused-Ring, QTc Prolonging Agents, Antineoplastic Agents, Histone Deacetylase Inhibitors, Moderate Risk QTc-Prolonging Agents	investigational	4
DB06555	Siramesine	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB06554	Gaboxadol	Drug	Neurotransmitter Agents, Anticonvulsants, Appetite Depressants, Sensory System Agents, Analgesics, GABA Agents, Central Nervous System Depressants, GABA Agonists, Central Nervous System Agents, Anesthetics, Peripheral Nervous System Agents	investigational	0
DB05224	REP8839	Drug	Sulfur Compounds, Amines, Polyamines	investigational	1
DB07885	Talviraline	Drug	Heterocyclic Compounds, Fused-Ring, Acquired Immunodeficiency Syndrome	investigational	1
DB05225	AM103	Drug	Acids, Acyclic, Heterocyclic Compounds, Fused-Ring, Fatty Acids, Fatty Acids, Volatile, Lipids	investigational	1
DB06557	Lerdelimumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB07888	3-(4-HYDROXYPHENYL)-4,5-DIHYDRO-5-ISOXAZOLE-ACETIC ACID METHYL ESTER	Drug	0	experimental	1
DB07887	(R)-1-(4-(4-(hydroxymethyl)-1,3,2-dioxaborolan-2-yl)benzyl)guanidine	Drug	0	experimental	1
DB05226	BTA9881	Drug	0	investigational	1
DB06556	Edifoligide	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides, Polynucleotides	investigational	0
DB06562	Emfilermin	Drug	Proteins, Biological Factors, Cytokines, Peptides, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins	investigational	0
DB05230	AC3056	Drug	0	investigational	0
DB07893	PHENYL[1-(N-SUCCINYLAMINO)PENTYL]PHOSPHONATE	Drug	0	experimental	1
DB07892	1-(2-HYDROXYETHYLOXYMETHYL)-6-PHENYL THIOTHYMINE	Drug	0	experimental	1
DB05232	Tetrodotoxin	Drug	Biological Factors, Sensory System Agents, Noxae, Cardiovascular Agents, Quinazolines, Anesthetics, Membrane Transport Modulators, Marine Toxins, Peripheral Nervous System Agents, Toxins, Biological, Heterocyclic Compounds, Fused-Ring, Poisons, Central Nervous System Depressants, Toxic Actions, Central Nervous System Agents, Sodium Channel Blockers, Compounds used in a research, industrial, or household setting, Anesthetics, Local	investigational	4
DB07895	ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID	Drug	Sesquiterpenes, Organophosphorus Compounds, Lipids, Terpenes, Fatty Alcohols, Alcohols	experimental	2
DB07894	4-(2-HYDROXY-4-FLUOROPHENYLTHIO)-BUTYLPHOSPHONIC ACID	Drug	0	experimental	2
DB05233	AP1081	Drug	0	investigational	1
DB07891	Estradiol hemisuccinate	Drug	0	experimental	0
DB06560	Pascolizumab	Drug	0	investigational	1
DB07890	4-(2-HYDROXYPHENYLTHIO)-1-BUTENYLPHOSPHONIC ACID	Drug	0	experimental	2
DB06569	P-57AS3	Drug	0	investigational	0
DB05239	Cobimetinib	Drug	MAP Kinase Kinase 1, antagonists & inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, OATP1B3 inhibitors, Antineoplastic Agents, Azetines, OATP1B3 substrates, Cytochrome P-450 CYP3A4 Substrates, Protein Kinase Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, OATP1B1/SLCO1B1 Substrates, Drugs causing inadvertant photosensitivity, P-glycoprotein substrates with narrow therapeutic index, Kinase Inhibitor	approved, investigational	1
DB05234	LGD2941	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring	investigational	1
DB07897	1-(HYDROXYMETHYLENEAMINO)-8-HYDROXY-OCTANE	Drug	0	experimental	1
DB05235	NRP409	Drug	0	investigational	2
DB07896	(2S)-hydroxy(4-hydroxyphenyl)ethanoic acid	Drug	0	experimental	1
DB06568	alpha-Hydroxy glycineamide	Drug	0	investigational	0
DB07899	(2S) N-acetyl-L-alanyl-αL-phenylalanyl-chloroethylketone	Drug	0	experimental	1
DB05236	ReN001	Drug	0	investigational	0
DB05237	rhMBL	Drug	0	investigational	0
DB07898	(2R)-3-[(tetrahydroxyphosphoranyl)oxy]-1,2-propanediyl dibutanoate	Drug	0	experimental	1
DB06573	Rebimastat	Drug	Matrix Metalloproteinases	investigational	0
DB05241	XL765	Drug	Phosphatidylinositol 3-Kinase, antagonists & inhibitors, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amides, Sulfones	investigational	5
DB05242	NUC B1000	Drug	0	investigational	0
DB05243	XL019	Drug	0	investigational	1
DB06575	Valomaciclovir	Drug	Heterocyclic Compounds, Fused-Ring, Purines, Varicellovirus, Herpes Zoster, Antiviral Agents, Xanthine derivatives, Purinones	investigational	0
DB05244	G4544	Drug	0	investigational	0
DB05249	FavId	Drug	0	investigational	1
DB05245	Silver sulfadiazine	Drug	Amines, Gynecological Antiinfectives and Antiseptics, Aniline Compounds, Dermatologicals, Genito Urinary System and Sex Hormones, Amides, Sulfanilamides, Anti-Infective Agents, Anti-Infective Agents, Local, Anti-Bacterial Agents, Sulfur Compounds, Sulfonamide Antibacterial, Sulfonamides, Sulfones, Miscellaneous Local Anti-infectives	approved, vet_approved	1
DB05246	Methsuximide	Drug	QTc Prolonging Agents, Decreased Central Nervous System Disorganized Electrical Activity, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Agents causing hyperkalemia, Cytochrome P-450 CYP2C19 Inhibitors, Anti-epileptic Agent, Imides, Cytochrome P-450 CYP2C19 Substrates, Calcium Channel Blockers, Anticonvulsants, Pyrrolidinones, Central Nervous System Depressants, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Pyrrolidines, Potential QTc-Prolonging Agents, Central Nervous System Agents, Succinimide Derivatives, Bradycardia-Causing Agents, Antiarrhythmic agents	approved	1
DB06576	Baminercept	Drug	Proteins, Amino Acids, Peptides, and Proteins, Recombinant Proteins	investigational	0
DB06579	Adipiplon	Drug	Neurotransmitter Agents, Tranquilizing Agents, GABA Agents, Central Nervous System Depressants, GABA Agonists, Anti-Anxiety Agents, Central Nervous System Agents, Psychotropic Drugs	investigational	1
DB06578	Tonabersat	Drug	Heterocyclic Compounds, Fused-Ring, Benzoates, Acids, Carbocyclic, Amides, Benzene Derivatives, Pyrans	investigational	0
DB05252	Fenoxaprop-ethyl	Drug	Acids, Acyclic, Herbicides, Fatty Acids, Agrochemicals, Fatty Acids, Volatile, Pesticides, Lipids, Toxic Actions, Compounds used in a research, industrial, or household setting	investigational	1
DB06584	TG4010	Drug	Membrane Proteins, Proteins, Carbohydrates, Complex Mixtures, Glycoconjugates, Biological Products, Amino Acids, Peptides, and Proteins, Glycoproteins, Vaccines	investigational	2
DB05253	Telapristone acetate	Drug	Norsteroids, Norpregnanes, Fused-Ring Compounds, Steroids	investigational	1
DB05254	Fibrinolysin	Drug	Anticoagulants, Enzymes, Blood and Blood Forming Organs, Fibrinolysin, antagonists & inhibitors, Fibrin Modulating Agents, Enzymes and Coenzymes, Hematologic Agents, Cardiovascular Agents, Fibrinolytic Agents, Serine Proteases, Hydrolases, Peptide Hydrolases, Serine Endopeptidases, Endopeptidases	investigational	2
DB06586	Cetilistat	Drug	Heterocyclic Compounds, Fused-Ring, Lipid Regulating Agents, Enzyme Inhibitors, Oxazines, Anti-Obesity Agents	investigational	1
DB06585	Fipamezole	Drug	Indenes	investigational	0
DB05255	Ronacaleret	Drug	Acids, Carbocyclic, Indenes	investigational	2
DB06580	Celgosivir	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB06582	Dextofisopam	Drug	Heterocyclic Compounds, Fused-Ring, Benzazepines, Central Nervous System Depressants, Stereoisomerism, Antidepressive Agents, Central Nervous System Agents, Psychotropic Drugs	investigational	0
DB06581	Bevirimat	Drug	Acids, Acyclic, Dicarboxylic Acids, Anti-HIV Agents, Terpenes	investigational	1
DB06588	Triphendiol	Drug	Heterocyclic Compounds, Fused-Ring, Flavonoids, Benzopyrans, Chromones, Pyrans	investigational	0
DB06587	Mitemcinal	Drug	Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Lactones	investigational	1
DB05257	Neocartilage	Drug	0	investigational	0
DB05258	Interferon alfa	Drug	Biological Factors, Immunologic Factors, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Cytokines, Peptides, Interferon-alpha, Interferons, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Antiviral Agents, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Anti-Infective Agents, Interferon Type I, Myelosuppressive Agents, Cytochrome P-450 CYP1A2 Inhibitors, Proteins	investigational	1
DB06589	Pazopanib	Drug	Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, Amides, Receptors, Vascular Endothelial Growth Factor, antagonists & inhibitors, Cytochrome P-450 CYP3A4 Substrates, Sulfur Compounds, Cytochrome P-450 CYP2C8 Inhibitors (weak), Hepatotoxic Agents, Cytochrome P-450 CYP2C8 Substrates, Sulfones, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, UGT1A1 Inhibitors, Angiogenesis Inhibitors, Moderate Risk QTc-Prolonging Agents, Protein Kinase Inhibitors, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2D6 Inhibitors (weak), Cytochrome P-450 CYP3A4 Inhibitors (weak), Kinase Inhibitor	approved	10
DB05259	Glatiramer	Drug	Membrane Proteins, Proteins, Immunologic Factors, Immunosuppressive Agents, Peptides, Adjuvants, Immunologic, Antineoplastic and Immunomodulating Agents, Antirheumatic Agents, T-Lymphocytes, Helper-Inducer, immunology, Amino Acids, Peptides, and Proteins, Immunomodulatory Agents, Vesicular Transport Proteins	approved, investigational	1
DB07901	5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE	Drug	0	experimental	1
DB07900	3-FORMYL-2-HYDROXY-5-METHYL-HEXANOIC ACID HYDROXYAMIDE	Drug	0	experimental	1
DB07903	3-[(2,2-DIMETHYLPROPANOYL)AMINO]-N-1,3-THIAZOL-2-YLPYRIDINE-2-CARBOXAMIDE	Drug	0	experimental	1
DB07902	TERT-BUTYL {2-[(1,3-THIAZOL-2-YLAMINO)CARBONYL]PYRIDIN-3-YL}CARBAMATE	Drug	0	experimental	1
DB07909	(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL	Drug	0	experimental	3
DB07908	7-HYDROXY-4-METHYL-3-(2-HYDROXY-ETHYL)COUMARIN	Drug	0	experimental	1
DB07905	(1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione	Drug	0	experimental	1
DB07907	(2S)-2-HYDROXYOCTANOIC ACID	Drug	0	experimental	2
DB07906	[(3R)-7-NITRO-1,2,3,4-TETRAHYDROISOQUINOLIN-3-YL]METHANOL	Drug	0	experimental	1
DB07912	2-OXOHEPTYLPHOSPHONIC ACID	Drug	0	experimental	1
DB07911	(3E)-2,6-DIOXO-6-PHENYLHEX-3-ENOATE	Drug	0	experimental	2
DB07914	2-hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid	Drug	Fatty Acids, Lipids	experimental	2
DB07913	HOMOPHENYLALANINYLMETHANE	Drug	0	experimental	1
DB07910	(2S)-2-amino-3-phenylpropane-1,1-diol	Drug	0	experimental	3
DB07919	Harmine	Drug	Pyridines, Carbolines, Enzyme Inhibitors, Monoamine Oxidase Inhibitors, Antidepressive Agents, Hallucinogens, Psychotropic Drugs, Indole Alkaloids, Alkaloids, Heterocyclic Compounds, Fused-Ring, Harmala Alkaloids, Central Nervous System Depressants, Central Nervous System Agents, Indoles	experimental	1
DB07916	3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRI ACID	Drug	0	experimental	1
DB07915	(2E,4E)-2-Hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid	Drug	0	experimental	1
DB07918	2-heptyl-4-hydroxyquinoline N-oxide	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring	experimental	9
DB07917	4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE	Drug	0	experimental	1
DB06630	Anacetrapib	Drug	Lipid Regulating Agents, Anticholesteremic Agents, Hypolipidemic Agents, Noxae, Oxazoles, Toxic Actions, Cholesterol Ester Transfer Proteins, antagonists & inhibitors	investigational	0
DB07961	1-(4-Cyano-phenyl)-3-[2-(2,6-dichloro-phenyl)-1-imino-ethyl]-thiourea	Drug	0	experimental	1
DB07960	5-ACETAMIDO-5,6-DIHYDRO-4-HYDROXY-6-ISOBUTOXY-4H-PYRAN-2-CARBOXYLIC ACID	Drug	0	experimental	1
DB06636	Isavuconazonium	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Isavuconazole and Prodrugs, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Cytochrome P-450 Enzyme Inducers, Azole Antifungals, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Antifungal Agents, P-glycoprotein inhibitors	approved, investigational	0
DB05304	Girentuximab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	2
DB07967	9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE	Drug	0	experimental	1
DB06635	Otamixaban	Drug	Anticoagulants, Enzyme Inhibitors, Antithrombins, Factor Xa Inhibitors, Protease Inhibitors, Hematologic Agents, Serine Protease Inhibitors	investigational	1
DB05305	Cintredekin Besudotox	Drug	Proteins, Toxins, Biological, Biological Factors, Cytokines, Interleukins, Peptides, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Recombinant Proteins	investigational	1
DB07966	[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile	Drug	0	experimental	1
DB06638	Quarfloxin	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Oxazines	investigational	0
DB05306	Alferminogene tadenovec	Drug	Antianginal Agents, Vasodilating Agents	investigational	0
DB07969	3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol	Drug	0	experimental	1
DB07968	N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA	Drug	0	experimental	1
DB06637	Dalfampridine	Drug	Aminopyridines, Pyridines, Cytochrome P-450 CYP2E1 Substrates, Amines, Cytochrome P-450 Substrates, Potassium Channel Antagonists, Nervous System, OCT2 Substrates, Other Miscellaneous Therapeutic Agents, Cardiovascular Agents, Drugs that are Mainly Renally Excreted, Membrane Transport Modulators, OCT2 substrates with narrow therapeutic index, Potassium Channel Blockers	approved	16
DB05300	PTI-801	Drug	0	investigational	0
DB07963	N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINE	Drug	0	experimental	0
DB05301	LAX-101	Drug	0	investigational	2
DB07962	METHYL N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINATE	Drug	0	experimental	0
DB06634	Casopitant	Drug	Autonomic Agents, Antiemetics and Antinauseants, Neurotransmitter Agents, Alimentary Tract and Metabolism, Antiemetics, Central Nervous System Agents, Neurokinin-1 Receptor Antagonists, Gastrointestinal Agents, Peripheral Nervous System Agents	investigational	2
DB07965	6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile	Drug	0	experimental	1
DB05303	OMS-103HP	Drug	Imidazoles, Acids, Carbocyclic, Phenylpropionates, Pharmaceutical Preparations, Benzocycloheptenes, Dibenzocycloheptenes	investigational	2
DB06633	N-chlorotaurine	Drug	Alkanesulfonic Acids, Enzyme Inhibitors, Inflammation Mediators, Sulfur Acids, Hydrocarbons, Acyclic, Protein-Serine-Threonine Kinases, antagonists & inhibitors, Alkanes, Anti-Infective Agents, Sulfur Compounds, Acids, Noncarboxylic, Nitric Oxide Synthase, antagonists & inhibitors, Acids, Sulfonic Acids	investigational	0
DB07964	(3S)-4-{[4-(BUT-2-YNYLOXY)PHENYL]SULFONYL}-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE	Drug	0	experimental	1
DB05308	ANX-510	Drug	0	investigational	1
DB05309	TP-508	Drug	0	investigational	1
DB07970	5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide	Drug	0	experimental	1
DB07972	1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE	Drug	0	experimental	1
DB06641	Perifosine	Drug	Amines, Ammonium Compounds, Quaternary Ammonium Compounds, Trimethyl Ammonium Compounds, Onium Compounds, Amino Alcohols, Ethanolamines, Nitrogen Compounds, Alcohols	investigational	3
DB07971	5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE	Drug	0	experimental	1
DB06640	Fispemifene	Drug	Stilbenes, Benzylidene Compounds, Benzene Derivatives	investigational	0
DB05310	FP-1096	Drug	0	investigational	0
DB06647	Volociximab	Drug	Immunoglobulins, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Growth Inhibitors, Angiogenesis Modulating Agents, Angiogenesis Inhibitors, Immunoproteins, Proteins, Serum Globulins, Globulins, Blood Proteins, Growth Substances	investigational	0
DB05315	MC-1	Drug	0	investigational	0
DB07978	2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID	Drug	0	experimental	1
DB05316	Pimavanserin	Drug	Psycholeptics, Tranquilizing Agents, Serotonin Agents, Nervous System, Antidepressive Agents, Psychotropic Drugs, Anti-Parkinson Drugs, Serotonin 5-HT2 Receptor Antagonists, Anti-Dyskinesia Agents, Neurotransmitter Agents, Antipsychotic Agents, Antipsychotic Agents (Second Generation Atypical), Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Serotonin Receptor Antagonists, Central Nervous System Agents, Neurotoxic agents	approved, investigational	2
DB07977	3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID	Drug	0	experimental	1
DB06649	Priralfinamide	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Hydrocarbons, Halogenated, Lipids, Hydrocarbons, Fluorinated, Benzene Derivatives	investigational	0
DB05317	TAK-475	Drug	Azepines, Farnesyl-Diphosphate Farnesyltransferase, antagonists & inhibitors	investigational	2
DB07979	(2E)-3-(3,4-DIHYDROXYPHENYL)-2-IMINOPROPANOIC ACID	Drug	0	experimental	1
DB07974	1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE	Drug	0	experimental	1
DB05311	Ecallantide	Drug	Analgesics, Non-Narcotic, Plasma Kallikrein Inhibitor, Blood and Blood Forming Organs, Sensory System Agents, Anti-Inflammatory Agents, Antirheumatic Agents, Amino Acids, Peptides, and Proteins, Kallikreins, antagonists & inhibitors, Peripheral Nervous System Agents, Kallikrein Inhibitors, Analgesics, Central Nervous System Agents, Drugs Used in Hereditary Angioedema	approved, investigational	1
DB06643	Denosumab	Drug	RANK Ligand Blocking Activity, Immunoglobulins, Immunosuppressive Agents, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Drugs Affecting Bone Structure and Mineralization, Immunoproteins, Proteins, Serum Globulins, Antibodies, Monoclonal, Humanized, Globulins, Blood Proteins, Musculo-Skeletal System, Drugs for Treatment of Bone Diseases, Bone Density Conservation Agents, RANK Ligand Inhibitor	approved	1
DB06642	Bevasiranib	Drug	Molecular Probes, RNA, Antisense, Antisense Elements (Genetics), Diagnostic Uses of Chemicals, Nucleic Acids, Nucleotides, and Nucleosides, RNA, RNA, Untranslated, Laboratory Chemicals, Nucleic Acid Probes, RNA, Small Untranslated, Compounds used in a research, industrial, or household setting, Nucleic Acids	investigational	1
DB05312	NVS antibody	Drug	0	investigational	0
DB07973	N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE	Drug	0	experimental	1
DB07976	3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID	Drug	0	experimental	1
DB06645	Anamorelin	Drug	Peptide Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Amino Acids, Peptides, and Proteins, Hormones	investigational	0
DB05313	MP4	Drug	0	investigational	0
DB07975	2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID	Drug	0	experimental	1
DB05319	Oportuzumab monatox	Drug	Proteins, Amino Acids, Peptides, and Proteins, Recombinant Proteins	investigational	1
DB06650	Ofatumumab	Drug	Immunoglobulins, Antigens, CD20, Antineoplastic and Immunomodulating Agents, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins, Proteins, Serum Globulins, CD20-directed Cytolytic Antibody, Globulins, Blood Proteins, CD20-directed Antibody Interactions	approved	1
DB07981	2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1R)-1-(hydroxymethyl)propyl]acetamide	Drug	0	experimental	1
DB07983	1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID	Drug	0	experimental	1
DB05320	ATG-Fresenius S	Drug	0	investigational	0
DB06652	Vicriviroc	Drug	Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates	investigational	1
DB05321	PEG-uricase	Drug	Enzymes, Ethylene Glycols, Enzymes and Coenzymes, Pegylated agents, Enzymes, Immobilized, Glycols, Oxidoreductases, Polymers, Compounds used in a research, industrial, or household setting, Alcohols, Macromolecular Substances	investigational	1
DB06651	DiaPep 277	Drug	Enzymes, Molecular Chaperones, Peptides, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Proteins, Acid Anhydride Hydrolases, Group I Chaperonins, Adenosine Triphosphatases, Heat-Shock Proteins, Diabetes Mellitus, Type 1, Hydrolases, Chaperonins	investigational	0
DB07982	2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol	Drug	0	experimental	1
DB07989	2-(ACETYL-HYDROXY-AMINO)-4-METHYL-PENTANOIC ACID METHYL ESTER	Drug	0	experimental	1
DB05326	INKP-102	Drug	0	investigational	0
DB07988	2-[3-(5-Mercapto-[1,3,4]thiadiazol-2yl)-ureido]-N-methyl-3-pentafluorophenyl-propionamide	Drug	Enzyme Inhibitors, Sulfur Compounds, Protease Inhibitors, Thiazoles, Matrix Metalloproteinase Inhibitors	experimental	1
DB05327	Ranirestat	Drug	Enzyme Inhibitors, Stereoisomerism, Aldehyde Reductase, antagonists & inhibitors	investigational	1
DB06657	Valrocemide	Drug	Amino Acids, Peptides, and Proteins, Amino Acids	investigational	0
DB05328	VGV-1	Drug	0	investigational	1
DB06659	Rostaporfin	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Photosensitizing Agents, Dermatologicals, Radiation-Sensitizing Agents, Pigments, Biological	investigational	0
DB05329	MDX-1379	Drug	0	investigational	0
DB05322	INGN 201	Drug	Gene Transfer Techniques, Genes, p53, Complex Mixtures, Biological Products	investigational	0
DB07985	+/-METHYL 4-(AMINOIMINOMETHYL)-BETA-[3- INH (AMINOIMINO)PHENYL]BENZENE PENTANOATE	Drug	0	experimental	1
DB06654	Safinamide	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, Amines, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Amino Acids, Peptides, and Proteins, Cytochrome P-450 CYP2C19 Inhibitors, Antidepressive Agents, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Cytochrome P-450 CYP2C9 Inhibitors, Breast Cancer Resistance Protein Inhibitors, Monoamine Oxidase B Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Benzene Derivatives, Agents that reduce seizure threshold, Dopamine Agents, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Cytochrome P-450 CYP2E1 Inhibitors, Benzyl Compounds, Cytochrome P-450 CYP3A5 Inhibitors, BCRP/ABCG2 Inhibitors, Monoamine Oxidase Inhibitors, Amino Acids, Anti-Parkinson Drugs, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Agents that produce hypertension, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)	approved, investigational	1
DB07984	2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1S)-1-(hydroxymethyl)propyl]acetamide	Drug	0	experimental	1
DB07987	[2-(5-Mercapto-[1,3,4]thiadiazol-2-ylcarbamoyl)-1-phenyl-ethyl]-carbamic acid benzyl ester	Drug	0	experimental	1
DB06656	TAS-106	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Glycosides, Nucleosides	investigational	0
DB05325	INGN 225	Drug	Complex Mixtures, Biological Products, Vaccines	investigational	0
DB07986	[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID	Drug	0	experimental	1
DB06655	Liraglutide	Drug	Glucagon-Like Peptide 1, Glucagon-like Peptide-1 (GLP-1) Agonists, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Gastrointestinal Hormones, Pancreatic Hormones, Hypoglycemia-Associated Agents, Glucagon-like peptide-1 (GLP-1) analogues, Amino Acids, Peptides, and Proteins, Blood Glucose Lowering Agents, GLP-1 Agonists, Hormones, Incretins, Proteins, Peptide Hormones, Glucagon-Like Peptides, Alimentary Tract and Metabolism, Incretin Mimetics, Protein Precursors, Drugs Used in Diabetes, Proglucagon	approved	1
DB07992	Indoxyl sulfate	Drug	Heterocyclic Compounds, Fused-Ring, Indoles	experimental	0
DB06660	Saredutant	Drug	Benzoates, Central Nervous System Depressants, Acids, Carbocyclic, Amides, Receptors, Neurokinin-2, antagonists & inhibitors, Antidepressive Agents, Benzene Derivatives	investigational	1
DB05330	ALTU-135	Drug	Enzymes, Glycoside Hydrolases, Carboxylic Ester Hydrolases, Enzymes and Coenzymes, Hydrolases, Esterases	investigational	0
DB07991	N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE	Drug	0	experimental	1
DB07994	N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE	Drug	0	experimental	1
DB06663	Pasireotide	Drug	QTc Prolonging Agents, Cytochrome P-450 Enzyme Inhibitors, Peptides, Hypoglycemia-Associated Agents, Pituitary and Hypothalamic Hormones and Analogues, Amino Acids, Peptides, and Proteins, Neuropeptides, Somatostatin Agonists, Hormones, Proteins, Peptide Hormones, Pituitary Hormone Release Inhibiting Hormones, Potential QTc-Prolonging Agents, Somatostatin and Analogues, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Bradycardia-Causing Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Pancreatic Hormones, Nerve Tissue Proteins, Cytochrome P-450 CYP3A Inhibitors, Somatostatin Receptor Agonists, Cytochrome P-450 CYP3A4 Inhibitors, Hypothalamic Hormones, Hyperglycemia-Associated Agents, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved	4
DB04000	Bromo-Willardiine	Drug	0	experimental	1
DB06662	Abetimus	Drug	Carbohydrates, Immunologic Factors, Immunosuppressive Agents, Nucleic Acids, Nucleotides, and Nucleosides, Antineoplastic and Immunomodulating Agents, Glycosides, Nucleotides, Selective Immunosuppressants, Polynucleotides	investigational	0
DB05332	Romiplostim	Drug	Hematinics, Biological Factors, Carbohydrates, Blood and Blood Forming Organs, Cytokines, Glycoconjugates, Peptides, Thrombopoietin Receptor Agonists, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Receptors, Cell Surface, Glycoproteins, Recombinant Proteins, Increased Platelet Production, Thrombopoietin Receptor Agonist, Hematopoietic Cell Growth Factors, Increased Megakaryocyte Maturation, Membrane Proteins, Proteins, Receptors, Thrombopoietin, agonists, Receptors, Immunologic, Hemostatics, Colony-Stimulating Factors	approved	1
DB04001	6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid	Drug	0	experimental	1
DB07993	N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE	Drug	0	experimental	1
DB07990	(RP,SP)-O-(2R)-(1-PHENOXYBUT-2-YL)-METHYLPHOSPHONIC ACID CHLORIDE	Drug	0	experimental	1
DB04006	[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone	Drug	0	experimental	1
DB06669	Arverapamil	Drug	0	investigational	0
DB05337	SOT-107	Drug	0	investigational	1
DB07999	{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID	Drug	0	experimental	1
DB04007	Bromo-WR99210	Drug	0	experimental	1
DB04008	Zinc;[amino-[2-[[5-[amino(azaniumylidene)methyl]benzimidazol-1-id-2-yl]methyl]benzimidazol-1-id-5-yl]methylidene]azanium	Drug	0	experimental	1
DB05339	MN-305	Drug	0	investigational	1
DB04009	Dimethyl Propionate Ester Heme	Drug	0	experimental	1
DB05333	TC-5231	Drug	0	investigational	0
DB04002	4-Sulfonamide-[4-(Thiomethylaminobutane)]Benzamide	Drug	0	experimental	1
DB07996	5-(2-methylpiperazine-1-sulfonyl)isoquinoline	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Sulfur Compounds, Piperazines, Isoquinolines, Sulfonamides, Amides, Sulfones	experimental	2
DB04003	{4-[(2S)-2-Acetamido-3-({(1S)-1-[3-carbamoyl-4-(cyclohexylmethoxy)phenyl]ethyl}amino)-3-oxopropyl]-2-phosphonophenoxy}acetic acid	Drug	0	experimental	1
DB07995	H-89	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Protein Kinase Inhibitors, Sulfur Compounds, Amides, Sulfones	experimental	3
DB04004	2,6-Diamino-8-(2-Dimethylaminoethylsulfanylmethyl)-3h-Quinazolin-4-One	Drug	0	experimental	1
DB07997	N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE	Drug	0	experimental	2
DB05336	Obiltoxaximab	Drug	Anthrax Protective Antigen-directed Antibody Interactions, Immunoglobulins, Immune Sera and Immunoglobulins, Immune Sera, Antibodies, Amino Acids, Peptides, and Proteins, Hemic and Immune Systems, Antiinfectives for Systemic Use, Blood, Immunoproteins, Proteins, Serum Globulins, Specific Immunoglobulins, Complex Mixtures, Globulins, Blood Proteins, Biological Products, Serum, Body Fluids, Fluids and Secretions, Anthrax Protective Antigen-directed Antibody	approved	0
DB06666	Lixivaptan	Drug	Benzoates, Acids, Carbocyclic, Amides, Benzene Derivatives	investigational	0
DB04005	Uridine 5'-triphosphate	Drug	Carbohydrates, Pyrimidines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Uracil Nucleotides, Nucleotides, Pyrimidine Nucleotides	investigational, experimental	3
DB07923	octyl alpha-L-altropyranoside	Drug	0	experimental	1
DB07922	N-oxo-2-(phenylsulfonylamino)ethanamide	Drug	0	experimental	1
DB07925	4-(2-HYDROXYPHENYLSULFINYL)-BUTYLPHOSPHONIC ACID	Drug	0	experimental	2
DB07924	octyl beta-D-galactopyranoside	Drug	Carbohydrates, Glycosides	experimental	1
DB07921	2-[(4-fluorophenyl)sulfonylamino]-N-oxo-ethanamide	Drug	0	experimental	1
DB07920	N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide	Drug	0	experimental	1
DB07927	3-[(4-Carboxy-2-hydroxyphenyl)sulfamoyl]-2-thiophenecarboxylic acid	Drug	0	experimental	1
DB07926	N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE	Drug	0	experimental	1
DB07929	N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE	Drug	0	experimental	2
DB07928	N-(2-OXOTETRAHYDROFURAN-3-YL)OCTANAMIDE	Drug	0	experimental	1
DB07934	[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE	Drug	0	experimental	1
DB06603	Panobinostat	Drug	Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Enzyme Inhibitors, Amines, Cytochrome P-450 Substrates, Hydroxy Acids, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Hydroxylamines, Antineoplastic Agents, Cytochrome P-450 CYP3A4 Substrates, Moderate Risk QTc-Prolonging Agents, Hydroxamic Acids, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Histone Deacetylase Inhibitors, Indoles	approved, investigational	1
DB06602	Reslizumab	Drug	Immunoglobulins, Interleukin-5 Antagonist, Anti-Asthmatic Agents, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Respiratory System Agents, Interleukin Antagonists, Immunoproteins, Proteins, Serum Globulins, Globulins, Blood Proteins, Drugs for Obstructive Airway Diseases	approved, investigational	1
DB07933	Erteberel	Drug	Heterocyclic Compounds, Fused-Ring, Pyrans	investigational, experimental	2
DB07936	N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine	Drug	0	experimental	1
DB06605	Apixaban	Drug	Anticoagulants, Pyridines, Enzyme Inhibitors, Blood and Blood Forming Organs, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Factor Xa Inhibitors, P-glycoprotein substrates, Protease Inhibitors, Hematologic Agents, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Antithrombins, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2C8 Substrates, Serine Protease Inhibitors	approved	1
DB06604	Ilepatril	Drug	Heterocyclic Compounds, Fused-Ring, Prodrugs	investigational	0
DB07935	5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]benzene-1,3-dicarbonitrile	Drug	0	experimental	1
DB07930	(3R)-3-HYDROXYDODECANOIC ACID	Drug	0	experimental	1
DB07932	dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate	Drug	0	experimental	2
DB07931	Hexestrol	Drug	Antineoplastic Agents, Hormonal, Stilbenes, Hormones, Hormone Substitutes, and Hormone Antagonists, Thyroxine-binding globulin inducers, Estrogens, Non-Steroidal, Estrogens, Antineoplastic Agents, Benzylidene Compounds, Hormones, Benzene Derivatives	withdrawn	4
DB06600	Nemonoxacin	Drug	Cytochrome P-450 CYP1A2 Inhibitors, Fluoroquinolones, Quinolines, Heterocyclic Compounds, Fused-Ring, QTc Prolonging Agents, Anti-Bacterial Agents, Cytochrome P-450 Enzyme Inhibitors, Antiinfectives for Systemic Use, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Moderate Risk QTc-Prolonging Agents, Antibacterials for Systemic Use	investigational	0
DB06607	Catumaxomab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antineoplastic and Immunomodulating Agents, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Gastrointestinal Agents, Immunoproteins	approved, investigational, withdrawn	6
DB07938	(S)-iclaprim	Drug	0	experimental	1
DB06606	Teplizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB07937	2-butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine	Drug	0	experimental	1
DB06609	Odiparcil	Drug	Carbohydrates	investigational	0
DB06608	Tafenoquine	Drug	Quinolines, Antiprotozoals, Cytochrome P-450 Substrates, Antimalarials, MATE inhibitors, MATE 1 Inhibitors, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, OCT2 Inhibitors, MATE 2 Inhibitors, Cytochrome P-450 CYP2D6 Substrates, Antiparasitic Agents, Aminoquinolines	approved, investigational	0
DB07939	N-(3-MERCAPTOPROPANOYL)-D-ALANINE	Drug	0	experimental	1
DB06614	Peramivir	Drug	Neuraminidase, antagonists & inhibitors, Antivirals for Systemic Use, Direct Acting Antivirals, Cycloparaffins, Enzyme Inhibitors, Amidines, Antiviral Agents, Neuraminidase Inhibitors, Antiinfectives for Systemic Use, Anti-Infective Agents	approved, investigational	3
DB07945	5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid	Drug	0	experimental	0
DB07944	N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE	Drug	0	experimental	1
DB07947	ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE	Drug	0	experimental	4
DB06616	Bosutinib	Drug	Amines, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Myelosuppressive Agents, Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors, P-glycoprotein substrates with narrow therapeutic index, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Kinase Inhibitor	approved	10
DB07946	N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide	Drug	0	experimental	1
DB07941	PH-797804	Drug	Pyridines, Benzoates, Acids, Carbocyclic, Amides, p38 Mitogen-Activated Protein Kinases, antagonists & inhibitors, Benzene Derivatives	investigational	1
DB06610	Omiganan	Drug	Membrane Proteins, Proteins, Peptides, Amino Acids, Peptides, and Proteins, Pore Forming Cytotoxic Proteins	investigational	0
DB07940	9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE	Drug	0	experimental	1
DB06612	Mepolizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Interleukin-5 Antagonist, Immunosuppressive Agents, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Drugs for Obstructive Airway Diseases, Antibodies, Monoclonal, Immunoproteins	approved, investigational	1
DB07943	SD-0006	Drug	0	investigational	1
DB07942	2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine	Drug	0	experimental	1
DB06611	Pegsunercept	Drug	Receptors, Cytokine, Amino Acids, Peptides, and Proteins, Receptors, Cell Surface, Receptors, Death Domain, Recombinant Proteins, Alcohols, Macromolecular Substances, Membrane Proteins, Proteins, Receptors, Tumor Necrosis Factor, Ethylene Glycols, Pegylated agents, Receptors, Immunologic, Glycols, Polymers, Compounds used in a research, industrial, or household setting	investigational	0
DB07949	({[(3E)-2'-Oxo-2',7'-dihydro-2,3'-biindol-3(7H)-ylidene]amino}oxy)acetic acid	Drug	0	experimental	1
DB06618	Cutamesine	Drug	Receptors, sigma, agonists, Central Nervous System Agents, Carbon Radioisotopes, Nootropic Agents	investigational	0
DB06619	Amdoxovir	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purines, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Dioxoles	investigational	0
DB07950	Indoleacetic acid	Drug	Heterocyclic Compounds, Fused-Ring, Indoles, Growth Substances, Plant Growth Regulators	experimental	3
DB06625	Vipadenant	Drug	Neurotransmitter Agents, Purinergic P1 Receptor Antagonists, Purinergic Antagonists, Purinergic Agents, Adenosine A2 Receptor Antagonists	investigational	0
DB07956	[1-(3-CHLORO-2-FORMYL-PHENYLCARBAMOYL)-2-METHYL-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER	Drug	0	experimental	1
DB07955	(2-BROMOETHYL)(2-'FORMYL-4'-AMINOPHENYL) ACETATE	Drug	0	experimental	1
DB06624	Taranabant	Drug	Neurotransmitter Agents, Cannabinoid Receptor Agonists, Hormones, Hormone Substitutes, and Hormone Antagonists, Cannabinoids and similars, Hormones	investigational	0
DB07958	(2-CARBAMOYLMETHYL-5-PROPYL-OCTAHYDRO-INDOL-7-YL)ACETIC ACID	Drug	0	experimental	1
DB06626	Axitinib	Drug	Enzyme Inhibitors, Cytochrome P-450 Substrates, Tyrosine Kinase Inhibitors, Acids, Carbocyclic, Amides, Cytochrome P-450 CYP3A4 Substrates, Benzene Derivatives, OATP1B1/SLCO1B1 Inhibitors, Benzoates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Pyrazoles, Antineoplastic and Immunomodulating Agents, Indazoles, Benzamides and benzamide derivatives, Antineoplastic Agents, Cytochrome P-450 CYP2C19 Substrates, Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors, Cytochrome P-450 CYP3A Substrates, UGT1A1 Substrates, Cytochrome P-450 CYP1A2 Substrates, Receptor Tyrosine Kinase Inhibitors, OATP1B1/SLCO1B1 Substrates, P-glycoprotein inhibitors, Kinase Inhibitor	approved, investigational	3
DB07957	METHYL(2-ACETOXY-2-(2-CARBOXY-4-AMINO-PHENYL))ACETATE	Drug	0	experimental	1
DB07952	N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID	Drug	0	experimental	2
DB07951	N-(indole-3-acetyl)-L-aspartic acid	Drug	Heterocyclic Compounds, Fused-Ring, Indoles	experimental	2
DB06620	Aplindore	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB06623	Flupirtine	Drug	Pyridines, Amines, Sensory System Agents, Analgesics, Nervous System, Central Nervous System Agents, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents	investigational	1
DB07954	3-isobutyl-1-methyl-7H-xanthine	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Phosphodiesterase Inhibitors, Purines, Enzyme Inhibitors, Xanthine derivatives, Purinones	experimental	8
DB06622	7-beta-Hydroxyepiandrosterone	Drug	0	investigational	0
DB07953	N-[1H-INDOL-3-YL-ACETYL]VALINE ACID	Drug	0	experimental	2
DB06629	Zibotentan	Drug	0	investigational	0
DB07959	3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE	Drug	0	experimental	1
DB05384	Carbopol 974P	Drug	Spermatocidal Agents, Plastics, Polymers, Compounds used in a research, industrial, or household setting, Macromolecular Substances, Resins, Synthetic	investigational	0
DB04053	Hypophosphite	Drug	0	experimental	1
DB04054	9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine	Drug	0	experimental	1
DB05385	PRO 2000	Drug	Arylsulfonates, Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfur Acids, Sulfonic Acids, Arylsulfonic Acids, Compounds used in a research, industrial, or household setting, Macromolecular Substances, Naphthalenes	investigational	0
DB04055	2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium	Drug	0	experimental	1
DB05386	Regramostim	Drug	Proteins, Biological Factors, Carbohydrates, Cholinesterase Inhibitors, Cytokines, Glycoconjugates, Peptides, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Glycoproteins, Colony-Stimulating Factors, Hematopoietic Cell Growth Factors	investigational	2
DB05387	AE-941	Drug	Cartilage, Complex Mixtures	investigational	3
DB05380	DOTMP HO-166	Drug	0	investigational	0
DB05381	Histamine	Drug	OCT1 substrates, Biological Factors, Other Diagnostics, Autacoids, Inflammation Mediators, Amines, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Adjuvants, Immunologic, OCT2 Substrates, Antineoplastic and Immunomodulating Agents, Histamine Agonists, Tests for Gastric Secretion, Biogenic Monoamines, Neurotransmitter Agents, Cytochrome P-450 CYP3A Inhibitors, Imidazoles, Cytochrome P-450 CYP3A Substrates, Ethylamines, OCT2 Inhibitors, Biogenic Amines, Gastric Function, Diagnostic Agents, Histamine Agents	approved, investigational	5
DB04050	N-Propyl Isocyanide	Drug	0	experimental	1
DB05382	Iodine	Drug	Antiseptics and Disinfectants, Dermatologicals, Herbs and Natural Products, Minerals, Elements, Anti-Infective Agents, Anti-Infective Agents, Local, Trace Elements, Micronutrients, Food and Beverages, Halogens, Iodine Products, Growth Substances, Diet, Food, and Nutrition, Food, Miscellaneous Local Anti-infectives	approved, investigational	2
DB04051	5-phenylpentanoic acid	Drug	Acids, Acyclic, Valerates, Fatty Acids, Fatty Acids, Volatile, Lipids	experimental	1
DB04052	3,4-Xylenol	Drug	Agrochemicals, Benzene Derivatives	experimental	1
DB05383	Pimagedine	Drug	Enzyme Inhibitors, Nitric Oxide Synthase, antagonists & inhibitors, OCT2 Inhibitors, Amidines	investigational	3
DB04057	N-[4-([(2-Amino-4-oxo-1,4-dihydropyrido[3,2-d]pyrimidin-6-yl)methyl]{(2E)-3-[4-carbamoyl-1-(5-O-phosphono-beta-D-ribofuranosyl)-1H-imidazol-5-yl]-2-propenoyl}amino)benzoyl]-L-glutamic acid	Drug	0	experimental	1
DB04058	N-Carbamoylphenylalanine	Drug	0	experimental	2
DB05389	Tetrachlorodecaoxide	Drug	Radiation-Protective Agents, Gases, Anions, Protective Agents, Halogens, Electrolytes, Ions, Elements, Compounds used in a research, industrial, or household setting, Oxygen Compounds	approved, investigational	2
DB04059	8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide	Drug	0	experimental	1
DB05390	INS 316	Drug	0	investigational	1
DB04064	Nogalaviketone	Drug	0	experimental	1
DB05395	Amibegron	Drug	Adrenergic beta-Agonists, Neurotransmitter Agents, Central Nervous System Depressants, Adrenergic Agonists, Agents that produce hypertension, Agents producing tachycardia, Antidepressive Agents, Adrenergic Agents, Naphthalenes	investigational	1
DB05396	Albinterferon Alfa-2B	Drug	Biological Factors, Cytochrome P-450 Enzyme Inhibitors, Cytokines, Peptides, Adjuvants, Immunologic, Interferons, Antineoplastic and Immunomodulating Agents, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Interferon Type I, Cytochrome P-450 CYP1A2 Inhibitors, Proteins	investigational	0
DB04065	N-Cyclopentyl-N-Cyclobutylformamide	Drug	0	experimental	1
DB04066	p-Coumaric acid	Drug	Acids, Acyclic, Contraceptive Agents, Male, Fatty Acids, Protective Agents, Adrenal Cortex Hormones, Reproductive Control Agents, Free Radical Scavengers, Lipids, Anti-Infective Agents, Antioxidants, Fatty Acids, Volatile, Compounds used in a research, industrial, or household setting, Hormonal Contraceptives for Systemic Use	experimental	4
DB05398	C31G	Drug	Amines, Ammonium Compounds, Fatty Acids, Quaternary Ammonium Compounds, Trimethyl Ammonium Compounds, Lipids, Onium Compounds, Nitrogen Compounds	investigational	2
DB04067	4-hydroxybenzyl coenzyme A	Drug	0	experimental	2
DB04060	(5-methyl-6-oxo-1,6-dihydro-pyridin-3-yl)-1,2-dideoxy-ribofuranose-5-monophosphate	Drug	0	experimental	0
DB05391	liposomal prostaglandin E1	Drug	0	investigational	1
DB04061	Alpha-Amino-2-Indanacetic Acid	Drug	0	experimental	0
DB04062	beta-D-fucose	Drug	0	experimental	2
DB05393	NOV-002	Drug	Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins, Pharmaceutical Preparations, Chlorine Compounds, Nitrogen Compounds	investigational	0
DB04063	alpha-Methylleucine	Drug	0	experimental	1
DB05394	Corticorelin	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Amino Acids, Peptides, and Proteins, Neuropeptides, Tests for Pituitary Function, Nerve Tissue Proteins, Hormones, Pituitary Hormone-Releasing Hormones, Corticotropin-Releasing Hormone, Proteins, Peptide Hormones, Corticotropin-Releasing Hormone, antagonists & inhibitors, Hypothalamic Hormones, Diagnostic Agents	investigational	0
DB05399	Succinobucol	Drug	Phenols, Benzene Derivatives	investigational	1
DB04068	2',3'-dideoxy-3'-fluoro-urididine-5'-diphosphate	Drug	0	experimental	1
DB04069	5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine	Drug	0	experimental	1
DB04070	6-Deoxyerythronolide B	Drug	Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Lactones	experimental	1
DB04075	N-Acetyl-L-Glutamate	Drug	0	experimental	2
DB04076	Hypoxanthine	Drug	Heterocyclic Compounds, Fused-Ring, Purines, Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 Substrates, Xanthine derivatives, Purinones	experimental	1
DB04071	Cpad	Drug	0	experimental	1
DB04072	Alpha-Methylisocitric Acid	Drug	0	experimental	1
DB04073	N-{3-[4-(3-amino-propyl)-piperazin-1-yl]-propyl}-3-nitro-5-(galactopyranosyl)-beta-benzamide	Drug	0	experimental	1
DB04074	alpha-Ketoisovalerate	Drug	Valerates, Pentanoic Acids	experimental	4
DB04079	Heptane-1,2,3-Triol	Drug	Lipids, Alcohols	experimental	3
DB04080	RU78191	Drug	0	experimental	1
DB04081	(4s-Trans)-4-(Methylamino)-5,6-Dihydro-6-Methyl-4h-Thieno(2,3-B)Thiopyran-2-Sulfonamide-7,7-Dioxide	Drug	0	experimental	1
DB04086	2',4'-Dinitrophenyl-2deoxy-2-Fluro-B-D-Cellobioside	Drug	0	experimental	1
DB04087	Open Form of 2'-Deoxy-Ribofuranose-5'-Phosphate	Drug	0	experimental	2
DB04088	2-[{4-[(2S)-2-{[(Allyloxy)carbonyl]amino}-3-({4-[3-hydroxy-2-(methoxycarbonyl)phenoxy]butyl}amino)-3-oxopropyl]phenyl}(carboxycarbonyl)amino]benzoic acid	Drug	0	experimental	1
DB04089	AL5300	Drug	0	experimental	1
DB04082	Decyloxy-Methanol	Drug	0	experimental	2
DB04083	N(6)-(pyridoxal phosphate)-L-lysine	Drug	0	experimental	11
DB04084	2-deoxy-2-fluoro-α-D-mannose	Drug	0	experimental	1
DB04085	Bis(N-maleimidomethyl)ether	Drug	Acids, Acyclic, Maleates, Dicarboxylic Acids, Imides	experimental	1
DB05340	ATL-2502	Drug	0	investigational	0
DB04010	2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide	Drug	0	experimental	1
DB04011	2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole	Drug	0	experimental	0
DB06674	Golimumab	Drug	Immunoglobulins, Biologics for Rheumatoid Arthritis Treatment, Immunosuppressive Agents, Tumor Necrosis Factor Alpha (TNF-α) Inhibitors, Antineoplastic and Immunomodulating Agents, Antibodies, Antirheumatic Agents, Amino Acids, Peptides, and Proteins, Agents reducing cytokine levels, Antibodies, Monoclonal, Disease-modifying Antirheumatic Agents, Immunoproteins, Proteins, Serum Globulins, Globulins, Blood Proteins, Tumor Necrosis Factor Receptor Blocking Activity, Tumor Necrosis Factor Blocker	approved	1
DB05343	Arundic acid	Drug	Acids, Acyclic, Fatty Acids, Lipids	investigational	1
DB04012	(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Leucine	Drug	0	experimental	1
DB06673	Almorexant	Drug	Acids, Acyclic, Heterocyclic Compounds, Fused-Ring, Fatty Acids, Fatty Acids, Volatile, Amides, Lipids, Acetates	investigational	0
DB06670	Odanacatib	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, P-glycoprotein substrates, Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP3A4 Substrates, Benzene Derivatives	investigational	1
DB04017	Clorgiline	Drug	Enzyme Inhibitors, Amines, Monoamine Oxidase A Inhibitors, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Agents that produce hypertension, Monoamine Oxidase Inhibitors, Antidepressive Agents, Central Nervous System Agents, Psychotropic Drugs, Propylamines	experimental	1
DB04018	S-Isopropyl-Isothiourea	Drug	0	experimental	1
DB06679	Amediplase	Drug	Anticoagulants, Biological Factors, Enzymes, Plasminogen Activators, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Fibrinolytic Agents, Proteins, Blood Proteins, Serine Proteases, Hydrolases, Agents causing angioedema, Peptide Hydrolases, Serine Endopeptidases, Endopeptidases	investigational	0
DB05344	Ciliary neurotrophic factor	Drug	Proteins, Biological Factors, Peptides, Nerve Growth Factors, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Nerve Tissue Proteins	investigational	0
DB04013	1-Deoxy-1-methoxycarbamido-beta-D-gluco-2-heptulopyranosonamide	Drug	0	experimental	1
DB05345	SO-101	Drug	0	investigational	1
DB04014	Alsterpaullone	Drug	CDC2 Protein Kinase, Heterocyclic Compounds, Fused-Ring, Cyclin B	experimental	3
DB05346	WL-1002	Drug	0	investigational	0
DB04015	Methionine Phosphinate	Drug	0	experimental	2
DB06678	Esmirtazapine	Drug	Tranquilizing Agents, Cytochrome P-450 Substrates, Serotonin Agents, Adrenergic alpha-Antagonists, Dibenzazepines, Serotonin 5-HT3 Receptor Antagonists, Antidepressive Agents, Psychotropic Drugs, Antidepressive Agents, Tetracyclic, Serotonin 5-HT2 Receptor Antagonists, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Histamine H1 Antagonists, Histamine Antagonists, Central Nervous System Depressants, Adrenergic Antagonists, Agents that produce hypertension, Anti-Anxiety Agents, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Adrenergic alpha-2 Receptor Antagonists, Histamine Agents, Adrenergic Agents	investigational	3
DB06677	Clazosentan	Drug	Sulfur Compounds, Amides, Receptor, Endothelin A, Vasospasm, Intracranial, Sulfones	investigational	1
DB04016	2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid	Drug	0	experimental	2
DB04020	4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol	Drug	0	experimental	1
DB06683	Clevudine	Drug	Carbohydrates, Ribonucleosides, Pyrimidine Nucleosides, Arabinonucleosides, Antiviral Agents, Antiinfectives for Systemic Use, Anti-Infective Agents, Antivirals for Systemic Use, Direct Acting Antivirals, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides	investigational	0
DB05351	Dexlansoprazole	Drug	Pyridines, Benzimidazoles, Enzyme Inhibitors, Proton-pump Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Proton Pump Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors, Sulfoxides, Anti-Ulcer Agents, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C19 Substrates, Heterocyclic Compounds, Fused-Ring, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Gastric Acid Lowering Agents, Sulfur Compounds, Cytochrome P-450 CYP3A Substrates, Alimentary Tract and Metabolism, Acid Reducers, 2-Pyridinylmethylsulfinylbenzimidazoles, Cytochrome P-450 CYP2C19 Inhibitors (weak), Drugs for Acid Related Disorders, Gastrointestinal Agents	approved, investigational	3
DB06682	Naproxcinod	Drug	Nitric Oxide Donors, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Musculo-Skeletal System, Propionates, Cardiovascular Agents, Naphthaleneacetic Acids, Naphthalenes	investigational	0
DB04021	MF268	Drug	0	experimental	1
DB05352	Fx-1006A	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB04022	Guanosine tetraphosphate	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Guanine Nucleotides, Nucleotides	experimental	2
DB06685	Laquinimod	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Nervous System, Cytochrome P-450 CYP3A4 Substrates	investigational	0
DB05353	CMC 001	Drug	0	investigational	0
DB06684	Vilazodone	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Serotonin 5-HT1 Receptor Agonists, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Benzofurans, Serotonin Modulators, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Indoles, Piperazines, Serotonin Receptor Agonists, Psychotropic Drugs, Membrane Transport Modulators, Cytochrome P-450 CYP2C19 Substrates, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Neurotransmitter Uptake Inhibitors, Agents that produce hypertension, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Psychoanaleptics	approved	2
DB04023	GDP-alpha-D-mannuronic acid	Drug	0	experimental	1
DB06681	Belatacept	Drug	Immunologic Factors, Immunosuppressive Agents, Noxae, Antineoplastic and Immunomodulating Agents, CD86-directed Antibody Interactions, Antibodies, Antirheumatic Agents, Amino Acids, Peptides, and Proteins, CD80-directed Antibody Interactions, Selective Immunosuppressants, Immunoproteins, Proteins, Serum Globulins, Globulins, Immunoconjugates, Blood Proteins, T Lymphocyte Costimulation Activity Blockade, Selective T Cell Costimulation Blocker, Toxic Actions	approved, investigational	2
DB06680	Asoprisnil	Drug	Amines, Estranes, Hydroxylamines, Fused-Ring Compounds, Steroids	investigational	1
DB04028	Tyvelose	Drug	Carbohydrates, Monosaccharides	experimental	1
DB04029	Phenylalanylamide	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Amino Acids, Essential, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	3
DB04024	Serine-3'-aminoadenosine	Drug	0	experimental	1
DB04026	Pseudotropine	Drug	Alkaloids, Aza Compounds, Azabicyclo Compounds	experimental	0
DB06689	Ethanolamine oleate	Drug	Fatty Acids, Lipids, Cardiovascular Agents, Fatty Acids, Monounsaturated, Sclerosing Agents for Local Injection, Pharmaceutical Solutions, Vasoprotectives, Fatty Acids, Unsaturated, Solutions, Sclerosing Solutions, Antivaricose Therapy, Pharmaceutical Preparations, Compounds used in a research, industrial, or household setting	approved	2
DB04027	D-arginine	Drug	0	experimental	1
DB06688	Sipuleucel-T	Drug	Cell-mediated Immunity, Complex Mixtures, Autologous Cellular Immunotherapy, Adjuvants, Immunologic, Antineoplastic and Immunomodulating Agents, Cancer Vaccines, Intercellular Adhesion Molecule-1	approved, investigational	1
DB05362	SSR-126517E	Drug	0	investigational	1
DB06694	Xylometazoline	Drug	Adrenergic alpha-Agonists, Adrenergic alpha-1 Receptor Agonists, Nasal Decongestants, Agents producing tachycardia, Cardiovascular Agents, Respiratory System Agents, Decongestants and Antiallergics, Ophthalmologicals, Calcium Channel Blockers, Adrenergic alpha-2 Receptor Agonists, Nasal Preparations, Vasoconstrictor Agents, Adrenergic Agonists, Sympathomimetics, Plain, Agents that produce hypertension, Antihistamine Drugs, Sensory Organs, Vasodilating Agents, Sympathomimetics Used as Decongestants, Antiarrhythmic agents	approved, investigational	6
DB04031	Serine vanadate	Drug	Vanadates	experimental	1
DB06693	Mevastatin	Drug	Lipid Regulating Agents, Anticholesteremic Agents, Enzyme Inhibitors, Hypolipidemic Agents, Noxae, Agents Causing Muscle Toxicity, Toxic Actions, Antifungal Agents, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Anti-Infective Agents, Naphthalenes	experimental	1
DB04032	Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Butyl-Amide	Drug	0	experimental	1
DB05363	LIC-477	Drug	0	investigational	0
DB06696	Arbekacin	Drug	Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Nephrotoxic agents, Carbohydrates, Anti-Bacterial Agents, Narrow Therapeutic Index Drugs, Aminoglycoside Antibacterials, Glycosides, Agents that produce neuromuscular block (indirect), Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use, Drugs that are Mainly Renally Excreted	investigational, experimental	1
DB04033	Z-Ala Prolinal	Drug	0	experimental	1
DB05364	ROX-888	Drug	0	investigational	1
DB06695	Dabigatran etexilate	Drug	Anticoagulants, Pyridines, Benzimidazoles, Enzyme Inhibitors, Blood and Blood Forming Organs, P-glycoprotein substrates, Protease Inhibitors, Hematologic Agents, Drugs that are Mainly Renally Excreted, Heterocyclic Compounds, Fused-Ring, Antithrombins, UGT2B7 substrates, UGT1A9 Substrates, Serine Protease Inhibitors	approved	1
DB04034	Ribulose-5-Phosphate	Drug	0	experimental	1
DB06690	Nitrous oxide	Drug	Analgesics, Non-Narcotic, Anesthetics, Inhalation, Sensory System Agents, Nervous System, Ions, Oxides, Anesthetics, Peripheral Nervous System Agents, Gases, Anesthetics, General, Anions, Analgesics, Central Nervous System Depressants, Agents that produce hypertension, Electrolytes, Central Nervous System Agents, Methemoglobinemia Associated Agents, Nitrogen Compounds, Nitrogen Oxides, Oxygen Compounds	approved, vet_approved	0
DB06692	Aprotinin	Drug	Enzyme Inhibitors, Blood and Blood Forming Organs, Cholinesterase Inhibitors, Protease Inhibitors, Amino Acids, Peptides, and Proteins, Hematologic Agents, Coagulants, Antifibrinolytic Agents, Proteins, Hemostatics, Decreased Fibrinolysis, Proteinase Inhibitors, Serine Protease Inhibitors, Trypsin Inhibitors	approved, investigational, withdrawn	4
DB04030	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	Drug	0	experimental	1
DB06691	Mepyramine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Aminopyridines, Pyridines, QTc Prolonging Agents, Amines, Anti-Allergic Agents, Cytochrome P-450 Enzyme Inhibitors, Antihistamines for Topical Use, Sleep Aids, Pharmaceutical, Dermatologicals, Neurotransmitter Agents, Histamine H1 Antagonists, Antipruritics, Incl. Antihistamines, Anesthetics, Etc., Histamine Antagonists, Central Nervous System Depressants, Potential QTc-Prolonging Agents, Hypnotics and Sedatives, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Histamine Agents, Antihistamines for Systemic Use, Substituted Ethylene Diamines	approved, vet_approved	1
DB05361	SR-123781A	Drug	0	investigational	2
DB04039	3-Oxo-Pentadecanoic Acid	Drug	0	experimental	3
DB04035	Ceftazidime BATSI	Drug	0	experimental	3
DB06698	Betahistine	Drug	Neurotransmitter Agents, Pyridines, Miscellaneous Therapeutic Agents, Histamine Antagonists, Antivertigo Preparations, Nervous System, Histamine Agonists, Miscellaneous Central Nervous System Agents, Cardiovascular Agents, Histamine Agents, Vasodilating Agents	approved, investigational	2
DB06697	Artemether	Drug	Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Cytochrome P-450 Substrates, Reactive Oxygen Species, Cytochrome P-450 CYP3A Inducers, Antimalarials, Oxides, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Anions, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C19 Inducers, Cytochrome P-450 CYP2B6 Inducers (weak), Sesquiterpenes, Cytochrome P-450 CYP2B6 Inducers, Peroxides, Oxygen Compounds, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Cytochrome P-450 CYP3A5 Substrates, Free Radicals, Cytochrome P-450 CYP3A4 Inducers, Ions, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A4 Inducers (weak), Artemisinins, Cytochrome P-450 CYP3A Substrates, Artemisinin and Derivatives, Plain, Electrolytes, Cytochrome P-450 CYP2B6 Substrates, Terpenes, Antiparasitic Agents	approved	0
DB04036	Coenzyme A persulfide	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Coenzymes, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Enzymes and Coenzymes, Glycosides, Nucleotides, Adenine Nucleotides	experimental	1
DB05367	Actelion-1	Drug	Sulfur Compounds, Endothelin A Receptor Antagonists, Amides, Endothelin B Receptor Antagonists, Endothelin Receptor Antagonists, Sulfones	investigational	1
DB04037	N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine	Drug	0	experimental	2
DB05368	Ragweed pollen extract	Drug	0	approved, investigational	0
DB06699	Degarelix	Drug	Endocrine Therapy, Gonadotropin-releasing Hormone Antagonists, QTc Prolonging Agents, Gonadotropin-Releasing Hormone, antagonists & inhibitors, Peptides, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Potential QTc-Prolonging Agents, Hormone Antagonists and Related Agents	approved	1
DB05369	HZT-501	Drug	0	investigational	1
DB04038	Ergosterol	Drug	Cholestanes, Micronutrients, Physiological Phenomena, Provitamins, Food and Beverages, Cholestenes, Growth Substances, Diet, Food, and Nutrition, Fused-Ring Compounds, Vitamins, Food, Steroids	approved, experimental	0
DB04042	2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol	Drug	0	experimental	1
DB05374	Rindopepimut	Drug	Antineoplastic Agents, Immunological, Complex Mixtures, Antineoplastic Agents, Biological Products, Vaccines	investigational	1
DB04043	Carboxymycobactin T	Drug	0	experimental	1
DB04044	4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid	Drug	0	experimental	1
DB04045	(R)-methylmalonyl-CoA	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Coenzymes, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Thioesters of coenzyme A, Enzymes and Coenzymes, Glycosides, Nucleotides, Adenine Nucleotides	experimental	1
DB04040	N-[1,3-Di(4-morpholinyl)-2-propanyl]-3-(α-D-galactopyranosyloxy)-5-nitrobenzamide	Drug	0	experimental	1
DB05371	ACR-16	Drug	0	investigational	0
DB04041	Nitrocefin Acyl-Serine	Drug	0	experimental	1
DB04046	Methyl beta-galactoside	Drug	Galactosides, Carbohydrates, Methylglycosides, Glycosides	experimental	0
DB05377	Chlorfenson	Drug	Arylsulfonates, Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfur Acids, Sulfonic Acids, Arylsulfonic Acids, Benzene Derivatives	investigational	0
DB04047	6-hydroxymethylpterin diphosphate	Drug	Heterocyclic Compounds, Fused-Ring	experimental	2
DB04048	N-Carbamoyl-Alanine	Drug	0	experimental	1
DB04049	Coelenteramide	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Amides, Lipids, Acetamides, Acetates, Benzene Derivatives	experimental	0
DB04090	RH-1	Drug	0	investigational, experimental	1
DB04092	Apstatin	Drug	Amino Acids, Peptides, and Proteins	experimental	1
DB04097	Uridine-5'-diphosphate-4-deoxy-4-fluoro-alpha-D-galactose	Drug	0	experimental	1
DB04098	Balanol	Drug	Benzoates, Hydroxy Acids, Acids, Carbocyclic, Phenols, Cyclic AMP-Dependent Protein Kinases, antagonists & inhibitors, Benzene Derivatives, Protein Kinase C, antagonists & inhibitors	experimental	1
DB04099	Deamido-Nad+	Drug	0	experimental	6
DB04093	Undecanal	Drug	0	experimental	0
DB04094	4-hydroxybutan-2-one	Drug	Ketones	experimental	1
DB04095	9-Deazahypoxanthine	Drug	Heterocyclic Compounds, Fused-Ring, Purines, Purinones	experimental	1
DB04096	(2R,3R,4R,5R)-4,5-Dihydroxy-2-(hydroxymethyl)-6-oxo-3-piperidinyl beta-D-glucopyranoside	Drug	0	experimental	0
DB06702	Fesoterodine	Drug	Cytochrome P-450 Substrates, P-glycoprotein substrates, Drugs for Urinary Frequency and Incontinence, Genito Urinary System and Sex Hormones, Urologicals, Agents producing tachycardia, Muscarinic Antagonists, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Anticholinergic Agents, Urological Agents, Neurotransmitter Agents, Cholinergic Agents, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2D6 Substrates, Benzene Derivatives	approved	5
DB06701	Dexmethylphenidate	Drug	Central Nervous System Stimulants, Serotonin Agents, Nervous System, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Methylphenidate and isomer, Psychostimulants, Agents Used for Adhd and Nootropics, Antidepressive Agents, Central Nervous System Stimulation, Membrane Transport Modulators, Centrally Acting Sympathomimetics, Neurotransmitter Agents, Serotonin Modulators, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Neurotransmitter Uptake Inhibitors, Piperidines, Agents that produce hypertension, Phenylacetates, Central Nervous System Agents, Dopamine Agents, Dopamine Uptake Inhibitors, Psychoanaleptics	approved, investigational	3
DB06704	Iobenguane	Drug	Enzyme Inhibitors, Iodobenzenes, Therapeutic Radiopharmaceuticals, Iodine (131I) Compounds, Laboratory Chemicals, Amidines, Hydrocarbons, Halogenated, Radiopharmaceutical Activity, Guanidines, Diagnostic Uses of Chemicals, Tumour Detection, Diagnostic Radiopharmaceuticals, Radioactive Diagnostic Agent, Indicators and Reagents, Radiopharmaceuticals, Compounds used in a research, industrial, or household setting, Benzene Derivatives, Hydrocarbons, Iodinated	approved, investigational	0
DB06703	Gadobutrol	Drug	Magnetic Resonance Imaging Contrast Media, Other Diagnostics, Paramagnetic Contrast Media, Contrast Media, Diagnostic Uses of Chemicals, Magnetic Resonance Contrast Activity, Compounds used in a research, industrial, or household setting, Gadolinium-based Contrast Agent	approved	0
DB06700	Desvenlafaxine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 Substrates, Serotonin Agents, Cyclohexanols, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Hypoglycemia-Associated Agents, Lipids, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Alcohols, Cyclohexanes, Serotonin Modulators, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Norepinephrine Uptake Inhibitors, Benzene Derivatives, Fatty Alcohols, Agents that reduce seizure threshold, Selective Serotonin Reuptake Inhibitors, Cycloparaffins, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Agents producing tachycardia, Psychotropic Drugs, Membrane Transport Modulators, Neurotransmitter Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Hexanols, Central Nervous System Depressants, Neurotransmitter Uptake Inhibitors, Serotonin and Noradrenaline Reuptake Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Phenols, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Inhibitors (weak), Psychoanaleptics	approved, investigational	3
DB06709	Methacholine	Drug	Autonomic Agents, Other Diagnostics, Amines, Ammonium Compounds, Cholinergic Agonists, Cholinergic Receptor Agonist, Quaternary Ammonium Compounds, Parasympathomimetics, Miotics, Trimethyl Ammonium Compounds, Onium Compounds, Respiratory System Agents, Peripheral Nervous System Agents, Muscarinic Agonists, Neurotransmitter Agents, Cholinergic Agents, Bronchoconstrictor Agents, Methacholine Compounds, Nitrogen Compounds	approved, investigational	1
DB06706	Isometheptene	Drug	Adrenergic alpha-Agonists, Amines, Alimentary Tract and Metabolism, Adrenergic Agonists, Agents that produce hypertension, Adrenergic alpha-1 Receptor Agonists, Agents producing tachycardia, Drugs for Functional Gastrointestinal Disorders, Methemoglobinemia Associated Agents	approved	2
DB06705	Gadofosveset trisodium	Drug	Magnetic Resonance Imaging Contrast Media, Lanthanoid Series Elements, Metals, Magnetic Resonance Angiography, Paramagnetic Contrast Agent, Elements, Drugs that are Mainly Renally Excreted, Paramagnetic Contrast Media, Contrast Media, Diagnostic Uses of Chemicals, Magnetic Resonance Contrast Activity, Compounds used in a research, industrial, or household setting, Metals, Rare Earth, Gadolinium-based Contrast Agent	approved	0
DB06708	Lumefantrine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Fluorenes, Antimalarials, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Antiparasitic Agents	approved	0
DB06707	Levonordefrin	Drug	Amines, Epinephrine and similars, Agents producing tachycardia, Catecholamines, Catechols, Cardiovascular Agents, Amino Alcohols, Ethanolamines, Biogenic Monoamines, Alcohols, Vasoconstrictor Agents, Adrenergic Agonists, Agents that produce hypertension, Biogenic Amines, Phenols, Benzene Derivatives	approved	1
DB06751	Drotaverine	Drug	Autonomic Agents, Benzylisoquinolines, Sensory System Agents, Isoquinolines, Papaverine and Derivatives, Parasympatholytics, Cardiovascular Agents, Peripheral Nervous System Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Opiate Alkaloids, Analgesics, Alimentary Tract and Metabolism, Drugs for Functional Gastrointestinal Disorders, Central Nervous System Agents, Vasodilating Agents	approved, investigational	2
DB06750	Ginsenoside Rg1	Drug	Carbohydrates, Panax, Saponins, Triterpenes, Drugs, Chinese Herbal, Glycosides, Central Nervous System Agents, Terpenes	nutraceutical	1
DB05420	Gallium maltolate	Drug	Gallium, Pyrans	investigational	1
DB06757	Manganese	Drug	Sulfur Acids, Metals, Ions, Metals, Heavy, Minerals, Paramagnetic Contrast Agent, Elements, Transition Elements, Sulfuric Acids, Trace Elements, Micronutrients, Anions, Sulfur Compounds, Acids, Noncarboxylic, Magnetic Resonance Contrast Activity, Physiological Phenomena, Acids, Replacement Preparations, Food and Beverages, Electrolytes, Growth Substances, Chlorine Compounds, Diet, Food, and Nutrition, Food	approved, nutraceutical	5
DB05426	Talactoferrin alfa	Drug	Glycoconjugates, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Recombinant Proteins, Whey, Proteins, Transferrins, Physiological Phenomena, Lactoglobulins, Milk Proteins, Dietary Proteins, Food and Beverages, Serine Proteases, Whey Proteins, Serine Endopeptidases, Beverages, Iron-Binding Proteins, Diet, Food, and Nutrition, Fluids and Secretions, Bodily Secretions, Carrier Proteins, Dairy Products, Food, Carbohydrates, Enzymes, Antineoplastic Agents, Glycoproteins, Metalloproteins, Milk components, Globulins, Hydrolases, Peptide Hydrolases, Endopeptidases	investigational	0
DB06756	Glycine betaine	Drug	Hypolipidemic Agents, Amines, Ammonium Compounds, Cholinesterase Inhibitors, Noxae, Quaternary Ammonium Compounds, Other Miscellaneous Therapeutic Agents, Trimethyl Ammonium Compounds, Onium Compounds, Methylating Activity, Lipid Regulating Agents, Alimentary Tract and Metabolism, Amino Acids and Derivatives, Methylating Agent, Digestives, Incl. Enzymes, Toxic Actions, Lipotropic Agents, Acid Preparations, Nitrogen Compounds, Gastrointestinal Agents	approved, nutraceutical	1
DB06759	Fomivirsen	Drug	Molecular Probes, Antisense Elements (Genetics), Carbohydrates, Oligonucleotides, Antisense, Laboratory Chemicals, Oligonucleotides, Antiviral Agents, Nucleic Acid Probes, Nucleotides, Anti-Infective Agents, Nucleic Acids, Polynucleotides, Ophthalmologicals, Sulfur Compounds, Diagnostic Uses of Chemicals, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Sensory Organs, Compounds used in a research, industrial, or household setting	approved, investigational, withdrawn	2
DB05427	IDD-3	Drug	0	investigational	0
DB05428	Motexafin gadolinium	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Contrast Media, Diagnostic Uses of Chemicals, Photosensitizing Agents, Dermatologicals, Antineoplastic Agents, Compounds used in a research, industrial, or household setting, Radiation-Sensitizing Agents, Pigments, Biological, Porphyrins	investigational	3
DB06753	Triclofos	Drug	Psycholeptics, Nervous System, Central Nervous System Depressants, Organophosphorus Compounds, Hypnotics and Sedatives	approved, withdrawn	0
DB05421	CP-122721	Drug	0	investigational	1
DB05422	OPC-14523	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring	investigational	1
DB06752	Chymopapain	Drug	Cysteine Endopeptidases, Enzymes, Cysteine Proteases, Musculo-Skeletal System, Enzymes and Coenzymes, Hydrolases, Peptide Hydrolases, Endopeptidases	approved, withdrawn	1
DB05423	ORG-34517	Drug	Heterocyclic Compounds, Fused-Ring, Receptors, Glucocorticoid, antagonists & inhibitors, Dioxoles, Fused-Ring Compounds	investigational	1
DB06755	Beta carotene	Drug	Provitamins, Alkenes, Cyclohexenes, Protectives Against UV-Radiation for Systemic Use, Emollients and Protectives, Cyclohexanes, Vitamin A, Carotenoids, Physiological Phenomena, Protectives Against UV-Radiation, Alimentary Tract and Metabolism, Food and Beverages, Polyenes, Growth Substances, Diet, Food, and Nutrition, Food, Biological Factors, Cycloparaffins, Dermatologicals, Hydrocarbons, Acyclic, Vitamins, Pigments, Biological, Micronutrients, Vitamins (Fat Soluble), Terpenes	approved, nutraceutical	1
DB05424	Canertinib	Drug	Cardiotonic Agents, Acids, Acyclic, Oxazines, Sensory System Agents, Tyrosine Kinase Inhibitors, Protective Agents, Antineoplastic Agents, Cardiovascular Agents, Central Nervous System Agents, Anesthetics, Compounds used in a research, industrial, or household setting, Peripheral Nervous System Agents	investigational	1
DB06754	Danaparoid	Drug	Anticoagulants, Carbohydrates, Blood and Blood Forming Organs, Glycosaminoglycans, Fibrin Modulating Agents, Agents causing hyperkalemia, Hematologic Agents, Cardiovascular Agents, Fibrinolytic Agents, Chondroitin, Heparinoids, Polysaccharides, Heparin and similars	approved, withdrawn	1
DB05429	CAT-213	Drug	0	investigational	1
DB06760	Sacrosidase	Drug	Enzymes, Glycoside Hydrolases, Alimentary Tract and Metabolism, Enzymes and Coenzymes, Hydrolases, Sucrose-specific Enzyme	approved	0
DB05430	VLTS-589	Drug	0	investigational	0
DB06762	Pinacidil	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Guanidine Derivatives, Arteriolar Smooth Muscle, Agents Acting On, Amidines, Cardiovascular Agents, Guanidines, Antihypertensive Agents, Cytochrome P-450 CYP3A4 Substrates, Vasodilating Agents, Membrane Transport Modulators	approved	0
DB04100	(1,10 Phenanthroline)-(Tri-Carbon Monoxide) Rhenium (I)	Drug	0	experimental	1
DB05431	MLN-977	Drug	0	investigational	1
DB06761	Beractant	Drug	Surface-Active Agents, Surfactant Activity, Complex Mixtures, Alveolar Surface Tension Reduction, Respiratory System Agents, Bradycardia-Causing Agents, Pulmonary Surfactants	approved	0
DB06768	Ammonium lactate	Drug	alpha-Hydroxy Acid	approved	0
DB04105	N-Heptylformamide	Drug	0	experimental	1
DB04106	Fotemustine	Drug	Alkylating Drugs, Nitroso Compounds, Nitrosoureas, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents	investigational	1
DB06767	Ammonium chloride	Drug	Ammonium Compounds, Blood and Blood Forming Organs, Agents causing hyperkalemia, Genito Urinary System and Sex Hormones, Urologicals, Ions, Blood Substitutes and Perfusion Solutions, Electrolyte Solutions, Drugs that are Mainly Renally Excreted, Anions, Acids, Noncarboxylic, I.V. Solution Additives, Acids, Acidifiers, Chlorides, Electrolytes, Urinary Acidifying Agents, Acidifying Agents, Chlorine Compounds, Nitrogen Compounds	approved, investigational, vet_approved	0
DB05437	NAV 1800	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB04107	[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester	Drug	0	experimental	1
DB05438	IDM-4	Drug	0	investigational	0
DB04108	(2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide	Drug	0	experimental	1
DB06769	Bendamustine	Drug	Acids, Acyclic, Benzimidazoles, Cytochrome P-450 Substrates, Fatty Acids, Immunosuppressive Agents, Noxae, Antineoplastic and Immunomodulating Agents, Nitrogen Mustard Analogues, Alkylating Activity, Antineoplastic Agents, Hydrocarbons, Halogenated, Lipids, Mustard Compounds, Nitrogen Mustard Compounds, Myelosuppressive Agents, Alkylating Drugs, Heterocyclic Compounds, Fused-Ring, Narrow Therapeutic Index Drugs, Butyrates, Fatty Acids, Volatile, Cytochrome P-450 CYP1A2 Substrates, Toxic Actions, P-glycoprotein substrates with narrow therapeutic index, Antineoplastic Agents, Alkylating	approved, investigational	0
DB05439	IDD-1	Drug	0	investigational	0
DB05432	DAS-431 IV	Drug	0	investigational	1
DB04101	N'-[4-(2,4-Dimethyl-1,3-thiazol-5-yl)-2-pyrimidinyl]-N-hydroxyimidoformamide	Drug	0	experimental	1
DB06764	Tetryzoline	Drug	Autonomic Agents, Adrenergic alpha-Agonists, Adrenergic alpha-1 Receptor Agonists, Nasal Decongestants, Agents producing tachycardia, Cardiovascular Agents, Respiratory System Agents, Decongestants and Antiallergics, Pharmaceutical Solutions, Peripheral Nervous System Agents, Ophthalmologicals, Nasal Preparations, Solutions, Sympathomimetics, Vasoconstrictor Agents, Adrenergic Agonists, Sympathomimetics, Plain, Agents that produce hypertension, Ophthalmic Solutions, Pharmaceutical Preparations, Sensory Organs, Compounds used in a research, industrial, or household setting, Sympathomimetics Used as Decongestants	approved	1
DB05433	rGLP-1	Drug	Proteins, Peptide Hormones, Glucagon-Like Peptides, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Gastrointestinal Hormones, Pancreatic Hormones, Protein Precursors, Amino Acids, Peptides, and Proteins, Hormones, Recombinant Fusion Proteins, Proglucagon	investigational	0
DB06763	Saralasin	Drug	Biological Factors, Autacoids, Inflammation Mediators, Hormones, Hormone Substitutes, and Hormone Antagonists, Oligopeptides, Peptides, Angiotensin Receptor Antagonists, Agents causing hyperkalemia, Angiotensins, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Hormones, Proteins, Peptide Hormones, Agents that produce hypertension, Agents Acting on the Renin-Angiotensin System	investigational	0
DB04102	2-Amino-Adenosine	Drug	0	experimental	0
DB04103	3-Methylcytosine	Drug	Pyrimidines, Pyrimidinones	experimental	1
DB05434	ABT-510	Drug	Peptides, Amino Acids, Peptides, and Proteins	investigational	4
DB06766	Alcaftadine	Drug	Ophthalmologicals, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, QTc Prolonging Agents, Histamine H1 Antagonists, Histamine Antagonists, Potential QTc-Prolonging Agents, Sensory Organs, Histamine Agents, Decongestants and Antiallergics, Drugs that are Mainly Renally Excreted	approved	1
DB04104	3-Methyladenine	Drug	Heterocyclic Compounds, Fused-Ring, Purines	experimental	1
DB04109	[4-(1,3,2-Dioxaborolan-2-Yloxy)Methyl]Benzamidine	Drug	0	experimental	1
DB06771	Besifloxacin	Drug	Fluoroquinolones, Quinolines, QTc Prolonging Agents, Quinolone Antimicrobial, Enzyme Inhibitors, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Antineoplastic Agents, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Moderate Risk QTc-Prolonging Agents, Anti-Infective Agents, Quinolones, Cytochrome P-450 CYP1A2 Inhibitors, Ophthalmologicals, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Topoisomerase II Inhibitors, Sensory Organs	approved	4
DB05440	SRP 299	Drug	Complex Mixtures, Biological Products, Vaccines	investigational	0
DB06770	Benzyl alcohol	Drug	Cytochrome P-450 CYP2E1 Substrates, Antiparasitic Products, Insecticides and Repellents, Cytochrome P-450 Substrates, Sensory System Agents, Benzyl Compounds, Ectoparasiticides, Incl. Scabicides, Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents, Anesthetics, Alcohols, Peripheral Nervous System Agents, Benzyl Alcohols, Pediculicides, Central Nervous System Depressants, Cytochrome P-450 CYP1A2 Substrates, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2C8 Substrates, Benzene Derivatives, Anesthetics, Local	approved	0
DB06773	Human calcitonin	Drug	Calcitonin Preparations, Bone Density Conservation Agents, Calcium Homeostasis, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins	approved, investigational	1
DB05441	AVAC	Drug	0	investigational	0
DB04110	2-Nitro-4-cresol	Drug	Phenols, Benzene Derivatives	experimental	0
DB05442	Etiprednol dicloacetate	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, Hormones	investigational	1
DB04111	Balhimycin	Drug	Carbohydrates, Glycoconjugates, Peptides, Amino Acids, Peptides, and Proteins, Glycopeptides	experimental	0
DB06772	Cabazitaxel	Drug	Microtubule Inhibitors, OATP1B1/SLCO1B1 Inhibitors, Taxane Derivatives, Cycloparaffins, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cyclodecanes, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, OATP1B3 inhibitors, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, Microtubule Inhibition, Cardiotoxic antineoplastic agents, Cytochrome P-450 CYP3A4 Substrates, Myelosuppressive Agents, Cytochrome P-450 CYP3A Substrates, Taxoids, Diterpenes, Cytochrome P-450 CYP2C8 Substrates, P-glycoprotein inhibitors, P-glycoprotein substrates with narrow therapeutic index, Terpenes	approved	2
DB05447	AVI-4557	Drug	0	investigational	1
DB06779	Dalteparin	Drug	Anticoagulants, Carbohydrates, Polysaccharides, Blood and Blood Forming Organs, Glycosaminoglycans, Fibrin Modulating Agents, Heparin (Low Molecular Weight), Agents causing hyperkalemia, Heparin and similars, Hematologic Agents, Cardiovascular Agents, Fibrinolytic Agents	approved	4
DB04116	Allolactose	Drug	Carbohydrates, Polysaccharides, Disaccharides, Oligosaccharides	experimental	1
DB05448	PX-12	Drug	Gases, Sulfides, Anions, Sulfur Compounds, Acids, Noncarboxylic, Acids, Hydrogen Sulfide, Electrolytes, Ions	investigational	1
DB06778	Cupric sulfate	Drug	Autonomic Agents, Antidotes, Sulfur Acids, Copper-containing Intrauterine Device, Protective Agents, Ions, Sulfates, Sulfuric Acids, Peripheral Nervous System Agents, Emetics, Anions, Sulfur Compounds, Acids, Noncarboxylic, Acids, Electrolytes, Central Nervous System Agents, Compounds used in a research, industrial, or household setting, Gastrointestinal Agents	approved	0
DB04117	4-(N,N-Dimethylamino)cinnamoyl-CoA	Drug	0	experimental	1
DB05449	FM-VP4	Drug	0	investigational	1
DB04118	N-Coeleneterazine	Drug	0	experimental	0
DB04119	Hexatantalum Dodecabromide	Drug	0	experimental	2
DB06775	Carglumic acid	Drug	Carbamoyl Phosphate Synthetase 1 Activator, Amino Acids, Dicarboxylic, Alimentary Tract and Metabolism, Amino Acids and Derivatives, Carbamoyl Phosphate Synthetase 1 Activators, Amino Acids, Peptides, and Proteins, Ammonia Detoxicants, Amino Acids, Acidic, Amino Acids	approved	1
DB04112	(2R)-2-Acetamido-3-(octadecyloxy)propyl 2-(methylsulfanyl)ethyl hydrogen phosphate	Drug	0	experimental	1
DB05443	ADL 10-0101	Drug	0	investigational	1
DB06774	Capsaicin	Drug	Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, Solanaceous Alkaloids, Cytochrome P-450 Substrates, Fatty Acids, Sensory System Agents, Alkenes, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Amides, Lipids, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Fatty Acids, Monounsaturated, Peripheral Nervous System Agents, Polyunsaturated Alkamides, Alkaloids, Capsaicin, antagonists & inhibitors, Cytochrome P-450 Enzyme Inducers, Musculo-Skeletal System, Antipruritics, Benzene Derivatives, Alkynes, Anesthetics, Local, Capsaicin and Similar Agents, Cytochrome P-450 CYP2E1 Substrates, Cholinesterase Inhibitors, Dermatologicals, Hydrocarbons, Acyclic, Catechols, Anesthetics, Topical Products for Joint and Muscular Pain, Basic Lotions and Liniments, Fatty Acids, Unsaturated, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP1A2 Inducers, Phenols	approved	2
DB05444	Iroxanadine	Drug	0	investigational	0
DB04113	N-Formylpiperidine	Drug	Alcohol Dehydrogenase, antagonists & inhibitors	experimental	1
DB04114	3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine	Drug	0	experimental	1
DB06777	Chenodeoxycholic acid	Drug	Cytochrome P-450 Substrates, Bile Acid Preparations, Bile Therapy, UGT2B7 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Bile Acids and Salts, Cholic Acids, Fused-Ring Compounds, Cytochrome P-450 CYP3A Substrates, Alimentary Tract and Metabolism, Bile acids and derivatives, Cholanes, Bile and Liver Therapy, Gastrointestinal Agents, Steroids	approved	4
DB05445	TA-NIC	Drug	Complex Mixtures, Biological Products	investigational	0
DB04115	Berberine	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Benzylisoquinolines, Isoquinolines, Berberine Alkaloids	approved, investigational	2
DB05446	LJP 1082	Drug	Proteins, Carbohydrates, Glycoconjugates, Ethylene Glycols, Amino Acids, Peptides, and Proteins, Glycols, Polymers, Compounds used in a research, industrial, or household setting, Alcohols, Macromolecular Substances	investigational	1
DB06776	Sodium cellulose phosphate	Drug	Carbohydrates, Calcium Binder, Polysaccharides, Calcium Chelating Activity, Glucans, Drugs for Treatment of Hypercalcemia, Cation Exchange Resins, Polymers, Biopolymers, Compounds used in a research, industrial, or household setting, Macromolecular Substances	approved	1
DB05450	Smilagenin	Drug	Sapogenins, Cholestanes, Saponins, Drugs, Chinese Herbal, Fused-Ring Compounds, Steroids	investigational	0
DB06782	Dimercaprol	Drug	Sulfur Compounds, Antidotes, Metal Chelating Activity, Sequestering Agents, Metal Chelator, Compounds used in a research, industrial, or household setting, Chelating Agents, Drugs that are Mainly Renally Excreted, Heavy Metal Antagonists, Sulfhydryl Compounds	approved	4
DB06781	Difluprednate	Drug	Corticosteroids, Dermatological Preparations, Pregnadienetriols, Corticosteroids, Cytochrome P-450 Substrates, Immunosuppressive Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Adrenal Cortex Hormones, Dermatologicals, Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Corticosteroids, Potent (Group III), Cytochrome P-450 CYP3A Substrates, Pregnanes, Steroids, Fluorinated, Steroids	approved	1
DB04120	4-Methyl-1,2-Benzenediol	Drug	0	experimental	2
DB05451	P54	Drug	0	investigational	2
DB05452	PH-284	Drug	0	investigational	2
DB06784	Gallium citrate Ga-67	Drug	Gallium, Gallium Radioisotopes, Radioactive Diagnostic Agent, Radiopharmaceutical Activity	approved	0
DB04121	Guanosine-3'-monophosphate-5'-diphosphate	Drug	0	experimental	1
DB04122	beta-D-glucose 6-phosphate	Drug	0	experimental	1
DB06783	Prussian blue	Drug	Antidotes, Iron Compounds, Protective Agents, Coloring Agents, Hydrogen Cyanide, Ions, Cyanides, Organometallic Compounds, Ferrous Compounds, Ion Exchange Activity, Anions, Acids, Noncarboxylic, Acids, Chelating Activity, Decorporation Agent, Electrolytes, Compounds used in a research, industrial, or household setting, Nitrogen Compounds	approved	0
DB06780	Desoxycorticosterone acetate	Drug	Cytochrome P-450 Substrates, Pregnenediones, Hormones, Hormone Substitutes, and Hormone Antagonists, Adrenal Cortex Hormones, Desoxycorticosterone, Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Hydroxycorticosteroids, Cytochrome P-450 CYP3A Substrates, Pregnanes, Mineralocorticoids, Pregnenes, Steroids	approved	1
DB04127	beta-D-arabinofuranose 5-phosphate	Drug	0	experimental	1
DB05458	Pozanicline	Drug	0	investigational	2
DB05459	Briakinumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Immunosuppressive Agents, Globulins, Blood Proteins, Antineoplastic and Immunomodulating Agents, Antibodies, Amino Acids, Peptides, and Proteins, Interleukin Inhibitors, Immunoproteins	investigational	2
DB04128	5-Nitroso-6-ribityl-amino-2,4(1H,3H)-pyrimidinedione	Drug	0	experimental	1
DB06789	Hydroxyprogesterone caproate	Drug	Cytochrome P-450 Substrates, Pregnenediones, Adrenal Cortex Hormones, Cytochrome P-450 CYP2C19 Inducers (strength unknown), Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Estrogen Antagonists, Progesterone Congeners, Cytochrome P-450 CYP2C19 Inducers, Hormone Antagonists, Hormonal Contraceptives for Systemic Use, Contraceptive Agents, Female, Gonadal Hormones, Cytochrome P-450 CYP3A5 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Antineoplastic Agents, Gonadal Steroid Hormones, Cytochrome P-450 CYP3A Substrates, Progestins, Hydroxyprogesterones, Pregnanes, Progesterone and Derivatives, Combination Contraceptives (with Estrogen and derivatives), Corpus Luteum Hormones, Hyperglycemia-Associated Agents, Pregnenes, Progestin Contraceptives, Steroids	approved, investigational	1
DB04129	Willardiine	Drug	Pyrimidines, Pyrimidinones, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	1
DB05454	Paliroden	Drug	0	investigational	0
DB06786	Halcinonide	Drug	Corticosteroids, Dermatological Preparations, Corticosteroids, Cytochrome P-450 Substrates, Immunosuppressive Agents, Pregnenediones, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Dermatologicals, Cytochrome P-450 CYP3A4 Substrates, Corticosteroids, Very Potent (Group IV), Fused-Ring Compounds, Cytochrome P-450 CYP3A Substrates, Pregnanes, Corticosteroid Hormone Receptor Agonists, Pregnenes, Steroids	approved, investigational, withdrawn	1
DB04123	(P-Iodophenylacetylamino)Methylphosphinic Acid	Drug	0	experimental	1
DB04124	Aurodox	Drug	Anti-Bacterial Agents, Alkenes, Hydrocarbons, Acyclic, Polyenes, Anti-Infective Agents	experimental	1
DB05455	SR 121463	Drug	0	investigational	1
DB06785	Ganirelix	Drug	Gonadotropin-releasing Hormone Antagonists, Gonadotropin-Releasing Hormone, antagonists & inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Oligopeptides, Peptides, Gonadotropin Releasing Hormone Receptor Antagonists, Pituitary and Hypothalamic Hormones and Analogues, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Hormones, Decreased GnRH Secretion, Pituitary Hormone-Releasing Hormones, Proteins, Peptide Hormones, Hypothalamic Hormones, Anti-Gonadotropin-Releasing Hormones, Hormone Antagonists, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins	approved	1
DB06788	Histrelin	Drug	Endocrine Therapy, QTc Prolonging Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Oligopeptides, Peptides, Adrenal Cortex Hormones, Antineoplastic and Immunomodulating Agents, Gonadotropin Releasing Hormone Receptor Agonists, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Hormones, Pituitary Hormone-Releasing Hormones, Proteins, Hormones and Related Agents, Peptide Hormones, Gonadotropin Releasing Hormone Receptor Agonist, Gonadotropin-releasing hormone agonist, Hypothalamic Hormones, Potential QTc-Prolonging Agents, Hyperglycemia-Associated Agents	approved	1
DB05456	ETC-588	Drug	Carbohydrates, Glycerophosphates, Sugar Phosphates, Sugar Alcohols, Lipids, Membrane Lipids, Phospholipids, Phosphatidic Acids, Triose Sugar Alcohols, Glycerophospholipids, Alcohols	investigational	0
DB04125	N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine	Drug	0	experimental	1
DB05457	OSI-7904L	Drug	Acids, Acyclic, Heterocyclic Compounds, Fused-Ring, Dicarboxylic Acids	investigational	1
DB04126	N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-2-Methyl-Butane	Drug	0	experimental	2
DB06787	Hexocyclium	Drug	Anticholinergic Agents, Synthetic Anticholinergics, Quaternary Ammonium Compounds, Alimentary Tract and Metabolism, Agents producing tachycardia, Drugs for Functional Gastrointestinal Disorders, Muscarinic Antagonists	approved	4
DB06713	Norelgestromin	Drug	Sex Hormones and Modulators of the Genital System, Amines, Cytochrome P-450 Substrates, Norsteroids, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, Reproductive Control Agents, Hydroxylamines, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 CYP3A Substrates, Progestins, Combination Contraceptives (with Estrogen and derivatives), Pharmaceutical Preparations, Norpregnenes, Hormonal Contraceptives for Systemic Use, Norpregnanes, Contraceptive Agents, Female, Steroids	approved, investigational	3
DB06712	Nilvadipine	Drug	Dihydropyridine Derivatives, QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Agents causing hyperkalemia, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Cytochrome P-450 CYP2C19 Inhibitors, Cardiovascular Agents, Cytochrome P-450 CYP2A6 Inhibitors, Hypotensive Agents, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2A6 Inhibitors (strength unknown), Calcium-Regulating Hormones and Agents, Antihypertensive Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Selective Calcium Channel Blockers With Mainly Vascular Effects, Pyridines, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 CYP2C8 Inhibitors, Moderate Risk QTc-Prolonging Agents, Membrane Transport Modulators, Calcium Channel Blockers, Dihydropyridines, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors (weak), Vasodilating Agents	approved, investigational	6
DB06715	Potassium Iodide	Drug	Potassium Salt, Thyroid Products, Antidotes, Iodides, Ions, Minerals, Potassium Compounds, Ophthalmologicals, Anions, Cough and Cold Preparations, Expectorants, Iodine Compounds, Electrolytes, Sensory Organs, Antithyroid agents	approved	1
DB06714	Propylhexedrine	Drug	Amines	approved	2
DB06711	Naphazoline	Drug	Adrenergic alpha-Agonists, Adrenergic alpha-1 Receptor Agonists, Nasal Decongestants, Agents producing tachycardia, Cardiovascular Agents, Respiratory System Agents, Decongestants and Antiallergics, Ophthalmologicals, Neurotransmitter Agents, Adrenergic alpha-2 Receptor Agonists, Nasal Preparations, Imidazoles, Vasoconstrictor Agents, Adrenergic Agonists, Sympathomimetics, Plain, Agents that produce hypertension, Sensory Organs, Adrenergic Agents, Sympathomimetics Used as Decongestants	approved, investigational	2
DB06710	Methyltestosterone	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Genito Urinary System and Sex Hormones, Anabolic Agents, Hormones, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, 3-Oxoandrosten (4) Derivatives, Androgens and Estrogens, Gonadal Hormones, Antineoplastic Agents, Hormonal, Hormones, Hormone Substitutes, and Hormone Antagonists, Androstenes, Antineoplastic Agents, Gonadal Steroid Hormones, Androgens, Androstanes, Cytochrome P-450 CYP3A Substrates, Androstenols, OAT3/SLC22A8 Inducers, Testosterone Congeners, Thyroxine-binding globulin inhibitors, Cytochrome P-450 CYP2B6 Substrates, Steroids	approved	2
DB06717	Fosaprepitant	Drug	Oxazines, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Peripheral Nervous System Agents, Cytochrome P-450 Enzyme Inducers, Neurokinin 1 Antagonists, Substance P/Neurokinin-1 Receptor Antagonist, Neurokinin-1 Receptor Antagonists, Gastrointestinal Agents, Autonomic Agents, Cytochrome P-450 CYP3A4 Inducers, Miscellaneous Antiemetics, Morpholines, Aprepitant and Prodrugs, Neurotransmitter Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Antiemetics, Central Nervous System Agents, Cytochrome P-450 CYP2C9 Inducers, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved	0
DB06716	Fospropofol	Drug	Anesthetics, General, Central Nervous System Depressants, Phenols, Hypnotics and Sedatives, Central Nervous System Agents, Anesthetics, Benzene Derivatives, Agents that reduce seizure threshold	approved, illicit, investigational	2
DB06719	Buserelin	Drug	Endocrine Therapy, QTc Prolonging Agents, Miscellaneous Therapeutic Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Oligopeptides, Peptides, Adrenal Cortex Hormones, Antineoplastic and Immunomodulating Agents, Reproductive Control Agents, Fertility Agents, Female, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Hormones, Pituitary Hormone-Releasing Hormones, Fertility Agents, Proteins, Hormones and Related Agents, Peptide Hormones, Gonadotropin-releasing hormone agonist, Hypothalamic Hormones, Potential QTc-Prolonging Agents, Hyperglycemia-Associated Agents	approved, investigational	2
DB06718	Stanozolol	Drug	Androstanols, Hormones, Hormone Substitutes, and Hormone Antagonists, Anabolic Agents, Hormones, Fused-Ring Compounds, Androgens, Androstanes, Alimentary Tract and Metabolism, Anabolic Steroids, Anabolic Agents for Systemic Use, Thyroxine-binding globulin inhibitors, Androstan Derivatives, Steroids	approved, vet_approved	2
DB06724	Calcium carbonate	Drug	Alkalies, Phosphate Binder, Calcium Compounds, Blood Coagulation Factors, Ions, Carbonic Acid, Mineral Supplements, Minerals, Carbon Compounds, Inorganic, Antacids and Adsorbents, Calcium Salts, Anions, Gastric Acid Lowering Agents, Acids, Noncarboxylic, Acids, Replacement Preparations, Alimentary Tract and Metabolism, Electrolytes, Polyvalent cation containing laxatives, antacids, oral supplements, Carbonates, Drugs for Acid Related Disorders, Antacids, Gastrointestinal Agents	approved, investigational	0
DB06723	Aluminum hydroxide	Drug	Alkalies, Immunologic Factors, Hydroxides, Adjuvants, Immunologic, Ions, Carbonic Acid, Carbon Compounds, Inorganic, Aluminum and magnesium containing antacids, Antacids and Adsorbents, Anions, Gastric Acid Lowering Agents, Acids, Noncarboxylic, Metal cations, Acids, Alimentary Tract and Metabolism, Metal divalent cations, Aluminium Compounds, Electrolytes, Drugs for Acid Related Disorders, Antacids, Gastrointestinal Agents, Miscellaneous Local Anti-infectives	approved, investigational	0
DB06726	Bufuralol	Drug	Neurotransmitter Agents, Amines, Cytochrome P-450 Substrates, Agents causing hyperkalemia, Adrenergic Antagonists, Adrenergic beta-Antagonists, Cytochrome P-450 CYP2D6 Substrates, Amino Alcohols, Adrenergic Agents, Bradycardia-Causing Agents, Alcohols	experimental	1
DB06725	Lornoxicam	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Cytochrome P-450 Substrates, Oxicams, Sensory System Agents, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Thiazines, Peripheral Nervous System Agents, Cytochrome P-450 CYP2C9 Substrates, Sulfur Compounds, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Musculo-Skeletal System, Agents that produce hypertension, Central Nervous System Agents	approved, investigational	2
DB06720	Velaglucerase alfa	Drug	Enzymes, Alimentary Tract and Metabolism, Hydrolytic Lysosomal Glucocerebroside-specific Enzyme	approved, investigational	1
DB06721	Gimatecan	Drug	Alkaloids, OATP1B1/SLCO1B1 Substrates	investigational	0
DB06728	Aniline	Drug	Carcinogens, Cytochrome P-450 CYP2E1 Substrates, Amines, Cytochrome P-450 Substrates, Noxae, Toxic Actions	experimental	2
DB06727	Sparteine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Reproductive Control Agents, Cardiovascular Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Quinolizines, Antiarrhythmics, Class I, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2D6 Substrates, Antiarrhythmics, Class Ia, Cardiac Therapy, Antiarrhythmic agents, Quinolizidines	experimental	0
DB06729	Sulfaphenazole	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Amines, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (strong), Aniline Compounds, Genito Urinary System and Sex Hormones, Amides, Sulfanilamides, Cytochrome P-450 CYP2B6 Inhibitors, Anti-Infective Agents, SULFONAMIDES AND TRIMETHOPRIM, Sulfur Compounds, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Intermediate-Acting Sulfonamides, Sulfones, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Long-Acting Sulfonamides, Cytochrome P-450 CYP2C8 Inhibitors, Gynecological Antiinfectives and Antiseptics, Pyrazoles, Antiinfectives for Systemic Use, Ophthalmologicals, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Sulfonamides, Sensory Organs, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), Antibacterials for Systemic Use	approved	1
DB06735	Enclomiphene	Drug	Cytochrome P-450 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Reproductive Control Agents, Fertility Agents, Female, Benzylidene Compounds, Estrogen Receptor Modulators, Clomiphene, Fertility Agents, Estrogen Antagonists, Selective Estrogen Receptor Modulators, Stilbenes, Cytochrome P-450 CYP2D6 Substrates, Hormone Antagonists, Benzene Derivatives	investigational	0
DB05403	CEP-1347	Drug	Heterocyclic Compounds, Fused-Ring, Indoles	investigational	1
DB05404	AZD 3355	Drug	GABA-A Receptor Agonists, Neurotransmitter Agents, Acids, Noncarboxylic, Amines, Acids, GABA Agents, GABA Agonists, Organophosphorus Compounds, Phosphorus Compounds, Phosphorus Acids, Gastrointestinal Agents	investigational	1
DB06734	Bafilomycin B1	Drug	Polyketides, Lactones	experimental	1
DB05405	XTL-001	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB06737	Zaltoprofen	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Acids, Acyclic, Cytochrome P-450 Substrates, Fatty Acids, Sensory System Agents, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Lipids, Peripheral Nervous System Agents, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Antigout Preparations, Sulfur Compounds, UGT2B7 substrates, Analgesics, Fatty Acids, Volatile, Agents that produce hypertension, Central Nervous System Agents, Pyrans	experimental	0
DB06736	Aceclofenac	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Acetic Acid Derivatives and Related Substances, Cytochrome P-450 Substrates, Sensory System Agents, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Antirheumatic Agents, Antiinflammatory Preparations, Non-Steroids for Topical Use, Topical Products for Joint and Muscular Pain, Drugs that are Mainly Renally Excreted, Selective Cyclooxygenase 2 Inhibitors (NSAIDs), Peripheral Nervous System Agents, Cytochrome P-450 CYP2C9 Substrates, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Musculo-Skeletal System, Agents that produce hypertension, Phenylacetates, Central Nervous System Agents	approved, investigational	2
DB05406	GTI-2501	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides, Polynucleotides	investigational	0
DB06731	Seproxetine	Drug	Selective Serotonin Reuptake Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Cytochrome P-450 CYP3A5 Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors, Antidepressive Agents, Cytochrome P-450 CYP3A7 Inhibitors (strength unknown), Serotonin Modulators, Cytochrome P-450 CYP3A Inhibitors, Central Nervous System Depressants, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP3A7 Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors	investigational	0
DB06730	Gestodene	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, Cytochrome P-450 CYP2C19 Inhibitors, Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 CYP3A7 Inhibitors (strength unknown), Contraceptives, Oral, Contraceptives, Oral, Synthetic, Progestogens and Estrogens, Sequential Preparations, Hormonal Contraceptives for Systemic Use, Norpregnanes, Contraceptive Agents, Female, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Hormones, Hormone Substitutes, and Hormone Antagonists, Norsteroids, Cytochrome P-450 CYP3A5 Inhibitors, Reproductive Control Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A7 Inhibitors, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Progestins, Combination Contraceptives (with Estrogen and derivatives), Progestin Contraceptives, Steroids	investigational	1
DB05400	QS-21	Drug	Carbohydrates, Immunologic Factors, Adjuvants, Immunologic, Glycosides	investigational	0
DB06733	Bafilomycin A1	Drug	Enzyme Inhibitors, Polyketides, Proton-Translocating ATPases, antagonists & inhibitors, Antifungal Agents, Anti-Infective Agents, Lactones	experimental	1
DB06732	beta-Naphthoflavone	Drug	Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 Enzyme Inducers, Enzyme Inhibitors, Flavonoids, Cytochrome P-450 CYP1A2 Inducers (strength unknown), Benzoflavones, Cytochrome P-450 CYP1A2 Inducers, Benzopyrans, Chromones, Pyrans	experimental	5
DB05407	TBC-3711	Drug	Sulfur Compounds, Endothelin A Receptor Antagonists, Endothelin Receptor Antagonists	investigational	1
DB06739	Seratrodast	Drug	Cytochrome P-450 Substrates, Fatty Acids, Sensory System Agents, Cytochrome P-450 Enzyme Inhibitors, Anti-Inflammatory Agents, Cytochrome P-450 CYP3A Inducers, Lipids, Cytochrome P-450 CYP2A6 Inhibitors, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2A6 Inhibitors (strength unknown), Peripheral Nervous System Agents, Quinones, Cytochrome P-450 Enzyme Inducers, Analgesics, Hormone Antagonists, Cytochrome P-450 CYP2C8 Substrates, Analgesics, Non-Narcotic, Hormones, Hormone Substitutes, and Hormone Antagonists, Anti-Asthmatic Agents, Cytochrome P-450 CYP3A4 Inducers, Antirheumatic Agents, Prostaglandin Antagonists, Respiratory System Agents, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, UGT1A9 Substrates, Drugs for Obstructive Airway Diseases, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates	experimental	1
DB06738	Ketobemidone	Drug	Cytochrome P-450 Substrates, Sensory System Agents, Narcotics, Nervous System, Cytochrome P-450 CYP3A4 Substrates, Peripheral Nervous System Agents, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Neurotransmitter Agents, Phenylpiperidine opioids, Analgesics, Cytochrome P-450 CYP3A Substrates, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Piperidines, Opioids, UGT1A9 Substrates, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2C8 Substrates, Excitatory Amino Acid Agents, Excitatory Amino Acid Antagonists, Isonipecotic Acids	investigational	4
DB05408	Emricasan	Drug	Acids, Acyclic, Valerates, Fatty Acids, Fatty Acids, Volatile, Lipids	investigational	3
DB05409	NCX 701	Drug	Anilides, Anions, Acids, Noncarboxylic, Amines, Acids, Aniline Compounds, Amides, Electrolytes, Ions, Nitric Acid, Acetanilides, Nitrogen Compounds	investigational	0
DB06740	BW-A 58C	Drug	Quinones, Naphthalenes	experimental	0
DB06746	ginkgolide-J	Drug	Diterpenes, Terpenes	nutraceutical	0
DB05414	Pipendoxifene	Drug	Heterocyclic Compounds, Fused-Ring	investigational	1
DB06745	ginkgolide-C	Drug	Diterpenes, Terpenes	nutraceutical	0
DB05415	OSI-461	Drug	Phosphodiesterase Inhibitors, Indenes	investigational	1
DB05416	Cardarine	Drug	Sulfur Compounds	investigational	2
DB06748	Ginsenoside C	Drug	Carbohydrates, Lipid Regulating Agents, Panax, Saponins, Triterpenes, Hypolipidemic Agents, Noxae, Antineoplastic Agents, Glycosides, Toxic Actions, Terpenes	nutraceutical	0
DB05417	GW 468816	Drug	Heterocyclic Compounds, Fused-Ring, Receptors, N-Methyl-D-Aspartate, antagonists & inhibitors	investigational	1
DB06747	ginkgolide-M	Drug	0	nutraceutical	0
DB06742	Ambroxol	Drug	Cycloparaffins, Amines, Cytochrome P-450 Substrates, Adrenergics for Systemic Use, Aniline Compounds, Cyclohexylamines, Cytochrome P-450 CYP3A4 Substrates, Respiratory System Agents, Cyclohexanes, Selective Beta 2-adrenergic Agonists, Cough and Cold Preparations, Cytochrome P-450 CYP3A Substrates, Expectorants, Drugs for Obstructive Airway Diseases	approved, investigational	0
DB05410	NCX 1022	Drug	Hydroxycorticosteroids, Pregnenediones, Hormones, Hormone Substitutes, and Hormone Antagonists, Adrenal Cortex Hormones, Pregnanes, 11-Hydroxycorticosteroids, Hormones, 17-Hydroxycorticosteroids, Fused-Ring Compounds, Pregnenes, Steroids	investigational	0
DB05411	VB2-011	Drug	0	investigational	0
DB06741	Gavestinel	Drug	Glycine Agents, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, UGT1A1 Substrates, UGT1A3 substrates, UGT1A9 Substrates, Excitatory Amino Acid Agents, Excitatory Amino Acid Antagonists	investigational	1
DB05412	Talmapimod	Drug	Heterocyclic Compounds, Fused-Ring	investigational	4
DB06744	ginkgolide-B	Drug	0	nutraceutical	0
DB06743	Ginkgolide A	Drug	Diterpenes, Terpenes	nutraceutical	0
DB05413	Tifuvirtide	Drug	Antigens, Biological Factors, Peptides, Human Immunodeficiency Virus Proteins, Viral Envelope Proteins, Amino Acids, Peptides, and Proteins, Gene Products, env, Viral Proteins, Retroviridae Proteins, Membrane Fusion Proteins, env Gene Products, Human Immunodeficiency Virus, Viral Structural Proteins, Membrane Proteins, Proteins, Antigens, Viral, HIV Antigens, Polyproteins, Viral Fusion Proteins	investigational	1
DB05418	GW 597599	Drug	0	investigational	1
DB05419	ADX-10061	Drug	0	investigational	1
DB06749	Ginsenoside Rb1	Drug	Carbohydrates, Panax, Saponins, Triterpenes, OATP1B3 inhibitors, Glycosides, Terpenes	nutraceutical	1
DB04174	3'-1-carboxy-1-phosphonooxy-ethoxy-uridine-diphosphate-N-acetylglucosamine	Drug	0	experimental	1
DB04175	Mdl-29951	Drug	Acids, Acyclic, Heterocyclic Compounds, Fused-Ring, Fatty Acids, Fatty Acids, Volatile, Lipids	experimental	1
DB04176	Phosporic Acid Mono-[3,4-Dihydroxy-5-(5-Methoxy-Benzoimidazol-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester	Drug	0	experimental	1
DB04177	Digitoxigenin	Drug	Carbohydrates, Cardanolides, Cardiac Glycosides, Digitalis Glycosides, Glycosides, Cardenolides, Fused-Ring Compounds, Steroids	experimental	0
DB04170	4-bromo-3-hydroxy-3-methyl butyl diphosphate	Drug	0	experimental	1
DB04171	D-Isovaline	Drug	0	experimental	0
DB04172	[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine	Drug	0	experimental	1
DB04173	Fructose	Drug	Food Additives, Carbohydrates, Hexoses, Flavoring Agents, General Nutrients, Fructose, Pharmaceutic Aids, Ketoses, Monosaccharides, Physiological Phenomena, Food and Beverages, Food Ingredients, Pharmaceutical Preparations, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food, Sweetening Agents	approved, experimental	1
DB04178	Di-Stearoyl-3-Sn-Phosphatidylcholine	Drug	0	experimental	2
DB04179	Benzofuran	Drug	Heterocyclic Compounds, Fused-Ring	experimental	1
DB04180	4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide	Drug	0	experimental	1
DB04185	Norvaline	Drug	Amino Acids, Essential, Amino Acids, Branched-Chain, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	2
DB04186	N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea	Drug	0	experimental	1
DB04187	(9S,10S)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene	Drug	0	experimental	1
DB04188	MDL72527	Drug	Diamines, Amines, Biogenic Amines, Polyamines, Biogenic Polyamines, Oxidoreductases Acting on CH-NH Group Donors, antagonists & inhibitors	experimental	1
DB04182	(S)-2-Amino-4-[(2s,3r)-2,3,5-Trihydroxy-4-Oxo-Pentyl]Mercapto-Butyric Acid	Drug	0	experimental	1
DB04183	Methylmalonic Acid	Drug	Acids, Acyclic, Malonates, Dicarboxylic Acids	experimental	1
DB04189	N(2)-(2-carboxyethyl)-L-arginine	Drug	Amino Acids, Basic, Amino Acids, Essential, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	0
DB04190	2,5-dibenzyloxy-3-hydroxy-hexanedioic acid bis-[(2-hydroxy-indan-1-yl)-amide]	Drug	0	experimental	1
DB04191	Skf 107457	Drug	Peptides, Amino Acids, Peptides, and Proteins	experimental	1
DB04196	Pteroic acid	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Pteridines, Pigments, Biological	experimental	1
DB04197	Descarboxy-nor-N(Omega)-Hydroxy-L-Arginine	Drug	0	experimental	1
DB04198	Formycin B	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Glycosides, Nucleosides	experimental	2
DB04199	1-Monohexanoyl-2-Hydroxy-Sn-Glycero-3-Phosphate	Drug	0	experimental	3
DB04193	L-Homoserine	Drug	0	experimental	0
DB04194	Triacetylchitotriose	Drug	0	experimental	1
DB04195	Heptulose-2-Phosphate	Drug	0	experimental	1
DB05461	OPC-28326	Drug	Amines	investigational	3
DB06793	Levopropoxyphene	Drug	Acids, Acyclic, Antitussive Agents, Fatty Acids, Fatty Acids, Volatile, Propionates, Lipids, Central Nervous System Agents, Respiratory System Agents, Agents that reduce seizure threshold	withdrawn	0
DB04130	5-Methoxybenzimidazole	Drug	0	experimental	1
DB06792	Lanthanum carbonate	Drug	Lanthanoid Series Elements, Metal cations, Phosphate Binder, Metals, Phosphate-removing Agents, Drugs for Treatment of Hyperkalemia and Hyperphosphatemia, Kidney Failure, Chronic, Elements, Metals, Rare Earth	approved	1
DB05462	Chlorotoxin I-131	Drug	Toxins, Biological, Biological Factors, Neurotoxins, Complex Mixtures, Noxae, Venoms, Toxic Actions, Fluids and Secretions, Arthropod Venoms, Bodily Secretions	investigational	0
DB04131	10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione	Drug	0	experimental	1
DB05463	ISS-1018	Drug	Carbohydrates, Immunologic Factors, Nucleic Acids, Nucleotides, and Nucleosides, Adjuvants, Immunologic, Oligonucleotides, Glycosides, Nucleotides, Polynucleotides	investigational	1
DB04132	S-Hexylglutathione	Drug	Enzyme Inhibitors, Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins, Lactoylglutathione Lyase, antagonists & inhibitors	experimental	6
DB06795	Mafenide	Drug	Enzyme Inhibitors, Gynecological Antiinfectives and Antiseptics, Dermatologicals, Genito Urinary System and Sex Hormones, Amides, Anti-Infective Agents, Anti-Infective Agents, Local, Drugs that are Mainly Renally Excreted, Anti-Bacterial Agents, Sulfur Compounds, Sulfonamide Antibacterial, Sulfonamides, Methemoglobinemia Associated Agents, Sulfones	approved, vet_approved	1
DB04133	Degraded Cephaloridine	Drug	0	experimental	2
DB06794	Lodoxamide	Drug	Anti-Allergic Agents, Amino Acids, Peptides, and Proteins, Propylene Glycols, Amino Acids, Decongestants and Antiallergics, Alcohols, Antioxidants, Ophthalmologicals, Neurotransmitter Agents, Decreased Histamine Release, Acids, Aldehydic, Glycols, Mast Cell Stabilizers, Glyoxylates, Sensory Organs, Histamine Agents	approved	0
DB05464	NOX-700	Drug	Acids, Acyclic, Sulfur Compounds, Carbamates	investigational	2
DB06791	Lanreotide	Drug	Cytochrome P-450 Enzyme Inhibitors, Peptides, Hypoglycemia-Associated Agents, Pituitary and Hypothalamic Hormones and Analogues, Acromegaly, Other Miscellaneous Therapeutic Agents, Amino Acids, Peptides, and Proteins, Neuropeptides, Hormones, Proteins, Peptide Hormones, Pituitary Hormone Release Inhibiting Hormones, Somatostatin and Analogues, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Bradycardia-Causing Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Pancreatic Hormones, Antineoplastic Agents, Nerve Tissue Proteins, Cytochrome P-450 CYP3A Inhibitors, Somatostatin Receptor Agonists, Cytochrome P-450 CYP3A4 Inhibitors, Hypothalamic Hormones, Hyperglycemia-Associated Agents, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved	2
DB05460	Ezatiostat	Drug	Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins	investigational	1
DB04138	5-[Bis(2-bromoethyl)amino]-N-(2,3-dioxopropyl)-2,4-dinitrobenzamide	Drug	0	experimental	1
DB05469	R450	Drug	0	investigational	3
DB04139	6-Hydroxypropylthymine	Drug	0	experimental	1
DB06797	Mebutamate	Drug	Psycholeptics, Nervous System, Central Nervous System Depressants, Carbamates, Anti-Anxiety Agents	approved	0
DB05465	Tandutinib	Drug	Heterocyclic Compounds, Fused-Ring, QTc Prolonging Agents, Tyrosine Kinase Inhibitors, Potential QTc-Prolonging Agents	investigational	2
DB05466	R673	Drug	0	investigational	1
DB04135	(4S)-5-Fluoro-4-hydroxy-3,4-dihydro-2(1H)-pyrimidinone	Drug	0	experimental	1
DB06796	Mangafodipir	Drug	Magnetic Resonance Imaging Contrast Media, Acids, Acyclic, Pyridines, Coenzymes, Amines, Fatty Acids, Enzymes and Coenzymes, Lipids, Paramagnetic Contrast Agent, Polyamines, Acetates, Drugs that are Mainly Renally Excreted, Ethylenediamines, Picolines, Diamines, Paramagnetic Contrast Media, Contrast Media, Diagnostic Uses of Chemicals, Magnetic Resonance Contrast Activity, Fatty Acids, Volatile, Compounds used in a research, industrial, or household setting	approved, investigational, withdrawn	0
DB05467	R667	Drug	0	investigational	1
DB06799	Methenamine	Drug	Cycloparaffins, Renal Agents, Amines, Anti-Infective Agents, Urinary, Benzoates, Hydroxy Acids, Acids, Carbocyclic, Amides, Polyamines, Antiinfectives for Systemic Use, Anti-Infective Agents, Anti-Bacterial Agents, Keto Acids, Urinary Acidifying Agents, Antibacterials for Systemic Use, Benzene Derivatives	approved, vet_approved	0
DB04136	Lysophosphotidylserine	Drug	0	experimental	1
DB05468	R411	Drug	0	investigational	1
DB04137	Guanosine-5'-Triphosphate	Drug	0	experimental	19
DB04141	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	Drug	0	experimental	15
DB05472	omega interferon	Drug	Immunosuppressive Agents, Myelosuppressive Agents	investigational	2
DB05473	QR-334	Drug	0	investigational	0
DB04142	3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide	Drug	0	experimental	1
DB05474	T487	Drug	0	investigational	0
DB04143	Indole-3-Glycerol Phosphate	Drug	Carbohydrates, Sugar Phosphates, Laboratory Chemicals, Sugar Alcohols, Indicators and Reagents, Lipids, Membrane Lipids, Phospholipids, Triose Sugar Alcohols, Compounds used in a research, industrial, or household setting, Alcohols	experimental	2
DB05475	Golotimod	Drug	Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins	investigational	4
DB04144	Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone	Drug	0	experimental	1
DB05470	VX-702	Drug	Benzene Derivatives	investigational	4
DB05471	SGN-30	Drug	0	investigational	2
DB04140	1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide	Drug	0	experimental	1
DB04149	(R)-Rolipram	Drug	0	experimental	2
DB04145	Nicotinyl alcohol	Drug	Lipid Modifying Agents, Lipid Modifying Agents, Plain, Pyridines, Nicotinic Acid and Derivatives, Peripheral Vasodilators, Cardiovascular Agents, Vasodilating Agents	experimental	0
DB05476	WX-UK1	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Amino Acids, Essential, Amino Acids, Peptides, and Proteins, Amino Acids	investigational	1
DB04146	I-Coeleneterazine	Drug	0	experimental	0
DB05477	MUC1 Dendritic Cell Vaccine	Drug	0	investigational	0
DB05478	Pradefovir mesylate	Drug	Heterocyclic Compounds, Fused-Ring, Purines	investigational	1
DB04147	Dodecyldimethylamine N-oxide	Drug	Surface-Active Agents, Amines, Methylamines, Detergents, Compounds used in a research, industrial, or household setting, Household Products	experimental	49
DB05479	CZEN 002	Drug	0	investigational	1
DB05483	PCL-016	Drug	0	investigational	2
DB04152	2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid	Drug	0	experimental	1
DB04153	S-Hydroxymethyl Glutathione	Drug	0	experimental	1
DB05484	MDX-018	Drug	0	investigational	1
DB05485	ADH-1	Drug	0	investigational	0
DB04154	N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide	Drug	0	experimental	2
DB04155	2-Fluoro-2-Deoxy-Beta-D-Galactopyranosyl-Beta-D-Glucopyranose	Drug	0	experimental	1
DB05480	PBI-1402	Drug	0	investigational	0
DB05481	Recombinant alpha 1-antitrypsin	Drug	0	investigational	1
DB04150	N-alpha-Acetyl-3,5-diiodotyrosyl-D-threonine	Drug	0	experimental	1
DB04151	1-Methylhistidine	Drug	Amino Acids, Cyclic, Amino Acids, Essential, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	1
DB05482	7-ethyl-10-hydroxycamptothecin	Drug	Alkaloids, Enzyme Inhibitors, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Substrates, Topoisomerase Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Topoisomerase I Inhibitors, Antineoplastic Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates	investigational	1
DB04156	Aspartate Beryllium Trifluoride	Drug	0	experimental	3
DB05487	Custirsen	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Nucleic Acids, Nucleotides, and Nucleosides, Oligonucleotides, Antisense, Glycosides, Nucleotides, Pyrans	investigational	3
DB05488	Technetium Tc-99m ciprofloxacin	Drug	Cytochrome P-450 CYP1A2 Inhibitors, Fluoroquinolones, Organometallic Compounds, Quinolines, Heterocyclic Compounds, Fused-Ring, QTc Prolonging Agents, Anti-Bacterial Agents, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (strong), Moderate Risk QTc-Prolonging Agents, Quinolones	investigational	2
DB04157	N-[(Aminooxy)Carbonyl]Aniline	Drug	0	experimental	1
DB05489	ACA 125	Drug	0	investigational	1
DB04158	6-(adenosine tetraphosphate-methyl)-7,8-dihydropterin	Drug	0	experimental	1
DB04159	Beta-Hydroxytryptophane	Drug	0	experimental	0
DB05494	Elacytarabine	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Fatty Acids, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Arabinonucleosides, Glycosides, Nucleosides, Lipids	investigational	1
DB04163	5-Phenylsulfanyl-2,4-Quinazolinediamine	Drug	0	experimental	2
DB04164	1,4-Deoxy-4-((5-Hydroxymethyl-2,3,4-Trihydroxycyclohex-5-Enyl)Amino)Fructose	Drug	0	experimental	1
DB05495	PG-530742	Drug	0	investigational	1
DB04165	Valpromide	Drug	Acids, Acyclic, Valerates, Anticonvulsants, Fatty Acids, Nervous System, Central Nervous System Depressants, Fatty Acids, Volatile, Pentanoic Acids, Lipids, Central Nervous System Agents, Fatty Acid Derivatives	experimental	1
DB05496	Otelixizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB04166	Anthranilic acid	Drug	Aminobenzoates, Benzoates, Acids, Carbocyclic, Central Nervous System Agents, Benzene Derivatives	experimental	2
DB05490	AMG-131	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amides, PPAR gamma, agonists, Sulfones	investigational	1
DB05491	ATN-161	Drug	0	investigational	0
DB04160	Pyrophosphoric acid	Drug	Anions, Acids, Noncarboxylic, Acids, Phosphoric Acids, Electrolytes, Ions, Phosphorus Compounds, Polyphosphates, Phosphate salts, Phosphorus Acids	approved, experimental	1
DB04161	Propionamide	Drug	0	experimental	0
DB05492	Epicept NP-1	Drug	0	investigational	12
DB05493	NX-1207	Drug	0	investigational	0
DB04162	5-Nitro-6-ribityl-amino-2,4(1H,3H)-pyrimidinedione	Drug	0	experimental	2
DB05498	KW-7158	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds	investigational	0
DB04167	Aceglutamide	Drug	Amino Acids, Neutral, Amino Acids, Basic, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	1
DB05499	TAK-428	Drug	0	investigational	0
DB04168	Bropirimine	Drug	Immunologic Factors, Pyrimidines, Adjuvants, Immunologic, Pyrimidinones, Antineoplastic Agents, Interferon Inducers	experimental	1
DB04169	3,5-Diaminophthalhydrazide	Drug	0	experimental	1
DB06801	Monoctanoin	Drug	Acids, Acyclic, Solvents, Fatty Acids, Lipids	experimental	0
DB06800	Methylnaltrexone	Drug	Amines, Ammonium Compounds, Sensory System Agents, Narcotics, Peripheral Opioid Receptor Antagonists, Drugs for Constipation, Onium Compounds, Drugs that are Mainly Renally Excreted, Morphinans, Peripheral Nervous System Agents, Opioid Antagonists, Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids, Alimentary Tract and Metabolism, Miscellaneous GI Drugs, Central Nervous System Agents, Nitrogen Compounds	approved	2
DB06803	Niclosamide	Drug	Amines, Cytochrome P-450 Substrates, Salicylamides, Cytochrome P-450 Enzyme Inhibitors, Aniline Compounds, Anthelmintics, Amides, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Anti-Infective Agents, Anilides, Cytochrome P-450 CYP1A2 Inhibitors, Agrochemicals, Compounds used in a research, industrial, or household setting, Antinematodal Agents, Anticestodals, Anticestodal Agents, Salicylanilides, Antiparasitic Products, Insecticides and Repellents, Molluscacides, Pesticides, Cytochrome P-450 CYP2C9 Substrates, Toxic Actions, Antiplatyhelmintic Agents, Antiparasitic Agents, Salicylic Acid Derivatives	approved, investigational, vet_approved	1
DB06802	Nepafenac	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Acids, Acyclic, Fatty Acids, Sensory System Agents, Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Antirheumatic Agents, Amides, Lipids, Acetates, Selective Cyclooxygenase 2 Inhibitors (NSAIDs), Peripheral Nervous System Agents, Ophthalmologicals, Analgesics, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Fatty Acids, Volatile, Acetamides, Central Nervous System Agents, Sensory Organs, Benzene Derivatives	approved, investigational	2
DB06809	Plerixafor	Drug	Hematinics, Hematopoietic Stem Cell Mobilizer, Adjuvants, Immunologic, Antineoplastic and Immunomodulating Agents, Increased Hematopoietic Stem Cell Mobilization, Anti-HIV Agents, Anti-Infective Agents, Drugs that are Mainly Renally Excreted	approved	1
DB06804	Nonoxynol-9	Drug	Antispermatogenic Agents, Surface-Active Agents, Contraceptive Agents, Male, Noxae, Polyethylene Glycols, Adrenal Cortex Hormones, Reproductive Control Agents, Alcohols, Macromolecular Substances, Spermatocidal Agents, Ethylene Glycols, Toxic Actions, Glycols, Polymers, Compounds used in a research, industrial, or household setting, Hormonal Contraceptives for Systemic Use, Contraceptive Agents, Female	approved, withdrawn	0
DB06807	Phenyl aminosalicylate	Drug	Benzoates, Hydroxy Acids, Acids, Carbocyclic, Hydroxybenzoates, Phenols, Salicylates, Benzene Derivatives	approved	0
DB06812	Povidone-iodine	Drug	Alkenes, Medicated Dressings, Genito Urinary System and Sex Hormones, Medicated Shampoos, Irrigating Solutions, Anti-Infective Agents, Anti-Infective Agents, Local, Medicated Dressings With Antiinfectives, Polyenes, Pyrrolidines, Polymers, Compounds used in a research, industrial, or household setting, Iodophors, Gynecological Antiinfectives and Antiseptics, Antiseptics and Disinfectants, Dermatologicals, Hydrocarbons, Acyclic, Vinyl Compounds, Macromolecular Substances, Ophthalmologicals, Pyrrolidinones, Throat Preparations, Iodine Compounds, Polyvinyls, Antifungal Agents (Vaginal), Iodine Products, Sensory Organs, Plastics, Miscellaneous Local Anti-infectives	approved	0
DB06811	Polidocanol	Drug	Surface-Active Agents, Polyethylene Glycols, Sclerosing Activity, Cardiovascular Agents, Sclerosing Agents for Local Injection, Detergents, Household Products, Pharmaceutical Solutions, Alcohols, Macromolecular Substances, Vasoprotectives, Solutions, Ethylene Glycols, Sclerosing Solutions, Antivaricose Therapy, Pegylated agents, Glycols, Pharmaceutical Preparations, Polymers, Vascular Sclerosing Activity, Compounds used in a research, industrial, or household setting	approved	0
DB06814	Protokylol	Drug	Amines, Epinephrine and similars, Agents producing tachycardia, Catecholamines, Catechols, Adrenergic beta-2 Receptor Agonists, Amino Alcohols, Ethanolamines, Biogenic Monoamines, Dioxoles, Alcohols, Adrenergic beta-Agonists, Agents to Treat Airway Disease, Adrenergic Agonists, Biogenic Amines, Phenols, Benzene Derivatives	approved, vet_approved	1
DB06813	Pralatrexate	Drug	Biological Factors, Immunosuppressive Agents, Folic Acid Antagonists, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Antimetabolites, Pteridines, Drugs that are Mainly Renally Excreted, Pigments, Biological, Heterocyclic Compounds, Fused-Ring, Folic Acid Analogues, BCRP/ABCG2 Substrates, Narrow Therapeutic Index Drugs, Pterins	approved, investigational	2
DB06810	Plicamycin	Drug	Carbohydrates, Anthracyclines, Enzyme Inhibitors, Cytotoxic Antibiotics and Related Substances, Antineoplastic and Immunomodulating Agents, Coloring Agents, Laboratory Chemicals, Antineoplastic Agents, Antibiotics, Antineoplastic, Luminescent Agents, Nucleic Acid Synthesis Inhibitors, Calcium-Regulating Hormones and Agents, Naphthacenes, Glycosides, Indicators and Reagents, Compounds used in a research, industrial, or household setting, Fluorescent Dyes, Protein Synthesis Inhibitors	approved, investigational, withdrawn	1
DB06819	Phenylbutyric acid	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Nitrogen Binding Agent, Urea Cycle Disorder Agents, Cytochrome P-450 Enzyme Inhibitors, Various Alimentary Tract and Metabolism Products, Alimentary Tract and Metabolism, Acids, Carbocyclic, Antineoplastic Agents, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Ammonium Ion Binding Activity	approved, investigational	2
DB06816	Pyrvinium	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Antiparasitic Products, Insecticides and Repellents, Quinolinium Compounds, Anthelmintics, Anti-Infective Agents, Antinematodal Agents, Antiparasitic Agents	approved	0
DB06815	Pyrithione	Drug	Sulfur Compounds, Dermatologicals, Gallium Radioisotopes, Antifungal Agents, Keratolytic Agents, Radiopharmaceuticals, Indium Radioisotopes, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Miscellaneous Local Anti-infectives	approved	0
DB06817	Raltegravir	Drug	Enzyme Inhibitors, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Antiinfectives for Systemic Use, Anti-Infective Agents, HIV Integrase Inhibitors, Antivirals for Systemic Use, Direct Acting Antivirals, Pyrrolidinones, Agents Causing Muscle Toxicity, UGT1A1 Substrates, Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor, Pyrrolidines, Integrase Inhibitors	approved	1
DB06823	Tiopronin	Drug	Cystine Disulfide Reduction, Sulfur Compounds, Peptides, Genito Urinary System and Sex Hormones, Urologicals, Amino Acids, Sulfur, Amino Acids, Peptides, and Proteins, N-substituted Glycines, Peptoids, Reducing and Complexing Thiol, Amino Acids, Drugs that are Mainly Renally Excreted	approved, investigational	0
DB06822	Tinzaparin	Drug	Anticoagulants, Carbohydrates, Polysaccharides, Blood and Blood Forming Organs, Glycosaminoglycans, Fibrin Modulating Agents, Heparin (Low Molecular Weight), Agents causing hyperkalemia, Heparin and similars, Hematologic Agents, Cardiovascular Agents, Fibrinolytic Agents	approved	3
DB06825	Triptorelin	Drug	Endocrine Therapy, QTc Prolonging Agents, Oligopeptides, Peptides, Adrenal Cortex Hormones, Gonadotropin Releasing Hormone Receptor Agonists, Amino Acids, Peptides, and Proteins, Neuropeptides, Hormones, Pituitary Hormone-Releasing Hormones, Proteins, Hormones and Related Agents, Peptide Hormones, Gonadotropin-releasing hormone agonist, Potential QTc-Prolonging Agents, Antineoplastic Agents, Hormonal, Hormones, Hormone Substitutes, and Hormone Antagonists, Antineoplastic and Immunomodulating Agents, Reproductive Control Agents, Antineoplastic Agents, Nerve Tissue Proteins, Gonadotropin Releasing Hormone Receptor Agonist, Hypothalamic Hormones, Luteolytic Agents, Hyperglycemia-Associated Agents	approved, vet_approved	1
DB06824	Triethylenetetramine	Drug	Diamines, Amines, Various Alimentary Tract and Metabolism Products, Alimentary Tract and Metabolism, Metal Chelating Activity, Sequestering Agents, Metal Chelator, Polyamines, Compounds used in a research, industrial, or household setting, Chelating Agents, Drugs that are Mainly Renally Excreted, Ethylenediamines	approved, investigational	0
DB06821	Sulfameter	Drug	Long-Acting Sulfonamides, Renal Agents, Amines, Anti-Infective Agents, Urinary, Gynecological Antiinfectives and Antiseptics, Aniline Compounds, Genito Urinary System and Sex Hormones, Amides, Sulfanilamides, Antiinfectives for Systemic Use, Leprostatic Agents, Anti-Infective Agents, SULFONAMIDES AND TRIMETHOPRIM, Anti-Bacterial Agents, Sulfur Compounds, Sulfonamide Antibacterial, Sulfonamides, Antibacterials for Systemic Use, Sulfones	approved	1
DB06820	Sulconazole	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Dermatologicals, Antifungals for Dermatological Use, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Anti-Infective Agents, Cytochrome P-450 CYP1A2 Inhibitors, Azole Antifungals, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Antifungals for Topical Use, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Antifungal Agents, Imidazole and Triazole Derivatives	approved	0
DB06827	Viomycin	Drug	Peptides, Cyclic, Anti-Bacterial Agents, Enzyme Inhibitors, Peptides, Antibiotics, Antitubercular, Amino Acids, Peptides, and Proteins, Agents that produce neuromuscular block (indirect), Anti-Infective Agents, Protein Synthesis Inhibitors, Antituberculosis Agents, Neurotoxic agents	approved	1
DB06826	Unoprostone	Drug	Biological Factors, Autacoids, Inflammation Mediators, Fatty Acids, Antiglaucoma Preparations and Miotics, Eicosanoids, Lipids, Cardiovascular Agents, Prostaglandins, Synthetic, Ophthalmologicals, Fatty Acids, Unsaturated, Prostaglandins, Prostaglandins F, Antihypertensive Agents, Sensory Organs	approved, investigational	0
DB06829	4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID	Drug	0	experimental	1
DB06828	5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole	Drug	0	experimental	1
DB06870	Tetrahydrogestrinone	Drug	Norpregnatrienes, Androgens, Hormones, Hormone Substitutes, and Hormone Antagonists, Norsteroids, Anabolic Agents, Hormones, Norpregnanes, Fused-Ring Compounds, Steroids	experimental	1
DB06872	1-((2-HYDROXYETHOXY)METHYL)-5-(PHENYLTHIO)PYRIMIDINE-2,4(1H,3H)-DIONE	Drug	0	experimental	1
DB05540	Alanosine	Drug	Sequestering Agents, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibiotics, Antineoplastic, Compounds used in a research, industrial, or household setting, Amino Acids, Chelating Agents	investigational	3
DB06871	17-METHYL-17-ALPHA-DIHYDROEQUILENIN	Drug	0	experimental	2
DB05541	Brivaracetam	Drug	Epoxide Hydrolase Inhibitors, Cytochrome P-450 Substrates, Nervous System, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Anticonvulsants, Miscellaneous Anticonvulsants, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Pyrrolidines, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates	approved, investigational	2
DB04210	3-(alpha-D-galactopyranosyloxy)-N-(3-{4-[3-({2-[(3-{4-[3-({[3-(hexopyranosyloxy)-5-nitrophenyl]carbonyl}amino)propyl]piperazin-1-yl}propyl)amino]-3,4-dioxocyclobut-1-en-1-yl}amino)propyl]piperazin-1-yl}propyl)-5-nitrobenzamide	Drug	0	experimental	1
DB06878	1-[(2R)-2-aminobutanoyl]-N-(3-chlorobenzyl)-L-prolinamide	Drug	0	experimental	1
DB04215	CRA_9076	Drug	0	experimental	1
DB04216	Quercetin	Drug	Flavonols, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Protective Agents, BCRP/ABCG2 Inhibitors, Benzopyrans, Antioxidants, Heterocyclic Compounds, Fused-Ring, Flavonoids, COMT Inhibitors, COMT Substrates, P-glycoprotein inhibitors, Compounds used in a research, industrial, or household setting, Chromones, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Pyrans	investigational, experimental	29
DB06877	N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	Drug	0	experimental	1
DB04217	L-2-amino-3-butynoic acid	Drug	Acids, Acyclic, Fatty Acids, Butyrates, Fatty Acids, Volatile, Amino Acids, Peptides, and Proteins, Lipids, Amino Acids	experimental	2
DB05549	INO-1001	Drug	Heterocyclic Compounds, Fused-Ring, Poly(ADP-ribose) Polymerases, antagonists & inhibitors	investigational	0
DB04218	1-Deaza-Adenosine	Drug	0	experimental	1
DB06879	5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE	Drug	0	experimental	1
DB06874	(6-[4-(AMINOMETHYL)-2,6-DIMETHYLPHENOXY]-2-{[4-(AMINOMETHYL)PHENYL]AMINO}-5-BROMOPYRIMIDIN-4-YL)METHANOL	Drug	0	experimental	1
DB05542	Naronapride	Drug	Neurotransmitter Agents, Benzoates, Serotonin Agents, Central Nervous System Depressants, Acids, Carbocyclic, Serotonin Receptor Agonists, Amides, Antidepressive Agents, Serotonin 5-HT4 Receptor Agonists, Benzene Derivatives	investigational	1
DB04211	5-(acetylamino)-3,5-dideoxy-3-fluoro-D-erythro-alpha-L-manno-non-2-ulopyranosonic acid	Drug	0	experimental	0
DB06873	1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)PYRIMIDINE-2,4(1H,3H)-DIONE	Drug	0	experimental	1
DB04212	2-Iminiopropanoate	Drug	0	experimental	1
DB06876	N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE	Drug	0	experimental	1
DB04213	N-Cyclohexyl-N'-(Propyl)Phenyl Urea	Drug	0	experimental	1
DB05545	AMG 108	Drug	Proteins, Serum Globulins, Immunoglobulins, Receptors, Interleukin-1, antagonists & inhibitors, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB06875	ERB-196	Drug	Estrogen Receptor beta, agonists, Naphthalenes	experimental	2
DB04214	4-Nitrophenyl Phosphate	Drug	Coloring Agents, Nitro Compounds, Laboratory Chemicals, Phenols, Indicators and Reagents, Compounds used in a research, industrial, or household setting, Benzene Derivatives, Chromogenic Compounds	experimental	2
DB04219	Trivanadate	Drug	Vanadates	experimental	0
DB06881	(1Z)-2-HYDROXY-3-OXOHEX-1-EN-1-YL DIHYDROGEN PHOSPHATE	Drug	0	experimental	1
DB05550	Iratumumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB06880	(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-PROP-1-YN-1-YLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE	Drug	0	experimental	1
DB04220	CGP 4832	Drug	Lactams, Macrocyclic, Heterocyclic Compounds, Fused-Ring, Amides, Lactams	experimental	1
DB06883	1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea	Drug	0	experimental	1
DB06882	1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea	Drug	0	experimental	2
DB05552	TG100-115	Drug	Phosphatidylinositol 3-Kinases, antagonists & inhibitors, Heterocyclic Compounds, Fused-Ring, Benzene Derivatives	investigational	2
DB04221	Didecyldimethylammonium	Drug	Amines, Ammonium Compounds, Quaternary Ammonium Compounds, Antiseptics and Disinfectants, Dermatologicals, Onium Compounds, Nitrogen Compounds	approved, experimental	2
DB04226	Dihydro-Acarbose	Drug	0	experimental	0
DB06889	3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one	Drug	0	experimental	1
DB04227	9-Amino-2-deoxy-2,3-dehydro-n-acetyl-neuraminic acid	Drug	0	experimental	1
DB06888	(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE	Drug	0	experimental	1
DB05559	NF-kappaB Decoy	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Oligonucleotides, Glycosides, Nucleotides, Polynucleotides	investigational	1
DB04228	Dihydroxyphenylglycine	Drug	Ethylene Glycols, Glycols, Alcohols	experimental	0
DB04229	7,10,13-Tri(Carboxymethyl)-5,15-Dioxo-4,7,10,13,16-Pentaaza-1,19-Dithianonadecane	Drug	0	experimental	1
DB06885	3-[({(1E)-[2-(trifluoromethyl)phenyl]methylidene}amino)oxy]propanoic acid	Drug	0	experimental	0
DB05553	Regrelor	Drug	Carbohydrates, Purinergic P2 Receptor Antagonists, Nucleotides, Purinergic Agents, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Purine Nucleotides, Purines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Purinergic Antagonists, Adenine Nucleotides	investigational	1
DB04222	Sparsomycin	Drug	Enzyme Inhibitors, Pyrimidines, Pyrimidinones, Antineoplastic Agents, Antibiotics, Antineoplastic, Protein Synthesis Inhibitors	experimental	0
DB04223	Nitroarginine	Drug	Enzyme Inhibitors, Arginine, Amino Acids, Basic, Amino Acids, Essential, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, Amino Acids	investigational, experimental	2
DB06884	4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE	Drug	0	experimental	2
DB04224	Oleic Acid	Drug	Fatty Acids, Unsaturated, Fatty Acids, Oleic Acids, Lipids, Fatty Acids, Monounsaturated	approved, investigational, vet_approved	5
DB05555	Enokizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB06887	[(3S)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid	Drug	0	experimental	1
DB06886	N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL	Drug	0	experimental	1
DB04225	N-Methyldehydrobutyrine	Drug	0	experimental	0
DB05560	Delcasertib	Drug	Amino Acids, Peptides, and Proteins, Protein Kinase C-delta, antagonists & inhibitors	investigational	0
DB06892	(5S)-4,5-difluoro-6-[(2-fluoro-4-iodophenyl)imino]-N-(2-hydroxyethoxy)cyclohexa-1,3-diene-1-carboxamide	Drug	0	experimental	1
DB04230	Nitromethyldethia coenzyme A	Drug	0	experimental	1
DB06891	5-{[(4-AMINO-3-CHLORO-5-FLUOROPHENYL)SULFONYL]AMINO}-1,3,4-THIADIAZOLE-2-SULFONAMIDE	Drug	0	experimental	1
DB06894	1-Dodecanol	Drug	Lipids, Fatty Alcohols, Alcohols	experimental	2
DB05562	Naluzotan	Drug	Serotonin 5-HT1 Receptor Agonists, Neurotransmitter Agents, Sulfur Compounds, Serotonin Agents, Central Nervous System Depressants, Serotonin Receptor Agonists, Agents that produce hypertension, Amides, Antidepressive Agents, Sulfones	investigational	1
DB04231	Tetra(Imidazole)Diaquacopper (I)	Drug	0	experimental	1
DB06893	Decylsulfonic acid	Drug	0	experimental	1
DB04232	N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide	Drug	0	experimental	1
DB06890	(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE	Drug	0	experimental	1
DB04237	Tris(Hydroxyethyl)Aminomethane	Drug	0	experimental	3
DB06899	N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE	Drug	0	experimental	1
DB04238	N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid	Drug	0	experimental	1
DB04239	2-Amino-6-Aminomethyl-8-Phenylsulfanylmethyl-3h-Quinazolin-4-One	Drug	0	experimental	1
DB06896	1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide	Drug	0	experimental	1
DB04233	(Hydroxyethyloxy)Tri(Ethyloxy)Octane	Drug	0	experimental	25
DB05565	PBT-1033	Drug	0	investigational	0
DB04234	N2-({[(4-Bromophenyl)Methyl]Oxy}Carbonyl)-N1-[(1s)-1-Formylpentyl]-L-Leucinamide	Drug	0	experimental	1
DB06898	4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol	Drug	0	experimental	2
DB04235	4-Amino Hexanoic Acid	Drug	0	experimental	1
DB04236	2-Amino-3-(1h-Indol-3-Yl)-Propan-1-Ol	Drug	0	experimental	0
DB06897	3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol	Drug	0	experimental	1
DB04240	(1S)-1-C-{(2R)-6-[(2R)-2-Butanyl]-5,10-dihydroxy-4-oxo-1,2,3,4-tetrahydro-2-anthracenyl}-5-deoxy-1-O-methyl-D-xylulose	Drug	0	experimental	0
DB04241	N-Pyridoxyl-2-Methylalanine-5-Phosphate	Drug	0	experimental	1
DB04242	4-hydroxybenzoic acid	Drug	Benzoates, Hydroxy Acids, Acids, Carbocyclic, Hydroxybenzoates, Phenols, Benzene Derivatives	experimental	4
DB04243	TMP	Drug	Thymine Nucleotides, Carbohydrates, Pyrimidines, Deoxyribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides, Pyrimidine Nucleotides	experimental	1
DB04248	beta-(1->4)-galactotriose	Drug	0	experimental	1
DB04249	Zinc Substituted Heme C	Drug	Metal cations, Zinc Compounds, Metal divalent cations	experimental	1
DB04244	(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide	Drug	0	experimental	1
DB05575	Motesanib	Drug	Heterocyclic Compounds, Fused-Ring, Pyridines, Enzyme Inhibitors, Protein Kinase Inhibitors, Tyrosine Kinase Inhibitors, Nicotinic Acids	investigational	0
DB04246	CRA_23653	Drug	0	experimental	1
DB05578	Ramucirumab	Drug	Immunoglobulins, Antineoplastic and Immunomodulating Agents, VEGFR2 Inhibitors, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins, Proteins, Serum Globulins, Vascular Endothelial Growth Factor Receptor 2 Antagonist, Narrow Therapeutic Index Drugs, Globulins, Blood Proteins	approved, investigational	1
DB06834	N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide	Drug	0	experimental	1
DB05502	AG-858	Drug	0	investigational	0
DB06833	1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE	Drug	0	experimental	1
DB06836	N-(5-{4-Chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl}-4-methyl-1,3-thiazol-2-yl)acetamide	Drug	0	experimental	2
DB06835	(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(S)-HYDROXY[(1R)-2-METHYL-1-{[(2-PHENYLETHYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID	Drug	0	experimental	1
DB05505	NM-702	Drug	0	investigational	1
DB06830	(1-HYDROXYHEPTANE-1,1-DIYL)BIS(PHOSPHONIC ACID)	Drug	0	experimental	1
DB06832	Prinaberel	Drug	Receptors, Estrogen, agonists	investigational	2
DB05500	AVN-944	Drug	Acids, Acyclic, IMP Dehydrogenase, antagonists & inhibitors, Benzene Derivatives	investigational	0
DB06831	2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE	Drug	0	experimental	2
DB05501	AMD-070	Drug	Receptors, CXCR4, antagonists & inhibitors	investigational	2
DB06838	methyl L-phenylalaninate	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Amino Acids, Essential, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	2
DB05506	ISIS 113715	Drug	0	investigational	1
DB05507	VX-765	Drug	Aminobenzoates, Benzoates, Oligopeptides, Peptides, Acids, Carbocyclic, Amino Acids, Peptides, and Proteins, Benzene Derivatives	investigational	2
DB06837	(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide	Drug	0	experimental	1
DB05509	LI-301	Drug	0	investigational	2
DB06839	N-(ethoxycarbonyl)-L-leucine	Drug	0	experimental	0
DB05513	Atiprimod	Drug	0	investigational	2
DB06845	(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide	Drug	0	experimental	2
DB06844	4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE	Drug	0	experimental	2
DB05514	Cobiprostone	Drug	Biological Factors, Autacoids, Fatty Acids, Unsaturated, Inflammation Mediators, Fatty Acids, Eicosanoids, Lipids	investigational	1
DB06847	5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine	Drug	0	experimental	1
DB05516	PI-0824	Drug	0	investigational	0
DB06841	[(2R)-1-[(2S)-2-[[(2S,3S)-1-Chloro-6-(diaminomethylideneamino)-2-hydroxyhexan-3-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]azanium	Drug	0	experimental	1
DB06840	diethyl [(1R)-1,5-diaminopentyl]boronate	Drug	0	experimental	1
DB05511	Piclidenoson	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purines, Ribonucleosides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Purine Nucleosides	investigational	1
DB06843	2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE	Drug	0	experimental	3
DB06842	(4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one	Drug	0	experimental	2
DB05512	MM-093	Drug	0	investigational	0
DB06849	1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine	Drug	0	experimental	1
DB06848	1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine	Drug	0	experimental	1
DB05518	Managlinat dialanetil	Drug	Fructose-Bisphosphatase, antagonists & inhibitors, Organophosphorus Compounds, Amino Acids, Peptides, and Proteins, Amino Acids	investigational	1
DB05519	Budiodarone	Drug	Heterocyclic Compounds, Fused-Ring, Benzofurans	investigational	0
DB06850	(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide	Drug	0	experimental	2
DB06856	6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE	Drug	0	experimental	1
DB05524	Pelitinib	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Protein Kinase Inhibitors, Amines, ErbB Receptors, antagonists & inhibitors, Antineoplastic Agents	investigational	1
DB05525	EW-A-401	Drug	0	investigational	0
DB06855	6-fluoro-2-(2-hydroxy-3-isobutoxy-phenyl)-1H-benzoimidazole-5-carboxamidine	Drug	0	experimental	2
DB06858	N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide	Drug	0	experimental	2
DB06857	N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE	Drug	0	experimental	1
DB06852	CHIR-124	Drug	Heterocyclic Compounds, Fused-Ring	experimental	1
DB05520	Mimopezil	Drug	0	investigational	0
DB05521	Telaprevir	Drug	OATP1B1/SLCO1B1 Inhibitors, Antivirals for treatment of HCV infections, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Peptides, P-glycoprotein substrates, Protease Inhibitors, Organic Anion Transporting Polypeptide 2B1 Inhibitors, Amino Acids, Peptides, and Proteins, Antiviral Agents, Organic Anion Transporting Polypeptide 1B1 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, HCV NS3/4A Protease Inhibitors, Antiinfectives for Systemic Use, Cytochrome P-450 CYP3A4 Inhibitors (strong), Antivirals for Systemic Use, Direct Acting Antivirals, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, NS3/4A Protease Inhibitors, P-glycoprotein inhibitors	approved, withdrawn	3
DB06851	N-(pyridin-3-ylmethyl)aniline	Drug	0	experimental	2
DB06853	N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide	Drug	0	experimental	2
DB05528	Mipomersen	Drug	Molecular Probes, Antisense Elements (Genetics), Oligonucleotides, Hypolipidemic Agents Indicated for Hyperlipidemia, Nucleotides, Nucleic Acids, Lipid Modifying Agents, Lipid Modifying Agents, Plain, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Hepatotoxic Agents, Oligodeoxyribonucleotides, Antisense, Compounds used in a research, industrial, or household setting, Carbohydrates, Anticholesteremic Agents, Hypolipidemic Agents, Oligonucleotides, Antisense, Noxae, Apolipoprotein B-100 Synthesis Inhibitor, Laboratory Chemicals, Nucleic Acid Probes, Decreased Protein Synthesis, Polynucleotides, Lipid Regulating Agents, Diagnostic Uses of Chemicals, DNA, Antisense, DNA, Toxic Actions	approved, investigational	1
DB06859	N-ALLYL-5-AMIDINOAMINOOXY-PROPYLOXY-3-CHLORO-N-CYCLOPENTYLBENZAMIDE	Drug	0	experimental	1
DB06861	6-(2-HYDROXY-CYCLOPENTYL)-7-OXO-HEPTANAMIDINE	Drug	0	experimental	1
DB05530	CPG 10101	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Oligonucleotides, Glycosides, Nucleotides, Polynucleotides	investigational	1
DB06860	2-(2-chloropyridin-4-yl)-4-methyl-1H-isoindole-1,3(2H)-dione	Drug	0	experimental	1
DB06867	3,6,9,12,15,18-HEXAOXAICOSANE	Drug	0	experimental	1
DB04204	[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid	Drug	0	experimental	1
DB04205	Thymidine-3',5'-Diphosphate	Drug	0	experimental	2
DB06866	6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID	Drug	0	experimental	1
DB04206	7-Aza-L-tryptophan	Drug	0	experimental	1
DB06869	1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE	Drug	0	experimental	1
DB06868	N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide	Drug	0	experimental	1
DB04207	L-Saccharopine	Drug	Amino Acids, Basic, Amino Acids, Essential, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	1
DB04200	Matairesinol	Drug	Benzyl Compounds, Plants, Benzene Derivatives	experimental	1
DB05531	alpha-Pyrrolidinononanophenone	Drug	0	investigational	0
DB04201	Histidyl-Adenosine Monophosphate	Drug	0	experimental	2
DB05532	BMS-488043	Drug	HIV Fusion Inhibitors, Viral Fusion Protein Inhibitors, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Anti-Infective Agents	investigational	1
DB06862	2-HYDROXY-5-(2-MERCAPTO-ETHYLSULFAMOYL)-BENZOIC ACID	Drug	0	experimental	1
DB06865	6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID	Drug	0	experimental	1
DB05533	QR-333	Drug	0	investigational	1
DB04202	Isoformononetin	Drug	0	experimental	0
DB04203	3-Mercuri-4-Aminobenzenesulfonamide	Drug	0	experimental	1
DB06864	2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID	Drug	0	experimental	1
DB04208	3-(3,4-dimethoxyphenyl)propanoic acid	Drug	0	experimental	1
DB04209	Dequalinium	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Quinoline Derivatives, Throat Preparations, Gynecological Antiinfectives and Antiseptics, Miscellaneous Anti-infectives, Quinolinium Compounds, Antiseptics and Disinfectants, Dermatologicals, Genito Urinary System and Sex Hormones, Anti-Infective Agents, Anti-Infective Agents, Local	approved, investigational	5
DB04295	N-(Benzoylcarbamoyl)-beta-D-glucopyranosylamine	Drug	Carbohydrates, Hexoses, Glycogen Phosphorylase, antagonists & inhibitors, Monosaccharides	experimental	1
DB04296	5-Oxo-L-Norleucine	Drug	0	experimental	1
DB04297	Trichostatin A	Drug	Enzyme Inhibitors, Amines, Hydroxy Acids, Hydroxylamines, Antineoplastic Agents, Antifungal Agents, Histone Deacetylase Inhibitors, Anti-Infective Agents, Protein Synthesis Inhibitors	experimental	3
DB04298	3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4-Hydroxy-Phenyl)-Ethyl]-5,6-Dihydro-Pyran-2-One	Drug	0	experimental	1
DB04291	Oxfenicine	Drug	Enzyme Inhibitors, Amino Acids, Peptides, and Proteins, Carnitine O-Palmitoyltransferase, antagonists & inhibitors, Amino Acids	experimental	0
DB04292	4-[(Isopropylamino)Methyl]Phenylalanine	Drug	0	experimental	0
DB04293	7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid	Drug	0	experimental	1
DB04294	5-Phosphoribosyl-1-(Beta-Methylene) Pyrophosphate	Drug	0	experimental	1
DB04299	Maleic Acid	Drug	Acids, Acyclic, Enzyme Inhibitors, Dicarboxylic Acids, Acid Etching, Dental, Aldehyde Reductase, antagonists & inhibitors	experimental	5
DB04252	N-Carbamoylaspartic acid	Drug	Amino Acids, Dicarboxylic, Excitatory Amino Acids, Amino Acids, Peptides, and Proteins, Amino Acids, Acidic, Amino Acids	experimental	1
DB04253	Tretazicar	Drug	Prodrugs, Antineoplastic Agents, Azirines, Radiation-Sensitizing Agents	investigational	2
DB05584	Praconase	Drug	Metalloproteases, Biological Factors, Enzymes, Transferases, Glycosyltransferases, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Metalloendopeptidases, Recombinant Proteins, Bacterial Proteins, Proteins, Toxins, Biological, Bacterial Toxins, Hydrolases, Peptide Hydrolases, Endopeptidases, Pentosyltransferases	investigational	0
DB05585	Verubulin	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB04254	8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine	Drug	0	experimental	1
DB05580	TRU-015	Drug	0	investigational	0
DB04250	Butyrylthiocholine	Drug	Thiocholine, Amines, Ammonium Compounds, Quaternary Ammonium Compounds, Trimethyl Ammonium Compounds, Onium Compounds, Amino Alcohols, Ethanolamines, Alcohols, Sulfur Compounds, Cholinesterase substrates, Nitrogen Compounds, Sulfhydryl Compounds	experimental	1
DB04259	7-Methyl-7,8-dihydroguanosine 5'-(dihydrogen phosphate)	Drug	0	experimental	0
DB04255	Inhibitor BEA388	Drug	0	experimental	1
DB05586	Facinicline	Drug	Heterocyclic Compounds, Fused-Ring, Pyrazoles	investigational	0
DB04256	(S)-alpha-methyl-4-carboxyphenylglycine	Drug	0	experimental	1
DB04257	Palmitoleic Acid	Drug	Fatty Acids, Unsaturated, Fatty Acids, Lipids	experimental	3
DB04258	Seocalcitol	Drug	Cholestanes, Immunologic Factors, Secosteroids, Immunosuppressive Agents, Antineoplastic Agents, Lipids, Fused-Ring Compounds, Vitamins, Sterols, Vitamin D and Analogues, Vitamins (Fat Soluble), Membrane Lipids, Cholestenes, Steroids	investigational	1
DB04262	3-(7-hydroxy-8-ribityllumazine-6-yl) propionic acid	Drug	0	experimental	1
DB04263	Geneticin	Drug	Nephrotoxic agents, Carbohydrates, Coccidiostats, Antiprotozoals, Agents that produce neuromuscular block (indirect), Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Anti-Bacterial Agents, Narrow Therapeutic Index Drugs, Aminoglycoside Antibacterials, Glycosides, Antiparasitic Agents, Amebicides	experimental	1
DB05594	Cantuzumab ravtansine	Drug	0	investigational	0
DB04264	(10R)-10-formyl-5,8,10-trideazafolic acid	Drug	0	experimental	1
DB05595	Farletuzumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	1
DB05596	PRX-03140	Drug	0	investigational	0
DB04265	N-acetyl-beta-neuraminic acid	Drug	0	experimental	4
DB05590	Bedoradrine	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Amides, Lipids, Acetates	investigational	1
DB04260	9-(5,5-Difluoro-5-Phosphonopentyl)Guanine	Drug	0	experimental	1
DB04261	Carbamic Acid	Drug	Acids, Acyclic	experimental	1
DB05592	Blarcamesine	Drug	0	investigational	0
DB04266	5-(6-D-ribitylamino-2,4-dihydroxypyrimidin-5-yl)-1-pentyl-phosphonic acid	Drug	0	experimental	0
DB04267	Dipicolinic acid	Drug	Pyridines, Enzyme Inhibitors, Sequestering Agents, Compounds used in a research, industrial, or household setting, Chelating Agents, Procollagen-Proline Dioxygenase, antagonists & inhibitors	experimental	2
DB04268	Methylumbelliferyl chitotriose	Drug	0	experimental	1
DB05599	Fibroblast growth factor-1	Drug	Proteins, Biological Factors, Peptides, Fibroblast Growth Factor 1, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Fibroblast Growth Factors	investigational	0
DB04269	Cyclotheonamide A	Drug	Peptides, Thrombin, antagonists & inhibitors, Amino Acids, Peptides, and Proteins	experimental	1
DB04273	8,9-Dichloro-2,3,4,5-Tetrahydro-1h-Benzo[C]Azepine	Drug	0	experimental	1
DB04274	(2S)-7-hydroxyflavanone	Drug	0	experimental	0
DB04275	N-acetylserotonin	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Autacoids, Inflammation Mediators, Amines, Biogenic Amines, Indoles, Tryptamines, Biogenic Monoamines	experimental	1
DB04276	4-[[(2S)-2-[[(2S)-3-Carboxy-2-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]butyl-(diaminomethylidene)azanium	Drug	0	experimental	2
DB04270	(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid	Drug	0	experimental	1
DB04271	3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester	Drug	0	experimental	1
DB04272	Citric acid	Drug	Acids, Acyclic, Citrates, Calculi Dissolution Agent, Hematologic Agents, Calcium Chelating Agents, Acidifying Activity, Tricarboxylic Acids, Urinary Alkalinisers, Calcium Chelating Activity, Alimentary Tract and Metabolism, Sequestering Agents, Decreased Coagulation Factor Activity, Digestives, Incl. Enzymes, Urinary Acidifying Agents, Acid Preparations, Compounds used in a research, industrial, or household setting, Chelating Agents	approved, nutraceutical, vet_approved	50
DB04277	Fructose -6-Phosphate	Drug	0	experimental	1
DB04278	2-[2-(2-Cyclohexyl-2-guanidino-acetylamino)-acetylamino]-N-(3-mercapto-propyl)-propionamide	Drug	0	experimental	1
DB04279	3-Isopropylmalic Acid	Drug	0	experimental	2
DB04284	L-proline betaine	Drug	Acids, Acyclic, Amino Acids, Cyclic, Imines, Amino Acids, Peptides, and Proteins, Imino Acids, Amino Acids	experimental	1
DB04285	{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid	Drug	0	experimental	1
DB04286	beta-D-Ribopyranose	Drug	0	experimental	2
DB04287	KH064	Drug	Acids, Acyclic, Valerates, Fatty Acids, Fatty Acids, Volatile, Lipids	experimental	1
DB04280	3,4-Dihydro-2'-deoxyuridine-5'-monophosphate	Drug	0	experimental	1
DB04281	2-[4-(4-Chlorophenyl)Cyclohexylidene]-3,4-Dihydroxy-1(2h)-Naphthalenone	Drug	0	experimental	1
DB04282	2-deoxy-2-fluoro-α-D-glucose	Drug	0	experimental	4
DB04283	2-Bromohypoxanthine	Drug	0	experimental	0
DB04288	2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine	Drug	0	experimental	1
DB04289	Genz-10850	Drug	Heterocyclic Compounds, Fused-Ring	experimental	1
DB06911	D-leucyl-N-(3-chlorobenzyl)-L-prolinamide	Drug	0	experimental	1
DB06910	[4-R-(4-ALPHA,6-BETA,7-BETA]-HEXAHYDRO-5,6-DI(HYDROXY)-1,3-DI(ALLYL)-4,7-BISPHENYLMETHYL)-2H-1,3-DIAZEPINONE	Drug	0	experimental	1
DB06913	(3R)-3-[3,5-Bis(trifluoromethyl)anilino]-2-cyano-3-sulfanylpropanamide	Drug	0	experimental	1
DB06912	UNDECA-3,7-DIENE-1,3,7,11-TETRACARBALDEHYDE	Drug	0	experimental	1
DB06919	D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide	Drug	0	experimental	1
DB06918	2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE	Drug	0	experimental	1
DB06915	naphthalene-1,2,4,5,7-pentol	Drug	0	experimental	0
DB06914	1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE	Drug	0	experimental	1
DB06917	(4-fluorophenyl)(pyridin-4-yl)methanone	Drug	0	experimental	1
DB06916	N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE	Drug	0	experimental	1
DB06922	2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid	Drug	0	experimental	1
DB06921	(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID	Drug	0	experimental	1
DB06924	(2R)-2-benzyl-3-nitropropanoic acid	Drug	0	experimental	1
DB06923	2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE	Drug	0	experimental	1
DB06920	Eribaxaban	Drug	0	experimental	1
DB06929	1-butanoyl-N-(4-carbamimidoylbenzyl)-L-prolinamide	Drug	0	experimental	1
DB06926	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	Drug	0	experimental	1
DB06925	3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE	Drug	0	experimental	1
DB06928	(2S)-2-{[HYDROXY(4-IODOBENZYL)PHOSPHORYL]METHYL}PENTANEDIOIC ACID	Drug	0	experimental	1
DB06927	[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE	Drug	0	experimental	3
DB06933	N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide	Drug	0	experimental	1
DB06932	10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine	Drug	0	experimental	1
DB06935	2',6'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID	Drug	0	experimental	0
DB06934	(1R)-3-chloro-1-phenylpropan-1-ol	Drug	0	experimental	1
DB06931	(1-HYDROXYNONANE-1,1-DIYL)BIS(PHOSPHONIC ACID)	Drug	0	experimental	1
DB06930	N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide	Drug	0	experimental	1
DB06937	4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL	Drug	0	experimental	1
DB05606	Beclanorsen	Drug	0	investigational	0
DB06936	N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide	Drug	0	experimental	1
DB05607	PRX-08066	Drug	Serotonin 5-HT2 Receptor Antagonists, Sulfur Compounds, Serotonin Agents, Central Nervous System Depressants, Serotonin Receptor Antagonists, Antidepressive Agents	investigational	1
DB06939	N-(TRANS-4-{(1S,2S)-2-AMINO-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-1-METHYL-3-OXOPROPYL}CYCLOHEXYL)-N-METHYLACETAMIDE	Drug	0	experimental	1
DB06938	4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide	Drug	0	experimental	1
DB05608	MKC-1	Drug	Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors	investigational	0
DB06944	N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide	Drug	0	experimental	2
DB06943	(3S)-1-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}pyrrolidine-3-thiol	Drug	0	experimental	1
DB06946	(2S,3S)-3-(4-fluorophenyl)-2,3-dihydroxypropanoic acid	Drug	0	experimental	1
DB06945	N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide	Drug	0	experimental	1
DB06940	N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide	Drug	0	experimental	1
DB06942	N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide	Drug	0	experimental	1
DB05611	Apilimod	Drug	Oxazines	investigational	0
DB06941	(Z)-2-[2-(4-methylpiperazin-1-yl)benzyl]diazenecarbothioamide	Drug	0	experimental	1
DB06948	2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE	Drug	0	experimental	2
DB05616	4'-Methylene-5,8,10-trideazaaminopterin	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Pterins, Pteridines, Pigments, Biological	investigational	0
DB06947	1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide	Drug	0	experimental	1
DB06949	N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]naphthalene-2-carbohydrazide	Drug	0	experimental	1
DB06900	1-[4-(hydroxymethyl)phenyl]guanidine	Drug	0	experimental	1
DB06902	p-Cumylphenol	Drug	Benzene Derivatives	experimental	1
DB06901	2-(2-HYDROXY-CYCLOPENTYL)-PENT-4-ENAL	Drug	0	experimental	1
DB06908	(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID	Drug	0	experimental	2
DB06907	2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID	Drug	0	experimental	0
DB06909	1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide	Drug	0	experimental	1
DB06904	(5S,6S)-6-[(R)ACETOXYETH-2-YL]-PENEM-3-CARBOXYLATEPROPANE	Drug	0	experimental	1
DB06903	(1S,3aS,5aR,8aS)-1,7,7-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene-4-carboxylic acid	Drug	0	experimental	1
DB06906	ethyl 2-amino-4-hydroxypyrimidine-5-carboxylate	Drug	0	experimental	1
DB06905	(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid	Drug	0	experimental	3
DB06991	N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide	Drug	0	experimental	1
DB05660	D-JNKI-1	Drug	Neuroprotective Agents, Amino Acids, Peptides, and Proteins	investigational	0
DB06990	4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID	Drug	0	experimental	1
DB06993	(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine	Drug	0	experimental	1
DB04330	Bilh 434	Drug	0	experimental	1
DB05662	NP-50301	Drug	0	investigational	1
DB04331	Monastrol	Drug	Enzyme Inhibitors, Sulfur Compounds, Antimitotic Agents, Antineoplastic Agents, Mitosis Modulators	experimental	1
DB06992	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	Drug	0	experimental	1
DB03000	S-9-(2-hydroxypropyl)adenine	Drug	0	experimental	1
DB06999	PLX-4720	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amides, Sulfones	experimental	1
DB05667	Levoketoconazole	Drug	0	investigational	2
DB04336	1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea	Drug	Benzoates, Acids, Carbocyclic, Amides, Benzene Derivatives	experimental	1
DB03004	(2S)-2-amino-6-[[(3R,4R)-1-[(1S)-1-carboxy-2-[(S)-methylsulfinyl]ethyl]-2-oxo-4-sulfanylazetidin-3-yl]amino]-6-oxohexanoic acid	Drug	0	experimental	0
DB05668	Palifosfamide	Drug	Oxazines, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, Hydrocarbons, Halogenated, Anions, Phosphoramides, Antineoplastic Agents, Alkylating, Phosphoramide Mustards, Noxae, Amino Acids, Essential, Antineoplastic Agents, Organophosphorus Compounds, Ions, Mustard Compounds, Nitrogen Mustard Compounds, Phosphorus Compounds, Amino Acids, Phosphorus Acids, Alkylating Drugs, Acids, Noncarboxylic, Acids, Phosphoric Acids, Amino Acids, Basic, Electrolytes, Toxic Actions	investigational	1
DB06998	[(5R)-5-(2,3-dibromo-5-ethoxy-4-hydroxybenzyl)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]acetic acid	Drug	0	experimental	1
DB03003	Glutathione sulfonic acid	Drug	0	experimental	4
DB04337	Isocyanomethane	Drug	0	experimental	1
DB04338	SB220025	Drug	Calcium-Calmodulin-Dependent Protein Kinases, antagonists & inhibitors	experimental	2
DB03002	p-Iodophenol	Drug	Hydrocarbons, Halogenated, Benzene Derivatives, Hydrocarbons, Iodinated	experimental	0
DB04339	Carbocisteine	Drug	Cough and Cold Preparations, Expectorants	approved, investigational	1
DB03001	Peridinin	Drug	Biological Factors, Cycloparaffins, Alkenes, Hydrocarbons, Acyclic, Polyenes, Cyclohexenes, Terpenes, Cyclohexanes, Pigments, Biological	experimental	0
DB04332	2-{2-[2-2-(Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethanol	Drug	0	experimental	0
DB06995	N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide	Drug	0	experimental	1
DB03008	5-fluoro-beta-L-gulosyl fluoride	Drug	Carbohydrates, Monosaccharides	experimental	1
DB03007	9r,13r-Opda	Drug	0	experimental	0
DB06994	(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine	Drug	0	experimental	1
DB04333	Octamethylenediamine	Drug	Amines, Polyamines	experimental	0
DB06997	2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide	Drug	0	experimental	1
DB04334	6-hydroxydopa quinone	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Amines, Phenylalanine, Amino Acids, Essential, Phenols, Amino Acids, Peptides, and Proteins, Catecholamines, Catechols, Amino Acids, Benzene Derivatives	experimental	3
DB03006	Arsanilic acid	Drug	Organometallic Compounds, Radiation-Protective Agents, Immunologic Factors, Alkenes, Adjuvants, Immunologic, Arsenicals, Protective Agents, Hydrocarbons, Acyclic, Compounds used in a research, industrial, or household setting, Anti-Infective Agents, Tellurium	experimental, vet_approved	1
DB04335	Inosine	Drug	Carbohydrates, Ribonucleosides, Gynecological Antiinfectives and Antiseptics, Dermatologicals, Genito Urinary System and Sex Hormones, Purine Nucleosides, Ophthalmologicals, Heterocyclic Compounds, Fused-Ring, Purines, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Sensory Organs	investigational, experimental	3
DB06996	D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide	Drug	0	experimental	1
DB03005	3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium	Drug	0	experimental	1
DB03009	2-{[2-Oxo-2-(1-piperidinyl)ethyl]sulfanyl}-6-(trifluoromethyl)-4(1H)-pyrimidinone	Drug	0	experimental	0
DB05670	ATL-104	Drug	0	investigational	0
DB04340	2-[(Dioxidophosphoranyl)oxy]benzoate	Drug	0	experimental	1
DB05671	AC-100	Drug	0	investigational	0
DB04341	S-(3-Iodobenzyl)glutathione	Drug	0	experimental	0
DB04342	7-((Carboxy(4-Hydroxyphenyl)Acetyl)Amino)-7-Methoxy-(3-((1-Methyl-1h-Tetrazol-5-Yl)Thio)Methyl)-8-Oxo-5-Oxa-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid	Drug	0	experimental	1
DB03011	Adenosine-5'-(Dithio)Phosphate	Drug	0	experimental	1
DB03010	Patupilone	Drug	Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Tubulin Modulators, Macrolides, Antimitotic Agents, Cytochrome P-450 CYP3A4 Inhibitors, Antineoplastic Agents, Mitosis Modulators, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Lactones	investigational, experimental	11
DB04347	3-Dehydroshikimate	Drug	Cycloparaffins, Hydroxy Acids, Acids, Carbocyclic, Cyclohexenes, Cyclohexanecarboxylic Acids, Cyclohexanes	experimental	2
DB03015	6-hydroxy-1,6-dihydro purine nucleoside	Drug	0	experimental	1
DB05678	SLx-4090	Drug	Heterocyclic Compounds, Fused-Ring, Benzoates, Acids, Carbocyclic, Amides, Benzene Derivatives	investigational	1
DB05679	Ustekinumab	Drug	Immunoglobulins, Immunosuppressive Agents, Interleukin-23 Antagonist, Antineoplastic and Immunomodulating Agents, Dermatologicals, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Misc. Skin and Mucous Membrane Agents, Interleukin Inhibitors, Immunoproteins, Interleukin-12 Antagonist, Proteins, Serum Globulins, Antibodies, Monoclonal, Humanized, Globulins, Biologics for psoriasis treatment, Blood Proteins, Immunomodulatory Agents	approved, investigational	2
DB04348	Taurocholic acid	Drug	Sulfur Acids, Alkanes, BSEP/ABCB11 Substrates, OAT1/SLC22A6 Substrates, OATP1B3 substrates, Cholic Acids, Fused-Ring Compounds, OAT3/SLC22A8 Substrates, Sulfur Compounds, BSEP/ABCB11 inducers, Sulfonic Acids, Cholagogues and Choleretics, Compounds used in a research, industrial, or household setting, Gastrointestinal Agents, Alkanesulfonic Acids, Surface-Active Agents, OATP1B1/SLCO1B1 Inhibitors, P-glycoprotein substrates, Hydrocarbons, Acyclic, BCRP/ABCG2 Inhibitors, Detergents, Bile Acids and Salts, Household Products, OAT1/SLC22A6 inhibitors, Acids, Noncarboxylic, Acids, OATP1B1/SLCO1B1 Substrates, OAT3/SLC22A8 Inhibitors, OATP1B1/SLCO1B1 Inducers, P-glycoprotein inhibitors, Cholanes, Steroids	approved, experimental	3
DB03013	N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine	Drug	0	experimental	3
DB04349	(S)-propane-1,2-diol	Drug	0	experimental	2
DB03012	Phenylalanine-N-Sulfonamide	Drug	0	experimental	1
DB03019	4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine	Drug	0	experimental	1
DB04343	Glyoxylic acid	Drug	Acids, Aldehydic	experimental	4
DB03018	3,4-dimethylaniline	Drug	Amines	experimental	1
DB05675	EP-2104R	Drug	Lanthanoid Series Elements, Contrast Media, Metals, Amino Acids, Peptides, and Proteins, Elements, Metals, Rare Earth	investigational	1
DB03017	Lauric acid	Drug	Fatty Acids, Lipids	approved, experimental	21
DB04345	Lumichrome	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Coenzymes, Enzymes and Coenzymes, Pteridines, Pigments, Biological	experimental	2
DB05676	Apremilast	Drug	Phosphodiesterase Inhibitors, Cytochrome P-450 Substrates, Immunosuppressive Agents, Anti-Inflammatory Agents, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Agents reducing cytokine levels, Cytochrome P-450 CYP3A4 Substrates, Disease-modifying Antirheumatic Agents, Selective Immunosuppressants, Drugs that are Mainly Renally Excreted, Isoindoles, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Substrates, Phthalimides, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2A6 Substrates, Phosphodiesterase 4 Inhibitors	approved, investigational	1
DB03016	CRA_1801	Drug	0	experimental	1
DB04346	(2r,4s)-2-Methyl-2,3,3,4-Tetrahydroxytetrahydrofuran	Drug	0	experimental	1
DB15004	MS-1819	Drug	0	investigational	0
DB15005	Viltolarsen	Drug	0	investigational	0
DB15002	Fitusiran	Drug	0	investigational	0
DB15003	PF-06700841	Drug	Enzyme Inhibitors, Protein Kinase Inhibitors	investigational	0
DB15008	GO-203-2C	Drug	0	investigational	0
DB15009	PF-04937319	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB15006	Flufenoxuron	Drug	Benzene Derivatives	investigational	0
DB15007	Sevuparin	Drug	Carbohydrates, Polysaccharides, Glycosaminoglycans	investigational	0
DB04350	Argadin	Drug	Peptides, Amino Acids, Peptides, and Proteins	experimental	2
DB04351	Aconitate Ion	Drug	0	experimental	2
DB04352	beta-D-Ribose-5-phosphate	Drug	0	experimental	2
DB05683	Iodofiltic acid I-123	Drug	Iodine Radioisotopes, Hydrocarbons, Halogenated, Lipids, Benzene Derivatives, Hydrocarbons, Iodinated	investigational	0
DB04353	Tert-butyl N-[(2S,5R)-6-[[(2S)-5-amino-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-benzyl-3,6-dioxo-1-phenylhexan-2-yl]carbamate	Drug	0	experimental	1
DB03022	3-[2,6,8-Trioxo-9-[(2R,3S,4R)-2,3,4,5-tetrahydroxypentyl]-3H-purin-7-yl]propyl dihydrogen phosphate	Drug	0	experimental	1
DB03021	Ulapualide A	Drug	Ionophores	experimental	1
DB03020	5-beta-D-ribofuranosylnicotinamide adenine dinucleotide	Drug	0	experimental	1
DB05680	Sotirimod	Drug	0	investigational	0
DB03026	Phosphoglycolohydroxamic Acid	Drug	0	experimental	6
DB03025	(S)-oct-1-en-3-ol	Drug	0	experimental	0
DB04359	Vinylsulfonic acid	Drug	Sulfur Compounds, Acids, Noncarboxylic, Acids, Alkenes, Sulfur Acids, Hydrocarbons, Acyclic, Phosphogluconate Dehydrogenase, antagonists & inhibitors	experimental	1
DB03024	2-Methyl-3-(2-Aminothiazolo)Propanal	Drug	0	experimental	1
DB03023	1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine	Drug	0	experimental	3
DB05685	FX06	Drug	0	investigational	1
DB05686	Sivifene	Drug	Hydrazines, Benzene Derivatives	investigational	0
DB05687	BL-1020	Drug	Acids, Acyclic, Fatty Acids, Phenothiazines, Amino Acids, Peptides, and Proteins, Lipids, Aminobutyrates, Amino Acids, Heterocyclic Compounds, Fused-Ring, Antipsychotic Agents, Sulfur Compounds, Butyrates, Central Nervous System Depressants, Fatty Acids, Volatile, Neurotoxic agents	investigational	2
DB03028	1h-Benoximidazole-2-Carboxylic Acid	Drug	0	experimental	1
DB04356	9-Deazaguanine	Drug	Heterocyclic Compounds, Fused-Ring, Purines, Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 Substrates, Xanthine derivatives, Purinones	experimental	1
DB04357	Pteric acid	Drug	0	experimental	0
DB05688	CRx-119	Drug	0	investigational	2
DB15000	Dianexin	Drug	0	investigational	0
DB15001	Eflapegrastim	Drug	0	investigational	0
DB15015	Recombinant CD40-ligand	Drug	Biological Factors, Carbohydrates, CD40 Ligand, antagonists & inhibitors, Cytokines, Glycoconjugates, Peptides, Intercellular Signaling Peptides and Proteins, Tumor Necrosis Factors, Amino Acids, Peptides, and Proteins, Glycoproteins, Membrane Proteins, Proteins, Membrane Glycoproteins	investigational	0
DB15016	Palladium Pd-103	Drug	0	investigational	0
DB15013	TAK-243	Drug	Carbohydrates, Sulfur Compounds, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Amides, Sulfones	investigational	0
DB15014	Gremubamab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB15019	Mongersen	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides, Polynucleotides	investigational	0
DB15017	Enoblituzumab	Drug	0	investigational	0
DB15018	Agatolimod	Drug	0	investigational	0
DB04361	Methyldiazene	Drug	0	experimental	1
DB04362	Adenosine Diphosphate 5-(Beta-Ethyl)-4-Methyl-Thiazole-2-Carboxylic Acid	Drug	0	experimental	0
DB04363	Mesobiliverdin IV alpha	Drug	0	experimental	1
DB04364	(R)-acetoin	Drug	0	experimental	0
DB05695	NPS-2143	Drug	0	investigational	1
DB03033	4-methoxybenzenesulfinate	Drug	0	experimental	2
DB03032	S-octylglutathione	Drug	Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins, Glutathione Transferase, antagonists & inhibitors	experimental	1
DB03031	Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Octyl-Amide	Drug	0	experimental	1
DB04360	Benzo[B]Thiophene-2-Boronic Acid	Drug	0	experimental	1
DB03030	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	Drug	0	experimental	1
DB03037	Oxidized Acetyl Dithranol	Drug	0	experimental	1
DB04369	1,3,2-Dioxaborolan-2-Ol	Drug	0	experimental	1
DB03035	1,8-Di-Hydroxy-4-Nitro-Anthraquinone	Drug	0	experimental	1
DB03034	D-Levofloxacin	Drug	OCT2 Inhibitors	experimental	1
DB04365	Arecoline	Drug	Alkaloids, Neurotransmitter Agents, Pyridines, Cholinergic Agents, Cholinergic Agonists, Nicotinic Acids	experimental	2
DB04366	3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate	Drug	0	experimental	1
DB03039	4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide	Drug	0	experimental	1
DB04367	Debromohymenialdisine	Drug	Protein Kinase C, antagonists & inhibitors	experimental	2
DB05698	GI-4000	Drug	0	investigational	0
DB03038	LY341770	Drug	0	experimental	1
DB04368	Bb-3497	Drug	Amines, Hydroxy Acids, Hydroxylamines	experimental	2
DB15011	Avacopan	Drug	Amines, Piperidines	investigational	0
DB15012	Farampator	Drug	Oxazoles	investigational	0
DB15010	Edasalonexent	Drug	Fatty Acids, Essential, Biological Factors, Autacoids, Fatty Acids, Unsaturated, Inflammation Mediators, Fatty Acids, Eicosanoids, Amides, Lipids	investigational	0
DB06955	3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid	Drug	0	experimental	1
DB06954	2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate	Drug	0	experimental	1
DB05624	Teverelix	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Amino Acids, Peptides, and Proteins, Hormone Antagonists	investigational	1
DB06957	4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL	Drug	0	experimental	1
DB05625	CTCE-9908	Drug	Amino Acids, Peptides, and Proteins	investigational	0
DB05626	Retaspimycin	Drug	Quinones, Protein-Serine-Threonine Kinases, antagonists & inhibitors, Amides, Lactams, HSP90 Heat-Shock Proteins, antagonists & inhibitors	investigational	0
DB06956	N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE	Drug	0	experimental	1
DB06951	(3R)-3-ethyl-N-[(4-methylphenyl)sulfonyl]-L-aspartic acid	Drug	0	experimental	1
DB06950	4-chloro-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide	Drug	0	experimental	1
DB05620	AVI-4065	Drug	0	investigational	0
DB06953	2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE	Drug	0	experimental	2
DB06952	(2S)-2-HYDROXY-2H-CHROMENE-2-CARBOXYLIC ACID	Drug	0	experimental	1
DB06959	(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine	Drug	0	experimental	2
DB06958	5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE	Drug	0	experimental	1
DB06960	N-[(1R,2R,3E)-2-hydroxy-1-(hydroxymethyl)heptadec-3-en-1-yl]acetamide	Drug	0	experimental	1
DB04303	4-O-methyl-alpha-D-glucuronic acid	Drug	0	experimental	2
DB06966	Hexylphosphonic acid (S)-2-methyl-3-phenylpropyl ester	Drug	0	experimental	1
DB04304	L-Gluconic Acid	Drug	0	experimental	1
DB06965	Hexylphosphonic acid (R)-2-methyl-3-phenylpropyl ester	Drug	0	experimental	1
DB06968	1,1'-HEXANE-1,6-DIYLBIS(1H-IMIDAZOLE)	Drug	0	experimental	1
DB04306	5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine	Drug	0	experimental	2
DB06967	6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE	Drug	0	experimental	1
DB06962	JNJ-27390467	Drug	0	experimental	1
DB05630	Sodium stibogluconate	Drug	Acids, Acyclic, Carbohydrates, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Hydroxy Acids, Gluconates, Antimony Compounds, Schistosomicides, Anti-Infective Agents, Organometallic Compounds, Agents Against Leishmaniasis and Trypanosomiasis, Sugar Acids, Antiplatyhelmintic Agents, Antiparasitic Agents	approved, investigational	1
DB04300	(1s,3r,4r,6s)-1,3,4,6-Tetrapkisphosphate	Drug	0	experimental	0
DB06961	5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide	Drug	0	experimental	1
DB05631	ALT-2074	Drug	Selenium Compounds	investigational	0
DB04301	Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate	Drug	0	experimental	1
DB06964	5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE	Drug	0	experimental	1
DB05633	Glypromate	Drug	Peptides, Amino Acids, Peptides, and Proteins	investigational	0
DB06963	3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide	Drug	0	experimental	1
DB04302	4-Hydroxy-3,5-Dimethyl-5-(2-Methyl-Buta-1,3-Dienyl)-5h-Thiophen-2-One	Drug	0	experimental	2
DB04307	5-Hydroxy-N-Propargyl-1(R)-Aminoindan	Drug	0	experimental	1
DB05638	Asvasiran	Drug	0	investigational	0
DB04308	D-4-hydroxyphenylglycine	Drug	Enzyme Inhibitors, Amino Acids, Peptides, and Proteins, Carnitine O-Palmitoyltransferase, antagonists & inhibitors, Amino Acids	experimental	0
DB06969	2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide	Drug	0	experimental	1
DB06971	N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA	Drug	0	experimental	1
DB06970	2-CHLORO-N-(3-CYANO-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHEN-2-YL)-5-DIETHYLSULFAMOYL-BENZAMIDE	Drug	0	experimental	1
DB06977	(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine	Drug	0	experimental	1
DB04314	1-Methylcytosine	Drug	Pyrimidines, Pyrimidinones	experimental	1
DB05645	Larazotide	Drug	Peptides, Amino Acids, Peptides, and Proteins	investigational	0
DB06976	1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA	Drug	0	experimental	1
DB04315	Guanosine-5'-Diphosphate	Drug	0	experimental	51
DB06979	5-(dodecylthio)-1H-1,2,3-triazole-4-carboxylic acid	Drug	0	experimental	1
DB04316	D-[(N-Hydroxyamino)Carbonyl]Phenylalanine	Drug	0	experimental	1
DB06978	N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]-4-methoxybenzohydrazide	Drug	0	experimental	1
DB04317	3,3-Dichloro-2-Phosphonomethyl-Acrylic Acid	Drug	0	experimental	1
DB06973	Bisphenol A	Drug	Air Pollutants, Occupational, Environmental Pollutants, Hormones, Hormone Substitutes, and Hormone Antagonists, Estrogens, Non-Steroidal, Protective Agents, Estrogens, Free Radical Scavengers, Benzopyrans, Hormones, Antioxidants, Heterocyclic Compounds, Fused-Ring, Air Pollutants, Toxic Actions, Compounds used in a research, industrial, or household setting, Benzene Derivatives, Pyrans	experimental	1
DB04310	2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide	Drug	0	experimental	11
DB06972	7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile	Drug	0	experimental	1
DB05642	DDP-225	Drug	0	investigational	2
DB04311	4-Phenylbutylamine	Drug	Amines, Hydrocarbons, Acyclic, Alkanes, Butanes	experimental	1
DB04312	2,3-Difluorobenzyl Alcohol	Drug	0	experimental	1
DB05643	IRX-2	Drug	Proteins, Biological Factors, Peptides, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins	investigational	0
DB06974	5-hydroxy-4-(7-methoxy-1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-2-(3-methylbutyl)-6-phenylpyridazin-3(2H)-one	Drug	0	experimental	1
DB04313	(3S)-3-methyl-D-aspartic acid	Drug	0	investigational, experimental	0
DB05644	KP-1461	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides	investigational	1
DB04318	Nα-[(2S)-2-{[(S)-[(1S)-1-{[(Benzyloxy)carbonyl]amino}-2-phenylethyl](hydroxy)phosphoryl]methyl}-5-phenylpentanoyl]-L-tryptophanamide	Drug	0	experimental	1
DB05649	NTx-265	Drug	0	investigational	0
DB06980	(2S)-2-(1H-indol-3-yl)hexanoic acid	Drug	0	experimental	1
DB06982	(2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid	Drug	0	experimental	1
DB05650	OT-551	Drug	0	investigational	0
DB04320	2-Bromo-2-Propene-1-Ol	Drug	0	experimental	1
DB06981	(2S)-2-(1H-indol-3-yl)pentanoic acid	Drug	0	experimental	1
DB06988	2-HYDROXY-5-{[(1E)-2-PHENYLETHYLIDENE]AMINO}-L-TYROSINE	Drug	0	experimental	1
DB04325	Phenethylamine	Drug	Amines, Ethylamines, Central Nervous System Depressants, Central Nervous System Agents, Psychotropic Drugs	experimental	3
DB05656	Veltuzumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB06987	(R)-Atenolol	Drug	0	experimental	2
DB04326	Dihydroxyacetone phosphate	Drug	Carbohydrates, Sugar Phosphates	investigational	4
DB04327	Phosphatidylethanolamine	Drug	Carbohydrates, Glycerophosphates, Sugar Phosphates, Sugar Alcohols, Lipids, Membrane Lipids, Phospholipids, Phosphatidic Acids, Triose Sugar Alcohols, Glycerophospholipids, Alcohols	experimental	3
DB06989	{4-[2-BENZYL-3-METHOXY-2-(METHOXYCARBONYL)-3-OXOPROPYL]PHENYL}SULFAMIC ACID	Drug	0	experimental	1
DB05659	Faropenem medoxomil	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amides, Lactams	investigational	3
DB04328	Shikimate-3-Phosphate	Drug	Cycloparaffins, Hydroxy Acids, Acids, Carbocyclic, Cyclohexenes, Cyclohexanecarboxylic Acids, Cyclohexanes	experimental	2
DB04321	N-Hexylphosphonate Ethyl Ester	Drug	0	experimental	0
DB05652	VTP-201227	Drug	0	investigational	0
DB06984	(1R,2R,3R,4S,5R)-4-(BENZYLAMINO)-5-(METHYLTHIO)CYCLOPENTANE-1,2,3-TRIOL	Drug	0	experimental	1
DB06983	(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol	Drug	0	experimental	1
DB04322	LY249543	Drug	0	experimental	1
DB05653	IRX-5183	Drug	Biological Factors, Cycloparaffins, Carotenoids, Alkenes, Hydrocarbons, Acyclic, Polyenes, Cyclohexenes, Terpenes, Cyclohexanes, Pigments, Biological	investigational	0
DB06986	2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE	Drug	0	experimental	1
DB04323	2-Amino-3-(Cystein-S-Yl)-Isoxazolidin-5-Yl-Acetic Acid	Drug	0	experimental	0
DB04324	Ovalicin	Drug	Terpenes	experimental	2
DB06985	2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid	Drug	0	experimental	0
DB04329	Isoquinoline	Drug	Heterocyclic Compounds, Fused-Ring	experimental	0
DB15068	Agerafenib	Drug	0	investigational	0
DB15069	Pexastimogene devacirepvec	Drug	0	investigational	0
DB03084	Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine	Drug	0	experimental	1
DB03083	IC261	Drug	Heterocyclic Compounds, Fused-Ring, Phenols, Benzene Derivatives	experimental	1
DB03082	6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide	Drug	0	experimental	1
DB03081	[N-[N-(4-Methoxy-2,3,6-trimethylphenylsulfonyl)-L-aspartyl]-D-(4-amidino-phenylalanyl)]-piperidine	Drug	0	experimental	1
DB03088	Pidolic acid	Drug	Acids, Acyclic, Amino Acids, Peptides, and Proteins, Mineral Supplements, Amino Acids, Acidic, Amino Acids, Amino Acids, Cyclic, Pyrrolidinones, Amino Acids, Dicarboxylic, Imines, Alimentary Tract and Metabolism, Pyrrolidines, Glutamates, Imino Acids	approved, investigational	14
DB03087	2-(Sec-Butyl)Thiazole	Drug	0	experimental	1
DB03086	N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide	Drug	0	experimental	1
DB03085	Glycolic acid	Drug	Acids, Acyclic, Fatty Acids, Hydroxy Acids, Fatty Acids, Volatile, Dermatologicals, Lipids, Keratolytic Agents, Acetates	approved, investigational	1
DB15062	Inarigivir	Drug	0	investigational	0
DB15063	Inarigivir soproxil	Drug	0	investigational	0
DB15061	Lefitolimod	Drug	0	investigational	0
DB15066	Givosiran	Drug	Nephrotoxic agents, RNA, Antisense, Oligonucleotides, Antisense, Oligonucleotides, Hepatotoxic Agents	approved, investigational	1
DB15067	Volanesorsen	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides, Polynucleotides	investigational	0
DB15064	Teprasiran	Drug	0	investigational	0
DB15065	PF-06291874	Drug	Alanine, Amino Acids, Peptides, and Proteins, Amino Acids	investigational	0
DB15079	Troriluzole	Drug	0	investigational	0
DB03091	Isoglutamine	Drug	Amino Acids, Neutral, Amino Acids, Basic, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	1
DB03090	Ethylaminobenzylmethylcarbonyl Group	Drug	0	experimental	1
DB03095	Tetramethylammonium	Drug	Autonomic Agents, Amines, Ammonium Compounds, Onium Compounds, Ganglionic Stimulants, Nitrogen Compounds, Peripheral Nervous System Agents	experimental	1
DB03094	3,5-Dihydro-5-Methylidene-4h-Imidazol-4-On	Drug	0	experimental	0
DB03093	8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine	Drug	0	experimental	1
DB03092	5-Hydroxymethyl-Chonduritol	Drug	0	experimental	3
DB03099	5-Amino 6-Nitro Uracil	Drug	0	experimental	0
DB03098	[Methylseleno]Acetate	Drug	Selenium Compounds	experimental	1
DB03097	PMP-hydroxyisoxazole, pyridoxamine-5-phosphate-hydroxyisoxazole	Drug	0	experimental	1
DB03096	2-Morpholinoethylamine	Drug	0	experimental	1
DB15070	GI heptapeptide	Drug	0	investigational	0
DB15073	Ribose	Drug	Carbohydrates, Pentoses, Monosaccharides	investigational	0
DB15074	Aglatimagene besadenovec	Drug	0	investigational	0
DB15071	Omidenepag isopropyl	Drug	0	investigational	0
DB15072	Beinaglutide	Drug	0	investigational	0
DB15077	Efinopegdutide	Drug	0	investigational	0
DB15078	Rogaratinib	Drug	Sulfur Compounds	investigational	0
DB15075	4-demethyl-4-cholesteryloxycarbonylpenclomedine	Drug	0	investigational	0
DB15076	Abrilumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB15080	ELX-02	Drug	0	investigational	0
DB15081	Melanoma antigen recognized by T-cells 1	Drug	0	investigational	0
DB15084	GS-9191	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Amino Acids, Essential, Amino Acids, Peptides, and Proteins, Amino Acids	investigational	0
DB15085	Fulacimstat	Drug	0	investigational	0
DB15082	Cabiralizumab	Drug	0	investigational	0
DB15083	Domagrozumab	Drug	0	investigational	0
DB15088	Oleclumab	Drug	0	investigational	0
DB15089	Frovocimab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB15086	Ocrylate	Drug	Acids, Acyclic, Acrylates, Equipment and Supplies, Nitriles, Surgical Equipment, Polymers, Tissue Adhesives, Compounds used in a research, industrial, or household setting, Surgical Fixation Devices, Macromolecular Substances	investigational	0
DB15087	Psicose	Drug	Carbohydrates, Hexoses, Ketoses, Monosaccharides	investigational	0
DB15091	Upadacitinib	Drug	OATP1B1/SLCO1B1 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 Substrates, P-glycoprotein substrates, Antirheumatic Agents, BCRP/ABCG2 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Disease-modifying Antirheumatic Agents, Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2D6 Substrates, P-glycoprotein inhibitors, Janus Kinase Inhibitors	approved, investigational	1
DB15092	LY-2624803	Drug	0	investigational	0
DB15090	Tezepelumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB15095	Leridistim	Drug	Biological Factors, Carbohydrates, Cytokines, Glycoconjugates, Peptides, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Glycoproteins, Recombinant Proteins, Hematopoietic Cell Growth Factors, Proteins, Interleukins, Colony-Stimulating Factors	investigational	0
DB15096	18-methoxycoronaridine	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Indoles, Secologanin Tryptamine Alkaloids, Indole Alkaloids	investigational	0
DB15093	Somapacitan	Drug	Peptide Hormones, Growth Hormone, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pituitary Hormones, Amino Acids, Peptides, and Proteins, Lipids, Hormones, Pituitary Hormones, Anterior	investigational	0
DB15094	Anfibatide	Drug	Proteins, Toxins, Biological, Biological Factors, Viper Venoms, Complex Mixtures, Venoms, Lectins, Amino Acids, Peptides, and Proteins, Snake Venoms, Fluids and Secretions, Bodily Secretions	investigational	0
DB15099	GW-468816	Drug	Heterocyclic Compounds, Fused-Ring, Receptors, N-Methyl-D-Aspartate, antagonists & inhibitors	investigational	0
DB15097	Gefapixant	Drug	0	investigational	0
DB15098	Morinidazole	Drug	Imidazoles, Nitro Compounds	investigational	0
DB15026	CXA-10	Drug	0	investigational	0
DB15027	Adriforant	Drug	0	investigational	0
DB15024	Apararenone	Drug	0	investigational	0
DB15025	Girentuximab I-124	Drug	0	investigational	0
DB15028	MK-1064	Drug	0	investigational	0
DB15029	AZD-8186	Drug	Heterocyclic Compounds, Fused-Ring, Amines, Benzopyrans, Pyrans	investigational	0
DB03040	Nitrilotriacetic acid	Drug	Acids, Acyclic, Fatty Acids, Peptides, Fatty Acids, Volatile, Sequestering Agents, Amino Acids, Peptides, and Proteins, Lipids, Acetates, Compounds used in a research, industrial, or household setting, Chelating Agents	experimental	1
DB04372	L-Dilinoleoyllecithin	Drug	Carbohydrates, Glycerophosphates, Sugar Phosphates, Sugar Alcohols, Lipids, Membrane Lipids, Phospholipids, Phosphatidic Acids, Triose Sugar Alcohols, Glycerophospholipids, Alcohols	experimental	1
DB04373	4-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide	Drug	0	experimental	1
DB04374	4-Carboxy-5-(1-Pentyl)Hexylsulfanyl-1,2,3-Triazole	Drug	0	experimental	1
DB03044	Doramapimod	Drug	Protein Kinase Inhibitors	investigational	1
DB03043	(S)-2-Amino-3-(6h-Selenolo[2,3-B]-Pyrrol-4-Yl)-Propionic Acid	Drug	Selenium Compounds	experimental	0
DB03042	5-Phosphoarabinonic Acid	Drug	0	experimental	2
DB04370	S-sulphocysteine	Drug	Amino Acids, Neutral, Sulfur Compounds, Amino Acids, Sulfur, Amino Acids, Peptides, and Proteins, Amino Acids, Sulfhydryl Compounds	experimental	0
DB03041	UDP-alpha-D-glucuronic acid	Drug	Carbohydrates, Pyrimidines, Ribonucleotides, Deoxyribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Uridine Diphosphate, Glycosides, Nucleoside Diphosphate Sugars, Uracil Nucleotides, Uridine Diphosphate Sugars, Nucleotides, Pyrimidine Nucleotides	experimental	3
DB04371	AL6528	Drug	0	experimental	1
DB03048	6-Carboxymethyluracil	Drug	0	experimental	1
DB03047	L-Alpha-Phosphatidyl-Beta-Oleoyl-Gamma-Palmitoyl-Phosphatidylethanolamine	Drug	0	experimental	0
DB03046	7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide	Drug	0	experimental	1
DB03045	Pantothenyl-Aminoethanol-Acetate Pivalic Acid	Drug	0	experimental	1
DB04376	13-Acetylphorbol	Drug	0	experimental	1
DB04377	Meglutol	Drug	Acids, Acyclic, Lipid Modifying Agents, Lipid Modifying Agents, Plain, Lipid Regulating Agents, Anticholesteremic Agents, Enzyme Inhibitors, Hypolipidemic Agents, Noxae, Glutarates, Dicarboxylic Acids, Toxic Actions, Antimetabolites	experimental	1
DB04378	3-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide	Drug	0	experimental	1
DB03049	S-Selanyl Cysteine	Drug	Selenium Compounds	experimental	1
DB04379	N-Methyl-N-(Methylbenzyl)Formamide	Drug	Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 Substrates	experimental	1
DB15022	Apomab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB15023	BMS-791826	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Thiazoles	investigational	0
DB15020	Mureletecan	Drug	0	investigational	0
DB15021	Leriglitazone	Drug	0	investigational	0
DB15037	Poly(lactic acid)	Drug	Membranes, Artificial, Dental Implants, Polymers, Compounds used in a research, industrial, or household setting, Delayed-Action Preparations, Drug Delivery Systems, Macromolecular Substances	investigational	0
DB15038	Litoxetine	Drug	0	investigational	0
DB15035	Zanubrutinib	Drug	Enzyme Inhibitors, Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 Substrates, Teratogens, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic Agents, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Hematologic Agents, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Enzyme Inducers, Protein Kinase Inhibitors, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2B6 Substrates	approved, investigational	15
DB15036	Sitravatinib	Drug	Amines, Aniline Compounds, Amides	investigational	0
DB15039	ITI-214	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB03051	(S)-2-Tetrahydrofuroic acid	Drug	0	experimental	2
DB04383	L-valinol	Drug	0	experimental	0
DB04384	Fe-Mesopone	Drug	0	experimental	0
DB04385	3-Deazacytidine	Drug	Carbohydrates, Cytidine Deaminase, antagonists & inhibitors, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Glycosides, Nucleosides	experimental	1
DB04386	4,6-O-(1-Carboxyethylidene)-Beta-D-Glucose	Drug	0	experimental	1
DB03054	Bromoform	Drug	Carcinogens, Noxae, Teratogens, Hydrocarbons, Halogenated, Toxic Actions	experimental	0
DB04380	Allantoate	Drug	0	experimental	1
DB04381	Crotonaldehyde	Drug	0	experimental	1
DB03053	1-Aminocyclopropylphosphonate	Drug	0	experimental	1
DB04382	2-Deoxy-alpha-D-galactopyranose	Drug	0	experimental	1
DB03052	Dazoxiben	Drug	Enzyme Inhibitors, Thromboxane-A Synthase, antagonists & inhibitors	experimental	1
DB03059	Acetoacetyl-CoA	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Coenzymes, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Thioesters of coenzyme A, Enzymes and Coenzymes, Glycosides, Nucleotides, Adenine Nucleotides	experimental	8
DB03058	2-Aminobenzyl alcohol	Drug	Benzyl Compounds, Benzene Derivatives, Alcohols	experimental	1
DB03057	Malonaldehyde	Drug	Aldehydes	experimental	1
DB03056	4-Piperidino-Piperidine	Drug	0	experimental	1
DB04387	1-Hydroxy-2-Amino-3-Cyclohexylpropane	Drug	0	experimental	2
DB04388	4-Carboxy-4-Aminobutanal	Drug	0	experimental	1
DB04389	Ado-P-Ch2-P-Ps-Ado	Drug	0	experimental	1
DB15030	GTI-2040	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Oligonucleotides, Glycosides, Nucleotides, Polynucleotides	investigational	0
DB15033	Flortaucipir	Drug	Heterocyclic Compounds, Fused-Ring, Pyridines, Contrast Media, Diagnostic Uses of Chemicals, Indoles, Compounds used in a research, industrial, or household setting	investigational	0
DB15034	PRI-724	Drug	Pyrimidines	investigational	0
DB15031	Nemorexant	Drug	0	investigational	0
DB15032	Obexelimab	Drug	0	investigational	0
DB15048	Licogliflozin	Drug	0	investigational	0
DB15046	LY-2881835	Drug	0	investigational	0
DB15047	BMS-919373	Drug	0	investigational	0
DB04394	3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide	Drug	0	experimental	1
DB03062	(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone	Drug	Dietary Supplements, Supplements	experimental	2
DB03061	(R)-N-(1-Methyl-Hexyl)-Formamide	Drug	0	experimental	1
DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	Drug	0	experimental	49
DB04396	Thiodigalactoside	Drug	Galactosides, Carbohydrates, Sulfur Compounds, Glycosides, Thioglycosides	experimental	4
DB03060	Sri-9662	Drug	0	experimental	1
DB04397	Alpha-D-Glucose-1-Phosphate-6-Vanadate	Drug	Vanadates	experimental	1
DB03066	D-Lactic acid	Drug	0	experimental	1
DB04391	Aeruginosin 98-B	Drug	Peptides, Amino Acids, Peptides, and Proteins	experimental	1
DB03065	7-Nitroindazole-2-Carboxamidine	Drug	0	experimental	1
DB03064	3-Decyl-2,5-Dioxo-4-Hydroxy-3-Pyrroline	Drug	0	experimental	1
DB04392	Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]	Drug	0	experimental	3
DB04393	Soneclosan	Drug	0	experimental	1
DB03063	N-[(2S,3S)-4-[2-[(5S)-3a,4,5,6,7,7a-Hexahydro-1,3-benzodioxol-5-yl]ethyl-[3-(1,3-dioxoisoindol-2-yl)propanoyl]amino]-3-hydroxy-1-phenylbutan-2-yl]-3,5-dimethoxy-4-phenylmethoxybenzamide	Drug	0	experimental	1
DB03069	Cytidine-5'-diphospho-beta-D-xylose	Drug	0	experimental	1
DB03068	Zebularine	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Glycosides, Nucleosides	experimental	1
DB03067	4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid	Drug	0	experimental	1
DB04398	Lactic acid	Drug	Lactates, Basic Ointments and Protectants, Hydroxy Acids, Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Organic Acids, Miscellaneous Local Anti-infectives	approved, vet_approved	2
DB15040	TP-271	Drug	Naphthacenes	investigational	0
DB15041	Florilglutamic acid F-18	Drug	0	investigational	0
DB15044	Tafasitamab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB15045	Ipafricept	Drug	Immunoglobulins, Peptide Fragments, Peptides, Amino Acids, Peptides, and Proteins, Receptors, Cell Surface, Recombinant Proteins, Immunoglobulin Fragments, Immunoproteins, Membrane Proteins, Proteins, Serum Globulins, Globulins, Blood Proteins, Immunoglobulin Constant Regions	investigational	0
DB15042	Tavolixizumab	Drug	0	investigational	0
DB15043	Toripalimab	Drug	0	investigational	0
DB15059	Aprocitentan	Drug	Sulfur Compounds, Amides, Sulfones	investigational	0
DB15057	NUC-1031	Drug	Carbohydrates, Pyrimidines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Cytosine Nucleotides, Antineoplastic Agents, Glycosides, Nucleotides, Pyrimidine Nucleotides	investigational	0
DB15058	Flutemetamol	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amines, Contrast Media, Diagnostic Uses of Chemicals, Laboratory Chemicals, Thiazoles, Indicators and Reagents, Radiopharmaceuticals, Compounds used in a research, industrial, or household setting	investigational	0
DB03073	3-Methoxybenzamide	Drug	Enzyme Inhibitors, Benzoates, Acids, Carbocyclic, Amides, Poly(ADP-ribose) Polymerase Inhibitors, Benzene Derivatives	experimental	1
DB03072	2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone	Drug	0	experimental	1
DB03071	4-Methylidene-5-One	Drug	0	experimental	0
DB03070	Selenazole-4-carboxyamide-adenine dinucleotide	Drug	Selenium Compounds	experimental	1
DB03077	3-Amino-4-{3-[2-(2-Propoxy-Ethoxy)-Ethoxy]-Propylamino}-Cyclobut-3-Ene-1,2-Dione	Drug	0	experimental	2
DB03076	3-[[(3R,4S,5S,6R)-7-Benzyl-4,5-dihydroxy-1,1-dioxo-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepan-2-yl]methyl]-N-methylbenzamide	Drug	0	experimental	1
DB03075	(Diphosphono)Aminophosphonic Acid	Drug	0	experimental	1
DB03074	7-cyano-7-deazaguanine	Drug	Heterocyclic Compounds, Fused-Ring, Purines, Xanthine derivatives, Purinones	experimental	1
DB03079	Alpha-Ribazole-5'-Phosphate Derivative	Drug	0	experimental	1
DB03078	PASBN	Drug	0	experimental	1
DB15051	Ethaselen	Drug	Selenium Compounds	investigational	0
DB15052	Ansofaxine	Drug	0	investigational	0
DB15050	Neopterin	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Coenzymes, Pterins, Enzymes and Coenzymes, Pteridines, Pigments, Biological	investigational	0
DB15055	ABT-639	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amides, Sulfones	investigational	0
DB15056	Bifenthrin	Drug	Sarcoma, Experimental, chemically induced, Tremor, chemically induced, Monoterpenes, Terpenes	investigational	0
DB15053	Lintuzumab satetraxetan AC-225	Drug	0	investigational	0
DB15054	TAS-117	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB05708	GTS-21	Drug	Neurotransmitter Agents, Cytochrome P-450 CYP2E1 Substrates, Cholinergic Agents, Cytochrome P-450 Substrates, Cholinergic Agonists, Nicotinic Agonists, Cytochrome P-450 CYP1A2 Substrates, Benzene Derivatives	investigational	1
DB05705	ALS-08	Drug	0	investigational	0
DB05706	13-deoxydoxorubicin	Drug	0	investigational	2
DB05712	AZD-9684	Drug	0	investigational	1
DB05713	LY-517717	Drug	Amino Acids, Peptides, and Proteins, Amino Acids	investigational	1
DB05714	Flovagatran	Drug	Acids, Noncarboxylic, Acids, Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins, Boron Compounds	investigational	1
DB05710	Gantacurium	Drug	Anticholinergic Agents, Heterocyclic Compounds, Fused-Ring, Muscle Relaxants, Peripherally Acting Agents, Central Nervous System Depressants, Muscle Relaxants, Nicotinic Antagonists	investigational	1
DB05719	Elesclomol	Drug	Sulfur Compounds, Amides	investigational	0
DB05718	Maxy-G34	Drug	Biological Factors, Carbohydrates, Cytokines, Glycoconjugates, Peptides, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Glycoproteins, Recombinant Proteins, Alcohols, Hematopoietic Cell Growth Factors, Macromolecular Substances, Proteins, Ethylene Glycols, Glycols, Polymers, Compounds used in a research, industrial, or household setting, Colony-Stimulating Factors	investigational	0
DB05722	CGC-11047	Drug	Amines	investigational	0
DB05723	ALKS 29	Drug	0	investigational	0
DB05724	alpha-Conotoxin VC 1.1	Drug	Toxins, Biological, Biological Factors, Mollusk Venoms, Complex Mixtures, Venoms, Fluids and Secretions, Bodily Secretions, Marine Toxins	investigational	0
DB05721	EVT 201	Drug	Heterocyclic Compounds, Fused-Ring, Benzazepines	investigational	0
DB05735	Cefilavancin	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Glycoconjugates, Peptides, Amides, Amino Acids, Peptides, and Proteins, Lactams, Thiazines, beta-Lactams	investigational	0
DB04404	Allosamizoline	Drug	Amino Sugars, Carbohydrates, Hexosamines, Chitinases	experimental	3
DB04405	2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid	Drug	0	experimental	1
DB05736	MIV-701	Drug	0	investigational	1
DB05730	PMI-001	Drug	0	investigational	0
DB04400	L-erythro-7,8-dihydrobiopterin	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Coenzymes, Pterins, Enzymes and Coenzymes, Pteridines, Pigments, Biological	experimental	6
DB04401	Betaine aldehyde	Drug	Amines, Ammonium Compounds, Quaternary Ammonium Compounds, Trimethyl Ammonium Compounds, Onium Compounds, Nitrogen Compounds	experimental	1
DB05732	Strontium malonate	Drug	0	investigational	0
DB05737	Varespladib methyl	Drug	Acids, Acyclic, Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Fatty Acids, Fatty Acids, Volatile, Lipids, Phospholipase A2 Inhibitors	investigational	2
DB04406	3-(Phosphonomethyl)Pyridine-2-Carboxylic Acid	Drug	0	experimental	0
DB05738	Vapitadine	Drug	0	investigational	0
DB04407	4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol	Drug	0	experimental	1
DB04408	Ncs-Chromophore	Drug	0	experimental	1
DB05739	CYT006-AngQb	Drug	Peptides, Amino Acids, Peptides, and Proteins	investigational	2
DB04409	Naphthalene Trisulfonate	Drug	0	experimental	1
DB15104	Telisotuzumab vedotin	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB15101	Tigatuzumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB15102	Pemigatinib	Drug	Cytochrome P-450 Substrates, Fibroblast Growth Factor 2, antagonists & inhibitors, P-glycoprotein substrates, Antineoplastic Agents, MATE inhibitors, Receptors, Fibroblast Growth Factor, antagonists & inhibitors, MATE 1 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Substrates, OCT2 Inhibitors, Receptor, Fibroblast Growth Factor, Type 1, antagonists & inhibitors, P-glycoprotein inhibitors, Kinase Inhibitor	approved, investigational	4
DB15108	Tipranavir C-14	Drug	0	investigational	0
DB15105	PF-06751979	Drug	0	investigational	0
DB15106	Surufatinib	Drug	0	investigational	0
DB05780	ATX-101	Drug	0	investigational	0
DB04450	Heptyl 1-Thiohexopyranoside	Drug	0	experimental	4
DB04451	4-Methylpiperazin-1-Yl Carbonyl Group	Drug	0	experimental	2
DB15109	Ingenol disoxate	Drug	Terpenes	investigational	0
DB04452	Aminoquinuride	Drug	0	experimental	1
DB03121	(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid	Drug	0	experimental	1
DB03120	p-Toluenesulfonic acid	Drug	Arylsulfonates, Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfur Acids, Sulfonic Acids, Arylsulfonic Acids, Benzene Derivatives	experimental	2
DB04457	2'-Deoxyguanosine-5'-Monophosphate	Drug	0	experimental	2
DB03125	2,4-Diamino-5-(3,4,5-Trimethoxy-Benzyl)-Pyrimidin-1-Ium	Drug	0	experimental	2
DB04458	2,2-Dichloro-1-methanesulfinyl-3-methyl-cyclopropanecarboxylic acid [1-(4-bromo-phenyl)-ethyl]-amide	Drug	0	experimental	0
DB05789	MX6	Drug	0	investigational	0
DB03124	5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid	Drug	0	experimental	1
DB04459	3,4-Dichloroisocoumarin	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Benzopyrans, Serine Protease Inhibitors, Pyrans	experimental	1
DB04453	4-O-(4,6-Dideoxy-4-{[4-[(4-O-Hexopyranosylhexopyranosyl)Oxy]-5,6-Dihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}Hexopyranosyl)Hexopyranose	Drug	0	experimental	1
DB03129	Diamino-N-[3-(1,3,2-dioxaborolan-2-yloxy)propyl]methaniminium	Drug	0	experimental	1
DB04454	Alpha-Aminobutyric Acid	Drug	Acids, Acyclic, Fatty Acids, Butyrates, Fatty Acids, Volatile, Amino Acids, Peptides, and Proteins, Lipids, Amino Acids	experimental	4
DB05785	LGD-1550	Drug	0	investigational	4
DB03128	Acetylcholine	Drug	OCT1 substrates, Amines, Cholinergic Agonists, Antiglaucoma Preparations and Miotics, Cholinergic Receptor Agonist, Parasympathomimetics, Miotics, Cardiovascular Agents, Ophthalmologicals, Neurotransmitter Agents, Cholinergic Agents, Biogenic Amines, Sensory Organs, Vasodilating Agents	approved, investigational	6
DB03127	Benzamidine	Drug	Enzyme Inhibitors, Protease Inhibitors, Amidines, Serine Protease Inhibitors	experimental	11
DB04455	N,N,N-trimethylglycinium	Drug	0	investigational, experimental	2
DB05786	Irofulven	Drug	Alkylating Drugs, Noxae, Antineoplastic Agents, Toxic Actions, Terpenes, Radiation-Sensitizing Agents, Antineoplastic Agents, Alkylating	investigational	1
DB03126	Mant-Adp	Drug	Aminobenzoates, Carbohydrates, Benzoates, Acids, Carbocyclic, Nucleotides, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Adenine Nucleotides, Benzene Derivatives	experimental	1
DB05787	LM-609	Drug	0	investigational	1
DB04456	Arsenous acid	Drug	Organometallic Compounds, Anions, Arsenicals, Electrolytes, Ions	investigational, experimental	2
DB15100	Cusatuzumab	Drug	0	investigational	0
DB15114	Vamorolone	Drug	Pregnadienes, Anti-Inflammatory Agents, Pregnanes, Fused-Ring Compounds, Steroids	investigational	0
DB15115	Nimacimab	Drug	0	investigational	0
DB15112	Somatropin pegol	Drug	Growth Hormone, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pituitary Hormones, Amino Acids, Peptides, and Proteins, Hormones, Alcohols, Macromolecular Substances, Peptide Hormones, Ethylene Glycols, Glycols, Polymers, Compounds used in a research, industrial, or household setting, Pituitary Hormones, Anterior	investigational	0
DB15113	Utomilumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Immunoglobulin Isotypes, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB15118	Zolbetuximab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB15119	Ropeginterferon alfa-2b	Drug	Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Adjuvants, Immunologic, Interferons, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)	investigational	0
DB15116	Ramatercept	Drug	0	investigational	0
DB15117	Transfluthrin	Drug	Cycloparaffins, Agrochemicals, Pesticides, Hydrocarbons, Halogenated, Insecticides, Toxic Actions, Hydrocarbons, Fluorinated, Compounds used in a research, industrial, or household setting, Benzene Derivatives	investigational	0
DB05791	Perflubron	Drug	Magnetic Resonance Imaging Contrast Media, Contrast Media, Diagnostic Uses of Chemicals, Emulsions, Anti-Obesity Agents, Hydrocarbons, Halogenated, Hydrocarbons, Fluorinated, Compounds used in a research, industrial, or household setting, Radiation-Sensitizing Agents	investigational	0
DB04460	(C8-S)-Hydantocidin 5'-phosphate	Drug	0	experimental	1
DB04461	Coproporphyrinogen III	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Porphyrinogens, Pigments, Biological, Porphyrins	experimental	1
DB05792	Arylacenamide	Drug	Immunologic Factors, Cycloparaffins, Enzyme Inhibitors, Receptors, sigma, antagonists & inhibitors	investigational	1
DB05793	PRO-542	Drug	Antigens, Biological Factors, Carbohydrates, Immunoglobulins, Peptide Fragments, Glycoconjugates, Peptides, Cell Adhesion Molecules, HIV Fusion Inhibitors, Immunoglobulin Fc Fragments, Amino Acids, Peptides, and Proteins, Glycoproteins, Recombinant Proteins, Recombinant Fusion Proteins, Immunoglobulin Fragments, Immunoproteins, Membrane Proteins, Proteins, Serum Globulins, Globulins, Blood Proteins, Immunoglobulin Constant Regions, Antigens, Surface, Membrane Glycoproteins	investigational	1
DB04462	Tetrabromo-2-Benzotriazole	Drug	0	experimental	1
DB04463	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	Drug	0	experimental	1
DB05794	Serelaxin	Drug	Vasodilators Used in Cardiac Diseases, Cardiac Therapy	investigational	0
DB03132	3-(2-Benzothiazolylthio)-1-Propanesulfonic Acid	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Triose-Phosphate Isomerase, antagonists & inhibitors, Acids, Noncarboxylic, Acids, Sulfur Acids, Hydrocarbons, Acyclic, Sulfonic Acids, Thiazoles, Alkanes	experimental	2
DB03130	S-P-Nitrobenzyloxycarbonylglutathione	Drug	0	experimental	1
DB05790	SR 140333	Drug	Stereoisomerism	investigational	1
DB05799	NOX-100	Drug	0	investigational	0
DB04468	Afimoxifene	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, Androstenes, Antineoplastic Agents, Benzylidene Compounds, Estrogen Receptor Modulators, Hormones, Fused-Ring Compounds, Receptors, Estrogen, agonists, Gonadal Steroid Hormones, Androstanes, Estrogen Antagonists, Selective Estrogen Receptor Modulators, Stilbenes, Androstenols, Hormone Antagonists, Benzene Derivatives, Gonadal Hormones, Steroids	investigational	7
DB03136	4-Iodobenzo[B]Thiophene-2-Carboxamidine	Drug	0	experimental	3
DB03135	[2(Formyl-Hydroxy-Amino)-Ethyl]-Phosphonic Acid	Drug	0	experimental	1
DB04469	1-(4-Methoxyphenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester	Drug	0	experimental	1
DB03134	L-2-aminopimelic acid	Drug	Acids, Acyclic, Dicarboxylic Acids	experimental	1
DB03133	2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole	Drug	0	experimental	1
DB04464	N-Formylmethionine	Drug	Amino Acids, Neutral, Sulfur Compounds, Amino Acids, Essential, Amino Acids, Sulfur, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	43
DB03139	6-[5-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Pentanoylamino]-Hexanoic Acid	Drug	0	experimental	1
DB04465	Lactose	Drug	Food Additives, Carbohydrates, Disaccharides, Flavoring Agents, Oligosaccharides, Pharmaceutic Aids, Polysaccharides, Physiological Phenomena, Food and Beverages, Food Ingredients, Pharmaceutical Preparations, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food, Sweetening Agents	approved, investigational, experimental	8
DB05796	Daglutril	Drug	Heterocyclic Compounds, Fused-Ring, Neprilysin, antagonists & inhibitors	investigational	1
DB04466	SR12813	Drug	0	experimental	1
DB05797	TNX-901	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	1
DB03138	Perchlorate	Drug	Acids, Noncarboxylic, Acids, Chlorine Compounds	experimental	1
DB04467	N-(5'-phosphopyridoxyl)-L-alanine	Drug	0	experimental	3
DB05798	GEM-231	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides, Polynucleotides	investigational	2
DB03137	8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine	Drug	0	experimental	1
DB15110	Onvansertib	Drug	0	investigational	0
DB15111	Acetic acid C-11	Drug	0	investigational	0
DB15125	Belapectin	Drug	0	investigational	0
DB15126	IMG-7289	Drug	0	investigational	0
DB15123	Dorzagliatin	Drug	0	investigational	0
DB15124	PF-05241328	Drug	0	investigational	0
DB15129	Pegadricase	Drug	0	investigational	0
DB15127	Hydrogen	Drug	Gases, Elements	investigational	0
DB15128	Remtolumab	Drug	Proteins, Serum Globulins, Globulins, Blood Proteins, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB04471	2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol	Drug	0	experimental	1
DB04472	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	Drug	0	experimental	2
DB04473	alpha-L-fucose	Drug	0	experimental	4
DB04474	8-anilinonaphthalene-1-sulfonic acid	Drug	Arylsulfonates, Amines, Sulfur Acids, Aniline Compounds, Coloring Agents, Arylsulfonic Acids, Laboratory Chemicals, Naphthalenes, Luminescent Agents, Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfonic Acids, Indicators and Reagents, Compounds used in a research, industrial, or household setting, Fluorescent Dyes, Naphthalenesulfonates	experimental	2
DB03143	Nonan-1-Ol	Drug	0	experimental	1
DB03142	Alpha-L-Arabinose	Drug	0	experimental	3
DB03141	3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril	Drug	0	experimental	2
DB03140	4-Carboxyphenylboronic Acid	Drug	0	experimental	1
DB04470	CRA_10656	Drug	0	experimental	1
DB04479	4-Nitro-Inden-1-One	Drug	0	experimental	0
DB03147	Flavin adenine dinucleotide	Drug	Biological Factors, Carbohydrates, Coenzymes, Enzymes and Coenzymes, Nucleotides, Pteridines, Vitamins, Pigments, Biological, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Vitamin B Complex, Adenine Nucleotides, Flavins	approved	86
DB03146	2-deazo-6-thiophosphate guanosine-5'-monophosphate	Drug	0	experimental	1
DB03145	4-Methyl-5-Hydroxyethylthiazole Phosphate	Drug	0	experimental	1
DB03144	N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine	Drug	Amino Acids, Basic, Amino Acids, Essential, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	5
DB04476	Trencam-3,2-Hopo	Drug	0	experimental	1
DB04477	2'-Deoxy-2'-[(3,5-dimethoxybenzoyl)amino]-N-[(1R)-1,2,3,4-tetrahydro-1-naphthalenyl]adenosine	Drug	0	experimental	1
DB03148	Adenosine 5'-methylenediphosphate	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Enzyme Inhibitors, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, 5'-Nucleotidase, antagonists & inhibitors, Glycosides, Nucleotides, Adenine Nucleotides	experimental	4
DB04478	Cp-166572, 2-Hydroxymethyl-4-(4-N,N-Dimethylaminosulfonyl-1-Piperazino)-Pyrimidine	Drug	0	experimental	1
DB15121	AT-001	Drug	0	investigational	0
DB15122	PCS-499	Drug	Deuterium, Alkaloids, Heterocyclic Compounds, Fused-Ring, Purines, Xanthine derivatives, Purinones	investigational	0
DB15120	GSK-239512	Drug	Heterocyclic Compounds, Fused-Ring, Histamine Antagonists, Nootropic Agents	investigational	0
DB15136	Rebaudioside A	Drug	Diterpenes, Terpenes, Sweetening Agents	investigational	0
DB15137	VK-2809	Drug	0	investigational	0
DB15134	Fluoroazomycin arabinoside F-18	Drug	Diagnostic Uses of Chemicals, Imidazoles, Nitro Compounds, Laboratory Chemicals, Indicators and Reagents, Fluorine Radioisotopes, Radiopharmaceuticals, Compounds used in a research, industrial, or household setting	investigational	0
DB15135	Ponezumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB15138	AZD-9496	Drug	Heterocyclic Compounds, Fused-Ring, Acids, Carbocyclic	investigational	0
DB15139	Bifunctional epoxide hydrolase 2	Drug	0	investigational	0
DB04482	Cmp-2-Keto-3-Deoxy-Octulosonic Acid	Drug	0	experimental	2
DB03150	2',3'-Dideoxythymidine-5'-Monophosphate	Drug	0	experimental	1
DB04483	2-deoxy-2-fluoro-β-D-mannose	Drug	0	experimental	1
DB04484	L-phenylalaninol	Drug	0	experimental	0
DB04485	Thymidine	Drug	Carbohydrates, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Glycosides, Nucleosides, Deoxyribonucleosides	investigational, experimental	7
DB03154	{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid	Drug	0	experimental	1
DB03153	3H-pyrazolo[4,3-d]pyrimidin-7-ol	Drug	0	experimental	1
DB04480	3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole	Drug	0	experimental	1
DB03152	B-2-Octylglucoside	Drug	0	experimental	9
DB04481	Erythritol	Drug	Carbohydrates, Sugar Alcohols, Cardiovascular Agents, Vasodilating Agents, Alcohols	experimental	1
DB03151	mu4-sulfido-quadro-tetracopper	Drug	0	experimental	2
DB03158	D-Myo-Inositol-1,4-Bisphosphate	Drug	0	experimental	1
DB03157	N,O-Didansyl-L-Tyrosine	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Sulfur Compounds, Amino Acids, Peptides, and Proteins, Thymidylate Synthase, antagonists & inhibitors, Amino Acids, Sulfones, Naphthalenes	experimental	1
DB03156	beta-D-glucuronic acid	Drug	0	experimental	3
DB03155	2'-fluoro-2'-deoxyuridine 3'-monophosphate	Drug	0	experimental	1
DB04486	(2s)-2,8-Diaminooctanoic Acid	Drug	0	experimental	0
DB04487	N-Methylleucine	Drug	0	experimental	1
DB04488	(6S)-N-[(2S,3R,6R,7R)-3-(Acetyloxymethyl)-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]octan-7-yl]-6-[(2-aminoacetyl)amino]-7-hydroxy-7-oxoheptanimidate	Drug	0	experimental	1
DB03159	CRA_8696	Drug	0	experimental	3
DB04489	Guanidinoethylmercaptosuccinic acid	Drug	Acids, Acyclic, Dicarboxylic Acids	experimental	1
DB15132	AZD-8165	Drug	0	investigational	0
DB15133	Tepotinib	Drug	0	investigational	0
DB15130	Dexpramipexole	Drug	Protective Agents, Anti-Parkinson Drugs, Dopamine Agonists, Antioxidants, Anti-Dyskinesia Agents, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Sulfur Compounds, Thiazoles, Anti-Parkinson Agents (Dopamine Agonist), Central Nervous System Agents, Compounds used in a research, industrial, or household setting, Benzothiazoles, Dopamine Agents	investigational	0
DB15131	Interferon alfa-2c	Drug	Cytochrome P-450 CYP1A2 Inhibitors, Proteins, Biological Factors, Cytochrome P-450 Enzyme Inhibitors, Cytokines, Peptides, Interferons, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Interferon Type I	investigational	0
DB05744	CRx-139	Drug	0	investigational	4
DB04414	Heptamolybdate	Drug	0	experimental	1
DB05746	PF-03187207	Drug	0	investigational	0
DB04415	3-Amino-1-Chloro-4-Phenyl-Butanol-2-Yl	Drug	0	experimental	0
DB04416	R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid	Drug	0	experimental	1
DB05747	R-851	Drug	0	investigational	0
DB05740	RPI-78M	Drug	0	investigational	6
DB05741	AGS-005	Drug	0	investigational	0
DB04410	3-Phenylpropylamine	Drug	Amines	experimental	2
DB05742	AGS-004	Drug	0	investigational	0
DB04411	Alpha-N-Dichloroacetyl-P-Aminophenylserinol	Drug	0	experimental	1
DB04417	P-Nitrophenol	Drug	Nitro Compounds, Phenols, Benzene Derivatives	experimental	2
DB04418	Adenylosuccinic acid	Drug	Carbohydrates, Amino Acids, Peptides, and Proteins, Nucleotides, Amino Acids, Acidic, Amino Acids, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Amino Acids, Dicarboxylic, Excitatory Amino Acids, Glycosides, Adenine Nucleotides	experimental	1
DB05749	MPI-674	Drug	0	investigational	1
DB04419	D-norleucine	Drug	0	experimental	3
DB05750	AVE-1625	Drug	0	investigational	1
DB05755	BF-37	Drug	0	investigational	0
DB04424	RPR128515	Drug	0	experimental	1
DB05756	PAC-113	Drug	0	investigational	0
DB04425	7,8-Dihydroneopterin	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Coenzymes, Pterins, Enzymes and Coenzymes, Pteridines, Pigments, Biological	experimental	1
DB04426	Alpha-Methyl-N-Acetyl-D-Glucosamine	Drug	0	experimental	1
DB05757	DNB-001	Drug	0	investigational	0
DB05758	CYT007-TNFQb	Drug	0	investigational	1
DB04427	4-Methyl-N-[(2S)-1-oxo-3-phenyl-1-[[(3S)-1-phenyl-5-(phenylmethoxysulfamoyl)pentan-3-yl]amino]propan-2-yl]piperazine-1-carboxamide	Drug	0	experimental	1
DB05751	RP01	Drug	0	investigational	0
DB04421	Nicotinamide adenine dinucleotide 3-pentanone adduct	Drug	0	experimental	0
DB05752	ALKS 27	Drug	0	investigational	5
DB05753	VSF-173	Drug	0	investigational	0
DB04422	Homocysteine	Drug	Sulfur Compounds, Amino Acids, Sulfur, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	3
DB04423	Coproporphyrin I containing CO(III)	Drug	0	experimental	0
DB05754	IPH 1101	Drug	0	investigational	0
DB04429	4'-Hydroxyflavanone	Drug	Heterocyclic Compounds, Fused-Ring, Flavonoids, Benzopyrans, Chromones, Pyrans	experimental	1
DB04430	3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile	Drug	0	experimental	2
DB05766	ACP-104	Drug	0	investigational	3
DB03103	Thymidine-5'- Diphosphate	Drug	0	experimental	1
DB04436	3-Fluoro-L-tyrosine	Drug	0	experimental	1
DB03102	2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid	Drug	0	experimental	1
DB05767	Andrographolide	Drug	Analgesics, Non-Narcotic, Antiprotozoals, Sensory System Agents, Anti-Inflammatory Agents, Stereoisomerism, Antirheumatic Agents, Hematologic Agents, Anti-Infective Agents, Peripheral Nervous System Agents, Complex Mixtures, Analgesics, Colitis, Ulcerative, drug therapy, Plant Preparations, Biological Products, Pharmaceutical Preparations, Central Nervous System Agents, Terpenes, Antiparasitic Agents, Antiplatelet agents	investigational	5
DB04437	Cysteine-Methylene-Carbamoyl-1,10-Phenanthroline	Drug	0	experimental	0
DB05768	Alkaline Phosphatase	Drug	Enzymes, Phosphoric Monoester Hydrolases, Enzymes and Coenzymes, Hydrolases, Alkaline Phosphatase, antagonists & inhibitors, Esterases	investigational	0
DB03101	Ribose-1-Phosphate	Drug	0	experimental	2
DB05769	LCP-AtorFen	Drug	0	investigational	0
DB04438	Brivudine monophosphate	Drug	0	experimental	1
DB03100	6-Nitroindazole	Drug	Heterocyclic Compounds, Fused-Ring, Nitric Oxide Synthase, antagonists & inhibitors, Pyrazoles	experimental	2
DB03107	beta-Alanine	Drug	Alanine, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	1
DB04431	4-epi-vancosaminyl derivative of vancomycin	Drug	0	experimental	0
DB04432	ZK-805623	Drug	0	experimental	1
DB03106	scyllo-inositol	Drug	Carbohydrates, Stereoisomerism, Sugar Alcohols, Alcohols	investigational	4
DB04433	Verpacamide A	Drug	0	experimental	1
DB03105	L-Pentahomoserine	Drug	Biomarkers, Amino Acids, Peptides, and Proteins	experimental	0
DB03104	2-[4-[(Z)-2-Acetamido-3-oxo-3-[[(3S)-2-oxo-1-[(4-phenylphenyl)methyl]azepan-3-yl]amino]prop-1-enyl]-2-formylphenyl]acetic acid	Drug	0	experimental	1
DB05765	ATX-201	Drug	0	investigational	0
DB04434	Naphthyridine Inhibitor	Drug	0	experimental	1
DB03109	2-acetylamino-2-deoxy-b-D-allopyranose	Drug	0	experimental	3
DB03108	4-phospho-D-erythronic acid	Drug	Acids, Acyclic, Carbohydrates, Hydroxy Acids	experimental	1
DB04439	Modified Acarbose Pentasaccharide	Drug	0	experimental	1
DB05771	LLL-3348	Drug	Complex Mixtures, Plant Preparations, Biological Products, Pharmaceutical Preparations	investigational	1
DB04440	Nebularine	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purines, Nucleic Acids, Nucleotides, and Nucleosides, Antineoplastic Agents, Glycosides, Nucleosides, Anti-Infective Agents	experimental	1
DB04441	2-Fluoroadenosine	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purines, Ribonucleosides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Purine Nucleosides	experimental	1
DB05772	Rabeximod	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB03110	2-Chlorophenol	Drug	Hydrocarbons, Chlorinated, Phenols, Hydrocarbons, Halogenated, Chlorobenzenes, Benzene Derivatives	experimental	1
DB04446	Benzo[B]Thiophene-2-Carboxamidine	Drug	0	experimental	1
DB05777	Thrombomodulin Alfa	Drug	Carbohydrates, Receptors, Proteinase-Activated, Receptors, Thrombin, Glycoconjugates, Receptors, G-Protein-Coupled, Amino Acids, Peptides, and Proteins, Receptors, Cell Surface, Glycoproteins, Membrane Proteins, Proteins, Platelet Membrane Glycoproteins, Receptors, Peptide, Receptors, Immunologic, Membrane Glycoproteins	approved, investigational	2
DB03114	PAS219	Drug	0	experimental	1
DB03113	3-Fluoro-2-(Phosphonooxy)Propanoic Acid	Drug	0	experimental	1
DB04447	1,4-Dithiothreitol	Drug	0	experimental	24
DB05778	Col-118	Drug	0	investigational	0
DB04448	2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene	Drug	0	experimental	1
DB03112	6-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Hexanoic Acid	Drug	0	experimental	1
DB05779	Oglufanide	Drug	Immunologic Factors, Antidotes, Oligopeptides, Peptides, Adjuvants, Immunologic, Protective Agents, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Cardiovascular Agents, Growth Inhibitors, Angiogenesis Modulating Agents, Growth Substances, Compounds used in a research, industrial, or household setting	investigational	0
DB03111	Glucosamine 1-Phosphate	Drug	Amino Sugars, Carbohydrates, Hexosephosphates, Sugar Phosphates, Hexosamines	experimental	1
DB04449	5-(3,3-Dihydroxypropeny)-3-Methoxy-Benzene-1,2-Diol	Drug	0	experimental	0
DB05773	Trastuzumab emtansine	Drug	Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Tubulin Modulators, Antibodies, Mitosis Modulators, Amides, Amino Acids, Peptides, and Proteins, Lactams, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Immunoproteins, Lactones, Lactams, Macrocyclic, Proteins, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, Anti-Bacterial Agents, Hepatotoxic Agents, P-glycoprotein substrates with narrow therapeutic index, Immunoglobulins, Cytochrome P-450 CYP3A5 Substrates, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Antibodies, Monoclonal, Myelosuppressive Agents, Serum Globulins, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Globulins, Blood Proteins, Antimitotic Agents, Cytochrome P-450 CYP3A4 Inhibitors, HER2 Receptor Antagonist	approved, investigational	1
DB04442	Imino[2-(2-oxo-1,2-dihydro-3-pyridinyl)-1H-benzimidazol-5-yl]methanaminium	Drug	0	experimental	1
DB03118	(2Z)-1-(5-Chloro-1H-indol-3-yl)-3-hydroxy-3-(1H-tetrazol-5-yl)-2-propen-1-one	Drug	0	experimental	1
DB03117	2-carboxypropyl-coenzyme A	Drug	0	experimental	1
DB03116	5-(1-Carboxy-1-Phosphonooxy-Ethoxyl)-Shikimate-3-Phosphate	Drug	0	experimental	1
DB05775	CRx-401	Drug	0	investigational	0
DB04444	Tetrafluoroaluminate Ion	Drug	0	experimental	9
DB03115	5-Bromo-N-[(2S)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide	Drug	0	experimental	1
DB04445	Mercuric iodide	Drug	Anions, Iodine Compounds, Antiseptics and Disinfectants, Dermatologicals, Mercurial Products, Electrolytes, Ions	experimental	1
DB05776	IC41	Drug	0	investigational	0
DB15189	Birabresib	Drug	Anilides, Heterocyclic Compounds, Fused-Ring, Amines, Aniline Compounds, Amides	investigational	0
DB15183	Fosmanogepix	Drug	0	investigational	0
DB15182	alpha-Lactalbumin	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	investigational	0
DB15187	Dubermatinib	Drug	Sulfur Compounds, Amides, Sulfones	investigational	0
DB15188	Livoletide	Drug	0	investigational	0
DB15185	Rasdegafusp alfa	Drug	0	investigational	0
DB15186	GDC-0084	Drug	Enzyme Inhibitors	investigational	0
DB15190	GLPG-0259	Drug	0	investigational	0
DB15191	MAX-40279	Drug	0	investigational	0
DB15194	Cotadutide	Drug	Amino Acids, Peptides, and Proteins	investigational	0
DB15195	Mibenratide	Drug	Peptides, Amino Acids, Peptides, and Proteins	investigational	0
DB15192	ABT-288	Drug	Histamine Antagonists	investigational	0
DB15193	BMS-955176	Drug	Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Terpenes, Anti-Infective Agents	investigational	0
DB15198	Dextromethadone	Drug	Analgesics, Non-Narcotic, Sensory System Agents, Analgesics, Ketones, Central Nervous System Agents, Peripheral Nervous System Agents	investigational	0
DB15199	Ciraparantag	Drug	Amino Acids, Basic, Amino Acids, Essential, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, Amino Acids	investigational	0
DB15197	RSV-604	Drug	Heterocyclic Compounds, Fused-Ring, Benzazepines, Benzene Derivatives	investigational	0
DB15147	Tinostamustine	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB15148	Lenzilumab	Drug	0	investigational	0
DB15145	Ziresovir	Drug	0	investigational	0
DB15146	Adrabetadex	Drug	0	investigational	0
DB15149	Futibatinib	Drug	0	investigational	0
DB03161	Thymidine-5'-diphospho-beta-D-xylose	Drug	0	experimental	2
DB04493	Fructose-6-phosphate	Drug	Carbohydrates, Hexosephosphates, Sugar Phosphates	experimental	5
DB03160	N-Pyridoxyl-7-Keto-8-Aminopelargonic Acid-5'-Monophosphate	Drug	0	experimental	1
DB04494	Dihydroxy(oxo)molybdenum(6+)	Drug	0	experimental	1
DB04495	Paratoulene phosphate	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Amides, Amino Acids, Peptides, and Proteins, Lactams, Phosphoamino Acids, Amino Acids, Azepines	experimental	1
DB04496	4-Phospho-D-erythronohydroxamic acid	Drug	Carbohydrates, Amines, Hydroxy Acids, Hydroxylamines	experimental	1
DB03165	2-Dimethylamino-Ethyl-Diphosphate	Drug	0	experimental	1
DB04490	3-(Mercaptomethylene)Pyridine	Drug	0	experimental	1
DB03164	6-amino-1-methyl-7H-purin-1-ium	Drug	0	experimental	1
DB03163	2-oxopropyl-CoM	Drug	0	experimental	1
DB04491	Diisopropylphosphono Group	Drug	0	experimental	4
DB04492	2-(acetylamino)-2-deoxy-4-O-sulfo-alpha-D-galactopyranose	Drug	0	experimental	1
DB03162	4-oxo-4,5-dihydro-1,2,5-thiadiazole-3-carboxylic acid	Drug	0	experimental	1
DB03169	(S)-Hmg-Coa	Drug	0	experimental	3
DB03168	Nicotinamide adenine dinucleotide cyclohexanone	Drug	0	experimental	0
DB03167	Pentabromophenol	Drug	Benzene Derivatives	experimental	0
DB03166	Acetic acid	Drug	Acids, Acyclic, Fatty Acids, Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Otologicals, Laboratory Chemicals, Lipids, Acetates, Organic Acids, Anti-Infective Agents, Anti-Bacterial Agents, Fatty Acids, Volatile, Indicators and Reagents, Sensory Organs, Compounds used in a research, industrial, or household setting	approved	0
DB04497	2'-Monophosphoadenosine-5'-Diphosphoribose	Drug	0	experimental	0
DB04498	Aspartate Semialdehyde	Drug	Amino Acids, Dicarboxylic, Excitatory Amino Acids, Amino Acids, Peptides, and Proteins, Amino Acids, Acidic, Amino Acids	experimental	1
DB04499	(R)-styrene oxide	Drug	0	experimental	1
DB15140	Bempegaldesleukin	Drug	Biological Factors, Cytokines, Peptides, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Lymphokines, Alcohols, Macromolecular Substances, Proteins, Interleukins, Ethylene Glycols, Glycols, Polymers, Compounds used in a research, industrial, or household setting	investigational	0
DB15143	PF-06650833	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB15144	Altropane I-123	Drug	0	investigational	0
DB15141	Deutivacaftor	Drug	0	investigational	0
DB15158	BPI-3016	Drug	Proteins, Peptide Hormones, Glucagon-Like Peptides, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Gastrointestinal Hormones, Pancreatic Hormones, Protein Precursors, Amino Acids, Peptides, and Proteins, Hormones, Proglucagon	investigational	0
DB15159	Trevogrumab	Drug	0	investigational	0
DB15156	ABT-072	Drug	Pyrimidines, Sulfur Compounds, Pyrimidinones, Amides, Sulfones	investigational	0
DB15157	Voruciclib	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Protein Kinase Inhibitors, Imines, Antineoplastic Agents, Pyrrolidines, Imino Sugars, Pyrans	investigational	0
DB03172	Tubercidin	Drug	Carbohydrates, Ribonucleosides, Noxae, Antineoplastic Agents, Antibiotics, Antineoplastic, Purine Nucleosides, Antimetabolites, Heterocyclic Compounds, Fused-Ring, Purines, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Toxic Actions	experimental	1
DB03171	Indole-3-Propanol Phosphate	Drug	0	experimental	3
DB03170	Dephospho Coenzyme A	Drug	0	experimental	1
DB03176	KB-141	Drug	Receptors, Thyroid Hormone, agonists, Acids, Carbocyclic, Phenols, Ligands, Ethers, Benzene Derivatives	experimental	2
DB03175	Propyl alcohol	Drug	Propanols, Antiseptics and Disinfectants, Dermatologicals, Alcohols	approved, experimental	1
DB03174	Phosphonoacetaldehyde	Drug	Aldehydes	experimental	1
DB03173	CRA_10433	Drug	0	experimental	1
DB03179	Sinapoyl coenzyme A	Drug	0	experimental	1
DB03178	Guanosine-2',3'-cyclophosphorothioate	Drug	0	experimental	1
DB03177	5-methylbenzimidazole	Drug	Heterocyclic Compounds, Fused-Ring	experimental	1
DB15150	Fibronectin	Drug	Membrane Proteins, Proteins, Scleroproteins, Serum Globulins, Carbohydrates, Globulins, Glycoconjugates, Blood Proteins, Extracellular Matrix Proteins, Amino Acids, Peptides, and Proteins, Glycoproteins, Membrane Glycoproteins	investigational	0
DB15151	RO-6870810	Drug	0	investigational	0
DB15154	Vunakizumab	Drug	0	investigational	0
DB15155	Pepinemab	Drug	0	investigational	0
DB15152	TMC-649128	Drug	0	investigational	0
DB15153	Dezamizumab	Drug	0	investigational	0
DB15169	H3B-6527	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB15167	Fallypride	Drug	Neurotransmitter Agents, Benzoates, Acids, Carbocyclic, Amides, Dopamine Antagonists, Dopamine D2 Receptor Antagonists, Benzene Derivatives, Dopamine Agents	investigational	0
DB15168	Cilofexor	Drug	0	investigational	0
DB03183	1-(4-Aminophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester	Drug	0	experimental	1
DB03182	alpha-Fluoro-carboxymethyldethia coenzyme A complex	Drug	0	experimental	1
DB03181	2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione	Drug	0	experimental	1
DB03180	4,5-Dimethyl-1,2-phenylenediamine	Drug	Diamines, Amines, Aniline Compounds, Polyamines	experimental	1
DB03187	6-(Hydroxyethyldithio)-8-(Aminomethylthio)Octanoic Acid	Drug	0	experimental	1
DB03186	Adenylate-3'-phosphate-[[2'-deoxy-uridine-5'-phosphate]-3'-phosphate]	Drug	0	experimental	1
DB03185	1-Beta-Ribofuranosyl-1,3-Diazepinone	Drug	0	experimental	1
DB03184	5-Amino-3-Methyl-Pyrrolidine-2-Carboxylic Acid	Drug	0	experimental	0
DB03189	Cu-Cyclam	Drug	0	experimental	1
DB15161	Pittsburgh Compound B	Drug	Sulfur Compounds, Amines, Carbon Radioisotopes	investigational	0
DB15162	Pegilodecakin	Drug	Biological Factors, Cytokines, Peptides, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Recombinant Proteins, Alcohols, Macromolecular Substances, Proteins, Interleukins, Ethylene Glycols, Glycols, Polymers, Compounds used in a research, industrial, or household setting	investigational	0
DB15160	Asunercept	Drug	Immunoglobulins, Receptors, Cytokine, Immunoglobulin Isotypes, Antibodies, Amino Acids, Peptides, and Proteins, Receptors, Cell Surface, Receptors, Death Domain, Recombinant Proteins, Immunoproteins, Membrane Proteins, Proteins, Serum Globulins, Globulins, Receptors, Tumor Necrosis Factor, Blood Proteins, Glioma, drug therapy, Receptors, Immunologic	investigational	0
DB15165	Avacincaptad pegol	Drug	0	investigational	0
DB15166	Albuvirtide	Drug	Acids, Acyclic, Maleates, Amino Acids, Peptides, and Proteins, Dicarboxylic Acids, Imides	investigational	0
DB15163	Selatogrel	Drug	Organophosphorus Compounds	investigational	0
DB15164	Apadamtase alfa	Drug	0	investigational	0
DB15178	Tomuzotuximab	Drug	0	investigational	0
DB03190	6-o-Capryloylsucrose	Drug	0	experimental	1
DB03194	Methyl beta-L-fucopyranoside	Drug	0	experimental	1
DB03193	Stearic acid	Drug	Fatty Acids, Lipids	approved, experimental	2
DB03192	(R)-3-hydroxydecanoyl-CoA	Drug	0	experimental	1
DB03191	3-Oxiran-2ylalanine	Drug	0	experimental	1
DB03198	Thio-Maltohexaose	Drug	0	experimental	1
DB03197	6-Hydroxymethylpterin	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Pteridines, Pigments, Biological	experimental	1
DB03196	4-Nitrophenyl-Ara	Drug	0	experimental	1
DB03195	3'-Fluoro-3'-deoxythymidine 5'-monophosphate	Drug	0	experimental	1
DB03199	4-Methoxy-E-Rhodomycin T	Drug	0	experimental	1
DB15172	Suvratoxumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB15173	JNJ-42165279	Drug	0	investigational	0
DB15170	Evobrutinib	Drug	0	investigational	0
DB15171	Tirzepatide	Drug	Incretins, Proteins, Peptide Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Gastrointestinal Hormones, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Blood Glucose Lowering Agents, Hormones	investigational	0
DB15176	Quilizumab	Drug	0	investigational	0
DB15177	VX-659	Drug	Chloride Channel Agonists, Membrane Transport Modulators	investigational	0
DB15175	Ofranergene obadenovec	Drug	0	investigational	0
DB05821	DP-VPA	Drug	Acids, Acyclic, Valerates, Fatty Acids, Fatty Acids, Volatile, Pentanoic Acids, Lipids	investigational	0
DB05824	CNS-5161	Drug	0	investigational	1
DB05820	DP-b99	Drug	Acids, Acyclic, Diamines, Amines, Fatty Acids, Fatty Acids, Volatile, Lipids, Polyamines, Acetates, Ethylenediamines	investigational	0
DB05829	Parathyroid hormone	Drug	Peptide Hormones, Thyroid Products, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Calcium-Regulating Hormones and Agents, Amino Acids, Peptides, and Proteins, Calcium Homeostasis, Hormones, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Parathyroid Hormones and Analogues	approved, investigational	2
DB05825	NCX 1015	Drug	Pregnadienetriols, Pregnadienes, Pregnanes, Fused-Ring Compounds, Steroids	investigational	0
DB05826	Prolease-r-hFSH	Drug	0	investigational	0
DB05827	G207	Drug	0	investigational	0
DB05828	LU-31130	Drug	0	investigational	0
DB05832	PPI-1019	Drug	0	investigational	0
DB04501	Camphane	Drug	Monoterpenes, Terpenes, Norbornanes	experimental	1
DB04502	WRR-204	Drug	0	experimental	1
DB05834	OC-1012	Drug	0	investigational	0
DB04503	Sp-722	Drug	0	experimental	1
DB04504	(3s)-2,3,4,5-Tetrahydropyridin-3-Amine	Drug	0	experimental	0
DB05835	NS-3728	Drug	0	investigational	0
DB05830	Trestolone	Drug	Contraceptive Agents, Male, Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, Adrenal Cortex Hormones, Estrenes, Reproductive Control Agents, Hormones, Fused-Ring Compounds, Gonadal Steroid Hormones, Testosterone Congeners, Hormonal Contraceptives for Systemic Use, Gonadal Hormones, Steroids	investigational	0
DB05831	ING-1	Drug	0	investigational	1
DB04500	Acedoben	Drug	Aminobenzoates, Benzoates, Acids, Carbocyclic, Benzene Derivatives	experimental	0
DB04509	N-Methylnaloxonium	Drug	0	experimental	0
DB05836	AG-702	Drug	0	investigational	0
DB04505	8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine	Drug	0	experimental	1
DB04506	Chlorophyll B	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Metalloporphyrins, Pigments, Biological, Porphyrins	experimental	0
DB05837	OSI-7836	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides	investigational	0
DB05838	OPC-51803	Drug	Heterocyclic Compounds, Fused-Ring, Receptors, Vasopressin, agonists	investigational	1
DB05839	BG-777	Drug	0	investigational	0
DB04508	Methyl(6s)-1-Thio-L-Manno-Hexodialdo-6,2-Pyranoside	Drug	0	experimental	1
DB04512	2-Isobutyl-3-methoxypyrazine	Drug	Odorants	experimental	1
DB05843	trans NV-04	Drug	0	investigational	0
DB04513	N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide	Drug	Enzyme Inhibitors, Sulfur Compounds, Amides, Cardiovascular Agents, Vasodilating Agents, Sulfones, Calcium-Calmodulin-Dependent Protein Kinases, antagonists & inhibitors	experimental	3
DB04514	Uridylyl-2'-5'-phospho-guanosine	Drug	0	experimental	1
DB05845	NV-07a	Drug	0	investigational	0
DB04515	2-O-methyl-alpha-L-fucopyranose	Drug	0	experimental	1
DB05846	Mito-4509	Drug	0	investigational	1
DB05840	AGI-1096	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Lipids, Benzene Derivatives	investigational	0
DB04510	3-phospho-D-glyceric acid	Drug	Acids, Acyclic, Carbohydrates, Hydroxy Acids, Sugar Acids	experimental	6
DB05841	AI-128	Drug	0	investigational	0
DB04511	N-Succinyl Methionine	Drug	0	experimental	1
DB05842	AI-850	Drug	Cycloparaffins, Taxoids, Cyclodecanes, Diterpenes, Terpenes	investigational	0
DB04516	2-Deoxy-Glucitol-6-Phosphate	Drug	0	experimental	1
DB05848	humanized SMART Anti-IL-12 Antibody	Drug	0	investigational	1
DB04517	Dipyrromethane Cofactor	Drug	Coenzymes	experimental	1
DB04518	3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol	Drug	0	experimental	1
DB05849	NCX 950	Drug	0	investigational	1
DB04519	Caprylic acid	Drug	Acids, Acyclic, Fatty Acids, Lipids, OAT3/SLC22A8 Inhibitors, OAT1/SLC22A6 inhibitors	investigational	3
DB05854	CLX-0921	Drug	Sulfur Compounds	investigational	1
DB04523	Tert-Butyl(1s)-1-Cyclohexyl-2-Oxoethylcarbamate	Drug	0	experimental	1
DB05855	Rivanicline	Drug	Alkaloids, Pyridines, Solanaceous Alkaloids	investigational	2
DB04524	Malonyl-CoA	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Coenzymes, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Thioesters of coenzyme A, Enzymes and Coenzymes, Glycosides, Nucleotides, Adenine Nucleotides	experimental	1
DB05856	CPD 923	Drug	0	investigational	0
DB04525	N-(3-Carboxypropanoyl)-L-phenylalanyl-3-carboxy-O-(carboxymethyl)-N-pentyl-L-tyrosinamide	Drug	0	experimental	1
DB05857	Q-Derp1	Drug	0	investigational	0
DB04526	L-Glycero-D-Manno-Heptopyranose	Drug	Carbohydrates, Monosaccharides	experimental	1
DB05851	Biomed 101	Drug	0	investigational	0
DB04520	(3s,8ar)-3-(4-Hydroxybenzyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione	Drug	0	experimental	2
DB05852	cryopreserved human liver cells	Drug	0	investigational	0
DB04521	4-S-Glutathionyl-5-pentyl-tetrahydro-furan-2-ol	Drug	0	experimental	1
DB04522	Dexfosfoserine	Drug	0	experimental	21
DB04527	beta-Hydroxyasparagine	Drug	Amino Acids, Neutral, Amino Acids, Basic, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	1
DB05858	BI-K0376	Drug	0	investigational	0
DB04528	2,4-Dinitrophenol	Drug	Enzyme Inhibitors, Uncoupling Agents, Dinitrophenols, Coloring Agents, Nitro Compounds, Phenols, Nitrophenols, Compounds used in a research, industrial, or household setting, Benzene Derivatives	experimental	1
DB05859	PI-166	Drug	0	investigational	0
DB04529	Desvancosaminyl vancomycin	Drug	0	experimental	2
DB05800	Alethine	Drug	Sulfur Compounds, Amines, Ethylamines, Mercaptoethylamines, Sulfhydryl Compounds	investigational	0
DB05801	GTI 2040	Drug	0	investigational	1
DB05807	HGTV-43	Drug	0	investigational	0
DB05808	PI-88	Drug	Carbohydrates, Polysaccharides	investigational	0
DB05809	TA-CIN	Drug	0	investigational	0
DB05803	ISIS 14803	Drug	0	investigational	0
DB05804	Prasterone sulfate	Drug	Cytochrome P-450 CYP3A7 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, 17-Ketosteroids, Adrenal Cortex Hormones, Androstenes, BSEP/ABCB11 Substrates, Hormones, Ketosteroids, Fused-Ring Compounds, Gonadal Steroid Hormones, Androstanes, Dehydroepiandrosterone, Androstenols, Testosterone Congeners, Gonadal Hormones, Steroids	investigational	0
DB05805	NS-2359	Drug	Alkaloids, Neurotransmitter Uptake Inhibitors, Aza Compounds, Azabicyclo Compounds	investigational	0
DB05806	Cositecan	Drug	Alkaloids	investigational	1
DB05810	99mTc-glucarate	Drug	0	investigational	0
DB05811	HSV-2 theracine	Drug	0	investigational	0
DB05812	Abiraterone	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Endocrine Therapy, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Cytochrome P-450 CYP2C19 Inhibitors, Hormone Antagonists and Related Agents, Cytochrome P-450 CYP2C9 Inhibitors (moderate), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (weak), Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Cytochrome P-450 CYP2C8 Inhibitors (moderate), Hormone Antagonists, Cytochrome P450 17A1 Inhibitors, Steroid Synthesis Inhibitors, Chemically-Induced Disorders, Hormones, Hormone Substitutes, and Hormone Antagonists, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP1A2 Inhibitors (strong), Androstenes, Antineoplastic Agents, Cytochrome P-450 CYP2C19 Inhibitors (moderate), Androstanes, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Steroids	approved	1
DB05818	SGN-15	Drug	0	investigational	0
DB05819	NBI-6024	Drug	Proteins, Peptide Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pancreatic Hormones, Protein Precursors, Amino Acids, Peptides, and Proteins, Blood Glucose Lowering Agents, Hormones	investigational	0
DB05814	GPI-1485	Drug	Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Lactones	investigational	1
DB05815	GnRH pharmaccine	Drug	0	investigational	0
DB05817	Laromustine	Drug	Sulfur Compounds, Amides, Sulfones	investigational	0
DB15224	Lisavanbulin	Drug	Heterocyclic Compounds, Fused-Ring, Oxazoles	investigational	0
DB15225	Mitazalimab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB15222	GS-6620	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides	investigational	0
DB15223	Flotetuzumab	Drug	0	investigational	0
DB15228	Avidin	Drug	Carbohydrates, Ovalbumin, Enzyme Inhibitors, Glycoconjugates, Peptides, Protease Inhibitors, Serpins, Amino Acids, Peptides, and Proteins, Glycoproteins, Egg Proteins, Eggs, Proteins, Albumins, Physiological Phenomena, Egg Proteins, Dietary, Dietary Proteins, Food and Beverages, Diet, Food, and Nutrition, Food	investigational	0
DB15229	CNV-2197944	Drug	0	investigational	0
DB15226	Dasiglucagon	Drug	0	investigational	0
DB15227	Tirabrutinib	Drug	0	investigational	0
DB04570	Latamoxef	Drug	Nephrotoxic agents, Third-Generation Cephalosporins, Amides, Ions, Lactams, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, Gases, Heterocyclic Compounds, Fused-Ring, Sulfides, Anions, Anti-Bacterial Agents, Sulfur Compounds, Acids, Noncarboxylic, Acids, Cephalosporins, Hydrogen Sulfide, Electrolytes, Antibacterials for Systemic Use	approved, investigational	4
DB04571	Trioxsalen	Drug	Antipsoriatics for Topical Use, Psoralens for Systemic Use, Dermatologicals, Coumarins, Psoralens for Topical Use, Benzopyrans, Radiation-Sensitizing Agents, Antipsoriatics, Heterocyclic Compounds, Fused-Ring, Photosensitizing agents used for phototherapy, Photosensitizing Agents, Antipsoriatics for Systemic Use, Furocoumarins, Pyrans	approved	1
DB04572	Thiotepa	Drug	Immunologic Factors, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Triethylenephosphoramide, Anions, Cytochrome P-450 CYP2B6 Inhibitors (moderate), Phosphoramides, Azirines, Antineoplastic Agents, Alkylating, Cholinesterase Inhibitors, Noxae, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Antineoplastic and Immunomodulating Agents, Alkylating Activity, Antineoplastic Agents, Organophosphorus Compounds, Ions, Myeloablative Agonists, Phosphorus Compounds, Phosphorus Acids, Myelosuppressive Agents, Alkylating Drugs, Acids, Noncarboxylic, Aziridines, Narrow Therapeutic Index Drugs, Acids, Cytochrome P-450 CYP3A Substrates, Phosphoric Acids, Ethylene Imines, Electrolytes, Toxic Actions	approved, investigational	1
DB04573	Estriol	Drug	Sex Hormones and Modulators of the Genital System, Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein substrates, Estrenes, Estrogens, Genito Urinary System and Sex Hormones, Natural and Semisynthetic Estrogens, Plain, Hormones, Fused-Ring Compounds, Gonadal Steroid Hormones, P-glycoprotein inducers, Thyroxine-binding globulin inducers, Estradiol Congeners, Gonadal Hormones, Steroids	approved, investigational, vet_approved	3
DB03242	P-Aminophenyl-Alpha-D-Galactopyranoside	Drug	0	experimental	1
DB03241	1-Amino-1-Carbonyl Pentane	Drug	0	experimental	1
DB03240	(S)-2-Amino-3-(1,3,5,7-Pentahydro-2,4-Dioxo-Cyclopenta[E]Pyrimidin-1-Yl) Proionic Acid	Drug	0	experimental	1
DB03246	Beta-L-Arabinose	Drug	0	experimental	1
DB04578	(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide	Drug	0	experimental	1
DB04579	N-{[(2S,3S)-3-(Ethoxycarbonyl)-2-oxiranyl]carbonyl}-L-threonyl-L-isoleucine	Drug	0	experimental	1
DB03245	S-4-Nitrobutyryl-CoA	Drug	0	experimental	1
DB03244	(S)-2-[4-(Aminomethyl)-1h-1,2,3-Triazol-1-Yl]-4-Methylpentanoic Acid	Drug	0	experimental	0
DB03243	4-Fluorobenzylamine	Drug	Benzoates, Radioimmunodetection, Acids, Carbocyclic, Amides, Fluorine Radioisotopes, Benzene Derivatives	experimental	1
DB04574	Estrone sulfate	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, 17-Ketosteroids, Adrenal Cortex Hormones, Estrogens, MATE 1 Substrates, Hormones, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Drugs that are Mainly Renally Excreted, Fused-Ring Compounds, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors, Estradiol Congeners, Estrogens, Conjugated (USP), Hormonal Contraceptives for Systemic Use, MATE substrates, Gonadal Hormones, Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, Estrenes, Reproductive Control Agents, Ketosteroids, Gonadal Steroid Hormones, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, Thyroxine-binding globulin inducers, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), MATE 2 Substrates, Cytochrome P-450 CYP1A2 Substrates, Hyperglycemia-Associated Agents, Steroids	approved	2
DB03249	2'-O-Methyl-3'-Methyl-3'-Deoxy-Arabinofuranosyl-Thymine-5'-Phosphate	Drug	0	experimental	0
DB04575	Quinestrol	Drug	Norpregnatrienes, Hormones, Hormone Substitutes, and Hormone Antagonists, Norsteroids, Estrogens, Estrogenic Steroids, Alkylated, Hormones, Ethinyl Estradiol, Fused-Ring Compounds, Gonadal Steroid Hormones, Thyroxine-binding globulin inducers, Estradiol Congeners, Norpregnanes, Gonadal Hormones, Steroids	approved	1
DB04576	Fleroxacin	Drug	Fluoroquinolones, Quinolines, QTc Prolonging Agents, Enzyme Inhibitors, Topoisomerase Inhibitors, Antineoplastic Agents, Antiinfectives for Systemic Use, Anti-Infective Agents, Quinolones, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Topoisomerase II Inhibitors, Potential QTc-Prolonging Agents, Antibacterials for Systemic Use	experimental	3
DB03248	2-(Phosphonooxy)Butanoic Acid	Drug	0	experimental	1
DB04577	1-(1-phenylcyclopentyl)methylamine	Drug	0	experimental	1
DB03247	Flavin mononucleotide	Drug	Biological Factors, Carbohydrates, Coenzymes, Enzymes and Coenzymes, Nucleotides, Pteridines, Vitamins, Pigments, Biological, Heterocyclic Compounds, Fused-Ring, Micronutrients, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Physiological Phenomena, Food and Beverages, Glycosides, Vitamin B Complex, Growth Substances, Diet, Food, and Nutrition, Flavins, Food	approved, investigational	54
DB15220	Seliforant	Drug	0	investigational	0
DB15221	PF-06260414	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB15235	Di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone	Drug	Sulfur Compounds, Semicarbazides, Semicarbazones	investigational	0
DB15236	Fucose	Drug	Carbohydrates, Deoxy Sugars	investigational	0
DB15233	Avapritinib	Drug	Cytochrome P-450 CYP2C9 Substrates, Protein Kinase Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates	approved, investigational	2
DB15234	Semorinemab	Drug	0	investigational	0
DB15239	PTI-428	Drug	0	investigational	0
DB15237	Fluciclovine	Drug	0	investigational	0
DB15238	Olinciguat	Drug	0	investigational	0
DB04581	1-benzylimidazole	Drug	Neurotransmitter Agents, Adrenergic alpha-Antagonists, Adrenergic Antagonists, Agents that produce hypertension, Adrenergic Agents	experimental	1
DB04582	Imazaquin	Drug	Herbicides, Heterocyclic Compounds, Fused-Ring, Agrochemicals, Pesticides, Toxic Actions, Compounds used in a research, industrial, or household setting	experimental	0
DB04583	5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid	Drug	0	experimental	1
DB04584	Phenyldehydroalanine	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Amino Acids, Essential, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	0
DB03253	(2s)-Pyrrolidin-2-Ylmethylamine	Drug	0	experimental	1
DB03252	D-Lysine	Drug	0	experimental	2
DB03251	RWJ-51084	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amino Acids, Basic, Amino Acids, Essential, Amino Acids, Diamino, Thiazoles, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	1
DB04580	1-Methyl-2-quinolone	Drug	0	experimental	1
DB03250	2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole	Drug	0	experimental	1
DB03257	5-[1-(Acetylamino)-3-Methylbutyl]-2,5-Anhydro-3,4-Dideoxy-4-(Methoxycarbonyl)Pentonic Acid	Drug	0	experimental	1
DB03256	(6R)-Folinic acid	Drug	Folic Acid and Derivatives, Vitamin B Complex, Vitamins	experimental	5
DB03255	Phenol	Drug	Miscellaneous Therapeutic Agents, Nervous System, Antiseptics and Disinfectants, Dermatologicals, Cardiovascular Agents, Sclerosing Agents for Local Injection, Anesthetics, Anti-Infective Agents, Anti-Infective Agents, Local, Pharmaceutical Solutions, Vasoprotectives, Histamine Antagonists, Throat Preparations, Disinfectants, Solutions, Sclerosing Solutions, Antivaricose Therapy, Phenols, Pharmaceutical Preparations, Compounds used in a research, industrial, or household setting, Benzene Derivatives, Anesthetics, Local, Phenol and Derivatives	approved, experimental	2
DB03254	4-Phenyl-1h-Imidazole	Drug	0	experimental	1
DB04585	DEHYDRO-2(S)-AMINO-6-BORONOHEXANOIC ACID	Drug	0	experimental	1
DB04586	o-Bromophenol	Drug	Benzene Derivatives	experimental	1
DB03259	2',6'-Dichloro-Biphenyl-2,6-Diol	Drug	0	experimental	1
DB04587	2'-O-butyl-5-methyluridine	Drug	0	experimental	0
DB03258	2'-Deoxycytidine 5'-triphosphate	Drug	Carbohydrates, Pyrimidines, Ribonucleotides, Deoxyribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Cytosine Nucleotides, Glycosides, Nucleotides, Pyrimidine Nucleotides	experimental	4
DB04588	N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE	Drug	0	experimental	1
DB15231	Brimapitide	Drug	Neuroprotective Agents, Amino Acids, Peptides, and Proteins	investigational	0
DB15232	Telaglenastat	Drug	Acids, Acyclic, Sulfur Compounds, Fatty Acids, Fatty Acids, Volatile, Thiazoles, Amides, Lipids, Acetamides, Acetates, Benzene Derivatives	investigational	0
DB15230	Dithiopyr	Drug	0	investigational	0
DB15246	Salvianolic acid A	Drug	Drugs, Chinese Herbal, Enzyme Inhibitors, Gastric Acid Lowering Agents, Hydroxy Acids, Acids, Carbocyclic, 4-Nitrophenylphosphatase, antagonists & inhibitors, Cinnamates	investigational	0
DB15247	Vorolanib	Drug	0	investigational	0
DB15244	NM-404 I-131	Drug	0	investigational	0
DB15245	Olorofim	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Amides, Lipids, Antifungal Agents, Acetates, Anti-Infective Agents	investigational	0
DB15248	Bulevirtide	Drug	0	investigational	0
DB15249	MK-6325	Drug	0	investigational	0
DB03260	Hexamethylene diamine	Drug	Amines, Ethylamines, Sympathomimetics, Amphetamines, Polyamines, Phenethylamines	experimental	1
DB04592	3-Bromo-3-buten-1-ol	Drug	0	experimental	1
DB04593	3-({1-[3-CARBAMIMIDOYL-1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-PROPYLCARBAMOYL]-2-METHYL-BUTYLSULFAMOYL}-METHYL)-BENZOIC ACID	Drug	0	experimental	1
DB04594	3-hydroxyglutaric acid	Drug	Acids, Acyclic, Dicarboxylic Acids	experimental	1
DB04595	(E)-(4S,6S)-8-METHYL-6-((S)-3-METHYL-2-{(S)-2-[(5-METHYL-ISOXAZOLE-3-CARBONYL)-AMINO]-PROPIONYLAMINO}-BUTYRYLAMINO)-5-OXO-4-((R)-2-OXO-PYRROLIDIN-3-YLMETHYL)-NON-2-ENOIC ACID BENZYL ESTER	Drug	0	experimental	0
DB03264	Dodecyl-Coa	Drug	0	experimental	2
DB03263	Thiocellobiose	Drug	Carbohydrates, Sulfur Compounds, Glycosides	experimental	0
DB03262	Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]	Drug	0	experimental	1
DB04590	(2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETICACID	Drug	0	experimental	1
DB04591	N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE	Drug	0	experimental	1
DB03268	RU82197	Drug	0	experimental	1
DB03267	1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine	Drug	0	experimental	1
DB03266	Glutaral	Drug	Cross-Linking Reagents, Disinfectants, Fixatives, Laboratory Chemicals, Indicators and Reagents, Aldehydes, Compounds used in a research, industrial, or household setting, Anti-Infective Agents	experimental	0
DB04596	4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-β-D-mannopyranosyl}-D-glucopyranuronic acid	Drug	0	experimental	1
DB04597	[4,6-O-(1-CARBOXYETHYLIDENE)-BETA-D-MANNOSE]	Drug	0	experimental	1
DB04598	2-AMINO-4-CHLORO-3-HYDROXYBENZOIC ACID	Drug	0	experimental	1
DB04599	Aniracetam	Drug	Nervous System, Central Nervous System Depressants, Psychostimulants, Agents Used for Adhd and Nootropics, Pyrrolidines, Antidepressive Agents, Central Nervous System Agents, Psychotropic Drugs, Nootropic Agents, Psychoanaleptics	experimental	4
DB03269	4,6-Dideoxy-4-{[4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino}hexopyranose	Drug	0	experimental	0
DB15242	MK-0533	Drug	0	investigational	0
DB15243	2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Metalloporphyrins, Pigments, Biological, Porphyrins	investigational	0
DB15240	Elezanumab	Drug	0	investigational	0
DB15241	Methylsamidorphan	Drug	0	investigational	0
DB15257	Milademetan	Drug	0	investigational	0
DB15258	Imlifidase	Drug	0	investigational	0
DB15256	Reldesemtiv	Drug	0	investigational	0
DB15259	VB-201	Drug	Carbohydrates, Phosphatidylcholines, Sugar Phosphates, Plant Extracts, Lipids, Phospholipids, Lecithins, Phosphatidic Acids, Glycerophospholipids, Alcohols, Glycerophosphates, Complex Mixtures, Plant Preparations, Sugar Alcohols, Biological Products, Membrane Lipids, Pharmaceutical Preparations, Triose Sugar Alcohols	investigational	0
DB03270	2,6-Difluorobenzenesulfonamide	Drug	0	experimental	1
DB03275	Cysteinamide	Drug	0	experimental	0
DB03274	2',5'-Dideoxyuridine	Drug	0	experimental	1
DB03273	3'-Oxo-Adenosine	Drug	0	experimental	1
DB03272	4-Bromo-3-(5'-Carboxy-4'-Chloro-2'-Fluorophenyl)-1-Methyl-5-Trifluoromethyl-Pyrazol	Drug	0	experimental	0
DB03279	Dodecyl-Alpha-D-Maltoside	Drug	0	experimental	1
DB03278	D-Treitol	Drug	0	experimental	1
DB03277	alpha-maltotriose	Drug	0	experimental	2
DB03276	4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid	Drug	0	experimental	1
DB15250	Vercirnon	Drug	Sulfur Compounds, Amides, Sulfones	investigational	1
DB15253	Bleselumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Immunosuppressive Agents, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB15254	RO-5126766 free base	Drug	Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors, Benzopyrans, Pyrans	investigational	0
DB15251	Antipain	Drug	Enzyme Inhibitors, Oligopeptides, Peptides, Protease Inhibitors, Amino Acids, Peptides, and Proteins	experimental	0
DB15252	Nemolizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB05860	Peginterferon alfacon-1	Drug	Pegylated agents	investigational	0
DB03202	2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide	Drug	0	experimental	1
DB04534	5-Nitroindazole	Drug	Heterocyclic Compounds, Fused-Ring, Pyrazoles	experimental	2
DB05865	VIT-100	Drug	0	investigational	0
DB05866	ETC-1001	Drug	0	investigational	0
DB03201	D-Cysteine	Drug	0	experimental	1
DB05867	99mTc-14 F7 Mab	Drug	0	investigational	1
DB03200	7-Alpha-D-Ribofuranosyl-Purine-5'-Phosphate	Drug	0	experimental	1
DB05868	Ciluprevir	Drug	Acids, Acyclic, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds	investigational	1
DB04537	Tryptophanamide	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Amino Acids, Essential, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	2
DB04530	S,S-(2-Hydroxyethyl)Thiocysteine	Drug	0	experimental	16
DB03206	Duvoglustat	Drug	Amino Sugars, Alkaloids, Carbohydrates, Enzyme Inhibitors, Imines, Imino Pyranoses, Piperidines, Hexosamines, Imino Sugars, Anti-Infective Agents	investigational	5
DB05861	Tasquinimod	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring	investigational	0
DB04531	S-Benzylcysteine	Drug	Amino Acids, Neutral, Sulfur Compounds, Amino Acids, Sulfur, Amino Acids, Peptides, and Proteins, Amino Acids, Sulfhydryl Compounds	experimental	1
DB03205	Pyrroloquinoline Quinone	Drug	0	experimental	5
DB04532	Indole	Drug	Heterocyclic Compounds, Fused-Ring	experimental	2
DB03204	4-amino-5-aminomethyl-2-methylpyrimidine	Drug	0	experimental	0
DB05863	TRX1	Drug	0	investigational	0
DB04533	2-Amino-4-methylphenol	Drug	Phenols, Benzene Derivatives	experimental	1
DB03203	Sphingosine	Drug	Amines, P-glycoprotein substrates, Glycols, Amino Alcohols, Alcohols	experimental	6
DB05864	PPI-2458	Drug	Amino Acids, Essential, Amino Acids, Branched-Chain, Amino Acids, Peptides, and Proteins, Ethers, Amino Acids, Ethers, Cyclic	investigational	1
DB03209	Oteracil	Drug	Triazines	approved	0
DB03208	Beta-1,2,3,4,6-Penta-O-Galloyl-D-Glucopyranose	Drug	0	experimental	0
DB03207	2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid	Drug	0	experimental	1
DB04538	threo-3-methyl-L-aspartic acid	Drug	0	experimental	1
DB05869	Ethyl pyruvate	Drug	Keto Acids	investigational	2
DB04539	Glyphosate	Drug	Herbicides, Enzyme Inhibitors, Uncoupling Agents, Agrochemicals, Pesticides, Amino Acids, Peptides, and Proteins, Toxic Actions, Compounds used in a research, industrial, or household setting, Amino Acids, Anti-Infective Agents	experimental	3
DB05870	anti-alpha5Beta1-integrin antibody	Drug	0	investigational	0
DB04540	Cholesterol	Drug	Cholestanes, Sterols, Lipids, Membrane Lipids, Cholestenes, P-glycoprotein inhibitors, Fused-Ring Compounds, BCRP/ABCG2 Inducers, Steroids	approved, investigational	4
DB05871	UC-781	Drug	Amines, Aniline Compounds, Amides, Anti-Retroviral Agents, Antiviral Agents, Anti-Infective Agents	investigational	1
DB04545	Afegostat	Drug	Carbohydrates, Imines, Glycoside Hydrolases, antagonists & inhibitors, Piperidines, Imino Sugars	investigational, experimental	3
DB03213	Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone	Drug	0	experimental	1
DB03212	4-Deoxyglucarate	Drug	0	experimental	1
DB04546	3-Deazaadenosine	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purines, Ribonucleosides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Purine Nucleosides, Isomerism	experimental	1
DB03211	(3-Formyl-but-3-Enyl)-Phosphonic Acid	Drug	0	experimental	1
DB04547	Inhibitor BEA409	Drug	0	experimental	1
DB03210	4-Aminohydrocinnamic Acid	Drug	0	experimental	1
DB05879	AME-527	Drug	0	investigational	1
DB04548	4-Deoxy-D-Glucuronic Acid	Drug	0	experimental	4
DB03217	DPI59	Drug	0	experimental	1
DB04541	Cyclo(prolylglycyl)	Drug	Peptides, Amino Acids, Peptides, and Proteins	experimental	1
DB05873	AVI-4020	Drug	0	investigational	0
DB04542	Zidovudine diphosphate	Drug	Carbohydrates, Pyrimidines, Deoxyribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Glycosides, Nucleosides, Deoxyribonucleosides, Nucleotides, Dideoxynucleosides, Pyrimidine Nucleotides	experimental	1
DB03216	(1'R,2'S)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-yl)Adenine	Drug	0	experimental	1
DB04543	2,6-Diamino-8-(1h-Imidazol-2-Ylsulfanylmethyl)-3h-Quinazoline-4-One	Drug	0	experimental	1
DB05874	AEOL 10150	Drug	Antioxidants, Biological Factors, Heterocyclic Compounds, Fused-Ring, Pigments, Biological, Porphyrins	investigational	0
DB03215	(2s,5s)-5-Carboxymethylproline	Drug	0	experimental	1
DB03214	Vinylglycine	Drug	Amino Acids, Peptides, and Proteins, Amino Acids	experimental	2
DB05875	Sar9, Met (O2)11-Substance P	Drug	Biological Factors, Autacoids, Inflammation Mediators, Oligopeptides, Peptides, Intercellular Signaling Peptides and Proteins, Kinins, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Receptors, Neurokinin-3, antagonists & inhibitors, Proteins, Tachykinins, Cholinesterase substrates	investigational	0
DB04544	1-Deoxy-1-acetylamino-beta-D-gluco-2-heptulopyranosonamide	Drug	0	experimental	1
DB03219	11-Deoxy-Beta-Rhodomycin	Drug	0	experimental	1
DB03218	N-acetyl-N'-beta-D-glucopyranosyl urea	Drug	Carbohydrates, Hexoses, Glycogen Phosphorylase, antagonists & inhibitors, Monosaccharides	experimental	1
DB04549	4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide	Drug	0	experimental	1
DB15202	Fluoroacetic acid F-18	Drug	0	investigational	0
DB15203	JNJ-26489112	Drug	Anticonvulsants, Sulfur Compounds, Central Nervous System Depressants, Amides, Sulfones	investigational	0
DB15200	Bixalomer	Drug	Amines	investigational	0
DB15201	Norbixin	Drug	Biological Factors, Cycloparaffins, Alkenes, Hydrocarbons, Acyclic, Polyenes, Cyclohexenes, Terpenes, Cyclohexanes, Pigments, Biological	investigational	0
DB15206	Uprifosbuvir	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Glycosides, Nucleosides, Antiviral Agents, Anti-Infective Agents	investigational	0
DB15207	Esaxerenone	Drug	Sulfur Compounds	investigational	0
DB15204	Fosravuconazole	Drug	0	investigational	0
DB15205	Capromorelin	Drug	0	investigational	0
DB05880	MBT-0312	Drug	0	investigational	0
DB05881	EHT 0202	Drug	0	investigational	0
DB15208	NOP-1A	Drug	0	investigational	0
DB05882	CHF 4227	Drug	Heterocyclic Compounds, Fused-Ring, Pyrans	investigational	2
DB04551	beta-D-fructofuranose 1,6-bisphosphate	Drug	0	experimental	2
DB15209	MK-0736	Drug	0	investigational	0
DB03220	FR-234938	Drug	0	experimental	1
DB04556	NAP-226-90	Drug	Amines, Ethylamines, Benzene Derivatives	experimental	1
DB03224	2-Formyl-Protoporphryn Ix	Drug	0	experimental	1
DB05887	TAFA-93	Drug	0	investigational	0
DB05888	MEM 1414	Drug	0	investigational	1
DB04557	Arachidonic Acid	Drug	Fatty Acids, Essential, Biological Factors, Cytochrome P-450 CYP2C9 Substrates, Arachidonic Acids, Autacoids, Fatty Acids, Unsaturated, Inflammation Mediators, Cytochrome P-450 Substrates, Fatty Acids, Eicosanoids, Lipids	experimental	5
DB03223	Diphthamide	Drug	Amino Acids, Cyclic, Amino Acids, Essential, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	1
DB03222	dATP	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Deoxyribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides, Adenine Nucleotides	experimental	6
DB05889	Inotuzumab ozogamicin	Drug	CD22-directed Immunoconjugate, Immunoglobulins, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins, Proteins, Serum Globulins, Increased Cellular Death, CD22-directed Antibody Interactions, Globulins, Blood Proteins, Hepatotoxic Agents, Decreased DNA Integrity	approved, investigational	1
DB03221	AL7099A	Drug	0	experimental	1
DB04559	N-(Chlorophenyl)-N'-hydroxyguanidine	Drug	0	experimental	1
DB05883	ABX-PTH	Drug	0	investigational	1
DB03228	5-[Bis-2(Chloro-Ethyl)-Amino]-2,4-Dintro-Benzamide	Drug	0	experimental	1
DB04552	Niflumic acid	Drug	Aminobenzoates, Nephrotoxic agents, Enzyme Inhibitors, Amines, Sensory System Agents, Cyclooxygenase Inhibitors, ortho-Aminobenzoates, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Aniline Compounds, Nicotinic Acids, Selective Cyclooxygenase 2 Inhibitors (NSAIDs), Peripheral Nervous System Agents, Fenamates, Antiinflammatory and Antirheumatic Products, Non-Steroids, Niflumic Acid and Prodrugs, Analgesics, Musculo-Skeletal System, Benzene Derivatives, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Pyridines, Benzoates, Antirheumatic Agents, Antiinflammatory Preparations, Non-Steroids for Topical Use, Topical Products for Joint and Muscular Pain, UGT1A9 Inhibitors, Antiinflammatory and Antirheumatic Products, Agents that produce hypertension, Central Nervous System Agents	experimental	6
DB04553	2-Oxobutanoic Acid	Drug	0	experimental	2
DB05884	HCV-086	Drug	0	investigational	0
DB03227	Nicotinamide Mononucleotide	Drug	Carbohydrates, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides	experimental	4
DB05885	Seletracetam	Drug	Calcium Channel Blockers, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Agents causing hyperkalemia, Pyrrolidines, Cytochrome P-450 CYP3A4 Substrates, Vasodilating Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	investigational	3
DB03226	Trifluoroethanol	Drug	Alcohols	experimental	3
DB04554	8-Bromoadenosine-5'-Diphosphate	Drug	0	experimental	1
DB05886	NV-18	Drug	0	investigational	0
DB03225	D-Tryptophan	Drug	0	experimental	1
DB04555	Cytidine-5'-Diphosphate	Drug	0	experimental	6
DB03229	2-Oxo-4-Methylpentanoic Acid	Drug	Caproates	experimental	2
DB15213	25-desacetylrifapentine	Drug	Lactams, Macrocyclic, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Amides, Lactams, Rifamycins	investigational	0
DB15214	BMS-986104	Drug	0	investigational	0
DB15211	Duvortuxizumab	Drug	0	investigational	0
DB15212	Pemafibrate	Drug	Acids, Acyclic, Heterocyclic Compounds, Fused-Ring, Fatty Acids, Fatty Acids, Volatile, Lipids	investigational	0
DB15217	Gastric inhibitory polypeptide	Drug	Incretins, Proteins, Peptide Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Gastrointestinal Hormones, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Blood Glucose Lowering Agents, Hormones, Gastrointestinal Agents	investigational	0
DB15218	Pozelimab	Drug	0	investigational	0
DB15215	KRN-5500	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purines, Enzyme Inhibitors, Nucleic Acids, Nucleotides, and Nucleosides, Antineoplastic Agents, Glycosides, Nucleosides, Protein Synthesis Inhibitors	investigational	0
DB15216	Amylose	Drug	Carbohydrates, Dietary Carbohydrates, Starch, Biopolymers, Macromolecular Substances, Polysaccharides, Physiological Phenomena, Food and Beverages, Glucans, Polymers, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food	investigational	0
DB05890	Veglin	Drug	0	investigational	1
DB04560	4,7-Dioxosebacic Acid	Drug	Fatty Acids, Porphobilinogen Synthase, antagonists & inhibitors, Lipids	experimental	3
DB04561	4-acetamido-2,4-didexoy-D-glycero-beta-D-galacto-octopyranosylphosphonic acid	Drug	0	experimental	1
DB05892	RI 624	Drug	Immunoglobulins, Sensory System Agents, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins, Peripheral Nervous System Agents, Proteins, Serum Globulins, Analgesics, Globulins, Blood Proteins, Central Nervous System Agents, Receptor, Nerve Growth Factor, antagonists & inhibitors	investigational	1
DB15219	Tomivosertib	Drug	0	investigational	0
DB04562	Tricarballylic acid	Drug	Acids, Acyclic	experimental	1
DB03231	3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide	Drug	0	experimental	1
DB03230	Adenosine-5'-Propylphosphate	Drug	0	experimental	1
DB03235	N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(alpha-D-galactopyranosyloxy)-5-nitrobenzamide	Drug	0	experimental	1
DB04567	Chromophore (Gly-Tyr-Gly)	Drug	0	experimental	0
DB05898	CERE-110	Drug	0	investigational	0
DB04568	5-Aminoimidazole Ribonucleoside	Drug	0	experimental	1
DB05899	IT-101	Drug	Carbohydrates, Dietary Carbohydrates, Starch, Biopolymers, Macromolecular Substances, Alkaloids, Polysaccharides, Physiological Phenomena, Food and Beverages, Glucans, Dextrins, Polymers, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food	investigational	0
DB03234	(4'-{[Allyl(Methyl)Amino]Methyl}-1,1'-Biphenyl-4-Yl)(4-Bromophenyl)Methanone	Drug	0	experimental	1
DB03233	3'-deoxy-3'-aminothymidine monophosphate	Drug	0	experimental	1
DB04569	Benzyl formate	Drug	Acids, Acyclic	experimental	1
DB03232	2-[(2e,6e,10e,14e,18e,22e,26e)-3,7,11,15,19,23,27,31-Octamethyldotriaconta-2,6,10,14,18,22,26,30-Octaenyl]Phenol	Drug	0	experimental	1
DB05894	GT 389-255	Drug	0	investigational	0
DB04563	CRA_9678	Drug	0	experimental	1
DB03239	3',5'-Dinitro-N-Acetyl-L-Thyronine	Drug	0	experimental	0
DB05895	HGS-TR2J	Drug	0	investigational	1
DB03238	3,5-Difluoroaniline	Drug	Amines	experimental	1
DB04564	Gluconolactone	Drug	Acids, Acyclic, Carbohydrates, Irrigation, Hydroxy Acids, Calculi Dissolution Agent, Sugar Acids	approved, experimental	1
DB03237	2,3-Dihydroxy-5-Oxo-Hexanedioate	Drug	0	experimental	1
DB04565	4-(Acetylamino)-3-[(Hydroxyacetyl)Amino]Benzoic Acid	Drug	0	experimental	1
DB05896	Sirna-027	Drug	0	investigational	0
DB04566	Inosinic Acid	Drug	0	experimental	8
DB03236	(2s)-4-(Beta-Alanylamino)-2-Aminobutanoic Acid	Drug	0	experimental	0
DB05897	rhIGFBP-3	Drug	0	investigational	1
DB15210	Chlorotoxin	Drug	Toxins, Biological, Biological Factors, Neurotoxins, Complex Mixtures, Noxae, Venoms, Toxic Actions, Fluids and Secretions, Arthropod Venoms, Bodily Secretions	investigational	0
DB15268	Afabicin	Drug	0	investigational	0
DB15269	ALK-4290	Drug	0	investigational	0
DB15266	TAK-580	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB15267	Lesinidase alfa	Drug	0	investigational	0
DB03281	2'-Deoxymaltose	Drug	0	experimental	0
DB03280	p1-(5'-adenosyl)p5-(5'-thymidyl)pentaphosphate	Drug	0	experimental	5
DB03286	C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide	Drug	0	experimental	1
DB03285	Isoliquiritigenin	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Flavonoids, Ketones, Propiophenones, Benzopyrans, Plants, Aldehyde Reductase, antagonists & inhibitors, Chromones, Pyrans	experimental	0
DB03284	2,6-Anhydro-3-Deoxy-D-Erythro-Hex-2-Enonic Acid	Drug	0	experimental	1
DB03283	beta-L-fucose	Drug	0	experimental	2
DB03289	Thiarsa Dihydroxy Cysteine	Drug	0	experimental	1
DB03288	5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide	Drug	0	experimental	1
DB03287	4-(2-Amino-Ethoxy)-2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Amino]-but-3-Enoic Acid	Drug	0	experimental	0
DB15260	Iscalimab	Drug	0	investigational	0
DB15261	Butafenacil	Drug	Hydrocarbons, Halogenated	investigational	0
DB15264	PD-0299685	Drug	0	investigational	0
DB15265	USL-311	Drug	0	investigational	0
DB15262	Futuximab	Drug	0	investigational	0
DB15263	Thyrotropin	Drug	Peptide Hormones, Thyroid Products, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pituitary Hormones, Amino Acids, Peptides, and Proteins, Tests for Thyreoidea Function, Diagnostic Agents, Hormones, Pituitary Hormones, Anterior	investigational	0
DB15279	CB-103	Drug	0	investigational	0
DB15277	Gedivumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB15278	Marzeptacog alfa (activated)	Drug	0	investigational	0
DB03293	9-Methyl Uric Acid	Drug	0	experimental	0
DB03292	3-Phosphono-D-alanine	Drug	0	experimental	1
DB03291	4-Deoxy-4-Amino-Beta-D-Glucose	Drug	0	experimental	0
DB03290	L-naphthyl-1-acetamido boronic acid alanine	Drug	0	experimental	1
DB03297	Benzylsulfonic acid	Drug	Alkanesulfonic Acids, Sulfur Compounds, Acids, Noncarboxylic, Alkanesulfonates, Acids, Sulfur Acids, Hydrocarbons, Acyclic, Sulfonic Acids, Alkanes	experimental	7
DB03296	3'-beta-Sialyl-beta-lactose	Drug	0	experimental	1
DB03295	Glutathionylspermidine	Drug	Diamines, Amines, Oligopeptides, Peptides, Biogenic Amines, Amino Acids, Peptides, and Proteins, Polyamines, Biogenic Polyamines	experimental	0
DB03294	1-Methyl-3-Oxo-1,3-Dihydro-Benzo[C]Isothiazole-5-Sulfonic Acid Amide	Drug	0	experimental	1
DB03299	N-Succinyl Phenylglycine	Drug	0	experimental	1
DB03298	Phenylphosphate	Drug	Organophosphorus Compounds	experimental	1
DB15271	Crizanlizumab	Drug	Serum Globulins, Antibodies, Monoclonal, Humanized, Immunoglobulins, Immunoglobulin G, Antibodies, Monoclonal	approved, investigational	1
DB15272	Edratide	Drug	Proteins, Serum Globulins, Globulins, Peptides, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB15270	Efgartigimod alfa	Drug	0	investigational	0
DB15275	GDC-0077	Drug	0	investigational	0
DB15276	PR1 leukemia peptide vaccine	Drug	0	investigational	0
DB15273	VS-4718	Drug	Pyridines, Amines, Focal Adhesion Protein-Tyrosine Kinases, antagonists & inhibitors	investigational	0
DB15274	Pertussis vaccine	Drug	Complex Mixtures, Biological Products, Vaccines, Bacterial Vaccines	approved, investigational	0
DB15288	Etamicastat	Drug	Heterocyclic Compounds, Fused-Ring, Pyrans	investigational	0
DB15289	Perillyl alcohol	Drug	Enzyme Inhibitors, Perilla, Antineoplastic Agents, Terpenes	investigational	0
DB15282	Fluorofuranylnorprogesterone F-18	Drug	0	investigational	0
DB15283	Tebentafusp	Drug	0	investigational	0
DB15280	Gimsilumab	Drug	0	investigational	0
DB15281	Ravoxertinib	Drug	0	investigational	0
DB15286	CB-1158	Drug	Enzyme Inhibitors	investigational	0
DB15287	Elismetrep	Drug	0	investigational	0
DB15284	Sulopenem	Drug	Amides	investigational	0
DB15285	ARC-19499	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Oligonucleotides, Glycosides, Nucleotides, Polynucleotides	investigational	0
DB15299	AMG-232	Drug	0	investigational	0
DB15290	Pegteograstim	Drug	Adjuvants, Immunologic, Antineoplastic and Immunomodulating Agents, Colony-Stimulating Factors	investigational	0
DB15293	Epalrestat	Drug	Enzyme Inhibitors, Sulfur Compounds, Thiazoles	investigational	0
DB15294	SB-1578	Drug	Heterocyclic Compounds, Fused-Ring, Janus Kinase 2, antagonists & inhibitors, fms-Like Tyrosine Kinase 3, antagonists & inhibitors	investigational	0
DB15291	BMS-986142	Drug	0	investigational	0
DB15292	Foliglurax	Drug	0	investigational	0
DB15297	Petesicatib	Drug	0	investigational	0
DB15298	Ontamalimab	Drug	0	investigational	0
DB15295	Tenalisib	Drug	0	investigational	0
DB15296	D-fluoromethyltyrosine F-18	Drug	0	investigational	0
DB05942	GI-5005	Drug	Proteins, Antigens, Biological Factors, Complex Mixtures, Biological Products, Amino Acids, Peptides, and Proteins, Recombinant Proteins, Vaccines	investigational	0
DB04612	N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE	Drug	0	experimental	1
DB05943	Resatorvid	Drug	Sulfur Compounds, Amides, Sulfones	investigational	2
DB04613	(E)-(4S,6S)-6-((S)-2-{(S)-2-[(FURAN-2-CARBONYL)-AMINO]-3-METHYL-BUTYRYLAMINO}-3-METHYL-BUTYRYLAMINO)-8-METHYL-5-OXO-4-((R)-2-OXO-PYRROLIDIN-3-YLMETHYL)-NON-2-ENOIC ACID ETHYL ESTER	Drug	0	experimental	0
DB05944	Varlitinib	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds	investigational	2
DB04614	(R)-tacrine(10)-hupyridone	Drug	0	experimental	1
DB05945	MDX-1303	Drug	0	investigational	2
DB05941	Leronlimab	Drug	Immunoglobulins, HIV Fusion Inhibitors, Deltaretrovirus Antibodies, Viral Fusion Protein Inhibitors, Antibodies, Amino Acids, Peptides, and Proteins, Experimental Unapproved Treatments for COVID-19, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Antibodies, Monoclonal, Antibodies, Viral, Anti-Infective Agents, Immunoproteins, Proteins, Serum Globulins, Globulins, Blood Proteins, Receptors, CCR5	investigational	1
DB04610	7,8-dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin	Drug	0	experimental	1
DB04619	Acetophenone	Drug	Ketones, Photosensitizing Agents, Dermatologicals, Radiation-Sensitizing Agents	experimental	1
DB04615	(S)-tacrine(10)-hupyridone	Drug	0	experimental	1
DB04616	TACRINE(8)-4-AMINOQUINOLINE	Drug	0	experimental	1
DB04617	(9S)-9-[(8-AMMONIOOCTYL)AMINO]-1,2,3,4,9,10-HEXAHYDROACRIDINIUM	Drug	0	experimental	1
DB04618	4,6-DIDEOXY-4-{[4-[(4-O-HEXOPYRANOSYLHEXOPYRANOSYL)OXY]-5,6-DIHYDROXY-3-(HYDROXYMETHYL)CYCLOHEX-2-EN-1-YL]AMINO}HEXOPYRANOSYL-(1->4)HEXOPYRANOSYL-(1->4)HEXOPYRANOSE	Drug	0	experimental	1
DB04622	N-acetylhistamine	Drug	Biological Factors, Autacoids, Inflammation Mediators, Amines, Imidazoles, Ethylamines, Biogenic Amines, Biogenic Monoamines	experimental	1
DB04623	2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE	Drug	0	experimental	1
DB04624	DERIVATIVE OF AKLANONIC ACID METHYL ESTER (AAME)	Drug	0	experimental	1
DB05956	EVT-101	Drug	0	investigational	2
DB05950	Contulakin-G	Drug	Proteins, Carbohydrates, Glycoconjugates, Peptides, Amino Acids, Peptides, and Proteins, Nerve Tissue Proteins	investigational	1
DB04620	Cycloleucine	Drug	Amino Acids, Cyclic, Cycloparaffins, Amino Acids, Peptides, and Proteins, Amino Acids, Cyclopentanes	experimental	1
DB04626	Apramycin	Drug	Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Nephrotoxic agents, Carbohydrates, Anti-Bacterial Agents, Narrow Therapeutic Index Drugs, Aminoglycoside Antibacterials, Glycosides, Agents that produce neuromuscular block (indirect), Anti-Infective Agents, Drugs that are Mainly Renally Excreted	experimental, vet_approved	1
DB04627	Cyclouridine	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Glycosides, Nucleosides	experimental	1
DB04628	Allosamidin	Drug	Amino Sugars, Carbohydrates, Enzyme Inhibitors, Polysaccharides, Agrochemicals, Pesticides, Hexosamines, Insecticides, Toxic Actions, Oligosaccharides, Compounds used in a research, industrial, or household setting, Chitinases, antagonists & inhibitors	experimental	2
DB05959	ENMD-1198	Drug	Estranes, Fused-Ring Compounds, Steroids	investigational	3
DB04629	Aplyronine A	Drug	Polyketides, Actins, antagonists & inhibitors, Lactones	experimental	1
DB03301	2-Allyl-6-Methyl-Phenol	Drug	0	experimental	1
DB05964	Amitifadine	Drug	Stereoisomerism	investigational	3
DB04633	N-ethyl-N-[3-(propylamino)propyl]propane-1,3-diamine	Drug	0	experimental	1
DB03300	Pterin Cytosine Dinucleotide	Drug	0	experimental	1
DB04634	N-BENZYLOXYCARBONYL-L-SERINE-BETALACTONE	Drug	0	experimental	3
DB05966	TAS-108	Drug	0	investigational	2
DB05967	ANZ-100	Drug	0	investigational	1
DB04636	Glutamine t-butyl ester	Drug	0	experimental	1
DB03305	N(G)-Iminoethylornithine	Drug	Enzyme Inhibitors, Nitric Oxide Synthase, antagonists & inhibitors, Amino Acids, Basic, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	1
DB05961	PPL-100	Drug	0	investigational	3
DB04630	Aldosterone	Drug	Aldosterone, metabolism, Corticosteroids for Systemic Use, Corticosteroids, Cytochrome P-450 Substrates, Immunosuppressive Agents, Pregnenediones, Corticosteroids for Systemic Use, Plain, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein substrates, Adrenal Cortex Hormones, Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Hydroxycorticosteroids, P-glycoprotein inducers, Cytochrome P-450 CYP3A Substrates, Pregnanes, Mineralocorticoids, 11-Hydroxycorticosteroids, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Pregnenes, Steroids	investigational, experimental	2
DB03304	7-Deaza-7-Aminomethyl-Guanine	Drug	0	experimental	1
DB04631	Atpenin A5	Drug	Pyridines	experimental	4
DB03303	3-deoxy-D-arabino-hexonic acid	Drug	Acids, Acyclic, Carbohydrates, Hydroxy Acids	experimental	0
DB04632	4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE	Drug	0	experimental	1
DB03302	4,5,6,7-Tetrachloro-3h-Isobenzofuran-1-One	Drug	0	experimental	0
DB03309	N-cyclohexyltaurine	Drug	Alkanesulfonic Acids, Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfur Acids, Hydrocarbons, Acyclic, Sulfonic Acids, Alkanes, Buffers	experimental	6
DB03308	L-Leucyl-Hydroxylamine	Drug	0	experimental	1
DB03307	4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide	Drug	0	experimental	1
DB03306	RU78300	Drug	0	experimental	1
DB05968	PR-104	Drug	Hydrocarbons, Halogenated, Mustard Compounds	investigational	1
DB04637	6-Bromo-1-hexanol	Drug	0	experimental	1
DB05969	SNS-032	Drug	Sulfur Compounds	investigational	2
DB04638	2,5-di-tert-butylhydroquinone	Drug	Antioxidants, Calcium-Transporting ATPases, antagonists & inhibitors, Enzyme Inhibitors, Protective Agents, Phenols, Compounds used in a research, industrial, or household setting, Benzene Derivatives	experimental	1
DB04639	Biphenylalanine	Drug	0	experimental	2
DB04644	4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID	Drug	0	experimental	1
DB03312	Brivudine	Drug	Carbohydrates, Ribonucleosides, Pyrimidine Nucleosides, Deoxyuridine, Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors, Antiviral Agents, Antiinfectives for Systemic Use, Anti-Infective Agents, Antivirals for Systemic Use, Direct Acting Antivirals, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Deoxyribonucleosides	approved, investigational	3
DB04645	5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID	Drug	0	experimental	1
DB03311	3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide	Drug	0	experimental	1
DB04646	Dibromothymoquinone	Drug	Quinones, Benzoquinones	experimental	8
DB03310	Glutathione disulfide	Drug	Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins	approved, investigational, experimental	5
DB04647	BOC-GAMMA-D-GLU-L-LYS(CBZ)-D-BOROALA	Drug	0	experimental	2
DB03316	1,4-Dioxane	Drug	0	experimental	5
DB04640	Naphthalene-2,6-disulfonic acid	Drug	Arylsulfonates, Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfur Acids, Sulfonic Acids, Arylsulfonic Acids, Naphthalenes	experimental	2
DB05971	Archexin	Drug	0	investigational	1
DB03315	Guanosine 3'-monophosphate	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Guanine Nucleotides, Nucleotides, Isomerism	experimental	2
DB04641	3,7-DIHYDROXYNAPHTHALENE-2-CARBOXYLIC ACID	Drug	0	experimental	1
DB04642	7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID	Drug	0	experimental	1
DB05973	Inosine 5'-sulfate	Drug	0	investigational	0
DB03314	5-fluorotryptophan	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Amino Acids, Essential, Amino Acids, Peptides, and Proteins, Amino Acids, Carbon Radioisotopes	experimental	2
DB05974	Transcrocetinate	Drug	Biological Factors, Cycloparaffins, Alkenes, Protective Agents, Hydrocarbons, Acyclic, Antineoplastic Agents, Cyclohexenes, Cyclohexanes, Pigments, Biological, Antioxidants, Polyenes, Anticarcinogenic Agents, Terpenes, Compounds used in a research, industrial, or household setting	investigational	0
DB04643	4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID	Drug	0	experimental	1
DB03313	Cephalosporin C	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amides, Lactams, Thiazines, beta-Lactams, Agents that reduce seizure threshold	experimental	6
DB03319	(2S)-2-Ammonio-3-[5-(2-methyl-2-propanyl)-3-oxido-1,2-oxazol-4-yl]propanoate	Drug	0	experimental	1
DB03318	6-Hydro-1-Methyladenosine-5'-Monophosphate	Drug	0	experimental	0
DB03317	Ferroheme C	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Metalloporphyrins, Pigments, Biological, Porphyrins	experimental	23
DB04648	S-propylamine-L-cysteine	Drug	0	experimental	1
DB04649	TETRAHEDRAL INTERMEDIATE OF BLASTICIDIN S	Drug	0	experimental	1
DB05906	CCR5 mAb	Drug	0	investigational	1
DB05903	KOS-1584	Drug	Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Macrolides, Cytochrome P-450 CYP3A4 Inhibitors, Antineoplastic Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Lactones	investigational	0
DB05904	BLX-883	Drug	0	investigational	0
DB05905	TD-2749	Drug	0	investigational	1
DB05911	RUS 3108	Drug	0	investigational	0
DB05912	REN-850	Drug	0	investigational	0
DB05918	LS11	Drug	0	investigational	0
DB05919	DDP-200	Drug	0	investigational	0
DB05913	OSI-930	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds	investigational	2
DB05915	MYO-029	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	1
DB05916	CT-011	Drug	Proteins, Serum Globulins, Antineoplastic Agents, Immunological, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	1
DB05920	RTA 744	Drug	0	investigational	1
DB05928	Dovitinib	Drug	Quinolines, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP1A2 Inducers (strength unknown), OATP1B3 inhibitors, BCRP/ABCG2 Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors, UGT2B7 Inhibitors, BCRP/ABCG2 Inducers, UGT1A3 Inhibitors, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP1A2 Inducers, Cytochrome P-450 CYP2C19 Inhibitors (weak), P-glycoprotein inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (weak)	investigational	1
DB05929	GPI-0100	Drug	Carbohydrates, Glycosides	investigational	0
DB05924	NLX-P101	Drug	0	investigational	0
DB04600	4-[(3-BROMO-4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE	Drug	0	experimental	1
DB05931	Pegdinetanib	Drug	Carbohydrates, Glycoconjugates, Peptides, Amino Acids, Peptides, and Proteins, Glycoproteins, Membrane Proteins, Proteins, Scleroproteins, Serum Globulins, Globulins, Blood Proteins, Extracellular Matrix Proteins, Membrane Glycoproteins, Vascular Endothelial Growth Factor Receptor-2, antagonists & inhibitors	investigational	1
DB04601	4-[(4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE	Drug	0	experimental	1
DB05932	Denibulin	Drug	Heterocyclic Compounds, Fused-Ring	investigational	3
DB04602	PUROMYCIN AMINONUCLEOSIDE-5'-MONOPHOSPHATE	Drug	0	experimental	1
DB04603	5-Formyl-2'-deoxy-cytidine-5'-monophosphate	Drug	0	experimental	0
DB05934	CTCE-0214	Drug	Proteins, Biological Factors, Inflammation Mediators, Cytokines, Peptides, Anti-Inflammatory Agents, Chemokines, CXC, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Chemotactic Factors, Chemokines	investigational	1
DB05930	SB-559448	Drug	0	investigational	1
DB05939	MK-0354	Drug	0	investigational	1
DB04608	9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE	Drug	0	experimental	1
DB04609	INHIBITOR Q8467 OF DUPONT MERCK	Drug	0	experimental	1
DB04604	5-iodotubercidin	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purines, Ribonucleosides, Enzyme Inhibitors, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Adenosine Kinase, antagonists & inhibitors, Purine Nucleosides	experimental	3
DB04605	5-Aminoisoquinoline	Drug	Heterocyclic Compounds, Fused-Ring	experimental	1
DB05936	CVT-6883	Drug	Heterocyclic Compounds, Fused-Ring, Adenosine A2 Receptor Antagonists	investigational	1
DB04606	2-[2-ETHANESULFONYLAMINO-3-(5-PROPOXY-1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIMIDOYL-BENZYLAMIDE)	Drug	0	experimental	1
DB04607	PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE	Drug	0	experimental	1
DB05938	Edonerpic	Drug	Acids, Acyclic, Sulfur Compounds, Dicarboxylic Acids	investigational	1
DB14014	SR-9011	Drug	Sulfur Compounds	experimental	2
DB15345	GSK-945237	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB15346	GLPG-1205	Drug	0	investigational	0
DB14015	Sodium bisulfite	Drug	Antioxidants, Anions, Sulfur Compounds, Mutagens, Noxae, Protective Agents, Electrolytes, Ions, Toxic Actions, Compounds used in a research, industrial, or household setting, Anti-Infective Agents, Anti-Infective Agents, Local	approved	0
DB15343	HM-43239	Drug	0	investigational	0
DB14012	Burosumab	Drug	Immunoglobulins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Drugs Affecting Bone Structure and Mineralization, Immunoproteins, Electrolytic, Caloric and Water Balance Agents, Miscellanous, Proteins, Serum Globulins, Globulins, Blood Proteins, Musculo-Skeletal System, Drugs for Treatment of Bone Diseases	approved, investigational	1
DB14013	SR-9009	Drug	Sulfur Compounds	experimental	2
DB15344	beta-Hydroxyisovaleric acid	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Lipids	investigational	0
DB15349	Sofituzumab vedotin	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Noxae, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Toxic Actions, Immunoproteins	investigational	0
DB14018	Bromotheophylline	Drug	Amines, Cytochrome P-450 Substrates, Propanols, Amino Alcohols, Alcohols, Alkaloids, Heterocyclic Compounds, Fused-Ring, Purines, Cytochrome P-450 CYP1A2 Substrates, Diuretics, Drugs for Obstructive Airway Diseases, Pharmaceutical Preparations, Xanthine derivatives, Purinones	approved	0
DB14019	Fosnetupitant	Drug	Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 Substrates, Netupitant and prodrug, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Substance P/Neurokinin-1 Receptor Antagonist	approved	1
DB14016	Ox bile extract	Drug	Bile Acids and Salts	approved, investigational, experimental	0
DB15347	Branebrutinib	Drug	0	investigational	0
DB15348	Ampreloxetine	Drug	Phenols, Ethers, Benzene Derivatives	investigational	0
DB14017	H3B-8800	Drug	0	investigational	1
DB04691	2'-O-[1-ethyl-1H-imidazol)] thymidine-5'-monophosphate	Drug	0	experimental	0
DB04692	Ethyl (2E)-4-({(2S)-2-[(N-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-valyl)amino]-2-phenylacetyl}amino)-5-[(3S)-2-oxo-3-pyrrolidinyl]-2-pentenoate	Drug	0	experimental	0
DB04693	Estrane-3,17-dione	Drug	Fused-Ring Compounds, Steroids	experimental	1
DB04694	2,6-anhydro-3-deoxy-3-fluoronononic acid	Drug	0	experimental	0
DB03363	3-Acetylpyridine Adenine Dinucleotide	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Coenzymes, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Enzymes and Coenzymes, Glycosides, Nucleotides, Adenine Nucleotides	experimental	1
DB02032	Epicaptopril	Drug	Protease Inhibitors, Agents that produce hypertension	experimental	6
DB03362	N-Dimethyl-Lysine	Drug	0	experimental	0
DB02031	(6S)-5,6,7,8-tetrahydrofolic acid	Drug	Folic Acid and Derivatives, Vitamin B Complex, Vitamins	experimental	2
DB02030	Alpha-Ribazole-5'-Phosphate	Drug	0	experimental	1
DB03361	2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-D][1,3]Thiazolo[3,2-a]Pyrimidin-8-Yl}Ethyl Trihydrogen Diphosphate	Drug	0	experimental	1
DB04690	Camptothecin	Drug	Alkaloids, Antineoplastic Agents, Phytogenic, Enzyme Inhibitors, BCRP/ABCG2 Substrates, Topoisomerase Inhibitors, P-glycoprotein substrates, Topoisomerase I Inhibitors, Antineoplastic Agents	experimental	1
DB03360	N-Acetylproline	Drug	Acids, Acyclic, Amino Acids, Cyclic, Imines, Amino Acids, Peptides, and Proteins, Imino Acids, Amino Acids	experimental	1
DB02036	2-(3,4-Dihydro-3-Oxo-2h-Benzo[B][1,4]Thiazin-2-Yl)-N-Hydroxyacetamide	Drug	0	experimental	1
DB04699	gamma-butyrolactone	Drug	Solvents, 4-Butyrolactone, Furans, 4-Butyrolactone, analogs & derivatives, Compounds used in a research, industrial, or household setting, Lactones	experimental	1
DB03367	PF-00356231	Drug	0	experimental	1
DB02035	Hexadecanesulfonyl fluoride	Drug	Sulfur Compounds, Fatty Acids, Palmitic Acids, Lipids	experimental	1
DB03366	Imidazole	Drug	Enzyme Inhibitors, Thromboxane-A Synthase, antagonists & inhibitors	investigational, experimental	26
DB03365	4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline	Drug	0	experimental	1
DB02034	Tridolgosir	Drug	0	experimental	1
DB02033	N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide	Drug	0	experimental	1
DB03364	N-Carbamyl-D-Methionine	Drug	0	experimental	1
DB04695	Farnesyl thiopyrophosphate	Drug	QTc Prolonging Agents, Organophosphorus Compounds, Potential QTc-Prolonging Agents, Terpenes, Organophosphates	experimental	4
DB02039	S-Acetyl-Cysteine	Drug	0	experimental	4
DB04696	4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN	Drug	0	experimental	1
DB04697	TRANS-4-(GUANIDINOMETHYL)-CYCLOHEXANE-L-YL-D-3-CYCLOHEXYLALANYL-L-AZETIDINE-2-YL-D-TYROSINYL-L-HOMOARGININAMIDE	Drug	0	experimental	1
DB03369	9-Aminophenanthrene	Drug	0	experimental	1
DB02038	D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide	Drug	0	experimental	4
DB02037	2,5-Diaminopyrimidin-4,6-diol	Drug	0	experimental	0
DB04698	N-(1,4-dihydro-5H-tetrazol-5-ylidene)-9-oxo-9H-xanthene-2-sulfonamide	Drug	0	experimental	1
DB03368	5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione	Drug	0	experimental	1
DB14010	5-methoxy-N,N-dimethyltryptamine	Drug	Serotonin 5-HT1 Receptor Agonists, Cytochrome P-450 Substrates, Serotonin Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Serotonin Receptor Agonists, Agents that produce hypertension, Antidepressive Agents, Cytochrome P-450 CYP2D6 Substrates, Serotonin 5-HT2 Receptor Agonists	illicit, experimental	2
DB15341	Dinalbuphine sebacate	Drug	0	investigational	0
DB15342	Panobacumab	Drug	0	investigational	0
DB14011	Nabiximols	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 Substrates, Sensory System Agents, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP3A7 Inhibitors (strength unknown), Peripheral Nervous System Agents, Cytochrome P-450 CYP1A2 Inhibitors, Analgesics, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP3A5 Inhibitors, BCRP/ABCG2 Inhibitors, Agents producing tachycardia, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cannabinoid Receptor Agonists, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cannabinoids and similars, Cytochrome P-450 CYP3A7 Inhibitors, Pharmaceutical Preparations, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Terpenes	investigational	44
DB15340	EC-0652	Drug	0	investigational	0
DB15356	SLV-334	Drug	0	investigational	0
DB14025	Clinafloxacin	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Quinolines, Enzyme Inhibitors, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (strong), Hypoglycemia-Associated Agents, Cytochrome P-450 CYP2C19 Inhibitors, Anti-Infective Agents, Quinolones, Cytochrome P-450 CYP1A2 Inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Cytochrome P-450 CYP2C9 Inhibitors, Topoisomerase II Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors (weak), Cytochrome P-450 CYP2C9 Inhibitors (weak), Cytochrome P-450 CYP2D6 Inhibitors (weak)	investigational	0
DB14026	Thiosalicylic acid	Drug	Analgesics, Non-Narcotic, Benzoates, Hydroxy Acids, Sensory System Agents, Acids, Carbocyclic, Hydroxybenzoates, Organomercury Compounds, Peripheral Nervous System Agents, Organometallic Compounds, Sulfur Compounds, Analgesics, Phenols, Central Nervous System Agents, Salicylates, Benzene Derivatives, Alkylmercury Compounds, Ethylmercury Compounds	experimental	0
DB15357	Xanomeline	Drug	Autonomic Agents, Muscarinic Agonists, Neurotransmitter Agents, Sulfur Compounds, Cholinergic Agents, Cholinergic Agonists, Parasympathomimetics, Thiazoles, Central Nervous System Agents, Peripheral Nervous System Agents	investigational	0
DB15354	Evinacumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB15355	PL-3994	Drug	Receptors, Atrial Natriuretic Factor, agonists, Peptides, Amino Acids, Peptides, and Proteins, Bronchodilator Agents	investigational	0
DB14029	Furafylline	Drug	Cytochrome P-450 CYP1A2 Inhibitors, Alkaloids, Heterocyclic Compounds, Fused-Ring, Purines, Enzyme Inhibitors, Chemically-Induced Disorders, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (strong), Xanthine derivatives, Purinones	experimental	0
DB15358	JNJ-54175446	Drug	0	investigational	0
DB14027	Taspoglutide	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Gastrointestinal Hormones, Pancreatic Hormones, Amino Acids, Peptides, and Proteins, Blood Glucose Lowering Agents, GLP-1 Agonists, Hormones, Proteins, Peptide Hormones, Glucagon-Like Peptides, Protein Precursors, Proglucagon	investigational	0
DB15359	Xanthohumol	Drug	Heterocyclic Compounds, Fused-Ring, Ketones, Benzopyrans, Chromones, Pyrans	investigational	0
DB14028	Nordazepam	Drug	Amino Acids, Aromatic, Psycholeptics, Tranquilizing Agents, GABA Agents, Nervous System, GABA Modulators, Amino Acids, Essential, Benzodiazepines and benzodiazepine derivatives, Amino Acids, Peptides, and Proteins, Psychotropic Drugs, Amino Acids, Amino Acids, Cyclic, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Benzazepines, Central Nervous System Depressants, Benzodiazepinones, Anti-Anxiety Agents, Central Nervous System Agents	experimental	2
DB03370	FR239087	Drug	0	experimental	1
DB03374	3,5-Diiodotyrosine	Drug	Thyroid Products, Antithyroid agents	experimental	6
DB02043	1,2-Dipalmitoyl-Phosphatidyl-Glycerole	Drug	0	experimental	1
DB03373	ZK-806711	Drug	0	experimental	1
DB02042	2-(2-{2-[2-(2-Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol	Drug	0	experimental	2
DB03372	3-Mercapto-1-(1,3,4,9-Tetrahydro-B-Carbolin-2-Yl)-Propan-1-One	Drug	0	experimental	1
DB02041	Isoluminol	Drug	Luminescent Agents, Pyridazines, Laboratory Chemicals, Indicators and Reagents, Luminescent Measurements, Compounds used in a research, industrial, or household setting	experimental	1
DB03371	Modified Ribosylated Glutamyl Ester	Drug	0	experimental	1
DB03378	4-Amino-1-[(1s,3r,4r,7s)-7-Hydroxy-1-(Hydroxymethyl)-2,5-Dioxabicyclo[2.2.1]Hept-3-Yl]-5-Methylpyrimidin-2(1h)-One	Drug	0	experimental	0
DB02047	(+)-2-(4-biphenyl)propionic acid	Drug	0	experimental	1
DB02046	N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid	Drug	0	experimental	1
DB02045	Amylamine	Drug	0	experimental	1
DB03376	5'-O-(N-(Alanyl)sulfamoyl)adenosine	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purines, Ribonucleosides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Amino Acids, Peptides, and Proteins, Purine Nucleosides, Amino Acids	experimental	1
DB02044	N-[3-(aminomethyl)benzyl]acetamidine	Drug	0	experimental	3
DB02049	2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide	Drug	0	experimental	1
DB02048	1,2,4-Triazole-Carboxamidine	Drug	0	experimental	1
DB03379	2-Carboxyethylphosphonic Acid	Drug	0	experimental	1
DB15352	Vorsetuzumab mafodotin	Drug	0	investigational	0
DB15353	Nacubactam	Drug	0	investigational	0
DB14022	Typhoid vaccine	Drug	Vaccines, Typhoid, Vaccines	approved	0
DB15350	D-chiro-Inositol	Drug	0	investigational	0
DB14020	Benzoin	Drug	Acetophenones, Ketones	approved, experimental	0
DB15367	LY-2623091	Drug	0	investigational	0
DB14037	Madecassic acid	Drug	Terpenes	experimental	0
DB15368	Yttrium Y-90 clivatuzumab tetraxetan	Drug	0	investigational	0
DB15365	Pegbelfermin	Drug	Proteins, Biological Factors, Peptides, Ethylene Glycols, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Glycols, Polymers, Compounds used in a research, industrial, or household setting, Alcohols, Macromolecular Substances	investigational	0
DB14034	Darglitazone	Drug	Sulfur Compounds, Thiazoles	experimental	1
DB15366	SOR-C13	Drug	Carbohydrates, Glycoconjugates, Ion Channels, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Cardiovascular Agents, Glycoproteins, Transient Receptor Potential Channels, Membrane Transport Modulators, Membrane Proteins, Proteins, Calcium Channel Blockers, Membrane Transport Proteins, Calcium-Regulating Hormones and Agents, Membrane Glycoproteins, Antiarrhythmic agents, Carrier Proteins	investigational	0
DB14035	Englitazone	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Thiazoles, Blood Glucose Lowering Agents, Pyrans	experimental	0
DB15369	Aganirsen	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides, Polynucleotides	investigational	0
DB14038	beta-Sitosterol	Drug	Biological Factors, Cholestanes, Hypolipidemic Agents, Noxae, Phytosterols, Lipids, Fused-Ring Compounds, Lipid Regulating Agents, Phytochemicals, Sterols, Toxic Actions, Membrane Lipids, Cholestenes, Steroids	experimental	0
DB14039	Erenumab	Drug	Calcitonin Gene-Related Peptide Receptor Antagonists, Immunoglobulins, Sensory System Agents, Nervous System, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Antimigraine Preparations, Immunoproteins, Peripheral Nervous System Agents, Proteins, Serum Globulins, Analgesics, Globulins, Blood Proteins, Central Nervous System Agents, Calcitonin-gene-related Peptide (Cgrp) Antagonists	approved, investigational	1
DB03381	Hexadecanal	Drug	0	experimental	2
DB03380	L-tyrosinamide	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	2
DB03385	4-Methylimidazole	Drug	0	experimental	3
DB02054	Gabaculine	Drug	Cycloparaffins, Enzyme Inhibitors, Acids, Carbocyclic, Transaminases, antagonists & inhibitors, Cyclohexanes	experimental	2
DB02053	Ribose-5-phosphate	Drug	Carbohydrates, Sugar Phosphates, Pentosephosphates	experimental	3
DB03384	Fica	Drug	0	experimental	1
DB02052	Indirubin-3'-monoxime	Drug	Heterocyclic Compounds, Fused-Ring, Amines, Hydroxylamines	experimental	6
DB03383	CP-320626	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Phosphorylase b, antagonists & inhibitors	experimental	1
DB03382	S-oxy-L-cysteine	Drug	0	experimental	7
DB02051	4-Nitrophenyl (3S)-3-({N-[(benzyloxy)carbonyl]-L-phenylalanyl}amino)-5-phenyl-1-pentanesulfonate	Drug	0	experimental	1
DB02058	3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone	Drug	Tyrosine Kinase Inhibitors	experimental	2
DB03389	alpha-D-Xylopyranose	Drug	0	experimental	16
DB03388	3-[(2,4-Dichlorobenzoyl)(Isopropyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid	Drug	0	experimental	1
DB02057	(S)-AMPA	Drug	0	experimental	1
DB02056	Prostaglandin D2	Drug	Biological Factors, Prostaglandins D, Autacoids, Fatty Acids, Unsaturated, Inflammation Mediators, Prostaglandins, Fatty Acids, Eicosanoids, Lipids, Prostaglandin D2, antagonists & inhibitors	investigational	2
DB03387	N-Hydroxy-N-Isopropyloxamic Acid	Drug	0	experimental	0
DB02055	N-Butyl-Benzenesulfonamide	Drug	0	experimental	0
DB03386	4-Fluorotryptophane	Drug	0	experimental	0
DB02059	Adenosine-5-Diphosphoribose	Drug	0	experimental	11
DB15360	Carfentanil, C-11	Drug	Sensory System Agents, Analgesics, Narcotics, Central Nervous System Depressants, Piperidines, Opioids, Central Nervous System Agents, Carbon Radioisotopes, Peripheral Nervous System Agents	investigational	0
DB15363	Istiratumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB14033	Acetyl sulfisoxazole	Drug	Amines, Cytochrome P-450 Enzyme Inhibitors, Gynecological Antiinfectives and Antiseptics, Aniline Compounds, Genito Urinary System and Sex Hormones, Amides, Sulfanilamides, Anti-Bacterial Agents, Sulfur Compounds, Sulfonamide Antibacterial, Sulfonamides, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (weak), Sulfones	approved, vet_approved	1
DB15361	Thallium Tl-201	Drug	Radioisotopes, Isotopes	investigational	0
DB14030	PZM21	Drug	0	experimental	0
DB14031	Tretamine	Drug	Alkylating Drugs, Triazines, Aziridines, Cholinesterase Inhibitors, Noxae, Antineoplastic Agents, Toxic Actions, Azirines, Antineoplastic Agents, Alkylating	experimental	0
DB15362	LSZ-102	Drug	0	investigational	0
DB15378	Vopratelimab	Drug	0	investigational	0
DB15379	Hydroxypropyl betadex	Drug	Carbohydrates, Excipients, Dietary Carbohydrates, Starch, Cyclodextrins, Biopolymers, Pharmaceutic Aids, Drug Delivery Systems, Macromolecular Substances, Polysaccharides, Physiological Phenomena, beta-Cyclodextrins, Food and Beverages, Glucans, Pharmaceutical Preparations, Dextrins, Polymers, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food, Pharmaceutical Vehicles	investigational	0
DB14048	Sodium zirconium cyclosilicate	Drug	Ions, Oxides, Minerals, Potassium-removing Agents, Silicon Compounds, Anions, Gastric Acid Lowering Agents, Acids, Noncarboxylic, Acids, Drugs for Treatment of Hyperkalemia and Hyperphosphatemia, Electrolytes, Potassium Binder, Oxygen Compounds	approved, investigational	1
DB15376	Gosuranemab	Drug	0	investigational	0
DB14045	Cholesteryl chloride	Drug	Cholestanes, Fused-Ring Compounds, Steroids	experimental	0
DB15377	ATB-346	Drug	Naphthaleneacetic Acids, Naphthalenes	investigational	0
DB14046	Dichlorobenzene	Drug	Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 Substrates, Benzene Derivatives	approved, experimental	0
DB14049	Nitrate	Drug	Anions, Acids, Noncarboxylic, Antianginal Agents, Acids, Electrolytes, Ions, Nitrates, Nitric Acid, Vasodilating Agents, Nitrogen Compounds, Organic Nitrates	investigational, experimental	0
DB02061	Cellobiose	Drug	Carbohydrates, Polysaccharides, Disaccharides, Glucans, Cellulose, Oligosaccharides, Polymers, Biopolymers, Compounds used in a research, industrial, or household setting, Macromolecular Substances	experimental	3
DB03392	(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester	Drug	0	experimental	1
DB03391	Chromophore (Met-Tyr-Gly)	Drug	0	experimental	0
DB02060	Cyclohexanone	Drug	Cycloparaffins, Ketones, Cyclohexanes	experimental	1
DB03390	(2R,3R)-2,3-Dihydroxy-4-oxo-4-(propylamino)butanoic acid	Drug	0	experimental	1
DB02065	4-Deoxylactose	Drug	0	experimental	1
DB03396	(2R,3R,4S,5R,6E)-3,4,5-Trihydroxy-N-[(3S,6R)-6-hydroxy-2-oxo-3-azepanyl]-2-methoxy-8,8-dimethyl-6-nonenamide	Drug	0	experimental	1
DB03395	Enalkiren	Drug	Renin-Inhibitors, Enzyme Inhibitors, Oligopeptides, Peptides, Protease Inhibitors, Agents Acting on the Renin-Angiotensin System, Amino Acids, Peptides, and Proteins	experimental	1
DB02063	CRA_16847	Drug	0	experimental	1
DB03394	Heptaethylene glycol	Drug	Pegylated agents	experimental	1
DB02062	N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine	Drug	0	experimental	2
DB03393	Sanglifehrin A	Drug	0	experimental	1
DB02069	N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide	Drug	0	experimental	1
DB03399	Ethyl Isocyanide	Drug	0	experimental	1
DB02068	Delta-Amino Valeric Acid	Drug	0	experimental	2
DB02067	Triglu-5-formyl-tetrahydrofolate	Drug	Folic Acid and Derivatives, Vitamin B Complex, Vitamins	experimental	1
DB02066	N7-Methyl-Formycin A	Drug	0	experimental	1
DB03397	Uridine-Diphosphate-N-Acetylglucosamine	Drug	0	experimental	8
DB15370	Balixafortide	Drug	Peptides, Amino Acids, Peptides, and Proteins	investigational	0
DB14040	Eptinezumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Antimigraine Preparations, Calcitonin-gene-related Peptide (Cgrp) Antagonists, Immunoproteins	approved, investigational	2
DB15371	MK-2748	Drug	Sulfur Compounds	investigational	0
DB15374	Cobalt Co-60	Drug	Metals, Cobalt Isotopes, Radioisotopes, Metals, Heavy, Elements, Transition Elements, Cobalt, Isotopes	investigational	0
DB14043	Palmidrol	Drug	Analgesics, Non-Narcotic, Amines, Fatty Acids, Sensory System Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Anti-Inflammatory Agents, Antirheumatic Agents, Agents producing tachycardia, Lipids, Hormones, Amino Alcohols, Anti-Infective Agents, Alcohols, Peripheral Nervous System Agents, Neurotransmitter Agents, Analgesics, Cannabinoids and similars, Central Nervous System Agents	nutraceutical, experimental	0
DB15375	Tozuleristide	Drug	Toxins, Biological, Biological Factors, Heterocyclic Compounds, Fused-Ring, Complex Mixtures, Venoms, Indoles, Fluids and Secretions, Arthropod Venoms, Bodily Secretions	investigational	0
DB14044	Hopantenic acid	Drug	Acids, Acyclic, Alanine, Fatty Acids, Butyrates, Fatty Acids, Volatile, Amino Acids, Peptides, and Proteins, Lipids, Central Nervous System Agents, Aminobutyrates, Amino Acids, Imides, Nootropic Agents	experimental	0
DB15372	JNJ-27548547	Drug	0	investigational	0
DB14041	Fremanezumab	Drug	Proteins, Serum Globulins, Antibodies, Monoclonal, Humanized, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Antimigraine Preparations, Immunoproteins	approved, investigational	2
DB15373	Tilmanocept	Drug	0	investigational	0
DB14042	Galcanezumab	Drug	Calcitonin Gene-Related Peptide Receptor Antagonists, Immunoglobulins, Sensory System Agents, Nervous System, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Antimigraine Preparations, Immunoproteins, Peripheral Nervous System Agents, Proteins, Serum Globulins, Antibodies, Monoclonal, Humanized, Analgesics, Globulins, Blood Proteins, Central Nervous System Agents, Calcitonin-gene-related Peptide (Cgrp) Antagonists	approved, investigational	2
DB15301	Bevifimod	Drug	Proteins, Antigens, Biological Factors, Amino Acids, Peptides, and Proteins, Antigens, Bacterial, Bacterial Proteins	investigational	0
DB15302	2-fluorofucose	Drug	0	investigational	0
DB15300	Hydroquinidine	Drug	Autonomic Agents, Quinolines, Parasympatholytics, Cardiovascular Agents, Peripheral Nervous System Agents, Alkaloids, Heterocyclic Compounds, Fused-Ring, Cinchona Alkaloids, Antiarrhythmics, Class I, Antiarrhythmics, Class Ia, Cardiac Therapy, Quinuclidines, Antiarrhythmic agents	investigational	0
DB15305	Risdiplam	Drug	Peripheral Nervous System Agents	investigational	0
DB15306	MEDI-6469	Drug	0	investigational	0
DB15303	Faricimab	Drug	0	investigational	0
DB15304	iota-Carrageenan	Drug	0	investigational	0
DB15307	Atabecestat	Drug	0	investigational	0
DB15308	Ridinilazole	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB04650	5-[(3AS,4R,6AR)-2-OXOHEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL]PENTANOIC ACID	Drug	0	experimental	1
DB04655	Metoprine	Drug	Enzyme Inhibitors, Pyrimidines, Folic Acid Antagonists, Antineoplastic Agents	experimental	1
DB03323	Maltose	Drug	Food Additives, Carbohydrates, Disaccharides, Flavoring Agents, Oligosaccharides, Biopolymers, Pharmaceutic Aids, Macromolecular Substances, Maltose, metabolism, Polysaccharides, Physiological Phenomena, Food and Beverages, Glucans, Food Ingredients, Pharmaceutical Preparations, Polymers, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food, Sweetening Agents	investigational, experimental	9
DB04656	1,3,4-TRIHYDROXY-5-(3-PHENOXYPROPYL)-CYCLOHEXANE-1-CARBOXYLIC A CID	Drug	0	experimental	1
DB03322	Dexpropranolol	Drug	Amines, Propanols, Phenoxypropanolamines, Adrenergic beta-Antagonists, Cardiovascular Agents, Amino Alcohols, Alcohols, Naphthalenes, Neurotransmitter Agents, Adrenergic Antagonists, Antihypertensive Agents, Vasodilating Agents, Adrenergic Agents, Antiarrhythmic agents, Propanolamines	experimental	0
DB03321	Des(carbamimidoyl) zanamivir	Drug	0	experimental	1
DB04657	Carboxin	Drug	Anilides, Fungicides, Industrial, Amines, Agrochemicals, Oxathiins, Aniline Compounds, Pesticides, Amides, Toxic Actions, Compounds used in a research, industrial, or household setting	approved, experimental	1
DB03320	3-Amino-Alanine	Drug	0	experimental	1
DB04658	(1S,2R,3S,4R,5S)-8-AZABICYCLO[3.2.1]OCTANE-1,2,3,4-TETROL	Drug	0	experimental	1
DB04651	BIOTINOL-5-AMP	Drug	0	experimental	1
DB03327	{1-[(3-Hydroxy-Methyl-5-Phosphonooxy-Methyl-Pyridin-4-Ylmethyl)-Amino]-Ethyl}-Phosphonic Acid	Drug	0	experimental	1
DB05983	Bardoxolone methyl	Drug	Sapogenins, Triterpenes, Pentacyclic Triterpenes, Terpenes, Fused-Ring Compounds, Steroids	investigational	1
DB03326	Deoxycytidylyl-3',5'-guanosine	Drug	Carbohydrates, Ribonucleosides, Cytosine Nucleotides, Nucleotides, Purine Nucleosides, Heterocyclic Compounds, Fused-Ring, Purines, Pyrimidines, Ribonucleotides, Deoxyribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Pyrimidine Nucleotides	experimental	1
DB04652	Corticosterone	Drug	Cytochrome P-450 Substrates, Pregnenediones, Hormones, Hormone Substitutes, and Hormone Antagonists, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Hormones, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Hydroxycorticosteroids, Cytochrome P-450 CYP3A Substrates, Pregnanes, 11-Hydroxycorticosteroids, Pregnenes, Steroids	experimental	3
DB05984	RAF-265	Drug	0	investigational	2
DB03325	Tyrosyladenylate	Drug	0	experimental	1
DB04653	N-[(benzyloxy)carbonyl]-L-leucyl-N-[(1S)-3-fluoro-1-(4-hydroxybenzyl)-2-oxopropyl]-L-leucinamide	Drug	0	experimental	1
DB04654	4-PIPERIDIN-4-YLBUTANAL	Drug	0	experimental	2
DB03329	2-Pyridinethiol	Drug	Sulfur Compounds	experimental	1
DB03328	Dioxo(sulfanyl)molybdenum	Drug	0	experimental	1
DB04659	(1S,2S,3R,4S,5S)-2,3,4-TRIHYDROXY-5-(HYDROXYMETHYL)CYCLOHEXYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE	Drug	0	experimental	1
DB15312	Orilanolimab	Drug	0	investigational	0
DB15313	DAS-181	Drug	Proteins, Amino Acids, Peptides, and Proteins, Recombinant Proteins	investigational	0
DB15310	Vactosertib	Drug	0	investigational	0
DB15311	Davanat	Drug	Carbohydrates, Hexoses, Monosaccharides	investigational	0
DB15316	Florasulam	Drug	Sulfur Compounds, Amides, Sulfones	investigational	0
DB15317	Posiphen	Drug	Acids, Acyclic, Alkaloids, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Enzyme Inhibitors, Cholinergic Agents, Cholinesterase Inhibitors, Stereoisomerism, Phenylcarbamates, Carbamates, Indoles, Indole Alkaloids	investigational	0
DB15314	Modimelanotide	Drug	Pyridines	investigational	0
DB15315	Coblopasvir	Drug	0	investigational	0
DB05990	Obeticholic acid	Drug	BSEP/ABCB11 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Farnesoid X Receptor Agonist, Bile Acid Preparations, Bile Therapy, Bile Acids and Salts, Cholic Acids, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Fused-Ring Compounds, Cytochrome P-450 CYP1A2 Inhibitors, Alimentary Tract and Metabolism, Bile acids and derivatives, BSEP/ABCB11 inducers, Miscellaneous GI Drugs, Cholanes, Farnesoid X Receptor Agonists, Bile and Liver Therapy	approved	1
DB04660	Choline alfoscerate	Drug	Carbohydrates, Phosphatidylcholines, Nervous System, Sugar Phosphates, Plant Extracts, Parasympathomimetics, Lipids, Phospholipids, Lecithins, Phosphatidic Acids, Glycerophospholipids, Alcohols, Glycerophosphates, Complex Mixtures, Plant Preparations, Sugar Alcohols, Biological Products, Membrane Lipids, Pharmaceutical Preparations, Triose Sugar Alcohols	investigational, experimental	1
DB15318	Neodymium	Drug	Lanthanoid Series Elements, Metals, Elements, Metals, Rare Earth	investigational	0
DB04661	cis-tetracosenoyl sulfatide	Drug	0	experimental	1
DB15319	VM4-037	Drug	Sulfur Compounds, Oligopeptides, Peptides, Amides, Amino Acids, Peptides, and Proteins, Fluorine Radioisotopes, Sulfones	investigational	0
DB05992	Plinabulin	Drug	Deuterium, Piperazines	investigational	1
DB03330	S-(N-hydroxy-N-iodophenylcarbamoyl)glutathione	Drug	0	experimental	1
DB04666	CHROMOPHORE (LYS-TYR-GLY)	Drug	0	experimental	0
DB03333	(4-sulfamoyl-phenyl)-thiocarbamic acid O-(2-thiophen-3-yl-ethyl) ester	Drug	0	experimental	1
DB02002	2-Aminoprop-2-Enamide	Drug	0	experimental	0
DB04667	CHROMOPHORE (HIS-TYR-GLY)	Drug	0	experimental	0
DB02001	5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine	Drug	0	experimental	2
DB03332	5,6-Cyclic-Tetrahydropteridine	Drug	0	experimental	1
DB04668	CHROMOPHORE (GLU-TYR-GLY)	Drug	0	experimental	0
DB03331	N-naphthalen-1-ylmethyl-2'-[3,5-dimethoxybenzamido]-2'-deoxy-adenosine	Drug	0	experimental	1
DB04669	TRIAZOLOPYRIMIDINE	Drug	0	experimental	1
DB02007	alpha-D-glucose 6-phosphate	Drug	0	experimental	9
DB03338	Heptyl glucoside	Drug	0	experimental	2
DB05993	PRX-07034	Drug	0	investigational	1
DB04662	OLOMOUCINE II	Drug	Heterocyclic Compounds, Fused-Ring, Cyclin-Dependent Kinases, antagonists & inhibitors	experimental	1
DB03337	1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea	Drug	0	experimental	1
DB02006	Br-Coeleneterazine	Drug	0	experimental	0
DB04663	2-KETO-6-PHOSPHATE-D-GLUCONIC ACID, ALPHA-FURANOSE FORM	Drug	0	experimental	0
DB04664	Cyclohexyl-pentyl-maltoside	Drug	Surface-Active Agents, Carbohydrates, Glycosides	experimental	1
DB02005	2-Oxo-3-Pentenoic Acid	Drug	0	experimental	1
DB03336	BIA	Drug	0	experimental	1
DB03335	(+)-1-bromo-2-propanol	Drug	0	experimental	1
DB05996	Glembatumumab vedotin	Drug	Proteins, Serum Globulins, Antineoplastic Agents, Immunological, Immunoglobulins, Globulins, Noxae, Blood Proteins, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Toxic Actions, Immunoproteins	investigational	1
DB02004	5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine	Drug	0	experimental	1
DB04665	Coumarin	Drug	Anticoagulants, Cytochrome P-450 CYP2C9 Substrates, Edema, drug therapy, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 Substrates, Benzopyrans, Pyrans, Vitamin K Antagonists	experimental	1
DB02009	L-756423	Drug	Antiviral Agents, Indenes, HIV Protease Inhibitors	experimental	1
DB02008	1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine	Drug	0	experimental	1
DB03339	3-Iodo-Benzyl Alcohol	Drug	0	experimental	0
DB15323	Trelagliptin	Drug	Pyrimidines, Pyrimidinones	investigational	0
DB15324	ORM-13070 C-11	Drug	Carbon Radioisotopes	investigational	0
DB15321	Tefinostat	Drug	Amines, Hydroxy Acids, Aniline Compounds, Hydroxylamines, Antineoplastic Agents, Amides, Histone Deacetylase Inhibitors	investigational	0
DB15322	Lacutamab	Drug	0	investigational	0
DB15327	Abivertinib	Drug	Enzyme Inhibitors, Protein Kinase Inhibitors	investigational	0
DB15328	Ubrogepant	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, OATP1B3 inhibitors, Cytochrome P-450 CYP2C19 Inhibitors, UGT1A1 Inhibitors, OATP1B3 substrates, Cytochrome P-450 CYP3A4 Substrates, Antimigraine Preparations, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C8 Inhibitors (weak), OCT2 Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors, OATP1B1/SLCO1B1 Substrates, Cytochrome P-450 CYP2C19 Inhibitors (weak), Cytochrome P-450 CYP2C9 Inhibitors (weak), Cytochrome P-450 CYP2D6 Inhibitors (weak)	approved, investigational	1
DB15325	ONO-8539	Drug	Sulfur Compounds, Acids, Carbocyclic, Benzene Derivatives, Receptors, Prostaglandin E, EP1 Subtype, antagonists & inhibitors	investigational	0
DB15326	CXL-1020	Drug	0	investigational	0
DB04671	[(1S)-4-[[Amino-[(2R)-2-amino-2-carboxyethyl]sulfanylmethylidene]amino]-1-carboxybutyl]azanium	Drug	0	experimental	1
DB15329	Nattokinase	Drug	Enzymes, Enzymes and Coenzymes, Serine Proteases, Hydrolases, Peptide Hydrolases, Serine Endopeptidases, Soy Foods, Endopeptidases	investigational	0
DB04672	Cyclic 3',5'-thymidine monophosphate	Drug	Thymine Nucleotides, Carbohydrates, Pyrimidines, Deoxyribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides, Pyrimidine Nucleotides	experimental	1
DB02010	Staurosporine	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Carbazoles, Enzyme Inhibitors, Indoles, P-glycoprotein inhibitors, Indole Alkaloids	experimental	13
DB03341	CoA-S-acetyl 5-bromotryptamine	Drug	0	experimental	1
DB03340	3-[(1-Amino-2-Carboxy-Ethyl)-Hydroxy-Phosphinoyl]-2-Methyl-Propionic Acid	Drug	0	experimental	1
DB03345	Mercaptoethanol	Drug	Sulfur Compounds, Alcohols, Sulfhydryl Compounds	experimental	10
DB02014	5-(2-Fluoro-5-{(1E)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]-1-propen-1-yl}phenyl)-1,2-oxazole-3-carboxylic acid	Drug	0	experimental	1
DB04677	N-METHYL-N-[(1R)-1-METHYL-2-PHENYLETHYL]PROP-2-EN-1-AMINE	Drug	0	experimental	1
DB03344	Inositol-(1,3,4,5,6)-Pentakisphosphate	Drug	0	experimental	1
DB02013	Iron azide hydrate	Drug	0	experimental	0
DB04678	H TYPE II TRISACCHARIDE	Drug	0	experimental	1
DB04679	Human blood group H type 1 trisaccharide	Drug	Antigens, Biological Factors, Antigens, Neoplasm, Biomarkers, Epitopes, Biomarkers, Tumor	experimental	1
DB03343	Malate Like Intermediate	Drug	0	experimental	1
DB02011	N-(Phosphonoacetyl)-L-Ornithine	Drug	Amino Acids, Basic, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	1
DB03342	4-(Acetylamino)-3-Guanidinobenzoic Acid	Drug	0	experimental	1
DB04673	4-[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE	Drug	0	experimental	1
DB03349	8-Bromo-Adenosine-5'-Monophosphate	Drug	0	experimental	2
DB02018	Amido Phenyl Pyruvic Acid	Drug	0	experimental	1
DB03348	Huperzine B	Drug	Drugs, Chinese Herbal	investigational	1
DB04674	2-HYDROXY-3,5-DIIODOBENZOIC ACID	Drug	0	experimental	2
DB02017	Imidazole-Derived Cellobiose	Drug	0	experimental	1
DB02016	R048-8071	Drug	0	experimental	1
DB03347	Triethyl phosphate	Drug	Organophosphorus Compounds	experimental	3
DB02015	Dihydrofolic Acid	Drug	0	experimental	2
DB04676	Dansyllysine	Drug	Amino Acids, Basic, Amino Acids, Essential, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	1
DB03346	3,3',5,5'-tetrachlorobiphenyl-4,4'-diol	Drug	0	experimental	1
DB02019	Acetyl Dithranol	Drug	0	experimental	1
DB15334	Biochanin A	Drug	Phytoestrogens, Hormones, Hormone Substitutes, and Hormone Antagonists, Estrogens, Non-Steroidal, Protective Agents, Estrogens, Antineoplastic Agents, Benzopyrans, Hormones, Heterocyclic Compounds, Fused-Ring, Flavonoids, Anticarcinogenic Agents, Compounds used in a research, industrial, or household setting, Chromones, Isoflavones, Pyrans	investigational	0
DB14003	alpha-Tocopherol acetate	Drug	Cytochrome P-450 Substrates, P-glycoprotein substrates, Protective Agents, Benzopyrans, Cytochrome P-450 CYP3A4 Substrates, Vitamins, Antioxidants, Heterocyclic Compounds, Fused-Ring, Micronutrients, Physiological Phenomena, Cytochrome P-450 CYP3A Substrates, Vitamin E, Vitamins (Fat Soluble), Food and Beverages, Tocopherols, Growth Substances, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food, Pyrans	approved	1
DB15335	Formononetin	Drug	Heterocyclic Compounds, Fused-Ring, Flavonoids, Phytoestrogens, Hormones, Hormone Substitutes, and Hormone Antagonists, Estrogens, Non-Steroidal, Estrogens, Benzopyrans, Hormones, Chromones, Pyrans	investigational	0
DB14004	Tildrakizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Interleukin-23 Antagonist, Blood Proteins, Antineoplastic and Immunomodulating Agents, Antibodies, Amino Acids, Peptides, and Proteins, Interleukin Inhibitors, Immunoproteins	approved, investigational	1
DB14001	alpha-Tocopherol succinate	Drug	Protective Agents, Benzopyrans, Vitamins, Antioxidants, Heterocyclic Compounds, Fused-Ring, Micronutrients, Physiological Phenomena, Vitamin E, Vitamins (Fat Soluble), Food and Beverages, Tocopherols, Growth Substances, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food, Pyrans	approved, nutraceutical, vet_approved	8
DB15332	Radavirsen	Drug	Carbohydrates, Oxazines, Nucleic Acids, Nucleotides, and Nucleosides, Oligonucleotides, Glycosides, Antiviral Agents, Nucleotides, Morpholines, Anti-Infective Agents, Polynucleotides	investigational	0
DB15333	AZD-1386	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB14002	D-alpha-Tocopherol acetate	Drug	Vitamin E, Vitamins (Fat Soluble), Tocopherols, Compounds used in a research, industrial, or household setting, Vitamins	approved, nutraceutical, vet_approved	6
DB15338	Rovatirelin	Drug	Oxazoles	investigational	0
DB14007	Pentetic acid	Drug	Acids, Acyclic, Amines, Antidotes, Fatty Acids, Protective Agents, Lipids, Polyamines, Acetates, Drugs that are Mainly Renally Excreted, Iron Chelating Agents, Lead Chelator, Fatty Acids, Volatile, Sequestering Agents, Compounds used in a research, industrial, or household setting, Lead Chelating Activity, Chelating Agents	approved	1
DB15339	Methcathinone	Drug	Ketones	investigational	0
DB14008	Hispidulin	Drug	Heterocyclic Compounds, Fused-Ring, Flavonoids, Benzopyrans, Chromones, Pyrans	experimental	0
DB14005	Dimethicone 410	Drug	0	approved	0
DB15336	Valanafusp alfa	Drug	Enzymes, Immunoglobulins, Antibodies, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Recombinant Proteins, Immunoproteins, Proteins, Serum Globulins, Globulins, Glycoside Hydrolases, Blood Proteins, Hydrolases	investigational	0
DB14006	Choline salicylate	Drug	OCT1 substrates, Amines, Ammonium Compounds, Nervous System, OCT2 Substrates, Acids, Carbocyclic, OCT1 inhibitors, Trimethyl Ammonium Compounds, Onium Compounds, Drugs that are Mainly Renally Excreted, Alcohols, Analgesics, Salicylates, Benzene Derivatives, Nitrogen Compounds, Benzoates, Hydroxy Acids, Quaternary Ammonium Compounds, Hydroxybenzoates, Amino Alcohols, Ethanolamines, OCT2 Inhibitors, Phenols, Pharmaceutical Preparations, Salicylic Acid and Derivatives	approved, nutraceutical	7
DB04680	GALACTOSE GREASE	Drug	0	experimental	1
DB04681	BETA-METHYLLACTOSIDE	Drug	0	experimental	1
DB14009	Medical Cannabis	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors, BCRP/ABCG2 Inhibitors, Agents producing tachycardia, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors (moderate), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP3A7 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A7 Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)	investigational, experimental	41
DB04682	Octylphenoxy polyethoxyethanol	Drug	Spermatocidal Agents, Contraceptive Agents, Male, Adrenal Cortex Hormones, Compounds used in a research, industrial, or household setting, Hormonal Contraceptives for Systemic Use, Contraceptive Agents, Female	experimental	1
DB04683	(2R)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(9E)-HEXADEC-9-ENOYLOXY]PROPYL (9E)-OCTADEC-9-ENOATE	Drug	0	experimental	1
DB03352	S-Arsonocysteine	Drug	0	experimental	3
DB02021	Fidarestat	Drug	Imidazoles, Aldehyde Reductase, antagonists & inhibitors	experimental	2
DB02020	Alrestatin	Drug	Autonomic Agents, Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Parasympatholytics, Peripheral Nervous System Agents	experimental	1
DB03351	Sri-9439	Drug	0	experimental	1
DB03350	Cobalt hexammine ion	Drug	0	experimental	2
DB04688	Methylecgonine	Drug	Alkaloids, Tropanes, Sensory System Agents, Analgesics, Narcotics, Aza Compounds, Azabicyclo Compounds, Central Nervous System Agents, Peripheral Nervous System Agents	experimental	2
DB02025	ACV tripeptide	Drug	Peptides, Amino Acids, Peptides, and Proteins	experimental	0
DB03355	5'-O-(L-Threonylsulfamoyl)adenosine	Drug	0	experimental	2
DB02024	3-phenylpropionic acid	Drug	Acids, Carbocyclic	experimental	3
DB04689	2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID	Drug	0	experimental	1
DB03354	2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole	Drug	Carbohydrates, Oxazoles, Glycosides, Glycogen Phosphorylase, antagonists & inhibitors	experimental	1
DB02023	8-oxo-dGMP	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Guanine Nucleotides, Nucleotides	experimental	1
DB03353	2-Iminobiotin	Drug	Coenzymes, Imidazoles, Enzymes and Coenzymes	investigational, experimental	1
DB02022	4-Amino-5-Hydroxymethyl-2-Methylpyrimidine	Drug	0	experimental	2
DB04684	Bis(6-aminohexyl)amine	Drug	0	experimental	0
DB02029	N-Cyclohexyl-N'-(4-Iodophenyl)Urea	Drug	0	experimental	1
DB04685	1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE	Drug	0	experimental	2
DB02028	(1R,2R,3S,4R,6S)-3,4,6-Trihydroxy-5-{[(S)-hydroxy(3-hydroxy-2-oxopropoxy)phosphoryl]oxy}-1,2-cyclohexanediyl bis[dihydrogen (phosphate)]	Drug	0	experimental	1
DB03359	M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene	Drug	0	experimental	1
DB02027	N-{(4S)-4-Amino-5-[(2-aminoethyl)amino]pentyl}-N'-nitroguanidine	Drug	0	experimental	2
DB04686	CHROMOPHORE (ASP-TYR-GLY)	Drug	0	experimental	0
DB03358	7-Methyl-7,8-dihydroguanosine 5'-(tetrahydrogen triphosphate)	Drug	0	experimental	1
DB03357	(S)-Mandelic acid	Drug	0	experimental	1
DB04687	DIMETHYL THIOPHOSPHATE	Drug	0	experimental	1
DB02026	Furo[2,3d]Pyrimidine Antifolate	Drug	0	experimental	1
DB15330	Nesvacumab	Drug	0	investigational	0
DB14000	Tetraglyme	Drug	Glycols, Alcohols	experimental	0
DB15331	Vocimagene amiretrorepvec	Drug	Proteins, Enzymes, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Hydrolases, Nucleoside Deaminases, Aminohydrolases	investigational	0
DB14090	Dimethyl sulfone	Drug	Sulfur Compounds, Anti-Inflammatory Agents, Sulfoxides	investigational, experimental	0
DB14091	Carbomer homopolymer type C	Drug	Anti-Infective Agents, Pharmaceutical Solutions, Macromolecular Substances, Dental Cavity Preparation, Solutions, Ophthalmic Solutions, Pharmaceutical Preparations, Dentin-Bonding Agents, Plastics, Polymers, Compounds used in a research, industrial, or household setting, Dental Materials, Resins, Synthetic	investigational, experimental	0
DB14094	Tocopherylquinone	Drug	Antioxidants, Anticoagulants, Heterocyclic Compounds, Fused-Ring, Protective Agents, Hematologic Agents, Benzopyrans, Cardiovascular Agents, Antihypertensive Agents, Compounds used in a research, industrial, or household setting, Pyrans	investigational, experimental	0
DB14092	8-epi-Cyanocobalamin	Drug	0	experimental	0
DB14093	(1,2,6,7-3H)Testosterone	Drug	Testosterone and derivatives	experimental	0
DB14098	Cobalamin	Drug	Heterocyclic Compounds, Fused-Ring, Micronutrients, Physiological Phenomena, Vitamin B 12, biosynthesis, Food and Beverages, Vitamin B Complex, Corrinoids, Growth Substances, Diet, Food, and Nutrition, Vitamins, Food	experimental	0
DB14099	1,2-Distearoyllecithin	Drug	Carbohydrates, Glycerophosphates, Sugar Phosphates, Sugar Alcohols, Lipids, Membrane Lipids, Phospholipids, Phosphatidic Acids, Triose Sugar Alcohols, Glycerophospholipids, Alcohols	approved, experimental	0
DB14096	1,2-icosapentoyl-sn-glycero-3-phosphoserine	Drug	0	approved, experimental	0
DB14097	13-cis-12-(3'-Carboxyphenyl)retinoic acid	Drug	Biological Factors, Cycloparaffins, Alkenes, Hydrocarbons, Acyclic, Cyclohexenes, Retinoids, Vitamins, Cyclohexanes, Pigments, Biological, Phospholipases A, antagonists & inhibitors, Vitamin A, Carotenoids, Vitamins (Fat Soluble), Polyenes, Terpenes	experimental	0
DB14058	Basifungin	Drug	Peptides, Cyclic, Enzyme Inhibitors, Peptides, Amino Acids, Peptides, and Proteins, Antifungal Agents, Anti-Infective Agents	experimental	1
DB15389	Teceleukin	Drug	0	investigational	0
DB14059	SC-236	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Enzyme Inhibitors, Sensory System Agents, Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Amides, Peripheral Nervous System Agents, Sulfur Compounds, Analgesics, Agents that produce hypertension, Central Nervous System Agents, Sulfones	investigational, experimental	2
DB14056	Nigericin	Drug	Anti-Bacterial Agents, Furans, Compounds used in a research, industrial, or household setting, Anti-Infective Agents, Ionophores, Membrane Transport Modulators, Pyrans	experimental	0
DB15387	Bintrafusp alfa	Drug	0	investigational	0
DB14057	Valinomycin	Drug	Peptides, Cyclic, Anti-Bacterial Agents, BSEP/ABCB11 Inhibitors, Peptides, P-glycoprotein substrates, Amino Acids, Peptides, and Proteins, Depsipeptides, P-glycoprotein inhibitors, Compounds used in a research, industrial, or household setting, Anti-Infective Agents, Ionophores, Membrane Transport Modulators	experimental	0
DB15388	Anti-GD2 monoclonal antibody 3F8	Drug	0	investigational	0
DB02072	2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Thiopyran-3-Carboxylic Acid	Drug	0	experimental	1
DB02071	WAY-151693	Drug	Sulfur Compounds, Amines, Hydroxy Acids, Hydroxylamines, Amides, Sulfones	experimental	1
DB02070	Kynurenine	Drug	Amino Acids, Peptides, and Proteins, Amino Acids	experimental	0
DB02076	6-phospho-D-gluconic acid	Drug	Acids, Acyclic, Carbohydrates, Hydroxy Acids, Sugar Acids	experimental	3
DB02075	[(2R,3R,4S,5S)-3,4-Dihydroxy-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)-2-pyrrolidinyl]methyl dihydrogen phosphate	Drug	0	experimental	1
DB02074	Butenoic Acid	Drug	0	experimental	0
DB02073	Biliverdine IX Alpha	Drug	0	experimental	3
DB02079	Aminooxyacetic acid	Drug	Acids, Acyclic, Neurotransmitter Agents, Enzyme Inhibitors, Amines, Fatty Acids, GABA Agents, Fatty Acids, Volatile, Hydroxylamines, Lipids, Acetates	experimental	1
DB02078	Triglyme	Drug	Ethylene Glycols, Glycols, Polymers, Compounds used in a research, industrial, or household setting, Alcohols, Macromolecular Substances	experimental	10
DB02077	L-N(omega)-nitroarginine-(4R)-amino-L-proline amide	Drug	0	experimental	2
DB15381	Menaquinone	Drug	Fibrin Modulating Agents, Phytol, Hematologic Agents, Coagulants, Vitamins, Naphthalenes, Micronutrients, Quinones, Physiological Phenomena, Vitamins (Fat Soluble), Food and Beverages, Vitamin K 2, Naphthoquinones, Diterpenes, Hemostatics, Growth Substances, Terpenes, Diet, Food, and Nutrition, Food, Vitamin K	investigational	0
DB14050	Cannabidivarin	Drug	Anticonvulsants, Central Nervous System Depressants, Terpenes	investigational	4
DB15382	SAR-125844	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Thiazoles	investigational	0
DB14051	Malacidin A	Drug	Anti-Bacterial Agents, Peptides, Amino Acids, Peptides, and Proteins, Lipids, Anti-Infective Agents, Malacidins	experimental	1
DB15380	Flutriciclamide F-18	Drug	0	investigational	0
DB14054	Asiatic acid	Drug	Triterpenes, Terpenes	experimental	0
DB15385	Acebilustat	Drug	Acids, Carbocyclic, Aza Compounds, Benzene Derivatives	investigational	0
DB14055	(S)-Warfarin	Drug	Cytochrome P-450 CYP2C19 Substrates, Anticoagulants, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP2C18 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C18 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C8 Substrates, Cytochrome P-450 CYP3A4 Substrates, Vitamin K Antagonists	investigational, experimental	0
DB15386	ALT-801	Drug	Biological Factors, Receptors, Antigen, Cytokines, Peptides, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Receptors, Cell Surface, Recombinant Proteins, Lymphokines, Membrane Proteins, Proteins, Interleukins, Receptors, Immunologic	investigational	0
DB14052	Malacidin B	Drug	Anti-Bacterial Agents, Peptides, Amino Acids, Peptides, and Proteins, Lipids, Anti-Infective Agents, Malacidins	experimental	1
DB15383	Pidilizumab	Drug	Proteins, Serum Globulins, Antineoplastic Agents, Immunological, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB15384	Simotaxel	Drug	Cycloparaffins, Cyclodecanes, Diterpenes, Terpenes	investigational	0
DB14069	ONT-093	Drug	Drug Resistance, Multiple, P-glycoprotein inhibitors	investigational	1
DB14067	Dofequidar	Drug	Heterocyclic Compounds, Fused-Ring, Antineoplastic Agents, P-glycoprotein inhibitors	investigational, experimental	2
DB15398	Dihydrocapsiate	Drug	Solanaceous Alkaloids, Fatty Acids, Alkenes, Hydrocarbons, Acyclic, Amides, Catechols, Lipids, Fatty Acids, Monounsaturated, Polyunsaturated Alkamides, Alkaloids, Fatty Acids, Unsaturated, Phenols, Benzene Derivatives, Alkynes	investigational	0
DB14068	Dexniguldipine	Drug	Pyridines, Cytochrome P-450 Substrates, Agents causing hyperkalemia, Antineoplastic Agents, Cytochrome P-450 CYP3A4 Substrates, Membrane Transport Modulators, Calcium Channel Blockers, Cytochrome P-450 CYP3A Substrates, Calcium-Regulating Hormones and Agents, Antihypertensive Agents, P-glycoprotein inhibitors, Bradycardia-Causing Agents, Antiarrhythmic agents	experimental	1
DB15399	BMS-754807	Drug	0	investigational	0
DB02083	N,N-dimethylglycine	Drug	Epilepsy, drug therapy, Peptides, Amino Acids, Peptides, and Proteins, N-substituted Glycines, Peptoids, Amino Acids	experimental	1
DB02082	Phosphoaminophosphonic acid guanylate ester	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Guanine Nucleotides, Nucleotides, Guanosine Triphosphate	experimental	1
DB02081	Bis-Benzamidine	Drug	0	experimental	1
DB02080	1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene	Drug	0	experimental	2
DB02087	3,5-Difluorobenzenesulfonamide	Drug	0	experimental	1
DB02086	(3,4-Dihydroxy-Phenyl)-Triphenyl-Arsonium	Drug	0	experimental	1
DB02085	1-Aminocyclopropanecarboxylic Acid	Drug	0	experimental	1
DB02084	CRA_17312	Drug	0	experimental	1
DB02089	CP-526423	Drug	Heterocyclic Compounds, Fused-Ring	experimental	1
DB02088	Norleucine Phosphonate	Drug	0	experimental	1
DB15392	Cesium	Drug	Metals, Metals, Heavy, Elements, Metals, Alkali	investigational	0
DB14061	Hycanthone	Drug	Xanthenes, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Anthelmintics, Antiplatyhelmintic Agents, Thioxanthenes, P-glycoprotein inhibitors, Schistosomicides, Anti-Infective Agents, Antiparasitic Agents	experimental	1
DB14062	Concanamycin A	Drug	Enzyme Inhibitors, Polyketides, Proton-Translocating ATPases, antagonists & inhibitors, P-glycoprotein inhibitors, Anti-Infective Agents, Lactones	experimental	1
DB15393	Telatinib	Drug	0	investigational	0
DB15390	Efizonerimod alfa	Drug	0	investigational	0
DB14060	NS-398	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Enzyme Inhibitors, Sensory System Agents, Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Amides, Peripheral Nervous System Agents, Sulfur Compounds, Analgesics, Nitro Compounds, Agents that produce hypertension, Central Nervous System Agents, Benzene Derivatives, Sulfones	experimental	1
DB15391	Elenbecestat	Drug	0	investigational	0
DB14065	Lomerizine	Drug	Calcium Channel Blockers, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Agents causing hyperkalemia, Calcium-Regulating Hormones and Agents, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, P-glycoprotein inhibitors, Bradycardia-Causing Agents, Membrane Transport Modulators, Antiarrhythmic agents	experimental	1
DB15396	PF-114	Drug	0	investigational	0
DB14066	Tetrandrine	Drug	Immunologic Factors, Antineoplastic Agents, Phytogenic, Drugs, Chinese Herbal, Antiprotozoals, Cytochrome P-450 Substrates, Immunosuppressive Agents, Isoquinolines, Agents causing hyperkalemia, Antimalarials, Antineoplastic Agents, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Membrane Transport Modulators, Alkaloids, Calcium Channel Blockers, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Substrates, Calcium-Regulating Hormones and Agents, P-glycoprotein inhibitors, Antiparasitic Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	experimental	1
DB15397	GMA-161	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB15394	gamma-Tocopherol	Drug	Protective Agents, Benzopyrans, Vitamins, Antioxidants, Heterocyclic Compounds, Fused-Ring, Micronutrients, Physiological Phenomena, Vitamin E, Vitamins (Fat Soluble), Food and Beverages, Tocopherols, Growth Substances, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food, Pyrans	investigational	0
DB14063	Dexverapamil	Drug	QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Agents causing hyperkalemia, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Moderate Risk QTc-Prolonging Agents, Phenethylamines, Membrane Transport Modulators, Calcium Channel Blockers, Cytochrome P-450 CYP3A Substrates, Ethylamines, Calcium-Regulating Hormones and Agents, P-glycoprotein inhibitors, Vasodilating Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	experimental	1
DB14064	Emopamil	Drug	Amines, Cytochrome P-450 Substrates, Agents causing hyperkalemia, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Phenethylamines, Membrane Transport Modulators, Calcium Channel Blockers, Cytochrome P-450 CYP3A Substrates, Ethylamines, Calcium-Regulating Hormones and Agents, P-glycoprotein inhibitors, Bradycardia-Causing Agents, Antiarrhythmic agents	experimental	1
DB15395	PF-06863135	Drug	0	investigational	0
DB14078	Medronic acid	Drug	0	approved, investigational	0
DB14079	Hydroxybutyloxide	Drug	0	experimental	0
DB02090	A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor	Drug	0	experimental	1
DB02094	N-2-Thiophen-2-Yl-Acetamide Boronic Acid	Drug	0	experimental	1
DB02093	5-phospho-D-arabinohydroxamic acid	Drug	0	experimental	1
DB02092	Cholesteryl Linoleate	Drug	Cholestanes, Sterols, Lipids, Membrane Lipids, Cholestenes, Fused-Ring Compounds, Steroids	experimental	1
DB02091	4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine	Drug	0	experimental	2
DB02098	Adenosine-2'-5'-Diphosphate	Drug	0	experimental	3
DB02097	Cytidine	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Glycosides, Nucleosides	experimental	1
DB02096	FR221647	Drug	0	experimental	1
DB02095	Isatin	Drug	Heterocyclic Compounds, Fused-Ring, Indoles	experimental	1
DB02099	S-azabisabolene	Drug	0	experimental	0
DB14072	Reversin 121	Drug	Peptides, Drug Resistance, Multiple, Amino Acids, Peptides, and Proteins, P-glycoprotein inhibitors	experimental	1
DB14073	Gondoic acid	Drug	Fatty Acids, Unsaturated, Fatty Acids, Lipids	experimental	0
DB14070	HM-30181	Drug	Heterocyclic Compounds, Fused-Ring, ATP Binding Cassette Transporter, Subfamily B, Member 1, antagonists & inhibitors, P-glycoprotein inhibitors, Pyrans	experimental	1
DB14071	Desmethylsertraline	Drug	Amines, 1-Naphthylamine, P-glycoprotein inhibitors, Agents that reduce seizure threshold, Naphthalenes	experimental	1
DB14076	Interleukin-1 alpha, human recombinant	Drug	Proteins, Biological Factors, Interleukin-1, Cytokines, Interleukins, Peptides, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Monokines	experimental	0
DB14077	Magnesium stearate	Drug	Fatty Acids, Lipids, Agents that produce neuromuscular block (indirect)	investigational	0
DB14074	Icaridin	Drug	Insect Repellents, Piperidines	experimental	1
DB14075	Imidurea	Drug	Preservatives, Pharmaceutical, Cell-mediated Immunity, Standardized Chemical Allergen, Pharmaceutic Aids, Increased Histamine Release	approved, experimental	0
DB14089	Dimercaptosuccinic acid	Drug	Metal Chelator, Compounds used in a research, industrial, or household setting, Chelating Agents	approved, experimental	2
DB14080	Acetylcysteine magnesium	Drug	0	experimental	0
DB14083	Bisphenol A diglycidyl ether	Drug	Carcinogens, Cell-mediated Immunity, Noxae, Standardized Chemical Allergen, Toxic Actions, Ethers, Benzene Derivatives, Ethers, Cyclic, Increased Histamine Release	approved, experimental	0
DB14084	Butylparaben	Drug	Cell-mediated Immunity, Benzoates, Hydroxy Acids, Acids, Carbocyclic, Hydroxybenzoates, Phenols, Standardized Chemical Allergen, Benzene Derivatives, Increased Histamine Release	approved, experimental	0
DB14081	Asiaticoside	Drug	Terpenes, Anti-Infective Agents	experimental	0
DB14082	Betiatide	Drug	0	approved, experimental	0
DB14087	Morrhuic acid	Drug	Fatty Acids, Solutions, Sclerosing Solutions, Lipids, Cardiovascular Agents, Pharmaceutical Preparations, Compounds used in a research, industrial, or household setting, Pharmaceutical Solutions	experimental	0
DB14088	Osbond acid	Drug	Fatty Acids, Lipids	experimental	0
DB14085	Cadmium	Drug	Metals, Metals, Heavy, Elements, Transition Elements	experimental	0
DB14086	Cianidanol	Drug	Heterocyclic Compounds, Fused-Ring, Catechin, Flavonoids, Chromans, Benzopyrans, Chromones, Pyrans	approved, withdrawn	0
DB04732	N-(4-MORPHOLINE)CARBONYL-B-(1-NAPHTHYL)-L-ALANINE-L-LEUCINE BORONIC ACID	Drug	0	experimental	2
DB03400	3-(P-Tolyl)Propionic Acid	Drug	0	experimental	1
DB04733	1,6-DI-O-PHOSPHONO-D-MANNITOL	Drug	0	experimental	1
DB04734	Citraconic acid	Drug	Acids, Acyclic, Dermatologicals, Dicarboxylic Acids	experimental	1
DB04735	MONOGALACTOSYL-DIACYLGLYCEROL	Drug	0	experimental	1
DB03404	Hemin	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Heme, Metalloporphyrins, Pigments, Biological, Porphyrins	approved, investigational	0
DB03403	Cytidine-5'-Monophosphate	Drug	Carbohydrates, Pyrimidines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Cytosine Nucleotides, Glycosides, Nucleotides, Pyrimidine Nucleotides	experimental	9
DB03402	1,2-Di-1-(3,7,11,15-Tetramethyl-Hexadecane)-Sn-Glycero-3-Phosphate	Drug	0	experimental	0
DB04731	1-ACETYL-2-LYSO-SN-GLYCERO-3-PHOSPHOETHANOLAMINE	Drug	0	experimental	1
DB03401	1D-myo-inositol 1,4,5-trisphosphate	Drug	Carbohydrates, Sugar Phosphates, Sugar Alcohols, Inositol Phosphates, Inositol 1,4,5-Trisphosphate, Alcohols	experimental	7
DB03408	gamma-Glutamylcysteine	Drug	Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins	experimental	1
DB03407	4-Nitrocatechol	Drug	Phenols, Benzene Derivatives	experimental	0
DB03406	O1-Methyl-4-Deoxy-4-Thio-Alpha-D-Glucose	Drug	0	experimental	0
DB03405	N2-[(Benzyloxy)carbonyl]-N-[(3R)-1-{N-[(benzyloxy)carbonyl]-L-leucyl}-4-oxo-3-pyrrolidinyl]-L-leucinamide	Drug	0	experimental	1
DB04736	2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE(BETA1-4)-2-ACETAMIDO-1,6-ANHYDRO-3-O-[(R)-1-CARBOXYETHYL]-2-DEOXY-BETA-D-GLUCOPYRANOSE-L-ALANYL-GAMMA-D-GLUTAMYL-MESO-DIAMINOPIMELYL-D-ALANINE	Drug	0	experimental	1
DB04737	(S)-mandelonitrile	Drug	0	experimental	0
DB04738	Motuporin	Drug	Cytotoxins, Peptides, Amino Acids, Peptides, and Proteins	experimental	1
DB04739	4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE	Drug	0	experimental	1
DB03409	L-Octahydroindole-2-carboxylic acid	Drug	0	experimental	0
DB04743	Nimesulide	Drug	Nephrotoxic agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Sensory System Agents, Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Agents causing hyperkalemia, Amides, Cytochrome P-450 CYP3A4 Substrates, Selective Cyclooxygenase 2 Inhibitors (NSAIDs), Peripheral Nervous System Agents, Sulfur Compounds, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Musculo-Skeletal System, Antiplatelet agents, Bradycardia-Causing Agents, Sulfones, Antiarrhythmic agents, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Antirheumatic Agents, Antiinflammatory Preparations, Non-Steroids for Topical Use, Topical Products for Joint and Muscular Pain, Calcium Channel Blockers, Antiinflammatory and Antirheumatic Products, Cytochrome P-450 CYP3A Substrates, Agents that produce hypertension, Central Nervous System Agents	approved, investigational, withdrawn	3
DB03411	2-Hydroxymethyl-Pyrrolidine-3,4-Diol	Drug	0	experimental	1
DB04744	Lawsone	Drug	Radiation-Protective Agents, Enzyme Inhibitors, Protective Agents, Coloring Agents, Dermatologicals, Anti-Infective Agents, Household Products, Naphthalenes, Quinones, Cosmetics, Antifungal Agents, Oxidoreductases, Sunscreen Agents, Compounds used in a research, industrial, or household setting	experimental	0
DB03410	4-hydroxycoumarin	Drug	Anticoagulants, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 Substrates, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Coumarins, Benzopyrans, Cytochrome P-450 CYP3A4 Substrates, Pyrans, Vitamin K Antagonists	experimental	1
DB04745	2-Hydroxyquinoline	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring	experimental	1
DB04746	(10E,12Z)-octadecadienoic acid	Drug	0	experimental	1
DB03415	3-thiaoctanoyl-CoA	Drug	0	experimental	1
DB04740	Moxalactam (hydrolyzed)	Drug	0	experimental	1
DB03414	5-Thio-a/B-D-Mannopyranosylamine	Drug	0	experimental	1
DB03413	Deoxyuridine-5'-Diphosphate	Drug	0	experimental	5
DB04741	Myxothiazol	Drug	Acids, Acyclic, Acrylates, Enzyme Inhibitors, Sulfur Compounds, Electron Transport Complex III, antagonists & inhibitors, Antifungal Agents, Anti-Infective Agents	experimental	1
DB04742	(2R)-2-{(1R)-2-oxo-1-[(2-thienylacetyl)amino]ethyl}-5,6-dihydro-2h-1,3-thiazine-4-carboxylic acid	Drug	0	experimental	1
DB03412	6-hydroxynorleucine	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Caproates, Amino Acids, Peptides, and Proteins, Lipids, Aminocaproates, Amino Acids	experimental	1
DB03419	Uracil	Drug	Pyrimidines, Fluorouracil and prodrugs, Pyrimidinones	investigational, experimental	7
DB03418	Diacetyldeuteroheme	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Pigments, Biological, Porphyrins	experimental	0
DB03417	(2S,3R)-2-[[4-(Tert-butylcarbamoyl)piperazine-1-carbonyl]amino]-6-(diaminomethylideneamino)-3-formylhexanoic acid	Drug	0	experimental	1
DB03416	Thiamine(1+) monophosphate	Drug	0	experimental	1
DB04747	11-TRANS-13-TRANS-15-CIS-OCTADECATRIENOIC ACID	Drug	0	experimental	1
DB04748	OXIMINOARYLSULFONAMIDE	Drug	0	experimental	0
DB04749	2-(3-OXO-PROPYLSULFANYLCARBONYL)-ETHANETHIOLATE	Drug	0	experimental	1
DB15400	Lifastuzumab vedotin	Drug	0	investigational	0
DB15401	Danicopan	Drug	0	investigational	0
DB15404	Heparin, bovine	Drug	0	investigational	0
DB15405	FET F-18	Drug	0	investigational	0
DB15402	Tucotuzumab celmoleukin	Drug	Proteins, Biological Factors, Cytokines, Interleukins, Peptides, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Lymphokines	investigational	0
DB15403	Ziritaxestat	Drug	0	investigational	0
DB15408	Silmitasertib	Drug	Casein Kinase II, antagonists & inhibitors, Heterocyclic Compounds, Fused-Ring	investigational	0
DB15409	Ladiratuzumab vedotin	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Noxae, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Toxic Actions, Immunoproteins	investigational	0
DB15406	GLPG-0974	Drug	Acids, Acyclic, Sulfur Compounds, Fatty Acids, Fatty Acids, Volatile, Lipids	investigational	0
DB15407	Acalisib	Drug	0	investigational	0
DB04754	GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE	Drug	0	experimental	1
DB03422	1,3-Thiazole-4-Carboxylic Acid	Drug	0	experimental	0
DB04755	PROPYL-1-PHOSPHATE	Drug	0	experimental	0
DB03421	2-Phenethyl-2,3-Dihydro-Phthalazine-1,4-Dione	Drug	0	experimental	1
DB03420	2,4-deoxy-4-guanidino-5-N-acetyl-neuraminic acid	Drug	0	experimental	1
DB04756	2-[(3,5-Dichloro-4-trioxidanylphenyl)amino]benzoic acid	Drug	0	experimental	0
DB04757	GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE	Drug	0	experimental	1
DB03426	Digalactosyl Diacyl Glycerol (Dgdg)	Drug	0	experimental	0
DB04750	OREGON GREEN 488 CARBOXYLATE	Drug	0	experimental	0
DB04751	Purvalanol A	Drug	Heterocyclic Compounds, Fused-Ring, CDC2 Protein Kinase, antagonists & inhibitors	experimental	3
DB03425	2s,4r-4-Methylglutamate	Drug	Amino Acids, Dicarboxylic, Amino Acids, Peptides, and Proteins, Amino Acids, Acidic, Amino Acids	experimental	1
DB03424	Ubenimex	Drug	Immunologic Factors, Aminopeptidases, antagonists & inhibitors, Enzyme Inhibitors, Adjuvants, Immunologic, Amino Acids, Essential, Protease Inhibitors, Amino Acids, Peptides, and Proteins, Anti-HIV Agents, Antibiotics, Antineoplastic, Amino Acids, Anti-Infective Agents, Anti-Bacterial Agents, Amino Acids, Branched-Chain	investigational	2
DB04752	Phosphatidyl ethanol	Drug	0	experimental	1
DB04753	9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE	Drug	0	experimental	1
DB03423	S-Adenosyl-L-Homoselenocysteine	Drug	Selenium Compounds	experimental	1
DB03429	Tetrastearoyl cardiolipin	Drug	0	experimental	1
DB03428	SU9516	Drug	Heterocyclic Compounds, Fused-Ring	experimental	3
DB03427	delta-(L-alpha-Aminoadipoyl)-L-cysteinyl-D-vinylglycine	Drug	0	experimental	0
DB04758	2-[2-ETHANESULFONYLAMINO-3-(1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIM IDOYL-BENZYLAMIDE)	Drug	0	experimental	1
DB04759	PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)	Drug	0	experimental	1
DB15411	ABP-700	Drug	0	investigational	0
DB15412	LB-100	Drug	0	investigational	0
DB15410	(S)-Propafenone	Drug	0	investigational	0
DB15415	Tomaralimab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Immunoglobulin G, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB15416	PX-102	Drug	0	investigational	0
DB15413	OTL-38	Drug	0	investigational	0
DB15414	CM-4307	Drug	0	investigational	0
DB15419	Nanatinostat	Drug	Aza Compounds, Antineoplastic Agents, Histone Deacetylase Inhibitors	investigational	0
DB15417	Recanaclotide	Drug	0	investigational	0
DB15418	AZD-9977	Drug	Acids, Carbocyclic, Benzene Derivatives	investigational	0
DB04760	PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)	Drug	0	experimental	1
DB04765	N-PYRIDOXYL-2-METHYL-L-GLUTAMIC ACID-5'-MONOPHOSPHATE	Drug	0	experimental	1
DB02102	Mozenavir	Drug	0	experimental	1
DB03433	{3-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Amino]-2-Methyl-Propyl}-Phosphonic Acid	Drug	0	experimental	1
DB02101	(S,R)-fidarestat	Drug	0	experimental	1
DB03432	Beta-Amino Isobutyrate	Drug	0	experimental	0
DB04767	N-[1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-3-METHYLSULFANYL-PROPYL]-3-HYDROXY-2-PROPOXYAMINO-BUTYRAMID	Drug	0	experimental	1
DB02100	Methyl alpha-galactoside	Drug	0	experimental	0
DB03430	(S)-4-hydroxymandelonitrile	Drug	0	experimental	1
DB04768	Pyrithiamine Pyrophosphate	Drug	0	experimental	1
DB04761	PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]	Drug	0	experimental	1
DB03437	(2R,4S)-2-[(1R)-1-{[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid	Drug	0	experimental	1
DB02106	[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid	Drug	0	experimental	1
DB02105	3,5-Dinitrocatechol	Drug	Anti-Dyskinesia Agents, Enzyme Inhibitors, COMT Inhibitors, Phenols, Central Nervous System Agents, Benzene Derivatives, Anti-Parkinson Drugs	experimental	1
DB04762	N-PYRIDOXYL-D-GLUTAMIC ACID-5'-MONOPHOSPHATE	Drug	0	experimental	1
DB03436	Gallichrome	Drug	Peptides, Cyclic, Gallium, Amines, Hydroxy Acids, Peptides, Hydroxylamines, Amino Acids, Peptides, and Proteins, Hydroxamic Acids	experimental	1
DB03435	Uridine-5'-Diphosphate	Drug	0	experimental	15
DB02104	2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine	Drug	0	experimental	1
DB04763	1-N-(4-SULFAMOYLPHENYL-ETHYL)-2,4,6-TRIMETHYLPYRIDINIUM	Drug	0	experimental	1
DB04764	[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE	Drug	0	experimental	1
DB02103	2-Chlorodideoxyadenosine	Drug	0	experimental	1
DB03434	3-(N-morpholino)propanesulfonic acid	Drug	Oxazines, Buffers	experimental	3
DB02109	Hadacidin	Drug	Noxae, Teratogens, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Toxic Actions, Antibiotics, Antineoplastic, Amino Acids	experimental	3
DB02108	2-Aminoethanimidic Acid	Drug	0	experimental	1
DB03439	4,6-dideoxy-4-amino-alpha-D-glucose	Drug	0	experimental	2
DB03438	Lysophosphatidylglycerol	Drug	Carbohydrates, Glycerophosphates, Sugar Phosphates, Sugar Alcohols, Lipids, Membrane Lipids, Phospholipids, Phosphatidic Acids, Triose Sugar Alcohols, Alcohols	experimental	0
DB02107	Leucine - Reduced Carbonyl	Drug	0	experimental	1
DB04769	5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE	Drug	0	experimental	1
DB04700	GLUTATHIONE SULFINATE	Drug	0	experimental	1
DB04701	S-Methyl glutathione	Drug	Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins	experimental	1
DB04702	S-[(2E)-3,7-DIMETHYLOCTA-2,6-DIENYL] TRIHYDROGENTHIODIPHOSPHATE	Drug	0	experimental	1
DB04707	Hydroxyfasudil	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Piperazines, Isoquinolines, Sulfonamides, Amides, Sulfones	experimental	3
DB04708	(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE	Drug	0	experimental	0
DB04709	(3AALPHA,4ALPHA,7ALPHA,7AALPHA)- 3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE	Drug	0	experimental	1
DB04703	Hesperidin	Drug	Heterocyclic Compounds, Fused-Ring, Flavonoids, Flavanones, Benzopyrans, Chromones, Pyrans	approved, investigational	1
DB04704	20-hydroxycholesterol	Drug	Cholestanes, Sterols, Oxysterols, Lipids, Membrane Lipids, Cholestenes, Fused-Ring Compounds, Steroids	experimental	0
DB04705	25-Hydroxycholesterol	Drug	Cholestanes, Sterols, Oxysterols, Lipids, Membrane Lipids, Cholestenes, Fused-Ring Compounds, Steroids	experimental	0
DB04706	7beta-hydroxycholesterol	Drug	Cholestanes, Sterols, Oxysterols, Lipids, Membrane Lipids, Cholestenes, Fused-Ring Compounds, Steroids	experimental	0
DB04710	(E)-(S)-4-[(S)-4-METHYL-2-((S)-3-METHYL-2{(S)-2-[(5-METHYL-ISOXAZOLE-3- CARBONYL)-AMINO]-PROPIONYLAMINO}-BUTYRYLAMINO)-PENTANOYLAMINO]-5-((S)-2- OXO-PYRROLIDIN-3-YL)-PENT-2-ENOIC ACID ETHYL ESTER	Drug	0	experimental	0
DB04711	Iodipamide	Drug	Benzoates, Acids, Carbocyclic, Roentgenography, Iodobenzoates, Iodinated Contrast Agents, Contrast Media, Diagnostic Uses of Chemicals, Radiographic Contrast Agent, Triiodobenzoic Acids, Watersoluble, Hepatotropic X-Ray Contrast Media, X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting, X-Ray Contrast Activity, Benzene Derivatives	approved	0
DB04712	ANILINOMETHYL GLUCO-PHENYLIMIDAZOLE	Drug	0	experimental	0
DB04713	4-Iodo-D-phenylalanine	Drug	0	experimental	1
DB04718	(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-2-O-{2-[(piperidin-3-ylmethyl)amino]ethyl}-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2-amino-2-deoxy-alpha-D-glucopyranoside	Drug	0	experimental	0
DB04719	DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE	Drug	0	experimental	1
DB04714	ISOPENTENYL PYROPHOSPHATE	Drug	Terpenes	experimental	6
DB04715	IMIDAZOPYRIDAZIN 1	Drug	0	experimental	1
DB04716	2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one	Drug	Heterocyclic Compounds, Fused-Ring, Pyridines	experimental	5
DB04717	2''-O-[N-(3-(aminopropyl)2-aminoethyl]paromomycin	Drug	0	experimental	0
DB04721	N1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO-BENZIMIDAZOLE	Drug	0	experimental	1
DB04722	2-[3-chloro-6-[2,2-difluoro-2-(1-oxidopyridin-1-ium-2-yl)ethyl]imino-1-hydroxypyridin-2-yl]-N-[(1R)-1-(3-chlorophenyl)ethyl]acetamide	Drug	0	experimental	1
DB04723	2-(3-GUANIDINOPHENYL)-3-MERCAPTOPROPANOIC ACID	Drug	0	experimental	1
DB04724	(S)-2-((S)-3-isobutyl-2,5-dioxo-4-quinolin-3-ylmethyl-[1,4]diazepan-1yl)-N-methyl-3-naphtalen-2-yl-propionamide	Drug	0	experimental	1
DB04720	S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE	Drug	0	experimental	1
DB04729	Gentamicin C1a	Drug	Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Nephrotoxic agents, Carbohydrates, Anti-Bacterial Agents, Narrow Therapeutic Index Drugs, Aminoglycoside Antibacterials, Glycosides, Agents that produce neuromuscular block (indirect), Drugs that are Mainly Renally Excreted	experimental	2
DB04725	Licofelone	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Enzyme Inhibitors, Cytochrome P-450 Substrates, Sensory System Agents, Cyclooxygenase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Anti-Inflammatory Agents, Cytochrome P-450 CYP2C8 Inhibitors, UGT1A3 substrates, Antirheumatic Agents, Peripheral Nervous System Agents, Cytochrome P-450 CYP2C9 Substrates, Analgesics, Central Nervous System Agents, Cytochrome P-450 CYP2C8 Substrates, Lipoxygenase Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)	investigational	3
DB04726	Lumiflavin	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Coenzymes, Enzymes and Coenzymes, Pteridines, Pigments, Biological	experimental	0
DB04727	1-{4-[4-Amino-6-(4-methoxyphenyl)furo[2,3-d]pyrimidin-5-yl]phenyl}-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea	Drug	0	experimental	1
DB04728	Lividomycin A	Drug	0	experimental	0
DB14135	Hypochlorous acid	Drug	Reactive Oxygen Species, Free Radicals, Noxae, Ions, Oxides, Anions, Acids, Noncarboxylic, Acids, Oxidants, Electrolytes, Toxic Actions, Compounds used in a research, industrial, or household setting, Chlorine Compounds, Oxygen Compounds	experimental	0
DB15466	Tallimustine	Drug	Alkylating Drugs, Noxae, Peptides, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Hydrocarbons, Halogenated, Mustard Compounds, Toxic Actions, Antineoplastic Agents, Alkylating	experimental	1
DB14136	(-)-menthol 1-propylene glycol carbonate	Drug	0	experimental	0
DB15467	Cinoxate	Drug	Acids, Carbocyclic, Sunscreen Agents	approved	0
DB15464	Urolithin A	Drug	Heterocyclic Compounds, Fused-Ring, Benzopyrans, Pyrans	investigational	0
DB14134	Octyldodecanol	Drug	Lipids, Alcohols	experimental	0
DB15465	Benzhydrocodone	Drug	Opioids	approved	0
DB14139	Hydroxyethyl ethylcellulose	Drug	Carbohydrates, Polysaccharides, Glucans, Polymers, Biopolymers, Compounds used in a research, industrial, or household setting, Macromolecular Substances	approved, experimental	0
DB15468	Iscotrizinol	Drug	Sunscreen Agents	experimental	0
DB14137	Palmitoyl tetrapeptide-7	Drug	0	experimental	0
DB15469	Octyl triazone	Drug	Acids, Carbocyclic, Sunscreen Agents, Benzene Derivatives	experimental	0
DB14138	Silicic acid	Drug	Anions, Acids, Noncarboxylic, Acids, Electrolytes, Ions, Oxides, Minerals, Oxygen Compounds, Silicon Compounds	experimental	0
DB03480	Brequinar Analog	Drug	0	experimental	1
DB03484	sn-glycero-3-phosphoethanolamine	Drug	Carbohydrates, Glycerophosphates, Sugar Phosphates, Sugar Alcohols, Lipids, Membrane Lipids, Phospholipids, Phosphatidic Acids, Triose Sugar Alcohols, Glycerophospholipids, Alcohols	experimental	1
DB02153	3-sulfino-L-alanine	Drug	0	experimental	13
DB03483	(4S)-5-[[(2S)-1-[[(2S)-1-Amino-3-[4-[difluoro(phosphono)methyl]phenyl]-1-oxopropan-2-yl]amino]-3-[4-[difluoro(phosphono)methyl]phenyl]-1-oxopropan-2-yl]amino]-4-benzamido-5-oxopentanoic acid	Drug	0	experimental	1
DB02152	K-252a	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Indoles, Protein Kinase C, antagonists & inhibitors	experimental	2
DB03482	8-demethyl-8-dimethylamino-flavin-adenine-dinucleotide	Drug	0	experimental	1
DB02151	Methionine Phosphonate	Drug	0	experimental	2
DB03481	5,10-Dimethylene Tetrahydromethanopterin	Drug	0	experimental	1
DB03488	Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose	Drug	0	experimental	1
DB02156	Sulfopyruvate	Drug	0	experimental	0
DB03487	(S)-Aspartimide	Drug	0	experimental	2
DB02155	3-[(3-sec-butyl-4-hydroxybenzoyl)amino]azepan-4-yl 4-(2-hydroxy-5-methoxybenzoyl)benzoate	Drug	0	experimental	1
DB03486	Phosphomethylphosphonic acid guanosyl ester	Drug	0	experimental	1
DB02154	2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid	Drug	0	experimental	2
DB03485	alpha-D-Fucopyranose	Drug	0	experimental	2
DB02159	(R)-Propylene glycol	Drug	0	experimental	2
DB03489	2-Keto-3-Deoxygluconate	Drug	Acids, Acyclic, Carbohydrates, Hydroxy Acids, Sugar Acids	experimental	1
DB02158	(2S,3S,4R,5S)-2-(4-Amino-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-[(methylsulfanyl)methyl]-3,4-pyrrolidinediol	Drug	0	experimental	2
DB14131	Basic Fibroblast Growth Factor	Drug	Proteins, Biological Factors, Peptides, Fibroblast Growth Factor 2, antagonists & inhibitors, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Fibroblast Growth Factors	investigational	0
DB15462	Fucoxanthin	Drug	Biological Factors, Cycloparaffins, Carotenoids, Alkenes, Hydrocarbons, Acyclic, Polyenes, Cyclohexenes, Terpenes, Cyclohexanes, Pigments, Biological	investigational	0
DB15463	PT2977	Drug	0	investigational	1
DB14132	8-chlorotheophylline	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Purines, Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 Substrates, Xanthine derivatives, Purinones	experimental	1
DB15460	AGG-523	Drug	0	investigational	0
DB15461	Yersinia pestis 195/p antigen (formaldehyde inactivated)	Drug	Complex Mixtures, Actively Acquired Immunity, Biological Products, Inactivated Yersinia Pestis Vaccine, Vaccines, Bacterial Vaccines	investigational	0
DB14130	Methyl salicylate 2-ethylbutyrate	Drug	0	experimental	0
DB14146	Loxicodegol	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Phenanthrenes, Opiate Alkaloids	investigational	3
DB15477	Alloin	Drug	Anthracenes, Quinones, Complex Mixtures, Plant Preparations, Anthraquinones, Plant Extracts, Biological Products, Cascara, Laxatives, Pharmaceutical Preparations, Gastrointestinal Agents	approved, experimental	0
DB15478	Frangula purshiana bark	Drug	Anthracenes, Quinones, Complex Mixtures, Plant Preparations, Anthraquinones, Plant Extracts, Biological Products, Cascara, Laxatives, Pharmaceutical Preparations, Gastrointestinal Agents	approved, experimental	0
DB14144	p-Aminophenol	Drug	Amines, Mutagens, Noxae, Aniline Compounds, Phenols, Toxic Actions, Benzene Derivatives	experimental	0
DB15475	Haemagglutinin-strain A(H3N2)	Drug	0	approved	0
DB15476	Haemagglutinin-strain A(H1N1)	Drug	0	approved	0
DB14145	Nepidermin	Drug	Proteins, Biological Factors, EGF Family of Proteins, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Gastrointestinal Hormones, Intercellular Signaling Peptides and Proteins, Amino Acids, Peptides, and Proteins, Hormones	experimental	0
DB15479	Zirconium chloride hydroxide	Drug	0	approved, experimental	0
DB14148	Human albumin microspheres	Drug	Ultrasound Contrast Activity, Ultrasound Contrast Media	approved, experimental	0
DB14149	Glyceryl stearate SE	Drug	0	experimental	0
DB02160	S-Butyryl-Cystein	Drug	0	experimental	1
DB03491	2'-Deoxyguanosine-5'-Diphosphate	Drug	0	experimental	1
DB03490	3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole	Drug	0	experimental	1
DB02164	N-sulfo-flavin mononucleotide	Drug	0	experimental	1
DB03495	4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1->4)-Alpha-D-Threo-Hexopyranosyl-(1->6)-Alpha-L-Threo-Hexopyranose	Drug	0	experimental	1
DB02163	2,5-Xylidine	Drug	0	experimental	1
DB02162	5'-O-(N-Ethyl-Sulfamoyl)Adenosine	Drug	0	experimental	1
DB03493	7-Methylguanosine	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purines, Ribonucleosides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, RNA Caps, Purine Nucleosides	experimental	1
DB03492	lambda-bis(2,2'-bipyridine)imidazole osmium (II)	Drug	0	experimental	1
DB02161	Hydroxy-Phenyl-Acetic Acid 8-Methyl-8-Aza-Bicyclo[3.2.1]Oct-3-Yl Ester	Drug	0	experimental	1
DB02168	6-bromopurine	Drug	0	experimental	1
DB03499	D-Malic acid	Drug	0	experimental	6
DB03498	Mercaptomethyl Phosphonate	Drug	0	experimental	1
DB02167	N,N-Dimethyl-L-Alanine	Drug	0	experimental	0
DB03497	L-serine O-sulfate	Drug	Amino Acids, Neutral, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	0
DB02166	Propidium	Drug	Heterocyclic Compounds, Fused-Ring, Phenanthridines, Coloring Agents, Laboratory Chemicals, Indicators and Reagents, Intercalating Agents, Compounds used in a research, industrial, or household setting	experimental	1
DB02165	Zinc trihydroxide	Drug	Metal cations, Zinc Compounds, Metal divalent cations	experimental	1
DB03496	Alvocidib	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Protein Kinase Inhibitors, BCRP/ABCG2 Substrates, Cyclin-Dependent Kinases, antagonists & inhibitors, UGT1A1 Substrates, Antineoplastic Agents, Benzopyrans, Growth Inhibitors, Growth Substances, Chromones, Pyrans	investigational, experimental	12
DB02169	9,10-Deepithio-9,10-Didehydroacanthifolicin	Drug	0	experimental	1
DB15470	Minretumomab	Drug	0	experimental	0
DB15473	Haemagglutinin-strain B (Victoria)	Drug	0	approved	0
DB14142	Methoxy PEG-12 retinamide	Drug	Pegylated agents	experimental	0
DB15474	Haemagglutinin-strain B (Yamagata)	Drug	0	approved	0
DB14143	Distearyldimonium	Drug	Surface-Active Agents, Immunologic Factors, Amines, Ammonium Compounds, Adjuvants, Immunologic, Onium Compounds, Compounds used in a research, industrial, or household setting, Anti-Infective Agents, Nitrogen Compounds	approved, experimental	0
DB15471	ZW-25	Drug	0	investigational	0
DB14140	Dipropylene glycol	Drug	0	experimental	0
DB15472	ZW-49	Drug	0	investigational	0
DB14141	p-Phenylenediamine	Drug	Antigens, Biological Factors, Cell-mediated Immunity, Amines, Aniline Compounds, Coloring Agents, Laboratory Chemicals, Standardized Chemical Allergen, Antigens, Bacterial, Tuberculin, Polyamines, Diamines, Azo Compounds, Indicators and Reagents, Compounds used in a research, industrial, or household setting, Increased Histamine Release	approved, experimental	0
DB14157	Hydrogenated soybean lecithin	Drug	0	experimental	0
DB15488	Echinacoside	Drug	Carbohydrates, Herbs and Natural Products, COMT Substrates	experimental	2
DB15489	Mexazolam	Drug	Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 Substrates, Benzazepines, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Benzodiazepines and benzodiazepine derivatives, Cytochrome P-450 CYP3A4 Substrates	experimental	2
DB14158	Microcrystalline cellulose	Drug	Carbohydrates, Excipients, Cellulose, Biopolymers, Pharmaceutic Aids, Drug Delivery Systems, Macromolecular Substances, Polysaccharides, Glucans, Pharmaceutical Preparations, Polymers, Compounds used in a research, industrial, or household setting, Pharmaceutical Vehicles	approved, investigational, experimental	0
DB14155	Chitosan low molecular weight (20-200 mpa.s)	Drug	0	experimental	0
DB15486	VIBRIO CHOLERAE OGAWA 50 CLASSICAL BIOTYPE, HEAT INACTIVATED	Drug	0	approved	0
DB14156	Synthetic camphor	Drug	0	approved, experimental	0
DB15487	VIBRIO CHOLERAE OGAWA 50 CLASSICAL BIOTYPE, FORMALIN INACTIVATED	Drug	0	approved	0
DB14159	Oxidronic acid	Drug	Organophosphonates, Organophosphorus Compounds	approved	0
DB02170	1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One	Drug	0	experimental	1
DB02175	Malonic acid	Drug	Acids, Acyclic, Thallium, Dicarboxylic Acids	experimental	7
DB02174	D-Glutamine	Drug	0	experimental	1
DB02173	Co(III)-(Deuteroporphyrin IX)	Drug	0	experimental	0
DB02172	2,5-Dideoxy-2,5-Imino-D-Glucitol	Drug	Carbohydrates, Sugar Alcohols, Alcohols	experimental	1
DB02179	O-Trifluoromethylphenyl Anthranilic Acid	Drug	0	experimental	0
DB02178	Phenylacetaldehyde	Drug	Oils, Volatile, Aldehydes	experimental	1
DB02177	1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine	Drug	0	experimental	1
DB02176	Mercury Acetate Ion	Drug	0	experimental	0
DB15480	Resorcinol monoacetate	Drug	Phenols, Benzene Derivatives	approved, experimental	0
DB14150	Chloric acid	Drug	Herbicides, Anions, Agrochemicals, Pesticides, Electrolytes, Ions, Toxic Actions, Compounds used in a research, industrial, or household setting, Chlorine Compounds	approved, experimental	0
DB15481	Fish liver oil	Drug	0	approved, experimental	0
DB15484	VIBRIO CHOLERAE INABA 6973 E1 TOR BIOTYPE, FORMALIN INACTIVATED	Drug	0	approved	0
DB14153	Polysorbate 60	Drug	0	experimental	0
DB15485	VIBRIO CHOLERAE INABA 48 CLASSICAL BIOTYPE, HEAT INACTIVATED	Drug	0	approved	0
DB14154	Gold	Drug	Gold, Cell-mediated Immunity, Gold Compounds, Metals, Standardized Chemical Allergen, Metals, Heavy, Elements, Transition Elements, Increased Histamine Release	experimental	0
DB15482	Haemagglutinin-strain B	Drug	0	approved	0
DB14151	Phosphorus	Drug	Phosphorus, Elements	approved, experimental	0
DB14152	Ginsenosides	Drug	Carbohydrates, Saponins, Triterpenes, Glycosides, Terpenes	experimental	0
DB15483	Modified vaccinia ankara	Drug	Vaccines	approved	0
DB14168	Sarocladium strictum	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB15499	Cerdulatinib	Drug	Sulfur Compounds	investigational	0
DB14169	Salix nigra bark	Drug	Non-Standardized Food Allergenic Extract	approved	0
DB15497	Smallpox and Monkeypox Vaccine, Live, Non-replicating	Drug	0	approved	0
DB14166	Rumex acetosella whole	Drug	Non-Standardized Food Allergenic Extract	approved	0
DB14167	Rumex crispus top	Drug	Non-Standardized Food Allergenic Extract	approved	0
DB15498	BOS172722	Drug	0	experimental	1
DB02182	Hybrid Between B and C Type Hemes (Protoporphyrin Ixcontaining Fe)	Drug	0	experimental	1
DB02181	2'-Deoxyguanosine-5'-Triphosphate	Drug	0	experimental	2
DB02180	Myristoyl-Coa	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Coenzymes, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Thioesters of coenzyme A, Enzymes and Coenzymes, Glycosides, Nucleotides, Adenine Nucleotides	experimental	2
DB02186	N-Acetyl-D-Galactosamine 6-Sulfate	Drug	0	experimental	2
DB02185	2,4-Dihydroxy-7-(Methyloxy)-2h-1,4-Benzoxazin-3(4h)-One	Drug	0	experimental	1
DB02184	D-1,4-dithiothreitol	Drug	0	experimental	1
DB02183	Adenosine-5'-ditungstate	Drug	0	experimental	1
DB02189	2',3'-Dideoxyadenosine triphosphate	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Deoxyribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides, Adenine Nucleotides	experimental	1
DB02188	N-Methylmesoporphyrin Containing Copper	Drug	0	experimental	1
DB02187	Equilin	Drug	Cytochrome P-450 Substrates, Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, 17-Ketosteroids, Adrenal Cortex Hormones, Estrenes, Hormones, Ketosteroids, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Gonadal Steroid Hormones, Cytochrome P-450 CYP3A Substrates, Estradiol Congeners, Gonadal Hormones, Steroids	experimental	2
DB14160	Titanium	Drug	Metals, Light, Metals, Elements, Transition Elements	experimental	0
DB15491	Oxazolam	Drug	Heterocyclic Compounds, Fused-Ring, Benzazepines	experimental	0
DB15492	Eticlopride	Drug	Neurotransmitter Agents, Amides, Dopamine Antagonists, Dopamine Agents	experimental	0
DB14161	Lecithin, soybean	Drug	0	experimental	0
DB15490	Zuranolone	Drug	Central Nervous System Depressants, Antidepressive Agents	experimental	0
DB14164	Betula lenta whole	Drug	Non-Standardized Food Allergenic Extract	approved	0
DB15495	Rocaglamide	Drug	Heterocyclic Compounds, Fused-Ring	experimental	2
DB15496	Didesmethylrocaglamide	Drug	0	experimental	2
DB14165	Culex pipiens	Drug	Non-Standardized Food Allergenic Extract	approved	0
DB14162	Northern bluefin tuna	Drug	Non-Standardized Food Allergenic Extract	approved	0
DB15493	Cambinol	Drug	Pyrimidines	experimental	3
DB14163	Anthoxanthum odoratum	Drug	Non-Standardized Food Allergenic Extract, Allergenic Extracts	approved	0
DB15494	Edotreotide gallium Ga-68	Drug	Tumour Detection, Diagnostic Radiopharmaceuticals, Gallium Radioisotopes, Radiopharmaceuticals	approved	4
DB15422	ILS-920	Drug	0	investigational	0
DB15423	Disaccharide tripeptide glycerol dipalmitoyl	Drug	0	investigational	0
DB15420	Coagulation factor XIa	Drug	0	investigational	0
DB15421	Cetrelimab	Drug	0	investigational	0
DB15426	Giripladib	Drug	Sulfur Compounds, Acids, Carbocyclic, Amides, Group IV Phospholipases A2, antagonists & inhibitors, Radiation-Sensitizing Agents, Benzene Derivatives, Sulfones	investigational	0
DB15427	Fialuridine	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Iodine Radioisotopes, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Arabinonucleosides, Glycosides, Nucleosides, Antiviral Agents, Anti-Infective Agents	investigational	0
DB15424	Bfpet F-18	Drug	0	investigational	0
DB15425	CYC-065	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purines, Ribonucleosides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Purine Nucleosides	investigational	0
DB15428	Vesencumab	Drug	Neuropilin-1, Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB04770	O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL	Drug	0	experimental	1
DB15429	Thioglycolic acid	Drug	Acids, Acyclic, Sulfur Compounds, Fatty Acids, Fatty Acids, Volatile, Lipids, Acetates, Sulfhydryl Compounds	investigational	0
DB04771	1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE	Drug	0	experimental	1
DB03440	N-hexadecanoylglycine	Drug	Fatty Acids, Amino Acids, Peptides, and Proteins, Lipids, Amino Acids	experimental	1
DB04776	(2R)-2-({6-[benzyl(methyl)amino]-9-isopropyl-9H-purin-2-yl}amino)butan-1-ol	Drug	Heterocyclic Compounds, Fused-Ring, Purines	experimental	1
DB02113	6-Methylpurine	Drug	Heterocyclic Compounds, Fused-Ring	experimental	1
DB03444	6-bromoindirubin-3'-oxime	Drug	Glycogen Synthase Kinase 3, antagonists & inhibitors, Heterocyclic Compounds, Fused-Ring, Amines, Hydroxylamines	experimental	1
DB02112	Zk-806450	Drug	0	experimental	1
DB04777	(R)-4-Nitrostyrene oxide	Drug	0	experimental	1
DB03443	bis(5-amidino-benzimidazolyl)methanone zinc	Drug	0	experimental	1
DB02111	3-hydroxyisoxazole-4-carboxylic acid	Drug	0	experimental	1
DB03442	Acid yellow 54 free acid	Drug	Arylsulfonates, Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfur Acids, Sulfonic Acids, Arylsulfonic Acids, Benzene Derivatives	experimental	1
DB04778	SC45647	Drug	Amidines, Sweetening Agents	experimental	0
DB02110	Protoporphyrin Ix Containing Co	Drug	0	experimental	2
DB04779	ETHYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE	Drug	0	experimental	1
DB03441	2-Benzyl-3-Iodopropanoic Acid	Drug	0	experimental	1
DB03448	2'-Deoxyuridine 3'-Monophosphate	Drug	0	experimental	2
DB04772	1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE	Drug	0	experimental	1
DB02116	Olomoucine	Drug	Cytokinins, Heterocyclic Compounds, Fused-Ring, Purines, Enzyme Inhibitors, Cyclin-Dependent Kinases, antagonists & inhibitors	experimental	4
DB03447	Uridylyl-2'-5'-phospho-adenosine	Drug	0	experimental	1
DB04773	METHYL (3R)-3-{[(3R)-3-{[(3R)-3-HYDROXYBUTANOYL]OXY}BUTANOYL]OXY}BUTANOATE	Drug	0	experimental	1
DB04774	Reidispongiolide A	Drug	Polyketides, Lactones	experimental	1
DB02115	Daidzin	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Flavonoids, Alcohol Deterrents, BCRP/ABCG2 Inhibitors, Benzopyrans, Central Nervous System Agents, Chromones, Pyrans	experimental	1
DB03446	N-Benzyl-3-(alpha-D-galactopyranosyloxy)benzamide	Drug	0	experimental	1
DB02114	Cumidine	Drug	Amines	experimental	1
DB04775	Reidispongiolide C	Drug	0	experimental	1
DB03445	(3S)-3-(dioxidosulfanyl)-N-[(1E)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine	Drug	0	experimental	1
DB02119	6-Hydroxymethyl-7,8-Dihydropterin	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Pteridines, Pigments, Biological	experimental	2
DB02118	CP-271485	Drug	0	experimental	1
DB03449	N-(4-{2-[(3-chlorobenzyl)amino]ethyl}phenyl)thiophene-2-carboximidamide	Drug	0	experimental	2
DB15433	AVI-7537	Drug	0	investigational	0
DB14102	Triethylhexanoin	Drug	Glycerides, Acids, Acyclic, Excipients, Fatty Acids, Lipids, Pharmaceutical Preparations, Compounds used in a research, industrial, or household setting, Pharmaceutic Aids, Drug Delivery Systems, Pharmaceutical Vehicles	experimental	0
DB14103	Methionine sulfoximine	Drug	Amino Acids, Neutral, Sulfur Compounds, Amino Acids, Essential, Amino Acids, Sulfur, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	0
DB15434	Mosunetuzumab	Drug	0	investigational	0
DB14100	Pork Collagen	Drug	0	approved, investigational	0
DB15431	M-2698	Drug	0	investigational	0
DB14101	Soy isoflavones	Drug	0	approved, experimental	0
DB15432	Pinatuzumab vedotin	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Noxae, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Toxic Actions, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB15437	Rocacetrapib	Drug	Hydrocarbons, Halogenated	investigational	0
DB14106	Tetrakis(2-methoxyisobutylisocyanide)copper(I) tetrafluoroborate	Drug	0	approved	0
DB14107	7-Aminodesacetoxycephalosporanic acid	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amides, Lactams, Thiazines, beta-Lactams	experimental	0
DB15438	Artemin	Drug	0	investigational	0
DB15435	BMS-986158	Drug	0	investigational	0
DB14104	Linoleic acid	Drug	Fatty Acids, Essential, Fatty Acids, Omega-6, Fatty Acids, Unsaturated, Fatty Acids, Linoleic Acids, Lipids	approved, experimental	0
DB15436	Glucoraphanin	Drug	Carbohydrates, Sulfur Compounds, Glycosides, Imides, Thioglucosides, Glucosides, Thioglycosides	investigational	0
DB14105	Sodium 1,2-Dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol)	Drug	0	approved, experimental	0
DB04780	Sulfatide	Drug	0	experimental	0
DB15439	Navoximod	Drug	0	investigational	0
DB04781	5-hydroxyvaleric acid	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Lipids	experimental	1
DB14108	1,2-Hexanediol	Drug	Hydrocarbons, Acyclic, Alkanes, Alcohols	experimental	0
DB04782	(S)-4-Nitrostyrene oxide	Drug	0	experimental	1
DB14109	alpha-Arbutin	Drug	0	approved, experimental	0
DB03451	Lexacalcitol	Drug	Cholestanes, Immunologic Factors, Secosteroids, Immunosuppressive Agents, Antineoplastic Agents, Lipids, Fused-Ring Compounds, Vitamins, Sterols, Vitamin D and Analogues, Vitamins (Fat Soluble), Membrane Lipids, Cholestenes, Steroids	experimental	1
DB02120	6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol	Drug	0	experimental	5
DB03450	Cephalothin Group	Drug	Nephrotoxic agents	experimental	2
DB03455	(1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid	Drug	0	experimental	1
DB02124	(2s,3s)-Trans-2,3-Dihydro-3-Hydroxyanthranilic Acid	Drug	0	experimental	1
DB04787	Tanaproget	Drug	Heterocyclic Compounds, Fused-Ring, Oxazines, Sulfur Compounds, Receptors, Progesterone, agonists	investigational	1
DB02123	Glycochenodeoxycholic Acid	Drug	Surface-Active Agents, BSEP/ABCB11 Inhibitors, Glycodeoxycholic Acid, Peptides, Amino Acids, Peptides, and Proteins, BSEP/ABCB11 Substrates, N-substituted Glycines, Peptoids, Detergents, Bile Acids and Salts, Cholic Acids, Amino Acids, Fused-Ring Compounds, Household Products, Cholanes, Compounds used in a research, industrial, or household setting, Steroids	experimental	1
DB03454	3-methyl-benzene-1,2-diol	Drug	0	experimental	1
DB04788	Tagetitoxin	Drug	Acids, Acyclic, Bacterial Toxins	experimental	2
DB03453	Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate	Drug	0	experimental	1
DB04789	5-methyltetrahydrofolic acid	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Coenzymes, Pterins, Folic Acid and Derivatives, Enzymes and Coenzymes, Vitamin B Complex, Pteridines, Vitamins, Pigments, Biological	investigational, nutraceutical	1
DB02122	4-iodo-acetamido phenylboronic acid	Drug	0	experimental	2
DB03452	3-Trimethylsilylsuccinic Acid	Drug	0	experimental	1
DB02121	Butyramide	Drug	0	experimental	1
DB03459	Sparfosic acid	Drug	Acids, Acyclic, Enzyme Inhibitors, Fatty Acids, Noxae, Antineoplastic Agents, Organophosphorus Compounds, Amino Acids, Peptides, and Proteins, Lipids, Amino Acids, Acidic, Acetates, Antimetabolites, Amino Acids, Anti-Infective Agents, Organophosphonates, Amino Acids, Dicarboxylic, Fatty Acids, Volatile, Excitatory Amino Acids, Toxic Actions	experimental	2
DB02128	[1-(3-hydroxy-2-oxo-1-phenethyl-propylcarbamoyl)2-phenyl-ethyl]-carbamic acid pyridin-4-ylmethyl ester	Drug	0	experimental	1
DB04783	Sphinxolide B	Drug	0	experimental	1
DB02127	Diisopropyl methylphosphonate	Drug	0	experimental	2
DB04784	(R)-1-phenylethanol	Drug	0	experimental	1
DB03458	N(4)-Adenosyl-N(4)-methyl-2,4-diaminobutanoic acid	Drug	Acids, Acyclic, Fatty Acids, Butyrates, Fatty Acids, Volatile, Amino Acids, Peptides, and Proteins, Lipids, Amino Acids	experimental	0
DB02126	4-Carboxycinnamic Acid	Drug	0	experimental	2
DB04785	Streptolydigin	Drug	Carbohydrates, Anti-Bacterial Agents, Glycosides, Anti-Infective Agents	experimental	0
DB02125	Adamantanone	Drug	Cycloparaffins	experimental	1
DB03456	N2-[(benzyloxy)carbonyl]-n1-[(3S)-1-cyanopyrrolidin-3-yl]-l-leucinamide	Drug	0	experimental	1
DB04786	Suramin	Drug	Arylsulfonates, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Sulfur Acids, Arylsulfonic Acids, Antineoplastic Agents, Anti-Infective Agents, Naphthalenes, Sulfur Compounds, Acids, Noncarboxylic, Acids, Agents Against Leishmaniasis and Trypanosomiasis, Sulfonic Acids, Trypanocidal Agents, Antinematodal Agents, Antiparasitic Agents, Naphthalenesulfonates	investigational	7
DB02129	Dihydroorotic Acid	Drug	0	experimental	1
DB15430	Elgemtumab	Drug	0	investigational	0
DB15444	Elexacaftor	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, OATP1B3 inhibitors, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, Membrane Transport Modulators, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), P-glycoprotein inhibitors	approved, investigational	1
DB14113	Black widow spider antivenin (equine)	Drug	Passively Acquired Immunity, Venom Neutralization, Antivenin	approved	0
DB15445	Iodohippuric acid	Drug	Benzoates, Contrast Media, Diagnostic Uses of Chemicals, Acids, Carbocyclic, Keto Acids, Benzamides and benzamide derivatives, Amides, Compounds used in a research, industrial, or household setting, Hippurates, Benzene Derivatives	investigational	0
DB14114	Viper antivenom	Drug	0	approved	0
DB15442	Trilaciclib	Drug	0	investigational	0
DB14111	Ceramide NP	Drug	Carbohydrates, Antigens, Neoplasm, Glycoconjugates, Glycolipids, Lipids, Membrane Lipids, Sphingolipids	experimental	0
DB14112	Human vaccinia virus immune globulin	Drug	Passively Acquired Immunity, Human Immunoglobulin G, Virus Neutralization	approved	0
DB15443	Lorukafusp alfa	Drug	Biological Factors, Immunoglobulins, Cytokines, Peptides, Intercellular Signaling Peptides and Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Lymphokines, Immunoproteins, Proteins, Serum Globulins, Globulins, Interleukins, Blood Proteins	investigational	0
DB15448	Acumapimod	Drug	0	investigational	0
DB14117	Silica dimethyl silylate	Drug	0	experimental	0
DB15449	Citarinostat	Drug	0	investigational	0
DB15446	Vidofludimus	Drug	Acids, Acyclic, Benzene Derivatives	investigational	0
DB14115	Human botulinum neurotoxin A/B immune globulin	Drug	Passively Acquired Immunity, Bacterial Neurotoxin Neutralization, Human Immunoglobulin G	approved	0
DB14116	Silodrate	Drug	0	approved, experimental	0
DB15447	Setogepram	Drug	0	investigational	0
DB04790	2,5-bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol	Drug	0	experimental	1
DB04791	2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL	Drug	0	experimental	1
DB04792	2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL	Drug	0	experimental	1
DB14119	Phytosphingosine	Drug	Amines, Glycols, Amino Alcohols, Alcohols	experimental	0
DB04793	1,4:3,6-Dianhydro-2-O-(3-carbamimidoylphenyl)-5-O-(4-carbamimidoylphenyl)-D-glucitol	Drug	0	experimental	1
DB03462	Thymine	Drug	Pyrimidines, Pyrimidinones	experimental	2
DB02131	N-1-methylheptylformamide	Drug	0	experimental	1
DB02130	Vanillic acid	Drug	Benzoates, Hydroxy Acids, Acids, Carbocyclic, Hydroxybenzoates, Phenols, Ethers, Hydroxybenzoate Ethers, Benzene Derivatives, Phenyl Ethers	experimental	1
DB03461	Nicotinamide adenine dinucleotide phosphate	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Coenzymes, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Enzymes and Coenzymes, Glycosides, Nucleotides, Adenine Nucleotides	experimental	60
DB03460	Violaxanthin	Drug	Biological Factors, Cycloparaffins, Carotenoids, Alkenes, Hydrocarbons, Acyclic, Polyenes, Cyclohexenes, Terpenes, Cyclohexanes, Pigments, Biological	experimental	0
DB02135	1-deoxy-1-{2,6,8-trioxo-7-[4-(phosphonooxy)butyl]-1,2,3,6,7,8-hexahydro-9H-purin-9-yl}-D-arabinitol	Drug	0	experimental	1
DB04798	THIO-ATPA	Drug	Sulfur Compounds, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	1
DB03466	BMS184394	Drug	0	experimental	1
DB04799	6-Hydroxy-5-undecyl-4,7-benzothiazoledione	Drug	Sulfur Compounds	experimental	10
DB02134	Xanthine	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Purines, Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 Substrates, Xanthine derivatives, Purinones	experimental	2
DB02133	Chlorophyll A	Drug	Biological Factors, Chlorophyll, Heterocyclic Compounds, Fused-Ring, Metalloporphyrins, Pigments, Biological, Porphyrins	experimental	1
DB03464	Formycin-5'-Monophosphate	Drug	0	experimental	1
DB02132	Zenarestat	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Aldehyde Reductase, antagonists & inhibitors	experimental	1
DB04794	Bifonazole	Drug	Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Dermatologicals, Antifungals for Dermatological Use, Anti-Infective Agents, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Azole Antifungals, Cytochrome P-450 CYP3A Inhibitors, Antifungals for Topical Use, Cytochrome P-450 CYP3A4 Inhibitors, Antifungal Agents, Imidazole and Triazole Derivatives, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved, investigational	2
DB02139	(2e)-N-Allyl-4-{[3-(4-Bromophenyl)-5-Fluoro-1-Methyl-1h-Indazol-6-Yl]Oxy}-N-Methyl-2-Buten-1-Amine	Drug	0	experimental	1
DB03469	Heme D	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Metalloporphyrins, Pigments, Biological, Porphyrins	experimental	2
DB02138	Diethyl 4-Methylbenzylphosphonate	Drug	Organophosphorus Compounds	experimental	2
DB04795	Thenoyltrifluoroacetone	Drug	Butanones, Sulfur Compounds, Ketones, Thiophenes, Sequestering Agents, Compounds used in a research, industrial, or household setting, Chelating Agents	experimental	2
DB03468	1,2,3,4-Tetrahydro-Isoquinoline-7-Sulfonic Acid Amide	Drug	0	experimental	1
DB02137	Molybdenum cofactor	Drug	Proteins, Heterocyclic Compounds, Fused-Ring, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins	experimental	1
DB04796	Inecalcitol	Drug	Cholestanes, Secosteroids, Sterols, Vitamin D and Analogues, Vitamins (Fat Soluble), Hydrocarbons, Acyclic, Lipids, Membrane Lipids, Cholestenes, Fused-Ring Compounds, Vitamins, Steroids	investigational	1
DB03467	Naringenin	Drug	Heterocyclic Compounds, Fused-Ring, Estrogen Antagonists, Flavonoids, Hormones, Hormone Substitutes, and Hormone Antagonists, BCRP/ABCG2 Inhibitors, Benzopyrans, Anti-Ulcer Agents, Hormone Antagonists, Chromones, Gastrointestinal Agents, Pyrans	experimental	8
DB02136	Cephalosporin analog	Drug	Agents that reduce seizure threshold	experimental	1
DB04797	Triazolopyridine	Drug	0	experimental	1
DB15440	GSK-3117391	Drug	0	investigational	0
DB14110	Butylene glycol	Drug	Glycols, Alcohols	approved, experimental	0
DB15441	Lulizumab pegol	Drug	Immunoglobulins, Amino Acids, Peptides, and Proteins, Alcohols, Immunoproteins, Macromolecular Substances, Proteins, Serum Globulins, Globulins, Blood Proteins, Ethylene Glycols, Glycols, Polymers, Compounds used in a research, industrial, or household setting	investigational	0
DB14124	Cyclomethicone	Drug	Polymers, Compounds used in a research, industrial, or household setting, Organosilicon Compounds, Silicon Compounds, Macromolecular Substances	experimental	0
DB15455	Cenersen	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleotides, Polynucleotides	investigational	0
DB15456	Vericiguat	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB14125	Benazeprilat	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors, Agents causing hyperkalemia, Protease Inhibitors, Agents Acting on the Renin-Angiotensin System, Agents causing angioedema, Cardiovascular Agents, Antihypertensive Agents, Decreased Blood Pressure	experimental	0
DB15453	Naratuximab emtansine	Drug	Proteins, Serum Globulins, Immunotoxins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB14122	Dihydroxymethoxychalcone	Drug	Heterocyclic Compounds, Fused-Ring, Flavonoids, Ketones, Propiophenones, Benzopyrans, Chromones, Pyrans, Zingiberaceae	experimental	0
DB14123	Racementhol	Drug	0	approved, experimental	0
DB14128	Nadide	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Coenzymes, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Enzymes and Coenzymes, Glycosides, Nucleotides, Adenine Nucleotides	experimental	0
DB14129	Macelignan	Drug	Benzyl Compounds, Benzene Derivatives	experimental	0
DB15457	Snubh-nm-333 F-18	Drug	0	investigational	0
DB14126	Tenofovir	Drug	Nephrotoxic agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Tenofovir and prodrugs, P-glycoprotein substrates, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Organophosphorus Compounds, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, OAT3/SLC22A8 Substrates, Organophosphonates, Heterocyclic Compounds, Fused-Ring, Purines, Nucleic Acid Synthesis Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Reverse Transcriptase Inhibitors, Nucleoside Reverse Transcriptase Inhibitors	investigational, experimental	3
DB14127	Sacubitrilat	Drug	Acids, Acyclic, Neprilysin Inhibitor, Fatty Acids, Butyrates, Fatty Acids, Volatile, Amino Acids, Peptides, and Proteins, Lipids, Neprilysin Inhibitors, Amino Acids, Benzene Derivatives	experimental	0
DB15458	Norleucine	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Caproates, Amino Acids, Peptides, and Proteins, Lipids, Aminocaproates, Amino Acids	investigational	0
DB03473	N5-Methylglutamine	Drug	0	experimental	1
DB02142	Pyridoxamine-5'-Phosphate	Drug	0	experimental	10
DB02141	S,S'-(1,4-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea	Drug	0	experimental	1
DB03472	Cyclohexyl-Hexyl-Beta-D-Maltoside	Drug	0	experimental	2
DB02140	N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide	Drug	0	experimental	1
DB03471	6-phenyl-4(R)-(7-phenyl-heptanoylamino)-hexanoic acid	Drug	0	experimental	1
DB03470	Trypanothione	Drug	Diamines, Amines, Trypanosoma, Oligopeptides, Peptides, Biogenic Amines, Amino Acids, Peptides, and Proteins, Polyamines, Biogenic Polyamines	experimental	1
DB03477	1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole	Drug	0	experimental	1
DB02146	Glutathione S-atrazine	Drug	0	experimental	0
DB03476	Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine	Drug	0	experimental	1
DB02145	Butyl alcohol	Drug	0	experimental	1
DB02144	1,2-diacyl-sn-glycero-3-phosphoinositol	Drug	0	experimental	1
DB03475	1-[4-Carboxy-2-(3-Pentylamino)Phenyl]-5,5'-Di(Hydroxymethyl)Pyrrolidin-2-One	Drug	0	experimental	1
DB03474	Reactive Red 1 Dye	Drug	0	experimental	0
DB02143	1-hydroxy-2-isopropylguanidine	Drug	0	experimental	1
DB03479	8,9,10-trihydroxy-7-hydroxymethyl-3-methyl-6-oxa-1,3-diaza-spiro[4.5]decane-2,4-dione	Drug	0	experimental	1
DB02148	3-Amino-4-Oxybenzyl-2-Butanone	Drug	0	experimental	1
DB03478	2'-O-Acetyl Adenosine-5-Diphosphoribose	Drug	0	experimental	1
DB02147	Cyclo-Tetrametavanadate	Drug	Vanadates	experimental	1
DB14120	Phenylethyl resorcinol	Drug	Phenols, Benzene Derivatives	approved, experimental	0
DB15451	SOBI-003	Drug	0	investigational	0
DB14121	Parasorbic acid	Drug	0	experimental	0
DB15452	Technetium Tc-99m epratuzumab	Drug	0	investigational	0
DB15450	PF-05105679	Drug	0	investigational	0
DB14179	Phleum pratense top	Drug	0	approved	0
DB14177	Propylparaben	Drug	Cell-mediated Immunity, Benzoates, Hydroxy Acids, Acids, Carbocyclic, Hydroxybenzoates, Standardized Chemical Allergen, Pharmaceutic Aids, Preservatives, Pharmaceutical, Phenols, Pharmaceutical Preparations, Compounds used in a research, industrial, or household setting, Benzene Derivatives, Increased Histamine Release	approved, experimental	0
DB14178	Tetramethylthiuram monosulfide	Drug	Acids, Acyclic, Cell-mediated Immunity, Sulfur Compounds, Carbamates, Dimethyldithiocarbamate, Standardized Chemical Allergen, Thiocarbamates, Increased Histamine Release	approved, experimental	0
DB02192	Phenylethyl alcohol	Drug	Preservatives, Pharmaceutical, Disinfectants, Pharmaceutical Preparations, Compounds used in a research, industrial, or household setting, Anti-Infective Agents, Anti-Infective Agents, Local, Pharmaceutic Aids, Alcohols	experimental	1
DB02191	(7as,12ar,12bs)-1,2,3,4,7a,12,12a,12b-Octahydroindolo[2,3-a]Quinolizin-7(6h)-One	Drug	0	experimental	2
DB02190	(S)-oxalosuccinic acid	Drug	0	experimental	1
DB02197	4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide	Drug	0	experimental	1
DB02196	Uridine-Diphosphate-N-Acetylgalactosamine	Drug	0	experimental	7
DB02195	3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine	Drug	0	experimental	1
DB02194	8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One	Drug	0	experimental	0
DB02199	1,3-Dedimethyl-1,3-Divinyl Heme	Drug	0	experimental	0
DB02198	2-Bromoacetyl Group	Drug	0	experimental	1
DB14171	Penicillium glaucum	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB14172	Evernia prunastri	Drug	Cell-mediated Immunity, Standardized Chemical Allergen, Increased Histamine Release	approved	0
DB14170	Artemisia vulgaris root	Drug	Non-Standardized Food Allergenic Extract	approved, investigational	0
DB14175	alpha-Amyl cinnamaldehyde	Drug	Cell-mediated Immunity, Perfume, Standardized Chemical Allergen, Increased Histamine Release	approved, experimental	0
DB14176	Benzylparaben	Drug	Cell-mediated Immunity, Benzoates, Hydroxy Acids, Acids, Carbocyclic, Hydroxybenzoates, Phenols, Standardized Chemical Allergen, Benzene Derivatives, Increased Histamine Release	approved, experimental	0
DB14173	Diazolidinylurea	Drug	Cell-mediated Immunity, Standardized Chemical Allergen, Increased Histamine Release	approved, experimental	0
DB14174	Dipentamethylenethiuram disulfide	Drug	Cell-mediated Immunity, Standardized Chemical Allergen, Increased Histamine Release	approved, experimental	0
DB14188	Isoeugenol	Drug	Cell-mediated Immunity, Acids, Carbocyclic, Caffeic Acids, Standardized Chemical Allergen, Cinnamates, Increased Histamine Release	approved, experimental	0
DB14189	Ethylenediamine	Drug	Allergens, Diamines, Cell-mediated Immunity, Amines, Standardized Chemical Allergen, Dermatitis, Contact, Polyamines, Increased Histamine Release	approved, experimental	0
DB14182	Dichromate	Drug	Anions, Noxae, Chromium Compounds, Coloring Agents, Electrolytes, Ions, Toxic Actions, Caustics, Chromates, Compounds used in a research, industrial, or household setting	approved, investigational	0
DB14183	Geraniol	Drug	Cell-mediated Immunity, Standardized Chemical Allergen, Increased Histamine Release	approved, experimental	0
DB14180	Nickel sulfate	Drug	Noxae, Metals, Toxic Actions, Metals, Heavy, Elements, Transition Elements, Compounds used in a research, industrial, or household setting, Irritants	approved, experimental	0
DB14181	Lanolin alcohols	Drug	Cell-mediated Immunity, Standardized Chemical Allergen, Increased Histamine Release	approved, experimental	0
DB14186	Cinnamyl alcohol	Drug	Cell-mediated Immunity, Standardized Chemical Allergen, Drugs that are Mainly Renally Excreted, Alcohols, Increased Histamine Release	approved, experimental	0
DB14187	Hydroxycitronellal	Drug	Cell-mediated Immunity, Perfume, Standardized Chemical Allergen, Increased Histamine Release	approved, experimental	0
DB14184	Cinnamaldehyde	Drug	Food Additives, Antineoplastic Agents, Phytogenic, Cell-mediated Immunity, Protective Agents, Flavoring Agents, Antineoplastic Agents, Standardized Chemical Allergen, Antimutagenic Agents, Aldehydes, Drugs that are Mainly Renally Excreted, Pharmaceutic Aids, Physiological Phenomena, Food and Beverages, Food Ingredients, Pharmaceutical Preparations, Compounds used in a research, industrial, or household setting, Diet, Food, and Nutrition, Food, Increased Histamine Release	approved, experimental	0
DB14185	Aripiprazole lauroxil	Drug	Quinolines, QTc Prolonging Agents, Tranquilizing Agents, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 CYP3A7 Substrates, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Quinolones, Serotonin 5-HT2 Receptor Antagonists, Antipsychotic Agents, Histamine H1 Antagonists, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Adrenergic Antagonists, Potential QTc-Prolonging Agents, Adrenergic alpha-1 Receptor Antagonists, Neurotoxic agents, Cytochrome P-450 CYP3A5 Substrates, Piperazines, Adrenergic alpha-Antagonists, Psychotropic Drugs, Heterocyclic Compounds, Fused-Ring, Aripiprazole and prodrugs, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Agents that produce hypertension, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates	approved, investigational	25
DB14199	Bromothalonil	Drug	Allergens, Preservatives, Pharmaceutical, Cell-mediated Immunity, Standardized Chemical Allergen, Pharmaceutical Preparations, Compounds used in a research, industrial, or household setting, Pharmaceutic Aids, Increased Histamine Release	approved, experimental	0
DB14190	P-Tert-Butylphenol-Formaldehyde Resin (Low Molecular Weight)	Drug	Cell-mediated Immunity, Standardized Chemical Allergen, Increased Histamine Release	approved, experimental	0
DB14193	Ditiocarb zinc	Drug	Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Allergens, Vasoprotectives, Cell-mediated Immunity, Metal cations, Zinc Compounds, Metal divalent cations, Standardized Chemical Allergen, Compounds used in a research, industrial, or household setting, Increased Histamine Release	approved	0
DB14194	Zinc dibutyldithiocarbamate	Drug	Acids, Acyclic, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Vasoprotectives, Cell-mediated Immunity, Sulfur Compounds, Metal cations, Zinc Compounds, Metal divalent cations, Carbamates, Standardized Chemical Allergen, Increased Histamine Release	approved, experimental	0
DB14191	Diphenylguanidine	Drug	Cell-mediated Immunity, Amidines, Standardized Chemical Allergen, Increased Histamine Release	approved, experimental	0
DB14192	N,N'-diphenyl-1,4-phenylenediamine	Drug	Antioxidants, Diamines, Cell-mediated Immunity, Amines, Protective Agents, Aniline Compounds, Standardized Chemical Allergen, Polyamines, Compounds used in a research, industrial, or household setting, Increased Histamine Release	approved, experimental	0
DB14197	Methylchloroisothiazolinone	Drug	Preservatives, Pharmaceutical, Cell-mediated Immunity, Sulfur Compounds, Disinfectants, Standardized Chemical Allergen, Compounds used in a research, industrial, or household setting, Anti-Infective Agents, Increased Histamine Release	approved, experimental	0
DB14198	Quaternium-15	Drug	Preservatives, Pharmaceutical, Cell-mediated Immunity, Cycloparaffins, Amines, Standardized Chemical Allergen, Polyamines, Increased Histamine Release	approved, experimental	0
DB14195	4-(Isopropylamino)diphenylamine	Drug	Antioxidants, Diamines, Cell-mediated Immunity, Amines, Protective Agents, Aniline Compounds, Standardized Chemical Allergen, Polyamines, Compounds used in a research, industrial, or household setting, Increased Histamine Release	approved, experimental	0
DB14196	N-Cyclohexyl-N'-phenyl-1,4-phenylenediamine	Drug	Diamines, Cell-mediated Immunity, Amines, Aniline Compounds, Standardized Chemical Allergen, Polyamines, Increased Histamine Release	approved	0
DB04800	1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID	Drug	0	experimental	1
DB04801	cis-Vaccenic acid	Drug	Fatty Acids, Unsaturated, Fatty Acids, Lipids, Fatty Acids, Monounsaturated	experimental	1
DB04806	(5-BROMO-4-CHLORO-3-INDOLYL)-A-D-MANNOSE	Drug	0	experimental	0
DB04807	4-NITROPHENYL-(6-S-ALPHA-D-XYLOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE	Drug	0	experimental	1
DB04808	Neamine	Drug	Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Nephrotoxic agents, Carbohydrates, Anti-Bacterial Agents, Narrow Therapeutic Index Drugs, Aminoglycoside Antibacterials, Glycosides, Agents that produce neuromuscular block (indirect), Drugs that are Mainly Renally Excreted	experimental	0
DB04809	SALOPHEN-10-PROPIONATE IRON CHELATE	Drug	0	experimental	1
DB04802	D-Erythro-2,3-diaminobutyric acid	Drug	0	experimental	0
DB04803	Verdoheme	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Metalloporphyrins, Pigments, Biological, Porphyrins	experimental	1
DB04804	(2S)-2,3-Diaminobutanoic acid	Drug	0	experimental	0
DB04805	Virginiamycin S1	Drug	Peptides, Cyclic, Peptides, Streptogramins, Amino Acids, Peptides, and Proteins	experimental	1
DB15500	Influenza A virus A/Brisbane/02/2018 IVR-190 (H1N1) antigen (propiolactone inactivated)	Drug	0	approved	0
DB15503	Amaranthus hybridus pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB15504	Acacia dealbata pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB15501	Influenza A virus A/Kansas/14/2017 X-327 (H3N2) antigen (propiolactone inactivated)	Drug	0	approved	0
DB15502	Baccharis sarothroides whole	Drug	0	approved	0
DB15507	Influenza B virus B/Singapore/INFTT-16-0610/2016 antigen (MDCK cell derived, propiolactone inactivated)	Drug	0	approved	0
DB15508	Influenza B virus B/Iowa/06/2017 antigen (MDCK cell derived, propiolactone inactivated)	Drug	0	approved	0
DB15505	Influenza A virus A/Idaho/07/2018 (H1N1) antigen (MDCK cell derived, propiolactone inactivated	Drug	0	approved	0
DB15506	Influenza A virus A/Indiana/08/2018 (H3N2) antigen (MDCK cell derived, propiolactone inactivated)	Drug	0	approved	0
DB15509	Alnus serrulata pollen	Drug	0	approved	0
DB04853	Binodenoson	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Purines, Ribonucleosides, Nucleic Acids, Nucleotides, and Nucleosides, Purinergic Agonists, Glycosides, Nucleosides, Purinergic Agents, Purine Nucleosides, Purinergic P1 Receptor Agonists	investigational	1
DB03520	6-Chloro-2-fluoropurine	Drug	0	experimental	0
DB04854	Febuxostat	Drug	Antigout Preparations, Sulfur Compounds, Photosensitizing Agents, Musculo-Skeletal System, Xanthine Oxidase Inhibitors, Thiazoles, Antirheumatic Agents, Drugs causing inadvertant photosensitivity, Preparations Inhibiting Uric Acid Production	approved	1
DB04855	Dronedarone	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (moderate), OATP1B3 inhibitors, OCT1 inhibitors, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Benzofurans, Adrenergic Antagonists, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Adrenergic alpha-1 Receptor Antagonists, Drugs causing inadvertant photosensitivity, Bradycardia-Causing Agents, Antiarrhythmic agents, Antiarrhythmics, Class III, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP3A5 Inhibitors (strength unknown), Cytochrome P-450 CYP3A5 Substrates, Adrenergic alpha-Antagonists, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A5 Inhibitors, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, OCT2 Inhibitors, Agents that produce hypertension, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2D6 Substrates, OAT3/SLC22A8 Inhibitors, P-glycoprotein inhibitors, Cardiac Therapy	approved	24
DB04856	Dexloxiglumide	Drug	Acids, Acyclic, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Fatty Acids, Cytochrome P-450 Enzyme Inhibitors, Lipids, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Substrates, Valerates, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Fatty Acids, Volatile, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2B6 Substrates	investigational	1
DB03525	RU79073	Drug	0	experimental	1
DB04850	Posizolid	Drug	OATP1B1/SLCO1B1 Inhibitors, Oxazoles	investigational	2
DB03524	N-[3-[4-(3-aminopropyl)piperazin-1-yl]propyl]-3-[(2-thiophen-2-ylacetyl)amino]-5-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzamide	Drug	0	experimental	1
DB03523	Brequinar	Drug	Immunologic Factors, Enzyme Inhibitors, Immunosuppressive Agents, Antineoplastic Agents, Oxidoreductases, Benzene Derivatives	experimental	1
DB04851	Biricodar	Drug	P-glycoprotein inhibitors	investigational	3
DB03522	Aspartic Acid-4-Carboxymethyl Ester	Drug	0	experimental	1
DB04852	Implitapide	Drug	Heterocyclic Compounds, Fused-Ring	investigational	1
DB03528	9-Beta-D-Xylofuranosyl-Adenine	Drug	0	experimental	1
DB03526	AL5927	Drug	0	experimental	1
DB04857	Brasofensine	Drug	Heterocyclic Compounds, Fused-Ring, Amines, Hydroxylamines	investigational	1
DB04858	Tirapazamine	Drug	Triazines, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 Substrates, Antineoplastic Agents, Radiation-Sensitizing Agents	investigational	1
DB04859	Zanapezil	Drug	Heterocyclic Compounds, Fused-Ring	investigational	1
DB15510	Prosopis velutina seed	Drug	0	approved	0
DB15511	Gibberella fujikuroi	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB15514	Influenza A virus A/Kansas/14/2017 (H3N2) live (attenuated) antigen	Drug	0	approved	0
DB15515	Influenza A virus A/Brisbane/02/2018 IVR-190 (H1N1) antigen (formaldehyde inactivated)	Drug	0	approved	0
DB15512	Mucor circinelloides f. circinelloides	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB15513	Influenza A virus A/Switzerland/3330/2017 (H1N1) live (attenuated) antigen	Drug	0	approved	0
DB15518	Influenza A virus A/Kansas/14/2017 (H3N2) recombinant hemagglutinin antigen	Drug	0	approved	0
DB15519	Influenza A virus A/Brisbane/02/2018 IVR-190 (H1N1) antigen (UV, formaldehyde inactivated)	Drug	0	approved	0
DB15516	Influenza A virus A/Kansas/14/2017 X-327 (H3N2) antigen (formaldehyde inactivated)	Drug	0	approved	0
DB15517	Influenza A virus A/Brisbane/02/2018 (H1N1) recombinant hemagglutinin antigen	Drug	0	approved	0
DB02201	Malonate Ion	Drug	0	experimental	2
DB03532	Phosphomethylphosphonic acid guanylate ester	Drug	0	experimental	1
DB04864	Huperzine A	Drug	Neuroprotective Agents, Neurotransmitter Agents, Enzyme Inhibitors, Cholinergic Agents, Cholinesterase Inhibitors, Protective Agents, Central Nervous System Agents, Terpenes, Compounds used in a research, industrial, or household setting	approved, experimental	1
DB03531	Flavin-adenine dinucleotide-N5-isobutyl ketone	Drug	0	experimental	1
DB04865	Omacetaxine mepesuccinate	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Antineoplastic Agents, Phytogenic, Enzyme Inhibitors, Narrow Therapeutic Index Drugs, Benzazepines, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Harringtonines, Protein Synthesis Inhibitors	approved, investigational	2
DB02200	3-[N-[benzyloxycarbonyl]-phenylalaninyl-amino]-5-phenyl-pentane-1-sulfonylmethylbenzene	Drug	0	experimental	1
DB04866	Halofuginone	Drug	Coccidiostats, Enzyme Inhibitors, Antiprotozoals, Antineoplastic Agents, Growth Inhibitors, Angiogenesis Modulating Agents, Quinazolines, Angiogenesis Inhibitors, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Growth Substances, Antiparasitic Agents, Protein Synthesis Inhibitors	investigational, vet_approved	2
DB03530	Acylated ceftazidime	Drug	0	experimental	2
DB04867	Lintitript	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Hormones, Hormone Substitutes, and Hormone Antagonists, Hormone Antagonists, Indoles	investigational	1
DB03536	Benzyl N-[(2S)-5-(diaminomethylamino)-1-[[(2S)-4-fluoro-3-oxobutan-2-yl]amino]-1-oxopentan-2-yl]carbamate	Drug	0	experimental	2
DB02205	(+)-Rutamarin alcohol	Drug	0	experimental	2
DB04860	Isatoribine	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purines, Ribonucleosides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Purine Nucleosides	investigational	1
DB03535	Z-Pro-Prolinal	Drug	Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins	experimental	2
DB04861	Nebivolol	Drug	Amines, Cytochrome P-450 Substrates, Agents causing hyperkalemia, Adrenergic beta-Antagonists, Cardiovascular Agents, Hypotensive Agents, Cytochrome P-450 CYP3A4 Substrates, Alcohols, Adrenergic Antagonists, Adrenergic beta-1 Receptor Agonists, Antihypertensive Agents, Adrenergic Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Beta Blocking Agents, Selective, and Thiazides, Antihypertensive Agents Indicated for Hypertension, Benzopyrans, Amino Alcohols, Ethanolamines, Beta Blocking Agents and Thiazides, Cytochrome P-450 CYP2C19 Substrates, Adrenergic beta-Agonists, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Adrenergic Agonists, Beta blocking agents and calcium channel blockers, Beta Blocking Agents, Selective, Beta-Blockers (Beta1 Selective), Cytochrome P-450 CYP2D6 Substrates, Vasodilating Agents, Pyrans	approved, investigational	3
DB03534	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	Drug	0	experimental	1
DB04862	Merimepodib	Drug	Acids, Acyclic, IMP Dehydrogenase, antagonists & inhibitors, Benzene Derivatives	investigational	1
DB02203	Acetone Cyanohydrin	Drug	0	experimental	0
DB04863	Lefradafiban	Drug	Antianginal Agents, Vasodilating Agents, Benzene Derivatives, Platelet Glycoprotein GPIIb-IIIa Complex, antagonists & inhibitors	investigational	2
DB02202	(S)-butane-1,3-diol	Drug	0	experimental	0
DB03533	Acetyleneurea	Drug	Hydrocarbons, Acyclic	experimental	1
DB02209	Pyridoxine phosphate	Drug	Pyridines, Coenzymes, Enzymes and Coenzymes, Vitamin B Complex, Picolines, Vitamins	experimental	2
DB03539	2-(Acetylamino)-2-Deoxy-6-O-Methyl-Alpha-D-Allopyranose	Drug	0	experimental	1
DB02207	7-Nitroindazole	Drug	Neuroprotective Agents, Tranquilizing Agents, Enzyme Inhibitors, Sensory System Agents, Protective Agents, Pyrazoles, Psychotropic Drugs, Peripheral Nervous System Agents, Heterocyclic Compounds, Fused-Ring, Anticonvulsants, Nitric Oxide Synthase, antagonists & inhibitors, Analgesics, Central Nervous System Depressants, Anti-Anxiety Agents, Central Nervous System Agents, Compounds used in a research, industrial, or household setting	experimental	2
DB03537	[4-(4-Hydroxy-Benzyl)-2-(2-Hydroxy-1-Methyl-Ethyl)-5-Oxo-Imidazolidin-1-Yl]-Acetic Acid	Drug	0	experimental	0
DB04868	Nilotinib	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A4 Inhibitors (strong), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Cytochrome P-450 CYP2C8 Inhibitors (moderate), Drugs causing inadvertant photosensitivity, P-glycoprotein substrates with narrow therapeutic index, OATP1B1/SLCO1B1 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, UGT1A1 Inhibitors, Myelosuppressive Agents, Protein Kinase Inhibitors, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors, Cytochrome P-450 CYP2C8 Inducers (strength unknown), Hyperglycemia-Associated Agents, Kinase Inhibitor	approved, investigational	2
DB04869	Olcegepant	Drug	Heterocyclic Compounds, Fused-Ring, Calcitonin Gene-Related Peptide, analogs & derivatives, Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins, Receptors, Calcitonin Gene-Related Peptide, antagonists & inhibitors	investigational	2
DB15521	Cyd dengue virus serotype 1 live (attenuated) antigen	Drug	0	approved	0
DB15522	Cyd dengue virus serotype 2 live (attenuated) antigen	Drug	0	approved	0
DB15520	Influenza A virus A/Kansas/14/2017 X-327 (H3N2) antigen (UV, formaldehyde inactivated)	Drug	0	approved	0
DB15525	Mucor circinelloides f. lusitanicus	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB15526	Eurotium amstelodami	Drug	Cell-mediated Immunity, Non-Standardized Fungal Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB15523	Cyd dengue virus serotype 3 live (attenuated) antigen	Drug	0	approved	0
DB15524	Cyd dengue virus serotype 4 live (attenuated) antigen	Drug	0	approved	0
DB15529	Leucanthemum vulgare pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB15527	Umirolimus	Drug	Immunologic Factors, Anti-Bacterial Agents, Polyketides, Immunosuppressive Agents, Anti-Inflammatory Agents, Macrolides, Lactones	experimental	0
DB04870	Oleoyl-estrone	Drug	Estranes, Fatty Acids, Hormones, Hormone Substitutes, and Hormone Antagonists, 17-Ketosteroids, Adrenal Cortex Hormones, Estrenes, Lipids, Fatty Acids, Monounsaturated, Hormones, Ketosteroids, Fused-Ring Compounds, Drug Carriers, Gonadal Steroid Hormones, Fatty Acids, Unsaturated, Anti-Obesity Agents, Estradiol Congeners, Gonadal Hormones, Steroids	investigational	0
DB15528	Onasemnogene abeparvovec	Drug	Genetic Therapy, Biological Products, Hepatotoxic Agents	approved	0
DB04875	Pralnacasan	Drug	Heterocyclic Compounds, Fused-Ring	investigational	1
DB03543	1-(O-Carboxy-Phenylamino)-1-Deoxy-D-Ribulose-5-Phosphate	Drug	0	experimental	2
DB03542	L-Myo-Inositol-1-Phosphate	Drug	0	experimental	1
DB04876	Vildagliptin	Drug	Cycloparaffins, Enzyme Inhibitors, Glucagon-Like Peptide 1, Alimentary Tract and Metabolism, Protease Inhibitors, Pyrrolidines, Drugs Used in Diabetes, Nitriles, Agents causing angioedema, Blood Glucose Lowering Agents, DPP-IV Inhibitors	approved, investigational	1
DB02211	(R)-N-methyl-N-2-propynyl-1-indanamine	Drug	0	experimental	1
DB02210	Hexane-1,6-Diol	Drug	0	experimental	6
DB04877	Voacamine	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Indoles, P-glycoprotein inhibitors, Secologanin Tryptamine Alkaloids, Indole Alkaloids	experimental	1
DB03541	10-Propargyl-5,8-Dideazafolic Acid	Drug	0	experimental	6
DB04878	Voglibose	Drug	Carbohydrates, Glycoside Hydrolase Inhibitors, Cycloparaffins, Enzyme Inhibitors, Lipids, Blood Glucose Lowering Agents, Alcohols, Cyclohexanes, Hexanols, Alimentary Tract and Metabolism, Sugar Alcohols, Drugs Used in Diabetes, Fatty Alcohols	investigational	1
DB03540	Norcamphor	Drug	Monoterpenes, Terpenes	experimental	1
DB02216	S-Methylcysteine	Drug	Amino Acids, Neutral, Sulfur Compounds, Amino Acids, Sulfur, Amino Acids, Peptides, and Proteins, Amino Acids, Carbon Radioisotopes, Sulfhydryl Compounds	experimental	2
DB04871	Lorcaserin	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Serotonin Modulators, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Alimentary Tract and Metabolism, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Centrally Acting Antiobesity Products, Serotonin Receptor Agonists, Cytochrome P-450 CYP2C19 Substrates, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2A6 Substrates, Antiobesity Preparations, Excl. Diet Products, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Serotonin 2c Receptor Agonists, Serotonin 5-HT2 Receptor Agonists, Serotonin 5-HT2C Receptor Agonists	approved	1
DB02215	Furoyl-Leucine	Drug	0	experimental	1
DB03546	N-({4-[(1R)-4-[(2R,4S,5S)-2,4-diamino-6-oxohexahydropyrimidin-5-yl]-1-(2,2,2-trifluoro-1,1-dihydroxyethyl)butyl]phenyl}carbonyl)-L-glutamic acid	Drug	0	experimental	1
DB04872	Osanetant	Drug	Tranquilizing Agents, Antipsychotic Agents, Central Nervous System Depressants, Central Nervous System Agents, Psychotropic Drugs, Neurotoxic agents	investigational	1
DB02214	6,7-dioxo-5H-8-ribitylaminolumazine	Drug	0	experimental	1
DB04873	Piboserod	Drug	Heterocyclic Compounds, Fused-Ring	investigational	1
DB02213	Metanitrophenyl-Alpha-D-Galactoside	Drug	0	experimental	2
DB03544	S-Phosphocysteine	Drug	Amino Acids, Neutral, Sulfur Compounds, Amino Acids, Sulfur, Amino Acids, Peptides, and Proteins, Amino Acids, Sulfhydryl Compounds	experimental	2
DB04874	Picoplatin	Drug	Organometallic Compounds	investigational	1
DB02219	3-(cyclohexylamino)propanesulfonic acid	Drug	Cycloparaffins, Sulfur Compounds, Acids, Noncarboxylic, Amines, Acids, Sulfur Acids, Hydrocarbons, Acyclic, Sulfonic Acids, Alkanes, Cyclohexanes	experimental	0
DB03549	Biotinyl P-Nitroaniline	Drug	0	experimental	1
DB02218	N-[4-hydroxymethyl-cyclohexan-6-yl-1,2,3-triol]-4,6-dideoxy-4-aminoglucopyranoside	Drug	0	experimental	3
DB03548	3-deoxy-alpha-D-manno-oct-2-ulopyranosonic acid	Drug	0	experimental	1
DB02217	Dpb-T	Drug	0	experimental	1
DB04879	Vatalanib	Drug	Pyridazines, Enzyme Inhibitors, Protein Kinase Inhibitors, Tyrosine Kinase Inhibitors	investigational	3
DB14201	2,2'-Dibenzothiazyl disulfide	Drug	Heterocyclic Compounds, Fused-Ring, Cell-mediated Immunity, Sulfur Compounds, Thiazoles, Latex Hypersensitivity, Standardized Chemical Allergen, Increased Histamine Release	approved, experimental	0
DB15532	Madecassoside	Drug	Terpenes	experimental	0
DB15533	Calcium sulfate	Drug	Sulfur Acids, Calcium Compounds, Blood Coagulation Factors, Ions, Minerals, Sulfates, Sulfuric Acids, Anions, Sulfur Compounds, Acids, Noncarboxylic, Acids, Electrolytes, Compounds used in a research, industrial, or household setting, Dental Materials	experimental	0
DB14202	Morpholinylmercaptobenzothiazole	Drug	Heterocyclic Compounds, Fused-Ring, Cell-mediated Immunity, Oxazines, Sulfur Compounds, Thiazoles, Standardized Chemical Allergen, Increased Histamine Release	approved, experimental	0
DB15530	Trifolium pratense pollen	Drug	Cell-mediated Immunity, Non-Standardized Pollen Allergenic Extract, Increased IgG Production, Increased Histamine Release	approved	0
DB15531	Silk sericin	Drug	Proteins, Silk, Arthropod Proteins, Amino Acids, Peptides, and Proteins, Polymers, Biopolymers, Compounds used in a research, industrial, or household setting, Macromolecular Substances	experimental	0
DB14200	Thiohexam	Drug	Heterocyclic Compounds, Fused-Ring, Cell-mediated Immunity, Sulfur Compounds, Thiazoles, Standardized Chemical Allergen, Increased Histamine Release	approved, experimental	0
DB14205	Cobaltous cation	Drug	0	experimental	0
DB15536	Ferric chloride	Drug	Anticoagulants, Noxae, Iron Compounds, Ions, Fibrinolytic Agents, Organometallic Compounds, Anions, Acids, Noncarboxylic, Acids, Electrolytes, Toxic Actions, Caustics, Chlorine Compounds	experimental	0
DB14206	Cobalt chloride	Drug	Protective Agents, Metals, Antimutagenic Agents, Metals, Heavy, Elements, Transition Elements, Compounds used in a research, industrial, or household setting	approved, experimental	0
DB15537	Eucalyptus gum	Drug	0	approved, experimental	0
DB14203	Disperse Blue 106	Drug	Allergens, Cell-mediated Immunity, Standardized Chemical Allergen, Increased Histamine Release	approved, experimental	0
DB15534	Colchiceine	Drug	Alkaloids, Colchicine Derivatives, Tubulin Inhibiting Agent	approved, experimental	2
DB14204	Nickel cation	Drug	0	experimental	0
DB15535	Cuprous chloride	Drug	Metals, Metals, Heavy, Elements, Transition Elements	experimental	0
DB14209	Trandolaprilat	Drug	Heterocyclic Compounds, Fused-Ring, Angiotensin-Converting Enzyme Inhibitors, Agents Acting on the Renin-Angiotensin System, Agents causing angioedema	experimental	0
DB04880	Enoximone	Drug	Phosphodiesterase Inhibitors, Enzyme Inhibitors, Protective Agents, Phosphodiesterase 3 Inhibitors, Cardiovascular Agents, Cardiotonic Agents, Imidazoles, Photosensitizing Agents, Cardiac Stimulants Excl. Cardiac Glycosides, Drugs causing inadvertant photosensitivity, Vasodilating Agents, Cardiac Therapy, Compounds used in a research, industrial, or household setting	approved, investigational	1
DB15538	Sea scallop	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB14207	Fosinoprilat	Drug	Acids, Acyclic, Phosphinic Acids, Enzyme Inhibitors, Prodrugs, Agents causing hyperkalemia, Protease Inhibitors, Organophosphorus Compounds, Amino Acids, Peptides, and Proteins, Cardiovascular Agents, Phosphorus Compounds, Amino Acids, Phosphorus Acids, Amino Acids, Cyclic, Acids, Noncarboxylic, Acids, Imines, Angiotensin-Converting Enzyme Inhibitors, Agents Acting on the Renin-Angiotensin System, Agents causing angioedema, Antihypertensive Agents, Imino Acids, Antiarrhythmic agents	experimental	0
DB15539	Northern brown shrimp	Drug	0	approved	0
DB04881	Elacridar	Drug	Heterocyclic Compounds, Fused-Ring, Drug Resistance, Multiple, Isoquinolines, BCRP/ABCG2 Inhibitors, P-glycoprotein inhibitors, Benzocycloheptenes	investigational	1
DB14208	Ramiprilat	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors, Agents causing hyperkalemia, Protease Inhibitors, Agents Acting on the Renin-Angiotensin System, Agents causing angioedema, Cardiovascular Agents, Antihypertensive Agents	experimental	0
DB03550	Isopenicillin N	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Amides, Lactams, beta-Lactams	experimental	0
DB03554	5-Iodouracil	Drug	Pyrimidines, Pyrimidinones	experimental	1
DB04886	Calanolide A	Drug	Cytochrome P-450 Substrates, Calophyllum, Plant Extracts, Coumarins, Anti-Retroviral Agents, Antiviral Agents, Benzopyrans, Anti-HIV Agents, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Substrates, Pyrans	investigational	1
DB02223	LY231514 tetra glu	Drug	0	experimental	1
DB03553	Glutaric Acid	Drug	Acids, Acyclic, Dicarboxylic Acids, OAT1/SLC22A6 Substrates, OAT3/SLC22A8 Inhibitors, OAT1/SLC22A6 inhibitors, OAT3/SLC22A8 Substrates	experimental	3
DB04887	Brecanavir	Drug	Acids, Acyclic, Heterocyclic Compounds, Fused-Ring, Dioxoles	investigational	1
DB02222	2,6-Diamino-(S)-9-[2-(Phosphonomethoxy)Propyl]Purine	Drug	0	experimental	1
DB03552	3-Tyrosine	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Amino Acids, Peptides, and Proteins, Isomerism, Amino Acids	experimental	1
DB02221	4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide	Drug	0	experimental	1
DB04888	Bifeprunox	Drug	Heterocyclic Compounds, Fused-Ring, Antipsychotic Agents, Antipsychotic Agents (Second Generation Atypical), Central Nervous System Depressants, Neurotoxic agents	investigational	2
DB04889	Bicifadine	Drug	Cytochrome P-450 Substrates, Analgesics, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2D6 Substrates, Monoamine Oxidase A Substrates	investigational	3
DB02220	AL7089A	Drug	0	experimental	1
DB03551	(3R,4R)-3-Hydroxy-4-(hydroxymethyl)-1-[(4-oxo-4,4a,5,7a-tetrahydro-3H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]pyrrolidinium	Drug	0	experimental	2
DB04882	Edotecarin	Drug	Heterocyclic Compounds, Fused-Ring, Indoles	investigational	1
DB03558	SP-876	Drug	0	experimental	1
DB02227	4,5-Dihydroxy-Tetrahydro-Pyran-2-Carboxylic Acid	Drug	0	experimental	1
DB02226	3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium	Drug	0	experimental	1
DB04883	Darusentan	Drug	Acids, Carbocyclic, Endothelin Receptor Antagonists	investigational	1
DB03557	4-[[(2S)-1-[[6-[(1-Amino-1-oxo-3-sulfanylpropan-2-yl)amino]-6-oxohexyl]amino]-3-[4-[difluoro(phosphono)methyl]phenyl]-1-oxopropan-2-yl]amino]-3-[[2-[4-[difluoro(phosphono)methyl]phenyl]acetyl]amino]-4-oxobutanoic acid	Drug	0	experimental	1
DB04884	Dapoxetine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Selective Serotonin Reuptake Inhibitors, Amines, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Benzyl Compounds, Genito Urinary System and Sex Hormones, Hypoglycemia-Associated Agents, Urologicals, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Serotonin Modulators, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2D6 Substrates, Benzene Derivatives, Cytochrome P-450 CYP3A4 Inhibitors (weak)	investigational	3
DB02225	1,2-Di-N-Pentanoyl-Sn-Glycero-3-Dithiophosphocholine	Drug	0	experimental	1
DB03556	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	Drug	0	experimental	2
DB02224	Taxifolin	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Flavonols, Sensory System Agents, Anti-Inflammatory Agents, Antirheumatic Agents, Non COX-2 selective NSAIDS, Benzopyrans, Peripheral Nervous System Agents, Heterocyclic Compounds, Fused-Ring, Flavonoids, Analgesics, Agents that produce hypertension, Central Nervous System Agents, Chromones, Pyrans	experimental	0
DB03555	CRA_11092	Drug	0	experimental	1
DB04885	Cilansetron	Drug	Heterocyclic Compounds, Fused-Ring, Serotonin Agents, Alimentary Tract and Metabolism, Central Nervous System Depressants, Drugs for Functional Gastrointestinal Disorders, Serotonin Receptor Antagonists, Antidepressive Agents, Indoles	investigational	1
DB02229	5'-O-[(L-methionyl)-sulphamoyl]adenosine	Drug	0	experimental	1
DB03559	Cyclohexylformamide	Drug	Acids, Acyclic, Amides, Formates, Alcohol Dehydrogenase, antagonists & inhibitors	experimental	2
DB02228	2-deoxy-2-fluoro-β-D-galactose	Drug	0	experimental	1
DB04810	Salophen-10-carboxylate iron chelate	Drug	0	experimental	1
DB04811	Salophen iron chelate	Drug	0	experimental	1
DB04812	Benoxaprofen	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Acids, Acyclic, Enzyme Inhibitors, Fatty Acids, Sensory System Agents, Anti-Inflammatory Agents, Agents causing hyperkalemia, Dermatologicals, Antirheumatic Agents, Lipids, Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Fatty Acids, Volatile, Musculo-Skeletal System, Propionates, Agents that produce hypertension, Central Nervous System Agents, Lipoxygenase Inhibitors	approved, withdrawn	0
DB04817	Metamizole	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Sensory System Agents, Nervous System, Anti-Inflammatory Agents, Pyrazoles, Agents causing hyperkalemia, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Non COX-2 selective NSAIDS, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Pyrazolones, Aminopyrine, Peripheral Nervous System Agents, Cytochrome P-450 Enzyme Inducers, Analgesics, Agents that produce hypertension, Cytochrome P-450 CYP2B6 Inducers, Central Nervous System Agents, Antipyretics	approved, investigational, withdrawn	1
DB04818	Iproniazid	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, Hydrazines, Pyridines, Enzyme Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Monoamine Oxidase Inhibitors, Antidepressive Agents, Cytochrome P-450 CYP2C9 Inhibitors (moderate), Psychotropic Drugs, Monoamine Oxidase Inhibitors, Non-Selective, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Cytochrome P-450 CYP2C9 Inhibitors, Agents that produce hypertension, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Isonicotinic Acids, Agents that reduce seizure threshold, Psychoanaleptics	withdrawn	0
DB04819	Methapyrilene	Drug	Aminopyridines, Pyridines, Amines, Anti-Allergic Agents, Polyamines, Ethylenediamines, Diamines, Neurotransmitter Agents, Histamine H1 Antagonists, Histamine Antagonists, Central Nervous System Depressants, Hypnotics and Sedatives, Central Nervous System Agents, Histamine Agents, Antihistamines for Systemic Use, Substituted Ethylene Diamines	withdrawn	0
DB04813	Bithionol	Drug	Antiparasitic Products, Insecticides and Repellents, Dermatologicals, Anthelmintics, Preparations Containing Sulfur, Anti-Acne Preparations, Anti-Infective Agents, Anti-Infective Agents, Local, Antitrematodals, Phenols, Antiplatyhelmintic Agents, Anti-Acne Preparations for Topical Use, Antiparasitic Agents, Benzene Derivatives	approved, withdrawn	0
DB04814	Bunamiodyl	Drug	0	withdrawn	0
DB04815	Clioquinol	Drug	Quinolines, Cell-mediated Immunity, Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Gynecological Antiinfectives and Antiseptics, Medicated Dressings, Antiseptics and Disinfectants, Dermatologicals, Genito Urinary System and Sex Hormones, Miscellaneous Antifungals, Otologicals, Standardized Chemical Allergen, Hydroxyquinolines, Anti-Infective Agents, Hydroxyquinoline Derivatives, Heterocyclic Compounds, Fused-Ring, Quinoline Derivatives, Medicated Dressings With Antiinfectives, Sensory Organs, Increased Histamine Release	approved, withdrawn, vet_approved	0
DB04816	Dantron	Drug	Anthracenes, Quinones, Mutagens, Noxae, Alimentary Tract and Metabolism, Drugs for Constipation, Laxatives, Toxic Actions, Contact Laxatives, Enemas, Gastrointestinal Agents	approved, investigational, withdrawn	0
DB04820	Nialamide	Drug	Pyridines, Enzyme Inhibitors, Nervous System, Monoamine Oxidase Inhibitors, Antidepressive Agents, Psychotropic Drugs, Monoamine Oxidase Inhibitors, Non-Selective, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Agents that produce hypertension, Central Nervous System Agents, Isonicotinic Acids, Agents that reduce seizure threshold, Psychoanaleptics	approved, withdrawn	3
DB04821	Nomifensine	Drug	Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Nervous System, Central Nervous System Depressants, Isoquinolines, Neurotransmitter Uptake Inhibitors, Antidepressive Agents, Membrane Transport Modulators, Dopamine Agents, Dopamine Uptake Inhibitors, Psychoanaleptics	approved, withdrawn	7
DB04822	Oxeladin	Drug	Antitussive Agents, Cough and Cold Preparations, Acids, Carbocyclic, Central Nervous System Agents, Respiratory System Agents	approved, withdrawn	0
DB04823	Oxyphenisatin	Drug	Heterocyclic Compounds, Fused-Ring, Alimentary Tract and Metabolism, Drugs for Constipation, Laxatives, Contact Laxatives, Indoles, Gastrointestinal Agents	investigational, withdrawn	0
DB04828	Zomepirac	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Acetic Acid Derivatives and Related Substances, Cytochrome P-450 Substrates, Sensory System Agents, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Cytochrome P-450 CYP3A4 Substrates, Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Cytochrome P-450 CYP3A Substrates, Musculo-Skeletal System, Agents that produce hypertension, Central Nervous System Agents	withdrawn	1
DB04829	Lysergic acid diethylamide	Drug	Cytochrome P-450 Substrates, Serotonin Agents, Serotonin Receptor Agonists, Lysergic Acid, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Ergolines, Hallucinogens, Psychotropic Drugs, Ergot Alkaloids and Derivatives, Alkaloids, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Agents that produce hypertension, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Serotonin 5-HT2 Receptor Agonists	illicit, investigational, withdrawn	3
DB04824	Phenolphthalein	Drug	Phenolphthaleins, Alimentary Tract and Metabolism, Drugs for Constipation, Laboratory Chemicals, Phenols, Indicators and Reagents, Laxatives, Contact Laxatives, Compounds used in a research, industrial, or household setting, Benzene Derivatives	approved, withdrawn	5
DB04825	Prenylamine	Drug	QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Hydroxy Acids, Agents causing hyperkalemia, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Moderate Risk QTc-Prolonging Agents, Phenethylamines, Calmodulin, antagonists & inhibitors, Membrane Transport Modulators, Calcium Channel Blockers, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Ethylamines, Calcium-Regulating Hormones and Agents, Vasodilators Used in Cardiac Diseases, Vasodilating Agents, Cardiac Therapy, Adrenergic Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	approved, withdrawn	2
DB04826	Thenalidine	Drug	Antipruritics, Incl. Antihistamines, Anesthetics, Etc., Antihistamines for Topical Use, Dermatologicals, Antihistamines for Systemic Use	approved, withdrawn	0
DB04827	Urethane	Drug	Acids, Acyclic, Anesthetics, General, Carcinogens, Noxae, Central Nervous System Depressants, Antineoplastic Agents, Carbamates, Anesthetics, Intravenous, Toxic Actions, Central Nervous System Agents, Anesthetics	approved, withdrawn	0
DB04831	Tienilic acid	Drug	Acids, Acyclic, High-Ceiling Diuretics, Renal Agents, Fatty Acids, Hydroxy Acids, Cytochrome P-450 Enzyme Inhibitors, Phenoxyacetates, Antirheumatic Agents, Lipids, Cardiovascular Agents, Acetates, Antigout Preparations, Sulfur Compounds, Glycolates, Thiophenes, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Fatty Acids, Volatile, Uricosuric Agents, Aryloxyacetic Acid Derivatives, Cytochrome P-450 CYP2C9 Inhibitors, Diuretics, Natriuretic Agents, Antihypertensive Agents	withdrawn	0
DB04832	Zimelidine	Drug	Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, Selective Serotonin Reuptake Inhibitors, Pyridines, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Hypoglycemia-Associated Agents, Antidepressive Agents, Membrane Transport Modulators, Neurotransmitter Agents, Serotonin Modulators, Cytochrome P-450 CYP3A Inhibitors, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Neurotransmitter Uptake Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors, Psychoanaleptics	approved, withdrawn	3
DB04833	Methaqualone	Drug	Psycholeptics, Quinazolinones, Cytochrome P-450 Substrates, Nervous System, Quinazolines, Cytochrome P-450 CYP3A4 Substrates, Muscle Relaxants, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Muscle Relaxants, Centrally Acting Agents, Hypnotics and Sedatives, Central Nervous System Agents	illicit, withdrawn	0
DB04834	Rapacuronium	Drug	Anticholinergic Agents, Neuromuscular Agents, Androstanols, Androstanes, Central Nervous System Depressants, Neuromuscular-Blocking Agents (Nondepolarizing), Neuromuscular Blocking Agents, Agents producing tachycardia, Muscarinic Antagonists, Fused-Ring Compounds, Peripheral Nervous System Agents, Steroids	approved, withdrawn	1
DB03503	4-Acetyl-4-guanidino-6-methyl(propyl)carboxamide-4,5-dihydro-2H-pyran-2-carboxylic acid	Drug	0	experimental	1
DB03502	(4s)-4-{[(2s)-2-Amino-3-Oxopropyl]Sulfanyl}-L-Homoserinate	Drug	0	experimental	1
DB03501	Galactose-uridine-5'-diphosphate	Drug	Carbohydrates, Pyrimidines, Ribonucleotides, Deoxyribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Uridine Diphosphate, Glycosides, Nucleoside Diphosphate Sugars, Uracil Nucleotides, Uridine Diphosphate Sugars, Nucleotides, Pyrimidine Nucleotides	experimental	3
DB03500	Tricosanoic acid	Drug	Fatty Acids, Lipids	experimental	1
DB04830	Buformin	Drug	OCT1 substrates, Biguanides, Alimentary Tract and Metabolism, Amidines, Drugs Used in Diabetes, Guanidines, Blood Glucose Lowering Agents	investigational, withdrawn	0
DB03507	6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One	Drug	0	experimental	1
DB04839	Cyproterone acetate	Drug	Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Adrenal Cortex Hormones, Genito Urinary System and Sex Hormones, Other Miscellaneous Therapeutic Agents, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Antiandrogens and Estrogens, Contraceptives, Oral, Hormone Antagonists, Hormonal Contraceptives for Systemic Use, Contraceptive Agents, Female, Contraceptive Agents, Male, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Reproductive Control Agents, Antineoplastic Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Progestins, Antiandrogens, Pregnanes, Combination Contraceptives (with Estrogen and derivatives), Hyperglycemia-Associated Agents, Cytochrome P-450 CYP3A4 Inhibitors (weak), Progestin Contraceptives, Steroids, Steroids, Chlorinated	approved, investigational	2
DB03506	9-Deazaadenine	Drug	0	experimental	1
DB03505	2,6-diaminoquinazolin-4-ol	Drug	0	experimental	1
DB03504	9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine	Drug	0	experimental	1
DB04835	Maraviroc	Drug	Cycloparaffins, Cytochrome P-450 Substrates, HIV Fusion Inhibitors, Viral Fusion Protein Inhibitors, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Cytochrome P-450 CYP3A4 Substrates, Antiinfectives for Systemic Use, Anti-Infective Agents, Cyclohexanes, Antivirals for Systemic Use, Direct Acting Antivirals, Cytochrome P-450 CYP3A Substrates, CCR5 Co-receptor Antagonist, Triazoles, Hepatotoxic Agents, CCR5 Receptor Antagonists	approved, investigational	1
DB04836	Amineptine	Drug	Nervous System, Antidepressive Agents, Benzocycloheptenes, Psychotropic Drugs, Non-Selective Monoamine Reuptake Inhibitors, Narrow Therapeutic Index Drugs, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Antidepressive Agents, Tricyclic, Agents that produce hypertension, Central Nervous System Agents, Agents that reduce seizure threshold, Neurotoxic agents, Psychoanaleptics	illicit, withdrawn	2
DB04837	Clofedanol	Drug	Antitussive Agents, Histamine H1 Antagonists, Amines, Histamine Antagonists, Propanols, Cough and Cold Preparations, Amino Alcohols, Alcohols	approved, withdrawn	1
DB03509	2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Antineoplastic Agents, Poly(ADP-ribose) Polymerase Inhibitors	experimental	1
DB04838	Cyclandelate	Drug	Mandelic Acids, Cytochrome P-450 Substrates, Hydroxy Acids, Acids, Carbocyclic, Agents causing hyperkalemia, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Calcium Channel Blockers, Cytochrome P-450 CYP3A Substrates, Peripheral Vasodilators, Vasodilating Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	approved	2
DB03508	Diethylene glycol ethyl methyl ether	Drug	0	experimental	0
DB03510	6-O-Phosphoryl Inosine Monophosphate	Drug	0	experimental	2
DB04842	Fluspirilene	Drug	Psycholeptics, QTc Prolonging Agents, Tranquilizing Agents, Cytochrome P-450 Substrates, Serotonin Agents, Nervous System, Agents causing hyperkalemia, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Serotonin 5-HT2 Receptor Antagonists, Spiro Compounds, Antipsychotic Agents, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Piperidines, Diphenylbutylpiperidine Derivatives, Dopamine Antagonists, Bradycardia-Causing Agents, Antiarrhythmic agents, Dopamine Agents, Neurotoxic agents, Moderate Risk QTc-Prolonging Agents, Psychotropic Drugs, Calcium Channel Blockers, Neurotransmitter Agents, Imidazoles, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Serotonin Receptor Antagonists, Central Nervous System Agents, Dopamine D2 Receptor Antagonists	approved, investigational	3
DB04843	Mepenzolate	Drug	Anticholinergic Agents, Synthetic Anticholinergics, Quaternary Ammonium Compounds, Hydroxy Acids, Alimentary Tract and Metabolism, Acids, Carbocyclic, Diphenylacetic Acids, Phenylacetates, Agents producing tachycardia, Drugs for Functional Gastrointestinal Disorders, Muscarinic Antagonists	approved	2
DB04844	Tetrabenazine	Drug	Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Cytochrome P-450 Substrates, Nervous System, Vesicular Monoamine Transporter 2 Inhibitor, Miscellaneous Central Nervous System Agents, Membrane Transport Modulators, Vesicular Monoamine Transporter 2 Inhibitors, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Quinolizines, Neurotransmitter Uptake Inhibitors, Cytochrome P-450 CYP2D6 Substrates, Adrenergic Agents	approved, investigational	2
DB04845	Ixabepilone	Drug	Microtubule Inhibitors, Cytochrome P-450 Substrates, Cytotoxic Antibiotics and Related Substances, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Tubulin Modulators, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Macrolides, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Microtubule Inhibition, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Lactones, Myelosuppressive Agents, Anti-Bacterial Agents, Polyketides, Cytochrome P-450 CYP3A Inhibitors, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors, P-glycoprotein substrates with narrow therapeutic index	approved, investigational	1
DB03514	4-Vinylguaiacol	Drug	Alkenes, Hydrocarbons, Acyclic, Methyl Ethers, Phenols, Catechols, Ethers, Benzene Derivatives, Phenyl Ethers	experimental	0
DB03513	(S)-2-Amino-3-(4h-Selenolo[3,2-B]-Pyrrol-6-Yl)-Propionic Acid	Drug	Selenium Compounds	experimental	0
DB04840	Debrisoquine	Drug	Autonomic Agents, Cytochrome P-450 Substrates, Sympatholytics, Isoquinolines, P-glycoprotein substrates, Antiadrenergic Agents, Peripherally Acting, Catecholamines, Cardiovascular Agents, Peripheral Nervous System Agents, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Guanidine Derivatives, Antihypertensive Agents, Cytochrome P-450 CYP2D6 Substrates, Adrenergic Agents	approved, investigational	1
DB03512	Uridine-2',3'-vanadate	Drug	Vanadates	experimental	1
DB03511	alpha-D-galacturonic acid	Drug	0	experimental	0
DB04841	Flunarizine	Drug	Cytochrome P-450 Substrates, Nervous System, Agents causing hyperkalemia, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Histamine H1 Antagonists, Antivertigo Preparations, Calcium-Regulating Hormones and Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Piperazines, Membrane Transport Modulators, Calcium Channel Blockers, Cytochrome P-450 CYP2C9 Substrates, Neurotransmitter Agents, Anticonvulsants, Piperazine Derivatives, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2A6 Substrates, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Histamine Agents, Vasodilating Agents, Antimigraine Agents, Miscellaneous	approved	5
DB03518	Mevalonic acid	Drug	Hydroxy Acids	experimental	1
DB03517	[Methylthio]Acetate	Drug	0	experimental	1
DB03516	Eniluracil	Drug	Enzyme Inhibitors, Pyrimidines, Pyrimidinones	investigational	3
DB03515	Equilenin	Drug	Cytochrome P-450 Substrates, Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, 17-Ketosteroids, Adrenal Cortex Hormones, Estrenes, Hormones, Ketosteroids, Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Gonadal Steroid Hormones, Cytochrome P-450 CYP3A Substrates, Estradiol Congeners, Gonadal Hormones, Steroids	experimental	2
DB04846	Celiprolol	Drug	QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Agents causing hyperkalemia, Adrenergic beta-Antagonists, Cardiovascular Agents, Phenylurea Compounds, Adrenergic beta-2 Receptor Agonists, Adrenergic beta-1 Receptor Antagonists, Alcohols, Peripheral Nervous System Agents, Adrenergic Antagonists, Potential QTc-Prolonging Agents, Antihypertensive Agents, Adrenergic Agents, Benzene Derivatives, Bradycardia-Causing Agents, Antiarrhythmic agents, Autonomic Agents, Propanols, Phenoxypropanolamines, Amino Alcohols, Adrenergic beta-Agonists, Neurotransmitter Agents, Sympathomimetics, Adrenergic Agonists, Beta Blocking Agents, Selective, Beta-Blockers (Beta1 Selective), Cytochrome P-450 CYP2D6 Substrates, Vasodilating Agents, Adrenergic beta-3 Receptor Agonists, Propanolamines	approved, investigational	6
DB04847	Roxadustat	Drug	Heterocyclic Compounds, Fused-Ring, Antianemic Preparations, Blood and Blood Forming Organs, Amino Acids, Peptides, and Proteins, Amino Acids, Hypoxia-Inducible Factor-Proline Dioxygenases, antagonists & inhibitors	investigational	3
DB04848	AZD0947	Drug	0	investigational	0
DB04849	Cediranib	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Protein Kinase Inhibitors, Tyrosine Kinase Inhibitors, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents	investigational	1
DB15587	Antimony potassium tartrate	Drug	Organometallic Compounds, Anthelmintics, Antiplatyhelmintic Agents, Schistosomicides, Anti-Infective Agents, Antiparasitic Agents	experimental	0
DB14256	Centella asiatica	Drug	Plant Extracts, Terpenes, Agents that reduce seizure threshold	approved, investigational, experimental	0
DB15588	Ursolic acid	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Antineoplastic Agents, Phytogenic, Enzyme Inhibitors, Sensory System Agents, Cyclooxygenase Inhibitors, Anti-Inflammatory Agents, Antineoplastic Agents, Antirheumatic Agents, Anti-Infective Agents, Peripheral Nervous System Agents, Analgesics, Central Nervous System Agents, Terpenes	experimental	0
DB14257	Aloe ferox leaf	Drug	0	approved, experimental	0
DB14254	Aloe vera flower	Drug	0	approved, experimental	0
DB15585	ORG-31710	Drug	Estranes, Fused-Ring Compounds, Steroids	experimental	0
DB15586	Patulin	Drug	Toxins, Biological, Biological Factors, Poisons, Mutagens, Noxae, Mycotoxins, Toxic Actions, Compounds used in a research, industrial, or household setting, Pyrans	experimental	0
DB14255	Angelica dahurica root	Drug	0	experimental	0
DB14258	Elm	Drug	0	approved, experimental	0
DB15589	Zingerone	Drug	Methyl Ethers, Phenols, Catechols, Ethers, Benzene Derivatives, Phenyl Ethers	experimental	0
DB14259	Eucommia ulmoides bark	Drug	0	experimental	0
DB02270	Dimethylallyl S-Thiolodiphosphate	Drug	0	experimental	3
DB02274	7-Keto-8-Aminopelargonic Acid	Drug	Amino Acids, Peptides, and Proteins	experimental	1
DB02273	2,6-Dimethyl-7-Octen-2-Ol	Drug	0	experimental	0
DB02272	Porphobilinogen	Drug	0	experimental	1
DB02271	S-(2-oxo)pentadecylcoa	Drug	0	experimental	1
DB02278	7,8-dihydro-7,7-dimethyl-6-hydroxypterin	Drug	0	experimental	1
DB02277	1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea	Drug	0	experimental	1
DB02276	(S)-2-(Phosphonoxy)Caproyl-L-Leucyl-P-Nitroanilide	Drug	0	experimental	1
DB02275	[2-Aminomethyl-5-Oxo-4-(4-Oxo-Cyclohexa-2,5-Dienylmethyl)-4,5-Dihydro-Imidazol-1-Yl] -Acetaldehyde	Drug	0	experimental	0
DB02279	Benzoylformic Acid	Drug	Hydroxy Acids, Acids, Carbocyclic, Acids, Aldehydic	experimental	1
DB15580	Climbazole	Drug	0	experimental	0
DB14252	Jojoba oil	Drug	Plant Extracts, Cosmetics, Lipids	approved, investigational, experimental	0
DB15583	Fluazuron	Drug	Benzene Derivatives	experimental	0
DB15584	Luteolin	Drug	Heterocyclic Compounds, Fused-Ring, Flavonoids, Flavones, Benzopyrans, Chromones, Pyrans	experimental	0
DB14253	Avena sativa flowering top	Drug	0	approved, experimental	0
DB15581	Chrysin	Drug	Heterocyclic Compounds, Fused-Ring, Benzopyrans, Chromones, Pyrans	experimental	0
DB14250	Royal jelly	Drug	Lipids, Insect Hormones, Bees	experimental	0
DB14251	Ostrea edulis shell	Drug	0	experimental	0
DB15582	Echinomycin	Drug	Peptides, Cyclic, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Enzyme Inhibitors, Nucleic Acid Synthesis Inhibitors, Peptides, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Quinoxalines, Antibiotics, Antineoplastic, Anti-Infective Agents	experimental	0
DB14267	Rumex crispus whole	Drug	0	approved, experimental	0
DB15598	Ferric maltol	Drug	Hematinics, Organometallic Compounds, Iron Trivalent, Oral Preparations, Antianemic Preparations, Blood and Blood Forming Organs, Iron Compounds, Hematologic Agents, Iron Preparations, UGT1A6 substrate, Pyrans	approved	2
DB14268	Swertia japonica whole flowering	Drug	0	experimental	0
DB15599	MIV-711	Drug	Anti-Inflammatory Agents, Antineoplastic Agents, Antirheumatic Agents	investigational	1
DB14265	Momordica charantia fruit	Drug	0	experimental	0
DB15596	Aminopromazine	Drug	0	experimental, vet_approved	0
DB14266	Tribulus terrestris root	Drug	0	experimental	0
DB15597	Aminopentamide	Drug	Benzene Derivatives	experimental, vet_approved	0
DB14269	Nardostachys chinensis whole	Drug	0	experimental	0
DB02281	Formycin	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Glycosides, Nucleosides	experimental	2
DB02280	(R)-Mandelic acid	Drug	0	experimental	2
DB02285	Protoporphyrin	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Photosensitizing Agents, Dermatologicals, Radiation-Sensitizing Agents, Pigments, Biological, Porphyrins	experimental	1
DB02283	2-Phenylamino-Ethanesulfonic Acid	Drug	0	experimental	1
DB02282	5'-S-methyl-5'-thioadenosine	Drug	Ribonucleosides, Enzyme Inhibitors, Folic Acid Antagonists, Amino Acids, Peptides, and Proteins, Amino Acids, Acidic, Anti-Infective Agents, Purines, Nucleic Acid Synthesis Inhibitors, Sulfur Compounds, Nucleic Acids, Nucleotides, and Nucleosides, Amino Acids, Dicarboxylic, Glycosides, Xanthine derivatives, Glutamates, Purinones, Carbohydrates, Antiprotozoals, Antineoplastic Agents, Purine Nucleosides, Amino Acids, Heterocyclic Compounds, Fused-Ring, Nucleosides, Protein O-Methyltransferase, antagonists & inhibitors, Deoxyribonucleosides, Antiparasitic Agents	experimental	2
DB02289	2-Aminopropanedioic Acid	Drug	0	experimental	1
DB02288	CRA-9334	Drug	0	experimental	1
DB02287	2-(2-hydroxy-phenyl)-3H-benzoimidazole-5-carboxamidine	Drug	0	experimental	3
DB02286	2-amino-3-(4-amino-1H-indol-3-yl)propanoic acid	Drug	0	experimental	0
DB15590	beta-Apopicropodophyllin	Drug	Complex Mixtures, Plant Preparations, Plant Extracts, Biological Products, Pharmaceutical Preparations	experimental	0
DB14260	Stypocaulon scoparium	Drug	0	experimental	0
DB15591	Atrial natriuretic peptide	Drug	Natriuretic Peptides, Peptide Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Atrial Natriuretic Factor, Amino Acids, Peptides, and Proteins, Cardiovascular Agents, Hormones, Vasodilating Agents	experimental	0
DB14263	Calendula officinalis flower	Drug	0	approved, experimental	0
DB15594	Brilliant blue G	Drug	Amines, Aniline Compounds, Laboratory Chemicals, Indicators and Reagents, Compounds used in a research, industrial, or household setting	approved	1
DB15595	Ebola Zaire vaccine (live, attenuated)	Drug	Immunologic Factors, Immunization, Viral Vaccines, Vaccines	approved	0
DB14264	Maclura tricuspidata whole	Drug	0	experimental	0
DB15592	Cucurbita pepo subsp. ovifera whole	Drug	0	approved	0
DB14261	Panax ginseng fruit	Drug	0	experimental	0
DB15593	Golodirsen	Drug	Oligonucleotides, Antisense, Drugs that are Mainly Renally Excreted	approved	1
DB14262	Bird pepper	Drug	0	approved, experimental	0
DB14278	Carthamus tinctorius flower bud	Drug	0	approved, experimental	0
DB14279	Corydalis ambigua tuber	Drug	0	approved, experimental	0
DB14276	Turmeric	Drug	Lilianae, Zingiberales, Protective Agents, Plants, Food Coloring Agents, Antioxidants, Complex Mixtures, Eukaryota, Plant Preparations, Biological Products, Embryophyta, Pharmaceutical Preparations, Plant Oils, Compounds used in a research, industrial, or household setting, Tracheophyta, Angiosperms, Streptophyta, Viridiplantae, Condiments, Zingiberaceae	approved, investigational, experimental	0
DB14277	Tripterygium wilfordii whole	Drug	0	experimental	0
DB02292	Irosustat	Drug	Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfur Acids, Steryl-Sulfatase, antagonists & inhibitors	investigational	2
DB02290	3-{2,6,8-trioxo-9-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate	Drug	0	experimental	1
DB02296	Isoamyl alcohol	Drug	Lipids, Fatty Alcohols, Alcohols	experimental	1
DB02295	N-[3-(Dimethylamino)Propyl]-2-({[4-({[4-(Formylamino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-5-Isopropyl-1,3-Thiazole-4-Carboxamide	Drug	0	experimental	0
DB02294	(5R,6S,7S,8S)-5-hydroxymethyl-6,7,8-trihydroxy-tetrazolo[1,5-A]piperidine	Drug	0	experimental	1
DB02293	(2S)-2,3-bis{[(3R,7R)-3,7,11,15-tetramethylhexadecyl]oxy}propyl (2R)-2-hydroxy-3-[(hydroxyphosphinato)oxy]propyl phosphate	Drug	0	experimental	0
DB02299	Arginineamide	Drug	0	experimental	1
DB02298	5-Hydroxyamino-3-Methyl-Pyrrolidine-2-Carboxylic Acid	Drug	0	experimental	0
DB02297	2-Amino-6-Chloropyrazine	Drug	0	experimental	1
DB14270	Simmondsia chinensis seed	Drug	0	experimental	0
DB14271	Morus alba root bark	Drug	0	experimental	0
DB14274	Salix alba bark	Drug	Herbs and Natural Products	approved, experimental	0
DB14275	Indian frankincense	Drug	0	approved, investigational, experimental	0
DB14272	Rosemary	Drug	0	experimental	0
DB14273	Ocimum tenuiflorum top	Drug	0	approved, experimental	0
DB14289	Larix sibirica wood	Drug	0	approved, experimental	0
DB14287	Trametes versicolor fruiting body	Drug	0	experimental	0
DB14288	Kaempferia galanga root	Drug	0	approved, experimental	0
DB14281	Lagerstroemia indica whole	Drug	0	experimental	0
DB14282	Phellinus linteus mycelium	Drug	0	experimental	0
DB14280	Lonicera caprifolium flower	Drug	0	approved, experimental	0
DB14285	Ginkgo biloba leaf oil	Drug	0	experimental	0
DB14286	Panax ginseng root oil	Drug	0	experimental	0
DB14283	Angelica archangelica root	Drug	0	approved, experimental	0
DB14284	Panax ginseng whole	Drug	0	experimental	0
DB14212	Methylparaben	Drug	Cell-mediated Immunity, Benzoates, Hydroxy Acids, Acids, Carbocyclic, Hydroxybenzoates, Standardized Chemical Allergen, Pharmaceutic Aids, Preservatives, Pharmaceutical, Phenols, Pharmaceutical Preparations, Compounds used in a research, industrial, or household setting, Benzene Derivatives, Increased Histamine Release	approved	0
DB15543	Pacific ocean perch	Drug	0	approved	0
DB14213	Perindoprilat	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors, Agents causing hyperkalemia, Protease Inhibitors, Agents Acting on the Renin-Angiotensin System, Agents causing angioedema, Cardiovascular Agents, Antihypertensive Agents	experimental	0
DB15544	Myristica fragrans fruit	Drug	0	approved	0
DB15541	Yellowfin tuna	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB14210	Moexiprilat	Drug	Heterocyclic Compounds, Fused-Ring, Angiotensin-Converting Enzyme Inhibitors, Isoquinolines, Agents Acting on the Renin-Angiotensin System, Agents causing angioedema	experimental	0
DB14211	Fanolesomab	Drug	Proteins, Serum Globulins, Immunoglobulins, Lewis X Antigen, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	approved, experimental	0
DB15542	Atlantic mackerel	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB15547	Black sea bass	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB15548	Channel catfish	Drug	0	approved	0
DB14217	Quinaprilat	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors, Isoquinolines, Agents causing hyperkalemia, Protease Inhibitors, Agents Acting on the Renin-Angiotensin System, Agents causing angioedema, Cardiovascular Agents, Antihypertensive Agents	experimental	0
DB15545	Pisum sativum whole	Drug	0	approved	0
DB14214	Rose bengal lactone	Drug	0	experimental	0
DB15546	Skim milk	Drug	0	approved	0
DB04890	Bepotastine	Drug	Histamine H1 Antagonists, Anti-Allergic Agents, Histamine Antagonists, Mast Cell Stabilizers, Drugs that are Mainly Renally Excreted	approved	1
DB04891	Becocalcidiol	Drug	Cholestanes, Secosteroids, Sterols, Vitamin D and Analogues, Vitamins (Fat Soluble), Lipids, Membrane Lipids, Cholestenes, Fused-Ring Compounds, Vitamins, Steroids	investigational	2
DB15549	Atlantic halibut	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Increased Histamine Release	approved	0
DB14218	Telotristat	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Various Alimentary Tract and Metabolism Products, Alimentary Tract and Metabolism, Amino Acids, Essential, Tryptophan Hydroxylase Inhibitors, Tryptophan Hydroxylase Inhibitor, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	0
DB04892	Phenserine	Drug	Acids, Acyclic, Alkaloids, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Enzyme Inhibitors, Cholinergic Agents, Cholinesterase Inhibitors, Stereoisomerism, Phenylcarbamates, Carbamates, Indoles, Indole Alkaloids	investigational	3
DB14219	Monomethyl fumarate	Drug	Acids, Acyclic, Immunosuppressive Agents, Dicarboxylic Acids	investigational, experimental	0
DB02230	Immucillin-G	Drug	Pyrimidines, Purine-Nucleoside Phosphorylase, antagonists & inhibitors	experimental	1
DB03560	P-Hydroxybenzaldehyde	Drug	Aldehydes	experimental	0
DB03565	1-O-Octyl-2-Heptylphosphonyl-Sn-Glycero-3-Phosphoethanolamine	Drug	0	experimental	1
DB02234	S-Ethylisothiourea	Drug	Enzyme Inhibitors, Sulfur Compounds, Nitric Oxide Synthase, antagonists & inhibitors, Central Nervous System Depressants, Vasoconstrictor Agents, Thiourea, Cardiovascular Agents, Hypnotics and Sedatives, Central Nervous System Agents	experimental	3
DB04897	Lucinactant	Drug	Carbohydrates, Sugar Phosphates, Amino Acids, Peptides, and Proteins, Lipids, Phospholipids, Phosphatidic Acids, Glycerophospholipids, Pulmonary Surfactants, Alcohols, Glycerophosphates, Sugar Alcohols, Membrane Lipids, Pharmaceutical Preparations, Triose Sugar Alcohols, Bradycardia-Causing Agents	approved, investigational	0
DB04898	Ximelagatran	Drug	Anticoagulants, Enzyme Inhibitors, Amines, Blood and Blood Forming Organs, Cytochrome P-450 Substrates, Benzyl Compounds, Protease Inhibitors, Azetines, Hematologic Agents, Cytochrome P-450 CYP2C9 Substrates, Antithrombins, Serine Protease Inhibitors, Benzene Derivatives	approved, investigational, withdrawn	1
DB03564	(4r)-2-Methylpentane-2,4-Diol	Drug	0	experimental	2
DB02233	6-hydroxy-D-norleucine	Drug	0	experimental	1
DB04899	Nesiritide	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Amino Acids, Peptides, and Proteins, Cardiovascular Agents, Hypotensive Agents, Nerve Tissue Proteins, Hormones, Proteins, Natriuretic Peptides, Peptide Hormones, Natriuretic Peptide, Brain, Natriuretic Agents, Vasodilators Used in Cardiac Diseases, Cardiac Therapy	approved, investigational	3
DB02232	1,2-Dihydroxybenzene	Drug	Phenols, Benzene Derivatives	experimental	2
DB03562	Tetrahydrodeoxyuridine	Drug	0	experimental	1
DB03569	4,5-Dehydro-L-Iduronic Acid	Drug	0	experimental	1
DB02238	4-methylthio-2-oxobutanoic acid	Drug	Amino Acids, Neutral, Sulfur Compounds, Amino Acids, Essential, Amino Acids, Sulfur, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	1
DB04893	AZD3409	Drug	0	investigational	2
DB02237	Maltotetraose	Drug	Carbohydrates, Anti-Bacterial Agents, Polysaccharides, Disaccharides, Glucans, Oligosaccharides, Polymers, Biopolymers, Compounds used in a research, industrial, or household setting, Anti-Infective Agents, Macromolecular Substances	experimental	2
DB03568	Butyric Acid	Drug	Acids, Acyclic, Neurotransmitter Agents, Fatty Acids, Butyrates, Fatty Acids, Volatile, Lipids, Histamine Agents	investigational, experimental	3
DB04894	Vapreotide	Drug	Sensory System Agents, Cytochrome P-450 Enzyme Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Pancreatic Hormones, Pituitary and Hypothalamic Hormones and Analogues, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Hormones, Peripheral Nervous System Agents, Proteins, Peptide Hormones, Cytochrome P-450 CYP3A Inhibitors, Analgesics, Cytochrome P-450 CYP3A4 Inhibitors, Hypothalamic Hormones, Pituitary Hormone Release Inhibiting Hormones, Somatostatin and Analogues, Central Nervous System Agents, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Cytochrome P-450 CYP3A4 Inhibitors (weak)	investigational, experimental	3
DB02236	Glycinamide Ribonucleotide	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Amino Acids, Peptides, and Proteins, Nucleotides, Amino Acids	experimental	3
DB03567	alpha-N-Acetyl-D-galactosamine	Drug	0	investigational, experimental	0
DB04895	Pegaptanib	Drug	Carbohydrates, Vascular Endothelial Growth Factor A, Oligonucleotides, Antineovascularisation Agents, Nucleotides, Ocular Vascular Disorder Agents, Drugs that are Mainly Renally Excreted, Polynucleotides, Ophthalmologicals, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Pegylated agents, Sensory Organs	approved, investigational	1
DB04896	Milnacipran	Drug	Adrenergic Uptake Inhibitors, Cytochrome P-450 Substrates, Sensory System Agents, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Hypoglycemia-Associated Agents, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Serotonin Modulators, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Norepinephrine Uptake Inhibitors, Adrenergic Agents, Analgesics, Non-Narcotic, Selective Serotonin Reuptake Inhibitors, Combined Inhibitors of Serotonin/Norepinephrine Reuptake, Cyclopropanes, Agents producing tachycardia, Psychotropic Drugs, Membrane Transport Modulators, Neurotransmitter Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Neurotransmitter Uptake Inhibitors, Serotonin and Noradrenaline Reuptake Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Central Nervous System Agents, Psychoanaleptics	approved, investigational	3
DB03566	Spermidine	Drug	OCT1 substrates, Diamines, Amines, Biogenic Amines, Polyamines, Biogenic Polyamines	experimental	5
DB02235	L-methionine (R)-S-oxide	Drug	Amino Acids, Neutral, Sulfur Compounds, Amino Acids, Essential, Amino Acids, Sulfur, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	3
DB02239	Laevulinic Acid	Drug	0	experimental	1
DB15540	Rainbow trout	Drug	0	approved	0
DB14223	Clostridium botulinum	Drug	0	experimental	0
DB15554	Leptazoline D	Drug	0	experimental	0
DB14224	Lactobacillus reuteri	Drug	0	investigational, experimental	0
DB15555	Magnesium malate	Drug	0	experimental	0
DB14221	Beclomethasone 17-monopropionate	Drug	Pregnadienetriols, Pregnadienes, Adrenal Cortex Hormones, Pregnanes, Fused-Ring Compounds, Steroids, Steroids, Chlorinated	experimental	0
DB15552	Leptazoline B	Drug	0	experimental	0
DB14222	Bifidobacterium longum infantis	Drug	0	approved, experimental	0
DB15553	Leptazoline C	Drug	0	experimental	0
DB15558	Imalumab	Drug	0	investigational	0
DB14227	Technetium Tc-99m	Drug	Metals, Elements, Radioactive, Radioisotopes, Metals, Heavy, Elements, Transition Elements, Isotopes	experimental	0
DB15559	Zenocutuzumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Immunoglobulin Isotypes, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB14228	Threonic acid	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Lipids	experimental	0
DB14225	Enterococcus faecium	Drug	0	experimental	0
DB15556	Zinc glycinate citrate	Drug	0	experimental	0
DB15557	24-Homo-1,25-dihydroxyvitamin D3	Drug	Cholestanes, Secosteroids, Sterols, Vitamin D and Analogues, Vitamins (Fat Soluble), Lipids, Membrane Lipids, Cholestenes, Fused-Ring Compounds, Vitamins, Steroids	experimental	0
DB14226	Lactobacillus helveticus	Drug	0	experimental	0
DB14229	Lowbush blueberry	Drug	0	experimental	0
DB03572	FR230513	Drug	0	experimental	1
DB02241	8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One	Drug	0	experimental	0
DB03571	3-(5-amino-7-hydroxy-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(3,5-dichlorobenzyl)-benzamide	Drug	0	experimental	1
DB02240	Quinacrine mustard	Drug	Luminescent Agents, Heterocyclic Compounds, Fused-Ring, Acridines, Coloring Agents, Laboratory Chemicals, Hydrocarbons, Halogenated, Indicators and Reagents, Mustard Compounds, Aminoacridines, Nitrogen Mustard Compounds, Compounds used in a research, industrial, or household setting, Fluorescent Dyes	experimental	1
DB03570	Tris-Hydroxymethyl-Methyl-Ammonium	Drug	0	experimental	3
DB02245	7-Deazaguanine	Drug	Heterocyclic Compounds, Fused-Ring, Purines, Xanthine derivatives, Purinones	experimental	0
DB03576	N-Pyridoxyl-Threonine-5-Monophosphate	Drug	0	experimental	1
DB03575	Phencyclidine	Drug	Enzyme Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2B6 Inhibitors, Hallucinogens, Psychotropic Drugs, Neurotransmitter Agents, Central Nervous System Depressants, Piperidines, NMDA Receptor Antagonists, Phencyclidine, antagonists & inhibitors, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), Excitatory Amino Acid Agents, Excitatory Amino Acid Antagonists	illicit	2
DB02243	4-Morpholin-4-Yl-Piperidine-1-Carboxylic Acid [1-(3-Benzenesulfonyl-1-Propyl-Allylcarbamoyl)-2-Phenylethyl]-Amide	Drug	0	experimental	1
DB03574	Ferricrocin-iron	Drug	0	experimental	1
DB03573	WRR-99	Drug	0	experimental	2
DB02242	Cyclohexanepropanoic acid	Drug	0	experimental	1
DB02249	2-Ethoxyethanol	Drug	Solvents, Glycols, Alcohols	experimental	1
DB02248	3-Methyl-5-Sulfo-Pyrrolidine-2-Carboxylic Acid	Drug	0	experimental	0
DB03578	Pyruvamide	Drug	Keto Acids	experimental	0
DB02247	Hydrolyzed Cephalothin	Drug	Nephrotoxic agents	experimental	1
DB03577	Alpha-Benzyl-Aminobenzyl-Phosphonic Acid	Drug	0	experimental	1
DB15550	Pradefovir	Drug	Heterocyclic Compounds, Fused-Ring, Purines	investigational	0
DB15551	Leptazoline A	Drug	0	experimental	0
DB15565	Cilazaprilat	Drug	Pyridazines, Enzyme Inhibitors, Angiotensin-Converting Enzyme Inhibitors, Protease Inhibitors, Agents Acting on the Renin-Angiotensin System, Cardiovascular Agents, Antihypertensive Agents	experimental	1
DB14234	Sus scrofa stomach	Drug	0	experimental	0
DB14235	Bilberry	Drug	Herbs and Natural Products	approved, experimental	0
DB15566	Prednisolone acetate	Drug	Pregnadienetriols, Corticosteroids, Cytochrome P-450 Substrates, Prodrugs, Pregnadienes, Anti-Inflammatory Agents, P-glycoprotein substrates, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A Substrates, Pregnanes, Steroids	approved, vet_approved	1
DB15563	Influenza B virus B/Iowa/06/2017 hemagglutinin antigen (MDCK cell derived, propiolactone inactivated)	Drug	0	approved	0
DB14232	Deacetylbisacodyl	Drug	Cresols, Phenols, Laxatives, Stimulation Large Intestine Fluid/Electrolyte Secretion, Contact Laxatives, Increased Large Intestinal Motility, Benzene Derivatives	experimental	0
DB14233	Egg phospholipids	Drug	0	approved, investigational, experimental	0
DB15564	Influenza B virus B/Singapore/INFTT-16-0610/2016 hemagglutinin antigen (MDCK cell derived, propiolactone inactivated)	Drug	0	approved	0
DB15569	AMG-510	Drug	0	investigational	1
DB14238	Echinacea purpurea flowering top	Drug	0	approved, experimental	0
DB14239	Echinacea purpurea	Drug	Herbs and Natural Products	approved, experimental	0
DB14236	Aloe vera leaf polysaccharides	Drug	0	experimental	0
DB15567	PCLX-001	Drug	0	investigational	0
DB14237	Echinacea angustifolia root	Drug	0	approved, experimental	0
DB15568	MRTX849	Drug	0	investigational	1
DB02252	Iodobenzene	Drug	Hydrocarbons, Halogenated, Benzene Derivatives, Hydrocarbons, Iodinated	experimental	1
DB03583	(2E,3S)-3-hydroxy-5'-[(4-hydroxypiperidin-1-yl)sulfonyl]-3-methyl-1,3-dihydro-2,3'-biindol-2'(1'H)-one	Drug	0	experimental	1
DB02251	O-Succinylbenzoate	Drug	Acids, Carbocyclic	experimental	3
DB03582	N~2~-Succinylornithine	Drug	0	experimental	1
DB03581	Glucose-6-Phosphate	Drug	Carbohydrates, Hexosephosphates, Sugar Phosphates, Glucosephosphates	experimental	2
DB03587	Pyruvaldehyde	Drug	Glyoxal, Aldehydes	experimental	1
DB02256	2'-Deoxyuridine	Drug	0	experimental	2
DB03586	(3R,4R,5S,6R)-6-Fluoro-3,4,5-trihydroxytetrahydro-2H-pyran-2-olate	Drug	0	experimental	1
DB02255	Ilomastat	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Amines, Hydroxy Acids, Oligopeptides, Peptides, Protease Inhibitors, Hydroxylamines, Matrix Metalloproteinase Inhibitors, Amino Acids, Peptides, and Proteins	experimental	3
DB02254	Trifluoro-thiamin phosphate	Drug	0	experimental	1
DB03585	Oxyphenbutazone	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Sensory System Agents, Anti-Inflammatory Agents, Pyrazoles, Agents causing hyperkalemia, Antirheumatic Agents, Non COX-2 selective NSAIDS, Antiinflammatory Preparations, Non-Steroids for Topical Use, Butylpyrazolidines, Topical Products for Joint and Muscular Pain, Pyrazolones, OAT1/SLC22A6 inhibitors, Peripheral Nervous System Agents, Ophthalmologicals, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Musculo-Skeletal System, Agents that produce hypertension, Central Nervous System Agents, Sensory Organs, Other Nonsteroidal Anti-inflammatory Agents	approved, withdrawn	1
DB02253	(1r)-4-[(1e,3e,5e,7z,9e,11z,13e,15e)-17-Hydroxy-3,7,12,16-Tetramethylheptadeca-1,3,5,7,9,11,13,15-Octaen-1-Yl]-3,5,5-Trimethylcyclohex-3-En-1-Ol	Drug	0	experimental	1
DB03584	4-Thio-beta-D-glucopyranose	Drug	0	experimental	4
DB02259	3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide	Drug	0	experimental	1
DB02258	SR11254	Drug	0	experimental	1
DB03589	Mesoxalic acid	Drug	Acids, Acyclic, Dicarboxylic Acids	experimental	1
DB02257	N-Bromoacetyl-Aminoethyl Phosphate	Drug	0	experimental	1
DB03588	Diphenylacetic acid	Drug	Acids, Carbocyclic, Phenylacetates	experimental	1
DB14230	Albumin Aggregated	Drug	0	approved	0
DB15561	Valoctocogene roxaparvovec	Drug	0	investigational	0
DB15562	Influenza A virus A/North carolina/04/2016 (H3N2) hemagglutinin antigen (MDCK cell derived, propiolactone inactivated)	Drug	0	approved	0
DB14231	Quinoline Yellow WS	Drug	Heterocyclic Compounds, Fused-Ring, Angiotensin-Converting Enzyme Inhibitors, Agents that produce hypertension, Agents Acting on the Renin-Angiotensin System, Agents causing angioedema	experimental	0
DB15560	Reloxaliase	Drug	0	investigational	0
DB15576	Ethyl salicylate	Drug	Benzoates, Hydroxy Acids, Acids, Carbocyclic, Hydroxybenzoates, Phenols, Benzene Derivatives	approved, experimental	0
DB14245	Snail, unspecified	Drug	0	approved, experimental	0
DB14246	Marine collagen, soluble	Drug	0	experimental	0
DB15574	beta-Pinene	Drug	Terpenes	experimental	0
DB14243	Sus scrofa placenta	Drug	0	experimental	0
DB14244	Garden snail mucin	Drug	0	experimental	0
DB15575	Padeliporfin	Drug	Biological Factors, Chlorophyll, Antineoplastic and Immunomodulating Agents, Sensitizers Used in Photodynamic/radiation Therapy, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Palladium, Metalloporphyrins, Photoreceptors, Microbial, Pigments, Biological, Proteins, Heterocyclic Compounds, Fused-Ring, Photosensitizing Agents, Porphyrins	experimental	0
DB14249	Pearl (hyriopsis cumingii)	Drug	0	experimental	0
DB15578	Desfesoterodine	Drug	Drugs for Urinary Frequency and Incontinence, Genito Urinary System and Sex Hormones, Urologicals	experimental	0
DB14247	Moschus berezovskii musk sac resin	Drug	0	experimental	0
DB14248	Bos taurus gallstone	Drug	Complex Mixtures, Gallstones	experimental	0
DB15579	Cryptotanshinone	Drug	Drugs, Chinese Herbal	experimental	0
DB03590	2,6-Diaminopimelic Acid	Drug	0	experimental	2
DB02263	Glyceraldehyde-3-Phosphate	Drug	0	experimental	3
DB03594	1,2,4-Triazole	Drug	0	experimental	1
DB03593	7-methyl-5'-guanylic acid	Drug	Carbohydrates, RNA, RNA Caps, Nucleotides, Nucleic Acids, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Guanine Nucleotides, RNA, Messenger	experimental	1
DB02262	Orotic acid	Drug	Pyrimidines, Pyrimidinones	investigational	5
DB02261	Platelet Activating Factor	Drug	Amines, Ammonium Compounds, Blood Coagulation Factors, Trimethyl Ammonium Compounds, Amino Acids, Peptides, and Proteins, Lipids, Onium Compounds, Cardiovascular Agents, Phospholipids, Phosphatidic Acids, Glycerophospholipids, Alcohols, Proteins, Glyceryl Ethers, Membrane Lipids, Ethers, Adrenergic Agents, Nitrogen Compounds, Biological Factors, Carbohydrates, Autacoids, Inflammation Mediators, Phospholipid Ethers, Platelet Activating Factor, antagonists & inhibitors, Sugar Phosphates, P-glycoprotein substrates, Quaternary Ammonium Compounds, Amino Alcohols, Ethanolamines, P-glycoprotein inducers, Neurotransmitter Agents, Glycerophosphates, Blood Proteins, Sugar Alcohols, Triose Sugar Alcohols	experimental	2
DB03592	Pterin-6-Yl-Methyl-Monophosphate	Drug	0	experimental	2
DB02260	4-Oxosebacic Acid	Drug	Fatty Acids, Porphobilinogen Synthase, antagonists & inhibitors, Lipids	experimental	2
DB03591	RU82209	Drug	0	experimental	1
DB03598	Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]	Drug	0	experimental	1
DB02267	Argininosuccinate	Drug	0	experimental	2
DB03597	gamma-Glutamyl[S-(2-iodobenzyl)cysteinyl]glycine	Drug	0	experimental	3
DB02266	Flufenamic acid	Drug	Aminobenzoates, Amines, Benzoates, ortho-Aminobenzoates, Anti-Inflammatory Agents, Acids, Carbocyclic, Aniline Compounds, OAT1/SLC22A6 inhibitors, Fenamates, Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids, Musculo-Skeletal System, Benzene Derivatives	approved	6
DB03596	N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide	Drug	0	experimental	1
DB02265	Ethyl-Trimethyl-Silane	Drug	0	experimental	1
DB03595	CRA_9785	Drug	0	experimental	1
DB02264	O2-Sulfo-Glucuronic Acid	Drug	0	experimental	4
DB02269	[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium	Drug	0	experimental	1
DB02268	4-(Acetylamino)-3-Amino Benzoic Acid	Drug	0	experimental	1
DB15572	CTX001	Drug	0	investigational	0
DB14241	Caviar, unspecified	Drug	0	approved, experimental	0
DB15573	alpha-Pinene	Drug	Terpenes	experimental	0
DB14242	Honey	Drug	0	approved, experimental	0
DB15570	FLX475	Drug	0	investigational	1
DB15571	(12R)-12-hydroxyeicosapentaenoic acid	Drug	0	experimental	0
DB14240	Echinacea	Drug	Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Herbs and Natural Products, Cytochrome P-450 CYP3A4 Inducers (moderate)	approved, experimental	0
DB14298	Gambir	Drug	0	experimental	0
DB14299	Mucuna pruriens seed	Drug	0	experimental	0
DB14292	Acorus calamus root	Drug	0	experimental	0
DB14293	Eutrema japonicum whole	Drug	0	experimental	0
DB14290	Rehmannia glutinosa root	Drug	0	experimental	0
DB14291	Wormwood	Drug	Oils, Lipids	approved, experimental	0
DB14296	Panax quinquefolius whole	Drug	0	investigational, experimental	0
DB14297	Arnica montana	Drug	0	investigational, experimental	0
DB14294	Styphnolobium japonicum flower bud	Drug	0	experimental	0
DB14295	Reynoutria multiflora root	Drug	0	experimental	0
DB04900	Thymalfasin	Drug	Proteins, Immunologic Factors, Peptide Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Adjuvants, Immunologic, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Thymus Hormones, Hormones	investigational	0
DB04905	Tesmilifene	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Hematologic Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, P-glycoprotein inducers, Neurotransmitter Agents, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Phenols, Cytochrome P-450 CYP2D6 Substrates, Ethers, Histamine Agents, P-glycoprotein inhibitors, Antiplatelet agents, Benzene Derivatives	investigational	2
DB04907	Sitimagene ceradenovec	Drug	Enzymes, Genetic Therapy, Phosphotransferases (Alcohol Group Acceptor), Antineoplastic and Immunomodulating Agents, Transferases, Antineoplastic Agents, Enzymes and Coenzymes, Phosphotransferases	investigational	0
DB04908	Flibanserin	Drug	Serotonin 5-HT1 Receptor Agonists, Cytochrome P-450 Substrates, Serotonin Agents, Genito Urinary System and Sex Hormones, Serotonin Receptor Agonists, Miscellaneous Central Nervous System Agents, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Serotonin 5-HT2 Receptor Antagonists, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Substrates, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Central Nervous System Depressants, Agents that produce hypertension, Serotonin Receptor Antagonists, P-glycoprotein inhibitors	approved, investigational	3
DB04901	Galiximab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Anti-Inflammatory Agents, Blood Proteins, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	1
DB04903	Pagoclone	Drug	Heterocyclic Compounds, Fused-Ring, GABA Agents, Central Nervous System Depressants, Hypnotics (Nonbenzodiazepine), Hypnotics and Sedatives	investigational	2
DB04904	Amolimogene	Drug	Nucleic Acids, Nucleotides, and Nucleosides, Nucleic Acids	investigational	0
DB04909	Sitamaquine	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring	investigational	0
DB04910	Oxibendazole	Drug	Heterocyclic Compounds, Fused-Ring, Anthelmintics, Anti-Infective Agents, Antiparasitic Agents	investigational, vet_approved	1
DB04911	Oritavancin	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Glycoconjugates, Peptides, Cytochrome P-450 CYP3A Inducers, Amino Acids, Peptides, and Proteins, Cytochrome P-450 CYP2C19 Inhibitors, Lipids, Anti-Infective Agents, Lipoglycopeptide Antibacterial, Anti-Bacterial Agents, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C9 Inhibitors, Carbohydrates, Glycopeptide Antibacterials, Cytochrome P-450 CYP3A4 Inducers, Antiinfectives for Systemic Use, Cytochrome P-450 CYP3A4 Inducers (weak), Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors (weak), Glycopeptides, Lipopeptides, Antibacterials for Systemic Use, Cytochrome P-450 CYP2C9 Inhibitors (weak), Cytochrome P-450 CYP2D6 Inhibitors (weak), Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved, investigational	3
DB04917	Renzapride	Drug	Neurotransmitter Agents, Benzoates, Serotonin Agents, Central Nervous System Depressants, Acids, Carbocyclic, Serotonin Receptor Agonists, Amides, Serotonin Receptor Antagonists, Antidepressive Agents, Serotonin 5-HT4 Receptor Agonists, Benzene Derivatives	investigational	2
DB04918	Ceftobiprole	Drug	Nephrotoxic agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Amides, Lactams, Thiazines, beta-Lactams, Anti-Infective Agents	approved, investigational	3
DB04919	Alfimeprase	Drug	Metalloproteases, Enzymes, Enzymes and Coenzymes, Hydrolases, Peptide Hydrolases, Endopeptidases	investigational	2
DB04912	Stannsoporfin	Drug	Heme Oxygenase (Decyclizing), antagonists & inhibitors, Biological Factors, Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Pigments, Biological, Porphyrins	investigational	2
DB04914	G17DT	Drug	Immunization, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Gastrointestinal Hormones, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Hormones, Vaccines, Proteins, Peptide Hormones, Complex Mixtures, Biological Products	investigational	0
DB04915	Idronoxil	Drug	Heterocyclic Compounds, Fused-Ring, Flavonoids, Benzopyrans, Chromones, Pyrans	investigational	1
DB04920	Clevidipine	Drug	Calcium Channel Blockers (Dihydropyridine), Dihydropyridine Derivatives, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Agents causing hyperkalemia, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP2C19 Inhibitors, Cardiovascular Agents, Hypotensive Agents, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C9 Inhibitors, Calcium-Regulating Hormones and Agents, Antihypertensive Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Selective Calcium Channel Blockers With Mainly Vascular Effects, Antihypertensive Agents Indicated for Hypertension, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 CYP3A4 Inducers, Membrane Transport Modulators, Calcium Channel Blockers, Dihydropyridines, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Cholinesterase substrates, Cytochrome P-450 CYP2D6 Substrates, Vasodilating Agents, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved, investigational	4
DB04921	Dirucotide	Drug	Membrane Proteins, Proteins, Peptides, Myelin Proteins, Amino Acids, Peptides, and Proteins, Nerve Tissue Proteins	investigational	0
DB04928	XP12B	Drug	0	investigational	0
DB04929	DG031	Drug	0	investigational	1
DB04923	rhThrombin	Drug	0	approved, investigational	0
DB04924	Itopride	Drug	Propulsives, Benzoates, Alimentary Tract and Metabolism, Acids, Carbocyclic, Amides, Drugs for Functional Gastrointestinal Disorders, Benzene Derivatives	investigational	2
DB04925	Desmoteplase	Drug	Anticoagulants, Biological Factors, Enzymes, Fibrin Modulating Agents, Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins, Hematologic Agents, Cardiovascular Agents, Recombinant Proteins, Fibrinolytic Agents, Proteins, Blood Proteins, Serine Proteases, Hydrolases, Peptide Hydrolases, Serine Endopeptidases, Endopeptidases	investigational	1
DB04926	Neramexane	Drug	Cycloparaffins	investigational	1
DB15620	Influenza B virus B/Washington/02/2019 antigen (formaldehyde inactivated)	Drug	0	approved	0
DB15621	Influenza A virus A/South australia/34/2019 IVR-197 (H3N2) antigen (formaldehyde inactivated)	Drug	0	approved	0
DB15624	Halicin	Drug	0	experimental	1
DB15622	Triazavirin	Drug	Experimental Unapproved Treatments for COVID-19, Guanine Nucleotides, Antiviral Agents	experimental	0
DB15623	TMC-310911	Drug	Antivirals for Systemic Use, Experimental Unapproved Treatments for COVID-19, Antiviral Agents, Anti-HIV Agents, HIV Protease Inhibitors	investigational	1
DB15628	Inolimomab	Drug	Proteins, Serum Globulins, Immunologic Factors, Immunoglobulins, Immunosuppression, Immunosuppressive Agents, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins, Receptors, Interleukin-2	investigational	0
DB15629	Garadacimab	Drug	0	investigational	0
DB15626	Spesolimab	Drug	0	investigational	0
DB15627	Dostarlimab	Drug	0	investigational	0
DB04974	Rimiducid	Drug	Cross-Linking Reagents	investigational	1
DB02311	Methyl Methylsulfinylmethyl Sulfide	Drug	0	experimental	1
DB03642	N-[(2S)-4-Methyl-1-oxo-1-{[(4S)-3-oxo-1-(2-pyridinylsulfonyl)-4-azepanyl]amino}-2-pentanyl]-1-benzofuran-2-carboxamide	Drug	0	experimental	1
DB04975	Banoxantrone	Drug	Anthracenes, Quinones, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Antineoplastic Agents, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP3A4 Substrates	investigational	1
DB02310	3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium	Drug	0	experimental	1
DB03641	2'-deoxyuridine 5'-alpha,beta-imido-diphosphate	Drug	0	experimental	1
DB04976	M40403	Drug	Metals, Metals, Heavy, Elements, Transition Elements	investigational	0
DB03640	Beta-Hydroxyaspartic Acid	Drug	Amino Acids, Dicarboxylic, Excitatory Amino Acids, Amino Acids, Peptides, and Proteins, Amino Acids, Acidic, Amino Acids	experimental	1
DB04977	Plitidepsin	Drug	Peptides, Cyclic, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Peptides, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP2A6 Substrates, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Cytochrome P-450 CYP3A4 Substrates	investigational	0
DB02315	Cyclic GMP	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Guanine Nucleotides, Nucleotides, Nucleotides, Cyclic	experimental	3
DB03646	2,3-di-O-phytanyl-sn-glycerol	Drug	Carbohydrates, Sugar Alcohols, Ethers, Triose Sugar Alcohols, Alcohols	experimental	0
DB04970	Lesopitron	Drug	0	investigational	1
DB04971	Reglitazar	Drug	0	investigational	2
DB03645	Phosphonoacetohydroxamic Acid	Drug	0	experimental	1
DB02314	Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate	Drug	0	experimental	2
DB02313	Ethyl (4R)-4-{[(2R,5S)-2-(4-fluorobenzyl)-6-methyl-5-{[(5-methyl-1,2-oxazol-3-yl)carbonyl]amino}-4-oxoheptanoyl]amino}-5-[(3S)-2-oxo-3-pyrrolidinyl]pentanoate	Drug	0	experimental	1
DB04972	Canfosfamide	Drug	Cytotoxins, Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins	investigational	1
DB03644	3-hydroxyanthranilic acid	Drug	Aminobenzoates, Antioxidants, Benzoates, Hydroxy Acids, ortho-Aminobenzoates, Protective Agents, Acids, Carbocyclic, Hydroxybenzoates, Phenols, Free Radical Scavengers, Compounds used in a research, industrial, or household setting, Benzene Derivatives	experimental	1
DB03643	CRA_1144	Drug	0	experimental	2
DB04973	LErafAON	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Oligonucleotides, Glycosides, Nucleotides, Polynucleotides	investigational	1
DB02312	beta-D-galactose 6-phosphate	Drug	0	experimental	1
DB02319	5,6-dihydroxy-NADP	Drug	0	experimental	1
DB03649	[{(5-Chloro-2-Pyridinyl)Amino} Methylene]-1,1-Bisphosphonate	Drug	0	experimental	1
DB02318	2-deoxy-2-fluoro-alpha-D-mannosyl fluoride	Drug	0	experimental	1
DB03648	(2S,2'S)-2,2'-(1,2-Hydrazinediylbis{methylene[(2S)-1-oxo-2,1-hexanediyl]imino})bis(6-amino-N-phenylhexanamide)	Drug	0	experimental	1
DB02317	Alpha-D-Galactose-1-Phosphate	Drug	0	experimental	1
DB03647	3-[Isopropyl(4-Methylbenzoyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid	Drug	0	experimental	1
DB02316	1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid	Drug	0	experimental	1
DB04978	SP1049C	Drug	Carbohydrates, Anthracyclines, Polyethylene Glycols, Ethylene Glycols, Naphthacenes, Glycosides, Glycols, Polymers, Compounds used in a research, industrial, or household setting, Alcohols, Macromolecular Substances	investigational	1
DB04979	AVR118	Drug	0	investigational	0
DB14300	Erythroxylum catuaba bark	Drug	0	experimental	0
DB15631	Edodekin alfa	Drug	Biological Factors, Immunologic Factors, Cytokines, Peptides, Adjuvants, Immunologic, Intercellular Signaling Peptides and Proteins, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Growth Inhibitors, Angiogenesis Modulating Agents, Angiogenesis Inhibitors, Interleukin-12, antagonists & inhibitors, Proteins, Interleukins, Growth Substances	investigational	0
DB15632	Zalifrelimab	Drug	0	investigational	0
DB14301	Epimedium grandiflorum top	Drug	0	experimental	0
DB15630	Glumetinib	Drug	0	investigational	0
DB15635	Omburtamab	Drug	0	investigational	0
DB14304	Panax notoginseng root	Drug	Complex Mixtures, Plant Preparations, Plant Extracts, Biological Products, Pharmaceutical Preparations	investigational, experimental	0
DB14305	Tribulus terrestris fruit	Drug	0	experimental	0
DB15636	Zilucoplan	Drug	0	investigational	0
DB15633	Pabinafusp alfa	Drug	0	investigational	0
DB14302	Turnera diffusa leaf	Drug	0	experimental	0
DB14303	Eleuthero	Drug	Herbs and Natural Products	approved, experimental	0
DB15634	Temelimab	Drug	0	investigational	0
DB15639	AMG-337	Drug	Pyridines, Antineoplastic Agents	investigational	0
DB14308	Camellia japonica seed oil	Drug	0	experimental	0
DB14309	Meadowfoam seed oil	Drug	Complex Mixtures, Oils, Plant Preparations, Biological Products, Lipids	experimental	0
DB15637	Fluzoparib	Drug	0	investigational	0
DB14306	Juglans regia shell	Drug	0	experimental	0
DB15638	Brensocatib	Drug	Heterocyclic Compounds, Fused-Ring, Azepines	investigational	0
DB14307	Green tea leaf	Drug	0	investigational, experimental	0
DB04980	Lemuteporfin	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Glycols, Alcohols, Pigments, Biological	investigational	0
DB02322	Heparin Disaccharide I-S	Drug	0	experimental	1
DB04985	Tigapotide	Drug	Proteins, Peptides, Amino Acids, Peptides, and Proteins, Seminal Plasma Proteins	investigational	1
DB03653	5-{[Ethyl(Methyl)Amino]Methyl}-2-Methyl-5,6-Dihydropyrimidin-4-Amine	Drug	0	experimental	0
DB02321	5-(3-Amino-4,4-Dihyroxy-Butylsulfanylmethyl)-Tetrahydro-Furan-2,3,4-Triol	Drug	0	experimental	1
DB03652	beta-D-Galactopyranuronic acid	Drug	0	experimental	2
DB04986	ZYC300	Drug	0	investigational	0
DB02320	N-beta-D-glucopyranosylacetamide	Drug	0	experimental	2
DB03651	Picric acid	Drug	Enzyme Inhibitors, Uncoupling Agents, Nitro Compounds, Laboratory Chemicals, Phenols, Indicators and Reagents, Nitrophenols, Compounds used in a research, industrial, or household setting, Benzene Derivatives	experimental	1
DB04987	P113D	Drug	0	investigational	0
DB03650	(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One	Drug	0	experimental	1
DB04988	IGN311	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	2
DB03657	1-deoxy-1-methoxycarbamido-beta-D-glucopyranose	Drug	0	experimental	1
DB02326	1-Hydroxyamine-2-Isobutylmalonic Acid	Drug	0	experimental	1
DB04981	CG7870	Drug	0	investigational	0
DB02325	Isopropyl alcohol	Drug	Solvents, Propanols, Antiseptics and Disinfectants, Dermatologicals, Compounds used in a research, industrial, or household setting, Alcohols, Miscellaneous Local Anti-infectives	approved, investigational	0
DB03656	Tribenuron Methyl	Drug	Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfur Acids, Sulfonic Acids, Arylsulfonic Acids	experimental	0
DB04982	Talampanel	Drug	Heterocyclic Compounds, Fused-Ring, Benzazepines, Receptors, AMPA, antagonists & inhibitors	investigational	4
DB04983	Denufosol	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Ribonucleotides, Deoxyribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Cytosine Nucleotides, Glycosides, Nucleosides, Nucleotides, Pyrimidine Nucleotides	investigational	1
DB02324	5-Iodo-2'-Deoxyuridine-5'-Monophosphate	Drug	0	experimental	1
DB02323	EM-1745	Drug	Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, Estrenes, 17-Hydroxysteroid Dehydrogenases, antagonists & inhibitors, Estradiol Congeners, Hormones, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Steroids	experimental	1
DB03654	S,S-Propylthiocysteine	Drug	0	experimental	2
DB02329	Carbenoxolone	Drug	Glycyrrhetinic Acid, Triterpenes, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Alimentary Tract and Metabolism, Pentacyclic Triterpenes, Anti-Ulcer Agents, Drugs for Acid Related Disorders, Terpenes, Gastrointestinal Agents	experimental	2
DB03659	Butylamine	Drug	Amines, Hydrocarbons, Acyclic, Alkanes, Butanes	experimental	1
DB02328	2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Imino]-5-Phosphono-Pent-3-Enoic Acid	Drug	0	experimental	1
DB02327	Triethylene glycol	Drug	Ethylene Glycols, Glycols, Polymers, Compounds used in a research, industrial, or household setting, Alcohols, Macromolecular Substances	experimental	3
DB03658	(2R,4S)-2-[(1R)-1-{[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid	Drug	0	experimental	1
DB04989	Ty800	Drug	0	investigational	0
DB14311	Shea butter	Drug	0	experimental	0
DB15642	Molidustat	Drug	0	investigational	0
DB14312	Glycyrrhiza glabra	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved, experimental	0
DB15643	N-(2-Aminoethyl)-1-aziridineethanamine	Drug	ACE Inhibitors and Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Agents Acting on the Renin-Angiotensin System, ACE Inhibitors and Diuretics	experimental	1
DB15640	CDC-801	Drug	0	investigational	0
DB15641	Droloxifene	Drug	Antioxidants, Estrogen Antagonists, Stilbenes, Hormones, Hormone Substitutes, and Hormone Antagonists, Protective Agents, Antineoplastic Agents, Benzylidene Compounds, Hormone Antagonists, Compounds used in a research, industrial, or household setting, Benzene Derivatives	investigational	0
DB14310	Argan oil	Drug	Complex Mixtures, Oils, Plant Preparations, Biological Products, Lipids	experimental	0
DB15646	Fasitibant	Drug	Immunologic Factors, Sulfur Compounds, Immunosuppressive Agents, Amino Acids, Basic, Amino Acids, Diamino, Bradykinin Receptor Antagonists, Complement Inactivating Agents, Amides, Amino Acids, Peptides, and Proteins, Bradykinin B2 Receptor Antagonists, Amino Acids, Sulfones	investigational	0
DB14315	Calendula officinalis whole	Drug	0	experimental	0
DB14316	Tangerine peel	Drug	Complex Mixtures, Plant Preparations, Plant Extracts, Biological Products, Pharmaceutical Preparations	experimental	0
DB15647	Ketodarolutamide	Drug	Antiandrogens, Antiandrogens, non-steroidal	experimental	1
DB15644	Ochromycinone	Drug	Anthracenes, Quinones	investigational	0
DB14313	Lawsonia inermis leaf	Drug	Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased IgG Production, Increased Histamine Release	experimental	0
DB15645	Dihydromyricetin	Drug	Heterocyclic Compounds, Fused-Ring, Flavonoids, Benzopyrans, Chromones, Pyrans	investigational	0
DB14314	Indigofera tinctoria leaf	Drug	0	experimental	0
DB14319	Magnolia kobus flowering top	Drug	0	experimental	0
DB14317	Pomegranate	Drug	0	investigational, experimental	0
DB15648	Calcium oxide	Drug	Anions, Electrolytes, Ions, Root Canal Filling Materials, Compounds used in a research, industrial, or household setting, Dental Materials, Oxygen Compounds	experimental	0
DB14318	Macadamia seed oil glycereth-8 esters	Drug	0	experimental	0
DB04991	XL784	Drug	0	investigational	1
DB15649	Carbomer	Drug	Protease Inhibitors, Plastics, Polymers, Compounds used in a research, industrial, or household setting, Dental Materials, Drug Carriers, Macromolecular Substances, Resins, Synthetic	experimental	0
DB03660	4-Iodo-L-phenylalanine	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Amino Acids, Essential, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	4
DB02333	Deoxyuridine-5'-Triphosphate	Drug	0	experimental	5
DB01001	Salbutamol	Drug	Adrenergics, Inhalants, QTc Prolonging Agents, Amines, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Adrenergic beta-2 Receptor Agonists, Phenethylamines, Tocolytic Agents, Drugs that are Mainly Renally Excreted, Alcohols, Peripheral Nervous System Agents, Sympathomimetic (Adrenergic) Agents, Selective Beta 2-adrenergic Agonists, Potential QTc-Prolonging Agents, Adrenergic Agents, Autonomic Agents, Anti-Asthmatic Agents, Reproductive Control Agents, Agents producing tachycardia, Bronchodilator Agents, Amino Alcohols, Ethanolamines, Respiratory System Agents, Adrenergic beta-Agonists, Agents to Treat Airway Disease, Cytochrome P-450 CYP3A Inhibitors, Adrenergic Agonists, Agents that produce hypertension, Cytochrome P-450 CYP3A4 Inhibitors, Drugs for Obstructive Airway Diseases	approved, vet_approved	3
DB04996	Satraplatin	Drug	Organometallic Compounds, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Platinum Compounds	investigational	1
DB03664	P1-(adenosine-5'-P5-(uridine-5')pentaphosphate	Drug	0	experimental	1
DB04997	ATL1102	Drug	0	investigational	1
DB02332	Flavin-N7 protonated-adenine dinucleotide	Drug	0	experimental	1
DB03663	1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol	Drug	0	experimental	1
DB01002	Levobupivacaine	Drug	Amines, Cytochrome P-450 Substrates, Sensory System Agents, Nervous System, Neuraxial Anesthetics, Aniline Compounds, Amides, Hypotensive Agents, Anesthetics, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Anilides, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Central Nervous System Agents, Anesthetics, Local	approved, investigational	1
DB02331	(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid	Drug	0	experimental	1
DB03662	Vitamin B6 Complexed with 2-Amino-Pentanoic Acid	Drug	0	experimental	1
DB04998	AGRO100	Drug	Carbohydrates, Nucleic Acids, Nucleotides, and Nucleosides, Aptamers, Nucleotide, Oligonucleotides, Glycosides, Nucleotides, Polynucleotides	investigational	1
DB01000	Cyclacillin	Drug	Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use	approved	4
DB03661	L-cysteic acid	Drug	0	experimental	15
DB04999	MBO7133	Drug	0	investigational	0
DB04992	AP5346	Drug	Organometallic Compounds	investigational	1
DB01005	Hydroxyurea	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Enzyme Inhibitors, Nucleic Acid Synthesis Inhibitors, Antisickling Agents, Immunosuppressive Agents, Narrow Therapeutic Index Drugs, Cytochrome P-450 Enzyme Inhibitors, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Hematologic Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Myelosuppressive Agents	approved	1
DB03668	6-oxouridine 5'-phosphate	Drug	0	experimental	1
DB02337	S-(D-Carboxybutyl)-L-Homocysteine	Drug	0	experimental	1
DB02336	RU83876	Drug	0	experimental	1
DB03667	Acetic Acid Salicyloyl-Amino-Ester	Drug	0	experimental	1
DB01006	Letrozole	Drug	Endocrine Therapy, Enzyme Inhibitors, Cytochrome P-450 Substrates, Steroid Synthesis Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2A6 Inhibitors, Hormone Antagonists and Related Agents, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2A6 Inhibitors (strong), Aromatase Inhibitors, Estrogen Antagonists, UGT2B7 substrates, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Triazoles, Cytochrome P-450 CYP2A6 Substrates, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Nitriles, Hormone Antagonists	approved, investigational	1
DB03666	Zidovudine monophosphate	Drug	Carbohydrates, Pyrimidines, Deoxyribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Glycosides, Nucleosides, Deoxyribonucleosides, Nucleotides, Dideoxynucleosides, Pyrimidine Nucleotides	experimental	2
DB01003	Cromoglicic acid	Drug	Agents for Dermatitis, Excluding Corticosteroids, Adrenergics, Inhalants, Mast-cell Stabilizers, Decongestants and Antiallergics, Intestinal Antiinflammatory Agents, Nasal Preparations, Decreased Histamine Release, Alimentary Tract and Metabolism, Antiallergic Agents, Excl. Corticosteroids, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Drugs causing inadvertant photosensitivity, Anti-Allergic Agents, Anti-Asthmatic Agents, Dermatologicals, Benzopyrans, Cromolyn Sodium, Respiratory System Agents, Ophthalmologicals, Heterocyclic Compounds, Fused-Ring, Photosensitizing Agents, Drugs for Obstructive Airway Diseases, Mast Cell Stabilizers, Sensory Organs, Chromones, Pyrans	approved	1
DB02335	2-Aminothiazoline	Drug	Sulfur Compounds	experimental	1
DB04995	AT1022	Drug	0	investigational	0
DB01004	Ganciclovir	Drug	OCT1 substrates, MATE 1 Substrates, OCT1 inhibitors, Ganciclovir and prodrug, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Antivirals for Systemic Use, Direct Acting Antivirals, Purines, Ganciclovir, Nucleic Acid Synthesis Inhibitors, MATE substrates, Nucleosides and Nucleotides, Purinones, Agents that reduce seizure threshold, Nucleoside Analog Antiviral, Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors, Antiviral Agents, Antiinfectives for Systemic Use, OAT1/SLC22A6 inhibitors, Ophthalmologicals, Heterocyclic Compounds, Fused-Ring, Agents Causing Muscle Toxicity, MATE 2 Substrates, OAT3/SLC22A8 Inhibitors, Sensory Organs, Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor	approved, investigational	3
DB02334	(R)-2-Hydroxy-3-Sulfopropanoic Acid	Drug	0	experimental	1
DB01009	Ketoprofen	Drug	Nephrotoxic agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Sensory System Agents, Cyclooxygenase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Non COX-2 selective NSAIDS, Phenylpropionates, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Non-Steroids, Analgesics, Cytochrome P-450 CYP2C8 Inhibitors (weak), Musculo-Skeletal System, Cytochrome P-450 CYP2C9 Inhibitors, Drugs causing inadvertant photosensitivity, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Cytochrome P-450 CYP2C8 Inhibitors, Antirheumatic Agents, Antiinflammatory Preparations, Non-Steroids for Topical Use, Topical Products for Joint and Muscular Pain, OAT1/SLC22A6 inhibitors, Cytochrome P-450 CYP2C9 Substrates, Antiinflammatory and Antirheumatic Products, Photosensitizing Agents, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), UGT1A1 Substrates, Propionates, Agents that produce hypertension, Central Nervous System Agents, OAT3/SLC22A8 Inhibitors, Other Nonsteroidal Anti-inflammatory Agents	approved, vet_approved	3
DB01007	Tioconazole	Drug	Enzyme Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Genito Urinary System and Sex Hormones, Antifungals for Dermatological Use, Cytochrome P-450 CYP2C19 Inhibitors, Anti-Infective Agents, Cytochrome P-450 CYP2E1 Inhibitors (strong), Antifungals for Topical Use, Antifungal Agents, Hormone Antagonists, Steroid Synthesis Inhibitors, Chemically-Induced Disorders, Cytochrome P-450 CYP2E1 Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Gynecological Antiinfectives and Antiseptics, Dermatologicals, Cytochrome P-450 CYP2C19 Inhibitors (strong), Azole Antifungals, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Antifungal Agents (Vaginal), Imidazole and Triazole Derivatives, Imidazole Derivatives, 14-alpha Demethylase Inhibitors	approved	2
DB02339	Allyl-{6-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-Hexyl-}-Methyl-Amin	Drug	0	experimental	1
DB01008	Busulfan	Drug	Immunologic Factors, Cytochrome P-450 Substrates, Immunosuppressive Agents, Sulfur Acids, Alkanes, Cardiotoxic antineoplastic agents, Cytochrome P-450 CYP3A4 Substrates, Alcohols, Sulfur Compounds, Alkanesulfonates, Sulfonic Acids, Mesylates, Antineoplastic Agents, Alkylating, Alkanesulfonic Acids, Butylene Glycols, Noxae, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Antineoplastic and Immunomodulating Agents, Hydrocarbons, Acyclic, Alkylating Activity, Antineoplastic Agents, Myeloablative Agonists, Myelosuppressive Agents, Alkylating Drugs, Acids, Noncarboxylic, Narrow Therapeutic Index Drugs, Acids, Cytochrome P-450 CYP3A Substrates, Toxic Actions, Glycols	approved, investigational	1
DB03669	4-Fluorophenethyl Alcohol	Drug	0	experimental	1
DB02338	NADPH	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Coenzymes, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Enzymes and Coenzymes, Glycosides, Nucleotides, Adenine Nucleotides	experimental	6
DB15653	Islatravir	Drug	Carbohydrates, Ribonucleosides, Enzyme Inhibitors, Lipids, Anti-Retroviral Agents, Antiviral Agents, Purine Nucleosides, Anti-Infective Agents, Alcohols, Heterocyclic Compounds, Fused-Ring, Purines, Nucleic Acid Synthesis Inhibitors, Nucleic Acids, Nucleotides, and Nucleosides, Sesquiterpenes, Azo Compounds, Glycosides, Nucleosides, Deoxyribonucleosides, Reverse Transcriptase Inhibitors, Terpenes, Fatty Alcohols	investigational	0
DB14322	Coconut oil	Drug	Complex Mixtures, Oils, Plant Preparations, Biological Products, Lipids, Plant Oils	experimental	0
DB15654	mRNA-1273	Drug	Experimental Unapproved Treatments for COVID-19	investigational	0
DB14323	Grape seed oil	Drug	0	experimental	0
DB15651	Valomaciclovir stearate	Drug	Heterocyclic Compounds, Fused-Ring, Purines, Varicellovirus, Herpes Zoster, Antiviral Agents, Xanthine derivatives, Purinones	investigational	0
DB14320	Eucalyptus globulus leaf	Drug	0	approved, experimental	0
DB14321	Bambusa vulgaris top	Drug	0	experimental	0
DB15652	Ravidasvir	Drug	Heterocyclic Compounds, Fused-Ring, Amino Acids, Essential, Amino Acids, Branched-Chain, Amino Acids, Peptides, and Proteins, Antiviral Agents, Amino Acids	investigational	0
DB14326	Amber	Drug	Complex Mixtures, Biological Products, Resins, Plant, Plant Exudates, Polymers, Biopolymers, Compounds used in a research, industrial, or household setting, Macromolecular Substances	experimental	0
DB15657	Ala-geninthiocin	Drug	Anti-Bacterial Agents	experimental	0
DB14327	Purslane	Drug	0	approved, experimental	0
DB15658	2-chloro-4,5-dimethylphenol	Drug	0	experimental	0
DB15655	Ad5-nCoV	Drug	Experimental Unapproved Treatments for COVID-19	investigational	0
DB14324	Apricot kernel oil	Drug	0	approved, experimental	0
DB15656	AZD1222	Drug	Experimental Unapproved Treatments for COVID-19	investigational	0
DB14325	Schisandra chinensis fruit	Drug	0	experimental	0
DB14328	Chamaemelum nobile flower	Drug	0	experimental	0
DB15659	alpha,alpha-Dibromo-D-camphor	Drug	0	experimental	0
DB14329	Sunflower oil	Drug	Complex Mixtures, Oils, Plant Preparations, Biological Products, Lipids, Plant Oils	investigational, experimental	0
DB02340	N-Acetyl-Serine	Drug	0	experimental	1
DB03671	Digoxigenin	Drug	Carbohydrates, Cardanolides, Cardiac Glycosides, Digitalis Glycosides, Glycosides, Cardenolides, Digoxin and derivatives, Fused-Ring Compounds, Steroids	experimental	0
DB03670	2-(Oxalyl-Amino)-4,5,6,7-Tetrahydro-Thieno[2,3-C]Pyridine-3-Carboxylic Acid	Drug	0	experimental	1
DB03675	2,3-Dihydroxy-Valerianic Acid	Drug	0	experimental	0
DB01012	Cinacalcet	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Other Miscellaneous Therapeutic Agents, Calcium Homeostasis, Increased Calcium-sensing Receptor Sensitivity, Cytochrome P-450 CYP3A4 Substrates, Anti-Parathyroid Agents, Naphthalenes, Cytochrome P-450 CYP3A Substrates, Calcium-Regulating Hormones and Agents, Cytochrome P-450 CYP1A2 Substrates, Calcium-sensing Receptor Agonist, Hormone Antagonists, Calcimimetic Agents, Cytochrome P-450 CYP2D6 Inhibitors (strong), Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins	approved	1
DB01013	Clobetasol propionate	Drug	Pregnadienetriols, Corticosteroids, Cytochrome P-450 Substrates, Immunosuppressive Agents, Glucocorticoids, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A Substrates, Pregnanes, Thyroxine-binding globulin inhibitors, Steroids, Fluorinated, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Hyperglycemia-Associated Agents, Cytochrome P-450 CYP3A5 Inducers, Steroids	approved	3
DB02343	3,6,9,12,15-Pentaoxaheptadecane	Drug	0	experimental	3
DB01010	Edrophonium	Drug	Enzyme Inhibitors, Amines, Ammonium Compounds, Antidotes, Cholinesterase Inhibitors, Protective Agents, Quaternary Ammonium Compounds, Onium Compounds, Drugs that are Mainly Renally Excreted, Neurotransmitter Agents, Cholinergic Agents, Phenylammonium Compounds, Compounds used in a research, industrial, or household setting, Nitrogen Compounds	approved	2
DB02342	2-Methoxyestradiol	Drug	Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, Tubulin Modulators, Estrenes, Antineoplastic Agents, Mitosis Modulators, Hormones, Fused-Ring Compounds, Gonadal Steroid Hormones, Antimitotic Agents, Estradiol Congeners, Gonadal Hormones, Steroids	investigational	5
DB03673	beta-2-Thienyl-L-alanine	Drug	0	experimental	1
DB01011	Metyrapone	Drug	Pyridines, Enzyme Inhibitors, Steroid Synthesis Inhibitors, Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Noxae, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Tests for Pituitary Function, Cytochrome P-450 CYP2A6 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP2A6 Inhibitors (strength unknown), Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Toxic Actions, Diagnostic Agents	approved, investigational	2
DB03672	9-N-Phenylmethylamino-Tacrine	Drug	0	experimental	1
DB02341	Mdl 101,146	Drug	Oxazines, Peptides, Amino Acids, Peptides, and Proteins, Pancreatic Elastase, antagonists & inhibitors	experimental	2
DB02348	Monofluorophosphate ion	Drug	Cariostatic Agents, Toothpastes, Protective Agents, Hydrofluoric Acid, Fluorine Compounds, Ions, Phosphorus Compounds, Phosphorus Acids, Anions, Acids, Noncarboxylic, Acids, Phosphoric Acids, Electrolytes, Compounds used in a research, industrial, or household setting	experimental	1
DB01016	Glyburide	Drug	BSEP/ABCB11 Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Hypoglycemia-Associated Agents, BSEP/ABCB11 Substrates, Cytochrome P-450 CYP3A4 Substrates, Sulfur Compounds, Alimentary Tract and Metabolism, Cytochrome P-450 CYP2C9 Inhibitors, Drugs Used in Diabetes, Drugs causing inadvertant photosensitivity, Sulfones, Cytochrome P-450 CYP3A5 Substrates, Blood Glucose Lowering Agents, OAT1/SLC22A6 inhibitors, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Sulfonylureas, P-glycoprotein inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (weak)	approved	8
DB03679	2-Hydroxy-Tryptophan	Drug	0	experimental	1
DB01017	Minocycline	Drug	Agents that produce neuromuscular block (indirect), Antiinfectives for Systemic Use, Anti-Infective Agents, OAT1/SLC22A6 inhibitors, Anti-Bacterial Agents, Antiinfectives and Antiseptics for Local Oral Treatment, Photosensitizing Agents, Agents Causing Muscle Toxicity, Alimentary Tract and Metabolism, Tetracyclines, Naphthacenes, OAT3/SLC22A8 Inhibitors, Drugs causing inadvertant photosensitivity, Antibacterials for Systemic Use, Stomatological Preparations	approved, investigational	12
DB03678	(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine	Drug	0	experimental	0
DB02347	2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid	Drug	Organophosphorus Compounds, Receptors, AMPA, antagonists & inhibitors	experimental	1
DB01014	Balsalazide	Drug	Aminobenzoates, Aminosalicylate, Nephrotoxic agents, Sensory System Agents, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, Non COX-2 selective NSAIDS, Peripheral Nervous System Agents, Intestinal Antiinflammatory Agents, Analgesics, Alimentary Tract and Metabolism, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Salicylates, Benzene Derivatives, Gastrointestinal Agents, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Colitis, Ulcerative, Hydrazines, Benzoates, Hydroxy Acids, Prodrugs, Inflammatory Bowel Diseases, Aminosalicylic Acids, meta-Aminobenzoates, Hydroxybenzoates, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Agents that produce hypertension, Phenols, Central Nervous System Agents	approved, investigational	4
DB02346	3'-O-N-Octanoyl-a-D-Glucopyranosyl-B-D-Fructofuranoside	Drug	0	experimental	1
DB03677	N-Cyclohexyl-N'-Decylurea	Drug	0	experimental	1
DB02345	Selenocysteine	Drug	Organoselenium Compounds, Amino Acids, Neutral, Cysteine, Sulfur Compounds, Amino Acids, Sulfur, Amino Acids, Peptides, and Proteins, Amino Acids, Selenium Compounds, Sulfhydryl Compounds	experimental	4
DB03676	Cystein-S-Yl Cacodylate	Drug	0	experimental	2
DB01015	Sulfamethoxazole	Drug	QTc Prolonging Agents, BSEP/ABCB11 Inhibitors, Amines, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Agents causing hyperkalemia, Aniline Compounds, Genito Urinary System and Sex Hormones, Hypoglycemia-Associated Agents, BSEP/ABCB11 Substrates, Antimycobacterials, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Sulfanilamides, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, SULFONAMIDES AND TRIMETHOPRIM, Anti-Bacterial Agents, Sulfur Compounds, Sulfonamide Antibacterial, Cytochrome P-450 CYP2C9 Inhibitors, Potential QTc-Prolonging Agents, Intermediate-Acting Sulfonamides, Drugs causing inadvertant photosensitivity, Sulfones, Antibiotics for Pneumocystis Pneumonia, Gynecological Antiinfectives and Antiseptics, Blood Glucose Lowering Agents, Antiinfectives for Systemic Use, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Inhibitors, Drugs for Treatment of Tuberculosis, Cytochrome P-450 CYP3A Substrates, Photosensitizing Agents, Agents Causing Muscle Toxicity, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Sulfonamides, Cytochrome P-450 CYP3A4 Inhibitors, Methemoglobinemia Associated Agents, Antibacterials for Systemic Use	approved	1
DB01018	Guanfacine	Drug	OCT1 substrates, Cytochrome P-450 Substrates, OCT2 Substrates, OCT1 inhibitors, MATE inhibitors, Cardiovascular Agents, Hypotensive Agents, MATE 1 Inhibitors, Antiadrenergic Agents, Centrally Acting, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Adrenergic alpha-2 Receptor Agonists, Imidazoline Receptor Agonists, Central Alpha-agonists, Antihypertensive Agents, Adrenergic Agents, Bradycardia-Causing Agents, Antihypertensive Agents Indicated for Hypertension, Adrenergic alpha-Agonists, Agents producing tachycardia, Amidines, Guanidines, Cytochrome P-450 CYP2C19 Substrates, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Adrenergic Agonists, Agents that produce hypertension, Central alpha-2 Adrenergic Agonist	approved, investigational	2
DB01019	Bethanechol	Drug	Autonomic Agents, Acids, Acyclic, Amines, Ammonium Compounds, Cholinergic Agonists, Nervous System, Quaternary Ammonium Compounds, Parasympathomimetics, Trimethyl Ammonium Compounds, Onium Compounds, Parasympathomemetic (Cholinergic) Agents, Peripheral Nervous System Agents, Muscarinic Agonists, Neurotransmitter Agents, Cholinergic Agents, Choline Esters, Carbamates, Bethanechol Compounds, Nitrogen Compounds	approved	4
DB02349	Nicotinamide-adenine-dinucleotide-5-hydroxy-4-oxonorvaline	Drug	0	experimental	0
DB15650	Efpeglenatide	Drug	0	investigational	0
DB04930	Permethrin	Drug	Enzyme Inhibitors, Antiparasitic Products, Insecticides and Repellents, Cytochrome P-450 Substrates, Pyrethrins, Ectoparasiticides, Incl. Scabicides, Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents, Pesticides, Scabicides and Pediculicides, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Insecticides, Drugs that are Mainly Renally Excreted, Cytochrome P-450 Enzyme Inducers, Agrochemicals, Cytochrome P-450 CYP3A Substrates, Pyrethrines, Incl. Synthetic Compounds, Cytochrome P-450 CYP2B6 Inducers, Toxic Actions, Monoterpenes, Cytochrome P-450 CYP2B6 Substrates, Terpenes, Compounds used in a research, industrial, or household setting	approved, investigational	3
DB04931	Afamelanotide	Drug	Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Protective Agents, Dermatologicals, Laboratory Chemicals, Protectives Against UV-Radiation for Systemic Use, Amino Acids, Peptides, and Proteins, Proteins, Peptide Hormones, Protectives Against UV-Radiation, Melanocyte-Stimulating Hormones, Indicators and Reagents, Compounds used in a research, industrial, or household setting	approved, investigational	1
DB04932	Defibrotide	Drug	Anticoagulants, Carbohydrates, Blood and Blood Forming Organs, Fibrin Modulating Agents, Hematologic Agents, Cardiovascular Agents, Nucleotides, Fibrinolytic Agents, Polynucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Aptamers, Nucleotide, Glycosides, Antiplatelet agents	approved, investigational	3
DB04933	Eritoran	Drug	Antigens, Biological Factors, Carbohydrates, Lipopolysaccharides, antagonists & inhibitors, Glycoconjugates, Polysaccharides, Bacterial, Toll-Like Receptor 4, antagonists & inhibitors, Endotoxins, Lipids, Antigens, Bacterial, Oligosaccharides, Lipopolysaccharides, Toxins, Biological, Polysaccharides, Bacterial Toxins	investigational	1
DB03602	S-benzylglutathione	Drug	Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins, Lactoylglutathione Lyase, antagonists & inhibitors	experimental	2
DB03601	5-deoxyflavanone	Drug	0	experimental	0
DB03600	Capric acid	Drug	Fatty Acids, Lipids, Antifungal Agents, Anti-Infective Agents	experimental	7
DB04938	Ospemifene	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Sex Hormones and Modulators of the Genital System, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Genito Urinary System and Sex Hormones, Benzylidene Compounds, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C19 Substrates, Estrogen Agonist/Antagonist, Cytochrome P-450 CYP2C9 Substrates, Selective Estrogen Receptor Modulators, Stilbenes, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2B6 Substrates, Benzene Derivatives, Cytochrome P-450 CYP2D6 Inhibitors (weak)	approved, investigational	1
DB03606	(S)-Rolipram	Drug	0	experimental	2
DB03605	(2s)-2-[(2,4-Dichloro-Benzoyl)-(3-Trifluoromethyl-Benzyl)-Amino]-3-Phenyl-Propionic Acid	Drug	0	experimental	1
DB03604	Tiratricol	Drug	Amino Acids, Aromatic, Amino Acids, Cyclic, Thyroid Products, Hormones, Hormone Substitutes, and Hormone Antagonists, Dermatologicals, Amino Acids, Peptides, and Proteins, Hormones, Thyronines, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Amino Acids, Agents used to treat hypothyroidism	investigational	1
DB03603	Glucaric acid	Drug	Acids, Acyclic, Carbohydrates, Hydroxy Acids, Sugar Acids	experimental	1
DB04934	Rifalazil	Drug	Lactams, Macrocyclic, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, Antibiotics, Antitubercular, Amides, Lactams, Cytochrome P-450 CYP3A4 Substrates, Leprostatic Agents, Anti-Infective Agents, Antituberculosis Agents	investigational	1
DB03609	3'-deoxyguanosine	Drug	0	experimental	1
DB04936	Tagatose	Drug	Carbohydrates, Iron Chelating Agents, Sequestering Agents, Compounds used in a research, industrial, or household setting, Chelating Agents, Monosaccharides	investigational	0
DB03608	Diminazene	Drug	Benzamidines, Antiprotozoals, Trypanocidal Agents, Amidines, Anti-Infective Agents, Antiparasitic Agents, Triazenes	experimental	4
DB03607	[(1R)-1-acetamido-2-(4-chlorophenyl)ethyl]-[(2S)-2-amino-3-hydroxy-3-oxo-propoxy]-dihydroxy-boron	Drug	0	experimental	1
DB04941	Crofelemer	Drug	Antidiarrheals, Benzopyrans, Biopolymers, Macromolecular Substances, Heterocyclic Compounds, Fused-Ring, Flavonoids, Tannins, Alimentary Tract and Metabolism, Chromans, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Polymers, Compounds used in a research, industrial, or household setting, Chromones, Pyrans	approved	2
DB04942	Tamibarotene	Drug	Acids, Carbocyclic, Benzene Derivatives, Naphthalenes	investigational	2
DB04943	LX201	Drug	0	investigational	0
DB04944	Acadesine	Drug	Carbohydrates, Imidazoles, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Cardiac Therapy	investigational	0
DB03613	4-hydroxyphenacyl coenzyme A	Drug	0	experimental	2
DB03612	3-Hydroxybutyryl-Coenzyme A	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Coenzymes, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Thioesters of coenzyme A, Enzymes and Coenzymes, Glycosides, Nucleotides, Adenine Nucleotides	experimental	1
DB03611	L-2-amino-4-methoxy-cis-but-3-enoic acid	Drug	0	experimental	1
DB03610	4-(trifluoromethyl)phenol	Drug	Benzene Derivatives	experimental	0
DB04949	Pexelizumab	Drug	Amino Acid Sequence, Immunoglobulins, Peptide Fragments, Peptides, Antibodies, Molecular Sequence Data, Amino Acids, Peptides, and Proteins, Information Science, Antibodies, Monoclonal, Information Services, Immunoglobulin Fragments, Immunoproteins, Proteins, Serum Globulins, Globulins, Blood Proteins, Biochemical Phenomena, Immunoglobulin Variable Region, Molecular Structure, Immunoglobulin Fab Fragments	investigational	0
DB03617	Modified Acarbose Hexasaccharide	Drug	0	experimental	0
DB03616	Kabiramide C	Drug	0	experimental	1
DB03615	Ribostamycin	Drug	Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Nephrotoxic agents, Carbohydrates, Anti-Bacterial Agents, Narrow Therapeutic Index Drugs, Aminoglycoside Antibacterials, Glycosides, Agents that produce neuromuscular block (indirect), Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use, Drugs that are Mainly Renally Excreted	approved, experimental	4
DB03614	Mecobalamin	Drug	Heterocyclic Compounds, Fused-Ring, Antianemic Preparations, Blood and Blood Forming Organs, Vitamin B Complex, Corrinoids, Vitamins, VITAMIN B12 AND FOLIC ACID	approved, investigational	1
DB04945	Hemoglobin	Drug	Proteins, Blood Proteins, Globins, Amino Acids, Peptides, and Proteins, Hemeproteins, Hemoglobins	approved, investigational, experimental	0
DB04946	Iloperidone	Drug	Highest Risk QTc-Prolonging Agents, Psycholeptics, QTc Prolonging Agents, Tranquilizing Agents, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 CYP3A7 Substrates, Nervous System, Schizophrenia, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Serotonin 5-HT2 Receptor Antagonists, Antipsychotic Agents, Histamine H1 Antagonists, Antipsychotic Agents (Second Generation Atypical), Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Adrenergic Antagonists, Adrenergic alpha-1 Receptor Antagonists, Dopamine Antagonists, Neurotoxic agents, Cytochrome P-450 CYP2E1 Substrates, Cytochrome P-450 CYP3A5 Substrates, Adrenergic alpha-Antagonists, Psychotropic Drugs, Histamine Antagonists, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Agents that produce hypertension, Serotonin Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Dopamine D2 Receptor Antagonists, Hyperglycemia-Associated Agents, Serotonin 5-HT1 Receptor Antagonists	approved	11
DB04947	Altropane	Drug	Alkaloids, Tropanes, Iodine Radioisotopes, Aza Compounds, Azabicyclo Compounds	investigational	1
DB03619	Deoxycholic acid	Drug	BSEP/ABCB11 inducers, Dermatologicals, Decreased Cell Membrane Integrity, Cholagogues and Choleretics, Other Miscellaneous Therapeutic Agents, Cytolytic Agent, Bile Acids and Salts, Cholanes, Cholic Acids, Fused-Ring Compounds, Gastrointestinal Agents, Steroids	approved	11
DB03618	2-(acetylamino)-2-deoxy-4-O-beta-D-galactopyranosyl-alpha-D-glucopyranose	Drug	0	experimental	0
DB04948	Lofexidine	Drug	QTc Prolonging Agents, Cytochrome P-450 Substrates, Sensory System Agents, Serotonin Agents, Nervous System, MATE inhibitors, Cardiovascular Agents, Hypotensive Agents, MATE 1 Inhibitors, Antidepressive Agents, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Adrenergic alpha-2 Receptor Agonists, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Antihypertensive Agents, Adrenergic Agents, Adrenergic alpha-Agonists, Serotonin Receptor Agonists, Agents producing tachycardia, Drugs Used in Addictive Disorders, Moderate Risk QTc-Prolonging Agents, Cytochrome P-450 CYP2C19 Substrates, Neurotransmitter Agents, Imidazolines, Imidazoles, Central Nervous System Depressants, Adrenergic Agonists, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Drugs Used in Opioid Dependence, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Serotonin 5-HT2 Receptor Agonists	approved, investigational	6
DB15602	Cashew fruit	Drug	0	approved	0
DB15603	Coffea arabica seed, roasted	Drug	0	approved	0
DB15601	NNZ-2591	Drug	Piperazines, Peptides, Amino Acids, Peptides, and Proteins	investigational	0
DB15606	White mustard seed	Drug	0	approved	0
DB15607	Hydrolyzed soy protein	Drug	0	experimental	0
DB15604	Lactuca sativa whole	Drug	0	approved	0
DB15605	Field mushroom	Drug	0	approved	0
DB15608	Theobroma cacao whole	Drug	0	approved	0
DB15609	JPC-3210	Drug	Antimalarials, Antiviral Agents	experimental	0
DB04952	Ramoplanin	Drug	Peptides, Cyclic, Anti-Bacterial Agents, Peptides, Amino Acids, Peptides, and Proteins, Anti-Infective Agents	investigational	0
DB04953	Ezogabine	Drug	Acids, Acyclic, QTc Prolonging Agents, Amines, Nervous System, Aniline Compounds, UGT1A3 substrates, Polyamines, Drugs that are Mainly Renally Excreted, Membrane Transport Modulators, Diamines, Anticonvulsants, Central Nervous System Depressants, UGT1A1 Substrates, Potassium Channel Openers, UGT1A9 Substrates, Potential QTc-Prolonging Agents, UGT1A4 substrates, Central Nervous System Agents, Potassium Channel Opener	approved, investigational	4
DB04954	Tecadenoson	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Purines, Ribonucleosides, Nucleic Acids, Nucleotides, and Nucleosides, Purinergic Agonists, Glycosides, Nucleosides, Purinergic Agents, Purine Nucleosides, Purinergic P1 Receptor Agonists	investigational	1
DB04955	Pumactant	Drug	Lipids, Membrane Lipids, Pulmonary Surfactants	investigational	0
DB03624	7-(Carboxyamino)-8-Amino-Nonanoic Acid	Drug	0	experimental	1
DB03623	9-(4-Hydroxyphenyl)-2,7-Phenanthroline	Drug	0	experimental	1
DB03622	5-[4-(2-Hydroxyethyl)-1-piperidinyl]-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione	Drug	0	experimental	1
DB04950	Ranpirnase	Drug	Enzymes, Enzyme Inhibitors, Antineoplastic Agents, Enzymes and Coenzymes, Hydrolases, Rana pipiens, Esterases, Egg Proteins, Protein Synthesis Inhibitors	investigational	1
DB04951	Pirfenidone	Drug	Analgesics, Non-Narcotic, Pyridines, Cytochrome P-450 Substrates, Immunosuppressive Agents, Sensory System Agents, Cytochrome P-450 Enzyme Inhibitors, Anti-Inflammatory Agents, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Antirheumatic Agents, Pyridones, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Peripheral Nervous System Agents, Antifibrotic Agents, Cytochrome P-450 CYP1A2 Inhibitors, Analgesics, Cytochrome P-450 CYP1A2 Substrates, Central Nervous System Agents	approved, investigational	1
DB03621	L-709,587	Drug	0	experimental	1
DB03628	ISO24	Drug	0	experimental	1
DB03627	Adamantane	Drug	Cycloparaffins	experimental	1
DB03626	5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione	Drug	0	experimental	1
DB04956	Afelimomab	Drug	Immunologic Factors, Immunoglobulins, Immunosuppressive Agents, Tumor Necrosis Factor Alpha (TNF-α) Inhibitors, Antineoplastic and Immunomodulating Agents, Antibodies, Amino Acids, Peptides, and Proteins, Agents reducing cytokine levels, Immunoproteins, Proteins, Serum Globulins, Globulins, Blood Proteins	investigational	1
DB04957	Azimilide	Drug	Antiarrhythmics, Class III, QTc Prolonging Agents, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Imidazolidines, Moderate Risk QTc-Prolonging Agents, Membrane Transport Modulators, Imidazoles, Cytochrome P-450 CYP3A Substrates, Calcium-Regulating Hormones and Agents, Cytochrome P-450 CYP2D6 Substrates, Antiarrhythmic agents	investigational	3
DB04958	Epratuzumab	Drug	Proteins, Serum Globulins, Antineoplastic Agents, Immunological, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	1
DB03629	Pyridoxal-5'-Phosphate-N-Oxide	Drug	0	experimental	1
DB04959	Verpasep caltespen	Drug	0	investigational	2
DB15610	(4-(trifluoromethoxy)phenyl)urea	Drug	0	experimental	0
DB15613	Musa acuminata fruit	Drug	0	approved	0
DB15614	Previtamin D(3)	Drug	Cholestanes, Secosteroids, Sterols, Vitamin D and Analogues, Vitamins (Fat Soluble), Lipids, Membrane Lipids, Cholestenes, Fused-Ring Compounds, Vitamins, Steroids	experimental	0
DB15611	Muskmelon	Drug	0	approved	0
DB15612	American hazelnut	Drug	Non-Standardized Food Allergenic Extract, Cell-mediated Immunity, Non-Standardized Plant Allergenic Extract, Increased Histamine Release	approved	0
DB15617	Ferric derisomaltose	Drug	Parenteral Iron Replacement, Antianemic Preparations, Antianemia Drugs, Iron Compounds, Anemia, Iron-Deficiency	approved	2
DB15618	(5E,7E,9)-decatrien-2-one	Drug	0	experimental	0
DB15615	Fennel	Drug	0	approved, experimental	0
DB15616	REC-994	Drug	0	investigational	0
DB15619	(5Z,7E,9)-decatrien-2-one	Drug	0	experimental	0
DB04963	rhGAD65	Drug	0	investigational	0
DB03631	3-(4-hydroxy-3-imino-6-oxo-cyclohexa-1,4-dienyl)-alanine	Drug	0	experimental	1
DB02300	Calcipotriol	Drug	Cholestanes, Secosteroids, Antipsoriatics for Topical Use, Dermatologicals, Lipids, Misc. Skin and Mucous Membrane Agents, Antipsoriatics, Fused-Ring Compounds, Vitamins, Sterols, Vitamin D and Analogues, Vitamins (Fat Soluble), Membrane Lipids, Cholestenes, Steroids	approved	1
DB03630	2-Iodobenzylthio Group	Drug	0	experimental	0
DB04964	Oregovomab	Drug	Proteins, Serum Globulins, Antineoplastic Agents, Immunological, Immunoglobulins, CA-125 Antigen, Globulins, Blood Proteins, Antibodies, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	1
DB03635	Ethanesulfonic acid	Drug	Alkanesulfonic Acids, Sulfur Compounds, Acids, Noncarboxylic, Acids, Sulfur Acids, Hydrocarbons, Acyclic, Sulfonic Acids, Alkanes	experimental	2
DB02304	Prostaglandin B2	Drug	Biological Factors, Autacoids, Fatty Acids, Unsaturated, Inflammation Mediators, Prostaglandins, Fatty Acids, Eicosanoids, Lipids	experimental	0
DB02303	(5S)-5-Iododihydro-2,4(1H,3H)-pyrimidinedione	Drug	0	experimental	1
DB04960	Tipifarnib	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Antineoplastic Agents, P-glycoprotein inhibitors	investigational	1
DB03634	1,3-DI(N-Propyloxy-A-mannopyranosyl)-carbomyl 5-methyazido-benzene	Drug	0	experimental	0
DB03633	Lpc-Ether	Drug	0	experimental	2
DB02302	Symmetric dimethylarginine	Drug	Amino Acids, Basic, Amino Acids, Essential, Amino Acids, Diamino, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	1
DB04961	Troxacitabine	Drug	Pyrimidines, Pyrimidinones, Antineoplastic Agents, Anti-HIV Agents, Anti-Infective Agents, Dioxoles	investigational	1
DB02301	5,10-Methylene-6-Hydrofolic Acid	Drug	0	experimental	3
DB04962	Bectumomab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB03632	Argifin	Drug	Peptides, Amino Acids, Peptides, and Proteins, Chitinases, antagonists & inhibitors	experimental	2
DB03639	1-Guanidinium-7-Aminoheptane	Drug	0	experimental	1
DB02308	4-(1,3,2-Dioxaborolan-2-Yloxy)Butan-1-Aminium	Drug	0	experimental	1
DB02307	N-(1-carboxy-3-phenylpropyl)phenylalanyl-alpha-asparagine	Drug	Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins	experimental	1
DB03638	Cytidyl-2'-5'-phospho-guanosine	Drug	0	experimental	0
DB02306	Palmitoyl-Linoleoyl Phosphatidylcholine	Drug	0	experimental	1
DB03637	Guanidine-3-propanol	Drug	0	experimental	1
DB03636	Glycinamide	Drug	Amino Acids, Peptides, and Proteins, Amino Acids	experimental	1
DB02305	4,5-Dehydro-D-Glucuronic Acid	Drug	0	experimental	1
DB04967	Lucanthone	Drug	Xanthenes, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Xanthones, Anthelmintics, Antiplatyhelmintic Agents, Thioxanthenes, Schistosomicides, Anti-Infective Agents, Antiparasitic Agents	investigational	4
DB04968	PH94B	Drug	0	investigational	0
DB04969	NV1020	Drug	0	investigational	0
DB02309	5-monophosphate-9-beta-D-ribofuranosyl xanthine	Drug	0	experimental	2
DB14377	Palm oil	Drug	Complex Mixtures, Oils, Plant Preparations, Biological Products, Lipids, Plant Oils	experimental	0
DB13045	Racotumomab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB14378	Camphor leaf oil	Drug	0	experimental	0
DB13044	Gossypol	Drug	Contraceptive Agents, Male, Adrenal Cortex Hormones, Reproductive Control Agents, Sesquiterpenes, Terpenes, Hormonal Contraceptives for Systemic Use	investigational	1
DB13047	Pentavalent Antimony	Drug	0	investigational	0
DB14375	Milk thistle	Drug	Herbs and Natural Products	approved, investigational, experimental	0
DB14376	Chicory leaf	Drug	0	experimental	0
DB13046	Tocladesine	Drug	Carbohydrates, Immunologic Factors, Antineoplastic Agents, Cyclic AMP, Nucleotides, Nucleotides, Cyclic, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Adenine Nucleotides	investigational	0
DB13049	Lobaplatin	Drug	Organometallic Compounds, Cycloparaffins	investigational	0
DB13048	PAC-1	Drug	0	investigational	0
DB14379	Zanthoxylum clava-herculis bark	Drug	0	experimental	0
DB02391	2-Amino-7-[2-(2-Hydroxy-1-Hydroxymethyl-Ethylamino)-Ethyl]-1,7-Dihydro-Purin-6-One	Drug	0	experimental	1
DB02390	5-Bromo-N[2-(Dimethylamino)Ethyl]-9-Aminoacridine-4-Carboxamide	Drug	0	experimental	0
DB01060	Amoxicillin	Drug	Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Penicillins With Extended Spectrum, Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Penicillin G, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, OAT1/SLC22A6 inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord), Sulfur Compounds, Alimentary Tract and Metabolism, Cytochrome P-450 CYP2C8 Inhibitors (weak), Penicillins, Aminopenicillins, Drugs for Acid Related Disorders, Antibacterials for Systemic Use	approved, vet_approved	1
DB01063	Acetophenazine	Drug	Heterocyclic Compounds, Fused-Ring, Psycholeptics, Antipsychotic Agents, Sulfur Compounds, Nervous System, Central Nervous System Depressants, Phenothiazines, Dopamine Antagonists, Dopamine D2 Receptor Antagonists, Phenothiazines With Piperazine Structure, Neurotoxic agents	approved	2
DB02395	3-Hydroxymethyl-5-Aziridinyl-1methyl-2-[1h-Indole-4,7-Dione]-Propanol	Drug	0	experimental	1
DB01064	Isoprenaline	Drug	Adrenergics, Inhalants, Amines, Cardiovascular Agents, Adrenergic beta-2 Receptor Agonists, Alcohols, Peripheral Nervous System Agents, Non-selective Beta-adrenergic Agonists, Compounds used in a research, industrial, or household setting, Adrenergic Agents, Benzene Derivatives, Autonomic Agents, Adrenergics for Systemic Use, Anti-Asthmatic Agents, Protective Agents, Agents producing tachycardia, Catecholamines, Catechols, Adrenergic and Dopaminergic Agents, Bronchodilator Agents, Amino Alcohols, Ethanolamines, Respiratory System Agents, Cardiotonic Agents, Adrenergic beta-Agonists, Neurotransmitter Agents, Sympathomimetics, Adrenergic Agonists, Cardiac Stimulants Excl. Cardiac Glycosides, Agents that produce hypertension, Phenols, Drugs for Obstructive Airway Diseases, Cardiac Therapy	approved, investigational	9
DB02394	Oxiranpseudoglucose	Drug	0	experimental	1
DB01061	Azlocillin	Drug	Penicillins With Extended Spectrum, Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Penicillin G, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, Antibacterials for Systemic Use, Agents that reduce seizure threshold	approved	1
DB02393	D-Gluco-2,5-Anhydro-1-Deoxy-1-Phosphonohexitol-6-Phosphate	Drug	0	experimental	1
DB01062	Oxybutynin	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Acids, Carbocyclic, Drugs for Urinary Frequency and Incontinence, Genito Urinary System and Sex Hormones, Urologicals, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Muscarinic Antagonists, Cytochrome P-450 CYP3A4 Substrates, Peripheral Nervous System Agents, Anticholinergic Agents, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Autonomic Agents, Cytochrome P-450 CYP3A5 Substrates, Hydroxy Acids, Cytochrome P-450 CYP2C8 Inhibitors, Agents producing tachycardia, Parasympatholytics, Urological Agents, Neurotransmitter Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors	approved, investigational	3
DB02399	L-Rhamnitol	Drug	0	experimental	1
DB01067	Glipizide	Drug	Cytochrome P-450 Substrates, Hypoglycemia-Associated Agents, BSEP/ABCB11 Substrates, Blood Glucose Lowering Agents, Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP2C9 Substrates, Sulfur Compounds, Cytochrome P-450 CYP3A Substrates, Alimentary Tract and Metabolism, UGT1A1 Substrates, Sulfonylureas, Drugs Used in Diabetes, Sulfones	approved, investigational	2
DB01068	Clonazepam	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, GABA Agents, Nervous System, GABA Modulators, Benzodiazepines and benzodiazepine derivatives, Cytochrome P-450 CYP3A4 Substrates, Muscle Relaxants, Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Heterocyclic Compounds, Fused-Ring, Anticonvulsants, Benzazepines, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Muscle Relaxants, Centrally Acting Agents, Benzodiazepinones, Central Nervous System Agents	approved, illicit	3
DB02398	6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine	Drug	0	experimental	1
DB01065	Melatonin	Drug	Psycholeptics, Melatonin Receptor Agonists, Amines, Cytochrome P-450 Substrates, Hormones, Hormone Substitutes, and Hormone Antagonists, Nervous System, Melatonin, antagonists & inhibitors, Protective Agents, Melatonin, agonists, Hormones, Biogenic Monoamines, Antioxidants, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Central Nervous System Depressants, Cytochrome P-450 CYP1A2 Substrates, Biogenic Amines, Hypnotics and Sedatives, Central Nervous System Agents, Indoles, OAT3/SLC22A8 Inhibitors, Tryptamines, Compounds used in a research, industrial, or household setting	approved, nutraceutical, vet_approved	10
DB02397	O-(N-acetyl-alpha-D-galactosaminyl)-L-serine	Drug	Antigens, Biological Factors, Antigens, Neoplasm, Biomarkers, Epitopes, Biomarkers, Tumor	experimental	0
DB02396	Methylethylamine	Drug	0	experimental	1
DB01066	Cefditoren	Drug	Nephrotoxic agents, Third-Generation Cephalosporins, Amides, Lactams, Thiazines, beta-Lactams, Antiinfectives for Systemic Use, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Cephalosporins, Antibacterials for Systemic Use	approved, investigational	2
DB01069	Promethazine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Muscarinic Antagonists, Antidepressive Agents, Drugs that are Mainly Renally Excreted, Anticholinergic Agents, Serotonin Modulators, Antipsychotic Agents, Histamine H1 Antagonists, Sulfur Compounds, Antipruritics, Incl. Antihistamines, Anesthetics, Etc., Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Acid Reducers, Cytochrome P-450 CYP2C9 Inhibitors, Potential QTc-Prolonging Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Drugs causing inadvertant photosensitivity, Phenothiazine Derivatives, Antihistamines for Systemic Use, Antipruritics, Dopamine Antagonists, Agents that reduce seizure threshold, Neurotoxic agents, Anti-Allergic Agents, Antidotes, Antihistamines for Topical Use, Phenothiazines, Dermatologicals, Agents producing tachycardia, Histamine H2 Antagonists, Miscellaneous Anxiolytics Sedatives and Hypnotics, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Histamine Antagonists, Photosensitizing Agents, Central Nervous System Depressants, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Histamine Agents, P-glycoprotein inhibitors, Dopamine D2 Receptor Antagonists, Propylamines	approved, investigational	13
DB14370	Phellodendron amurense bark	Drug	0	experimental	0
DB13041	Odalasvir	Drug	Acids, Acyclic, Heterocyclic Compounds, Fused-Ring, Antiviral Agents, Anti-Infective Agents	investigational	0
DB14373	Quercus acutissima whole	Drug	0	experimental	0
DB13040	Gandotinib	Drug	Janus Kinase 2, antagonists & inhibitors	investigational	0
DB14374	Pumice	Drug	Anions, Acids, Noncarboxylic, Acids, Electrolytes, Ions, Oxides, Minerals, Oxygen Compounds, Silicon Compounds	experimental	0
DB14371	Mangostin	Drug	Xanthenes, Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors	experimental	0
DB14372	Melaleuca alternifolia leaf	Drug	0	experimental	0
DB13042	Fenoverine	Drug	Autonomic Agents, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Alimentary Tract and Metabolism, Parasympatholytics, Drugs for Functional Gastrointestinal Disorders, Peripheral Nervous System Agents	investigational	0
DB13056	Irsogladine	Drug	Radiation-Protective Agents, Protective Agents, Anticarcinogenic Agents, Anti-Ulcer Agents, Compounds used in a research, industrial, or household setting, Gastrointestinal Agents	investigational	0
DB14388	Bordetella pertussis toxoid antigen (formaldehyde inactivated)	Drug	0	approved	0
DB13055	Oteseconazole	Drug	0	investigational	0
DB14389	Influenza A virus A/Texas/50/2012 X-223A (H3N2) hemagglutinin antigen (formaldehyde inactivated)	Drug	0	approved	0
DB13058	Methanesulfonyl Fluoride	Drug	Neurotransmitter Agents, Enzyme Inhibitors, Sulfur Compounds, Cholinergic Agents, Cholinesterase Inhibitors	investigational	0
DB14386	Influenza A virus A/Victoria/361/2011 IVR-165 (H3N2) hemagglutinin antigen (formaldehyde inactivated)	Drug	0	approved	0
DB13057	Torapsel	Drug	0	investigational	0
DB14387	Influenza B virus B/Texas/6/2011 hemagglutinin antigen (formaldehyde inactivated)	Drug	0	approved	0
DB13059	PF-03814735	Drug	Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors	investigational	0
DB01070	Dihydrotachysterol	Drug	Cholestanes, Secosteroids, Lipids, Fused-Ring Compounds, Vitamins, Micronutrients, Physiological Phenomena, Sterols, Vitamin D and Analogues, Alimentary Tract and Metabolism, Vitamins (Fat Soluble), Food and Beverages, Bone Density Conservation Agents, Membrane Lipids, Cholestenes, Growth Substances, Diet, Food, and Nutrition, Food, Steroids	approved	1
DB01071	Mequitazine	Drug	QTc Prolonging Agents, Anti-Allergic Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Bronchodilator Agents, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Histamine H1 Antagonists, Sulfur Compounds, Cytochrome P-450 CYP3A Inhibitors, Histamine Antagonists, Cytochrome P-450 CYP3A4 Inhibitors, Potential QTc-Prolonging Agents, Cytochrome P-450 CYP2D6 Substrates, Histamine Agents, Phenothiazine Derivatives, Antihistamines for Systemic Use	experimental	1
DB01074	Perhexiline	Drug	Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Agents causing hyperkalemia, Non-Selective Calcium Channel Blockers, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Substrates, Membrane Transport Modulators, Calcium Channel Blockers, Cytochrome P-450 CYP3A Substrates, Piperidines, Calcium-Regulating Hormones and Agents, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Potential QTc-Prolonging Agents, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Vasodilating Agents, Bradycardia-Causing Agents, Antiarrhythmic agents	approved, investigational	3
DB01075	Diphenhydramine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Sleep Aids, Pharmaceutical, Ethanolamine Derivatives, Muscarinic Antagonists, Anticholinergic Agents, Histamine H1 Antagonists, Antipruritics, Incl. Antihistamines, Anesthetics, Etc., Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, First Generation Antihistamines, Potential QTc-Prolonging Agents, Hypnotics and Sedatives, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Drugs causing inadvertant photosensitivity, Antihistamines for Systemic Use, Benzene Derivatives, Anesthetics, Local, Gastrointestinal Agents, Anti-Allergic Agents, Benzhydryl Compounds, Antihistamines for Topical Use, Dermatologicals, Agents producing tachycardia, Anesthetics, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Histamine Antagonists, Ethylamines, Photosensitizing Agents, Central Nervous System Depressants, OCT2 Inhibitors, Antiemetics, Central Nervous System Agents, Cytochrome P-450 CYP2D6 Substrates, Histamine Agents, Aminoalkyl Ethers	approved, investigational	2
DB01072	Atazanavir	Drug	Nephrotoxic agents, QTc Prolonging Agents, Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Oligopeptides, Peptides, Protease Inhibitors, OATP1B3 inhibitors, Amino Acids, Peptides, and Proteins, BSEP/ABCB11 Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Anti-Infective Agents, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strong), Antivirals for Systemic Use, Direct Acting Antivirals, Cytochrome P-450 CYP2C8 Inhibitors (weak), Cytochrome P-450 CYP2C9 Inhibitors, Potential QTc-Prolonging Agents, UDP Glucuronosyltransferases Inhibitors, OATP1B1/SLCO1B1 Inhibitors, Pyridines, Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, UGT1A1 Inhibitors, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Antiinfectives for Systemic Use, HIV Protease Inhibitors, P-glycoprotein inducers, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors, Hyperglycemia-Associated Agents	approved, investigational	1
DB01073	Fludarabine	Drug	Immunologic Factors, Ribonucleosides, Enzyme Inhibitors, Immunosuppressive Agents, Cardiotoxic antineoplastic agents, DNA (Cytosine-5-)-Methyltransferases, antagonists & inhibitors, Nucleotides, Purine Nucleotides, Purines, Nucleic Acid Synthesis Inhibitors, Nucleic Acids, Nucleotides, and Nucleosides, Purine Analogues, Glycosides, Carbohydrates, Arabinonucleosides, Noxae, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Myeloablative Agonists, Purine Nucleosides, Antimetabolites, Myelosuppressive Agents, Heterocyclic Compounds, Fused-Ring, Ribonucleotides, Narrow Therapeutic Index Drugs, Nucleoside Metabolic Inhibitor, Arabinonucleotides, Nucleosides, Toxic Actions, Adenine Nucleotides	approved	4
DB01078	Deslanoside	Drug	Carbohydrates, Cardanolides, Cardiac Glycosides, Enzyme Inhibitors, Protective Agents, Cardiovascular Agents, Lanatosides, Fused-Ring Compounds, Cardiotonic Agents, Digitalis Glycosides, Glycosides, Cardenolides, Cardiac Therapy, Compounds used in a research, industrial, or household setting, Antiarrhythmic agents, Steroids	approved	1
DB01079	Tegaserod	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, Cytochrome P-450 CYP2E1 Inhibitors (weak), Drugs for Constipation, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inhibitors, Heterocyclic Compounds, Fused-Ring, BCRP/ABCG2 Substrates, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Alimentary Tract and Metabolism, Cytochrome P-450 CYP2C8 Inhibitors (weak), Cytochrome P-450 CYP2D6 Inhibitors (moderate), Laxatives, Cytochrome P-450 CYP2D6 Substrates, Gastrointestinal Agents	approved, investigational, withdrawn	4
DB01076	Atorvastatin	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 Substrates, Fatty Acids, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, UGT1A3 substrates, Cytochrome P-450 CYP2B6 Inducers (strength unknown), BSEP/ABCB11 Substrates, Cytochrome P-450 CYP2C19 Inhibitors, Hypolipidemic Agents Indicated for Hyperlipidemia, Lipids, OATP1B3 substrates, Cytochrome P-450 CYP3A4 Substrates, Lipid Modifying Agents, Lipid Modifying Agents, Plain, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2C8 Substrates, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), OATP1B1/SLCO1B1 Inhibitors, Anticholesteremic Agents, Hypolipidemic Agents, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, Lipid Regulating Agents, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), UGT1A1 Substrates, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), OATP1B1/SLCO1B1 Substrates, Toxic Actions, P-glycoprotein inhibitors, Heptanoic Acids	approved	5
DB01077	Etidronic acid	Drug	Organophosphonates, Musculo-Skeletal System, Drugs for Treatment of Bone Diseases, Bone Density Conservation Agents, Organophosphorus Compounds, Drugs Affecting Bone Structure and Mineralization, Bisphosphonates	approved	6
DB13050	Tirilazad	Drug	Antioxidants, Neuroprotective Agents, Nervous System, Protective Agents, Pregnanes, Central Nervous System Agents, Compounds used in a research, industrial, or household setting, Fused-Ring Compounds, Steroids	investigational	0
DB13052	Upamostat	Drug	Sulfur Compounds, Amides, Urokinase-Type Plasminogen Activator, antagonists & inhibitors, Sulfones	investigational	0
DB14384	Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated)	Drug	Influenza Vaccines, Vaccines, Inactivated Influenza A Virus Vaccine	approved	0
DB13051	CH-5132799	Drug	Sulfur Compounds, Class I Phosphatidylinositol 3-Kinases, antagonists & inhibitors, Amides, Sulfones	investigational	0
DB14385	Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated)	Drug	Inactivated Influenza B Virus Vaccine, Influenza Vaccines, Vaccines	approved, investigational	0
DB13054	ACT-451840	Drug	Acids, Acyclic, Acrylates, Amides	investigational	0
DB14382	Influenza A virus A/California/7/2009 (H1N1)-like hemagglutinin antigen (formaldehyde inactivated)	Drug	0	approved	0
DB14383	Influenza A virus A/California/7/2009 X-179A (H1N1) hemagglutinin antigen (formaldehyde inactivated)	Drug	0	approved	0
DB13053	CP-195543	Drug	Heterocyclic Compounds, Fused-Ring, Benzopyrans, Pyrans	investigational	0
DB13067	Rotigaptide	Drug	Peptides, Amino Acids, Peptides, and Proteins	investigational	0
DB14399	Influenza A virus A/Texas/50/2012 X-223A (H3N2) hemagglutinin antigen (MDCK cell derived, propiolactone inactivated)	Drug	0	approved	0
DB13066	Liarozole	Drug	Antineoplastic Agents, Hormonal, Enzyme Inhibitors, Hormones, Hormone Substitutes, and Hormone Antagonists, Dermatologicals, Antineoplastic Agents, Hormone Antagonists	investigational	0
DB13069	Nimustine	Drug	Alkylating Drugs, Nitroso Compounds, Nitrosoureas, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Nitrosourea Compounds	investigational	0
DB14397	Influenza B virus B/Massachusetts/2/2012 BX-51B hemagglutinin antigen (formaldehyde inactivated)	Drug	0	approved	0
DB13068	9-(N-methyl-L-isoleucine)-cyclosporin A	Drug	Peptides, Cyclic, Immunosuppressive Agents, Peptides, Cyclosporins, Amino Acids, Peptides, and Proteins	investigational	0
DB14398	Influenza A virus A/Brisbane/10/2010 (H1N1) hemagglutinin antigen (MDCK cell derived, propiolactone inactivated)	Drug	0	approved	0
DB01081	Diphenoxylate	Drug	Sensory System Agents, Antidiarrheals, Antipropulsives, Peripheral Nervous System Agents, Analgesics, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Alimentary Tract and Metabolism, Central Nervous System Depressants, Piperidines, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Opioids, Central Nervous System Agents, Isonipecotic Acids, Gastrointestinal Agents	approved, illicit	2
DB01082	Streptomycin	Drug	Nephrotoxic agents, Carbohydrates, Streptomycins, Enzyme Inhibitors, Antimycobacterials, Agents that produce neuromuscular block (indirect), Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, OAT1/SLC22A6 inhibitors, Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Anti-Bacterial Agents, Drugs for Treatment of Tuberculosis, Narrow Therapeutic Index Drugs, Intestinal Antiinfectives, Alimentary Tract and Metabolism, Aminoglycoside Antibacterials, Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents, Glycosides, Antibacterials for Systemic Use, Protein Synthesis Inhibitors	approved, vet_approved	3
DB01080	Vigabatrin	Drug	Acids, Acyclic, Enzyme Inhibitors, Fatty Acids, GABA Agents, Nervous System, Lipids, Aminobutyrates, Anti-epileptic Agent, Cytochrome P-450 CYP2C9 Inducers (strength unknown), Fatty Acid Derivatives, Neurotransmitter Agents, Anticonvulsants, Cytochrome P-450 Enzyme Inducers, Miscellaneous Anticonvulsants, Butyrates, Central Nervous System Depressants, Central Nervous System Agents, Cytochrome P-450 CYP2C9 Inducers	approved	1
DB01085	Pilocarpine	Drug	Autonomic Agents, Cholinergic Agonists, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Antiglaucoma Preparations and Miotics, Cholinergic Receptor Agonist, Parasympathomimetics, Miotics, Cytochrome P-450 CYP2A6 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Parasympathomemetic (Cholinergic) Agents, Peripheral Nervous System Agents, Cytochrome P-450 CYP2A6 Inhibitors (strong), Muscarinic Agonists, Ophthalmologicals, Alkaloids, Neurotransmitter Agents, Cholinergic Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Sensory Organs	approved, investigational	4
DB01086	Benzocaine	Drug	Aminobenzoates, para-Aminobenzoates, Cell-mediated Immunity, Benzoates, Sensory System Agents, Nervous System, Acids, Carbocyclic, Dermatologicals, Standardized Chemical Allergen, Anesthetics for Topical Use, Anesthetics, Peripheral Nervous System Agents, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Vasoprotectives, Antipruritics, Incl. Antihistamines, Anesthetics, Etc., Throat Preparations, Antipruritics and Local Anesthetics, Esters of Aminobenzoic Acid, Central Nervous System Agents, Methemoglobinemia Associated Agents, P-glycoprotein inhibitors, Benzene Derivatives, Anesthetics, Local, Increased Histamine Release	approved, investigational	1
DB01083	Orlistat	Drug	Enzyme Inhibitors, Lipase Inhibitors, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Lactones, Lipid Regulating Agents, Cytochrome P-450 Enzyme Inducers, Peripherally Acting Antiobesity Products, Alimentary Tract and Metabolism, Anti-Obesity Agents, Miscellaneous GI Drugs, Antiobesity Preparations, Excl. Diet Products, Intestinal Lipase Inhibitor	approved, investigational	3
DB01084	Emedastine	Drug	Ophthalmologicals, Heterocyclic Compounds, Fused-Ring, Histamine H1 Inhibitors, Neurotransmitter Agents, QTc Prolonging Agents, Histamine H1 Antagonists, Anti-Allergic Agents, Histamine Antagonists, Sensory Organs, Histamine Agents, Moderate Risk QTc-Prolonging Agents, Decongestants and Antiallergics	approved	1
DB01089	Deserpidine	Drug	Alkaloids, Heterocyclic Compounds, Fused-Ring, Decreased Sympathetic Activity, Catecholamine-depleting Sympatholytic, Antiadrenergic Agents, Centrally Acting, Antihypertensive Agents, Indoles, Secologanin Tryptamine Alkaloids, Indole Alkaloids	approved	1
DB01087	Primaquine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Quinolines, QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (moderate), Cytochrome P-450 CYP1A2 Inducers (strength unknown), Antimalarials, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Antibiotics for Pneumocystis Pneumonia, Moderate Risk QTc-Prolonging Agents, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP1A2 Inducers, Methemoglobinemia Associated Agents, P-glycoprotein inhibitors, Antiparasitic Agents, Aminoquinolines, Cytochrome P-450 CYP2D6 Inhibitors (weak)	approved	3
DB01088	Iloprost	Drug	Anticoagulants, Biological Factors, Autacoids, Inflammation Mediators, Blood and Blood Forming Organs, Fatty Acids, Eicosanoids, Hematologic Agents, Lipids, Cardiovascular Agents, Hypotensive Agents, Fibrinolytic Agents, Prostacyclin Analogues, Prostaglandins, Synthetic, Fatty Acids, Unsaturated, Prostaglandins, Platelet Aggregation Inhibitors Excl. Heparin, Agents Causing Muscle Toxicity, Vasodilating Agents, Antiplatelet agents	approved, investigational	8
DB14391	Influenza A virus A/Christchurch/16/2010 NIB-74 (H1N1) hemagglutinin antigen (propiolactone inactivated)	Drug	0	approved	0
DB14392	Influenza A virus A/Texas/50/2012 X-223 (H3N2) hemagglutinin antigen (propiolactone inactivated)	Drug	0	approved	0
DB13061	MLN8054	Drug	Heterocyclic Compounds, Fused-Ring, Protein Kinase Inhibitors	investigational	1
DB13060	CEP-37440	Drug	Benzoates, Acids, Carbocyclic, Amides, Benzene Derivatives	investigational	0
DB14390	Influenza B virus B/Massachusetts/2/2012 hemagglutinin antigen (formaldehyde inactivated)	Drug	0	approved	0
DB13063	Parthenolide	Drug	Analgesics, Non-Narcotic, Cell-mediated Immunity, Sensory System Agents, Anti-Inflammatory Agents, Antirheumatic Agents, Standardized Chemical Allergen, Peripheral Nervous System Agents, Analgesics, Magnoliaceae, Asteraceae, Central Nervous System Agents, Terpenes, NF-kappa B, antagonists & inhibitors, Increased Histamine Release	approved, investigational	0
DB14395	Influenza A virus A/Victoria/361/2011 (H3N2) live (attenuated) antigen	Drug	0	approved	0
DB13062	ME-344	Drug	Heterocyclic Compounds, Fused-Ring, Flavonoids, Benzopyrans, Chromones, Pyrans	investigational	0
DB14396	Influenza B virus B/Wisconsin/1/2010 live (attenuated) antigen	Drug	0	approved	0
DB13065	LY-2811376	Drug	Sulfur Compounds	investigational	0
DB14393	Influenza B virus B/Massachusetts/2/2012 hemagglutinin antigen (propiolactone inactivated)	Drug	0	approved	0
DB14394	Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen	Drug	Live Attenuated Influenza A Virus Vaccine, Actively Acquired Immunity, Influenza Vaccines, Vaccines	approved	0
DB13064	Tramazoline	Drug	Autonomic Agents, Nasal Preparations, Sympathomimetics, Sympathomimetics, Plain, Agents that produce hypertension, Agents producing tachycardia, Peripheral Nervous System Agents	investigational	0
DB13078	KOSN-1724	Drug	0	investigational	0
DB13077	LCB01-0371	Drug	Anti-Bacterial Agents, Enzyme Inhibitors, Oxazoles, Anti-Infective Agents, Protein Synthesis Inhibitors	investigational	0
DB01092	Ouabain	Drug	Carbohydrates, Cardanolides, Cardiac Glycosides, OATP1B1/SLCO1B1 Inhibitors, Enzyme Inhibitors, Protective Agents, Cardiovascular Agents, OATP1B3 substrates, Fused-Ring Compounds, Strophanthins, Cardiotonic Agents, Glycosides, OATP1B1/SLCO1B1 Substrates, Strophanthus Glycosides, Cardenolides, OAT3/SLC22A8 Inhibitors, Cardiac Therapy, Compounds used in a research, industrial, or household setting, Steroids	approved	3
DB01093	Dimethyl sulfoxide	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Solvents, Miscellaneous Therapeutic Agents, Cytochrome P-450 Enzyme Inhibitors, Protective Agents, Genito Urinary System and Sex Hormones, Urologicals, Cytochrome P-450 CYP2C19 Inhibitors, Free Radical Scavengers, Sulfoxides, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Topical Products for Joint and Muscular Pain, Drugs that are Mainly Renally Excreted, Antioxidants, Sulfur Compounds, Cytochrome P-450 CYP3A Inhibitors, Musculo-Skeletal System, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Compounds used in a research, industrial, or household setting, Cryoprotective Agents	approved, vet_approved	0
DB01090	Pentolinium	Drug	Anticholinergic Agents, Autonomic Agents, Neurotransmitter Agents, Cholinergic Agents, Ganglion Blockers, Pyrrolidines, Cardiovascular Agents, Antihypertensive Agents, Nicotinic Antagonists, Peripheral Nervous System Agents	approved	3
DB01091	Butenafine	Drug	Amines, Benzyl Compounds, Benzylamine Antifungal, Antifungals for Topical Use, Dermatologicals, Antifungals for Dermatological Use, Benzylamines, Antifungal Agents, Anti-Infective Agents, Benzene Derivatives	approved	1
DB01096	Oxamniquine	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Quinolines, Antiparasitic Products, Insecticides and Repellents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Antihelminthic, Anthelmintics, Schistosomicides, Hydroxyquinolines, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Nitroquinolines, Antitrematodals, Nitro Compounds, Quinoline Derivatives and Related Substances, Antiplatyhelmintic Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Cytochrome P-450 CYP2D6 Substrates, Antiparasitic Agents	approved	1
DB01097	Leflunomide	Drug	Immunologic Factors, Enzyme Inhibitors, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Antineoplastic and Immunomodulating Agents, Antirheumatic Agents, Adjuvants, Disease-modifying Antirheumatic Agents, Selective Immunosuppressants, Cytochrome P-450 CYP2C9 Substrates, BCRP/ABCG2 Substrates, Agents Causing Muscle Toxicity, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP1A2 Substrates, Isoxazoles	approved, investigational	3
DB01094	Hesperetin	Drug	Heterocyclic Compounds, Fused-Ring, Flavonoids, Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 Substrates, BCRP/ABCG2 Inhibitors, Flavanones, Benzopyrans, Chromones, Pyrans	experimental	4
DB01095	Fluvastatin	Drug	Cytochrome P-450 Substrates, Fatty Acids, Cytochrome P-450 Enzyme Inhibitors, UGT1A3 substrates, Cytochrome P-450 CYP2B6 Inducers (strength unknown), Cytochrome P-450 CYP2C19 Inhibitors, Hypolipidemic Agents Indicated for Hyperlipidemia, Lipids, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), OATP1B3 substrates, Cytochrome P-450 CYP3A4 Substrates, Lipid Modifying Agents, Lipid Modifying Agents, Plain, Cytochrome P-450 Enzyme Inducers, UGT2B7 substrates, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2B6 Inducers, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Indoles, Cytochrome P-450 CYP2C8 Substrates, Hydroxymethylglutaryl-CoA Reductase Inhibitors, OATP1B1/SLCO1B1 Inhibitors, Hypolipidemic Agents, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Lipid Regulating Agents, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), UGT1A1 Substrates, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Cytochrome P-450 CYP3A4 Inhibitors, OATP1B1/SLCO1B1 Substrates, Cytochrome P-450 CYP2D6 Substrates, Heptanoic Acids	approved	2
DB01098	Rosuvastatin	Drug	Enzyme Inhibitors, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Genito Urinary System and Sex Hormones, Amides, BSEP/ABCB11 Substrates, Hydrocarbons, Halogenated, Hypolipidemic Agents Indicated for Hyperlipidemia, Cytochrome P-450 CYP3A4 Substrates, OAT3/SLC22A8 Substrates, Lipid Modifying Agents, Lipid Modifying Agents, Plain, Pyrimidines, Sulfur Compounds, Alimentary Tract and Metabolism, Drugs Used in Diabetes, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Benzene Derivatives, Sulfones, OATP1B1/SLCO1B1 Inhibitors, Anticholesteremic Agents, Hypolipidemic Agents, Cytochrome P-450 CYP3A5 Substrates, Noxae, Gynecological Antiinfectives and Antiseptics, Cytochrome P-450 CYP3A5 Inhibitors, Fluorobenzenes, Hydrocarbons, Fluorinated, Cytochrome P-450 CYP2C9 Substrates, Lipid Regulating Agents, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Sulfonamides, OATP1B1/SLCO1B1 Substrates, Toxic Actions, OAT3/SLC22A8 Inhibitors	approved	2
DB01099	Flucytosine	Drug	Immunosuppressive Agents, Noxae, Antimycotics for Systemic Use, Dermatologicals, Fluorouracil and prodrugs, Antifungals for Dermatological Use, Pyrimidinones, Nucleoside Analog Antifungal, Antiinfectives for Systemic Use, Antimetabolites, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Myelosuppressive Agents, Pyrimidines, Photosensitizing Agents, Antifungals for Topical Use, Toxic Actions, Antifungal Agents, Cytosine, Drugs causing inadvertant photosensitivity	approved, investigational	3
DB13070	Surinabant	Drug	Neurotransmitter Agents, Hormones, Hormone Substitutes, and Hormone Antagonists, Cannabinoid Receptor Antagonists, Cannabinoids and similars, Receptor, Cannabinoid, CB1, antagonists & inhibitors, Agents producing tachycardia, Hormones	investigational	0
DB13072	GDC-0349	Drug	Benzene Derivatives	investigational	0
DB13071	Creatinolfosfate	Drug	Cardiac Therapy	investigational	0
DB13074	Macimorelin	Drug	Amino Acids, Aromatic, Growth Hormone Secretagogue Receptor Agonists, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Cytochrome P-450 Substrates, Amino Acids, Essential, Amino Acids, Peptides, and Proteins, Tests for Pituitary Function, Cytochrome P-450 CYP3A4 Substrates, Amino Acids, Amino Acids, Cyclic, Heterocyclic Compounds, Fused-Ring, Growth Hormone Secretagogue Receptor Agonist, Cytochrome P-450 CYP3A Substrates, Diagnostic Agents	approved, investigational	1
DB13073	Tregalizumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins	investigational	0
DB13076	Yttrium Y-90	Drug	Acids, Acyclic, Anti-Inflammatory Agents, Therapeutic Radiopharmaceuticals, Yttrium Isotopes, Metals, Radioisotopes, Elements, Transition Elements, Tricarboxylic Acids, Yttrium (90Y) Compounds, Yttrium Radioisotopes, Yttrium, Isotopes, Metals, Rare Earth	approved, investigational	0
DB13075	Menaquinone 7	Drug	Quinones, Vitamins (Fat Soluble), Phytol, Naphthoquinones, Diterpenes, Hematologic Agents, Coagulants, Hemostatics, Terpenes, Vitamins, Naphthalenes, Vitamin K	investigational	0
DB13001	Tinoridine	Drug	Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, Nephrotoxic agents, Pyridines, Sensory System Agents, Anti-Inflammatory Agents, Agents causing hyperkalemia, Antirheumatic Agents, Peripheral Nervous System Agents, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Analgesics, Thiophenes, Agents that produce hypertension, Central Nervous System Agents	investigational	0
DB15664	Vitamin K7	Drug	0	experimental	0
DB14333	Nelumbo nucifera flower	Drug	Complex Mixtures, Plant Preparations, Plant Extracts, Biological Products, Pharmaceutical Preparations	approved, experimental	0
DB15665	SEP-363856	Drug	0	investigational	2
DB14334	Hydrogenated coconut oil	Drug	0	experimental	0
DB13000	PCI-27483	Drug	Heterocyclic Compounds, Fused-Ring, Amino Acids, Dicarboxylic, Excitatory Amino Acids, Amino Acids, Peptides, and Proteins, Amino Acids, Acidic, Amino Acids	investigational	0
DB14331	Heterotheca inuloides flower	Drug	0	approved, experimental	0
DB13003	Cortivazol	Drug	Corticosteroids for Systemic Use, Corticosteroids, Immunosuppressive Agents, Corticosteroids for Systemic Use, Plain, Glucocorticoids, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Pregnanes, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Hyperglycemia-Associated Agents, Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins, Cytochrome P-450 CYP3A5 Inducers, Steroids	investigational	1
DB15662	Myristyl glyceryl ether	Drug	0	experimental	0
DB14332	Inonotus obliquus fruiting body	Drug	0	approved, experimental	0
DB13002	HKI-357	Drug	0	investigational	0
DB15663	Grapefruit oil	Drug	0	experimental	0
DB15668	Silver oxide	Drug	Anions, Electrolytes, Ions, Anti-Infective Agents, Oxygen Compounds	experimental	0
DB13005	Rebastinib	Drug	Heterocyclic Compounds, Fused-Ring, Enzyme Inhibitors, Protein Kinase Inhibitors, Antineoplastic Agents, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, drug therapy	investigational	0
DB14337	Salvia miltiorrhiza root	Drug	Drugs, Chinese Herbal, Plant Preparations, Herbs (Hypotensive Properties), Herbs and Natural Products	experimental	0
DB15669	Fezolinetant	Drug	Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Thiazoles	investigational	0
DB14338	Atractylodes lancea root oil	Drug	0	approved, experimental	0
DB13004	Mavoglurant	Drug	Heterocyclic Compounds, Fused-Ring	investigational	0
DB13007	Enfortumab vedotin	Drug	Microtubule Inhibitors, Serum Globulins, Antibodies, Monoclonal, Humanized, Immunoglobulins, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates, P-glycoprotein substrates, Antibodies, Monoclonal, Cytochrome P-450 CYP3A4 Substrates	approved, investigational	1
DB15666	Iodopropynyl butylcarbamate	Drug	Acids, Acyclic, Allergens	experimental	0
DB14335	Bergamot oil	Drug	Complex Mixtures, Oils, Plant Preparations, Perfume, Biological Products, Cosmetics, Lipids, Compounds used in a research, industrial, or household setting, Household Products	experimental	0
DB14336	Angelica sinensis root	Drug	Complex Mixtures, Plant Preparations, Plant Extracts, Biological Products, Pharmaceutical Preparations	experimental	0
DB13006	Cibinetide	Drug	Peptides, Amino Acids, Peptides, and Proteins	investigational	0
DB15667	Bacillus amyloliquefaciens	Drug	0	experimental	0
DB13009	Carbendazim	Drug	Fungicides, Industrial, Acids, Acyclic, Noxae, Pesticides, Anthelmintics, Anti-Infective Agents, Heterocyclic Compounds, Fused-Ring, Agrochemicals, Mutagens, Toxic Actions, Compounds used in a research, industrial, or household setting, Antinematodal Agents, Antiparasitic Agents	investigational	0
DB13008	2,2-bis(4-hydroxy-3-tert-butylphenyl)propane	Drug	0	investigational	0
DB14339	Scutellaria lateriflora	Drug	0	approved, experimental	0
DB03682	Dibenzofuran-4,6-Dicarboxylic Acid	Drug	Acids, Acyclic, Heterocyclic Compounds, Fused-Ring	experimental	0
DB02350	N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide	Drug	0	experimental	1
DB01020	Isosorbide mononitrate	Drug	Carbohydrates, Antianginal Agents, Cytochrome P-450 Substrates, Cardiovascular Agents, Hypotensive Agents, Drugs that are Mainly Renally Excreted, Organic Nitrates, Vasodilation, Alcohols, Nitric Oxide Donors, Cytochrome P-450 CYP3A Substrates, Nitrate Vasodilator, Nitrates and Nitrites, Sugar Alcohols, Vasodilators Used in Cardiac Diseases, Methemoglobinemia Associated Agents, Vasodilating Agents, Cardiac Therapy, Delayed-Action Preparations	approved	1
DB03680	Tartronate	Drug	0	experimental	2
DB01023	Felodipine	Drug	Calcium Channel Blockers (Dihydropyridine), Cytochrome P-450 CYP2D6 Inhibitors, Dihydropyridine Derivatives, QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Agents causing hyperkalemia, BSEP/ABCB11 Substrates, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Hypotensive Agents, Cytochrome P-450 CYP3A4 Substrates, ACE Inhibitors and Calcium Channel Blockers, Cytochrome P-450 CYP2C9 Inhibitors, Calcium-Regulating Hormones and Agents, Potential QTc-Prolonging Agents, Antihypertensive Agents, Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), Bradycardia-Causing Agents, Antiarrhythmic agents, Selective Calcium Channel Blockers With Mainly Vascular Effects, Antihypertensive Agents Indicated for Hypertension, Pyridines, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 CYP2C8 Inhibitors, Membrane Transport Modulators, Cytochrome P-450 CYP2C8 Inhibitors (strong), Calcium Channel Blockers, Dihydropyridines, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Beta blocking agents and calcium channel blockers, Cytochrome P-450 CYP3A4 Inhibitors, P-glycoprotein inhibitors, Vasodilating Agents	approved, investigational	13
DB02355	Adenosine-5'-Rp-Alpha-Thio-Triphosphate	Drug	0	experimental	1
DB03686	S-(4-nitrobenzyl)glutathione	Drug	Oligopeptides, Peptides, Amino Acids, Peptides, and Proteins	experimental	1
DB02354	4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine	Drug	0	experimental	1
DB01024	Mycophenolic acid	Drug	Acids, Acyclic, Enzyme Inhibitors, Fatty Acids, Immunosuppressive Agents, Lipids, Antimetabolite Immunosuppressant, Selective Immunosuppressants, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, UGT1A9 substrates with narrow therapeutic index, Anti-Bacterial Agents, UGT2B7 substrates, Fatty Acids, Volatile, Antibiotics, Antitubercular, UGT2B7 substrates with narrow therapeutic index, Caproates, Mycophenolic Acid and Prodrugs, Antituberculosis Agents, Antineoplastic and Immunomodulating Agents, Antibiotics, Antineoplastic, UGT1A6 substrate, UGT1A1 substrates with narrow therapeutic index, UGT1A6 substrate with narrow therapeutic index, Narrow Therapeutic Index Drugs, UGT1A1 Substrates, UGT1A9 Substrates	approved	2
DB03685	Uridine monophosphate	Drug	Carbohydrates, Pyrimidines, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Uracil Nucleotides, Nucleotides, Pyrimidine Nucleotides	experimental	13
DB01021	Trichlormethiazide	Drug	Sodium Chloride Symporter Inhibitors, Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Low-Ceiling Diuretics and Potassium-Sparing Agents, Amides, Cardiovascular Agents, Membrane Transport Modulators, Heterocyclic Compounds, Fused-Ring, Sulfur Compounds, Benzothiadiazines, Sulfonamides, Diuretics, Natriuretic Agents, Antihypertensive Agents, Thiazides, Hyperglycemia-Associated Agents, Sulfones	approved, vet_approved	5
DB02353	Heparin Disaccharide Iii-S	Drug	0	experimental	1
DB02352	3-(Benzyloxy)Pyridin-2-Amine	Drug	0	experimental	2
DB01022	Phylloquinone	Drug	Increased Prothrombin Activity, Blood and Blood Forming Organs, Fibrin Modulating Agents, Phytol, Hematologic Agents, Coagulants, Drugs that are Mainly Renally Excreted, Vitamins, Naphthalenes, Micronutrients, Quinones, Physiological Phenomena, Vitamins (Fat Soluble), Food and Beverages, Warfarin Reversal Agent, Naphthoquinones, Diterpenes, Hemostatics, Growth Substances, Reversed Anticoagulation Activity, Terpenes, Diet, Food, and Nutrition, Food, Vitamin K	approved, investigational	2
DB03683	2-{[Formyl(Hydroxy)Amino]Methyl}-4-Methylpentanoic Acid	Drug	0	experimental	1
DB02359	9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine	Drug	0	experimental	1
DB02358	LY374571	Drug	0	experimental	1
DB01028	Methoxyflurane	Drug	Anesthetics, Inhalation, Cytochrome P-450 CYP2E1 Substrates, Miscellaneous Analgesics and Antipyretics, Cytochrome P-450 Substrates, Nervous System, Ethyl Ethers, Methyl Ethers, Anesthetics, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP2C9 Substrates, Anesthetics, General, Analgesics, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2A6 Substrates, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Ethers	approved, investigational, vet_approved	7
DB02357	Methyl-O3-(Alpha-D-Mannose)-Alpha-D-Mannose	Drug	0	experimental	0
DB01025	Amlexanox	Drug	Pyridines, Amines, Anti-Allergic Agents, Decreased Histamine Release, Alimentary Tract and Metabolism, Ophthalmic Solutions, Drugs for Obstructive Airway Diseases, Stomatological Preparations	approved, investigational, withdrawn	4
DB03688	Hydracrylic acid	Drug	Lactates, Hydroxy Acids, Isomerism	experimental	1
DB03687	4-(Cytidine 5'-diphospho)-2-C-methyl-D-erythritol	Drug	0	experimental	3
DB01026	Ketoconazole	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Agents causing hyperkalemia, Antifungals for Dermatological Use, Cytochrome P-450 CYP3A5 Inhibitors (strong), BSEP/ABCB11 Substrates, UGT2B7 Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors (moderate), Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP3A4 Inhibitors (strong), Cytochrome P-450 CYP2B6 Inhibitors (moderate), Hepatotoxic Agents, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Cytochrome P-450 CYP2D6 Inhibitors (strength unknown), OATP1B1/SLCO1B1 Inhibitors, Steroid Synthesis Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (strong), Cytochrome P-450 CYP2A6 Inhibitors (moderate), Photosensitizing Agents, Cytochrome P-450 CYP3A7 Inhibitors, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Imidazole and Triazole Derivatives, 14-alpha Demethylase Inhibitors, Cytochrome P-450 CYP1A2 Inhibitors (moderate), Cytochrome P-450 CYP2D6 Inhibitors, QTc Prolonging Agents, BSEP/ABCB11 Inhibitors, Enzyme Inhibitors, Antimycotics for Systemic Use, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2A6 Inhibitors, Cytochrome P-450 CYP2B6 Inhibitors, Anti-Infective Agents, Cytochrome P-450 CYP1A2 Inhibitors, Antifungals for Topical Use, Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (moderate), Cytochrome P-450 CYP3A7 Inhibitors (strong), Potential QTc-Prolonging Agents, Antifungal Agents, Drugs causing inadvertant photosensitivity, Piperazines, Gynecological Antiinfectives and Antiseptics, P-glycoprotein substrates, Cytochrome P-450 CYP3A5 Inhibitors, Dermatologicals, UGT1A1 Inhibitors, Antiinfectives for Systemic Use, Azole Antifungals, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Inhibitors, Imidazole Derivatives, P-glycoprotein inhibitors	approved, investigational	7
DB02356	4-Imidazolmethylene-5-Imidazolone Chromophore	Drug	0	experimental	0
DB01029	Irbesartan	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Angiotensin Receptor Antagonists, Agents causing hyperkalemia, UGT1A3 substrates, Cardiovascular Agents, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Hypotensive Agents, Tetrazoles, Spiro Compounds, Agents Acting on the Renin-Angiotensin System, Cytochrome P-450 CYP2C8 Inhibitors (moderate), Antihypertensive Agents, Cytochrome P-450 CYP2C8 Substrates, Benzene Derivatives, Antihypertensive Agents Indicated for Hypertension, Angiotensin II receptor blockers (ARBs) and diuretics, Cytochrome P-450 CYP2C8 Inhibitors, Angiotensin II receptor blockers (ARBs) and calcium channel blockers, Angiotensin II receptor blockers (ARBs), plain, Biphenyl Compounds, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Angiotensin II Type 2 Receptor Blockers, Angiotensin 2 Receptor Blocker	approved, investigational	2
DB15660	N4-Hydroxycytidine	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Cytosine Nucleotides, Glycosides, Nucleosides, Experimental Unapproved Treatments for COVID-19	experimental	0
DB15661	EIDD-2801	Drug	Prodrugs, Cytosine Nucleotides, Esters, Experimental Unapproved Treatments for COVID-19	experimental	0
DB14330	Macadamia oil	Drug	0	experimental	0
DB15675	Baloxavir	Drug	Enzyme Inhibitors, Sulfur Compounds, Chelating Activity, Polymerase Acidic Endonuclease Inhibitors, Polymerase Acidic Endonuclease Inhibitor, Antiviral Agents, Anti-Infective Agents	investigational	0
DB13012	AQX-1125	Drug	Cycloparaffins, Hexanols, Lipids, Indenes, Fatty Alcohols, Alcohols, Cyclohexanes	investigational	0
DB14344	Lonicera confusa flower	Drug	0	experimental	0
DB15676	Balstilimab	Drug	0	investigational	0
DB14345	Forsythia suspensa fruit	Drug	Complex Mixtures, Plant Preparations, Plant Extracts, Biological Products, Pharmaceutical Preparations	experimental	0
DB13011	Diethylhomospermine	Drug	0	investigational	0
DB15673	Lenacapavir	Drug	0	investigational	0
DB14342	Taraxacum officinale leaf	Drug	0	experimental	0
DB13014	Hypericin	Drug	Immunologic Factors, Enzyme Inhibitors, Benz(a)Anthracenes, Immunosuppressive Agents, Antineoplastic Agents, Antidepressive Agents, Psychotropic Drugs, Radiation-Sensitizing Agents, Anti-Infective Agents, Phenalenes, Central Nervous System Depressants, Central Nervous System Agents, Protein Kinase C, antagonists & inhibitors	investigational	2
DB14343	Arnica montana flower	Drug	0	approved, experimental	0
DB15674	Sisunatovir	Drug	0	investigational	0
DB13013	LFF-571	Drug	Sulfur Compounds	investigational	0
DB13016	LY-2300559	Drug	Ketones, Acids, Carbocyclic, Benzene Derivatives	investigational	0
DB15679	Aluminum subacetate	Drug	Astringents	approved, experimental	0
DB14348	Citrus junos fruit	Drug	0	experimental	0
DB14349	Equisetum arvense top	Drug	0	approved, experimental	0
DB15677	Polyaminopropyl biguanide	Drug	Preservatives, Pharmaceutical, Amidines, Guanidines	experimental	0
DB14346	Mentha arvensis top	Drug	0	experimental	0
DB13018	Dimiracetam	Drug	0	investigational	0
DB13017	Rovalpituzumab Tesirine	Drug	Immunoglobulins, Noxae, Antibodies, Amino Acids, Peptides, and Proteins, Antibodies, Monoclonal, Immunoproteins, Proteins, Serum Globulins, Heterocyclic Compounds, Fused-Ring, Benzazepines, Globulins, Blood Proteins, Toxic Actions	investigational	0
DB14347	Platycodon grandiflorus root	Drug	0	experimental	0
DB15678	Calcium undecylenate	Drug	0	approved, experimental	0
DB13019	Henatinib	Drug	Heterocyclic Compounds, Fused-Ring, Vascular Endothelial Growth Factors, antagonists & inhibitors	investigational	0
DB01030	Topotecan	Drug	Enzyme Inhibitors, Immunosuppressive Agents, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, MATE 1 Substrates, Topoisomerase I Inhibitors, MATE inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), MATE 1 Inhibitors, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Drugs that are Mainly Renally Excreted, Alkaloids, Cytochrome P-450 Enzyme Inducers, P-glycoprotein substrates with narrow therapeutic index, MATE substrates, P-glycoprotein substrates, Antineoplastic and Immunomodulating Agents, Cytochrome P-450 CYP3A4 Inducers, Antineoplastic Agents, Myelosuppressive Agents, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Inhibitors, Narrow Therapeutic Index Drugs, MATE 2 Substrates with a Narrow Therapeutic Index, MATE 2 Substrates, Cytochrome P-450 CYP3A4 Inhibitors, MATE 1 Substrates with a Narrow Therapeutic Index	approved, investigational	3
DB03693	N-(2-Aminoethyl)-5-Chloroisoquinoline-8-Sulfonamide	Drug	Heterocyclic Compounds, Fused-Ring	experimental	1
DB02362	Aminobenzoic acid	Drug	Aminobenzoates, para-Aminobenzoates, Benzoates, Acids, Carbocyclic, Dermatologicals, 4-Aminobenzoic Acid, Emollients and Protectives, Vitamins, Protectives Against UV-Radiation for Topical Use, Protectives Against UV-Radiation, Vitamin B Complex, Sunscreen Agents, Benzene Derivatives	approved, experimental	1
DB03692	1-Hexadecanosulfonyl-O-L-Serine	Drug	0	experimental	1
DB01031	Ethinamate	Drug	Acids, Acyclic	approved, illicit, withdrawn	2
DB02361	S-Methyl Thiocysteine Group	Drug	0	experimental	1
DB03691	WRR-112	Drug	0	experimental	2
DB02360	Bis-Napthyl Beta-Ketophosphonic Acid	Drug	0	experimental	1
DB03690	(Z,Z)-4-Hydroxy-N,N,N-Trimethyl-10-Oxo-7-[(1-Oxo-9-Octadecenyl)Oxy]-3,5,9-Trioxa-4-Phosphaheptacos-18-En-1-Aminium-4-Oxide	Drug	0	experimental	1
DB03697	4-Sulfonamide-[1-(4-Aminobutane)]Benzamide	Drug	0	experimental	1
DB02366	CRA_10762	Drug	0	experimental	1
DB01034	Cerulenin	Drug	Lipid Regulating Agents, Fatty Acid Synthesis Inhibitors, Hypolipidemic Agents, Noxae, Amides, Toxic Actions, Antifungal Agents, Anti-Infective Agents	experimental	4
DB02365	1,10-Phenanthroline	Drug	Cross-Linking Reagents, Enzyme Inhibitors, Cholinesterase Inhibitors, Laboratory Chemicals, Intercalating Agents, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cholinergic Agents, Iron Chelating Agents, Sequestering Agents, Indicators and Reagents, Compounds used in a research, industrial, or household setting, Chelating Agents	experimental	2
DB01035	Procainamide	Drug	Aminobenzoates, para-Aminobenzoates, Highest Risk QTc-Prolonging Agents, QTc Prolonging Agents, Voltage-Gated Sodium Channel Blockers, Cytochrome P-450 Substrates, Acids, Carbocyclic, MATE 1 Substrates, OCT1 inhibitors, Amides, Cardiovascular Agents, Agents that produce neuromuscular block (indirect), Drugs that are Mainly Renally Excreted, Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index, Antiarrhythmics, Class I, OCT2 substrates with narrow therapeutic index, MATE substrates, Benzene Derivatives, Antiarrhythmic agents, Benzoates, Cholinesterase Inhibitors, Benzamides and benzamide derivatives, Membrane Transport Modulators, Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index, Narrow Therapeutic Index Drugs, MATE 2 Substrates with a Narrow Therapeutic Index, Agents Causing Muscle Toxicity, OCT2 Inhibitors, MATE 2 Substrates, Cytochrome P-450 CYP2D6 Substrates, Sodium Channel Blockers, Antiarrhythmics, Class Ia, Cardiac Therapy, MATE 1 Substrates with a Narrow Therapeutic Index	approved	3
DB03696	Lanosterol	Drug	Cholestanes, Triterpenes, Sterols, Lanosterol, metabolism, Cholestadienols, Cholestadienes, Lipids, Membrane Lipids, Cholestenes, Terpenes, Fused-Ring Compounds, Steroids	experimental	1
DB03695	Piritrexim	Drug	Enzyme Inhibitors, Folic Acid Antagonists, Antineoplastic Agents	investigational	1
DB02364	2-Amino-3-(Diethoxy-Phosphoryloxy)-Propionic Acid	Drug	0	experimental	1
DB01032	Probenecid	Drug	Renal Agents, Cytochrome P-450 CYP2C8 Inducers, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, Genito Urinary System and Sex Hormones, OCT1 inhibitors, Preparations Increasing Uric Acid Excretion, Amides, Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Drugs that are Mainly Renally Excreted, Cytochrome P-450 Enzyme Inducers, Sulfur Compounds, Musculo-Skeletal System, Cytochrome P-450 CYP2C9 Inhibitors, Compounds used in a research, industrial, or household setting, Sulfones, Adjuvants, Pharmaceutic, Gynecological Antiinfectives and Antiseptics, Cytochrome P-450 CYP3A4 Inducers, Antirheumatic Agents, UGT1A1 Inhibitors, Pharmaceutic Aids, OAT1/SLC22A6 inhibitors, Antigout Preparations, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), OCT2 Inhibitors, Sulfonamides, Uricosuric Agents, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Pharmaceutical Preparations, OAT3/SLC22A8 Inhibitors, Cytochrome P-450 CYP2C8 Inducers (strength unknown)	approved, investigational	5
DB02363	2'-Monophosphoadenosine-5'-Diphosphate	Drug	0	experimental	3
DB01033	Mercaptopurine	Drug	Immunologic Factors, Enzyme Inhibitors, Thiopurine Analogs, Immunosuppressive Agents, Noxae, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Antimetabolites, Myelosuppressive Agents, OAT3/SLC22A8 Substrates, Heterocyclic Compounds, Fused-Ring, Purines, Nucleic Acid Synthesis Inhibitors, Sulfur Compounds, Narrow Therapeutic Index Drugs, Purine Analogues, Nucleoside Metabolic Inhibitor, Toxic Actions, Drugs for Obstructive Airway Diseases, Xanthine derivatives, OAT3/SLC22A8 Inhibitors, Sulfhydryl Compounds	approved	3
DB03694	N-phenylthiourea	Drug	Sulfur Compounds, Thiourea	experimental	0
DB01038	Carphenazine	Drug	Dopamine Antagonists, Dopamine D2 Receptor Antagonists	withdrawn	3
DB02369	3-Aza-2,3-Dihydrogeranyl Diphosphate	Drug	Phosphate salts	experimental	0
DB01039	Fenofibrate	Drug	Acids, Acyclic, Peroxisome Proliferator Receptor alpha Agonist, Cytochrome P-450 Substrates, Fatty Acids, Cytochrome P-450 Enzyme Inhibitors, BSEP/ABCB11 Substrates, Cytochrome P-450 CYP2C19 Inhibitors, Hypolipidemic Agents Indicated for Hyperlipidemia, Lipids, Cytochrome P-450 CYP2A6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Phenyl Ethers, Fribic Acid Derivatives, Lipid Modifying Agents, Lipid Modifying Agents, Plain, Butyrates, Cytochrome P-450 CYP2C8 Inhibitors (weak), Fatty Acids, Volatile, Cytochrome P-450 CYP2C9 Inhibitors, Fibric Acids, Ethers, Benzene Derivatives, Hypolipidemic Agents, Peroxisome Proliferator-activated Receptor alpha Agonists, Ketones, Noxae, Cytochrome P-450 CYP2C8 Inhibitors, Isobutyrates, Lipid Regulating Agents, Cytochrome P-450 CYP3A4 Substrates (strength unknown), Cytochrome P-450 CYP3A Substrates, Agents Causing Muscle Toxicity, Cytochrome P-450 CYP2C9 Inhibitors (strength unknown), Benzophenones, Phenols, UGT1A9 Substrates, Toxic Actions, Cytochrome P-450 CYP2C19 Inhibitors (weak), Cytochrome P-450 CYP2A6 Inhibitors (weak), P-glycoprotein inhibitors	approved	3
DB02368	N-Acetyl-L-Citrulline	Drug	0	experimental	1
DB01036	Tolterodine	Drug	QTc Prolonging Agents, Amines, Cytochrome P-450 Substrates, Drugs for Urinary Frequency and Incontinence, Genito Urinary System and Sex Hormones, Urologicals, Muscarinic Antagonists, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Alcohols, Anticholinergic Agents, Cholinergic Agents, Cresols, Potential QTc-Prolonging Agents, Benzene Derivatives, Genitourinary Smooth Muscle Relaxants, Propanols, Benzhydryl Compounds, Agents producing tachycardia, Amino Alcohols, Cytochrome P-450 CYP2C19 Substrates, Urological Agents, Cytochrome P-450 CYP2C9 Substrates, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Phenols, Cytochrome P-450 CYP2D6 Substrates, Propanolamines	approved, investigational	5
DB03699	Succinyl-Coenzyme A	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purine Nucleotides, Purines, Coenzymes, Ribonucleotides, Nucleic Acids, Nucleotides, and Nucleosides, Thioesters of coenzyme A, Enzymes and Coenzymes, Glycosides, Nucleotides, Adenine Nucleotides	experimental	1
DB02367	(1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine	Drug	0	experimental	1
DB03698	5-Mercaptoethanol-2-decenoyl-coenzyme A	Drug	0	experimental	1
DB01037	Selegiline	Drug	Cytochrome P-450 CYP2D6 Inhibitors, Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates, Neuroprotective Agents, Enzyme Inhibitors, Amines, Cytochrome P-450 Substrates, Serotonin Agents, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Cytochrome P-450 CYP2A6 Inhibitors, Hypotensive Agents, Antidepressive Agents, Cytochrome P-450 CYP2B6 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Cytochrome P-450 CYP2A6 Inhibitors (strength unknown), Phenethylamines, Cytochrome P-450 CYP1A2 Inhibitors, Anti-Dyskinesia Agents, Cytochrome P-450 CYP2E1 Inhibitors (strength unknown), Serotonin Modulators, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Monoamine Oxidase B Inhibitors, Cytochrome P-450 CYP2C8 Substrates, Compounds used in a research, industrial, or household setting, Agents that reduce seizure threshold, Dopamine Agents, Cytochrome P-450 CYP2E1 Inhibitors, Protective Agents, Monoamine Oxidase Inhibitors, Psychotropic Drugs, Anti-Parkinson Drugs, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Cytochrome P-450 CYP3A Substrates, Ethylamines, Central Nervous System Depressants, Agents that produce hypertension, Cytochrome P-450 CYP1A2 Substrates, Cytochrome P-450 CYP2A6 Substrates, Central Nervous System Agents, Cytochrome P-450 CYP2B6 Substrates, Cytochrome P-450 CYP2D6 Substrates, Cytochrome P-450 CYP2B6 Inhibitors (strength unknown), P-glycoprotein inhibitors, Cytochrome P-450 CYP2D6 Inhibitors (weak)	approved, investigational, vet_approved	2
DB14340	Prunus armeniaca seed	Drug	0	experimental	0
DB15671	Besifovir	Drug	Heterocyclic Compounds, Fused-Ring, Purines, Organophosphorus Compounds, Xanthine derivatives, Purinones	investigational	0
DB14341	Chamaecyparis obtusa wood oil	Drug	0	experimental	0
DB15672	Rilematovir	Drug	Heterocyclic Compounds, Fused-Ring, Imidazoles	investigational	0
DB13010	4-isothioureidobutyronitrile	Drug	0	investigational	0
DB15670	Gusacitinib	Drug	0	investigational	0
DB13023	IPI-493	Drug	Quinones, Protein-Serine-Threonine Kinases, antagonists & inhibitors, Amides, Lactams, HSP90 Heat-Shock Proteins, antagonists & inhibitors	investigational	0
DB15686	GS-441524	Drug	Antivirals for Systemic Use, Direct Acting Antivirals, Nucleoside Analog Antiviral, Experimental Unapproved Treatments for COVID-19, Antiviral Agents, Adenine Nucleotides	experimental	2
DB14355	Apple fruit oil	Drug	0	experimental	0
DB14356	Platycodon grandiflorus leaf	Drug	0	experimental	0
DB13022	LY-2874455	Drug	Heterocyclic Compounds, Fused-Ring, Pyrazoles, Receptors, Fibroblast Growth Factor, antagonists & inhibitors	investigational	0
DB15687	Tridecactide	Drug	Melanocyte-Stimulating Hormones, Experimental Unapproved Treatments for COVID-19	investigational	0
DB15684	2,3-dichloro-5,6-dicyanobenzoquinone	Drug	Quinones	experimental	0
DB14353	Zanthoxylum clava-herculis whole	Drug	0	approved, experimental	0
DB13025	Tiapride	Drug	Psycholeptics, Tranquilizing Agents, Amines, Benzoates, Nervous System, Acids, Carbocyclic, Benzamides and benzamide derivatives, Amides, Psychotropic Drugs, Drugs that are Mainly Renally Excreted, Neurotransmitter Agents, Antipsychotic Agents, Ethylamines, Central Nervous System Depressants, Central Nervous System Agents, Dopamine Antagonists, Dopamine D2 Receptor Antagonists, Benzene Derivatives, Dopamine Agents, Neurotoxic agents	investigational	5
DB14354	Salix alba bark volatile oil	Drug	0	experimental	0
DB15685	Selpercatinib	Drug	QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Tyrosine Kinase Inhibitors, Cytochrome P-450 CYP2C8 Inhibitors, P-glycoprotein substrates, Antineoplastic Agents, BCRP/ABCG2 Inhibitors, MATE inhibitors, MATE 1 Inhibitors, Cytochrome P-450 CYP3A4 Substrates, BCRP/ABCG2 Substrates, Cytochrome P-450 CYP3A Substrates, Agents that produce hypertension, Hepatotoxic Agents, P-glycoprotein inhibitors, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)	approved, investigational	6
DB13024	MK-8245	Drug	Acids, Acyclic, Fatty Acids, Fatty Acids, Volatile, Lipids, Stearoyl-CoA Desaturase, antagonists & inhibitors	investigational	0
DB14359	Tremella fuciformis whole	Drug	0	experimental	0
DB13027	Tucaresol	Drug	Acids, Carbocyclic, Aldehydes, Benzene Derivatives	investigational	0
DB13026	Ornidazole	Drug	Antiparasitic Products, Insecticides and Repellents, Antiprotozoals, Gynecological Antiinfectives and Antiseptics, Genito Urinary System and Sex Hormones, Antitrichomonal Agents, Antiinfectives for Systemic Use, Nitroimidazoles, Radiation-Sensitizing Agents, Anti-Infective Agents, Imidazoles, Nitroimidazole Derivatives, Nitro Compounds, Imidazole Derivatives, Antibacterials for Systemic Use, Antiparasitic Agents, Amebicides	investigational	0
DB13029	MK-0873	Drug	Heterocyclic Compounds, Fused-Ring, Phosphodiesterase Inhibitors, Enzyme Inhibitors, Phosphodiesterase 4 Inhibitors	investigational	0
DB14357	Chamomile	Drug	0	approved, investigational, experimental	0
DB15688	Vazegepant	Drug	Quinolines, Heterocyclic Compounds, Fused-Ring, Pyrazoles, Experimental Unapproved Treatments for COVID-19, Receptors, Calcitonin Gene-Related Peptide, antagonists & inhibitors, Antimigraine Preparations, Calcitonin-gene-related Peptide (Cgrp) Antagonists	investigational	1
DB15689	Azoximer bromide	Drug	0	investigational	0
DB13028	Biapenem	Drug	Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Amides, Lactams, beta-Lactams, Carbapenems, Antiinfectives for Systemic Use, Anti-Infective Agents, Antibacterials for Systemic Use	investigational	0
DB14358	Tribulus terrestris	Drug	0	experimental	0
DB01041	Thalidomide	Drug	Immunologic Factors, Phthalic Acids, Cytochrome P-450 Substrates, Immunosuppressive Agents, Cytochrome P-450 Enzyme Inhibitors, Decreased Immunologically Active Molecule Activity, Teratogens, Acids, Carbocyclic, Cytochrome P-450 CYP3A Inducers, Cardiotoxic antineoplastic agents, Cytochrome P-450 CYP2C19 Inhibitors, Growth Inhibitors, Hypotensive Agents, Angiogenesis Modulating Agents, Piperidones, Anti-Infective Agents, Imides, Isoindoles, Anti-Bacterial Agents, Cytochrome P-450 Enzyme Inducers, Piperidines, Immunomodulatory Agents, Drugs causing inadvertant photosensitivity, Growth Substances, Cytochrome P-450 CYP3A5 Inducers (strength unknown), Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP2E1 Substrates, Noxae, Antineoplastic and Immunomodulating Agents, Antineoplastic Agents, Angiogenesis Inhibitors, Leprostatic Agents, Myelosuppressive Agents, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Heterocyclic Compounds, Fused-Ring, Photosensitizing Agents, Central Nervous System Depressants, Phthalimides, Cytochrome P-450 CYP2C19 inhibitors (strength unknown), Toxic Actions	approved, investigational, withdrawn	7
DB02373	Adenosine monotungstate	Drug	0	experimental	1
DB02372	2,5-Dimethylpyrimidin-4-Amine	Drug	0	experimental	0
DB01042	Melphalan	Drug	Amino Acids, Aromatic, Immunologic Factors, Immunosuppressive Agents, Noxae, Phenylalanine, Amino Acids, Essential, Antineoplastic and Immunomodulating Agents, Nitrogen Mustard Analogues, Alkylating Activity, Antineoplastic Agents, Amino Acids, Peptides, and Proteins, Hydrocarbons, Halogenated, Mustard Compounds, Myeloablative Agonists, Nitrogen Mustard Compounds, Amino Acids, Myelosuppressive Agents, Alkylating Drugs, Amino Acids, Cyclic, Narrow Therapeutic Index Drugs, Toxic Actions, Antineoplastic Agents, Alkylating	approved	1
DB02371	2-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Ethanesulfonic Acid	Drug	0	experimental	1
DB02370	Nz-(1-Carboxyethyl)-Lysine	Drug	0	experimental	1
DB01045	Rifampicin	Drug	Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A Inducers, OATP1B3 substrates, UGT1A1 Inducers, Cytochrome P-450 CYP2C19 Inducers (moderate), Cytochrome P-450 CYP3A4 Inducers (strong), Nucleic Acid Synthesis Inhibitors, Cytochrome P-450 CYP2C19 Inducers, Cytochrome P-450 CYP1A2 Inducers (moderate), Hepatotoxic Agents, Rifamycin Antibacterial, Cytochrome P-450 CYP2C8 Inhibitors (strength unknown), Cytochrome P-450 CYP2E1 Inducers (strength unknown), OATP1B1/SLCO1B1 Inhibitors, Chemically-Induced Disorders, Cytochrome P-450 CYP2C9 Inducers (moderate), Cytochrome P-450 CYP3A Inducers (strong), Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP3A4 Inducers, Leprostatic Agents, OAT1/SLC22A6 inhibitors, Narrow Therapeutic Index Drugs, Cytochrome P-450 CYP1A2 Inducers (strong), Cytochrome P-450 CYP1A2 Inducers, Cytochrome P-450 CYP3A5 Inducers (strong), OAT3/SLC22A8 Inhibitors, BSEP/ABCB11 Inhibitors, Enzyme Inhibitors, Cytochrome P-450 CYP2C8 Inducers, OATP1B3 inhibitors, Amides, Lactams, Antimycobacterials, Cytochrome P-450 CYP2C19 Inducers (strong), Rifamycins, Anti-Infective Agents, Cytochrome P-450 CYP2A6 Inducers (moderate), Cytochrome P-450 CYP3A7 Inducers (weak), UGT1A9 Inducers, Lactams, Macrocyclic, Anti-Bacterial Agents, Cytochrome P-450 Enzyme Inducers, Cytochrome P-450 CYP3A7 Inducers (strong), Cytochrome P-450 CYP2B6 Inducers (moderate), Antibiotics, Antitubercular, Cytochrome P-450 CYP2B6 Inducers, Antituberculosis Agents, Cytochrome P-450 CYP3A5 Inducers, Cytochrome P-450 CYP2E1 Inducers, Cytochrome P-450 CYP2A6 Inducers, Cytochrome P-450 CYP2C8 Inducers (strong), Antiinfectives for Systemic Use, Cytochrome P-450 CYP3A7 Inducers, P-glycoprotein inducers, Heterocyclic Compounds, Fused-Ring, UGT1A9 Inhibitors, Drugs for Treatment of Tuberculosis, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP2C9 Inducers	approved	2
DB02377	Guanine	Drug	Heterocyclic Compounds, Fused-Ring, Purines, Xanthine derivatives, Purinones	experimental	5
DB02376	D-gluconhydroximo-1,5-lactam	Drug	0	experimental	1
DB01046	Lubiprostone	Drug	Biological Factors, Autacoids, Inflammation Mediators, Fatty Acids, Drugs for Constipation, Eicosanoids, Lipids, Fatty Acids, Monounsaturated, Drugs that are Mainly Renally Excreted, Membrane Transport Modulators, Fatty Acids, Unsaturated, Alimentary Tract and Metabolism, Miscellaneous GI Drugs, Prostaglandins E, Chloride Channel Agonists, Laxatives	approved, investigational	1
DB01043	Memantine	Drug	Cholinesterase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Nervous System, OCT2 Substrates, Cytochrome P-450 CYP2C19 Inhibitors, Miscellaneous Central Nervous System Agents, Cytochrome P-450 CYP2A6 Inhibitors, Cytochrome P-450 CYP2B6 Inhibitors, Drugs that are Mainly Renally Excreted, Anti-Parkinson Drugs, Anti-Dyskinesia Agents, Neurotransmitter Agents, Anti-Dementia Drugs, Cytochrome P-450 CYP2B6 Inhibitors (strong), N-methyl-D-aspartate Receptor Antagonist, NMDA Receptor Antagonists, Central Nervous System Agents, Cytochrome P-450 CYP2C19 Inhibitors (weak), Cytochrome P-450 CYP2A6 Inhibitors (weak), Excitatory Amino Acid Antagonists, Dopamine Agents, Psychoanaleptics	approved, investigational	7
DB02375	Myricetin	Drug	Heterocyclic Compounds, Fused-Ring, Benzopyrans, Chromones, Pyrans	experimental	2
DB02374	Xylose-Derived Imidazole	Drug	0	experimental	1
DB01044	Gatifloxacin	Drug	Fluoroquinolones, Quinolines, QTc Prolonging Agents, Enzyme Inhibitors, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Hypoglycemia-Associated Agents, Anti-Infective Agents, Pharmaceutical Solutions, Quinolones, Cytochrome P-450 CYP1A2 Inhibitors, Anti-Bacterial Agents, Solutions, Topoisomerase II Inhibitors, Ophthalmic Solutions, Potential QTc-Prolonging Agents, Compounds used in a research, industrial, or household setting, Quinolone Antimicrobial, Antiinfectives for Systemic Use, Ophthalmologicals, Heterocyclic Compounds, Fused-Ring, Pharmaceutical Preparations, Sensory Organs, Antibacterials for Systemic Use, Cytochrome P-450 CYP1A2 Inhibitors (moderate)	approved, investigational	4
DB01049	Ergoloid mesylate	Drug	Ergot-derivative Dopamine Receptor Agonists, Cytochrome P-450 Substrates, Serotonin Agents, Cardiovascular Agents, Antidepressive Agents, Cytochrome P-450 CYP3A4 Substrates, Dopamine Agonists, Ergot Alkaloids and Derivatives, Ergotamines, Sympatholytic (Adrenergic Blocking) Agents, Alkaloids, Serotonin Modulators, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Adrenergic Antagonists, Adrenergic Agents, Dopamine Agents, Adrenergic alpha-Antagonists, Dihydroergotoxine, Heterocyclic Compounds, Fused-Ring, Neurotransmitter Agents, Cytochrome P-450 CYP3A Substrates, Central Nervous System Depressants, Agents that produce hypertension, Peripheral Vasodilators, Central Nervous System Agents, Vasodilating Agents, Nootropic Agents	approved	4
DB02379	Beta-D-Glucose	Drug	0	experimental	91
DB01047	Fluocinonide	Drug	Corticosteroids, Dermatological Preparations, Cytochrome P-450 Substrates, Immunosuppressive Agents, Glucocorticoids, Anti-Inflammatory Agents, Adrenal Cortex Hormones, Cytochrome P-450 CYP3A Inducers, Hormones, Cytochrome P-450 CYP3A4 Inducers (strength unknown), Cytochrome P-450 CYP3A4 Substrates, Fused-Ring Compounds, Cytochrome P-450 Enzyme Inducers, Corticosteroids, Potent (Group III), Cytochrome P-450 CYP3A5 Inducers (strength unknown), Corticosteroid Hormone Receptor Agonists, Cytochrome P-450 CYP3A5 Inducers, Anti-Allergic Agents, Corticosteroids, Hormones, Hormone Substitutes, and Hormone Antagonists, Pregnadienes, Cytochrome P-450 CYP3A4 Inducers, Dermatologicals, Cytochrome P-450 CYP3A Substrates, Pregnanes, Thyroxine-binding globulin inhibitors, Steroids, Fluorinated, Steroids	approved, investigational	2
DB02378	MMI-175	Drug	0	experimental	1
DB01048	Abacavir	Drug	Carbohydrates, Enzyme Inhibitors, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Anti-Retroviral Agents, Antiviral Agents, Anti-HIV Agents, Antiinfectives for Systemic Use, Anti-Infective Agents, Drugs that are Mainly Renally Excreted, Antivirals for Systemic Use, Direct Acting Antivirals, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors, Nucleic Acid Synthesis Inhibitors, Nucleic Acids, Nucleotides, and Nucleosides, UGT1A1 Substrates, Glycosides, Nucleosides, Deoxyribonucleosides, Reverse Transcriptase Inhibitors, Nucleoside Reverse Transcriptase Inhibitors	approved, investigational	2
DB14351	Usnea barbata	Drug	0	approved, experimental	0
DB15682	Neisseria meningitidis group Y capsular polysaccharide tetanus toxoid conjugate antigen	Drug	0	approved	0
DB15683	Neisseria meningitidis group W-135 capsular polysaccharide tetanus toxoid conjugate antigen	Drug	0	approved	0
DB14352	Azadirachta indica leaf	Drug	0	approved, experimental	0
DB15680	Neisseria meningitidis group A capsular polysaccharide tetanus toxoid conjugate antigen	Drug	0	approved	0
DB13021	123I-iodometomidate	Drug	0	investigational	0
DB15681	Neisseria meningitidis group C capsular polysaccharide tetanus toxoid conjugate antigen	Drug	0	approved	0
DB13020	Apratastat	Drug	Oxazines	investigational	0
DB14350	Inula helenium root	Drug	0	approved, experimental	0
DB13034	Foxy-5	Drug	0	investigational	0
DB14366	Ilex paraguariensis leaf	Drug	0	experimental	0
DB14367	Chondrus crispus	Drug	0	experimental	0
DB13033	Urocortin-2	Drug	Proteins, Peptide Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Peptides, Amino Acids, Peptides, and Proteins, Neuropeptides, Nerve Tissue Proteins, Hormones	investigational	0
DB14364	Scutellaria baicalensis root	Drug	Complex Mixtures, Plant Preparations, Biological Products, Pharmaceutical Preparations, Scutellaria baicalensis	experimental	0
DB13036	Ramatroban	Drug	Heterocyclic Compounds, Fused-Ring, Receptors, Thromboxane, antagonists & inhibitors, Sulfur Compounds, Amides, Hematologic Agents, Indoles, Antiplatelet agents, Sulfones	investigational	1
DB14365	Garcinia gummi-gutta fruit	Drug	0	experimental	0
DB13035	AG-24322	Drug	Heterocyclic Compounds, Fused-Ring, Cyclin-Dependent Kinase 2, antagonists & inhibitors, Cyclin-Dependent Kinase 4, antagonists & inhibitors, Pyrazoles, CDC2 Protein Kinase, antagonists & inhibitors	investigational	0
DB13038	Glyceryl Trioleate	Drug	Glycerides, Fats, Unsaturated, Lipids, Triglycerides, Fats	investigational	0
DB13037	Namilumab	Drug	Proteins, Serum Globulins, Immunoglobulins, Globulins, Blood Proteins, Antibodies, Amino Acids, Peptides, and Proteins, Immunoproteins	investigational	0
DB14368	Capsicum annuum whole	Drug	0	experimental	0
DB13039	Aminaphthone	Drug	Aminobenzoates, Benzoates, Acids, Carbocyclic, Hematologic Agents, Coagulants, Hemostatics, Benzene Derivatives	investigational	0
DB14369	Typhonium giganteum whole	Drug	0	experimental	0
DB02380	Deoxyinosine	Drug	Carbohydrates, Heterocyclic Compounds, Fused-Ring, Purines, Ribonucleosides, Nucleic Acids, Nucleotides, and Nucleosides, Glycosides, Nucleosides, Purine Nucleosides	experimental	0
DB02384	(E)-2-Fluoro-P-Hydroxycinnamate	Drug	0	experimental	1
DB02383	Tolrestat	Drug	Enzyme Inhibitors, Aldose Reductase Inhibitors, Alimentary Tract and Metabolism, Drugs Used in Diabetes, Aldehyde Reductase, antagonists & inhibitors	withdrawn	3
DB01053	Benzylpenicillin	Drug	Amides, Lactams, beta-Lactams, Beta-Lactam Antibacterials, Antiinfectives for Systemic Use, Beta-Lactamase Sensitive Penicillins, Penicillin G, Anti-Infective Agents, OAT1/SLC22A6 inhibitors, OAT3/SLC22A8 Substrates, Ophthalmologicals, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Sulfur Compounds, Penicillins, OATP1B1/SLCO1B1 Substrates, OAT3/SLC22A8 Inhibitors, Sensory Organs, Natural Penicillins, Antibacterials for Systemic Use	approved, vet_approved	4
DB02382	Namn	Drug	0	experimental	2
DB01050	Ibuprofen	Drug	Nephrotoxic agents, Antiinflammatory Products for Vaginal Administration, Enzyme Inhibitors, Cytochrome P-450 Substrates, Sensory System Agents, Cyclooxygenase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Nervous System, Anti-Inflammatory Agents, Acids, Carbocyclic, Agents causing hyperkalemia, UGT1A3 substrates, Non COX-2 selective NSAIDS, Experimental Unapproved Treatments for COVID-19, Phenylpropionates, Cytochrome P-450 CYP3A4 Substrates, Drugs that are Mainly Renally Excreted, Peripheral Nervous System Agents, Antiinflammatory and Antirheumatic Products, Non-Steroids, COX-2 Inhibitors, UGT2B7 substrates, Analgesics, Agents causing angioedema, Cytochrome P-450 CYP2C8 Substrates, Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal, COX-1 Inhibitors, P-glycoprotein substrates, Antirheumatic Agents, Antiinflammatory Preparations, Non-Steroids for Topical Use, Topical Products for Joint and Muscular Pain, OAT1/SLC22A6 inhibitors, Cytochrome P-450 CYP2C19 Substrates, Cytochrome P-450 CYP2C9 Substrates, Antiinflammatory and Antirheumatic Products, Throat Preparations, Cytochrome P-450 CYP3A Substrates, UGT1A1 Substrates, Propionates, Agents that produce hypertension, UGT1A9 Substrates, Central Nervous System Agents, OAT3/SLC22A8 Inhibitors, P-glycoprotein inhibitors, Other Nonsteroidal Anti-inflammatory Agents	approved	10
DB02381	nor-NOHA	Drug	0	investigational	1
DB01051	Novobiocin	Drug	Carbohydrates, OATP1B1/SLCO1B1 Inhibitors, Enzyme Inhibitors, OATP1B3 inhibitors, BCRP/ABCG2 Inhibitors, Coumarins, Aminocoumarins, Benzopyrans, Anti-Infective Agents, OAT1/SLC22A6 inhibitors, Heterocyclic Compounds, Fused-Ring, Anti-Bacterial Agents, Nucleic Acid Synthesis Inhibitors, Glycosides, OAT3/SLC22A8 Inhibitors, Pyrans	approved, investigational, vet_approved	2
DB02388	Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine	Drug	0	experimental	1
DB01056	Tocainide	Drug	Cytochrome P-450 CYP1A2 Inhibitors (weak), Voltage-Gated Sodium Channel Blockers, Amines, Cytochrome P-450 Substrates, Cytochrome P-450 Enzyme Inhibitors, Aniline Compounds, Amides, Cardiovascular Agents, Membrane Transport Modulators, Anilides, Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP1A2 Substrates, Antiarrhythmics, Class I, Sodium Channel Blockers, Antiarrhythmics, Class Ib, Cardiac Therapy, Antiarrhythmic agents	approved	1
DB01057	Echothiophate	Drug	Autonomic Agents, Organothiophosphorus Compounds, QTc Prolonging Agents, Enzyme Inhibitors, Cholinesterase Inhibitors, Antiglaucoma Preparations and Miotics, Parasympathomimetics, Miotics, Organophosphorus Compounds, Organophosphates, Peripheral Nervous System Agents, Ophthalmologicals, Neurotransmitter Agents, Sulfur Compounds, Cholinergic Agents, Organothiophosphates, Potential QTc-Prolonging Agents, Sensory Organs	approved	1
DB02386	Leucine Phosphonic Acid	Drug	Amino Acids, Essential, Amino Acids, Branched-Chain, Organophosphorus Compounds, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	2
DB01054	Nitrendipine	Drug	Dihydropyridine Derivatives, QTc Prolonging Agents, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Cytochrome P-450 Enzyme Inhibitors, Agents causing hyperkalemia, BSEP/ABCB11 Substrates, Cardiovascular Agents, Hypotensive Agents, Cytochrome P-450 CYP3A4 Substrates, ACE Inhibitors and Calcium Channel Blockers, Calcium-Regulating Hormones and Agents, Potential QTc-Prolonging Agents, Antihypertensive Agents, Bradycardia-Causing Agents, Antiarrhythmic agents, Selective Calcium Channel Blockers With Mainly Vascular Effects, Pyridines, Cytochrome P-450 CYP3A5 Substrates, Membrane Transport Modulators, Calcium Channel Blockers, Dihydropyridines, Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A Substrates, P-glycoprotein inhibitors, Vasodilating Agents	approved, investigational	7
DB01055	Mimosine	Drug	Pyridines, Alanine, Pyridones, Amino Acids, Peptides, and Proteins, Amino Acids	experimental	3
DB02385	D-threo-neopterin	Drug	Biological Factors, Heterocyclic Compounds, Fused-Ring, Coenzymes, Pterins, Enzymes and Coenzymes, Pteridines, Pigments, Biological	experimental	0
DB01058	Praziquantel	Drug	Antiparasitic Products, Insecticides and Repellents, Cytochrome P-450 CYP3A5 Substrates, Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A7 Substrates, Antihelminthic, Isoquinolines, Anthelmintics, Cytochrome P-450 CYP3A4 Substrates, Anti-Infective Agents, Cytochrome P-450 CYP2C19 Substrates, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Substrates, Antitrematodals, Cytochrome P-450 CYP1A2 Substrates, Quinoline Derivatives and Related Substances, Antiparasitic Agents	approved, investigational, vet_approved	1
DB01059	Norfloxacin	Drug	Fluoroquinolones, Quinolines, QTc Prolonging Agents, Enzyme Inhibitors, Topoisomerase Inhibitors, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors (strength unknown), Cytochrome P-450 CYP1A2 Inhibitors (strength unknown), Anti-Infective Agents, Cytochrome P-450 CYP3A7 Inhibitors (strength unknown), Quinolones, Cytochrome P-450 CYP1A2 Inhibitors, Anti-Bacterial Agents, Topoisomerase II Inhibitors, Potential QTc-Prolonging Agents, Quinolone Antimicrobial, Chemically-Induced Disorders, Antiinfectives for Systemic Use, OAT1/SLC22A6 inhibitors, Ophthalmologicals, Heterocyclic Compounds, Fused-Ring, Cytochrome P-450 CYP3A Inhibitors, Agents Causing Muscle Toxicity, Cytochrome P-450 CYP3A7 Inhibitors, Cytochrome P-450 CYP3A4 Inhibitors, Sensory Organs, Antibacterials for Systemic Use	approved	3
DB15690	Fluoroestradiol F-18	Drug	Estranes, Hormones, Hormone Substitutes, and Hormone Antagonists, Estrogens, Estrogens, agonists, Estradiol Congeners, Fluorine Radioisotopes, Hormones, Fused-Ring Compounds, Gonadal Hormones, Gonadal Steroid Hormones, Steroids	approved	2
DB15693	INO-4800	Drug	Experimental Unapproved Treatments for COVID-19	investigational	0
DB13030	2'-fluoro-5-ethylarabinosyluracil	Drug	Carbohydrates, Ribonucleosides, Pyrimidines, Nucleic Acids, Nucleotides, and Nucleosides, Pyrimidine Nucleosides, Arabinonucleosides, Glycosides, Nucleosides	investigational	0
DB14362	Moringa oleifera leaf	Drug	0	experimental	0
DB14363	Rosa centifolia flower oil	Drug	0	experimental	0
DB13032	Enecadin	Drug	0	investigational	0
DB15691	Anti-SARS-CoV-2 REGN-COV2	Drug	Experimental Unapproved Treatments for COVID-19	investigational	0
DB14360	Saw palmetto	Drug	Prostatic Hyperplasia, Urological Agents, Complex Mixtures, Plant Preparations, Biological Products, Herbs and Natural Products, Pharmaceutical Preparations, Serenoa	approved, investigational, experimental	0
DB13031	Niobium	Drug	Metals, Metals, Heavy, Elements, Transition Elements	investigational	0
DB14361	Rice bran	Drug	0	approved, experimental	0
DB15692	COVID-19 convalescent plasma	Drug	Experimental Unapproved Treatments for COVID-19	investigational	0
ENSG00000110148	CCKBR	Gene	0
ENSG00000163914	RHO	Gene	0
ENSG00000080644	CHRNA3	Gene	0
ENSG00000114982	KANSL3	Gene	0
ENSG00000135446	CDK4	Gene	0
ENSG00000000971	CFH	Gene	0
ENSG00000170214	ADRA1B	Gene	0
ENSG00000159899	NPR2	Gene	0
ENSG00000172867	KRT2	Gene	0
ENSG00000196839	ADA	Gene	0
ENSG00000166197	NOLC1	Gene	0
ENSG00000170209	ANKK1	Gene	0
ENSG00000205403	CFI	Gene	0
ENSG00000166199	ALKBH3	Gene	0
ENSG00000168374	ARF4	Gene	0
ENSG00000100345	MYH9	Gene	0
ENSG00000122133	PAEP	Gene	0
ENSG00000102524	TNFSF13B	Gene	0
ENSG00000147432	CHRNB3	Gene	0
ENSG00000100346	CACNA1I	Gene	0
ENSG00000127824	TUBA4A	Gene	0
ENSG00000178172	SPINK6	Gene	0
ENSG00000070831	CDC42	Gene	0
ENSG00000100342	APOL1	Gene	0
ENSG00000122136	OBP2A	Gene	0
ENSG00000058729	RIOK2	Gene	0
ENSG00000147434	CHRNA6	Gene	0
ENSG00000109158	GABRA4	Gene	0
ENSG00000115828	QPCT	Gene	0
ENSG00000092621	PHGDH	Gene	0
ENSG00000133275	CSNK1G2	Gene	0
ENSG00000171552	BCL2L1	Gene	0
ENSG00000159403	C1R	Gene	0
ENSG00000099250	NRP1	Gene	0
ENSG00000269058	CALR3	Gene	0
ENSG00000171557	FGG	Gene	0
ENSG00000157227	MMP14	Gene	0
ENSG00000169239	CA5B	Gene	0
ENSG00000163931	TKT	Gene	0
ENSG00000145242	EPHA5	Gene	0
ENSG00000108298	RPL19	Gene	0
ENSG00000163932	PRKCD	Gene	0
ENSG00000102996	MMP15	Gene	0
ENSG00000125656	CLPP	Gene	0
ENSG00000182674	KCNB2	Gene	0
ENSG00000157219	HTR5A	Gene	0
ENSG00000172890	NADSYN1	Gene	0
ENSG00000171560	FGA	Gene	0
ENSG00000044574	HSPA5	Gene	0
ENSG00000144381	HSPD1	Gene	0
ENSG00000103876	FAH	Gene	0
ENSG00000170231	FABP6	Gene	0
ENSG00000137601	NEK1	Gene	0
ENSG00000171564	FGB	Gene	0
ENSG00000136750	GAD2	Gene	0
ENSG00000110169	HPX	Gene	0
ENSG00000168393	DTYMK	Gene	0
ENSG00000172893	DHCR7	Gene	0
ENSG00000009765	IYD	Gene	0
ENSG00000131069	ACSS2	Gene	0
ENSG00000115850	LCT	Gene	0
ENSG00000135423	GLS2	Gene	0
ENSG00000111012	CYP27B1	Gene	0
ENSG00000205867	KRTAP5-2	Gene	0
ENSG00000010322	NISCH	Gene	0
ENSG00000248144	ADH1C	Gene	0
ENSG00000147416	ATP6V1B2	Gene	0
ENSG00000012504	NR1H4	Gene	0
ENSG00000168398	BDKRB2	Gene	0
ENSG00000169245	CXCL10	Gene	0
ENSG00000100368	CSF2RB	Gene	0
ENSG00000162613	FUBP1	Gene	0
ENSG00000101213	PTK6	Gene	0
ENSG00000239672	NME1	Gene	0
ENSG00000087263	OGFOD1	Gene	0
ENSG00000221914	PPP2R2A	Gene	0
ENSG00000100362	PVALB	Gene	0
ENSG00000101680	LAMA1	Gene	0
ENSG00000160439	RDH13	Gene	0
ENSG00000080618	CPB2	Gene	0
ENSG00000135437	RDH5	Gene	0
ENSG00000169252	ADRB2	Gene	0
ENSG00000142192	APP	Gene	0
ENSG00000112335	SNX3	Gene	0
ENSG00000173757	STAT5B	Gene	0
ENSG00000115840	SLC25A12	Gene	0
ENSG00000102539	MLNR	Gene	0
ENSG00000109163	GNRHR	Gene	0
ENSG00000101204	CHRNA4	Gene	0
ENSG00000123454	DBH	Gene	0
ENSG00000000938	FGR	Gene	0
ENSG00000078304	PPP2R5C	Gene	0
ENSG00000087250	MT3	Gene	0
ENSG00000147403	RPL10	Gene	0
ENSG00000124784	RIOK1	Gene	0
ENSG00000090013	BLVRB	Gene	0
ENSG00000135409	AMHR2	Gene	0
ENSG00000103811	CTSH	Gene	0
ENSG00000167085	PHB	Gene	0
ENSG00000171105	INSR	Gene	0
ENSG00000011677	GABRA3	Gene	0
ENSG00000005381	MPO	Gene	0
ENSG00000142186	SCYL1	Gene	0
ENSG00000102967	DHODH	Gene	0
ENSG00000126934	MAP2K2	Gene	0
ENSG00000083720	OXCT1	Gene	0
ENSG00000088179	PTPN4	Gene	0
ENSG00000145692	BHMT	Gene	0
ENSG00000100300	TSPO	Gene	0
ENSG00000089022	MAPKAPK5	Gene	0
ENSG00000112759	SLC29A1	Gene	0
ENSG00000184408	KCND2	Gene	0
ENSG00000019169	MARCO	Gene	0
ENSG00000111424	VDR	Gene	0
ENSG00000113600	C9	Gene	0
ENSG00000061938	TNK2	Gene	0
ENSG00000170266	GLB1	Gene	0
ENSG00000159840	ZYX	Gene	0
ENSG00000196876	SCN8A	Gene	0
ENSG00000135898	GPR55	Gene	0
ENSG00000077044	DGKD	Gene	0
ENSG00000132386	SERPINF1	Gene	0
ENSG00000204580	DDR1	Gene	0
ENSG00000142178	SIK1	Gene	0
ENSG00000124767	GLO1	Gene	0
ENSG00000079215	SLC1A3	Gene	0
ENSG00000145681	HAPLN1	Gene	0
ENSG00000070886	EPHA8	Gene	0
ENSG00000122585	NPY	Gene	0
ENSG00000124762	CDKN1A	Gene	0
ENSG00000134538	SLCO1B1	Gene	0
ENSG00000112304	ACOT13	Gene	0
ENSG00000077498	TYR	Gene	0
ENSG00000205420	KRT6A	Gene	0
ENSG00000131023	LATS1	Gene	0
ENSG00000132356	PRKAA1	Gene	0
ENSG00000009724	MASP2	Gene	0
ENSG00000111452	ADGRD1	Gene	0
ENSG00000135862	LAMC1	Gene	0
ENSG00000142168	SOD1	Gene	0
ENSG00000142166	IFNAR1	Gene	0
ENSG00000035664	DAPK2	Gene	0
ENSG00000124731	TREM1	Gene	0
ENSG00000153292	ADGRF1	Gene	0
ENSG00000100324	TAB1	Gene	0
ENSG00000145675	PIK3R1	Gene	0
ENSG00000148702	HABP2	Gene	0
ENSG00000147852	VLDLR	Gene	0
ENSG00000022355	GABRA1	Gene	0
ENSG00000184428	TOP1MT	Gene	0
ENSG00000019186	CYP24A1	Gene	0
ENSG00000155465	SLC7A7	Gene	0
ENSG00000133216	EPHB2	Gene	0
ENSG00000067225	PKM	Gene	0
ENSG00000262406	MMP12	Gene	0
ENSG00000169297	NR0B1	Gene	0
ENSG00000196411	EPHB4	Gene	0
ENSG00000171132	PRKCE	Gene	0
ENSG00000196415	PRTN3	Gene	0
ENSG00000197746	PSAP	Gene	0
ENSG00000197747	S100A10	Gene	0
ENSG00000196408	NOXO1	Gene	0
ENSG00000100316	RPL3	Gene	0
ENSG00000123416	TUBA1B	Gene	0
ENSG00000185760	KCNQ5	Gene	0
ENSG00000163513	TGFBR2	Gene	0
ENSG00000182255	KCNA4	Gene	0
ENSG00000179097	HTR1F	Gene	0
ENSG00000100311	PDGFB	Gene	0
ENSG00000182256	GABRG3	Gene	0
ENSG00000122566	HNRNPA2B1	Gene	0
ENSG00000163993	S100P	Gene	0
ENSG00000179091	CYC1	Gene	0
ENSG00000010379	SLC6A13	Gene	0
ENSG00000074800	ENO1	Gene	0
ENSG00000106049	HIBADH	Gene	0
ENSG00000114904	NEK4	Gene	0
ENSG00000090054	SPTLC1	Gene	0
ENSG00000129167	TPH1	Gene	0
ENSG00000133661	SFTPD	Gene	0
ENSG00000132330	SCLY	Gene	0
ENSG00000198626	RYR2	Gene	0
ENSG00000244165	P2RY11	Gene	0
ENSG00000173327	MAP3K11	Gene	0
ENSG00000132334	PTPRE	Gene	0
ENSG00000035687	ADSS	Gene	0
ENSG00000164850	GPER1	Gene	0
ENSG00000124713	GNMT	Gene	0
ENSG00000121207	LRAT	Gene	0
ENSG00000160014	CALM3	Gene	0
ENSG00000151090	THRB	Gene	0
ENSG00000188822	CNR2	Gene	0
ENSG00000160013	PTGIR	Gene	0
ENSG00000183134	PTGDR2	Gene	0
ENSG00000186642	PDE2A	Gene	0
ENSG00000143473	KCNH1	Gene	0
ENSG00000165704	HPRT1	Gene	0
ENSG00000185313	SCN10A	Gene	0
ENSG00000255292		Gene	0
ENSG00000112715	VEGFA	Gene	0
ENSG00000172482	AGXT	Gene	0
ENSG00000196433	ASMT	Gene	0
ENSG00000198610	AKR1C4	Gene	0
ENSG00000132341	RAN	Gene	0
ENSG00000197766	CFD	Gene	0
ENSG00000082898	XPO1	Gene	0
ENSG00000130164	LDLR	Gene	0
ENSG00000005339	CREBBP	Gene	0
ENSG00000131495	NDUFA2	Gene	0
ENSG00000023228	NDUFS1	Gene	0
ENSG00000174669	SLC29A2	Gene	0
ENSG00000100739	BDKRB1	Gene	0
ENSG00000204941	PSG5	Gene	0
ENSG00000164867	NOS3	Gene	0
ENSG00000121691	CAT	Gene	0
ENSG00000108691	CCL2	Gene	0
ENSG00000074803	SLC12A1	Gene	0
ENSG00000069431	ABCC9	Gene	0
ENSG00000153253	SCN3A	Gene	0
ENSG00000049860	HEXB	Gene	0
ENSG00000196465	MYL6B	Gene	0
ENSG00000112742	TTK	Gene	0
ENSG00000135821	GLUL	Gene	0
ENSG00000198648	STK39	Gene	0
ENSG00000131462	TUBG1	Gene	0
ENSG00000151079	KCNA6	Gene	0
ENSG00000154589	LY96	Gene	0
ENSG00000162692	VCAM1	Gene	0
ENSG00000162694	EXTL2	Gene	0
ENSG00000224586	GPX5	Gene	0
ENSG00000122512	PMS2	Gene	0
ENSG00000123843	C4BPB	Gene	0
ENSG00000108242	CYP2C18	Gene	0
ENSG00000164879	CA3	Gene	0
ENSG00000259207	ITGB3	Gene	0
ENSG00000167900	TK1	Gene	0
ENSG00000184009	ACTG1	Gene	0
ENSG00000141279	NPEPPS	Gene	0
ENSG00000188846	RPL14	Gene	0
ENSG00000109576	AADAT	Gene	0
ENSG00000163545	NUAK2	Gene	0
ENSG00000145632	PLK2	Gene	0
ENSG00000131477	RAMP2	Gene	0
ENSG00000151067	CACNA1C	Gene	0
ENSG00000090020	SLC9A1	Gene	0
ENSG00000112739	PRPF4B	Gene	0
ENSG00000132329	RAMP1	Gene	0
ENSG00000111886	GABRR2	Gene	0
ENSG00000129151	BBOX1	Gene	0
ENSG00000175535	PNLIP	Gene	0
ENSG00000026751	SLAMF7	Gene	0
ENSG00000131471	AOC3	Gene	0
ENSG00000131473	ACLY	Gene	0
ENSG00000004468	CD38	Gene	0
ENSG00000003137	CYP26B1	Gene	0
ENSG00000101608	MYL12A	Gene	0
ENSG00000145626	UGT3A1	Gene	0
ENSG00000184470	TXNRD2	Gene	0
ENSG00000186652	PRG2	Gene	0
ENSG00000080224	EPHA6	Gene	0
ENSG00000257017	HP	Gene	0
ENSG00000164405	UQCRQ	Gene	0
ENSG00000163558	PRKCI	Gene	0
ENSG00000013441	CLK1	Gene	0
ENSG00000164400	CSF2	Gene	0
ENSG00000164885	CDK5	Gene	0
ENSG00000165731	RET	Gene	0
ENSG00000129159	KCNC1	Gene	0
ENSG00000215644	GCGR	Gene	0
ENSG00000213465	ARL2	Gene	0
ENSG00000196482	ESRRG	Gene	0
ENSG00000131446	MGAT1	Gene	0
ENSG00000006638	TBXA2R	Gene	0
ENSG00000128271	ADORA2A	Gene	0
ENSG00000095303	PTGS1	Gene	0
ENSG00000004455	AK2	Gene	0
ENSG00000198668	CALM1	Gene	0
ENSG00000171189	GRIK1	Gene	0
ENSG00000204991	SPIRE2	Gene	0
ENSG00000025434	NR1H3	Gene	0
ENSG00000173369	C1QB	Gene	0
ENSG00000116288	PARK7	Gene	0
ENSG00000081148	IMPG2	Gene	0
ENSG00000138074	SLC5A6	Gene	0
ENSG00000106483	SFRP4	Gene	0
ENSG00000164418	GRIK2	Gene	0
ENSG00000138071	ACTR2	Gene	0
ENSG00000080293	SCTR	Gene	0
ENSG00000012124	CD22	Gene	0
ENSG00000185359	HGS	Gene	0
ENSG00000122971	ACADS	Gene	0
ENSG00000105146	AURKC	Gene	0
ENSG00000048545	GUCA1A	Gene	0
ENSG00000176884	GRIN1	Gene	0
ENSG00000212122	TSSK1B	Gene	0
ENSG00000053918	KCNQ1	Gene	0
ENSG00000095777	MYO3A	Gene	0
ENSG00000128285	MCHR1	Gene	0
ENSG00000198650	TAT	Gene	0
ENSG00000173372	C1QA	Gene	0
ENSG00000179915	NRXN1	Gene	0
ENSG00000156738	MS4A1	Gene	0
ENSG00000007952	NOX1	Gene	0
ENSG00000140396	NCOA2	Gene	0
ENSG00000036565	SLC18A1	Gene	0
ENSG00000123838	C4BPA	Gene	0
ENSG00000204983	PRSS1	Gene	0
ENSG00000120329	SLC25A2	Gene	0
ENSG00000184012	TMPRSS2	Gene	0
ENSG00000121653	MAPK8IP1	Gene	0
ENSG00000108654	DDX5	Gene	0
ENSG00000105143	SLC1A6	Gene	0
ENSG00000140398	NEIL1	Gene	0
ENSG00000166603	MC4R	Gene	0
ENSG00000176890	TYMS	Gene	0
ENSG00000179921	GPBAR1	Gene	0
ENSG00000077097	TOP2B	Gene	0
ENSG00000174238	PITPNA	Gene	0
ENSG00000167941	SOST	Gene	0
ENSG00000204977	TRIM13	Gene	0
ENSG00000077092	RARB	Gene	0
ENSG00000187553	CYP26C1	Gene	0
ENSG00000163581	SLC2A2	Gene	0
ENSG00000163106	HPGDS	Gene	0
ENSG00000184047	DIABLO	Gene	0
ENSG00000108684	ASIC2	Gene	0
ENSG00000073969	NSF	Gene	0
ENSG00000172062	SMN1	Gene	0
ENSG00000126088	UROD	Gene	0
ENSG00000129596	CDO1	Gene	0
ENSG00000198670	LPA	Gene	0
ENSG00000153208	MERTK	Gene	0
ENSG00000178607	ERN1	Gene	0
ENSG00000027644	INSRR	Gene	0
ENSG00000090060	PAPOLA	Gene	0
ENSG00000132763	MMACHC	Gene	0
ENSG00000156711	MAPK13	Gene	0
ENSG00000268104	SLC6A14	Gene	0
ENSG00000122966	CIT	Gene	0
ENSG00000123815	COQ8B	Gene	0
ENSG00000100714	MTHFD1	Gene	0
ENSG00000117143	UAP1	Gene	0
ENSG00000079277	MKNK1	Gene	0
ENSG00000138061	CYP1B1	Gene	0
ENSG00000183185	GABRR3	Gene	0
ENSG00000156709	AIFM1	Gene	0
ENSG00000168806	LCMT2	Gene	0
ENSG00000180914	OXTR	Gene	0
ENSG00000162267	ITIH3	Gene	0
ENSG00000163114	PDHA2	Gene	0
ENSG00000163599	CTLA4	Gene	0
ENSG00000149295	DRD2	Gene	0
ENSG00000127022	CANX	Gene	0
ENSG00000197253	TPSB2	Gene	0
ENSG00000243238	IGKV2-30	Gene	0
ENSG00000133706	LARS	Gene	0
ENSG00000133703	KRAS	Gene	0
ENSG00000198586	TLK1	Gene	0
ENSG00000084207	GSTP1	Gene	0
ENSG00000117215	PLA2G2D	Gene	0
ENSG00000152465	NMT2	Gene	0
ENSG00000163485	ADORA1	Gene	0
ENSG00000119888	EPCAM	Gene	0
ENSG00000188786	MTF1	Gene	0
ENSG00000188784	PLA2G2E	Gene	0
ENSG00000163482	STK36	Gene	0
ENSG00000140009	ESR2	Gene	0
ENSG00000081181	ARG2	Gene	0
ENSG00000103056	SMPD3	Gene	0
ENSG00000130203	APOE	Gene	0
ENSG00000196396	PTPN1	Gene	0
ENSG00000269858	EGLN2	Gene	0
ENSG00000074410	CA12	Gene	0
ENSG00000197249	SERPINA1	Gene	0
ENSG00000140474	ULK3	Gene	0
ENSG00000165675	ENOX2	Gene	0
ENSG00000120885	CLU	Gene	0
ENSG00000164344	KLKB1	Gene	0
ENSG00000163013	FBXO41	Gene	0
ENSG00000116350	SRSF4	Gene	0
ENSG00000138160	KIF11	Gene	0
ENSG00000120889	TNFRSF10B	Gene	0
ENSG00000188778	ADRB3	Gene	0
ENSG00000180815	MAP3K15	Gene	0
ENSG00000187446	CHP1	Gene	0
ENSG00000142657	PGD	Gene	0
ENSG00000129219	PLD2	Gene	0
ENSG00000105220	GPI	Gene	0
ENSG00000166523	CLEC4E	Gene	0
ENSG00000129214	SHBG	Gene	0
ENSG00000105221	AKT2	Gene	0
ENSG00000104375	STK3	Gene	0
ENSG00000106588	PSMA2	Gene	0
ENSG00000127483	HP1BP3	Gene	0
ENSG00000007908	SELE	Gene	0
ENSG00000095321	CRAT	Gene	0
ENSG00000106105	GARS	Gene	0
ENSG00000174156	GSTA3	Gene	0
ENSG00000109618	SEPSECS	Gene	0
ENSG00000147099	HDAC8	Gene	0
ENSG00000072682	P4HA2	Gene	0
ENSG00000198125	MB	Gene	0
ENSG00000127481	UBR4	Gene	0
ENSG00000065911	MTHFD2	Gene	0
ENSG00000178999	AURKB	Gene	0
ENSG00000185291	IL3RA	Gene	0
ENSG00000131981	LGALS3	Gene	0
ENSG00000084676	NCOA1	Gene	0
ENSG00000100804	PSMB5	Gene	0
ENSG00000162174	ASRGL1	Gene	0
ENSG00000137285	TUBB2B	Gene	0
ENSG00000084674	APOB	Gene	0
ENSG00000188322	SBK1	Gene	0
ENSG00000130649	CYP2E1	Gene	0
ENSG00000231274	SBK3	Gene	0
ENSG00000140464	PML	Gene	0
ENSG00000070019	GUCY2C	Gene	0
ENSG00000140465	CYP1A1	Gene	0
ENSG00000176340	COX8A	Gene	0
ENSG00000129673	AANAT	Gene	0
ENSG00000072694	FCGR2B	Gene	0
ENSG00000072210	ALDH3A2	Gene	0
ENSG00000198598	MMP17	Gene	0
ENSG00000130669	PAK4	Gene	0
ENSG00000204084	INPP5B	Gene	0
ENSG00000132840	BHMT2	Gene	0
ENSG00000004864	SLC25A13	Gene	0
ENSG00000165695	AK8	Gene	0
ENSG00000120868	APAF1	Gene	0
ENSG00000164362	TERT	Gene	0
ENSG00000085511	MAP3K4	Gene	0
ENSG00000140459	CYP11A1	Gene	0
ENSG00000131508	UBE2D2	Gene	0
ENSG00000149269	PAK1	Gene	0
ENSG00000082482	KCNK2	Gene	0
ENSG00000166548	TK2	Gene	0
ENSG00000128311	TST	Gene	0
ENSG00000105675	ATP4A	Gene	0
ENSG00000108700	CCL8	Gene	0
ENSG00000243678	NME2	Gene	0
ENSG00000105679	GAPDHS	Gene	0
ENSG00000070087	PFN2	Gene	0
ENSG00000142619	PADI3	Gene	0
ENSG00000174175	SELP	Gene	0
ENSG00000116329	OPRD1	Gene	0
ENSG00000027697	IFNGR1	Gene	0
ENSG00000152422	XRCC4	Gene	0
ENSG00000137267	TUBB2A	Gene	0
ENSG00000151577	DRD3	Gene	0
ENSG00000138115	CYP2C8	Gene	0
ENSG00000178537	SLC25A20	Gene	0
ENSG00000178538	CA8	Gene	0
ENSG00000117650	NEK2	Gene	0
ENSG00000118515	SGK1	Gene	0
ENSG00000142627	EPHA2	Gene	0
ENSG00000103018	CYB5B	Gene	0
ENSG00000142623	PADI1	Gene	0
ENSG00000140443	IGF1R	Gene	0
ENSG00000198130	HIBCH	Gene	0
ENSG00000128322	IGLL1	Gene	0
ENSG00000105664	COMP	Gene	0
ENSG00000130643	CALY	Gene	0
ENSG00000004846	ABCB5	Gene	0
ENSG00000131979	GCH1	Gene	0
ENSG00000064651	SLC12A2	Gene	0
ENSG00000075785	RAB7A	Gene	0
ENSG00000072274	TFRC	Gene	0
ENSG00000065989	PDE4A	Gene	0
ENSG00000118520	ARG1	Gene	0
ENSG00000135094	SDS	Gene	0
ENSG00000137274	BPHL	Gene	0
ENSG00000137275	RIPK1	Gene	0
ENSG00000116791	CRYZ	Gene	0
ENSG00000163050	COQ8A	Gene	0
ENSG00000187486	KCNJ11	Gene	0
ENSG00000188338	SLC38A3	Gene	0
ENSG00000142615	CELA2A	Gene	0
ENSG00000106991	ENG	Gene	0
ENSG00000135090	TAOK3	Gene	0
ENSG00000168748	CA7	Gene	0
ENSG00000017427	IGF1	Gene	0
ENSG00000106992	AK1	Gene	0
ENSG00000103485	QPRT	Gene	0
ENSG00000104365	IKBKB	Gene	0
ENSG00000073578	SDHA	Gene	0
ENSG00000003989	SLC7A2	Gene	0
ENSG00000211662	IGLV3-21	Gene	0
ENSG00000106546	AHR	Gene	0
ENSG00000096696	DSP	Gene	0
ENSG00000104368	PLAT	Gene	0
ENSG00000148386	LCN9	Gene	0
ENSG00000135069	PSAT1	Gene	0
ENSG00000120805	ARL1	Gene	0
ENSG00000151552	QDPR	Gene	0
ENSG00000117676	RPS6KA1	Gene	0
ENSG00000114166	KAT2B	Gene	0
ENSG00000152402	GUCY1A2	Gene	0
ENSG00000273079	GRIN2B	Gene	0
ENSG00000164399	IL3	Gene	0
ENSG00000085563	ABCB1	Gene	0
ENSG00000143933	CALM2	Gene	0
ENSG00000084234	APLP2	Gene	0
ENSG00000186188	FFAR4	Gene	0
ENSG00000234745	HLA-B	Gene	0
ENSG00000010803	SCMH1	Gene	0
ENSG00000102189	EEA1	Gene	0
ENSG00000169604	ANTXR1	Gene	0
ENSG00000127445	PIN1	Gene	0
ENSG00000102172	SMS	Gene	0
ENSG00000105204	DYRK1B	Gene	0
ENSG00000105205	CLC	Gene	0
ENSG00000073584	SMARCE1	Gene	0
ENSG00000147044	CASK	Gene	0
ENSG00000176387	HSD11B2	Gene	0
ENSG00000211652	IGLV7-43	Gene	0
ENSG00000115008	IL1A	Gene	0
ENSG00000138109	CYP2C9	Gene	0
ENSG00000139433	GLTP	Gene	0
ENSG00000115488	NEU2	Gene	0
ENSG00000178568	ERBB4	Gene	0
ENSG00000242372	EIF6	Gene	0
ENSG00000115486	GGCX	Gene	0
ENSG00000177239	MAN1B1	Gene	0
ENSG00000167434	CA4	Gene	0
ENSG00000168765	GSTM4	Gene	0
ENSG00000137252	HCRTR2	Gene	0
ENSG00000140416	TPM1	Gene	0
ENSG00000141744	PNMT	Gene	0
ENSG00000010810	FYN	Gene	0
ENSG00000104783	KCNN4	Gene	0
ENSG00000160801	PTH1R	Gene	0
ENSG00000198189	HSD17B11	Gene	0
ENSG00000135047	CTSL	Gene	0
ENSG00000135046	ANXA1	Gene	0
ENSG00000105639	JAK3	Gene	0
ENSG00000065534	MYLK	Gene	0
ENSG00000205362	MT1A	Gene	0
ENSG00000116761	CTH	Gene	0
ENSG00000188386	PPP3R2	Gene	0
ENSG00000166598	HSP90B1	Gene	0
ENSG00000188389	PDCD1	Gene	0
ENSG00000170606	HSPA4	Gene	0
ENSG00000165264	NDUFB6	Gene	0
ENSG00000141736	ERBB2	Gene	0
ENSG00000277893	SRD5A2	Gene	0
ENSG00000125249	RAP2A	Gene	0
ENSG00000125245	GPR18	Gene	0
ENSG00000243649	CFB	Gene	0
ENSG00000126581	BECN1	Gene	0
ENSG00000126583	PRKCG	Gene	0
ENSG00000015285	WAS	Gene	0
ENSG00000115425	PECR	Gene	0
ENSG00000117601	SERPINC1	Gene	0
ENSG00000114573	ATP6V1A	Gene	0
ENSG00000113240	CLK4	Gene	0
ENSG00000189221	MAOA	Gene	0
ENSG00000166123	GPT2	Gene	0
ENSG00000166126	AMN	Gene	0
ENSG00000139410	SDSL	Gene	0
ENSG00000051382	PIK3CB	Gene	0
ENSG00000187048	CYP4A11	Gene	0
ENSG00000188379	IFNA2	Gene	0
ENSG00000165272	AQP3	Gene	0
ENSG00000166128	RAB8B	Gene	0
ENSG00000101266	CSNK2A1	Gene	0
ENSG00000125255	SLC10A2	Gene	0
ENSG00000125257	ABCC4	Gene	0
ENSG00000104321	TRPA1	Gene	0
ENSG00000099769	IGFALS	Gene	0
ENSG00000101294	HM13	Gene	0
ENSG00000105655	ISYNA1	Gene	0
ENSG00000104324	CPQ	Gene	0
ENSG00000104325	DECR1	Gene	0
ENSG00000122194	PLG	Gene	0
ENSG00000165280	VCP	Gene	0
ENSG00000137204	SLC22A7	Gene	0
ENSG00000167460	TPM4	Gene	0
ENSG00000171960	PPIH	Gene	0
ENSG00000137200	CMTR1	Gene	0
ENSG00000166135	HIF1AN	Gene	0
ENSG00000116783	TNNI3K	Gene	0
ENSG00000167468	GPX4	Gene	0
ENSG00000166136	NDUFB8	Gene	0
ENSG00000008394	MGST1	Gene	0
ENSG00000062485	CS	Gene	0
ENSG00000148346	LCN2	Gene	0
ENSG00000102144	PGK1	Gene	0
ENSG00000105650	PDE4C	Gene	0
ENSG00000127884	ECHS1	Gene	0
ENSG00000105641	SLC5A5	Gene	0
ENSG00000104312	RIPK2	Gene	0
ENSG00000178127	NDUFV2	Gene	0
ENSG00000105647	PIK3R2	Gene	0
ENSG00000114115	RBP1	Gene	0
ENSG00000028137	TNFRSF1B	Gene	0
ENSG00000067704	IARS2	Gene	0
ENSG00000139874	SSTR1	Gene	0
ENSG00000065518	NDUFB4	Gene	0
ENSG00000204007	GLT6D1	Gene	0
ENSG00000113263	ITK	Gene	0
ENSG00000170634	ACYP2	Gene	0
ENSG00000166148	AVPR1A	Gene	0
ENSG00000134184	GSTM1	Gene	0
ENSG00000172819	RARG	Gene	0
ENSG00000177272	KCNA3	Gene	0
ENSG00000145293	ENOPH1	Gene	0
ENSG00000090530	P3H2	Gene	0
ENSG00000155097	ATP6V1C1	Gene	0
ENSG00000147471	PLPBP	Gene	0
ENSG00000187091	PLCD1	Gene	0
ENSG00000135002	RFK	Gene	0
ENSG00000158125	XDH	Gene	0
ENSG00000152822	GRM1	Gene	0
ENSG00000187094	CCK	Gene	0
ENSG00000152818	UTRN	Gene	0
ENSG00000167004	PDIA3	Gene	0
ENSG00000007047	MARK4	Gene	0
ENSG00000109193	SULT1E1	Gene	0
ENSG00000135480	KRT7	Gene	0
ENSG00000103415	HMOX2	Gene	0
ENSG00000124357	NAGK	Gene	0
ENSG00000070915	SLC12A3	Gene	0
ENSG00000100385	IL2RB	Gene	0
ENSG00000125686	MED1	Gene	0
ENSG00000125691	RPL23	Gene	0
ENSG00000075388	FGF4	Gene	0
ENSG00000099337	KCNK6	Gene	0
ENSG00000042445	RETSAT	Gene	0
ENSG00000115866	DARS	Gene	0
ENSG00000116711	PLA2G4A	Gene	0
ENSG00000074054	CLASP1	Gene	0
ENSG00000137673	MMP7	Gene	0
ENSG00000137674	MMP20	Gene	0
ENSG00000137675	MMP27	Gene	0
ENSG00000171503	ETFDH	Gene	0
ENSG00000169676	DRD5	Gene	0
ENSG00000171989	LDHAL6B	Gene	0
ENSG00000166165	CKB	Gene	0
ENSG00000078401	EDN1	Gene	0
ENSG00000101224	CDC25B	Gene	0
ENSG00000148795	CYP17A1	Gene	0
ENSG00000221823	PPP3R1	Gene	0
ENSG00000079739	PGM1	Gene	0
ENSG00000181789	COPG1	Gene	0
ENSG00000160862	AZGP1	Gene	0
ENSG00000160868	CYP3A4	Gene	0
ENSG00000160867	FGFR4	Gene	0
ENSG00000115419	GLS	Gene	0
ENSG00000105613	MAST1	Gene	0
ENSG00000179002	TAS1R2	Gene	0
ENSG00000076685	NT5C2	Gene	0
ENSG00000116745	RPE65	Gene	0
ENSG00000115414	FN1	Gene	0
ENSG00000115896	PLCL1	Gene	0
ENSG00000171522	PTGER4	Gene	0
ENSG00000158104	HPD	Gene	0
ENSG00000240583	AQP1	Gene	0
ENSG00000212907	MT-ND4L	Gene	0
ENSG00000168356	SCN11A	Gene	0
ENSG00000229314	ORM1	Gene	0
ENSG00000169684	CHRNA5	Gene	0
ENSG00000091831	ESR1	Gene	0
ENSG00000160870	CYP3A7	Gene	0
ENSG00000184845	DRD1	Gene	0
ENSG00000181333	HEPHL1	Gene	0
ENSG00000159423	ALDH4A1	Gene	0
ENSG00000099795	NDUFB7	Gene	0
ENSG00000105607	GCDH	Gene	0
ENSG00000166183	ASPG	Gene	0
ENSG00000110195	FOLR1	Gene	0
ENSG00000189283	FHIT	Gene	0
ENSG00000158578	ALAS2	Gene	0
ENSG00000158571	PFKFB1	Gene	0
ENSG00000160882	CYP11B1	Gene	0
ENSG00000125675	GRIA3	Gene	0
ENSG00000126522	ASL	Gene	0
ENSG00000123496	IL13RA2	Gene	0
ENSG00000102572	STK24	Gene	0
ENSG00000183648	NDUFB1	Gene	0
ENSG00000070961	ATP2B1	Gene	0
ENSG00000162704	ARPC5	Gene	0
ENSG00000104824	HNRNPL	Gene	0
ENSG00000066468	FGFR2	Gene	0
ENSG00000137745	MMP13	Gene	0
ENSG00000148408	CACNA1B	Gene	0
ENSG00000127948	POR	Gene	0
ENSG00000168496	FEN1	Gene	0
ENSG00000127947	PTPN12	Gene	0
ENSG00000055332	EIF2AK2	Gene	0
ENSG00000184984	CHRM5	Gene	0
ENSG00000179142	CYP11B2	Gene	0
ENSG00000184500	PROS1	Gene	0
ENSG00000143198	MGST3	Gene	0
ENSG00000184983	NDUFA6	Gene	0
ENSG00000184502	GAST	Gene	0
ENSG00000182326	C1S	Gene	0
ENSG00000159527	PGLYRP3	Gene	0
ENSG00000140905	GCSH	Gene	0
ENSG00000104814	MAP4K1	Gene	0
ENSG00000170345	FOS	Gene	0
ENSG00000136425	CIB2	Gene	0
ENSG00000196954	CASP4	Gene	0
ENSG00000137752	CASP1	Gene	0
ENSG00000168028	RPSA	Gene	0
ENSG00000173846	PLK3	Gene	0
ENSG00000133392	MYH11	Gene	0
ENSG00000124449	IRGC	Gene	0
ENSG00000101306	MYLK2	Gene	0
ENSG00000088247	KHSRP	Gene	0
ENSG00000127955	GNAI1	Gene	0
ENSG00000182793	GSTA5	Gene	0
ENSG00000010438	PRSS3	Gene	0
ENSG00000094916	CBX5	Gene	0
ENSG00000086062	B4GALT1	Gene	0
ENSG00000101782	RIOK3	Gene	0
ENSG00000123595	RAB9A	Gene	0
ENSG00000120088	CRHR1	Gene	0
ENSG00000241635	UGT1A1	Gene	0
ENSG00000164904	ALDH7A1	Gene	0
ENSG00000076248	UNG	Gene	0
ENSG00000143171	RXRG	Gene	0
ENSG00000162728	KCNJ9	Gene	0
ENSG00000116824	CD2	Gene	0
ENSG00000172531	PPP1CA	Gene	0
ENSG00000115977	AAK1	Gene	0
ENSG00000136872	ALDOB	Gene	0
ENSG00000104848	KCNA7	Gene	0
ENSG00000196502	SULT1A1	Gene	0
ENSG00000136877	FPGS	Gene	0
ENSG00000131187	F12	Gene	0
ENSG00000113790	EHHADH	Gene	0
ENSG00000008311	AASS	Gene	0
ENSG00000168036	CTNNB1	Gene	0
ENSG00000120053	GOT1	Gene	0
ENSG00000125743	SNRPD2	Gene	0
ENSG00000101336	HCK	Gene	0
ENSG00000120054	CPN1	Gene	0
ENSG00000162733	DDR2	Gene	0
ENSG00000103512	NOMO1	Gene	0
ENSG00000160551	TAOK1	Gene	0
ENSG00000100003	SEC14L2	Gene	0
ENSG00000123561	SERPINA7	Gene	0
ENSG00000143179	UCK2	Gene	0
ENSG00000164919	COX6C	Gene	0
ENSG00000104833	TUBB4A	Gene	0
ENSG00000113302	IL12B	Gene	0
ENSG00000115963	RND3	Gene	0
ENSG00000131196	NFATC1	Gene	0
ENSG00000136881	BAAT	Gene	0
ENSG00000196975	ANXA4	Gene	0
ENSG00000157326	DHRS4	Gene	0
ENSG00000137731	FXYD2	Gene	0
ENSG00000145349	CAMK2D	Gene	0
ENSG00000173868	PHOSPHO1	Gene	0
ENSG00000171209	CSN3	Gene	0
ENSG00000103507	BCKDK	Gene	0
ENSG00000100479	POLE2	Gene	0
ENSG00000184990	SIVA1	Gene	0
ENSG00000156471	PTDSS1	Gene	0
ENSG00000103502	CDIPT	Gene	0
ENSG00000101323	HAO1	Gene	0
ENSG00000146674	IGFBP3	Gene	0
ENSG00000164924	YWHAZ	Gene	0
ENSG00000182333	LIPF	Gene	0
ENSG00000239732	TLR9	Gene	0
ENSG00000115919	KYNU	Gene	0
ENSG00000183207	RUVBL2	Gene	0
ENSG00000156467	UQCRB	Gene	0
ENSG00000186716	BCR	Gene	0
ENSG00000162747	FCGR3B	Gene	0
ENSG00000069535	MAOB	Gene	0
ENSG00000180176	TH	Gene	0
ENSG00000144481	TRPM8	Gene	0
ENSG00000204231	RXRB	Gene	0
ENSG00000169385	RNASE2	Gene	0
ENSG00000198704	GPX6	Gene	0
ENSG00000077150	NFKB2	Gene	0
ENSG00000171219	CDC42BPG	Gene	0
ENSG00000100429	HDAC10	Gene	0
ENSG00000108381	ASPA	Gene	0
ENSG00000122694	GLIPR2	Gene	0
ENSG00000121361	KCNJ8	Gene	0
ENSG00000183696	UPP1	Gene	0
ENSG00000058404	CAMK2B	Gene	0
ENSG00000181019	NQO1	Gene	0
ENSG00000145335	SNCA	Gene	0
ENSG00000110218	PANX1	Gene	0
ENSG00000136869	TLR4	Gene	0
ENSG00000154277	UCHL1	Gene	0
ENSG00000137714	FDX1	Gene	0
ENSG00000078018	MAP2	Gene	0
ENSG00000115902	SLC1A4	Gene	0
ENSG00000113721	PDGFRB	Gene	0
ENSG00000137710	RDX	Gene	0
ENSG00000168065	SLC22A11	Gene	0
ENSG00000134684	YARS	Gene	0
ENSG00000196511	TPK1	Gene	0
ENSG00000169393	ELSPBP1	Gene	0
ENSG00000131174	COX7B	Gene	0
ENSG00000171236	LRG1	Gene	0
ENSG00000134201	GSTM5	Gene	0
ENSG00000134202	GSTM3	Gene	0
ENSG00000176919	C8G	Gene	0
ENSG00000204228	HSD17B8	Gene	0
ENSG00000143149	ALDH9A1	Gene	0
ENSG00000174738	NR1D2	Gene	0
ENSG00000168066	SF1	Gene	0
ENSG00000169398	PTK2	Gene	0
ENSG00000124406	ATP8A1	Gene	0
ENSG00000169397	RNASE3	Gene	0
ENSG00000168067	MAP4K2	Gene	0
ENSG00000100412	ACO2	Gene	0
ENSG00000145321	GC	Gene	0
ENSG00000148834	GSTO1	Gene	0
ENSG00000125730	C3	Gene	0
ENSG00000214021	TTLL3	Gene	0
ENSG00000181029	TRAPPC5	Gene	0
ENSG00000170390	DCLK2	Gene	0
ENSG00000214013	GANC	Gene	0
ENSG00000135503	ACVR1B	Gene	0
ENSG00000065154	OAT	Gene	0
ENSG00000172572	PDE3A	Gene	0
ENSG00000163618	CADPS	Gene	0
ENSG00000152086	TUBA3E	Gene	0
ENSG00000198721	ECI2	Gene	0
ENSG00000110244	APOA4	Gene	0
ENSG00000132470	ITGB4	Gene	0
ENSG00000110245	APOC3	Gene	0
ENSG00000130294	KIF1A	Gene	0
ENSG00000104805	NUCB1	Gene	0
ENSG00000131143	COX4I1	Gene	0
ENSG00000198727	MT-CYB	Gene	0
ENSG00000005249	PRKAR2B	Gene	0
ENSG00000196549	MME	Gene	0
ENSG00000204217	BMPR2	Gene	0
ENSG00000122679	RAMP3	Gene	0
ENSG00000146648	EGFR	Gene	0
ENSG00000174748	RPL15	Gene	0
ENSG00000100448	CTSG	Gene	0
ENSG00000089127	OAS1	Gene	0
ENSG00000012660	ELOVL5	Gene	0
ENSG00000091436	MAP3K20	Gene	0
ENSG00000058866	DGKG	Gene	0
ENSG00000182389	CACNB4	Gene	0
ENSG00000135517	MIP	Gene	0
ENSG00000113749	HRH2	Gene	0
ENSG00000188906	LRRK2	Gene	0
ENSG00000165806	CASP7	Gene	0
ENSG00000204681	GABBR1	Gene	0
ENSG00000003056	M6PR	Gene	0
ENSG00000198712	MT-CO2	Gene	0
ENSG00000157764	BRAF	Gene	0
ENSG00000112893	MAN2A1	Gene	0
ENSG00000121351	IAPP	Gene	0
ENSG00000089597	GANAB	Gene	0
ENSG00000070501	POLB	Gene	0
ENSG00000163631	ALB	Gene	0
ENSG00000162302	RPS6KA4	Gene	0
ENSG00000197891	SLC22A12	Gene	0
ENSG00000023330	ALAS1	Gene	0
ENSG00000197894	ADH5	Gene	0
ENSG00000174775	HRAS	Gene	0
ENSG00000136810	TXN	Gene	0
ENSG00000172115	CYCS	Gene	0
ENSG00000007402	CACNA2D2	Gene	0
ENSG00000284741		Gene	0
ENSG00000197408	CYP2B6	Gene	0
ENSG00000079385	CEACAM1	Gene	0
ENSG00000147955	SIGMAR1	Gene	0
ENSG00000117298	ECE1	Gene	0
ENSG00000057593	F7	Gene	0
ENSG00000082556	OPRK1	Gene	0
ENSG00000123505	AMD1	Gene	0
ENSG00000184588	PDE4B	Gene	0
ENSG00000203747	FCGR3A	Gene	0
ENSG00000134640	MTNR1B	Gene	0
ENSG00000198734	F5	Gene	0
ENSG00000181072	CHRM2	Gene	0
ENSG00000196557	CACNA1H	Gene	0
ENSG00000119013	NDUFB3	Gene	0
ENSG00000130287	NCAN	Gene	0
ENSG00000197406	DIO3	Gene	0
ENSG00000132465	JCHAIN	Gene	0
ENSG00000143105	KCNA10	Gene	0
ENSG00000143106	PSMA5	Gene	0
ENSG00000271447	MMP28	Gene	0
ENSG00000254087	LYN	Gene	0
ENSG00000163655	GMPS	Gene	0
ENSG00000123992	DNPEP	Gene	0
ENSG00000156885	COX6A2	Gene	0
ENSG00000132437	DDC	Gene	0
ENSG00000110203	FOLR3	Gene	0
ENSG00000111537	IFNG	Gene	0
ENSG00000198763	MT-ND2	Gene	0
ENSG00000113712	CSNK1A1	Gene	0
ENSG00000181085	MAPK15	Gene	0
ENSG00000154229	PRKCA	Gene	0
ENSG00000196588	MKL1	Gene	0
ENSG00000260314	MRC1	Gene	0
ENSG00000110680	CALCA	Gene	0
ENSG00000176974	SHMT1	Gene	0
ENSG00000172137	CALB2	Gene	0
ENSG00000135940	COX5B	Gene	0
ENSG00000006534	ALDH3B1	Gene	0
ENSG00000118137	APOA1	Gene	0
ENSG00000120457	KCNJ5	Gene	0
ENSG00000187630	DHRS4L2	Gene	0
ENSG00000012223	LTF	Gene	0
ENSG00000165841	CYP2C19	Gene	0
ENSG00000011376	LARS2	Gene	0
ENSG00000059758	CDK17	Gene	0
ENSG00000066056	TIE1	Gene	0
ENSG00000136807	CDK9	Gene	0
ENSG00000171298	GAA	Gene	0
ENSG00000083845	RPS5	Gene	0
ENSG00000141385	AFG3L2	Gene	0
ENSG00000163673	DCLK3	Gene	0
ENSG00000144891	AGTR1	Gene	0
ENSG00000162344	FGF19	Gene	0
ENSG00000161016	RPL8	Gene	0
ENSG00000237541	HLA-DQA2	Gene	0
ENSG00000130234	ACE2	Gene	0
ENSG00000072786	STK10	Gene	0
ENSG00000074966	TXK	Gene	0
ENSG00000106128	GHRHR	Gene	0
ENSG00000213585	VDAC1	Gene	0
ENSG00000198785	GRIN3A	Gene	0
ENSG00000214435	AS3MT	Gene	0
ENSG00000198786	MT-ND5	Gene	0
ENSG00000196126	HLA-DRB1	Gene	0
ENSG00000172156	CCL11	Gene	0
ENSG00000133742	CA1	Gene	0
ENSG00000118596	SLC16A7	Gene	0
ENSG00000118113	MMP8	Gene	0
ENSG00000143556	S100A7	Gene	0
ENSG00000140043	PTGR2	Gene	0
ENSG00000121764	HCRTR1	Gene	0
ENSG00000100823	APEX1	Gene	0
ENSG00000144407	PTH2R	Gene	0
ENSG00000120437	ACAT2	Gene	0
ENSG00000083444	PLOD1	Gene	0
ENSG00000084774	CAD	Gene	0
ENSG00000160179	ABCG1	Gene	0
ENSG00000188501	LCTL	Gene	0
ENSG00000145730	PAM	Gene	0
ENSG00000166710	B2M	Gene	0
ENSG00000108786	HSD17B1	Gene	0
ENSG00000110619	CARS	Gene	0
ENSG00000108784	NAGLU	Gene	0
ENSG00000152495	CAMK4	Gene	0
ENSG00000196591	HDAC2	Gene	0
ENSG00000107447	DNTT	Gene	0
ENSG00000134602	STK26	Gene	0
ENSG00000096746	HNRNPH3	Gene	0
ENSG00000174343	CHRNA9	Gene	0
ENSG00000072310	SREBF1	Gene	0
ENSG00000081248	CACNA1S	Gene	0
ENSG00000197448	GSTK1	Gene	0
ENSG00000178700	DHFR2	Gene	0
ENSG00000078098	FAP	Gene	0
ENSG00000160182	TFF1	Gene	0
ENSG00000160181	TFF2	Gene	0
ENSG00000143546	S100A8	Gene	0
ENSG00000116396	KCNC4	Gene	0
ENSG00000143549	TPM3	Gene	0
ENSG00000161031	PGLYRP2	Gene	0
ENSG00000139053	PDE6H	Gene	0
ENSG00000168906	MAT2A	Gene	0
ENSG00000204628	RACK1	Gene	0
ENSG00000186318	BACE1	Gene	0
ENSG00000164543	STK17A	Gene	0
ENSG00000270550	IGHV3-30	Gene	0
ENSG00000162368	CMPK1	Gene	0
ENSG00000013588	GPRC5A	Gene	0
ENSG00000108773	KAT2A	Gene	0
ENSG00000155511	GRIA1	Gene	0
ENSG00000173020	GRK2	Gene	0
ENSG00000004799	PDK4	Gene	0
ENSG00000119421	NDUFA8	Gene	0
ENSG00000184160	ADRA2C	Gene	0
ENSG00000138175	ARL3	Gene	0
ENSG00000163220	S100A9	Gene	0
ENSG00000084754	HADHA	Gene	0
ENSG00000163221	S100A12	Gene	0
ENSG00000160191	PDE9A	Gene	0
ENSG00000078061	ARAF	Gene	0
ENSG00000185010	F8	Gene	0
ENSG00000105290	APLP1	Gene	0
ENSG00000120899	PTK2B	Gene	0
ENSG00000160194	NDUFV3	Gene	0
ENSG00000161048	NAPEPLD	Gene	0
ENSG00000185015	CA13	Gene	0
ENSG00000115091	ACTR3	Gene	0
ENSG00000185499	MUC1	Gene	0
ENSG00000142208	AKT1	Gene	0
ENSG00000166736	HTR3A	Gene	0
ENSG00000049540	ELN	Gene	0
ENSG00000074935	TUBE1	Gene	0
ENSG00000172183	ISG20	Gene	0
ENSG00000108799	EZH1	Gene	0
ENSG00000198793	MTOR	Gene	0
ENSG00000165409	TSHR	Gene	0
ENSG00000135914	HTR2B	Gene	0
ENSG00000178726	THBD	Gene	0
ENSG00000196136	SERPINA3	Gene	0
ENSG00000196139	AKR1C3	Gene	0
ENSG00000133731	IMPA1	Gene	0
ENSG00000173039	RELA	Gene	0
ENSG00000162383	SLC1A7	Gene	0
ENSG00000166741	NNMT	Gene	0
ENSG00000057149	SERPINB3	Gene	0
ENSG00000078070	MCCC1	Gene	0
ENSG00000258429	PDF	Gene	0
ENSG00000187664	HAPLN4	Gene	0
ENSG00000115085	ZAP70	Gene	0
ENSG00000105281	SLC1A5	Gene	0
ENSG00000096717	SIRT1	Gene	0
ENSG00000184156	KCNQ3	Gene	0
ENSG00000168925	CTRB1	Gene	0
ENSG00000142676	RPL11	Gene	0
ENSG00000144852	NR1I2	Gene	0
ENSG00000255398	HCAR3	Gene	0
ENSG00000105355	PLIN3	Gene	0
ENSG00000105357	MYH14	Gene	0
ENSG00000103174	NAGPA	Gene	0
ENSG00000106688	SLC1A1	Gene	0
ENSG00000132975	GPR12	Gene	0
ENSG00000004779	NDUFAB1	Gene	0
ENSG00000107537	PHYH	Gene	0
ENSG00000197375	SLC22A5	Gene	0
ENSG00000110700	RPS13	Gene	0
ENSG00000099822	HCN2	Gene	0
ENSG00000198223	CSF2RA	Gene	0
ENSG00000152580	IGSF10	Gene	0
ENSG00000176435	CLEC14A	Gene	0
ENSG00000143632	ACTA1	Gene	0
ENSG00000100902	PSMA6	Gene	0
ENSG00000085662	AKR1B1	Gene	0
ENSG00000136098	NEK3	Gene	0
ENSG00000059377	TBXAS1	Gene	0
ENSG00000167969	ECI1	Gene	0
ENSG00000106683	LIMK1	Gene	0
ENSG00000165304	MELK	Gene	0
ENSG00000175591	P2RY2	Gene	0
ENSG00000198695	MT-ND6	Gene	0
ENSG00000176444	CLK2	Gene	0
ENSG00000099810	MTAP	Gene	0
ENSG00000133835	HSD17B4	Gene	0
ENSG00000276293	PIP4K2B	Gene	0
ENSG00000198216	CACNA1E	Gene	0
ENSG00000178623	GPR35	Gene	0
ENSG00000003436	TFPI	Gene	0
ENSG00000116478	HDAC1	Gene	0
ENSG00000152578	GRIA4	Gene	0
ENSG00000205076	LGALS7	Gene	0
ENSG00000151247	EIF4E	Gene	0
ENSG00000002587	HS3ST1	Gene	0
ENSG00000163131	CTSS	Gene	0
ENSG00000038427	VCAN	Gene	0
ENSG00000119535	CSF3R	Gene	0
ENSG00000121853	GHSR	Gene	0
ENSG00000143627	PKLR	Gene	0
ENSG00000185386	MAPK11	Gene	0
ENSG00000139131	YARS2	Gene	0
ENSG00000140598	EFL1	Gene	0
ENSG00000131620	ANO1	Gene	0
ENSG00000198242	RPL23A	Gene	0
ENSG00000177301	KCNA2	Gene	0
ENSG00000249915	PDCD6	Gene	0
ENSG00000109738	GLRB	Gene	0
ENSG00000213923	CSNK1E	Gene	0
ENSG00000062524	LTK	Gene	0
ENSG00000063854	HAGH	Gene	0
ENSG00000168830	HTR1E	Gene	0
ENSG00000115170	ACVR1	Gene	0
ENSG00000119508	NR4A3	Gene	0
ENSG00000140105	WARS	Gene	0
ENSG00000105372	RPS19	Gene	0
ENSG00000110717	NDUFS8	Gene	0
ENSG00000141433	ADCYAP1	Gene	0
ENSG00000108878	CACNG1	Gene	0
ENSG00000132965	ALOX5AP	Gene	0
ENSG00000132964	CDK8	Gene	0
ENSG00000197386	HTT	Gene	0
ENSG00000220205	VAMP2	Gene	0
ENSG00000148053	NTRK2	Gene	0
ENSG00000153406	NMRAL1	Gene	0
ENSG00000159189	C1QC	Gene	0
ENSG00000154736	ADAMTS5	Gene	0
ENSG00000116016	EPAS1	Gene	0
ENSG00000116014	KISS1R	Gene	0
ENSG00000151224	MAT1A	Gene	0
ENSG00000100906	NFKBIA	Gene	0
ENSG00000167996	FTH1	Gene	0
ENSG00000166664	CHRFAM7A	Gene	0
ENSG00000184076	UQCR10	Gene	0
ENSG00000140575	IQGAP1	Gene	0
ENSG00000106211	HSPB1	Gene	0
ENSG00000151694	ADAM17	Gene	0
ENSG00000108821	COL1A1	Gene	0
ENSG00000174292	TNK1	Gene	0
ENSG00000071054	MAP4K4	Gene	0
ENSG00000075413	MARK3	Gene	0
ENSG00000130758	MAP3K10	Gene	0
ENSG00000120949	TNFRSF8	Gene	0
ENSG00000065613	SLK	Gene	0
ENSG00000114268	PFKFB4	Gene	0
ENSG00000139567	ACVRL1	Gene	0
ENSG00000258818	RNASE4	Gene	0
ENSG00000115594	IL1R1	Gene	0
ENSG00000166670	MMP10	Gene	0
ENSG00000187134	AKR1C1	Gene	0
ENSG00000159176	CSRP1	Gene	0
ENSG00000142748	FCN3	Gene	0
ENSG00000169704	GP9	Gene	0
ENSG00000165349	SLC7A3	Gene	0
ENSG00000102287	GABRE	Gene	0
ENSG00000140564	FURIN	Gene	0
ENSG00000002549	LAP3	Gene	0
ENSG00000095015	MAP3K1	Gene	0
ENSG00000106633	GCK	Gene	0
ENSG00000065621	GSTO2	Gene	0
ENSG00000121807	CCR2	Gene	0
ENSG00000144908	ALDH1L1	Gene	0
ENSG00000112079	STK38	Gene	0
ENSG00000164024	METAP1	Gene	0
ENSG00000167531	LALBA	Gene	0
ENSG00000169710	FASN	Gene	0
ENSG00000159164	SV2A	Gene	0
ENSG00000137392	CLPS	Gene	0
ENSG00000103126	AXIN1	Gene	0
ENSG00000126267	COX6B1	Gene	0
ENSG00000142733	MAP3K6	Gene	0
ENSG00000141401	IMPA2	Gene	0
ENSG00000124089	MC3R	Gene	0
ENSG00000126266	FFAR1	Gene	0
ENSG00000167535	CACNB3	Gene	0
ENSG00000100097	LGALS1	Gene	0
ENSG00000142731	PLK4	Gene	0
ENSG00000166206	GABRB3	Gene	0
ENSG00000103152	MPG	Gene	0
ENSG00000125384	PTGER2	Gene	0
ENSG00000176014	TUBB6	Gene	0
ENSG00000140538	NTRK3	Gene	0
ENSG00000026025	VIM	Gene	0
ENSG00000115138	POMC	Gene	0
ENSG00000138696	BMPR1B	Gene	0
ENSG00000258839	MC1R	Gene	0
ENSG00000082175	PGR	Gene	0
ENSG00000137364	TPMT	Gene	0
ENSG00000188488	SERPINA5	Gene	0
ENSG00000180509	KCNE1	Gene	0
ENSG00000129749	CHRNA10	Gene	0
ENSG00000132906	CASP9	Gene	0
ENSG00000129744	ART1	Gene	0
ENSG00000127564	PKMYT1	Gene	0
ENSG00000130741	EIF2S3	Gene	0
ENSG00000075886	TUBA3D	Gene	0
ENSG00000042980	ADAM28	Gene	0
ENSG00000198276	UCKL1	Gene	0
ENSG00000105329	TGFB1	Gene	0
ENSG00000117308	GALE	Gene	0
ENSG00000163191	S100A11	Gene	0
ENSG00000150337	FCGR1A	Gene	0
ENSG00000117305	HMGCL	Gene	0
ENSG00000120937	NPPB	Gene	0
ENSG00000070190	DAPP1	Gene	0
ENSG00000066926	FECH	Gene	0
ENSG00000167553	TUBA1C	Gene	0
ENSG00000112096	SOD2	Gene	0
ENSG00000166224	SGPL1	Gene	0
ENSG00000167552	TUBA1A	Gene	0
ENSG00000186297	GABRA5	Gene	0
ENSG00000186298	PPP1CC	Gene	0
ENSG00000147168	IL2RG	Gene	0
ENSG00000078900	TP73	Gene	0
ENSG00000169738	DCXR	Gene	0
ENSG00000124067	SLC12A4	Gene	0
ENSG00000126247	CAPNS1	Gene	0
ENSG00000166228	PCBD1	Gene	0
ENSG00000179546	HTR1D	Gene	0
ENSG00000127540	UQCR11	Gene	0
ENSG00000180530	NRIP1	Gene	0
ENSG00000182718	ANXA2	Gene	0
ENSG00000106605	BLVRA	Gene	0
ENSG00000151655	ITIH2	Gene	0
ENSG00000120903	CHRNA2	Gene	0
ENSG00000120907	ADRA1A	Gene	0
ENSG00000111199	TRPV4	Gene	0
ENSG00000067829	IDH3G	Gene	0
ENSG00000116882	HAO2	Gene	0
ENSG00000168412	MTNR1A	Gene	0
ENSG00000136011	STAB2	Gene	0
ENSG00000164051	CCDC51	Gene	0
ENSG00000159131	GART	Gene	0
ENSG00000052344	PRSS8	Gene	0
ENSG00000126218	F10	Gene	0
ENSG00000147155	EBP	Gene	0
ENSG00000130707	ASS1	Gene	0
ENSG00000102245	CD40LG	Gene	0
ENSG00000102230	PCYT1B	Gene	0
ENSG00000095059	DHPS	Gene	0
ENSG00000104897	SF3A2	Gene	0
ENSG00000141837	CACNA1A	Gene	0
ENSG00000140505	CYP1A2	Gene	0
ENSG00000175198	PCCA	Gene	0
ENSG00000138207	RBP4	Gene	0
ENSG00000112038	OPRM1	Gene	0
ENSG00000120915	EPHX2	Gene	0
ENSG00000112033	PPARD	Gene	0
ENSG00000138685	FGF2	Gene	0
ENSG00000159128	IFNGR2	Gene	0
ENSG00000116874	WARS2	Gene	0
ENSG00000096384	HSP90AB1	Gene	0
ENSG00000115541	HSPE1	Gene	0
ENSG00000140990	NDUFB10	Gene	0
ENSG00000111181	SLC6A12	Gene	0
ENSG00000139531	SUOX	Gene	0
ENSG00000147145	LPAR4	Gene	0
ENSG00000127554	GFER	Gene	0
ENSG00000140511	HAPLN3	Gene	0
ENSG00000125378	BMP4	Gene	0
ENSG00000140992	PDPK1	Gene	0
ENSG00000124491	F13A1	Gene	0
ENSG00000241119	UGT1A9	Gene	0
ENSG00000124493	GRM4	Gene	0
ENSG00000150787	PTS	Gene	0
ENSG00000139988	RDH12	Gene	0
ENSG00000151632	AKR1C2	Gene	0
ENSG00000112062	MAPK14	Gene	0
ENSG00000167588	GPD1	Gene	0
ENSG00000164078	MST1R	Gene	0
ENSG00000166257	SCN3B	Gene	0
ENSG00000159593	NAE1	Gene	0
ENSG00000159110	IFNAR2	Gene	0
ENSG00000140988	RPS2	Gene	0
ENSG00000061273	HDAC7	Gene	0
ENSG00000149311	ATM	Gene	0
ENSG00000168439	STIP1	Gene	0
ENSG00000160951	PTGER1	Gene	0
ENSG00000099875	MKNK2	Gene	0
ENSG00000130702	LAMA5	Gene	0
ENSG00000106615	RHEB	Gene	0
ENSG00000151623	NR3C2	Gene	0
ENSG00000139514	SLC7A1	Gene	0
ENSG00000138668	HNRNPD	Gene	0
ENSG00000164082	GRM2	Gene	0
ENSG00000113389	NPR3	Gene	0
ENSG00000138669	PRKG2	Gene	0
ENSG00000074590	NUAK1	Gene	0
ENSG00000152952	PLOD2	Gene	0
ENSG00000001630	CYP51A1	Gene	0
ENSG00000168447	SCNN1B	Gene	0
ENSG00000119912	IDE	Gene	0
ENSG00000172939	OXSR1	Gene	0
ENSG00000150768	DLAT	Gene	0
ENSG00000151617	EDNRA	Gene	0
ENSG00000171608	PIK3CD	Gene	0
ENSG00000146276	GABRR1	Gene	0
ENSG00000100079	LGALS2	Gene	0
ENSG00000100077	GRK3	Gene	0
ENSG00000149305	HTR3B	Gene	0
ENSG00000125356	NDUFA1	Gene	0
ENSG00000127533	F2RL3	Gene	0
ENSG00000105711	SCN1B	Gene	0
ENSG00000001626	CFTR	Gene	0
ENSG00000135124	P2RX4	Gene	0
ENSG00000213903	LTB4R	Gene	0
ENSG00000151611	MMAA	Gene	0
ENSG00000213906	LTB4R2	Gene	0
ENSG00000173801	JUP	Gene	0
ENSG00000008256	CYTH3	Gene	0
ENSG00000169302	STK32A	Gene	0
ENSG00000136450	SRSF1	Gene	0
ENSG00000006071	ABCC8	Gene	0
ENSG00000033627	ATP6V0A1	Gene	0
ENSG00000123143	PKN1	Gene	0
ENSG00000179115	FARSA	Gene	0
ENSG00000100490	CDKL1	Gene	0
ENSG00000113327	GABRG2	Gene	0
ENSG00000105707	HPN	Gene	0
ENSG00000157388	CACNA1D	Gene	0
ENSG00000111142	METAP2	Gene	0
ENSG00000111144	LTA4H	Gene	0
ENSG00000233927	RPS28	Gene	0
ENSG00000169313	P2RY12	Gene	0
ENSG00000101349	PAK5	Gene	0
ENSG00000147100	SLC16A2	Gene	0
ENSG00000182752	PAPPA	Gene	0
ENSG00000100012	SEC14L3	Gene	0
ENSG00000147588	PMP2	Gene	0
ENSG00000185803	SLC52A2	Gene	0
ENSG00000180596	HIST1H2BC	Gene	0
ENSG00000125780	TGM3	Gene	0
ENSG00000140937	CDH11	Gene	0
ENSG00000147571	CRH	Gene	0
ENSG00000145391	SETD7	Gene	0
ENSG00000105737	GRIK5	Gene	0
ENSG00000065675	PRKCQ	Gene	0
ENSG00000135100	HNF1A	Gene	0
ENSG00000241553	ARPC4	Gene	0
ENSG00000170312	CDK1	Gene	0
ENSG00000134259	NGF	Gene	0
ENSG00000204174	NPY4R	Gene	0
ENSG00000080824	HSP90AA1	Gene	0
ENSG00000114200	BCHE	Gene	0
ENSG00000137764	MAP2K5	Gene	0
ENSG00000182782	HCAR2	Gene	0
ENSG00000102225	CDK16	Gene	0
ENSG00000087460	GNAS	Gene	0
ENSG00000100030	MAPK1	Gene	0
ENSG00000105723	GSK3A	Gene	0
ENSG00000104879	CKM	Gene	0
ENSG00000115525	ST3GAL5	Gene	0
ENSG00000115523	GNLY	Gene	0
ENSG00000115524	SF3B1	Gene	0
ENSG00000136448	NMT1	Gene	0
ENSG00000138621	PPCDC	Gene	0
ENSG00000196924	FLNA	Gene	0
ENSG00000114670	NEK11	Gene	0
ENSG00000173826	KCNH6	Gene	0
ENSG00000170315	UBB	Gene	0
ENSG00000172977	KAT5	Gene	0
ENSG00000152904	GGPS1	Gene	0
ENSG00000128829	EIF2AK4	Gene	0
ENSG00000023839	ABCC2	Gene	0
ENSG00000103546	SLC6A2	Gene	0
ENSG00000145384	FABP2	Gene	0
ENSG00000145386	CCNA2	Gene	0
ENSG00000182774	RPS17	Gene	0
ENSG00000101365	IDH3B	Gene	0
ENSG00000100033	PRODH	Gene	0
ENSG00000100031	GGT1	Gene	0
ENSG00000181104	F2R	Gene	0
ENSG00000133028	SCO1	Gene	0
ENSG00000137869	CYP19A1	Gene	0
ENSG00000077238	IL4R	Gene	0
ENSG00000263528	IKBKE	Gene	0
ENSG00000243910	TUBA4B	Gene	0
ENSG00000167283	ATP5L	Gene	0
ENSG00000136531	SCN2A	Gene	0
ENSG00000171302	CANT1	Gene	0
ENSG00000171303	KCNK3	Gene	0
ENSG00000109390	NDUFC1	Gene	0
ENSG00000128918	ALDH1A2	Gene	0
ENSG00000132170	PPARG	Gene	0
ENSG00000168135	KCNJ4	Gene	0
ENSG00000167286	CD3D	Gene	0
ENSG00000145494	NDUFS6	Gene	0
ENSG00000177084	POLE	Gene	0
ENSG00000089220	PEBP1	Gene	0
ENSG00000160654	CD3G	Gene	0
ENSG00000156136	DCK	Gene	0
ENSG00000114738	MAPKAPK3	Gene	0
ENSG00000113407	TARS	Gene	0
ENSG00000177098	SCN4B	Gene	0
ENSG00000171791	BCL2	Gene	0
ENSG00000161509	GRIN2C	Gene	0
ENSG00000111229	ARPC3	Gene	0
ENSG00000113889	KNG1	Gene	0
ENSG00000171793	CTPS1	Gene	0
ENSG00000159640	ACE	Gene	0
ENSG00000137876	RSL24D1	Gene	0
ENSG00000104936	DMPK	Gene	0
ENSG00000134363	FST	Gene	0
ENSG00000171314	PGAM1	Gene	0
ENSG00000197915	HRNR	Gene	0
ENSG00000128928	IVD	Gene	0
ENSG00000101425	BPI	Gene	0
ENSG00000102755	FLT1	Gene	0
ENSG00000100577	GSTZ1	Gene	0
ENSG00000121053	EPX	Gene	0
ENSG00000183765	CHEK2	Gene	0
ENSG00000184611	KCNH7	Gene	0
ENSG00000161513	FDXR	Gene	0
ENSG00000136999	NOV	Gene	0
ENSG00000105810	CDK6	Gene	0
ENSG00000047849	MAP4	Gene	0
ENSG00000137843	PAK6	Gene	0
ENSG00000189091	SF3B3	Gene	0
ENSG00000197953	AADACL2	Gene	0
ENSG00000137845	ADAM10	Gene	0
ENSG00000111252	SH2B3	Gene	0
ENSG00000133488	SEC14L4	Gene	0
ENSG00000132155	RAF1	Gene	0
ENSG00000136997	MYC	Gene	0
ENSG00000134333	LDHA	Gene	0
ENSG00000197956	S100A6	Gene	0
ENSG00000198804	MT-CO1	Gene	0
ENSG00000196616	ADH1B	Gene	0
ENSG00000169006	NTSR2	Gene	0
ENSG00000125868	DSTN	Gene	0
ENSG00000089685	BIRC5	Gene	0
ENSG00000091513	TF	Gene	0
ENSG00000185973	TMLHE	Gene	0
ENSG00000179284	DAND5	Gene	0
ENSG00000160678	S100A1	Gene	0
ENSG00000205629	LCMT1	Gene	0
ENSG00000133019	CHRM3	Gene	0
ENSG00000064393	HIPK2	Gene	0
ENSG00000135679	MDM2	Gene	0
ENSG00000156113	KCNMA1	Gene	0
ENSG00000104951	IL4I1	Gene	0
ENSG00000065243	PKN2	Gene	0
ENSG00000156110	ADK	Gene	0
ENSG00000136521	NDUFB5	Gene	0
ENSG00000173511	VEGFB	Gene	0
ENSG00000173992	CCS	Gene	0
ENSG00000075043	KCNQ2	Gene	0
ENSG00000253729	PRKDC	Gene	0
ENSG00000196611	MMP1	Gene	0
ENSG00000005156	LIG3	Gene	0
ENSG00000132164	SLC6A11	Gene	0
ENSG00000157445	CACNA2D3	Gene	0
ENSG00000100116	GCAT	Gene	0
ENSG00000232810	TNF	Gene	0
ENSG00000160200	CBS	Gene	0
ENSG00000101444	AHCY	Gene	0
ENSG00000100596	SPTLC2	Gene	0
ENSG00000125877	ITPA	Gene	0
ENSG00000054116	TRAPPC3	Gene	0
ENSG00000183785	TUBA8	Gene	0
ENSG00000179295	PTPN11	Gene	0
ENSG00000161533	ACOX1	Gene	0
ENSG00000011422	PLAUR	Gene	0
ENSG00000160209	PDXK	Gene	0
ENSG00000134318	ROCK2	Gene	0
ENSG00000091583	APOH	Gene	0
ENSG00000156103	MMP16	Gene	0
ENSG00000137825	ITPKA	Gene	0
ENSG00000181143	MUC16	Gene	0
ENSG00000111679	PTPN6	Gene	0
ENSG00000111674	ENO2	Gene	0
ENSG00000169021	UQCRFS1	Gene	0
ENSG00000198822	GRM3	Gene	0
ENSG00000113851	CRBN	Gene	0
ENSG00000169020	ATP5I	Gene	0
ENSG00000104904	OAZ1	Gene	0
ENSG00000198821	CD247	Gene	0
ENSG00000197977	ELOVL2	Gene	0
ENSG00000196639	HRH1	Gene	0
ENSG00000079462	PAFAH1B3	Gene	0
ENSG00000145451	GLRA3	Gene	0
ENSG00000160211	G6PD	Gene	0
ENSG00000125844	RRBP1	Gene	0
ENSG00000087085	ACHE	Gene	0
ENSG00000120156	TEK	Gene	0
ENSG00000185513	L3MBTL1	Gene	0
ENSG00000186847	KRT14	Gene	0
ENSG00000143278	F13B	Gene	0
ENSG00000185515	BRCC3	Gene	0
ENSG00000087086	FTL	Gene	0
ENSG00000160213	CSTB	Gene	0
ENSG00000089250	NOS1	Gene	0
ENSG00000240857	RDH14	Gene	0
ENSG00000069667	RORA	Gene	0
ENSG00000111669	TPI1	Gene	0
ENSG00000169032	MAP2K1	Gene	0
ENSG00000007312	CD79B	Gene	0
ENSG00000007314	SCN4A	Gene	0
ENSG00000112992	NNT	Gene	0
ENSG00000198805	PNP	Gene	0
ENSG00000012779	ALOX5	Gene	0
ENSG00000101868	POLA1	Gene	0
ENSG00000169035	KLK7	Gene	0
ENSG00000186832	KRT16	Gene	0
ENSG00000079459	FDFT1	Gene	0
ENSG00000124523	SIRT5	Gene	0
ENSG00000163736	PPBP	Gene	0
ENSG00000162889	MAPKAPK2	Gene	0
ENSG00000125851	PCSK2	Gene	0
ENSG00000158748	HTR6	Gene	0
ENSG00000165916	PSMC3	Gene	0
ENSG00000163737	PF4	Gene	0
ENSG00000104921	FCER2	Gene	0
ENSG00000198840	MT-ND3	Gene	0
ENSG00000197993	KEL	Gene	0
ENSG00000181163	NPM1	Gene	0
ENSG00000196664	TLR7	Gene	0
ENSG00000110367	DDX6	Gene	0
ENSG00000118298	CA14	Gene	0
ENSG00000172216	CEBPB	Gene	0
ENSG00000198848	CES1	Gene	0
ENSG00000112541	PDE10A	Gene	0
ENSG00000075073	TACR2	Gene	0
ENSG00000174876	AMY1B	Gene	0
ENSG00000006451	RALA	Gene	0
ENSG00000224389	C4B	Gene	0
ENSG00000169047	IRS1	Gene	0
ENSG00000100567	PSMA3	Gene	0
ENSG00000169045	HNRNPH1	Gene	0
ENSG00000102743	SLC25A15	Gene	0
ENSG00000143252	SDHC	Gene	0
ENSG00000123643	SLC36A1	Gene	0
ENSG00000186868	MAPT	Gene	0
ENSG00000143257	NR1I3	Gene	0
ENSG00000070614	NDST1	Gene	0
ENSG00000157404	KIT	Gene	0
ENSG00000134308	YWHAQ	Gene	0
ENSG00000174886	NDUFA11	Gene	0
ENSG00000170043	TRAPPC1	Gene	0
ENSG00000134780	DAGLA	Gene	0
ENSG00000196655	TRAPPC4	Gene	0
ENSG00000077264	PAK3	Gene	0
ENSG00000144579	CTDSP1	Gene	0
ENSG00000198829	SUCNR1	Gene	0
ENSG00000206503	HLA-A	Gene	0
ENSG00000101405	OXT	Gene	0
ENSG00000125834	STK35	Gene	0
ENSG00000088386	SLC15A1	Gene	0
ENSG00000185527	PDE6G	Gene	0
ENSG00000163754	GYG1	Gene	0
ENSG00000091140	DLD	Gene	0
ENSG00000135605	TEC	Gene	0
ENSG00000069696	DRD4	Gene	0
ENSG00000112964	GHR	Gene	0
ENSG00000068366	ACSL4	Gene	0
ENSG00000118271	TTR	Gene	0
ENSG00000171385	KCND3	Gene	0
ENSG00000006432	MAP3K9	Gene	0
ENSG00000196689	TRPV1	Gene	0
ENSG00000174417	TRHR	Gene	0
ENSG00000136931	NR5A1	Gene	0
ENSG00000130396	AFDN	Gene	0
ENSG00000172236	TPSAB1	Gene	0
ENSG00000136930	PSMB7	Gene	0
ENSG00000175745	NR2F1	Gene	0
ENSG00000187730	GABRD	Gene	0
ENSG00000100985	MMP9	Gene	0
ENSG00000100983	GSS	Gene	0
ENSG00000107130	NCS1	Gene	0
ENSG00000187733	AMY1C	Gene	0
ENSG00000164615	CAMLG	Gene	0
ENSG00000233276	GPX1	Gene	0
ENSG00000162434	JAK1	Gene	0
ENSG00000144566	RAB5A	Gene	0
ENSG00000158716	DUSP23	Gene	0
ENSG00000278195	SSTR3	Gene	0
ENSG00000198851	CD3E	Gene	0
ENSG00000091136	LAMB1	Gene	0
ENSG00000278196	IGLV2-8	Gene	0
ENSG00000132581	SDF2	Gene	0
ENSG00000176601	MAP3K19	Gene	0
ENSG00000136943	CTSV	Gene	0
ENSG00000136942	RPL35	Gene	0
ENSG00000158710	TAGLN2	Gene	0
ENSG00000153029	MR1	Gene	0
ENSG00000145888	GLRA1	Gene	0
ENSG00000143226	FCGR2A	Gene	0
ENSG00000140199	SLC12A6	Gene	0
ENSG00000122787	AKR1D1	Gene	0
ENSG00000203857	HSD3B1	Gene	0
ENSG00000011485	PPP5C	Gene	0
ENSG00000184216	IRAK1	Gene	0
ENSG00000146733	PSPH	Gene	0
ENSG00000203859	HSD3B2	Gene	0
ENSG00000166800	LDHAL6A	Gene	0
ENSG00000109339	MAPK10	Gene	0
ENSG00000107159	CA9	Gene	0
ENSG00000090273	NUDC	Gene	0
ENSG00000026508	CD44	Gene	0
ENSG00000198400	NTRK1	Gene	0
ENSG00000094631	HDAC6	Gene	0
ENSG00000128052	KDR	Gene	0
ENSG00000198886	MT-ND4	Gene	0
ENSG00000196224	KRTAP5-3	Gene	0
ENSG00000128050	PAICS	Gene	0
ENSG00000198888	MT-ND1	Gene	0
ENSG00000173585	CCR9	Gene	0
ENSG00000169083	AR	Gene	0
ENSG00000078142	PIK3C3	Gene	0
ENSG00000198408	MGEA5	Gene	0
ENSG00000174437	ATP2A2	Gene	0
ENSG00000081320	STK17B	Gene	0
ENSG00000143217	NECTIN4	Gene	0
ENSG00000101856	PGRMC1	Gene	0
ENSG00000163788	SNRK	Gene	0
ENSG00000139180	NDUFA9	Gene	0
ENSG00000164638	SLC29A4	Gene	0
ENSG00000128059	PPAT	Gene	0
ENSG00000187758	ADH1A	Gene	0
ENSG00000153002	CPB1	Gene	0
ENSG00000131238	PPT1	Gene	0
ENSG00000108479	GALK1	Gene	0
ENSG00000211455	STK38L	Gene	0
ENSG00000136928	GABBR2	Gene	0
ENSG00000110799	VWF	Gene	0
ENSG00000090266	NDUFB2	Gene	0
ENSG00000092445	TYRO3	Gene	0
ENSG00000118260	CREB1	Gene	0
ENSG00000112972	HMGCS1	Gene	0
ENSG00000111640	GAPDH	Gene	0
ENSG00000173599	PC	Gene	0
ENSG00000174444	RPL4	Gene	0
ENSG00000173597	SULT1B1	Gene	0
ENSG00000156515	HK1	Gene	0
ENSG00000196218	RYR1	Gene	0
ENSG00000101846	STS	Gene	0
ENSG00000228716	DHFR	Gene	0
ENSG00000160285	LSS	Gene	0
ENSG00000116096	SPR	Gene	0
ENSG00000160282	FTCD	Gene	0
ENSG00000182054	IDH2	Gene	0
ENSG00000082641	NFE2L1	Gene	0
ENSG00000109320	NFKB1	Gene	0
ENSG00000166825	ANPEP	Gene	0
ENSG00000100994	PYGB	Gene	0
ENSG00000139190	VAMP1	Gene	0
ENSG00000107140	TESK1	Gene	0
ENSG00000123610	TNFAIP6	Gene	0
ENSG00000092439	TRPM7	Gene	0
ENSG00000145864	GABRB2	Gene	0
ENSG00000145863	GABRA6	Gene	0
ENSG00000070669	ASNS	Gene	0
ENSG00000131203	IDO1	Gene	0
ENSG00000099901	RANBP1	Gene	0
ENSG00000131686	CA6	Gene	0
ENSG00000073756	PTGS2	Gene	0
ENSG00000132535	DLG4	Gene	0
ENSG00000151292	CSNK1G3	Gene	0
ENSG00000166828	SCNN1G	Gene	0
ENSG00000261701	HPR	Gene	0
ENSG00000127184	COX7C	Gene	0
ENSG00000170099	SERPINA6	Gene	0
ENSG00000178814	OPLAH	Gene	0
ENSG00000156508	EEF1A1	Gene	0
ENSG00000154328	NEIL2	Gene	0
ENSG00000091181	IL5RA	Gene	0
ENSG00000146701	MDH2	Gene	0
ENSG00000034152	MAP2K3	Gene	0
ENSG00000108423	TUBD1	Gene	0
ENSG00000105397	TYK2	Gene	0
ENSG00000105398	SULT2A1	Gene	0
ENSG00000105388	CEACAM5	Gene	0
ENSG00000213694	S1PR3	Gene	0
ENSG00000047457	CP	Gene	0
ENSG00000154310	TNIK	Gene	0
ENSG00000196230	TUBB	Gene	0
ENSG00000197561	ELANE	Gene	0
ENSG00000198899	MT-ATP6	Gene	0
ENSG00000121897	LIAS	Gene	0
ENSG00000116032	GRIN3B	Gene	0
ENSG00000175309	PHYKPL	Gene	0
ENSG00000166840	GLYATL1	Gene	0
ENSG00000117362	APH1A	Gene	0
ENSG00000184254	ALDH1A3	Gene	0
ENSG00000185100	ADSSL1	Gene	0
ENSG00000105383	CD33	Gene	0
ENSG00000162009	SSTR5	Gene	0
ENSG00000121410	A1BG	Gene	0
ENSG00000107562	CXCL12	Gene	0
ENSG00000165995	CACNB2	Gene	0
ENSG00000109743	BST1	Gene	0
ENSG00000165997	ARL5B	Gene	0
ENSG00000092010	PSME1	Gene	0
ENSG00000073734	ABCB11	Gene	0
ENSG00000196262	PPIA	Gene	0
ENSG00000197594	ENPP1	Gene	0
ENSG00000172296	SPTLC3	Gene	0
ENSG00000197119	SLC25A29	Gene	0
ENSG00000139144	PIK3C2G	Gene	0
ENSG00000162496	DHRS3	Gene	0
ENSG00000057252	SOAT1	Gene	0
ENSG00000166851	PLK1	Gene	0
ENSG00000188643	S100A16	Gene	0
ENSG00000117394	SLC2A1	Gene	0
ENSG00000188641	DPYD	Gene	0
ENSG00000082212	ME2	Gene	0
ENSG00000165527	ARF6	Gene	0
ENSG00000186469	GNG2	Gene	0
ENSG00000092009	CMA1	Gene	0
ENSG00000015413	DPEP1	Gene	0
ENSG00000167701	GPT	Gene	0
ENSG00000106258	CYP3A5	Gene	0
ENSG00000067064	IDI1	Gene	0
ENSG00000052802	MSMO1	Gene	0
ENSG00000198431	TXNRD1	Gene	0
ENSG00000050628	PTGER3	Gene	0
ENSG00000197584	KCNMB2	Gene	0
ENSG00000108439	PNPO	Gene	0
ENSG00000173153	ESRRA	Gene	0
ENSG00000100949	RABGGTA	Gene	0
ENSG00000166863	TAC3	Gene	0
ENSG00000117385	P3H1	Gene	0
ENSG00000166862	CACNG2	Gene	0
ENSG00000004660	CAMKK1	Gene	0
ENSG00000121879	PIK3CA	Gene	0
ENSG00000185122	HSF1	Gene	0
ENSG00000142319	SLC6A3	Gene	0
ENSG00000271503	CCL5	Gene	0
ENSG00000226979	LTA	Gene	0
ENSG00000142798	HSPG2	Gene	0
ENSG00000167711	SERPINF2	Gene	0
ENSG00000095587	TLL2	Gene	0
ENSG00000177885	GRB2	Gene	0
ENSG00000151376	ME3	Gene	0
ENSG00000138395	CDK15	Gene	0
ENSG00000162396	PARS2	Gene	0
ENSG00000116120	FARSB	Gene	0
ENSG00000138398	PPIG	Gene	0
ENSG00000117450	PRDX1	Gene	0
ENSG00000115271	GCA	Gene	0
ENSG00000184185	KCNJ12	Gene	0
ENSG00000121966	CXCR4	Gene	0
ENSG00000130429	ARPC1B	Gene	0
ENSG00000168938	PPIC	Gene	0
ENSG00000099937	SERPIND1	Gene	0
ENSG00000278588	HIST1H2BI	Gene	0
ENSG00000108984	MAP2K6	Gene	0
ENSG00000167601	AXL	Gene	0
ENSG00000107643	MAPK8	Gene	0
ENSG00000178741	COX5A	Gene	0
ENSG00000106799	TGFBR1	Gene	0
ENSG00000196154	S100A4	Gene	0
ENSG00000092068	SLC7A8	Gene	0
ENSG00000011083	SLC6A7	Gene	0
ENSG00000110811	P3H3	Gene	0
ENSG00000117448	AKR1A1	Gene	0
ENSG00000151366	NDUFC2	Gene	0
ENSG00000086619	ERO1B	Gene	0
ENSG00000186350	RXRA	Gene	0
ENSG00000282608	ADORA3	Gene	0
ENSG00000243480	AMY2A	Gene	0
ENSG00000188536	HBA2	Gene	0
ENSG00000187688	TRPV2	Gene	0
ENSG00000137070	IL11RA	Gene	0
ENSG00000105464	GRIN2D	Gene	0
ENSG00000092054	MYH7	Gene	0
ENSG00000109854	HTATIP2	Gene	0
ENSG00000106348	IMPDH1	Gene	0
ENSG00000107679	PLEKHA1	Gene	0
ENSG00000198363	ASPH	Gene	0
ENSG00000130413	STK33	Gene	0
ENSG00000130414	NDUFA10	Gene	0
ENSG00000131747	TOP2A	Gene	0
ENSG00000037241	RPL26L1	Gene	0
ENSG00000152207	CYSLTR2	Gene	0
ENSG00000179603	GRM8	Gene	0
ENSG00000148180	GSN	Gene	0
ENSG00000005961	ITGA2B	Gene	0
ENSG00000138379	MSTN	Gene	0
ENSG00000164111	ANXA5	Gene	0
ENSG00000118777	ABCG2	Gene	0
ENSG00000116141	MARK1	Gene	0
ENSG00000168959	GRM5	Gene	0
ENSG00000108515	ENO3	Gene	0
ENSG00000108518	PFN1	Gene	0
ENSG00000253293	HOXA10	Gene	0
ENSG00000132603	NIP7	Gene	0
ENSG00000196177	ACADSB	Gene	0
ENSG00000131759	RARA	Gene	0
ENSG00000198356	ASNA1	Gene	0
ENSG00000149021	SCGB1A1	Gene	0
ENSG00000198355	PIM3	Gene	0
ENSG00000176105	YES1	Gene	0
ENSG00000119630	PGF	Gene	0
ENSG00000115286	NDUFS7	Gene	0
ENSG00000168961	LGALS9	Gene	0
ENSG00000117461	PIK3R3	Gene	0
ENSG00000185043	CIB1	Gene	0
ENSG00000119638	NEK9	Gene	0
ENSG00000143727	ACP1	Gene	0
ENSG00000164120	HPGD	Gene	0
ENSG00000164129	NPY5R	Gene	0
ENSG00000189403	HMGB1	Gene	0
ENSG00000165457	FOLR2	Gene	0
ENSG00000142875	PRKACB	Gene	0
ENSG00000189409	MMP23B	Gene	0
ENSG00000169813	HNRNPF	Gene	0
ENSG00000164128	NPY1R	Gene	0
ENSG00000014138	POLA2	Gene	0
ENSG00000105486	LIG1	Gene	0
ENSG00000107611	CUBN	Gene	0
ENSG00000152661	GJA1	Gene	0
ENSG00000049249	TNFRSF9	Gene	0
ENSG00000107614	TRDMT1	Gene	0
ENSG00000108946	PRKAR1A	Gene	0
ENSG00000178772	CPN2	Gene	0
ENSG00000211445	GPX3	Gene	0
ENSG00000138356	AOX1	Gene	0
ENSG00000139687	RB1	Gene	0
ENSG00000166311	SMPD1	Gene	0
ENSG00000163285	GABRG1	Gene	0
ENSG00000115232	ITGA4	Gene	0
ENSG00000163286	ALPPL2	Gene	0
ENSG00000166794	PPIB	Gene	0
ENSG00000139684	ESD	Gene	0
ENSG00000116560	SFPQ	Gene	0
ENSG00000163288	GABRB1	Gene	0
ENSG00000166796	LDHC	Gene	0
ENSG00000163283	ALPP	Gene	0
ENSG00000278540	ACACA	Gene	0
ENSG00000187258	NPSR1	Gene	0
ENSG00000164136	IL15	Gene	0
ENSG00000101076	HNF4A	Gene	0
ENSG00000048392	RRM2B	Gene	0
ENSG00000049239	H6PD	Gene	0
ENSG00000108932	SLC16A6	Gene	0
ENSG00000177453	NIM1K	Gene	0
ENSG00000131730	CKMT2	Gene	0
ENSG00000177455	CD19	Gene	0
ENSG00000102393	GLA	Gene	0
ENSG00000148154	UGCG	Gene	0
ENSG00000105426	PTPRS	Gene	0
ENSG00000149485	FADS1	Gene	0
ENSG00000074695	LMAN1	Gene	0
ENSG00000179639	FCER1A	Gene	0
ENSG00000139219	COL2A1	Gene	0
ENSG00000170820	FSHR	Gene	0
ENSG00000117400	MPL	Gene	0
ENSG00000213619	NDUFS3	Gene	0
ENSG00000186395	KRT10	Gene	0
ENSG00000187242	KRT12	Gene	0
ENSG00000138363	ATIC	Gene	0
ENSG00000163297	ANTXR2	Gene	0
ENSG00000165471	MBL2	Gene	0
ENSG00000141526	SLC16A3	Gene	0
ENSG00000180616	SSTR2	Gene	0
ENSG00000140678	ITGAX	Gene	0
ENSG00000277224	HIST1H2BF	Gene	0
ENSG00000140675	SLC5A2	Gene	0
ENSG00000167658	EEF2	Gene	0
ENSG00000169836	TACR3	Gene	0
ENSG00000167657	DAPK3	Gene	0
ENSG00000126351	THRA	Gene	0
ENSG00000176136	MC5R	Gene	0
ENSG00000109814	UGDH	Gene	0
ENSG00000153976	HS3ST3A1	Gene	0
ENSG00000099960	SLC7A4	Gene	0
ENSG00000116106	EPHA4	Gene	0
ENSG00000037280	FLT4	Gene	0
ENSG00000088827	SIGLEC1	Gene	0
ENSG00000206075	SERPINB5	Gene	0
ENSG00000115252	PDE1A	Gene	0
ENSG00000168995	SIGLEC7	Gene	0
ENSG00000088832	FKBP1A	Gene	0
ENSG00000141510	TP53	Gene	0
ENSG00000211892	IGHG4	Gene	0
ENSG00000105443	CYTH2	Gene	0
ENSG00000211893	IGHG2	Gene	0
ENSG00000211890	IGHA2	Gene	0
ENSG00000095596	CYP26A1	Gene	0
ENSG00000108953	YWHAE	Gene	0
ENSG00000211896	IGHG1	Gene	0
ENSG00000099953	MMP11	Gene	0
ENSG00000211895	IGHA1	Gene	0
ENSG00000159267	HLCS	Gene	0
ENSG00000067900	ROCK1	Gene	0
ENSG00000211899	IGHM	Gene	0
ENSG00000088826	SMOX	Gene	0
ENSG00000136160	EDNRB	Gene	0
ENSG00000165496	RPL10L	Gene	0
ENSG00000164167	LSM6	Gene	0
ENSG00000168522	FNTA	Gene	0
ENSG00000137491	SLCO2B1	Gene	0
ENSG00000258947	TUBB3	Gene	0
ENSG00000187266	EPOR	Gene	0
ENSG00000141503	MINK1	Gene	0
ENSG00000166347	CYB5A	Gene	0
ENSG00000053747	LAMA3	Gene	0
ENSG00000126368	NR1D1	Gene	0
ENSG00000278535	DHRS11	Gene	0
ENSG00000102362	SYTL4	Gene	0
ENSG00000176153	GPX2	Gene	0
ENSG00000149452	SLC22A8	Gene	0
ENSG00000177000	MTHFR	Gene	0
ENSG00000153956	CACNA2D1	Gene	0
ENSG00000104549	SQLE	Gene	0
ENSG00000072062	PRKACA	Gene	0
ENSG00000114349	GNAT1	Gene	0
ENSG00000138795	LEF1	Gene	0
ENSG00000138796	HADH	Gene	0
ENSG00000112164	GLP1R	Gene	0
ENSG00000138798	EGF	Gene	0
ENSG00000113494	PRLR	Gene	0
ENSG00000138792	ENPEP	Gene	0
ENSG00000137462	TLR2	Gene	0
ENSG00000165025	SYK	Gene	0
ENSG00000113492	AGXT2	Gene	0
ENSG00000256713	PGA5	Gene	0
ENSG00000128519	TAS2R16	Gene	0
ENSG00000086232	EIF2AK1	Gene	0
ENSG00000214078	CPNE1	Gene	0
ENSG00000167207	NOD2	Gene	0
ENSG00000168539	CHRM1	Gene	0
ENSG00000165029	ABCA1	Gene	0
ENSG00000124157	SEMG2	Gene	0
ENSG00000244734	HBB	Gene	0
ENSG00000161905	ALOX15	Gene	0
ENSG00000124160	NCOA5	Gene	0
ENSG00000147262	GPR119	Gene	0
ENSG00000204264	PSMB8	Gene	0
ENSG00000244731	C4A	Gene	0
ENSG00000169877	AHSP	Gene	0
ENSG00000115661	STK16	Gene	0
ENSG00000188130	MAPK12	Gene	0
ENSG00000085377	PREP	Gene	0
ENSG00000168542	COL3A1	Gene	0
ENSG00000118729	CASQ2	Gene	0
ENSG00000197081	IGF2R	Gene	0
ENSG00000126790	L3HYPDH	Gene	0
ENSG00000240382	IGKV1-17	Gene	0
ENSG00000138778	CENPE	Gene	0
ENSG00000139625	MAP3K12	Gene	0
ENSG00000139626	ITGB7	Gene	0
ENSG00000072042	RDH11	Gene	0
ENSG00000171720	HDAC3	Gene	0
ENSG00000265203	RBP3	Gene	0
ENSG00000169403	PTAFR	Gene	0
ENSG00000023909	GCLM	Gene	0
ENSG00000138772	ANXA3	Gene	0
ENSG00000086696	HSD17B2	Gene	0
ENSG00000133083	DCLK1	Gene	0
ENSG00000055957	ITIH1	Gene	0
ENSG00000055955	ITIH4	Gene	0
ENSG00000277632	CCL3	Gene	0
ENSG00000124140	SLC12A5	Gene	0
ENSG00000213199	ASIC3	Gene	0
ENSG00000267855	NDUFA7	Gene	0
ENSG00000130821	SLC6A8	Gene	0
ENSG00000105409	ATP1A3	Gene	0
ENSG00000179218	CALR	Gene	0
ENSG00000139631	CSAD	Gene	0
ENSG00000228278	ORM2	Gene	0
ENSG00000205571	SMN2	Gene	0
ENSG00000159228	CBR1	Gene	0
ENSG00000086205	FOLH1	Gene	0
ENSG00000171723	GPHN	Gene	0
ENSG00000147246	HTR2C	Gene	0
ENSG00000146399	TAAR1	Gene	0
ENSG00000130816	DNMT1	Gene	0
ENSG00000169418	NPR1	Gene	0
ENSG00000103222	ABCC1	Gene	0
ENSG00000010610	CD4	Gene	0
ENSG00000100197	CYP2D6	Gene	0
ENSG00000101470	TNNC2	Gene	0
ENSG00000180210	F2	Gene	0
ENSG00000067992	PDK3	Gene	0
ENSG00000105835	NAMPT	Gene	0
ENSG00000165060	FXN	Gene	0
ENSG00000077312	SNRPA	Gene	0
ENSG00000170890	PLA2G1B	Gene	0
ENSG00000138756	BMP2K	Gene	0
ENSG00000114302	PRKAR2A	Gene	0
ENSG00000136573	BLK	Gene	0
ENSG00000116962	NID1	Gene	0
ENSG00000111275	ALDH2	Gene	0
ENSG00000151729	SLC25A4	Gene	0
ENSG00000170889	RPS9	Gene	0
ENSG00000149418	ST14	Gene	0
ENSG00000151726	ACSL1	Gene	0
ENSG00000159692	CTBP1	Gene	0
ENSG00000133063	CHIT1	Gene	0
ENSG00000231852	CYP21A2	Gene	0
ENSG00000153904	DDAH1	Gene	0
ENSG00000123268	ATF1	Gene	0
ENSG00000182400	TRAPPC6B	Gene	0
ENSG00000103653	CSK	Gene	0
ENSG00000169429	CXCL8	Gene	0
ENSG00000169427	KCNK9	Gene	0
ENSG00000128951	DUT	Gene	0
ENSG00000182866	LCK	Gene	0
ENSG00000161944	ASGR2	Gene	0
ENSG00000017260	ATP2C1	Gene	0
ENSG00000113448	PDE4D	Gene	0
ENSG00000064012	CASP8	Gene	0
ENSG00000205155	PSENEN	Gene	0
ENSG00000159200	RCAN1	Gene	0
ENSG00000041357	PSMA4	Gene	0
ENSG00000075142	SRI	Gene	0
ENSG00000112115	IL17A	Gene	0
ENSG00000138769	CDKL2	Gene	0
ENSG00000139610	CELA1	Gene	0
ENSG00000170421	KRT8	Gene	0
ENSG00000111262	KCNA1	Gene	0
ENSG00000081803	CADPS2	Gene	0
ENSG00000170899	GSTA4	Gene	0
ENSG00000051180	RAD51	Gene	0
ENSG00000114770	ABCC5	Gene	0
ENSG00000169432	SCN9A	Gene	0
ENSG00000135250	SRPK2	Gene	0
ENSG00000100138	SNU13	Gene	0
ENSG00000169439	SDC2	Gene	0
ENSG00000149403	GRIK4	Gene	0
ENSG00000105851	PIK3CG	Gene	0
ENSG00000124570	SERPINB6	Gene	0
ENSG00000104522	TSTA3	Gene	0
ENSG00000144182	LIPT1	Gene	0
ENSG00000104524	PYCR3	Gene	0
ENSG00000012817	KDM5D	Gene	0
ENSG00000132196	HSD17B7	Gene	0
ENSG00000138735	PDE5A	Gene	0
ENSG00000170430	MGMT	Gene	0
ENSG00000116984	MTR	Gene	0
ENSG00000171766	GATM	Gene	0
ENSG00000008118	CAMK1G	Gene	0
ENSG00000112144	ICK	Gene	0
ENSG00000234906	APOC2	Gene	0
ENSG00000275896	PRSS2	Gene	0
ENSG00000007264	MATK	Gene	0
ENSG00000170425	ADORA2B	Gene	0
ENSG00000171759	PAH	Gene	0
ENSG00000151704	KCNJ1	Gene	0
ENSG00000276747	PADI6	Gene	0
ENSG00000169442	CD52	Gene	0
ENSG00000189058	APOD	Gene	0
ENSG00000161960	EIF4A1	Gene	0
ENSG00000101017	CD40	Gene	0
ENSG00000087586	AURKA	Gene	0
ENSG00000121064	SCPEP1	Gene	0
ENSG00000178394	HTR1A	Gene	0
ENSG00000062282	DGAT2	Gene	0
ENSG00000183735	TBK1	Gene	0
ENSG00000242534	IGKV2D-28	Gene	0
ENSG00000145020	AMT	Gene	0
ENSG00000138744	NAAA	Gene	0
ENSG00000165092	ALDH1A1	Gene	0
ENSG00000133056	PIK3C2B	Gene	0
ENSG00000065325	GLP2R	Gene	0
ENSG00000077782	FGFR1	Gene	0
ENSG00000204287	HLA-DRA	Gene	0
ENSG00000157005	SST	Gene	0
ENSG00000197901	SLC22A6	Gene	0
ENSG00000170445	HARS	Gene	0
ENSG00000189046	ALKBH2	Gene	0
ENSG00000007255	TRAPPC6A	Gene	0
ENSG00000189043	NDUFA4	Gene	0
ENSG00000157483	MYO1E	Gene	0
ENSG00000182890	GLUD2	Gene	0
ENSG00000124588	NQO2	Gene	0
ENSG00000100156	SLC16A8	Gene	0
ENSG00000147684	NDUFB9	Gene	0
ENSG00000101000	PROCR	Gene	0
ENSG00000115718	PROC	Gene	0
ENSG00000180370	PAK2	Gene	0
ENSG00000082701	GSK3B	Gene	0
ENSG00000158445	KCNB1	Gene	0
ENSG00000198900	TOP1	Gene	0
ENSG00000196715	VKORC1L1	Gene	0
ENSG00000204435	CSNK2B	Gene	0
ENSG00000169100	SLC25A6	Gene	0
ENSG00000101557	USP14	Gene	0
ENSG00000144285	SCN1A	Gene	0
ENSG00000100220	RTCB	Gene	0
ENSG00000102882	MAPK3	Gene	0
ENSG00000123342	MMP19	Gene	0
ENSG00000067560	RHOA	Gene	0
ENSG00000066230	SLC9A3	Gene	0
ENSG00000115705	TPO	Gene	0
ENSG00000114859	CLCN2	Gene	0
ENSG00000113525	IL5	Gene	0
ENSG00000114854	TNNC1	Gene	0
ENSG00000135333	EPHA7	Gene	0
ENSG00000047936	ROS1	Gene	0
ENSG00000137513	NARS2	Gene	0
ENSG00000268089	GABRQ	Gene	0
ENSG00000134489	HRH4	Gene	0
ENSG00000157103	SLC6A1	Gene	0
ENSG00000173614	NMNAT1	Gene	0
ENSG00000113520	IL4	Gene	0
ENSG00000111341	MGP	Gene	0
ENSG00000169118	CSNK1G1	Gene	0
ENSG00000172757	CFL1	Gene	0
ENSG00000149968	MMP3	Gene	0
ENSG00000010671	BTK	Gene	0
ENSG00000125538	IL1B	Gene	0
ENSG00000184730	APOBR	Gene	0
ENSG00000088002	SULT2B1	Gene	0
ENSG00000090316	MAEA	Gene	0
ENSG00000161634	DCD	Gene	0
ENSG00000122025	FLT3	Gene	0
ENSG00000108179	PPIF	Gene	0
ENSG00000213366	GSTM2	Gene	0
ENSG00000160307	S100B	Gene	0
ENSG00000161638	ITGA5	Gene	0
ENSG00000241878	PISD	Gene	0
ENSG00000180398	MCFD2	Gene	0
ENSG00000138814	PPP3CA	Gene	0
ENSG00000163815	CLEC3B	Gene	0
ENSG00000145592	RPL37	Gene	0
ENSG00000113558	SKP1	Gene	0
ENSG00000065357	DGKA	Gene	0
ENSG00000142082	SIRT3	Gene	0
ENSG00000196743	GM2A	Gene	0
ENSG00000113552	GNPDA1	Gene	0
ENSG00000136634	IL10	Gene	0
ENSG00000125508	SRMS	Gene	0
ENSG00000111371	SLC38A1	Gene	0
ENSG00000160791	CCR5	Gene	0
ENSG00000126838	PZP	Gene	0
ENSG00000092964	DPYSL2	Gene	0
ENSG00000063177	RPL18	Gene	0
ENSG00000183431	SF3A3	Gene	0
ENSG00000100243	CYB5R3	Gene	0
ENSG00000138829	FBN2	Gene	0
ENSG00000063180	CA11	Gene	0
ENSG00000135318	NT5E	Gene	0
ENSG00000043591	ADRB1	Gene	0
ENSG00000065361	ERBB3	Gene	0
ENSG00000025708	TYMP	Gene	0
ENSG00000196730	DAPK1	Gene	0
ENSG00000138823	MTTP	Gene	0
ENSG00000112699	GMDS	Gene	0
ENSG00000198910	L1CAM	Gene	0
ENSG00000135312	HTR1B	Gene	0
ENSG00000122008	POLK	Gene	0
ENSG00000175806	MSRA	Gene	0
ENSG00000162980	ARL5A	Gene	0
ENSG00000198909	MAP3K3	Gene	0
ENSG00000134460	IL2RA	Gene	0
ENSG00000036828	CASR	Gene	0
ENSG00000161653	NAGS	Gene	0
ENSG00000178084	HTR3C	Gene	0
ENSG00000078668	VDAC3	Gene	0
ENSG00000155380	SLC16A1	Gene	0
ENSG00000079999	KEAP1	Gene	0
ENSG00000183421	RIPK4	Gene	0
ENSG00000100234	TIMP3	Gene	0
ENSG00000184752	NDUFA12	Gene	0
ENSG00000103740	ACSBG1	Gene	0
ENSG00000182578	CSF1R	Gene	0
ENSG00000125510	OPRL1	Gene	0
ENSG00000109047	RCVRN	Gene	0
ENSG00000111319	SCNN1A	Gene	0
ENSG00000239975	IGKV1D-33	Gene	0
ENSG00000162989	KCNJ3	Gene	0
ENSG00000090376	IRAK3	Gene	0
ENSG00000129084	PSMA1	Gene	0
ENSG00000137944	KYAT3	Gene	0
ENSG00000135766	EGLN1	Gene	0
ENSG00000168291	PDHB	Gene	0
ENSG00000198947	DMD	Gene	0
ENSG00000198938	MT-CO3	Gene	0
ENSG00000109471	IL2	Gene	0
ENSG00000005022	SLC25A5	Gene	0
ENSG00000125966	MMP24	Gene	0
ENSG00000168298	HIST1H1E	Gene	0
ENSG00000149930	TAOK2	Gene	0
ENSG00000143393	PI4KB	Gene	0
ENSG00000100665	SERPINA4	Gene	0
ENSG00000183454	GRIN2A	Gene	0
ENSG00000109472	CPE	Gene	0
ENSG00000185633	NDUFA4L2	Gene	0
ENSG00000184304	PRKD1	Gene	0
ENSG00000155368	DBI	Gene	0
ENSG00000136628	EPRS	Gene	0
ENSG00000240972	MIF	Gene	0
ENSG00000162517	PEF1	Gene	0
ENSG00000070770	CSNK2A2	Gene	0
ENSG00000157540	DYRK1A	Gene	0
ENSG00000138801	PAPSS1	Gene	0
ENSG00000170145	SIK2	Gene	0
ENSG00000198931	APRT	Gene	0
ENSG00000196754	S100A2	Gene	0
ENSG00000137955	RABGGTB	Gene	0
ENSG00000110455	ACCS	Gene	0
ENSG00000157542	KCNJ6	Gene	0
ENSG00000134440	NARS	Gene	0
ENSG00000158874	APOA2	Gene	0
ENSG00000133112	TPT1	Gene	0
ENSG00000011566	MAP4K3	Gene	0
ENSG00000149925	ALDOA	Gene	0
ENSG00000060971	ACAA1	Gene	0
ENSG00000143384	MCL1	Gene	0
ENSG00000186951	PPARA	Gene	0
ENSG00000185624	P4HB	Gene	0
ENSG00000101981	F9	Gene	0
ENSG00000143387	CTSK	Gene	0
ENSG00000158869	FCER1G	Gene	0
ENSG00000160349	LCN1	Gene	0
ENSG00000173660	UQCRH	Gene	0
ENSG00000174990	CA5A	Gene	0
ENSG00000164708	PGAM2	Gene	0
ENSG00000008516	MMP25	Gene	0
ENSG00000198963	RORB	Gene	0
ENSG00000197632	SERPINB2	Gene	0
ENSG00000197635	DPP4	Gene	0
ENSG00000135744	AGT	Gene	0
ENSG00000196305	IARS	Gene	0
ENSG00000158864	NDUFS2	Gene	0
ENSG00000156689	GLYATL2	Gene	0
ENSG00000198959	TGM2	Gene	0
ENSG00000100206	DMC1	Gene	0
ENSG00000120251	GRIA2	Gene	0
ENSG00000055118	KCNH2	Gene	0
ENSG00000143374	TARS2	Gene	0
ENSG00000205309	NT5M	Gene	0
ENSG00000163864	NMNAT3	Gene	0
ENSG00000092529	CAPN3	Gene	0
ENSG00000172340	SUCLG2	Gene	0
ENSG00000111325	OGFOD2	Gene	0
ENSG00000113504	SLC12A7	Gene	0
ENSG00000069764	PLA2G10	Gene	0
ENSG00000135750	KCNK1	Gene	0
ENSG00000198951	NAGA	Gene	0
ENSG00000169174	PCSK9	Gene	0
ENSG00000130066	SAT1	Gene	0
ENSG00000131398	KCNC3	Gene	0
ENSG00000010256	UQCRC1	Gene	0
ENSG00000103707	MTFMT	Gene	0
ENSG00000126803	HSPA2	Gene	0
ENSG00000079557	AFM	Gene	0
ENSG00000102854	MSLN	Gene	0
ENSG00000121594	CD80	Gene	0
ENSG00000070748	CHAT	Gene	0
ENSG00000146872	TLK2	Gene	0
ENSG00000241837	ATP5O	Gene	0
ENSG00000161217	PCYT1A	Gene	0
ENSG00000090339	ICAM1	Gene	0
ENSG00000163873	GRIK3	Gene	0
ENSG00000145545	SRD5A1	Gene	0
ENSG00000120265	PCMT1	Gene	0
ENSG00000130037	KCNA5	Gene	0
ENSG00000091262	ABCC6	Gene	0
ENSG00000154485	MMP21	Gene	0
ENSG00000023572	GLRX2	Gene	0
ENSG00000166908	PIP4K2C	Gene	0
ENSG00000005469	CROT	Gene	0
ENSG00000132693	CRP	Gene	0
ENSG00000173200	PARP15	Gene	0
ENSG00000110422	HIPK3	Gene	0
ENSG00000173207	CKS1B	Gene	0
ENSG00000175868	CALCB	Gene	0
ENSG00000130035	GALNT8	Gene	0
ENSG00000101958	GLRA2	Gene	0
ENSG00000162551	ALPL	Gene	0
ENSG00000117054	ACADM	Gene	0
ENSG00000183010	PYCR1	Gene	0
ENSG00000166913	YWHAB	Gene	0
ENSG00000108582	CPD	Gene	0
ENSG00000163406	SLC15A2	Gene	0
ENSG00000257365	FNTB	Gene	0
ENSG00000164733	CTSB	Gene	0
ENSG00000141179	PCTP	Gene	0
ENSG00000237763	AMY1A	Gene	0
ENSG00000171033	PKIA	Gene	0
ENSG00000169194	IL13	Gene	0
ENSG00000153147	SMARCA5	Gene	0
ENSG00000078295	ADCY2	Gene	0
ENSG00000269335	IKBKG	Gene	0
ENSG00000010278	CD9	Gene	0
ENSG00000124608	AARS2	Gene	0
ENSG00000121578	B4GALT4	Gene	0
ENSG00000250722	SELENOP	Gene	0
ENSG00000186510	CLCNKA	Gene	0
ENSG00000108576	SLC6A4	Gene	0
ENSG00000106397	PLOD3	Gene	0
ENSG00000164742	ADCY1	Gene	0
ENSG00000072506	HSD17B10	Gene	0
ENSG00000122420	PTGFR	Gene	0
ENSG00000170190	SLC16A5	Gene	0
ENSG00000239951	IGKV3-20	Gene	0
ENSG00000158825	CDA	Gene	0
ENSG00000164749	HNF4G	Gene	0
ENSG00000173221	GLRX	Gene	0
ENSG00000094755	GABRP	Gene	0
ENSG00000196344	ADH7	Gene	0
ENSG00000132671	SSTR4	Gene	0
ENSG00000134853	PDGFRA	Gene	0
ENSG00000282301	CYP3A7-CYP3A51P	Gene	0
ENSG00000244067	GSTA2	Gene	0
ENSG00000060982	BCAT1	Gene	0
ENSG00000162572	SCNN1D	Gene	0
ENSG00000001084	GCLC	Gene	0
ENSG00000100644	HIF1A	Gene	0
ENSG00000120217	CD274	Gene	0
ENSG00000014641	MDH1	Gene	0
ENSG00000120694	HSPH1	Gene	0
ENSG00000073803	MAP3K13	Gene	0
ENSG00000090382	LYZ	Gene	0
ENSG00000152270	PDE3B	Gene	0
ENSG00000171051	FPR1	Gene	0
ENSG00000150093	ITGB1	Gene	0
ENSG00000110436	SLC1A2	Gene	0
ENSG00000176749	CDK5R1	Gene	0
ENSG00000178921	PFAS	Gene	0
ENSG00000134864	GGACT	Gene	0
ENSG00000198515	CNGA1	Gene	0
ENSG00000155304	HSPA13	Gene	0
ENSG00000175899	A2M	Gene	0
ENSG00000101966	XIAP	Gene	0
ENSG00000183023	SLC8A1	Gene	0
ENSG00000107262	BAG1	Gene	0
ENSG00000125910	S1PR4	Gene	0
ENSG00000143321	HDGF	Gene	0
ENSG00000122884	P4HA1	Gene	0
ENSG00000145982	FARS2	Gene	0
ENSG00000143322	ABL2	Gene	0
ENSG00000153113	CAST	Gene	0
ENSG00000070366	SMG6	Gene	0
ENSG00000152266	PTH	Gene	0
ENSG00000111716	LDHB	Gene	0
ENSG00000129484	PARP2	Gene	0
ENSG00000177606	JUN	Gene	0
ENSG00000244005	NFS1	Gene	0
ENSG00000005421	PON1	Gene	0
ENSG00000177602	HASPIN	Gene	0
ENSG00000178934	LGALS7B	Gene	0
ENSG00000175426	PCSK1	Gene	0
ENSG00000101916	TLR8	Gene	0
ENSG00000144644	GADL1	Gene	0
ENSG00000117013	KCNQ4	Gene	0
ENSG00000140287	HDC	Gene	0
ENSG00000139287	TPH2	Gene	0
ENSG00000143799	PARP1	Gene	0
ENSG00000184381	PLA2G6	Gene	0
ENSG00000059573	ALDH18A1	Gene	0
ENSG00000123700	KCNJ2	Gene	0
ENSG00000185231	MC2R	Gene	0
ENSG00000143318	CASQ1	Gene	0
ENSG00000164778	EN2	Gene	0
ENSG00000161267	BDH1	Gene	0
ENSG00000067191	CACNB1	Gene	0
ENSG00000122852	SFTPA1	Gene	0
ENSG00000213341	CHUK	Gene	0
ENSG00000185238	PRMT3	Gene	0
ENSG00000106366	SERPINE1	Gene	0
ENSG00000164776	PHKG1	Gene	0
ENSG00000130005	GAMT	Gene	0
ENSG00000111700	SLCO1B3	Gene	0
ENSG00000196352	CD55	Gene	0
ENSG00000165629	ATP5C1	Gene	0
ENSG00000111701	APOBEC1	Gene	0
ENSG00000152256	PDK1	Gene	0
ENSG00000197208	SLC22A4	Gene	0
ENSG00000116157	GPX7	Gene	0
ENSG00000119699	TGFB3	Gene	0
ENSG00000163453	IGFBP7	Gene	0
ENSG00000183044	ABAT	Gene	0
ENSG00000117480	FAAH	Gene	0
ENSG00000164305	CASP3	Gene	0
ENSG00000165637	VDAC2	Gene	0
ENSG00000015520	NPC1L1	Gene	0
ENSG00000182199	SHMT2	Gene	0
ENSG00000167815	PRDX2	Gene	0
ENSG00000183049	CAMK1D	Gene	0
ENSG00000166963	MAP1A	Gene	0
ENSG00000122861	PLAU	Gene	0
ENSG00000258643	BCL2L2-PABPN1	Gene	0
ENSG00000153574	RPIA	Gene	0
ENSG00000178950	GAK	Gene	0
ENSG00000068024	HDAC4	Gene	0
ENSG00000178952	TUFM	Gene	0
ENSG00000198563	DDX39B	Gene	0
ENSG00000110887	DAO	Gene	0
ENSG00000132639	SNAP25	Gene	0
ENSG00000110881	ASIC1	Gene	0
ENSG00000175445	LPL	Gene	0
ENSG00000081479	LRP2	Gene	0
ENSG00000177628	GBA	Gene	0
ENSG00000005882	PDK2	Gene	0
ENSG00000223572	CKMT1A	Gene	0
ENSG00000161281	COX7A1	Gene	0
ENSG00000140263	SORD	Gene	0
ENSG00000163464	CXCR1	Gene	0
ENSG00000120659	TNFSF11	Gene	0
ENSG00000036473	OTC	Gene	0
ENSG00000121989	ACVR2A	Gene	0
ENSG00000108561	C1QBP	Gene	0
ENSG00000072518	MARK2	Gene	0
ENSG00000096968	JAK2	Gene	0
ENSG00000142449	FBN3	Gene	0
ENSG00000165644	COMTD1	Gene	0
ENSG00000163466	ARPC2	Gene	0
ENSG00000165646	SLC18A2	Gene	0
ENSG00000163468	CCT3	Gene	0
ENSG00000143774	GUK1	Gene	0
ENSG00000113905	HRG	Gene	0
ENSG00000111726	CMAS	Gene	0
ENSG00000111725	PRKAB1	Gene	0
ENSG00000134824	FADS2	Gene	0
ENSG00000171094	ALK	Gene	0
ENSG00000132646	PCNA	Gene	0
ENSG00000050748	MAPK9	Gene	0
ENSG00000134827	TCN1	Gene	0
ENSG00000129473	BCL2L2	Gene	0
ENSG00000213316	LTC4S	Gene	0
ENSG00000171097	KYAT1	Gene	0
ENSG00000152234	ATP5A1	Gene	0
ENSG00000139278	GLIPR1	Gene	0
ENSG00000145949	MYLK4	Gene	0
ENSG00000273802	HIST1H2BG	Gene	0
ENSG00000185245	GP1BA	Gene	0
ENSG00000257335	MGAM	Gene	0
ENSG00000067182	TNFRSF1A	Gene	0
ENSG00000143761	ARF1	Gene	0
ENSG00000166501	PRKCB	Gene	0
ENSG00000014216	CAPN1	Gene	0
ENSG00000164326	CARTPT	Gene	0
ENSG00000110944	IL23A	Gene	0
ENSG00000104267	CA2	Gene	0
ENSG00000206172	HBA1	Gene	0
ENSG00000109956	B3GAT1	Gene	0
ENSG00000151012	SLC7A11	Gene	0
ENSG00000175344	CHRNA7	Gene	0
ENSG00000107779	BMPR1A	Gene	0
ENSG00000151498	ACAD8	Gene	0
ENSG00000088926	F11	Gene	0
ENSG00000118432	CNR1	Gene	0
ENSG00000138039	LHCGR	Gene	0
ENSG00000167720	SRR	Gene	0
ENSG00000142541	RPL13A	Gene	0
ENSG00000143878	RHOB	Gene	0
ENSG00000146904	EPHA1	Gene	0
ENSG00000164692	COL1A2	Gene	0
ENSG00000169906	S100G	Gene	0
ENSG00000164219	PGGT1B	Gene	0
ENSG00000186009	ATP4B	Gene	0
ENSG00000167723	TRPV3	Gene	0
ENSG00000128245	YWHAH	Gene	0
ENSG00000126067	PSMB2	Gene	0
ENSG00000075624	ACTB	Gene	0
ENSG00000072110	ACTN1	Gene	0
ENSG00000197122	SRC	Gene	0
ENSG00000132746	ALDH3B2	Gene	0
ENSG00000110931	CAMKK2	Gene	0
ENSG00000196277	GRM7	Gene	0
ENSG00000173175	ADCY5	Gene	0
ENSG00000155846	PPARGC1B	Gene	0
ENSG00000119772	DNMT3A	Gene	0
ENSG00000114054	PCCB	Gene	0
ENSG00000184292	TACSTD2	Gene	0
ENSG00000115386	REG1A	Gene	0
ENSG00000137193	PIM1	Gene	0
ENSG00000137198	GMPR	Gene	0
ENSG00000131408	NR1H2	Gene	0
ENSG00000185149	NPY2R	Gene	0
ENSG00000081052	COL4A4	Gene	0
ENSG00000166402	TUB	Gene	0
ENSG00000166405	RIC3	Gene	0
ENSG00000111816	FRK	Gene	0
ENSG00000176697	BDNF	Gene	0
ENSG00000198001	IRAK4	Gene	0
ENSG00000107317	PTGDS	Gene	0
ENSG00000038210	PI4K2B	Gene	0
ENSG00000040531	CTNS	Gene	0
ENSG00000005844	ITGAL	Gene	0
ENSG00000002330	BAD	Gene	0
ENSG00000117118	SDHB	Gene	0
ENSG00000117115	PADI2	Gene	0
ENSG00000166411	IDH3A	Gene	0
ENSG00000117594	HSD11B1	Gene	0
ENSG00000117593	DARS2	Gene	0
ENSG00000117592	PRDX6	Gene	0
ENSG00000143858	SYT2	Gene	0
ENSG00000130529	TRPM4	Gene	0
ENSG00000170906	NDUFA3	Gene	0
ENSG00000167748	KLK1	Gene	0
ENSG00000106462	EZH2	Gene	0
ENSG00000109971	HSPA8	Gene	0
ENSG00000107796	ACTA2	Gene	0
ENSG00000180720	CHRM4	Gene	0
ENSG00000110955	ATP5B	Gene	0
ENSG00000093010	COMT	Gene	0
ENSG00000110958	PTGES3	Gene	0
ENSG00000068078	FGFR3	Gene	0
ENSG00000173198	CYSLTR1	Gene	0
ENSG00000196296	ATP2A1	Gene	0
ENSG00000134905	CARS2	Gene	0
ENSG00000142507	PSMB6	Gene	0
ENSG00000143839	REN	Gene	0
ENSG00000072571	HMMR	Gene	0
ENSG00000177556	ATOX1	Gene	0
ENSG00000154975	CA10	Gene	0
ENSG00000186010	NDUFA13	Gene	0
ENSG00000085871	MGST2	Gene	0
ENSG00000163394	CCKAR	Gene	0
ENSG00000142515	KLK3	Gene	0
ENSG00000163399	ATP1A1	Gene	0
ENSG00000073417	PDE8A	Gene	0
ENSG00000014257	ACPP	Gene	0
ENSG00000167755	KLK6	Gene	0
ENSG00000129521	EGLN3	Gene	0
ENSG00000041880	PARP3	Gene	0
ENSG00000131844	MCCC2	Gene	0
ENSG00000175387	SMAD2	Gene	0
ENSG00000149131	SERPING1	Gene	0
ENSG00000105559	PLEKHA4	Gene	0
ENSG00000140319	SRP14	Gene	0
ENSG00000015592	STMN4	Gene	0
ENSG00000099624	ATP5D	Gene	0
ENSG00000075651	PLD1	Gene	0
ENSG00000139329	LUM	Gene	0
ENSG00000115353	TACR1	Gene	0
ENSG00000115350	POLE4	Gene	0
ENSG00000168610	STAT3	Gene	0
ENSG00000188229	TUBB4B	Gene	0
ENSG00000167768	KRT1	Gene	0
ENSG00000125166	GOT2	Gene	0
ENSG00000168615	ADAM9	Gene	0
ENSG00000141655	TNFRSF11A	Gene	0
ENSG00000164258	NDUFS4	Gene	0
ENSG00000018625	ATP1A2	Gene	0
ENSG00000105552	BCAT2	Gene	0
ENSG00000104695	PPP2CB	Gene	0
ENSG00000102032	RENBP	Gene	0
ENSG00000177575	CD163	Gene	0
ENSG00000150594	ADRA2A	Gene	0
ENSG00000073008	PVR	Gene	0
ENSG00000101182	PSMA7	Gene	0
ENSG00000128683	GAD1	Gene	0
ENSG00000132703	APCS	Gene	0
ENSG00000101180	HRH3	Gene	0
ENSG00000141639	MAPK4	Gene	0
ENSG00000197168	NEK5	Gene	0
ENSG00000117525	F3	Gene	0
ENSG00000116678	LEPR	Gene	0
ENSG00000198019	FCGR1B	Gene	0
ENSG00000114013	CD86	Gene	0
ENSG00000113161	HMGCR	Gene	0
ENSG00000118402	ELOVL4	Gene	0
ENSG00000168621	GDNF	Gene	0
ENSG00000114491	UMPS	Gene	0
ENSG00000137154	RPS6	Gene	0
ENSG00000180739	S1PR5	Gene	0
ENSG00000186038	HTR3E	Gene	0
ENSG00000165119	HNRNPK	Gene	0
ENSG00000149124	GLYAT	Gene	0
ENSG00000129538	RNASE1	Gene	0
ENSG00000175390	EIF3F	Gene	0
ENSG00000140795	MYLK3	Gene	0
ENSG00000108602	ALDH3A1	Gene	0
ENSG00000149591	TAGLN	Gene	0
ENSG00000146085	MUT	Gene	0
ENSG00000213722	DDAH2	Gene	0
ENSG00000110921	MVK	Gene	0
ENSG00000179761	PIPOX	Gene	0
ENSG00000198049	AVPR1B	Gene	0
ENSG00000137124	ALDH1B1	Gene	0
ENSG00000164270	HTR4	Gene	0
ENSG00000065833	ME1	Gene	0
ENSG00000064989	CALCRL	Gene	0
ENSG00000240065	PSMB9	Gene	0
ENSG00000274286	ADRA2B	Gene	0
ENSG00000143811	PYCR2	Gene	0
ENSG00000169962	TAS1R3	Gene	0
ENSG00000167780	SOAT2	Gene	0
ENSG00000125148	MT2A	Gene	0
ENSG00000277791	PSMB3	Gene	0
ENSG00000048052	HDAC9	Gene	0
ENSG00000127329	PTPRB	Gene	0
ENSG00000084110	HAL	Gene	0
ENSG00000128655	PDE11A	Gene	0
ENSG00000169967	MAP3K2	Gene	0
ENSG00000146070	PLA2G7	Gene	0
ENSG00000110911	SLC11A2	Gene	0
ENSG00000129991	TNNI3	Gene	0
ENSG00000178445	GLDC	Gene	0
ENSG00000198033	TUBA3C	Gene	0
ENSG00000179776	CDH5	Gene	0
ENSG00000130985	UBA1	Gene	0
ENSG00000105568	PPP2R1A	Gene	0
ENSG00000075643	MOCOS	Gene	0
ENSG00000072133	RPS6KA6	Gene	0
ENSG00000130988	RGN	Gene	0
ENSG00000004948	CALCR	Gene	0
ENSG00000274290	HIST1H2BE	Gene	0
ENSG00000213719	CLIC1	Gene	0
ENSG00000242252	BGLAP	Gene	0
ENSG00000117543	DPH5	Gene	0
ENSG00000170962	PDGFD	Gene	0
ENSG00000154930	ACSS1	Gene	0
ENSG00000151422	FER	Gene	0
ENSG00000119711	ALDH6A1	Gene	0
ENSG00000154928	EPHB1	Gene	0
ENSG00000119715	ESRRB	Gene	0
ENSG00000167792	NDUFV1	Gene	0
ENSG00000131828	PDHA1	Gene	0
ENSG00000102057	KCND1	Gene	0
ENSG00000174080	CTSF	Gene	0
ENSG00000101150	TPD52L2	Gene	0
ENSG00000180772	AGTR2	Gene	0
ENSG00000142937	RPS8	Gene	0
ENSG00000097007	ABL1	Gene	0
ENSG00000019991	HGF	Gene	0
ENSG00000130956	HABP4	Gene	0
ENSG00000159377	PSMB4	Gene	0
ENSG00000186081	KRT5	Gene	0
ENSG00000204394	VARS	Gene	0
ENSG00000138435	CHRNA1	Gene	0
ENSG00000117971	CHRNB4	Gene	0
ENSG00000167325	RRM1	Gene	0
ENSG00000008056	SYN1	Gene	0
ENSG00000168653	NDUFS5	Gene	0
ENSG00000165140	FBP1	Gene	0
ENSG00000021826	CPS1	Gene	0
ENSG00000134072	CAMK1	Gene	0
ENSG00000126457	PRMT1	Gene	0
ENSG00000142945	KIF2C	Gene	0
ENSG00000130948	HSD17B3	Gene	0
ENSG00000149575	SCN2B	Gene	0
ENSG00000124275	MTRR	Gene	0
ENSG00000102001	CACNA1F	Gene	0
ENSG00000100294	MCAT	Gene	0
ENSG00000178467	P4HTM	Gene	0
ENSG00000100292	HMOX1	Gene	0
ENSG00000076555	ACACB	Gene	0
ENSG00000147383	NSDHL	Gene	0
ENSG00000115306	SPTBN1	Gene	0
ENSG00000138448	ITGAV	Gene	0
ENSG00000204386	NEU1	Gene	0
ENSG00000204381	LAYN	Gene	0
ENSG00000065427	KARS	Gene	0
ENSG00000254647	INS	Gene	0
ENSG00000110092	CCND1	Gene	0
ENSG00000188257	PLA2G2A	Gene	0
ENSG00000166483	WEE1	Gene	0
ENSG00000157184	CPT2	Gene	0
ENSG00000110090	CPT1A	Gene	0
ENSG00000063245	EPN1	Gene	0
ENSG00000166484	MAPK7	Gene	0
ENSG00000118849	RARRES1	Gene	0
ENSG00000100299	ARSA	Gene	0
ENSG00000255974	CYP2A6	Gene	0
ENSG00000166006	KCNC2	Gene	0
ENSG00000030304	MUSK	Gene	0
ENSG00000145192	AHSG	Gene	0
ENSG00000104687	GSR	Gene	0
ENSG00000104205	SGK3	Gene	0
ENSG00000136235	GPNMB	Gene	0
ENSG00000205220	PSMB10	Gene	0
ENSG00000204370	SDHD	Gene	0
ENSG00000068903	SIRT2	Gene	0
ENSG00000150540	HNMT	Gene	0
ENSG00000136238	RAC1	Gene	0
ENSG00000134058	CDK7	Gene	0
ENSG00000021852	C8B	Gene	0
ENSG00000138413	IDH1	Gene	0
ENSG00000167346	MMP26	Gene	0
ENSG00000170502	NUDT9	Gene	0
ENSG00000170989	S1PR1	Gene	0
ENSG00000165168	CYBB	Gene	0
ENSG00000149554	CHEK1	Gene	0
ENSG00000124253	PCK1	Gene	0
ENSG00000103356	EARS2	Gene	0
ENSG00000126432	PRDX5	Gene	0
ENSG00000142920	AZIN2	Gene	0
ENSG00000148229	POLE3	Gene	0
ENSG00000168679	SLC16A4	Gene	0
ENSG00000140740	UQCRC2	Gene	0
ENSG00000215021	PHB2	Gene	0
ENSG00000179335	CLK3	Gene	0
ENSG00000101162	TUBB1	Gene	0
ENSG00000198074	AKR1B10	Gene	0
ENSG00000102010	BMX	Gene	0
ENSG00000240038	AMY2B	Gene	0
ENSG00000183813	CCR4	Gene	0
ENSG00000106853	PTGR1	Gene	0
ENSG00000160712	IL6R	Gene	0
ENSG00000149541	B3GAT3	Gene	0
ENSG00000002726	AOC1	Gene	0
ENSG00000160716	CHRNB2	Gene	0
ENSG00000136244	IL6	Gene	0
ENSG00000186090	HTR3D	Gene	0
ENSG00000159348	CYB5R1	Gene	0
ENSG00000241360	PDXP	Gene	0
ENSG00000117984	CTSD	Gene	0
ENSG00000113140	SPARC	Gene	0
ENSG00000112294	ALDH5A1	Gene	0
ENSG00000171848	RRM2	Gene	0
ENSG00000083290	ULK2	Gene	0
ENSG00000007171	NOS2	Gene	0
ENSG00000148218	ALAD	Gene	0
ENSG00000103342	GSPT1	Gene	0
ENSG00000140718	FTO	Gene	0
ENSG00000177169	ULK1	Gene	0
ENSG00000105953	OGDH	Gene	0
ENSG00000148680	HTR7	Gene	0
ENSG00000115758	ODC1	Gene	0
ENSG00000243955	GSTA1	Gene	0
ENSG00000113578	FGF1	Gene	0
ENSG00000106804	C5	Gene	0
ENSG00000152700	SAR1B	Gene	0
ENSG00000110063	DCPS	Gene	0
ENSG00000113575	PPP2CA	Gene	0
ENSG00000171862	PTEN	Gene	0
ENSG00000159339	PADI4	Gene	0
ENSG00000136699	SMPD4	Gene	0
ENSG00000008018	PSMB1	Gene	0
ENSG00000171855	IFNB1	Gene	0
ENSG00000109072	VTN	Gene	0
ENSG00000149534	MS4A2	Gene	0
ENSG00000090402	SI	Gene	0
ENSG00000087245	MMP2	Gene	0
ENSG00000123384	LRP1	Gene	0
ENSG00000124233	SEMG1	Gene	0
ENSG00000126895	AVPR2	Gene	0
ENSG00000237289	CKMT1B	Gene	0
ENSG00000198099	ADH4	Gene	0
ENSG00000148672	GLUD1	Gene	0
ENSG00000068976	PYGM	Gene	0
ENSG00000150995	ITPR1	Gene	0
ENSG00000165194	PCDH19	Gene	0
ENSG00000067646	ZFY	Gene	0
ENSG00000158477	CD1A	Gene	0
ENSG00000171873	ADRA1D	Gene	0
ENSG00000170542	SERPINB9	Gene	0
ENSG00000150991	UBC	Gene	0
ENSG00000171867	PRNP	Gene	0
ENSG00000128609	NDUFA5	Gene	0
ENSG00000231500	RPS18	Gene	0
ENSG00000070808	CAMK2A	Gene	0
ENSG00000103769	RAB11A	Gene	0
ENSG00000158473	CD1D	Gene	0
ENSG00000087237	CETP	Gene	0
ENSG00000128602	SMO	Gene	0
ENSG00000182511	FES	Gene	0
ENSG00000168229	PTGDR	Gene	0
ENSG00000177189	RPS6KA3	Gene	0
ENSG00000123360	PDE1B	Gene	0
ENSG00000075239	ACAT1	Gene	0
ENSG00000148660	CAMK2G	Gene	0
ENSG00000105976	MET	Gene	0
ENSG00000178035	IMPDH2	Gene	0
ENSG00000151834	GABRA2	Gene	0
ENSG00000211949	IGHV3-23	Gene	0
ENSG00000171403	KRT9	Gene	0
ENSG00000189171	S100A13	Gene	0
ENSG00000169567	HINT1	Gene	0
ENSG00000205268	PDE7A	Gene	0
ENSG00000157131	C8A	Gene	0
ENSG00000103316	CRYM	Gene	0
ENSG00000102468	HTR2A	Gene	0
ENSG00000182541	LIMK2	Gene	0
ENSG00000183873	SCN5A	Gene	0
ENSG00000160752	FDPS	Gene	0
ENSG00000124212	PTGIS	Gene	0
ENSG00000243989	ACY1	Gene	0
ENSG00000090861	AARS	Gene	0
ENSG00000211934	IGHV1-2	Gene	0
ENSG00000044524	EPHA3	Gene	0
ENSG00000073060	SCARB1	Gene	0
ENSG00000136689	IL1RN	Gene	0
ENSG00000174915	PTDSS2	Gene	0
ENSG00000113580	NR3C1	Gene	0
ENSG00000167397	VKORC1	Gene	0
ENSG00000006283	CACNA1G	Gene	0
ENSG00000123374	CDK2	Gene	0
ENSG00000149503	INCENP	Gene	0
ENSG00000031698	SARS	Gene	0
ENSG00000091704	CPA1	Gene	0
ENSG00000161610	HCRT	Gene	0
